Citrus Sinensis ID: 023752

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------28
Protein Sequence
MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAKLHHHHHHHNHHQGIKHTNPPRKTSITNSK
Secondary Structure (PSIPRED)
ccHHHHHHHHcccccccccEEEEEcccccEEEEEEEcccccHHccccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHcccccEEEEEEEEccccEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccEEcccccHHHEEEcccccEEEccccccEccccccccEEEEEEEcccccccHHHHHcccccccccHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHHccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MWQTEVIYLGQLRHENLVKLIGYcsesdnrllvyefmpkgslenhlfrkgvqpiswptRVKIAIDVARGLSFLHGLDANVIYRDLKASNvlldsnfnaklsdfglardgptgdnthvstrivgtrgyaapeyvatghltpksdvySFGVVLLELLSGrraldedrgglaeqtlvewadpflrdSRRVLRIMDtrlggqyskKEAQAVAAVVLQClhmdpknrpsMVDVLTSLEQlhtskdmprtpppaklhhhhhhhnhhqgikhtnpprktsitnsk
Flexible Loop (DISEMBL)
MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDfglardgptgdnthvstrivgtRGYAAPEYvatghltpksdVYSFGVVLLELLSGRRALdedrgglaeqtlvewadpflrdsrRVLRIMDTrlggqyskkEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAKLHHHHHHhnhhqgikhtnpprktsitnsk
Low Complexity Region (SEG)
MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQavaavvLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAKLhhhhhhhnhhQGIKHTNPPRKTSITNSK
Disordered region (IsUnstruct)
***TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM*************************************************************
Disordered Region (DISOPRED)
MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ********************************************
Disordered Region (DISEMBL)
MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD**************************************
Disordered Region (DISPRO)
MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL*******************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAKLHHHHHHHNHHQGIKHTNPPRKTSITNSK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	278	2.2.26 [Sep-21-2011]
O49840	426	Protein kinase 2B, chloro	yes	no	0.852	0.556	0.672	7e-94
O49839	426	Protein kinase 2A, chloro	no	no	0.956	0.624	0.597	2e-93
P43293	389	Probable serine/threonine	no	no	0.956	0.683	0.579	2e-89
P46573	412	Protein kinase APK1B, chl	no	no	0.845	0.570	0.634	3e-85
Q06548	410	Protein kinase APK1A, chl	no	no	0.845	0.573	0.621	1e-84
Q8H186	389	Probable receptor-like pr	no	no	0.892	0.637	0.607	4e-84
O48814	395	Serine/threonine-protein	no	no	0.888	0.625	0.592	1e-82
Q8GXZ3	410	Serine/threonine-protein	no	no	0.856	0.580	0.615	2e-82
Q9FM85	408	Probable receptor-like pr	no	no	0.888	0.605	0.556	1e-79
Q9LFP7	493	Probable receptor-like pr	no	no	0.856	0.482	0.609	4e-79

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  343 bits (881), Expect = 7e-94,   Method: Compositional matrix adjust.
 Identities = 160/238 (67%), Positives = 195/238 (81%), Gaps = 1/238 (0%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W TEV YLGQL H NLVKL+GYC E +NRLLVYEFMPKGSLENHLFR+G QP++W  R+K
Sbjct: 134 WLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMK 193

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +AI  A+GL+FLH   + VIYRD KA+N+LLD+ FN+KLSDFGLA+ GPTGD THVST++
Sbjct: 194 VAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQV 253

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT GYAAPEYVATG LT KSDVYSFGVVLLELLSGRRA+D+ + G+ EQ+LV+WA P+L
Sbjct: 254 MGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGM-EQSLVDWATPYL 312

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
            D R++ RIMDTRLGGQY +K A   A++ LQCL+ D K RP M +VL  L+QL ++K
Sbjct: 313 GDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK 370

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  342 bits (876), Expect = 2e-93,   Method: Compositional matrix adjust.
 Identities = 165/276 (59%), Positives = 205/276 (74%), Gaps = 10/276 (3%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W TEV YLGQL H NLV L+GYC+E +NRLLVYEFMPKGSLENHLFR+G QP++W  R+K
Sbjct: 137 WLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMK 196

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +A+  A+GL+FLH   + VIYRD KA+N+LLD++FNAKLSDFGLA+ GPTGDNTHVST++
Sbjct: 197 VAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKV 256

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT GYAAPEYVATG LT KSDVYSFGVVLLEL+SGRRA+D   GG  E +LV+WA P+L
Sbjct: 257 IGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGG-NEYSLVDWATPYL 315

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL------ 235
            D R++ RIMDT+LGGQY +K A   A + LQCL+ D K RP M +VL +LEQL      
Sbjct: 316 GDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLESVAKP 375

Query: 236 ---HTSKDMPRTPPPAKLHHHHHHHNHHQGIKHTNP 268
              HT  + PR    + +      ++H + + H  P
Sbjct: 376 GTKHTQMESPRFHHSSVMQKSPVRYSHDRPLLHMTP 411

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  329 bits (843), Expect = 2e-89,   Method: Compositional matrix adjust.
 Identities = 156/269 (57%), Positives = 204/269 (75%), Gaps = 3/269 (1%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTR 59
           W  E+ YLGQL H NLVKLIGYC E ++RLLVYEFM +GSLENHLFR+G   QP+SW TR
Sbjct: 119 WLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTR 178

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           V++A+  ARGL+FLH     VIYRD KASN+LLDSN+NAKLSDFGLARDGP GDN+HVST
Sbjct: 179 VRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVST 238

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
           R++GT+GYAAPEY+ATGHL+ KSDVYSFGVVLLELLSGRRA+D+++  + E  LV+WA P
Sbjct: 239 RVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQ-PVGEHNLVDWARP 297

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
           +L + RR+LR+MD RL GQYS   A  +A + L C+ +D K+RP+M +++ ++E+LH  K
Sbjct: 298 YLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQK 357

Query: 240 DMPRTPPPAKLHHHHHHHNHHQGIKHTNP 268
           +  +     ++   +  +   Q + +  P
Sbjct: 358 EASKEQQNPQISIDNIINKSPQAVNYPRP 386

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  315 bits (806), Expect = 3e-85,   Method: Compositional matrix adjust.
 Identities = 151/238 (63%), Positives = 188/238 (78%), Gaps = 3/238 (1%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTR 59
           W  EV YLGQ  H NLVKLIGYC E ++RLLVYEFMP+GSLENHLFR+G   QP+SW  R
Sbjct: 120 WLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLR 179

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +K+A+  A+GL+FLH  + +VIYRD K SN+LLDS +NAKLSDFGLA+DGPTGD +HVST
Sbjct: 180 LKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVST 239

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
           RI+GT GYAAPEY+ATGHLT KSDVYS+GVVLLE+LSGRRA+D++R    EQ LVEWA P
Sbjct: 240 RIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPP-GEQKLVEWARP 298

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
            L + R++ R++D RL  QYS +EA  VA + L+CL  + K RP+M +V++ LE + T
Sbjct: 299 LLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQT 356

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  312 bits (800), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 148/238 (62%), Positives = 188/238 (78%), Gaps = 3/238 (1%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTR 59
           W  EV YLGQ  H +LVKLIGYC E ++RLLVYEFMP+GSLENHLFR+G+  QP+SW  R
Sbjct: 119 WLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLSWKLR 178

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +K+A+  A+GL+FLH  +  VIYRD K SN+LLDS +NAKLSDFGLA+DGP GD +HVST
Sbjct: 179 LKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKSHVST 238

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
           R++GT GYAAPEY+ATGHLT KSDVYSFGVVLLELLSGRRA+D++R    E+ LVEWA P
Sbjct: 239 RVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPS-GERNLVEWAKP 297

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
           +L + R++ R++D RL  QYS +EA  VA + L+CL  + K RP+M +V++ LE + +
Sbjct: 298 YLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQS 355

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  311 bits (796), Expect = 4e-84,   Method: Compositional matrix adjust.
 Identities = 153/252 (60%), Positives = 189/252 (75%), Gaps = 4/252 (1%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---VQPISWPT 58
           W TE+ YLGQL H NLVKLIGYC E + RLLVYEFM KGSLENHLF  G    +P+SW  
Sbjct: 112 WLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKDFKPLSWIL 171

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           R+K+A+D A+GL+FLH     VIYRD+KASN+LLDS+FNAKLSDFGLARDGP G+ ++VS
Sbjct: 172 RIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGPMGEQSYVS 231

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
           TR++GT GYAAPEYV+TGHL  +SDVYSFGVVLLELL GR+ALD +R    EQ LV+WA 
Sbjct: 232 TRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPA-KEQNLVDWAR 290

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
           P+L   R+VL I+DTRL  QY  + A  +A++ +QCL  +PK+RP+M  V+ +L QL  S
Sbjct: 291 PYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRALVQLQDS 350

Query: 239 KDMPRTPPPAKL 250
              P    P K+
Sbjct: 351 VVKPANVDPLKV 362

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  306 bits (784), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 148/250 (59%), Positives = 191/250 (76%), Gaps = 3/250 (1%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTR 59
           W TE+ YLGQL H NLVKLIGYC E ++RLLVYEFM KGSLENHLFR+G   +P+ W  R
Sbjct: 118 WLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLR 177

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           V +A+D A+GL+FLH     VIYRD+KASN+LLD+++NAKLSDFGLARDGP GD ++VST
Sbjct: 178 VNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVST 237

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
           R++GT GYAAPEY+++GHL  +SDVYSFGV+LLE+LSG+RALD +R    E+ LV+WA P
Sbjct: 238 RVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPA-KEENLVDWARP 296

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
           +L   R+VL I+D RL  QY  +EA  +A+V +QCL  +PK+RP+M  V+ +L+QL  + 
Sbjct: 297 YLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQDNL 356

Query: 240 DMPRTPPPAK 249
             P    P K
Sbjct: 357 GKPSQTNPVK 366

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  305 bits (781), Expect = 2e-82,   Method: Compositional matrix adjust.
 Identities = 147/239 (61%), Positives = 181/239 (75%), Gaps = 1/239 (0%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W TEV +LGQLRH NLVKLIGYC E D+RLLVYEFM +GSLENHLFRK   P+SW  R+ 
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMM 176

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA+  A+GL+FLH  +  VIYRD K SN+LLDS++ AKLSDFGLA+ GP GD THVSTR+
Sbjct: 177 IALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 236

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT GYAAPEYV TGHLT +SDVYSFGVVLLE+L+GR+++D+ R    EQ LV+WA P L
Sbjct: 237 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPS-KEQNLVDWARPKL 295

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
            D R++L+I+D RL  QYS + AQ   ++   CL  +PK RP M DV+ +LE L  + D
Sbjct: 296 NDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGD 354

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  296 bits (758), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 138/248 (55%), Positives = 183/248 (73%), Gaps = 1/248 (0%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W  EVI+LGQL H NLVKLIGYC E ++R+L+YE+M +GS+EN+LF + + P+SW  R+K
Sbjct: 127 WLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLPLSWAIRMK 186

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+GL+FLH     VIYRD K SN+LLD ++NAKLSDFGLA+DGP GD +HVSTRI
Sbjct: 187 IAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRI 246

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT GYAAPEY+ TGHLTP SDVYSFGVVLLELL+GR++LD+ R    EQ L++WA P L
Sbjct: 247 MGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSR-PTREQNLIDWALPLL 305

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
           ++ ++VL I+D ++  +Y  K  Q  A +   CL+ +PK RP M D++ SLE L  +++ 
Sbjct: 306 KEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPLQATEEE 365

Query: 242 PRTPPPAK 249
               PP +
Sbjct: 366 ALLVPPVQ 373

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  294 bits (753), Expect = 4e-79,   Method: Compositional matrix adjust.
 Identities = 147/241 (60%), Positives = 177/241 (73%), Gaps = 3/241 (1%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W  E+ +LG L H NLVKL+GYC E D RLLVYEFMP+GSLENHLFR+ + P+ W  R+K
Sbjct: 193 WLAEINFLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSL-PLPWSIRMK 251

Query: 62  IAIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           IA+  A+GLSFLH      VIYRD K SN+LLD+++NAKLSDFGLA+D P    THVSTR
Sbjct: 252 IALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTR 311

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           ++GT GYAAPEYV TGHLT KSDVYSFGVVLLE+L+GRR++D++R    E  LVEWA P 
Sbjct: 312 VMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPN-GEHNLVEWARPH 370

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
           L D RR  R++D RL G +S K AQ V  +  QCL  DPK RP M DV+ +L+ L   KD
Sbjct: 371 LLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKD 430

Query: 241 M 241
           M
Sbjct: 431 M 431

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	278
224104557	340	predicted protein [Populus trichocarpa]	0.906	0.741	0.833	1e-116
296083955	422	unnamed protein product [Vitis vinifera]	0.946	0.623	0.780	1e-114
225435985	403	PREDICTED: protein kinase 2B, chloroplas	0.946	0.652	0.780	1e-114
449463895	403	PREDICTED: protein kinase 2B, chloroplas	0.899	0.620	0.740	1e-111
357493723	407	Protein kinase 2B [Medicago truncatula]	0.906	0.619	0.761	1e-110
356549815	382	PREDICTED: protein kinase 2A, chloroplas	0.877	0.638	0.774	1e-104
356574647	382	PREDICTED: protein kinase 2A, chloroplas	0.917	0.667	0.731	1e-104
357113846	421	PREDICTED: protein kinase 2B, chloroplas	0.852	0.562	0.693	9e-94
351726080	402	protein kinase [Glycine max] gi|22345235	0.866	0.599	0.677	1e-93
242036781	439	hypothetical protein SORBIDRAFT_01g04578	0.852	0.539	0.697	1e-93

>gi|224104557|ref|XP_002313478.1| predicted protein [Populus trichocarpa] gi|222849886|gb|EEE87433.1| predicted protein [Populus trichocarpa]

 Score =  423 bits (1087), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 211/253 (83%), Positives = 230/253 (90%), Gaps = 1/253 (0%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W TEV YLGQL HENLVKLIGYCSESDNRLLVYEFMPKGSLE HLFRKGVQPI+W  R+ 
Sbjct: 74  WLTEVTYLGQLHHENLVKLIGYCSESDNRLLVYEFMPKGSLEQHLFRKGVQPITWTMRMN 133

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS++NAKLSDFGLARDGPTGDNTHVST++
Sbjct: 134 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSDYNAKLSDFGLARDGPTGDNTHVSTKV 193

Query: 122 VGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           +GTRGYAAPEYVAT GHLTPKSDVYS+GVVLLELLSGRRA+DE+RGG  ++TLV+WA PF
Sbjct: 194 LGTRGYAAPEYVATAGHLTPKSDVYSYGVVLLELLSGRRAMDEERGGFDDETLVDWAKPF 253

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
           L DSRRVLRIMDTRLGGQY KK AQA AA+ LQCLH DPKNRP M+DVLT+LE+L TSKD
Sbjct: 254 LIDSRRVLRIMDTRLGGQYPKKAAQAAAALALQCLHTDPKNRPPMIDVLTTLEKLITSKD 313

Query: 241 MPRTPPPAKLHHH 253
           +PRT  P KL +H
Sbjct: 314 IPRTARPVKLDNH 326

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296083955|emb|CBI24343.3| unnamed protein product [Vitis vinifera]

 Score =  418 bits (1075), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 206/264 (78%), Positives = 232/264 (87%), Gaps = 1/264 (0%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W  EV YLGQL HENLVKLIGYCSES+NRLLVYEFM KGSLENHLF+KGVQPI+W TR+ 
Sbjct: 131 WLAEVNYLGQLHHENLVKLIGYCSESENRLLVYEFMSKGSLENHLFKKGVQPITWATRMS 190

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IAIDVA+G+SFLH LDANVIYRDLKASN+LLDS+F AKLSDFGLARDGPTGDNTHVSTR+
Sbjct: 191 IAIDVAQGISFLHSLDANVIYRDLKASNILLDSDFKAKLSDFGLARDGPTGDNTHVSTRV 250

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA+D+++ G  E+TLV+WA PFL
Sbjct: 251 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAMDDEKAGGVEETLVDWAKPFL 310

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
            D+RRVLRIMDTRLGGQYSKK AQA A++ LQCLH DPKNRP M DVL +LE+L TSKD+
Sbjct: 311 SDNRRVLRIMDTRLGGQYSKKGAQAAASLALQCLHTDPKNRPLMTDVLAALERLPTSKDI 370

Query: 242 PRTPPPAKLHHHHHHHNHHQGIKH 265
           PRTP P ++ +H   H+ + G  H
Sbjct: 371 PRTPSP-RVEYHIMKHSSNPGHTH 393

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225435985|ref|XP_002272310.1| PREDICTED: protein kinase 2B, chloroplastic-like [Vitis vinifera]

 Score =  418 bits (1075), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 206/264 (78%), Positives = 232/264 (87%), Gaps = 1/264 (0%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W  EV YLGQL HENLVKLIGYCSES+NRLLVYEFM KGSLENHLF+KGVQPI+W TR+ 
Sbjct: 131 WLAEVNYLGQLHHENLVKLIGYCSESENRLLVYEFMSKGSLENHLFKKGVQPITWATRMS 190

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IAIDVA+G+SFLH LDANVIYRDLKASN+LLDS+F AKLSDFGLARDGPTGDNTHVSTR+
Sbjct: 191 IAIDVAQGISFLHSLDANVIYRDLKASNILLDSDFKAKLSDFGLARDGPTGDNTHVSTRV 250

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA+D+++ G  E+TLV+WA PFL
Sbjct: 251 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAMDDEKAGGVEETLVDWAKPFL 310

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
            D+RRVLRIMDTRLGGQYSKK AQA A++ LQCLH DPKNRP M DVL +LE+L TSKD+
Sbjct: 311 SDNRRVLRIMDTRLGGQYSKKGAQAAASLALQCLHTDPKNRPLMTDVLAALERLPTSKDI 370

Query: 242 PRTPPPAKLHHHHHHHNHHQGIKH 265
           PRTP P ++ +H   H+ + G  H
Sbjct: 371 PRTPSP-RVEYHIMKHSSNPGHTH 393

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449463895|ref|XP_004149666.1| PREDICTED: protein kinase 2B, chloroplastic-like [Cucumis sativus] gi|449515432|ref|XP_004164753.1| PREDICTED: protein kinase 2B, chloroplastic-like [Cucumis sativus]

 Score =  405 bits (1042), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 191/258 (74%), Positives = 218/258 (84%), Gaps = 8/258 (3%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W  EV YLGQLRHENLV+LIGYCSESDNRLLVYE+MPKGSLENHLFRKGV PISW  R+ 
Sbjct: 145 WLAEVNYLGQLRHENLVRLIGYCSESDNRLLVYEYMPKGSLENHLFRKGVTPISWRVRMD 204

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA+DVARGL+FLH  + NVIYRDLKASN+LLDS FNAKLSDFGLAR+GPTGD THVSTR+
Sbjct: 205 IAVDVARGLAFLHSSEPNVIYRDLKASNILLDSEFNAKLSDFGLAREGPTGDKTHVSTRV 264

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG+RALD ++ G  E+TLV+W  P L
Sbjct: 265 MGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGKRALDHEKVGRVEETLVDWGKPLL 324

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
            D +R+LRIMDTR+GGQYS+KEAQA A++ L CLH DPKNRPSM +VL  LE+LHT+KD+
Sbjct: 325 SDGKRMLRIMDTRMGGQYSRKEAQAAASLALNCLHTDPKNRPSMAEVLDELERLHTAKDI 384

Query: 242 PRTP--------PPAKLH 251
             TP        PP++  
Sbjct: 385 LGTPNAHAIRRTPPSRFQ 402

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357493723|ref|XP_003617150.1| Protein kinase 2B [Medicago truncatula] gi|355518485|gb|AET00109.1| Protein kinase 2B [Medicago truncatula]

 Score =  404 bits (1038), Expect = e-110,   Method: Compositional matrix adjust.
 Identities = 192/252 (76%), Positives = 217/252 (86%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W  EV YLGQL HENLVKLIGYCSE  NRLLVYEFM KGSLENHLFRKGVQPISW TR+ 
Sbjct: 121 WLAEVNYLGQLHHENLVKLIGYCSEGKNRLLVYEFMQKGSLENHLFRKGVQPISWMTRIS 180

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IAI VARGL+FLH LDANVIYRDLKASN+LLDS+FNA LSDFGLARDGPTGDNTHVSTRI
Sbjct: 181 IAIGVARGLAFLHSLDANVIYRDLKASNILLDSDFNANLSDFGLARDGPTGDNTHVSTRI 240

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT GYAAPEYVATGHLT +SDVYSFGVVLLELL+GRR +++DR    E+TLV+WA PFL
Sbjct: 241 IGTHGYAAPEYVATGHLTLRSDVYSFGVVLLELLTGRRVVEDDRQVYTEETLVDWAMPFL 300

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
            DSRR+LRIMDT+LGGQYSKK AQA AA+VL+CL+ DPK+RP+MV+VL +LE LH+S   
Sbjct: 301 SDSRRILRIMDTKLGGQYSKKGAQAAAALVLKCLNTDPKHRPTMVNVLAALEALHSSNSF 360

Query: 242 PRTPPPAKLHHH 253
           P+ P     +H+
Sbjct: 361 PKKPKSGTDNHN 372

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356549815|ref|XP_003543286.1| PREDICTED: protein kinase 2A, chloroplastic-like [Glycine max]

 Score =  385 bits (989), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 189/244 (77%), Positives = 214/244 (87%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W  EV YLG L+HENLVKLIGYC E  NRLLVYEFM KGSLENHLFRKGVQP++W TRV 
Sbjct: 123 WLQEVNYLGMLQHENLVKLIGYCLEGKNRLLVYEFMQKGSLENHLFRKGVQPMAWVTRVN 182

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IAI VARGL+FLH LD NVI+RDLKASN+LLDS+FNAKLSDFGLARDGPTGDNTHVSTR+
Sbjct: 183 IAIGVARGLTFLHSLDQNVIFRDLKASNILLDSDFNAKLSDFGLARDGPTGDNTHVSTRV 242

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT+GYAAPEYVATGHLTP+SDVYSFGVVLLELL+GRRA+++D  G +E+TLV+WA PFL
Sbjct: 243 IGTQGYAAPEYVATGHLTPRSDVYSFGVVLLELLTGRRAVEDDGPGFSEETLVDWAKPFL 302

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
            D+RRVLRIMDTRLGGQYSKK AQA AA+ LQCL+ DPK RP MV+VL +LE L++S   
Sbjct: 303 NDNRRVLRIMDTRLGGQYSKKGAQAAAALALQCLNTDPKFRPPMVEVLAALEALNSSNSF 362

Query: 242 PRTP 245
            RTP
Sbjct: 363 TRTP 366

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356574647|ref|XP_003555457.1| PREDICTED: protein kinase 2A, chloroplastic-like [Glycine max]

 Score =  384 bits (987), Expect = e-104,   Method: Compositional matrix adjust.
 Identities = 191/261 (73%), Positives = 219/261 (83%), Gaps = 6/261 (2%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W  EV YLGQL+HENLVKLIGYC E  NRLLVYEFM KGSLENHLFRKGVQP++W TRV 
Sbjct: 123 WLQEVNYLGQLQHENLVKLIGYCLEGKNRLLVYEFMQKGSLENHLFRKGVQPMAWVTRVN 182

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IAI VARGL+ LH LD NVI+RDLKASN+LLDS+FNAKLSDFGLARDGPTGDNTHVSTR+
Sbjct: 183 IAIGVARGLTLLHSLDQNVIFRDLKASNILLDSDFNAKLSDFGLARDGPTGDNTHVSTRV 242

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT+GYAAPEYVATGHLTP+SDVYS+GVVLLELL+GRRA+++DR G +E+TLV+WA PFL
Sbjct: 243 LGTQGYAAPEYVATGHLTPRSDVYSYGVVLLELLTGRRAVEDDRPGFSEETLVDWAKPFL 302

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
            D+RRVLRIMDT+LGGQYSKK AQA AA+ LQCL++DPK RP MV+VL +LE L++S   
Sbjct: 303 SDNRRVLRIMDTKLGGQYSKKGAQAAAALALQCLNIDPKFRPPMVEVLAALEALNSSNSF 362

Query: 242 PRTPPPAKLHHHHHHHNHHQG 262
            RTP       H  H     G
Sbjct: 363 TRTP------KHESHATKQSG 377

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357113846|ref|XP_003558712.1| PREDICTED: protein kinase 2B, chloroplastic-like [Brachypodium distachyon]

 Score =  349 bits (895), Expect = 9e-94,   Method: Compositional matrix adjust.
 Identities = 165/238 (69%), Positives = 193/238 (81%), Gaps = 1/238 (0%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W TEV YLGQL H NLVKLIGYC++ DNRLLVYEFMPKGSLENHLFR+G  P+SW  R+K
Sbjct: 138 WLTEVNYLGQLHHANLVKLIGYCTDGDNRLLVYEFMPKGSLENHLFRRGADPLSWAIRLK 197

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +AI  ARGLSFLH  +  VIYRD KASN+LLDS FN+KLSDFGLA+ GPTGD THVST++
Sbjct: 198 VAIGAARGLSFLHDAENQVIYRDFKASNILLDSEFNSKLSDFGLAKAGPTGDRTHVSTQV 257

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT GYAAPEY+ATG L+ K+DVYSFGVVLLELL+GRRALD+ + G+ EQ LV+WA P L
Sbjct: 258 MGTHGYAAPEYIATGRLSAKADVYSFGVVLLELLTGRRALDKSKPGI-EQNLVDWAKPHL 316

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
           RD RR+ R+MDT+LGGQY KK A A+A + LQC+  D K RP M +VL  LEQL  SK
Sbjct: 317 RDKRRLYRVMDTKLGGQYPKKGAHAIANLALQCICNDAKMRPQMSEVLEELEQLQESK 374

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351726080|ref|NP_001238650.1| protein kinase [Glycine max] gi|223452351|gb|ACM89503.1| protein kinase [Glycine max]

 Score =  349 bits (895), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 164/242 (67%), Positives = 195/242 (80%), Gaps = 1/242 (0%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W TEV YLGQL H+NLVKLIGYC++ +NRLLVYEFM KGSLENHLFR+G QP+SW  R+K
Sbjct: 130 WLTEVDYLGQLHHQNLVKLIGYCADGENRLLVYEFMSKGSLENHLFRRGPQPLSWSVRMK 189

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +AI  ARGLSFLH   + VIYRD KASN+LLD+ FNAKLSDFGLA+ GPTGD THVST++
Sbjct: 190 VAIGAARGLSFLHNAKSQVIYRDFKASNILLDAEFNAKLSDFGLAKAGPTGDRTHVSTQV 249

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT+GYAAPEYVATG LT KSDVYSFGVVLLELLSGRRA+D  + G+ EQ LVEWA P+L
Sbjct: 250 MGTQGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDRSKAGV-EQNLVEWAKPYL 308

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
            D RR+ RIMDT+LGGQY +K A   A + L+CL+ + K RP + +VL +LEQ+  SK  
Sbjct: 309 GDKRRLFRIMDTKLGGQYPQKGAYMAATLALKCLNREAKGRPPITEVLQTLEQIAASKTA 368

Query: 242 PR 243
            R
Sbjct: 369 GR 370

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242036781|ref|XP_002465785.1| hypothetical protein SORBIDRAFT_01g045780 [Sorghum bicolor] gi|241919639|gb|EER92783.1| hypothetical protein SORBIDRAFT_01g045780 [Sorghum bicolor]

 Score =  348 bits (893), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 166/238 (69%), Positives = 192/238 (80%), Gaps = 1/238 (0%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           W TEV YLGQL H+NLVKLIGYCS+ DNRLLVYEFMPKGSLENHLFR+G  P+SW  R+K
Sbjct: 138 WLTEVDYLGQLHHKNLVKLIGYCSDGDNRLLVYEFMPKGSLENHLFRRGADPLSWAIRLK 197

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +AI  ARGLSFLH  +  VIYRD KASN+LLDS FNAKLSDFGLA+ GPTGD THVST++
Sbjct: 198 VAIGAARGLSFLHDAENQVIYRDFKASNILLDSEFNAKLSDFGLAKAGPTGDKTHVSTQV 257

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +GT GYAAPEY+ATG L+ K+DVYSFGVVLLELL+GRRALD+ + G  EQ LV+WA P L
Sbjct: 258 MGTHGYAAPEYIATGRLSAKADVYSFGVVLLELLTGRRALDKSKPGF-EQNLVDWARPHL 316

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
            D RR+ RIMDT+LGGQY KK A A+A++ LQC+  D K RP M  VL  LEQL  +K
Sbjct: 317 GDKRRLYRIMDTKLGGQYPKKGANAIASIALQCICGDAKLRPPMSQVLEELEQLQDAK 374

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	278
TAIR|locus:2058847	426	APK2B "protein kinase 2B" [Ara	0.852	0.556	0.668	1e-84
TAIR|locus:2012492	426	APK2A "protein kinase 2A" [Ara	0.845	0.551	0.665	4.4e-84
TAIR|locus:2205050	387	AT1G69790 [Arabidopsis thalian	0.863	0.620	0.663	5e-83
TAIR|locus:2180127	389	NAK [Arabidopsis thaliana (tax	0.956	0.683	0.576	1.2e-81
TAIR|locus:2205714	412	AT1G26970 [Arabidopsis thalian	0.935	0.631	0.615	5.2e-81
TAIR|locus:2053240	423	PK1B "protein kinase 1B" [Arab	0.845	0.555	0.626	2.7e-77
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.863	0.519	0.614	3.9e-76
TAIR|locus:2039772	395	BIK1 "botrytis-induced kinase1	0.888	0.625	0.584	1.7e-75
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.856	0.580	0.615	3.5e-75
TAIR|locus:2200863	424	AT1G61590 [Arabidopsis thalian	0.859	0.563	0.591	4.5e-75

TAIR|locus:2058847 APK2B "protein kinase 2B" [Arabidopsis thaliana (taxid:3702)]

 Score = 848 (303.6 bits), Expect = 1.0e-84, P = 1.0e-84
 Identities = 159/238 (66%), Positives = 192/238 (80%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
             W TEV YLGQL H NLVKL+GYC E +NRLLVYEFMPKGSLENHLFR+G QP++W  R+K
Sbjct:   134 WLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMK 193

Query:    62 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
             +AI  A+GL+FLH   + VIYRD KA+N+LLD+ FN+KLSDFGLA+ GPTGD THVST++
Sbjct:   194 VAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQV 253

Query:   122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
             +GT GYAAPEYVATG LT KSDVYSFGVVLLELLSGRRA+D+ + G+ EQ+LV+WA P+L
Sbjct:   254 MGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGM-EQSLVDWATPYL 312

Query:   182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
              D R++ RIMDTRLGGQY +K A       LQCL+ D K RP M +VL  L+QL ++K
Sbjct:   313 GDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLESTK 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2012492 APK2A "protein kinase 2A" [Arabidopsis thaliana (taxid:3702)]

 Score = 842 (301.5 bits), Expect = 4.4e-84, P = 4.4e-84
 Identities = 157/236 (66%), Positives = 190/236 (80%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
             W TEV YLGQL H NLV L+GYC+E +NRLLVYEFMPKGSLENHLFR+G QP++W  R+K
Sbjct:   137 WLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLENHLFRRGAQPLTWAIRMK 196

Query:    62 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
             +A+  A+GL+FLH   + VIYRD KA+N+LLD++FNAKLSDFGLA+ GPTGDNTHVST++
Sbjct:   197 VAVGAAKGLTFLHEAKSQVIYRDFKAANILLDADFNAKLSDFGLAKAGPTGDNTHVSTKV 256

Query:   122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
             +GT GYAAPEYVATG LT KSDVYSFGVVLLEL+SGRRA+D   GG  E +LV+WA P+L
Sbjct:   257 IGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRAMDNSNGG-NEYSLVDWATPYL 315

Query:   182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHT 237
              D R++ RIMDT+LGGQY +K A       LQCL+ D K RP M +VL +LEQL +
Sbjct:   316 GDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKLRPKMSEVLVTLEQLES 371

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2205050 AT1G69790 [Arabidopsis thaliana (taxid:3702)]

 Score = 832 (297.9 bits), Expect = 5.0e-83, P = 5.0e-83
 Identities = 162/244 (66%), Positives = 193/244 (79%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
             W TEV YLG+L H NLVKLIGYC E + RLLVYE+MPKGSLENHLFR+G +PI W TR+K
Sbjct:   135 WLTEVHYLGRLHHMNLVKLIGYCLEGEKRLLVYEYMPKGSLENHLFRRGAEPIPWKTRMK 194

Query:    62 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
             +A   ARGLSFLH  +A VIYRD KASN+LLD +FNAKLSDFGLA+ GPTGD THV+T++
Sbjct:   195 VAFSAARGLSFLH--EAKVIYRDFKASNILLDVDFNAKLSDFGLAKAGPTGDRTHVTTQV 252

Query:   122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
             +GT+GYAAPEY+ATG LT KSDVYSFGVVLLELLSGR  LD+ + G+ E+ LV+WA P+L
Sbjct:   253 IGTQGYAAPEYIATGRLTSKSDVYSFGVVLLELLSGRPTLDKSKVGV-ERNLVDWAIPYL 311

Query:   182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS-KD 240
              D R+V RIMDT+LGGQY  K A       L+CL+ +PK RP M DVL++L+QL TS K 
Sbjct:   312 VDRRKVFRIMDTKLGGQYPHKGACAAANIALRCLNTEPKLRPDMADVLSTLQQLETSSKK 371

Query:   241 MPRT 244
             M  T
Sbjct:   372 MGST 375

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2180127 NAK [Arabidopsis thaliana (taxid:3702)]

 Score = 819 (293.4 bits), Expect = 1.2e-81, P = 1.2e-81
 Identities = 155/269 (57%), Positives = 199/269 (73%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTR 59
             W  E+ YLGQL H NLVKLIGYC E ++RLLVYEFM +GSLENHLFR+G   QP+SW TR
Sbjct:   119 WLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTR 178

Query:    60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
             V++A+  ARGL+FLH     VIYRD KASN+LLDSN+NAKLSDFGLARDGP GDN+HVST
Sbjct:   179 VRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVST 238

Query:   120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             R++GT+GYAAPEY+ATGHL+ KSDVYSFGVVLLELLSGRRA+D+++  + E  LV+WA P
Sbjct:   239 RVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQP-VGEHNLVDWARP 297

Query:   180 FLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
             +L + RR+LR+MD RL GQYS   A       L C+ +D K+RP+M +++ ++E+LH  K
Sbjct:   298 YLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQK 357

Query:   240 DMPRTPPPAKLXXXXXXXXXXQGIKHTNP 268
             +  +     ++          Q + +  P
Sbjct:   358 EASKEQQNPQISIDNIINKSPQAVNYPRP 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2205714 AT1G26970 [Arabidopsis thaliana (taxid:3702)]

 Score = 813 (291.2 bits), Expect = 5.2e-81, P = 5.2e-81
 Identities = 163/265 (61%), Positives = 197/265 (74%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
             W  EV  LG+L H NLVKLIGYCS+ D+ RLLVYE+MPKGSLENHLFR+G +PI W TR+
Sbjct:   134 WLAEVDCLGRLHHMNLVKLIGYCSKGDHIRLLVYEYMPKGSLENHLFRRGAEPIPWRTRI 193

Query:    61 KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
             K+AI  ARGL+FLH  +A VIYRD KASN+LLDS FNAKLSDFGLA+ GPTGD THVST+
Sbjct:   194 KVAIGAARGLAFLH--EAQVIYRDFKASNILLDSEFNAKLSDFGLAKVGPTGDRTHVSTQ 251

Query:   121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
             ++GT+GYAAPEYVATG +T KSDVYSFGVVLLELLSGR  +D+ + G+ E+ LV+WA P+
Sbjct:   252 VMGTQGYAAPEYVATGRITAKSDVYSFGVVLLELLSGRLTVDKTKVGV-ERNLVDWAIPY 310

Query:   181 LRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLH-TSK 239
             L D R+V RIMDT+LGGQY  K A       LQCL+ +PK RP M DVL++LE+L  T K
Sbjct:   311 LGDKRKVFRIMDTKLGGQYPHKGACLTANTALQCLNQEPKLRPKMSDVLSTLEELEMTLK 370

Query:   240 DMPRTPPPAKLXXXXXXXXXXQGIK 264
                 +    KL          Q ++
Sbjct:   371 SGSISNSVMKLTSSSSSFTAKQRVR 395

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2053240 PK1B "protein kinase 1B" [Arabidopsis thaliana (taxid:3702)]

 Score = 778 (278.9 bits), Expect = 2.7e-77, P = 2.7e-77
 Identities = 149/238 (62%), Positives = 185/238 (77%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTR 59
             W  EV YLGQ  H NLVKLIGYC E ++RLLVYEFMP+GSLENHLFR+G   QP+SW  R
Sbjct:   131 WLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLSWTLR 190

Query:    60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
             +K+A+  A+GL+FLH  + +VIYRD K SN+LLDS +NAKLSDFGLA+DGPTGD +HVST
Sbjct:   191 LKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKSHVST 250

Query:   120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             RI+GT GYAAPEY+ATGHLT KSDVYS+GVVLLE+LSGRRA+D++R    EQ LVEWA P
Sbjct:   251 RIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPP-GEQKLVEWARP 309

Query:   180 FLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHT 237
              L + R++ R++D RL  QYS +EA       L+CL  + K RP+M +V++ LE + T
Sbjct:   310 LLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQT 367

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 767 (275.1 bits), Expect = 3.9e-76, P = 3.9e-76
 Identities = 148/241 (61%), Positives = 181/241 (75%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
             W TEV++LGQL+H+NLVKLIGYC E ++R LVYEFMP+GSLEN LFR+    + W TR+K
Sbjct:   135 WLTEVMFLGQLKHKNLVKLIGYCCEEEHRTLVYEFMPRGSLENQLFRRYSASLPWSTRMK 194

Query:    62 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
             IA   A GL FLH  +  VIYRD KASN+LLDS++ AKLSDFGLA+DGP GD+THVSTR+
Sbjct:   195 IAHGAATGLQFLHEAENPVIYRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRV 254

Query:   122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
             +GT+GYAAPEY+ TGHLT +SDVYSFGVVLLELL+GRR++D+ R    EQ LV+WA P L
Sbjct:   255 MGTQGYAAPEYIMTGHLTARSDVYSFGVVLLELLTGRRSVDKKRSS-REQNLVDWARPML 313

Query:   182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
              D R++ RIMD RL GQYS+  A+       QCL   PKNRP M  V++ L  L    D+
Sbjct:   314 NDPRKLSRIMDPRLEGQYSETGARKAATLAYQCLSHRPKNRPCMSAVVSILNDLKDYNDI 373

Query:   242 P 242
             P
Sbjct:   374 P 374

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2039772 BIK1 "botrytis-induced kinase1" [Arabidopsis thaliana (taxid:3702)]

 Score = 761 (272.9 bits), Expect = 1.7e-75, P = 1.7e-75
 Identities = 146/250 (58%), Positives = 187/250 (74%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTR 59
             W TE+ YLGQL H NLVKLIGYC E ++RLLVYEFM KGSLENHLFR+G   +P+ W  R
Sbjct:   118 WLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYFKPLPWFLR 177

Query:    60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
             V +A+D A+GL+FLH     VIYRD+KASN+LLD+++NAKLSDFGLARDGP GD ++VST
Sbjct:   178 VNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPMGDLSYVST 237

Query:   120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             R++GT GYAAPEY+++GHL  +SDVYSFGV+LLE+LSG+RALD +R    E+ LV+WA P
Sbjct:   238 RVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPA-KEENLVDWARP 296

Query:   180 FLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
             +L   R+VL I+D RL  QY  +EA       +QCL  +PK+RP+M  V+ +L+QL  + 
Sbjct:   297 YLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRALQQLQDNL 356

Query:   240 DMPRTPPPAK 249
               P    P K
Sbjct:   357 GKPSQTNPVK 366

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009620 "response to fungus" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0050832 "defense response to fungus" evidence=RCA;IMP

GO:0052033 "pathogen-associated molecular pattern dependent induction by symbiont of host innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 758 (271.9 bits), Expect = 3.5e-75, P = 3.5e-75
 Identities = 147/239 (61%), Positives = 179/239 (74%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
             W TEV +LGQLRH NLVKLIGYC E D+RLLVYEFM +GSLENHLFRK   P+SW  R+ 
Sbjct:   117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPLSWSRRMM 176

Query:    62 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
             IA+  A+GL+FLH  +  VIYRD K SN+LLDS++ AKLSDFGLA+ GP GD THVSTR+
Sbjct:   177 IALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 236

Query:   122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
             +GT GYAAPEYV TGHLT +SDVYSFGVVLLE+L+GR+++D+ R    EQ LV+WA P L
Sbjct:   237 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPS-KEQNLVDWARPKL 295

Query:   182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
              D R++L+I+D RL  QYS + AQ        CL  +PK RP M DV+ +LE L  + D
Sbjct:   296 NDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCTGD 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)]

 Score = 757 (271.5 bits), Expect = 4.5e-75, P = 4.5e-75
 Identities = 142/240 (59%), Positives = 185/240 (77%)

Query:     2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
             W +EVI+LGQL+H NLVKLIGYC E + R+L+YEFMP+GSLENHLFR+    + W TR+K
Sbjct:   147 WLSEVIFLGQLKHPNLVKLIGYCCEEEERVLIYEFMPRGSLENHLFRRISLSLPWATRLK 206

Query:    62 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
             IA+  A+GL+FLH L++ +IYRD K SN+LLDS+F AKLSDFGLA+ GP G  +HV+TR+
Sbjct:   207 IAVAAAKGLAFLHDLESPIIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSKSHVTTRV 266

Query:   122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
             +GT GYAAPEYV+TGHLT KSDVYS+GVVLLELL+GRRA ++ R    +Q +++W+ P+L
Sbjct:   267 MGTYGYAAPEYVSTGHLTTKSDVYSYGVVLLELLTGRRATEKSRPK-NQQNIIDWSKPYL 325

Query:   182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
               SRR+  +MD RL GQYS K A+      LQC+  +PK+RP M+ V+ +LE L   KDM
Sbjct:   326 TSSRRLRCVMDPRLAGQYSVKAAKDTALLALQCVSPNPKDRPKMLAVVEALESLIHYKDM 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00017351001 SubName- Full=Chromosome chr6 scaffold_15, whole genome shotgun sequence; (388 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	278
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-50
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-48
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-47
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-45
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-31
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-27
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-27
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-26
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-26
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-25
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-25
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-24
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-24
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-24
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-24
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	9e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-23
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-23
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-23
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-23
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-21
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-21
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	6e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-21
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-21
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-20
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-20
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	7e-20
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-19
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-19
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-19
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-19
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-18
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-18
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-18
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-17
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-17
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-17
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-17
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-16
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	6e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-15
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-15
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-15
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	5e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-14
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-14
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-14
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-14
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	6e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	7e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	7e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	9e-13
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	6e-12
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-12
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-12
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-11
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-11
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-11
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-11
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-11
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	6e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-10
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-10
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	6e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-10
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-09
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-09
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-09
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	4e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-09
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-09
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	9e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-08
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-08
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-08
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-08
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	1e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-07
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-07
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-07
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-06
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	4e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	4e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-04
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.002
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  166 bits (423), Expect = 1e-50
 Identities = 72/233 (30%), Positives = 122/233 (52%), Gaps = 22/233 (9%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
            +  E   + +L H N+VKL+G C+E +  ++V E+MP G L ++L +   + +S    +
Sbjct: 47  EFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLL 106

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
             A+ +ARG+ +L     N I+RDL A N L+  N   K+SDFGL+RD    D   V   
Sbjct: 107 SFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG 164

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 179
            +  R + APE +  G  T KSDV+SFGV+L E+ + G    +E   G++   ++E+   
Sbjct: 165 KLPIR-WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG----EEPYPGMSNAEVLEY--- 216

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
            L+   R+ +  +              +  ++LQC   DP++RP+  +++  L
Sbjct: 217 -LKKGYRLPKPPNCP----------PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  164 bits (417), Expect = 1e-49
 Identities = 71/233 (30%), Positives = 121/233 (51%), Gaps = 23/233 (9%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
            +  E   + +L H N+VKL+G C+E +   +V E+M  G L ++L RK    +S    +
Sbjct: 47  EFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLL 105

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
             A+ +ARG+ +L     N I+RDL A N L+  N   K+SDFGL+RD    D       
Sbjct: 106 SFALQIARGMEYLE--SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG 163

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 179
            +  R + APE +  G  T KSDV+SFGV+L E+ + G    ++   G++ + ++E+   
Sbjct: 164 KLPIR-WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLG----EQPYPGMSNEEVLEY--- 215

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
            L++  R+ +  +              +  ++LQC   DP++RP+  +++  L
Sbjct: 216 -LKNGYRLPQPPNCP----------PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  160 bits (407), Expect = 3e-48
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 23/229 (10%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E+  L +L H N+V+LI    + D+  LV E+   G L ++L R G  P+S     KIA
Sbjct: 47  REIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIA 104

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
           + + RGL +LH     +I+RDLK  N+LLD N   K++DFGLA+      ++ ++T  VG
Sbjct: 105 LQILRGLEYLH--SNGIIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTT-FVG 160

Query: 124 TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           T  Y APE +  G    PK DV+S GV+L ELL+G+                   +  L 
Sbjct: 161 TPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK--------------PPFSGENILD 206

Query: 183 DSRRVLRIMDTRLGGQYSKK--EAQAVAAVVLQCLHMDPKNRPSMVDVL 229
             + + RI+   L     K    ++    ++ +CL+ DP  RP+  ++L
Sbjct: 207 QLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  159 bits (404), Expect = 1e-47
 Identities = 69/235 (29%), Positives = 116/235 (49%), Gaps = 34/235 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +L H N+V+L+G C++ +   +V E+MP G L + L RK  + ++    +++A+
Sbjct: 51  EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMAL 109

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A+G+ +L     N ++RDL A N L+  N   K+SDFGL+RD    D         G 
Sbjct: 110 QIAKGMEYLE--SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG---GG 164

Query: 125 RG---YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP-- 179
           +    + APE +  G  T KSDV+SFGV+L E+ +           L EQ     ++   
Sbjct: 165 KLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFT-----------LGEQPYPGMSNEEV 213

Query: 180 --FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
              L D  R+ R  +              +  ++LQC   DP++RP+  +++  L
Sbjct: 214 LELLEDGYRLPRPENC----------PDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  157 bits (400), Expect = 1e-47
 Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 57/234 (24%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
               E+  L +L H N+VKL G   + ++  LV E+   GSL++ L       +S    +
Sbjct: 37  ELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEIL 95

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVST 119
           +I + +  GL +LH     +I+RDLK  N+LLDS N   KL+DFGL++      +  +  
Sbjct: 96  RILLQILEGLEYLH--SNGIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLK 151

Query: 120 RIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
            IVGT  Y APE  +  G+ + KSD++S GV+L EL                        
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
           P L+D                          ++ + L  DP+ RPS  ++L  L
Sbjct: 188 PELKD--------------------------LIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  156 bits (396), Expect = 2e-46
 Identities = 70/240 (29%), Positives = 115/240 (47%), Gaps = 42/240 (17%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------FRKGVQPISWPTRVK 61
           + +L H N+V+L+G C+E +   LV E+M  G L ++L              +S    + 
Sbjct: 50  MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLS 109

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-R 120
            AI +A+G+ +L       ++RDL A N L+  +   K+SDFGL+RD    D     T  
Sbjct: 110 FAIQIAKGMEYLASK--KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQTLVE 175
            +  R + APE +  G  T KSDV+SFGV+L E+ +         G     GL+ + ++E
Sbjct: 168 KLPIR-WMAPESLKDGIFTSKSDVWSFGVLLWEIFT--------LGATPYPGLSNEEVLE 218

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
               +LR             G +  K E     +  ++L C  +DP++RP+  +++  LE
Sbjct: 219 ----YLRK------------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  152 bits (386), Expect = 4e-45
 Identities = 61/233 (26%), Positives = 97/233 (41%), Gaps = 32/233 (13%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  L +L+H N+V+L     + D   LV E+   G L + L ++G   +S       
Sbjct: 45  LREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG--RLSEDEARFY 102

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +   L +LH     +++RDLK  N+LLD + + KL+DFGLAR     D     T  V
Sbjct: 103 LRQILSALEYLH--SKGIVHRDLKPENILLDEDGHVKLADFGLARQ---LDPGEKLTTFV 157

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  Y APE +         D++S GV+L ELL+G+                    PF  
Sbjct: 158 GTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKP-------------------PF-P 197

Query: 183 DSRRVLRIMDTRLGGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLT 230
              ++L +       +                ++ + L  DP+ R +  + L 
Sbjct: 198 GDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  119 bits (302), Expect = 1e-32
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 22/224 (9%)

Query: 3   QTEVIYLGQLRHENLVKLIG-YCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+  L  L+H N+V+  G    E  N L ++ E++  GSL + L + G   +  P   
Sbjct: 47  EREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIR 104

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           K    +  GL++LH     +++RD+K +N+L+DS+   KL+DFG A+     +    +  
Sbjct: 105 KYTRQILEGLAYLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           + GT  + APE +        +D++S G  ++E+ +G+    E    +A           
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA---------- 212

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
                 + +I  +    +  +  ++     + +CL  DPK RP+
Sbjct: 213 ------LYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 1e-31
 Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 34/228 (14%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
            LRH NLV+L+G   + +   +V E+M KGSL ++L  +G   I+   ++  A+DV  G+
Sbjct: 56  TLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGM 115

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
            +L     N ++RDL A NVL+  +  AK+SDFGLA++   G     S ++     + AP
Sbjct: 116 EYLEE--KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG---QDSGKL--PVKWTAP 168

Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 190
           E +     + KSDV+SFG++L E+ S  R                   P+ R     L+ 
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PYPRIP---LKD 207

Query: 191 MDTRLGGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
           +   +   Y + EA       V  V+  C  +DP  RP+   +   L 
Sbjct: 208 VVPHVEKGY-RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  115 bits (290), Expect = 7e-31
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 30/224 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L + +H N+VK  G   + D   +V EF   GSL++ L +   Q ++      +  
Sbjct: 47  EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCK 105

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++ +GL +LH     +I+RD+KA+N+LL S+   KL DFGL+         +    +VGT
Sbjct: 106 ELLKGLEYLHSN--GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGT 160

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 184
             + APE +       K+D++S G+  +EL  G+                    P   + 
Sbjct: 161 PYWMAPEVINGKPYDYKADIWSLGITAIELAEGK--------------------PPYSEL 200

Query: 185 RRVLRIMDTRLGGQY----SKKEAQAVAAVVLQCLHMDPKNRPS 224
             +  +      G       +K +      + +CL  +P+ RP+
Sbjct: 201 PPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  109 bits (272), Expect = 1e-27
 Identities = 70/281 (24%), Positives = 112/281 (39%), Gaps = 20/281 (7%)

Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRV 60
             E+  L  L H  N+VKL  +  +  +  LV E++  GSLE+ L       P+S    +
Sbjct: 45  LREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEAL 104

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLAR----DGPTGDNT 115
            I   +   L +LH     +I+RD+K  N+LLD +    KL DFGLA+     G T    
Sbjct: 105 FILAQILSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162

Query: 116 HVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
            + +  VGT GY APE +      + +  SD++S G+ L ELL+G    + ++   A   
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ 222

Query: 173 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
            ++        +  +   +        SK    A + ++ + L  DPKNR S    L   
Sbjct: 223 TLKIILEL--PTPSLASPLSPSNPELISK----AASDLLKKLLAKDPKNRLSSSSDL--S 274

Query: 233 EQLHTSKDMPRTPPPAKLHHHHHHHNHHQGIKHTNPPRKTS 273
             L     +  +     L                     + 
Sbjct: 275 HDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSL 315

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  106 bits (267), Expect = 2e-27
 Identities = 61/242 (25%), Positives = 100/242 (41%), Gaps = 46/242 (19%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRV 60
             EV  L +L H N++K      E     +V E+   G L   +   +K  +P      +
Sbjct: 47  LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL 106

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
              + +   L +LH     +++RD+K  N+ L SN   KL DFG+++         ++  
Sbjct: 107 DWFVQLCLALKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKT 162

Query: 121 IVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
           +VGT  Y +PE      Y        KSD++S G VL EL + +                
Sbjct: 163 VVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKH--------------- 201

Query: 175 EWADPFLRDSRR--VLRIMD---TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
               PF  ++     L+I+      +  QYS +    +  +V   L  DP+ RPS+  +L
Sbjct: 202 ----PFEGENLLELALKILKGQYPPIPSQYSSE----LRNLVSSLLQKDPEERPSIAQIL 253

Query: 230 TS 231
            S
Sbjct: 254 QS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  106 bits (266), Expect = 2e-27
 Identities = 55/156 (35%), Positives = 86/156 (55%), Gaps = 8/156 (5%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L ++ H  +VKL  Y  +++ +L LV E+ P G L +HL ++G        R   
Sbjct: 42  TERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYA 99

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           A ++   L +LH L   +IYRDLK  N+LLD++ + KL+DFGLA++  +  +   +    
Sbjct: 100 A-EIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FC 154

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           GT  Y APE +         D +S GV+L E+L+G+
Sbjct: 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 8e-27
 Identities = 67/239 (28%), Positives = 120/239 (50%), Gaps = 34/239 (14%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           TE   +GQ  H N+++L G  ++S   +++ E+M  GSL+  L R+     +    V + 
Sbjct: 54  TEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGML 112

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             +A G+ +L   + N ++RDL A N+L++SN   K+SDFGL+R     + T+       
Sbjct: 113 RGIASGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------ 164

Query: 124 TRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEW 176
           T+G      + APE +A    T  SDV+SFG+V+ E++S G R        ++ Q +++ 
Sbjct: 165 TKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY----WDMSNQDVIK- 219

Query: 177 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
               + D  R+   MD             A+  ++L C   D   RP+   ++++L+++
Sbjct: 220 ---AVEDGYRLPPPMDC----------PSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  104 bits (262), Expect = 1e-26
 Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 8/159 (5%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L HEN+VK  G C +   R   L+ E++P GSL ++L ++    I+    
Sbjct: 53  FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRL 111

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  + +G+ +L       I+RDL A N+L++S    K+SDFGLA+  P   + +   
Sbjct: 112 LLFSSQICKGMDYLG--SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVK 169

Query: 120 --RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                    Y APE + T   +  SDV+SFGV L EL +
Sbjct: 170 EPGESPIFWY-APECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 2e-26
 Identities = 70/229 (30%), Positives = 111/229 (48%), Gaps = 28/229 (12%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           L Q  H N+VKLIG C +     +V E +P GSL   L +K  + ++    +++++D A 
Sbjct: 46  LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNR-LTVKKLLQMSLDAAA 104

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G+ +L     N I+RDL A N L+  N   K+SDFG++R+   G  T VS    G +   
Sbjct: 105 GMEYLES--KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT-VSD---GLKQIP 158

Query: 126 -GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 184
             + APE +  G  T +SDV+S+G++L E  S     D    G++ Q   E  +   R  
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLG---DTPYPGMSNQQTRERIESGYRMP 215

Query: 185 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
                           +   + +  ++LQC   DP+NRPS  ++   L+
Sbjct: 216 A--------------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  103 bits (259), Expect = 2e-26
 Identities = 53/160 (33%), Positives = 86/160 (53%), Gaps = 12/160 (7%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
            +Q EV  L +LRH++L+ L   CS  +   ++ E M KGSL   L     Q +   + +
Sbjct: 48  DFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI 107

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTH 116
            +A  VA G+++L   + N I+RDL A N+L+  +   K++DFGLAR    D     +  
Sbjct: 108 DMACQVAEGMAYLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165

Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  +      + APE  + G  + KSDV+SFG++L E+ +
Sbjct: 166 IPYK------WTAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 4e-26
 Identities = 57/152 (37%), Positives = 87/152 (57%), Gaps = 10/152 (6%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +LRH+ LV+L   CSE +   +V E+M KGSL + L     + +  P  V +A  +A G+
Sbjct: 57  KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           ++L     N I+RDL A N+L+  N   K++DFGLAR     ++   + R  G +    +
Sbjct: 117 AYLE--SRNYIHRDLAARNILVGENLVCKIADFGLAR---LIEDDEYTAR-EGAKFPIKW 170

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLS-GR 158
            APE    G  T KSDV+SFG++L E+++ GR
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  101 bits (252), Expect = 1e-25
 Identities = 74/238 (31%), Positives = 114/238 (47%), Gaps = 37/238 (15%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E   + QLRH NLV+L+G   E    L +V E+M KGSL ++L  +G   +     +K +
Sbjct: 49  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIV 122
           +DV   + +L     N ++RDL A NVL+  +  AK+SDFGL ++   T D   +  +  
Sbjct: 109 LDVCEAMEYLEA--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + APE +     + KSDV+SFG++L E+ S  R                   P+  
Sbjct: 165 ----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV------------------PY-- 200

Query: 183 DSRRVLRIMDTRLGGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
             R  L+ +  R+   Y K +A       V  V+ QC H+D   RPS + +   LE +
Sbjct: 201 -PRIPLKDVVPRVEKGY-KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  102 bits (255), Expect = 2e-25
 Identities = 68/244 (27%), Positives = 115/244 (47%), Gaps = 34/244 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL----ENHLFRKGVQP------- 53
           EV  L +L+  N+++L+G C + D   ++ E+M  G L     +H      +        
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 54  ------ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 107
                 IS+ + + +A+ +A G+ +L  L  N ++RDL   N L+  N   K++DFG++R
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYLSSL--NFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 167
           +   GD   +  R V    + A E +  G  T  SDV++FGV L E+L   +   +  G 
Sbjct: 187 NLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE--QPYGE 244

Query: 168 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA---QAVAAVVLQCLHMDPKNRPS 224
           L ++ ++E A  F RD  R +          Y  +     Q +  ++LQC   D + RPS
Sbjct: 245 LTDEQVIENAGEFFRDQGRQV----------YLFRPPPCPQGLYELMLQCWSRDCRERPS 294

Query: 225 MVDV 228
             D+
Sbjct: 295 FSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  100 bits (251), Expect = 2e-25
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 26/223 (11%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           L +L    +++   Y S  D   L  V E+   G L   L  +  +P+      +  I +
Sbjct: 53  LAKLDSSYIIRY--YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQI 110

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
             GL+ LH     +++RD+K+ N+ LD+  N K+ D G+A+     DNT+ +  IVGT  
Sbjct: 111 LLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPY 166

Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRR 186
           Y +PE         KSDV++ GVVL E  +G+   D +  G     L+           +
Sbjct: 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG----ALI----------LK 212

Query: 187 VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           ++R +   +   YS    Q +A ++ QCL  D + RP    +L
Sbjct: 213 IIRGVFPPVSQMYS----QQLAQLIDQCLTKDYRQRPDTFQLL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  100 bits (252), Expect = 2e-25
 Identities = 63/223 (28%), Positives = 103/223 (46%), Gaps = 29/223 (13%)

Query: 14  HENLVKLIG-YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 72
              +VK  G +  E +  + V E+M  GSL +    K V  I  P    IA  + +GL +
Sbjct: 58  SPYVVKCYGAFYKEGEISI-VLEYMDGGSLAD--LLKKVGKIPEPVLAYIARQILKGLDY 114

Query: 73  LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPE 131
           LH    ++I+RD+K SN+L++S    K++DFG+++    T D  +     VGT  Y +PE
Sbjct: 115 LHT-KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF---VGTVTYMSPE 170

Query: 132 YVATGHLTPKSDVYSFGVVLLELLSGRRA-LDEDRGGLAE--QTLVEWADPFLRDSRRVL 188
            +     +  +D++S G+ LLE   G+   L   +    E  Q + +   P L       
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPA----- 225

Query: 189 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 231
                    ++S +    ++A    CL  DPK RPS  ++L  
Sbjct: 226 --------EEFSPEFRDFISA----CLQKDPKKRPSAAELLQH 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 4e-25
 Identities = 66/234 (28%), Positives = 111/234 (47%), Gaps = 43/234 (18%)

Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S     L+V E M KG L+++L           G+ P +    +++A ++A
Sbjct: 70  HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR-- 125
            G+++L       ++RDL A N ++  +   K+ DFG+ RD           R  G    
Sbjct: 130 DGMAYLAAK--KFVHRDLAARNCMVAEDLTVKIGDFGMTRD----IYETDYYRKGGKGLL 183

Query: 126 --GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
              + APE +  G  T KSDV+SFGVVL E+ +           LAEQ       P+   
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT-----------LAEQ-------PYQGL 225

Query: 184 S-RRVLR-IMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
           S   VL+ ++D   GG     E     +  ++  C   +PK RP+ +++++SL+
Sbjct: 226 SNEEVLKFVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 98.5 bits (245), Expect = 2e-24
 Identities = 57/157 (36%), Positives = 90/157 (57%), Gaps = 10/157 (6%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +L H+NLV+L+G     +   +V E M KG+L N L  +G   +S    ++ ++
Sbjct: 49  ETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG-DNTHVSTRIVG 123
           DVA G+ +L      +++RDL A N+L+  +  AK+SDFGLAR G  G DN+ +  +   
Sbjct: 108 DVAEGMEYLE--SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK--- 162

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA 160
              + APE +     + KSDV+S+GV+L E+ S  RA
Sbjct: 163 ---WTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 98.3 bits (245), Expect = 3e-24
 Identities = 68/247 (27%), Positives = 115/247 (46%), Gaps = 35/247 (14%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG------VQPIS 55
           ++ E   L   +HEN+VK  G C+E D  ++V+E+M  G L   L   G        P S
Sbjct: 55  FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 56  WPTR------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG 109
                     ++IA+ +A G+ +L     + ++RDL   N L+  +   K+ DFG++RD 
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQ--HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV 172

Query: 110 PTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGG 167
            T D   V    ++  R +  PE +     T +SDV+SFGVVL E+ + G++       G
Sbjct: 173 YTTDYYRVGGHTMLPIR-WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW----YG 227

Query: 168 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD 227
           L+ + ++E          R+L+   T             V  ++L C   DP+ R ++ D
Sbjct: 228 LSNEEVIECI-----TQGRLLQRPRTC---------PSEVYDIMLGCWKRDPQQRINIKD 273

Query: 228 VLTSLEQ 234
           +   L++
Sbjct: 274 IHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 97.5 bits (243), Expect = 3e-24
 Identities = 55/157 (35%), Positives = 81/157 (51%), Gaps = 12/157 (7%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIA 63
           E   + +L H NLV+L G C++     +V E+M  G L N+L  RKG     W   + + 
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMC 106

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
            DV   + +L       I+RDL A N L+  +   K+SDFGLAR     D+ + S+   G
Sbjct: 107 SDVCEAMEYLE--SNGFIHRDLAARNCLVGEDNVVKVSDFGLAR--YVLDDQYTSS--QG 160

Query: 124 TR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           T+    +A PE       + KSDV+SFGV++ E+ S 
Sbjct: 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 97.7 bits (244), Expect = 3e-24
 Identities = 53/157 (33%), Positives = 85/157 (54%), Gaps = 8/157 (5%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  L  L+H N+VK IG    SD+  ++ E+   GSL   + + G  P S    V +
Sbjct: 47  MQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPES---LVAV 103

Query: 63  AI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            +  V +GL++LH  +  VI+RD+KA+N+L   +   KL+DFG+A      D +     +
Sbjct: 104 YVYQVLQGLAYLH--EQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASV 159

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           VGT  + APE +     +  SD++S G  ++ELL+G 
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  101 bits (253), Expect = 4e-24
 Identities = 73/233 (31%), Positives = 112/233 (48%), Gaps = 18/233 (7%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E+  +G+L+H N+VKLIG C       L++E++   +L   L     + +SW  R KIA
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL-----RNLSWERRRKIA 786

Query: 64  IDVARGLSFLH-GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           I +A+ L FLH      V+  +L    +++D      L      R    G     +   +
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFI 840

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
            +  Y APE   T  +T KSD+Y FG++L+ELL+G+   D + G     ++VEWA     
Sbjct: 841 SS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYS 897

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAA--VVLQCLHMDPKNRPSMVDVLTSLE 233
           D    + I D  + G  S  + + V    + L C   DP  RP   DVL +LE
Sbjct: 898 DCHLDMWI-DPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 97.3 bits (242), Expect = 9e-24
 Identities = 66/242 (27%), Positives = 119/242 (49%), Gaps = 26/242 (10%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---------KGVQPIS 55
           E+  + +L+  N+++L+  C  SD   ++ E+M  G L   L R           V  IS
Sbjct: 69  EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128

Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
           + T + +A  +A G+ +L  L  N ++RDL   N L+  N+  K++DFG++R+  +GD  
Sbjct: 129 YSTLIFMATQIASGMKYLSSL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
            +  R V    + + E +  G  T  SDV++FGV L E+L+  +  ++    L+++ ++E
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK--EQPYSQLSDEQVIE 244

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEA---QAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
               F RD  R +          Y  K A    ++  ++L C   + K RPS  ++  +L
Sbjct: 245 NTGEFFRDQGRQV----------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294

Query: 233 EQ 234
            +
Sbjct: 295 LE 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.4 bits (240), Expect = 2e-23
 Identities = 49/169 (28%), Positives = 83/169 (49%), Gaps = 16/169 (9%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK------------ 49
           ++ E   +  L+H N+V L+G C++     +++E++  G L   L R             
Sbjct: 55  FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114

Query: 50  --GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 107
                 +     + IAI +A G+ +L     + ++RDL A N L+      K+SDFGL+R
Sbjct: 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSS--HHFVHRDLAARNCLVGEGLTVKISDFGLSR 172

Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           D  + D   V ++ +    +  PE +  G  T +SD++SFGVVL E+ S
Sbjct: 173 DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.4 bits (237), Expect = 3e-23
 Identities = 72/231 (31%), Positives = 115/231 (49%), Gaps = 27/231 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +L H  LV+L G C+E     LV+EFM  G L ++L R      S  T + + +
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCL 107

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           DV  G+++L    +NVI+RDL A N L+  N   K+SDFG+ R     D+ + S+   GT
Sbjct: 108 DVCEGMAYLE--SSNVIHRDLAARNCLVGENQVVKVSDFGMTR--FVLDDQYTSST--GT 161

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    +++PE  +    + KSDV+SFGV++ E+ S  +   E+R   +   +VE      
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR---SNSEVVE------ 212

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
                  R+   RL        +Q+V  ++  C    P++RPS   +L  L
Sbjct: 213 -TINAGFRLYKPRLA-------SQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 3e-23
 Identities = 51/152 (33%), Positives = 82/152 (53%), Gaps = 10/152 (6%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +LRH  L++L   C+  +   +V E M  GSL  +L     + +  P  + +A  VA G+
Sbjct: 57  KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           ++L     N I+RDL A NVL+  N   K++DFGLAR     ++ + +    G +    +
Sbjct: 117 AYLE--AQNYIHRDLAARNVLVGENNICKVADFGLAR--VIKEDIYEAR--EGAKFPIKW 170

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLS-GR 158
            APE       + KSDV+SFG++L E+++ GR
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 95.9 bits (239), Expect = 3e-23
 Identities = 67/241 (27%), Positives = 117/241 (48%), Gaps = 24/241 (9%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK----------GVQPI 54
           EV  L +L   N+ +L+G C+      ++ E+M  G L N   +K            + +
Sbjct: 69  EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLACNSKSL 127

Query: 55  SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
           S+ T + +A  +A G+ +L  L  N ++RDL   N L+  N+  K++DFG++R+  + D 
Sbjct: 128 SFSTLLYMATQIASGMRYLESL--NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185

Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
             V  R      + A E V  G  T KSDV++FGV L E+L+  R    +   L +Q ++
Sbjct: 186 YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH--LTDQQVI 243

Query: 175 EWADPFLRD-SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
           E A  F RD  R++              K+   +  ++L+C   D ++RP+  ++   L+
Sbjct: 244 ENAGHFFRDDGRQIYLPRPPN-----CPKD---IYELMLECWRRDEEDRPTFREIHLFLQ 295

Query: 234 Q 234
           +
Sbjct: 296 R 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 4e-23
 Identities = 65/238 (27%), Positives = 98/238 (41%), Gaps = 27/238 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN-HLFRKGVQPISWPTRVKIA 63
           EV  L QLRHEN+V L           LV+E++ +  LE       G+ P +   R    
Sbjct: 50  EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA--VR-SYI 106

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             + + +++ H    N+I+RD+K  N+L+  +   KL DFG AR       + + T  V 
Sbjct: 107 WQLLQAIAYCHSH--NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL-TDYVA 163

Query: 124 TRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL-----DEDR--------GGLA 169
           TR Y APE  V   +     DV++ G ++ ELL G   L     D D+        G L 
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLP 222

Query: 170 E-QTLVEWADPFLRDSRRVLRIMDTRLGGQ--YSKKEAQAVAAVVLQCLHMDPKNRPS 224
                +  ++P                  +  Y  K +      +  CL MDPK R +
Sbjct: 223 PSHQELFSSNPRFAGVA--FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 95.3 bits (237), Expect = 4e-23
 Identities = 67/247 (27%), Positives = 110/247 (44%), Gaps = 41/247 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLF--RKGVQPISW 56
           E   +    H N++KLIG C E+ +       +++  FM  G L + L   R G  P   
Sbjct: 51  EAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKL 110

Query: 57  PTR--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD- 113
           P +  +K  +D+A G+ +L   + N I+RDL A N +L  +    ++DFGL++   +GD 
Sbjct: 111 PLQTLLKFMVDIALGMEYLS--NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY 168

Query: 114 --NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 171
                ++   V    + A E +A    T KSDV++FGV + E+ +        RG    Q
Sbjct: 169 YRQGRIAKMPV---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT--------RG----Q 213

Query: 172 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA---VAAVVLQCLHMDPKNRPSMVDV 228
           T      P + +      I D    G   K+       +  ++  C   DPK+RP+   +
Sbjct: 214 T----PYPGVENH----EIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKL 265

Query: 229 LTSLEQL 235
              LE +
Sbjct: 266 REVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.0 bits (236), Expect = 4e-23
 Identities = 72/236 (30%), Positives = 119/236 (50%), Gaps = 27/236 (11%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N+++L G  ++    +++ E+M  G+L+ +L R      S    V + 
Sbjct: 55  SEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGML 113

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTR 120
             +A G+ +L   D N ++RDL A N+L++SN   K+SDFGL+R   D P G  T    +
Sbjct: 114 RGIAAGMKYLS--DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGK 171

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 179
           I     + APE +A    T  SDV+SFG+V+ E++S G R   +    ++   +++    
Sbjct: 172 I--PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD----MSNHEVMK---- 221

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
            + D  R+   MD             AV  ++LQC   D   RP  VD++  L++L
Sbjct: 222 AINDGFRLPAPMDC----------PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 95.4 bits (237), Expect = 5e-23
 Identities = 58/230 (25%), Positives = 117/230 (50%), Gaps = 21/230 (9%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP----------I 54
           E+  + +L++ N+++L+G C   D   ++ E+M  G L   L ++ ++           +
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126

Query: 55  SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
           S    + +A+ +A G+ +L  L  N ++RDL   N L+ +++  K++DFG++R+  +GD 
Sbjct: 127 SIANLLYMAVQIASGMKYLASL--NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
             +  R V    + A E +  G  T  SDV++FGV L E+ +  +  ++    L+++ ++
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCK--EQPYSLLSDEQVI 242

Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
           E    F R+  R + +  T L           V  ++++C   D K+RP+
Sbjct: 243 ENTGEFFRNQGRQIYLSQTPLC-------PSPVFKLMMRCWSRDIKDRPT 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 2e-22
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 33/224 (14%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           QL H  +V+LIG C + +  +LV E  P G L  +L ++   P+S     ++A  VA G+
Sbjct: 52  QLDHPCIVRLIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVS--DLKELAHQVAMGM 108

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           ++L     + ++RDL A NVLL +   AK+SDFG++R    G + + +T     R    +
Sbjct: 109 AYLES--KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWPLKW 164

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRR 186
            APE +  G  + KSDV+S+GV L E  S G +   E +G  AE                
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AE---------------- 206

Query: 187 VLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDV 228
           V+ ++++  G +  + E   Q + +++L C    P++RP+  ++
Sbjct: 207 VIAMLES--GERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 92.8 bits (231), Expect = 3e-22
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 46/226 (20%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV--KIAIDVARGL 70
               +V   G    + +  +  E+M  GSL+  + ++    I  P R+  KIA+ V +GL
Sbjct: 57  NSPYIVGFYGAFYNNGDISICMEYMDGGSLDK-ILKEVQGRI--PERILGKIAVAVLKGL 113

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV-------- 122
           ++LH     +I+RD+K SN+L++S    KL DFG            VS ++V        
Sbjct: 114 TYLHE-KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFV 160

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  Y APE +     + KSD++S G+ L+EL +GR                   DP   
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP------------PENDPPDG 208

Query: 183 DSRRVLRIMDT---RL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
               +  I++    RL  G++S  + Q     V  CL  DP+ RPS
Sbjct: 209 IFELLQYIVNEPPPRLPSGKFS-PDFQ---DFVNLCLIKDPRERPS 250

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 92.3 bits (230), Expect = 5e-22
 Identities = 61/236 (25%), Positives = 103/236 (43%), Gaps = 37/236 (15%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSL----ENHLFRKGVQPISWPT 58
            E++ +   +H N+V          + L +V E+M  GSL      +  R     I++  
Sbjct: 64  NEILIMKDCKHPNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-- 120

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +  +V +GL +LH    NVI+RD+K+ N+LL  + + KL+DFG A       +   S
Sbjct: 121 ---VCREVLQGLEYLHSQ--NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175

Query: 119 TRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
             +VGT  + APE V       PK D++S G++ +E+  G      +    A   +    
Sbjct: 176 --VVGTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKG 232

Query: 178 DPFLRDSRRVLRIMDTRLGGQYSK--KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 231
            P L++  +             S   K+       + +CL  DP+ RPS  ++L  
Sbjct: 233 IPPLKNPEKW------------SPEFKD------FLNKCLVKDPEKRPSAEELLQH 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.7 bits (228), Expect = 5e-22
 Identities = 66/234 (28%), Positives = 106/234 (45%), Gaps = 30/234 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  L HENL++L G    +   ++V E  P GSL + L +  +      T    A+
Sbjct: 46  EAAIMHSLDHENLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV 104

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST--RIV 122
            +A G+ +L       I+RDL A N+LL S+   K+ DFGL R  P  ++ +V      V
Sbjct: 105 QIANGMRYLE--SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV 162

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFL 181
               + APE + T   +  SDV+ FGV L E+ + G                    +P+ 
Sbjct: 163 PF-AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGE-------------------EPWA 202

Query: 182 -RDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
                ++L+ +D   G +  + EA  Q +  V+LQC   +P +RP+   +   L
Sbjct: 203 GLSGSQILKKIDKE-GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 91.1 bits (226), Expect = 2e-21
 Identities = 69/241 (28%), Positives = 115/241 (47%), Gaps = 17/241 (7%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           W+ E+  L  L HEN+VK  G CSE   +   L+ E++P GSL ++L +     ++    
Sbjct: 53  WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQL 109

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VS 118
           +  A  +  G+++LH    + I+RDL A NVLLD++   K+ DFGLA+  P G   + V 
Sbjct: 110 LLFAQQICEGMAYLHS--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 167

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
                   + A E +     +  SDV+SFGV L ELL+   +         E  ++    
Sbjct: 168 EDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE--MIGPKQ 225

Query: 179 PFLRDSRRVLRIMDTRLGGQY---SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
             +     V+R+++    G      K   Q V  ++  C   + K RP+   ++  L+++
Sbjct: 226 GQM----TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Query: 236 H 236
           H
Sbjct: 282 H 282

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 89.7 bits (222), Expect = 3e-21
 Identities = 72/232 (31%), Positives = 114/232 (49%), Gaps = 27/232 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRH+ LV L    SE +   +V EFM KGSL + L     + +  P  V +A 
Sbjct: 51  EAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAA 109

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N I+RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 110 QIADGMAYIERM--NYIHRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTARQ--GA 163

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL++  R       G+  + ++E  +   
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV---PYPGMVNREVLEQVERGY 220

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
           R        M    G   S  E      ++  C   DP  RP+   + + LE
Sbjct: 221 R--------MPCPQGCPESLHE------LMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 91.1 bits (227), Expect = 3e-21
 Identities = 57/165 (34%), Positives = 89/165 (53%), Gaps = 21/165 (12%)

Query: 5   EVIYLGQLR-HENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHL---FRKGV-QPISWP 57
           E+++L +L  H N+VKL+    +E+D  + LV+E+M     E  L    R  + + +   
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVH-- 108

Query: 58  TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH- 116
            +  I   + + L ++H    NVI+RDLK SN+LL+S+   KL+DFGLAR     +    
Sbjct: 109 -KRYIMYQLLKALKYIHS--GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPE 165

Query: 117 --VSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
             V T  V TR Y APE  + +   T   D++S G +L E+L G+
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 89.9 bits (224), Expect = 3e-21
 Identities = 51/162 (31%), Positives = 86/162 (53%), Gaps = 18/162 (11%)

Query: 5   EVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMP---KGSLENHLFRKGVQPISWPTR 59
           E+  L +LRH N+V+L     S+    + +V+E+M     G L++   +      +  ++
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FT-ESQ 101

Query: 60  VK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +K     +  GL +LH     +++RD+K SN+L++++   KL+DFGLAR   T  N+   
Sbjct: 102 IKCYMKQLLEGLQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADY 158

Query: 119 TRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 158
           T  V T  Y  PE +  AT    P+ D++S G +L EL  G+
Sbjct: 159 TNRVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 89.4 bits (222), Expect = 6e-21
 Identities = 58/235 (24%), Positives = 110/235 (46%), Gaps = 30/235 (12%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGV-----QPISWPTRVK 61
             +L H+N+V+L+G C E++   ++ E+   G L+  L   +         P+S   +V 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVA 121

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +   +A G+  L   +A  ++RDL A N L+ S    K+S   L++D    +   +   +
Sbjct: 122 LCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL 179

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF- 180
           +  R + APE V     + KSDV+SFGV++ E+ +             E        PF 
Sbjct: 180 IPLR-WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT-----------QGEL-------PFY 220

Query: 181 -LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 234
            L D   + R+   +L     +     +  ++ +C  ++PK+RPS  +++++L +
Sbjct: 221 GLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 89.5 bits (222), Expect = 7e-21
 Identities = 56/156 (35%), Positives = 82/156 (52%), Gaps = 18/156 (11%)

Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           +LG   HEN+V L+G C+     L++ E+   G L N L RK    ++    +  +  VA
Sbjct: 94  HLGN--HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
           +G++FL     N I+RDL A NVLL      K+ DFGLARD    D+ +V       +G 
Sbjct: 152 KGMAFLAS--KNCIHRDLAARNVLLTHGKIVKICDFGLARD-IMNDSNYVV------KGN 202

Query: 128 A-------APEYVATGHLTPKSDVYSFGVVLLELLS 156
           A       APE +     T +SDV+S+G++L E+ S
Sbjct: 203 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 88.8 bits (221), Expect = 8e-21
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 22/164 (13%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 72
            H  ++KL     + +N   V E+ P G L  ++ + G   +        A ++   L +
Sbjct: 60  GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEY 117

Query: 73  LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD----NTHVSTRI------- 121
           LH     +I+RDLK  N+LLD + + K++DFG A+          N   +T I       
Sbjct: 118 LHSK--GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175

Query: 122 -------VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
                  VGT  Y +PE +        SD+++ G ++ ++L+G+
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 88.6 bits (219), Expect = 1e-20
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 10/158 (6%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 51  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 109

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 110 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GA 163

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           +    + APE    G  T KSDV+SFG++L EL +  R
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.8 bits (217), Expect = 2e-20
 Identities = 67/224 (29%), Positives = 113/224 (50%), Gaps = 29/224 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRH+ LV+L    SE +   +V E+M KGSL + L     + +  P  V +A 
Sbjct: 51  EAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAA 109

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            VA G++++  +  N I+RDL+++N+L+      K++DFGLAR     DN + + +  G 
Sbjct: 110 QVAAGMAYIERM--NYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQ--GA 163

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL++  R                   P+ 
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV------------------PYP 205

Query: 182 -RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
             ++R VL  ++        +    ++  ++LQC   DP+ RP+
Sbjct: 206 GMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 87.7 bits (218), Expect = 2e-20
 Identities = 63/237 (26%), Positives = 101/237 (42%), Gaps = 37/237 (15%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHL--FRKGVQPISWPTRV 60
           EV  L +L+H N+V+      +  N+ L  V E+   G L   +   +K  + I      
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 61  KIAIDVARGLSFLHGLDAN---VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 117
           +I   +   L   H        V++RDLK +N+ LD+N N KL DFGLA+    G ++  
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSSF 166

Query: 118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
           +   VGT  Y +PE +       KSD++S G ++ EL +                     
Sbjct: 167 AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS------------------- 207

Query: 178 DPFLRDSRRVLRIM-----DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
            PF   ++  L          R+  +YS      +  V+   L++DP  RPS  ++L
Sbjct: 208 PPFTARNQLQLASKIKEGKFRRIPYRYSS----ELNEVIKSMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 87.2 bits (216), Expect = 3e-20
 Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 33/229 (14%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDVAR 68
           +L HE LV+L G C++     +V E+M  G L N+L    K  QP      +++  DV  
Sbjct: 55  KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCE 111

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G+++L       I+RDL A N L+D     K+SDFGL+R     D+ + S+  VG++   
Sbjct: 112 GMAYLE--SKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSS--VGSKFPV 165

Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 184
            ++ PE +     + KSDV++FGV++ E+ S G+   +           VE     LR  
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER----FNNSETVEKVSQGLRLY 221

Query: 185 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
           R  L               ++ V A++  C H   + RP+   +L+S+E
Sbjct: 222 RPHL--------------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 87.0 bits (215), Expect = 3e-20
 Identities = 53/153 (34%), Positives = 82/153 (53%), Gaps = 4/153 (2%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   L Q  H N+VKLIG C++     +V E +P G   + L RK    +     VK A
Sbjct: 41  SEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFA 99

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
           +D A G+++L     N I+RDL A N L+  N   K+SDFG++R    G  +    + + 
Sbjct: 100 LDAAAGMAYLE--SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + APE +  G  + +SDV+S+G++L E  S
Sbjct: 158 IK-WTAPEALNYGRYSSESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 87.7 bits (217), Expect = 3e-20
 Identities = 63/255 (24%), Positives = 113/255 (44%), Gaps = 43/255 (16%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL----------------- 46
           +E   L Q+ H +++KL G CS+    LL+ E+   GSL + L                 
Sbjct: 52  SEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNR 111

Query: 47  -----FRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 101
                     + ++    +  A  ++RG+ +L  +   +++RDL A NVL+      K+S
Sbjct: 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM--KLVHRDLAARNVLVAEGRKMKIS 169

Query: 102 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA 160
           DFGL+RD    D+    ++      + A E +     T +SDV+SFGV+L E+++ G   
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229

Query: 161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 220
                 G+A + L       L+   R+ R           +  ++ +  ++L C   +P 
Sbjct: 230 YP----GIAPERLFN----LLKTGYRMER----------PENCSEEMYNLMLTCWKQEPD 271

Query: 221 NRPSMVDVLTSLEQL 235
            RP+  D+   LE++
Sbjct: 272 KRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 87.6 bits (218), Expect = 4e-20
 Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 11/157 (7%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IA 63
           E+  L +L+H N++ L+       N  LV+EFM    LE  + +     ++ P  +K   
Sbjct: 52  EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLE-KVIKDKSIVLT-PADIKSYM 108

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
           +   RGL +LH     +++RDLK +N+L+ S+   KL+DFGLAR   +  N  ++ ++V 
Sbjct: 109 LMTLRGLEYLH--SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV- 164

Query: 124 TRGYAAPE--YVATGHLTPKSDVYSFGVVLLELLSGR 158
           TR Y APE  + A  H     D++S G +  ELL   
Sbjct: 165 TRWYRAPELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 87.0 bits (215), Expect = 4e-20
 Identities = 72/247 (29%), Positives = 117/247 (47%), Gaps = 41/247 (16%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLF--RKGVQPIS 55
           +E + + +  H N+++LIG C ++         +++  FM  G L + L   R G  P  
Sbjct: 49  SEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQY 108

Query: 56  WPTR--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
            PT+  VK   D+A G+ +L     + I+RDL A N +L+ N N  ++DFGL++    GD
Sbjct: 109 LPTQMLVKFMTDIASGMEYLS--SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Query: 114 NTHVSTRIVGTR-GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----G 167
             +   RI      + A E +A    T KSDV+SFGV + E+ +        RG     G
Sbjct: 167 -YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT--------RGQTPYPG 217

Query: 168 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD 227
           +    + +    +LR   R+ +  D  L G YS         ++  C  ++PK+RPS   
Sbjct: 218 VENSEIYD----YLRQGNRLKQPPDC-LDGLYS---------LMSSCWLLNPKDRPSFET 263

Query: 228 VLTSLEQ 234
           +   LE+
Sbjct: 264 LRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 86.8 bits (215), Expect = 4e-20
 Identities = 56/190 (29%), Positives = 86/190 (45%), Gaps = 19/190 (10%)

Query: 21  IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN 79
           + Y  E+ + L LV   M  G L+ H++  G         +  A  +  GL  LH     
Sbjct: 58  LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--R 115

Query: 80  VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT 139
           ++YRDLK  NVLLD + N ++SD GLA +   G          GT GY APE +      
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYD 172

Query: 140 PKSDVYSFGVVLLELLSGR-----RALDEDRGGLAEQTL---VEWADPFLRDSRRVLRIM 191
              D ++ G  L E+++GR     R    ++  L  +TL   VE+ D F  +++ +   +
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232

Query: 192 -----DTRLG 196
                + RLG
Sbjct: 233 LQKDPEKRLG 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 86.9 bits (215), Expect = 4e-20
 Identities = 71/241 (29%), Positives = 116/241 (48%), Gaps = 39/241 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N++ L G  ++S   ++V E+M  GSL+  L RK     +    V +  
Sbjct: 55  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLR 113

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 114 GIASGMKYLS--DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT------ 165

Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + APE +A    T  SDV+S+G+V+ E++S G R   E    ++ Q ++
Sbjct: 166 --TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE----MSNQDVI 219

Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  +    +  R+   MD             A+  ++L C   D   RP    +++ L++
Sbjct: 220 KAIE----EGYRLPAPMDC----------PAALHQLMLDCWQKDRNERPKFEQIVSILDK 265

Query: 235 L 235
           L
Sbjct: 266 L 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 87.0 bits (216), Expect = 7e-20
 Identities = 54/153 (35%), Positives = 83/153 (54%), Gaps = 8/153 (5%)

Query: 13  RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           +H  L +L   C ++ +RL  V E++  G L  H+ R G      P     A ++  GL 
Sbjct: 54  KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE--PRARFYAAEIVLGLQ 110

Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 131
           FLH  +  +IYRDLK  NVLLDS  + K++DFG+ ++G  G  T  ++   GT  Y APE
Sbjct: 111 FLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE 166

Query: 132 YVATGHLTPKSDVYSFGVVLLELLSGRRALDED 164
            ++     P  D ++ GV+L E+L+G+   + D
Sbjct: 167 ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 85.8 bits (213), Expect = 1e-19
 Identities = 58/163 (35%), Positives = 83/163 (50%), Gaps = 14/163 (8%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
            TE   L Q +   +VKL  Y  +    L LV E++P G L + L   G        R+ 
Sbjct: 41  LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV-ARIY 98

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS--- 118
           IA ++   L +LH     +I+RDLK  N+L+DSN + KL+DFGL++ G      +++   
Sbjct: 99  IA-EIVLALEYLHSN--GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155

Query: 119 ---TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSG 157
               RIVGT  Y APE +   GH +   D +S G +L E L G
Sbjct: 156 KEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 85.7 bits (212), Expect = 1e-19
 Identities = 50/153 (32%), Positives = 83/153 (54%), Gaps = 9/153 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 52  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD     T   G 
Sbjct: 112 QISSAMEYLEK--KNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGD---TYTAHAGA 165

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
           +    + APE +A    + KSDV++FGV+L E+
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 85.7 bits (212), Expect = 1e-19
 Identities = 71/247 (28%), Positives = 110/247 (44%), Gaps = 41/247 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYC--SESDNRL----LVYEFMPKGSLENHLF--RKGVQPISW 56
           E   + +  H N++KLIG    S +  RL    ++  FM  G L   L   R G +P + 
Sbjct: 51  EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL 110

Query: 57  P--TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
           P  T V+  ID+A G+ +L     N I+RDL A N +L+ N    ++DFGL++   +GD 
Sbjct: 111 PLQTLVRFMIDIASGMEYLS--SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY 168

Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL- 173
                       + A E +A    T  SDV++FGV + E+++        RG    QT  
Sbjct: 169 YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT--------RG----QTPY 216

Query: 174 --VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAV---VLQCLHMDPKNRPSMVDV 228
             VE ++           I +  + G   K+    +  V   + QC   +PK RPS   +
Sbjct: 217 AGVENSE-----------IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHL 265

Query: 229 LTSLEQL 235
              LE +
Sbjct: 266 RDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 43/93 (46%), Positives = 59/93 (63%), Gaps = 4/93 (4%)

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVGTRG 126
           RGL ++H   ANV++RDLK SN+LL++N + K+ DFGLAR   P  D+T   T  V TR 
Sbjct: 117 RGLKYIHS--ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 127 YAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
           Y APE +       K+ D++S G +L E+LS R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 85.3 bits (211), Expect = 1e-19
 Identities = 66/226 (29%), Positives = 105/226 (46%), Gaps = 29/226 (12%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +L H  LV+L G C++     +V EFM  G L N+L R+    +S    + +  DV  G+
Sbjct: 55  KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGM 113

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
            +L     + I+RDL A N L+ S    K+SDFG+ R     D+ + S+   G +    +
Sbjct: 114 EYLE--RNSFIHRDLAARNCLVSSTGVVKVSDFGMTR--YVLDDEYTSS--SGAKFPVKW 167

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
           + PE       + KSDV+SFGV++ E+ +                  E   PF + S   
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFT------------------EGKMPFEKKSNYE 209

Query: 188 LRIMDTRLGGQYSKKEA-QAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
           +  M +R    Y  K A   V  V+  C H  P+ RP+  ++L ++
Sbjct: 210 VVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 85.3 bits (211), Expect = 2e-19
 Identities = 53/160 (33%), Positives = 87/160 (54%), Gaps = 8/160 (5%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q EV  L  L+H N+V+ +G C + +   +  EF+P GS+ + L R G  P+  P   K 
Sbjct: 50  QEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKY 107

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD----GPTGDNTHVS 118
              +  G+++LH  +  V++RD+K +NV+L  N   KL DFG AR     G  G ++++ 
Sbjct: 108 TKQILDGVAYLH--NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNML 165

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             + GT  + APE +       KSD++S G  + E+ +G+
Sbjct: 166 KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 85.1 bits (211), Expect = 2e-19
 Identities = 49/156 (31%), Positives = 71/156 (45%), Gaps = 9/156 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   L +L H  LV L     + +N  LV + +  G L  HL +K         +VK  I
Sbjct: 50  ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS---EEQVKFWI 106

Query: 65  -DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
            ++   L +LH     +I+RD+K  N+LLD   +  ++DF +A        T   T   G
Sbjct: 107 CEIVLALEYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSG 161

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           T GY APE +     +   D +S GV   E L G+R
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 85.3 bits (211), Expect = 2e-19
 Identities = 56/164 (34%), Positives = 94/164 (57%), Gaps = 15/164 (9%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--PISWPTRVK 61
           +E   +GQ  H N++ L G  ++S   +++ EFM  G+L++ L +   Q   I     V 
Sbjct: 54  SEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VG 110

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVST 119
           +   +A G+ +L   + N ++RDL A N+L++SN   K+SDFGL+R  +  T D T+ S+
Sbjct: 111 MLRGIAAGMKYLS--EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSS 168

Query: 120 RIVGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR 159
             +G +    + APE +A    T  SDV+S+G+V+ E++S G R
Sbjct: 169 --LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 85.1 bits (211), Expect = 2e-19
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 13/158 (8%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IA 63
           E+  L +L H N++KL+       +  LV+EFM    L   L +   + +   + +K   
Sbjct: 48  EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLP-ESLIKSYL 104

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 121
             + +GL+F H     +++RDLK  N+L+++    KL+DFGLAR    P    TH     
Sbjct: 105 YQLLQGLAFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY---- 158

Query: 122 VGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
           V TR Y APE  +     +   D++S G +  ELLS R
Sbjct: 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 84.7 bits (209), Expect = 2e-19
 Identities = 48/148 (32%), Positives = 84/148 (56%), Gaps = 9/148 (6%)

Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L+H+ LV+L    ++ +   ++ E+M KGSL + L       +  P  +  +  +A G++
Sbjct: 58  LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYA 128
           ++     N I+RDL+A+NVL+  +   K++DFGLAR     DN + +    G +    + 
Sbjct: 118 YIE--RKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTARE--GAKFPIKWT 171

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
           APE +  G  T KSDV+SFG++L E+++
Sbjct: 172 APEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 14/151 (9%)

Query: 14  HENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDVARG 69
              +VK  G +  ES + + +  E+   GSL++     +K    I      KIA  V +G
Sbjct: 58  SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 70  LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD--NTHVSTRIVGTRGY 127
           LS+LH     +I+RD+K SN+LL      KL DFG+     +G+  N+   T   GT  Y
Sbjct: 118 LSYLH--SRKIIHRDIKPSNILLTRKGQVKLCDFGV-----SGELVNSLAGT-FTGTSFY 169

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
            APE +     +  SDV+S G+ LLE+   R
Sbjct: 170 MAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 84.4 bits (209), Expect = 3e-19
 Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 24/163 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP---ISWPTRVK 61
           E+  L +L+H N+V+ +G   E DN  +  E +P GSL   L + G  P   I   TR  
Sbjct: 52  EIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-- 109

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-- 119
               +  GL +LH  D N ++RD+K +N+L+D+N   KL+DFG+A+         V    
Sbjct: 110 ---QILLGLEYLH--DRNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFS 156

Query: 120 ---RIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
                 G+  + APE +A  G     +D++S G  +LE+ +G+
Sbjct: 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 84.7 bits (209), Expect = 3e-19
 Identities = 49/168 (29%), Positives = 81/168 (48%), Gaps = 15/168 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------- 50
           +Q E   L  L+H+++V+  G C+E    L+V+E+M  G L   L   G           
Sbjct: 54  FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113

Query: 51  --VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
                ++    + IA  +A G+ +L  L  + ++RDL   N L+      K+ DFG++RD
Sbjct: 114 VAPGQLTLGQMLAIASQIASGMVYLASL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRD 171

Query: 109 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + D   V  R +    +  PE +     T +SD++SFGVVL E+ +
Sbjct: 172 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.5 bits (209), Expect = 3e-19
 Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 37/234 (15%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWP-----TR 59
           E   +    H N+VKL+G C  ++ + ++ E M  G L ++L    V+    P       
Sbjct: 49  EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLL-----DSNFNAKLSDFGLARDGPTGDN 114
           + I +DVA+G  +L     + I+RDL A N L+     D++   K+ DFGLARD    D 
Sbjct: 109 LDICLDVAKGCVYLE--QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166

Query: 115 THV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
                  ++  R + APE +  G  T +SDV+SFGV++ E+L+           L +Q  
Sbjct: 167 YRKEGEGLLPVR-WMAPESLLDGKFTTQSDVWSFGVLMWEILT-----------LGQQ-- 212

Query: 174 VEWADPF-LRDSRRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPS 224
                P+   +++ VL+ +    GG+  K E     +  ++  C   DP  RP+
Sbjct: 213 -----PYPALNNQEVLQHVTA--GGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 82.9 bits (205), Expect = 1e-18
 Identities = 61/224 (27%), Positives = 88/224 (39%), Gaps = 37/224 (16%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           M Q E           + KL       D   LV E++  G   + +   G  P  W    
Sbjct: 51  MIQGE--------SPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK-- 100

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           +   +V  G+  LH     +I+RD+K  N+L+D   + KL+DFGL+R+G        + +
Sbjct: 101 QYIAEVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKK 152

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
            VGT  Y APE +        SD +S G V+ E L G           AE     +    
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH------AETPDAVFD--- 203

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVL--QCLHMDPKNR 222
                    I+  R+      KE  +  AV L  + L MDP  R
Sbjct: 204 --------NILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.5 bits (204), Expect = 1e-18
 Identities = 55/230 (23%), Positives = 101/230 (43%), Gaps = 28/230 (12%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E++ L  L+H N++    +  + +  L+  E+   G+L + + R+  Q       +  
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY 106

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +   +S++H   A +++RD+K  N+ L      KL DFG+++    G    ++  +V
Sbjct: 107 LFQIVSAVSYIH--KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVV 162

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  Y +PE         KSD+++ G VL ELL+ +R  D                    
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-----------------N 205

Query: 183 DSRRVLRIMD---TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
               V++I+    T +   YS      + ++V   L  DP+ RP+  +VL
Sbjct: 206 PLNLVVKIVQGNYTPVVSVYS----SELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 82.8 bits (205), Expect = 1e-18
 Identities = 70/258 (27%), Positives = 112/258 (43%), Gaps = 60/258 (23%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHL------FRKGVQPISW 56
            E   L  L H+N++ ++  C E  +   ++Y +M  G+L+  L           Q +S 
Sbjct: 57  QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALST 116

Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPT---- 111
              V +AI +A G+S+LH     VI++D+ A N ++D     K++D  L+RD  P     
Sbjct: 117 QQLVHMAIQIACGMSYLHKR--GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174

Query: 112 -GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
            GDN +   +      + A E +     +  SDV+SFGV+L EL++           L +
Sbjct: 175 LGDNENRPVK------WMALESLVNKEYSSASDVWSFGVLLWELMT-----------LGQ 217

Query: 171 QTLVEWADPF-----LRDSRRVLRIMDTRLGGQYSKKEAQAVA------AVVLQCLHMDP 219
              VE  DPF     L+D  R+                AQ +       AV+  C  +DP
Sbjct: 218 TPYVE-IDPFEMAAYLKDGYRL----------------AQPINCPDELFAVMACCWALDP 260

Query: 220 KNRPSMVDVLTSLEQLHT 237
           + RPS   ++  L   H 
Sbjct: 261 EERPSFSQLVQCLTDFHA 278

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 82.5 bits (204), Expect = 2e-18
 Identities = 65/241 (26%), Positives = 105/241 (43%), Gaps = 35/241 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---KGVQPISWPTR-- 59
           E + + +  H+N+V+LIG   E   R ++ E M  G L++ L     +  +P S   +  
Sbjct: 59  EALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTH 116
           +  A DVA+G  +L   + + I+RD+ A N LL        AK++DFG+ARD        
Sbjct: 119 LFCARDVAKGCKYLE--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176

Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 175
              R +    +  PE    G  T K+DV+SFGV+L E+ S G                  
Sbjct: 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM---------------- 220

Query: 176 WADPFLRDSRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
              P+    R    +M+   GG      K     V  ++  C    P++RP+   +L  +
Sbjct: 221 ---PY--PGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Query: 233 E 233
           +
Sbjct: 276 Q 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 82.6 bits (205), Expect = 2e-18
 Identities = 55/153 (35%), Positives = 80/153 (52%), Gaps = 17/153 (11%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           L  +RH  LV L G   +  N  LV E++P G L +HL + G  P     R   A  V  
Sbjct: 55  LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPV-ARFYAA-QVVL 112

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTR 125
            L +LH LD  ++YRDLK  N+LLDS+   K++DFG A+         V  R   + GT 
Sbjct: 113 ALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTP 162

Query: 126 GYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSG 157
            Y APE + + G+     D ++ G+++ E+L+G
Sbjct: 163 EYLAPEIILSKGYGKA-VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 82.4 bits (203), Expect = 2e-18
 Identities = 64/232 (27%), Positives = 117/232 (50%), Gaps = 37/232 (15%)

Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--------RKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L++ E M +G L+++L              P S    +++A ++A
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 68  RGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
            G+++L   +AN  ++RDL A N ++  +F  K+ DFG+ RD    D      + +    
Sbjct: 130 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL-RDSR 185
           + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ       P+    + 
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ-------PYQGMSNE 228

Query: 186 RVLR-IMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 234
           +VLR +M+   GG   K +     +  ++  C   +PK RPS +++++S+++
Sbjct: 229 QVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 82.3 bits (203), Expect = 2e-18
 Identities = 54/155 (34%), Positives = 81/155 (52%), Gaps = 6/155 (3%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           E+  L  L HEN+VK  G C+E       L+ EF+P GSL+ +L R     I+   ++K 
Sbjct: 56  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKY 114

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRI 121
           A+ + +G+ +L       ++RDL A NVL++S    K+ DFGL +   T    + V   +
Sbjct: 115 AVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                + APE +        SDV+SFGV L ELL+
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 81.8 bits (202), Expect = 2e-18
 Identities = 50/152 (32%), Positives = 85/152 (55%), Gaps = 11/152 (7%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           QL+H  LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A G+
Sbjct: 57  QLQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           +F+     N I+RDL+A+N+L+      K++DFGLAR     DN + +    G +    +
Sbjct: 116 AFIE--RKNYIHRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTARE--GAKFPIKW 169

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLS-GR 158
            APE +  G  T KSDV+SFG++L E+++ GR
Sbjct: 170 TAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.0 bits (203), Expect = 3e-18
 Identities = 52/162 (32%), Positives = 79/162 (48%), Gaps = 14/162 (8%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLEN---HLFRKGVQPISWPTR 59
           EV  + Q  H N+VK   Y S      L  V  ++  GSL +     + +G         
Sbjct: 49  EVQAMSQCNHPNVVKY--YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD--EAII 104

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTH-V 117
             +  +V +GL +LH      I+RD+KA N+LL  + + K++DFG+ A     GD T  V
Sbjct: 105 ATVLKEVLKGLEYLH--SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKV 162

Query: 118 STRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGR 158
               VGT  + APE +   H    K+D++SFG+  +EL +G 
Sbjct: 163 RKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 81.6 bits (201), Expect = 3e-18
 Identities = 60/233 (25%), Positives = 113/233 (48%), Gaps = 29/233 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  L+H+ LVKL    ++ +   ++ EFM KGSL + L          P  +  + 
Sbjct: 51  EANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++F+     N I+RDL+A+N+L+ ++   K++DFGLAR     DN + +    G 
Sbjct: 110 QIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTARE--GA 163

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE +  G  T KSDV+SFG++L+E+++  R                   P+ 
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI------------------PYP 205

Query: 182 -RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
              +  V+R ++        +   + +  ++++C    P+ RP+   + + L+
Sbjct: 206 GMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.5 bits (201), Expect = 4e-18
 Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 37/205 (18%)

Query: 28  DNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK 86
           +NR+ +  EFM  GSL+  ++RK    I      +IA+ V +GL++L  L   +++RD+K
Sbjct: 71  ENRISICTEFMDGGSLD--VYRK----IPEHVLGRIAVAVVKGLTYLWSL--KILHRDVK 122

Query: 87  ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS 146
            SN+L+++    KL DFG++          ++   VGT  Y APE ++       SDV+S
Sbjct: 123 PSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWS 178

Query: 147 FGVVLLELLSGR---RALDEDRGGLAE----QTLVEWADPFLRDSRRVLRIMDTRLGGQY 199
            G+  +EL  GR     + +++G L      Q +V+   P L               GQ+
Sbjct: 179 LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV-------------GQF 225

Query: 200 SKKEAQAVAAVVLQCLHMDPKNRPS 224
           S+K    +     QC+   PK RP+
Sbjct: 226 SEKFVHFIT----QCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 81.8 bits (202), Expect = 4e-18
 Identities = 62/253 (24%), Positives = 107/253 (42%), Gaps = 39/253 (15%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--------- 52
           +Q E   + +  H N+VKL+G C+      L++E+M  G L   L  +  +         
Sbjct: 55  FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHST 114

Query: 53  -----------PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 101
                      P+S   ++ IA  VA G+++L   +   ++RDL   N L+  N   K++
Sbjct: 115 SSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIA 172

Query: 102 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
           DFGL+R+  + D    S        +  PE +     T +SDV+++GVVL E+ S    +
Sbjct: 173 DFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--YGM 230

Query: 162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN 221
               G   E+ +      ++RD   VL   D              +  ++  C    P +
Sbjct: 231 QPYYGMAHEEVIY-----YVRDG-NVLSCPDNC---------PLELYNLMRLCWSKLPSD 275

Query: 222 RPSMVDVLTSLEQ 234
           RPS   +   L++
Sbjct: 276 RPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 81.3 bits (201), Expect = 6e-18
 Identities = 70/247 (28%), Positives = 109/247 (44%), Gaps = 37/247 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN-HLFRKGVQPISWPTRVKIA 63
           E+  L QLRHENLV LI          LV+EF+    L++   +  G   +      K  
Sbjct: 50  EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYL 106

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 121
             + RG+ F H    N+I+RD+K  N+L+  +   KL DFG AR    P G+   V T  
Sbjct: 107 FQILRGIEFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GE---VYTDY 160

Query: 122 VGTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGRRALDEDR------------GGL 168
           V TR Y APE +       ++ D+++ G ++ E+L+G      D             G L
Sbjct: 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNL 220

Query: 169 AE--QTLVEWADPFLRDSRRVLRIMDTR----LGGQYSKKEAQAVAAVVLQCLHMDPKNR 222
               Q + +    F       +R+ + +    L  ++ K     +  +  QCL +DP +R
Sbjct: 221 IPRHQEIFQKNPLFA-----GMRLPEVKEIEPLEKRFPKLSGLVL-DLAKQCLRIDPDDR 274

Query: 223 PSMVDVL 229
           PS   +L
Sbjct: 275 PSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 80.6 bits (199), Expect = 6e-18
 Identities = 73/247 (29%), Positives = 114/247 (46%), Gaps = 41/247 (16%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVK- 61
            E I +    H N++ L+G C  S+   L+V  +M  G L  +  R        PT VK 
Sbjct: 45  KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLR-NFIRS---ETHNPT-VKD 99

Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTH 116
                + VA+G+ +L       ++RDL A N +LD +F  K++DFGLARD       + H
Sbjct: 100 LIGFGLQVAKGMEYL--ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157

Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
             T       + A E + T   T KSDV+SFGV+L EL++        RG      +   
Sbjct: 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDV--- 206

Query: 177 ADPF-----LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 231
            D F     L   RR+L+        +Y       +  V+L C H  P+ RP+  ++++ 
Sbjct: 207 -DSFDITVYLLQGRRLLQ-------PEYC---PDPLYEVMLSCWHPKPEMRPTFSELVSR 255

Query: 232 LEQLHTS 238
           +EQ+ ++
Sbjct: 256 IEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 80.6 bits (199), Expect = 7e-18
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 37/211 (17%)

Query: 29  NRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV--KIAIDVARGLSFLHGLDANVIYRDL 85
           N+L +V E+ P G L   + ++  +    P +   +I I + RGL  LH  +  +++RDL
Sbjct: 72  NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQKILHRDL 129

Query: 86  KASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVY 145
           K++N+LL +N   K+ D G+++           T+I GT  Y APE       + KSD++
Sbjct: 130 KSANILLVANDLVKIGDLGISK---VLKKNMAKTQI-GTPHYMAPEVWKGRPYSYKSDIW 185

Query: 146 SFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF----LRDSR-RVLRIMDTRLGGQYS 200
           S G +L E+ +                      PF    ++D R +V R     +   YS
Sbjct: 186 SLGCLLYEMATFAP-------------------PFEARSMQDLRYKVQRGKYPPIPPIYS 226

Query: 201 KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 231
               Q +   +   L + PK RP+   +L S
Sbjct: 227 ----QDLQNFIRSMLQVKPKLRPNCDKILAS 253

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 81.0 bits (200), Expect = 8e-18
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 43/205 (20%)

Query: 35  EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 94
           EFM  GSL+  +++KG  PI      KIA+ V  GL++L+ +   +++RD+K SN+L++S
Sbjct: 83  EFMDCGSLDR-IYKKG-GPIPVEILGKIAVAVVEGLTYLYNVH-RIMHRDIKPSNILVNS 139

Query: 95  NFNAKLSDFGLARDGPTGD--NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL 152
               KL DFG+     +G+  N+ ++   VGT  Y +PE +  G  T KSDV+S G+ ++
Sbjct: 140 RGQIKLCDFGV-----SGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISII 193

Query: 153 ELLSGRRALDE----DRGGLAE-------QTLVEWADPFLRDSR--RVLRIMDTRLGGQY 199
           EL  G+         D G           Q +V+   P L  S     LR          
Sbjct: 194 ELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF-------- 245

Query: 200 SKKEAQAVAAVVLQCLHMDPKNRPS 224
                      V  CL  DP  RP+
Sbjct: 246 -----------VDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 81.0 bits (200), Expect = 9e-18
 Identities = 54/144 (37%), Positives = 79/144 (54%), Gaps = 10/144 (6%)

Query: 24  CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 82
           C ++ +RL  V E++  G L  H+ + G      P  V  A ++A GL FLH     +IY
Sbjct: 69  CFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH--SKGIIY 124

Query: 83  RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAAPEYVATGHLTPK 141
           RDLK  NV+LD+  + K++DFG+ ++   G  T   TR   GT  Y APE +A       
Sbjct: 125 RDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 142 SDVYSFGVVLLELLSGRRALD-ED 164
            D ++FGV+L E+L+G+   D ED
Sbjct: 182 VDWWAFGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 79.8 bits (197), Expect = 2e-17
 Identities = 46/158 (29%), Positives = 84/158 (53%), Gaps = 8/158 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E+  L  L H N+V+ +G    ++  L ++ E++P GS+ + L   G             
Sbjct: 58  EIETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFT 114

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             V  GL++LH     +++RDLKA N+L+D++   K+SDFG+++      +   +  + G
Sbjct: 115 EQVLEGLAYLH--SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172

Query: 124 TRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRR 159
           +  + APE + +     + K D++S G V+LE+ +GRR
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 79.8 bits (197), Expect = 2e-17
 Identities = 49/162 (30%), Positives = 84/162 (51%), Gaps = 17/162 (10%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL----ENHLFRKGVQPI-SWPTR 59
           E   +  + H ++V+L+G C  S    L+ + MP G L     NH    G Q + +W   
Sbjct: 59  EAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW--- 114

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVS 118
               + +A+G+S+L   +  +++RDL A NVL+ +  + K++DFGLA+     +   H  
Sbjct: 115 ---CVQIAKGMSYLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE 169

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR 159
              V  + + A E +     T KSDV+S+GV + EL++ G +
Sbjct: 170 GGKVPIK-WMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 80.0 bits (197), Expect = 2e-17
 Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 36/236 (15%)

Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FR------KGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L+V E M  G L+++L   R       G  P +    +++A ++A
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D      + +    +
Sbjct: 130 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 185
            APE +  G  T  SD++SFGVVL E+ S           LAEQ       P+  L + +
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 229

Query: 186 RVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSL-EQLHTS 238
            +  +MD   GG   + +   + V  ++  C   +PK RP+ ++++  L + LH S
Sbjct: 230 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.5 bits (197), Expect = 2e-17
 Identities = 51/158 (32%), Positives = 85/158 (53%), Gaps = 13/158 (8%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IA 63
           E+  L +L+H N+VKL+          LV+E+     L+ +L ++   P+S P  +K I 
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRP-GPLS-PNLIKSIM 104

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRI 121
             + RGL++ H     +++RDLK  N+L++ +   KL+DFGLAR    P    TH     
Sbjct: 105 YQLLRGLAYCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE---- 158

Query: 122 VGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
           V T  Y APE  + + H +   D++S G +  E+++G+
Sbjct: 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 3e-17
 Identities = 66/239 (27%), Positives = 104/239 (43%), Gaps = 48/239 (20%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+ +L Q R   + K  G   +     ++ E+   GS    L + G   +       I
Sbjct: 47  QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPG--KLDETYIAFI 103

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-- 120
             +V  GL +LH      I+RD+KA+N+LL    + KL+DFG++     G  T   ++  
Sbjct: 104 LREVLLGLEYLHE--EGKIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRN 156

Query: 121 -IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             VGT  + APE +       K+D++S G+  +EL  G                    +P
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG--------------------EP 196

Query: 180 FLRD--SRRVLRIM-----DTRLGGQYSK--KEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
            L D    RVL ++      +  G ++SK  K+       V  CL+ DPK RPS  ++L
Sbjct: 197 PLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKD------FVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.0 bits (195), Expect = 4e-17
 Identities = 65/250 (26%), Positives = 115/250 (46%), Gaps = 34/250 (13%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   LV E++P GSL ++L +K  + +     
Sbjct: 52  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKL 110

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A  + +G+ +L       ++RDL   N+L++S    K+ DFGL +  P  D  +   
Sbjct: 111 LLYASQICKGMEYLGSK--RYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKV 167

Query: 120 RIVGTRG--YAAPEYVATGHLTPKSDVYSFGVVLLELLS------------GRRALDEDR 165
           R  G     + APE +     +  SDV+SFGVVL EL +             R   ++ +
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ 227

Query: 166 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 225
           G +    L+E     L+++ R+                   + A++ +C + DP  RPS 
Sbjct: 228 GQMIVYHLIE----LLKNNGRLPAPPGC----------PAEIYAIMKECWNNDPSQRPSF 273

Query: 226 VDVLTSLEQL 235
            ++   +E +
Sbjct: 274 SELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 78.5 bits (193), Expect = 5e-17
 Identities = 45/139 (32%), Positives = 70/139 (50%), Gaps = 6/139 (4%)

Query: 21  IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN 79
           + Y  ES   L LV   M  G L+ H++  G + +     +  +  +  G+  LH +D  
Sbjct: 58  LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD-- 115

Query: 80  VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT 139
           ++YRD+K  NVLLD   N +LSD GLA +   G      T+  GT GY APE +     +
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKEEPYS 172

Query: 140 PKSDVYSFGVVLLELLSGR 158
              D ++ G  + E+++GR
Sbjct: 173 YPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 79.1 bits (196), Expect = 6e-17
 Identities = 59/165 (35%), Positives = 87/165 (52%), Gaps = 15/165 (9%)

Query: 5   EVIYLGQLRHENLVKLIGY----CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR 59
           E+  L  LRHEN++ L+        E  N + +V E M   +  + + +   QP++    
Sbjct: 49  EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVIKSP-QPLT-DDH 104

Query: 60  VK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHV 117
           ++     + RGL +LH   ANVI+RDLK SN+L++SN + K+ DFGLAR   P  D    
Sbjct: 105 IQYFLYQILRGLKYLHS--ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 118 STRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRAL 161
            T  V TR Y APE + +    T   D++S G +  ELL  R+ L
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 77.7 bits (191), Expect = 6e-17
 Identities = 50/155 (32%), Positives = 82/155 (52%), Gaps = 7/155 (4%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E   + QL +  +V++IG C E++  +LV E    G L   L  K  + I+    V++ 
Sbjct: 44  REAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDE-ITVSNVVELM 101

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             V+ G+ +L G   N ++RDL A NVLL +   AK+SDFGL++     D+++   R  G
Sbjct: 102 HQVSMGMKYLEG--KNFVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAG 158

Query: 124 T--RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                + APE +     + +SDV+S+G+ + E  S
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 6e-17
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 10/160 (6%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E+  L + +H N+V L       +   ++ EF   G+L++ +  +  + ++ P    + 
Sbjct: 51  VEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVC 109

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             +   L+FLH     VI+RDLKA N+LL  + + KL+DFG++    +      +   +G
Sbjct: 110 RQMLEALNFLH--SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIG 165

Query: 124 TRGYAAPEYVA--TGHLTP---KSDVYSFGVVLLELLSGR 158
           T  + APE VA  T    P   K+D++S G+ L+EL    
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 78.0 bits (192), Expect = 6e-17
 Identities = 64/227 (28%), Positives = 112/227 (49%), Gaps = 25/227 (11%)

Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWP-TRVKIAIDVAR 68
           L H N+++ +G C ES   LLV EF P G L+N+L   R  V  ++      ++A +VA 
Sbjct: 52  LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           GL +LH   A+ I+ DL   N  L ++ + K+ D+GLA +    D             + 
Sbjct: 112 GLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169

Query: 129 APEYVATGH-------LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           APE V            T KS+++S GV + EL +   A D+    L+++ +++     +
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT---AADQPYPDLSDEQVLKQV---V 223

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 228
           R+  + +++   +L  +YS +  +     V+Q   +DP+ RP+  +V
Sbjct: 224 RE--QDIKLPKPQLDLKYSDRWYE-----VMQFCWLDPETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 77.7 bits (192), Expect = 7e-17
 Identities = 54/153 (35%), Positives = 73/153 (47%), Gaps = 13/153 (8%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY---EFMPKGSLENHLFRKGVQPISWPTRVKIAID 65
           L +  H  +VKL  Y +  D +  +Y   E+   G L   L  +G+    +  R  IA  
Sbjct: 47  LEECNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRDRGLFD-EYTARFYIAC- 101

Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 125
           V     +LH     +IYRDLK  N+LLDSN   KL DFG A+   +G  T       GT 
Sbjct: 102 VVLAFEYLHNR--GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTP 156

Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
            Y APE +         D +S G++L ELL+GR
Sbjct: 157 EYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 77.7 bits (191), Expect = 8e-17
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 39/236 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-KGV-----QPISW 56
           + EVI L +++H N+V       E+    +V E+   G L   + R +GV     Q +SW
Sbjct: 47  KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW 106

Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNT 115
                  + ++ GL  +H  D  +++RD+K+ N+ L  N   AKL DFG+AR     D+ 
Sbjct: 107 ------FVQISLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSM 156

Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
            ++   VGT  Y +PE         K+D++S G VL EL + +                 
Sbjct: 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKH---------------- 200

Query: 176 WADPFLRDS--RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
              PF  ++  + VL+I         S   ++ + +++ Q   + P++RPS+  +L
Sbjct: 201 ---PFEGNNLHQLVLKICQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 77.6 bits (191), Expect = 9e-17
 Identities = 60/232 (25%), Positives = 104/232 (44%), Gaps = 30/232 (12%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E   L  L H N+++      E    ++V E+ P G+L  ++ ++    +   T +  
Sbjct: 47  QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHF 106

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRI 121
            + +   L  +H     +++RDLK  N+LLD +    K+ DFG+++       +   T +
Sbjct: 107 FVQILLALHHVH--TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-V 161

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           VGT  Y +PE         KSD+++ G VL EL S +RA +      A         P L
Sbjct: 162 VGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE------AANL------PAL 209

Query: 182 RDSRRVLRIMDTR---LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 230
                VL+IM      +  +YS      +  ++L  L++DP  RP +  ++ 
Sbjct: 210 -----VLKIMSGTFAPISDRYSPD----LRQLILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 77.7 bits (191), Expect = 1e-16
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 16/169 (9%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------QP 53
           +Q E   L  L+HE++VK  G C + D  ++V+E+M  G L   L   G         QP
Sbjct: 54  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113

Query: 54  ------ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 107
                 +     + IA  +A G+ +L     + ++RDL   N L+ +N   K+ DFG++R
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           D  + D   V    +    +  PE +     T +SDV+SFGV+L E+ +
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 76.8 bits (189), Expect = 2e-16
 Identities = 48/162 (29%), Positives = 91/162 (56%), Gaps = 12/162 (7%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  L +L+HEN+V+ +G   ++D+  +  E++P GS+   L   G       T V+ 
Sbjct: 54  AREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE---ETLVRN 110

Query: 63  AI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-----GPTGDNTH 116
            +  + +GL++LH     +I+RD+K +N+L+D+    K+SDFG+++        T  N  
Sbjct: 111 FVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168

Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             + + G+  + APE V     T K+D++S G +++E+L+G+
Sbjct: 169 RPS-LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           + E     +L H N+V L+         L  V+E++P  +L   L   G  P       +
Sbjct: 26  RRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG--ETGR 83

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGP-TGDNTHV 117
           + + V   L+  H  +  +++RDLK  N+++       +AK+ DFG+    P   D    
Sbjct: 84  LMLQVLDALACAH--NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVA 141

Query: 118 ----STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
               +T ++GT  Y APE +    +TP SD+Y++G++ LE L+G+R +
Sbjct: 142 TLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 6/159 (3%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
               E+  L   +H  +VKL+         +LV E+MP   L   L R   +P+      
Sbjct: 45  QALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVL-RDEERPLPEAQVK 102

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
                + +G++++H     +++RDLK +N+L+ ++   K++DFGLAR     +    S +
Sbjct: 103 SYMRMLLKGVAYMHAN--GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ 160

Query: 121 IVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 158
            V TR Y APE +       P  D+++ G +  ELL+G 
Sbjct: 161 -VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 50/158 (31%), Positives = 78/158 (49%), Gaps = 16/158 (10%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     +V E+   G+L + L               R   + ++   
Sbjct: 74  KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ FL       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 134 LVSFAYQVARGMEFLA--SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 76.7 bits (189), Expect = 3e-16
 Identities = 46/124 (37%), Positives = 73/124 (58%), Gaps = 7/124 (5%)

Query: 35  EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 94
           E M  GSL+  L + G  P +   ++ IA  V RGL++L      +++RD+K SN+L++S
Sbjct: 79  EHMDGGSLDQVLKKAGRIPENILGKISIA--VLRGLTYLRE-KHKIMHRDVKPSNILVNS 135

Query: 95  NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
               KL DFG++  G   D+  ++   VGTR Y +PE +   H T +SD++S G+ L+E+
Sbjct: 136 RGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Query: 155 LSGR 158
             GR
Sbjct: 192 AIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 77.0 bits (190), Expect = 3e-16
 Identities = 58/163 (35%), Positives = 83/163 (50%), Gaps = 14/163 (8%)

Query: 5   EVIYLGQLRHENLVKLIGY----CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR 59
           E+  L  L HEN++ +         E+ N + +VYE M     + H   +  Q +S    
Sbjct: 54  EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM---DTDLHQIIRSSQTLSDDHC 110

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
                 + RGL ++H   ANV++RDLK SN+LL++N + K+ DFGLAR   T +     T
Sbjct: 111 QYFLYQLLRGLKYIH--SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMT 166

Query: 120 RIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             V TR Y APE +      T   DV+S G +  ELL GR+ L
Sbjct: 167 EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 75.7 bits (186), Expect = 5e-16
 Identities = 54/231 (23%), Positives = 104/231 (45%), Gaps = 27/231 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  + +L H ++++++G   E  +  L  E+M  GS+ + L + G         +    
Sbjct: 53  EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTE 110

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFG----LARDGPTGDNTHVST 119
            + RGLS+LH  +  +I+RD+K +N+L+DS     +++DFG    LA  G          
Sbjct: 111 QLLRGLSYLH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG--EFQG 166

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-AD 178
           +++GT  + APE +         DV+S G V++E+ + +                 W A+
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK---------------PPWNAE 211

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                   + +I          +  +  +  V L+CL + P++RP   ++L
Sbjct: 212 KHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 75.9 bits (186), Expect = 6e-16
 Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 13/166 (7%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPI-----SW 56
           +  E   L  L+HE++VK  G C E D  ++V+E+M  G L   L   G   +     + 
Sbjct: 54  FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113

Query: 57  PTRVK------IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
           P  +       IA  +A G+ +L     + ++RDL   N L+  N   K+ DFG++RD  
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171

Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           + D   V    +    +  PE +     T +SDV+S GVVL E+ +
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 75.4 bits (185), Expect = 6e-16
 Identities = 61/207 (29%), Positives = 93/207 (44%), Gaps = 29/207 (14%)

Query: 21  IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN 79
           + Y  E+ + L LV   M  G L+ H++  G         V  A ++  GL  LH     
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QER 122

Query: 80  VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT 139
           ++YRDLK  N+LLD + + ++SD GLA   P G    +  R VGT GY APE V     T
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR-VGTVGYMAPEVVKNERYT 179

Query: 140 PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL---- 195
              D ++ G +L E+++G+                    PF +  +++ R    RL    
Sbjct: 180 FSPDWWALGCLLYEMIAGQ-------------------SPFQQRKKKIKREEVERLVKEV 220

Query: 196 GGQYSKKEAQAVAAVVLQCLHMDPKNR 222
             +YS+K +    ++    L  DPK R
Sbjct: 221 QEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 7e-16
 Identities = 70/234 (29%), Positives = 106/234 (45%), Gaps = 30/234 (12%)

Query: 3   QTEVIYLGQLRH---ENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           Q EV  L QLR     N+ K  G       RL ++ E+   GS+   L + G  PI+   
Sbjct: 47  QREVALLSQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAG--PIAEKY 102

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              I  +V   L ++H     VI+RD+KA+N+L+ +  N KL DFG+A       N+   
Sbjct: 103 ISVIIREVLVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ--NSSKR 158

Query: 119 TRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
           +  VGT  + APE +  G     K+D++S G+ + E+ +G     +     A   + +  
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK 218

Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 231
            P L D+              YSK   + VAA    CL  +PK R S  ++L S
Sbjct: 219 PPRLEDN-------------GYSKLLREFVAA----CLDEEPKERLSAEELLKS 255

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 75.8 bits (186), Expect = 7e-16
 Identities = 53/147 (36%), Positives = 77/147 (52%), Gaps = 11/147 (7%)

Query: 23  YCS--ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV 80
           YC+    ++   V EF+  G L  H+  KG   +   T    A ++  GL FLH     +
Sbjct: 62  YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY--AAEIVCGLQFLH--SKGI 117

Query: 81  IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP 140
           IYRDLK  NV+LD + + K++DFG+ ++   GDN   ++   GT  Y APE +     T 
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTF 175

Query: 141 KSDVYSFGVVLLELLSGRRAL---DED 164
             D +SFGV+L E+L G+      DED
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGDDED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 8e-16
 Identities = 47/155 (30%), Positives = 83/155 (53%), Gaps = 9/155 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E+  L  L+HE +V+  G C   D  L ++ E+MP GS+++ L   G   ++     K  
Sbjct: 54  EIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYT 110

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT--GDNTHVSTRI 121
             +  G+ +LH     +++RD+K +N+L DS  N KL DFG ++   T     T + + +
Sbjct: 111 RQILEGVEYLH--SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-V 167

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            GT  + +PE ++      K+DV+S G  ++E+L+
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 75.4 bits (185), Expect = 9e-16
 Identities = 55/155 (35%), Positives = 85/155 (54%), Gaps = 11/155 (7%)

Query: 24  CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 82
           C ++ +RL  V E++  G L  H+ + G      P  V  A +++ GL FLH     +IY
Sbjct: 69  CFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH--RRGIIY 124

Query: 83  RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAAPEYVATGHLTPK 141
           RDLK  NV+LDS  + K++DFG+ ++        V+TR   GT  Y APE +A       
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAPEIIAYQPYGKS 181

Query: 142 SDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVE 175
            D +++GV+L E+L+G+   D ED   L  Q+++E
Sbjct: 182 VDWWAYGVLLYEMLAGQPPFDGEDEDELF-QSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 74.8 bits (184), Expect = 1e-15
 Identities = 56/236 (23%), Positives = 100/236 (42%), Gaps = 30/236 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + Q  H ++VKLIG  +E +   +V E  P G L ++L +     +   + +  + 
Sbjct: 57  EAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSY 114

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  L++L       ++RD+ A NVL+ S    KL DFGL+R          S   +  
Sbjct: 115 QLSTALAYLESK--RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPI 172

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LR 182
           + + APE +     T  SDV+ FGV + E+L          G            PF  ++
Sbjct: 173 K-WMAPESINFRRFTSASDVWMFGVCMWEILM--------LG----------VKPFQGVK 213

Query: 183 DSRRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
           ++  + RI +   G +          + +++ +C   DP  RP   ++   L  + 
Sbjct: 214 NNDVIGRIEN---GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 75.2 bits (185), Expect = 1e-15
 Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 13/148 (8%)

Query: 23  YCS--ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGLSFLHGLDAN 79
           +C+    ++   V E++  G L  H+   G    +   R +  A ++  GL FLH     
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEA---RARFYAAEIICGLQFLH--KKG 116

Query: 80  VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT 139
           +IYRDLK  NVLLD + + K++DFG+ ++   G+    ++   GT  Y APE +      
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPEILKGQKYN 174

Query: 140 PKSDVYSFGVVLLELLSGRRAL---DED 164
              D +SFGV+L E+L G+      DED
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSPFHGEDED 202

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 74.5 bits (183), Expect = 1e-15
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 21/203 (10%)

Query: 21  IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN 79
           + Y  E+ + L LV   M  G L+ H++  G         V  A ++  GL  LH     
Sbjct: 65  LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RER 122

Query: 80  VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT 139
           ++YRDLK  N+LLD   + ++SD GLA + P G+   +  R VGT GY APE V     T
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGR-VGTVGYMAPEVVKNERYT 179

Query: 140 PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY 199
              D +  G ++ E++ G+    + +    E+   E  +      RRV    +      Y
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSPFRQRK----EKVKREEVE------RRVKEDQEE-----Y 224

Query: 200 SKKEAQAVAAVVLQCLHMDPKNR 222
           S+K ++A  ++  Q L  DP  R
Sbjct: 225 SEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 73.5 bits (180), Expect = 2e-15
 Identities = 61/225 (27%), Positives = 101/225 (44%), Gaps = 30/225 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   L Q  H N+V+LIG C++     +V E +  G     L  +G + +     +++  
Sbjct: 43  EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVE 101

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST---RI 121
           + A G+ +L     + I+RDL A N L+      K+SDFG++R+    D  + ST   + 
Sbjct: 102 NAAAGMEYLE--SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQ 157

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +  + + APE +  G  + +SDV+SFG++L E  S                    A P+ 
Sbjct: 158 IPVK-WTAPEALNYGRYSSESDVWSFGILLWEAFS------------------LGAVPYA 198

Query: 182 RDSRRVLRIMDTRLGGQYSKKE--AQAVAAVVLQCLHMDPKNRPS 224
             S +  R    + G +    E    AV  ++ +C   DP  RPS
Sbjct: 199 NLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 74.5 bits (183), Expect = 2e-15
 Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 13/156 (8%)

Query: 5   EVIYLGQLRHENLVKLIG-YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E+  L  LRHEN++ L   + S  ++   V E +  G+  + L      P+         
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSR--PLEKQFIQYFL 114

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             + RGL ++H   A V++RDLK SN+L++ N + K+ DFGLAR           T  V 
Sbjct: 115 YQILRGLKYVH--SAGVVHRDLKPSNILINENCDLKICDFGLAR-----IQDPQMTGYVS 167

Query: 124 TRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGR 158
           TR Y APE + T      + D++S G +  E+L G+
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 74.3 bits (183), Expect = 2e-15
 Identities = 54/157 (34%), Positives = 78/157 (49%), Gaps = 14/157 (8%)

Query: 13  RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           RH  LV L   C ++++ +  V E+   G L  H+        S P  V  A  V  GL 
Sbjct: 60  RHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQ 115

Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP-TGDNTHVSTRIVGTRGYAAP 130
           +LH  +  ++YRDLK  N+LLD+    K++DFGL ++G   GD T  ST   GT  + AP
Sbjct: 116 YLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT--ST-FCGTPEFLAP 170

Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGR---RALDED 164
           E +     T   D +  GV++ E+L G       DE+
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE 207

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 74.0 bits (182), Expect = 3e-15
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 25/203 (12%)

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTHVSTRIVG 123
           R L ++H   ANV +RDLK  N+L +++   K+ DFGLAR    D PT       T  V 
Sbjct: 114 RALKYIHT--ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT---AIFWTDYVA 168

Query: 124 TRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGR---------RALDEDRGGLAEQT 172
           TR Y APE   +     TP  D++S G +  E+L+G+           LD     L   +
Sbjct: 169 TRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228

Query: 173 LVEWADPFLRDSRRVLRIMDTRLGGQYSKK--EAQAVAAVVLQ-CLHMDPKNRPSMVDVL 229
               +      +RR L  M  +    +S+K   A  +A  +L+  L  DPK+RP+  + L
Sbjct: 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288

Query: 230 TS--LEQLHTSKDMPRTPPPAKL 250
                + L   +  P   P  KL
Sbjct: 289 ADPYFKGLAKVEREPSAQPITKL 311

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 59/176 (33%), Positives = 75/176 (42%), Gaps = 47/176 (26%)

Query: 17  LVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKI-----AIDVARG 69
           +VKL  Y S  D   L  V E+MP G L N L RK V P     R  I     A+D    
Sbjct: 63  IVKL--YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLALDSVHK 119

Query: 70  LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG----------------D 113
           L F+H        RD+K  N+L+D++ + KL+DFGL +                     D
Sbjct: 120 LGFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 114 NTHVSTR-----------IVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSG 157
           N  V  R            VGT  Y APE V  G     + D +S GV+L E+L G
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 73.0 bits (180), Expect = 4e-15
 Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 15/160 (9%)

Query: 5   EVIYLGQLRHENLVKL--IGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTR 59
           E+  L +L+H N+V +  +   S  D   +V E++    K  +E        QP      
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM-----KQPFLQSEV 108

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
             + + +  G++ LH  D  +++RDLK SN+LL++    K+ DFGLAR    G      T
Sbjct: 109 KCLMLQLLSGVAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYT 164

Query: 120 RIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
           ++V T  Y APE  +     +   D++S G +  ELL+ +
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.8 bits (178), Expect = 4e-15
 Identities = 46/159 (28%), Positives = 83/159 (52%), Gaps = 7/159 (4%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLV--YEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+  L  L+HE +V+  G   +   + L    E+MP GS+++ L  K    ++     
Sbjct: 52  ECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTR 109

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           K    +  G+S+LH     +++RD+K +N+L DS  N KL DFG ++   T   +    R
Sbjct: 110 KYTRQILEGMSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIR 167

Query: 121 -IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
            + GT  + +PE ++      K+DV+S G  ++E+L+ +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 42/148 (28%), Positives = 80/148 (54%), Gaps = 4/148 (2%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           +G L H  +V+L+G C  +  +L V +  P GSL +H+ R+    +     +   + +A+
Sbjct: 63  MGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHV-RQHRDSLDPQRLLNWCVQIAK 120

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+ +L   +  +++R+L A N+LL S+   +++DFG+A      D  +  +       + 
Sbjct: 121 GMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
           A E +  G  T +SDV+S+GV + E++S
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 52/167 (31%), Positives = 81/167 (48%), Gaps = 31/167 (18%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPI 54
           LG   H N++ L+G C       +  E+ P G+L + L +  V                +
Sbjct: 59  LGH--HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 55  SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
           +    ++ A DVA G+ +L   +   I+RDL A NVL+  N  +K++DFGL+R    G+ 
Sbjct: 117 TSQQLLQFASDVATGMQYLS--EKQFIHRDLAARNVLVGENLASKIADFGLSR----GEE 170

Query: 115 THVSTRIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLS 156
            +V      T G     ++A   L     T KSDV+SFGV+L E++S
Sbjct: 171 VYVKK----TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 73.1 bits (179), Expect = 5e-15
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 16/158 (10%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 79  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     VARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 139 LVSCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 72.6 bits (178), Expect = 5e-15
 Identities = 48/158 (30%), Positives = 83/158 (52%), Gaps = 7/158 (4%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E + LGQ  H N+V+L G  +  +  ++V E+M  G+L++ L RK    +     + + 
Sbjct: 55  AEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGML 113

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG-LARDGPTGDNTHVSTRIV 122
             +A G+ +L   +   +++ L A  VL++S+   K+S F  L  D      T +S +  
Sbjct: 114 PGLASGMKYLS--EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP 171

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR 159
               +AAPE +   H +  SDV+SFG+V+ E++S G R
Sbjct: 172 VL--WAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 73.4 bits (180), Expect = 6e-15
 Identities = 50/145 (34%), Positives = 73/145 (50%), Gaps = 8/145 (5%)

Query: 14  HENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 72
           H  L +L   C ++ +RL  V EF+  G L  H+  +  +          A ++   L F
Sbjct: 55  HPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEITSALMF 111

Query: 73  LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           LH  D  +IYRDLK  NVLLD   + KL+DFG+ ++G    N   ++   GT  Y APE 
Sbjct: 112 LH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCGTPDYIAPEI 167

Query: 133 VATGHLTPKSDVYSFGVVLLELLSG 157
           +      P  D ++ GV+L E+L G
Sbjct: 168 LQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 73.1 bits (179), Expect = 6e-15
 Identities = 55/158 (34%), Positives = 83/158 (52%), Gaps = 17/158 (10%)

Query: 24  CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 82
           C ++ +RL  V E++  G L   +  + V     P  V  A ++A GL FLH     +IY
Sbjct: 69  CFQTMDRLYFVMEYVNGGDLMYQI--QQVGRFKEPHAVFYAAEIAIGLFFLH--SKGIIY 124

Query: 83  RDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTHVSTRIVGTRGYAAPEYVATGHL 138
           RDLK  NV+LDS  + K++DFG+ +    DG T      +    GT  Y APE +A    
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT------TKTFCGTPDYIAPEIIAYQPY 178

Query: 139 TPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVE 175
               D ++FGV+L E+L+G+   + ED   L  Q+++E
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF-QSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 72.7 bits (178), Expect = 6e-15
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 21/203 (10%)

Query: 21  IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN 79
           + Y  E+ + L LV   M  G L+ H++  G         +  A ++  GL  LH    N
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--REN 122

Query: 80  VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT 139
            +YRDLK  N+LLD   + ++SD GLA   P G++  +  R VGT GY APE +     T
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGR-VGTVGYMAPEVLNNQRYT 179

Query: 140 PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY 199
              D +  G ++ E++ G+        G  E+   E  D      RRVL   +      Y
Sbjct: 180 LSPDYWGLGCLIYEMIEGQSPFR----GRKEKVKREEVD------RRVLETEEV-----Y 224

Query: 200 SKKEAQAVAAVVLQCLHMDPKNR 222
           S K ++   ++    L  DPK R
Sbjct: 225 SAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 72.9 bits (179), Expect = 8e-15
 Identities = 49/141 (34%), Positives = 76/141 (53%), Gaps = 9/141 (6%)

Query: 24  CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 82
           C ++++RL  V EF+  G L  H+ R+   P          I +A  L+FLH  +  +IY
Sbjct: 64  CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNFLH--ERGIIY 119

Query: 83  RDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK 141
           RDLK  NVLLD+  + KL+D+G+ ++G   GD T   +   GT  Y APE +        
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIAPEILRGEDYGFS 176

Query: 142 SDVYSFGVVLLELLSGRRALD 162
            D ++ GV++ E+++GR   D
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 72.3 bits (178), Expect = 1e-14
 Identities = 67/265 (25%), Positives = 109/265 (41%), Gaps = 51/265 (19%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSE-----SDNRLLVYEFMP------KGSLENHLFRKGV 51
             E+  L +L+H N+V LI    E        R  VY   P       G LEN   +   
Sbjct: 55  LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLT- 113

Query: 52  QPISWPTRVK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--- 107
                 +++K   + +  G+++LH  + ++++RD+KA+N+L+D+    K++DFGLAR   
Sbjct: 114 -----ESQIKCYMLQLLEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYD 166

Query: 108 ------DGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRA 160
                  G  G  T   T +V TR Y  PE +      T   D++  G V  E+ + R  
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226

Query: 161 L----DEDR--------GGLAEQTLVEWAD----PFLRDSRRVLRIMDTRLGGQYSKKEA 204
           L    D D+        G   E+T   W        +       R ++ R G    +   
Sbjct: 227 LQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE--- 283

Query: 205 QAVAAVVLQCLHMDPKNRPSMVDVL 229
                ++ + L +DP  R +  D L
Sbjct: 284 --GLDLLSKLLSLDPYKRLTASDAL 306

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 38/102 (37%), Positives = 57/102 (55%), Gaps = 4/102 (3%)

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           A +V   L FLH     VIYRDLK  N+LLD+  + KL+DFG+ ++G     T  +T   
Sbjct: 102 AAEVTLALMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFC 157

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDED 164
           GT  Y APE +      P  D ++ GV++ E+++G+   + D
Sbjct: 158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 72.3 bits (177), Expect = 1e-14
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 16/158 (10%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L   L               +   + +S+  
Sbjct: 76  KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLAR     D    +
Sbjct: 136 LVSCAYQVARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +       + APE +     T +SDV+SFG+++ E+ +
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.9 bits (176), Expect = 1e-14
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 29/207 (14%)

Query: 21  IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN 79
           + Y  E+ + L LV   M  G L+ H++  G         +  A ++  GL  L      
Sbjct: 65  LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RER 122

Query: 80  VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT 139
           ++YRDLK  N+LLD   + ++SD GLA   P G+   V  R VGT GY APE +     T
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGR-VGTVGYMAPEVINNEKYT 179

Query: 140 PKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI-MDTRLGG- 197
              D +  G ++ E++ G+                    PF +   RV R  +D R+   
Sbjct: 180 FSPDWWGLGCLIYEMIQGQ-------------------SPFRKRKERVKREEVDRRVKED 220

Query: 198 --QYSKKEAQAVAAVVLQCLHMDPKNR 222
             +YS+K ++   ++    L  +PK R
Sbjct: 221 QEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 71.3 bits (175), Expect = 1e-14
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 29/238 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E+  L QL H N++K +    E++   +V E    G L   +  F+K  + I   T  K 
Sbjct: 52  EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +   L  +H     +++RD+K +NV + +    KL D GL R       T  +  +V
Sbjct: 112 FVQLCSALEHMH--SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLV 167

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  Y +PE +       KSD++S G +L E                   +     PF  
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYE-------------------MAALQSPFYG 208

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAA----VVLQCLHMDPKNRPSMVDVLTSLEQLH 236
           D   +  +        Y    A   +     +V +C++ DP+ RP +  VL   +++H
Sbjct: 209 DKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 71.7 bits (176), Expect = 1e-14
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 24/202 (11%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           L ++ H  +++L  + +E D R L  + E++P G L ++L   G    S  T +  A ++
Sbjct: 55  LKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEI 110

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LH     ++YRDLK  N+LLD   + KL+DFG A+     D T     + GT  
Sbjct: 111 VCALEYLHSK--EIVYRDLKPENILLDKEGHIKLTDFGFAKK--LRDRTWT---LCGTPE 163

Query: 127 YAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTL---VEWA---D 178
           Y APE +   GH     D ++ G+++ E+L G     D++  G+ E+ L   +E+    D
Sbjct: 164 YLAPEVIQSKGHNK-AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLD 222

Query: 179 PFLRDSRRVLRIMD--TRLGGQ 198
            + +D  + L ++D   RLG  
Sbjct: 223 LYAKDLIKKLLVVDRTRRLGNM 244

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 16/158 (10%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--------------GVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L  +                + +S+  
Sbjct: 82  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 142 LVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.5 bits (175), Expect = 2e-14
 Identities = 63/188 (33%), Positives = 93/188 (49%), Gaps = 22/188 (11%)

Query: 23  YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI 81
           Y   + ++L  + + M  G L  HL + GV   S       A ++  GL  +H  +  V+
Sbjct: 64  YAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEAEMRFYAAEIILGLEHMH--NRFVV 119

Query: 82  YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK 141
           YRDLK +N+LLD + + ++SD GLA D  +    H S   VGT GY APE +  G     
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMAPEVLQKGVAYDS 175

Query: 142 S-DVYSFGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFLRDSRRVL----- 188
           S D +S G +L +LL G    R+   +D+  +   TL   VE  D F  + R +L     
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235

Query: 189 RIMDTRLG 196
           R ++ RLG
Sbjct: 236 RDVNRRLG 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 25/227 (11%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L Q     + +  G   +     ++ E++  GS  + L + G  P+       I
Sbjct: 50  QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPG--PLEETYIATI 106

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++ +GL +LH      I+RD+KA+NVLL    + KL+DFG+A  G   D        V
Sbjct: 107 LREILKGLDYLH--SERKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFV 162

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  + APE +       K+D++S G+  +EL  G    + D   +    L+    P   
Sbjct: 163 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP-NSDLHPMRVLFLIPKNSP--- 218

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                       L GQYSK   + V A    CL+ DP+ RP+  ++L
Sbjct: 219 ----------PTLEGQYSKPFKEFVEA----CLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 71.6 bits (175), Expect = 2e-14
 Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 29/162 (17%)

Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTR 59
           H N++ L+G C       L  E+ P G+L + L +  V                +S    
Sbjct: 67  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A DVARG+ +L       I+RDL A N+L+  N+ AK++DFGL+R    G   +V  
Sbjct: 127 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 180

Query: 120 RIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLS 156
               T G     ++A   L     T  SDV+S+GV+L E++S
Sbjct: 181 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 72.0 bits (176), Expect = 2e-14
 Identities = 49/141 (34%), Positives = 77/141 (54%), Gaps = 9/141 (6%)

Query: 24  CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 82
           C ++ +RL LV E++  G L  H+ R+   P          I +A  L+FLH  +  +IY
Sbjct: 64  CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA--LNFLH--ERGIIY 119

Query: 83  RDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK 141
           RDLK  NVLLD++ + KL+D+G+ ++G   GD T   +   GT  Y APE +        
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPEILRGEEYGFS 176

Query: 142 SDVYSFGVVLLELLSGRRALD 162
            D ++ GV++ E+++GR   D
Sbjct: 177 VDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 71.6 bits (176), Expect = 2e-14
 Identities = 55/172 (31%), Positives = 80/172 (46%), Gaps = 39/172 (22%)

Query: 5   EVIYLGQLRHENLVKL---------------IGYCSESDNRLLVYEFMPKGSLENHLFRK 49
           E+  L  LRH N+V+L               + YC +    LL  + MP           
Sbjct: 56  EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL--DNMP----------- 102

Query: 50  GVQPISWPTRVK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
              P S   +VK + + + RGL +LH  +  +I+RDLK SN+LL      K++DFGLAR 
Sbjct: 103 --TPFSES-QVKCLMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR- 156

Query: 109 GPTGDNTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 158
              G      T  V T  Y APE +   T + T   D+++ G +L ELL+ +
Sbjct: 157 -TYGLPAKPMTPKVVTLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 58/167 (34%), Positives = 75/167 (44%), Gaps = 33/167 (19%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFM-----------PKGSLENHLFRKGVQP 53
           E+  L QL+H NLV LI          LV+E+            P+G +  HL +K    
Sbjct: 50  EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKK---- 104

Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPT 111
           I W T         + ++F H    N I+RD+K  N+L+      KL DFG AR   GP 
Sbjct: 105 IIWQT--------LQAVNFCHKH--NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154

Query: 112 GDNTHVSTRIVGTRGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSG 157
            D T      V TR Y APE  V      P  DV++ G V  ELL+G
Sbjct: 155 DDYTDY----VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 3e-14
 Identities = 45/138 (32%), Positives = 70/138 (50%), Gaps = 8/138 (5%)

Query: 23  YCS--ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV 80
           YC+    +N   V E++  G L  H+  +       P     A ++  GL FLH     +
Sbjct: 62  YCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLH--SKGI 117

Query: 81  IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP 140
           +YRDLK  N+LLD++ + K++DFG+ ++   GD    +    GT  Y APE +       
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAPEILLGQKYNT 175

Query: 141 KSDVYSFGVVLLELLSGR 158
             D +SFGV+L E+L G+
Sbjct: 176 SVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 71.2 bits (174), Expect = 3e-14
 Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 6/151 (3%)

Query: 7   IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + L  ++H  LV L      ++    V +F+  G L  HL R+   P   P     A ++
Sbjct: 48  VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFP--EPRARFYAAEI 105

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           A  L +LH +  N++YRDLK  N+LLDS  +  L+DFGL ++G    +T  +T   GT  
Sbjct: 106 ASALGYLHSI--NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPE 161

Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 71.2 bits (174), Expect = 3e-14
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 9/162 (5%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           QTE     Q  +   +  +  C ++++RL  V E++  G L  H+ R+   P        
Sbjct: 43  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 102

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTR 120
             I +A  L++LH  +  +IYRDLK  NVLLDS  + KL+D+G+ ++G   GD T   + 
Sbjct: 103 AEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---ST 155

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 162
             GT  Y APE +         D ++ GV++ E+++GR   D
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 3e-14
 Identities = 50/175 (28%), Positives = 78/175 (44%), Gaps = 24/175 (13%)

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD--NTHVS 118
           KIA+   + L++L   +  +I+RD+K SN+LLD N N KL DFG++     G   ++   
Sbjct: 111 KIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGIS-----GQLVDSIAK 164

Query: 119 TRIVGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
           TR  G R Y APE +          +SDV+S G+ L E+ +G+    +      + T V 
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV 224

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 230
             DP          I+      ++S      +      CL  D   RP   ++L 
Sbjct: 225 KGDP---------PILSNSEEREFSPSFVNFINL----CLIKDESKRPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 70.8 bits (173), Expect = 3e-14
 Identities = 44/170 (25%), Positives = 81/170 (47%), Gaps = 17/170 (10%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP-------- 53
           +Q E   + +L H N+V L+G  ++     +++E++ +G L   L  +            
Sbjct: 54  FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113

Query: 54  -------ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 106
                  +     + IAI +A G+ +L       +++DL A N+L+    + K+SD GL+
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLS 171

Query: 107 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R+  + D   V  + +    +  PE +  G  +  SD++SFGVVL E+ S
Sbjct: 172 REIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 70.7 bits (173), Expect = 4e-14
 Identities = 59/232 (25%), Positives = 104/232 (44%), Gaps = 35/232 (15%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP--ISWPTRVKI 62
           E++ + + +H N+V  +      D   +V E++  GSL + +    +    I+   R   
Sbjct: 66  EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR--- 122

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTHVSTRI 121
             +  + L FLH     VI+RD+K+ N+LL  + + KL+DFG  A+  P        + +
Sbjct: 123 --ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTM 175

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           VGT  + APE V      PK D++S G++ +E                   +VE   P+L
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE-------------------MVEGEPPYL 216

Query: 182 RDSR-RVLRIMDTRLGGQYSKKEAQAVA--AVVLQCLHMDPKNRPSMVDVLT 230
            ++  R L ++ T    +    E  +      + +CL MD + R S  ++L 
Sbjct: 217 NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 70.2 bits (172), Expect = 4e-14
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 16/162 (9%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+     L+H N+V+ +G  SE+    +  E +P GSL   L  K G    +  T +   
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFG----LARDGPTGDNTHVS 118
             +  GL +LH  D  +++RD+K  NVL+++     K+SDFG    LA   P       +
Sbjct: 115 KQILEGLKYLH--DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CT 166

Query: 119 TRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGR 158
               GT  Y APE +  G       +D++S G  ++E+ +G+
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.3 bits (173), Expect = 4e-14
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 28/166 (16%)

Query: 5   EVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-----RKGVQPISWPT 58
           EV  L +L  H N+VKL     E+D    V+E+M     E +L+     RKG +P S   
Sbjct: 47  EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKG-KPFSESV 100

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              I   + +GL+ +H       +RDLK  N+L+      K++DFGLAR         + 
Sbjct: 101 IRSIIYQILQGLAHIH--KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--------EIR 150

Query: 119 -----TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 158
                T  V TR Y APE +  +   +   D+++ G ++ EL + R
Sbjct: 151 SRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 69.7 bits (171), Expect = 5e-14
 Identities = 65/241 (26%), Positives = 103/241 (42%), Gaps = 44/241 (18%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L  L+H NLVK  G     +   +  E+   G+LE  L    +       RV   +
Sbjct: 49  EMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-IRV-YTL 106

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +  GL++LH     +++RD+K +N+ LD N   KL DFG A    +  T     V + +
Sbjct: 107 QLLEGLAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS-L 163

Query: 122 VGTRGYAAPEYVATGHLTPK---SDVYSFGVVLLELLSGRR---ALDEDRGGLAEQTLVE 175
            GT  Y APE +  G        +D++S G V+LE+ +G+R    LD            E
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-----------E 212

Query: 176 WADPFLRDSRRVLRIMDTRLGGQY------SKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           +             IM   +G  +      S + +      + +CL  DPK RP+  ++L
Sbjct: 213 FQ------------IM-FHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELL 259

Query: 230 T 230
            
Sbjct: 260 Q 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 70.6 bits (173), Expect = 5e-14
 Identities = 52/152 (34%), Positives = 75/152 (49%), Gaps = 8/152 (5%)

Query: 7   IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AID 65
           + L  ++H  LV L      +D    V +++  G L  HL R+   P     R +  A +
Sbjct: 48  VLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP---RARFYAAE 104

Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 125
           +A  L +LH L  N+IYRDLK  N+LLDS  +  L+DFGL ++G     T  ++   GT 
Sbjct: 105 IASALGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTP 160

Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            Y APE +         D +  G VL E+L G
Sbjct: 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 70.9 bits (174), Expect = 5e-14
 Identities = 42/110 (38%), Positives = 65/110 (59%), Gaps = 8/110 (7%)

Query: 52  QPISWPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
           QP+S    VK+ +  + RGL +LH   A +++RD+K  N+L++SN   K+ DFGLAR   
Sbjct: 98  QPLS-SDHVKVFLYQILRGLKYLHS--AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154

Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 158
             ++ H++  +V T+ Y APE +  G  H T   D++S G +  ELL  R
Sbjct: 155 PDESKHMTQEVV-TQYYRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 70.2 bits (172), Expect = 6e-14
 Identities = 45/159 (28%), Positives = 78/159 (49%), Gaps = 19/159 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           EV+ +   +H N+V++       D   +V EF+  G+L +         I   TR+    
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQ 116

Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              + + V + LSFLH     VI+RD+K+ ++LL S+   KLSDFG              
Sbjct: 117 IATVCLAVLKALSFLHA--QGVIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRR 172

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             +VGT  + APE ++      + D++S G++++E++ G
Sbjct: 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 70.4 bits (173), Expect = 6e-14
 Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 23/199 (11%)

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTR 125
           RGL ++H   ANVI+RDLK SN+L++ +   ++ DFG+AR       ++ +  T  V TR
Sbjct: 118 RGLKYIHS--ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175

Query: 126 GYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDR-------------GGLAEQ 171
            Y APE + +    T   D++S G +  E+L GRR L   +             G  +E+
Sbjct: 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQLFPGKNYVHQLKLILSVLGSPSEE 234

Query: 172 TLVEWADPFLRDSRRVL-RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 230
            L       +R   + L R         + K   +A+  ++ Q L  DP+ R ++   L 
Sbjct: 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEAL-DLLSQMLQFDPEERITVEQALQ 293

Query: 231 S--LEQLHTSKDMPRTPPP 247
              L Q H   D P  PPP
Sbjct: 294 HPFLAQYHDPDDEPTCPPP 312

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 70.4 bits (172), Expect = 6e-14
 Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 6/151 (3%)

Query: 7   IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + L  L+H  LV L      ++    V +++  G L  HL R+  +    P     A +V
Sbjct: 48  VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEV 105

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           A  + +LH L  N+IYRDLK  N+LLDS  +  L+DFGL ++G   + T  ++   GT  
Sbjct: 106 ASAIGYLHSL--NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPE 161

Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 69.8 bits (171), Expect = 7e-14
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 28/175 (16%)

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD--NTHVS 118
           KIA+ + + L +LH    +VI+RD+K SNVL++ N   KL DFG+     +G   ++   
Sbjct: 107 KIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGI-----SGYLVDSVAK 160

Query: 119 TRIVGTRGYAAPEYV----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
           T   G + Y APE +           KSDV+S G+ ++EL +GR   D            
Sbjct: 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD------------ 208

Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
            W  PF +  ++V+     +L  +    E Q     V +CL  + K RP+  ++L
Sbjct: 209 SWKTPF-QQLKQVVEEPSPQLPAEKFSPEFQ---DFVNKCLKKNYKERPNYPELL 259

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 55/175 (31%), Positives = 85/175 (48%), Gaps = 11/175 (6%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R + 
Sbjct: 44  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 99

Query: 63  -AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L +LH    +V+YRD+K  N++LD + + K++DFGL ++G +   T  +   
Sbjct: 100 YGAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--F 155

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
            GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 210

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 55/151 (36%), Positives = 83/151 (54%), Gaps = 10/151 (6%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L ++ H  +VKL  Y  +++ +L L+ +F+  G L   L  K V       +  +A ++A
Sbjct: 52  LAEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELA 108

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
             L  LH L   +IYRDLK  N+LLD   + KL+DFGL+++    +    S    GT  Y
Sbjct: 109 LALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 164

Query: 128 AAPEYV-ATGHLTPKSDVYSFGVVLLELLSG 157
            APE V   GH T  +D +SFGV++ E+L+G
Sbjct: 165 MAPEVVNRRGH-TQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.3 bits (167), Expect = 2e-13
 Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 14/160 (8%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L  +R    +  + Y  ++D +L L+ +++  G L  HL+++     S    V++
Sbjct: 53  TERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRV 109

Query: 63  AI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVST 119
            I ++   L  LH L   +IYRD+K  N+LLDS  +  L+DFGL+++      +  +   
Sbjct: 110 YIAEIVLALDHLHQL--GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY--- 164

Query: 120 RIVGTRGYAAPEYVATGHLTPKS--DVYSFGVVLLELLSG 157
              GT  Y APE +  G        D +S GV+  ELL+G
Sbjct: 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)

Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 47  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 106

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 107 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 159

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 68.3 bits (167), Expect = 3e-13
 Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 9/174 (5%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V   S       
Sbjct: 44  TESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFY 100

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++   L +LH    +V+YRDLK  N++LD + + K++DFGL ++G +   T       
Sbjct: 101 GAEIVSALGYLH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFC 156

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
           GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 54/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)

Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L  K  + I    
Sbjct: 47  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEI 104

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
             K++I V RGL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 105 LGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 159

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+EL  GR
Sbjct: 160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 16/158 (10%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               +   + +++  
Sbjct: 76  KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 136 LVSCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 3e-13
 Identities = 44/158 (27%), Positives = 84/158 (53%), Gaps = 9/158 (5%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+  L  LRH+ +V+  G   + + + L    E+MP GS+++ L  K    ++     
Sbjct: 52  ECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTR 109

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT--GDNTHVS 118
           +    + +G+S+LH     +++RD+K +N+L DS  N KL DFG ++   T     T + 
Sbjct: 110 RYTRQILQGVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIK 167

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           + + GT  + +PE ++      K+DV+S    ++E+L+
Sbjct: 168 S-VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 68.2 bits (166), Expect = 3e-13
 Identities = 56/174 (32%), Positives = 84/174 (48%), Gaps = 9/174 (5%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E++  G L  HL R+ V   S       
Sbjct: 44  TESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFY 100

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++   L +LH     ++YRDLK  N++LD + + K++DFGL ++G T   T  +    
Sbjct: 101 GAEIVSALDYLH--SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FC 156

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
           GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 210

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 67.3 bits (164), Expect = 4e-13
 Identities = 47/148 (31%), Positives = 80/148 (54%), Gaps = 8/148 (5%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           QL +  +V++IG C E+++ +LV E    G L  + F +  + ++     ++   V+ G+
Sbjct: 52  QLDNPYIVRMIGIC-EAESWMLVMELAELGPL--NKFLQKNKHVTEKNITELVHQVSMGM 108

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT--RGYA 128
            +L   + N ++RDL A NVLL +   AK+SDFGL++     D  +   +  G     + 
Sbjct: 109 KYLE--ETNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWY 165

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
           APE +     + KSDV+SFGV++ E  S
Sbjct: 166 APECMNYYKFSSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.5 bits (165), Expect = 4e-13
 Identities = 53/157 (33%), Positives = 88/157 (56%), Gaps = 9/157 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IA 63
           E+  + +L+HEN+V+L       +  +LV+E+M K  L+ ++   GV+    P  VK   
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             + +G++F H  +  V++RDLK  N+L++     KL+DFGLAR      NT  S  +V 
Sbjct: 107 YQLLKGIAFCH--ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV- 162

Query: 124 TRGYAAPEYVATGHLTPKS--DVYSFGVVLLELLSGR 158
           T  Y AP+ V  G  T  +  D++S G ++ E+++GR
Sbjct: 163 TLWYRAPD-VLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 39/95 (41%), Positives = 57/95 (60%), Gaps = 7/95 (7%)

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGT 124
            GL ++H   ANV++RDLK  N+L++++   K+ DFGLAR   + P G+N    T  V T
Sbjct: 116 CGLKYIH--SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP-GENAGFMTEYVAT 172

Query: 125 RGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
           R Y APE + +     K+ DV+S G +L ELL  +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.7 bits (166), Expect = 5e-13
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 18/157 (11%)

Query: 9   LGQLRHENLVKLIG-YCSESDNR-----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           L  + HEN++ L+  +   S         LV   M  G+  N++ +   Q +S      +
Sbjct: 68  LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKC--QKLSDDHIQFL 123

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              + RGL ++H   A +I+RDLK SN+ ++ +   K+ DFGLAR           T  V
Sbjct: 124 VYQILRGLKYIHS--AGIIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYV 176

Query: 123 GTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 158
            TR Y APE +    H     D++S G ++ ELL+G+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 67.3 bits (164), Expect = 5e-13
 Identities = 69/229 (30%), Positives = 108/229 (47%), Gaps = 35/229 (15%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR-V 60
           +TE   L  +R    +  + Y  ++D +L L+ +++  G L  HL     Q   +  + V
Sbjct: 52  RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEV 107

Query: 61  KIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +I   ++   L  LH L   +IYRD+K  N+LLDSN +  L+DFGL+++    D    + 
Sbjct: 108 QIYSGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAY 164

Query: 120 RIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRR--ALDEDRGGLAEQTLV 174
              GT  Y AP+ V     GH     D +S GV++ ELL+G     +D ++   AE    
Sbjct: 165 SFCGTIEYMAPDIVRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI--- 220

Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM-DPKNR 222
                    SRR+L+            +E  A+A  ++Q L M DPK R
Sbjct: 221 ---------SRRILK------SEPPYPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 67.6 bits (165), Expect = 6e-13
 Identities = 56/174 (32%), Positives = 86/174 (49%), Gaps = 26/174 (14%)

Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV---STRIV 122
           VARG+ FL       I+RDL A N+LL  N   K+ DFGLARD    D  +V     R+ 
Sbjct: 182 VARGMEFLA--SRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYVRKGDARL- 237

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + APE +     T +SDV+SFGV+L E+ S          G +    V+  + F R
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LGASPYPGVQIDEEFCR 287

Query: 183 DSRRVLRIMDTRLGG-QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
             +       TR+   +Y+  E   + +++L C H +P++RP+  +++  L  L
Sbjct: 288 RLKE-----GTRMRAPEYATPE---IYSIMLDCWHNNPEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 67.0 bits (163), Expect = 6e-13
 Identities = 61/182 (33%), Positives = 88/182 (48%), Gaps = 21/182 (11%)

Query: 28  DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 87
           D    + + M  G L  HL + GV   S       A ++  GL  +H  +  V+YRDLK 
Sbjct: 70  DKLCFILDLMNGGDLHYHLSQHGV--FSEKEMRFYATEIILGLEHMH--NRFVVYRDLKP 125

Query: 88  SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS-DVYS 146
           +N+LLD + + ++SD GLA D  +    H S   VGT GY APE +  G     S D +S
Sbjct: 126 ANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMAPEVLQKGTAYDSSADWFS 181

Query: 147 FGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFLRDSRRVL-----RIMDTR 194
            G +L +LL G    R+   +D+  +   TL   VE  D F  + + +L     R +  R
Sbjct: 182 LGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKR 241

Query: 195 LG 196
           LG
Sbjct: 242 LG 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 67.0 bits (163), Expect = 6e-13
 Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 29/162 (17%)

Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTR 59
           H N++ L+G C       L  E+ P G+L + L +  V                +S    
Sbjct: 55  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A DVARG+ +L       I+RDL A N+L+  N+ AK++DFGL+R    G   +V  
Sbjct: 115 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 168

Query: 120 RIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLS 156
               T G     ++A   L     T  SDV+S+GV+L E++S
Sbjct: 169 ----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 68.0 bits (166), Expect = 6e-13
 Identities = 52/169 (30%), Positives = 75/169 (44%), Gaps = 37/169 (21%)

Query: 69  GLSFLHGLDA-------NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           GL F+  L A       ++I+RD+K++N+LL SN   KL DFG ++      +  V    
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
            GT  Y APE       + K+D++S GV+L ELL+ +R                   PF 
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKR-------------------PF- 245

Query: 182 RDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPS 224
            D   +  +M   L G+Y         E Q +   +L     DPK RPS
Sbjct: 246 -DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSS---DPKRRPS 290

Length = 496

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.0 bits (164), Expect = 7e-13
 Identities = 44/122 (36%), Positives = 67/122 (54%), Gaps = 18/122 (14%)

Query: 46  LFRKGVQPISWPTRV--KIAIDVARGLSFL---HGLDANVIYRDLKASNVLLDSNFNAKL 100
           L ++   PI  P  +  K+ + + + L +L   HG    VI+RD+K SN+LLD++ N KL
Sbjct: 103 LLKRIQGPI--PEDILGKMTVAIVKALHYLKEKHG----VIHRDVKPSNILLDASGNVKL 156

Query: 101 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK----SDVYSFGVVLLELLS 156
            DFG++  G   D +   TR  G   Y APE +      PK    +DV+S G+ L+EL +
Sbjct: 157 CDFGIS--GRLVD-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT 213

Query: 157 GR 158
           G+
Sbjct: 214 GQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 66.6 bits (162), Expect = 7e-13
 Identities = 63/227 (27%), Positives = 98/227 (43%), Gaps = 25/227 (11%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L Q     + K  G   +     ++ E++  GS  + L   G  P+       I
Sbjct: 50  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATI 106

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++ +GL +LH      I+RD+KA+NVLL  +   KL+DFG+A  G   D        V
Sbjct: 107 LREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFV 162

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  + APE +       K+D++S G+  +EL  G     E    +    L+   +P   
Sbjct: 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH-PMKVLFLIPKNNP--- 218

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                       L G YSK   + V A    CL+ +P  RP+  ++L
Sbjct: 219 ----------PTLEGNYSKPLKEFVEA----CLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 66.4 bits (162), Expect = 9e-13
 Identities = 52/159 (32%), Positives = 84/159 (52%), Gaps = 9/159 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E+  L +L H N+VKL+     ++N+L LV+EF+ +  L+  +    +  I  P      
Sbjct: 49  EISLLKELNHPNIVKLLDVI-HTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYL 106

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V 
Sbjct: 107 FQLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVV 162

Query: 124 TRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
           T  Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 59/191 (30%), Positives = 89/191 (46%), Gaps = 33/191 (17%)

Query: 53  PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
           P++    +  +  VARG+ FL       I+RDL A N+LL  N   K+ DFGLARD    
Sbjct: 170 PLTMEDLICYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYK 226

Query: 113 DNTHV---STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 169
           D  +V   S R+     + APE +     T +SDV+SFGV+L E+ S          G +
Sbjct: 227 DPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS---------LGAS 275

Query: 170 EQTLVEWADPF---LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-- 224
               V+  + F   L+D  R+          +  +     +  ++L C   DPK RP+  
Sbjct: 276 PYPGVQINEEFCQRLKDGTRM----------RAPENATPEIYRIMLACWQGDPKERPTFS 325

Query: 225 -MVDVLTSLEQ 234
            +V++L  L Q
Sbjct: 326 ALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.2 bits (161), Expect = 1e-12
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 25/227 (11%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L Q     + K  G   +     ++ E++  GS  + L R G  P        +
Sbjct: 50  QQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAG--PFDEFQIATM 106

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++ +GL +LH      I+RD+KA+NVLL    + KL+DFG+A  G   D        V
Sbjct: 107 LKEILKGLDYLH--SEKKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFV 162

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  + APE +       K+D++S G+  +EL  G    + D   +    L+   +P   
Sbjct: 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP-NSDMHPMRVLFLIPKNNP--- 218

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                       L G++SK   + + A    CL+ DP  RP+  ++L
Sbjct: 219 ----------PTLTGEFSKPFKEFIDA----CLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 66.6 bits (162), Expect = 1e-12
 Identities = 58/174 (33%), Positives = 85/174 (48%), Gaps = 8/174 (4%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V   S       
Sbjct: 44  TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFY 100

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++   L +LH  + NV+YRDLK  N++LD + + K++DFGL ++G   D   + T   
Sbjct: 101 GAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FC 157

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
           GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 211

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 65.7 bits (161), Expect = 1e-12
 Identities = 59/231 (25%), Positives = 99/231 (42%), Gaps = 31/231 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN--HLFRKGVQPISWPTRVKI 62
           E+  L Q     +VK  G   ++ +  +V E+   GS+ +   +  K +      T  +I
Sbjct: 48  EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTL------TEEEI 101

Query: 63  AI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           A       +GL +LH      I+RD+KA N+LL+    AKL+DFG++  G   D      
Sbjct: 102 AAILYQTLKGLEYLH--SNKKIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRN 157

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
            ++GT  + APE +       K+D++S G+  +E+  G+    +     A   +     P
Sbjct: 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP 217

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 230
            L D                 +K +      V +CL  DP+ RPS + +L 
Sbjct: 218 TLSD----------------PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 66.3 bits (161), Expect = 1e-12
 Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 7/153 (4%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++ + +L++ N+V  +      D   +V E++  GSL + +    +          +  
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA---VCR 122

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           +  + L FLH     VI+RD+K+ NVLL  + + KL+DFG      T + +  ST +VGT
Sbjct: 123 ECLQALEFLHA--NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGT 178

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             + APE V      PK D++S G++ +E++ G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 65.1 bits (159), Expect = 2e-12
 Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 11/158 (6%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E+  L +L+H N+V L     + ++RL L++EF+    L+ +L             VK  
Sbjct: 49  EISLLKELQHPNIVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSY 106

Query: 64  I-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           +  + +G+ F H     V++RDLK  N+L+D+    KL+DFGLAR    G    V T  V
Sbjct: 107 LYQILQGILFCHS--RRVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEV 162

Query: 123 GTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 158
            T  Y APE +  +  + TP  D++S G +  E+ + +
Sbjct: 163 VTLWYRAPEVLLGSPRYSTP-VDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.8 bits (160), Expect = 2e-12
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 6/151 (3%)

Query: 7   IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + L  ++H  LV L      +D    V +++  G L  HL R+  +    P     A ++
Sbjct: 48  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEI 105

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           A  L +LH L  N++YRDLK  N+LLDS  +  L+DFGL ++    + T  ++   GT  
Sbjct: 106 ASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPE 161

Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y APE +         D +  G VL E+L G
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 7/159 (4%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+  L  L HE +V+  G   +   R L    E MP GS+++ L  K    ++     
Sbjct: 52  ECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTR 109

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           K    +  G+S+LH     +++RD+K +N+L DS  N KL DFG ++   T   +    +
Sbjct: 110 KYTRQILEGVSYLH--SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167

Query: 121 -IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
            + GT  + +PE ++      K+D++S G  ++E+L+ +
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 65.0 bits (158), Expect = 3e-12
 Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 15/157 (9%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVKI 62
           EV+ +   +HEN+V++       D   +V EF+  G+L + +   R   + I+      +
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AV 121

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-- 120
            + V + LS LH     VI+RD+K+ ++LL  +   KLSDFG         +  V  R  
Sbjct: 122 CLAVLKALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV----SKEVPRRKS 175

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           +VGT  + APE ++     P+ D++S G++++E++ G
Sbjct: 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 65.2 bits (159), Expect = 3e-12
 Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 31/160 (19%)

Query: 9   LGQLRHENLVKLIGYCS-ESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           L +L H  +V +   CS + +NR+  + EF+  G L  HL + G          +   DV
Sbjct: 72  LMELSHPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHLRKAG----------RFPNDV 119

Query: 67  AR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           A+           +LH  D  +IYRDLK  N+LLD+  + K++DFG A+  P  D T   
Sbjct: 120 AKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT- 174

Query: 119 TRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSG 157
             + GT  Y APE + + GH     D ++ GV+L E ++G
Sbjct: 175 --LCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 65.1 bits (158), Expect = 3e-12
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 7/208 (3%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV+ +    HEN+V +       D   +V EF+  G+L + +    +      T   + +
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCL 125

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            V R LS+LH  +  VI+RD+K+ ++LL S+   KLSDFG                +VGT
Sbjct: 126 SVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGT 181

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 184
             + APE ++      + D++S G++++E++ G      +    A + + +   P ++DS
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS 241

Query: 185 RRVLRIMDTRLGGQYSKKEAQAVAAVVL 212
            +V  ++   L     ++ +Q   A  L
Sbjct: 242 HKVSSVLRGFLDLMLVREPSQRATAQEL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 64.2 bits (156), Expect = 5e-12
 Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 12/154 (7%)

Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWP---TRVKIAIDVAR 68
           L+H NL++ +G C+E    LLV EF P G L+ +L       +  P   T  ++A ++A 
Sbjct: 52  LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           GL  LH    N I+ DL   N LL ++   K+ D+GL+ +    D      ++     + 
Sbjct: 112 GLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWI 169

Query: 129 APEYVATGH-------LTPKSDVYSFGVVLLELL 155
           APE V   H        T +S+V+S GV + EL 
Sbjct: 170 APELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.1 bits (156), Expect = 5e-12
 Identities = 56/225 (24%), Positives = 96/225 (42%), Gaps = 33/225 (14%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFM---PKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           QLRH N+V+      E+D   +V + +   P G   N L  K  Q  +      I + + 
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWNIFVQMV 123

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
             L +LH  +  +++RDL  +N++L  +    ++DFGLA+       + + T +VGT  Y
Sbjct: 124 LALRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ--KQPESKL-TSVVGTILY 179

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
           + PE V       K+DV++FG +L +                   +     PF   S  +
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQ-------------------MCTLQPPFY--STNM 218

Query: 188 LRIMDTRLGGQYSKKE----AQAVAAVVLQCLHMDPKNRPSMVDV 228
           L +    +   Y        ++ V  V+  CL  D + RP ++ V
Sbjct: 219 LSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 6e-12
 Identities = 43/158 (27%), Positives = 67/158 (42%), Gaps = 5/158 (3%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E+  L  + H  ++ LI        +  V   MPK   +   +     P+     + I 
Sbjct: 135 REIDILKTISHRAIINLIHAYR---WKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQ 191

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             +   L++LHG    +I+RD+K  N+ LD   NA L DFG A       +T       G
Sbjct: 192 RRLLEALAYLHG--RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
           T    +PE +A      K+D++S G+VL E+      L
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (157), Expect = 6e-12
 Identities = 55/168 (32%), Positives = 83/168 (49%), Gaps = 12/168 (7%)

Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNV 90
           LV  F+  G L +HL R+G   +   +R +    ++   L  LH    NVIYRDLK  N+
Sbjct: 70  LVLAFINGGELFHHLQREGRFDL---SRARFYTAELLCALENLHKF--NVIYRDLKPENI 124

Query: 91  LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 150
           LLD   +  L DFGL +     D+   +    GT  Y APE +     T   D ++ GV+
Sbjct: 125 LLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVL 182

Query: 151 LLELLSGRRAL-DEDRGGLAEQTLVE---WADPFLRDSRRVLRIMDTR 194
           L E+L+G     DE+   +  + L E   + D F RD++ +L  + +R
Sbjct: 183 LYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR 230

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 64.5 bits (157), Expect = 7e-12
 Identities = 38/109 (34%), Positives = 56/109 (51%), Gaps = 2/109 (1%)

Query: 48  RKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 107
            +   P+     ++ +  VA+G+ FL     N I+RD+ A NVLL     AK+ DFGLAR
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFLAS--KNCIHRDVAARNVLLTDGRVAKICDFGLAR 260

Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           D     N  V         + APE +     T +SDV+S+G++L E+ S
Sbjct: 261 DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 64.7 bits (157), Expect = 7e-12
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 26/206 (12%)

Query: 34  YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD 93
           Y+      ++N L   G + ++    +     VARG+ FL     N ++RDL A NVLL 
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLA 271

Query: 94  SNFNAKLSDFGLARDGPTGDNTHVS--TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL 151
                K+ DFGLARD    D+ +VS  +  +  + + APE +     T  SDV+S+G++L
Sbjct: 272 QGKIVKICDFGLARD-IMHDSNYVSKGSTFLPVK-WMAPESIFDNLYTTLSDVWSYGILL 329

Query: 152 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKE--AQAVAA 209
            E+ S         GG     ++        DS    +I   + G + +K +   Q V  
Sbjct: 330 WEIFS--------LGGTPYPGMIV-------DSTFYNKI---KSGYRMAKPDHATQEVYD 371

Query: 210 VVLQCLHMDPKNRPSMVDVLTSLEQL 235
           ++++C + +P+ RPS + +   +E L
Sbjct: 372 IMVKCWNSEPEKRPSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.3 bits (154), Expect = 9e-12
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 16/164 (9%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGV-----QPISWPT 58
           EV  L  ++H N+V+      E+ N  +V ++   G L   +  ++GV     Q + W  
Sbjct: 49  EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV 108

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           ++ +A+         H  D  +++RD+K+ N+ L  +   KL DFG+AR         ++
Sbjct: 109 QICLALK--------HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELA 158

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 162
              +GT  Y +PE         KSD+++ G VL E+ + + A +
Sbjct: 159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 64.1 bits (156), Expect = 9e-12
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 31/167 (18%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L  + H N+VK       +    ++ EFM  GSLE                     
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQF----------LA 171

Query: 65  DVAR----GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVST 119
           DVAR    G+++LH    ++++RD+K SN+L++S  N K++DFG++R    T D  + S 
Sbjct: 172 DVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228

Query: 120 RIVGTRGYAAPEYVAT--------GHLTPKSDVYSFGVVLLELLSGR 158
             VGT  Y +PE + T        G+     D++S GV +LE   GR
Sbjct: 229 --VGTIAYMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 63.7 bits (155), Expect = 1e-11
 Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 12/152 (7%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L  ++H  +V LI Y  ++  +L L+ E++  G L  HL R+G+      T      +++
Sbjct: 54  LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDTACFYLSEIS 110

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN-THVSTRIVGTRG 126
             L  LH     +IYRDLK  N+LLD+  + KL+DFGL ++       TH      GT  
Sbjct: 111 LALEHLHQQ--GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIE 165

Query: 127 YAAPEYVA-TGHLTPKSDVYSFGVVLLELLSG 157
           Y APE +  +GH     D +S G ++ ++L+G
Sbjct: 166 YMAPEILMRSGH-GKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 37/91 (40%), Positives = 50/91 (54%), Gaps = 2/91 (2%)

Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR 125
           VA+G+SFL     N I+RDL A N+LL      K+ DFGLARD     N  V        
Sbjct: 223 VAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + APE +     T +SDV+S+G++L E+ S
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 14/158 (8%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L + RH N+V   G     D   +V E+   GSL++ +++    P+S      +
Sbjct: 48  QQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYV 106

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-- 120
             +  +GL++LH      I+RD+K +N+LL  + + KL+DFG++        T    +  
Sbjct: 107 CRETLKGLAYLHET--GKIHRDIKGANILLTEDGDVKLADFGVS-----AQLTATIAKRK 159

Query: 121 -IVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLEL 154
             +GT  + APE  A    G    K D+++ G+  +EL
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 2e-11
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 12/158 (7%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E+  L +L H N+V+L+     S+N+L LV+EF+    L+ ++    +  +  P  +K  
Sbjct: 48  EISLLKELNHPNIVRLLDVV-HSENKLYLVFEFLDL-DLKKYMDSSPLTGLD-PPLIKSY 104

Query: 64  I-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           +  + +G+++ H     V++RDLK  N+L+D     KL+DFGLAR    G      T  V
Sbjct: 105 LYQLLQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEV 160

Query: 123 GTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR 158
            T  Y APE +       TP  D++S G +  E+++ R
Sbjct: 161 VTLWYRAPEILLGSRQYSTP-VDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 63.2 bits (154), Expect = 2e-11
 Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 21/164 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYC---SESDNR-----LLVYEFMP---KGSLENHLFRKGVQP 53
           E+  L  L+HEN+V LI  C   +   NR      LV+EF      G L N    K V+ 
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN----KNVK- 115

Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPT 111
            +     K+   +  GL ++H     +++RD+KA+N+L+  +   KL+DFGLAR      
Sbjct: 116 FTLSEIKKVMKMLLNGLYYIH--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSK 173

Query: 112 GDNTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLEL 154
               +  T  V T  Y  PE  +      P  D++  G ++ E+
Sbjct: 174 NSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 25/236 (10%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E+  L QL H N++K +    E +   +V E    G L   +  F+K  + I   T  K 
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +   +  +H     V++RD+K +NV + +    KL D GL R   +   T  +  +V
Sbjct: 112 FVQLCSAVEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLV 167

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE--QTLVEWADPF 180
           GT  Y +PE +       KSD++S G +L E+ + +     D+  L    Q + +   P 
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
           L                 YS+K  + V+     C++ DP  RP +  V    +Q+H
Sbjct: 228 LP-------------TEHYSEKLRELVS----MCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 56/166 (33%), Positives = 76/166 (45%), Gaps = 30/166 (18%)

Query: 2   WQ---TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS----LENHLFRKGVQPI 54
           WQ    EV +L QLRH N ++  G         LV E+   GS    LE H  +K +Q  
Sbjct: 59  WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVH--KKPLQ-- 113

Query: 55  SWPTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
                V+IA       +GL++LH      I+RD+KA N+LL      KL+DFG A     
Sbjct: 114 ----EVEIAAICHGALQGLAYLHSH--ERIHRDIKAGNILLTEPGTVKLADFGSA----- 162

Query: 112 GDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLEL 154
                 +   VGT  + APE +     G    K DV+S G+  +EL
Sbjct: 163 -SLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.6 bits (152), Expect = 2e-11
 Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 7/148 (4%)

Query: 14  HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQP--ISWPTRVKIAIDVARGL 70
           H   +  + Y  ++   L LV   M  G L  H++    +      P        +  GL
Sbjct: 51  HSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGL 110

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
             LH     +IYRDLK  NVLLD++ N ++SD GLA +   G +   +    GT G+ AP
Sbjct: 111 EHLH--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAP 166

Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGR 158
           E +         D ++ GV L E+++ R
Sbjct: 167 ELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 47/161 (29%), Positives = 80/161 (49%), Gaps = 16/161 (9%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E+  L    H N+VKL+      +N  ++ EF   G+++  +     +P++ P    
Sbjct: 49  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRV 107

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR- 120
           +       L++LH  +  +I+RDLKA N+L   + + KL+DFG+     +  NT    R 
Sbjct: 108 VCKQTLEALNYLH--ENKIIHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRTIQRR 160

Query: 121 --IVGTRGYAAPEYV--ATGHLTP---KSDVYSFGVVLLEL 154
              +GT  + APE V   T    P   K+DV+S G+ L+E+
Sbjct: 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 62.3 bits (151), Expect = 2e-11
 Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 29/238 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E+  L QL H N++K      E +   +V E    G L   +  F+K  + I   T  K 
Sbjct: 52  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +   L  +H     V++RD+K +NV + +    KL D GL R   +   T  +  +V
Sbjct: 112 FVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLV 167

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  Y +PE +       KSD++S G +L E+ +                      PF  
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA-------------------LQSPFYG 208

Query: 183 DSRRVLRIMDTRLGGQY----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
           D   +  +        Y    S   ++ +  +V  C++ DP+ RP +  V    +++H
Sbjct: 209 DKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 57/248 (22%), Positives = 105/248 (42%), Gaps = 39/248 (15%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-------------- 47
           ++ E +   +L+H N+V L+G  ++     +++ +     L   L               
Sbjct: 55  FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDD 114

Query: 48  ---RKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG 104
              +  ++P      V I   +A G+ FL     +V+++DL   NVL+    N K+SD G
Sbjct: 115 KTVKSTLEP---ADFVHIVTQIAAGMEFLS--SHHVVHKDLATRNVLVFDKLNVKISDLG 169

Query: 105 LARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDED 164
           L R+    D   +    +    + +PE +  G  +  SD++S+GVVL E+ S      + 
Sbjct: 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL---QP 226

Query: 165 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
             G + Q ++E     +  +R+VL   D      Y          ++L+C +  P  RP 
Sbjct: 227 YCGYSNQDVIE-----MIRNRQVLPCPDDCPAWVY---------TLMLECWNEFPSRRPR 272

Query: 225 MVDVLTSL 232
             D+ + L
Sbjct: 273 FKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 62.2 bits (151), Expect = 3e-11
 Identities = 47/133 (35%), Positives = 73/133 (54%), Gaps = 16/133 (12%)

Query: 35  EFMPKGSLENHLFRKGVQPISWPTRV--KIAIDVARGLSFLHGLDANVIYRDLKASNVLL 92
           E+M  GSL+  L+  GV     P  V  +I   V +GL FL   + N+I+RD+K +NVL+
Sbjct: 79  EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNIIHRDVKPTNVLV 136

Query: 93  DSNFNAKLSDFGLARDGPTGD-NTHVSTRIVGTRGYAAPEYVATGHL------TPKSDVY 145
           + N   KL DFG+     +G+    ++   +G + Y APE + +G        T +SDV+
Sbjct: 137 NGNGQVKLCDFGV-----SGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVW 191

Query: 146 SFGVVLLELLSGR 158
           S G+ +LE+  GR
Sbjct: 192 SLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 62.3 bits (151), Expect = 3e-11
 Identities = 54/219 (24%), Positives = 106/219 (48%), Gaps = 25/219 (11%)

Query: 19  KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA 78
           +L+G C  S  +L V + MP G L +++ R+    I     +   + +A+G+S+L   + 
Sbjct: 73  RLLGICLTSTVQL-VTQLMPYGCLLDYV-RENKDRIGSQDLLNWCVQIAKGMSYLE--EV 128

Query: 79  NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGH 137
            +++RDL A NVL+ S  + K++DFGLAR     +   H     V  + + A E +    
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK-WMALESILHRR 187

Query: 138 LTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG 196
            T +SDV+S+GV + EL++ G +  D    G+  + + +  +   R  +  +  +D    
Sbjct: 188 FTHQSDVWSYGVTVWELMTFGAKPYD----GIPAREIPDLLEKGERLPQPPICTID---- 239

Query: 197 GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
                     V  ++++C  +D + RP   +++    ++
Sbjct: 240 ----------VYMIMVKCWMIDSECRPRFRELVDEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 66  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 121

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 122 VQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 174

Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.4 bits (151), Expect = 3e-11
 Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 24/176 (13%)

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           +  VA+G+ FL       I+RDL A N+LL  N   K+ DFGLARD    D  +V  R  
Sbjct: 185 SFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARD-IYKDPDYV--RKG 239

Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             R    + APE +     T +SDV+SFGV+L E+ S          G +    V+  + 
Sbjct: 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGVKIDEE 290

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
           F R  +   R+        Y+  E   +   +L C H +P  RP+  +++  L  L
Sbjct: 291 FCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 61.6 bits (149), Expect = 5e-11
 Identities = 45/187 (24%), Positives = 93/187 (49%), Gaps = 15/187 (8%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV+ +   +H+N+V++       +   ++ EF+  G+L + + +  +      T   +  
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIAT---VCE 124

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHVSTR 120
            V + L +LH     VI+RD+K+ ++LL  +   KLSDFG    +++D P          
Sbjct: 125 SVLQALCYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKS 176

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           +VGT  + APE ++      + D++S G++++E++ G      D    A + L +   P 
Sbjct: 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK 236

Query: 181 LRDSRRV 187
           L+++ ++
Sbjct: 237 LKNAHKI 243

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 61.1 bits (149), Expect = 5e-11
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 13/99 (13%)

Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR--IVG 123
             RGL++LH  +  VI+RD+K  N+LL  N   KL DFG++      D+T +  R   +G
Sbjct: 122 TLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ---LDST-LGRRNTFIG 175

Query: 124 TRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSG 157
           T  + APE +A           +SDV+S G+  +EL  G
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (149), Expect = 6e-11
 Identities = 44/129 (34%), Positives = 66/129 (51%), Gaps = 11/129 (8%)

Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNV 90
           LV ++M  G L  HL ++G        R K  I ++   L  LH    +++YRDLK  N+
Sbjct: 73  LVTDYMSGGELFWHLQKEGRFS---EDRAKFYIAELVLALEHLH--KYDIVYRDLKPENI 127

Query: 91  LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFG 148
           LLD+  +  L DFGL++   T + T  +    GT  Y APE +    G+ T   D +S G
Sbjct: 128 LLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGY-TKHVDFWSLG 184

Query: 149 VVLLELLSG 157
           V++ E+  G
Sbjct: 185 VLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 60.7 bits (147), Expect = 7e-11
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 25/227 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E   L +L H  +VK      E D   ++ E+     L+  L   +   + +S     + 
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            I +  G+ ++H     +++RDLKA N+ L +N   K+ DFG++R      +  ++T   
Sbjct: 112 FIQLLLGVHYMH--QRRILHRDLKAKNIFLKNNL-LKIGDFGVSR--LLMGSCDLATTFT 166

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  Y +PE +       KSD++S G +L E+     A +          +VE   P L 
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP 226

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           ++              YS++    + +++   L+ DP  RPS  ++L
Sbjct: 227 ET--------------YSRQ----LNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.2 bits (146), Expect = 1e-10
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 22/168 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL----------LVYEFMPK---GSLENHLFRKGV 51
           E+  L QL H N+V L    ++  + L          LV+E+M     G LE+ L     
Sbjct: 56  EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115

Query: 52  QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
             I   + +K  ++   GL++ H    N ++RD+K SN+LL++    KL+DFGLAR   +
Sbjct: 116 DHIK--SFMKQLLE---GLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168

Query: 112 GDNTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
            ++   + +++ T  Y  PE  +      P  DV+S G +L EL + +
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 1e-10
 Identities = 52/192 (27%), Positives = 74/192 (38%), Gaps = 47/192 (24%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
            TE   L  L H  L  L           LV ++ P G L   L ++  QP        +
Sbjct: 49  LTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQR--QPGK-----CL 100

Query: 63  AIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL--------- 105
           + +VAR         L +LH L   ++YRDLK  N+LL  + +  LSDF L         
Sbjct: 101 SEEVARFYAAEVLLALEYLHLL--GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158

Query: 106 -----ARDGPTGDNTHVSTR-------------IVGTRGYAAPEYVA-TGHLTPKSDVYS 146
                 R G    + +                  VGT  Y APE ++  GH     D ++
Sbjct: 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWT 217

Query: 147 FGVVLLELLSGR 158
            G++L E+L G 
Sbjct: 218 LGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 43/153 (28%), Positives = 78/153 (50%), Gaps = 7/153 (4%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++ + + ++ N+V  +      D   +V E++  GSL + +    +          +  
Sbjct: 66  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 122

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           +  + L FLH     VI+RD+K+ N+LL  + + KL+DFG      T + +  ST +VGT
Sbjct: 123 ECLQALDFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGT 178

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             + APE V      PK D++S G++ +E++ G
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.8 bits (145), Expect = 2e-10
 Identities = 52/163 (31%), Positives = 85/163 (52%), Gaps = 21/163 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHL-----FRKGVQPISWPT 58
           E+  L +++H N+V+L      S+ RL LV+E++    L+ H+     F K       P 
Sbjct: 51  EISLLKEMQHGNIVRLQDVV-HSEKRLYLVFEYLDL-DLKKHMDSSPDFAKN------PR 102

Query: 59  RVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTH 116
            +K  +  + RG+++ H     V++RDLK  N+L+D   NA KL+DFGLAR    G    
Sbjct: 103 LIKTYLYQILRGIAYCH--SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVR 158

Query: 117 VSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
             T  V T  Y APE  + + H +   D++S G +  E+++ +
Sbjct: 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 60.1 bits (145), Expect = 2e-10
 Identities = 44/152 (28%), Positives = 79/152 (51%), Gaps = 4/152 (2%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + +  + H +LV+L+G C  S    LV + MP G L +++       I     +   +
Sbjct: 59  EALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCV 116

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A+G+ +L   +  +++RDL A NVL+ S  + K++DFGLAR     +  + +      
Sbjct: 117 QIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + A E +     T +SDV+S+GV + EL++
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 45/159 (28%), Positives = 82/159 (51%), Gaps = 11/159 (6%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +TE   L  +R    +  + Y  +++ +L L+ +++  G +  HL+++     S    V+
Sbjct: 52  RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR--DNFS-EDEVR 108

Query: 62  IAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
               ++   L  LH L   ++YRD+K  N+LLDS  +  L+DFGL+++  + +     + 
Sbjct: 109 FYSGEIILALEHLHKL--GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS- 165

Query: 121 IVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSG 157
             GT  Y APE +    GH     D +S G+++ ELL+G
Sbjct: 166 FCGTIEYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 41/146 (28%), Positives = 69/146 (47%), Gaps = 11/146 (7%)

Query: 14  HENLVKLIG--YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           H N+++LI   +  ++    LV+E M     E  L +   +P+           + + L 
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLD 114

Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 131
            +H     + +RD+K  N+L+  +   KL+DFG  R      +    T  + TR Y APE
Sbjct: 115 HMHR--NGIFHRDIKPENILIKDD-ILKLADFGSCR---GIYSKPPYTEYISTRWYRAPE 168

Query: 132 YVAT-GHLTPKSDVYSFGVVLLELLS 156
            + T G+  PK D+++ G V  E+LS
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 20/163 (12%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR--KGVQPISWPTR 59
           +  E+  L    H  +VKL+G         ++ EF P G+++  +    +G+     P  
Sbjct: 56  YMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTE---PQI 112

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
             I   +   L +LH +   +I+RDLKA NVLL  + + KL+DFG+     +  N     
Sbjct: 113 QVICRQMLEALQYLHSM--KIIHRDLKAGNVLLTLDGDIKLADFGV-----SAKNVKTLQ 165

Query: 120 R---IVGTRGYAAPEYV--ATGHLTP---KSDVYSFGVVLLEL 154
           R    +GT  + APE V   T   TP   K+D++S G+ L+E+
Sbjct: 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 9/154 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++ + + ++ N+V  +      D   +V E++  GSL + +    +          +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 123

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTHVSTRIVG 123
           +  + L FLH     VI+RD+K+ N+LL  + + KL+DFG  A+  P        + +VG
Sbjct: 124 ECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVG 178

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           T  + APE V      PK D++S G++ +E++ G
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 3e-10
 Identities = 49/154 (31%), Positives = 71/154 (46%), Gaps = 9/154 (5%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           TE   L   + E LVKL+    + +   L  E++P G     L   GV       R  +A
Sbjct: 50  TERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS-EDHARFYMA 108

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
                 +  LH L    I+RDLK  N L+D++ + KL+DFGL++   T  N+     +VG
Sbjct: 109 EMFE-AVDALHEL--GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVG 160

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           +  Y APE +         D +S G +L E L G
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 59.7 bits (144), Expect = 3e-10
 Identities = 63/234 (26%), Positives = 97/234 (41%), Gaps = 33/234 (14%)

Query: 2   WQ---TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           WQ    EV +L QL+H N ++  G   +     LV E+   GS  + L     +P+    
Sbjct: 65  WQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASD-LLEVHKKPLQEVE 122

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              I     +GL++LH    N+I+RD+KA N+LL      KL+DFG A      ++    
Sbjct: 123 IAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS---- 176

Query: 119 TRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
              VGT  + APE +     G    K DV+S G+  +EL   +  L       A   + +
Sbjct: 177 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
              P L+                 S +   +    V  CL   P+ RP+  ++L
Sbjct: 235 NDSPTLQ-----------------SNEWTDSFRGFVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 58.1 bits (140), Expect = 6e-10
 Identities = 56/229 (24%), Positives = 101/229 (44%), Gaps = 25/229 (10%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           + E   L QL+H N+V         D  L +V  F   G L + L  +  + +     V+
Sbjct: 47  EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
             + +A  L +LH  + ++++RDLK  NV L      K+ D G+AR     +   +++ +
Sbjct: 107 WFVQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQCDMASTL 162

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTLVEWADPF 180
           +GT  Y +PE  +      KSDV++ G  + E+ + + A + +D   L            
Sbjct: 163 IGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------------ 210

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                 V RI++ +L     K  +  +  ++   L   P+ RPS+  +L
Sbjct: 211 ------VYRIIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 57.9 bits (140), Expect = 6e-10
 Identities = 61/227 (26%), Positives = 105/227 (46%), Gaps = 41/227 (18%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-KGVQPISWPTRVKIAIDVA 67
           + QL H++LV   G C   D  ++V E++  GSL+ +L + K +  ISW  ++++A  +A
Sbjct: 53  MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLA 110

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNA--------KLSDFGLARDGPTGDNTHVST 119
             L FL   D  + + ++ A NVLL    +         KLSD G++        T +  
Sbjct: 111 WALHFLE--DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI-------TVLPK 161

Query: 120 RIVGTR-GYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
            I+  R  +  PE +    +L+  +D +SFG  L E+ SG            ++ L    
Sbjct: 162 EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG-----------GDKPLS--- 207

Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
                DS++ L+  + R   Q    +   +A ++ QC+  +P  RPS
Sbjct: 208 ---ALDSQKKLQFYEDRH--QLPAPKWTELANLINQCMDYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 58.1 bits (140), Expect = 7e-10
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 7/155 (4%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L  L+ EN+V+L           LV+E++ K  LE     + +     P +V+  I
Sbjct: 50  ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE---LLEEMPNGVPPEKVRSYI 106

Query: 65  -DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             + + + + H  D  +++RD+K  N+L+  N   KL DFG AR+   G N +  T  V 
Sbjct: 107 YQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVA 163

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           TR Y +PE +         D++S G +L EL  G+
Sbjct: 164 TRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 58.1 bits (140), Expect = 7e-10
 Identities = 52/163 (31%), Positives = 78/163 (47%), Gaps = 16/163 (9%)

Query: 5   EVIYLGQLR---HENLVKLIGYCSES----DNRL-LVYEFMPKGSLENHLFRKGVQPISW 56
           EV  L  L    H N+V+L   C+ S    + +L LV+E + +  L  +L  K  +P   
Sbjct: 51  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVP 108

Query: 57  PTRVK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
              +K +   + RGL FLH     V++RDLK  N+L+ S+   KL+DFGLAR        
Sbjct: 109 TETIKDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQ 163

Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              T +V T  Y APE +         D++S G +  E+   +
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 57.7 bits (139), Expect = 8e-10
 Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 28/229 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E + L +++H N+V       E+D  L +V E+   G L   +  +  +     T ++  
Sbjct: 48  EAVLLAKMKHPNIVAF-KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF 106

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 121
           + +  G+  +H  +  V++RD+K+ N+ L  N   KL DFG AR    P       +   
Sbjct: 107 VQMCLGVQHIH--EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----YACTY 160

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           VGT  Y  PE         KSD++S G +L EL + +     +           W +  L
Sbjct: 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN----------SWKNLIL 210

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 230
               +V +     L   YS +    + +++ Q    +P++RPS   +L+
Sbjct: 211 ----KVCQGSYKPLPSHYSYE----LRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 58.2 bits (141), Expect = 8e-10
 Identities = 46/142 (32%), Positives = 70/142 (49%), Gaps = 14/142 (9%)

Query: 23  YCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV 80
           + +  D++ L  V E+MP G L N +    + P  W  R   A +V   L  +H +    
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDI-PEKW-ARFYTA-EVVLALDAIHSM--GF 163

Query: 81  IYRDLKASNVLLDSNFNAKLSDFGLA-RDGPTGDNTHVSTRIVGTRGYAAPEYVAT---- 135
           I+RD+K  N+LLD + + KL+DFG   +    G      T  VGT  Y +PE + +    
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDT-AVGTPDYISPEVLKSQGGD 221

Query: 136 GHLTPKSDVYSFGVVLLELLSG 157
           G+   + D +S GV L E+L G
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 57.4 bits (138), Expect = 1e-09
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 9/155 (5%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+I +   +H N+V   G     D   +  EF   GSL++     G  P+S      +
Sbjct: 54  QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYV 111

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           + +  +GL +LH      ++RD+K +N+LL  N + KL+DFG++               +
Sbjct: 112 SRETLQGLYYLH--SKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFI 167

Query: 123 GTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLEL 154
           GT  + APE  A    G      D+++ G+  +EL
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 45/141 (31%), Positives = 68/141 (48%), Gaps = 12/141 (8%)

Query: 23  YCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV 80
           +C+  D++ L  V E+MP G L N +    V P  W        +V   L  +H +   +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFY--TAEVVLALDAIHSM--GL 163

Query: 81  IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----G 136
           I+RD+K  N+LLD + + KL+DFG              T  VGT  Y +PE + +    G
Sbjct: 164 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDG 222

Query: 137 HLTPKSDVYSFGVVLLELLSG 157
           +   + D +S GV L E+L G
Sbjct: 223 YYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 57.8 bits (139), Expect = 1e-09
 Identities = 36/92 (39%), Positives = 51/92 (55%), Gaps = 8/92 (8%)

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
           RGL ++H   A +I+RDLK SNV ++ +   ++ DFGLAR     D     T  V TR Y
Sbjct: 129 RGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLARQ--ADDEM---TGYVATRWY 181

Query: 128 AAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
            APE +    H     D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 47/168 (27%), Positives = 79/168 (47%), Gaps = 32/168 (19%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPK--GSLENH--LFRKGVQPI 54
           E+  L  ++HEN++ L+   +   +        LV  FM    G L  H  L    +Q +
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123

Query: 55  SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
            +         + +GL ++H   A +I+RDLK  N+ ++ +   K+ DFGLAR       
Sbjct: 124 VY--------QMLKGLKYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLAR------- 166

Query: 115 THVSTRIVG---TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
               + + G   TR Y APE +    H T   D++S G ++ E+L+G+
Sbjct: 167 -QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 130 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 184

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           APE +         D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 57.0 bits (137), Expect = 2e-09
 Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 16/159 (10%)

Query: 2   WQ---TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           WQ    EV +L +LRH N ++  G         LV E+   GS  + L     +P+    
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVE 116

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +     +GL++LH    N+I+RD+KA N+LL      KL DFG A      +     
Sbjct: 117 IAAVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX---- 170

Query: 119 TRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLEL 154
              VGT  + APE +     G    K DV+S G+  +EL
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 56.4 bits (136), Expect = 2e-09
 Identities = 42/158 (26%), Positives = 72/158 (45%), Gaps = 21/158 (13%)

Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR-------VKIAI 64
           L+H N+++ +G C E+   LLV+E+   G L+++L ++      W  R        ++A 
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMAC 106

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A G++ +H    N ++ DL   N  L S+   K+ D+G+       D           
Sbjct: 107 EIAAGVTHMHKH--NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164

Query: 125 RGYAAPEYVATGH-------LTPKSDVYSFGVVLLELL 155
             + APE V   H        T  S+V++ GV L EL 
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.4 bits (136), Expect = 3e-09
 Identities = 45/145 (31%), Positives = 68/145 (46%), Gaps = 10/145 (6%)

Query: 26  ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 85
           + DN  LV E+ P G L + L R   Q      +  +A ++   +  +H +    ++RD+
Sbjct: 72  DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-ELVLAIHSVHQM--GYVHRDI 128

Query: 86  KASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS--- 142
           K  NVL+D   + KL+DFG A    T +    S   VGT  Y APE + T +   K    
Sbjct: 129 KPENVLIDRTGHIKLADFGSAA-RLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYG 187

Query: 143 ---DVYSFGVVLLELLSGRRALDED 164
              D +S GV+  E++ GR    E 
Sbjct: 188 VECDWWSLGVIAYEMIYGRSPFHEG 212

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 47/144 (32%), Positives = 70/144 (48%), Gaps = 28/144 (19%)

Query: 28  DNRLL--VYEFMPKGSLENHLFRKGVQPISWP----TRVKIAIDVARGLSFLHGLDANVI 81
           D+R L  V E+MP G L N +    V P  W       V +A+D    + F+H       
Sbjct: 114 DDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFIH------- 165

Query: 82  YRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-- 135
            RD+K  N+LLD + + KL+DFG    + ++G    +T      VGT  Y +PE + +  
Sbjct: 166 -RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-----AVGTPDYISPEVLKSQG 219

Query: 136 --GHLTPKSDVYSFGVVLLELLSG 157
             G+   + D +S GV L E+L G
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 53/161 (32%), Positives = 83/161 (51%), Gaps = 18/161 (11%)

Query: 9   LGQLRHENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRKGVQPISWPTRVK-I 62
           L    H N+V+L+  C    +D  L   LV+E + +  L  +L  K  +P   P  +K +
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL-SKCPKPGLPPETIKDL 112

Query: 63  AIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              + RG+ FLH   ++ +++RDLK  N+L+ S+   K++DFGLAR           T +
Sbjct: 113 MRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR---IYSFEMALTSV 166

Query: 122 VGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
           V T  Y APE  + + + TP  D++S G +  EL   RR L
Sbjct: 167 VVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAELFR-RRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 56.2 bits (135), Expect = 4e-09
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 5/89 (5%)

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T     + T  V TR Y 
Sbjct: 135 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ EL+ G
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.8 bits (134), Expect = 4e-09
 Identities = 49/156 (31%), Positives = 79/156 (50%), Gaps = 9/156 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L  L+H N+V L        +  LV+E++ K  L+ ++   G   I     VKI +
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG--NIMSMHNVKIFL 110

Query: 65  -DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             + RGL++ H     V++RDLK  N+L++     KL+DFGLAR       T+ S  +V 
Sbjct: 111 YQILRGLAYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV- 166

Query: 124 TRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
           T  Y  P+  + +   + + D++  G +  E+ SGR
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 42/153 (27%), Positives = 82/153 (53%), Gaps = 6/153 (3%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L + + MP G L +++ R+    I     +   +
Sbjct: 59  EAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYV-REHKDNIGSQYLLNWCV 116

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   +  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 117 QIAKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 175 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 56.2 bits (135), Expect = 5e-09
 Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 11/159 (6%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLV---YEFMPKGSLENHLFRKGVQPISWPTR 59
           + E++ LG+L HEN++K+        N  ++   Y+F     + +  F    +P+   TR
Sbjct: 211 ENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTR 270

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
             I   +   + ++H  D  +I+RD+K  N+ L+ +    L DFG A      +    + 
Sbjct: 271 -AIMKQLLCAVEYIH--DKKLIHRDIKLENIFLNCDGKIVLGDFGTAM---PFEKEREAF 324

Query: 120 RI--VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
               VGT    +PE +A       +D++S G++LL++LS
Sbjct: 325 DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 54/183 (29%), Positives = 77/183 (42%), Gaps = 54/183 (29%)

Query: 18  VKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 75
           VKL  Y S  D     L+ E++P G +   L +K        TR  IA +    +  +H 
Sbjct: 64  VKL--YYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFYIA-ETILAIDSIHK 119

Query: 76  LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG-DNTHVST--RI----------- 121
           L    I+RD+K  N+LLD+  + KLSDFGL     TG   +H +   RI           
Sbjct: 120 L--GYIHRDIKPDNLLLDAKGHIKLSDFGLC----TGLKKSHRTEFYRILSHALPSNFLD 173

Query: 122 --------------------------VGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLEL 154
                                     VGT  Y APE ++ TG+   + D +S GV++ E+
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEM 232

Query: 155 LSG 157
           L G
Sbjct: 233 LVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.2 bits (133), Expect = 6e-09
 Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 40/234 (17%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP-ISWPTRVKIAIDVA 67
           + QL H++LVKL G C   +N ++V E++  G L+  L R+     + W  ++ +A  +A
Sbjct: 55  MSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLA 111

Query: 68  RGLSFLHGLDANVIYRDLKASNVLL---DSNFN----AKLSDFGLARDGPTGDNTHVSTR 120
             L +L   D  +++ ++   N+L+     N       KLSD G+              R
Sbjct: 112 SALHYLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVER 167

Query: 121 IVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
           I     + APE +  G   LT  +D +SFG  LLE+ S         G     TL     
Sbjct: 168 I----PWIAPECIRNGQASLTIAADKWSFGTTLLEICS--------NGEEPLSTL----- 210

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
                S    R        +    +   +A ++ QC   DP  RPS   +L  L
Sbjct: 211 ----SSSEKERFYQD--QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.1 bits (133), Expect = 6e-09
 Identities = 51/159 (32%), Positives = 79/159 (49%), Gaps = 9/159 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E+  L +L+H+N+V+L      SD +L LV+E+  +  L+ + F      I         
Sbjct: 49  EICLLKELKHKNIVRLYDVL-HSDKKLTLVFEYCDQ-DLKKY-FDSCNGDIDPEIVKSFM 105

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             + +GL+F H    NV++RDLK  N+L++ N   KL+DFGLAR    G      +  V 
Sbjct: 106 FQLLKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVV 161

Query: 124 TRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGRRAL 161
           T  Y  P+ +    L   S D++S G +  EL +  R L
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 55.8 bits (134), Expect = 8e-09
 Identities = 60/246 (24%), Positives = 100/246 (40%), Gaps = 46/246 (18%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT---- 58
           ++E+  L    H  +VK        D  LL+ E+   G L   + ++  + + +      
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172

Query: 59  ----RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
               ++ +A+D       +H        RDLK++N+ L      KL DFG ++      +
Sbjct: 173 LLFYQIVLALDEVHSRKMMH--------RDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224

Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
             V++   GT  Y APE       + K+D++S GV+L ELL+  R               
Sbjct: 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR--------------- 269

Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSK---KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 231
               PF   S+R   IM   L G+Y       +  + A++   L  +P  RP      T+
Sbjct: 270 ----PFKGPSQR--EIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRP------TT 317

Query: 232 LEQLHT 237
            + LHT
Sbjct: 318 QQLLHT 323

Length = 478

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 55.3 bits (133), Expect = 8e-09
 Identities = 38/162 (23%), Positives = 73/162 (45%), Gaps = 11/162 (6%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP--KGSLENHLFRKGVQPISWPTRVKI 62
           E + L  + H +++++           +V   +P     L  +L ++  +P+     + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKR-SRPLPIDQALII 162

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  GL +LH     +I+RD+K  N+ ++      + D G A+  P      +   + 
Sbjct: 163 EKQILEGLRYLHAQ--RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLG--LA 217

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDED 164
           GT    APE +A      K+D++S G+VL E+L+    + ED
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259

Length = 357

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 55.1 bits (132), Expect = 8e-09
 Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 33/237 (13%)

Query: 2   WQ---TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           WQ    EV +L +++H N ++  G         LV E+   GS  + L     +P+    
Sbjct: 69  WQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVE 126

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              I     +GL++LH    N+I+RD+KA N+LL      KL+DFG A      ++    
Sbjct: 127 IAAITHGALQGLAYLH--SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS---- 180

Query: 119 TRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
              VGT  + APE +     G    K DV+S G+  +EL   +  L       A   + +
Sbjct: 181 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
              P L+                 S + +      V  CL   P++RP+  ++L  +
Sbjct: 239 NESPTLQ-----------------SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 55.2 bits (133), Expect = 8e-09
 Identities = 48/172 (27%), Positives = 89/172 (51%), Gaps = 25/172 (14%)

Query: 5   EVIYLGQLRHENLVKL--------------IGYCSESDNRLLVYEFMPKGSLENHLFRKG 50
           E+  + +L H+N+VK+              +G  +E ++  +V E+M +  L N L +  
Sbjct: 52  EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQ-- 108

Query: 51  VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLAR-- 107
             P+S          + RGL ++H   ANV++RDLK +NV +++ +   K+ DFGLAR  
Sbjct: 109 -GPLSEEHARLFMYQLLRGLKYIH--SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV 165

Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 158
           D       ++S  +V T+ Y +P  + +  + T   D+++ G +  E+L+G+
Sbjct: 166 DPHYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 54.5 bits (131), Expect = 9e-09
 Identities = 44/178 (24%), Positives = 74/178 (41%), Gaps = 19/178 (10%)

Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP----ISWPTRVKIAIDVARGLS 71
           N+V L  Y    D+  LV +    G L +H+ +    P      W   + +A+D      
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100

Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAP 130
            LH     ++ RDL  +N+LLD   + +L+ F    +   + D   V         Y AP
Sbjct: 101 -LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVE------NMYCAP 151

Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 188
           E       T   D +S G +L ELL+G+  ++    G+   T +   +    ++R +L
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLL 209

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 40/151 (26%), Positives = 74/151 (49%), Gaps = 18/151 (11%)

Query: 16  NLVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           N++K+ G+  +  + L    L+ E+  +G L   L ++  + +S+ T++ +AID  +GL 
Sbjct: 79  NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLY 136

Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAA 129
            L+    N  Y++L + + L+  N+  K+   GL +    P   N       V    Y +
Sbjct: 137 NLYKYT-NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN-------VNFMVYFS 188

Query: 130 PEYVAT--GHLTPKSDVYSFGVVLLELLSGR 158
            + +       T K D+YS GVVL E+ +G+
Sbjct: 189 YKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 19/161 (11%)

Query: 5   EVIYLGQLRHENLVKLIG-YCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           E+  L  ++HEN++ L+  + S    D     Y  MP   ++  L +    P+S      
Sbjct: 64  ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMP--YMQTDLQKIMGHPLSEDKVQY 121

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +   +  GL ++H   A +I+RDLK  N+ ++ +   K+ DFGLAR        H    +
Sbjct: 122 LVYQMLCGLKYIHS--AGIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEM 171

Query: 122 VG---TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
            G   TR Y APE +    H     D++S G ++ E+L+G+
Sbjct: 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 43/169 (25%), Positives = 75/169 (44%), Gaps = 26/169 (15%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL--LVYEFMPKGSLE--NHLFRKGVQPISWPTRV 60
           E+  L +L+HEN+V L+    E  ++   L++++      +      +     I      
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK 111

Query: 61  KIAIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNA----KLSDFGLAR--DGP--- 110
            +   +  G+ +LH   +N V++RDLK +N+L+          K+ D GLAR  + P   
Sbjct: 112 SLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 111 --TGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLS 156
               D       +V T  Y APE +    H T   D+++ G +  ELL+
Sbjct: 169 LADLD------PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.7 bits (131), Expect = 1e-08
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           APE +         D++S G ++ E++ G 
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 11/157 (7%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L  L+H N+V L           LV+E++    L+ +L   G   +     VKI +
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCG--NLMSMHNVKIFM 109

Query: 65  -DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             + RGLS+ H     +++RDLK  N+L++     KL+DFGLAR       T+ S  +V 
Sbjct: 110 FQLLRGLSYCH--KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY-SNEVV- 165

Query: 124 TRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 158
           T  Y  P+ +  +T + TP  D++  G +L E+ +GR
Sbjct: 166 TLWYRPPDVLLGSTEYSTP-IDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 131 GIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185

Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 54.0 bits (130), Expect = 2e-08
 Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 55/214 (25%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           L +  +E +VKL     + DN   V +++P G + + L R G+       R  IA ++  
Sbjct: 55  LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-ARFYIA-ELTC 112

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN-THVS--------- 118
            +  +H +    I+RD+K  N+L+D + + KL+DFGL     TG   TH S         
Sbjct: 113 AIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLC----TGFRWTHDSKYYQKGDHH 166

Query: 119 ------------------------------TRI-----VGTRGYAAPEYVA-TGHLTPKS 142
                                          R      VGT  Y APE +  TG+ T   
Sbjct: 167 RQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLC 225

Query: 143 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
           D +S GV+L E+L G+     D     +  ++ W
Sbjct: 226 DWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 53.2 bits (127), Expect = 3e-08
 Identities = 45/138 (32%), Positives = 63/138 (45%), Gaps = 15/138 (10%)

Query: 28  DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 87
           D   LV EF   GS+ + +       +       I  ++ RGLS LH     VI+RD+K 
Sbjct: 82  DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKG 139

Query: 88  SNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP----- 140
            NVLL  N   KL DFG++   D   G         +GT  + APE +A     P     
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQLDRTVGRR----NTFIGTPYWMAPEVIACDE-NPDATYD 194

Query: 141 -KSDVYSFGVVLLELLSG 157
            KSD++S G+  +E+  G
Sbjct: 195 FKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 43/163 (26%), Positives = 77/163 (47%), Gaps = 6/163 (3%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           TE   L  + H ++++L G  + +    L+   +P+   + + +    + I+    + I 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIE 188

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             V R + +LH  +  +I+RD+KA N+ ++   +  L DFG A   P   N +      G
Sbjct: 189 RSVLRAIQYLH--ENRIIHRDIKAENIFINHPGDVCLGDFGAAC-FPVDINANKYYGWAG 245

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
           T    APE +A     P  D++S G+VL E+ +   +L E  G
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Length = 391

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.4 bits (128), Expect = 3e-08
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 15/154 (9%)

Query: 9   LGQLRHENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           L    H N+V+L+  C  S +D      LV+E + +  L  +L +     +   T   + 
Sbjct: 56  LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114

Query: 64  IDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRI 121
               RGL FLH   AN +++RDLK  N+L+ S    KL+DFGLAR      +  ++ T +
Sbjct: 115 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPV 167

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           V T  Y APE +         D++S G +  E+ 
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 53.5 bits (128), Expect = 3e-08
 Identities = 36/103 (34%), Positives = 51/103 (49%), Gaps = 2/103 (1%)

Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
           +S+   V  +  VA G+ FL     N ++RDL A NVL+      K+ DFGLARD     
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDS 293

Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           N            + APE +     T  SDV+SFG++L E+ +
Sbjct: 294 NYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 37/103 (35%), Positives = 50/103 (48%), Gaps = 18/103 (17%)

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG--LARDGPTGDNTHVST 119
           +AID    L ++H        RD+K  NVLLD N + +L+DFG  L       D T  S 
Sbjct: 113 LAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLL---ADGTVQSN 161

Query: 120 RIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSG 157
             VGT  Y +PE +       G   P+ D +S GV + E+L G
Sbjct: 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 9/155 (5%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  + + +H N+V   G     +   +  E+   GSL++     G  P+S      +
Sbjct: 54  QQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYV 111

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             +  +GL++LH      ++RD+K +N+LL  N + KL+DFG+A               +
Sbjct: 112 CRETLQGLAYLH--SKGKMHRDIKGANILLTDNGDVKLADFGVA--AKITATIAKRKSFI 167

Query: 123 GTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLEL 154
           GT  + APE  A    G      D+++ G+  +EL
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 44/149 (29%), Positives = 64/149 (42%), Gaps = 9/149 (6%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           L  + H   V L G   +     LV EF+  G     L R       +P  V        
Sbjct: 85  LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK----RFPNDVGCFYAAQI 140

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
            L F +    N++YRDLK  N+LLD +   K++DFG A+   T   T     + GT  Y 
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT-----LCGTPEYI 195

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +        +D ++ G+ + E+L G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 52.5 bits (126), Expect = 6e-08
 Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 22/169 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IA 63
           E+  + +++HEN++ L+    E D   LV + M    L+  + RK     S   +VK I 
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTES---QVKCIL 125

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-------DGPTGDNTH 116
           + +  GL+ LH      ++RDL  +N+ ++S    K++DFGLAR             +  
Sbjct: 126 LQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 117 VSTRI-----VGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 158
           +  R      V T  Y APE +  A  +     D++S G +  ELL+G+
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKY-HFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 52.3 bits (125), Expect = 7e-08
 Identities = 45/141 (31%), Positives = 65/141 (46%), Gaps = 17/141 (12%)

Query: 26  ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDL 85
             D   LV EF   GS+ + +       +       I  ++ RGL+ LH     VI+RD+
Sbjct: 90  HDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA--HKVIHRDI 147

Query: 86  KASNVLLDSNFNAKLSDFGLAR--DGPTG-DNTHVSTRIVGTRGYAAPEYVATGHLTP-- 140
           K  NVLL  N   KL DFG++   D   G  NT      +GT  + APE +A     P  
Sbjct: 148 KGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-----FIGTPYWMAPEVIACDE-NPDA 201

Query: 141 ----KSDVYSFGVVLLELLSG 157
               +SD++S G+  +E+  G
Sbjct: 202 TYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 47/190 (24%), Positives = 71/190 (37%), Gaps = 38/190 (20%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMP--KGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
            L H  +V +   CS+ D    VY  MP  +G     L +   Q  S    +     V  
Sbjct: 58  DLIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114

Query: 69  GLSFLHGLDANVIY--------RDLKASNVLLDSNFNAKLSDFGLA-------------- 106
            LS  H + A + Y        RDLK  N+LL       + D+G A              
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 107 --RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-------- 156
                    +  +  +IVGT  Y APE +     +  +D+Y+ GV+L ++L+        
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234

Query: 157 -GRRALDEDR 165
            GR+    D 
Sbjct: 235 KGRKISYRDV 244

Length = 932

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 37/105 (35%), Positives = 52/105 (49%), Gaps = 22/105 (20%)

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHV 117
           IAID    L ++H        RD+K  N+L+D N + +L+DFG    L  DG     T  
Sbjct: 113 IAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQ 159

Query: 118 STRIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSG 157
           S+  VGT  Y +PE +       G   P+ D +S GV + E+L G
Sbjct: 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 48/179 (26%), Positives = 71/179 (39%), Gaps = 47/179 (26%)

Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV----QPISWPTRVKIAIDVARGLSF 72
           +VK+     +  N  L+ EF+P G +   L +K          +     +AID    L F
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 73  LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA---------------RDGPTGD---- 113
           +H        RD+K  N+LLD+  + KLSDFGL                   P  D    
Sbjct: 123 IH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174

Query: 114 --------------NTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSG 157
                            ++   VGT  Y APE ++ TG+     D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 65/254 (25%), Positives = 98/254 (38%), Gaps = 32/254 (12%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           Q E+I   QL+H N++         D+ L +V   M  GS E+ L  K   P   P    
Sbjct: 47  QQEIITSRQLQHPNILP-YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELA- 102

Query: 62  IAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD----GPTGDN 114
           IA    DV   L ++H      I+R +KAS++LL  +    LS    +      G     
Sbjct: 103 IAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160

Query: 115 THVSTR-IVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSG---------RRALD 162
            H   +  V    + +PE +         KSD+YS G+   EL +G          + L 
Sbjct: 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220

Query: 163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ------YSKKEAQAVAAVVLQCLH 216
           E   G     L +   P   DS    R  +     +      Y++  ++     V  CL 
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280

Query: 217 MDPKNRPSMVDVLT 230
            DP++RPS   +L 
Sbjct: 281 RDPESRPSASQLLN 294

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 46/155 (29%), Positives = 76/155 (49%), Gaps = 7/155 (4%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L  L+H N+V L        +  LV+E++ K  L+ +L   G   I+         
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NSINMHNVKLFLF 111

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + RGL++ H     V++RDLK  N+L++     KL+DFGLAR       T+ S  +V T
Sbjct: 112 QLLRGLNYCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-T 167

Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  P+  + +   + + D++  G +  E+ +GR
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 47/199 (23%), Positives = 78/199 (39%), Gaps = 57/199 (28%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS----WPTRVKIAI 64
           L +  +E +V+L     + DN   V +++P G + + L R G+ P      +   +  A+
Sbjct: 55  LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAV 114

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL--------------ARDGP 110
           +    + F+H        RD+K  N+L+D + + KL+DFGL              + D  
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166

Query: 111 TGDNTHVSTR-------------------------------IVGTRGYAAPEYVATGHLT 139
             D+   S                                 +VGT  Y APE +     T
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT 226

Query: 140 PKSDVYSFGVVLLELLSGR 158
              D +S GV+L E+L G+
Sbjct: 227 QLCDWWSVGVILYEMLVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.3 bits (120), Expect = 3e-07
 Identities = 64/234 (27%), Positives = 106/234 (45%), Gaps = 40/234 (17%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-KGVQPISWPTRVKIAIDVA 67
           + Q+ H +L  + G C      ++V EF+  G L+  L + KG  P++W  ++ +A  +A
Sbjct: 70  MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLA 127

Query: 68  RGLSFLHGLDANVIYRDLKASNVLL--------DSNFNAKLSDFGLARDGPTGDNTHVST 119
             LS+L   D N+++ ++ A N+LL         S F  KLSD G++    + +      
Sbjct: 128 SALSYLE--DKNLVHGNVCAKNILLARLGLAEGTSPF-IKLSDPGVSFTALSREER---- 180

Query: 120 RIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             V    + APE V  G  L+  +D +SFG  LLE+       D +   L E+T  E  +
Sbjct: 181 --VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI-----CFDGE-VPLKERTPSE-KE 231

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
            F     R+             +   + +A ++ QCL  +P  RPS   +L  L
Sbjct: 232 RFYEKKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 49.6 bits (118), Expect = 4e-07
 Identities = 49/162 (30%), Positives = 70/162 (43%), Gaps = 28/162 (17%)

Query: 14  HENLVKLIGYCSESDNRL-----LVYEFMPKGS---LENHLFRKGVQPISWPTRVKIAID 65
           H N+VK  G   ++D  +     LV E    GS   L   L   G Q +       I   
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG-QRLDEAMISYILYG 136

Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI---- 121
              GL  LH  +  +I+RD+K +N+LL +    KL DFG++           STR+    
Sbjct: 137 ALLGLQHLH--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ-------LTSTRLRRNT 187

Query: 122 -VGTRGYAAPEYVATGH-----LTPKSDVYSFGVVLLELLSG 157
            VGT  + APE +A           + DV+S G+  +EL  G
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.0 bits (119), Expect = 4e-07
 Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 14/86 (16%)

Query: 81  IYRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHVSTRIVGTRGYAAPEYV--- 133
           ++RD+K  NVLLD N + +L+DFG    + +DG     T  S+  VGT  Y +PE +   
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-----TVQSSVAVGTPDYISPEILQAM 178

Query: 134 --ATGHLTPKSDVYSFGVVLLELLSG 157
               G   P+ D +S GV + E+L G
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 6e-07
 Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 15/159 (9%)

Query: 5   EVIYLGQLRHENLVKL--IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           E   L  L+H N+V L  I +  ++    LV+E++    L+ ++   G         V++
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLT--LVFEYLDT-DLKQYMDDCG--GGLSMHNVRL 107

Query: 63  AI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            +  + RGL++ H     V++RDLK  N+L+      KL+DFGLAR       T+ S  +
Sbjct: 108 FLFQLLRGLAYCH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-SNEV 164

Query: 122 VGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 158
           V T  Y  P+ +  +T + T   D++  G +  E+ +GR
Sbjct: 165 V-TLWYRPPDVLLGSTEYSTS-LDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.3 bits (117), Expect = 7e-07
 Identities = 47/178 (26%), Positives = 68/178 (38%), Gaps = 45/178 (25%)

Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV----QPISWPTRVKIAIDVARGLSF 72
           +VK+     +  N  L+ EF+P G +   L +K      +   +     +AID    L F
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 73  LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA-------------------------- 106
           +H        RD+K  N+LLDS  + KLSDFGL                           
Sbjct: 123 IH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174

Query: 107 -----RDGPT--GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
                R   T   +   ++   VGT  Y APE           D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 49.2 bits (117), Expect = 8e-07
 Identities = 67/250 (26%), Positives = 110/250 (44%), Gaps = 41/250 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKI 62
           E   L  L+H N+V L       +    V+E+M    L  ++ +   G+ P +   R+  
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN--VRL-F 108

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              + RGL+++HG   ++++RDLK  N+L+      KL+DFGLAR       T+ S   V
Sbjct: 109 MFQLLRGLAYIHG--QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE--V 164

Query: 123 GTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA--- 177
            T  Y  P+ +  AT + +   D++  G + +E+L G+ A       + EQ    W    
Sbjct: 165 VTLWYRPPDVLLGATDYSS-ALDIWGAGCIFIEMLQGQPAF-PGVSDVFEQLEKIWTVLG 222

Query: 178 ------------------DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP 219
                             + FL    + LR++  RL       +A+ +A+   Q L M P
Sbjct: 223 VPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPP---KAEDLAS---QMLMMFP 276

Query: 220 KNRPSMVDVL 229
           K+R S  D L
Sbjct: 277 KDRISAQDAL 286

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 48.3 bits (115), Expect = 1e-06
 Identities = 39/134 (29%), Positives = 65/134 (48%), Gaps = 16/134 (11%)

Query: 32  LVYEFMP---KGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 88
           LV+E++    K  ++++  R   +P+   T       + +G++  H     V++RDLK  
Sbjct: 83  LVFEYLDSDLKKFMDSN-GRGPGRPLPAKTIKSFMYQLLKGVAHCHKH--GVMHRDLKPQ 139

Query: 89  NVLLDSNFNA-KLSDFGLARDG--PTGDNTHVSTRIVGTRGYAAPEYV--ATGHLTPKSD 143
           N+L+D      K++D GL R    P    TH    IV T  Y APE +  +T + TP  D
Sbjct: 140 NLLVDKQKGLLKIADLGLGRAFSIPVKSYTH---EIV-TLWYRAPEVLLGSTHYSTP-VD 194

Query: 144 VYSFGVVLLELLSG 157
           ++S G +  E+   
Sbjct: 195 IWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.0 bits (116), Expect = 2e-06
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 31/182 (17%)

Query: 5   EVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFR--KGVQPISWPTRV 60
           EV  + +L+H+N+V+ I  + ++++ +L ++ EF   G L  ++ +  K    I     V
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 61  KIAIDVARGLSFLHGLD-----ANVIYRDLKASNVLLDS-------------NFN----A 98
            I   +   L++ H L        V++RDLK  N+ L +             N N    A
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 99  KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLS 156
           K+ DFGL+++       H     VGT  Y +PE +   T     KSD+++ G ++ EL S
Sbjct: 182 KIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Query: 157 GR 158
           G+
Sbjct: 239 GK 240

Length = 1021

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.9 bits (111), Expect = 4e-06
 Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 16/162 (9%)

Query: 14  HENLVKLIGYCSESDNR-----LLVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDV 66
           H N+VK  G   + D +      LV E    GS+ + +  F K  + +  P    I  + 
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
             GL  LH      I+RD+K +N+LL +    KL DFG++               VGT  
Sbjct: 134 LMGLQHLH--VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPF 189

Query: 127 YAAPEYVATGH-----LTPKSDVYSFGVVLLELLSGRRALDE 163
           + APE +A           + DV+S G+  +EL  G   L +
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.9 bits (111), Expect = 4e-06
 Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 40/223 (17%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           Q+ H+++V L G C      ++V EF+  G L+  + RK    ++ P + K+A  +A  L
Sbjct: 60  QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASAL 118

Query: 71  SFLHGLDANVIYRDLKASNVLL-----DSNFNA--KLSDFGLARDGPTGDNTHVSTR--I 121
           S+L   D ++++ ++   N+LL     D       KLSD G+           V +R   
Sbjct: 119 SYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQEC 168

Query: 122 VGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           V    + APE V  + +L+  +D +SFG  L E+        +D+  LAE+         
Sbjct: 169 VERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK-TLAEKE-------- 219

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 223
                   R  + +          + +A ++  C++ DP  RP
Sbjct: 220 --------RFYEGQC--MLVTPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.8 bits (111), Expect = 5e-06
 Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 2/103 (1%)

Query: 51  VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
           ++P+       +A  +   + ++HG    +I+RD+K  NVL++   +  L DFG A    
Sbjct: 254 LRPLGLAQVTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311

Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE 153
              +T     I GT    APE +A    TP  D++S G+V+ E
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 15/162 (9%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKG---SLENHLFRKGVQPISWPTRVK 61
           E   L  L+H N+V L       +   LV+E++       ++ H    G+ P      VK
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKH--PGGLHP----ENVK 106

Query: 62  IAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           + +  + RGLS++H     +++RDLK  N+L+      KL+DFGLAR      +T+ S  
Sbjct: 107 LFLFQLLRGLSYIH--QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY-SNE 163

Query: 121 IVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
           +V T  Y  P+  + +   +   D++  G + +E++ G  A 
Sbjct: 164 VV-TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 46.3 bits (110), Expect = 6e-06
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 19/150 (12%)

Query: 23  YCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV 80
           +CS    R L  V E++  G     L   G  P+    R+  A  V   L +LH  +  +
Sbjct: 67  FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM-ARMYFAETVL-ALEYLH--NYGI 122

Query: 81  IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-------STR------IVGTRGY 127
           ++RDLK  N+L+ S  + KL+DFGL++ G     T++        TR      + GT  Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            APE +         D ++ G++L E L G
Sbjct: 183 IAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 12/101 (11%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPIS----WPTRVKIAI 64
           L +  +E +VKL     + DN   V +++P G + + L R  V P      +   + +AI
Sbjct: 55  LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAI 114

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 105
           +    + F+H        RD+K  N+L+D + + KL+DFGL
Sbjct: 115 ESVHKMGFIH--------RDIKPDNILIDLDGHIKLTDFGL 147

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.4 bits (107), Expect = 1e-05
 Identities = 32/106 (30%), Positives = 56/106 (52%), Gaps = 13/106 (12%)

Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGT 124
           + R L+++H     + +RDLK  N+L+D N +  KL DFG A++   G     S   + +
Sbjct: 179 LCRALAYIH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICS 233

Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           R Y APE  +   + T   D++S G ++ E      + SG+ ++D+
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279

Length = 440

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 27/79 (34%), Positives = 43/79 (54%), Gaps = 4/79 (5%)

Query: 29  NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS 88
           N  LV E++  G +++ L   G         VK   +VA  L +LH     +I+RDLK  
Sbjct: 78  NVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLH--RHGIIHRDLKPD 133

Query: 89  NVLLDSNFNAKLSDFGLAR 107
           N+L+ +  + KL+DFGL++
Sbjct: 134 NMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 41.4 bits (97), Expect = 3e-04
 Identities = 44/181 (24%), Positives = 61/181 (33%), Gaps = 69/181 (38%)

Query: 32  LVYEFMPKGSLENHL-----FRKGVQPISWPTRVKIA-----IDVARGLSFLHGLDANVI 81
           L+ EF+P G L   L     F + V      TR  +A     I+    L F+H       
Sbjct: 78  LIMEFLPGGDLMTMLIKYDTFSEDV------TRFYMAECVLAIEAVHKLGFIH------- 124

Query: 82  YRDLKASNVLLDSNFNAKLSDFGL---------------------ARDGPTGDNTHVSTR 120
            RD+K  N+L+D   + KLSDFGL                      ++     N+     
Sbjct: 125 -RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDS 183

Query: 121 I------------------------VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           I                        VGT  Y APE         + D +S G ++ E L 
Sbjct: 184 INLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243

Query: 157 G 157
           G
Sbjct: 244 G 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 23/202 (11%)

Query: 5   EVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQ----PISWPT 58
           E+  L +L+H N++ L   + S SD ++ L++++          F +  +    P+  P 
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP- 106

Query: 59  RVKIAIDVARGLSFLHGLDAN-VIYRDLKASNVLL----DSNFNAKLSDFGLAR--DGPT 111
           R  +   + + L  +H L AN V++RDLK +N+L+          K++D G AR  + P 
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 112 GDNTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
                +   +V T  Y APE  +   H T   D+++ G +  ELL+              
Sbjct: 167 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH------CR 219

Query: 171 QTLVEWADPFLRDS-RRVLRIM 191
           Q  ++ ++PF  D   R+  +M
Sbjct: 220 QEDIKTSNPFHHDQLDRIFSVM 241

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 39.3 bits (91), Expect = 0.002
 Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 16/166 (9%)

Query: 5   EVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQ----PISWPT 58
           E+  L +L+H N++ L   + S +D ++ L++++          F +  +    P+  P 
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP- 106

Query: 59  RVKIAIDVARGLSFLHGLDAN-VIYRDLKASNVLL----DSNFNAKLSDFGLAR--DGPT 111
           R  +   + + L  +H L AN V++RDLK +N+L+          K++D G AR  + P 
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166

Query: 112 GDNTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLS 156
                +   +V T  Y APE  +   H T   D+++ G +  ELL+
Sbjct: 167 KPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 17/157 (10%)

Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 73
           + N +KL    +     +L+ +++  G L + L ++G   +S     KI   +   L+ L
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDL 125

Query: 74  HGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIV--GTRGYAAP 130
           H    N+I+ D+K  NVL D +     L D+GL +         + T     GT  Y +P
Sbjct: 126 HK--HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--------IIGTPSCYDGTLDYFSP 175

Query: 131 EYVATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRG 166
           E +  GH    S D ++ GV+  ELL+G+    ED  
Sbjct: 176 EKIK-GHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211

Length = 267

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	278
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.98
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.98
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.98
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.98
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.98
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.94
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.78
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
PRK09188	365	serine/threonine protein kinase; Provisional	99.75
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.75
PRK12274	218	serine/threonine protein kinase; Provisional	99.74
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.73
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.72
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.65
PRK10345	210	hypothetical protein; Provisional	99.64
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.63
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.63
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.62
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.59
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.57
KOG1243	690	consensus Protein kinase [General function predict	99.56
PRK14879	211	serine/threonine protein kinase; Provisional	99.51
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.48
smart00090	237	RIO RIO-like kinase.	99.48
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.47
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.45
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.34
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.29
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.27
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
COG4248	637	Uncharacterized protein with protein kinase and he	99.17
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.14
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.13
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.08
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.0
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.0
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.0
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.0
KOG3087	229	consensus Serine/threonine protein kinase [General	99.0
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.99
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.98
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.9
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.82
PRK09902	216	hypothetical protein; Provisional	98.68
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.66
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.66
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.53
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.51
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.24
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.19
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.03
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.01
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.0
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.81
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.77
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.59
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.54
PLN02876	822	acyl-CoA dehydrogenase	97.38
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.08
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.97
PF01636	239	APH: Phosphotransferase enzyme family This family	96.77
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.55
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.54
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.4
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	96.29
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.12
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.63
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	95.45
PTZ00384	383	choline kinase; Provisional	95.45
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.32
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.31
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.04
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.98
PRK10271	188	thiK thiamine kinase; Provisional	94.94
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.75
PRK05231	319	homoserine kinase; Provisional	94.75
KOG2270	520	consensus Serine/threonine protein kinase involved	94.73
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.49
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.39
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.98
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	93.25
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	92.54
PLN02236	344	choline kinase	92.53
COG2334	331	Putative homoserine kinase type II (protein kinase	92.08
PRK10593	297	hypothetical protein; Provisional	91.68
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	91.54
COG4499	434	Predicted membrane protein [Function unknown]	91.31
PRK06148	1013	hypothetical protein; Provisional	90.53
PRK14559	645	putative protein serine/threonine phosphatase; Pro	89.87
PRK11768	325	serine/threonine protein kinase; Provisional	89.47
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	89.42
KOG2269	531	consensus Serine/threonine protein kinase [Signal	87.54

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-46  Score=301.52  Aligned_cols=210  Identities=31%  Similarity=0.434  Sum_probs=180.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc-cEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      ..+|+++++..+||+||.+|+.|..++. ..++|||+++|||++++...+  ++++..+..++.+++.||.|||. ..+|
T Consensus       124 i~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~-~~~I  200 (364)
T KOG0581|consen  124 ILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHE-ERKI  200 (364)
T ss_pred             HHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh-ccCe
Confidence            3689999999999999999999999995 999999999999999998764  79999999999999999999994 3899


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++..|.|||+|||.+....+.    ....++||..|+|||.+.+..|+.++||||||++++|+..|+.|
T Consensus       201 IHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP  276 (364)
T KOG0581|consen  201 IHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFP  276 (364)
T ss_pred             eeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCC
Confidence            99999999999999999999999999765444    33457899999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |....             +.....-.....+-...++..|.. +++++++||..||++||.+|||+.|+++|
T Consensus       277 ~~~~~-------------~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  277 YPPPN-------------PPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CCCcC-------------CCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            97641             111122333333333345566665 99999999999999999999999999976

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-46  Score=308.50  Aligned_cols=209  Identities=25%  Similarity=0.404  Sum_probs=179.3

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+|++||++++|||||+++++|+.....|+|+||++||+|.+++..++  .+.++....+++|++.|+.|||  +.||+|
T Consensus       224 ~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH--~~GI~H  299 (475)
T KOG0615|consen  224 QNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLH--SQGIIH  299 (475)
T ss_pred             HHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHH--HcCccc
Confidence            589999999999999999999999999999999999999999998886  6888889999999999999999  999999


Q ss_pred             cCCCCCceEEcCC---CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC---CccchhHHHHHHHHHHh
Q 023752           83 RDLKASNVLLDSN---FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLS  156 (278)
Q Consensus        83 ~dl~p~ni~~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~DiwslG~il~~l~~  156 (278)
                      |||||+||++..+   -.+||+|||++....   ....+....|++.|.|||++.+....   .+.|+|||||++|.+++
T Consensus       300 RDiKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs  376 (475)
T KOG0615|consen  300 RDIKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS  376 (475)
T ss_pred             ccCCcceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence            9999999999765   569999999998643   45566678899999999999776443   47899999999999999


Q ss_pred             CCCCCccccCCc-hhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          157 GRRALDEDRGGL-AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       157 g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      |.+||.+...+. ..+.+......               ..++.+..++++..+||.+||..||++|||+.++|+|-.
T Consensus       377 G~pPFS~~~~~~sl~eQI~~G~y~---------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  377 GYPPFSEEYTDPSLKEQILKGRYA---------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             cCCCcccccCCccHHHHHhcCccc---------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence            999998766554 33333332221               224557789999999999999999999999999997643

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-44  Score=310.11  Aligned_cols=205  Identities=27%  Similarity=0.436  Sum_probs=180.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      ..+||+|.++|+|||||+++++|++.++.|+|.|.|..++|..++++++  .+++.++..++.||+.||.|||  +.+|+
T Consensus        65 v~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH--~~~Ii  140 (592)
T KOG0575|consen   65 VLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLH--SLGII  140 (592)
T ss_pred             HHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHH--hcCce
Confidence            4689999999999999999999999999999999999999999998665  8999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |||||..|++++++.+|||+|||+++......  .......||+.|.|||++....-+..+||||+||++|.|+.|++||
T Consensus       141 HRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPF  218 (592)
T KOG0575|consen  141 HRDLKLGNLFLNENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPF  218 (592)
T ss_pred             ecccchhheeecCcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCc
Confidence            99999999999999999999999999865432  2334467999999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +..+.......+...                   .-..|...+.++.+||.+||+.||.+|||+.+|+.|
T Consensus       219 etk~vkety~~Ik~~-------------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  219 ETKTVKETYNKIKLN-------------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             ccchHHHHHHHHHhc-------------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            876544333333331                   233466889999999999999999999999999954

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-44  Score=282.27  Aligned_cols=213  Identities=25%  Similarity=0.342  Sum_probs=174.5

Q ss_pred             hHHHHHHHhccCCccccceee-eeecCCc-cEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcC-
Q 023752            2 WQTEVIYLGQLRHENLVKLIG-YCSESDN-RLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFLHGL-   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-   76 (278)
                      +-.|+.+|++|+|||||++++ .|.+++. ++++||+|++|+|..+++.  ...+.+++..+|+++.|++.||..+|+. 
T Consensus        65 ~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~  144 (375)
T KOG0591|consen   65 CVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI  144 (375)
T ss_pred             HHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc
Confidence            357999999999999999999 6666665 8999999999999999864  3456899999999999999999999942 


Q ss_pred             -CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           77 -DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        77 -~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                       .+-+.||||||.||+++.+|.+||+|||++..+.+...  .....+|+++|++||.+.+.+|+.++|||||||++|+|+
T Consensus       145 ~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMc  222 (375)
T KOG0591|consen  145 PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMC  222 (375)
T ss_pred             cccceeeccCcchheEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence             23499999999999999999999999999987655433  334578999999999999999999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS-KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      .-+.||.+.+-...-.+|.+                  ..-.+.| ..+|..+..+|..|+..||+.||+.-.++..+.+
T Consensus       223 aL~~PF~g~n~~~L~~KI~q------------------gd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  223 ALQSPFYGDNLLSLCKKIEQ------------------GDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             hcCCCcccccHHHHHHHHHc------------------CCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            99999987532211112222                  1223455 6899999999999999999999985444444433

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=294.29  Aligned_cols=216  Identities=34%  Similarity=0.524  Sum_probs=190.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++|+|++||++++++..++-++|||||+..|+|.+++.......+...++..++.||++|.+||+  +++++
T Consensus       248 f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe--s~~~I  325 (468)
T KOG0197|consen  248 FLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE--SKNYI  325 (468)
T ss_pred             HHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            7899999999999999999999999888999999999999999999866668999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      ||||...||+|+++..+||+|||+++....... .......-..-|.|||.+....++.+|||||||++++|++| |+.|
T Consensus       326 HRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~p  404 (468)
T KOG0197|consen  326 HRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVP  404 (468)
T ss_pred             chhhhhhheeeccCceEEEcccccccccCCCce-eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCC
Confidence            999999999999999999999999984322211 11111223456999999999999999999999999999999 8888


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.++..                  ......+....+.+.|..+|.++++++..||+.+|++|||++.+...|+.+...
T Consensus       405 y~~msn------------------~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  405 YPGMSN------------------EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             CCCCCH------------------HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            877654                  455666777778888999999999999999999999999999999999998765

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-43  Score=299.88  Aligned_cols=208  Identities=25%  Similarity=0.421  Sum_probs=180.8

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..+|+.+|+..+|+|||++++.|...+.+|+||||++||+|.+.+...   .+++.++..++..++.||+|||  ..||
T Consensus       316 LilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH--~~gI  390 (550)
T KOG0578|consen  316 LLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH--ARGI  390 (550)
T ss_pred             hhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH--hcce
Confidence            3579999999999999999999999999999999999999999999766   4999999999999999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+|||.+||+++.+|.+||+|||++..+.....  .....+|+++|+|||+.....|+++.||||||+++.||+.|++|
T Consensus       391 iHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPP  468 (550)
T KOG0578|consen  391 IHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPP  468 (550)
T ss_pred             eeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCC
Confidence            9999999999999999999999999987655543  33457899999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |-..+.-.....+.....+                ....+..++.++++|+.+||+.|+++|+++.+||+|
T Consensus       469 YlnE~PlrAlyLIa~ng~P----------------~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  469 YLNENPLRALYLIATNGTP----------------KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ccCCChHHHHHHHhhcCCC----------------CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            9654332222333332222                233467789999999999999999999999999975

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=288.15  Aligned_cols=220  Identities=33%  Similarity=0.574  Sum_probs=188.7

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCC-ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESD-NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      .|.+|+.+|.+++||||+++++++.++. .+++||||+.+|+|.+++.......++...+..++.+|+.|+.|||  +.+
T Consensus        85 ~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH--~~~  162 (362)
T KOG0192|consen   85 AFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH--SEG  162 (362)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCC
Confidence            3789999999999999999999999987 7999999999999999998743357999999999999999999999  888


Q ss_pred             -eeecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCccccccccCCcccCccccc--cCCCCCccchhHHHHHHHHHH
Q 023752           80 -VIYRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        80 -i~H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~il~~l~  155 (278)
                       |+|+||||+||+++.++ ++||+|||++.......  .......|++.|+|||++.  ...|+.++||||||+++|+|+
T Consensus       163 ~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~  240 (362)
T KOG0192|consen  163 PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELL  240 (362)
T ss_pred             CeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHH
Confidence             99999999999999997 99999999997643321  2223357899999999999  569999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      ||..||.+...                 .......+....+..++..+++.+..+|.+||+.||..||++.+++..|+.+
T Consensus       241 t~~~Pf~~~~~-----------------~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  241 TGEIPFEDLAP-----------------VQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             HCCCCCCCCCH-----------------HHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            99999976543                 1222233445556677777999999999999999999999999999999988


Q ss_pred             hcCCCC
Q 023752          236 HTSKDM  241 (278)
Q Consensus       236 ~~~~~~  241 (278)
                      ......
T Consensus       304 ~~~~~~  309 (362)
T KOG0192|consen  304 MSHISS  309 (362)
T ss_pred             HHhhcc
Confidence            775444

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-42  Score=289.53  Aligned_cols=206  Identities=25%  Similarity=0.403  Sum_probs=178.7

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      ..|-..|.+| .||.|++++-.|++...+|+|+||+.+|+|.+++.+.+  .+++.....++.+|+.||.|||  +.||+
T Consensus       121 ~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH--~~GII  196 (604)
T KOG0592|consen  121 TREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLH--SNGII  196 (604)
T ss_pred             hHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHH--hcCce
Confidence            4677889999 89999999999999999999999999999999999886  7999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCC-----------ccccccccCCcccCccccccCCCCCccchhHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-----------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i  150 (278)
                      ||||||+||+++.+++++|+|||.+..+......           .....++|+..|++||++.+...++.+|+|+|||+
T Consensus       197 HRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCi  276 (604)
T KOG0592|consen  197 HRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCI  276 (604)
T ss_pred             eccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHH
Confidence            9999999999999999999999999865543222           11244789999999999999999999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      +|+|+.|.+||.+.+.-..-+.+..                   ..-+++.++++.+.+||+++|..||.+|+++.+|.+
T Consensus       277 lyQmlaG~PPFra~NeyliFqkI~~-------------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  277 LYQMLAGQPPFRAANEYLIFQKIQA-------------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             HHHHhcCCCCCccccHHHHHHHHHH-------------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence            9999999999976554222222222                   124557778899999999999999999999999986


Q ss_pred             H
Q 023752          231 S  231 (278)
Q Consensus       231 ~  231 (278)
                      |
T Consensus       338 H  338 (604)
T KOG0592|consen  338 H  338 (604)
T ss_pred             C
Confidence            5

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.5e-42  Score=273.44  Aligned_cols=223  Identities=26%  Similarity=0.339  Sum_probs=181.2

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+||++|++++|+|+|.++++|...+..++|||||+. ++.+.+.+.. .++++..+..+++|++.|+.|+|  +.+++|
T Consensus        49 lREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cH--k~n~IH  124 (396)
T KOG0593|consen   49 LREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCH--KNNCIH  124 (396)
T ss_pred             HHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhh--hcCeec
Confidence            5899999999999999999999999999999999976 5555565554 36999999999999999999999  999999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |||||+||+++.+|.+||+|||+++....  +....+..+.+.+|+|||.+.| -.|+.+.|||++||++.+|++|.+.|
T Consensus       125 RDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~  202 (396)
T KOG0593|consen  125 RDIKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLW  202 (396)
T ss_pred             ccCChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCC
Confidence            99999999999999999999999987654  3344456788999999999987 58999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhh--ccCCC-------C---CHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT--RLGGQ-------Y---SKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-------~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      .+.++-.+...|..-..+.+..-..++..-..  +...+       .   .+..+..+.+|+.+||+.||++|++.++++
T Consensus       203 PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  203 PGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             CCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence            99888777776666555444322222111000  00000       0   134567899999999999999999999998


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      .|
T Consensus       283 ~H  284 (396)
T KOG0593|consen  283 HH  284 (396)
T ss_pred             cC
Confidence            43

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-42  Score=285.51  Aligned_cols=222  Identities=26%  Similarity=0.338  Sum_probs=183.2

Q ss_pred             HHHHHHHhccC-CccccceeeeeecCC-ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            3 QTEVIYLGQLR-HENLVKLIGYCSESD-NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         3 ~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .+|+.-|++++ |||||++.+++.++. .+|+||||+ ..+|.+++..+ .+.+++..+..|+.||++||+|+|  ++|+
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH--k~Gf  131 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH--KHGF  131 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH--hcCc
Confidence            58999999998 999999999999887 899999999 56999999888 578999999999999999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-cCCCCCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      .|||+||+||++.....+||+|||+++...+..   ..+..+.+.+|+|||++. ...|+.+.|+|++|||++|+.+-++
T Consensus       132 FHRDlKPENiLi~~~~~iKiaDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrP  208 (538)
T KOG0661|consen  132 FHRDLKPENILISGNDVIKIADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRP  208 (538)
T ss_pred             ccccCChhheEecccceeEecccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcc
Confidence            999999999999999999999999998755433   344567899999999875 4678999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhcccc-ch---hHHHHHHhhhccCCCC-------CHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFL-RD---SRRVLRIMDTRLGGQY-------SKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      .|.+.+...+..++-+...... ..   .......++...+...       -...+.++.++|.+||.+||++|||+.|+
T Consensus       209 LFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a  288 (538)
T KOG0661|consen  209 LFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA  288 (538)
T ss_pred             cCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH
Confidence            9998877666555544433222 22   1223333333322211       13378899999999999999999999999


Q ss_pred             HHH
Q 023752          229 LTS  231 (278)
Q Consensus       229 l~~  231 (278)
                      +++
T Consensus       289 l~~  291 (538)
T KOG0661|consen  289 LQH  291 (538)
T ss_pred             hcC
Confidence            975

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=281.18  Aligned_cols=218  Identities=27%  Similarity=0.469  Sum_probs=178.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC--ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD--NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+++|.+++|||||++++......  .++++|||+.+|+|.+++.+.+. .+++..+..+..|+++||.|||  ++|
T Consensus        61 l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH--s~g  137 (313)
T KOG0198|consen   61 LEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH--SKG  137 (313)
T ss_pred             HHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            579999999999999999999754444  58999999999999999998875 6999999999999999999999  999


Q ss_pred             eeecCCCCCceEEcC-CCceEEeccccccCCCC-CCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHh
Q 023752           80 VIYRDLKASNVLLDS-NFNAKLSDFGLARDGPT-GDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        80 i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~  156 (278)
                      ++|+||||.||+++. ++.+||+|||.+..... ...........+++.|+|||++.+. ..+.++|||||||++.+|+|
T Consensus       138 ~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T  217 (313)
T KOG0198|consen  138 IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT  217 (313)
T ss_pred             EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence            999999999999999 79999999999876553 1112223346789999999999853 34459999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      |..||...                ................+.++..++.+.++|+.+|++.||.+|||+.++|.|.--..
T Consensus       218 g~~PW~~~----------------~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  218 GKPPWSEF----------------FEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             CCCcchhh----------------cchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            99998642                11112222222222334778889999999999999999999999999998765544


Q ss_pred             cC
Q 023752          237 TS  238 (278)
Q Consensus       237 ~~  238 (278)
                      ..
T Consensus       282 ~~  283 (313)
T KOG0198|consen  282 NS  283 (313)
T ss_pred             cc
Confidence            44

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=277.57  Aligned_cols=205  Identities=27%  Similarity=0.461  Sum_probs=167.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +..|+.||+.++|||||.+++.+..++.+|+|||||+||+|.+++.+++  .+++..+..++.||+.|+.+||  +++|+
T Consensus        56 L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~--~~~Ii  131 (429)
T KOG0595|consen   56 LLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH--ENNII  131 (429)
T ss_pred             HHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5689999999999999999999999999999999999999999999886  7999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCC------CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSN------FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        82 H~dl~p~ni~~~~~------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                      ||||||+||+++..      -.+||+|||+++...+.   .......|++.|+|||++....|+.|+|+||+|+++|+++
T Consensus       132 HRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l  208 (429)
T KOG0595|consen  132 HRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCL  208 (429)
T ss_pred             eccCCcceEEeccCCCCCCCceEEecccchhhhCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHH
Confidence            99999999999764      45899999999976533   3334567999999999999999999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      +|..||+..........+..                .....+..+...+..+.+++...++.+|.+|.+..+-.
T Consensus       209 ~g~~Pf~a~t~~eL~~~~~k----------------~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  209 TGKPPFDAETPKELLLYIKK----------------GNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             hCCCCccccCHHHHHHHHhc----------------cccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence            99999975433211111110                01111223445566666777777777777777665544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=287.29  Aligned_cols=204  Identities=27%  Similarity=0.435  Sum_probs=175.2

Q ss_pred             HHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .+|+.+++++. ||||+++++++......|+||||+.||+|.+++.+.+  ++.+..+..++.|+++|+.|||  +.||+
T Consensus        67 ~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H--~~gi~  142 (370)
T KOG0583|consen   67 KREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCH--SRGIV  142 (370)
T ss_pred             HHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            47999999998 9999999999999999999999999999999998854  7999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCC-CceEEeccccccCCCCCCCCccccccccCCcccCccccccCC-CC-CccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LT-PKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~-~~~DiwslG~il~~l~~g~  158 (278)
                      ||||||+||+++.+ +.+||+|||++....  ..........|++.|+|||++.+.. |+ .++|+||+|+++|.|++|.
T Consensus       143 HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~  220 (370)
T KOG0583|consen  143 HRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR  220 (370)
T ss_pred             eCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC
Confidence            99999999999999 999999999998753  2233344567999999999999877 86 7899999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKE-AQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||++.+.......+                   ......++..+ +.++.+|+.+||..||.+|+++.+++.+
T Consensus       221 ~PF~d~~~~~l~~ki-------------------~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  221 LPFDDSNVPNLYRKI-------------------RKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             CCCCCccHHHHHHHH-------------------hcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence            999874322111111                   11224455666 9999999999999999999999999944

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-41  Score=293.62  Aligned_cols=205  Identities=28%  Similarity=0.439  Sum_probs=179.3

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+||-||+.+.||||+.+|++++++.++|+|.||+.||-|.+++.+++  ++++.++..+++||+.|+.|+|  ..+|||
T Consensus        60 erEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH--~~~icH  135 (786)
T KOG0588|consen   60 EREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH--AFNICH  135 (786)
T ss_pred             hhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh--hhccee
Confidence            589999999999999999999999999999999999999999999887  7999999999999999999999  899999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC-CccchhHHHHHHHHHHhCCCCC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||+||+|++++..+.+||+|||.+.....   ......-.|+++|.+||+++|..|+ .++||||-|+|+|.|++|+.||
T Consensus       136 RDLKpENlLLd~~~nIKIADFGMAsLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF  212 (786)
T KOG0588|consen  136 RDLKPENLLLDVKNNIKIADFGMASLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF  212 (786)
T ss_pred             ccCCchhhhhhcccCEeeeccceeecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC
Confidence            99999999999999999999999975333   3334445689999999999999987 6899999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      ++.+-.....+.                   .....+.|..++.++++||.+||..||..|.|.++|++|--
T Consensus       213 dDdNir~LLlKV-------------------~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  213 DDDNIRVLLLKV-------------------QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             CCccHHHHHHHH-------------------HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            864322111111                   11235567899999999999999999999999999998753

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=273.48  Aligned_cols=205  Identities=25%  Similarity=0.383  Sum_probs=176.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .+.|..||.+++||.||+++..|++.+.+|+|+||+.||.|...+++.+  .+++..+.-++..|+.||.|||  +.||+
T Consensus        72 ~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH--~~gIi  147 (357)
T KOG0598|consen   72 TKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH--SKGII  147 (357)
T ss_pred             HHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH--hCCee
Confidence            3689999999999999999999999999999999999999999998776  7999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.+|+++|+|||++...-...  .......||+.|+|||++.+..++.++|.||||+++|+|++|..||
T Consensus       148 yRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF  225 (357)
T KOG0598|consen  148 YRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPF  225 (357)
T ss_pred             eccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCC
Confidence            99999999999999999999999998533322  2223367999999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC----CHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP----SMVDVLT  230 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp----s~~~ll~  230 (278)
                      ...+.....+.+....                  ....+...+.+.++++.++|+.||++|.    ++.+|.+
T Consensus       226 ~~~~~~~~~~~I~~~k------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  226 YAEDVKKMYDKILKGK------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             cCccHHHHHHHHhcCc------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence            8766544444433322                  1333455888999999999999999995    5666553

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=274.65  Aligned_cols=218  Identities=27%  Similarity=0.363  Sum_probs=175.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +++|++.++.++||||++++.+|..++.+|+||.|+.+||+.+++......++++..+..++.++++||.|||  .+|.+
T Consensus        71 l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH--~~G~I  148 (516)
T KOG0582|consen   71 LRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH--QNGHI  148 (516)
T ss_pred             HHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH--hcCce
Confidence            5789999999999999999999999999999999999999999999887778999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cc-cccccCCcccCcccccc--CCCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VS-TRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~-~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |||||+.||+++.+|.|||+|||............ .. ...+++++|+|||++..  ..|+.|+||||||++..||.+|
T Consensus       149 HRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G  228 (516)
T KOG0582|consen  149 HRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHG  228 (516)
T ss_pred             ecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcC
Confidence            99999999999999999999999865443333211 11 44689999999999644  5899999999999999999999


Q ss_pred             CCCCccccCCchh-hhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAE-QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||.....-... .++.. .-|...         -...+......++..++++|..||+.||.+|||+.+++++
T Consensus       229 ~aPf~k~pPmkvLl~tLqn-~pp~~~---------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  229 HAPFSKYPPMKVLLLTLQN-DPPTLL---------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CCCcccCChHHHHHHHhcC-CCCCcc---------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            9999765432111 11111 000000         0001122234567799999999999999999999999953

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.4e-40  Score=275.46  Aligned_cols=223  Identities=26%  Similarity=0.349  Sum_probs=184.2

Q ss_pred             HHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .+||.||++|+||||+++.+...+.  +.+|+||||++ .+|.-++...+. .|++.++..++.||++||.|||  .+|+
T Consensus       164 ~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~v-kft~~qIKc~mkQLl~Gl~~cH--~~gv  239 (560)
T KOG0600|consen  164 IREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPGV-KFTEPQIKCYMKQLLEGLEYCH--SRGV  239 (560)
T ss_pred             HHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcCCCc-ccChHHHHHHHHHHHHHHHHHh--hcCe
Confidence            5899999999999999999998776  68999999995 488888866543 5999999999999999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      .|||||..||+++.+|.+||+|||++..+....... .+..+.+.+|+|||++.|. .|+.+.|+||.|||+.||+.|++
T Consensus       240 lHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkP  318 (560)
T KOG0600|consen  240 LHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKP  318 (560)
T ss_pred             eeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCC
Confidence            999999999999999999999999999776654332 4556779999999999875 79999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHh--hh-ccCCCCC-------HHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM--DT-RLGGQYS-------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      +|.+.....+...|.........+.+....+-  .. ....++.       ...+....+|+..||..||.+|.|+.+++
T Consensus       319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL  398 (560)
T KOG0600|consen  319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL  398 (560)
T ss_pred             CcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence            99999988888888877665444433311111  10 1111122       23467788999999999999999999998


Q ss_pred             H
Q 023752          230 T  230 (278)
Q Consensus       230 ~  230 (278)
                      .
T Consensus       399 ~  399 (560)
T KOG0600|consen  399 Q  399 (560)
T ss_pred             c
Confidence            5

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5e-40  Score=278.29  Aligned_cols=207  Identities=25%  Similarity=0.360  Sum_probs=183.1

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCc-cEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .+|+.+++++.|||||.++++|.+++. .+|+|+||+||++.+.+.+.....+++..+..|+.|++.|+.|||  +.+|.
T Consensus        51 ~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH--~~~iL  128 (426)
T KOG0589|consen   51 IQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH--ENRVL  128 (426)
T ss_pred             HHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH--hhhhh
Confidence            579999999999999999999999988 899999999999999998877678999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |||||+.||+++.++.|+|+|||++....+..  ......+|++.|+.||++.+.+|+.++|||||||++|+|++-+.+|
T Consensus       129 HRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF  206 (426)
T KOG0589|consen  129 HRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAF  206 (426)
T ss_pred             cccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhccccc
Confidence            99999999999999999999999999866554  2344578999999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+-.....++..                  ..-.+.+..++.+++.+|..||..+|..||++.+++.+
T Consensus       207 ~a~~m~~Li~ki~~------------------~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  207 KASNMSELILKINR------------------GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CccchHHHHHHHhh------------------ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            76543222222221                  22356788999999999999999999999999999976

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.4e-38  Score=272.58  Aligned_cols=217  Identities=29%  Similarity=0.429  Sum_probs=172.4

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCC-ccEEEEeccCCCCHHHHHhhcC-----------------------------
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESD-NRLLVYEFMPKGSLENHLFRKG-----------------------------   50 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~-----------------------------   50 (278)
                      +.+|+.+++.+ +||||+++++++...+ ..+++|||+.+|+|.+++....                             
T Consensus        57 ~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (338)
T cd05102          57 LMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRR  136 (338)
T ss_pred             HHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccc
Confidence            57899999999 8999999999887654 5789999999999999986532                             


Q ss_pred             -------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceE
Q 023752           51 -------------------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK   99 (278)
Q Consensus        51 -------------------------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~k   99 (278)
                                                     ...+++..+..++.|++.||.|||  +.|++|+||||+||+++.++.++
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH--~~~ivHrDiKp~Nil~~~~~~~k  214 (338)
T cd05102         137 IEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVK  214 (338)
T ss_pred             cccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHH--HCCEECCCCccceEEEcCCCcEE
Confidence                                           124777888999999999999999  89999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhc
Q 023752          100 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWAD  178 (278)
Q Consensus       100 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~  178 (278)
                      |+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||........         
T Consensus       215 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~---------  285 (338)
T cd05102         215 ICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE---------  285 (338)
T ss_pred             EeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH---------
Confidence            999999875432222111122334567999999988899999999999999999997 9999975432111         


Q ss_pred             cccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                              ....+........+..++..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       286 --------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         286 --------FCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             --------HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                    111111111223345667889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.2e-38  Score=266.49  Aligned_cols=210  Identities=22%  Similarity=0.358  Sum_probs=172.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      |.+|+.+|++++||||+++++++.+    ....++++||+.+|+|.+++....  .+++.....++.+++.|+.|||  .
T Consensus        65 ~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH--~  140 (283)
T PHA02988         65 TENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLY--K  140 (283)
T ss_pred             HHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHH--h
Confidence            5799999999999999999999876    346789999999999999997654  6888899999999999999999  6


Q ss_pred             -CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc--CCCCCccchhHHHHHHHHH
Q 023752           78 -ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        78 -~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l  154 (278)
                       .+++|+||+|+||+++.++.+||+|||++.......     ....++..|+|||.+.+  ..++.++||||||+++|+|
T Consensus       141 ~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el  215 (283)
T PHA02988        141 YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEI  215 (283)
T ss_pred             cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHH
Confidence             589999999999999999999999999987543221     12346788999999876  6789999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      ++|..||...+......                 ...........+...+.++.+++.+||+.||++|||+.++++.|+.
T Consensus       216 ~~g~~Pf~~~~~~~~~~-----------------~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        216 FTGKIPFENLTTKEIYD-----------------LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             HHCCCCCCCCCHHHHHH-----------------HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            99999997543211111                 1111222233444678899999999999999999999999999998


Q ss_pred             hhc
Q 023752          235 LHT  237 (278)
Q Consensus       235 ~~~  237 (278)
                      +..
T Consensus       279 ~~~  281 (283)
T PHA02988        279 YKF  281 (283)
T ss_pred             HHh
Confidence            764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.4e-39  Score=251.44  Aligned_cols=223  Identities=24%  Similarity=0.317  Sum_probs=181.3

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+||+.|+.++|+||+.++|+|...+.+.+|+||++ .+|+..+..+. ..+....+..++.+++.||+|||  .+.|.|
T Consensus        49 lREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H--~~~IlH  124 (318)
T KOG0659|consen   49 LREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCH--SKWILH  124 (318)
T ss_pred             HHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHH--hhhhhc
Confidence            589999999999999999999999999999999994 69998887654 47999999999999999999999  999999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCCC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |||||+|++++.+|.+||+|||+++.+.+........  +.+.+|+|||++.|. .|+...|+||.||++.||+-|.+.|
T Consensus       125 RDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~--V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~f  202 (318)
T KOG0659|consen  125 RDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ--VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFF  202 (318)
T ss_pred             ccCCccceEEcCCCcEEeecccchhccCCCCcccccc--eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCC
Confidence            9999999999999999999999999877765544332  678899999999774 7999999999999999999999888


Q ss_pred             ccccCCchhhhHHh-hhccccchhHHHH---HHhhhc-----cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVE-WADPFLRDSRRVL---RIMDTR-----LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+.++-.+...+.. ...|...++....   ..+.-.     .....-...+..+.+|+.+|+..||.+|+++.|++++
T Consensus       203 pG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  203 PGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            88777666655543 3333333322111   111111     1111234467788999999999999999999999975

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1e-39  Score=256.27  Aligned_cols=208  Identities=27%  Similarity=0.434  Sum_probs=176.9

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .+|+.||+++ .||+|+++.|+|+.+...++|+|.+..|.|.|++...-  .+++.....++.|+++|++|||  ..+||
T Consensus        70 ~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylH--a~~IV  145 (411)
T KOG0599|consen   70 RQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLH--ARNIV  145 (411)
T ss_pred             HHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHH--Hhhhh
Confidence            5799999999 69999999999999999999999999999999998776  6999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc------CCCCCccchhHHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~il~~l~  155 (278)
                      ||||||+||+++++-.++|+|||+++.......   .....|++.|+|||++..      ..|+...|+|+.|+++|.|+
T Consensus       146 HRDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL  222 (411)
T KOG0599|consen  146 HRDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL  222 (411)
T ss_pred             hcccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence            999999999999999999999999997655443   234568999999999854      36778899999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .|.+||.-...-.....+.+..               ..+..+.+.+++.+..+||.+||+.||.+|.|++|+|.|-
T Consensus       223 aGcpPFwHRkQmlMLR~ImeGk---------------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  223 AGCPPFWHRKQMLMLRMIMEGK---------------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             cCCCchhHHHHHHHHHHHHhcc---------------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            9999996433222222222211               1233455778999999999999999999999999999763

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4e-39  Score=255.21  Aligned_cols=192  Identities=29%  Similarity=0.439  Sum_probs=171.4

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+|..+|+.+.||.++++++.|.+.+.+|+||||+.||.|.+++.+.+  ++++..+.-++.||+.||+|||  +.+|++
T Consensus        92 ~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH--~~~iiY  167 (355)
T KOG0616|consen   92 HNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLH--SLDIIY  167 (355)
T ss_pred             hhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHH--hcCeee
Confidence            579999999999999999999999999999999999999999998765  7999999999999999999999  999999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      |||||+||+++.+|.+||+|||++.......     -...|++.|+|||++...++..++|.|+||+++|+|+.|..||-
T Consensus       168 RDLKPENiLlD~~G~iKitDFGFAK~v~~rT-----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~  242 (355)
T KOG0616|consen  168 RDLKPENLLLDQNGHIKITDFGFAKRVSGRT-----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY  242 (355)
T ss_pred             ccCChHHeeeccCCcEEEEeccceEEecCcE-----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence            9999999999999999999999998754332     22468999999999999999999999999999999999999998


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ..+.....++|...                   ...+|..++.++++|+.++|+.|-.+|
T Consensus       243 ~~~~~~iY~KI~~~-------------------~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  243 DDNPIQIYEKILEG-------------------KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CCChHHHHHHHHhC-------------------cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence            76654333333332                   245688899999999999999999999

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.4e-38  Score=262.97  Aligned_cols=214  Identities=29%  Similarity=0.509  Sum_probs=175.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAIDVA   67 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~~l~   67 (278)
                      |.+|++++++++||||+++++++...+..++++||+.+++|.+++.....              ..+++..+..++.|++
T Consensus        55 ~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  134 (283)
T cd05048          55 FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIA  134 (283)
T ss_pred             HHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHH
Confidence            67899999999999999999999988899999999999999999875421              3578889999999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHH
Q 023752           68 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF  147 (278)
Q Consensus        68 ~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  147 (278)
                      .||.|||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|||
T Consensus       135 ~al~~lH--~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl  212 (283)
T cd05048         135 AGMEYLS--SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF  212 (283)
T ss_pred             HHHHHHH--hCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH
Confidence            9999999  89999999999999999999999999999875433222122222345678999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          148 GVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       148 G~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      ||++|+|++ |..||.+.....                  ....+........+..++.++.+++.+||+.||.+||++.
T Consensus       213 G~il~el~~~g~~p~~~~~~~~------------------~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~  274 (283)
T cd05048         213 GVVLWEIFSYGLQPYYGFSNQE------------------VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFK  274 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHH------------------HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            999999998 999986543211                  1112222223344567889999999999999999999999


Q ss_pred             HHHHHHHhh
Q 023752          227 DVLTSLEQL  235 (278)
Q Consensus       227 ~ll~~l~~~  235 (278)
                      +|+++|+++
T Consensus       275 ~i~~~l~~~  283 (283)
T cd05048         275 DIHTRLRSW  283 (283)
T ss_pred             HHHHHHhcC
Confidence            999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.9e-39  Score=273.62  Aligned_cols=204  Identities=29%  Similarity=0.395  Sum_probs=176.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++|++.++||||+.++++|+...++|+|+|||.| +|..++...+  .++++.+..++.++++||.|||  +.+|.
T Consensus        48 l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLh--s~ril  122 (808)
T KOG0597|consen   48 LRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLH--SNRIL  122 (808)
T ss_pred             HHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH--hcCcc
Confidence            57899999999999999999999999999999999976 9999998766  6999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+|+||+||++...|.+|++|||+++.....  ........|++.|+|||+..+..|+..+|+|||||++|+++.|++||
T Consensus       123 hrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF  200 (808)
T KOG0597|consen  123 HRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPF  200 (808)
T ss_pred             cccCCcceeeecCCCceeechhhhhhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCc
Confidence            9999999999999999999999999875442  33344567999999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      -...       +...           .+.+. ..+...|...+..+..|+..+|++||.+|.+..+++.|
T Consensus       201 ~a~s-------i~~L-----------v~~I~-~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  201 YARS-------ITQL-----------VKSIL-KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             hHHH-------HHHH-----------HHHHh-cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            5321       1111           11111 12344566889999999999999999999999999953

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=283.24  Aligned_cols=217  Identities=25%  Similarity=0.329  Sum_probs=179.0

Q ss_pred             hHHHHHHHhccC-Cccccceeee-eecC------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGY-CSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~-~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      .++||++|++|+ |+|||.++|. ....      -+++|+||||.||.|.|++.++...+|++.++.+|++++++||.+|
T Consensus        81 v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~m  160 (738)
T KOG1989|consen   81 VKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAM  160 (738)
T ss_pred             HHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHH
Confidence            579999999996 9999999994 3211      2467999999999999999987767799999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCC-CCccc------cccccCCcccCcccc---ccCCCCCccc
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD-NTHVS------TRIVGTRGYAAPEYV---ATGHLTPKSD  143 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~-~~~~~------~~~~~~~~~~aPE~~---~~~~~~~~~D  143 (278)
                      |..+-.|+|||||-+|||+..+|.+||+|||.++.-.... .....      -....|+.|++||.+   .+...+.|+|
T Consensus       161 H~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsD  240 (738)
T KOG1989|consen  161 HYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSD  240 (738)
T ss_pred             hcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhH
Confidence            9665669999999999999999999999999987532222 11110      013568899999976   6778999999


Q ss_pred             hhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          144 VYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       144 iwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      ||+|||++|-||....||+....                     ..++......+-...++..+.+||+.||+.||++||
T Consensus       241 IWALGclLYkLCy~t~PFe~sg~---------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RP  299 (738)
T KOG1989|consen  241 IWALGCLLYKLCYFTTPFEESGK---------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERP  299 (738)
T ss_pred             HHHHHHHHHHHHHhCCCcCcCcc---------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCC
Confidence            99999999999999999986422                     233334444444578999999999999999999999


Q ss_pred             CHHHHHHHHHhhhcCC
Q 023752          224 SMVDVLTSLEQLHTSK  239 (278)
Q Consensus       224 s~~~ll~~l~~~~~~~  239 (278)
                      ++.+++..+-.+....
T Consensus       300 nI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  300 NIYQVLEEIFELANKP  315 (738)
T ss_pred             CHHHHHHHHHHHhcCC
Confidence            9999999999988763

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-38  Score=271.11  Aligned_cols=205  Identities=25%  Similarity=0.374  Sum_probs=171.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++.+..++..|+||||+.+++|.+++....  .+++..+..++.||+.||.|||  +.|++
T Consensus        42 ~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH--~~~iv  117 (323)
T cd05571          42 TLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLH--SCDVV  117 (323)
T ss_pred             HHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeE
Confidence            4579999999999999999999999999999999999999999987654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.++.+||+|||++.......  .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       118 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf  195 (323)
T cd05571         118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  195 (323)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCC
Confidence            99999999999999999999999986432211  1122345789999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...+.......+                 .  .....++..++.++.+||.+||+.||++||     ++.++++|
T Consensus       196 ~~~~~~~~~~~~-----------------~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         196 YNQDHEKLFELI-----------------L--MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCHHHHHHHH-----------------H--cCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            653321111110                 0  112344566788999999999999999999     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-38  Score=280.22  Aligned_cols=210  Identities=23%  Similarity=0.319  Sum_probs=172.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+.+++.++||||+++++++..++..|+||||+.+++|.+.+...  ....+++..+..++.|++.||.|||  +.+
T Consensus       112 ~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH--~~~  189 (478)
T PTZ00267        112 ARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH--SRK  189 (478)
T ss_pred             HHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            568999999999999999999999999999999999999999887542  2236889999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++|+|||||++|+|++|..
T Consensus       190 ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~  269 (478)
T PTZ00267        190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR  269 (478)
T ss_pred             EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999876543322222333457889999999988899999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||.......                  ....+......+.+..++.++.++|.+||+.||++||++.+++.+
T Consensus       270 Pf~~~~~~~------------------~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        270 PFKGPSQRE------------------IMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCCCCHHH------------------HHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            996533211                  111111111223445677899999999999999999999998753

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=266.77  Aligned_cols=202  Identities=24%  Similarity=0.346  Sum_probs=170.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++...+  .+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~  123 (291)
T cd05612          48 VHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLH--SKEIV  123 (291)
T ss_pred             HHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5689999999999999999999999999999999999999999997664  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++|||||||++|+|++|..||
T Consensus       124 H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf  198 (291)
T cd05612         124 YRDLKPENILLDKEGHIKLTDFGFAKKLRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF  198 (291)
T ss_pred             ecCCCHHHeEECCCCCEEEEecCcchhccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999987543221     1235788999999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      ...........+..                   .....+...+..+.++|.+||+.||.+||+     +.++++|
T Consensus       199 ~~~~~~~~~~~i~~-------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         199 FDDNPFGIYEKILA-------------------GKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CCCCHHHHHHHHHh-------------------CCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            75432211111111                   112345566788999999999999999995     8898866

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-37  Score=260.22  Aligned_cols=217  Identities=26%  Similarity=0.463  Sum_probs=177.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVA   67 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~   67 (278)
                      |.+|++++++++|+||+++++++...+..++|+||+.+++|.+++..+.              ...+++..+..++.|++
T Consensus        54 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~  133 (291)
T cd05094          54 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA  133 (291)
T ss_pred             HHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHH
Confidence            6789999999999999999999999999999999999999999997543              12478899999999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHH
Q 023752           68 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF  147 (278)
Q Consensus        68 ~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  147 (278)
                      .||.|||  +.|++|+||+|.||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|||
T Consensus       134 ~al~~lH--~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl  211 (291)
T cd05094         134 SGMVYLA--SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF  211 (291)
T ss_pred             HHHHHHH--hCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHH
Confidence            9999999  99999999999999999999999999999875433322121222345678999999988899999999999


Q ss_pred             HHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          148 GVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       148 G~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      |+++|+|++ |..||.........+                  ..........+...+..+.+++.+||+.+|++||++.
T Consensus       212 G~il~el~t~g~~p~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  273 (291)
T cd05094         212 GVILWEIFTYGKQPWFQLSNTEVIE------------------CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIK  273 (291)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHH------------------HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHH
Confidence            999999998 999986543221111                  1111112223345677899999999999999999999


Q ss_pred             HHHHHHHhhhcC
Q 023752          227 DVLTSLEQLHTS  238 (278)
Q Consensus       227 ~ll~~l~~~~~~  238 (278)
                      ++++.|.++...
T Consensus       274 ~v~~~l~~~~~~  285 (291)
T cd05094         274 EIYKILHALGKA  285 (291)
T ss_pred             HHHHHHHHHHhh
Confidence            999999999664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-39  Score=247.29  Aligned_cols=208  Identities=23%  Similarity=0.332  Sum_probs=174.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++|-+.|+||||+++.+.+.+.+..|+|||+++|++|..-+..+.  .+++..+...+.||+++|.|+|  .++|+
T Consensus        57 l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~--~ySEa~aSH~~rQiLeal~yCH--~n~Iv  132 (355)
T KOG0033|consen   57 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILEALAYCH--SNGIV  132 (355)
T ss_pred             HHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHH--hcCce
Confidence            5789999999999999999999999999999999999999977665543  5888999999999999999999  99999


Q ss_pred             ecCCCCCceEEcC---CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |||++|+|+++..   ..-+||+|||++....   ....-....|++.|+|||++...+|+..+|||+-|+++|-|+.|.
T Consensus       133 HRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~  209 (355)
T KOG0033|consen  133 HRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY  209 (355)
T ss_pred             eccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCC
Confidence            9999999999954   3459999999998765   233334468999999999999999999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +||.+.+.....+.+...               ....+.+.+.+++++.++||++||..||.+|+|+.|.|+|
T Consensus       210 ~PF~~~~~~rlye~I~~g---------------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  210 PPFWDEDQHRLYEQIKAG---------------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CCCCCccHHHHHHHHhcc---------------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            999764332222222111               1123455678899999999999999999999999999865

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-37  Score=265.67  Aligned_cols=224  Identities=24%  Similarity=0.301  Sum_probs=172.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-Ce
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA-NV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~i   80 (278)
                      +.+|++++++++||||+++++++...+..++||||+.+++|.+++....  .+++..+..++.|++.||.|||  +. ++
T Consensus        50 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~~i  125 (331)
T cd06649          50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLR--EKHQI  125 (331)
T ss_pred             HHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh--hcCCE
Confidence            6789999999999999999999999999999999999999999997654  6899999999999999999999  54 69


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++.......    .....++..|+|||.+.+..++.++|+|||||++|+|++|+.|
T Consensus       126 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p  201 (331)
T cd06649         126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP  201 (331)
T ss_pred             EcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999986543221    1224578899999999988999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhcc----------------------------ccchhHHHHHHhhhccCCC-CCHHHHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADP----------------------------FLRDSRRVLRIMDTRLGGQ-YSKKEAQAVAAVV  211 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li  211 (278)
                      |...+.......+......                            ...........+....... ....++.++.+||
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  281 (331)
T cd06649         202 IPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFV  281 (331)
T ss_pred             CCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHH
Confidence            9654332211111100000                            0000001111111111111 1234678999999


Q ss_pred             HHhccCCCCCCCCHHHHHHHHH
Q 023752          212 LQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       212 ~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      .+||+.||++|||+.++++|.-
T Consensus       282 ~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         282 NKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             HHHccCCcccCCCHHHHhcChH
Confidence            9999999999999999998753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.6e-37  Score=255.70  Aligned_cols=213  Identities=25%  Similarity=0.406  Sum_probs=175.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++|+||+++++++...+..++++||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus        49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH--~~~i~  126 (263)
T cd05052          49 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFI  126 (263)
T ss_pred             HHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            5789999999999999999999999999999999999999999997665556899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.......... ......+..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       127 H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p  205 (263)
T cd05052         127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP  205 (263)
T ss_pred             ecccCcceEEEcCCCcEEeCCCccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999987644322111 111223457999999988899999999999999999998 8889


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |........                  ...+........+..++.++.++|.+||+.+|++||++.++++.|+.+
T Consensus       206 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         206 YPGIDLSQV------------------YELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCCHHHH------------------HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            865432111                  111112222344556788999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=6.8e-38  Score=262.26  Aligned_cols=210  Identities=25%  Similarity=0.380  Sum_probs=172.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|++|+++++.+.+++..++|+||+.+++|.+.+.......+++..+..++.|++.||.|||  +.|++
T Consensus        47 ~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~ii  124 (285)
T cd05631          47 ALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ--RERIV  124 (285)
T ss_pred             HHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEE
Confidence            5689999999999999999999999999999999999999998886554456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       125 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf  201 (285)
T cd05631         125 YRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF  201 (285)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876432211   12345788999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      ...........+..              .+ ......++..++.++.+||.+||+.||.+||+     +.++++|
T Consensus       202 ~~~~~~~~~~~~~~--------------~~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         202 RKRKERVKREEVDR--------------RV-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             CCCCcchhHHHHHH--------------Hh-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            76543222111111              01 11123345567889999999999999999997     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.6e-37  Score=259.11  Aligned_cols=217  Identities=27%  Similarity=0.457  Sum_probs=176.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-----------VQPISWPTRVKIAIDVARGL   70 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~l   70 (278)
                      |.+|++++++++||||+++++++...+..++++||+.+++|.+++....           ...+++..+..++.|++.||
T Consensus        54 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL  133 (288)
T cd05093          54 FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGM  133 (288)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHH
Confidence            6789999999999999999999999999999999999999999986443           12489999999999999999


Q ss_pred             HHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHH
Q 023752           71 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        71 ~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i  150 (278)
                      .|||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||++
T Consensus       134 ~~lH--~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~i  211 (288)
T cd05093         134 VYLA--SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV  211 (288)
T ss_pred             HHHH--hCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHH
Confidence            9999  89999999999999999999999999999875433222222222334667999999988889999999999999


Q ss_pred             HHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          151 LLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       151 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      +|+|++ |..||...........+                  ........+..++.++.+++.+||+.||.+|||+.+++
T Consensus       212 l~~l~t~g~~p~~~~~~~~~~~~i------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~  273 (288)
T cd05093         212 LWEIFTYGKQPWYQLSNNEVIECI------------------TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIH  273 (288)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHH------------------HcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence            999998 88888654321111111                  11111222345677899999999999999999999999


Q ss_pred             HHHHhhhcC
Q 023752          230 TSLEQLHTS  238 (278)
Q Consensus       230 ~~l~~~~~~  238 (278)
                      +.|+.+...
T Consensus       274 ~~l~~~~~~  282 (288)
T cd05093         274 SLLQNLAKA  282 (288)
T ss_pred             HHHHHHHHh
Confidence            999998865

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3e-38  Score=269.58  Aligned_cols=202  Identities=25%  Similarity=0.362  Sum_probs=169.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+++..++|+||+.+++|.+.+...+  .+++..+..++.|++.||.|||  +.|++
T Consensus        65 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~iv  140 (329)
T PTZ00263         65 VAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLH--SKDII  140 (329)
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5689999999999999999999999999999999999999999997664  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.+||+|||++.......     ....+++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       141 H~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf  215 (329)
T PTZ00263        141 YRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF  215 (329)
T ss_pred             ecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCC
Confidence            99999999999999999999999987543221     1235788999999999888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      .+.........                 ...  .....+..++..+.+||.+||+.||.+||+     +.+++.|
T Consensus       216 ~~~~~~~~~~~-----------------i~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        216 FDDTPFRIYEK-----------------ILA--GRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCCCHHHHHHH-----------------Hhc--CCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            65432111111                 111  112334557788999999999999999986     7888866

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=8.6e-38  Score=261.75  Aligned_cols=225  Identities=23%  Similarity=0.304  Sum_probs=169.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++++...+..++|+||+.++.+..+....  ..+++..+..++.|++.||.|||  +.+++
T Consensus        47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH--~~~i~  122 (287)
T cd07848          47 TLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCH--KNDIV  122 (287)
T ss_pred             HHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            568999999999999999999999999999999999887665544322  36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||
T Consensus       123 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf  201 (287)
T cd07848         123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF  201 (287)
T ss_pred             cCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998764332211 112245788899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHH----Hhhhcc---------CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLR----IMDTRL---------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      ...+.......+.....+..........    ......         ........+.++.+||.+||+.||++|||+.++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~  281 (287)
T cd07848         202 PGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQC  281 (287)
T ss_pred             CCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHH
Confidence            7654433222222222111111000000    000000         001122367789999999999999999999999


Q ss_pred             HHH
Q 023752          229 LTS  231 (278)
Q Consensus       229 l~~  231 (278)
                      ++|
T Consensus       282 l~h  284 (287)
T cd07848         282 LNH  284 (287)
T ss_pred             hcC
Confidence            874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.6e-37  Score=257.80  Aligned_cols=212  Identities=28%  Similarity=0.489  Sum_probs=173.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC------------CCCCCHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG------------VQPISWPTRVKIAIDVARG   69 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~i~~~l~~~   69 (278)
                      |.+|+++++.+.|+||+++++++...+..++++||+.+++|.+++...+            ...+++..+..++.|++.|
T Consensus        55 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~  134 (280)
T cd05049          55 FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASG  134 (280)
T ss_pred             HHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHH
Confidence            6789999999999999999999999999999999999999999997543            2347888999999999999


Q ss_pred             HHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHH
Q 023752           70 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGV  149 (278)
Q Consensus        70 l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~  149 (278)
                      +.+||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+
T Consensus       135 l~~lH--~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~  212 (280)
T cd05049         135 MVYLA--SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV  212 (280)
T ss_pred             HHHHh--hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHH
Confidence            99999  8999999999999999999999999999986543322211122233467899999999899999999999999


Q ss_pred             HHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          150 VLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       150 il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      ++|++++ |..||.........                  ..+........+..++..+.+++.+||+.||++||++.++
T Consensus       213 il~e~~~~g~~p~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  274 (280)
T cd05049         213 VLWEIFTYGKQPWYGLSNEEVI------------------ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI  274 (280)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHH------------------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            9999998 99998654332111                  1111122223345677899999999999999999999999


Q ss_pred             HHHHH
Q 023752          229 LTSLE  233 (278)
Q Consensus       229 l~~l~  233 (278)
                      ++.|.
T Consensus       275 l~~l~  279 (280)
T cd05049         275 HERLQ  279 (280)
T ss_pred             HHHhh
Confidence            99885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.7e-38  Score=259.64  Aligned_cols=205  Identities=23%  Similarity=0.373  Sum_probs=175.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .++||+||..|+||||+.+|++|+..+.+++||||..+|.|.+++.+.+  .+++.+...++.||++|+.|+|  +++++
T Consensus       100 IRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCH--knrVv  175 (668)
T KOG0611|consen  100 IRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCH--KNRVV  175 (668)
T ss_pred             HHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHh--hccce
Confidence            3689999999999999999999999999999999999999999998886  7999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC-CccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p  160 (278)
                      |||||.+||+++.++.+||+|||++..+...   .....+.|++-|.+||++.|.+|. +..|.||||+++|-|..|..|
T Consensus       176 HRDLKLENILLD~N~NiKIADFGLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMP  252 (668)
T KOG0611|consen  176 HRDLKLENILLDQNNNIKIADFGLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMP  252 (668)
T ss_pred             ecccchhheeecCCCCeeeeccchhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccc
Confidence            9999999999999999999999998765433   334457789999999999988876 789999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      |++.+.......+......                    .+.-+....-||++||..||+.|.|+.+|..|..
T Consensus       253 FDG~Dhk~lvrQIs~GaYr--------------------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  253 FDGRDHKRLVRQISRGAYR--------------------EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             cCCchHHHHHHHhhccccc--------------------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            9986653333322221110                    1223445677999999999999999999998874

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=264.21  Aligned_cols=234  Identities=54%  Similarity=0.931  Sum_probs=189.5

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCC-ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CC
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESD-NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL-DA   78 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-~~   78 (278)
                      .|.+|+.++.+++|||+++++|+|.+.+ ..+||+||+..|+|.+.+.......++|....+|+..++.||+|||+. ..
T Consensus       117 eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~  196 (361)
T KOG1187|consen  117 EFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPP  196 (361)
T ss_pred             HHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCC
Confidence            3889999999999999999999999998 499999999999999999765433789999999999999999999952 12


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCcccccc-ccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI-VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~-~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      .|+|||||+.||+++.+...||+|||++...... ... .... .++..|++||.......+.++||||||+++.++++|
T Consensus       197 ~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitg  274 (361)
T KOG1187|consen  197 PIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITG  274 (361)
T ss_pred             CEecCCCCHHHeeECCCCCEEccCccCcccCCcc-ccc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhC
Confidence            4999999999999999999999999999654331 111 1111 688999999999889999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccC-CCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG-GQYSK-KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      +.+.+.... .....+..|..+.+.+. ....+++.... ..++. ..-..+..+..+|++.+|.+||++.++++.|+.+
T Consensus       275 r~~~d~~~~-~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  275 RKAVDQSRP-RGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             CcccCCCCC-cccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            988876542 12222666665555444 55566666654 44443 4666788999999999999999999999999766


Q ss_pred             hcC
Q 023752          236 HTS  238 (278)
Q Consensus       236 ~~~  238 (278)
                      ...
T Consensus       353 ~~~  355 (361)
T KOG1187|consen  353 LSL  355 (361)
T ss_pred             ccc
Confidence            554

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-38  Score=265.98  Aligned_cols=205  Identities=26%  Similarity=0.357  Sum_probs=169.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++.+.+.+..++|+||+.+++|.+++.+.+  .+++..+..++.|++.||.|||  +.|++
T Consensus        40 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~  115 (312)
T cd05585          40 TLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG--RFDLSRARFYTAELLCALENLH--KFNVI  115 (312)
T ss_pred             HHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeE
Confidence            4679999999999999999999999999999999999999999997654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.......  .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       116 HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf  193 (312)
T cd05585         116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF  193 (312)
T ss_pred             eCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCc
Confidence            99999999999999999999999987532221  1122345788999999999989999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS---MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~  231 (278)
                      ...+......                 ....  .....+..++.++.++|.+||+.||.+||+   +.+++.|
T Consensus       194 ~~~~~~~~~~-----------------~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         194 YDENVNEMYR-----------------KILQ--EPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCCHHHHHH-----------------HHHc--CCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            7543211111                 1111  123445667889999999999999999974   6777765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-37  Score=268.99  Aligned_cols=216  Identities=27%  Similarity=0.433  Sum_probs=173.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC------------------------------
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG------------------------------   50 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------------------   50 (278)
                      +.+|+++++.+ +|+||+++++.+...+..++||||+.+|+|.+++....                              
T Consensus        88 ~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (374)
T cd05106          88 LMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYI  167 (374)
T ss_pred             HHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccc
Confidence            56899999999 89999999999999999999999999999999885431                              


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEE
Q 023752           51 --------------------------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL   92 (278)
Q Consensus        51 --------------------------------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~   92 (278)
                                                            ..++++..+..++.|++.||.|||  +.|++|+||||+||++
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH--~~giiHrDLkp~Nil~  245 (374)
T cd05106         168 RSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA--SKNCIHRDVAARNVLL  245 (374)
T ss_pred             cccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCEEeccCchheEEE
Confidence                                                  124677889999999999999999  8999999999999999


Q ss_pred             cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCCCccccCCchhh
Q 023752           93 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQ  171 (278)
Q Consensus        93 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~  171 (278)
                      +.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||........  
T Consensus       246 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--  323 (374)
T cd05106         246 TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--  323 (374)
T ss_pred             eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--
Confidence            9999999999999875433322211112234567999999988889999999999999999997 9999965432111  


Q ss_pred             hHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          172 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                                     .............+...+.++.++|.+||+.||.+|||+.++++.|+++.
T Consensus       324 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         324 ---------------FYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ---------------HHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                           11111111122233445788999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-38  Score=255.81  Aligned_cols=240  Identities=27%  Similarity=0.367  Sum_probs=192.8

Q ss_pred             HHHHHHHhccCCccccceeeeeec-----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSE-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      .+|+.+|+.++|+||+.+++++..     -+..|+|+|++ +.+|.+.+..+.  .+++..+..+++|++.||.|+|  +
T Consensus        69 lRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiH--S  143 (359)
T KOG0660|consen   69 LRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIH--S  143 (359)
T ss_pred             HHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhh--c
Confidence            479999999999999999999865     24679999999 679999987664  5999999999999999999999  9


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHh
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~  156 (278)
                      .+++||||||.|++++.+-.+||+|||+++...........+..+.|.+|.|||++.. ..|+.+.||||+|||+.+|++
T Consensus       144 AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~  223 (359)
T KOG0660|consen  144 ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT  223 (359)
T ss_pred             ccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc
Confidence            9999999999999999999999999999998655433444566788999999998854 689999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHH------HHHHhhhc-cCCCC-----CHHHHHHHHHHHHHhccCCCCCCCC
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRR------VLRIMDTR-LGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPS  224 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps  224 (278)
                      |++.|.+.+.-.+.+.+.+.....-.+.-.      ....+... ..++.     -++.++...+|+.+||.+||.+|+|
T Consensus       224 gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit  303 (359)
T KOG0660|consen  224 GKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT  303 (359)
T ss_pred             CCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC
Confidence            999999988877777666655543222111      11111111 11111     2456789999999999999999999


Q ss_pred             HHHHHHH--HHhhhcCCCCCCCCCC
Q 023752          225 MVDVLTS--LEQLHTSKDMPRTPPP  247 (278)
Q Consensus       225 ~~~ll~~--l~~~~~~~~~~~~~~~  247 (278)
                      ++|+|+|  |..++...+-|.....
T Consensus       304 a~eAL~hPYl~~~hdp~dEP~~~~~  328 (359)
T KOG0660|consen  304 AEEALAHPYLAPYHDPEDEPVCQPI  328 (359)
T ss_pred             HHHHhcChhhhhhcCCccCCCCCCC
Confidence            9999976  7777777777744443

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.7e-37  Score=268.00  Aligned_cols=215  Identities=29%  Similarity=0.412  Sum_probs=171.7

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-----------------------------
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-----------------------------   51 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------------------------   51 (278)
                      +.+|+++++.+ +||||+++++++.+.+..++||||+.+|+|.+++.....                             
T Consensus        85 ~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (375)
T cd05104          85 LMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDS  164 (375)
T ss_pred             HHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchh
Confidence            57899999999 899999999999999999999999999999998864321                             


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 023752           52 --------------------------------------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA   87 (278)
Q Consensus        52 --------------------------------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p   87 (278)
                                                                  ..+++..+..++.|++.||.|||  +.|++|+||||
T Consensus       165 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ivH~Dlkp  242 (375)
T cd05104         165 LNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA--SKNCIHRDLAA  242 (375)
T ss_pred             hhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCeeccCCch
Confidence                                                        14677889999999999999999  89999999999


Q ss_pred             CceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCCCccccC
Q 023752           88 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG  166 (278)
Q Consensus        88 ~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~  166 (278)
                      +||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..||.....
T Consensus       243 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~  322 (375)
T cd05104         243 RNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV  322 (375)
T ss_pred             hhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence            999999999999999999875443322211122234557999999988899999999999999999998 8888865332


Q ss_pred             CchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      ..                 .....+........+...+.++.++|.+||+.||++||++.+|++.|++.
T Consensus       323 ~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         323 DS-----------------KFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             hH-----------------HHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            11                 11111122112223344567899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.1e-38  Score=266.27  Aligned_cols=205  Identities=25%  Similarity=0.370  Sum_probs=170.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++.|..++..|+||||+.+++|..++....  .+++..+..++.||+.||.|||  +.|++
T Consensus        42 ~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~iv  117 (323)
T cd05595          42 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH--SRDVV  117 (323)
T ss_pred             HHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            4579999999999999999999999999999999999999998887654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       118 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf  195 (323)
T cd05595         118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  195 (323)
T ss_pred             ecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCC
Confidence            999999999999999999999998764322111  112245788999999998889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...+.......+                 .  ......+..++.++.++|.+||+.||++|+     ++.++++|
T Consensus       196 ~~~~~~~~~~~~-----------------~--~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         196 YNQDHERLFELI-----------------L--MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCHHHHHHHH-----------------h--cCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            654322111111                 0  011234556788999999999999999998     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=244.69  Aligned_cols=217  Identities=22%  Similarity=0.359  Sum_probs=171.5

Q ss_pred             HHHHHHHhccCCccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      ++|++..++++||||++++++...+.     ..|++++|+..|+|.+.+.+...  ..+++.++..|+.++++||.+|| 
T Consensus        66 ~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH-  144 (302)
T KOG2345|consen   66 LREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALH-  144 (302)
T ss_pred             HHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHh-
Confidence            58999999999999999999875433     48999999999999998865432  36999999999999999999999 


Q ss_pred             CCCC--eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccc-------cccccCCcccCcccccc---CCCCCccc
Q 023752           76 LDAN--VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-------TRIVGTRGYAAPEYVAT---GHLTPKSD  143 (278)
Q Consensus        76 ~~~~--i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~-------~~~~~~~~~~aPE~~~~---~~~~~~~D  143 (278)
                       +..  ++|+||||.||++++++.+++.|||.++........+..       ....++..|+|||.+..   ...+.++|
T Consensus       145 -~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertD  223 (302)
T KOG2345|consen  145 -EKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTD  223 (302)
T ss_pred             -ccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccc
Confidence             666  999999999999999999999999999864443322211       11457889999999854   45778999


Q ss_pred             hhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          144 VYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       144 iwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      ||||||++|.|+.|..||+..-..               ...............+....+++.+.++|..||+.||.+||
T Consensus       224 IWSLGCtLYa~mf~~sPfe~~~~~---------------GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP  288 (302)
T KOG2345|consen  224 IWSLGCTLYAMMFGESPFERIYQQ---------------GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRP  288 (302)
T ss_pred             hhhhhHHHHHHHHcCCcchHHhhc---------------CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCC
Confidence            999999999999999999642110               00000111122222333445899999999999999999999


Q ss_pred             CHHHHHHHHHhhh
Q 023752          224 SMVDVLTSLEQLH  236 (278)
Q Consensus       224 s~~~ll~~l~~~~  236 (278)
                      ++.+++.++..+.
T Consensus       289 ~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  289 TIPELLSKLDDLI  301 (302)
T ss_pred             CHHHHHHHHHhhc
Confidence            9999999998764

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.2e-37  Score=261.22  Aligned_cols=224  Identities=22%  Similarity=0.278  Sum_probs=169.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+. ++|.+++...+ ..+++..+..++.|++.||.|||  +.|++
T Consensus        50 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~iv  125 (288)
T cd07871          50 AIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH--KRKIL  125 (288)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            4689999999999999999999999889999999996 48998886554 35788999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.+||+|||++........  ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.|
T Consensus       126 H~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~p  203 (288)
T cd07871         126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPM  203 (288)
T ss_pred             cCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999865332211  1122356788999998865 5688999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccch-------hHHHHHHhhhccC----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRD-------SRRVLRIMDTRLG----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |...+.......+..........       .............    .......+.++.+||.+||+.||.+|||+.+++
T Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l  283 (288)
T cd07871         204 FPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL  283 (288)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            97655443333332222111111       0111111100000    001123567899999999999999999999998


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      +|
T Consensus       284 ~h  285 (288)
T cd07871         284 RH  285 (288)
T ss_pred             cC
Confidence            65

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.7e-37  Score=252.50  Aligned_cols=211  Identities=27%  Similarity=0.427  Sum_probs=170.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++...+..++|+||+.+++|.+++.... ..+++..+..++.|+++||.|||  +.|++
T Consensus        40 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~  116 (252)
T cd05084          40 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLE--SKHCI  116 (252)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            6789999999999999999999999999999999999999999986543 35889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|.||+++.++.++|+|||++....................|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       117 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p  196 (252)
T cd05084         117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVP  196 (252)
T ss_pred             ccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999875332211111111122356999999988889999999999999999998 8888


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      |......                  .....+........+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus       197 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         197 YANLSNQ------------------QTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccccCHH------------------HHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            8643221                  111112222223445566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=263.64  Aligned_cols=205  Identities=23%  Similarity=0.382  Sum_probs=178.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++-|+..+||||+++|++......+|||+|.-++|+|.+++.+.. .++.+....+++.||+.|+.|+|  ...+|
T Consensus        64 lfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH--qLHVV  140 (864)
T KOG4717|consen   64 LFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH--QLHVV  140 (864)
T ss_pred             HHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh--hhhhh
Confidence            4689999999999999999999999999999999999999999998775 46999999999999999999999  89999


Q ss_pred             ecCCCCCceEE-cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC-CccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLL-DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~  159 (278)
                      ||||||+||.+ ..-|-|||+|||+.-.+.+....   ....|+..|.|||++.|..|+ ++.||||||+|+|.|.+|+.
T Consensus       141 HRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~  217 (864)
T KOG4717|consen  141 HRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQP  217 (864)
T ss_pred             cccCCcceeEEeeecCceEeeeccccccCCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCC
Confidence            99999999877 45688999999999876555443   334688999999999999998 68999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||+.-++....-+|.++                   .-.+|..++.++++||..||..||++|.++++|..+
T Consensus       218 PFqeANDSETLTmImDC-------------------KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  218 PFQEANDSETLTMIMDC-------------------KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             ccccccchhhhhhhhcc-------------------cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            99876554444444332                   245688999999999999999999999999999864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.2e-38  Score=278.08  Aligned_cols=218  Identities=30%  Similarity=0.501  Sum_probs=189.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------CC----CCCHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------VQ----PISWPTRVKIAIDVARG   69 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~~----~~~~~~~~~i~~~l~~~   69 (278)
                      |++|++++..|+|||||+++|++.+++-.++||||+..|||.+++....        ..    +++..+...++.||+.|
T Consensus       536 F~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaG  615 (774)
T KOG1026|consen  536 FRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAG  615 (774)
T ss_pred             HHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHH
Confidence            8999999999999999999999999999999999999999999996442        12    38889999999999999


Q ss_pred             HHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHH
Q 023752           70 LSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGV  149 (278)
Q Consensus        70 l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~  149 (278)
                      ..||-  ++.+|||||-..|++|+++..|||+|||+++...+.+.-.......-..+|+|||.+..+.|+.+|||||+|+
T Consensus       616 M~YLs--~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GV  693 (774)
T KOG1026|consen  616 MEYLS--SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGV  693 (774)
T ss_pred             HHHHH--hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhh
Confidence            99999  8999999999999999999999999999998766655444443344567899999999999999999999999


Q ss_pred             HHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          150 VLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       150 il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      ++||+++ |..||.+..+++..                  ..+..+.-.+.|.++|.++++|+..||+.+|.+||++.+|
T Consensus       694 vLWEIFsyG~QPy~glSn~EVI------------------e~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  694 VLWEIFSYGKQPYYGLSNQEVI------------------ECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             hhhhhhccccCcccccchHHHH------------------HHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            9999998 88998776654333                  3333344467788999999999999999999999999999


Q ss_pred             HHHHHhhhcCC
Q 023752          229 LTSLEQLHTSK  239 (278)
Q Consensus       229 l~~l~~~~~~~  239 (278)
                      -..|+......
T Consensus       756 ~~~L~~~~~~s  766 (774)
T KOG1026|consen  756 HSRLQAWAQAS  766 (774)
T ss_pred             HHHHHHHHhcC
Confidence            99999887664

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=269.19  Aligned_cols=206  Identities=25%  Similarity=0.354  Sum_probs=177.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .++|+.+|.+++++||.++|+.|..+..++++||||.||++.+.+....  .+.+..+.-++.+++.|+.|||  ..+.+
T Consensus        58 iqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH--~~~ki  133 (467)
T KOG0201|consen   58 IQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLH--SEKKI  133 (467)
T ss_pred             HHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhh--hccee
Confidence            3689999999999999999999999999999999999999999997665  4588889999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+|||+.||++..+|.+|++|||++.........  ...++|++.|+|||++.+..|+.++||||||++.++|.+|.+|+
T Consensus       134 HrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~  211 (467)
T KOG0201|consen  134 HRDIKAANILLSESGDVKLADFGVAGQLTNTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPH  211 (467)
T ss_pred             cccccccceeEeccCcEEEEecceeeeeechhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCC
Confidence            9999999999999999999999999765544332  25688999999999999899999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+......                  .-.+.+..++.+...+++.+++||..||+.||+.||+|.++++|
T Consensus       212 s~~hPmrv------------------lflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  212 SKLHPMRV------------------LFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             cccCcceE------------------EEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            76543111                  11222333444556789999999999999999999999999854

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=7.6e-38  Score=267.94  Aligned_cols=202  Identities=25%  Similarity=0.295  Sum_probs=170.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++++.+.+..++||||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +.|++
T Consensus        78 ~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~iv  153 (340)
T PTZ00426         78 VFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQ--SLNIV  153 (340)
T ss_pred             HHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            4679999999999999999999999999999999999999999997665  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++......     .....+++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       154 HrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf  228 (340)
T PTZ00426        154 YRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF  228 (340)
T ss_pred             ccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCC
Confidence            9999999999999999999999998754322     12245788999999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...+.......+..                   ....++...+..+.++|.+||+.||.+|+     ++.++++|
T Consensus       229 ~~~~~~~~~~~i~~-------------------~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        229 YANEPLLIYQKILE-------------------GIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCHHHHHHHHhc-------------------CCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            75433211111111                   11233455677899999999999999995     89999876

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.2e-38  Score=258.57  Aligned_cols=211  Identities=36%  Similarity=0.589  Sum_probs=168.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++...+..++|+||+.+|+|.+++.......+++..+..++.|++.||.|||  +.+++
T Consensus        48 ~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh--~~~ii  125 (259)
T PF07714_consen   48 FLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH--SNNII  125 (259)
T ss_dssp             HHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             eeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccc
Confidence            6789999999999999999999998888999999999999999998874457999999999999999999999  88999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |++|++.||+++.++.+||+|||+.....................|.|||.+.+..++.++||||||+++|++++ |..|
T Consensus       126 H~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p  205 (259)
T PF07714_consen  126 HGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFP  205 (259)
T ss_dssp             EST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999999999999876533222222233445678999999988889999999999999999999 6788


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |.+.+...                  ....+........+..++..+.++|.+||..||++|||+.++++.|
T Consensus       206 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  206 FSDYDNEE------------------IIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTTSCHHH------------------HHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             cccccccc------------------ccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            86543211                  1122222233444566788899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=262.93  Aligned_cols=216  Identities=29%  Similarity=0.398  Sum_probs=175.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCC-CCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQP-ISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      .++||.||++++|||||+++++..+.  +.+|+|+|||..|.+..--   ..+. +.+.+++.++.+++.||.|||  .+
T Consensus       155 v~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH--~Q  229 (576)
T KOG0585|consen  155 VRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLH--YQ  229 (576)
T ss_pred             HHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHH--hc
Confidence            36899999999999999999999876  4789999999888765422   2234 889999999999999999999  99


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCC---CCCccccccccCCcccCccccccCC----CCCccchhHHHHHH
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG---DNTHVSTRIVGTRGYAAPEYVATGH----LTPKSDVYSFGVVL  151 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~il  151 (278)
                      ||+||||||.|++++.+|++||+|||.+..+...   .........+|++.|+|||...+..    .+.+.||||+|+++
T Consensus       230 giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL  309 (576)
T KOG0585|consen  230 GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL  309 (576)
T ss_pred             CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence            9999999999999999999999999998765332   1222233468999999999987632    34689999999999


Q ss_pred             HHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          152 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       152 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |-|+.|+.||.+....                 +...+++......+....+.+.+++||.+||.+||++|.++.+|..|
T Consensus       310 YCllfG~~PF~~~~~~-----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  310 YCLLFGQLPFFDDFEL-----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             HHhhhccCCcccchHH-----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            9999999999764332                 22233444444445555678899999999999999999999999998


Q ss_pred             HHhhhcCC
Q 023752          232 LEQLHTSK  239 (278)
Q Consensus       232 l~~~~~~~  239 (278)
                      ..-.....
T Consensus       373 pwvt~~g~  380 (576)
T KOG0585|consen  373 PWVTRDGD  380 (576)
T ss_pred             ceeccCCC
Confidence            87766643

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.6e-37  Score=253.76  Aligned_cols=212  Identities=23%  Similarity=0.414  Sum_probs=173.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++..++..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        53 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH--~~~ii  129 (266)
T cd05064          53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS--EMGYV  129 (266)
T ss_pred             HHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            6789999999999999999999999999999999999999999987653 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++++|||........... ......++..|+|||.+.+..++.++|+|||||++|++++ |..|
T Consensus       130 H~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p  208 (266)
T cd05064         130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP  208 (266)
T ss_pred             eccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCC
Confidence            9999999999999999999999987643221111 1111233467999999988999999999999999999775 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |........                  ...+......+.+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       209 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         209 YWDMSGQDV------------------IKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             cCcCCHHHH------------------HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            975433211                  111122222344566788899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-37  Score=265.19  Aligned_cols=205  Identities=25%  Similarity=0.372  Sum_probs=170.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++.+..++..|+||||+.+++|.+.+.+.+  .+.+..+..++.|++.||.|||  +.|++
T Consensus        47 ~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~iv  122 (323)
T cd05584          47 TKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLH--QQGII  122 (323)
T ss_pred             HHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            4679999999999999999999999999999999999999999987665  6888899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf  200 (323)
T cd05584         123 YRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPF  200 (323)
T ss_pred             cCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCC
Confidence            999999999999999999999999864322111  112245788999999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...+......                 ....  .....+...+..+.++|.+||+.||++||     ++.+++++
T Consensus       201 ~~~~~~~~~~-----------------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         201 TAENRKKTID-----------------KILK--GKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCHHHHHH-----------------HHHc--CCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            7543211111                 1111  12334556778899999999999999999     89998875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-37  Score=265.56  Aligned_cols=205  Identities=25%  Similarity=0.362  Sum_probs=170.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++.+...+..++||||+.+++|.+.+....  .+++..+..++.||+.||.|||  +.|++
T Consensus        42 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~~iv  117 (328)
T cd05593          42 TLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLH--SGKIV  117 (328)
T ss_pred             HHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeE
Confidence            4679999999999999999999999999999999999999998887654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.++.+||+|||++.......  .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       118 HrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf  195 (328)
T cd05593         118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  195 (328)
T ss_pred             ecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCC
Confidence            99999999999999999999999986432211  1122345788999999998889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...+.......                  + ......++..++.++.++|.+||+.||.+|+     ++.++++|
T Consensus       196 ~~~~~~~~~~~------------------~-~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         196 YNQDHEKLFEL------------------I-LMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHH------------------h-ccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            65332111110                  0 0112334556788999999999999999997     89999976

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.3e-37  Score=257.72  Aligned_cols=215  Identities=27%  Similarity=0.430  Sum_probs=174.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--------------CCCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--------------GVQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~i~~~l   66 (278)
                      +.+|+++++++ +|+||+++++++..++..++++||+.+++|.+++..+              ....+++..+..++.|+
T Consensus        62 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  141 (293)
T cd05053          62 LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQV  141 (293)
T ss_pred             HHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHH
Confidence            46799999999 8999999999999999999999999999999998653              23468889999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.+++|+||+|.||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||
T Consensus       142 ~~al~~LH--~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  219 (293)
T cd05053         142 ARGMEFLA--SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  219 (293)
T ss_pred             HHHHHHHH--HCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceee
Confidence            99999999  8999999999999999999999999999987644322211111223346799999998889999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      |||++|++++ |..||........                  ...+........+..++..+.+|+.+||..||++|||+
T Consensus       220 lG~il~el~~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  281 (293)
T cd05053         220 FGVLLWEIFTLGGSPYPGIPVEEL------------------FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTF  281 (293)
T ss_pred             hhhHHHHHhcCCCCCCCCCCHHHH------------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence            9999999997 8888865332111                  11112222233445667889999999999999999999


Q ss_pred             HHHHHHHHhhh
Q 023752          226 VDVLTSLEQLH  236 (278)
Q Consensus       226 ~~ll~~l~~~~  236 (278)
                      .++++.|+.+.
T Consensus       282 ~eil~~l~~~~  292 (293)
T cd05053         282 KQLVEDLDRML  292 (293)
T ss_pred             HHHHHHHHHhh
Confidence            99999998864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.7e-37  Score=262.10  Aligned_cols=222  Identities=25%  Similarity=0.352  Sum_probs=170.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i   80 (278)
                      +.+|++++++++|+||++++++|.+++..++||||+.+++|.+++.+.+  .+++..+..++.+++.||.|||  . .++
T Consensus        50 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~~i  125 (333)
T cd06650          50 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR--EKHKI  125 (333)
T ss_pred             HHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hcCCE
Confidence            5789999999999999999999999999999999999999999997654  6889999999999999999999  5 479


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++.......    .....++..|+|||.+.+..++.++|+|||||++|++++|..|
T Consensus       126 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p  201 (333)
T cd06650         126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP  201 (333)
T ss_pred             EecCCChhhEEEcCCCCEEEeeCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            999999999999999999999999986542221    1223577899999999888899999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhc-----------------------cccc---hhHHHHHHhhhccCCCCC-HHHHHHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWAD-----------------------PFLR---DSRRVLRIMDTRLGGQYS-KKEAQAVAAVVLQ  213 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~-----------------------~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~  213 (278)
                      |...........+.....                       +..+   ........+........+ ..++.++.+||.+
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  281 (333)
T cd06650         202 IPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNK  281 (333)
T ss_pred             CCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHH
Confidence            975433222111100000                       0000   000011111111111111 2357789999999


Q ss_pred             hccCCCCCCCCHHHHHHH
Q 023752          214 CLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       214 ~l~~dp~~Rps~~~ll~~  231 (278)
                      ||+.||++|||+.+++.|
T Consensus       282 ~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         282 CLIKNPAERADLKQLMVH  299 (333)
T ss_pred             hccCCcccCcCHHHHhhC
Confidence            999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.5e-37  Score=252.19  Aligned_cols=212  Identities=30%  Similarity=0.472  Sum_probs=175.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|+||+++++++.+.+..++++||+.+++|.+++.......++...+..++.|++.||.|||  +.|++
T Consensus        49 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~  126 (261)
T cd05148          49 FQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE--EQNSI  126 (261)
T ss_pred             HHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999998765557899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+.........  .....++..|+|||...+..++.++|+||||+++|++++ |..|
T Consensus       127 h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p  204 (261)
T cd05148         127 HRDLAARNILVGEDLVCKVADFGLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVP  204 (261)
T ss_pred             ccccCcceEEEcCCceEEEccccchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999998764332111  112234567999999988889999999999999999998 8899


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |.......                  ....+......+.+..++..+.++|.+||+.||++|||+.++++.|+.+
T Consensus       205 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         205 YPGMNNHE------------------VYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCcCCHHH------------------HHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            96543211                  1111112222334556778899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-37  Score=253.05  Aligned_cols=210  Identities=26%  Similarity=0.350  Sum_probs=179.4

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      +-|-+||+.+.||.++.+|..|+.+...|++||||.||+|..+++++..+.+++..+..++..++-||+|||  ..||++
T Consensus       125 ~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH--mlGivY  202 (459)
T KOG0610|consen  125 QTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH--MLGIVY  202 (459)
T ss_pred             HHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH--hhceee
Confidence            458889999999999999999999999999999999999999999998899999999999999999999999  999999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCC--------------------------------CCC---------------
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTG--------------------------------DNT---------------  115 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~--------------------------------~~~---------------  115 (278)
                      |||||+||++.++|+|.|+||+++......                                ...               
T Consensus       203 RDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~  282 (459)
T KOG0610|consen  203 RDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPE  282 (459)
T ss_pred             ccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchh
Confidence            999999999999999999999986532110                                000               


Q ss_pred             -------ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHH
Q 023752          116 -------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL  188 (278)
Q Consensus       116 -------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (278)
                             .....++|+-.|+|||++.|..=+.+.|.|.||+++|||+.|..||.+.+.                 .+.+.
T Consensus       283 ~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~-----------------~~Tl~  345 (459)
T KOG0610|consen  283 LVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN-----------------KETLR  345 (459)
T ss_pred             hhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc-----------------hhhHH
Confidence                   000125678889999999999999999999999999999999999987654                 24444


Q ss_pred             HHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC----HHHHHHH
Q 023752          189 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS----MVDVLTS  231 (278)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~  231 (278)
                      .++.+....+-...++..+++||+++|.+||.+|.-    +.||.+|
T Consensus       346 NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  346 NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence            555555555555588899999999999999999987    8888754

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.5e-37  Score=259.04  Aligned_cols=220  Identities=28%  Similarity=0.463  Sum_probs=169.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-----------------CCCCHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-----------------QPISWPTRVKIAI   64 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------------~~~~~~~~~~i~~   64 (278)
                      |.+|+.++++++||||+++++++.+.+..++++||+.+++|.+++.....                 ..+++..+..++.
T Consensus        66 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  145 (304)
T cd05096          66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVAL  145 (304)
T ss_pred             HHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHH
Confidence            67899999999999999999999999999999999999999998865321                 2366778899999


Q ss_pred             HHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccch
Q 023752           65 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDV  144 (278)
Q Consensus        65 ~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  144 (278)
                      |++.||.|||  +.|++|+||+|+||+++.++.+||+|||++................++..|+|||.+.+..++.++|+
T Consensus       146 ~i~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  223 (304)
T cd05096         146 QIASGMKYLS--SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDV  223 (304)
T ss_pred             HHHHHHHHHH--HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhh
Confidence            9999999999  89999999999999999999999999999875433322222222334678999999988889999999


Q ss_pred             hHHHHHHHHHHh--CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          145 YSFGVVLLELLS--GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       145 wslG~il~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ||||+++|+|++  +..||................           ...........+..++..+.++|.+||+.||.+|
T Consensus       224 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R  292 (304)
T cd05096         224 WAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFF-----------RDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRER  292 (304)
T ss_pred             HHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHh-----------hhccccccccCCCCCCHHHHHHHHHHccCCchhC
Confidence            999999999987  556776543221111111100           0000000111233567789999999999999999


Q ss_pred             CCHHHHHHHHHh
Q 023752          223 PSMVDVLTSLEQ  234 (278)
Q Consensus       223 ps~~~ll~~l~~  234 (278)
                      ||+.+|.+.|++
T Consensus       293 Ps~~~i~~~l~~  304 (304)
T cd05096         293 PSFSDIHAFLTE  304 (304)
T ss_pred             cCHHHHHHHHhC
Confidence            999999988763

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-36  Score=256.67  Aligned_cols=215  Identities=28%  Similarity=0.422  Sum_probs=174.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++++ +||||+++++++...+..++++||+.+++|.+++.......+++..+..++.+++.||.|||  +.++
T Consensus        85 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH--~~~i  162 (302)
T cd05055          85 LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA--SKNC  162 (302)
T ss_pred             HHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            57899999999 79999999999999999999999999999999997654445899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      +|+||+|+||+++.++.++++|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus       163 vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~  242 (302)
T cd05055         163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN  242 (302)
T ss_pred             ehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999875433322111222334667999999988889999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      ||.......                 ..............+...+.++.+++.+||+.+|++|||+.++++.|.++
T Consensus       243 p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         243 PYPGMPVDS-----------------KFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CcCCCCchH-----------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            986533211                 11111111112223345677899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=266.14  Aligned_cols=210  Identities=23%  Similarity=0.304  Sum_probs=172.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~iv  123 (333)
T cd05600          48 VLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALH--ELGYI  123 (333)
T ss_pred             HHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5679999999999999999999999999999999999999999997654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.+||+|||++.....     ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       124 H~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf  198 (333)
T cd05600         124 HRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF  198 (333)
T ss_pred             ccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCC
Confidence            999999999999999999999999875433     122345788999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+.......+..+....           ...........++.++.++|.+||+.+|.+||++.+++++
T Consensus       199 ~~~~~~~~~~~i~~~~~~~-----------~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         199 SGSTPNETWENLKYWKETL-----------QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCHHHHHHHHHhccccc-----------cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            7654332222222211100           0000000012467889999999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=251.42  Aligned_cols=213  Identities=28%  Similarity=0.466  Sum_probs=173.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+.+..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~  128 (266)
T cd05033          52 FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS--EMNYV  128 (266)
T ss_pred             HHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            5779999999999999999999999999999999999999999987654 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|.||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       129 H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p  208 (266)
T cd05033         129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERP  208 (266)
T ss_pred             cCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCC
Confidence            999999999999999999999999986542221111111233567999999988889999999999999999998 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |........                  ...+......+.+..++..+.+++.+||+.+|++||++.+++++|.++
T Consensus       209 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         209 YWDMSNQDV------------------IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCHHHH------------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            865432111                  111111112233445678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-36  Score=254.42  Aligned_cols=212  Identities=27%  Similarity=0.468  Sum_probs=171.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-------------CCCCHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-------------QPISWPTRVKIAIDVAR   68 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~i~~~l~~   68 (278)
                      |.+|+++++.++|+||+++++++.+.+..++++||+.+++|.+++.....             ..+++..+..++.|++.
T Consensus        54 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~  133 (280)
T cd05092          54 FQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIAS  133 (280)
T ss_pred             HHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHH
Confidence            67899999999999999999999999999999999999999999865431             24788999999999999


Q ss_pred             HHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHH
Q 023752           69 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFG  148 (278)
Q Consensus        69 ~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG  148 (278)
                      |+.|||  +.|++|+||+|+||++++++.++|+|||++................++..|+|||.+.+..++.++|+||||
T Consensus       134 al~~LH--~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  211 (280)
T cd05092         134 GMVYLA--SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG  211 (280)
T ss_pred             HHHHHH--HCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHH
Confidence            999999  899999999999999999999999999998654322211111122345679999999888999999999999


Q ss_pred             HHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 023752          149 VVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD  227 (278)
Q Consensus       149 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  227 (278)
                      |++|+|++ |..||........                  ............+..++..+.++|.+||+.||.+||++.+
T Consensus       212 ~il~el~~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~  273 (280)
T cd05092         212 VVLWEIFTYGKQPWYQLSNTEA------------------IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKD  273 (280)
T ss_pred             HHHHHHHcCCCCCCccCCHHHH------------------HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            99999998 8888854332111                  1111121222334567788999999999999999999999


Q ss_pred             HHHHHH
Q 023752          228 VLTSLE  233 (278)
Q Consensus       228 ll~~l~  233 (278)
                      |++.|+
T Consensus       274 l~~~l~  279 (280)
T cd05092         274 IHSRLQ  279 (280)
T ss_pred             HHHHHh
Confidence            999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1e-36  Score=253.96  Aligned_cols=213  Identities=24%  Similarity=0.417  Sum_probs=169.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------VQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      |.+|+.+++.++||||+++++++.+.+..++|+||+.+++|.+++....        ...++...+..++.|++.||.||
T Consensus        56 ~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l  135 (277)
T cd05062          56 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYL  135 (277)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            5689999999999999999999999899999999999999999986532        12356778899999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.+++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|+
T Consensus       136 H--~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e  213 (277)
T cd05062         136 N--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE  213 (277)
T ss_pred             H--HCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHH
Confidence            9  89999999999999999999999999999865433222111112234567999999988889999999999999999


Q ss_pred             HHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +++ |..||.........                  ..+........+...+..+.+++.+||+.||++|||+.++++.|
T Consensus       214 l~~~~~~p~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  275 (277)
T cd05062         214 IATLAEQPYQGMSNEQVL------------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  275 (277)
T ss_pred             HHcCCCCCCCCCCHHHHH------------------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHh
Confidence            999 67888653321111                  11111111223445677899999999999999999999999988


Q ss_pred             Hh
Q 023752          233 EQ  234 (278)
Q Consensus       233 ~~  234 (278)
                      ++
T Consensus       276 ~~  277 (277)
T cd05062         276 KE  277 (277)
T ss_pred             hC
Confidence            63

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-36  Score=251.39  Aligned_cols=213  Identities=24%  Similarity=0.411  Sum_probs=173.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+++.++|+||+++++.+.+.+..++++||+.+++|.+++.......++...+..++.|++.||.|||  +.+++
T Consensus        48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH--~~~i~  125 (261)
T cd05072          48 FLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--RKNYI  125 (261)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999997655456888899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++......... ......++..|+|||...+..++.++|+||||+++|+|++ |..|
T Consensus       126 H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p  204 (261)
T cd05072         126 HRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP  204 (261)
T ss_pred             ccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCC
Confidence            9999999999999999999999998764332211 1111234567999999988889999999999999999998 8999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |...........                  +......+....++.++.+++.+||+.+|++||++.++++.|+.+
T Consensus       205 ~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         205 YPGMSNSDVMSA------------------LQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             CCCCCHHHHHHH------------------HHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            865332111111                  111112223345678899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.4e-36  Score=253.31  Aligned_cols=212  Identities=27%  Similarity=0.426  Sum_probs=170.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-----QPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      |.+|+.+++.++|+||+++++++.+.+..++++||+.+++|.+++.....     ..+++..+..++.|++.||.|||  
T Consensus        56 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--  133 (277)
T cd05036          56 FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE--  133 (277)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            67899999999999999999999998899999999999999999876532     25888999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCC---ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      +.+++|+||+|+||+++.++   .++|+|||++.................+..|+|||.+.+..++.++|||||||++|+
T Consensus       134 ~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e  213 (277)
T cd05036         134 ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE  213 (277)
T ss_pred             HCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHH
Confidence            89999999999999998654   589999999876422211111111223457999999988899999999999999999


Q ss_pred             HHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |++ |..||........                  ...+........+..++..+.+++.+||+.+|++||++.+++++|
T Consensus       214 l~~~g~~pf~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l  275 (277)
T cd05036         214 IFSLGYMPYPGRTNQEV------------------MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI  275 (277)
T ss_pred             HHcCCCCCCCCCCHHHH------------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHh
Confidence            997 9999875432111                  111222222334556778899999999999999999999999998


Q ss_pred             H
Q 023752          233 E  233 (278)
Q Consensus       233 ~  233 (278)
                      .
T Consensus       276 ~  276 (277)
T cd05036         276 Q  276 (277)
T ss_pred             h
Confidence            6

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-36  Score=250.39  Aligned_cols=213  Identities=28%  Similarity=0.406  Sum_probs=173.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++|+||+++++++...+..++++|++.+++|.+++.......+++..+..++.|++.||.+||  +.|++
T Consensus        48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i~  125 (261)
T cd05068          48 FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQNYI  125 (261)
T ss_pred             HHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999999999999997654456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........... ........|+|||...+..++.++|+||||++++++++ |..|
T Consensus       126 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  204 (261)
T cd05068         126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP  204 (261)
T ss_pred             eccCCcceEEEcCCCCEEECCcceEEEccCCccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999876542211111 11122357999999988889999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |.........                  ..+........+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       205 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         205 YPGMTNAEVL------------------QQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             CCCCCHHHHH------------------HHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            8654321111                  11111112233445678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.6e-36  Score=254.51  Aligned_cols=217  Identities=27%  Similarity=0.439  Sum_probs=175.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC----------------------CCCCCHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------------------VQPISWPTR   59 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~   59 (278)
                      |.+|+.+++.++||||+++++.+...+..++++||+.+++|.+++....                      ...+++..+
T Consensus        50 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  129 (290)
T cd05045          50 LLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDL  129 (290)
T ss_pred             HHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHH
Confidence            5789999999999999999999999999999999999999999875421                      134788899


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC
Q 023752           60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT  139 (278)
Q Consensus        60 ~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  139 (278)
                      ..++.|++.||.|||  +.+++|+||+|+||++++++.++|+|||++................++..|+|||...+..++
T Consensus       130 ~~i~~~i~~~l~~LH--~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~  207 (290)
T cd05045         130 ISFAWQISRGMQYLA--EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT  207 (290)
T ss_pred             HHHHHHHHHHHHHHH--HCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc
Confidence            999999999999999  899999999999999999999999999998754332221111122345679999998888899


Q ss_pred             CccchhHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCC
Q 023752          140 PKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       140 ~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  218 (278)
                      .++|+||||+++++|++ |..||.+....                  ..............+..++..+.+++.+||+.+
T Consensus       208 ~~~Di~slG~~l~el~t~g~~p~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~  269 (290)
T cd05045         208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPE------------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQE  269 (290)
T ss_pred             hHhHHHHHHHHHHHHHhcCCCCCCCCCHH------------------HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCC
Confidence            99999999999999998 99998653321                  111122222223345567788999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhcC
Q 023752          219 PKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       219 p~~Rps~~~ll~~l~~~~~~  238 (278)
                      |++||++.++++.|+++...
T Consensus       270 P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         270 PDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             cccCCCHHHHHHHHHHHHhc
Confidence            99999999999999988653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-36  Score=253.33  Aligned_cols=212  Identities=26%  Similarity=0.447  Sum_probs=171.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------VQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+++++.++|+||+++++++......++++||+.+++|.+++....        ...+++..+..++.|++.||.||
T Consensus        56 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l  135 (277)
T cd05032          56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYL  135 (277)
T ss_pred             HHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            5789999999999999999999999999999999999999999986532        12467888999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.+++|+||+|+||+++.++.++|+|||++................++..|.|||.+.+..++.++|+||||+++|+
T Consensus       136 H--~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  213 (277)
T cd05032         136 A--AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWE  213 (277)
T ss_pred             H--hCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHH
Confidence            9  89999999999999999999999999999865433222111222334668999999988889999999999999999


Q ss_pred             HHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +++ |..||...+...                  .............+..++..+.++|.+||+.+|++|||+.++++.|
T Consensus       214 l~t~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l  275 (277)
T cd05032         214 MATLAEQPYQGLSNEE------------------VLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL  275 (277)
T ss_pred             hhccCCCCCccCCHHH------------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHh
Confidence            998 888986533211                  1111122222334555688999999999999999999999999987


Q ss_pred             H
Q 023752          233 E  233 (278)
Q Consensus       233 ~  233 (278)
                      +
T Consensus       276 ~  276 (277)
T cd05032         276 K  276 (277)
T ss_pred             c
Confidence            6

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2e-36  Score=249.53  Aligned_cols=212  Identities=30%  Similarity=0.485  Sum_probs=176.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-------VQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      +.+|+++++.++|+||+++++++......++++||+.+++|.+++....       ...+++..++.++.|++.||.|||
T Consensus        43 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH  122 (262)
T cd00192          43 FLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA  122 (262)
T ss_pred             HHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence            5689999999999999999999999889999999999999999997652       246999999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                        +.+++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||||+++|++
T Consensus       123 --~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l  200 (262)
T cd00192         123 --SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEI  200 (262)
T ss_pred             --cCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHH
Confidence              899999999999999999999999999999865543321222234467789999999888899999999999999999


Q ss_pred             Hh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          155 LS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       155 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      ++ |..||........                  ...+........+..++.++.+++.+||+.+|++|||+.+++++|+
T Consensus       201 ~~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         201 FTLGATPYPGLSNEEV------------------LEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HhcCCCCCCCCCHHHH------------------HHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            99 5899876532111                  1111112233445667889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-37  Score=265.25  Aligned_cols=205  Identities=26%  Similarity=0.358  Sum_probs=169.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i   80 (278)
                      +.+|+++++.++||||+++++.+..++..|+||||+.+++|.+++.+..  .+++..+..++.||+.||.|||  + .|+
T Consensus        42 ~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH--~~~~i  117 (325)
T cd05594          42 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH--SEKNV  117 (325)
T ss_pred             HHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hcCCE
Confidence            4678899999999999999999999999999999999999999887654  6899999999999999999999  6 799


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||||+||+++.++.+||+|||++.......  .......++..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus       118 vHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~P  195 (325)
T cd05594         118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  195 (325)
T ss_pred             EecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCC
Confidence            999999999999999999999999886432211  112234578899999999888999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      |...+.......+                  . .....++..++.++.++|.+||+.||++|+     ++.++++|
T Consensus       196 f~~~~~~~~~~~i------------------~-~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         196 FYNQDHEKLFELI------------------L-MEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCCHHHHHHHH------------------h-cCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            9654321111111                  0 112234556788899999999999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.8e-36  Score=253.28  Aligned_cols=213  Identities=26%  Similarity=0.470  Sum_probs=171.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC---------------CCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---------------VQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~i~~~l   66 (278)
                      |.+|+.+++.++||||+++++++...+..|+++||+.+++|.+++....               ...+++..+..++.|+
T Consensus        54 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i  133 (283)
T cd05090          54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI  133 (283)
T ss_pred             HHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHH
Confidence            6789999999999999999999999999999999999999999985332               1247788899999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||
T Consensus       134 ~~al~~lH--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s  211 (283)
T cd05090         134 AAGMEYLS--SHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS  211 (283)
T ss_pred             HHHHHHHH--hcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHH
Confidence            99999999  8999999999999999999999999999987654332222222233456799999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++ |..||......                  .....+........+..++..+.+++.+||+.||.+||++
T Consensus       212 lG~il~el~~~g~~p~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  273 (283)
T cd05090         212 FGVVLWEIFSFGLQPYYGFSNQ------------------EVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRF  273 (283)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHH------------------HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCH
Confidence            9999999998 88888643321                  1111111222233445677889999999999999999999


Q ss_pred             HHHHHHHHh
Q 023752          226 VDVLTSLEQ  234 (278)
Q Consensus       226 ~~ll~~l~~  234 (278)
                      .+|+++|..
T Consensus       274 ~~i~~~l~~  282 (283)
T cd05090         274 KDIHTRLRS  282 (283)
T ss_pred             HHHHHHhhc
Confidence            999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=250.84  Aligned_cols=209  Identities=24%  Similarity=0.397  Sum_probs=171.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.++...++++|++.+++|.+.+....  .+++..+..++.|++.||.|||  +.|++
T Consensus        51 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~i~  126 (263)
T cd06625          51 LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLH--SNMIV  126 (263)
T ss_pred             HHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5679999999999999999999999999999999999999999987654  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+........... .....++..|+|||.+.+..++.++|+||||+++|++++|+.|
T Consensus       127 H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  206 (263)
T cd06625         127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP  206 (263)
T ss_pred             cCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999865433211111 1123456789999999988899999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |......                 ...............+..++..+.++|.+||..+|++|||+.+++++
T Consensus       207 ~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         207 WAEFEAM-----------------AAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ccccchH-----------------HHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            8643221                 11111112222344556778899999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.7e-36  Score=249.45  Aligned_cols=208  Identities=26%  Similarity=0.379  Sum_probs=172.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++.+.+.+..++++||+.+++|.+++.......+++..++.++.+++.||.|||  +.|++
T Consensus        46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH--~~~i~  123 (256)
T cd08529          46 AIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH--SKKIL  123 (256)
T ss_pred             HHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5689999999999999999999999999999999999999999997764457899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||...+..++.++|+||||+++++|++|..||
T Consensus       124 h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  201 (256)
T cd08529         124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF  201 (256)
T ss_pred             cCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999988754432211  12234677899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+.....                  ...........+..++..+.++|.+||+.+|++||++.+++++
T Consensus       202 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         202 DANNQGALI------------------LKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCHHHHH------------------HHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            654321111                  1111112233444678899999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-37  Score=240.17  Aligned_cols=207  Identities=24%  Similarity=0.392  Sum_probs=181.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++|-..|+||||+++|++|.+....|+++||..+|.+...+..+..+.+++...+.+..|++.|+.|+|  ..+++
T Consensus        69 lrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h--~k~VI  146 (281)
T KOG0580|consen   69 LRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH--LKRVI  146 (281)
T ss_pred             hhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc--cCCcc
Confidence            5688999999999999999999999999999999999999999999877788999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+|++++..|.+|++|||-+...++    .......|+..|.|||...+...+...|+|++|++.|+++.|.+||
T Consensus       147 hRdiKpenlLlg~~~~lkiAdfGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppF  222 (281)
T KOG0580|consen  147 HRDIKPENLLLGSAGELKIADFGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPF  222 (281)
T ss_pred             cCCCCHHHhccCCCCCeeccCCCceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCch
Confidence            999999999999999999999999876432    2233456899999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      ...........+..                   .+..+|..++.+++++|.+|+..+|.+|.+..+++.|-.
T Consensus       223 es~~~~etYkrI~k-------------------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  223 ESQSHSETYKRIRK-------------------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             hhhhhHHHHHHHHH-------------------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence            86553322222222                   123456788999999999999999999999999998754

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-36  Score=254.57  Aligned_cols=218  Identities=26%  Similarity=0.405  Sum_probs=175.1

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~~l   66 (278)
                      +.+|+.+++.+ +||||+++++++...+..++++||+.+++|.+++.....              ..++...+..++.|+
T Consensus        67 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi  146 (304)
T cd05101          67 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQV  146 (304)
T ss_pred             HHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHH
Confidence            56899999999 899999999999999999999999999999999976421              246778899999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||
T Consensus       147 ~~al~~LH--~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  224 (304)
T cd05101         147 ARGMEYLA--SQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  224 (304)
T ss_pred             HHHHHHHH--HCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHH
Confidence            99999999  8999999999999999999999999999987654332221112223456799999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|++++ |..||.........                  ..+........+..++..+.+|+.+||+.+|++|||+
T Consensus       225 lG~~l~el~~~g~~p~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~  286 (304)
T cd05101         225 FGVLMWEIFTLGGSPYPGIPVEELF------------------KLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTF  286 (304)
T ss_pred             HHHHHHHHHcCCCCCcccCCHHHHH------------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCH
Confidence            9999999998 77887543221111                  1111111222344567889999999999999999999


Q ss_pred             HHHHHHHHhhhcCC
Q 023752          226 VDVLTSLEQLHTSK  239 (278)
Q Consensus       226 ~~ll~~l~~~~~~~  239 (278)
                      .++++.|.++....
T Consensus       287 ~e~l~~l~~~~~~~  300 (304)
T cd05101         287 KQLVEDLDRILTLT  300 (304)
T ss_pred             HHHHHHHHHHHHhh
Confidence            99999999987763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-36  Score=260.54  Aligned_cols=225  Identities=25%  Similarity=0.381  Sum_probs=167.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+++++.++||||+++++++...+     ..|+|+||+ +++|.+++....  .+++..+..++.|++.||.|||  
T Consensus        46 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--  120 (338)
T cd07859          46 ILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIH--  120 (338)
T ss_pred             HHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHH--
Confidence            568999999999999999999885432     479999999 568999887654  6899999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCcccccc--CCCCCccchhHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~  153 (278)
                      +.|++|+||||+||+++.++.+||+|||++......... .......++..|+|||++.+  ..++.++|+|||||++|+
T Consensus       121 ~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~e  200 (338)
T cd07859         121 TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE  200 (338)
T ss_pred             HCCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHH
Confidence            899999999999999999999999999998754322211 11123467889999999865  578899999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchh---------HHHHHHhhhccCCCC---CHHHHHHHHHHHHHhccCCCCC
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDS---------RRVLRIMDTRLGGQY---SKKEAQAVAAVVLQCLHMDPKN  221 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~  221 (278)
                      |++|+.||.+.+.......+...........         ......+........   ....+..+.++|.+||+.||++
T Consensus       201 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  280 (338)
T cd07859         201 VLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKD  280 (338)
T ss_pred             HHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCccc
Confidence            9999999976544322222222211111100         001111111111111   1234677899999999999999


Q ss_pred             CCCHHHHHHH
Q 023752          222 RPSMVDVLTS  231 (278)
Q Consensus       222 Rps~~~ll~~  231 (278)
                      |||+.+++++
T Consensus       281 Rpt~~e~l~h  290 (338)
T cd07859         281 RPTAEEALAD  290 (338)
T ss_pred             CCCHHHHhcC
Confidence            9999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.3e-36  Score=248.25  Aligned_cols=211  Identities=26%  Similarity=0.402  Sum_probs=171.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+++.+.||||+++++++.. ...++++||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        43 ~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~i~  117 (257)
T cd05116          43 LLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLE--ETNFV  117 (257)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            5789999999999999999998854 56789999999999999987654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|.||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus       118 H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~  197 (257)
T cd05116         118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQK  197 (257)
T ss_pred             ecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876443322111 111223468999999888888999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      ||........                  ...+......+.+..++.++.++|.+||+.||++||++.+|.+.|+.+
T Consensus       198 p~~~~~~~~~------------------~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         198 PYKGMKGNEV------------------TQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCHHHH------------------HHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            9975432111                  112222222344556788999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=260.23  Aligned_cols=207  Identities=29%  Similarity=0.349  Sum_probs=179.7

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      ..+|+.||+++. ||||+.++++|++....++|||+|.||.|.+.+.+.   .+++..+..++.|+++++.|||  +.|+
T Consensus        82 v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH--~~gv  156 (382)
T KOG0032|consen   82 VRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH--SLGV  156 (382)
T ss_pred             HHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH--hCCc
Confidence            578999999998 999999999999999999999999999999999877   3999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcC----CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           81 IYRDLKASNVLLDS----NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        81 ~H~dl~p~ni~~~~----~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      +|+||||+|+++..    ++.++++|||++.....   ........|++.|+|||++....|+..+|+||+|+++|.|++
T Consensus       157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~  233 (382)
T KOG0032|consen  157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS  233 (382)
T ss_pred             eeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh
Confidence            99999999999954    34799999999987655   334455789999999999998999999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||.+.........+.....               ....+.+..++..+.++|.+||..||..|+|+.++++|
T Consensus       234 G~~PF~~~~~~~~~~~i~~~~~---------------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  234 GVPPFWGETEFEIFLAILRGDF---------------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCCCCcCCChhHHHHHHHcCCC---------------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence            9999987654333332222111               23455677889999999999999999999999999996

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.5e-36  Score=253.04  Aligned_cols=211  Identities=24%  Similarity=0.387  Sum_probs=169.1

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      ..|++++++++||||+++++.+.++...++||||+.|++|.+++.......+++..+..++.|++.||.|||  +.|++|
T Consensus        41 ~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~ivH  118 (277)
T cd05607          41 LLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH--SMDIVY  118 (277)
T ss_pred             HHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HCCEEE
Confidence            468999999999999999999999999999999999999999887666556899999999999999999999  899999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      +||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.
T Consensus       119 ~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~  195 (277)
T cd05607         119 RDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK  195 (277)
T ss_pred             ccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999876433221   122357789999999988889999999999999999999999996


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ..........+..             ....... ......++.++.++|.+||+.||++||++.++++++
T Consensus       196 ~~~~~~~~~~~~~-------------~~~~~~~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         196 DHKEKVAKEELKR-------------RTLEDEV-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCcchhhHHHHHH-------------Hhhcccc-ccccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            5332111111100             1111110 111235678899999999999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.8e-36  Score=249.35  Aligned_cols=212  Identities=27%  Similarity=0.425  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC-----CCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-----VQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      |.+|+++++.++||||+++++++...+..++++||+.+++|.+++....     ...+++..+..++.|++.||.|||  
T Consensus        46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--  123 (269)
T cd05044          46 FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE--  123 (269)
T ss_pred             HHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH--
Confidence            6789999999999999999999999899999999999999999986532     134788899999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCC-----ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNF-----NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~-----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il  151 (278)
                      +.+++|+||+|+||+++.++     .++++|||++.................+..|+|||.+.+..++.++|+||||+++
T Consensus       124 ~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il  203 (269)
T cd05044         124 QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLM  203 (269)
T ss_pred             hCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHH
Confidence            89999999999999999877     8999999998654332221112223345679999999888999999999999999


Q ss_pred             HHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          152 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       152 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |+|++ |..||........                  ...+........+..++..+.++|.+||+.+|++||++.++++
T Consensus       204 ~ellt~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         204 WEILTLGQQPYPALNNQEV------------------LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHHHcCCCCCcccCHHHH------------------HHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            99998 9999864332111                  1111111223345567889999999999999999999999999


Q ss_pred             HHH
Q 023752          231 SLE  233 (278)
Q Consensus       231 ~l~  233 (278)
                      .|.
T Consensus       266 ~l~  268 (269)
T cd05044         266 ILQ  268 (269)
T ss_pred             HHh
Confidence            886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.7e-36  Score=247.77  Aligned_cols=209  Identities=32%  Similarity=0.472  Sum_probs=170.7

Q ss_pred             hHHHHHHHhccCCccccceeeeee-cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCS-ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|+.++++++|+||+++++++. +++..++++||+.+++|.+++.......+++..+..++.|++.||.|||  ..|+
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i  123 (256)
T cd05082          46 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANNF  123 (256)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCE
Confidence            578999999999999999999764 4567899999999999999998766556889999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      +|+||+|+||+++.++.++|+|||++........     ....+..|+|||.+.+..++.++|+|||||++|+|++ |..
T Consensus       124 ~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~  198 (256)
T cd05082         124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV  198 (256)
T ss_pred             eccccchheEEEcCCCcEEecCCccceeccccCC-----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998865332221     1223457999999988889999999999999999997 899


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      ||.......                  ....+........+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       199 p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         199 PYPRIPLKD------------------VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCHHH------------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            886432211                  1111111222334456788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-37  Score=264.23  Aligned_cols=205  Identities=25%  Similarity=0.348  Sum_probs=168.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+++..|+|+||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +.|++
T Consensus        45 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~i~  120 (318)
T cd05582          45 TKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH--SLGII  120 (318)
T ss_pred             HHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            4579999999999999999999999999999999999999999987654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||
T Consensus       121 H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~  198 (318)
T cd05582         121 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF  198 (318)
T ss_pred             cCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC
Confidence            999999999999999999999999875332211  112245788999999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      ...........                 ...  .....+..++..+.++|.+||+.||.+||+     +.+++.+
T Consensus       199 ~~~~~~~~~~~-----------------i~~--~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         199 QGKDRKETMTM-----------------ILK--AKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             CCCCHHHHHHH-----------------HHc--CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            75432111111                 111  112345567888999999999999999999     5556643

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.7e-36  Score=255.15  Aligned_cols=219  Identities=26%  Similarity=0.421  Sum_probs=175.6

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~~l   66 (278)
                      +.+|+++++.+ +||||+++++++...+..++|+||+.+++|.+++.....              ..++...+..++.|+
T Consensus        70 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  149 (307)
T cd05098          70 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQV  149 (307)
T ss_pred             HHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHH
Confidence            45799999999 799999999999999999999999999999999976431              247888999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||
T Consensus       150 ~~aL~~lH--~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws  227 (307)
T cd05098         150 ARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS  227 (307)
T ss_pred             HHHHHHHH--HCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHH
Confidence            99999999  8999999999999999999999999999987543221111111122345799999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++ |..||......                  .....+......+.+...+.++.++|.+||+.+|++|||+
T Consensus       228 lG~~l~el~~~g~~p~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  289 (307)
T cd05098         228 FGVLLWEIFTLGGSPYPGVPVE------------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF  289 (307)
T ss_pred             HHHHHHHHHcCCCCCCCcCCHH------------------HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCH
Confidence            9999999998 78888543211                  1111112222233455677899999999999999999999


Q ss_pred             HHHHHHHHhhhcCCC
Q 023752          226 VDVLTSLEQLHTSKD  240 (278)
Q Consensus       226 ~~ll~~l~~~~~~~~  240 (278)
                      .++++.|.++.....
T Consensus       290 ~evl~~l~~~~~~~~  304 (307)
T cd05098         290 KQLVEDLDRILALTS  304 (307)
T ss_pred             HHHHHHHHHHHHHhh
Confidence            999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.3e-36  Score=262.48  Aligned_cols=217  Identities=28%  Similarity=0.406  Sum_probs=173.8

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC------------------------------
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG------------------------------   50 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------------------------   50 (278)
                      |.+|+++++++. ||||+++++++.+.+..|+||||+.+|+|.+++....                              
T Consensus        87 ~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (400)
T cd05105          87 LMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSY  166 (400)
T ss_pred             HHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccch
Confidence            678999999996 9999999999999999999999999999999875431                              


Q ss_pred             ----------------------------------------------------------------CCCCCHHHHHHHHHHH
Q 023752           51 ----------------------------------------------------------------VQPISWPTRVKIAIDV   66 (278)
Q Consensus        51 ----------------------------------------------------------------~~~~~~~~~~~i~~~l   66 (278)
                                                                                      ...+++..+..++.|+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi  246 (400)
T cd05105         167 VILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQV  246 (400)
T ss_pred             hhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHH
Confidence                                                                            1246778889999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.+++|+||+|.||+++.++.++|+|||++................++..|+|||.+.+..++.++||||
T Consensus       247 ~~aL~~LH--~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwS  324 (400)
T cd05105         247 ARGMEFLA--SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWS  324 (400)
T ss_pred             HHHHHHHH--hCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHH
Confidence            99999999  8999999999999999999999999999987543322221122234566799999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++ |..||........                 ....+........+...+.++.+++.+||+.||++||++
T Consensus       325 lGvil~ellt~g~~P~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~  387 (400)
T cd05105         325 YGILLWEIFSLGGTPYPGMIVDST-----------------FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF  387 (400)
T ss_pred             HHHHHHHHHHCCCCCCcccchhHH-----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCH
Confidence            9999999997 8899865322110                 111111112233345677899999999999999999999


Q ss_pred             HHHHHHHHhhhc
Q 023752          226 VDVLTSLEQLHT  237 (278)
Q Consensus       226 ~~ll~~l~~~~~  237 (278)
                      .+|.+.|+++..
T Consensus       388 ~~l~~~l~~l~~  399 (400)
T cd05105         388 LHLSDIVESLLP  399 (400)
T ss_pred             HHHHHHHHHHcC
Confidence            999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.7e-36  Score=251.43  Aligned_cols=227  Identities=29%  Similarity=0.452  Sum_probs=174.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+++++.++||||+++++++...  ...++++||+.+++|.+++...   .+++..+..++.|++.||.|||  +.+
T Consensus        53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH--~~~  127 (283)
T cd05080          53 WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH--SQH  127 (283)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            57899999999999999999987654  3578999999999999998764   4899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++++|++|.
T Consensus       128 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~  207 (283)
T cd05080         128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC  207 (283)
T ss_pred             eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence            99999999999999999999999999876543222111 11123455699999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      .||........  ......... ................+.+..++.++.+++.+||+.+|++|||+.++++.|+++.
T Consensus       208 ~p~~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         208 DSKQSPPKKFE--EMIGPKQGQ-MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCcchhh--hhhcccccc-cchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            99865432111  001111000 0111111222222233445667889999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.1e-37  Score=260.53  Aligned_cols=205  Identities=27%  Similarity=0.399  Sum_probs=167.3

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|..+++.+ +||||+++++++...+..|+||||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +.|+
T Consensus        42 ~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH--~~~i  117 (320)
T cd05590          42 TMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLH--DKGI  117 (320)
T ss_pred             HHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            35677888766 69999999999999999999999999999999887664  6899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++.......  .......+++.|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus       118 vH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~P  195 (320)
T cd05590         118 IYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP  195 (320)
T ss_pred             EeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCC
Confidence            999999999999999999999999976432211  112234578899999999888999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~  231 (278)
                      |...+.......+.                 .  .....+..++.++.++|.+||+.||.+||++      .++++|
T Consensus       196 f~~~~~~~~~~~i~-----------------~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         196 FEAENEDDLFEAIL-----------------N--DEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCHHHHHHHHh-----------------c--CCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            97543221111111                 1  1123345577889999999999999999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.9e-36  Score=252.87  Aligned_cols=211  Identities=27%  Similarity=0.385  Sum_probs=170.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +..|+++++.++|+||+++.+++...+..++||||+.+++|.+.+...  ....+++..+..++.|++.||.|||  +.+
T Consensus        40 ~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~  117 (280)
T cd05608          40 AMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--QRR  117 (280)
T ss_pred             HHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            457999999999999999999999999999999999999998877432  2246899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|+|++|+.
T Consensus       118 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~  195 (280)
T cd05608         118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARG  195 (280)
T ss_pred             cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999998654332211  122457889999999999999999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ||..............             ...  .....++..++..+.+++.+||+.||++||     +++++++|
T Consensus       196 pf~~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         196 PFRARGEKVENKELKQ-------------RIL--NDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCCCCCcchhHHHHHH-------------hhc--ccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            9975433211111111             000  111234456788999999999999999999     77888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.4e-36  Score=254.71  Aligned_cols=224  Identities=25%  Similarity=0.344  Sum_probs=168.1

Q ss_pred             hHHHHHHHhcc---CCccccceeeeee-----cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL---RHENLVKLIGYCS-----ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+.+++.+   .||||+++++++.     .....++|+|++. ++|.+++.......+++..+..++.|++.||.||
T Consensus        48 ~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~l  126 (290)
T cd07862          48 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL  126 (290)
T ss_pred             HHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            34677777766   6999999999885     2346899999995 6999998776555689999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.|++|+||+|+||+++.++.++|+|||++......   .......++..|+|||.+.+..++.++|+|||||++|+
T Consensus       127 H--~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~e  201 (290)
T cd07862         127 H--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE  201 (290)
T ss_pred             H--HCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHH
Confidence            9  899999999999999999999999999998754332   11223457889999999988889999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccch-hHHHHH----HhhhccCC---CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRD-SRRVLR----IMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      |++|..||.+.........+.......... ......    ........   ......+..+.+++.+||+.||++|||+
T Consensus       202 l~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~  281 (290)
T cd07862         202 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  281 (290)
T ss_pred             HHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCH
Confidence            999999998765544443333322111110 000000    00000000   0112456788999999999999999999


Q ss_pred             HHHHHH
Q 023752          226 VDVLTS  231 (278)
Q Consensus       226 ~~ll~~  231 (278)
                      .++++|
T Consensus       282 ~~~l~h  287 (290)
T cd07862         282 YSALSH  287 (290)
T ss_pred             HHHhcC
Confidence            999964

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-36  Score=263.83  Aligned_cols=225  Identities=24%  Similarity=0.275  Sum_probs=172.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++......+++++++ +++|.+++...  ..+++..+..++.||+.||.|||  +.|++
T Consensus       133 ~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH--~~giv  207 (392)
T PHA03207        133 PGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLH--GRGII  207 (392)
T ss_pred             HHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            468999999999999999999999999999999999 46888888544  36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+|++|+.||
T Consensus       208 HrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf  287 (392)
T PHA03207        208 HRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL  287 (392)
T ss_pred             ccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            99999999999999999999999987654433222223356889999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhc---c----ccch-hHHHHH---HhhhccCCC--CC-----HHHHHHHHHHHHHhccCCCCCCC
Q 023752          162 DEDRGGLAEQTLVEWAD---P----FLRD-SRRVLR---IMDTRLGGQ--YS-----KKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~---~----~~~~-~~~~~~---~~~~~~~~~--~~-----~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      .+.........+.....   .    +..+ ......   ........+  .+     ...+.++.++|.+||..||++||
T Consensus       288 ~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp  367 (392)
T PHA03207        288 FGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP  367 (392)
T ss_pred             CCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC
Confidence            76554332222221110   0    0000 000000   011111111  11     23466889999999999999999


Q ss_pred             CHHHHHHH
Q 023752          224 SMVDVLTS  231 (278)
Q Consensus       224 s~~~ll~~  231 (278)
                      |+.+++.+
T Consensus       368 sa~e~l~~  375 (392)
T PHA03207        368 SAQDILSL  375 (392)
T ss_pred             CHHHHhhC
Confidence            99999986

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.5e-36  Score=254.08  Aligned_cols=217  Identities=24%  Similarity=0.406  Sum_probs=173.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l   66 (278)
                      +.+|+++++++ .||||+++++++.+.+..++++||+.+++|.+++....              ...++...+..++.|+
T Consensus        64 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  143 (314)
T cd05099          64 LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQV  143 (314)
T ss_pred             HHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHH
Confidence            56899999999 69999999999999889999999999999999996542              1347888899999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|+||
T Consensus       144 ~~aL~~lH--~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  221 (314)
T cd05099         144 ARGMEYLE--SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS  221 (314)
T ss_pred             HHHHHHHH--HCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhH
Confidence            99999999  8999999999999999999999999999987543221111111122345799999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|++++ |..||.........                  ..+........+..++.++.+++.+||+.+|++||++
T Consensus       222 lG~~l~el~~~g~~p~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~  283 (314)
T cd05099         222 FGILMWEIFTLGGSPYPGIPVEELF------------------KLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTF  283 (314)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHH------------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCH
Confidence            9999999999 88888643321111                  1111111223345567789999999999999999999


Q ss_pred             HHHHHHHHhhhcC
Q 023752          226 VDVLTSLEQLHTS  238 (278)
Q Consensus       226 ~~ll~~l~~~~~~  238 (278)
                      .++++.|.++...
T Consensus       284 ~~ll~~l~~~~~~  296 (314)
T cd05099         284 KQLVEALDKVLAA  296 (314)
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.9e-36  Score=247.33  Aligned_cols=213  Identities=25%  Similarity=0.403  Sum_probs=172.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.. ...++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        42 ~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~  117 (257)
T cd05115          42 MMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLE--GKNFV  117 (257)
T ss_pred             HHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hcCee
Confidence            6789999999999999999998854 57899999999999999886543 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus       118 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~  197 (257)
T cd05115         118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQK  197 (257)
T ss_pred             ecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999875433222111 111122467999999888889999999999999999996 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      ||......                  .....+........+...+.++.++|.+||+.+|++||++.+|.+.|+.+.
T Consensus       198 p~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         198 PYKKMKGP------------------EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             CcCcCCHH------------------HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            99754321                  111222222333445667889999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4e-36  Score=247.74  Aligned_cols=210  Identities=29%  Similarity=0.443  Sum_probs=169.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+.+..++++||+.+++|.+++..... .+++..+..++.|++.||.|||  +.|++
T Consensus        46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH--~~~i~  122 (256)
T cd05113          46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLE--SKQFI  122 (256)
T ss_pred             HHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            67899999999999999999999988889999999999999999876543 6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|.||+++.++.++|+|||.+......... ......++..|.|||...+..++.++|+||||+++|+|++ |..|
T Consensus       123 H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p  201 (256)
T cd05113         123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMP  201 (256)
T ss_pred             ccccCcceEEEcCCCCEEECCCccceecCCCcee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCC
Confidence            9999999999999999999999988654322111 1111234467999999988889999999999999999998 8899


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      |...........                  +........+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus       202 ~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         202 YERFNNSETVEK------------------VSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             cCcCCHHHHHHH------------------HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            864332111111                  1111112223445788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-36  Score=248.04  Aligned_cols=209  Identities=28%  Similarity=0.422  Sum_probs=169.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++++||+.+++|.+++..+. ..+++..+..++.|++.||.|||  +.|++
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~  122 (256)
T cd05059          46 FIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE--SNGFI  122 (256)
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5689999999999999999999999999999999999999999987654 26899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+.......... ......+..|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       123 H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p  201 (256)
T cd05059         123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMP  201 (256)
T ss_pred             cccccHhhEEECCCCcEEECCcccceecccccccc-cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCC
Confidence            99999999999999999999999886543221111 111122346999999988889999999999999999998 7888


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |...+.....                  ..+........+..++.++.+++.+||+.+|++|||+.++++.|
T Consensus       202 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         202 YERFSNSEVV------------------ESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCHHHHH------------------HHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            8653321111                  11111122334455788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-36  Score=259.02  Aligned_cols=214  Identities=26%  Similarity=0.391  Sum_probs=169.2

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|..+++.+ +||||+++++++.+.+..|+||||+.+++|.+++.+.+  .+++..+..++.|++.||.|||  +.|+
T Consensus        42 ~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~i  117 (329)
T cd05588          42 VQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLH--ERGI  117 (329)
T ss_pred             HHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            46788899888 79999999999999999999999999999999887654  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus       118 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~P  195 (329)
T cd05588         118 IYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP  195 (329)
T ss_pred             EecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCC
Confidence            999999999999999999999999886422111  112234578899999999998999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS------MVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~ll~~  231 (278)
                      |+.......         +...........+. ......+..++..+.++|.+||+.||.+|++      +.++++|
T Consensus       196 f~~~~~~~~---------~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         196 FDIVGMSDN---------PDQNTEDYLFQVIL-EKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             ccccccccc---------ccccchHHHHHHHH-cCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            964221110         00000001111111 1123445667888999999999999999987      6788765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-37  Score=253.66  Aligned_cols=230  Identities=24%  Similarity=0.349  Sum_probs=178.2

Q ss_pred             HHHHHHHhccCCccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      .+|+++|+.+.|||||++.-+|....     ...+||||++ .+|.+++...  ..+.++...+.-+.+||+.||.||| 
T Consensus        65 nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh-  142 (364)
T KOG0658|consen   65 NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH-  142 (364)
T ss_pred             cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH-
Confidence            47999999999999999999886543     2358999995 5999988742  2246888899999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCC-CceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~  153 (278)
                       +.|||||||||+|++++.+ |.+||+|||.+.........   ....++..|+|||.+.|. .|+.+.||||.||++.|
T Consensus       143 -~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE  218 (364)
T KOG0658|consen  143 -SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE  218 (364)
T ss_pred             -hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence             8999999999999999986 89999999999875544332   335678999999999875 79999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHh---------hhccCCC-CCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIM---------DTRLGGQ-YSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      |+-|++.|.+.+...+...+.+.......+.-......         ......+ .....++++.+|+.++|+.+|.+|.
T Consensus       219 Ll~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~  298 (364)
T KOG0658|consen  219 LLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL  298 (364)
T ss_pred             HhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC
Confidence            99999999998777666666555443333221111110         0000001 3456788999999999999999999


Q ss_pred             CHHHHHHH--HHhhhcC
Q 023752          224 SMVDVLTS--LEQLHTS  238 (278)
Q Consensus       224 s~~~ll~~--l~~~~~~  238 (278)
                      ++.+++.|  +..+...
T Consensus       299 ~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  299 SALEALAHPFFDELRDP  315 (364)
T ss_pred             CHHHHhcchhhHHhhCc
Confidence            99999953  5555444

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.9e-36  Score=247.04  Aligned_cols=209  Identities=28%  Similarity=0.438  Sum_probs=169.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++++.++||||+++++++.+.+..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~  122 (256)
T cd05114          46 FIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE--RNSFI  122 (256)
T ss_pred             HHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5789999999999999999999999999999999999999999886543 25889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       123 H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p  201 (256)
T cd05114         123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP  201 (256)
T ss_pred             ccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999988754322111 1111234457999999988889999999999999999999 8899


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |...+.......+..                  ......+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       202 ~~~~~~~~~~~~i~~------------------~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         202 FEKKSNYEVVEMISR------------------GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCHHHHHHHHHC------------------CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            865433221111111                  111222334567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-36  Score=246.82  Aligned_cols=212  Identities=29%  Similarity=0.484  Sum_probs=172.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++++.|+||+++++++.. +..++++||+.+++|.+++....  .+++..+..++.|++.||.|||  ..+++
T Consensus        43 ~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh--~~~i~  117 (257)
T cd05060          43 FLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE--SKHFV  117 (257)
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh--hcCee
Confidence            5789999999999999999998764 56899999999999999997665  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.++|+|||.+........... .....++..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus       118 H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~  197 (257)
T cd05060         118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK  197 (257)
T ss_pred             ccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999876533322111 111122357999999988889999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      ||...+....                  ...+......+.+..++..+.++|.+||+.+|++||++.++++.|+.+.
T Consensus       198 p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         198 PYGEMKGAEV------------------IAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CcccCCHHHH------------------HHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            9965432111                  1111122223345567789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-36  Score=261.64  Aligned_cols=205  Identities=26%  Similarity=0.370  Sum_probs=163.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|+||+++++++.+++..++|+||+.+++|.+..      ...+..+..++.||+.||.|||  +.|++
T Consensus       119 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH--~~~iv  190 (353)
T PLN00034        119 ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLH--RRHIV  190 (353)
T ss_pred             HHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            578999999999999999999999999999999999999986532      3567788899999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-----CCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~il~~l~~  156 (278)
                      |+||+|+||+++.++.+||+|||++........  ......++..|+|||.+..     ...+.++|||||||++|+|++
T Consensus       191 HrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~  268 (353)
T PLN00034        191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL  268 (353)
T ss_pred             ecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh
Confidence            999999999999999999999999875432211  1122457889999998743     234568999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |+.||........               ...............+..++.++.+||.+||+.||++||++.++++|
T Consensus       269 g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        269 GRFPFGVGRQGDW---------------ASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCCCCCCCCccH---------------HHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9999973322111               11111111122233455678899999999999999999999999986

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.9e-36  Score=254.61  Aligned_cols=216  Identities=21%  Similarity=0.359  Sum_probs=174.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+++.++||||+++++++... ..+++++++.+|+|.+++..+. ..++...+..++.|++.||.|||  +.|++
T Consensus        56 ~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~ii  131 (316)
T cd05108          56 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--ERRLV  131 (316)
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH--hcCee
Confidence            57899999999999999999998764 5789999999999999987654 35888899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||||+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       132 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p  211 (316)
T cd05108         132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  211 (316)
T ss_pred             ccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999986543322211111223557999999988899999999999999999997 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      |.+.....                  ....+......+.+..++..+.+++.+||+.+|.+||++.+++..+..+....
T Consensus       212 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         212 YDGIPASE------------------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             CCCCCHHH------------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            86532211                  11112222223334456778999999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-36  Score=258.75  Aligned_cols=205  Identities=29%  Similarity=0.473  Sum_probs=168.6

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++.+ +||||+++++++.+.+..|+|+||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +.++
T Consensus        42 ~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH--~~~i  117 (318)
T cd05570          42 TMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH--ERGI  117 (318)
T ss_pred             HHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            35688888877 69999999999999999999999999999999887664  6899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus       118 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~p  195 (318)
T cd05570         118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSP  195 (318)
T ss_pred             EccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCC
Confidence            9999999999999999999999998864222111  11223578899999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  231 (278)
                      |...+.......+                 ..  .....+..++..+.++|.+||+.||.+||++     .+++++
T Consensus       196 f~~~~~~~~~~~i-----------------~~--~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         196 FEGDDEDELFQSI-----------------LE--DEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCCCHHHHHHHH-----------------Hc--CCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            9754321111111                 11  1223455678899999999999999999999     888865

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.8e-36  Score=246.21  Aligned_cols=213  Identities=30%  Similarity=0.430  Sum_probs=171.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++.+.+ ...++++||+.+++|.+++.+.....+++..+..++.|++.||.|||  +.+++
T Consensus        48 ~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~  124 (262)
T cd05071          48 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE--RMNYV  124 (262)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999998754 56899999999999999997654446889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|.||+++.++.++|+|||.+.......... .....++..|+|||...+..++.++|+||||+++|++++ |..|
T Consensus       125 H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p  203 (262)
T cd05071         125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP  203 (262)
T ss_pred             ccccCcccEEEcCCCcEEeccCCceeecccccccc-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999987543322111 112234567999999888889999999999999999999 7888


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      |..........                  ........+.+..++..+.+++.+|++.+|++||++.++++.|+...
T Consensus       204 ~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         204 YPGMVNREVLD------------------QVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             CCCCChHHHHH------------------HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            86543211111                  11111122334567788999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1e-36  Score=258.63  Aligned_cols=209  Identities=22%  Similarity=0.332  Sum_probs=176.0

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      +.|-.+|..-.+|.||++|.+|++..++||||||++||++..++.+.+  .+++..+..++.+++.|+..+|  +.|++|
T Consensus       189 ~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH--~~gyIH  264 (550)
T KOG0605|consen  189 RAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH--QLGYIH  264 (550)
T ss_pred             HHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH--HcCccc
Confidence            456778888889999999999999999999999999999999998887  7999999999999999999999  999999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCC-------------------C---CCc----c-------------------
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTG-------------------D---NTH----V-------------------  117 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~-------------------~---~~~----~-------------------  117 (278)
                      |||||+|++++..|++||+|||++......                   .   ...    .                   
T Consensus       265 RDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~  344 (550)
T KOG0605|consen  265 RDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQL  344 (550)
T ss_pred             ccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhh
Confidence            999999999999999999999998632220                   0   000    0                   


Q ss_pred             ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCC
Q 023752          118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGG  197 (278)
Q Consensus       118 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (278)
                      ....+|+|.|+|||++.+..|+..+|.||||||+|||+.|.+||...+.......+..|...+..               
T Consensus       345 a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------------  409 (550)
T KOG0605|consen  345 AYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------------  409 (550)
T ss_pred             hhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------------
Confidence            01247999999999999999999999999999999999999999888877777777776643222               


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCC---CHHHHHHH
Q 023752          198 QYSKKEAQAVAAVVLQCLHMDPKNRP---SMVDVLTS  231 (278)
Q Consensus       198 ~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~  231 (278)
                      +.....+.++.+||.+||. ||++|.   .+.||.+|
T Consensus       410 P~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  410 PEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             CCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            2233456899999999999 999995   57777743

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=253.27  Aligned_cols=210  Identities=28%  Similarity=0.404  Sum_probs=172.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++.+.+++..++||||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus        47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~iv  124 (285)
T cd05605          47 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH--RERIV  124 (285)
T ss_pred             HHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--HCCcE
Confidence            4679999999999999999999999999999999999999998886654456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|+||+|+++|++++|..||
T Consensus       125 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf  201 (285)
T cd05605         125 YRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPF  201 (285)
T ss_pred             ecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCC
Confidence            999999999999999999999999875432211   12235778999999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      .+.........+              ...+. .....++..++..+.+||.+||+.||.+||     ++.+++++
T Consensus       202 ~~~~~~~~~~~~--------------~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         202 RQRKEKVKREEV--------------ERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             CCCchhhHHHHH--------------HHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            754332111111              11111 112334556788999999999999999999     88898865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.6e-36  Score=247.59  Aligned_cols=214  Identities=26%  Similarity=0.441  Sum_probs=171.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc------cEEEEeccCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN------RLLVYEFMPKGSLENHLFRKG----VQPISWPTRVKIAIDVARGLS   71 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~l~~~l~   71 (278)
                      +.+|++.++.++||||+++++++.....      .++++||+.+++|.+++....    ...+++..+..++.|++.||.
T Consensus        48 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~  127 (273)
T cd05035          48 FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGME  127 (273)
T ss_pred             HHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHH
Confidence            5689999999999999999998865543      789999999999999885431    235889999999999999999


Q ss_pred             HHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHH
Q 023752           72 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        72 ~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il  151 (278)
                      |||  +.+++|+||+|+||+++.++.++|+|||++.................+..|.|||.+.+..++.++|+|||||++
T Consensus       128 ~lH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il  205 (273)
T cd05035         128 YLS--NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM  205 (273)
T ss_pred             HHH--hCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHH
Confidence            999  899999999999999999999999999998754333221111112234579999999888899999999999999


Q ss_pred             HHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          152 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       152 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |++++ |..||.......                  ....+........+..++..+.+++.+||+.||++||++.++++
T Consensus       206 ~el~~~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         206 WEIATRGQTPYPGVENHE------------------IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             HHHHhCCCCCCCCCCHHH------------------HHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999 888886533211                  11122222233445667889999999999999999999999999


Q ss_pred             HHHhh
Q 023752          231 SLEQL  235 (278)
Q Consensus       231 ~l~~~  235 (278)
                      .|+++
T Consensus       268 ~l~~~  272 (273)
T cd05035         268 VLENI  272 (273)
T ss_pred             HHHhh
Confidence            99876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=262.08  Aligned_cols=221  Identities=30%  Similarity=0.441  Sum_probs=188.0

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +|.+|++++++++||||+++||+.....-+++|||+|.||+|.+++.+++. .++..+...++.+.+.||+|||  ++++
T Consensus       207 e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh--~k~~  283 (474)
T KOG0194|consen  207 EFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH--SKNC  283 (474)
T ss_pred             HHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH--HCCC
Confidence            378999999999999999999999999999999999999999999998863 5999999999999999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      +||||-..|++++.++.+||+|||++............  ..-...|+|||.+....|+.++||||||+++||+++ |..
T Consensus       284 IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~--~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~  361 (474)
T KOG0194|consen  284 IHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFL--KKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAE  361 (474)
T ss_pred             cchhHhHHHheecCCCeEEeCccccccCCcceeecccc--ccCcceecChhhhccCccccccchhheeeeEEeeeccCCC
Confidence            99999999999999999999999998764311111101  123568999999999999999999999999999999 788


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ||.+.......                 ..++....+.+.+...+.++..++.+|+..+|++||++.++.+.++.+....
T Consensus       362 Py~g~~~~~v~-----------------~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~  424 (474)
T KOG0194|consen  362 PYPGMKNYEVK-----------------AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK  424 (474)
T ss_pred             CCCCCCHHHHH-----------------HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence            99876543222                 2222444456667788899999999999999999999999999999999887


Q ss_pred             CCCC
Q 023752          240 DMPR  243 (278)
Q Consensus       240 ~~~~  243 (278)
                      ..+.
T Consensus       425 ~~~~  428 (474)
T KOG0194|consen  425 EAFD  428 (474)
T ss_pred             cccc
Confidence            7653

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=8.2e-36  Score=255.25  Aligned_cols=217  Identities=29%  Similarity=0.440  Sum_probs=172.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecC-CccEEEEeccCCCCHHHHHhhcCC----------------------------
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKGV----------------------------   51 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~----------------------------   51 (278)
                      +.+|+++++++ +|+||+++++++... ...++++||+.+++|.+++.....                            
T Consensus        57 ~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (337)
T cd05054          57 LMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSV  136 (337)
T ss_pred             HHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccC
Confidence            45799999999 899999999988654 467899999999999998864321                            


Q ss_pred             -------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEE
Q 023752           52 -------------------------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL  100 (278)
Q Consensus        52 -------------------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl  100 (278)
                                                     ..+++..+..++.|++.||.|||  +.|++|+||+|.||+++.++.++|
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH--~~~ivHrDikp~Nill~~~~~vkL  214 (337)
T cd05054         137 SSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA--SRKCIHRDLAARNILLSENNVVKI  214 (337)
T ss_pred             CccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCCcceEEEeCCCcEEE
Confidence                                           25788899999999999999999  899999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhcc
Q 023752          101 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP  179 (278)
Q Consensus       101 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~  179 (278)
                      +|||++................++..|+|||.+.+..++.++|+|||||+++++++ |..||........          
T Consensus       215 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----------  284 (337)
T cd05054         215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----------  284 (337)
T ss_pred             eccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----------
Confidence            99999876533222222222344567999999999999999999999999999998 9999865322111          


Q ss_pred             ccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                             ....+........+...+.++.+++.+||+.+|++||++.+++++|+++..
T Consensus       285 -------~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         285 -------FCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             -------HHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                   111111111222344567789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=263.53  Aligned_cols=210  Identities=28%  Similarity=0.459  Sum_probs=178.8

Q ss_pred             HHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      .+|+-|++|+|||||++.++|....-+|||||||..|-|..++....  .+....+..|..+|+.|+.|||  ...|+||
T Consensus       161 TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH--~hKIIHR  236 (904)
T KOG4721|consen  161 TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLH--LHKIIHR  236 (904)
T ss_pred             hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHH--HhhHhhh
Confidence            47888999999999999999999999999999999999999998765  7899999999999999999999  8999999


Q ss_pred             CCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCcc
Q 023752           84 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE  163 (278)
Q Consensus        84 dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~  163 (278)
                      |||.-||+|+.+..|||+|||-.......   ...-.+.|+..|+|||++.+.+.+.|.||||||+++|+|+||..||.+
T Consensus       237 DLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd  313 (904)
T KOG4721|consen  237 DLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD  313 (904)
T ss_pred             ccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence            99999999999999999999988753322   222236789999999999999999999999999999999999999965


Q ss_pred             ccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          164 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      -+....                 +...-...+..+.|..++..+.=||++||+..|.+||++++++.||+-..+
T Consensus       314 VdssAI-----------------IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p  370 (904)
T KOG4721|consen  314 VDSSAI-----------------IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP  370 (904)
T ss_pred             cchhee-----------------EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence            432111                 000111223456788899999999999999999999999999999975543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.6e-36  Score=257.61  Aligned_cols=203  Identities=28%  Similarity=0.421  Sum_probs=164.7

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      ..|..++... +||||+++++++.+++..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        43 ~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~iv  118 (316)
T cd05620          43 MVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLH--SKGII  118 (316)
T ss_pred             HHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            4567777654 89999999999999999999999999999999887654  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       119 HrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf  196 (316)
T cd05620         119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             ecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence            99999999999999999999999876422111  1122345788999999999899999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLT  230 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~  230 (278)
                      ...+.......+                  . ......+..++.++.++|.+||+.||.+||++. +++.
T Consensus       197 ~~~~~~~~~~~~------------------~-~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         197 HGDDEDELFESI------------------R-VDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCCHHHHHHHH------------------H-hCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            754321111111                  0 011233445778899999999999999999984 6653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.5e-36  Score=250.32  Aligned_cols=213  Identities=24%  Similarity=0.409  Sum_probs=171.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVA   67 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~   67 (278)
                      |.+|+.++++++||||+++++++.+.+..+++++|+.+++|.+++....              ...++...+..++.|++
T Consensus        55 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~  134 (283)
T cd05091          55 FKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIA  134 (283)
T ss_pred             HHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHH
Confidence            5789999999999999999999999999999999999999999885321              12478888999999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHH
Q 023752           68 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF  147 (278)
Q Consensus        68 ~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  147 (278)
                      .||.|||  +.|++|+||||.||++++++.+||+|||++................+++.|+|||.+.+..++.++|+|||
T Consensus       135 ~aL~~lH--~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl  212 (283)
T cd05091         135 AGMEFLS--SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY  212 (283)
T ss_pred             HHHHHHH--HcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHH
Confidence            9999999  89999999999999999999999999998875433222221222334668999999988889999999999


Q ss_pred             HHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          148 GVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       148 G~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      |+++++|++ |..||.+.....                  ....+........+..++..+.+++.+||+.+|.+||++.
T Consensus       213 G~~l~el~~~g~~p~~~~~~~~------------------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~  274 (283)
T cd05091         213 GVVLWEVFSYGLQPYCGYSNQD------------------VIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFK  274 (283)
T ss_pred             HHHHHHHHcCCCCCCCCCCHHH------------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHH
Confidence            999999998 777876532211                  1111222222334556788899999999999999999999


Q ss_pred             HHHHHHHh
Q 023752          227 DVLTSLEQ  234 (278)
Q Consensus       227 ~ll~~l~~  234 (278)
                      +|+..|+.
T Consensus       275 ~i~~~l~~  282 (283)
T cd05091         275 DIHSRLRT  282 (283)
T ss_pred             HHHHHhhC
Confidence            99998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.8e-36  Score=263.82  Aligned_cols=224  Identities=24%  Similarity=0.287  Sum_probs=167.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||++++++|..+...+++++++ +++|.+++....  .+++..+..++.|++.||.|||  +.||+
T Consensus       130 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH--~~~Iv  204 (391)
T PHA03212        130 TATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLH--ENRII  204 (391)
T ss_pred             hHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            468999999999999999999999999999999999 568988886654  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.++.++|+|||++........ .......+++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       205 HrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~  283 (391)
T PHA03212        205 HRDIKAENIFINHPGDVCLGDFGAACFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL  283 (391)
T ss_pred             cCCCChHhEEEcCCCCEEEEeCCcccccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence            999999999999999999999999864322111 1122346889999999998889999999999999999999999877


Q ss_pred             ccccCC-------chhhhHHhhhcc----ccchh-HHHH----HHhhhcc--CC--CC---CHHHHHHHHHHHHHhccCC
Q 023752          162 DEDRGG-------LAEQTLVEWADP----FLRDS-RRVL----RIMDTRL--GG--QY---SKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       162 ~~~~~~-------~~~~~~~~~~~~----~~~~~-~~~~----~~~~~~~--~~--~~---~~~~~~~l~~li~~~l~~d  218 (278)
                      ......       .....+......    +.... ....    .......  ..  +.   ....+.++.+||.+||+.|
T Consensus       284 ~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~d  363 (391)
T PHA03212        284 FEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD  363 (391)
T ss_pred             CCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCC
Confidence            543211       111111111110    00000 0000    0000000  00  00   1235778999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 023752          219 PKNRPSMVDVLTS  231 (278)
Q Consensus       219 p~~Rps~~~ll~~  231 (278)
                      |.+|||+.+++++
T Consensus       364 P~~Rpta~elL~h  376 (391)
T PHA03212        364 AHHRPSAEALLDF  376 (391)
T ss_pred             hhhCCCHHHHhcC
Confidence            9999999999964

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.2e-36  Score=246.34  Aligned_cols=209  Identities=23%  Similarity=0.336  Sum_probs=173.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++++.+.+..++++||+.+++|.+++.......+++..+..++.|++.+|.|||  +.|++
T Consensus        46 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~  123 (256)
T cd08221          46 ALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH--KAGIL  123 (256)
T ss_pred             HHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            5689999999999999999999999999999999999999999997764456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|.|||.+.+..++.++|+||||+++++|++|..||
T Consensus       124 h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~  201 (256)
T cd08221         124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF  201 (256)
T ss_pred             ccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCC
Confidence            999999999999999999999999875433321  122345778899999998888899999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ...........                  .......+.+..++.++.++|.+||+.+|++||++.++++++
T Consensus       202 ~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         202 DATNPLNLVVK------------------IVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCCHHHHHHH------------------HHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            65332111111                  111112233456778899999999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-37  Score=242.78  Aligned_cols=214  Identities=24%  Similarity=0.319  Sum_probs=173.3

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecC----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      ++|++..=.- .|||||.++++|+..    .-+.+|||+++||.|.+.++.++.+.+++.++..|+.||..|+.|||  +
T Consensus       102 RrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH--~  179 (400)
T KOG0604|consen  102 RREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH--S  179 (400)
T ss_pred             HhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH--h
Confidence            4666654444 699999999998654    24579999999999999999999889999999999999999999999  8


Q ss_pred             CCeeecCCCCCceEEcC---CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           78 ANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                      .+|.||||||+|++++.   +..+||+|||++..-...   ........+++|.|||++....|+.++|+||+|+++|-|
T Consensus       180 ~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIl  256 (400)
T KOG0604|consen  180 MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL  256 (400)
T ss_pred             cchhhccCChhheeeecCCCCcceEecccccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHh
Confidence            99999999999999964   456999999999864322   112234568999999999999999999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ++|.+||-...+...           -......+..-...++.+.+..+|+...++|+++|..+|.+|.|+.+++.|-
T Consensus       257 LCGyPPFYS~hg~ai-----------spgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  257 LCGYPPFYSNHGLAI-----------SPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             hcCCCcccccCCccC-----------ChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            999999965443211           1122222233333455666788999999999999999999999999999763

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.2e-36  Score=258.89  Aligned_cols=205  Identities=26%  Similarity=0.388  Sum_probs=168.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|.++++.+ +||||+++++++.+.+..|+||||+.+++|...+....  .+++..+..++.|++.||.|||  +.|+
T Consensus        42 ~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~i  117 (321)
T cd05591          42 TMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLH--RHGV  117 (321)
T ss_pred             HHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            35678888766 79999999999999999999999999999999887654  6889999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++|+.|
T Consensus       118 vHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~P  195 (321)
T cd05591         118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP  195 (321)
T ss_pred             eccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCC
Confidence            9999999999999999999999998864322211  12234578899999999888999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-------CHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-------SMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-------s~~~ll~~  231 (278)
                      |...+.......+.                 .  .....+...+.++.++|.+||+.||++||       ++.+++++
T Consensus       196 f~~~~~~~~~~~i~-----------------~--~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         196 FEADNEDDLFESIL-----------------H--DDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHH-----------------c--CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            97544321111111                 1  11223445678899999999999999999       88888866

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-36  Score=245.71  Aligned_cols=209  Identities=31%  Similarity=0.498  Sum_probs=173.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++++.+.+..++|+||+.+++|.+++.......+++..+..++.|++.||.|||  ..|++
T Consensus        47 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh--~~~i~  124 (256)
T cd05039          47 FLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKNFV  124 (256)
T ss_pred             HHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            5689999999999999999999998889999999999999999998776557899999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|.||+++.++.++|+|||.+........     .......|.|||.+.+..++.++|+||||++++++++ |..|
T Consensus       125 H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p  199 (256)
T cd05039         125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP  199 (256)
T ss_pred             chhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCC
Confidence            999999999999999999999999876532211     1223457999999988888999999999999999997 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |.......                  ....+........+..++..+.++|.+||+.+|++|||+.++++.|+++
T Consensus       200 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         200 YPRIPLKD------------------VVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             CCCCCHHH------------------HHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            86432211                  1111111222333455678999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.1e-36  Score=251.12  Aligned_cols=215  Identities=27%  Similarity=0.401  Sum_probs=173.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l   66 (278)
                      |.+|++++.++ +||||+++++++.+.+..++++||+.+++|.+++....              ...+++..+..++.|+
T Consensus        49 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  128 (297)
T cd05089          49 FAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV  128 (297)
T ss_pred             HHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHH
Confidence            56899999999 79999999999999999999999999999999996542              1248888999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.++|+|||++........   ......+..|+|||...+..++.++|+||
T Consensus       129 ~~al~~lH--~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS  203 (297)
T cd05089         129 ATGMQYLS--EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWS  203 (297)
T ss_pred             HHHHHHHH--HCCcccCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHH
Confidence            99999999  89999999999999999999999999999863221111   11112245699999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++ |..||........                  ...+........+..++..+.+|+.+||+.+|.+||++
T Consensus       204 lG~il~el~t~g~~pf~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  265 (297)
T cd05089         204 FGVLLWEIVSLGGTPYCGMTCAEL------------------YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPF  265 (297)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHH------------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            9999999997 9999965432111                  11111112233345577889999999999999999999


Q ss_pred             HHHHHHHHhhhcCC
Q 023752          226 VDVLTSLEQLHTSK  239 (278)
Q Consensus       226 ~~ll~~l~~~~~~~  239 (278)
                      .++++.|..+....
T Consensus       266 ~~i~~~l~~~~~~~  279 (297)
T cd05089         266 AQISVQLSRMLEAR  279 (297)
T ss_pred             HHHHHHHHHHHHhh
Confidence            99999999988764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.2e-36  Score=258.46  Aligned_cols=210  Identities=23%  Similarity=0.358  Sum_probs=169.4

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++.+ +|++|+++++.+..++..++||||+.+++|.+++.++.  .+++..+..++.||+.||.|||  +.|+
T Consensus        51 ~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i  126 (332)
T cd05614          51 TRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLH--KLGI  126 (332)
T ss_pred             HHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCc
Confidence            45789999999 59999999999999999999999999999999987654  6899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      +||||||+||+++.++.++|+|||++.......... .....++..|+|||.+.+. .++.++|||||||++|+|++|..
T Consensus       127 vHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~  205 (332)
T cd05614         127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS  205 (332)
T ss_pred             EecCCCHHHeEECCCCCEEEeeCcCCccccccCCCc-cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCC
Confidence            999999999999999999999999987543322211 1224578899999998765 47889999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ||...........+..             ...  .....++..++..+.++|.+||+.||++||     ++.++++|
T Consensus       206 pf~~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         206 PFTLEGERNTQSEVSR-------------RIL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CCCCCCCCCCHHHHHH-------------HHh--cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            9964332211111110             011  122344556788899999999999999999     78888875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.3e-36  Score=247.20  Aligned_cols=208  Identities=22%  Similarity=0.328  Sum_probs=171.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++.+.+++..++++||+.+++|.+++.......+++..+..++.|++.||.+||  +.|++
T Consensus        45 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~i~  122 (255)
T cd08219          45 SRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH--EKRVL  122 (255)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh--hCCcc
Confidence            4679999999999999999999999999999999999999999887654456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++++|||.+........  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       123 H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~  200 (255)
T cd08219         123 HRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPF  200 (255)
T ss_pred             cCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCC
Confidence            999999999999999999999999875433221  112245677899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+....                  ...+......+.+..++..+.++|.+||+.||++||++.+++..
T Consensus       201 ~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         201 QANSWKNL------------------ILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCHHHH------------------HHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            65332111                  11111122233455677889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-37  Score=263.75  Aligned_cols=210  Identities=26%  Similarity=0.359  Sum_probs=172.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++..++|+||+++++++.+++..++|+||+.+++|.+++.+..  .+++..+..++.|++.||.|||  ..|++
T Consensus        48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~gii  123 (350)
T cd05573          48 VRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD--VFPEETARFYIAELVLALDSVH--KLGFI  123 (350)
T ss_pred             HHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999998763  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC---------------------------CccccccccCCcccCccccc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN---------------------------THVSTRIVGTRGYAAPEYVA  134 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~---------------------------~~~~~~~~~~~~~~aPE~~~  134 (278)
                      |+||+|+||+++.++.++|+|||++........                           ........+++.|+|||.+.
T Consensus       124 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  203 (350)
T cd05573         124 HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR  203 (350)
T ss_pred             ccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence            999999999999999999999999876443320                           01112346788999999999


Q ss_pred             cCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHh
Q 023752          135 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQC  214 (278)
Q Consensus       135 ~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  214 (278)
                      +..++.++|||||||++|+|++|..||...........+..+.               .....+....++.++.++|.+|
T Consensus       204 ~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~~~~~~~li~~l  268 (350)
T cd05573         204 GTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWK---------------ESLRFPPDPPVSPEAIDLICRL  268 (350)
T ss_pred             CCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccC---------------CcccCCCCCCCCHHHHHHHHHH
Confidence            9999999999999999999999999997654322222222111               1111111223688999999999


Q ss_pred             ccCCCCCCCC-HHHHHHH
Q 023752          215 LHMDPKNRPS-MVDVLTS  231 (278)
Q Consensus       215 l~~dp~~Rps-~~~ll~~  231 (278)
                      |. ||.+||+ +.++++|
T Consensus       269 l~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         269 LC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             cc-ChhhcCCCHHHHhcC
Confidence            98 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-35  Score=245.63  Aligned_cols=211  Identities=31%  Similarity=0.468  Sum_probs=170.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++|++|+++++++.+ +..++++||+.+++|.+++.......+++..+..++.+++.||.|||  +.+++
T Consensus        48 ~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~  124 (260)
T cd05070          48 FLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE--RMNYI  124 (260)
T ss_pred             HHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999998854 56899999999999999987654456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+.......... .....++..|+|||...+..++.++|+||||+++|++++ |..|
T Consensus       125 H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p  203 (260)
T cd05070         125 HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP  203 (260)
T ss_pred             cCCCccceEEEeCCceEEeCCceeeeeccCccccc-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCC
Confidence            99999999999999999999999987543322111 111223457999999888889999999999999999999 8888


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      |.+.+....                  ...+......+.+...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus       204 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         204 YPGMNNREV------------------LEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCHHHH------------------HHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            865332111                  11111112233455677889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.8e-37  Score=245.58  Aligned_cols=224  Identities=25%  Similarity=0.279  Sum_probs=180.4

Q ss_pred             HHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .+||.+|.+.+||||+.+..+..-.  +.+|+|||||+ .+|..++.+-. +++...++..+..|++.|+.|||  ...|
T Consensus       123 LREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH--~~wi  198 (419)
T KOG0663|consen  123 LREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH--DNWI  198 (419)
T ss_pred             HHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh--hcee
Confidence            5899999999999999999988654  46899999995 49999887665 57999999999999999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      +|||||++|++++..|.+||+|||+++.+.++..  ..+..+-+.+|+|||++.+. .|+.+.|+||+|||+.+++++.+
T Consensus       199 lHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP  276 (419)
T KOG0663|consen  199 LHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP  276 (419)
T ss_pred             EecccchhheeeccCCcEEecccchhhhhcCCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC
Confidence            9999999999999999999999999998776633  23445678999999998774 79999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhH---HHHHHhhhc---------cCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSR---RVLRIMDTR---------LGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---------~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      .|.+...-.+...+.......-....   .....+...         ....++.. .++.-.+|+..+|..||.+|.|+.
T Consensus       277 lf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~  356 (419)
T KOG0663|consen  277 LFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE  356 (419)
T ss_pred             CCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH
Confidence            99998887777777665443222111   111111100         11111111 568889999999999999999999


Q ss_pred             HHHHHH
Q 023752          227 DVLTSL  232 (278)
Q Consensus       227 ~ll~~l  232 (278)
                      +.|+|=
T Consensus       357 ~~L~h~  362 (419)
T KOG0663|consen  357 DGLKHE  362 (419)
T ss_pred             Hhhccc
Confidence            999763

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.5e-36  Score=254.02  Aligned_cols=224  Identities=21%  Similarity=0.257  Sum_probs=163.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++++.+....++|+||+. ++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        50 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~iv  125 (303)
T cd07869          50 AIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIH--QRYIL  125 (303)
T ss_pred             HHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            4689999999999999999999999999999999994 68888876543 35888999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||||+||+++.++.+||+|||++........  ......++..|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus       126 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  203 (303)
T cd07869         126 HRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA  203 (303)
T ss_pred             cCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999864322211  1122456788999998865 4578899999999999999999999


Q ss_pred             CccccCC-chhhhHHhh-hccccchhH---HHHHHhhhccCCCCC---------HHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          161 LDEDRGG-LAEQTLVEW-ADPFLRDSR---RVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       161 ~~~~~~~-~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      |.+.... .....+... ..+......   ..............+         ...+..+.+|+.+||+.||.+|||+.
T Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~  283 (303)
T cd07869         204 FPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ  283 (303)
T ss_pred             CCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence            9764321 111111110 000000000   000000000000000         11346788999999999999999999


Q ss_pred             HHHHH
Q 023752          227 DVLTS  231 (278)
Q Consensus       227 ~ll~~  231 (278)
                      ++++|
T Consensus       284 ~~l~h  288 (303)
T cd07869         284 AALSH  288 (303)
T ss_pred             HHhcC
Confidence            99964

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.1e-36  Score=257.73  Aligned_cols=203  Identities=28%  Similarity=0.418  Sum_probs=164.2

Q ss_pred             HHHHHHH---hccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            3 QTEVIYL---GQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         3 ~~E~~~l---~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      .+|++++   +.++||||+++++++.+.+..|+|+||+.+++|...+...   .+++..+..++.|++.||.|||  +.|
T Consensus        47 ~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH--~~~  121 (324)
T cd05589          47 MCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLH--ENK  121 (324)
T ss_pred             HHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            4455544   5668999999999999999999999999999998887543   5899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|+||+++.++.+||+|||++.......  .......++..|+|||.+.+..++.++|+|||||++|+|++|..
T Consensus       122 ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~  199 (324)
T cd05589         122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGES  199 (324)
T ss_pred             eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCC
Confidence            9999999999999999999999999876432211  11223457889999999998899999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ||...+.......                 ...  .....+..++..+.++|.+||+.||.+||     ++.+++++
T Consensus       200 pf~~~~~~~~~~~-----------------i~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         200 PFPGDDEEEVFDS-----------------IVN--DEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCCCCCHHHHHHH-----------------HHh--CCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            9975432111111                 111  11234556788899999999999999999     67888765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-35  Score=244.79  Aligned_cols=211  Identities=30%  Similarity=0.443  Sum_probs=170.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++|+|++++++++.. +..+++|||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH--~~~i~  124 (260)
T cd05069          48 FLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE--RMNYI  124 (260)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            6789999999999999999998854 56899999999999999997655456889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||++++++.++|+|||.+......... ......++..|+|||...+..++.++|+||||+++|++++ |..|
T Consensus       125 H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p  203 (260)
T cd05069         125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP  203 (260)
T ss_pred             ecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998754322111 1111234567999999988889999999999999999999 8899


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      |.+.......                  .........+.+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus       204 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         204 YPGMVNREVL------------------EQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCCHHHHH------------------HHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            8653321111                  1111111223345677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6e-36  Score=247.91  Aligned_cols=208  Identities=23%  Similarity=0.448  Sum_probs=170.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++++||+.+++|.+++...+  .+++..+..++.|++.||.|||  +.|++
T Consensus        53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH--~~~iv  128 (267)
T cd06628          53 LAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLH--NRGII  128 (267)
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHH--hcCcc
Confidence            5789999999999999999999999999999999999999999997654  6888999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc----cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |+||+|+||+++.++.++|+|||.+..........    ......++..|+|||.+.+..++.++|+||||+++|++++|
T Consensus       129 H~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g  208 (267)
T cd06628         129 HRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG  208 (267)
T ss_pred             cccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhC
Confidence            99999999999999999999999987654221111    11123467789999999888899999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||.......   .+              .. .........+...+..+.++|.+||+.||++||++.+++++
T Consensus       209 ~~p~~~~~~~~---~~--------------~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         209 KHPFPDCTQLQ---AI--------------FK-IGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             CCCCCCccHHH---HH--------------HH-HhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            99997532211   11              01 11112234455678899999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.6e-36  Score=252.38  Aligned_cols=216  Identities=28%  Similarity=0.413  Sum_probs=173.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l   66 (278)
                      +.+|++++.++ +|+||+++++++.+.+..++++||+.+++|.+++.+..              ...+++..+..++.|+
T Consensus        54 ~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  133 (303)
T cd05088          54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV  133 (303)
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHH
Confidence            56799999999 89999999999999999999999999999999986543              1257889999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.++|+|||++........   ......+..|+|||.+.+..++.++|+||
T Consensus       134 ~~al~~LH--~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  208 (303)
T cd05088         134 ARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWS  208 (303)
T ss_pred             HHHHHHHH--hCCccccccchheEEecCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchh
Confidence            99999999  89999999999999999999999999999853211110   01112345699999988888899999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|++++ |..||.........                  ..+........+...+..+.+++.+||+.+|++||++
T Consensus       209 lG~il~ellt~g~~p~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~  270 (303)
T cd05088         209 YGVLLWEIVSLGGTPYCGMTCAELY------------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF  270 (303)
T ss_pred             hhhHHHHHHhcCCCCcccCChHHHH------------------HHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            9999999998 99998644321111                  1111111222334567789999999999999999999


Q ss_pred             HHHHHHHHhhhcCCC
Q 023752          226 VDVLTSLEQLHTSKD  240 (278)
Q Consensus       226 ~~ll~~l~~~~~~~~  240 (278)
                      .+++..|.++.....
T Consensus       271 ~~il~~l~~~~~~~~  285 (303)
T cd05088         271 AQILVSLNRMLEERK  285 (303)
T ss_pred             HHHHHHHHHHHHhhh
Confidence            999999998876643

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=264.47  Aligned_cols=210  Identities=21%  Similarity=0.303  Sum_probs=166.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +++|++++++++||||++++++|.+++..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH--~~giv  123 (377)
T cd05629          48 VKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVH--KLGFI  123 (377)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5679999999999999999999999999999999999999999997654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCC------------c---------------------------------
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT------------H---------------------------------  116 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~------------~---------------------------------  116 (278)
                      |+||||+||+++.++.++|+|||++..+......            .                                 
T Consensus       124 HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (377)
T cd05629         124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL  203 (377)
T ss_pred             ccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence            9999999999999999999999998632211000            0                                 


Q ss_pred             cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccC
Q 023752          117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG  196 (278)
Q Consensus       117 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (278)
                      ......+++.|+|||++.+..++.++|+|||||++|+|++|..||...........+..+..               ...
T Consensus       204 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~  268 (377)
T cd05629         204 MAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE---------------TLY  268 (377)
T ss_pred             cccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC---------------ccC
Confidence            00013578899999999888999999999999999999999999975443222111111110               011


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 023752          197 GQYSKKEAQAVAAVVLQCLHMDPKNR---PSMVDVLTS  231 (278)
Q Consensus       197 ~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~  231 (278)
                      .+....++.++.+||.+||+ +|.+|   +++.+++.|
T Consensus       269 ~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         269 FPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             CCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            11122467889999999998 77775   599999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-35  Score=246.87  Aligned_cols=214  Identities=26%  Similarity=0.415  Sum_probs=167.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC------CccEEEEeccCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRK----GVQPISWPTRVKIAIDVARGLS   71 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~~l~~~l~   71 (278)
                      |.+|+++++.++|+||+++++.+...      ...+++++|+.+++|.+++...    ....+++..+..++.|++.||.
T Consensus        47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  126 (272)
T cd05075          47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME  126 (272)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHH
Confidence            57899999999999999999976432      2468999999999999887432    2235789999999999999999


Q ss_pred             HHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHH
Q 023752           72 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        72 ~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il  151 (278)
                      |||  +.+++|+||+|+||+++.++.++|+|||++.................+..|++||...+..++.++|+||||+++
T Consensus       127 ~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il  204 (272)
T cd05075         127 YLS--SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTM  204 (272)
T ss_pred             HHH--HCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHH
Confidence            999  899999999999999999999999999998764332211111112345679999999888899999999999999


Q ss_pred             HHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          152 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       152 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |++++ |..||.........                  ..+......+.+..++..+.++|.+||+.||++|||+.++++
T Consensus       205 ~el~~~g~~p~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  266 (272)
T cd05075         205 WEIATRGQTPYPGVENSEIY------------------DYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC  266 (272)
T ss_pred             HHHHcCCCCCCCCCCHHHHH------------------HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999 78888653221111                  111111112234456778999999999999999999999999


Q ss_pred             HHHhh
Q 023752          231 SLEQL  235 (278)
Q Consensus       231 ~l~~~  235 (278)
                      .|+++
T Consensus       267 ~l~~~  271 (272)
T cd05075         267 ELEKA  271 (272)
T ss_pred             HHHhh
Confidence            99875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-35  Score=246.78  Aligned_cols=212  Identities=29%  Similarity=0.419  Sum_probs=169.7

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l   66 (278)
                      +.+|+++++++ +||||+++++++...+..++++||+.+++|.+++..+.              ...+++..+..++.|+
T Consensus        42 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i  121 (270)
T cd05047          42 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV  121 (270)
T ss_pred             HHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHH
Confidence            56799999999 79999999999999999999999999999999986542              1247889999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.++|+|||++........   ......+..|+|||.+.+..++.++|+||
T Consensus       122 ~~al~~lH--~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~---~~~~~~~~~y~apE~~~~~~~~~~~Di~s  196 (270)
T cd05047         122 ARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWS  196 (270)
T ss_pred             HHHHHHHH--HCCEeecccccceEEEcCCCeEEECCCCCccccchhhh---ccCCCCccccCChHHHccCCCCchhhHHH
Confidence            99999999  89999999999999999999999999998753211110   01112245699999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++++|++ |..||........                  ...+......+.+...+.++.+++.+||+.+|.+|||+
T Consensus       197 lG~il~el~~~g~~pf~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  258 (270)
T cd05047         197 YGVLLWEIVSLGGTPYCGMTCAEL------------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF  258 (270)
T ss_pred             HHHHHHHHHcCCCCCccccCHHHH------------------HHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCH
Confidence            9999999997 9999865332111                  11111111222334566789999999999999999999


Q ss_pred             HHHHHHHHhhh
Q 023752          226 VDVLTSLEQLH  236 (278)
Q Consensus       226 ~~ll~~l~~~~  236 (278)
                      .+++..|.++.
T Consensus       259 ~~il~~l~~~~  269 (270)
T cd05047         259 AQILVSLNRML  269 (270)
T ss_pred             HHHHHHHHHhh
Confidence            99999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=263.24  Aligned_cols=210  Identities=22%  Similarity=0.323  Sum_probs=168.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++.+.+++..|+||||+.+++|.+++..++  .+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH--~~~iv  123 (364)
T cd05599          48 VRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIH--KLGYI  123 (364)
T ss_pred             HHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            5679999999999999999999999999999999999999999997665  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc------------------------------------cccccccCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH------------------------------------VSTRIVGTR  125 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~------------------------------------~~~~~~~~~  125 (278)
                      |+||||+||+++.++.++|+|||++..........                                    ......|++
T Consensus       124 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  203 (364)
T cd05599         124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTP  203 (364)
T ss_pred             eccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCc
Confidence            99999999999999999999999986532211100                                    001135788


Q ss_pred             cccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHH
Q 023752          126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQ  205 (278)
Q Consensus       126 ~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (278)
                      .|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..+..               ....+....+++
T Consensus       204 ~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~  268 (364)
T cd05599         204 DYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKE---------------TLQFPDEVPLSP  268 (364)
T ss_pred             cccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCC---------------ccCCCCCCCCCH
Confidence            99999999888999999999999999999999999975443221111111110               001111224578


Q ss_pred             HHHHHHHHhccCCCCCCCC---HHHHHHH
Q 023752          206 AVAAVVLQCLHMDPKNRPS---MVDVLTS  231 (278)
Q Consensus       206 ~l~~li~~~l~~dp~~Rps---~~~ll~~  231 (278)
                      ++.++|.+|+. +|.+|++   +.++++|
T Consensus       269 ~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         269 EAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             HHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            89999999997 9999997   9999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.8e-36  Score=256.08  Aligned_cols=203  Identities=26%  Similarity=0.420  Sum_probs=164.6

Q ss_pred             HHHHHHHhc-cCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQ-LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      ..|..++.. .+||||+++++++..++..++||||+.|++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        43 ~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH--~~~iv  118 (316)
T cd05592          43 MVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLH--KKGII  118 (316)
T ss_pred             HHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence            345566654 489999999999999999999999999999999887654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       119 H~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf  196 (316)
T cd05592         119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             eCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCC
Confidence            99999999999999999999999986532221  1122345788999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLT  230 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~  230 (278)
                      .+.+.......+                 .  .....++..++.++.++|.+||+.||.+||++. +++.
T Consensus       197 ~~~~~~~~~~~i-----------------~--~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         197 HGEDEDELFDSI-----------------L--NDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHHH-----------------H--cCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            754321111111                 0  112334556788899999999999999999875 5554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-35  Score=245.88  Aligned_cols=215  Identities=24%  Similarity=0.327  Sum_probs=173.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+++++.++||||+++++++.+.+..++++||+.+++|.+++...  ....+++..+..++.|++.||.|||  +.+
T Consensus        49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~  126 (267)
T cd08228          49 CVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH--SRR  126 (267)
T ss_pred             HHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh--hCC
Confidence            568999999999999999999999999999999999999999888532  2235888999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+..++.++|+||||+++|++++|+.
T Consensus       127 i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~  204 (267)
T cd08228         127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS  204 (267)
T ss_pred             eeCCCCCHHHEEEcCCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999998876433221  1122356778999999988889999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ-YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      ||.......                ......+......+ ....++..+.++|.+||+.+|++||++.++++.++++.
T Consensus       205 p~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         205 PFYGDKMNL----------------FSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCccccccH----------------HHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            985432110                01111111111111 23456788999999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.5e-35  Score=244.09  Aligned_cols=216  Identities=24%  Similarity=0.360  Sum_probs=174.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|++++++++|+||+++++.+.+.+..++++||+.+++|.+++...  ....+++..+..++.+++.||.|||  +.|
T Consensus        49 ~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~  126 (267)
T cd08224          49 CLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH--SKR  126 (267)
T ss_pred             HHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            568999999999999999999999999999999999999999988642  2245889999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|+||+++.++.++|+|||++.........  .....++..|.|||.+.+..++.++|+||||+++|++++|..
T Consensus       127 i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~  204 (267)
T cd08224         127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS  204 (267)
T ss_pred             EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCC
Confidence            999999999999999999999999988654332211  122346778999999988889999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK-KEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      ||........                ............+.+. .++..+.++|.+||..+|++|||+.+|++.|+++++
T Consensus       205 p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~  267 (267)
T cd08224         205 PFYGDKMNLY----------------SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA  267 (267)
T ss_pred             CcccCCccHH----------------HHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence            9854321100                0001111111222333 677889999999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-35  Score=245.76  Aligned_cols=215  Identities=25%  Similarity=0.356  Sum_probs=173.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+.+++.++|+||+++++++.+++..++++|++.+++|.+++...  ....+++..++.++.|++.||.|||  +.|
T Consensus        49 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH--~~~  126 (267)
T cd08229          49 CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH--SRR  126 (267)
T ss_pred             HHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            568999999999999999999999999999999999999999988642  2235899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|+||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       127 i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~  204 (267)
T cd08229         127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS  204 (267)
T ss_pred             eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999988654332211  122346778999999988889999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhh-ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT-RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      ||........                .....+.. ......+..++.++.+++.+||+.||++|||+.+|++.+++++
T Consensus       205 p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         205 PFYGDKMNLY----------------SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             CcccccchHH----------------HHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            9864322100                00011111 1111123457889999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-35  Score=249.14  Aligned_cols=213  Identities=27%  Similarity=0.428  Sum_probs=169.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------------CCCCCHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------------VQPISWPTRVK   61 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~   61 (278)
                      |.+|+.++++++||||+++++++.++...++++||+.+++|.+++....                    ...+++..+..
T Consensus        55 ~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  134 (288)
T cd05050          55 FQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLC  134 (288)
T ss_pred             HHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHH
Confidence            6789999999999999999999999999999999999999999986432                    12467888999


Q ss_pred             HHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCc
Q 023752           62 IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK  141 (278)
Q Consensus        62 i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  141 (278)
                      ++.|++.||.|||  ..+++|+||+|.||+++.++.++|+|||++.................+..|+|||.+.+..++.+
T Consensus       135 ~~~~i~~aL~~lH--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  212 (288)
T cd05050         135 IAKQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE  212 (288)
T ss_pred             HHHHHHHHHHHHH--hCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCch
Confidence            9999999999999  89999999999999999999999999998865433221111111233556999999988889999


Q ss_pred             cchhHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCC
Q 023752          142 SDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK  220 (278)
Q Consensus       142 ~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~  220 (278)
                      +|+||||+++|+|++ |..||.+.....                  ....+........+..++.++.+||.+||+.+|+
T Consensus       213 ~Dv~slG~il~el~~~~~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~  274 (288)
T cd05050         213 SDVWAYGVVLWEIFSYGMQPYYGMAHEE------------------VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPS  274 (288)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCCCCHHH------------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence            999999999999997 777885432211                  1111111111223445678899999999999999


Q ss_pred             CCCCHHHHHHHHHh
Q 023752          221 NRPSMVDVLTSLEQ  234 (278)
Q Consensus       221 ~Rps~~~ll~~l~~  234 (278)
                      +|||+.++++.|++
T Consensus       275 ~Rpt~~el~~~l~~  288 (288)
T cd05050         275 DRPSFASINRILQR  288 (288)
T ss_pred             cCCCHHHHHHHhhC
Confidence            99999999998864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.8e-36  Score=257.99  Aligned_cols=199  Identities=27%  Similarity=0.388  Sum_probs=162.3

Q ss_pred             HHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 023752            8 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA   87 (278)
Q Consensus         8 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p   87 (278)
                      +++.++||||+++++.+.+.+..++||||+.+++|.+++.+..  .+++..+..++.||+.||.|||  +.|++|+||+|
T Consensus        49 ~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~givH~dikp  124 (323)
T cd05575          49 LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLH--SLNIIYRDLKP  124 (323)
T ss_pred             HHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeCCCCH
Confidence            5678899999999999999999999999999999999887654  6899999999999999999999  89999999999


Q ss_pred             CceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCC
Q 023752           88 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG  167 (278)
Q Consensus        88 ~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~  167 (278)
                      +||+++.++.+||+|||++.......  .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..
T Consensus       125 ~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~  202 (323)
T cd05575         125 ENILLDSQGHVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA  202 (323)
T ss_pred             HHeEECCCCcEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH
Confidence            99999999999999999886432211  1122345788999999999889999999999999999999999999754321


Q ss_pred             chhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH----HHHHH
Q 023752          168 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV----DVLTS  231 (278)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~----~ll~~  231 (278)
                      .....                 ....  ....+...+..+.++|.+||+.||.+||++.    +++++
T Consensus       203 ~~~~~-----------------i~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         203 EMYDN-----------------ILNK--PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             HHHHH-----------------HHcC--CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence            11111                 1111  1233445688899999999999999999874    66543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.4e-36  Score=256.17  Aligned_cols=214  Identities=26%  Similarity=0.407  Sum_probs=168.1

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.++.++ +||||+++++++...+..++|+||+.+++|.+.+.+..  .+++..+..++.|++.||.|||  +.|+
T Consensus        42 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH--~~~i  117 (329)
T cd05618          42 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH--ERGI  117 (329)
T ss_pred             HHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            45788888776 79999999999999999999999999999998887654  6899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus       118 vH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~P  195 (329)
T cd05618         118 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP  195 (329)
T ss_pred             eeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCC
Confidence            9999999999999999999999999864322111  12234578899999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC------HHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS------MVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~ll~~  231 (278)
                      |........         +............ ......++...+..+.++|.+||+.||++||+      +.++++|
T Consensus       196 f~~~~~~~~---------~~~~~~~~~~~~i-~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         196 FDIVGSSDN---------PDQNTEDYLFQVI-LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CccCCCcCC---------cccccHHHHHHHH-hcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            953211100         0000000111111 11223456677889999999999999999998      4677765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-35  Score=245.48  Aligned_cols=212  Identities=31%  Similarity=0.476  Sum_probs=173.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++|+||+++++++......++++|++.+++|.+++.......++...+..++.+++.|+.|||  +.+++
T Consensus        48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh--~~~i~  125 (261)
T cd05034          48 FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE--SRNYI  125 (261)
T ss_pred             HHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            5789999999999999999999998889999999999999999997765456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+......... .......+..|+|||.+.+..++.++|+||||++++++++ |..|
T Consensus       126 h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p  204 (261)
T cd05034         126 HRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP  204 (261)
T ss_pred             cCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998754331111 1111223457999999988889999999999999999998 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      |.+.........                  .......+.+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       205 ~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         205 YPGMTNREVLEQ------------------VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCHHHHHHH------------------HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            865432111111                  11111223344557789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6e-36  Score=255.27  Aligned_cols=228  Identities=21%  Similarity=0.247  Sum_probs=167.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +++|+++++.++||||+++++++..++..++|+||+.+++|.+++.......+++..+..++.|++.||.|||  +.+++
T Consensus        46 ~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~ii  123 (327)
T cd08227          46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH--HMGYV  123 (327)
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            4679999999999999999999999999999999999999999997654456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCC-----ccccccccCCcccCcccccc--CCCCCccchhHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l  154 (278)
                      |+||+|+||+++.++.+++.||+...........     .......++..|+|||.+.+  ..++.++|+|||||+++++
T Consensus       124 H~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el  203 (327)
T cd08227         124 HRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL  203 (327)
T ss_pred             cCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHH
Confidence            9999999999999999999999764432111110     01112245567999999875  4688999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchh-----HHH----------------------HHHhhhccCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDS-----RRV----------------------LRIMDTRLGGQYSKKEAQAV  207 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~----------------------~~~~~~~~~~~~~~~~~~~l  207 (278)
                      ++|..||.................+.....     +..                      ..........+....++..+
T Consensus       204 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (327)
T cd08227         204 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHF  283 (327)
T ss_pred             HHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHH
Confidence            999999975432211111111000000000     000                      00000000112234567889


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 023752          208 AAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       208 ~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+||.+||+.||++|||+.+++++
T Consensus       284 ~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         284 HHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             HHHHHHHHhhCchhcCCHHHHhcC
Confidence            999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-36  Score=278.16  Aligned_cols=219  Identities=30%  Similarity=0.442  Sum_probs=186.6

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc-----CCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-----GVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +|.+|..+|+.++||||+++++++.+.+..++++||+.||+|..++.+.     +...+....+..++.+++.|..||+ 
T Consensus       741 ~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe-  819 (1025)
T KOG1095|consen  741 DFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE-  819 (1025)
T ss_pred             HHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH-
Confidence            4889999999999999999999999988999999999999999999765     1246888999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                       +++++||||...|++++....|||+|||+++...............-...|+|||.+....++.++||||||+++||++
T Consensus       820 -~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif  898 (1025)
T KOG1095|consen  820 -SKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF  898 (1025)
T ss_pred             -hCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH
Confidence             9999999999999999999999999999998544433332222233456799999999999999999999999999999


Q ss_pred             h-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          156 S-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       156 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      + |..||...++.                  ..+..+....+.+.|..++..++++|..||+.+|++||++..|++.+..
T Consensus       899 slG~~PY~~~~n~------------------~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~  960 (1025)
T KOG1095|consen  899 SLGATPYPSRSNF------------------EVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPA  960 (1025)
T ss_pred             hCCCCCCCCcchH------------------HHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhh
Confidence            9 88999765542                  2222222223677788999999999999999999999999999998888


Q ss_pred             hhcCC
Q 023752          235 LHTSK  239 (278)
Q Consensus       235 ~~~~~  239 (278)
                      +.+..
T Consensus       961 i~~~~  965 (1025)
T KOG1095|consen  961 ISNAA  965 (1025)
T ss_pred             hhhhh
Confidence            87663

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.1e-36  Score=254.98  Aligned_cols=203  Identities=26%  Similarity=0.423  Sum_probs=164.5

Q ss_pred             HHHHHHHhc-cCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQ-LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      ..|..+++. ++||||+++++++.+.+..++||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        43 ~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH--~~~iv  118 (316)
T cd05619          43 MVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLH--SKGIV  118 (316)
T ss_pred             HHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeE
Confidence            456777765 489999999999999999999999999999999987653  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       119 Hrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf  196 (316)
T cd05619         119 YRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF  196 (316)
T ss_pred             eCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence            999999999999999999999998864322111  112345788999999998889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLT  230 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~  230 (278)
                      ...+.......                  +.. ....++..++.++.++|.+||+.||++||++. +++.
T Consensus       197 ~~~~~~~~~~~------------------i~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         197 HGHDEEELFQS------------------IRM-DNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCCCHHHHHHH------------------HHh-CCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            75432111111                  110 11223445778899999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-35  Score=242.54  Aligned_cols=211  Identities=30%  Similarity=0.481  Sum_probs=170.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++|+||+++++++.+.+..++++|++.+++|.+++.... ..++...+..++.+++.+|.|||  +.+++
T Consensus        39 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH--~~~i~  115 (251)
T cd05041          39 FLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE--SKNCI  115 (251)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            6789999999999999999999999999999999999999999986543 35788899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+.................+..|.|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       116 h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p  195 (251)
T cd05041         116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP  195 (251)
T ss_pred             hhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCC
Confidence            999999999999999999999999875432111111111222456999999988889999999999999999998 7888


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      |...........                  +........+...+.++.+++.+||+.+|++||++.++++.|.
T Consensus       196 ~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         196 YPGMSNQQTRER------------------IESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CccCCHHHHHHH------------------HhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            865432111111                  1111122334556789999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.6e-35  Score=245.86  Aligned_cols=215  Identities=23%  Similarity=0.385  Sum_probs=170.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +..|+.+++++.||||+++++++.. ...++++|++.+++|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        56 ~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ii  131 (279)
T cd05111          56 ITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE--EHRMV  131 (279)
T ss_pred             HHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            4567778899999999999998754 56789999999999999997643 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       132 H~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p  211 (279)
T cd05111         132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP  211 (279)
T ss_pred             ccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999875433222111222345567999999988889999999999999999998 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.+......                  ...+........+..++..+.+++.+||..||.+|||+.++++.|..+...
T Consensus       212 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         212 YAGMRPHEV------------------PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCCCCHHHH------------------HHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            865432111                  111122222222334566789999999999999999999999999987754

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.6e-36  Score=255.40  Aligned_cols=212  Identities=26%  Similarity=0.388  Sum_probs=168.7

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.++.++ +||+|+++++.+.+.+..|+||||+.+++|.+++....  .+++..+..++.||+.||.|||  +.|+
T Consensus        42 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~i  117 (327)
T cd05617          42 VQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLH--ERGI  117 (327)
T ss_pred             HHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            46788888888 69999999999999999999999999999999887654  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++.......  .......+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus       118 vHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~p  195 (327)
T cd05617         118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP  195 (327)
T ss_pred             eccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCC
Confidence            999999999999999999999999886422211  112234578899999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~  231 (278)
                      |.........           .......... .......+...+..+.++|.+||+.||.+|+++      .+++.|
T Consensus       196 f~~~~~~~~~-----------~~~~~~~~~~-~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         196 FDIITDNPDM-----------NTEDYLFQVI-LEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCccCCCccc-----------ccHHHHHHHH-HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            9643221110           0001111111 112234556678889999999999999999984      577654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2e-35  Score=246.58  Aligned_cols=217  Identities=27%  Similarity=0.402  Sum_probs=173.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeec-CCccEEEEeccCCCCHHHHHhhcCC------CCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHLFRKGV------QPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      +.+|+.+++.++|+||+++++++.. +...+++++++.+++|.+++.....      ..+++..+..++.|++.||.|||
T Consensus        55 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH  134 (280)
T cd05043          55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH  134 (280)
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            5789999999999999999998765 4678999999999999999865422      35889999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                        +.+++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++
T Consensus       135 --~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el  212 (280)
T cd05043         135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL  212 (280)
T ss_pred             --HCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHH
Confidence              899999999999999999999999999998754332221111122345679999999888899999999999999999


Q ss_pred             Hh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          155 LS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       155 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      ++ |..||...+...                  ....+........+..++.++.+++.+||+.||++|||+.++++.|.
T Consensus       213 ~~~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         213 MTLGQTPYVEIDPFE------------------MAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             hcCCCCCcCcCCHHH------------------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            99 999996533211                  11111111122233446778999999999999999999999999999


Q ss_pred             hhhcC
Q 023752          234 QLHTS  238 (278)
Q Consensus       234 ~~~~~  238 (278)
                      .+...
T Consensus       275 ~~~~~  279 (280)
T cd05043         275 DFHAQ  279 (280)
T ss_pred             HHHhc
Confidence            88653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.3e-35  Score=244.62  Aligned_cols=213  Identities=30%  Similarity=0.470  Sum_probs=172.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++|+||+++.+++.+.+..++++||+.+++|.+++.... ..+++..+..++.|++.|+.|||  +.|++
T Consensus        53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH--~~~i~  129 (268)
T cd05063          53 FLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS--DMNYV  129 (268)
T ss_pred             HHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5679999999999999999999999999999999999999999987643 36889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccc-cccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.++|+|||++............ .....+..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus       130 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~  209 (268)
T cd05063         130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER  209 (268)
T ss_pred             ccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998754332221111 11122356999999988889999999999999999997 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      ||.......                  ....+......+.+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       210 p~~~~~~~~------------------~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         210 PYWDMSNHE------------------VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCcCCHHH------------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            986433211                  1111111122233345677899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.3e-36  Score=264.10  Aligned_cols=210  Identities=24%  Similarity=0.356  Sum_probs=167.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++.+.+++..|+||||+.+++|.+++.+.+  .+++..+..++.||+.||.|||  +.|++
T Consensus        48 ~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~iv  123 (376)
T cd05598          48 VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVH--KMGFI  123 (376)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            5689999999999999999999999999999999999999999997664  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC-----------------------------------------Cccccc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN-----------------------------------------THVSTR  120 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~-----------------------------------------~~~~~~  120 (278)
                      ||||||+||+++.++.++|+|||++..+.....                                         ......
T Consensus       124 HrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (376)
T cd05598         124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS  203 (376)
T ss_pred             eCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccc
Confidence            999999999999999999999998753211000                                         000012


Q ss_pred             cccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC
Q 023752          121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS  200 (278)
Q Consensus       121 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (278)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||...........+..+.               .....+..
T Consensus       204 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~  268 (376)
T cd05598         204 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWE---------------TTLHIPSQ  268 (376)
T ss_pred             cCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccC---------------ccccCCCC
Confidence            357889999999999999999999999999999999999997654322111111111               01111222


Q ss_pred             HHHHHHHHHHHHHhccCCCCCCC---CHHHHHHH
Q 023752          201 KKEAQAVAAVVLQCLHMDPKNRP---SMVDVLTS  231 (278)
Q Consensus       201 ~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~  231 (278)
                      ..++.++.++|.+|+ .+|.+|+   ++.++++|
T Consensus       269 ~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         269 AKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             CCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            356778899999976 5999999   89999977

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.3e-36  Score=261.23  Aligned_cols=211  Identities=23%  Similarity=0.311  Sum_probs=166.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++.+.+.+..++||||+.+|+|.+++.+..  .+++..+..++.|++.||.|||  ..|++
T Consensus        48 ~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH--~~giv  123 (381)
T cd05626          48 VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVH--KMGFI  123 (381)
T ss_pred             HHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5689999999999999999999999999999999999999999997664  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC---------------------------------------------Cc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN---------------------------------------------TH  116 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~---------------------------------------------~~  116 (278)
                      ||||||+||+++.+++++|+|||++........                                             ..
T Consensus       124 HrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (381)
T cd05626         124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC  203 (381)
T ss_pred             ecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccc
Confidence            999999999999999999999998753211000                                             00


Q ss_pred             cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccC
Q 023752          117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG  196 (278)
Q Consensus       117 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (278)
                      ......++..|+|||.+.+..++.++|||||||++|+|++|..||...........+..+.               ....
T Consensus       204 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~  268 (381)
T cd05626         204 LAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE---------------NTLH  268 (381)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccc---------------cccC
Confidence            0112468899999999988889999999999999999999999997543321111111110               0011


Q ss_pred             CCCCHHHHHHHHHHHHHhcc--CCCCCCCCHHHHHHH
Q 023752          197 GQYSKKEAQAVAAVVLQCLH--MDPKNRPSMVDVLTS  231 (278)
Q Consensus       197 ~~~~~~~~~~l~~li~~~l~--~dp~~Rps~~~ll~~  231 (278)
                      .+....++.++.+||.+|+.  .++..|+++.+++.|
T Consensus       269 ~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         269 IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            12223467889999999654  455569999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.4e-36  Score=259.56  Aligned_cols=210  Identities=23%  Similarity=0.323  Sum_probs=166.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +++|+.++++++|+||+++++.+.+....|+||||+.||+|.+++.+.+  .+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH--~~giv  123 (363)
T cd05628          48 IRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIH--QLGFI  123 (363)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeE
Confidence            4679999999999999999999999999999999999999999997664  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCC---------------------------------ccccccccCCccc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT---------------------------------HVSTRIVGTRGYA  128 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~  128 (278)
                      ||||||+||+++.++.++|+|||++.........                                 .......|++.|+
T Consensus       124 HrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~  203 (363)
T cd05628         124 HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYI  203 (363)
T ss_pred             ecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCcccc
Confidence            9999999999999999999999998653321100                                 0011246889999


Q ss_pred             CccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHH
Q 023752          129 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVA  208 (278)
Q Consensus       129 aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  208 (278)
                      |||++.+..++.++|+|||||++|+|++|..||...........+..+...               ...+....++.++.
T Consensus       204 aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p~~~~~s~~~~  268 (363)
T cd05628         204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKET---------------LIFPPEVPISEKAK  268 (363)
T ss_pred             CHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCc---------------ccCCCcCCCCHHHH
Confidence            999999999999999999999999999999999754432222222211100               00111123567889


Q ss_pred             HHHHHhccCCCC---CCCCHHHHHHH
Q 023752          209 AVVLQCLHMDPK---NRPSMVDVLTS  231 (278)
Q Consensus       209 ~li~~~l~~dp~---~Rps~~~ll~~  231 (278)
                      ++|.+|+. +|.   .||++.+|++|
T Consensus       269 ~li~~l~~-~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         269 DLILRFCC-EWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHHHHcC-ChhhcCCCCCHHHHhCC
Confidence            99998775 444   45899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.8e-36  Score=244.83  Aligned_cols=228  Identities=27%  Similarity=0.299  Sum_probs=177.6

Q ss_pred             HHHHHHHhccCCcc-ccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHH
Q 023752            3 QTEVIYLGQLRHEN-LVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         3 ~~E~~~l~~l~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      .+|+.+|+.++|+| |+.+++++...+      .+++||||. ..+|.+++.....  +.++...+..++.||+.||+||
T Consensus        58 iREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~  136 (323)
T KOG0594|consen   58 IREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL  136 (323)
T ss_pred             hHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH
Confidence            58999999999999 999999998877      788999999 5699999976553  3678889999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLL  152 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~  152 (278)
                      |  +++|+||||||+||+++.+|.+||+|||++.....+...  ....+.+.+|+|||++.+. .|+...||||+||+++
T Consensus       137 H--~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfa  212 (323)
T KOG0594|consen  137 H--SHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFA  212 (323)
T ss_pred             H--hCCeecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHH
Confidence            9  999999999999999999999999999999864433322  3345678899999999887 7999999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccc-cchhHHHHHHhhhc---cCCCCC-------HHHHHHHHHHHHHhccCCCCC
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPF-LRDSRRVLRIMDTR---LGGQYS-------KKEAQAVAAVVLQCLHMDPKN  221 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~-------~~~~~~l~~li~~~l~~dp~~  221 (278)
                      +|++++..|.+.........+....... ...+..........   ....-+       +..+....+++.+||+.+|.+
T Consensus       213 Em~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~  292 (323)
T KOG0594|consen  213 EMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAK  292 (323)
T ss_pred             HHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCccc
Confidence            9999999999887755555555443322 11111111111100   011101       122358889999999999999


Q ss_pred             CCCHHHHHHH--HHhh
Q 023752          222 RPSMVDVLTS--LEQL  235 (278)
Q Consensus       222 Rps~~~ll~~--l~~~  235 (278)
                      |.|+..+++|  +..+
T Consensus       293 R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  293 RISAKGALTHPYFSEL  308 (323)
T ss_pred             CcCHHHHhcChhhccc
Confidence            9999999987  4444

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.4e-35  Score=247.20  Aligned_cols=216  Identities=25%  Similarity=0.413  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------VQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+.+++.++||||+++++++.+++..+++|||+.+++|.+++....        ........+..++.|++.||.||
T Consensus        56 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~l  135 (288)
T cd05061          56 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYL  135 (288)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            5679999999999999999999999999999999999999999996532        12345678889999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.+++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|||||++|+
T Consensus       136 H--~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~e  213 (288)
T cd05061         136 N--AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWE  213 (288)
T ss_pred             H--hCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHH
Confidence            9  89999999999999999999999999998875333222111112234567999999988889999999999999999


Q ss_pred             HHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +++ |..||.......                  ....+........+...+..+.+++.+||+.||++|||+.++++.|
T Consensus       214 l~~~~~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l  275 (288)
T cd05061         214 ITSLAEQPYQGLSNEQ------------------VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL  275 (288)
T ss_pred             HHhCCCCCCCCCCHHH------------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            998 778886433211                  1111111111223345568899999999999999999999999999


Q ss_pred             Hhhhc
Q 023752          233 EQLHT  237 (278)
Q Consensus       233 ~~~~~  237 (278)
                      .+...
T Consensus       276 ~~~~~  280 (288)
T cd05061         276 KDDLH  280 (288)
T ss_pred             HhhcC
Confidence            88643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2e-35  Score=252.71  Aligned_cols=219  Identities=26%  Similarity=0.423  Sum_probs=175.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l   66 (278)
                      +.+|+++++++ +||||+++++++.+.+..++++||+.+++|.+++.+..              ...++...+..++.|+
T Consensus        64 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  143 (334)
T cd05100          64 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQV  143 (334)
T ss_pred             HHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHH
Confidence            56899999999 79999999999999899999999999999999987542              1246778889999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||
T Consensus       144 ~~al~~LH--~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  221 (334)
T cd05100         144 ARGMEYLA--SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  221 (334)
T ss_pred             HHHHHHHH--HCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHH
Confidence            99999999  8999999999999999999999999999987543322111111122345799999998889999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++ |..||.......                  ....+........+..++.++.+++.+||+.+|++||++
T Consensus       222 lG~il~el~~~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~  283 (334)
T cd05100         222 FGVLLWEIFTLGGSPYPGIPVEE------------------LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTF  283 (334)
T ss_pred             HHHHHHHHHhcCCCCCCCCCHHH------------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCH
Confidence            9999999998 888886533211                  111111222233345567789999999999999999999


Q ss_pred             HHHHHHHHhhhcCCC
Q 023752          226 VDVLTSLEQLHTSKD  240 (278)
Q Consensus       226 ~~ll~~l~~~~~~~~  240 (278)
                      .++++.|..+.....
T Consensus       284 ~ell~~l~~~~~~~~  298 (334)
T cd05100         284 KQLVEDLDRVLTVTS  298 (334)
T ss_pred             HHHHHHHHHHhhhcC
Confidence            999999999986543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.1e-36  Score=262.26  Aligned_cols=210  Identities=23%  Similarity=0.346  Sum_probs=166.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++.+.+++..|+||||+.+|+|.+++.+.+  .+++..+..++.|++.||.|||  +.||+
T Consensus        48 ~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH--~~~iv  123 (382)
T cd05625          48 VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVH--KMGFI  123 (382)
T ss_pred             HHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5689999999999999999999999999999999999999999987654  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC---------------------------------------------Cc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN---------------------------------------------TH  116 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~---------------------------------------------~~  116 (278)
                      ||||||+||+++.++.++|+|||++........                                             ..
T Consensus       124 HrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (382)
T cd05625         124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRC  203 (382)
T ss_pred             cCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence            999999999999999999999998753211000                                             00


Q ss_pred             cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccC
Q 023752          117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG  196 (278)
Q Consensus       117 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (278)
                      ......+++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..+.               ....
T Consensus       204 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~---------------~~~~  268 (382)
T cd05625         204 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQ---------------TSLH  268 (382)
T ss_pred             cccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccC---------------CCcC
Confidence            0112357889999999998899999999999999999999999997543221111111110               1111


Q ss_pred             CCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 023752          197 GQYSKKEAQAVAAVVLQCLHMDPKNRPS---MVDVLTS  231 (278)
Q Consensus       197 ~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~  231 (278)
                      .+....++.++.++|.+|+ .+|.+|++   +.++++|
T Consensus       269 ~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         269 IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            2223456788999999986 49999987   8888865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.3e-35  Score=243.03  Aligned_cols=212  Identities=28%  Similarity=0.438  Sum_probs=171.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+ ...++++||+.+++|.+.+.......+++..++.++.|++.||.|||  +.|++
T Consensus        43 ~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~  119 (257)
T cd05040          43 FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SKRFI  119 (257)
T ss_pred             HHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            6789999999999999999999988 88899999999999999987654346899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++++|++ |..
T Consensus       120 H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~  199 (257)
T cd05040         120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE  199 (257)
T ss_pred             ccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999987654422211 1112345667999999988889999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      ||...+.......+..                 .......+...+..+.+++.+||+.+|.+||++.+++..|.
T Consensus       200 p~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         200 PWAGLSGSQILKKIDK-----------------EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCCCCHHHHHHHHHh-----------------cCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            9864332211111110                 11112233456788999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-35  Score=244.85  Aligned_cols=213  Identities=27%  Similarity=0.433  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+++..++++||+.+++|.+++.... +.+++..+..++.|++.||.|||  +.|++
T Consensus        52 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH--~~g~~  128 (269)
T cd05065          52 FLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS--EMNYV  128 (269)
T ss_pred             HHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            6789999999999999999999999999999999999999999887653 35889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccc---cccCCcccCccccccCCCCCccchhHHHHHHHHHHh-C
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-G  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~---~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g  157 (278)
                      |+||+|+||+++.++.++|+|||++..............   ...+..|+|||.+.+..++.++|+||||+++|++++ |
T Consensus       129 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g  208 (269)
T cd05065         129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG  208 (269)
T ss_pred             ecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCC
Confidence            999999999999999999999998865433221111111   111346999999988899999999999999999886 9


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      ..||..........                  .+......+.+..++..+.+++.+||+.+|++||++.+++..|+++
T Consensus       209 ~~p~~~~~~~~~~~------------------~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         209 ERPYWDMSNQDVIN------------------AIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCCCCCCCHHHHHH------------------HHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            99986543211111                  1111112233445677899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.7e-36  Score=252.62  Aligned_cols=224  Identities=21%  Similarity=0.304  Sum_probs=168.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++..++..++|+||+. ++|.+++.... ..++...+..++.|++.||.|||  +.|++
T Consensus        51 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH--~~~iv  126 (309)
T cd07872          51 AIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH--RRKVL  126 (309)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            4689999999999999999999999999999999996 48888876553 35888999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.|
T Consensus       127 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~p  204 (309)
T cd07872         127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKT--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPL  204 (309)
T ss_pred             cCCCCHHHEEECCCCCEEECccccceecCCCccc--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998653322211  122346788999998865 4688999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhH-HH---HHHhhhccCC-------CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSR-RV---LRIMDTRLGG-------QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |...+.......+.........+.. ..   ..........       .....++.++.++|.+||+.||.+|||+.+++
T Consensus       205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l  284 (309)
T cd07872         205 FPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM  284 (309)
T ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence            9766544333333222111111100 00   0000000000       01124577899999999999999999999999


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      ++
T Consensus       285 ~h  286 (309)
T cd07872         285 KH  286 (309)
T ss_pred             cC
Confidence            74

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.7e-35  Score=243.17  Aligned_cols=211  Identities=26%  Similarity=0.404  Sum_probs=171.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++|+||+++++++. .+..++++|++.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH--~~~i~  124 (260)
T cd05067          48 FLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKNYI  124 (260)
T ss_pred             HHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh--cCCee
Confidence            678999999999999999999874 457899999999999999987655557899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       125 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p  203 (260)
T cd05067         125 HRDLRAANILVSETLCCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP  203 (260)
T ss_pred             cccccHHhEEEcCCCCEEEccCcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999875432211 11112234567999999988888999999999999999998 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      |...+.....                  ..+......+.+...+.++.+++.+||+.+|++||++.+++..|+.
T Consensus       204 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         204 YPGMTNPEVI------------------QNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCChHHHH------------------HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            9754321111                  1111222233445567889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.8e-35  Score=245.64  Aligned_cols=215  Identities=22%  Similarity=0.364  Sum_probs=172.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++++.. ...+++++++.+|+|.+++..+. ..+++..+..++.|++.||.|||  +.+++
T Consensus        56 ~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~ii  131 (279)
T cd05109          56 ILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE--EVRLV  131 (279)
T ss_pred             HHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5688999999999999999999875 45789999999999999987643 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.................+..|+|||...+..++.++|+|||||++|++++ |..|
T Consensus       132 H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p  211 (279)
T cd05109         132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999876543222111111233567999999988889999999999999999998 8898


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |......                  .....+......+.+..++..+.+++.+||+.||++||++.+++..|..+...
T Consensus       212 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         212 YDGIPAR------------------EIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             CCCCCHH------------------HHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            8643221                  11122222222333456778899999999999999999999999999887655

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.3e-35  Score=244.02  Aligned_cols=214  Identities=23%  Similarity=0.367  Sum_probs=173.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+ +..++++||+.+++|.+++.+.. ..+++..+..++.+++.||.|||  +.+++
T Consensus        54 ~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~~  129 (270)
T cd05056          54 FLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE--SKRFV  129 (270)
T ss_pred             HHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            6789999999999999999998876 56789999999999999997654 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++......... .......+..|+|||.+.+..++.++|+||||++++++++ |..|
T Consensus       130 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  208 (270)
T cd05056         130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKP  208 (270)
T ss_pred             ccccChheEEEecCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999998754332111 1111223457999999888889999999999999999986 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |...........                  +........+..++..+.++|.+|+..+|++|||+.+++..|..+...
T Consensus       209 f~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         209 FQGVKNNDVIGR------------------IENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CCCCCHHHHHHH------------------HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            965433211111                  111122334556778999999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4e-36  Score=260.26  Aligned_cols=207  Identities=23%  Similarity=0.273  Sum_probs=167.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++++.+++..++|+||+.+|+|.+++...   .+++..+..++.|++.||.|||  +.|++
T Consensus        90 ~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH--~~~iv  164 (370)
T cd05596          90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH--SMGFI  164 (370)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            467999999999999999999999999999999999999999988654   4888899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC----CCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~il~~l~~g  157 (278)
                      |+||+|+||+++.++.++|+|||++......... ......+++.|+|||.+.+.    .++.++|+|||||++|+|++|
T Consensus       165 HrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG  243 (370)
T cd05596         165 HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG  243 (370)
T ss_pred             ccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhC
Confidence            9999999999999999999999998754332211 11234578999999998653    478899999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCC--CHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY--SKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~  231 (278)
                      ..||...+.......                 +.........  ...++.++.+||.+||+.+|++  |+++.+++.|
T Consensus       244 ~~Pf~~~~~~~~~~~-----------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         244 DTPFYADSLVGTYSK-----------------IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCcCCCCHHHHHHH-----------------HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            999975432111111                 1111111112  2346889999999999999988  9999999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=3.2e-35  Score=241.23  Aligned_cols=210  Identities=30%  Similarity=0.467  Sum_probs=169.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++++.++||||+++++++...+..++|+||+.+++|.+++.... ..+.+..+..++.+++.+|.|+|  +.|++
T Consensus        39 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~~  115 (250)
T cd05085          39 FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE--SKNCI  115 (250)
T ss_pred             HHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999999999999886554 35789999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++......... ..........|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       116 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p  194 (250)
T cd05085         116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCP  194 (250)
T ss_pred             ecccChheEEEcCCCeEEECCCccceeccccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCC
Confidence            9999999999999999999999988643222111 1111223457999999988889999999999999999998 8899


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      |..........                  .+........+..++..+.+++.+||+.+|++||++.++++.|.
T Consensus       195 ~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         195 YPGMTNQQARE------------------QVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCHHHHHH------------------HHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            86543211111                  11111122334456788999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.2e-36  Score=259.84  Aligned_cols=210  Identities=23%  Similarity=0.283  Sum_probs=168.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++.+.+.+..++||||+.+++|.+++.+.. ..+++..+..++.|++.||.|||  +.+++
T Consensus        48 ~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH--~~~i~  124 (330)
T cd05601          48 FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH--QMGYV  124 (330)
T ss_pred             HHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            5789999999999999999999999999999999999999999997653 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc------cCCCCCccchhHHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA------TGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~il~~l~  155 (278)
                      |+||+|+||+++.++.++|+|||++......... ......++..|+|||++.      +..++.++|+|||||++|+|+
T Consensus       125 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~  203 (330)
T cd05601         125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI  203 (330)
T ss_pred             cccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeec
Confidence            9999999999999999999999998764433221 122245788999999986      456778999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +|..||...........+...               ......+....++..+.+||.+||+ +|.+||++.++++|
T Consensus       204 ~g~~Pf~~~~~~~~~~~i~~~---------------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         204 YGRSPFHEGTSAKTYNNIMNF---------------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             cCCCCCCCCCHHHHHHHHHcC---------------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            999999754322111111110               0001111223467889999999998 99999999999965

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=3.7e-35  Score=242.55  Aligned_cols=215  Identities=27%  Similarity=0.422  Sum_probs=167.5

Q ss_pred             hHHHHHHHhccCCccccceeeeee-cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCS-ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|+.+++.++||||+++++++. .++..+++++|+.+++|.+++.... ...+...+..++.|+++||.|||  ..++
T Consensus        43 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i  119 (262)
T cd05058          43 FLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA--SKKF  119 (262)
T ss_pred             HHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCc
Confidence            567999999999999999999765 4556899999999999999987653 24677778889999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC-
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG-  157 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g-  157 (278)
                      +|+||+|+||+++.++.++|+|||++..........  ......++..|+|||.+.+..++.++|+||||+++|+|++| 
T Consensus       120 ~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~  199 (262)
T cd05058         120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG  199 (262)
T ss_pred             cccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCC
Confidence            999999999999999999999999986543221111  11122345679999999888899999999999999999995 


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      ..||...+...                  ....+........+...+..+.+++.+||+.+|++||++.++++.|+++..
T Consensus       200 ~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         200 APPYPDVDSFD------------------ITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCCCCHHH------------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            55564322111                  111111112223344567789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.2e-35  Score=243.73  Aligned_cols=213  Identities=28%  Similarity=0.438  Sum_probs=172.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+++..++++||+.+++|.+++.... ..++...+..++.|++.||.+||  +.+++
T Consensus        52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~  128 (267)
T cd05066          52 FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS--DMGYV  128 (267)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            6789999999999999999999999999999999999999999997654 35889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccc-cccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.++|+|||++............ .....+..|+|||.+.+..++.++|+||||+++|++++ |..
T Consensus       129 h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~  208 (267)
T cd05066         129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER  208 (267)
T ss_pred             ehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCC
Confidence            9999999999999999999999998764432211111 11122457999999988889999999999999999886 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      ||...........+                  ......+.+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       209 p~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         209 PYWEMSNQDVIKAI------------------EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CcccCCHHHHHHHH------------------hCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            98654322111111                  11112233445678899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.6e-36  Score=256.43  Aligned_cols=196  Identities=27%  Similarity=0.379  Sum_probs=160.6

Q ss_pred             HHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 023752            7 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK   86 (278)
Q Consensus         7 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~   86 (278)
                      .+++.++||||+++++++.+.+..++|+||+.+++|.+++....  .+.+..+..++.|++.||.|||  +.|++|+|||
T Consensus        48 ~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH--~~giiHrDlk  123 (325)
T cd05602          48 VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH--SLNIVYRDLK  123 (325)
T ss_pred             HHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEecCCC
Confidence            35678899999999999999999999999999999999987654  5888899999999999999999  8999999999


Q ss_pred             CCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccC
Q 023752           87 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG  166 (278)
Q Consensus        87 p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~  166 (278)
                      |+||+++.++.++|+|||++.......  .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus       124 p~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  201 (325)
T cd05602         124 PENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT  201 (325)
T ss_pred             HHHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999986432211  112234578899999999999999999999999999999999999975432


Q ss_pred             CchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 023752          167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD  227 (278)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  227 (278)
                      ......+                 ..  .....+..++..+.++|.+||+.||.+|+++.+
T Consensus       202 ~~~~~~i-----------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         202 AEMYDNI-----------------LN--KPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             HHHHHHH-----------------Hh--CCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence            2111111                 11  112234467888999999999999999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.5e-35  Score=249.15  Aligned_cols=219  Identities=26%  Similarity=0.432  Sum_probs=170.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---------VQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      |.+|++++++++||||+++++++..++..++++|++.+++|.+++.+..         ...+++..+..++.|++.||.|
T Consensus        66 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~  145 (296)
T cd05051          66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRY  145 (296)
T ss_pred             HHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHH
Confidence            5679999999999999999999999999999999999999999987653         1258899999999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           73 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      ||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|
T Consensus       146 LH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~  223 (296)
T cd05051         146 LE--SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW  223 (296)
T ss_pred             HH--HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHH
Confidence            99  8999999999999999999999999999987543332222222334566799999998888999999999999999


Q ss_pred             HHHh--CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          153 ELLS--GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       153 ~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      ++++  +..||...............    .       .........+.+..++.++.+++.+||+.||.+|||+.+|++
T Consensus       224 el~~~~~~~p~~~~~~~~~~~~~~~~----~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         224 EILTLCREQPYEHLTDQQVIENAGHF----F-------RDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHhcCCCCCCCCcChHHHHHHHHhc----c-------ccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            9998  66777543321111111100    0       000001111223456688999999999999999999999999


Q ss_pred             HHH
Q 023752          231 SLE  233 (278)
Q Consensus       231 ~l~  233 (278)
                      .|.
T Consensus       293 ~L~  295 (296)
T cd05051         293 FLQ  295 (296)
T ss_pred             Hhc
Confidence            886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-35  Score=243.74  Aligned_cols=215  Identities=22%  Similarity=0.367  Sum_probs=174.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.. ...++++||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        56 ~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~i~  131 (279)
T cd05057          56 ILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE--EKRLV  131 (279)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCEE
Confidence            5789999999999999999999987 78899999999999999987654 25899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|+||||++++++++ |..|
T Consensus       132 H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  211 (279)
T cd05057         132 HRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP  211 (279)
T ss_pred             ecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999999876543222111111223457999999888889999999999999999998 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |........                  ...+......+.+...+..+.+++.+||..+|++||++.++++.|.++...
T Consensus       212 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         212 YEGIPAVEI------------------PDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CCCCCHHHH------------------HHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            875432111                  111122222333445667899999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.5e-36  Score=254.32  Aligned_cols=205  Identities=29%  Similarity=0.430  Sum_probs=166.4

Q ss_pred             hHHHHHHHhccCC-ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|++++..+.| ++|+++++.+.+.+..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|+
T Consensus        47 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~i  122 (324)
T cd05587          47 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLH--SKGI  122 (324)
T ss_pred             HHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            4578888888866 468889999999999999999999999999987654  6889999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++|+.|
T Consensus       123 vH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p  200 (324)
T cd05587         123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP  200 (324)
T ss_pred             EecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCC
Confidence            9999999999999999999999998764322111  12234578899999999988999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  231 (278)
                      |...+.......+..                   ....++..++.++.+++.+||+.||.+|++.     .++++|
T Consensus       201 f~~~~~~~~~~~i~~-------------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         201 FDGEDEDELFQSIME-------------------HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CCCCCHHHHHHHHHc-------------------CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            975432211111111                   1233455678889999999999999999976     677654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.8e-35  Score=246.93  Aligned_cols=220  Identities=26%  Similarity=0.442  Sum_probs=169.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC---------CCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---------QPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      |.+|+.+++.++|+||+++++++...+..++++||+.+++|.+++.....         ..+++..+..++.|++.||.|
T Consensus        66 ~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~  145 (296)
T cd05095          66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKY  145 (296)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            57899999999999999999999999999999999999999999876431         236677899999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           73 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      ||  +.|++|+||+|+||+++.++.++|+|||++.................+..|++||...+..++.++|+|||||++|
T Consensus       146 lH--~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~  223 (296)
T cd05095         146 LS--SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW  223 (296)
T ss_pred             HH--HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHH
Confidence            99  8999999999999999999999999999987543322211122223356799999888888999999999999999


Q ss_pred             HHHh--CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          153 ELLS--GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       153 ~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      +|++  |..||..............           ...........+.+..++..+.+++.+||+.||.+||++.+|++
T Consensus       224 el~~~~~~~p~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         224 EILTLCKEQPYSQLSDEQVIENTGE-----------FFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHhCCCCCccccChHHHHHHHHH-----------HHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9998  6778864332211111000           00000011112223456688999999999999999999999999


Q ss_pred             HHHh
Q 023752          231 SLEQ  234 (278)
Q Consensus       231 ~l~~  234 (278)
                      .|++
T Consensus       293 ~l~~  296 (296)
T cd05095         293 TLLE  296 (296)
T ss_pred             HHhC
Confidence            8863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=4.1e-35  Score=245.27  Aligned_cols=226  Identities=27%  Similarity=0.453  Sum_probs=173.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|++++++++||||+++++++.+.  ...++++||++|++|.+++.+.. ..+++..+..++.|++.||.|||  +.|
T Consensus        53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH--~~g  129 (284)
T cd05079          53 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG--SRQ  129 (284)
T ss_pred             HHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            67899999999999999999998775  56789999999999999986653 35889999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++|+||||+++|+++++.
T Consensus       130 i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~  209 (284)
T cd05079         130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYC  209 (284)
T ss_pred             eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCC
Confidence            9999999999999999999999999987654332211 111234556799999998888999999999999999999987


Q ss_pred             CCCccccCCchhhhHHhhhcccc--chhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          159 RALDEDRGGLAEQTLVEWADPFL--RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      .|........     .....+..  .........+......+.+..++..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus       210 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         210 DSESSPMTLF-----LKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             CCCccccchh-----hhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            6643211100     00000000  001111122222223344556788999999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.7e-35  Score=242.56  Aligned_cols=208  Identities=24%  Similarity=0.332  Sum_probs=169.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC-CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|++++++++|+|++++++.+... +..++++||+.+++|.+++.......+++.++..++.+++.||.+||  +.|+
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH--~~~i  123 (257)
T cd08223          46 AEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH--EKHI  123 (257)
T ss_pred             HHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            56799999999999999999988644 45789999999999999987654456899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++........  ......++..|+|||...+..++.++|+||||++++++++|+.|
T Consensus       124 ~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~  201 (257)
T cd08223         124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA  201 (257)
T ss_pred             eccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999875433221  12234567889999999888899999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |...+......                 . .........+..++..+.+++.+||+.||++||++.+++++
T Consensus       202 ~~~~~~~~~~~-----------------~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         202 FNAKDMNSLVY-----------------R-IIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCCCHHHHHH-----------------H-HHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            86432211100                 1 11111123445678899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=4.9e-35  Score=241.69  Aligned_cols=211  Identities=27%  Similarity=0.450  Sum_probs=170.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++|+||+++++.+.+ ...++++||+.+++|.+++.+.....++...+..++.|++.||.|||  +.|++
T Consensus        48 ~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH--~~~i~  124 (260)
T cd05073          48 FLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYI  124 (260)
T ss_pred             HHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            5789999999999999999999987 77899999999999999997754456788899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+.......... .....++..|.|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       125 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p  203 (260)
T cd05073         125 HRDLRAANILVSASLVCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP  203 (260)
T ss_pred             ccccCcceEEEcCCCcEEECCCcceeeccCCCccc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCC
Confidence            99999999999999999999999887543321111 111234566999999988889999999999999999998 8899


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      |...+......                  .+......+.+...+.++.+++.+||+.+|++||++.++++.|+.
T Consensus       204 ~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         204 YPGMSNPEVIR------------------ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCCHHHHHH------------------HHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            86543211111                  111111223345677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.8e-35  Score=243.42  Aligned_cols=209  Identities=24%  Similarity=0.350  Sum_probs=170.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++.+.+....|+++|++.+++|.+++.... ..+++..+..++.|++.|+.|||  +.+++
T Consensus        45 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh--~~~i~  121 (256)
T cd06612          45 IIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH--SNKKI  121 (256)
T ss_pred             HHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999999999999999999999999999986543 46899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|.||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||+++++|++|..||
T Consensus       122 H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~  199 (256)
T cd06612         122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPY  199 (256)
T ss_pred             cCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876443321  112234677899999998889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..............                ........+..++..+.++|.+||+.||++|||+.+++++
T Consensus       200 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         200 SDIHPMRAIFMIPN----------------KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CCcchhhhhhhhcc----------------CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            75432111110000                0001112234567789999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4e-35  Score=255.57  Aligned_cols=216  Identities=25%  Similarity=0.377  Sum_probs=172.9

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-----------------------------
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-----------------------------   51 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------------------------   51 (278)
                      +.+|+.+|.++. ||||+++++++...+..++|+||+.+|+|.+++.+...                             
T Consensus        87 ~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (401)
T cd05107          87 LMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKS  166 (401)
T ss_pred             HHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccccc
Confidence            568999999997 99999999999999999999999999999999865321                             


Q ss_pred             -------------------------------------------------------------------CCCCHHHHHHHHH
Q 023752           52 -------------------------------------------------------------------QPISWPTRVKIAI   64 (278)
Q Consensus        52 -------------------------------------------------------------------~~~~~~~~~~i~~   64 (278)
                                                                                         ..+++..+..++.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  246 (401)
T cd05107         167 HVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSY  246 (401)
T ss_pred             chhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHH
Confidence                                                                               1356677888999


Q ss_pred             HHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccch
Q 023752           65 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDV  144 (278)
Q Consensus        65 ~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  144 (278)
                      |++.||.|||  +.+++|+||+|.||+++.++.++|+|||++................++..|+|||.+.+..++.++|+
T Consensus       247 qi~~aL~~LH--~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  324 (401)
T cd05107         247 QVANGMEFLA--SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV  324 (401)
T ss_pred             HHHHHHHHHh--cCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence            9999999999  89999999999999999999999999999875432222111122345678999999988889999999


Q ss_pred             hHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          145 YSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       145 wslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      ||||+++|++++ |+.||.......                 .....+........+..++.++.+++.+||+.+|.+||
T Consensus       325 wslGvil~e~l~~g~~P~~~~~~~~-----------------~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP  387 (401)
T cd05107         325 WSFGILLWEIFTLGGTPYPELPMNE-----------------QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP  387 (401)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCchH-----------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc
Confidence            999999999998 888886432211                 11111222222334556778999999999999999999


Q ss_pred             CHHHHHHHHHhhh
Q 023752          224 SMVDVLTSLEQLH  236 (278)
Q Consensus       224 s~~~ll~~l~~~~  236 (278)
                      ++.+|+..|+.+.
T Consensus       388 s~~ell~~L~~~~  400 (401)
T cd05107         388 DFSQLVHLVGDLL  400 (401)
T ss_pred             CHHHHHHHHHHHh
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=260.03  Aligned_cols=220  Identities=28%  Similarity=0.472  Sum_probs=179.8

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +|++|+.++++-+|.||+-+.|++..++. .+|+-||+|-+|+.++.-.. ..|.....+.|+.|++.|+.|||  .++|
T Consensus       434 aFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH--AK~I  509 (678)
T KOG0193|consen  434 AFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH--AKNI  509 (678)
T ss_pred             HHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh--hhhh
Confidence            59999999999999999999999999877 99999999999999885443 24888899999999999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      +|+|||.+||++.+++.|||+|||+++.-.............+...|+|||+++   ..+|++.+||||||+++|||++|
T Consensus       510 IHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg  589 (678)
T KOG0193|consen  510 IHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTG  589 (678)
T ss_pred             hhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhC
Confidence            999999999999999999999999998644443333334456778899999985   35789999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      ..||.....   .+.+......+....           ........++++.+|+..||.+++++||.+.+|+..|+.+..
T Consensus       590 ~lPysi~~~---dqIifmVGrG~l~pd-----------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  590 ELPYSIQNR---DQIIFMVGRGYLMPD-----------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             cCCcCCCCh---hheEEEecccccCcc-----------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            999983322   222222222221111           122345678899999999999999999999999998888877


Q ss_pred             C
Q 023752          238 S  238 (278)
Q Consensus       238 ~  238 (278)
                      .
T Consensus       656 ~  656 (678)
T KOG0193|consen  656 S  656 (678)
T ss_pred             c
Confidence            4

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.5e-35  Score=248.54  Aligned_cols=223  Identities=26%  Similarity=0.343  Sum_probs=171.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i   80 (278)
                      +.+|++++++++||||+++++.+.+++..++++||+++++|.+++.+..  .+++..+..++.|+++||.|||  + .++
T Consensus        46 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~~i  121 (308)
T cd06615          46 IIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPENILGKISIAVLRGLTYLR--EKHKI  121 (308)
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hhCCE
Confidence            5689999999999999999999999999999999999999999997653  6899999999999999999999  6 589


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|.||+++.++.++|+|||++.......    .....++..|+|||.+.+..++.++|+||||++++++++|..|
T Consensus       122 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p  197 (308)
T cd06615         122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP  197 (308)
T ss_pred             EECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876432221    1224567889999999888899999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccc------------------hhHHHHHHhhhccCCCCC-HHHHHHHHHHHHHhccCCCCC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLR------------------DSRRVLRIMDTRLGGQYS-KKEAQAVAAVVLQCLHMDPKN  221 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~  221 (278)
                      |...+.......+.........                  .................+ ..++.++.++|.+||+.+|++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  277 (308)
T cd06615         198 IPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKE  277 (308)
T ss_pred             CCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhh
Confidence            9654422221111111000000                  000111111111111111 236778999999999999999


Q ss_pred             CCCHHHHHHHH
Q 023752          222 RPSMVDVLTSL  232 (278)
Q Consensus       222 Rps~~~ll~~l  232 (278)
                      ||++.+++++-
T Consensus       278 Rpt~~~ll~~~  288 (308)
T cd06615         278 RADLKELTKHP  288 (308)
T ss_pred             CcCHHHHhcCh
Confidence            99999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.1e-35  Score=241.34  Aligned_cols=210  Identities=31%  Similarity=0.504  Sum_probs=171.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++++.+.+..++++|++.+++|.+++.......+++..+..++.|++.||.+||  +.+++
T Consensus        48 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh--~~~~~  125 (258)
T smart00219       48 FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--SKNFI  125 (258)
T ss_pred             HHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh--cCCee
Confidence            5789999999999999999999999999999999999999999997655333899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++............ ...++..|+|||...+..++.++|+||||++++++++ |..|
T Consensus       126 h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p  204 (258)
T smart00219      126 HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESP  204 (258)
T ss_pred             ecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998765443221111 1225678999999988889999999999999999998 7888


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |........                  ...+........+...+.++.+++.+||+.||++|||+.++++.|
T Consensus       205 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      205 YPGMSNEEV------------------LEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCHHHH------------------HHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            765322111                  111112222333445788999999999999999999999998754

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-35  Score=247.42  Aligned_cols=220  Identities=24%  Similarity=0.443  Sum_probs=169.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC----------CCCCCHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------VQPISWPTRVKIAIDVARGLS   71 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~i~~~l~~~l~   71 (278)
                      |.+|++++++++|+||+++++++...+..++||||+.+++|.+++....          ...+++..+..++.|++.||.
T Consensus        64 ~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~  143 (295)
T cd05097          64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMK  143 (295)
T ss_pred             HHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHH
Confidence            6789999999999999999999999999999999999999999885432          123678889999999999999


Q ss_pred             HHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHH
Q 023752           72 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        72 ~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il  151 (278)
                      |||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||+++
T Consensus       144 ~lH--~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l  221 (295)
T cd05097         144 YLA--SLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL  221 (295)
T ss_pred             HHH--hcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHH
Confidence            999  899999999999999999999999999998754332222212223345679999999888899999999999999


Q ss_pred             HHHHh--CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          152 LELLS--GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       152 ~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ++|++  +..||...............           ............+...+..+.+++.+||+.||++|||+.+|+
T Consensus       222 ~el~~~~~~~p~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~  290 (295)
T cd05097         222 WEMFTLCKEQPYSLLSDEQVIENTGEF-----------FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIH  290 (295)
T ss_pred             HHHHHcCCCCCCcccChHHHHHHHHHh-----------hhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence            99998  56677654332211111110           000000011122334677899999999999999999999999


Q ss_pred             HHHHh
Q 023752          230 TSLEQ  234 (278)
Q Consensus       230 ~~l~~  234 (278)
                      +.|.+
T Consensus       291 ~~l~~  295 (295)
T cd05097         291 HFLRE  295 (295)
T ss_pred             HHHhC
Confidence            98863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.7e-35  Score=264.58  Aligned_cols=210  Identities=26%  Similarity=0.315  Sum_probs=170.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC--------ccEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD--------NRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLS   71 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~   71 (278)
                      +.+|+.++..++|+||+++++.+....        ..++|+||+.+|+|.+++..+.  ...+++..+..++.|++.||.
T Consensus        78 ~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~  157 (496)
T PTZ00283         78 AQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVH  157 (496)
T ss_pred             HHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            567999999999999999988775432        2579999999999999886532  246899999999999999999


Q ss_pred             HHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHH
Q 023752           72 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        72 ~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il  151 (278)
                      |||  +.+++|+||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++
T Consensus       158 ~lH--~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvil  235 (496)
T PTZ00283        158 HVH--SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLL  235 (496)
T ss_pred             HHH--hCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHH
Confidence            999  899999999999999999999999999998765433222223335678899999999988999999999999999


Q ss_pred             HHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          152 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       152 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |+|++|..||...+....                  ..........+.+..+++++.+++.+||+.||.+||++.+++++
T Consensus       236 yeLltG~~Pf~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        236 YELLTLKRPFDGENMEEV------------------MHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHHHHCCCCCCCCCHHHH------------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            999999999965332111                  11111112233456678899999999999999999999999875

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.2e-36  Score=255.02  Aligned_cols=195  Identities=29%  Similarity=0.409  Sum_probs=159.6

Q ss_pred             HHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCC
Q 023752            7 IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLK   86 (278)
Q Consensus         7 ~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~   86 (278)
                      .+++.++||||+++++.+.+.+..|+|+||+.+++|.+.+....  .+++..+..++.||+.||.|||  +.|++|+|||
T Consensus        48 ~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH--~~~ivH~Dlk  123 (321)
T cd05603          48 VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLH--SLNIIYRDLK  123 (321)
T ss_pred             HHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeEeccCC
Confidence            46788899999999999999999999999999999998886654  6889999999999999999999  8999999999


Q ss_pred             CCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccC
Q 023752           87 ASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG  166 (278)
Q Consensus        87 p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~  166 (278)
                      |+||+++.++.+||+|||++.......  .......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.
T Consensus       124 p~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  201 (321)
T cd05603         124 PENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV  201 (321)
T ss_pred             HHHeEECCCCCEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH
Confidence            999999999999999999886432211  112234578899999999888899999999999999999999999965432


Q ss_pred             CchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      .....                 ....  .....+...+..+.++|.+||+.||.+||++.
T Consensus       202 ~~~~~-----------------~i~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         202 SQMYD-----------------NILH--KPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHH-----------------HHhc--CCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            11111                 1111  12334556778899999999999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.7e-35  Score=247.80  Aligned_cols=210  Identities=28%  Similarity=0.416  Sum_probs=170.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++|++|+++++.+.+.+..++++||+.+++|.+++.......+++..+..++.|++.||.|||  +.+++
T Consensus        47 ~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~ii  124 (285)
T cd05630          47 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH--QERIV  124 (285)
T ss_pred             HHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCEE
Confidence            4679999999999999999999999999999999999999999886655456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||
T Consensus       125 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf  201 (285)
T cd05630         125 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF  201 (285)
T ss_pred             eCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998865332211   12235788999999998889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      ..............              .. .......+..++.++.+|+.+||+.||.+|||     +.++++|
T Consensus       202 ~~~~~~~~~~~~~~--------------~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         202 QQRKKKIKREEVER--------------LV-KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             CCCCccchHHHHHh--------------hh-hhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            75432211111111              00 00111234456778999999999999999999     8899864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-35  Score=248.92  Aligned_cols=207  Identities=24%  Similarity=0.374  Sum_probs=168.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++.+..+...++|+||+.+++|.+++...   .+++..+..++.|++.||.|||  +.|++
T Consensus        64 ~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH--~~gi~  138 (296)
T cd06654          64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVI  138 (296)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            568999999999999999999999999999999999999999988644   4788999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       139 H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf  216 (296)
T cd06654         139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY  216 (296)
T ss_pred             cCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999988653322111  12235678899999998888899999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ............                ..........+..++..+.++|.+||..+|++||++.+++.+
T Consensus       217 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         217 LNENPLRALYLI----------------ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCHHHhHHHH----------------hcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            654321110000                000111122345577889999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=6.1e-35  Score=240.25  Aligned_cols=207  Identities=31%  Similarity=0.480  Sum_probs=168.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+++.++||||+++++.+..+ ..++++||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus        46 ~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~~~  122 (254)
T cd05083          46 FLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE--SKKLV  122 (254)
T ss_pred             HHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            67899999999999999999998764 5799999999999999997765556899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........     .......|.|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       123 H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  197 (254)
T cd05083         123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVD-----NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP  197 (254)
T ss_pred             ccccCcceEEEcCCCcEEECCCccceeccccCC-----CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998865322111     1223457999999988889999999999999999997 8999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      |.........                  ...........+..++..+.+++.+||+.+|++||++.++++.|+.
T Consensus       198 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         198 YPKMSLKEVK------------------ECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CccCCHHHHH------------------HHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            8654321111                  1111112222344567889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=7.7e-36  Score=259.25  Aligned_cols=221  Identities=24%  Similarity=0.335  Sum_probs=174.9

Q ss_pred             HHHHHHHhccC-C-----ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            3 QTEVIYLGQLR-H-----ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         3 ~~E~~~l~~l~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      ..|+.||..++ |     -|+|+++++|...++.|||+|.+ +.+|.++++.+...+++...+..++.||+.||.+||  
T Consensus       230 ~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~--  306 (586)
T KOG0667|consen  230 QIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH--  306 (586)
T ss_pred             HHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            46889999996 3     49999999999999999999998 679999999998889999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCC--ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                      +.+|+|+||||+||++..-+  .|||+|||.++.......     ....+..|+|||++.|..|+.+.||||||||++||
T Consensus       307 ~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL  381 (586)
T KOG0667|consen  307 ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAEL  381 (586)
T ss_pred             hCCeeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhH
Confidence            99999999999999996543  599999999986433222     45678899999999999999999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccc--------------h----------hH--------HHHHH-----hhhccC-
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLR--------------D----------SR--------RVLRI-----MDTRLG-  196 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~--------------~----------~~--------~~~~~-----~~~~~~-  196 (278)
                      ++|.+.|.+.+...+...|.+.......              .          ..        .....     .....+ 
T Consensus       382 ~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~  461 (586)
T KOG0667|consen  382 FTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPP  461 (586)
T ss_pred             hcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCC
Confidence            9999999887766555544433221100              0          00        00000     000000 


Q ss_pred             ------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          197 ------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       197 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                            ..........+.+||++||..||.+|+|+.++++|
T Consensus       462 ~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~H  502 (586)
T KOG0667|consen  462 GSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNH  502 (586)
T ss_pred             CCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                  00112456788999999999999999999999976

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=242.51  Aligned_cols=211  Identities=25%  Similarity=0.359  Sum_probs=169.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++.+.+.+..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        47 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh--~~~i~  123 (262)
T cd06613          47 IQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLH--ETGKI  123 (262)
T ss_pred             HHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCce
Confidence            5789999999999999999999999999999999999999999887652 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC---CCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+.   .++.++|+||||+++++|++|.
T Consensus       124 h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~  201 (262)
T cd06613         124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ  201 (262)
T ss_pred             ecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCC
Confidence            999999999999999999999999875433211  11223567789999998776   7889999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||................             . ..........++.++.+++.+||+.+|.+|||+.+++.+
T Consensus       202 ~p~~~~~~~~~~~~~~~~~-------------~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         202 PPMFDLHPMRALFLISKSN-------------F-PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             CCCCCCCHHHHHHHHHhcc-------------C-CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9996543211111111000             0 000111234567889999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3e-35  Score=245.76  Aligned_cols=210  Identities=22%  Similarity=0.326  Sum_probs=167.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++.+...+..++++||+.+++|..++.+.. ..+++..+..++.|++.||.|||  +.|++
T Consensus        49 ~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH--~~~i~  125 (282)
T cd06643          49 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLH--ENKII  125 (282)
T ss_pred             HHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5689999999999999999999999999999999999999988876533 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~  156 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.     +..++.++|+||||+++|+|++
T Consensus       126 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~  203 (282)
T cd06643         126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ  203 (282)
T ss_pred             ecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence            999999999999999999999999865432211  112235678899999873     3457789999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |+.||...+.......+...                .......+..++.++.++|.+||+.||.+||++.+++++-
T Consensus       204 g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         204 IEPPHHELNPMRVLLKIAKS----------------EPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             CCCCccccCHHHHHHHHhhc----------------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            99998653321111111000                0011123445678899999999999999999999998653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-35  Score=244.28  Aligned_cols=205  Identities=26%  Similarity=0.370  Sum_probs=169.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|+||+++++++.++...++++||+.+++|.+++...   .+++..+..++.|++.|+.|||  +.+++
T Consensus        46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh--~~~i~  120 (274)
T cd06609          46 IQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH--EEGKI  120 (274)
T ss_pred             HHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            568999999999999999999999999999999999999999998754   6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       121 h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~  198 (274)
T cd06609         121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL  198 (274)
T ss_pred             cCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            999999999999999999999999876543321  122235677899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+.....                  ..+........+.. ++..+.+++.+||..+|++||++++++++
T Consensus       199 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         199 SDLHPMRVL------------------FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ccCchHHHH------------------HHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            654321111                  11111112222333 77889999999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-35  Score=247.88  Aligned_cols=225  Identities=23%  Similarity=0.234  Sum_probs=166.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.++++++||||+++++++.+++..++|+||+. ++|.+++..... ..+++..+..++.|++.||.|||  +.|+
T Consensus        46 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i  122 (285)
T cd07861          46 AIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--SRRV  122 (285)
T ss_pred             HHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            5689999999999999999999999999999999996 688888765432 46899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      +|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+. .++.++|+||||+++++|++|+.
T Consensus       123 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~  200 (285)
T cd07861         123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP  200 (285)
T ss_pred             eecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence            9999999999999999999999999865432211  11223456789999987654 57889999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccc----hhHHHHHH---hhh---ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLR----DSRRVLRI---MDT---RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ||.....................    ........   ...   .........++.++.++|.+||+.||.+|||+.+++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll  280 (285)
T cd07861         201 LFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL  280 (285)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence            99754332221111111100000    00000000   000   000011234678899999999999999999999998


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      ++
T Consensus       281 ~~  282 (285)
T cd07861         281 NH  282 (285)
T ss_pred             cC
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.6e-35  Score=243.92  Aligned_cols=209  Identities=31%  Similarity=0.443  Sum_probs=170.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++++.+.+..++++||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +.+++
T Consensus        49 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~  124 (265)
T cd06631          49 LQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLH--NNCVV  124 (265)
T ss_pred             HHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            5789999999999999999999999999999999999999999997654  5889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC----CccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN----THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |+||+|+||+++.++.++|+|||.+........    ........++..|+|||.+.+..++.++|+||||++++++++|
T Consensus       125 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g  204 (265)
T cd06631         125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG  204 (265)
T ss_pred             cCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhC
Confidence            999999999999999999999998865322111    1111223567889999999888899999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhh-ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT-RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||...+.....                 ...... ....+.+..++.++.++|.+||+.+|.+||++.+++++
T Consensus       205 ~~p~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         205 KPPLASMDRLAAM-----------------FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCccccCChHHHH-----------------HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            9999643221110                 000000 11233455678899999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-35  Score=253.12  Aligned_cols=209  Identities=24%  Similarity=0.326  Sum_probs=167.2

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|+..|.+| .|.+||+++|+-..++.+|+||||- ..+|...+..+.. .++...+..+..|++.++.++|  ..||
T Consensus       406 y~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH--~~gI  481 (677)
T KOG0596|consen  406 YRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIH--QHGI  481 (677)
T ss_pred             HHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHH--Hhce
Confidence            68999999999 5899999999999999999999975 6799999987753 3444488899999999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-----------CCCCccchhHHHH
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----------HLTPKSDVYSFGV  149 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~DiwslG~  149 (278)
                      ||.||||.|+++ ..|.+||+|||++..............-+|++.|++||.+...           ..+.++|||||||
T Consensus       482 VHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGC  560 (677)
T KOG0596|consen  482 VHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGC  560 (677)
T ss_pred             eecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhh
Confidence            999999999988 5679999999999877666555555556899999999998542           2567899999999


Q ss_pred             HHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHH-HHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          150 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKE-AQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       150 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      |+|+|+.|+.||....                .....+..+....-..+++..- ..++.++++.||+.||++||++.++
T Consensus       561 ILYqMvYgktPf~~~~----------------n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eL  624 (677)
T KOG0596|consen  561 ILYQMVYGKTPFGQII----------------NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPEL  624 (677)
T ss_pred             HHHHHHhcCCchHHHH----------------HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHH
Confidence            9999999999996422                1222233333333323333221 1239999999999999999999999


Q ss_pred             HHH
Q 023752          229 LTS  231 (278)
Q Consensus       229 l~~  231 (278)
                      |+|
T Consensus       625 Lqh  627 (677)
T KOG0596|consen  625 LQH  627 (677)
T ss_pred             hcC
Confidence            974

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4.2e-35  Score=243.25  Aligned_cols=216  Identities=29%  Similarity=0.373  Sum_probs=162.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---QPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      |.+|+++++.++|+||+++++.+.+.+..++|+||+.+++|.+++.....   ...++..+..++.|++.||.|||  +.
T Consensus        42 ~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~  119 (269)
T cd05042          42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH--QA  119 (269)
T ss_pred             HHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH--hc
Confidence            57899999999999999999999999999999999999999999876432   23467788899999999999999  89


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-------CCCCCccchhHHHHHH
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVL  151 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~il  151 (278)
                      +++|+||+|.||+++.++.++|+|||++................++..|+|||+...       ..++.++|+|||||++
T Consensus       120 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  199 (269)
T cd05042         120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM  199 (269)
T ss_pred             CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence            999999999999999999999999998864322211111111234567999998742       3567899999999999


Q ss_pred             HHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          152 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       152 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |+|++ |..||.................             ........+..++..+.+++..|+ .||++|||+.+|++
T Consensus       200 ~el~~~~~~p~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         200 WELFTAADQPYPDLSDEQVLKQVVREQD-------------IKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHHHhCCCCCCCcCCHHHHHHHHhhccC-------------ccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            99999 7788864432111111000000             000112233456778888999998 59999999999998


Q ss_pred             HHH
Q 023752          231 SLE  233 (278)
Q Consensus       231 ~l~  233 (278)
                      .|.
T Consensus       266 ~l~  268 (269)
T cd05042         266 LLT  268 (269)
T ss_pred             Hhc
Confidence            763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.2e-35  Score=241.39  Aligned_cols=208  Identities=24%  Similarity=0.351  Sum_probs=171.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++.+.+.+..++|+||+.+++|.+++.......+++..+..++.|++.|+.|||  +.+++
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~  123 (256)
T cd08218          46 SRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--DRKIL  123 (256)
T ss_pred             HHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            5689999999999999999999999999999999999999999887654446889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||.+.........  .....++..|+|||.+.+..++.++|+||||++++++++|..||
T Consensus       124 h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~  201 (256)
T cd08218         124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF  201 (256)
T ss_pred             cCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCc
Confidence            9999999999999999999999988754332211  12234677899999998888899999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+....                 .... ......+.+...+..+.++|.+||+.+|++||++.+++++
T Consensus       202 ~~~~~~~~-----------------~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         202 EAGNMKNL-----------------VLKI-IRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCCCHHHH-----------------HHHH-hcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            64321111                 1111 1112233455678889999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=245.65  Aligned_cols=209  Identities=25%  Similarity=0.371  Sum_probs=167.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++|+||+++++++..+...++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh--~~~i~  125 (280)
T cd06611          49 FMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH--SHKVI  125 (280)
T ss_pred             HHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5689999999999999999999999999999999999999999887644 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~  156 (278)
                      |+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.     +..++.++|+||||+++|++++
T Consensus       126 h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~  203 (280)
T cd06611         126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ  203 (280)
T ss_pred             cCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHh
Confidence            999999999999999999999998765432211  112245677899999874     3457789999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||...........+...                .......+..++.++.++|.+||+.+|.+||++.+++++
T Consensus       204 g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         204 MEPPHHELNPMRVLLKILKS----------------EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCCcccCCHHHHHHHHhcC----------------CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            99999754321111111000                000112244567789999999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=5.9e-35  Score=244.47  Aligned_cols=210  Identities=27%  Similarity=0.381  Sum_probs=170.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|++|+++.+.+..++..++++||+.+++|.+.+.......+++..+..++.|++.||.|||  +.|++
T Consensus        47 ~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~ii  124 (285)
T cd05632          47 ALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH--RENTV  124 (285)
T ss_pred             HHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5679999999999999999999999999999999999999998886655456999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|.||+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       125 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~  201 (285)
T cd05632         125 YRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF  201 (285)
T ss_pred             ecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998865332211   12235788999999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      ...........+..              .+ ......++..++..+.+|+.+||+.||++||+     +.+++.+
T Consensus       202 ~~~~~~~~~~~~~~--------------~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         202 RGRKEKVKREEVDR--------------RV-LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CCCCHHHHHHHHHH--------------hh-hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            75432211111111              00 00112234556778999999999999999999     7788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-35  Score=260.51  Aligned_cols=226  Identities=23%  Similarity=0.259  Sum_probs=166.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++|+||+++++++...+..+++++++ .++|.+++.... ..+++..+..++.|++.||.|||  +.||+
T Consensus       207 ~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~gIv  282 (461)
T PHA03211        207 SVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH--GEGII  282 (461)
T ss_pred             HHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence            468999999999999999999999999999999999 468888886543 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++|..++
T Consensus       283 HrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l  362 (461)
T PHA03211        283 HRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL  362 (461)
T ss_pred             ECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence            99999999999999999999999987543322222222345789999999999999999999999999999999987655


Q ss_pred             ccccCC--------chhhhHHhhhcc---ccch-hHHHHHHhh----hccCC----CCC---HHHHHHHHHHHHHhccCC
Q 023752          162 DEDRGG--------LAEQTLVEWADP---FLRD-SRRVLRIMD----TRLGG----QYS---KKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       162 ~~~~~~--------~~~~~~~~~~~~---~~~~-~~~~~~~~~----~~~~~----~~~---~~~~~~l~~li~~~l~~d  218 (278)
                      ......        .....+......   +... .........    .....    ..+   ...+..+.+||.+||+.|
T Consensus       363 f~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~D  442 (461)
T PHA03211        363 FSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFD  442 (461)
T ss_pred             ccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccC
Confidence            322111        111111111100   0000 000000000    00000    001   134568899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 023752          219 PKNRPSMVDVLTS  231 (278)
Q Consensus       219 p~~Rps~~~ll~~  231 (278)
                      |.+|||+.|+|+|
T Consensus       443 P~~RPsa~elL~h  455 (461)
T PHA03211        443 GARRPSAAELLRL  455 (461)
T ss_pred             hhhCcCHHHHhhC
Confidence            9999999999986

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8e-35  Score=243.40  Aligned_cols=229  Identities=24%  Similarity=0.374  Sum_probs=171.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|++++++++||||+++++++...  ...++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|
T Consensus        52 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH--~~~  128 (284)
T cd05081          52 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG--SKR  128 (284)
T ss_pred             HHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            57899999999999999999987543  46789999999999999986543 35889999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccc-cccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++............ ........|+|||.+.+..++.++|+||||+++++|++|.
T Consensus       129 i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~  208 (284)
T cd05081         129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYS  208 (284)
T ss_pred             ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcC
Confidence            999999999999999999999999998765432221111 1112334589999998888999999999999999999987


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      .++........ ..+...... ..........+......+.+..++.++.++|.+||..+|++|||+.+|++.|+.+
T Consensus       209 ~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         209 DKSCSPPAEFM-RMMGNDKQG-QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             CcCCCcchhhh-hhccccccc-ccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            76543221110 000000000 0001111122222223334456778999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.3e-35  Score=252.53  Aligned_cols=221  Identities=24%  Similarity=0.336  Sum_probs=163.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++.++||||+++++++...+      ..|+|+||+.+ +|.+.+..    .++...+..++.|++.||.||| 
T Consensus        67 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH-  140 (359)
T cd07876          67 AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLH-  140 (359)
T ss_pred             HHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHH-
Confidence            468999999999999999999986543      46999999954 66666532    4788899999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                       +.|++|+||+|+||+++.++.++|+|||++......   .......++..|+|||.+.+..++.++|+|||||++|+|+
T Consensus       141 -~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  216 (359)
T cd07876         141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELV  216 (359)
T ss_pred             -hCCcccCCCCHHHEEECCCCCEEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHH
Confidence             899999999999999999999999999998653221   1122245688899999999999999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccch-hHHH----HHHhhhc------------------cCCCCCHHHHHHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRD-SRRV----LRIMDTR------------------LGGQYSKKEAQAVAAVVL  212 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~------------------~~~~~~~~~~~~l~~li~  212 (278)
                      +|..||...+.......+.......... ....    .......                  .........+.++.+||.
T Consensus       217 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  296 (359)
T cd07876         217 KGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLS  296 (359)
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHH
Confidence            9999997654322222211111111000 0000    0000000                  000111234678899999


Q ss_pred             HhccCCCCCCCCHHHHHHHH
Q 023752          213 QCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       213 ~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +||+.||++|||+.|++.|-
T Consensus       297 ~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         297 KMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHhccCcccCCCHHHHhcCc
Confidence            99999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.3e-35  Score=247.29  Aligned_cols=207  Identities=25%  Similarity=0.395  Sum_probs=168.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++++...+..++|+||+.+++|.+++...   .+++..+..++.+++.||.|||  +.|++
T Consensus        63 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~~i~  137 (296)
T cd06655          63 IINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLH--ANQVI  137 (296)
T ss_pred             HHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            568999999999999999999999999999999999999999988654   4899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       138 H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf  215 (296)
T cd06655         138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY  215 (296)
T ss_pred             cCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999987654332211  12234677899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+.......+..                ........+..++..+.++|.+||..||.+||++.+++.+
T Consensus       216 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         216 LNENPLRALYLIAT----------------NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             CCCCHHHHHHHHHh----------------cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            65432111110000                0001122344567889999999999999999999999954

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.7e-35  Score=251.99  Aligned_cols=204  Identities=28%  Similarity=0.415  Sum_probs=165.8

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      ..|..++..+ +|++|+++++.+.+.+..++||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~iv  123 (323)
T cd05616          48 MVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH--SKGII  123 (323)
T ss_pred             HHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence            4567777766 58999999999999999999999999999999887654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||
T Consensus       124 HrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf  201 (323)
T cd05616         124 YRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF  201 (323)
T ss_pred             ecCCCHHHeEECCCCcEEEccCCCceecCCCCC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCC
Confidence            999999999999999999999999864322111  112345788999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  231 (278)
                      ...+.......+..                   ....++...+.++.+++.+||+.||.+|++.     .+++++
T Consensus       202 ~~~~~~~~~~~i~~-------------------~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         202 EGEDEDELFQSIME-------------------HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             CCCCHHHHHHHHHh-------------------CCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            75433211111111                   1233455678899999999999999999974     666654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.8e-35  Score=256.03  Aligned_cols=207  Identities=23%  Similarity=0.269  Sum_probs=165.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++.+.+++..|+||||+.+|+|.+++...   .+++..+..++.||+.||.|||  +.|++
T Consensus        90 ~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH--~~~Iv  164 (370)
T cd05621          90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH--SMGLI  164 (370)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            568999999999999999999999999999999999999999998654   4888999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC----CCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~il~~l~~g  157 (278)
                      ||||||+||+++.++.+||+|||++......... ......+++.|+|||++.+.    .++.++|+|||||++|+|++|
T Consensus       165 HrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G  243 (370)
T cd05621         165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG  243 (370)
T ss_pred             ecCCCHHHEEECCCCCEEEEecccceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhC
Confidence            9999999999999999999999998764322211 11234688999999998654    377899999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhc--cCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR--LGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~  231 (278)
                      ..||...+......                 .+....  ...+....++..+.++|.+||+.++..  |+++.++++|
T Consensus       244 ~~Pf~~~~~~~~~~-----------------~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         244 DTPFYADSLVGTYS-----------------KIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCCCCCCCHHHHHH-----------------HHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            99997543211111                 111111  111222346888999999999855543  8899999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.4e-35  Score=241.80  Aligned_cols=216  Identities=27%  Similarity=0.352  Sum_probs=162.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---VQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      |.+|+.++++++||||+++++.+.+....++|+||+.+++|.+++....   ....+...+..++.|++.|+.|||  +.
T Consensus        42 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~  119 (269)
T cd05087          42 FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--KN  119 (269)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HC
Confidence            5679999999999999999999999889999999999999999986532   124566777889999999999999  89


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-------CCCCccchhHHHHHH
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-------HLTPKSDVYSFGVVL  151 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-------~~~~~~DiwslG~il  151 (278)
                      +++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+.       .++.++|+||||+++
T Consensus       120 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  199 (269)
T cd05087         120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI  199 (269)
T ss_pred             CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence            9999999999999999999999999998643222111111123456779999988542       357899999999999


Q ss_pred             HHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          152 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       152 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |++++ |..||..............             ...............+..+.+++..|+ .+|++|||+.+|+.
T Consensus       200 ~el~~~g~~p~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         200 WELFELGSQPYRHLSDEQVLTYTVR-------------EQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             HHHHhCCCCCCCCCChHHHHHHHhh-------------cccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            99996 9999965432111110000             000000111222345677899999998 58999999999998


Q ss_pred             HHH
Q 023752          231 SLE  233 (278)
Q Consensus       231 ~l~  233 (278)
                      .|+
T Consensus       266 ~l~  268 (269)
T cd05087         266 LLS  268 (269)
T ss_pred             Hhc
Confidence            775

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.6e-35  Score=247.66  Aligned_cols=224  Identities=22%  Similarity=0.309  Sum_probs=167.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++++..++..++|+||+. ++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        51 ~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH--~~~i~  126 (301)
T cd07873          51 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH--RRKVL  126 (301)
T ss_pred             HHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            4689999999999999999999999999999999996 58988886553 35889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus       127 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~  204 (301)
T cd07873         127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPL  204 (301)
T ss_pred             CCCCCHHHEEECCCCcEEECcCcchhccCCCCCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998653322111  1123457789999987654 578899999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccch-hHHHHH---Hhh---hccC----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRD-SRRVLR---IMD---TRLG----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~---~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |...+.......+.......... ......   ...   ....    ......++..+.+||.+||+.||.+|||+.+++
T Consensus       205 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil  284 (301)
T cd07873         205 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM  284 (301)
T ss_pred             CCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence            97654433322222221111110 000000   000   0000    011234577899999999999999999999999


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      +|
T Consensus       285 ~h  286 (301)
T cd07873         285 KH  286 (301)
T ss_pred             cC
Confidence            74

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9.8e-35  Score=240.27  Aligned_cols=202  Identities=25%  Similarity=0.427  Sum_probs=160.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+++.++||||+++++++..+...++++||+.+++|..++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        51 ~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~iv  127 (262)
T cd05077          51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE--DKDLV  127 (262)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh--hCCeE
Confidence            5678899999999999999999999899999999999999988876543 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCc-------eEEeccccccCCCCCCCCccccccccCCcccCccccc-cCCCCCccchhHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFN-------AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~-------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~il~~  153 (278)
                      |+||+|+||+++.++.       ++++|||++.......      ...++..|+|||.+. +..++.++||||||+++|+
T Consensus       128 H~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~e  201 (262)
T cd05077         128 HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE  201 (262)
T ss_pred             CCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHH
Confidence            9999999999976654       8999999886532221      123567799999886 4678899999999999999


Q ss_pred             HH-hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LL-SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |+ +|..||.........                  .....  ........+.++.++|.+||+.||.+||++.+|++++
T Consensus       202 l~~~~~~p~~~~~~~~~~------------------~~~~~--~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         202 ICYNGEIPLKDKTLAEKE------------------RFYEG--QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             HHhCCCCCCCCcchhHHH------------------HHHhc--CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            98 577887543211110                  00000  0111223456789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.1e-35  Score=240.91  Aligned_cols=202  Identities=26%  Similarity=0.402  Sum_probs=162.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+++.++||||+++++++..+...++||||+.+++|.+++..++. .+++..+..++.|++.||.|||  +.|++
T Consensus        46 ~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH--~~~ii  122 (258)
T cd05078          46 FFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLE--DKGLT  122 (258)
T ss_pred             HHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            56789999999999999999999998999999999999999999876542 5889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCc--------eEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFN--------AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~  152 (278)
                      |+||+|+||+++.++.        ++++|||.+......      ....++..|+|||.+.+ ..++.++|+||||+++|
T Consensus       123 H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~  196 (258)
T cd05078         123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLW  196 (258)
T ss_pred             cCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence            9999999999987664        689999987643221      12345678999999876 45788999999999999


Q ss_pred             HHHhCC-CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          153 ELLSGR-RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       153 ~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++++|. .||........                  ......  ....+...+.++.++|.+||+.||++|||+.++++.
T Consensus       197 ~l~~g~~~~~~~~~~~~~------------------~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         197 EIFSGGDKPLSALDSQKK------------------LQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHcCCCCChhhccHHHH------------------HHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            999985 55543221100                  011111  123344456789999999999999999999999987


Q ss_pred             H
Q 023752          232 L  232 (278)
Q Consensus       232 l  232 (278)
                      |
T Consensus       257 l  257 (258)
T cd05078         257 L  257 (258)
T ss_pred             c
Confidence            6

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1e-34  Score=241.96  Aligned_cols=206  Identities=24%  Similarity=0.352  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+++.+.|+||+++++.+.+++..++|+||+.+++|.+++..+   .+++..+..++.|++.||.|||  +.+++
T Consensus        49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh--~~~iv  123 (277)
T cd06640          49 IQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLH--SEKKI  123 (277)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            578999999999999999999999999999999999999999988643   5888999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++++|||++........  ......++..|.|||.+.+..++.++|+||||+++|++++|..||
T Consensus       124 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~  201 (277)
T cd06640         124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN  201 (277)
T ss_pred             CcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999999999999865433221  112234667899999998888999999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .........                  ...........+..++..+.++|.+||+.+|++||++.+++++-
T Consensus       202 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         202 SDMHPMRVL------------------FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             CCcChHhHh------------------hhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence            654321111                  11111122344567888999999999999999999999999773

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7e-35  Score=243.01  Aligned_cols=210  Identities=27%  Similarity=0.389  Sum_probs=170.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++.+...+..|+|+||+.+++|.+++.+.....+++..+..++.|++.||.|||  ..|++
T Consensus        40 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH--~~~i~  117 (277)
T cd05577          40 ALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH--QRRIV  117 (277)
T ss_pred             HHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            4679999999999999999999999999999999999999999997765557899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||.+.......   ......++..|.|||.+.+..++.++|+||||+++|++++|..||
T Consensus       118 H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  194 (277)
T cd05577         118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF  194 (277)
T ss_pred             cCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCC
Confidence            99999999999999999999999886543211   112234567899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...........+....               .......+...+..+.++|.+||+.||.+||     ++.+++.|
T Consensus       195 ~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         195 RQRKEKVEKEELKRRT---------------LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CCCcccccHHHHHhcc---------------ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            7544321111111100               0112334455688999999999999999999     77778753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.9e-35  Score=245.70  Aligned_cols=223  Identities=26%  Similarity=0.334  Sum_probs=165.1

Q ss_pred             HHHHHHHhcc---CCccccceeeeeecC-----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            3 QTEVIYLGQL---RHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         3 ~~E~~~l~~l---~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      .+|+.+++.+   +||||+++++++...     ...++++|++. ++|.+++.......+++..+..++.|++.||.|||
T Consensus        47 ~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH  125 (288)
T cd07863          47 VREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH  125 (288)
T ss_pred             HHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4677777665   799999999988643     35789999996 58988887665556899999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                        +.|++|+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|+|||||++|+|
T Consensus       126 --~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l  200 (288)
T cd07863         126 --ANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM  200 (288)
T ss_pred             --hCCeecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHH
Confidence              89999999999999999999999999999875433221   1223567889999999888899999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccc-hhHHHHHH----hhhccC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLR-DSRRVLRI----MDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      ++|..||...........+......... ........    ......   ......++..+.++|.+||+.||++|||+.
T Consensus       201 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~  280 (288)
T cd07863         201 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAF  280 (288)
T ss_pred             HhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHH
Confidence            9999999765443333222221111000 00000000    000000   011234577889999999999999999999


Q ss_pred             HHHHH
Q 023752          227 DVLTS  231 (278)
Q Consensus       227 ~ll~~  231 (278)
                      +++.|
T Consensus       281 ~~l~h  285 (288)
T cd07863         281 RALQH  285 (288)
T ss_pred             HHhcC
Confidence            99864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=6.3e-35  Score=243.23  Aligned_cols=206  Identities=25%  Similarity=0.360  Sum_probs=169.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++.+..++..++|+||+.+++|.+++..+   .+++..+..++.+++.|+.|||  ..|++
T Consensus        49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH--~~~iv  123 (277)
T cd06642          49 IQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG---PLEETYIATILREILKGLDYLH--SERKI  123 (277)
T ss_pred             HHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHh--cCCee
Confidence            678999999999999999999999999999999999999999988643   5889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++++|||++........  ......++..|+|||.+.+..++.++|+||||++++++++|..||
T Consensus       124 H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~  201 (277)
T cd06642         124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN  201 (277)
T ss_pred             ccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999865433211  112234677899999998888999999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ..........                  .............++..+.++|.+||+.+|++||++.+++++-
T Consensus       202 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         202 SDLHPMRVLF------------------LIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             cccchhhHHh------------------hhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            6433211111                  1111112233445678899999999999999999999999863

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9e-35  Score=239.26  Aligned_cols=207  Identities=25%  Similarity=0.396  Sum_probs=170.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++.+...+..++|+||+.+++|.+++.......+++..+..++.+++.++.|||  +.|++
T Consensus        46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~  123 (256)
T cd08220          46 AQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH--TKLIL  123 (256)
T ss_pred             HHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            6789999999999999999999999899999999999999999997765456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++ .++|+|||.+.........   ....++..|+|||.+.+..++.++|+||||++++++++|..|
T Consensus       124 h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~  200 (256)
T cd08220         124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRA  200 (256)
T ss_pred             cCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCC
Confidence            999999999998654 5799999998765433211   123467789999999888889999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |...+......                 . .........+..++..+.+++.+||+.+|++|||+.+++.+
T Consensus       201 ~~~~~~~~~~~-----------------~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         201 FEAANLPALVL-----------------K-IMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             cccCchHHHHH-----------------H-HHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            96543211111                 1 11111223345578889999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.2e-35  Score=241.15  Aligned_cols=212  Identities=24%  Similarity=0.461  Sum_probs=172.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++|+||+++++++.+.+..++|+||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +.|++
T Consensus        50 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH--~~~i~  125 (268)
T cd06630          50 LRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLH--ENQII  125 (268)
T ss_pred             HHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999999999999987654  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC-ceEEeccccccCCCCCCCC--ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|.||+++.++ .++|+|||.+.........  .......++..|+|||.+.+..++.++|+||||++++++++|.
T Consensus       126 H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~  205 (268)
T cd06630         126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK  205 (268)
T ss_pred             cCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCC
Confidence            999999999998776 5999999998765443211  1112235677899999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||...........              .............+..++.++.+++.+||+.+|++||++.+++++
T Consensus       206 ~p~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         206 PPWNAEKHSNHLAL--------------IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             CCCCCCCCcchHHH--------------HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            99964332111111              111111122344566788999999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.9e-35  Score=242.10  Aligned_cols=210  Identities=28%  Similarity=0.397  Sum_probs=169.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i   80 (278)
                      +.+|++++++++||||+++++.+..++..++++|++.+++|.+++.... ..+++..+..++.|++.++.|||  + .|+
T Consensus        46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~i  122 (265)
T cd06605          46 ILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH--EKHKI  122 (265)
T ss_pred             HHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc--CCCCe
Confidence            5789999999999999999999999999999999999999999987653 47899999999999999999999  7 999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||.+.........    ...++..|+|||.+.+..++.++|+||||++++++++|..|
T Consensus       123 ~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p  198 (265)
T cd06605         123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP  198 (265)
T ss_pred             ecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999987654222111    14567789999999888999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |........             .................+.. ++.++.++|.+||..||++|||+.+++.+
T Consensus       199 ~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         199 YPPENDPPD-------------GIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             CCccccccc-------------cHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            965432100             00001111111112223333 78889999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.1e-35  Score=245.44  Aligned_cols=202  Identities=28%  Similarity=0.418  Sum_probs=169.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH--~~~i~  123 (290)
T cd05580          48 VLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLH--SLDIV  123 (290)
T ss_pred             HHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            5679999999999999999999999999999999999999999997764  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|.||+++.++.++|+|||++......     .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       124 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  198 (290)
T cd05580         124 YRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF  198 (290)
T ss_pred             cCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998764333     12234678899999998888899999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...........                 ..  ......+...+..+.++|.+||+.||.+|+     ++++++.+
T Consensus       199 ~~~~~~~~~~~-----------------~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         199 FDDNPIQIYEK-----------------IL--EGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             CCCCHHHHHHH-----------------Hh--cCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            65432111111                 11  112334555688999999999999999998     77888754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.7e-35  Score=247.34  Aligned_cols=229  Identities=22%  Similarity=0.264  Sum_probs=171.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++++.+.+..++++||+.+++|.+++.......+++..+..++.|++.||.|||  +.+++
T Consensus        46 ~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH--~~~iv  123 (314)
T cd08216          46 LQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH--SKGFI  123 (314)
T ss_pred             HHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999998654456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC-----CccccccccCCcccCcccccc--CCCCCccchhHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN-----THVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l  154 (278)
                      |+||+|+||+++.++.++++||+.+........     ........++..|+|||.+.+  ..++.++|+||+|++++++
T Consensus       124 H~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el  203 (314)
T cd08216         124 HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL  203 (314)
T ss_pred             cCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHH
Confidence            999999999999999999999998764332211     111112345667999999865  3588899999999999999


Q ss_pred             HhCCCCCccccCCchh-hhHHhhhccccchhH--------------HHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCC
Q 023752          155 LSGRRALDEDRGGLAE-QTLVEWADPFLRDSR--------------RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP  219 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  219 (278)
                      ++|..||......... +.+............              .................++.++.+|+.+||+.||
T Consensus       204 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  283 (314)
T cd08216         204 ANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDP  283 (314)
T ss_pred             HhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCC
Confidence            9999999754322111 111100000000000              0000001111223345677899999999999999


Q ss_pred             CCCCCHHHHHHHH
Q 023752          220 KNRPSMVDVLTSL  232 (278)
Q Consensus       220 ~~Rps~~~ll~~l  232 (278)
                      ++|||+.+++++-
T Consensus       284 ~~Rpt~~~ll~~p  296 (314)
T cd08216         284 ESRPSASQLLNHS  296 (314)
T ss_pred             CcCcCHHHHhcCc
Confidence            9999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1e-35  Score=257.10  Aligned_cols=210  Identities=24%  Similarity=0.342  Sum_probs=166.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++.+++|++|+++++.+.+.+..|+||||+.|++|.+++.+..  .+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH--~~giv  123 (360)
T cd05627          48 IRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIH--QLGFI  123 (360)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            4679999999999999999999999999999999999999999997654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCC---------------------------------ccccccccCCccc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT---------------------------------HVSTRIVGTRGYA  128 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~---------------------------------~~~~~~~~~~~~~  128 (278)
                      |+||||+||+++.++.++|+|||++.........                                 .......+++.|+
T Consensus       124 HrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  203 (360)
T cd05627         124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI  203 (360)
T ss_pred             ccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCcccc
Confidence            9999999999999999999999998643221100                                 0011235788999


Q ss_pred             CccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHH
Q 023752          129 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVA  208 (278)
Q Consensus       129 aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  208 (278)
                      |||++.+..++.++|+|||||++|+|++|..||...........+..+..               ....+.....+.++.
T Consensus       204 APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~~~~s~~~~  268 (360)
T cd05627         204 APEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKE---------------TLVFPPEVPISEKAK  268 (360)
T ss_pred             CHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCC---------------ceecCCCCCCCHHHH
Confidence            99999999999999999999999999999999976543222222211110               000111123577899


Q ss_pred             HHHHHhccCCCCCCCC---HHHHHHH
Q 023752          209 AVVLQCLHMDPKNRPS---MVDVLTS  231 (278)
Q Consensus       209 ~li~~~l~~dp~~Rps---~~~ll~~  231 (278)
                      ++|.+|+. ||.+|++   +.++++|
T Consensus       269 ~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         269 DLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             HHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            99999875 9999984   7788866

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.4e-35  Score=248.30  Aligned_cols=227  Identities=19%  Similarity=0.259  Sum_probs=160.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcC-------CCCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKG-------VQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      +.+|++++++++||||+++++++...  ...++++||+ +++|.+++....       ...+++..+..++.|++.||.|
T Consensus        45 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  123 (317)
T cd07868          45 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY  123 (317)
T ss_pred             HHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHH
Confidence            46899999999999999999998653  4678999998 468888775321       1258899999999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEE----cCCCceEEeccccccCCCCCCCC-ccccccccCCcccCcccccc-CCCCCccchhH
Q 023752           73 LHGLDANVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYS  146 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~----~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Diws  146 (278)
                      ||  +.|++|+||||+||++    +.++.+||+|||++......... .......+++.|+|||++.+ ..++.++|+||
T Consensus       124 LH--~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  201 (317)
T cd07868         124 LH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA  201 (317)
T ss_pred             HH--hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHH
Confidence            99  8999999999999999    45678999999999765433211 11223457888999999876 45889999999


Q ss_pred             HHHHHHHHHhCCCCCccccCCchh---------hhHHh-hhccccchhHHH---------HHHhhhccC--CC-------
Q 023752          147 FGVVLLELLSGRRALDEDRGGLAE---------QTLVE-WADPFLRDSRRV---------LRIMDTRLG--GQ-------  198 (278)
Q Consensus       147 lG~il~~l~~g~~p~~~~~~~~~~---------~~~~~-~~~~~~~~~~~~---------~~~~~~~~~--~~-------  198 (278)
                      +||++|+|++|..||.........         ..+.. ...+........         .........  ..       
T Consensus       202 lG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (317)
T cd07868         202 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK  281 (317)
T ss_pred             HHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHh
Confidence            999999999999999754432111         01111 000100000000         000000000  00       


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          199 YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       199 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .....+..+.+||.+||+.||.+|||++|+++|
T Consensus       282 ~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         282 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             cCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            001123568899999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-34  Score=241.18  Aligned_cols=212  Identities=25%  Similarity=0.431  Sum_probs=169.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-------QPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      |.+|++++++++|+||+++++++.+.+..++++||+.+++|.+++.....       ..+++..+..++.|++.||.|||
T Consensus        55 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH  134 (275)
T cd05046          55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS  134 (275)
T ss_pred             HHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh
Confidence            67899999999999999999999998899999999999999999976542       15899999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                        +.+++|+||+|+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++|+||||+++|++
T Consensus       135 --~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l  211 (275)
T cd05046         135 --NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV  211 (275)
T ss_pred             --hcCcccCcCccceEEEeCCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHH
Confidence              899999999999999999999999999987643221111 11122345679999998888889999999999999999


Q ss_pred             Hh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          155 LS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       155 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      ++ |..||...........                 ..........+..++..+.+++.+||+.+|.+||++.+++..|.
T Consensus       212 ~~~~~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         212 FTQGELPFYGLSDEEVLNR-----------------LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HhCCCCCccccchHHHHHH-----------------HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            98 7788854332111111                 11111112233456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.9e-35  Score=255.31  Aligned_cols=224  Identities=25%  Similarity=0.358  Sum_probs=169.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+++++.++|+||+++++++...+     ..|+|+||+. ++|.+.+....  .+++..+..++.|++.||.|||  
T Consensus        46 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH--  120 (372)
T cd07853          46 VFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLH--  120 (372)
T ss_pred             HHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH--
Confidence            468999999999999999999998776     7899999995 68888776543  6899999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~  155 (278)
                      +.|++|+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++|+|||||++|+|+
T Consensus       121 ~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~  199 (372)
T cd07853         121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELL  199 (372)
T ss_pred             hCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHH
Confidence            89999999999999999999999999999875433221 112223567889999998764 5789999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhc-cccchhH----HHHHHhhh-ccCC-------CCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          156 SGRRALDEDRGGLAEQTLVEWAD-PFLRDSR----RVLRIMDT-RLGG-------QYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~-~~~~-------~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      +|+.||...+.......+.+... +......    .....+.. ....       ......+.++.+||.+||+.||.+|
T Consensus       200 ~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R  279 (372)
T cd07853         200 GRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKR  279 (372)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhC
Confidence            99999987655444443333221 1111100    00011100 0000       1123347789999999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      ||+.++++|
T Consensus       280 ~t~~e~l~h  288 (372)
T cd07853         280 ISAADALAH  288 (372)
T ss_pred             cCHHHHhcC
Confidence            999999976

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9.6e-35  Score=243.96  Aligned_cols=208  Identities=25%  Similarity=0.369  Sum_probs=165.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++.+..++..++||||+.+++|..++.+.. ..+++..+..++.|++.++.|||  +.+++
T Consensus        56 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH--~~~i~  132 (292)
T cd06644          56 YMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH--SMKII  132 (292)
T ss_pred             HHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh--cCCee
Confidence            5679999999999999999999999999999999999999988876543 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~  156 (278)
                      |+||+|+||+++.++.++|+|||.+.......  .......++..|+|||.+.     ...++.++|+||||+++|+|++
T Consensus       133 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~  210 (292)
T cd06644         133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ  210 (292)
T ss_pred             ecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc
Confidence            99999999999999999999999876432211  1112245677899999874     3457789999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhc-cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR-LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||........   ..              ...... .....+..++.++.++|.+||+.+|++||++.+++++
T Consensus       211 g~~p~~~~~~~~~---~~--------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         211 IEPPHHELNPMRV---LL--------------KIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             CCCCCccccHHHH---HH--------------HHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            9999865332111   11              110000 0112244567789999999999999999999999864

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-34  Score=238.59  Aligned_cols=209  Identities=31%  Similarity=0.477  Sum_probs=168.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++......++++||+.+++|.+++.... ..+++..+..++.+++.++.+||  +.+++
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~i~  122 (256)
T cd05112          46 FIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE--SSNVI  122 (256)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999999999999999999999999999887543 35789999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|.||+++.++.++|+|||.+......... .......+..|+|||.+.+..++.++|+||||+++|++++ |..|
T Consensus       123 h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p  201 (256)
T cd05112         123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTP  201 (256)
T ss_pred             ccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999988654322111 1111223467999999988889999999999999999998 8999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |.........+.+                  ........+...+..+.+++.+||+.+|++||++.++++.|
T Consensus       202 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         202 YENRSNSEVVETI------------------NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCcCCHHHHHHHH------------------hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            8654322111111                  11111122334567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-35  Score=253.01  Aligned_cols=194  Identities=27%  Similarity=0.387  Sum_probs=159.0

Q ss_pred             HHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 023752            8 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA   87 (278)
Q Consensus         8 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p   87 (278)
                      +++.++||||+++++.+...+..++||||+.+++|...+.+..  .+++..+..++.||+.||.|||  +.|++|+||||
T Consensus        49 ~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH--~~givH~Dlkp  124 (325)
T cd05604          49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLH--SINIVYRDLKP  124 (325)
T ss_pred             HHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeeecCCCH
Confidence            5677899999999999999999999999999999998887654  6899999999999999999999  89999999999


Q ss_pred             CceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCC
Q 023752           88 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG  167 (278)
Q Consensus        88 ~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~  167 (278)
                      +||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...+..
T Consensus       125 ~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~  202 (325)
T cd05604         125 ENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA  202 (325)
T ss_pred             HHeEECCCCCEEEeecCCcccCCCCCC--CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH
Confidence            999999999999999999864322111  122345788999999999989999999999999999999999999754321


Q ss_pred             chhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          168 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      .....                 ....  ........+..+.++|.+||+.+|.+||++.
T Consensus       203 ~~~~~-----------------~~~~--~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         203 EMYDN-----------------ILHK--PLVLRPGASLTAWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             HHHHH-----------------HHcC--CccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence            11111                 1111  1223345678899999999999999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=256.85  Aligned_cols=208  Identities=25%  Similarity=0.401  Sum_probs=173.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.-||+||..+.||+|+++++.|...+.+|++.|||.||.++..+..-+ ..+++.++..+++|++.||.|||  +..|+
T Consensus        76 ylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LH--s~~iI  152 (1187)
T KOG0579|consen   76 YLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLH--SQNII  152 (1187)
T ss_pred             hhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHh--hcchh
Confidence            4669999999999999999999999999999999999999999887766 47999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~  156 (278)
                      |||||..||+++-+|.++|+|||.+-....  .......+.|+++|+|||+..     +.+|+.++||||||+++.+|..
T Consensus       153 HRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq  230 (1187)
T KOG0579|consen  153 HRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ  230 (1187)
T ss_pred             hhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc
Confidence            999999999999999999999999864222  222234478999999999874     4689999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhcc-CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +.+|...-+.                 ...++.+..... ..-.|..-+..+.+|+.+||..||..||++.++++|
T Consensus       231 iEPPHhelnp-----------------MRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  231 IEPPHHELNP-----------------MRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cCCCccccch-----------------HHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            9998754332                 222222222111 122356778899999999999999999999999965

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-34  Score=244.43  Aligned_cols=215  Identities=24%  Similarity=0.393  Sum_probs=171.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+++.++||||+++++++... ..+++++++.+|+|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        56 ~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~iv  131 (303)
T cd05110          56 FMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE--ERRLV  131 (303)
T ss_pred             HHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh--hcCee
Confidence            56899999999999999999998754 5678999999999999987654 35888899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.+||+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |+.|
T Consensus       132 H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p  211 (303)
T cd05110         132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP  211 (303)
T ss_pred             ccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999976543222111112234567999999988899999999999999999997 8899


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.+......                  ...+......+.+...+..+.+++.+||..+|++||++.++++.|..+...
T Consensus       212 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         212 YDGIPTREI------------------PDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCCCCHHHH------------------HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            865321111                  111111122223344567899999999999999999999999999987655

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-34  Score=240.96  Aligned_cols=203  Identities=27%  Similarity=0.427  Sum_probs=160.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.++...++||||+++++|..++.+.. +.+++..+..++.|++.||.|||  +.+++
T Consensus        63 ~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~ii  139 (274)
T cd05076          63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLE--DKNLV  139 (274)
T ss_pred             HHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--cCCcc
Confidence            5678899999999999999999999999999999999999998886543 36889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC-------ceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNF-------NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        82 H~dl~p~ni~~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~  153 (278)
                      |+||+|.||+++..+       .++++|||.+......      ....++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus       140 H~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~e  213 (274)
T cd05076         140 HGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE  213 (274)
T ss_pred             CCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHH
Confidence            999999999997543       3799999987542221      11235677999998865 568899999999999999


Q ss_pred             HH-hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LL-SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ++ +|..||..........                  ....  ....+...+..+.++|.+||+.+|++|||+.++++.|
T Consensus       214 l~~~g~~p~~~~~~~~~~~------------------~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         214 ICFDGEVPLKERTPSEKER------------------FYEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHhCCCCCccccChHHHHH------------------HHHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            85 6888886543211100                  1111  1112223456789999999999999999999999987


Q ss_pred             H
Q 023752          233 E  233 (278)
Q Consensus       233 ~  233 (278)
                      .
T Consensus       274 ~  274 (274)
T cd05076         274 T  274 (274)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1e-34  Score=242.30  Aligned_cols=208  Identities=25%  Similarity=0.348  Sum_probs=164.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++.+...+..++++||+.+++|..+.      .+++..+..++.|++.||.|||  +.|++
T Consensus        46 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH--~~~i~  117 (279)
T cd06619          46 IMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW--SLKIL  117 (279)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            568999999999999999999999999999999999999986542      4788899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.......    .....++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       118 H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf  193 (279)
T cd06619         118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY  193 (279)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCc
Confidence            99999999999999999999999987543221    22245778899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...........          .....................+.++.++|.+||+.+|++||++.+++.+
T Consensus       194 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         194 PQIQKNQGSLM----------PLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             hhhcccccccc----------hHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            65322111000          0000001111111111123467789999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.2e-35  Score=258.32  Aligned_cols=223  Identities=22%  Similarity=0.330  Sum_probs=162.7

Q ss_pred             HHHHHHHhccCCccccceeeeeecC--------CccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHH
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSES--------DNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      .+|+.+++.++||||+++++++...        ..+++||||+. ++|.+++...  ....+++..+..++.|++.||.|
T Consensus       107 ~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~y  185 (440)
T PTZ00036        107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAY  185 (440)
T ss_pred             HHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            5799999999999999999887432        23578999996 5777766532  23468999999999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHH
Q 023752           73 LHGLDANVIYRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVV  150 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~i  150 (278)
                      ||  +.|++||||||+||+++.++ .+||+|||++........   .....+++.|+|||++.+. .++.++|+|||||+
T Consensus       186 LH--~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvi  260 (440)
T PTZ00036        186 IH--SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI  260 (440)
T ss_pred             HH--HCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHH
Confidence            99  89999999999999998665 699999999976433221   1124568889999987654 68999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhc-cccchhHHHHHHhh---------hccCCCCCHHHHHHHHHHHHHhccCCCC
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRDSRRVLRIMD---------TRLGGQYSKKEAQAVAAVVLQCLHMDPK  220 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~  220 (278)
                      +|+|++|.+||.+.........+..... +.............         ......++...+.++.+||.+||+.||.
T Consensus       261 l~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~  340 (440)
T PTZ00036        261 IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPL  340 (440)
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChh
Confidence            9999999999976554333333222211 11111000000000         0000112334567899999999999999


Q ss_pred             CCCCHHHHHHH
Q 023752          221 NRPSMVDVLTS  231 (278)
Q Consensus       221 ~Rps~~~ll~~  231 (278)
                      +|||+.++++|
T Consensus       341 ~R~ta~e~l~h  351 (440)
T PTZ00036        341 KRLNPIEALAD  351 (440)
T ss_pred             HCcCHHHHhCC
Confidence            99999999965

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.8e-35  Score=243.19  Aligned_cols=211  Identities=25%  Similarity=0.340  Sum_probs=166.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++...+..++|+||+.+++|.+++....  .+++..+..++.|++.|+.|||  +.|++
T Consensus        53 ~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~  128 (267)
T cd06646          53 IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLH--SKGKM  128 (267)
T ss_pred             HHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5689999999999999999999999999999999999999999887554  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.   ...++.++|+||+|+++|+|++|+
T Consensus       129 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~  206 (267)
T cd06646         129 HRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             ccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999999875432211  112234677899999874   345778999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .||...........+....   .           ..........++..+.++|.+||+.+|++||++.++++++
T Consensus       207 ~p~~~~~~~~~~~~~~~~~---~-----------~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         207 PPMFDLHPMRALFLMSKSN---F-----------QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCccccchhhhheeeecCC---C-----------CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            9986433211110000000   0           0000111234577899999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-34  Score=239.38  Aligned_cols=208  Identities=25%  Similarity=0.424  Sum_probs=165.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+.++++++||||+++++++.+.  ...++++||+.+++|.+++....  .+++..+..++.|++.||.|||  +.+
T Consensus        51 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH--~~~  126 (266)
T cd06651          51 LECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH--SNM  126 (266)
T ss_pred             HHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            56799999999999999999998764  46789999999999999987654  5889999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCC-CccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN-THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++|+||||+++|++++|+
T Consensus       127 i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~  206 (266)
T cd06651         127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK  206 (266)
T ss_pred             eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCC
Confidence            99999999999999999999999999865432211 11111234677899999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||......                 ...............+...+..+.+++ +||..+|++||+++++++|
T Consensus       207 ~pf~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         207 PPWAEYEAM-----------------AAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             CCccccchH-----------------HHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            999643211                 111111111122344566778889999 6777899999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.2e-34  Score=239.46  Aligned_cols=208  Identities=28%  Similarity=0.363  Sum_probs=171.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++.+.+++..++++||+.+++|.+++.+..  .++...+..++.|++.||.|||  +.+++
T Consensus        40 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH--~~~~~  115 (262)
T cd05572          40 IFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLH--NRGII  115 (262)
T ss_pred             HHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh--hCCcc
Confidence            6789999999999999999999999999999999999999999997654  5899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.......   ......++..|++||.+.+..++.++|+||||+++|++++|..||
T Consensus       116 h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  192 (262)
T cd05572         116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPF  192 (262)
T ss_pred             cCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCc
Confidence            99999999999999999999999987654332   112235677899999988888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      .....+.               ................+...+.++.++|.+||+.+|++||+     +.+++++
T Consensus       193 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         193 GEDDEDP---------------MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCCCCH---------------HHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            7544210               01111111112233445556889999999999999999999     8888863

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=246.22  Aligned_cols=211  Identities=25%  Similarity=0.312  Sum_probs=170.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|+||+++++.+.+....++++||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH--~~~i~  125 (316)
T cd05574          48 VLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH--LLGIV  125 (316)
T ss_pred             HHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5679999999999999999999999999999999999999999987655457899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc---------------------------cccccccCCcccCccccc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH---------------------------VSTRIVGTRGYAAPEYVA  134 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~---------------------------~~~~~~~~~~~~aPE~~~  134 (278)
                      |+||+|+||+++.++.++|+|||++..........                           ......++..|+|||.+.
T Consensus       126 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  205 (316)
T cd05574         126 YRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS  205 (316)
T ss_pred             ccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHc
Confidence            99999999999999999999999876433221100                           011235677899999998


Q ss_pred             cCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHh
Q 023752          135 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQC  214 (278)
Q Consensus       135 ~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  214 (278)
                      +..++.++|+||||+++|++++|..||...+.....                 ..........+.....+..+.++|.+|
T Consensus       206 ~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~li~~~  268 (316)
T cd05574         206 GDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETF-----------------SNILKKEVTFPGSPPVSSSARDLIRKL  268 (316)
T ss_pred             CCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHH-----------------HHHhcCCccCCCccccCHHHHHHHHHH
Confidence            888999999999999999999999999754432111                 111111111122223688999999999


Q ss_pred             ccCCCCCCCC----HHHHHHH
Q 023752          215 LHMDPKNRPS----MVDVLTS  231 (278)
Q Consensus       215 l~~dp~~Rps----~~~ll~~  231 (278)
                      |+.||++||+    +.+++.+
T Consensus       269 l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         269 LVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             ccCCHhHCCCchhhHHHHHcC
Confidence            9999999999    8888875

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-34  Score=241.68  Aligned_cols=228  Identities=27%  Similarity=0.406  Sum_probs=174.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeec--CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+++++.+.|+||+++++++..  ....++++||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|
T Consensus        53 ~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH--~~~  129 (284)
T cd05038          53 FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG--SQR  129 (284)
T ss_pred             HHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            6889999999999999999999887  457899999999999999997654 25899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccc-cccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|.||+++.++.++|+|||.+............ ....+...|.+||...+..++.++|+||||+++++|++|.
T Consensus       130 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~  209 (284)
T cd05038         130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYG  209 (284)
T ss_pred             eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccC
Confidence            999999999999999999999999998765432221111 1123345699999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      .|+......... ....  .............+......+.+..++.++.+++.+||+.+|++||++.+|++.|+.+
T Consensus       210 ~p~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         210 DPSQSPPAEFLR-MIGI--AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             CCcccccchhcc-cccc--ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            988543221110 0000  0000011111222222223333455678899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.1e-34  Score=240.50  Aligned_cols=210  Identities=25%  Similarity=0.347  Sum_probs=165.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++.+...+..++++||+.+++|.+++...+  .+++..+..++.|++.|+.|||  +.|++
T Consensus        53 ~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~  128 (267)
T cd06645          53 VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLH--SKGKM  128 (267)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5689999999999999999999999999999999999999999987665  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.   ...++.++|+|||||++|+|++|.
T Consensus       129 H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~  206 (267)
T cd06645         129 HRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ  206 (267)
T ss_pred             cCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCC
Confidence            999999999999999999999999865432211  112245778899999874   456888999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||................             .. .........++..+.++|.+||+.+|++||++.+++.+
T Consensus       207 ~p~~~~~~~~~~~~~~~~~-------------~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         207 PPMFDLHPMRALFLMTKSN-------------FQ-PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCcccccchhhHHhhhccC-------------CC-CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            9985433211110000000             00 00000112356678999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-34  Score=247.37  Aligned_cols=218  Identities=28%  Similarity=0.404  Sum_probs=169.3

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecC-CccEEEEeccCCCCHHHHHhhcC-----------------------------
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKG-----------------------------   50 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-----------------------------   50 (278)
                      +.+|+.++.++ +||||+++++++... ...++++||+.+|+|.+++....                             
T Consensus        57 ~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  136 (343)
T cd05103          57 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKR  136 (343)
T ss_pred             HHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhh
Confidence            46899999999 689999999988655 45789999999999999886432                             


Q ss_pred             ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcC
Q 023752           51 ------------------------------------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS   94 (278)
Q Consensus        51 ------------------------------------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~   94 (278)
                                                          ...++...+..++.|+++||.|||  +.|++|+||+|.||+++.
T Consensus       137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH--~~~i~H~dikp~Nil~~~  214 (343)
T cd05103         137 RLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSE  214 (343)
T ss_pred             hccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH--hCCeecCCCccCeEEEcC
Confidence                                                123677788899999999999999  899999999999999999


Q ss_pred             CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCCCccccCCchhhhH
Q 023752           95 NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTL  173 (278)
Q Consensus        95 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~  173 (278)
                      ++.++|+|||++................++..|+|||.+.+..++.++|+||||+++|++++ |..||.......     
T Consensus       215 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----  289 (343)
T cd05103         215 NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----  289 (343)
T ss_pred             CCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----
Confidence            99999999999875432222111122234567999999988889999999999999999997 888886532211     


Q ss_pred             HhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          174 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                                  .....+........+...++.+.+++.+||+.||++|||+.+|+++|+.+...
T Consensus       290 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         290 ------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             ------------HHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                        01111111112223334567899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-34  Score=240.10  Aligned_cols=215  Identities=27%  Similarity=0.389  Sum_probs=171.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++.++|+||+++++.+...+..++++|++.+++|.+++..... ..+++..+..++.|++.||.+||  +.|+
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh--~~~i  123 (267)
T cd06610          46 LRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH--SNGQ  123 (267)
T ss_pred             HHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            57899999999999999999999999999999999999999999976532 46899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--cccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g  157 (278)
                      +|+||+|+||++++++.++|+|||++..........  ......++..|+|||.+... .++.++|+||||+++++|++|
T Consensus       124 ~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g  203 (267)
T cd06610         124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATG  203 (267)
T ss_pred             ecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhC
Confidence            999999999999999999999999987654433221  22234567889999998766 788999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||.................+..             ........++..+.+++.+||+.||++||++.++++|
T Consensus       204 ~~p~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         204 AAPYSKYPPMKVLMLTLQNDPPSL-------------ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCCccccChhhhHHHHhcCCCCCc-------------CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            999975433211111111000000             0000123567889999999999999999999999975

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.7e-35  Score=253.56  Aligned_cols=208  Identities=23%  Similarity=0.258  Sum_probs=165.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++.+.+++..++||||+.+++|.+++...   .+++..+..++.||+.||.|||  +.|++
T Consensus        90 ~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH--~~~iv  164 (371)
T cd05622          90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH--SMGFI  164 (371)
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence            467899999999999999999999999999999999999999998654   4888899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC----CCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----HLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----~~~~~~DiwslG~il~~l~~g  157 (278)
                      |+||||+||+++.++.+||+|||++........ .......+++.|+|||++.+.    .++.++|+|||||++|+|++|
T Consensus       165 HrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G  243 (371)
T cd05622         165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG  243 (371)
T ss_pred             eCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhC
Confidence            999999999999999999999999876433221 111234688999999998654    378899999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhc--cCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR--LGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTSL  232 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~l  232 (278)
                      ..||...+......                 .+....  ...+....++.++.++|.+||..++.+  |+++.++++|.
T Consensus       244 ~~Pf~~~~~~~~~~-----------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         244 DTPFYADSLVGTYS-----------------KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCCCCCCCHHHHHH-----------------HHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            99997543211111                 111111  112223457889999999999844433  68999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.3e-34  Score=238.75  Aligned_cols=216  Identities=21%  Similarity=0.316  Sum_probs=161.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+.+++.++||||+++++.+.+....++++||+.+++|.+++.+..  ....+...+..++.|++.||.|||  +.+
T Consensus        42 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH--~~~  119 (268)
T cd05086          42 FLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH--KHN  119 (268)
T ss_pred             HHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH--HCC
Confidence            6788899999999999999999999999999999999999999987542  234667778899999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-------CCCCCccchhHHHHHHH
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-------GHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~DiwslG~il~  152 (278)
                      ++|+||+|+||+++.++.++|+|||++................++..|+|||.+..       ..++.++|+||||+++|
T Consensus       120 i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~  199 (268)
T cd05086         120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLW  199 (268)
T ss_pred             eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHH
Confidence            99999999999999999999999998753221111111122345678999998743       24567899999999999


Q ss_pred             HHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          153 ELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       153 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +|++ |..||...........+..             ..............++..+.+++..|| .+|++||++.++++.
T Consensus       200 el~~~~~~p~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~  265 (268)
T cd05086         200 ELFENAAQPYSHLSDREVLNHVIK-------------DQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRL  265 (268)
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHh-------------hcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHH
Confidence            9997 4667754322111111000             000000112233446778899999999 679999999999987


Q ss_pred             HH
Q 023752          232 LE  233 (278)
Q Consensus       232 l~  233 (278)
                      |.
T Consensus       266 l~  267 (268)
T cd05086         266 LT  267 (268)
T ss_pred             hc
Confidence            74

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=9.9e-35  Score=242.91  Aligned_cols=224  Identities=25%  Similarity=0.324  Sum_probs=167.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++++......++++||++++.|..+.....  .+++..+..++.|++.+|.|||  +.|++
T Consensus        47 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH--~~~i~  122 (286)
T cd07847          47 ALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCH--KHNCI  122 (286)
T ss_pred             HHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH--HCCce
Confidence            5689999999999999999999999999999999999888777665433  5899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|.||+++.++.++|+|||++.........  .....++..|+|||.+.+ ..++.++|+||||+++++|++|..|
T Consensus       123 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p  200 (286)
T cd07847         123 HRDVKPENILITKQGQIKLCDFGFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL  200 (286)
T ss_pred             ecCCChhhEEEcCCCcEEECccccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998765433211  112345678999998865 4578899999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHH---HHh----hhccCC-----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVL---RIM----DTRLGG-----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~----~~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      |.+.........+...............   ...    ......     .....++..+.+||.+||+.+|++||++.++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei  280 (286)
T cd07847         201 WPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL  280 (286)
T ss_pred             CCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence            9765443222222211111111000000   000    000000     0012357889999999999999999999999


Q ss_pred             HHH
Q 023752          229 LTS  231 (278)
Q Consensus       229 l~~  231 (278)
                      +.+
T Consensus       281 l~~  283 (286)
T cd07847         281 LEH  283 (286)
T ss_pred             hcC
Confidence            864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.4e-35  Score=243.94  Aligned_cols=224  Identities=23%  Similarity=0.261  Sum_probs=165.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++++||+. ++|.+++.... ..+++..+..++.|++.||.|||  ..+++
T Consensus        46 ~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH--~~~i~  121 (284)
T cd07839          46 ALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH--SHNVL  121 (284)
T ss_pred             hhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            5679999999999999999999999999999999995 58888776543 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus       122 H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p  199 (284)
T cd07839         122 HRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  199 (284)
T ss_pred             cCCCCHHHEEEcCCCcEEECccchhhccCCCCCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999998754332211  1223457789999988664 478999999999999999999988


Q ss_pred             CccccC-CchhhhHHhhhccccch-hHHHHHHhhhccC---------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRG-GLAEQTLVEWADPFLRD-SRRVLRIMDTRLG---------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      +..... ......+.......... .............         ......++.++.++|.+||+.||.+|||+.+++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il  279 (284)
T cd07839         200 LFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEAL  279 (284)
T ss_pred             CcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHh
Confidence            643322 11111111111100000 0000000000000         011234678899999999999999999999998


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      +|
T Consensus       280 ~h  281 (284)
T cd07839         280 QH  281 (284)
T ss_pred             cC
Confidence            75

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=6.5e-35  Score=252.40  Aligned_cols=220  Identities=23%  Similarity=0.323  Sum_probs=163.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++.++||||+++++++...      ...|+|+||+. ++|.+.+..    .++...+..++.|++.||.||| 
T Consensus        70 ~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH-  143 (364)
T cd07875          70 AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH-  143 (364)
T ss_pred             HHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHh-
Confidence            46799999999999999999987543      34699999995 577777642    3788899999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                       +.|++|+||+|+||+++.++.++|+|||++.......   ......++..|+|||++.+..++.++|+|||||++|+|+
T Consensus       144 -~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  219 (364)
T cd07875         144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI  219 (364)
T ss_pred             -hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHH
Confidence             8999999999999999999999999999997543321   112245788999999999999999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchh-HHH---H-HHhhhc------------------cCCCCCHHHHHHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDS-RRV---L-RIMDTR------------------LGGQYSKKEAQAVAAVVL  212 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~-~~~~~~------------------~~~~~~~~~~~~l~~li~  212 (278)
                      +|+.||...+.......+........... ...   . ......                  .........+..+.+||.
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  299 (364)
T cd07875         220 KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS  299 (364)
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHH
Confidence            99999976554333222222111110000 000   0 000000                  001111223567899999


Q ss_pred             HhccCCCCCCCCHHHHHHH
Q 023752          213 QCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       213 ~~l~~dp~~Rps~~~ll~~  231 (278)
                      +||+.||.+|||+.++++|
T Consensus       300 ~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         300 KMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhcCcCcccCCCHHHHhcC
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.3e-34  Score=239.12  Aligned_cols=213  Identities=24%  Similarity=0.443  Sum_probs=168.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++|+||+++++++...+..++|+||+.+++|.+++.+.+  .+++..+..++.|++.||.|||  +.+++
T Consensus        55 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~i~  130 (272)
T cd06629          55 LRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLH--SKGIL  130 (272)
T ss_pred             HHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHh--hCCee
Confidence            5679999999999999999999999999999999999999999987664  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC--CCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~  159 (278)
                      |+||+|+||+++.++.++++|||.+................++..|+|||.+....  ++.++|+||||++++++++|..
T Consensus       131 H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  210 (272)
T cd06629         131 HRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR  210 (272)
T ss_pred             ecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCC
Confidence            99999999999999999999999987543322111122234677899999987654  7889999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||......   ..+.+...          ..............++..+.++|.+||+.+|++||++.+++++
T Consensus       211 p~~~~~~~---~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         211 PWSDEEAI---AAMFKLGN----------KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CCcCcchH---HHHHHhhc----------cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            98643221   11111000          0000011112234567899999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.6e-35  Score=245.95  Aligned_cols=207  Identities=24%  Similarity=0.372  Sum_probs=167.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++.+...+..++++||+.+++|.+++...   .+++..+..++.|++.||.|||  +.+++
T Consensus        66 ~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH--~~~iv  140 (292)
T cd06658          66 LFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLH--NQGVI  140 (292)
T ss_pred             HHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            568999999999999999999999999999999999999999987543   4889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||++++++++|..||
T Consensus       141 H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~  218 (292)
T cd06658         141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY  218 (292)
T ss_pred             ecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998865332221  112245678899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...........+..              ..  .........++..+.+++.+||..||.+|||+.+++++
T Consensus       219 ~~~~~~~~~~~~~~--------------~~--~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         219 FNEPPLQAMRRIRD--------------NL--PPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CCCCHHHHHHHHHh--------------cC--CCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            65332111100000              00  00111223467789999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.3e-35  Score=245.73  Aligned_cols=207  Identities=24%  Similarity=0.365  Sum_probs=168.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++.+...+..++|+||+.+++|.+++.+.   .+++..+..++.|++.+|.|||  +.|++
T Consensus        63 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH--~~~i~  137 (297)
T cd06656          63 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLH--SNQVI  137 (297)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            568999999999999999999999999999999999999999998654   4888999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       138 H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf  215 (297)
T cd06656         138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY  215 (297)
T ss_pred             cCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999988654332211  12235677899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+...........                .......+..++..+.+++.+||+.+|++||++.+++++
T Consensus       216 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         216 LNENPLRALYLIATN----------------GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             CCCCcchheeeeccC----------------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            653321111000000                000112244567789999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-35  Score=242.06  Aligned_cols=211  Identities=31%  Similarity=0.512  Sum_probs=167.2

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+|+.++++++||||+++++++.+....+++++++.+++|.+++....  .++...+..++.|++.||.+||  +.+++|
T Consensus        46 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~Lh--~~~i~H  121 (260)
T PF00069_consen   46 IREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK--PLSEEEILKIAYQILEALAYLH--SKGIVH  121 (260)
T ss_dssp             HHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS--SBBHHHHHHHHHHHHHHHHHHH--HTTEEE
T ss_pred             hhhhhccccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccc--cccccc
Confidence            348999999999999999999999999999999999999999998443  6899999999999999999999  889999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-cCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      +||+|+||+++.++.++|+|||.+....  ..........++..|.|||... +..++.++|+||||+++++|++|..||
T Consensus       122 ~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~  199 (260)
T PF00069_consen  122 RDIKPENILLDENGEVKLIDFGSSVKLS--ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPF  199 (260)
T ss_dssp             SSBSGGGEEESTTSEEEESSGTTTEEST--STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSS
T ss_pred             cccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999987531  1122223345678899999998 788999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...........+........          ..  ........+.++.++|.+||+.||++||++.+++++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~----------~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  200 EESNSDDQLEIIEKILKRPL----------PS--SSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             TTSSHHHHHHHHHHHHHTHH----------HH--HTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             ccccchhhhhhhhhcccccc----------cc--cccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            76521111111111110000          00  000011124799999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=8.1e-35  Score=247.84  Aligned_cols=205  Identities=27%  Similarity=0.409  Sum_probs=165.4

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|+.+++.+. |++|+++++++.+.+..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|+
T Consensus        47 ~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~i  122 (323)
T cd05615          47 TMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLH--RRGI  122 (323)
T ss_pred             HHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            456788888775 5788889999999999999999999999999987654  6899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus       123 vHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p  200 (323)
T cd05615         123 IYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP  200 (323)
T ss_pred             eccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCC
Confidence            9999999999999999999999999864322211  11224578899999999888899999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  231 (278)
                      |...........+.                 .  .....+...+.++.+++.+||+.+|.+|++.     .++++|
T Consensus       201 f~~~~~~~~~~~i~-----------------~--~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         201 FDGEDEDELFQSIM-----------------E--HNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             CCCCCHHHHHHHHH-----------------h--CCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence            97543211111111                 1  1223455677889999999999999999974     556554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.2e-35  Score=250.66  Aligned_cols=220  Identities=24%  Similarity=0.327  Sum_probs=163.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++.++||||+++++++....      ..++++||+++ +|.+.+..    .++...+..++.|++.||.||| 
T Consensus        63 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH-  136 (355)
T cd07874          63 AYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH-  136 (355)
T ss_pred             HHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH-
Confidence            457999999999999999999886443      46899999954 67776642    3788899999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                       +.|++|+||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+|||||++|+|+
T Consensus       137 -~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~  212 (355)
T cd07874         137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV  212 (355)
T ss_pred             -hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence             8999999999999999999999999999987543221   112245788999999999889999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHh-hhccccchhH----HHHHHhhhc------------------cCCCCCHHHHHHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVE-WADPFLRDSR----RVLRIMDTR------------------LGGQYSKKEAQAVAAVVL  212 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~------------------~~~~~~~~~~~~l~~li~  212 (278)
                      +|..||.+.+.......... ...+......    .........                  .....+...+.++.+||.
T Consensus       213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  292 (355)
T cd07874         213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS  292 (355)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHH
Confidence            99999976543222211111 1111000000    000000000                  001112234678899999


Q ss_pred             HhccCCCCCCCCHHHHHHH
Q 023752          213 QCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       213 ~~l~~dp~~Rps~~~ll~~  231 (278)
                      +||+.||++|||+.++++|
T Consensus       293 ~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         293 KMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhcCCchhcCCHHHHhcC
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.8e-34  Score=239.70  Aligned_cols=209  Identities=27%  Similarity=0.351  Sum_probs=164.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecC------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      +.+|+.+++++ +|+||+++++.+...      ...|+++||+.+++|.+++.......+++..+..++.|++.|+.|||
T Consensus        49 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH  128 (272)
T cd06637          49 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH  128 (272)
T ss_pred             HHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            56889999998 699999999998653      35789999999999999987654456899999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGV  149 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~  149 (278)
                        +.+++|+||+|.||+++.++.++|+|||++........  ......++..|+|||.+.     +..++.++|+||||+
T Consensus       129 --~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv  204 (272)
T cd06637         129 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI  204 (272)
T ss_pred             --HCCCccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHH
Confidence              89999999999999999999999999999875432211  112245677899999885     335788999999999


Q ss_pred             HHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          150 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       150 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ++|+|++|..||..........                 ...............+..+.+|+.+||+.+|.+|||+.+++
T Consensus       205 ~l~el~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il  267 (272)
T cd06637         205 TAIEMAEGAPPLCDMHPMRALF-----------------LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLM  267 (272)
T ss_pred             HHHHHHhCCCCccccCHHHHHH-----------------HHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            9999999999996432211110                 00011111122334677899999999999999999999998


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      ++
T Consensus       268 ~~  269 (272)
T cd06637         268 KH  269 (272)
T ss_pred             hC
Confidence            74

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-34  Score=242.13  Aligned_cols=207  Identities=24%  Similarity=0.359  Sum_probs=167.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++...+..++++||+.+++|.+++...   .++...+..++.|++.||.|||  +.|++
T Consensus        63 ~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH--~~~i~  137 (285)
T cd06648          63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLH--AQGVI  137 (285)
T ss_pred             HHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            468999999999999999999999999999999999999999988763   5889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+..++.++|+||||++++++++|..||
T Consensus       138 H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~  215 (285)
T cd06648         138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPY  215 (285)
T ss_pred             cCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998764332211  112235678899999998888999999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+.......+...                .......+..++..+.++|.+||+.+|++||++.+++++
T Consensus       216 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         216 FNEPPLQAMKRIRDN----------------LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             cCCCHHHHHHHHHhc----------------CCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            653321111111110                000111123367789999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-35  Score=251.34  Aligned_cols=203  Identities=24%  Similarity=0.333  Sum_probs=161.0

Q ss_pred             HHHHHHhcc---CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            4 TEVIYLGQL---RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         4 ~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .|..++...   .||||+++++.+.+.+..|+|+||+.+++|.+.+.+.+  .+++..+..++.||+.||.|||  +.|+
T Consensus        42 ~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH--~~~i  117 (330)
T cd05586          42 GERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLH--KYDI  117 (330)
T ss_pred             HHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            455666555   69999999999999999999999999999999887654  6899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      +|+||||+||+++.++.++|+|||++........  ......++..|+|||.+.+. .++.++|+|||||++|+|++|..
T Consensus       118 vHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~  195 (330)
T cd05586         118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWS  195 (330)
T ss_pred             EeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCC
Confidence            9999999999999999999999999865322211  12234578899999998654 57899999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC-HHHHHHHHHHHHHhccCCCCCCC----CHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS-KKEAQAVAAVVLQCLHMDPKNRP----SMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rp----s~~~ll~~  231 (278)
                      ||...+.......+.                 ..  ....+ ..++.++.++|.+||+.||.+||    ++.++++|
T Consensus       196 Pf~~~~~~~~~~~i~-----------------~~--~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         196 PFYAEDTQQMYRNIA-----------------FG--KVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCCCCCHHHHHHHHH-----------------cC--CCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            996543211111110                 00  01111 23677899999999999999998    67777764

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-34  Score=236.27  Aligned_cols=202  Identities=28%  Similarity=0.439  Sum_probs=162.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.. ...++|+||+.+++|.+++..... .++...+..++.|++.||.|||  +.|++
T Consensus        48 ~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH--~~~i~  123 (259)
T cd05037          48 FFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE--DKKLV  123 (259)
T ss_pred             HHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh--hCCee
Confidence            6789999999999999999999988 778999999999999999876542 5889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC-------ceEEeccccccCCCCCCCCccccccccCCcccCccccccC--CCCCccchhHHHHHHH
Q 023752           82 YRDLKASNVLLDSNF-------NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLL  152 (278)
Q Consensus        82 H~dl~p~ni~~~~~~-------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~il~  152 (278)
                      |+||+|+||+++.++       .++|+|||++......      ....+...|+|||.+.+.  .++.++|+||||++++
T Consensus       124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~  197 (259)
T cd05037         124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLL  197 (259)
T ss_pred             cccCccceEEEecCccccCCceeEEeCCCCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHH
Confidence            999999999998887       7999999998754331      112345679999998776  7889999999999999


Q ss_pred             HHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          153 ELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       153 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++++ |..||...+.........                  ..  ...+......+.++|.+||..+|.+|||+.++++.
T Consensus       198 ~l~~~~~~p~~~~~~~~~~~~~~------------------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  257 (259)
T cd05037         198 EICSNGEEPLSTLSSSEKERFYQ------------------DQ--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRD  257 (259)
T ss_pred             HHHhCCCCCcccCCchhHHHHHh------------------cC--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            9999 567775443211111100                  00  11111122788999999999999999999999987


Q ss_pred             HH
Q 023752          232 LE  233 (278)
Q Consensus       232 l~  233 (278)
                      |+
T Consensus       258 l~  259 (259)
T cd05037         258 LN  259 (259)
T ss_pred             cC
Confidence            63

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.9e-35  Score=245.10  Aligned_cols=207  Identities=22%  Similarity=0.354  Sum_probs=167.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++++..++..++++||+.+++|.+++...   .+++..+..++.|++.||.|||  +.|++
T Consensus        65 ~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH--~~~iv  139 (297)
T cd06659          65 LFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLH--SQGVI  139 (297)
T ss_pred             HHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            568999999999999999999999999999999999999999977543   5889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++++|++|..||
T Consensus       140 H~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~  217 (297)
T cd06659         140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY  217 (297)
T ss_pred             cCCCCHHHeEEccCCcEEEeechhHhhccccccc--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999988643322111  12245678899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...........+...                ...........+..+.++|.+||+.+|++||++.+++++
T Consensus       218 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         218 FSDSPVQAMKRLRDS----------------PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHhcc----------------CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            643321111111100                000111233456789999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-34  Score=237.07  Aligned_cols=206  Identities=29%  Similarity=0.484  Sum_probs=169.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++++.++|+||+++++++.+....++++||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +.|++
T Consensus        49 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~  124 (258)
T cd06632          49 LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLH--DRNTV  124 (258)
T ss_pred             HHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999999999999999999999999999987654  5889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC-CCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+.......   ......++..|++||.+.... ++.++|+||||+++|++++|..|
T Consensus       125 H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p  201 (258)
T cd06632         125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP  201 (258)
T ss_pred             cCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999887543322   122345677899999887666 88999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |........                 .............+..++..+.+++.+||+.+|++||++.+++.+
T Consensus       202 f~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         202 WSQLEGVAA-----------------VFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             cccCcHHHH-----------------HHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            965431100                 011111111233455678889999999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8e-35  Score=249.92  Aligned_cols=219  Identities=24%  Similarity=0.342  Sum_probs=163.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|++++++++||||+++++++...      ...|++++++ +++|.+++...   .+++..+..++.|++.||.||| 
T Consensus        61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH-  135 (343)
T cd07878          61 TYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIH-  135 (343)
T ss_pred             HHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-
Confidence            45799999999999999999988543      3468999988 78998877543   5899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.|++|+||+|+||+++.++.+||+|||++.......     ....++..|+|||++.+ ..++.++|||||||++|+|
T Consensus       136 -~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  209 (343)
T cd07878         136 -SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL  209 (343)
T ss_pred             -HCCeecccCChhhEEECCCCCEEEcCCccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHH
Confidence             8999999999999999999999999999987643321     22457889999999876 5688999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchh------HHHHHHhhhcc--C----CCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDS------RRVLRIMDTRL--G----GQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~--~----~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||...+.......+...........      ...........  .    .......++.+.+||.+||+.||.+|
T Consensus       210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R  289 (343)
T cd07878         210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR  289 (343)
T ss_pred             HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence            999999976543333222222111110000      00000000000  0    00112345678899999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      ||+.+++.|
T Consensus       290 ~s~~ell~h  298 (343)
T cd07878         290 ISASEALAH  298 (343)
T ss_pred             CCHHHHhcC
Confidence            999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=239.85  Aligned_cols=209  Identities=25%  Similarity=0.340  Sum_probs=164.1

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      +.+|+.+++++ .|+||+++++.+.+..      ..++++||+.+++|.+++....  ...+++..+..++.|++.||.|
T Consensus        49 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~  128 (275)
T cd06608          49 IKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY  128 (275)
T ss_pred             HHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            57899999999 7999999999997644      4799999999999999886533  3478999999999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-----CCCCCccchhHH
Q 023752           73 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSF  147 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Diwsl  147 (278)
                      ||  +.+++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+..     ..++.++|+|||
T Consensus       129 lH--~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  204 (275)
T cd06608         129 LH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSL  204 (275)
T ss_pred             Hh--cCCcccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHh
Confidence            99  89999999999999999999999999998865432211  1122456778999998753     346788999999


Q ss_pred             HHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhh-ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          148 GVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT-RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       148 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      |++++++++|..||...........                 .... ......+..++.++.++|.+||..||++|||+.
T Consensus       205 G~il~~l~~g~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~  267 (275)
T cd06608         205 GITAIELADGKPPLCDMHPMRALFK-----------------IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFME  267 (275)
T ss_pred             HHHHHHHHhCCCCccccchHHHHHH-----------------hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHH
Confidence            9999999999999964322111110                 0000 011122334678899999999999999999999


Q ss_pred             HHHHH
Q 023752          227 DVLTS  231 (278)
Q Consensus       227 ~ll~~  231 (278)
                      +++++
T Consensus       268 ~ll~~  272 (275)
T cd06608         268 ELLEH  272 (275)
T ss_pred             HHhcC
Confidence            99864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-34  Score=249.58  Aligned_cols=222  Identities=21%  Similarity=0.320  Sum_probs=162.3

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      ..|+.++++++||||+++++++.+.+..++|++++ .++|.+++.... ..+++..+..++.|++.||.|||  +.|++|
T Consensus       105 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH  180 (357)
T PHA03209        105 LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLH--AQRIIH  180 (357)
T ss_pred             HHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeec
Confidence            57999999999999999999999999999999999 468888886543 36899999999999999999999  899999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC-
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-  161 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~-  161 (278)
                      |||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+..++.++|+|||||++|+|+++..++ 
T Consensus       181 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        181 RDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             CCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            9999999999999999999999986422211   112245788999999998889999999999999999999865554 


Q ss_pred             ccccCCch------hhhHHhhhc-------ccc--chhHHHHHHhhhc--cCCCC-------CHHHHHHHHHHHHHhccC
Q 023752          162 DEDRGGLA------EQTLVEWAD-------PFL--RDSRRVLRIMDTR--LGGQY-------SKKEAQAVAAVVLQCLHM  217 (278)
Q Consensus       162 ~~~~~~~~------~~~~~~~~~-------~~~--~~~~~~~~~~~~~--~~~~~-------~~~~~~~l~~li~~~l~~  217 (278)
                      ........      ...+.....       .+.  ........++...  ...+.       ...++..+.+||.+||+.
T Consensus       258 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  337 (357)
T PHA03209        258 EDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTF  337 (357)
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcC
Confidence            33221100      000100000       000  0000000111100  00000       113456778899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 023752          218 DPKNRPSMVDVLTS  231 (278)
Q Consensus       218 dp~~Rps~~~ll~~  231 (278)
                      ||.+|||+.|+++|
T Consensus       338 dP~~Rpta~e~l~h  351 (357)
T PHA03209        338 DAAMRPSAEEILNY  351 (357)
T ss_pred             CcccCcCHHHHhcC
Confidence            99999999999976

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.7e-34  Score=235.92  Aligned_cols=209  Identities=26%  Similarity=0.387  Sum_probs=172.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i   80 (278)
                      |.+|+.++++++|+||+++++++...+..++++||+.+++|.+++....  .+++..+..++.|++.|+.|||  + .++
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lh--~~~~~  121 (264)
T cd06623          46 LLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG--KIPEPVLAYIARQILKGLDYLH--TKRHI  121 (264)
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHh--ccCCC
Confidence            6789999999999999999999999999999999999999999997653  6899999999999999999999  8 999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||.+..........  ....++..|.|||.+.+..++.++|+||||+++|++++|..|
T Consensus       122 ~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p  199 (264)
T cd06623         122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP  199 (264)
T ss_pred             ccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999987644332221  123467789999999888899999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |........               ......+........+.. ++..+.++|.+||..+|++||++.+++++
T Consensus       200 ~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         200 FLPPGQPSF---------------FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CccccccCH---------------HHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            965432111               111111112222333444 78899999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.6e-34  Score=240.35  Aligned_cols=225  Identities=22%  Similarity=0.298  Sum_probs=168.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++...+..++|+||+ +++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~  121 (286)
T cd07832          46 ALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH--ANGIM  121 (286)
T ss_pred             HHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            568999999999999999999999999999999999 999999886554 46999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+......... ......++..|+|||.+.+. .++.++|+||||++++++++|..|
T Consensus       122 H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~  200 (286)
T cd07832         122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPL  200 (286)
T ss_pred             cCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcC
Confidence            9999999999999999999999998765443221 11223567889999988654 468899999999999999999888


Q ss_pred             CccccCCchhhhHHhhhc-cccchhH------HHHHHhhhccC----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWAD-PFLRDSR------RVLRIMDTRLG----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~-~~~~~~~------~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |...........+..... +......      ...........    .......+..+.++|.+||+.+|++||++++++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l  280 (286)
T cd07832         201 FPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL  280 (286)
T ss_pred             cCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHh
Confidence            865443222211111110 0000000      00000000000    001124568999999999999999999999999


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      +|
T Consensus       281 ~h  282 (286)
T cd07832         281 RH  282 (286)
T ss_pred             hC
Confidence            76

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.5e-34  Score=238.44  Aligned_cols=222  Identities=27%  Similarity=0.362  Sum_probs=171.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++++.++||||+++++.+...+..++|+||+.+++|.+++.+.+  .+++..+..++.+++.+|.|||+ ..+++
T Consensus        50 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~-~~~i~  126 (284)
T cd06620          50 ILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYN-VHRIM  126 (284)
T ss_pred             HHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHH-hcCee
Confidence            5789999999999999999999999999999999999999999887654  68999999999999999999993 25899


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........    ....++..|+|||.+.+..++.++|+|||||++|++++|..||
T Consensus       127 H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~  202 (284)
T cd06620         127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPF  202 (284)
T ss_pred             ccCCCHHHEEECCCCcEEEccCCcccchhhhcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998764322111    1235778899999988888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC-HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS-KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      .............      ..-.......... .....+ ..++..+.+|+.+||+.||++|||+.+++++..-+..
T Consensus       203 ~~~~~~~~~~~~~------~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         203 AFSNIDDDGQDDP------MGILDLLQQIVQE-PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             cccchhhhhhhhh------hHHHHHHHHHhhc-cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            7543321100000      0000000111111 111122 2367789999999999999999999999987544443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.7e-34  Score=238.97  Aligned_cols=210  Identities=26%  Similarity=0.357  Sum_probs=167.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|++++++++|+||+++++.+..++..++|+||+.+++|.+++.... ...+++..+..++.+++.||.|||+ +.++
T Consensus        46 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~~i  124 (286)
T cd06622          46 IIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-EHNI  124 (286)
T ss_pred             HHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-cCCE
Confidence            5689999999999999999999999999999999999999998886541 2368999999999999999999993 2599


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC------CCCCccchhHHHHHHHHH
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG------HLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~------~~~~~~DiwslG~il~~l  154 (278)
                      +|+||+|+||+++.++.++|+|||.+........    ....++..|+|||.+.+.      .++.++|+|||||++|++
T Consensus       125 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l  200 (286)
T cd06622         125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM  200 (286)
T ss_pred             eeCCCCHHHEEECCCCCEEEeecCCcccccCCcc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHH
Confidence            9999999999999999999999998865432211    223466789999988543      347899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|..||...........               ............+..++.++.++|.+||+.+|++||++.+++.+
T Consensus       201 ~~g~~pf~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         201 ALGRYPYPPETYANIFAQ---------------LSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HhCCCCCCCcchhhHHHH---------------HHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            999999964322111100               01111122234556688999999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=7.3e-34  Score=235.28  Aligned_cols=208  Identities=24%  Similarity=0.359  Sum_probs=166.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+++++++.||||+++++.+.+.  ..+++++||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +.+
T Consensus        51 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH--~~~  126 (265)
T cd06652          51 LECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLH--SNM  126 (265)
T ss_pred             HHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            56799999999999999999998764  45789999999999999987654  5788899999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|++++|+
T Consensus       127 i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~  206 (265)
T cd06652         127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK  206 (265)
T ss_pred             EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCC
Confidence            999999999999999999999999988754321111 1112234677899999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||......                 ...............+..++..+.++|.+|+. +|++||++++++++
T Consensus       207 ~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         207 PPWAEFEAM-----------------AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             CCCCccchH-----------------HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            998643211                 11111111222344566778889999999995 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-34  Score=239.84  Aligned_cols=209  Identities=27%  Similarity=0.336  Sum_probs=163.6

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeec------CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSE------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      +..|+.+++++ +|+||+++++++..      ....+++|||+.+++|.+++.......+++..+..++.|++.|+.|||
T Consensus        59 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH  138 (282)
T cd06636          59 IKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH  138 (282)
T ss_pred             HHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            46788889988 79999999999853      356799999999999999997655456888899999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGV  149 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~  149 (278)
                        +.|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.     +..++.++|+||||+
T Consensus       139 --~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~  214 (282)
T cd06636         139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGI  214 (282)
T ss_pred             --HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHH
Confidence              89999999999999999999999999999865432211  112245678899999875     346778999999999


Q ss_pred             HHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          150 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       150 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ++|+|++|..||..........                 ..............++.++.++|.+||+.||.+||++.+|+
T Consensus       215 ~l~el~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell  277 (282)
T cd06636         215 TAIEMAEGAPPLCDMHPMRALF-----------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLL  277 (282)
T ss_pred             HHHHHHhCCCCccccCHHhhhh-----------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHh
Confidence            9999999999996432211100                 00111111112335678899999999999999999999998


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      ++
T Consensus       278 ~~  279 (282)
T cd06636         278 KH  279 (282)
T ss_pred             cC
Confidence            64

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.3e-34  Score=240.55  Aligned_cols=225  Identities=25%  Similarity=0.283  Sum_probs=167.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++++||+. ++|.+++.......+++..+..++.|++.||.|||  ..+++
T Consensus        46 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh--~~~i~  122 (284)
T cd07860          46 AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH--SHRVL  122 (284)
T ss_pred             HHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5689999999999999999999999999999999995 68998887655557899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+. .++.++|+||||+++|++++|+.|
T Consensus       123 H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p  200 (284)
T cd07860         123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL  200 (284)
T ss_pred             cCCCCHHHEEECCCCCEEEeeccchhhcccCccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999998654322111  1122356789999988664 458889999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchh----HHHHHHhhhcc------CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDS----RRVLRIMDTRL------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |...+.......+...........    ...........      .......++.++.++|.+||+.||.+||++.++++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         201 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            975443222222221111111000    00000000000      00011235678899999999999999999999986


Q ss_pred             H
Q 023752          231 S  231 (278)
Q Consensus       231 ~  231 (278)
                      +
T Consensus       281 ~  281 (284)
T cd07860         281 H  281 (284)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.5e-34  Score=255.00  Aligned_cols=225  Identities=21%  Similarity=0.317  Sum_probs=163.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---QPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      |.+|+++|++++||||+++++++.+.+..|++++++ +++|.+++.....   .......+..++.||+.||.|||  +.
T Consensus       210 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH--~~  286 (501)
T PHA03210        210 LENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH--DK  286 (501)
T ss_pred             HHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH--hC
Confidence            578999999999999999999999999999999998 5678887754321   12345667889999999999999  89


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ||+|+||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++|.
T Consensus       287 gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~  365 (501)
T PHA03210        287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD  365 (501)
T ss_pred             CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999999999976543221 1122346789999999999999999999999999999999987


Q ss_pred             CC-CccccCCchhhhHHhhhc-------cccchhHHHHHHhhhccCCCCC---------HHHHHHHHHHHHHhccCCCCC
Q 023752          159 RA-LDEDRGGLAEQTLVEWAD-------PFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKN  221 (278)
Q Consensus       159 ~p-~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dp~~  221 (278)
                      .+ +...... ....+.+...       .+..........+........+         ...+..+.++|.+||+.||.+
T Consensus       366 ~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~  444 (501)
T PHA03210        366 FCPIGDGGGK-PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHL  444 (501)
T ss_pred             CCCccCCCCC-HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCccc
Confidence            54 4332222 1111111110       0011111111111111000000         123456788899999999999


Q ss_pred             CCCHHHHHHH
Q 023752          222 RPSMVDVLTS  231 (278)
Q Consensus       222 Rps~~~ll~~  231 (278)
                      |||+.|++.+
T Consensus       445 Rpsa~elL~h  454 (501)
T PHA03210        445 RPGAAELLAL  454 (501)
T ss_pred             CcCHHHHhhC
Confidence            9999999975

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.1e-34  Score=239.44  Aligned_cols=209  Identities=26%  Similarity=0.400  Sum_probs=169.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++.+...+..++++||+.+++|.+++.... ..++...+..++.|++.||.|||  +.|++
T Consensus        62 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH--~~gi~  138 (286)
T cd06614          62 IINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH--SQNVI  138 (286)
T ss_pred             HHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999999999999998764 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       139 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~  216 (286)
T cd06614         139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPY  216 (286)
T ss_pred             eCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998765433221  112234567899999998888999999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+.......+..                ........+..++..+.++|.+||+.+|.+||++.+++++
T Consensus       217 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         217 LREPPLRALFLITT----------------KGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CCCCHHHHHHHHHh----------------cCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            65332111111000                0000111223367889999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.2e-34  Score=242.28  Aligned_cols=212  Identities=20%  Similarity=0.256  Sum_probs=165.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++.+..++..++++||+.|++|.+++...+  .+++..+..++.|++.|+.|||  +.+++
T Consensus        48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~  123 (305)
T cd05609          48 VFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLH--NYGIV  123 (305)
T ss_pred             HHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            4689999999999999999999999999999999999999999997654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCC-------------ccccccccCCcccCccccccCCCCCccchhHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-------------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFG  148 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG  148 (278)
                      |+||+|.||+++.++.++|+|||.+.........             .......++..|+|||.+.+..++.++|+||||
T Consensus       124 H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  203 (305)
T cd05609         124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG  203 (305)
T ss_pred             ccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHH
Confidence            9999999999999999999999987532111000             001113456789999999888899999999999


Q ss_pred             HHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhcc-CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 023752          149 VVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD  227 (278)
Q Consensus       149 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  227 (278)
                      +++|++++|..||.+.........                 ...... .......++.++.++|.+||+.||++||+..+
T Consensus       204 ~vl~el~~g~~pf~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~  266 (305)
T cd05609         204 IILYEFLVGCVPFFGDTPEELFGQ-----------------VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGG  266 (305)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHH-----------------HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccC
Confidence            999999999999965332111111                 111100 01112256788999999999999999998544


Q ss_pred             HHHHHHh
Q 023752          228 VLTSLEQ  234 (278)
Q Consensus       228 ll~~l~~  234 (278)
                      +.+.|+.
T Consensus       267 ~~~ll~~  273 (305)
T cd05609         267 AFEVKQH  273 (305)
T ss_pred             HHHHHhC
Confidence            4444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.8e-34  Score=235.83  Aligned_cols=209  Identities=26%  Similarity=0.427  Sum_probs=165.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPI--SWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+.++++++|+||+++++++..++..++++||+.+++|.+++.... ..+  +...+..++.|++.||.|||  +.|
T Consensus        52 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH--~~~  128 (268)
T cd06624          52 LHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH--DNQ  128 (268)
T ss_pred             HHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH--HCC
Confidence            6789999999999999999999999999999999999999999987542 234  78888899999999999999  899


Q ss_pred             eeecCCCCCceEEcC-CCceEEeccccccCCCCCCCCccccccccCCcccCccccccC--CCCCccchhHHHHHHHHHHh
Q 023752           80 VIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        80 i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~il~~l~~  156 (278)
                      ++|+||+|.||+++. ++.++|+|||.+........  ......++..|+|||.+.+.  .++.++|+||||+++|++++
T Consensus       129 i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~  206 (268)
T cd06624         129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT  206 (268)
T ss_pred             EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh
Confidence            999999999999976 67899999998865432211  11123467789999998654  37889999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||........                .............++..++.++.+++.+||+.+|++|||+.+++.+
T Consensus       207 g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         207 GKPPFIELGEPQA----------------AMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             CCCCCccccChhh----------------hHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            9999864321100                0000001112234456678899999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.9e-34  Score=237.75  Aligned_cols=206  Identities=26%  Similarity=0.343  Sum_probs=170.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++.+.++...++|+||+.+++|.+++....  .+++..+..++.|+++||.|||  ..+++
T Consensus        47 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lh--~~~i~  122 (258)
T cd05578          47 VLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV--KFSEEQVKFWICEIVLALEYLH--SKGII  122 (258)
T ss_pred             HHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999999999999997663  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||.+........   .....++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       123 h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  199 (258)
T cd05578         123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY  199 (258)
T ss_pred             ccCCCHHHeEEcCCCCEEEeecccccccCCCcc---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCC
Confidence            999999999999999999999999876543321   12234677899999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH--HHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM--VDVLT  230 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~--~~ll~  230 (278)
                      ...+......               ....... .....+...+..+.++|.+||+.||.+||++  .++++
T Consensus       200 ~~~~~~~~~~---------------~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         200 RGHSRTIRDQ---------------IRAKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             CCCCccHHHH---------------HHHHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            7654321111               0111110 2234455677899999999999999999999  77664

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.8e-35  Score=250.75  Aligned_cols=205  Identities=23%  Similarity=0.375  Sum_probs=168.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc--cEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN--RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |..|+.+|+.|+||||+++|+++.+...  ..+|+|.+.+|+|..|+.+.+  .++...+..|+.||+.||.|||+..-.
T Consensus        88 ~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PP  165 (632)
T KOG0584|consen   88 LYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPP  165 (632)
T ss_pred             HHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCC
Confidence            7789999999999999999999987765  779999999999999998886  789999999999999999999987788


Q ss_pred             eeecCCCCCceEEcC-CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+|||||=+||+|+. .|.|||+|+|+++......    ....+||+.|+|||... ..|+...||||||+++.+|.|+.
T Consensus       166 IIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~e  240 (632)
T KOG0584|consen  166 IIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSE  240 (632)
T ss_pred             ccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhcc
Confidence            999999999999965 5899999999998643322    23368999999999885 88999999999999999999999


Q ss_pred             CCCccc-cCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDED-RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||..= +....+.+.....                 .+..+..--.+++++||.+||.. ..+|+|+.++|.+
T Consensus       241 YPYsEC~n~AQIYKKV~SGi-----------------KP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  241 YPYSECTNPAQIYKKVTSGI-----------------KPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             CChhhhCCHHHHHHHHHcCC-----------------CHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            999532 2222222222111                 11122223367899999999999 9999999999963

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.2e-34  Score=243.97  Aligned_cols=230  Identities=23%  Similarity=0.277  Sum_probs=168.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +++|+.+++.++||||++++++|..++..++++||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus        46 ~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~~~iv  123 (328)
T cd08226          46 LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH--QNGYI  123 (328)
T ss_pred             HHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999999999999988765556899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-c----ccccccCCcccCccccccC--CCCCccchhHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-V----STRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~----~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~il~~l  154 (278)
                      |+||||+||+++.++.+++.||+............ .    .....+...|+|||.+.+.  .++.++|+|||||+++++
T Consensus       124 HrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el  203 (328)
T cd08226         124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACEL  203 (328)
T ss_pred             cCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHH
Confidence            99999999999999999999997543221111100 0    0111234569999998663  478899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhc--cc----cchhHHHH----------------------HHhhhccCCCCCHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWAD--PF----LRDSRRVL----------------------RIMDTRLGGQYSKKEAQA  206 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~  206 (278)
                      ++|..||.................  +.    ........                      .........+....++..
T Consensus       204 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (328)
T cd08226         204 ATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPA  283 (328)
T ss_pred             HhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHH
Confidence            999999976543211111110000  00    00000000                      000011112234567889


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          207 VAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       207 l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      +.+||.+||+.||++|||+.+++++--
T Consensus       284 ~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         284 FQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhhCHH
Confidence            999999999999999999999996543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.8e-34  Score=242.36  Aligned_cols=227  Identities=21%  Similarity=0.260  Sum_probs=159.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeec--CCccEEEEeccCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRK-------GVQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      +.+|++++++++||||+++++++..  +...++++||+. ++|.+++...       ....+++..+..++.|++.||.|
T Consensus        45 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~  123 (317)
T cd07867          45 ACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY  123 (317)
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHH
Confidence            5689999999999999999998854  456789999985 5887776422       11248888999999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEE----cCCCceEEeccccccCCCCCCCC-ccccccccCCcccCcccccc-CCCCCccchhH
Q 023752           73 LHGLDANVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYS  146 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~----~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Diws  146 (278)
                      ||  +.+++|+||||+||++    +.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||
T Consensus       124 lH--~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS  201 (317)
T cd07867         124 LH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA  201 (317)
T ss_pred             HH--hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHh
Confidence            99  8999999999999999    45678999999999765433221 11223456788999998866 45789999999


Q ss_pred             HHHHHHHHHhCCCCCccccCCchh------hhHH---h-hhccccchhHHH------HHHhhhcc------------CCC
Q 023752          147 FGVVLLELLSGRRALDEDRGGLAE------QTLV---E-WADPFLRDSRRV------LRIMDTRL------------GGQ  198 (278)
Q Consensus       147 lG~il~~l~~g~~p~~~~~~~~~~------~~~~---~-~~~~~~~~~~~~------~~~~~~~~------------~~~  198 (278)
                      |||++|+|++|..||.........      ..+.   . ...+........      ........            ...
T Consensus       202 lG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (317)
T cd07867         202 IGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEK  281 (317)
T ss_pred             HHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhc
Confidence            999999999999999754332110      0000   0 000000000000      00000000            000


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          199 YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       199 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .....+..+.+||.+||+.||.+|||+.|+++|
T Consensus       282 ~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         282 HKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             ccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            011234568899999999999999999999964

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-35  Score=233.48  Aligned_cols=234  Identities=24%  Similarity=0.328  Sum_probs=176.0

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .+|++++.+. .|+||++++++|+++..+|||||.+.||+|.+.+.++.  .+++.++..++.+|+.||.+||  .+||.
T Consensus       123 fREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH--~kgIA  198 (463)
T KOG0607|consen  123 FREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLH--TKGIA  198 (463)
T ss_pred             HHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHh--hcCcc
Confidence            5899999999 69999999999999999999999999999999998775  7999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCc---eEEeccccccCCCCCCCCcc-----ccccccCCcccCccccc-----cCCCCCccchhHHH
Q 023752           82 YRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHV-----STRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFG  148 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~---~kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG  148 (278)
                      |||+||+||+....+.   |||+||++..........+.     .....|+..|+|||+..     ...|+.++|.||||
T Consensus       199 HRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLG  278 (463)
T KOG0607|consen  199 HRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLG  278 (463)
T ss_pred             cccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHH
Confidence            9999999999966544   89999998765333222221     22357888999999873     23689999999999


Q ss_pred             HHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhh--hccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          149 VVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD--TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       149 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      +++|-|++|.+||.+.=+..--..-.+.-  -.++..-+..+..  ..++.+-+..++.+..++|..+|..|+.+|.++.
T Consensus       279 vIlYImLsGYpPFvG~Cg~dCGWdrGe~C--r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~  356 (463)
T KOG0607|consen  279 VILYIMLSGYPPFVGHCGADCGWDRGEVC--RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAA  356 (463)
T ss_pred             HHHHHHHhCCCCccCccCCcCCccCCCcc--HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhh
Confidence            99999999999997643211100000000  0001111111111  1133445678999999999999999999999999


Q ss_pred             HHHH--HHHhhhcCCCCC
Q 023752          227 DVLT--SLEQLHTSKDMP  242 (278)
Q Consensus       227 ~ll~--~l~~~~~~~~~~  242 (278)
                      +++.  .+..+...+..|
T Consensus       357 ~vlnhPw~~~~~~ekalp  374 (463)
T KOG0607|consen  357 QVLNHPWVQRCAPEKALP  374 (463)
T ss_pred             hccCCccccccchhccCC
Confidence            9996  344444443333

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-36  Score=237.86  Aligned_cols=208  Identities=24%  Similarity=0.357  Sum_probs=174.1

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      ..|+.|++++..|+|+++|+++..+..+|+|||||..|++.+.+..+. +++.++++..++..-+.||.|||  ...-+|
T Consensus        76 IKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH--~~~KIH  152 (502)
T KOG0574|consen   76 IKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLH--DLKKIH  152 (502)
T ss_pred             HHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHH--HHHHHH
Confidence            579999999999999999999999999999999999999999886554 57999999999999999999999  888999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      ||||..||+++.+|..||+|||.+.......  .......|++.|+|||++..-.|+.++||||||++..+|..|++||.
T Consensus       153 RDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYs  230 (502)
T KOG0574|consen  153 RDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYS  230 (502)
T ss_pred             hhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcc
Confidence            9999999999999999999999986543321  12234689999999999999999999999999999999999999997


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +...-...-.+....-|.                ..-|..-+.++.+||++||-.+|++|.|+.++++|
T Consensus       231 DIHPMRAIFMIPT~PPPT----------------F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  231 DIHPMRAIFMIPTKPPPT----------------FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             cccccceeEeccCCCCCC----------------CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            654321111111111111                12245568899999999999999999999999876

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.3e-33  Score=234.70  Aligned_cols=214  Identities=27%  Similarity=0.402  Sum_probs=165.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKG----VQPISWPTRVKIAIDVARGLS   71 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~l~~~l~   71 (278)
                      +.+|++++++++||||+++++++....      ..+++++|+.+++|.+++....    ...++...+..++.|++.||.
T Consensus        48 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~  127 (273)
T cd05074          48 FLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGME  127 (273)
T ss_pred             HHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHH
Confidence            568999999999999999999886432      2368889999999988774321    124788899999999999999


Q ss_pred             HHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHH
Q 023752           72 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        72 ~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il  151 (278)
                      |||  +.|++|+||+|+||+++.++.++|+|||.+................+...|++||.+.+..++.++|+||||+++
T Consensus       128 ~lH--~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il  205 (273)
T cd05074         128 YLS--SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTM  205 (273)
T ss_pred             HHH--hCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHH
Confidence            999  899999999999999999999999999998754332211111122334678999999888899999999999999


Q ss_pred             HHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          152 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       152 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |++++ |..||........                  ............+...+..+.+++.+||+.+|++||++.++++
T Consensus       206 ~el~~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         206 WEIMTRGQTPYAGVENSEI------------------YNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             HHHhhCCCCCCCCCCHHHH------------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999 8888864332111                  1111111112223456678999999999999999999999999


Q ss_pred             HHHhh
Q 023752          231 SLEQL  235 (278)
Q Consensus       231 ~l~~~  235 (278)
                      .|+.+
T Consensus       268 ~l~~~  272 (273)
T cd05074         268 QLELI  272 (273)
T ss_pred             HHHhh
Confidence            99876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5e-34  Score=234.93  Aligned_cols=208  Identities=26%  Similarity=0.414  Sum_probs=169.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|+||+++++.+.+.+..++++||+.+++|.+++.+.....+++..+..++.+++.||.|||  +.+++
T Consensus        46 ~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh--~~~i~  123 (257)
T cd08225          46 SKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH--DRKIL  123 (257)
T ss_pred             HHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5689999999999999999999999999999999999999999987665446899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCc-eEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFN-AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|.||+++.++. ++|+|||.+.........  .....++..|.|||...+..++.++|+||||++++++++|..|
T Consensus       124 H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p  201 (257)
T cd08225         124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHP  201 (257)
T ss_pred             cccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999988764 699999988765432211  1223467789999998888899999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |...+....   ..              .. ......+....++..+.++|.+||+.+|++|||+.+++++
T Consensus       202 ~~~~~~~~~---~~--------------~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         202 FEGNNLHQL---VL--------------KI-CQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCccHHHH---HH--------------HH-hcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            864322111   00              10 1111122344567789999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.1e-34  Score=233.75  Aligned_cols=210  Identities=25%  Similarity=0.419  Sum_probs=173.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+.++++++|+||+++++.+.+.  +..++++|++.+++|.+++....  .+++..++.++.+++.+|.|||  +.+
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh--~~~  121 (260)
T cd06606          46 LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH--SNG  121 (260)
T ss_pred             HHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            67899999999999999999999988  78999999999999999997765  7899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|+||+++.++.++|+|||.+................++..|.|||...+..++.++|+||||++++++++|..
T Consensus       122 ~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~  201 (260)
T cd06606         122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP  201 (260)
T ss_pred             ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999876544432111223456778999999988889999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||......  ..              ..............+...+..+.++|.+||+.||++||++.+++.+
T Consensus       202 p~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         202 PWSELGNP--MA--------------ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCCCCCch--HH--------------HHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            99754410  00              0111111122234455668899999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1e-33  Score=233.86  Aligned_cols=210  Identities=25%  Similarity=0.320  Sum_probs=170.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeec--CCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC-
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGL-   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~-   76 (278)
                      +.+|++++++++|+||+++++.+..  ....++++||+.+++|.+++...  ....+++..++.++.|++.||.|||.. 
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~  125 (265)
T cd08217          46 LVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS  125 (265)
T ss_pred             HHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCc
Confidence            5679999999999999999998754  34578999999999999998653  224689999999999999999999944 


Q ss_pred             --CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           77 --DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        77 --~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                        +.+++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||++++++
T Consensus       126 ~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l  203 (265)
T cd08217         126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYEL  203 (265)
T ss_pred             cccCcceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHH
Confidence              568999999999999999999999999998865443321  1223567889999999888899999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|..||...+....                  ...+........+...+..+.+++.+||+.+|++||++.+|+++
T Consensus       204 ~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         204 CALSPPFTARNQLQL------------------ASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHCCCcccCcCHHHH------------------HHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            999999975432111                  11122222234456778899999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.5e-34  Score=240.59  Aligned_cols=224  Identities=28%  Similarity=0.399  Sum_probs=167.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++++..++..++|+||+.+++|.++.....  .+++..+..++.|++.||.|||  +.|++
T Consensus        47 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH--~~~i~  122 (286)
T cd07846          47 AMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCH--SHNII  122 (286)
T ss_pred             HHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5689999999999999999999999999999999999888887665443  5899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+ ..++.++|+||||++++++++|..|
T Consensus       123 h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~  200 (286)
T cd07846         123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPL  200 (286)
T ss_pred             ccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999875433221  1122346778999998865 4567889999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHH---HhhhccC---------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLR---IMDTRLG---------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      |...........+................   .......         ......++..+.+++.+||+.+|++||++.++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i  280 (286)
T cd07846         201 FPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQL  280 (286)
T ss_pred             CCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHH
Confidence            97544322222222211111110000000   0000000         00123467889999999999999999999999


Q ss_pred             HHH
Q 023752          229 LTS  231 (278)
Q Consensus       229 l~~  231 (278)
                      +++
T Consensus       281 l~~  283 (286)
T cd07846         281 LHH  283 (286)
T ss_pred             hcC
Confidence            875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-34  Score=239.28  Aligned_cols=225  Identities=26%  Similarity=0.358  Sum_probs=167.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++++..++..++++||+.++.+..+....  ..+++..+..++.|++.||.|||  ..+++
T Consensus        47 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH--~~~i~  122 (288)
T cd07833          47 ALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCH--SHNII  122 (288)
T ss_pred             HHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            578999999999999999999999989999999999876665555433  35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+. .++.++|+||||+++|++++|..|
T Consensus       123 H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  201 (288)
T cd07833         123 HRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPL  201 (288)
T ss_pred             cCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998765443321 11223567789999999887 888999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHH---------HHhhh----ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVL---------RIMDT----RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD  227 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  227 (278)
                      |...........+...............         .....    .....++..++.++.+||.+||..+|++||++.+
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  281 (288)
T cd07833         202 FPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE  281 (288)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence            9754332222221111111100000000         00000    0000122335788999999999999999999999


Q ss_pred             HHHH
Q 023752          228 VLTS  231 (278)
Q Consensus       228 ll~~  231 (278)
                      ++++
T Consensus       282 il~~  285 (288)
T cd07833         282 LLQH  285 (288)
T ss_pred             HhcC
Confidence            9864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.6e-33  Score=230.78  Aligned_cols=206  Identities=28%  Similarity=0.423  Sum_probs=169.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|++|+++++++..++..++++||+.+++|.+++.... ..+++..+..++.|++.+|.+||  ..|++
T Consensus        44 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh--~~~i~  120 (253)
T cd05122          44 IINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH--SNGII  120 (253)
T ss_pred             HHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh--cCCEe
Confidence            5789999999999999999999999999999999999999999987653 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|.||+++.++.++|+|||.+........   .....++..|+|||.+.+..++.++|+||||++++++++|..||
T Consensus       121 h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~  197 (253)
T cd05122         121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY  197 (253)
T ss_pred             cCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876544321   22345677899999998888899999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCC--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY--SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+.........                  .......  ...++..+.++|.+||+.||++|||+.+++++
T Consensus       198 ~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         198 SELPPMKALFKIA------------------TNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             CCCchHHHHHHHH------------------hcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            6543211111000                  0111111  22237889999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.9e-34  Score=264.90  Aligned_cols=209  Identities=24%  Similarity=0.381  Sum_probs=161.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      |..|+.++++++||||++++++|.+.  ..+|+||||+.+++|.+++....  ...+++..++.|+.||+.||.|||+..
T Consensus        59 ~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g  138 (1021)
T PTZ00266         59 LVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLK  138 (1021)
T ss_pred             HHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcc
Confidence            67899999999999999999988544  46899999999999999886532  236999999999999999999999321


Q ss_pred             -----CCeeecCCCCCceEEcC-----------------CCceEEeccccccCCCCCCCCccccccccCCcccCcccccc
Q 023752           78 -----ANVIYRDLKASNVLLDS-----------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT  135 (278)
Q Consensus        78 -----~~i~H~dl~p~ni~~~~-----------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~  135 (278)
                           .+|+|+||||+||+++.                 .+.+||+|||++.......   ......+++.|+|||++.+
T Consensus       139 ~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~g  215 (1021)
T PTZ00266        139 DGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLH  215 (1021)
T ss_pred             cccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhc
Confidence                 45999999999999964                 2348999999987543221   1223467899999999854


Q ss_pred             --CCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHH
Q 023752          136 --GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQ  213 (278)
Q Consensus       136 --~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  213 (278)
                        ..++.++|||||||++|+|++|..||.......                 .....+...... .....+.++.+||..
T Consensus       216 e~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~-----------------qli~~lk~~p~l-pi~~~S~eL~dLI~~  277 (1021)
T PTZ00266        216 ETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS-----------------QLISELKRGPDL-PIKGKSKELNILIKN  277 (1021)
T ss_pred             cCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH-----------------HHHHHHhcCCCC-CcCCCCHHHHHHHHH
Confidence              458899999999999999999999996432210                 111111111111 113457889999999


Q ss_pred             hccCCCCCCCCHHHHHHH
Q 023752          214 CLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       214 ~l~~dp~~Rps~~~ll~~  231 (278)
                      ||+.+|.+||++.+++.+
T Consensus       278 ~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        278 LLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HhcCChhHCcCHHHHhcc
Confidence            999999999999999954

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.2e-34  Score=253.00  Aligned_cols=219  Identities=20%  Similarity=0.295  Sum_probs=159.9

Q ss_pred             HHHHHHHhccCC------ccccceeeeeecC-CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            3 QTEVIYLGQLRH------ENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         3 ~~E~~~l~~l~h------~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      ..|+++++.+.|      .++++++++|..+ +..|+|++++ |++|.+++.+.+  .+++..+..++.||+.||.||| 
T Consensus       173 ~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH-  248 (467)
T PTZ00284        173 KIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFH-  248 (467)
T ss_pred             HHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH-
Confidence            457777777754      4588899988765 4688999988 778999887664  6999999999999999999999 


Q ss_pred             CC-CCeeecCCCCCceEEcCCC----------------ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC
Q 023752           76 LD-ANVIYRDLKASNVLLDSNF----------------NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL  138 (278)
Q Consensus        76 ~~-~~i~H~dl~p~ni~~~~~~----------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  138 (278)
                       . .||+||||||+||+++.++                .+||+|||.+......     .....++..|+|||++.+..+
T Consensus       249 -~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~  322 (467)
T PTZ00284        249 -TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGW  322 (467)
T ss_pred             -hcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCC
Confidence             6 5999999999999998665                4999999987542211     223467899999999999999


Q ss_pred             CCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchh---------HHHHHHhhhccCC------------
Q 023752          139 TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS---------RRVLRIMDTRLGG------------  197 (278)
Q Consensus       139 ~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~------------  197 (278)
                      +.++|||||||++|+|++|+.||...+.......+...........         ..+..........            
T Consensus       323 ~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  402 (467)
T PTZ00284        323 MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARA  402 (467)
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcc
Confidence            9999999999999999999999987654333333322211111000         0000000000000            


Q ss_pred             --CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          198 --QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       198 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                        .........+.+||.+||+.||.+|||+.|+++|
T Consensus       403 ~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        403 RPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             cchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence              0001124678899999999999999999999974

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.6e-33  Score=232.78  Aligned_cols=209  Identities=27%  Similarity=0.406  Sum_probs=167.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|+||+++++++...+..++++||+.+++|.+++....  .+++..+..++.+++.||.|||  +.|++
T Consensus        46 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh--~~~i~  121 (264)
T cd06626          46 IADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLH--SHGIV  121 (264)
T ss_pred             HHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5789999999999999999999999899999999999999999987654  5788899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccc--cccccCCcccCccccccCC---CCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS--TRIVGTRGYAAPEYVATGH---LTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~il~~l~~  156 (278)
                      |+||+|+||+++.++.++|+|||++............  ....++..|+|||.+.+..   ++.++|+||||++++++++
T Consensus       122 H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~  201 (264)
T cd06626         122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT  201 (264)
T ss_pred             cCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHh
Confidence            9999999999999999999999998765443322111  1234567899999987665   7889999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS--KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||...+.....                 ............+  ..++..+.++|.+||+.+|++||++.+++.+
T Consensus       202 g~~pf~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         202 GKRPWSELDNEFQI-----------------MFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCCccCCcchHHH-----------------HHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            99999643211000                 0000111112222  2347889999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=272.43  Aligned_cols=209  Identities=26%  Similarity=0.347  Sum_probs=177.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|..++..++|||++++|++=.+.+..+|.||||.+|+|.+++....  -.++.....+..|+++|+.|||  +.|||
T Consensus      1281 i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH--~~gIV 1356 (1509)
T KOG4645|consen 1281 IAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLH--EHGIV 1356 (1509)
T ss_pred             hHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHH--hcCce
Confidence            5789999999999999999999999899999999999999999997664  4566677788899999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc--ccccccCCcccCccccccCC---CCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIVGTRGYAAPEYVATGH---LTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~il~~l~~  156 (278)
                      ||||||.||+++.+|.+|++|||.+....+....-.  .....|++.|+|||++.+..   -..+.|||||||++.+|+|
T Consensus      1357 HRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t 1436 (1509)
T KOG4645|consen 1357 HRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT 1436 (1509)
T ss_pred             ecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec
Confidence            999999999999999999999999987655432111  12367999999999997643   3468999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |+.||...+.                 ...++-.+.....+.+|...+.+-++||..||+.||..|+++.|++++
T Consensus      1437 GkrPW~~~dn-----------------e~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1437 GKRPWAELDN-----------------EWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CCCchhhccc-----------------hhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            9999965432                 234444556666778888899999999999999999999999999875

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-33  Score=236.16  Aligned_cols=217  Identities=27%  Similarity=0.328  Sum_probs=165.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      +.+|++++++++||||+++++++.+.  +..++|+||+.+++|.+++...  ....+++..+..++.|++.||.|||  .
T Consensus        46 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH--~  123 (287)
T cd06621          46 ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH--S  123 (287)
T ss_pred             HHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--H
Confidence            67899999999999999999988654  4689999999999999887532  2345889999999999999999999  8


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      .|++|+||+|+||+++.++.++|+|||++.........    ...++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       124 ~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g  199 (287)
T cd06621         124 RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG----TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQN  199 (287)
T ss_pred             CCcccCCCCHHHEEEecCCeEEEeeccccccccccccc----cccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence            99999999999999999999999999997654322211    23456789999999888899999999999999999999


Q ss_pred             CCCCccccCC-chhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          158 RRALDEDRGG-LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       158 ~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ..||...... ........+.....   .  ..   ...........+..+.++|.+||..+|.+|||+.+++++-
T Consensus       200 ~~p~~~~~~~~~~~~~~~~~~~~~~---~--~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         200 RFPFPPEGEPPLGPIELLSYIVNMP---N--PE---LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             CCCCCcccCCCCChHHHHHHHhcCC---c--hh---hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            9999754321 00000111000000   0  00   0000111123567899999999999999999999999753

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.2e-33  Score=232.45  Aligned_cols=208  Identities=25%  Similarity=0.361  Sum_probs=172.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|++++++++|+|++++.+.+...+..++++|++++++|.+++....  ...+++..+..++.+++.||.+||  +.|
T Consensus        46 ~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh--~~~  123 (258)
T cd08215          46 ALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH--SRK  123 (258)
T ss_pred             HHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            5689999999999999999999999999999999999999999987653  247999999999999999999999  889


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|+||+++.++.++|+|||.+.......  .......++..|+|||...+..++.++|+||+|++++++++|..
T Consensus       124 ~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~  201 (258)
T cd08215         124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKH  201 (258)
T ss_pred             EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999987654432  12222456778999999888889999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||...+....                  ............+..++..+.+++.+||+.+|++||++.+++++
T Consensus       202 p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         202 PFEGENLLEL------------------ALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCcHHHH------------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            9865432111                  11111111233445677889999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1e-33  Score=237.77  Aligned_cols=224  Identities=24%  Similarity=0.286  Sum_probs=167.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+.++++++||||+++++++...  +..|+++||+. ++|.+++.... ..+++..+..++.|++.||.|||  +.|
T Consensus        51 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~  126 (293)
T cd07843          51 SLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH--DNW  126 (293)
T ss_pred             HHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            45799999999999999999998877  78999999996 59999887654 36899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+. .++.++|+||||+++++|++|.
T Consensus       127 i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  204 (293)
T cd07843         127 ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK  204 (293)
T ss_pred             eeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999999988765443211  1223456789999988654 4688999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhh------------hccCCCCCHH-HHHHHHHHHHHhccCCCCCCCCH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD------------TRLGGQYSKK-EAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      .||...........+.................+.            ......++.. +++.+.++|.+||+.+|++|||+
T Consensus       205 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~  284 (293)
T cd07843         205 PLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA  284 (293)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence            9997654433322222211111110000000000            0001112222 47889999999999999999999


Q ss_pred             HHHHHH
Q 023752          226 VDVLTS  231 (278)
Q Consensus       226 ~~ll~~  231 (278)
                      .+++.+
T Consensus       285 ~ell~~  290 (293)
T cd07843         285 EDALKH  290 (293)
T ss_pred             HHHhcC
Confidence            999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.3e-34  Score=239.20  Aligned_cols=207  Identities=25%  Similarity=0.370  Sum_probs=168.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++.+...+..++|+||+.+++|.+++.+.   .+++..+..++.|++.|+.|||  +.|++
T Consensus        63 ~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH--~~gi~  137 (293)
T cd06647          63 IINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVI  137 (293)
T ss_pred             HHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            568999999999999999999999999999999999999999998654   4788899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|++||.+.+..++.++|+||||+++|++++|..||
T Consensus       138 H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf  215 (293)
T cd06647         138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY  215 (293)
T ss_pred             eccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998765433221  112234677899999998888899999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+.......+...                .......+..++..+.++|.+||..+|++||++.+++.|
T Consensus       216 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         216 LNENPLRALYLIATN----------------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCChhhheeehhcC----------------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            754332111111000                000111233467789999999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.6e-33  Score=234.87  Aligned_cols=205  Identities=25%  Similarity=0.369  Sum_probs=168.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++.+.+++..++|+||+.+++|.+++...   .+++..+..++.+++.++.+||  ..|++
T Consensus        49 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh--~~~i~  123 (277)
T cd06641          49 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH--SEKKI  123 (277)
T ss_pred             HHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHc--cCCee
Confidence            568999999999999999999999999999999999999999988643   5889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|.||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||+++|++++|..||
T Consensus       124 h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~  201 (277)
T cd06641         124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH  201 (277)
T ss_pred             cCCCCHHhEEECCCCCEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999998765433211  111234677899999998888899999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..........                  .+........+..++.++.++|.+||+.+|.+||++.+++++
T Consensus       202 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         202 SELHPMKVLF------------------LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CccchHHHHH------------------HHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            6433211111                  111111223445677889999999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.2e-34  Score=240.21  Aligned_cols=224  Identities=27%  Similarity=0.276  Sum_probs=166.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+.++++++|+||+++++++...  +..++|+||+. ++|.+++.... ..+++..+..++.|++.||.|||  +.|
T Consensus        53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH--~~~  128 (309)
T cd07845          53 SLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH--ENF  128 (309)
T ss_pred             hhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            35799999999999999999998765  46799999995 58888886543 46899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++.........  ......+..|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus       129 i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~  206 (309)
T cd07845         129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK  206 (309)
T ss_pred             eecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999998765433211  111234677999998865 46789999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhh-------ccCCC----CCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT-------RLGGQ----YSKKEAQAVAAVVLQCLHMDPKNRPSMVD  227 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~  227 (278)
                      .||...+.......+....................       .....    .....++.+.++|.+||+.||++|||+.+
T Consensus       207 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~  286 (309)
T cd07845         207 PLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE  286 (309)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHH
Confidence            99986655444333333222111110000000000       00000    01224778899999999999999999999


Q ss_pred             HHHH
Q 023752          228 VLTS  231 (278)
Q Consensus       228 ll~~  231 (278)
                      ++.|
T Consensus       287 il~h  290 (309)
T cd07845         287 ALES  290 (309)
T ss_pred             HhcC
Confidence            9975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-34  Score=242.96  Aligned_cols=212  Identities=19%  Similarity=0.231  Sum_probs=164.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+++.++|+||+++++.+.+++..|+|+||+.+++|.+++.+.. ..+++..+..++.|++.||.|||  +.+++
T Consensus        48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~iv  124 (331)
T cd05597          48 FREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVH--QLGYV  124 (331)
T ss_pred             HHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeE
Confidence            5689999999999999999999999999999999999999999997643 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-----CCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~il~~l~~  156 (278)
                      |+||+|+||+++.++.++|+|||++......... ......+++.|+|||++.+     ..++.++|+|||||++|+|++
T Consensus       125 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~  203 (331)
T cd05597         125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY  203 (331)
T ss_pred             ECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh
Confidence            9999999999999999999999998654332211 1122357889999999863     457789999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~  231 (278)
                      |..||...+.......+....              ...........++..+.++|.+||..+++.  |+++.++++|
T Consensus       204 g~~Pf~~~~~~~~~~~i~~~~--------------~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         204 GETPFYAESLVETYGKIMNHK--------------EHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             CCCCCCCCCHHHHHHHHHcCC--------------CcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            999996543211111111000              000001112346788999999988764443  7899999987

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=7.7e-34  Score=239.08  Aligned_cols=224  Identities=27%  Similarity=0.318  Sum_probs=167.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++++.+.+..++|+||+ +++|.+++.... ..+++..+..++.|+++||.|||  +.|++
T Consensus        49 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH--~~~i~  124 (298)
T cd07841          49 ALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH--SNWIL  124 (298)
T ss_pred             HHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            457999999999999999999999989999999999 889999987654 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|.|||.+.+ ..++.++|+|||||+++++++|..|
T Consensus       125 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~  202 (298)
T cd07841         125 HRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK--MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPF  202 (298)
T ss_pred             ecCCChhhEEEcCCCCEEEccceeeeeccCCCcc--ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcc
Confidence            9999999999999999999999998765433211  112234677999998854 4678899999999999999999888


Q ss_pred             CccccCCchhhhHHhhhc-cccchhHHHH---HHhhhccC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWAD-PFLRDSRRVL---RIMDTRLG-----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |...........+..... +.........   ........     .......+..+.++|.+||+.+|++|||+.+++++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         203 LPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            765443222222211111 0000000000   00000000     01123457889999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=8.1e-34  Score=237.51  Aligned_cols=211  Identities=26%  Similarity=0.322  Sum_probs=162.4

Q ss_pred             hHHHHHHHhcc-CCccccceeeeee-----cCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCS-----ESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+.+++.+ +||||+++++.+.     .++..++++||+++++|.+++...  ....+++..+..++.|++.||.||
T Consensus        61 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l  140 (286)
T cd06638          61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL  140 (286)
T ss_pred             HHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH
Confidence            46789999999 6999999999874     345689999999999999987532  224688899999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-----CCCCCccchhHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFG  148 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG  148 (278)
                      |  +.+++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+..     ..++.++|+||||
T Consensus       141 H--~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  216 (286)
T cd06638         141 H--VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG  216 (286)
T ss_pred             H--hCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHH
Confidence            9  89999999999999999999999999999875433211  1122357788999998743     4578899999999


Q ss_pred             HHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          149 VVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       149 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      +++|+|++|..||...........+...                .......+..++..+.++|.+||+.||++|||+.++
T Consensus       217 vi~~el~~g~~p~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~el  280 (286)
T cd06638         217 ITAIELGDGDPPLADLHPMRALFKIPRN----------------PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDL  280 (286)
T ss_pred             HHHHHHhcCCCCCCCCchhHHHhhcccc----------------CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHH
Confidence            9999999999998654321111000000                000111223356789999999999999999999999


Q ss_pred             HHHH
Q 023752          229 LTSL  232 (278)
Q Consensus       229 l~~l  232 (278)
                      +++.
T Consensus       281 l~~~  284 (286)
T cd06638         281 LQHV  284 (286)
T ss_pred             hhcc
Confidence            9864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.5e-33  Score=232.55  Aligned_cols=211  Identities=24%  Similarity=0.382  Sum_probs=167.2

Q ss_pred             hHHHHHHHhc-cCCccccceeeeeecCCccEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQ-LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~-l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|+.++.+ ++||||+++++++.+++..++++||+.+++|.+++..  .....+++..++.++.|++.+|.|||+ ..
T Consensus        55 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~  133 (269)
T cd08528          55 IVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK-EK  133 (269)
T ss_pred             HHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc-CC
Confidence            3467777764 7999999999999999999999999999999998743  222468999999999999999999993 26


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      +++|+||+|.||+++.++.++|+|||.+.......   ......++..|++||.+.+..++.++|+||||+++|++++|.
T Consensus       134 ~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~  210 (269)
T cd08528         134 RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQ  210 (269)
T ss_pred             ceeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCC
Confidence            89999999999999999999999999987643332   222345678899999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      .||...........                 .............++..+.++|.+||+.||++||++.++.++++
T Consensus       211 ~p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         211 PPFYSTNMLSLATK-----------------IVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcccccCHHHHHHH-----------------HhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            99864322111111                 11111111112246788999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=237.02  Aligned_cols=224  Identities=22%  Similarity=0.295  Sum_probs=162.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++++.+++..++|+||+. ++|.+++.+.. ..+++..+..++.|+++||.|||  +.+++
T Consensus        50 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH--~~~i~  125 (291)
T cd07844          50 AIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH--QRRVL  125 (291)
T ss_pred             HHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            4579999999999999999999999999999999996 59999887654 26889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..|
T Consensus       126 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~  203 (291)
T cd07844         126 HRDLKPQNLLISERGELKLADFGLARAKSVPSKT--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL  203 (291)
T ss_pred             cccCCHHHEEEcCCCCEEECccccccccCCCCcc--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998643222111  112235678999998865 4678899999999999999999999


Q ss_pred             CccccC-CchhhhHHhhhccccch-hHHHHHH---hhhccC----C---CCCHHHH--HHHHHHHHHhccCCCCCCCCHH
Q 023752          161 LDEDRG-GLAEQTLVEWADPFLRD-SRRVLRI---MDTRLG----G---QYSKKEA--QAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       161 ~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~----~---~~~~~~~--~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      |..... ......+.......... .......   ......    .   ......+  ..+.+++.+||+.+|.+|||+.
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~  283 (291)
T cd07844         204 FPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA  283 (291)
T ss_pred             CCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHH
Confidence            965432 11111111110000000 0000000   000000    0   0001122  6788999999999999999999


Q ss_pred             HHHHH
Q 023752          227 DVLTS  231 (278)
Q Consensus       227 ~ll~~  231 (278)
                      +++.+
T Consensus       284 e~l~~  288 (291)
T cd07844         284 EAMKH  288 (291)
T ss_pred             HHhcC
Confidence            99864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-33  Score=232.05  Aligned_cols=206  Identities=24%  Similarity=0.325  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|++++++++|+||+++++++.+....++++||+.+++|.+++.+..  ...+++..++.++.|++.||.|||  +.|
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh--~~~  123 (256)
T cd08530          46 AVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH--EQK  123 (256)
T ss_pred             HHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh--hCC
Confidence            4578999999999999999999999999999999999999999886632  236889999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|.||+++.++.++|+|||++.......    .....++..|+|||.+.+..++.++|+||||++++++++|..
T Consensus       124 i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~  199 (256)
T cd08530         124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP  199 (256)
T ss_pred             cccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999987654431    112346778999999988889999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||...+...                  .............+..++.++.+++.+||+.+|++||++.+++++
T Consensus       200 p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         200 PFEARSMQD------------------LRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCCCCHHH------------------HHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            996543211                  111112222234455778899999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.1e-34  Score=234.44  Aligned_cols=208  Identities=28%  Similarity=0.379  Sum_probs=166.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++.+...+..|+++||+.+++|.+++.+..  .+++..+..++.|++.||.|||  +.+++
T Consensus        40 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH--~~~i~  115 (265)
T cd05579          40 VLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLH--SNGII  115 (265)
T ss_pred             HHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HcCee
Confidence            5688999999999999999999999999999999999999999997655  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC------CccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN------THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                      |+||+|+||+++.++.++|+|||++........      ........++..|++||...+...+.++|+||||+++++++
T Consensus       116 H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~  195 (265)
T cd05579         116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFL  195 (265)
T ss_pred             cCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence            999999999999999999999998875433211      11122245677899999998888899999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH---HHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM---VDVLT  230 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~  230 (278)
                      +|..||...........                 ........+.....+..+.+++.+||+.+|.+|||+   .++++
T Consensus       196 ~g~~p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         196 VGIPPFHGETPEEIFQN-----------------ILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             hCCCCCCCCCHHHHHHH-----------------HhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            99999965432111111                 111111111111247889999999999999999999   55554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-34  Score=236.95  Aligned_cols=225  Identities=24%  Similarity=0.262  Sum_probs=168.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|||++++++++.+.+..++++||++ ++|.+++.......+++..+..++.|++.||.|||  +.+++
T Consensus        45 ~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH--~~~~~  121 (283)
T cd07835          45 AIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH--SHRVL  121 (283)
T ss_pred             HHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5689999999999999999999999999999999994 68999887665446899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|.||+++.++.++|+|||++.........  .....++..|+|||.+.+. .++.++|+||||+++|+|++|..|
T Consensus       122 H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  199 (283)
T cd07835         122 HRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPL  199 (283)
T ss_pred             CCCCCHHHEEEcCCCcEEEeecccccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998654322211  1112346789999987654 578899999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhH----HHHHHhhhc------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSR----RVLRIMDTR------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |...+.......+............    .........      ........++..+.++|.+||+.+|.+||++.+++.
T Consensus       200 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         200 FPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             CCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            9765432222222221111110000    000000000      001112345678999999999999999999999986


Q ss_pred             H
Q 023752          231 S  231 (278)
Q Consensus       231 ~  231 (278)
                      +
T Consensus       280 ~  280 (283)
T cd07835         280 H  280 (283)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-33  Score=260.85  Aligned_cols=219  Identities=21%  Similarity=0.306  Sum_probs=170.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC---------CCCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---------VQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      |.+|++++++++||||+++++++.+++..+++|||++|++|.+++....         ....+...+..++.|++.||.|
T Consensus        49 flrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~y  128 (932)
T PRK13184         49 FLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEY  128 (932)
T ss_pred             HHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHH
Confidence            6789999999999999999999999999999999999999999886421         1234566788999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCC----------------CccccccccCCcccCccccccC
Q 023752           73 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN----------------THVSTRIVGTRGYAAPEYVATG  136 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~----------------~~~~~~~~~~~~~~aPE~~~~~  136 (278)
                      ||  +.|++||||||+||+++.++.++|+|||++........                ........+++.|+|||.+.+.
T Consensus       129 LH--s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~  206 (932)
T PRK13184        129 VH--SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV  206 (932)
T ss_pred             HH--HCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC
Confidence            99  89999999999999999999999999999875421110                0011124588999999999999


Q ss_pred             CCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhcc
Q 023752          137 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLH  216 (278)
Q Consensus       137 ~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  216 (278)
                      .++.++|+|||||++|+|++|..||...........                ..............++..+.+++.+||+
T Consensus       207 ~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~----------------~~i~~P~~~~p~~~iP~~L~~LI~rcL~  270 (932)
T PRK13184        207 PASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR----------------DVILSPIEVAPYREIPPFLSQIAMKALA  270 (932)
T ss_pred             CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh----------------hhccChhhccccccCCHHHHHHHHHHcc
Confidence            999999999999999999999999965332111000                0000000001123567789999999999


Q ss_pred             CCCCCCC-CHHHHHHHHHhhhcC
Q 023752          217 MDPKNRP-SMVDVLTSLEQLHTS  238 (278)
Q Consensus       217 ~dp~~Rp-s~~~ll~~l~~~~~~  238 (278)
                      .||++|+ +++++++.|+.....
T Consensus       271 ~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        271 VDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             CChhhCcCHHHHHHHHHHHHHhc
Confidence            9999996 677888888877554

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.2e-33  Score=237.46  Aligned_cols=207  Identities=24%  Similarity=0.361  Sum_probs=166.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++|+||+++++.+..++..++++||+.+++|.+++...   .+++..+..++.|++.+|.|||  +.|++
T Consensus        64 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH--~~giv  138 (292)
T cd06657          64 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLH--AQGVI  138 (292)
T ss_pred             HHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            568999999999999999999999999999999999999999987543   4889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|.||+++.++.++|+|||+.........  ......++..|+|||.+.+..++.++|+||+|+++|++++|..||
T Consensus       139 H~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~  216 (292)
T cd06657         139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY  216 (292)
T ss_pred             cCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999998765433211  112234677899999988888899999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...........+....                .........++..+.+++.+||+.+|.+||++.+++.+
T Consensus       217 ~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         217 FNEPPLKAMKMIRDNL----------------PPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CCCCHHHHHHHHHhhC----------------CcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            6533211111111000                00111223467788999999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-34  Score=236.69  Aligned_cols=224  Identities=25%  Similarity=0.321  Sum_probs=169.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++++..++..++++||+. ++|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        45 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~  120 (283)
T cd05118          45 ALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH--SHGIL  120 (283)
T ss_pred             HHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5689999999999999999999999999999999996 48888887654 46899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+........  ......+...|.|||.+.+. .++.++|+||||+++|++++|+.|
T Consensus       121 H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~  198 (283)
T cd05118         121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPL  198 (283)
T ss_pred             ecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876544331  11123466789999998776 788999999999999999999999


Q ss_pred             CccccCCchhhhHHhh-hccccchhHHHHH-------HhhhccC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRGGLAEQTLVEW-ADPFLRDSRRVLR-------IMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-------~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |...+.......+... ..+..........       .......   ......++.++.++|.+||+.||.+||++.+++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll  278 (283)
T cd05118         199 FPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL  278 (283)
T ss_pred             CCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence            9765543222222211 1111000000000       0000000   112235678999999999999999999999998


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      .+
T Consensus       279 ~~  280 (283)
T cd05118         279 AH  280 (283)
T ss_pred             hC
Confidence            74

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.9e-33  Score=236.02  Aligned_cols=210  Identities=26%  Similarity=0.304  Sum_probs=162.1

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecC-----CccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+.+++++ +||||+++++++...     +..++|+||+.+++|.+++...  ....+++..+..++.|++.||.||
T Consensus        65 ~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l  144 (291)
T cd06639          65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHL  144 (291)
T ss_pred             HHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            45789999998 899999999998654     3579999999999999988532  224689999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-----CCCCccchhHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFG  148 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG  148 (278)
                      |  ..+++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+...     .++.++|+||||
T Consensus       145 H--~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG  220 (291)
T cd06639         145 H--NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLG  220 (291)
T ss_pred             H--hCCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHH
Confidence            9  899999999999999999999999999998754322211  1123467789999987543     367899999999


Q ss_pred             HHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          149 VVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       149 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      +++|+|++|..||...........+....                ......+...+..+.++|.+||+.+|++||++.++
T Consensus       221 vi~~el~~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~i  284 (291)
T cd06639         221 ITAIELGDGDPPLFDMHPVKTLFKIPRNP----------------PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHL  284 (291)
T ss_pred             HHHHHHhhCCCCCCCCcHHHHHHHHhcCC----------------CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHH
Confidence            99999999999996543211111110000                00111233456789999999999999999999999


Q ss_pred             HHH
Q 023752          229 LTS  231 (278)
Q Consensus       229 l~~  231 (278)
                      +.|
T Consensus       285 l~~  287 (291)
T cd06639         285 LEH  287 (291)
T ss_pred             hcC
Confidence            975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-35  Score=249.59  Aligned_cols=202  Identities=31%  Similarity=0.403  Sum_probs=170.4

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      ..|+..|+++.|||+|.+.+.|..+...|||||||- ||-.|++.-.. +++.+..+..|+++.+.||+|||  +.+.+|
T Consensus        74 lKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLH--S~~~IH  149 (948)
T KOG0577|consen   74 LKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH--SHNRIH  149 (948)
T ss_pred             HHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHH--HhhHHh
Confidence            479999999999999999999999999999999995 57777775443 57999999999999999999999  899999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhCCC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ||||..||++++.|.|||+|||.+....      +...++|+++|+|||++.   .+.|+.++||||||++..+|...++
T Consensus       150 RDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkP  223 (948)
T KOG0577|consen  150 RDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP  223 (948)
T ss_pred             hhccccceEecCCCeeeeccccchhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCC
Confidence            9999999999999999999999987532      233468999999999874   4689999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |+..++.-....-|.+...|.+                 ..+.-+..+++|++.||+.-|.+|||.+++++|
T Consensus       224 PlFnMNAMSALYHIAQNesPtL-----------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  224 PLFNMNAMSALYHIAQNESPTL-----------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CccCchHHHHHHHHHhcCCCCC-----------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            9877655433333333322221                 234568899999999999999999999999865

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=230.69  Aligned_cols=208  Identities=24%  Similarity=0.375  Sum_probs=168.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +++|++++++++|+||+++++.+.+.  +..++++||+.+++|.+++...+  .+++..+..++.|++.||.|||  +.|
T Consensus        51 ~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH--~~~  126 (264)
T cd06653          51 LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH--SNM  126 (264)
T ss_pred             HHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            57899999999999999999998764  45789999999999999987654  5888899999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||||++++++++|+
T Consensus       127 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  206 (264)
T cd06653         127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEK  206 (264)
T ss_pred             EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999998754322111 1112235678899999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||.....                 ................+..++.++.++|.+||+ +|..||++.+++.|
T Consensus       207 ~p~~~~~~-----------------~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         207 PPWAEYEA-----------------MAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             CCCCccCH-----------------HHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence            99964321                 111122222223345677888999999999999 57999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.3e-33  Score=234.14  Aligned_cols=196  Identities=25%  Similarity=0.352  Sum_probs=159.5

Q ss_pred             cCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceE
Q 023752           12 LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL   91 (278)
Q Consensus        12 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~   91 (278)
                      ..||+|+.+++.+..++..++|+||+.+++|.+++...+  .+++..+..++.|++.||.|||  +.+++|+||+|+||+
T Consensus        54 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH--~~~ivH~dikp~Nil  129 (279)
T cd05633          54 GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMH--NRFVVYRDLKPANIL  129 (279)
T ss_pred             CCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcCCCCCCHHHEE
Confidence            379999999999999899999999999999999887654  6999999999999999999999  899999999999999


Q ss_pred             EcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-cCCCCCccchhHHHHHHHHHHhCCCCCccccCCchh
Q 023752           92 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE  170 (278)
Q Consensus        92 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~  170 (278)
                      ++.++.++|+|||++........    ....++..|+|||... +..++.++|+||+|+++|++++|..||.........
T Consensus       130 ~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  205 (279)
T cd05633         130 LDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH  205 (279)
T ss_pred             ECCCCCEEEccCCcceeccccCc----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH
Confidence            99999999999999865432211    1235788999999886 456889999999999999999999999754321110


Q ss_pred             hhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                       .+               ...........+..++.++.++|.+||+.||.+||     ++.++++|
T Consensus       206 -~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         206 -EI---------------DRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -HH---------------HHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             00               00111122344566788999999999999999999     69999876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.4e-33  Score=237.06  Aligned_cols=209  Identities=18%  Similarity=0.244  Sum_probs=165.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++..++|++|+++++.+.+.+..++||||+.+|+|.+++.+.. ..+++..+..++.|++.||.|||  +.+++
T Consensus        48 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH--~~~ii  124 (332)
T cd05623          48 FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH--QLHYV  124 (332)
T ss_pred             HHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            5788999999999999999999999999999999999999999997643 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~  156 (278)
                      ||||||+||+++.++.++|+|||++......... ......+++.|+|||++.     ...++.++|+|||||++|+|++
T Consensus       125 HrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~  203 (332)
T cd05623         125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY  203 (332)
T ss_pred             ecCCCHHHEEECCCCCEEEeecchheecccCCcc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc
Confidence            9999999999999999999999988653222111 112245788999999885     3467889999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccC---CCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~  231 (278)
                      |+.||...+.......+.                 .....   ......++.++.+||.+||..+++.  |+++.++++|
T Consensus       204 g~~Pf~~~~~~~~~~~i~-----------------~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         204 GETPFYAESLVETYGKIM-----------------NHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCCCCCCCHHHHHHHHh-----------------CCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            999997543221111111                 11111   1112356889999999999765544  6899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-33  Score=233.99  Aligned_cols=205  Identities=27%  Similarity=0.386  Sum_probs=165.2

Q ss_pred             hHHHHHHHhccC---CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLR---HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|+.+++++.   |||++++++++.+....++++||+.+++|.+++...   .+++..+..++.|++.+|.|||  ..
T Consensus        46 ~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh--~~  120 (277)
T cd06917          46 IQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH--KV  120 (277)
T ss_pred             HHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH--hC
Confidence            567899999996   999999999999989999999999999999988654   5889999999999999999999  89


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhC
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |++|+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+ ..++.++|+||||+++|+|++|
T Consensus       121 ~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g  198 (277)
T cd06917         121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG  198 (277)
T ss_pred             CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhC
Confidence            9999999999999999999999999998765443311  122356778999998764 4578899999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCH-HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK-KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||...........                  .........+. .++.++.+++.+||+.||++||++.+++++
T Consensus       199 ~~p~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         199 NPPYSDVDAFRAMML------------------IPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCCCCChhhhhhc------------------cccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            999965432111000                  00001111122 267789999999999999999999999874

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=250.68  Aligned_cols=208  Identities=27%  Similarity=0.433  Sum_probs=173.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPI--SWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +..||...++++|.|||++++.+.+++.+-+.||.++||||.+++..+= +++  ++..+..+.+||++||.|||  ...
T Consensus       619 LhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLH--en~  695 (1226)
T KOG4279|consen  619 LHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLH--ENK  695 (1226)
T ss_pred             HHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhh--hcc
Confidence            4689999999999999999999999999999999999999999986542 245  88899999999999999999  999


Q ss_pred             eeecCCCCCceEEc-CCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc--CCCCCccchhHHHHHHHHHHh
Q 023752           80 VIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        80 i~H~dl~p~ni~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l~~  156 (278)
                      |||||||.+||+++ -.|.+||.|||-+.+...  -..+...+.|+.-|+|||++..  ..|+.++|||||||++.+|.|
T Consensus       696 IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT  773 (1226)
T KOG4279|consen  696 IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT  773 (1226)
T ss_pred             eeeccccCCcEEEeeccceEEecccccchhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc
Confidence            99999999999995 589999999998876432  2233345678999999999965  478899999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |++||-.....                -...++.-.....+++|...+.+.+.||.+|+..||..||++.+++.
T Consensus       774 GrPPF~Elgsp----------------qAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  774 GRPPFVELGSP----------------QAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             CCCCeeecCCh----------------hHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            99999543221                01111222233457889999999999999999999999999999995

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-34  Score=249.09  Aligned_cols=202  Identities=28%  Similarity=0.449  Sum_probs=168.7

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.|-+|+... +||.++.++..|+.++++|+||||+.||++....   ....+++..+.-++..++.||.|||  ++||+
T Consensus       416 ~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH--~~~II  490 (694)
T KOG0694|consen  416 MCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLH--ENGII  490 (694)
T ss_pred             HHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHH--hcCce
Confidence            4577777766 5999999999999999999999999999933222   2236999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |||||.+||+++.+|++||+|||++.......  .......||+.|+|||++.+..|+.+.|.|+||+++|+|+.|+.||
T Consensus       491 YRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF  568 (694)
T KOG0694|consen  491 YRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPF  568 (694)
T ss_pred             eeecchhheEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999998644332  2334577999999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLT  230 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~  230 (278)
                      .+.+.+..-..|                 +.  ....+|...+.+..++++++|..+|++|.-     +.+|.+
T Consensus       569 ~gddEee~FdsI-----------------~~--d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~  623 (694)
T KOG0694|consen  569 PGDDEEEVFDSI-----------------VN--DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK  623 (694)
T ss_pred             CCCCHHHHHHHH-----------------hc--CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence            876543222222                 22  136678899999999999999999999964     455553

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-34  Score=247.46  Aligned_cols=205  Identities=25%  Similarity=0.359  Sum_probs=175.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|+.++||||++++.+.+....+|+|+||+.+|.+.+++.+.+  ++.+..+...+.|+++|++|||  .++||
T Consensus       102 ~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH--~k~iv  177 (596)
T KOG0586|consen  102 LGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCH--SKNIV  177 (596)
T ss_pred             HHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHh--hccee
Confidence            4689999999999999999999999999999999999999999999887  6777999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC-CccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+|||.+||+++.+-.+||+|||++..+..   ......+.+++.|.|||++.+..++ +.+|+||+|+++|.|++|..|
T Consensus       178 HrdLk~eNilL~~~mnikIaDfgfS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLP  254 (596)
T KOG0586|consen  178 HRDLKAENILLDENMNIKIADFGFSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLP  254 (596)
T ss_pred             ccccchhhcccccccceeeeccccceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccc
Confidence            999999999999999999999999987653   2333446789999999999988776 789999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |++..-.........                   ....++.-.+.++.++|+++|-.+|.+|+++.++.++-
T Consensus       255 FDG~~lk~Lr~rvl~-------------------gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  255 FDGQNLKELRPRVLR-------------------GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             cCCcccccccchhee-------------------eeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            987554222111110                   11334556778899999999999999999999999753

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-33  Score=229.11  Aligned_cols=206  Identities=29%  Similarity=0.445  Sum_probs=171.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+|++++++++.+.+..+++++++.+++|.+++....  .+++..+..++.|++.+|.+||  +.|++
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~~l~~lH--~~~i~  121 (254)
T cd06627          46 IMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLAYLH--EQGVI  121 (254)
T ss_pred             HHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHh--hCCcc
Confidence            5789999999999999999999999999999999999999999987663  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|.||+++.++.++|+|||.+.........  .....++..|+|||...+..++.++|+|+||++++++++|..||
T Consensus       122 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~  199 (254)
T cd06627         122 HRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY  199 (254)
T ss_pred             cCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998765443221  12235677899999988777889999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .........                 .. .........+..++..+.+++.+||+.+|++||++.+++.+
T Consensus       200 ~~~~~~~~~-----------------~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         200 YDLNPMAAL-----------------FR-IVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCccHHHHH-----------------HH-HhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence            643311100                 01 01112234455678899999999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.1e-33  Score=241.01  Aligned_cols=220  Identities=24%  Similarity=0.312  Sum_probs=164.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.++++++|+||++++++|....      ..|+|+||+. ++|.+.+...    ++...+..++.|++.||.||| 
T Consensus        62 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH-  135 (353)
T cd07850          62 AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLH-  135 (353)
T ss_pred             HHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHH-
Confidence            357999999999999999999886443      4699999995 5888877533    788899999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                       ..|++|+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|+|||||++++|+
T Consensus       136 -~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~  211 (353)
T cd07850         136 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI  211 (353)
T ss_pred             -hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHH
Confidence             89999999999999999999999999999875433211   12234677899999999999999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHH-----HHHhhhcc-------------------CCCCCHHHHHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRV-----LRIMDTRL-------------------GGQYSKKEAQAVAAVV  211 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~-------------------~~~~~~~~~~~l~~li  211 (278)
                      +|..||...+.......+..............     ........                   ....+...+..+.++|
T Consensus       212 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  291 (353)
T cd07850         212 RGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLL  291 (353)
T ss_pred             HCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHH
Confidence            99999976543222222221111110000000     00000000                   0001224577889999


Q ss_pred             HHhccCCCCCCCCHHHHHHH
Q 023752          212 LQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       212 ~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+||+.||++|||+.+++.+
T Consensus       292 ~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         292 SKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHcCCChhhCcCHHHHhcC
Confidence            99999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=245.86  Aligned_cols=222  Identities=27%  Similarity=0.439  Sum_probs=184.7

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .|.+|+++|.+++||||++++++|..++-+++|+||++.|+|.+++.++............++.||++|++||.  +.++
T Consensus       581 ~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe--s~nf  658 (807)
T KOG1094|consen  581 DFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE--SLNF  658 (807)
T ss_pred             HHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH--hhch
Confidence            38899999999999999999999999999999999999999999999885444455677889999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh--CC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS--GR  158 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~  158 (278)
                      |||||.+.|++++.++++||+|||.++..........+...+-..+|+|+|.+..++++.++|+|++|+++|++++  ..
T Consensus       659 VHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e  738 (807)
T KOG1094|consen  659 VHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCRE  738 (807)
T ss_pred             hhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhh
Confidence            9999999999999999999999999997777666666667777889999999999999999999999999999775  77


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      .||....++...+....    ..       ..-....-...|.-++..+.+++.+||..+-.+||+++++..+|.+.
T Consensus       739 ~Py~~lt~e~vven~~~----~~-------~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  739 QPYSQLTDEQVVENAGE----FF-------RDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CchhhhhHHHHHHhhhh----hc-------CCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            88876544322211111    11       11111112334667888999999999999999999999999998764

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=246.55  Aligned_cols=201  Identities=25%  Similarity=0.307  Sum_probs=165.2

Q ss_pred             HHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            4 TEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         4 ~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      +|+.++... +||||+++.+.+.++.+.|+|||.+.|+-+.+.+....   .....+..|+.+|+.|+.|||  .+|++|
T Consensus       364 ~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH--~~gvvh  438 (612)
T KOG0603|consen  364 DEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLH--EQGVVH  438 (612)
T ss_pred             cccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHH--hcCeee
Confidence            456555544 79999999999999999999999999998888776554   333677889999999999999  899999


Q ss_pred             cCCCCCceEE-cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           83 RDLKASNVLL-DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        83 ~dl~p~ni~~-~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |||||+||++ +..++++|+|||.+........     ...-+..|.|||++....|+.++|+||||+++|+|++|+.||
T Consensus       439 RDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~-----tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~  513 (612)
T KOG0603|consen  439 RDLKPGNILLDGSAGHLRLTYFGFWSELERSCD-----TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLF  513 (612)
T ss_pred             cCCChhheeecCCCCcEEEEEechhhhCchhhc-----ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcc
Confidence            9999999999 6889999999999987554411     123467899999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      .....+  .                  .+...-...++...+|.++++||.+||+.||.+|+++.++..|-.-
T Consensus       514 ~~~P~~--~------------------ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  514 AAHPAG--I------------------EIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             ccCCch--H------------------HHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            765543  1                  1111111233346789999999999999999999999999977555

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.4e-33  Score=232.78  Aligned_cols=225  Identities=24%  Similarity=0.335  Sum_probs=167.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|++++++++|+||+++++.+.+.+..++|+||+. ++|.+++.... ...+++..+..++.|++.||.|||  +.|+
T Consensus        45 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i  121 (284)
T cd07836          45 AIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH--ENRV  121 (284)
T ss_pred             HHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            3579999999999999999999999999999999996 48888876543 245899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      +|+||+|+||+++.++.++|+|||++.........  .....++..|++||.+.+ ..++.++|+||||+++|++++|..
T Consensus       122 ~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  199 (284)
T cd07836         122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP  199 (284)
T ss_pred             eeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999998654322111  112245678999998765 456889999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhc-cccchhHHHHHH--hhhccC-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWAD-PFLRDSRRVLRI--MDTRLG-------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ||.+.+.......+..... +...........  ......       .......+..+.++|.+||+.||.+||++.+++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l  279 (284)
T cd07836         200 LFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL  279 (284)
T ss_pred             CCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence            9976554333222222111 111111000000  000000       001124577899999999999999999999998


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      ++
T Consensus       280 ~~  281 (284)
T cd07836         280 QH  281 (284)
T ss_pred             cC
Confidence            64

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=5.7e-33  Score=230.31  Aligned_cols=194  Identities=24%  Similarity=0.343  Sum_probs=159.0

Q ss_pred             CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEE
Q 023752           13 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL   92 (278)
Q Consensus        13 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~   92 (278)
                      +||||+++++.+..++..++|+||+.+++|.+++..+.  .+++..+..++.|++.||.|||  +.|++|+||+|+||++
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH--~~~i~H~dl~p~nil~  142 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLY  142 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCeeeCCCCHHHEEE
Confidence            69999999999999999999999999999999997764  7999999999999999999999  8999999999999999


Q ss_pred             cCCC-ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhh
Q 023752           93 DSNF-NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ  171 (278)
Q Consensus        93 ~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~  171 (278)
                      +.++ .++|+|||++.......      ...++..|+|||.+.+..++.++|+||||+++|++++|..||......... 
T Consensus       143 ~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-  215 (267)
T PHA03390        143 DRAKDRIYLCDYGLCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELD-  215 (267)
T ss_pred             eCCCCeEEEecCccceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhh-
Confidence            9988 99999999886543221      124677899999998888999999999999999999999999744322110 


Q ss_pred             hHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 023752          172 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLTS  231 (278)
Q Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~  231 (278)
                       .           .......  ......+...+..+.++|.+||+.+|.+||+ ++++++|
T Consensus       216 -~-----------~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        216 -L-----------ESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             -H-----------HHHHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence             0           0000111  1122334568889999999999999999996 6999864

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=244.12  Aligned_cols=221  Identities=25%  Similarity=0.386  Sum_probs=190.5

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +|..|+.+|+.++|||+++++++|..+.-+|||+||+..|+|.+++.+-....++.-.+..++.||.+|+.||.  .+++
T Consensus       309 EFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE--kknF  386 (1157)
T KOG4278|consen  309 EFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE--KKNF  386 (1157)
T ss_pred             HHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH--Hhhh
Confidence            48899999999999999999999999999999999999999999998877777888889999999999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      +||||...|+++.++..||+.|||+++............ .--..-|.|||-+.-..++.++|+|+||+++|++.| |-.
T Consensus       387 IHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG-AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMs  465 (1157)
T KOG4278|consen  387 IHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG-AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMS  465 (1157)
T ss_pred             hhhhhhhhhccccccceEEeeccchhhhhcCCceecccC-ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCC
Confidence            999999999999999999999999998754433222211 112346999999999999999999999999999998 778


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ||.+.+.                  .....++.+..+...|.++++.+++|++.||+++|.+||++.++-+.++.++...
T Consensus       466 PYPGidl------------------SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~s  527 (1157)
T KOG4278|consen  466 PYPGIDL------------------SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSS  527 (1157)
T ss_pred             CCCCccH------------------HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccc
Confidence            8876543                  2333445556667778999999999999999999999999999999999998876


Q ss_pred             CCC
Q 023752          240 DMP  242 (278)
Q Consensus       240 ~~~  242 (278)
                      +..
T Consensus       528 Sis  530 (1157)
T KOG4278|consen  528 SIS  530 (1157)
T ss_pred             ccc
Confidence            654

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4e-33  Score=235.81  Aligned_cols=226  Identities=23%  Similarity=0.325  Sum_probs=162.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC--------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD--------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|++++++++||||+++++++...+        ..++|+||+. ++|.+.+.... ..+++..+..++.|+++||.||
T Consensus        58 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~l  135 (310)
T cd07865          58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYI  135 (310)
T ss_pred             HHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHH
Confidence            357999999999999999999986654        3499999995 58888776543 3589999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC--ccccccccCCcccCccccccC-CCCCccchhHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVV  150 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~i  150 (278)
                      |  +.|++|+||+|+||+++.++.++|+|||++.........  .......++..|+|||.+.+. .++.++|+||||++
T Consensus       136 H--~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~  213 (310)
T cd07865         136 H--RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCI  213 (310)
T ss_pred             H--HCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHH
Confidence            9  889999999999999999999999999998754332221  111223456789999987654 47889999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchh---HHHHHHhhh-ccCCCC---------CHHHHHHHHHHHHHhccC
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS---RRVLRIMDT-RLGGQY---------SKKEAQAVAAVVLQCLHM  217 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~~---------~~~~~~~l~~li~~~l~~  217 (278)
                      +|+|++|..||...+.......+...........   ......... ......         +...+..+.++|.+||+.
T Consensus       214 l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~  293 (310)
T cd07865         214 MAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL  293 (310)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcC
Confidence            9999999999976544322222222111100000   000000000 000000         011245678999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 023752          218 DPKNRPSMVDVLTS  231 (278)
Q Consensus       218 dp~~Rps~~~ll~~  231 (278)
                      ||.+|||+.++++|
T Consensus       294 ~P~~R~t~~e~l~h  307 (310)
T cd07865         294 DPAKRIDADTALNH  307 (310)
T ss_pred             ChhhccCHHHHhcC
Confidence            99999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.8e-32  Score=232.87  Aligned_cols=210  Identities=28%  Similarity=0.383  Sum_probs=167.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|||++++++++.+++..++|+||+. ++|.+.+.... ..+++..+..++.+++.|+.|||  +.+++
T Consensus        72 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH--~~~i~  147 (317)
T cd06635          72 IIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH--SHNMI  147 (317)
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5679999999999999999999999999999999996 57877775443 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.++.++|+|||++......      ....++..|+|||.+.   +..++.++|+||||+++|+|++|.
T Consensus       148 H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~  221 (317)
T cd06635         148 HRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  221 (317)
T ss_pred             cCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCC
Confidence            9999999999999999999999987643221      1234677899999873   456888999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      .||..........                 ..............++..+.+++.+||+.+|.+||++.++++++..+...
T Consensus       222 ~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         222 PPLFNMNAMSALY-----------------HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             CCCCCccHHHHHH-----------------HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            9986432211111                 11111111222345677899999999999999999999999987766554

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-33  Score=228.57  Aligned_cols=205  Identities=28%  Similarity=0.405  Sum_probs=169.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++.+..++..++++||+.+++|.+++....  .+++..+..++.|++.|+.|||  +.+++
T Consensus        40 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh--~~~~~  115 (250)
T cd05123          40 TLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLH--SLGII  115 (250)
T ss_pred             HHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCce
Confidence            5689999999999999999999999999999999999999999997664  5899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||.+........  ......++..|.+||...+..++.++|+||||+++|++++|..||
T Consensus       116 H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~  193 (250)
T cd05123         116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF  193 (250)
T ss_pred             ecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            999999999999999999999999876433211  112234677899999998888899999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH---HHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM---VDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~  231 (278)
                      ...+......                 ....  .....+...+..+.++|.+||..||++||++   .+++++
T Consensus       194 ~~~~~~~~~~-----------------~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~  247 (250)
T cd05123         194 YAEDRKEIYE-----------------KILK--DPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH  247 (250)
T ss_pred             CCCCHHHHHH-----------------HHhc--CCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence            6543211000                 1111  1234455668899999999999999999999   666543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.3e-33  Score=230.82  Aligned_cols=218  Identities=22%  Similarity=0.289  Sum_probs=163.7

Q ss_pred             HHHHHHHhccC-CccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            3 QTEVIYLGQLR-HENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         3 ~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      .+|+.+++++. |+||+++++++.++  +..++|+||+. ++|.+.+.... ..+++..+..++.|++.||.|||  +.|
T Consensus        45 ~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH--~~~  120 (282)
T cd07831          45 LREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH--RNG  120 (282)
T ss_pred             HHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            46888888885 99999999999887  78999999996 58888776543 36899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-cCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++. +.++|+|||++.........   ....++..|+|||.+. +..++.++|+|||||++|+|++|.
T Consensus       121 i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~  196 (282)
T cd07831         121 IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF  196 (282)
T ss_pred             ceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCC
Confidence            999999999999999 99999999998764332221   1234677899999764 456788999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhc--cCC-----------CCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR--LGG-----------QYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-----------~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      .||...+.......+...........   .......  ...           .....++..+.++|.+||+.+|++||++
T Consensus       197 ~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  273 (282)
T cd07831         197 PLFPGTNELDQIAKIHDVLGTPDAEV---LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITA  273 (282)
T ss_pred             cCCCCCCHHHHHHHHHHHcCCCCHHH---HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCH
Confidence            99976544322222222111111100   0000000  000           0123467899999999999999999999


Q ss_pred             HHHHHH
Q 023752          226 VDVLTS  231 (278)
Q Consensus       226 ~~ll~~  231 (278)
                      .+++++
T Consensus       274 ~~~l~~  279 (282)
T cd07831         274 KQALRH  279 (282)
T ss_pred             HHHhhC
Confidence            999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-33  Score=230.50  Aligned_cols=198  Identities=24%  Similarity=0.329  Sum_probs=158.2

Q ss_pred             HhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 023752            9 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS   88 (278)
Q Consensus         9 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~   88 (278)
                      ..+.+|+||+++++.+...+..++++||+.+++|.+++....  .+++..+..++.|++.||.|||  +.+++|+||+|.
T Consensus        51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH--~~~i~H~dl~p~  126 (260)
T cd05611          51 MIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLH--QRGIIHRDIKPE  126 (260)
T ss_pred             hhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCCHH
Confidence            445589999999999999999999999999999999997654  6899999999999999999999  899999999999


Q ss_pred             ceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCc
Q 023752           89 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL  168 (278)
Q Consensus        89 ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~  168 (278)
                      ||+++.++.++|+|||++.....      .....++..|++||.+.+..++.++|+||||+++|++++|..||...+...
T Consensus       127 nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  200 (260)
T cd05611         127 NLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA  200 (260)
T ss_pred             HeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            99999999999999998865322      112346778999999988888999999999999999999999996543221


Q ss_pred             hhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH---HHHHHH
Q 023752          169 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM---VDVLTS  231 (278)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~---~~ll~~  231 (278)
                      ....+..               ............++..+.++|.+||+.+|++||++   .+++.|
T Consensus       201 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         201 VFDNILS---------------RRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             HHHHHHh---------------cccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            1111100               00011122233568899999999999999999966   565544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.6e-33  Score=239.37  Aligned_cols=209  Identities=19%  Similarity=0.240  Sum_probs=164.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++..++|++|+++++.+.+++..|+||||+.||+|.+++.+.. ..+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH--~~~ii  124 (331)
T cd05624          48 FREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH--QLHYV  124 (331)
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5678999999999999999999999999999999999999999997643 36889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-----CCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~il~~l~~  156 (278)
                      |+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+     ..++.++|+||||+++|+|++
T Consensus       125 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~  203 (331)
T cd05624         125 HRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY  203 (331)
T ss_pred             eccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh
Confidence            9999999999999999999999998654332211 1122457889999998865     467889999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCC---CCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~  231 (278)
                      |..||...+.......+                 .......   .....++.++.++|.+||..++++  |+++.++++|
T Consensus       204 g~~Pf~~~~~~~~~~~i-----------------~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         204 GETPFYAESLVETYGKI-----------------MNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             CCCCccCCCHHHHHHHH-----------------HcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            99999654321111111                 1111111   112345788999999999876554  4689999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=254.65  Aligned_cols=216  Identities=28%  Similarity=0.458  Sum_probs=188.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |..|+.||-|++||||+++.++.....-..+|+||++.|+|+.++..+.. .++.-++..++.-|+.|+.||.  +.++|
T Consensus       677 FL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLs--dm~YV  753 (996)
T KOG0196|consen  677 FLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLS--DMNYV  753 (996)
T ss_pred             hhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHh--hcCch
Confidence            78999999999999999999999998888999999999999999988874 4999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccc-cccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~-~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      ||||...||+++.+...|++|||+++...........+. .--..+|.|||.+.-..++.++|+||+|+++||.++ |..
T Consensus       754 HRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGER  833 (996)
T KOG0196|consen  754 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER  833 (996)
T ss_pred             hhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCC
Confidence            999999999999999999999999987655442222111 122468999999999999999999999999999887 889


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      ||.++.++                  +.++.+....+.+-|..++..|++|+..||++|-.+||.+.+|+..|.++.-.
T Consensus       834 PYWdmSNQ------------------dVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  834 PYWDMSNQ------------------DVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             cccccchH------------------HHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            99877663                  33444555566777889999999999999999999999999999999998755

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.2e-33  Score=234.93  Aligned_cols=225  Identities=23%  Similarity=0.273  Sum_probs=164.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+. ++|.+.+.......+++..+..++.|++.||.|||  +.+++
T Consensus        48 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH--~~~i~  124 (294)
T PLN00009         48 AIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH--SHRVL  124 (294)
T ss_pred             HHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5689999999999999999999999999999999995 58888886655445788899999999999999999  89999


Q ss_pred             ecCCCCCceEEcC-CCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      |+||+|+||+++. ++.+||+|||++.........  .....++..|+|||.+.+ ..++.++|+||||+++|++++|..
T Consensus       125 H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~  202 (294)
T PLN00009        125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP  202 (294)
T ss_pred             CCCCCcceEEEECCCCEEEEcccccccccCCCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999999985 557999999998654332111  112245678999998765 457889999999999999999999


Q ss_pred             CCccccCCchhhhHHhh-hccccchh---HHHHHHhh--hccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEW-ADPFLRDS---RRVLRIMD--TRLGG----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~--~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ||...........+... ..+.....   ........  .....    .....++..+.+++.+||+.+|++||++.+++
T Consensus       203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l  282 (294)
T PLN00009        203 LFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL  282 (294)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence            99754332111111111 11100000   00000000  00000    01234577899999999999999999999999


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      ++
T Consensus       283 ~~  284 (294)
T PLN00009        283 EH  284 (294)
T ss_pred             cC
Confidence            64

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.2e-32  Score=232.82  Aligned_cols=204  Identities=29%  Similarity=0.374  Sum_probs=162.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++.+++.+++..++|+||+. +++.+++.... +.+++..+..++.|++.||.|||  +.|++
T Consensus        62 ~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH--~~~i~  137 (307)
T cd06607          62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH--SHERI  137 (307)
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCce
Confidence            5689999999999999999999999999999999996 57777765433 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|.||+++.++.++|+|||++......      ....++..|+|||.+.   ...++.++|+||||+++|++++|.
T Consensus       138 H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~  211 (307)
T cd06607         138 HRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (307)
T ss_pred             ecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCC
Confidence            9999999999999999999999988653322      1234667899999874   356888999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .||...+.......+.                 ............+..+.++|.+||+.+|++||++.+++.+.
T Consensus       212 ~p~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         212 PPLFNMNAMSALYHIA-----------------QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             CCCCCccHHHHHHHHh-----------------cCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            9986543211110000                 00001111234677899999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-33  Score=235.81  Aligned_cols=227  Identities=22%  Similarity=0.266  Sum_probs=164.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKG---VQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.++++++||||+++++++.+.  ...++|+||+. ++|.+.+....   ...+++..++.++.|++.||.|||  
T Consensus        49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--  125 (316)
T cd07842          49 ACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH--  125 (316)
T ss_pred             HHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH--
Confidence            45799999999999999999999988  78999999995 57777664332   136889999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcC----CCceEEeccccccCCCCCCCCc-cccccccCCcccCcccccc-CCCCCccchhHHHHH
Q 023752           77 DANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVV  150 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~----~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~i  150 (278)
                      +.+++|+||+|+||+++.    ++.+||+|||++.......... ......++..|+|||.+.+ ..++.++|+||||++
T Consensus       126 ~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~  205 (316)
T cd07842         126 SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCI  205 (316)
T ss_pred             hCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHH
Confidence            899999999999999998    8999999999987644332211 1122345778999998766 457899999999999


Q ss_pred             HHHHHhCCCCCccccCCch---------hhhHHhhhccccchhH-------HHHHHhhhccCCCCC-----------HHH
Q 023752          151 LLELLSGRRALDEDRGGLA---------EQTLVEWADPFLRDSR-------RVLRIMDTRLGGQYS-----------KKE  203 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~---------~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~-----------~~~  203 (278)
                      +++|++|..||........         ...+............       .............++           ...
T Consensus       206 l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (316)
T cd07842         206 FAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKP  285 (316)
T ss_pred             HHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCC
Confidence            9999999999976554331         0000000000000000       000000000001111           145


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          204 AQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       204 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +..+.+++.+||+.||++|||+.+++.+
T Consensus       286 ~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         286 DSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            5689999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.3e-33  Score=233.81  Aligned_cols=207  Identities=24%  Similarity=0.411  Sum_probs=170.8

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++++. |+||+++++++..++..++++|++.+++|.+++.+..  .+++..+..++.|++.||.+||  +.|+
T Consensus        48 ~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh--~~~~  123 (280)
T cd05581          48 VKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH--SKGI  123 (280)
T ss_pred             HHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            467899999998 9999999999999999999999999999999998765  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCC------------------ccccccccCCcccCccccccCCCCCcc
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT------------------HVSTRIVGTRGYAAPEYVATGHLTPKS  142 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~  142 (278)
                      +|+||+|+||+++.++.++++|||++.........                  .......++..|+|||...+..++.++
T Consensus       124 ~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~  203 (280)
T cd05581         124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSS  203 (280)
T ss_pred             eecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhh
Confidence            99999999999999999999999998765443221                  111223467789999998888889999


Q ss_pred             chhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          143 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       143 DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      |+||||++++++++|..||...........                 ..  ......+..+++.+.++|.+||+.+|.+|
T Consensus       204 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-----------------~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R  264 (280)
T cd05581         204 DLWALGCIIYQMLTGKPPFRGSNEYLTFQK-----------------IL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDR  264 (280)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCccHHHHHHH-----------------HH--hcCCCCCCccCHHHHHHHHHHhcCCHhhC
Confidence            999999999999999999975442111111                 11  11233455668889999999999999999


Q ss_pred             CCH----HHHHHH
Q 023752          223 PSM----VDVLTS  231 (278)
Q Consensus       223 ps~----~~ll~~  231 (278)
                      |++    .++++|
T Consensus       265 ~~~~~~~~~ll~~  277 (280)
T cd05581         265 LGVNEGYDELKAH  277 (280)
T ss_pred             CCcccCHHHHhcC
Confidence            999    888764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-33  Score=239.74  Aligned_cols=234  Identities=27%  Similarity=0.383  Sum_probs=172.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC-----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.+++.++|+||+++++++...     ...++++||+. ++|.+++...+  .+++..+..++.|++.||.|||  
T Consensus        51 ~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH--  125 (337)
T cd07858          51 TLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIH--  125 (337)
T ss_pred             HHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH--
Confidence            45799999999999999999988654     34799999994 68988887654  6999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~  155 (278)
                      +.+++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+ ..++.++|+||||+++|+|+
T Consensus       126 ~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  203 (337)
T cd07858         126 SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL  203 (337)
T ss_pred             hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHH
Confidence            8999999999999999999999999999987643321  11122346778999998764 46889999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchh------HHHHHHhhh---ccCC---CCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDS------RRVLRIMDT---RLGG---QYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~---~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      +|+.||...+.......+.........+.      ......+..   ....   .....++.++.++|.+||+.+|++||
T Consensus       204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  283 (337)
T cd07858         204 GRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI  283 (337)
T ss_pred             cCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc
Confidence            99999976543222222222111111000      000011100   0000   11234678899999999999999999


Q ss_pred             CHHHHHHH--HHhhhcCCCCC
Q 023752          224 SMVDVLTS--LEQLHTSKDMP  242 (278)
Q Consensus       224 s~~~ll~~--l~~~~~~~~~~  242 (278)
                      |+.++++|  +..+......|
T Consensus       284 s~~ell~h~~~~~~~~~~~~~  304 (337)
T cd07858         284 TVEEALAHPYLASLHDPSDEP  304 (337)
T ss_pred             CHHHHHcCcchhhhcCcccCc
Confidence            99999988  77766554443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-34  Score=232.31  Aligned_cols=221  Identities=21%  Similarity=0.275  Sum_probs=174.5

Q ss_pred             HHHHHHHhccC-C-c----cccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            3 QTEVIYLGQLR-H-E----NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         3 ~~E~~~l~~l~-h-~----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +-|+++|+++. + |    -++.+.++|+..++.|+|+|.+ |-|+.+++.+++..+++...+..+.+||++++++||  
T Consensus       133 ~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh--  209 (415)
T KOG0671|consen  133 LIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH--  209 (415)
T ss_pred             HHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH--
Confidence            35889999993 2 2    4678888899999999999988 779999999988889999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcC--------------------CCceEEeccccccCCCCCCCCccccccccCCcccCccccccC
Q 023752           77 DANVIYRDLKASNVLLDS--------------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG  136 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~--------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  136 (278)
                      +.+++|.||||+||++..                    +..|+++|||.++...     ......+.|..|.|||++.+-
T Consensus       210 ~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgL  284 (415)
T KOG0671|consen  210 DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGL  284 (415)
T ss_pred             hcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheecc
Confidence            999999999999999831                    2348999999998632     223446789999999999999


Q ss_pred             CCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHH---HHhhhc-------------------
Q 023752          137 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL---RIMDTR-------------------  194 (278)
Q Consensus       137 ~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------------------  194 (278)
                      +|+.++|+||+|||++|+++|...|...++......+.....|.........   +.+...                   
T Consensus       285 GwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~  364 (415)
T KOG0671|consen  285 GWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEP  364 (415)
T ss_pred             CcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcC
Confidence            9999999999999999999999999988876666555555554333221111   111100                   


Q ss_pred             cC-----CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          195 LG-----GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       195 ~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..     .........+|.+|+++||.+||.+|+|+.|++.|
T Consensus       365 ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  365 CKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             CccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcC
Confidence            00     00123355689999999999999999999999965

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=243.47  Aligned_cols=224  Identities=23%  Similarity=0.384  Sum_probs=187.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+|.+|+|+|++++|++..+ .-.-+|+|.+.+|+|.+.+.+.....+-...+..++.||+.|+.||.  .++++
T Consensus       158 flrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe--skrlv  234 (1039)
T KOG0199|consen  158 FLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE--SKRLV  234 (1039)
T ss_pred             HHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh--hhhhh
Confidence            7899999999999999999999987 45678999999999999998855567888899999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccc-cccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~-~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      ||||-..|+++.....|||+|||+.+.+........+.. ..-...|+|||.+....++.++|+|++|+++|||++ |..
T Consensus       235 HRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEe  314 (1039)
T KOG0199|consen  235 HRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEE  314 (1039)
T ss_pred             hhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCC
Confidence            999999999999988999999999987666554433322 233457999999999999999999999999999999 678


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ||.+-.+                  ..++..++.+...+-+..+++.+++++..||..+|.+|||+..|.+.+-......
T Consensus       315 PW~G~~g------------------~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp  376 (1039)
T KOG0199|consen  315 PWVGCRG------------------IQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQP  376 (1039)
T ss_pred             CCCCCCH------------------HHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCC
Confidence            8866443                  3444555555566778889999999999999999999999999986666555554


Q ss_pred             CCCCCCC
Q 023752          240 DMPRTPP  246 (278)
Q Consensus       240 ~~~~~~~  246 (278)
                      ...+...
T Consensus       377 ~~a~~~~  383 (1039)
T KOG0199|consen  377 AVARETY  383 (1039)
T ss_pred             ceeeeec
Confidence            4444443

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-32  Score=235.51  Aligned_cols=231  Identities=28%  Similarity=0.409  Sum_probs=169.2

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|+.+++++ +||||+++++++...  ...++|+||+. ++|.+++..+   .+++..+..++.|++.||.|||  +.
T Consensus        53 ~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH--~~  126 (337)
T cd07852          53 TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH--SG  126 (337)
T ss_pred             hhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HC
Confidence            45799999999 999999999998654  36799999996 5998888654   5788899999999999999999  89


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC---ccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT---HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                      |++|+||+|+||+++.++.++|+|||.+.........   .......++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus       127 ~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el  206 (337)
T cd07852         127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM  206 (337)
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHH
Confidence            9999999999999999999999999998765433221   12223456788999998755 4678899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchh---------HHHHHHhhhccC---CCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDS---------RRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|+.||...........+.........+.         ............   ......++.++.++|.+||+.||++|
T Consensus       207 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R  286 (337)
T cd07852         207 LLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR  286 (337)
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccc
Confidence            999999976543332222222211111000         000000000000   01112357889999999999999999


Q ss_pred             CCHHHHHHH--HHhhhcC
Q 023752          223 PSMVDVLTS--LEQLHTS  238 (278)
Q Consensus       223 ps~~~ll~~--l~~~~~~  238 (278)
                      ||+.+++.+  +.++...
T Consensus       287 ps~~~il~~~~~~~~~~~  304 (337)
T cd07852         287 LTAEEALEHPYVAQFHNP  304 (337)
T ss_pred             cCHHHHhhChhhhhhccC
Confidence            999999976  5555444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-32  Score=229.28  Aligned_cols=200  Identities=25%  Similarity=0.367  Sum_probs=161.4

Q ss_pred             HHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 023752            8 YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA   87 (278)
Q Consensus         8 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p   87 (278)
                      .++...||+|+++++.+.+.+..++|+||+.|++|.+++...+  .+++..+..++.|++.||.|||  +.+++|+||+|
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH--~~~i~H~di~p  125 (278)
T cd05606          50 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMH--NRFVVYRDLKP  125 (278)
T ss_pred             HHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEEcCCCCH
Confidence            3444579999999999999999999999999999999887654  6999999999999999999999  89999999999


Q ss_pred             CceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCCCccccC
Q 023752           88 SNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRG  166 (278)
Q Consensus        88 ~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~  166 (278)
                      +||+++.++.++|+|||++........    ....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.....
T Consensus       126 ~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~  201 (278)
T cd05606         126 ANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT  201 (278)
T ss_pred             HHEEECCCCCEEEccCcCccccCccCC----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence            999999999999999999865432211    223578889999998644 688999999999999999999999975432


Q ss_pred             CchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      .....               . ...........+...+..+.+++.+||..+|.+||     ++.+++++
T Consensus       202 ~~~~~---------------~-~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         202 KDKHE---------------I-DRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             cchHH---------------H-HHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            11111               0 00011122344555688999999999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-32  Score=229.61  Aligned_cols=223  Identities=26%  Similarity=0.354  Sum_probs=168.0

Q ss_pred             HHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .+|+..++++. |+||+++++.+.+++..++|+||+ +++|.+.+.......+++..+..++.|++.+|.|||  +.|++
T Consensus        45 ~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh--~~~i~  121 (283)
T cd07830          45 LREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--KHGFF  121 (283)
T ss_pred             HHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            46888999998 999999999999999999999999 789999887665456899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-cCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|.||+++.++.++|+|||.+.........   ....++..|+|||.+. +..++.++|+||||++++++++|+.|
T Consensus       122 H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~  198 (283)
T cd07830         122 HRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPL  198 (283)
T ss_pred             cCCCChhhEEEcCCCCEEEeecccceeccCCCCc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCc
Confidence            9999999999999999999999998754332211   1234677899999874 45678999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhH-HHH---HHhhhccC----C---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSR-RVL---RIMDTRLG----G---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~~~~~~~----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |...........+.....+...... ...   ........    .   ......+..+.++|.+||+.+|++||++.+++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~  278 (283)
T cd07830         199 FPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL  278 (283)
T ss_pred             cCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence            9766543333332222221111100 000   00000000    0   00112257899999999999999999999998


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      .+
T Consensus       279 ~~  280 (283)
T cd07830         279 QH  280 (283)
T ss_pred             hC
Confidence            64

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=241.73  Aligned_cols=213  Identities=24%  Similarity=0.382  Sum_probs=180.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |..|..+|+++.||||++++|++.+. -.|+|||.+.-|.|..+++.+.. .++...+..+++||+.||.|||  +..+|
T Consensus       438 flqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLe--SkrfV  513 (974)
T KOG4257|consen  438 FLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLE--SKRFV  513 (974)
T ss_pred             HHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHH--hhchh
Confidence            78999999999999999999999874 67999999999999999987763 5888899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      ||||...||++.....|||+|||+++.......-... ...-..-|+|||-+.-..++.++|+|.||+++|+++. |..|
T Consensus       514 HRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkP  592 (974)
T KOG4257|consen  514 HRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKP  592 (974)
T ss_pred             hhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCc
Confidence            9999999999999999999999999876544322211 2223456999999888899999999999999999887 8899


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      |.+-.+....                  ..+..+.+.+.|.++++.++.++.+||..+|.+||++.++...|..+..
T Consensus       593 fqgvkNsDVI------------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  593 FQGVKNSDVI------------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             cccccccceE------------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            9765443221                  2233344577889999999999999999999999999999988887765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.9e-33  Score=227.34  Aligned_cols=191  Identities=23%  Similarity=0.293  Sum_probs=155.8

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+|...+....||||+++++++.+.+..++++||+.+++|.+++.+..  .+++..+..++.|+++||.|||  +.|++|
T Consensus        33 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH--~~~i~H  108 (237)
T cd05576          33 SRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL--NIPEECVKRWAAEMVVALDALH--REGIVC  108 (237)
T ss_pred             hhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH--hCCeec
Confidence            455566666689999999999999999999999999999999987654  5899999999999999999999  899999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      +||+|+||+++.++.++++|||.+........     ....+..|+|||...+..++.++|+||+|+++|++++|..|+.
T Consensus       109 ~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~  183 (237)
T cd05576         109 RDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE  183 (237)
T ss_pred             cCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence            99999999999999999999998754333211     1234567999999888888999999999999999999998875


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      .....                       .........+..++..+.++|.+||+.||++||++
T Consensus       184 ~~~~~-----------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         184 CHPSG-----------------------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             cCchh-----------------------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            32110                       00001122345577889999999999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.3e-33  Score=236.91  Aligned_cols=225  Identities=24%  Similarity=0.357  Sum_probs=166.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      +.+|+.++++++||||+++++++..    ....++|+||+. ++|.+++...+  .+++..+..++.|++.||.|||  .
T Consensus        51 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH--~  125 (334)
T cd07855          51 TLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIH--S  125 (334)
T ss_pred             HHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHH--H
Confidence            4579999999999999999998863    346799999995 68988886554  5899999999999999999999  8


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC--ccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                      .|++|+||+|+||+++.++.++|+|||++.........  .......++..|.|||.+.+ ..++.++|+||||+++|+|
T Consensus       126 ~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el  205 (334)
T cd07855         126 ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM  205 (334)
T ss_pred             CCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHH
Confidence            99999999999999999999999999998654332211  11123456788999998765 4688999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccch------hHHHHHHhhh-ccCCCC-----CHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRD------SRRVLRIMDT-RLGGQY-----SKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~-~~~~~~-----~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||...+.......+..........      .......... ......     ....+..+.++|.+||+.+|++|
T Consensus       206 ~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  285 (334)
T cd07855         206 LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER  285 (334)
T ss_pred             HcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence            99999997654433222222211110000      0000011110 001111     13457889999999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      |++.+++.+
T Consensus       286 pt~~~~l~~  294 (334)
T cd07855         286 ITVEQALQH  294 (334)
T ss_pred             cCHHHHHhC
Confidence            999999975

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.2e-33  Score=233.47  Aligned_cols=212  Identities=25%  Similarity=0.330  Sum_probs=161.1

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHH---hhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHL---FRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~---~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      +.+|+.++.++. |+||+++++++..++..++++|++. +++.++.   .......+++..+..++.+++.||.|||+ .
T Consensus        49 ~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~-~  126 (288)
T cd06616          49 LLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE-E  126 (288)
T ss_pred             HHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-c
Confidence            567999999996 9999999999999899999999984 5665543   22233469999999999999999999993 2


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC---CCCCccchhHHHHHHHHH
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~il~~l  154 (278)
                      .+++|+||+|+||+++.++.++|+|||++.........   ....++..|+|||.+.+.   .++.++|+||||+++|++
T Consensus       127 ~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el  203 (288)
T cd06616         127 LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV  203 (288)
T ss_pred             CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHH
Confidence            59999999999999999999999999998654322211   122467789999998765   688999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|+.||.....  ..+.+......           .........+..++.++.+||.+||+.+|++|||+.+++++
T Consensus       204 ~~g~~p~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         204 ATGKFPYPKWNS--VFDQLTQVVKG-----------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             HhCCCCchhcch--HHHHHhhhcCC-----------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            999999965331  10111110000           00001111223578899999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.3e-32  Score=227.13  Aligned_cols=206  Identities=23%  Similarity=0.325  Sum_probs=166.0

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      ..|+.+++.++||||+++++.+.+....++++||+.+++|.+++...  ....+++..+..++.|++.||.|||  +.|+
T Consensus        50 ~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH--~~~i  127 (260)
T cd08222          50 NQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH--QRRI  127 (260)
T ss_pred             HHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH--HcCc
Confidence            46889999999999999999999999999999999999999988642  2346899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++. +.++|+|||++........  ......++..|+|||...+..++.++|+||||++++++++|..|
T Consensus       128 ~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~  204 (260)
T cd08222         128 LHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA  204 (260)
T ss_pred             cccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999975 5799999998865433211  11223467789999998888889999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |.......   ..               ...........+..++.++.++|.+||+.+|++||++.+++++
T Consensus       205 ~~~~~~~~---~~---------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         205 FEGQNFLS---VV---------------LRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCCccHHH---HH---------------HHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            86432110   00               0111112233456778899999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.9e-32  Score=230.68  Aligned_cols=207  Identities=29%  Similarity=0.359  Sum_probs=164.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|+|++++++++......++|+||+. +++.+.+.... ..+++..+..++.|++.|+.|||  +.+++
T Consensus        62 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH--~~~i~  137 (308)
T cd06634          62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH--SHNMI  137 (308)
T ss_pred             HHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            4579999999999999999999999999999999995 58877765443 35889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|.||+++.++.++|+|||++......      ....++..|+|||.+.   ...++.++|+||||+++|++++|.
T Consensus       138 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  211 (308)
T cd06634         138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (308)
T ss_pred             cCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC
Confidence            9999999999999999999999988653321      1234677899999874   346788999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      .||...+.......                 .............++..+.++|.+||+.+|++||++.+++++..-.
T Consensus       212 ~p~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         212 PPLFNMNAMSALYH-----------------IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             CCCccccHHHHHHH-----------------HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence            99865322111111                 1111111112345778899999999999999999999999874433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-33  Score=237.48  Aligned_cols=232  Identities=28%  Similarity=0.392  Sum_probs=175.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.++++++|+||+++++++....     ..|++++|+. ++|.+++.+..  .+++..+..++.+++.||.+||  
T Consensus        46 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH--  120 (330)
T cd07834          46 ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH--  120 (330)
T ss_pred             HHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH--
Confidence            578999999999999999999998765     7899999996 58988886654  7999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCccccccC-CCCCccchhHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l  154 (278)
                      +.|++|+||+|.||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||||+++++|
T Consensus       121 ~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l  200 (330)
T cd07834         121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL  200 (330)
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHH
Confidence            899999999999999999999999999998865443211 111223567789999999877 889999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccch------hHHHHHHhhh---ccC---CCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRD------SRRVLRIMDT---RLG---GQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||...........+.........+      .......+..   ...   ......++..+.++|.+||+.+|.+|
T Consensus       201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  280 (330)
T cd07834         201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR  280 (330)
T ss_pred             HcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhC
Confidence            99999997765433333322221111100      0001111110   000   01123357889999999999999999


Q ss_pred             CCHHHHHHH--HHhhhcC
Q 023752          223 PSMVDVLTS--LEQLHTS  238 (278)
Q Consensus       223 ps~~~ll~~--l~~~~~~  238 (278)
                      |++.+++.+  ++++...
T Consensus       281 pt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         281 ITADEALAHPYLAQLHDP  298 (330)
T ss_pred             CCHHHHHhCccHHhhccc
Confidence            999999986  6665554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.6e-32  Score=230.67  Aligned_cols=225  Identities=21%  Similarity=0.266  Sum_probs=162.7

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCc-----cEEEEeccCCCCHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDN-----RLLVYEFMPKGSLENHLFRKG---VQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      +.+|+.+++.+. |+||+++++++.....     .|+++||+.+ +|.+++....   ...+++..+..++.|++.||.|
T Consensus        47 ~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~  125 (295)
T cd07837          47 ALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH  125 (295)
T ss_pred             HHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHH
Confidence            568999999995 6999999999877655     7999999975 8988876542   2358999999999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEEcC-CCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHH
Q 023752           73 LHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVV  150 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~i  150 (278)
                      ||  ..|++|+||+|+||+++. ++.++|+|||.+..........  ....+++.|.|||.+.+ ..++.++|+||||++
T Consensus       126 LH--~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~  201 (295)
T cd07837         126 CH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCI  201 (295)
T ss_pred             HH--HCCeeecCCChHHEEEecCCCeEEEeecccceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHH
Confidence            99  899999999999999998 8899999999887543321111  11235677999998765 457899999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhc-cccchh---HHHHHHhh-hccC----CCCCHHHHHHHHHHHHHhccCCCCC
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWAD-PFLRDS---RRVLRIMD-TRLG----GQYSKKEAQAVAAVVLQCLHMDPKN  221 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~-~~~~----~~~~~~~~~~l~~li~~~l~~dp~~  221 (278)
                      +|+|++|..||...........+..... +.....   ........ ....    ......++.++.+||.+||+.||.+
T Consensus       202 l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~  281 (295)
T cd07837         202 FAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAK  281 (295)
T ss_pred             HHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhh
Confidence            9999999999976443222222221110 000000   00000000 0000    0011246788999999999999999


Q ss_pred             CCCHHHHHHH
Q 023752          222 RPSMVDVLTS  231 (278)
Q Consensus       222 Rps~~~ll~~  231 (278)
                      ||++.+++.+
T Consensus       282 R~~~~eil~~  291 (295)
T cd07837         282 RISAKAALTH  291 (295)
T ss_pred             cCCHHHHhcC
Confidence            9999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-32  Score=230.35  Aligned_cols=203  Identities=29%  Similarity=0.407  Sum_probs=162.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|||++++++++.+....|+++||+. +++.+++.... ..+++..+..++.|++.++.|||  +.|++
T Consensus        68 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH--~~gi~  143 (313)
T cd06633          68 IIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH--SHNMI  143 (313)
T ss_pred             HHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            4679999999999999999999999999999999995 57877776543 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.++.++|+|||++.....      .....++..|+|||.+.   +..++.++|+||||+++|+|++|.
T Consensus       144 H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~  217 (313)
T cd06633         144 HRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  217 (313)
T ss_pred             cCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            999999999999999999999998754221      11235677899999874   356888999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||...+.......+.                 ...........++..+.+|+.+||+.+|.+||++.+++.+
T Consensus       218 ~p~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         218 PPLFNMNAMSALYHIA-----------------QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCCCCCChHHHHHHHH-----------------hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9986543211111111                 0111111223456679999999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-33  Score=237.15  Aligned_cols=235  Identities=26%  Similarity=0.363  Sum_probs=169.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.++++++|+||+++++++....     ..++++|++. ++|.+++..+   .+++..+..++.|++.||.|||  
T Consensus        50 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH--  123 (336)
T cd07849          50 TLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIH--  123 (336)
T ss_pred             HHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--
Confidence            467999999999999999999876543     4789999995 5888877543   5899999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                      +.|++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+ ..++.++|+||||+++|+|
T Consensus       124 ~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el  203 (336)
T cd07849         124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM  203 (336)
T ss_pred             hCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHH
Confidence            8999999999999999999999999999987543322111 1122456788999998654 5688999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhcc-ccchhH--------HHHHHhhhccCCC---CCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADP-FLRDSR--------RVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|+.||.+.+.......+...... ......        ............+   ....++.++.++|.+||+.+|.+|
T Consensus       204 ~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  283 (336)
T cd07849         204 LSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR  283 (336)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhC
Confidence            9999999754432221111111110 000000        0000000000000   012356789999999999999999


Q ss_pred             CCHHHHHHH--HHhhhcCCCCC
Q 023752          223 PSMVDVLTS--LEQLHTSKDMP  242 (278)
Q Consensus       223 ps~~~ll~~--l~~~~~~~~~~  242 (278)
                      ||+.+++++  +.++....+.|
T Consensus       284 pt~~e~l~hp~~~~~~~~~~~~  305 (336)
T cd07849         284 ITVEEALAHPYLEQYHDPSDEP  305 (336)
T ss_pred             cCHHHHhcCccccccCCCCCcc
Confidence            999999987  76666554433

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.2e-32  Score=228.49  Aligned_cols=224  Identities=23%  Similarity=0.289  Sum_probs=161.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|+||+++++++...+..++|+||+. +++.+.+.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        50 ~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~  125 (291)
T cd07870          50 AIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH--GQHIL  125 (291)
T ss_pred             HHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            4689999999999999999999999889999999995 68877775543 35788889999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+. .++.++|+||||++++++++|..|
T Consensus       126 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~  203 (291)
T cd07870         126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPA  203 (291)
T ss_pred             cCCCChHHEEEcCCCcEEEeccccccccCCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999988653322211  1123457789999988653 578899999999999999999999


Q ss_pred             CccccCCc-hhhhH-HhhhccccchhHHHHH-------HhhhccCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          161 LDEDRGGL-AEQTL-VEWADPFLRDSRRVLR-------IMDTRLGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       161 ~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~-------~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      |....... ..... .....+..........       ..........     ....+..+.+++.+|++.||.+|||+.
T Consensus       204 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~  283 (291)
T cd07870         204 FPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQ  283 (291)
T ss_pred             CCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHH
Confidence            97544311 00000 0000010000000000       0000000000     001256889999999999999999999


Q ss_pred             HHHHH
Q 023752          227 DVLTS  231 (278)
Q Consensus       227 ~ll~~  231 (278)
                      +++.|
T Consensus       284 ~~l~h  288 (291)
T cd07870         284 DALLH  288 (291)
T ss_pred             HHhcC
Confidence            99864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-32  Score=230.25  Aligned_cols=225  Identities=24%  Similarity=0.324  Sum_probs=167.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|++++++++|+|++++++++.+.  +..++|++|+. ++|.+++.... ..+++..+..++.|++.||.|||  +.|
T Consensus        45 ~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH--~~~  120 (287)
T cd07840          45 AIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH--SNG  120 (287)
T ss_pred             HHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            56799999999999999999999888  78999999996 58988886553 36899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|.||+++.++.++|+|||++.......... .....++..|+|||.+.+ ..++.++|+||||++++++++|.
T Consensus       121 ~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~  199 (287)
T cd07840         121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK  199 (287)
T ss_pred             ceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999987654433211 122345678999997765 46788999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccch-hHHHHH---HhhhccCCC--------CCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRD-SRRVLR---IMDTRLGGQ--------YSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      .||...........+.......... ......   .........        ....++..+.+++.+||+.+|.+||++.
T Consensus       200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~  279 (287)
T cd07840         200 PIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISAD  279 (287)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            9997655433222222211110000 000000   000000000        0111377899999999999999999999


Q ss_pred             HHHHH
Q 023752          227 DVLTS  231 (278)
Q Consensus       227 ~ll~~  231 (278)
                      +++++
T Consensus       280 ~~l~~  284 (287)
T cd07840         280 QALQH  284 (287)
T ss_pred             HHhhC
Confidence            99864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-32  Score=227.97  Aligned_cols=224  Identities=23%  Similarity=0.299  Sum_probs=166.2

Q ss_pred             hHHHHHHHhcc---CCccccceeeeeecCCc-----cEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL---RHENLVKLIGYCSESDN-----RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+.+++++   +|+||+++++++.....     .++++|++. ++|.+++.......+++..+..++.|++.||.||
T Consensus        45 ~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~L  123 (287)
T cd07838          45 TLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFL  123 (287)
T ss_pred             HHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            34677777666   59999999999988776     899999996 5899888765544689999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.+++|+||+|+||+++.++.++|+|||.+.........   ....++..|+|||.+.+..++.++|+||||+++|+
T Consensus       124 H--~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~  198 (287)
T cd07838         124 H--SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAE  198 (287)
T ss_pred             H--HCCeeeccCChhhEEEccCCCEEEeccCcceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHH
Confidence            9  899999999999999999999999999998765333221   11235678999999988889999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccch-----hHHHHHHhhhcc---CCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRD-----SRRVLRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      |++|..||...........+..........     ............   ........+..+.++|.+||+.||.+||++
T Consensus       199 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~  278 (287)
T cd07838         199 LFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISA  278 (287)
T ss_pred             HHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCH
Confidence            999999997654433322222211100000     000000000000   011123457888999999999999999999


Q ss_pred             HHHHHH
Q 023752          226 VDVLTS  231 (278)
Q Consensus       226 ~~ll~~  231 (278)
                      .+++.+
T Consensus       279 ~~il~~  284 (287)
T cd07838         279 FEALQH  284 (287)
T ss_pred             HHHhcC
Confidence            999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-33  Score=225.87  Aligned_cols=227  Identities=21%  Similarity=0.284  Sum_probs=169.1

Q ss_pred             HHHHHHhccCCccccceeeeeec-CCccEEEEeccCCCCHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHLFRK---GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +|+-.++.++||||+.+..+|.. +...++++||.+ .+|...+.-.   ..+.++...+..+++||+.|+.|||  ++-
T Consensus        76 REiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH--~NW  152 (438)
T KOG0666|consen   76 REIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH--SNW  152 (438)
T ss_pred             HHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh--hhh
Confidence            78999999999999999999987 567899999995 4899888532   2246899999999999999999999  999


Q ss_pred             eeecCCCCCceEEcCC----CceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccC-CCCCccchhHHHHHHHH
Q 023752           80 VIYRDLKASNVLLDSN----FNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~----~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~  153 (278)
                      |.||||||.||++..+    |.|||+|+|+++.+.+.-.... ....+-+.+|+|||++.|. .|+.+.|+|++|||+.|
T Consensus       153 vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaE  232 (438)
T KOG0666|consen  153 VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAE  232 (438)
T ss_pred             eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHH
Confidence            9999999999999887    8999999999998776654432 2335668899999998774 79999999999999999


Q ss_pred             HHhCCCCCccccCCchh---------hhHHhhhc-------cccchhHHHHHHhhhcc---CCCC--------CHHHHHH
Q 023752          154 LLSGRRALDEDRGGLAE---------QTLVEWAD-------PFLRDSRRVLRIMDTRL---GGQY--------SKKEAQA  206 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~---------~~~~~~~~-------~~~~~~~~~~~~~~~~~---~~~~--------~~~~~~~  206 (278)
                      |++..+.|.+.......         ..+.+...       |.+.+.-+....+....   ....        ...-++.
T Consensus       233 lLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~  312 (438)
T KOG0666|consen  233 LLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPS  312 (438)
T ss_pred             HHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCch
Confidence            99999888664333222         12222111       11111111101111110   0000        0112345


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          207 VAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       207 l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      ..+|+.+||+.||-+|.|+++++++.-
T Consensus       313 a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  313 ALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHHHHhccCchhhccHHHHhcccc
Confidence            789999999999999999999998753

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.5e-32  Score=228.05  Aligned_cols=205  Identities=27%  Similarity=0.375  Sum_probs=158.5

Q ss_pred             HHHHH-HhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-C
Q 023752            4 TEVIY-LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDA-N   79 (278)
Q Consensus         4 ~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~   79 (278)
                      .|+.+ ++.++||||+++++++..++..++++||++ ++|.+++...  ....+++..++.++.|++.||.|||  +. +
T Consensus        48 ~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~~  124 (283)
T cd06617          48 MDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLS  124 (283)
T ss_pred             HHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--hcCC
Confidence            34454 566789999999999999999999999995 6888877542  2246899999999999999999999  76 9


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc----CCCCCccchhHHHHHHHHHH
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----GHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~il~~l~  155 (278)
                      ++|+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+    ..++.++|+||||+++|+|+
T Consensus       125 i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~  201 (283)
T cd06617         125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELA  201 (283)
T ss_pred             eecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHH
Confidence            99999999999999999999999999875432211   122346778999998865    45688999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCC-CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQY-SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +|+.||.......  +.              ...... ...... ...++.++.++|.+||+.+|++||++.+++++
T Consensus       202 ~g~~p~~~~~~~~--~~--------------~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         202 TGRFPYDSWKTPF--QQ--------------LKQVVE-EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             hCCCCCCccccCH--HH--------------HHHHHh-cCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9999996432210  00              111111 111112 23467889999999999999999999999974

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.7e-32  Score=234.69  Aligned_cols=225  Identities=23%  Similarity=0.275  Sum_probs=166.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++|+||+++++++...+..++++|++. ++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        67 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH--~~~i~  141 (335)
T PTZ00024         67 TLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLH--KWYFM  141 (335)
T ss_pred             HHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            4689999999999999999999999999999999995 68999887654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC------------CccccccccCCcccCccccccC-CCCCccchhHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN------------THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFG  148 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG  148 (278)
                      |+||+|+||+++.++.++|+|||.+........            ........++..|+|||.+.+. .++.++|+||||
T Consensus       142 H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  221 (335)
T PTZ00024        142 HRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG  221 (335)
T ss_pred             cccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence            999999999999999999999998875442110            0111112356789999988664 468899999999


Q ss_pred             HHHHHHHhCCCCCccccCCchhhhHHhhhccccch-hHHHHH---Hh--hhccC---CCCCHHHHHHHHHHHHHhccCCC
Q 023752          149 VVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD-SRRVLR---IM--DTRLG---GQYSKKEAQAVAAVVLQCLHMDP  219 (278)
Q Consensus       149 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~--~~~~~---~~~~~~~~~~l~~li~~~l~~dp  219 (278)
                      ++++++++|..||...+.......+.......... ......   ..  ....+   .......+..+.++|.+||+.+|
T Consensus       222 ~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  301 (335)
T PTZ00024        222 CIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP  301 (335)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc
Confidence            99999999999997655433222222211111000 000000   00  00000   00112346789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 023752          220 KNRPSMVDVLTS  231 (278)
Q Consensus       220 ~~Rps~~~ll~~  231 (278)
                      ++||++.+++.+
T Consensus       302 ~~R~s~~~~l~~  313 (335)
T PTZ00024        302 LERISAKEALKH  313 (335)
T ss_pred             hhccCHHHHhcC
Confidence            999999999964

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.1e-32  Score=229.33  Aligned_cols=213  Identities=25%  Similarity=0.353  Sum_probs=168.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++++ +||||+++++.+......++|+||+.+++|.+.+....  .+++..+..++.|++.+|.|||  ..++
T Consensus        51 ~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH--~~~~  126 (288)
T cd05583          51 TRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLH--QLGI  126 (288)
T ss_pred             HHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            46799999999 69999999999999999999999999999999887654  6889999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC--CCCccchhHHHHHHHHHHhCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~  158 (278)
                      +|+||+|.||+++.++.++|+|||++.......... .....++..|++||.+.+..  .+.++|+||||+++++|++|.
T Consensus       127 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~  205 (288)
T cd05583         127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA  205 (288)
T ss_pred             eccCCCHHHeEECCCCCEEEEECccccccccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCC
Confidence            999999999999999999999999887543332111 11234678899999986654  778999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      .||...........+.              ..+. ....+.+..++..+.++|.+||+.||++|||+.++...|..
T Consensus       206 ~p~~~~~~~~~~~~~~--------------~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         206 SPFTVDGEQNSQSEIS--------------RRIL-KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             CCcccCcccchHHHHH--------------HHHH-ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            9996432211111110              1011 11234455677889999999999999999998777655544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-32  Score=228.87  Aligned_cols=224  Identities=25%  Similarity=0.327  Sum_probs=168.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++|+||+++++++.+.+..++++|++. ++|.+++.+.. ..+++..+..++.+++.||.+||  +.|++
T Consensus        45 ~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH--~~~i~  120 (282)
T cd07829          45 ALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH--SHRIL  120 (282)
T ss_pred             HHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            4679999999999999999999999999999999996 59999997663 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+.........  ......+..|+|||.+.+. .++.++|+||||++++++++|..|
T Consensus       121 H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~  198 (282)
T cd07829         121 HRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPL  198 (282)
T ss_pred             cCCCChheEEEcCCCCEEEecCCcccccCCCccc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998764332211  1122345679999998766 788999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccch-hHHHHHH--hh---hcc----CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRD-SRRVLRI--MD---TRL----GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~---~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |...........+.......... .......  ..   ...    ........+..+.++|.+||..||++||++.+++.
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         199 FPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             CCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            97654332222222211111000 0000000  00   000    00011234678999999999999999999999986


Q ss_pred             H
Q 023752          231 S  231 (278)
Q Consensus       231 ~  231 (278)
                      +
T Consensus       279 ~  279 (282)
T cd07829         279 H  279 (282)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.9e-32  Score=229.87  Aligned_cols=225  Identities=25%  Similarity=0.285  Sum_probs=164.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC----------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD----------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS   71 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~   71 (278)
                      +.+|++++++++||||+++++++.+..          ..++++||+.+ ++.+++.... ..+++..+..++.|++.||.
T Consensus        53 ~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~  130 (302)
T cd07864          53 AIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGL-VHFSEDHIKSFMKQLLEGLN  130 (302)
T ss_pred             HHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHH
Confidence            467999999999999999999987654          78999999965 7777776542 36899999999999999999


Q ss_pred             HHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHH
Q 023752           72 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVV  150 (278)
Q Consensus        72 ~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~i  150 (278)
                      |||  +.|++|+||+|.||+++.++.++|+|||++......... .......+..|+|||.+.+ ..++.++|+||||++
T Consensus       131 ~LH--~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~  207 (302)
T cd07864         131 YCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI  207 (302)
T ss_pred             HHH--hCCeecCCCCHHHEEECCCCcEEeCcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHH
Confidence            999  899999999999999999999999999998764433211 1111234667999998754 457889999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchh----HHHHHH--hhh-----ccCCCCCHHHHHHHHHHHHHhccCCC
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS----RRVLRI--MDT-----RLGGQYSKKEAQAVAAVVLQCLHMDP  219 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~--~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp  219 (278)
                      ++++++|+.||...........+...........    ......  ...     .........++..+.+++.+||+.||
T Consensus       208 ~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P  287 (302)
T cd07864         208 LGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDP  287 (302)
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCCh
Confidence            9999999999976544333322222211110000    000000  000     00000112357789999999999999


Q ss_pred             CCCCCHHHHHHH
Q 023752          220 KNRPSMVDVLTS  231 (278)
Q Consensus       220 ~~Rps~~~ll~~  231 (278)
                      .+||++.+++.+
T Consensus       288 ~~Rp~~~~il~~  299 (302)
T cd07864         288 SKRCTAEEALNS  299 (302)
T ss_pred             hhCCCHHHHhcC
Confidence            999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.1e-32  Score=227.16  Aligned_cols=210  Identities=25%  Similarity=0.352  Sum_probs=165.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++++ +|++|+++++.+..++..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|+
T Consensus        51 ~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~i  126 (290)
T cd05613          51 TRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLH--KLGI  126 (290)
T ss_pred             HHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            46799999999 69999999999999889999999999999999987654  6889999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC--CCCCccchhHHHHHHHHHHhCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~  158 (278)
                      +|+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+.  .++.++|+||||+++|++++|.
T Consensus       127 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~  205 (290)
T cd05613         127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA  205 (290)
T ss_pred             eccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCC
Confidence            99999999999999999999999998754332111 11223467789999998653  4678899999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      .||...........+.              ..+.. ...+++..++..+.+++.+||+.||++||     ++.+++.+
T Consensus       206 ~p~~~~~~~~~~~~~~--------------~~~~~-~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         206 SPFTVDGEKNSQAEIS--------------RRILK-SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CCCCcCCccccHHHHH--------------HHhhc-cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            9986432211111111              11111 12334556778899999999999999997     67777754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=4e-32  Score=229.77  Aligned_cols=226  Identities=23%  Similarity=0.307  Sum_probs=161.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC--------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD--------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+++++.++||||+++++++.+..        ..+++++|+. ++|.+.+.... ..+++..+..++.|+++||.||
T Consensus        54 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~l  131 (311)
T cd07866          54 ALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS-VKLTESQIKCYMLQLLEGINYL  131 (311)
T ss_pred             HHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHH
Confidence            467999999999999999999875443        3589999985 57777765433 3699999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc---------ccccccCCcccCcccccc-CCCCCccc
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV---------STRIVGTRGYAAPEYVAT-GHLTPKSD  143 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~---------~~~~~~~~~~~aPE~~~~-~~~~~~~D  143 (278)
                      |  +.|++|+||+|+||+++.++.++|+|||++...........         .....++..|+|||.+.+ ..++.++|
T Consensus       132 H--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  209 (311)
T cd07866         132 H--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVD  209 (311)
T ss_pred             H--hCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhH
Confidence            9  89999999999999999999999999999875433222111         112345677999998765 45788999


Q ss_pred             hhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhh----ccCCCC-------CHHHHHHHHHHHH
Q 023752          144 VYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT----RLGGQY-------SKKEAQAVAAVVL  212 (278)
Q Consensus       144 iwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~-------~~~~~~~l~~li~  212 (278)
                      +||||+++|+|++|..||.+.+.......+.................+..    ......       ....+..+.++|.
T Consensus       210 v~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  289 (311)
T cd07866         210 IWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLS  289 (311)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHH
Confidence            99999999999999999976544332222222111100000000000000    000000       1123467899999


Q ss_pred             HhccCCCCCCCCHHHHHHH
Q 023752          213 QCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       213 ~~l~~dp~~Rps~~~ll~~  231 (278)
                      +||+.||.+|||+.+++.+
T Consensus       290 ~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         290 KLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHcccCcccCcCHHHHhcC
Confidence            9999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-32  Score=229.82  Aligned_cols=204  Identities=26%  Similarity=0.391  Sum_probs=175.6

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+|-+||++++.+.||.+--.|+..+.+++|+..++||+|.-.+...+...+++..+..++.+|+-||.+||  ..+||+
T Consensus       233 LnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH--~~~iVY  310 (591)
T KOG0986|consen  233 LNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH--RRRIVY  310 (591)
T ss_pred             hHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH--hcceee
Confidence            578999999999999999999999999999999999999998887777778999999999999999999999  999999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      ||+||+||++++.|++.|+|+|+++.+......   ...+||..|+|||++.+..|+.+.|.|+|||++|+|+.|+.||.
T Consensus       311 RDLKPeNILLDd~GhvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr  387 (591)
T KOG0986|consen  311 RDLKPENILLDDHGHVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFR  387 (591)
T ss_pred             ccCChhheeeccCCCeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchh
Confidence            999999999999999999999999976554432   33479999999999999999999999999999999999999997


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      ........+.+...               -.....+++..++++++++.+.+|+.||.+|.-..
T Consensus       388 ~~KeKvk~eEvdrr---------------~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  388 QRKEKVKREEVDRR---------------TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hhhhhhhHHHHHHH---------------HhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            65443332222221               11123566788999999999999999999996543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-32  Score=236.01  Aligned_cols=219  Identities=24%  Similarity=0.337  Sum_probs=164.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc------cEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN------RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++++.|+||+++.+++...+.      .++|++|+ +++|.+++...   .+++..+..++.|++.||.||| 
T Consensus        61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH-  135 (343)
T cd07851          61 TYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIH-  135 (343)
T ss_pred             HHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-
Confidence            4579999999999999999998866554      89999998 67999988653   5899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.|++|+||+|+||+++.++.++|+|||++......     .....++..|+|||.+.+ ..++.++|+||||+++|++
T Consensus       136 -~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~el  209 (343)
T cd07851         136 -SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL  209 (343)
T ss_pred             -HCCeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHH
Confidence             899999999999999999999999999998764332     122345678999998865 3678899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchh------HHHHHHhh---hccCCC---CCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDS------RRVLRIMD---TRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||...........+.+.........      ......+.   ......   ....++..+.++|.+||+.||++|
T Consensus       210 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~R  289 (343)
T cd07851         210 LTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR  289 (343)
T ss_pred             HhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhC
Confidence            999999976554333332222211110000      00000101   000000   112347889999999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      ||+.+|+++
T Consensus       290 pt~~ell~h  298 (343)
T cd07851         290 ITAAEALAH  298 (343)
T ss_pred             CCHHHHhcC
Confidence            999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.98  E-value=6.8e-32  Score=230.75  Aligned_cols=225  Identities=24%  Similarity=0.301  Sum_probs=162.3

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecC----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.+++++ +||||+++++.+...    ...+++++++ +++|.+.+....  .+++..+..++.|++.||.|||  
T Consensus        48 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--  122 (332)
T cd07857          48 ALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIH--  122 (332)
T ss_pred             HHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH--
Confidence            46799999999 599999999875322    4568888988 468998886543  6899999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC--ccccccccCCcccCcccccc-CCCCCccchhHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~  153 (278)
                      ..|++|+||+|+||+++.++.++|+|||++.........  .......++..|+|||.+.+ ..++.++|+||||+++|+
T Consensus       123 ~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~  202 (332)
T cd07857         123 SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE  202 (332)
T ss_pred             hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHH
Confidence            899999999999999999999999999998754432211  11122457788999998755 568899999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchh---------HHHHHHhhhccCC---CCCHHHHHHHHHHHHHhccCCCCC
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDS---------RRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKN  221 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~  221 (278)
                      +++|..||...+.......+.........+.         .............   .....++..+.+++.+||+.||.+
T Consensus       203 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  282 (332)
T cd07857         203 LLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTK  282 (332)
T ss_pred             HHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCccc
Confidence            9999999976543222222222111110000         0000000000000   111234678999999999999999


Q ss_pred             CCCHHHHHHH
Q 023752          222 RPSMVDVLTS  231 (278)
Q Consensus       222 Rps~~~ll~~  231 (278)
                      |||+.+++.+
T Consensus       283 R~t~~~ll~~  292 (332)
T cd07857         283 RISVEEALEH  292 (332)
T ss_pred             CCCHHHHhcC
Confidence            9999999854

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.98  E-value=7.6e-33  Score=217.63  Aligned_cols=196  Identities=26%  Similarity=0.407  Sum_probs=157.4

Q ss_pred             CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEE
Q 023752           13 RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL   92 (278)
Q Consensus        13 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~   92 (278)
                      .+|.|++.+++|..+...++.||.+ +..++.++.+-. +++++..+-++...++.||.||-. +.||+|||+||+||++
T Consensus       149 dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik-~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILl  225 (391)
T KOG0983|consen  149 DCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIK-GPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILL  225 (391)
T ss_pred             CCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhc-CCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEE
Confidence            4799999999999999999999988 556666665443 579999999999999999999975 7899999999999999


Q ss_pred             cCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc---CCCCCccchhHHHHHHHHHHhCCCCCccccCCch
Q 023752           93 DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA  169 (278)
Q Consensus        93 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~  169 (278)
                      +..|.+||+|||++-+......   ...-.|-+.|+|||.+..   ..|+.++|+||||+.+++|.||+.||.+-+.+. 
T Consensus       226 De~GniKlCDFGIsGrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-  301 (391)
T KOG0983|consen  226 DERGNIKLCDFGISGRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-  301 (391)
T ss_pred             ccCCCEEeecccccceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-
Confidence            9999999999999876544332   223357788999998854   478899999999999999999999998644322 


Q ss_pred             hhhHHhhhccccchhHHHHHHhhhccCCCC--CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          170 EQTLVEWADPFLRDSRRVLRIMDTRLGGQY--SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                                     +.....++. .++..  ..++++.+.+|+..||+.|+.+||...++++|
T Consensus       302 ---------------e~ltkvln~-ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  302 ---------------EVLTKVLNE-EPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             ---------------HHHHHHHhc-CCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence                           222222221 11111  23478999999999999999999999999965

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.98  E-value=9.7e-32  Score=229.34  Aligned_cols=226  Identities=27%  Similarity=0.385  Sum_probs=166.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeec-CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|++++++++||||+++.++|.. .+..++++||+ +++|.+++...   .+++..+..++.|+++||.|||  +.++
T Consensus        56 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH--~~~i  129 (328)
T cd07856          56 TYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVH--SAGV  129 (328)
T ss_pred             HHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCc
Confidence            4679999999999999999999876 45789999998 66898887643   4788888999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      +|+||+|.||+++.++.++|+|||.+.......     ....++..|+|||.+.+ ..++.++|+||||++++++++|..
T Consensus       130 iH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~  204 (328)
T cd07856         130 VHRDLKPSNILINENCDLKICDFGLARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP  204 (328)
T ss_pred             ccCCCCHHHEeECCCCCEEeCccccccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence            999999999999999999999999987532211     12345678999998765 578899999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchh------HHHHHHhhh-ccCCCCC-----HHHHHHHHHHHHHhccCCCCCCCCHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDS------RRVLRIMDT-RLGGQYS-----KKEAQAVAAVVLQCLHMDPKNRPSMVD  227 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~  227 (278)
                      ||...........+.+.......+.      ......... ......+     ..++..+.++|.+||+.+|++||++.+
T Consensus       205 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e  284 (328)
T cd07856         205 LFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE  284 (328)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            9976543222222222111111000      000111110 0001111     235688999999999999999999999


Q ss_pred             HHHH--HHhhhcC
Q 023752          228 VLTS--LEQLHTS  238 (278)
Q Consensus       228 ll~~--l~~~~~~  238 (278)
                      ++.+  ++.....
T Consensus       285 ll~~~~~~~~~~~  297 (328)
T cd07856         285 ALAHPYLAPYHDP  297 (328)
T ss_pred             HhcCCccccccCC
Confidence            9976  4444444

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.98  E-value=6.7e-32  Score=231.70  Aligned_cols=224  Identities=24%  Similarity=0.326  Sum_probs=159.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--------------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--------------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA   67 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~   67 (278)
                      +.+|++++++++||||+++++++...              ...++++||+. ++|.+++...   .+++..+..++.|++
T Consensus        49 ~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~  124 (342)
T cd07854          49 ALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLL  124 (342)
T ss_pred             HHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHH
Confidence            56899999999999999999877654              24689999996 5898887543   588999999999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCceEEcC-CCceEEeccccccCCCCCCCCc-cccccccCCcccCcccccc-CCCCCccch
Q 023752           68 RGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDV  144 (278)
Q Consensus        68 ~~l~~Lh~~~~~i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~Di  144 (278)
                      +||.|||  +.|++|+||+|+||+++. ++.++++|||.+.......... ......++..|.|||.+.+ ..++.++|+
T Consensus       125 ~aL~~LH--~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  202 (342)
T cd07854         125 RGLKYIH--SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM  202 (342)
T ss_pred             HHHHHHH--hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhH
Confidence            9999999  899999999999999974 5578999999987543221111 1112345778999997644 567889999


Q ss_pred             hHHHHHHHHHHhCCCCCccccCCchhhhHHhh-hccccchhHHHHH----Hhh-hccCCC-----CCHHHHHHHHHHHHH
Q 023752          145 YSFGVVLLELLSGRRALDEDRGGLAEQTLVEW-ADPFLRDSRRVLR----IMD-TRLGGQ-----YSKKEAQAVAAVVLQ  213 (278)
Q Consensus       145 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~-~~~~~~-----~~~~~~~~l~~li~~  213 (278)
                      |||||++|+|++|+.||............... ..+..........    ... ......     .....+.++.+||.+
T Consensus       203 wSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  282 (342)
T cd07854         203 WAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQ  282 (342)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHH
Confidence            99999999999999999755432222111110 0000000000000    000 000000     112456789999999


Q ss_pred             hccCCCCCCCCHHHHHHH
Q 023752          214 CLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       214 ~l~~dp~~Rps~~~ll~~  231 (278)
                      ||+.||.+|||+.+++.+
T Consensus       283 ~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         283 ILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HhCCCchhccCHHHHhCC
Confidence            999999999999999954

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1e-31  Score=230.57  Aligned_cols=218  Identities=23%  Similarity=0.332  Sum_probs=162.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|++++++++||||+++++++....      ..++|++++ +++|.+++...   .+++..+..++.|++.||.||| 
T Consensus        61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH-  135 (343)
T cd07880          61 AYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIH-  135 (343)
T ss_pred             HHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-
Confidence            568999999999999999999987654      348999998 77998887643   5899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.|++|+||+|+||+++.++.++|+|||++.......     ....++..|+|||.+.+ ..++.++|+||||++++++
T Consensus       136 -~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l  209 (343)
T cd07880         136 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM  209 (343)
T ss_pred             -hCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence             8999999999999999999999999999987543221     12345778999998865 4578899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchh---------HHHHHHhhhccC---CCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDS---------RRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||...+.......+...........         ......+.....   ......++..+.++|.+||+.||++|
T Consensus       210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  289 (343)
T cd07880         210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR  289 (343)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence            999999976543322222222111110000         000000000000   01123456789999999999999999


Q ss_pred             CCHHHHHH
Q 023752          223 PSMVDVLT  230 (278)
Q Consensus       223 ps~~~ll~  230 (278)
                      ||+.+++.
T Consensus       290 ~t~~~~l~  297 (343)
T cd07880         290 ITAAEALA  297 (343)
T ss_pred             CCHHHHhc
Confidence            99999994

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.98  E-value=1.6e-31  Score=229.65  Aligned_cols=219  Identities=24%  Similarity=0.340  Sum_probs=161.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.++++++||||+++++++...      ...+++++++ +++|.+++...   .+++..+..++.|++.||.||| 
T Consensus        63 ~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH-  137 (345)
T cd07877          63 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH-  137 (345)
T ss_pred             HHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-
Confidence            45799999999999999999988643      3467888877 78998877543   4899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.|++|+||+|+||+++.++.++|+|||++......     .....++..|+|||.+.+ ..++.++|+||||++++++
T Consensus       138 -~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el  211 (345)
T cd07877         138 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL  211 (345)
T ss_pred             -HCCeeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHH
Confidence             899999999999999999999999999998753221     122346778999998866 4688899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccch---------hHHHHHHhhhccCC---CCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRD---------SRRVLRIMDTRLGG---QYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||...+.......+..........         .......+......   ......+.++.++|.+||+.||.+|
T Consensus       212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  291 (345)
T cd07877         212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR  291 (345)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhc
Confidence            99999996544322222222111100000         00000100000000   0011346789999999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      |++.+++.+
T Consensus       292 ~t~~e~l~h  300 (345)
T cd07877         292 ITAAQALAH  300 (345)
T ss_pred             CCHHHHhcC
Confidence            999999976

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.97  E-value=4e-31  Score=222.47  Aligned_cols=207  Identities=26%  Similarity=0.399  Sum_probs=158.1

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANV   80 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i   80 (278)
                      ..|+.++.+. .|+||+++++++.+....++++||+ ++++.+++.... ..+++..+..++.|++.|+.|||  . .|+
T Consensus        61 ~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH--~~~~i  136 (296)
T cd06618          61 LMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK--EKHGV  136 (296)
T ss_pred             HHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hhCCE
Confidence            3466656566 5999999999999999999999998 457877776543 36899999999999999999999  6 599


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC----CCCccchhHHHHHHHHHHh
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH----LTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~il~~l~~  156 (278)
                      +|+||+|+||+++.++.++|+|||++.........   ....++..|+|||.+.+..    ++.++|+||||+++|+|++
T Consensus       137 ~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~  213 (296)
T cd06618         137 IHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT  213 (296)
T ss_pred             ecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh
Confidence            99999999999999999999999998654322211   1224567899999986543    7889999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhc-cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR-LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |+.||.......  +.+              ....... ...+....++.++.+||.+||+.||++||++.+++.+-
T Consensus       214 g~~p~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         214 GQFPYKNCKTEF--EVL--------------TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCCCCCcchhHH--HHH--------------HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            999996432110  000              0111110 01111224677899999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=5.1e-31  Score=221.63  Aligned_cols=210  Identities=14%  Similarity=0.143  Sum_probs=154.0

Q ss_pred             HHHhccCCccccceeeeeecCC----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            7 IYLGQLRHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         7 ~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      ..+..+.|++|+++++......    ..+++++++ ..++.+.+....  ..++..+..++.|++.||.|||  +.+++|
T Consensus        75 ~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~iiH  149 (294)
T PHA02882         75 KNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIH--EHGISH  149 (294)
T ss_pred             HHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHH--hCCeec
Confidence            3455678999999998765443    236777876 457777665443  4678889999999999999999  899999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCC-----ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |||||+||+++.++.++|+|||++.........     .......+++.|+|||...+..++.++|+|||||++++|++|
T Consensus       150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g  229 (294)
T PHA02882        150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI  229 (294)
T ss_pred             CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence            999999999999999999999998764322111     111224588999999999999999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ..||..............         ......+...  .......++++.+++..|++.+|++||++.++++.+
T Consensus       230 ~~P~~~~~~~~~~~~~~~---------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        230 KLPWKGFGHNGNLIHAAK---------CDFIKRLHEG--KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             CCCCCccccchHHHHHhH---------HHHHHHhhhh--hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            999976532111100000         0000100000  001223468899999999999999999999999876

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=233.97  Aligned_cols=232  Identities=24%  Similarity=0.328  Sum_probs=170.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      |.+|+++|++++|+|||++.++=++..      ...++||||.||||..++.+- ...++++.++..++..++.|+.|||
T Consensus        58 ~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr  137 (732)
T KOG4250|consen   58 WCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR  137 (732)
T ss_pred             HHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            678999999999999999999876544      468999999999999999643 2347999999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEc--CCCc--eEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHH
Q 023752           75 GLDANVIYRDLKASNVLLD--SNFN--AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGV  149 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~--~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~  149 (278)
                        ..||+||||||.||++.  .+|+  .||+|||++.......   .....+||..|++||.... ..|+..+|.|||||
T Consensus       138 --En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv  212 (732)
T KOG4250|consen  138 --ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV  212 (732)
T ss_pred             --HcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence              99999999999999983  3344  7899999998754433   4455789999999999984 78999999999999


Q ss_pred             HHHHHHhCCCCCccccCC-----chhhhHHhhhccccchhH-----HHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCC
Q 023752          150 VLLELLSGRRALDEDRGG-----LAEQTLVEWADPFLRDSR-----RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP  219 (278)
Q Consensus       150 il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  219 (278)
                      ++|+.+||..||....+.     .....+........-...     .......-..+....+.....+...+..+|..+|
T Consensus       213 tlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~  292 (732)
T KOG4250|consen  213 TLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNP  292 (732)
T ss_pred             HHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhH
Confidence            999999999999654433     222222222221111000     0000000001122233444556678889999999


Q ss_pred             CCCC--CHHHHHHHHHhhhcC
Q 023752          220 KNRP--SMVDVLTSLEQLHTS  238 (278)
Q Consensus       220 ~~Rp--s~~~ll~~l~~~~~~  238 (278)
                      .+|.  ...+....+..|-.-
T Consensus       293 ~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  293 RKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             HHhCCCCcchHHHHHHHHHhh
Confidence            9998  666666666665543

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=5.9e-31  Score=214.07  Aligned_cols=205  Identities=30%  Similarity=0.435  Sum_probs=167.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++.+++++|+||+++++.+......++++|++.+++|.+++....  .++...+..++.+++.++.+||  +.+++
T Consensus        34 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh--~~~i~  109 (244)
T smart00220       34 ILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLH--SNGII  109 (244)
T ss_pred             HHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH--HcCee
Confidence            5789999999999999999999999899999999999889999987654  3889999999999999999999  88999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|.||+++.++.++++|||.+.......   ......+...|++||...+..++.++|+|+||++++++++|..||
T Consensus       110 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~  186 (244)
T smart00220      110 HRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPF  186 (244)
T ss_pred             cCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999987654432   112234677899999998888899999999999999999999998


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHH--HHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK--EAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      ......                 ..................  ++.++.+++.+||..+|++||++.++++
T Consensus       187 ~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      187 PGDDQL-----------------LELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             CCCCcH-----------------HHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            652111                 111111111111111111  6788999999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.1e-31  Score=227.57  Aligned_cols=225  Identities=22%  Similarity=0.328  Sum_probs=163.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++.++||||+++++++....      ..+++++|+. .+|.+...    ..+++..+..++.|++.||.||| 
T Consensus        61 ~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH-  134 (342)
T cd07879          61 AYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIH-  134 (342)
T ss_pred             HHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHH-
Confidence            568999999999999999999987543      3589999985 47766542    25889999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.+++|+||+|+||+++.++.++|+|||++.......     ....++..|+|||.+.+ ..++.++|+||||+++++|
T Consensus       135 -~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el  208 (342)
T cd07879         135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEM  208 (342)
T ss_pred             -HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHH
Confidence             8999999999999999999999999999986532211     12345678999998865 4688899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHH------HHHHhhhc---cCCC---CCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRR------VLRIMDTR---LGGQ---YSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~---~~~~---~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|+.||...+.......+.............      ........   ....   .....+..+.++|.+||+.||.+|
T Consensus       209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R  288 (342)
T cd07879         209 LTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKR  288 (342)
T ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhC
Confidence            99999997644322222111111100000000      00000000   0000   012356778999999999999999


Q ss_pred             CCHHHHHHH--HHhhhcC
Q 023752          223 PSMVDVLTS--LEQLHTS  238 (278)
Q Consensus       223 ps~~~ll~~--l~~~~~~  238 (278)
                      |++.+++.|  ++.+...
T Consensus       289 ~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         289 LTATEALEHPYFDSFRDA  306 (342)
T ss_pred             cCHHHHhcCcchhhcccc
Confidence            999999976  7766554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-32  Score=217.44  Aligned_cols=203  Identities=26%  Similarity=0.380  Sum_probs=171.4

Q ss_pred             HHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      .|-++|+..+||.+..+.-+|+.+..+|+||||..||.|.-.+.+..  .++++....+-..|++||.|||  +++|++|
T Consensus       217 TE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLH--s~~ivYR  292 (516)
T KOG0690|consen  217 TENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLH--SRNIVYR  292 (516)
T ss_pred             hHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhh--hCCeeee
Confidence            46678999999999999999999999999999999999988887654  6899999999999999999999  8999999


Q ss_pred             CCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCcc
Q 023752           84 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE  163 (278)
Q Consensus        84 dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~  163 (278)
                      |||.+|.+++.+|++||+|||++......  ......+.|++.|+|||++....|+.+.|.|.+|+++|+|++|+.||-.
T Consensus       293 DlKLENLlLDkDGHIKitDFGLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  293 DLKLENLLLDKDGHIKITDFGLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             echhhhheeccCCceEeeecccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence            99999999999999999999999753332  3334557899999999999999999999999999999999999999965


Q ss_pred             ccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          164 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      .+...                  +...+ ......+|..++++...|+..+|..||.+|.     ++.+|.++
T Consensus       371 ~dh~k------------------LFeLI-l~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  371 KDHEK------------------LFELI-LMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             cchhH------------------HHHHH-HhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            44321                  11111 1123566888999999999999999999994     46777643

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=2e-30  Score=250.04  Aligned_cols=221  Identities=33%  Similarity=0.552  Sum_probs=167.4

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL-DANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~-~~~i~   81 (278)
                      ..|++++++++||||+++++++.+++..++||||+++++|.+++.     .+++..+..++.+++.|+.|||.. ..+++
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~ii  805 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVV  805 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCee
Confidence            467899999999999999999999999999999999999999984     378889999999999999999943 45899


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++..++. ++.......      .....++..|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus       806 H~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~  878 (968)
T PLN00113        806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA  878 (968)
T ss_pred             cCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCC
Confidence            99999999999988877764 444322111      11124678899999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhcc--CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL--GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      +.....  ...+..|........ .....++...  ....+.....++.+++.+||+.||++||++.++++.|+++...
T Consensus       879 ~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        879 DAEFGV--HGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             CcccCC--CCcHHHHHHHhcCcc-chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            543221  112222221111110 0111111111  1223445667888999999999999999999999999998664

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5e-32  Score=228.81  Aligned_cols=206  Identities=23%  Similarity=0.307  Sum_probs=179.4

Q ss_pred             HHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      .|-+||...+.|.|+++|..|.++...|++||.|-||.|+..+..++  .+.+.....++..+++|+.|||  .+||++|
T Consensus       469 sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH--~k~iIYR  544 (732)
T KOG0614|consen  469 SERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLH--RKGIIYR  544 (732)
T ss_pred             hHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHH--hcCceec
Confidence            57789999999999999999999999999999999999999998776  7999999999999999999999  9999999


Q ss_pred             CCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCcc
Q 023752           84 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE  163 (278)
Q Consensus        84 dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~  163 (278)
                      ||||+|.+++.+|-+||.|||++...........   +.|++.|.|||++.+..-+.+.|.|+||+++|+|++|.+||.+
T Consensus       545 DLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT---FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~  621 (732)
T KOG0614|consen  545 DLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT---FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG  621 (732)
T ss_pred             cCChhheeeccCCceEEeehhhHHHhccCCceee---ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999999999988766655443   5689999999999999999999999999999999999999987


Q ss_pred             ccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHHHH
Q 023752          164 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTSLE  233 (278)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~l~  233 (278)
                      .+.-...+.+....                 ....+|..++....+||++++..+|.+|.-     +.+|.+|-.
T Consensus       622 ~dpmktYn~ILkGi-----------------d~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  622 VDPMKTYNLILKGI-----------------DKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             CchHHHHHHHHhhh-----------------hhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence            66543333333322                 224567888999999999999999999964     777777643

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=237.79  Aligned_cols=217  Identities=26%  Similarity=0.424  Sum_probs=181.7

Q ss_pred             ChHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC------CC--------CCCHHHHHHHHHH
Q 023752            1 MWQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG------VQ--------PISWPTRVKIAID   65 (278)
Q Consensus         1 ~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~--------~~~~~~~~~i~~~   65 (278)
                      ++..|+++|+.+ .|+||+.+++.+...+..++|.||+..|+|.+++.++.      ..        .+....+..+++|
T Consensus       347 ~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~Q  426 (609)
T KOG0200|consen  347 DLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQ  426 (609)
T ss_pred             HHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHH
Confidence            368899999999 69999999999999889999999999999999997664      01        2888899999999


Q ss_pred             HHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCcccc-ccccCCcccCccccccCCCCCccch
Q 023752           66 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-RIVGTRGYAAPEYVATGHLTPKSDV  144 (278)
Q Consensus        66 l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~-~~~~~~~~~aPE~~~~~~~~~~~Di  144 (278)
                      |+.|+.||+  +..++||||-..||+++.+..+||+|||+++............ ...-...|+|||.+....|+.++|+
T Consensus       427 Ia~GMe~L~--~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDV  504 (609)
T KOG0200|consen  427 IANGMEYLA--SVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDV  504 (609)
T ss_pred             HHHHHHHHh--hCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchh
Confidence            999999999  8899999999999999999999999999998644433222111 1012445999999999999999999


Q ss_pred             hHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          145 YSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       145 wslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      ||+|+++|++++ |..||.+..                 ........+..+.+.+.|..++.+++++++.||+.+|++||
T Consensus       505 WSfGI~L~EifsLG~~PYp~~~-----------------~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP  567 (609)
T KOG0200|consen  505 WSFGILLWEIFTLGGTPYPGIP-----------------PTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRP  567 (609)
T ss_pred             hHHHHHHHHHhhCCCCCCCCCC-----------------cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCC
Confidence            999999999999 778886421                 11233445666667788889999999999999999999999


Q ss_pred             CHHHHHHHHHhhh
Q 023752          224 SMVDVLTSLEQLH  236 (278)
Q Consensus       224 s~~~ll~~l~~~~  236 (278)
                      ++.++.+.++...
T Consensus       568 ~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  568 TFSECVEFFEKHL  580 (609)
T ss_pred             CHHHHHHHHHHHH
Confidence            9999999999853

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.6e-31  Score=206.88  Aligned_cols=226  Identities=24%  Similarity=0.323  Sum_probs=172.3

Q ss_pred             HHHHHHHhccCCccccceeeeeecC--------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSES--------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      .+|+.+|+.++|+|++.+++.|...        ..+|+||++|+ .+|.-++.... .+++...+.+++.++.+||.|+|
T Consensus        64 lreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iH  141 (376)
T KOG0669|consen   64 LREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIH  141 (376)
T ss_pred             HHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHH
Confidence            4799999999999999999877432        24799999995 48888776543 36899999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc--ccccccCCcccCcccccc-CCCCCccchhHHHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVL  151 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il  151 (278)
                        ...|.|||+|+.|++|+.+|.++|+|||+++.+........  .+..+-+.+|++||.+.| ..|+++.|+|+.||++
T Consensus       142 --r~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCim  219 (376)
T KOG0669|consen  142 --RNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIM  219 (376)
T ss_pred             --HhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHH
Confidence              88999999999999999999999999999976554443322  233556889999998876 5799999999999999


Q ss_pred             HHHHhCCCCCccccCCchhhhHHhhhccccc-------hhHHHHHHhhhccCC----CC-----CHHHHHHHHHHHHHhc
Q 023752          152 LELLSGRRALDEDRGGLAEQTLVEWADPFLR-------DSRRVLRIMDTRLGG----QY-----SKKEAQAVAAVVLQCL  215 (278)
Q Consensus       152 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~----~~-----~~~~~~~l~~li~~~l  215 (278)
                      .+|+++.+.+.+.........+.........       +..-...+-......    .+     +..-.++..+|++++|
T Consensus       220 aeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll  299 (376)
T KOG0669|consen  220 AEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL  299 (376)
T ss_pred             HHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh
Confidence            9999999999988877777666654432211       111111110000000    00     1112457889999999


Q ss_pred             cCCCCCCCCHHHHHHHH
Q 023752          216 HMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       216 ~~dp~~Rps~~~ll~~l  232 (278)
                      ..||.+|+++.+++.|-
T Consensus       300 ~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  300 KLDPTKRIDADQALNHD  316 (376)
T ss_pred             ccCcccCcchHhhhchh
Confidence            99999999999998653

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=240.93  Aligned_cols=209  Identities=23%  Similarity=0.271  Sum_probs=172.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |..|-.+|-.-+.+.|+.+.-.|++++++|+||||+.||+|..++.+.+  .+++..+..++..++.||..||  +.|+|
T Consensus       122 F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH--~mgyV  197 (1317)
T KOG0612|consen  122 FREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH--SMGYV  197 (1317)
T ss_pred             HHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH--hccce
Confidence            6778888888889999999999999999999999999999999998887  7999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc----c-CCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA----T-GHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~----~-~~~~~~~DiwslG~il~~l~~  156 (278)
                      ||||||+||+++..|++||+|||.+......+... ....+|||.|.+||++.    + +.|+..+|.||+|+++|+|+.
T Consensus       198 HRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~-s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly  276 (1317)
T KOG0612|consen  198 HRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVR-SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY  276 (1317)
T ss_pred             eccCCcceeEecccCcEeeccchhHHhcCCCCcEE-eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc
Confidence            99999999999999999999999998766554433 23468999999999984    3 568899999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC---HHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS---MVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~  231 (278)
                      |..||-..+...-+.+|.              .... .+..+-...+|.++.+||.+.+. +|+.|..   ++++..|
T Consensus       277 G~TPFYadslveTY~KIm--------------~hk~-~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  277 GETPFYADSLVETYGKIM--------------NHKE-SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             CCCcchHHHHHHHHHHHh--------------chhh-hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence            999995433222222222              2211 11122234589999999999888 8999987   8888865

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.3e-30  Score=222.91  Aligned_cols=201  Identities=25%  Similarity=0.387  Sum_probs=164.7

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      +-|-.||..-.++.||++|-+|++.+.+|+||+|+.||++-.++.+.+  -|++..+..++..|.-|+++.|  +.|++|
T Consensus       677 KAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH--kmGFIH  752 (1034)
T KOG0608|consen  677 KAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH--KMGFIH  752 (1034)
T ss_pred             hhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH--hcccee
Confidence            457778888899999999999999999999999999999999998887  6999999999999999999999  999999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCC--------CCC----------------c----------------cccccc
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTG--------DNT----------------H----------------VSTRIV  122 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~--------~~~----------------~----------------~~~~~~  122 (278)
                      |||||+||+|+.+|++||+|||+++.+.=.        ...                .                .....+
T Consensus       753 RDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslv  832 (1034)
T KOG0608|consen  753 RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLV  832 (1034)
T ss_pred             cccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhc
Confidence            999999999999999999999998732110        000                0                012257


Q ss_pred             cCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHH
Q 023752          123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK  202 (278)
Q Consensus       123 ~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  202 (278)
                      |++.|+|||++....++..+|.||.|+|+|+|+.|+.||-..........+.+|..        .       +...+-.+
T Consensus       833 gt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~--------~-------l~~~~~~~  897 (1034)
T KOG0608|consen  833 GTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN--------F-------LHIPYQGN  897 (1034)
T ss_pred             CCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh--------c-------cccccccc
Confidence            99999999999999999999999999999999999999977665544444444432        1       12334457


Q ss_pred             HHHHHHHHHHHhccCCCCCCC
Q 023752          203 EAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       203 ~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      ++.++.++|.+++. +++.|.
T Consensus       898 ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  898 LSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             cCHHHHHHHHHHhc-Chhhhh
Confidence            78889999887665 677774

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.2e-30  Score=215.10  Aligned_cols=213  Identities=23%  Similarity=0.343  Sum_probs=167.5

Q ss_pred             HHHHHHHhccCCccccceeeeeecC-CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .+|.+|.+.|.||.||++|++|.-+ ..+|-|+|||+|.+|+-++..+.  .+++.++..|+.||+.||.||-..+..|+
T Consensus       515 cREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPII  592 (775)
T KOG1151|consen  515 CREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPII  592 (775)
T ss_pred             HHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCee
Confidence            3789999999999999999999644 57899999999999998887665  79999999999999999999987778899


Q ss_pred             ecCCCCCceEEc---CCCceEEeccccccCCCCCCCCccc-----cccccCCcccCcccccc----CCCCCccchhHHHH
Q 023752           82 YRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTHVS-----TRIVGTRGYAAPEYVAT----GHLTPKSDVYSFGV  149 (278)
Q Consensus        82 H~dl~p~ni~~~---~~~~~kl~dfg~~~~~~~~~~~~~~-----~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~  149 (278)
                      |-||||.||++-   ..|.+||+|||++............     ....|+.+|+|||++.-    ...+.+.|+||+|+
T Consensus       593 HYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGV  672 (775)
T KOG1151|consen  593 HYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGV  672 (775)
T ss_pred             eeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeeh
Confidence            999999999984   3577999999999876665444322     33678999999998843    35677999999999


Q ss_pred             HHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          150 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       150 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |+|+.+.|+.||........   +.+        ...++..  .....+.-+.++.+..+||++||+...++|.+..++.
T Consensus       673 IFyQClYGrKPFGhnqsQQd---ILq--------eNTIlkA--tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  673 IFYQCLYGRKPFGHNQSQQD---ILQ--------ENTILKA--TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhhhhhccCCCCCCchhHHH---HHh--------hhchhcc--eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            99999999999975432211   111        0111110  0111222356788999999999999999999988876


Q ss_pred             H
Q 023752          230 T  230 (278)
Q Consensus       230 ~  230 (278)
                      .
T Consensus       740 ~  740 (775)
T KOG1151|consen  740 C  740 (775)
T ss_pred             c
Confidence            4

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-31  Score=224.01  Aligned_cols=205  Identities=24%  Similarity=0.316  Sum_probs=171.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +++|+.||+++.||.|+.+.-.|+..+..++|||.+ .|+..+++.....+++++.....++.||+.||.|||  -++|+
T Consensus       610 lR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH--~knIv  686 (888)
T KOG4236|consen  610 LRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH--FKNIV  686 (888)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh--hccee
Confidence            689999999999999999999999999999999999 668888887666678999999999999999999999  99999


Q ss_pred             ecCCCCCceEEcCCC---ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||||+||++....   ++||+|||+++......   .....+|++.|+|||++.++.|..+.|+||+|+++|.-++|.
T Consensus       687 HCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGT  763 (888)
T KOG4236|consen  687 HCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGT  763 (888)
T ss_pred             eccCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEeccc
Confidence            999999999996543   59999999999765543   344578999999999999999999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      -||....+  ..+.+.+               ...-.+..-+.+++.+..+||..+|+..-.+|-|....+
T Consensus       764 FPFNEdEd--IndQIQN---------------AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  764 FPFNEDED--INDQIQN---------------AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             ccCCCccc--hhHHhhc---------------cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            99964321  1111111               111123344678899999999999999999999887665

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-29  Score=207.43  Aligned_cols=218  Identities=25%  Similarity=0.360  Sum_probs=183.2

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecC-CccEEEEeccCCCCHHHHHh------hcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLF------RKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~------~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +|..|.-.+....|||+..+.++..+. ...++++.+..-|+|..++.      .+..+.++..++..++.|++.|+.||
T Consensus       333 ~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl  412 (563)
T KOG1024|consen  333 LLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL  412 (563)
T ss_pred             HHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH
Confidence            356777778888999999999987554 57899999999999999996      22334577888999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.|++|.||...|++|++..++||+|=.+++..-+.+.............|++||.+.+..|+.++|+||||+++|+
T Consensus       413 h--~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWE  490 (563)
T KOG1024|consen  413 H--NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWE  490 (563)
T ss_pred             H--hcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHH
Confidence            9  99999999999999999999999999888876555444333333445667999999999999999999999999999


Q ss_pred             HHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |+| |+.||.+.+.                  .+....+.++.+...|.+++.++..++..||...|++||+++|+...|
T Consensus       491 Lmtlg~~PyaeIDP------------------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL  552 (563)
T KOG1024|consen  491 LMTLGKLPYAEIDP------------------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICL  552 (563)
T ss_pred             HHhcCCCCccccCH------------------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence            999 8899865443                  334455566666777889999999999999999999999999999999


Q ss_pred             HhhhcC
Q 023752          233 EQLHTS  238 (278)
Q Consensus       233 ~~~~~~  238 (278)
                      .+++..
T Consensus       553 seF~~q  558 (563)
T KOG1024|consen  553 SEFHTQ  558 (563)
T ss_pred             HHHHHH
Confidence            988764

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=6.8e-31  Score=222.51  Aligned_cols=222  Identities=22%  Similarity=0.246  Sum_probs=175.5

Q ss_pred             HHHHHHHhccC------CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            3 QTEVIYLGQLR------HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         3 ~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      ..|++||++|+      --|+++++..|...+++|||||.. ..+|.+++.+.+. -++....+..++.||+.||..|- 
T Consensus       476 l~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK-  553 (752)
T KOG0670|consen  476 LKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK-  553 (752)
T ss_pred             hHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH-
Confidence            47999999994      358999999999999999999988 6899999987754 25788899999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                       ..|++|.||||+||++++.. .+||+|||.+.......-    +.+.-+..|.|||++.|..|+...|+||+||++|+|
T Consensus       554 -~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYEl  628 (752)
T KOG0670|consen  554 -KCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYEL  628 (752)
T ss_pred             -hcCeeecccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEe
Confidence             89999999999999998754 589999999976433322    223446789999999999999999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhcc---------------------------------------
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL---------------------------------------  195 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------------------  195 (278)
                      +||+..|.+..+........+...++....-..-.+.+..+                                       
T Consensus       629 YtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~  708 (752)
T KOG0670|consen  629 YTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAV  708 (752)
T ss_pred             eccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhcc
Confidence            99999999988776666655555443332211111111111                                       


Q ss_pred             --CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          196 --GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       196 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                        -..-....-..+.+|+.+||..||++|.|..++|+|
T Consensus       709 q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  709 QRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             CCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence              011123455688999999999999999999999975

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=7.2e-30  Score=196.25  Aligned_cols=220  Identities=16%  Similarity=0.257  Sum_probs=164.9

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCC--ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESD--NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      .++|+.||+.|. ||||++++++..++.  ...+|||+++..+...+..     .++...+..++.+++.||.|+|  +.
T Consensus        79 IkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCH--S~  151 (338)
T KOG0668|consen   79 IKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCH--SM  151 (338)
T ss_pred             HHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHH--hc
Confidence            368999999996 999999999998764  6789999998888776663     5777789999999999999999  89


Q ss_pred             CeeecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHh
Q 023752           79 NVIYRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~  156 (278)
                      ||+|||+||+|++++... .++|+|||++.++-....-..   .+.+..|..||++.+ ..|+.+.|+|||||++..|+.
T Consensus       152 GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miF  228 (338)
T KOG0668|consen  152 GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF  228 (338)
T ss_pred             CcccccCCcceeeechhhceeeeeecchHhhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHh
Confidence            999999999999998754 599999999987655443322   456778999999866 578999999999999999999


Q ss_pred             CCCCCc-cccCCchhhhHHhhhcccc-----c-----hhHHHHHHhhhcc--------CCCCCHHHHHHHHHHHHHhccC
Q 023752          157 GRRALD-EDRGGLAEQTLVEWADPFL-----R-----DSRRVLRIMDTRL--------GGQYSKKEAQAVAAVVLQCLHM  217 (278)
Q Consensus       157 g~~p~~-~~~~~~~~~~~~~~~~~~~-----~-----~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~  217 (278)
                      .+.||. +.++..+.-.+........     .     -......++....        ..+...-+++++.+|+.++|..
T Consensus       229 rkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrY  308 (338)
T KOG0668|consen  229 RKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRY  308 (338)
T ss_pred             ccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhh
Confidence            998885 4444444433333221100     0     0011111111111        1111223468999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 023752          218 DPKNRPSMVDVLTS  231 (278)
Q Consensus       218 dp~~Rps~~~ll~~  231 (278)
                      |.++|+|+.|.+.|
T Consensus       309 DHqeRlTakEam~H  322 (338)
T KOG0668|consen  309 DHQERLTAKEAMAH  322 (338)
T ss_pred             ccccccchHHHhcC
Confidence            99999999999865

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-30  Score=191.98  Aligned_cols=223  Identities=24%  Similarity=0.292  Sum_probs=172.1

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+||-+|+.++|.||++++++...+..+-+|+||| +.+|..+...-. +.+..+.+..++.|++.||.++|  +.++.|
T Consensus        49 lreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fch--shnvlh  124 (292)
T KOG0662|consen   49 LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCH--SHNVLH  124 (292)
T ss_pred             HHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhh--hhhhhh
Confidence            47999999999999999999999999999999999 558888775432 36889999999999999999999  899999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHh-CCCC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      ||+||+|.+|+.+|.+|+.|||+++.+..+.  .+....+-+.+|.+|.++.|. -|+.+.|+||.||++.++.. |.+.
T Consensus       125 rdlkpqnllin~ngelkladfglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrpl  202 (292)
T KOG0662|consen  125 RDLKPQNLLINRNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL  202 (292)
T ss_pred             ccCCcceEEeccCCcEEecccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCC
Confidence            9999999999999999999999998755443  223334568899999998774 68899999999999999998 6666


Q ss_pred             CccccCCchhhhHHhhhccccc-hhHHHHHHhhhccCCCC---------CHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLR-DSRRVLRIMDTRLGGQY---------SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |.+.+...+...+......... ++......-+...-+.+         .+.....-++++.++|.-+|.+|+++++.++
T Consensus       203 fpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  203 FPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            7777766666655543332222 22111111111111111         1334456678999999999999999999987


Q ss_pred             H
Q 023752          231 S  231 (278)
Q Consensus       231 ~  231 (278)
                      +
T Consensus       283 h  283 (292)
T KOG0662|consen  283 H  283 (292)
T ss_pred             C
Confidence            5

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-31  Score=232.22  Aligned_cols=206  Identities=25%  Similarity=0.395  Sum_probs=158.6

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      ++|++.|+.- .|||||++++.-.+....|+..|.| ..+|.+++...  ..........+.++.|+++||++||  +.+
T Consensus       550 ~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH--sl~  626 (903)
T KOG1027|consen  550 QREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH--SLK  626 (903)
T ss_pred             HHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH--hcc
Confidence            5899999888 6999999999999999999999999 46999999763  1111121356789999999999999  899


Q ss_pred             eeecCCCCCceEEcC---C--CceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           80 VIYRDLKASNVLLDS---N--FNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        80 i~H~dl~p~ni~~~~---~--~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |+||||||+||+|..   +  .+++|.|||++.......... ......|+..|.|||.+.......+.|||||||++|+
T Consensus       627 iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyY  706 (903)
T KOG1027|consen  627 IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYY  706 (903)
T ss_pred             cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEE
Confidence            999999999999965   2  458999999999876655432 2344678999999999998888889999999999999


Q ss_pred             HHhC-CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccC-CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          154 LLSG-RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG-GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       154 l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      .++| .+||++....               +.    .++..... .........+..+||.+|++.+|..||++.+|+.
T Consensus       707 vltgG~HpFGd~~~R---------------~~----NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  707 VLTGGSHPFGDSLER---------------QA----NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             EecCCccCCCchHHh---------------hh----hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence            9986 8999764221               10    00000000 0001111118899999999999999999999983

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.96  E-value=2.5e-29  Score=232.14  Aligned_cols=102  Identities=31%  Similarity=0.401  Sum_probs=95.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +..|+.+++.++||||+++++.+...+..|+||||+.+++|.+++...+  .+++..+..++.||+.||.|||  ..+|+
T Consensus        51 ~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH--~~gIi  126 (669)
T cd05610          51 VQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLH--RHGII  126 (669)
T ss_pred             HHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEE
Confidence            5678999999999999999999999999999999999999999997654  6889999999999999999999  88999


Q ss_pred             ecCCCCCceEEcCCCceEEecccccc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLAR  107 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~  107 (278)
                      |+||||+||+++.++.++|+|||++.
T Consensus       127 HrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         127 HRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.8e-30  Score=227.30  Aligned_cols=216  Identities=25%  Similarity=0.391  Sum_probs=185.5

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +|..|+.+|.++.|||++++++++.... +-||++|+++|+|.+++..+. ..+.......|+.||++|+.|||  ++++
T Consensus       744 e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe--~qrl  819 (1177)
T KOG1025|consen  744 ELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE--EQRL  819 (1177)
T ss_pred             HHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH--hcch
Confidence            3678999999999999999999998765 778999999999999997654 46889999999999999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      +||||-..||++..-.++|+.|||++...............-...-|+|-|.+....++.++||||+|+++||++| |..
T Consensus       820 VHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~  899 (1177)
T KOG1025|consen  820 VHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAK  899 (1177)
T ss_pred             hhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCC
Confidence            9999999999999999999999999987655444332222223456888899999999999999999999999998 899


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      ||++...                  +++...+....+.+.|+.++..++.++.+||..|++.||+++++...+.+....
T Consensus       900 Py~gi~~------------------~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard  960 (1177)
T KOG1025|consen  900 PYDGIPA------------------EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD  960 (1177)
T ss_pred             ccCCCCH------------------HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence            9987654                  444555666666788999999999999999999999999999999999887544

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=226.02  Aligned_cols=209  Identities=27%  Similarity=0.358  Sum_probs=168.2

Q ss_pred             HHHHHHHhcc-CCccccceeeeeec-----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSE-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +-|++||+.. .|||++.+|++|..     ++.+|||||||.|||+.|+++.-....+.+..+..|+..++.|+.+||  
T Consensus        63 E~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH--  140 (953)
T KOG0587|consen   63 ELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH--  140 (953)
T ss_pred             HHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh--
Confidence            4577788887 69999999998853     357899999999999999998766678999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-----CCCCccchhHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKSDVYSFGVVL  151 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~DiwslG~il  151 (278)
                      ...++||||+..||+++.++.|||.|||++......  .......+|++.|+|||++...     .|+.++|+||||++.
T Consensus       141 ~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITa  218 (953)
T KOG0587|consen  141 NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITA  218 (953)
T ss_pred             hcceeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhcccee
Confidence            899999999999999999999999999998754332  2223446899999999998653     477899999999999


Q ss_pred             HHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          152 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       152 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+|.-|.+|+-++......-.+....-|                ...-+..-++++.+||..||..|-.+||+..++++|
T Consensus       219 IEladG~PPl~DmHPmraLF~IpRNPPP----------------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  219 IEMAEGAPPLCDMHPMRALFLIPRNPPP----------------KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ehhcCCCCCccCcchhhhhccCCCCCCc----------------cccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            9999999998665432111111111111                112255678899999999999999999999998853

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-29  Score=207.54  Aligned_cols=194  Identities=31%  Similarity=0.453  Sum_probs=163.6

Q ss_pred             HHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            5 EVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         5 E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      |-++|... +.|.++++...|+.-+.+|+||||+.||+|--.++.-+  .+.+..+..++..|+-||-+||  ++||++|
T Consensus       399 EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh--~kgIiYR  474 (683)
T KOG0696|consen  399 EKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLH--SKGIIYR  474 (683)
T ss_pred             hhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhh--cCCeeee
Confidence            44444444 46788888989999999999999999999998887766  6888899999999999999999  9999999


Q ss_pred             CCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCcc
Q 023752           84 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE  163 (278)
Q Consensus        84 dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~  163 (278)
                      |||.+||+++.+|++||+|||++.......  .......|++.|+|||++..++|+.+.|.||+|+++|+|+.|+.||++
T Consensus       475 DLKLDNvmLd~eGHiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG  552 (683)
T KOG0696|consen  475 DLKLDNVMLDSEGHIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG  552 (683)
T ss_pred             eccccceEeccCCceEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999987532222  222346799999999999999999999999999999999999999987


Q ss_pred             ccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          164 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      .+.+..-+.+.+                   .+..+|...+.+..+++...|...|.+|.
T Consensus       553 eDE~elF~aI~e-------------------hnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  553 EDEDELFQAIME-------------------HNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             CCHHHHHHHHHH-------------------ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            665333222222                   24667889999999999999999999994

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=203.00  Aligned_cols=219  Identities=26%  Similarity=0.329  Sum_probs=165.7

Q ss_pred             HHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      .+|...+..++|+||++++.+|.-..      ..|+|||++ ..+|.+.+.-.    +.=..+..++.|++-|+.|||  
T Consensus        63 ~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lh--  135 (369)
T KOG0665|consen   63 YRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLH--  135 (369)
T ss_pred             hhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHH--
Confidence            36888899999999999999996543      568999999 56888887622    455688999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      +.||+||||||+||++..+..+||.|||++......   -..+..+.+..|.|||++-+-.+...+||||+||++.+|++
T Consensus       136 s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~  212 (369)
T KOG0665|consen  136 SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELIL  212 (369)
T ss_pred             hcceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhh
Confidence            999999999999999999999999999999754332   23455677889999999988889999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccc---------------hhHHHHHH-hhhcc-------CCCCCHHHHHHHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLR---------------DSRRVLRI-MDTRL-------GGQYSKKEAQAVAAVVLQ  213 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~-~~~~~-------~~~~~~~~~~~l~~li~~  213 (278)
                      |...|.+.+.-.+..++.+.....-.               +....... +....       ..+.+...+..+++++.+
T Consensus       213 ~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~  292 (369)
T KOG0665|consen  213 GTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSK  292 (369)
T ss_pred             ceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHH
Confidence            99999865543333333322221111               00000000 00000       111223456788999999


Q ss_pred             hccCCCCCCCCHHHHHHH
Q 023752          214 CLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       214 ~l~~dp~~Rps~~~ll~~  231 (278)
                      ||..||++|.|+.++|+|
T Consensus       293 MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  293 MLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hhccChhhcccHHHHhcC
Confidence            999999999999999976

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-30  Score=204.64  Aligned_cols=211  Identities=25%  Similarity=0.292  Sum_probs=159.6

Q ss_pred             HHHH-HHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            4 TEVI-YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---KGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         4 ~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      .|.+ +++.-+.|||+++|+....++..|+.||.+ +.||..+...   -....+++..+..+....+.||.||-. ...
T Consensus       111 ~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~-~lk  188 (361)
T KOG1006|consen  111 MEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE-ELK  188 (361)
T ss_pred             HHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH-Hhh
Confidence            3444 344447899999999999999999999999 6788776542   123468999999999999999999964 678


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc--CCCCCccchhHHHHHHHHHHhC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |+|||+||+||+++..|.+||+|||.+......   ...+...|-..|+|||.+..  ..|+.++|+||||++++++.||
T Consensus       189 iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG  265 (361)
T KOG1006|consen  189 IIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATG  265 (361)
T ss_pred             hhhccCChhheEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecC
Confidence            999999999999999999999999998653222   22233457778999998853  4699999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||..++.....-.......+..-.            ...-..+++..+..+|..||.+|...||...+++++
T Consensus       266 ~fPyr~w~svfeql~~Vv~gdpp~l~------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  266 NFPYRKWDSVFEQLCQVVIGDPPILL------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCCcchHHHHHHHHHHHHcCCCCeec------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            99998765421111111111111000            011123578899999999999999999999999863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=2.2e-28  Score=230.71  Aligned_cols=199  Identities=20%  Similarity=0.227  Sum_probs=140.2

Q ss_pred             HhccCC-ccccceeeee-------ecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            9 LGQLRH-ENLVKLIGYC-------SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         9 l~~l~h-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .+.++| .||++++++|       .++..+++++|++ +++|.+++.... ..+++..+..++.||+.||.|||  ++||
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~gI  101 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-RSVDAFECFHVFRQIVEIVNAAH--SQGI  101 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-ccccHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            455667 7899999988       3334567888987 679999996432 46999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceE-------------------EeccccccCCCCCCC--------------CccccccccCCcc
Q 023752           81 IYRDLKASNVLLDSNFNAK-------------------LSDFGLARDGPTGDN--------------THVSTRIVGTRGY  127 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~k-------------------l~dfg~~~~~~~~~~--------------~~~~~~~~~~~~~  127 (278)
                      +||||||+||+++..+.++                   ++|||++........              ........+++.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            9999999999997655555                   445554432110000              0000113467789


Q ss_pred             cCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHH
Q 023752          128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAV  207 (278)
Q Consensus       128 ~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  207 (278)
                      +|||++.+..++.++|||||||++|+|++|..|+.....     .+....              .... .+.........
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~--------------~~~~-~~~~~~~~~~~  241 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLR--------------HRVL-PPQILLNWPKE  241 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHH--------------Hhhc-ChhhhhcCHHH
Confidence            999999888999999999999999999998887643211     000000              0000 00011123345


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 023752          208 AAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       208 ~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..++.+||+.+|.+||++.+++++
T Consensus       242 ~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        242 ASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHhCCCChhhCcChHHHhhc
Confidence            688999999999999999999875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.95  E-value=3.6e-28  Score=223.21  Aligned_cols=182  Identities=29%  Similarity=0.447  Sum_probs=133.0

Q ss_pred             ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           29 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        29 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      .+||-||||+...+.+++.++... -.....|.++.+|++||.|+|  ++|++||||||.||+++..+.|||+|||+++.
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH--~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~  746 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIH--DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATD  746 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHH--hCceeeccCCcceeEEcCCCCeeecccccchh
Confidence            468999999887777777766521 146789999999999999999  89999999999999999999999999999986


Q ss_pred             CC----C------------CCCCccccccccCCcccCccccccC---CCCCccchhHHHHHHHHHHhCCCCCccccCCch
Q 023752          109 GP----T------------GDNTHVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA  169 (278)
Q Consensus       109 ~~----~------------~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~  169 (278)
                      ..    .            .......+..+||..|+|||++.+.   .|+.|+|+||||+++|+|+.   ||....  ..
T Consensus       747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ER  821 (1351)
T KOG1035|consen  747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ER  821 (1351)
T ss_pred             hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchH--HH
Confidence            21    0            0111123457899999999999764   49999999999999999985   453211  11


Q ss_pred             hhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          170 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      ...+.+...+.+...            ..+.....+.-..+|++|++.||.+||||.|+|.
T Consensus       822 a~iL~~LR~g~iP~~------------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  822 ASILTNLRKGSIPEP------------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHhcccCCCCCC------------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            111111111111110            0112233455678999999999999999999995

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=201.66  Aligned_cols=224  Identities=24%  Similarity=0.326  Sum_probs=163.3

Q ss_pred             HHHHHHHhccC--------CccccceeeeeecC----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 023752            3 QTEVIYLGQLR--------HENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL   70 (278)
Q Consensus         3 ~~E~~~l~~l~--------h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l   70 (278)
                      ..||.+|+++.        ..+||+++|.|...    .++|+|+|+. |.+|..++.....++++...+..|+.|++.||
T Consensus       122 lDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GL  200 (590)
T KOG1290|consen  122 LDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGL  200 (590)
T ss_pred             HHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHH
Confidence            47999999982        24899999999754    3789999998 88999999988888999999999999999999


Q ss_pred             HHHhcCCCCeeecCCCCCceEEcCC-------------------------------------------------------
Q 023752           71 SFLHGLDANVIYRDLKASNVLLDSN-------------------------------------------------------   95 (278)
Q Consensus        71 ~~Lh~~~~~i~H~dl~p~ni~~~~~-------------------------------------------------------   95 (278)
                      .|||. ..||+|.||||+||++..+                                                       
T Consensus       201 dYLH~-ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r  279 (590)
T KOG1290|consen  201 DYLHR-ECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKR  279 (590)
T ss_pred             HHHHH-hcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhh
Confidence            99997 7899999999999998400                                                       


Q ss_pred             --------------------------------------------------------------------------------
Q 023752           96 --------------------------------------------------------------------------------   95 (278)
Q Consensus        96 --------------------------------------------------------------------------------   95 (278)
                                                                                                      
T Consensus       280 ~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t  359 (590)
T KOG1290|consen  280 QAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSAT  359 (590)
T ss_pred             hhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccc
Confidence                                                                                            


Q ss_pred             -------------------------------CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccch
Q 023752           96 -------------------------------FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDV  144 (278)
Q Consensus        96 -------------------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  144 (278)
                                                     -++||+|||-+++.....     +....|.-|++||++.|..|+..+||
T Consensus       360 ~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF-----T~DIQTRQYRapEVllGsgY~~~ADi  434 (590)
T KOG1290|consen  360 PSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF-----TEDIQTRQYRAPEVLLGSGYSTSADI  434 (590)
T ss_pred             cccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhh-----chhhhhhhccCcceeecCCCCCchhH
Confidence                                           012333444333321111     11245667999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCCccccCCc------hhhhHHhhhccc----cchhHHHHHHhhhcc-------------------
Q 023752          145 YSFGVVLLELLSGRRALDEDRGGL------AEQTLVEWADPF----LRDSRRVLRIMDTRL-------------------  195 (278)
Q Consensus       145 wslG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~----~~~~~~~~~~~~~~~-------------------  195 (278)
                      ||++|++|+|+||-..|+..++..      ....+.+.....    .........+++.+.                   
T Consensus       435 WS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~e  514 (590)
T KOG1290|consen  435 WSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIE  514 (590)
T ss_pred             HHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHH
Confidence            999999999999999997654432      222222222211    111111111111110                   


Q ss_pred             CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          196 GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       196 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      .-..+.....++.+|+.-||+.+|++||||.+.++|-.
T Consensus       515 KY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPw  552 (590)
T KOG1290|consen  515 KYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPW  552 (590)
T ss_pred             HhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCcc
Confidence            12345678899999999999999999999999997644

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=199.81  Aligned_cols=224  Identities=26%  Similarity=0.448  Sum_probs=169.7

Q ss_pred             hHHHHHHHhcc--CCccccceeeeeecCC----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh-
Q 023752            2 WQTEVIYLGQL--RHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH-   74 (278)
Q Consensus         2 ~~~E~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh-   74 (278)
                      |.+|.+|.+..  +|+||+.+++.-..++    .+|||++|-+.|||.|++.++   .++.....+++..++.||++|| 
T Consensus       250 WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~  326 (513)
T KOG2052|consen  250 WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHM  326 (513)
T ss_pred             hhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHH
Confidence            77888888876  9999999999876554    579999999999999999886   5999999999999999999999 


Q ss_pred             -----cCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCC--CccccccccCCcccCccccccC----CCC--Cc
Q 023752           75 -----GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN--THVSTRIVGTRGYAAPEYVATG----HLT--PK  141 (278)
Q Consensus        75 -----~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~----~~~--~~  141 (278)
                           +-+-.|.|||||..||++..++..-|+|+|++........  .......+|+.+|+|||++...    .++  ..
T Consensus       327 eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~  406 (513)
T KOG2052|consen  327 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKR  406 (513)
T ss_pred             HHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhH
Confidence                 2245699999999999999999999999999987555432  2223446899999999998543    222  36


Q ss_pred             cchhHHHHHHHHHHh----------CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC-----HHHHHH
Q 023752          142 SDVYSFGVVLLELLS----------GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS-----KKEAQA  206 (278)
Q Consensus       142 ~DiwslG~il~~l~~----------g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  206 (278)
                      +||||||.++||++.          .+.||-+.-..          +|.+.+..+....  .+.++.+|     ...-..
T Consensus       407 ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~----------DPs~eeMrkVVCv--~~~RP~ipnrW~s~~~l~~  474 (513)
T KOG2052|consen  407 ADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS----------DPSFEEMRKVVCV--QKLRPNIPNRWKSDPALRV  474 (513)
T ss_pred             HHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC----------CCCHHHHhcceee--cccCCCCCcccccCHHHHH
Confidence            999999999999986          25666432110          1112222211111  11122222     345567


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCCC
Q 023752          207 VAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       207 l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  240 (278)
                      +..+++.||..||.-|.|+-.+.+.|.++....+
T Consensus       475 m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e  508 (513)
T KOG2052|consen  475 MAKLMKECWYANPAARLTALRIKKTLAKLSNSDE  508 (513)
T ss_pred             HHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence            8889999999999999999999999999986533

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=2.9e-27  Score=183.88  Aligned_cols=168  Identities=22%  Similarity=0.211  Sum_probs=126.5

Q ss_pred             CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCcccc
Q 023752           40 GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST  119 (278)
Q Consensus        40 ~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~  119 (278)
                      |+|.+++..++ ..+++..++.++.|++.||.|||  +.+      ||+||+++.++.+++  ||.+.......      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH--~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELH--RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--hcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            68999887643 36999999999999999999999  666      999999999999999  99886543221      


Q ss_pred             ccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCC-chhhhHHhhhccccchhHHHHHHhhhccCCC
Q 023752          120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG-LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ  198 (278)
Q Consensus       120 ~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (278)
                       ..+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.....+..            .....
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~~~~~  130 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD------------PRDRS  130 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC------------ccccc
Confidence             24678999999999999999999999999999999999999653221 11111110000000            00001


Q ss_pred             CCHHHHH--HHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          199 YSKKEAQ--AVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       199 ~~~~~~~--~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      .+..++.  ++.++|.+||+.+|.+||++.++++++..+..
T Consensus       131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            2233444  69999999999999999999999999887654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-27  Score=193.41  Aligned_cols=202  Identities=26%  Similarity=0.373  Sum_probs=162.5

Q ss_pred             HHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            5 EVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         5 E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      |-.+..+- +||.++-+...|+.+..+++|.||++||+|--.+++..  .+++..+..+...|+.||.|||  ++||++|
T Consensus       300 ek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh--~rgiiyr  375 (593)
T KOG0695|consen  300 EKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLH--ERGIIYR  375 (593)
T ss_pred             hHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHh--hcCeeee
Confidence            44444444 68999999999999999999999999999987776654  6999999999999999999999  9999999


Q ss_pred             CCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCcc
Q 023752           84 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE  163 (278)
Q Consensus        84 dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~  163 (278)
                      |||.+|++++..|++||+|+|.+......  ......+.|++.|.|||++.+..|..+.|.|+||+++|+|+.|+.||+-
T Consensus       376 dlkldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  376 DLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             eccccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            99999999999999999999998763332  2233446799999999999999999999999999999999999999964


Q ss_pred             ccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          164 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      -.-+.          + ..+.+...-.+--.....+|...+-....+++.-|++||.+|.
T Consensus       454 vgm~n----------~-d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  454 VGMDN----------P-DMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ecCCC----------c-ccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence            22111          1 1111222222222223566778888888999999999999994

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.95  E-value=1e-26  Score=184.78  Aligned_cols=176  Identities=36%  Similarity=0.576  Sum_probs=153.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++.++.+.|++|+++++++......++++|++.+++|.+++.... ..++...+..++.+++.++.+||  ..|++
T Consensus        38 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh--~~~~~  114 (215)
T cd00180          38 LLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH--SNGII  114 (215)
T ss_pred             HHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            6789999999999999999999999899999999999899999987653 35889999999999999999999  88999


Q ss_pred             ecCCCCCceEEcC-CCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      |+||+|.||+++. ++.++|+|||.+........  ..........|.+||..... ..+.+.|+|+||++++++     
T Consensus       115 H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----  187 (215)
T cd00180         115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----  187 (215)
T ss_pred             ccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----
Confidence            9999999999999 89999999999876443321  11223466789999998776 788899999999999999     


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                                                                   ..+.+++.+|++.+|++||++.++++++
T Consensus       188 ---------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                                         3578899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=194.13  Aligned_cols=226  Identities=24%  Similarity=0.354  Sum_probs=175.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.+|..++|.||+..++..+...     ++|+++|.+. .+|...+..-.  .++.+.+.-+++||+.||.|||  
T Consensus        99 vFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVSPQ--~Ls~DHvKVFlYQILRGLKYLH--  173 (449)
T KOG0664|consen   99 VFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVSPQ--ALTPDHVKVFVYQILRGLKYLH--  173 (449)
T ss_pred             HHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheeccCC--CCCcchhhhhHHHHHhhhHHHh--
Confidence            468999999999999999999887654     4678888884 57777775443  6889999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~  155 (278)
                      +.+|.||||||.|.+++.+-.+||+|||+++...... ...++..+-+.+|.|||+++|. .|+.+.||||+||++.+++
T Consensus       174 sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELL  252 (449)
T KOG0664|consen  174 TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELL  252 (449)
T ss_pred             hcchhhccCCCccEEeccCceEEecccccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHH
Confidence            8999999999999999999999999999998754432 3334555668899999999885 7999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccch-hHHH-----HHHhhhccCCC---------CCHHHHHHHHHHHHHhccCCCC
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRD-SRRV-----LRIMDTRLGGQ---------YSKKEAQAVAAVVLQCLHMDPK  220 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~  220 (278)
                      ..+..|...+.-...+.+.+.......+ ....     ...+....+.+         .+..-..+...++.+++.+||+
T Consensus       253 gRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~d  332 (449)
T KOG0664|consen  253 QRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPD  332 (449)
T ss_pred             hhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCc
Confidence            9999998888777777777665543322 1111     11111111111         1123345677889999999999


Q ss_pred             CCCCHHHHHHHHH
Q 023752          221 NRPSMVDVLTSLE  233 (278)
Q Consensus       221 ~Rps~~~ll~~l~  233 (278)
                      +|.+..+.+.++.
T Consensus       333 kris~~~A~~~~~  345 (449)
T KOG0664|consen  333 KRISVEEALQHRY  345 (449)
T ss_pred             ccccHhhhccccc
Confidence            9999999987654

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-26  Score=191.54  Aligned_cols=235  Identities=29%  Similarity=0.394  Sum_probs=174.8

Q ss_pred             hHHHHHHHhcc--CCccccceeeeeecCC----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQL--RHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l--~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      |++|-+|.+..  .|+||+++++.-....    .++||++|.+.|+|.+++..+   ..++....+++..++.||+|||+
T Consensus       249 ~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHe  325 (534)
T KOG3653|consen  249 FQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHE  325 (534)
T ss_pred             HHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcc
Confidence            56777776655  8999999999876655    789999999999999999887   48999999999999999999993


Q ss_pred             -------CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCC-----Ccc
Q 023752           76 -------LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLT-----PKS  142 (278)
Q Consensus        76 -------~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~-----~~~  142 (278)
                             .+..|+|||||..||++..+++.-|+|||++..+...........-+|+.+|+|||++.+. ++.     .+.
T Consensus       326 e~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~  405 (534)
T KOG3653|consen  326 ELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRI  405 (534)
T ss_pred             cCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHH
Confidence                   3567999999999999999999999999999988766555444446899999999999764 222     369


Q ss_pred             chhHHHHHHHHHHhCCCCCcc-ccCCchhhhHHh-hhccccchhHHHHHHhhhccCCCCCH-----HHHHHHHHHHHHhc
Q 023752          143 DVYSFGVVLLELLSGRRALDE-DRGGLAEQTLVE-WADPFLRDSRRVLRIMDTRLGGQYSK-----KEAQAVAAVVLQCL  215 (278)
Q Consensus       143 DiwslG~il~~l~~g~~p~~~-~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~li~~~l  215 (278)
                      ||||+|.++|++++...-+.. .-...+...-.+ ...|.+.+...  -.+.++.++.++.     .....+.+.+..||
T Consensus       406 DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~--~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCW  483 (534)
T KOG3653|consen  406 DVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQE--LVVRKKQRPKIPDAWRKHAGMAVLCETIEECW  483 (534)
T ss_pred             HHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHH--HHHhhccCCCChhhhhcCccHHHHHHHHHHHc
Confidence            999999999999986544321 100000000000 01122222111  1233333444432     34668899999999


Q ss_pred             cCCCCCCCCHHHHHHHHHhhhcCCCC
Q 023752          216 HMDPKNRPSMVDVLTSLEQLHTSKDM  241 (278)
Q Consensus       216 ~~dp~~Rps~~~ll~~l~~~~~~~~~  241 (278)
                      ..|++-|.|+.=+-+.+.++......
T Consensus       484 DhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  484 DHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCchhhhhhhHHHHHHHHHHhccCCc
Confidence            99999999999999999888877543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=179.13  Aligned_cols=159  Identities=25%  Similarity=0.309  Sum_probs=130.2

Q ss_pred             HHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            3 QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         3 ~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      .+|+.+..+. .+|.++.+|+.+.+.+..|+.||.+ ..||+.+..+-  ..+.+++..+-+++..++.||.|||+ +..
T Consensus        92 L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~-kL~  169 (282)
T KOG0984|consen   92 LMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS-KLS  169 (282)
T ss_pred             HHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH-Hhh
Confidence            3455544444 6899999999999999999999999 56888876432  22479999999999999999999997 679


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc----CCCCCccchhHHHHHHHHHH
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----GHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~----~~~~~~~DiwslG~il~~l~  155 (278)
                      ++|||+||.||+++.+|+||++|||.+-...+..-..   ...|-..|+|||.+..    ..|+.++||||||+.+++|.
T Consensus       170 vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA  246 (282)
T KOG0984|consen  170 VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA  246 (282)
T ss_pred             hhhccCCcceEEEccCCcEEEcccccceeehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence            9999999999999999999999999987654432221   1345667999998743    47899999999999999999


Q ss_pred             hCCCCCccccC
Q 023752          156 SGRRALDEDRG  166 (278)
Q Consensus       156 ~g~~p~~~~~~  166 (278)
                      +++.||+.+..
T Consensus       247 ~lr~PY~~w~t  257 (282)
T KOG0984|consen  247 ILRFPYESWGT  257 (282)
T ss_pred             hccccccccCC
Confidence            99999986543

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.94  E-value=2.9e-26  Score=207.24  Aligned_cols=198  Identities=20%  Similarity=0.237  Sum_probs=130.0

Q ss_pred             cCCccEEEEeccCCCCHHHHHhhcCCC------------------CCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCC
Q 023752           26 ESDNRLLVYEFMPKGSLENHLFRKGVQ------------------PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA   87 (278)
Q Consensus        26 ~~~~~~lv~e~~~~~~L~~~~~~~~~~------------------~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p   87 (278)
                      .....++|++|+.+++|.+++......                  ......+..++.|++.||.|||  +.+|+||||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH--~~gIiHRDLKP  283 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH--STGIVHRDVKP  283 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH--HCCEEeCcCCH
Confidence            455789999999999999988654311                  0123346689999999999999  89999999999


Q ss_pred             CceEEcC-CCceEEeccccccCCCCCCCCccccccccCCcccCccccccC----------------------CCCCccch
Q 023752           88 SNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG----------------------HLTPKSDV  144 (278)
Q Consensus        88 ~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~----------------------~~~~~~Di  144 (278)
                      +||+++. ++.+||+|||++........ .......+++.|+|||.+...                      .++.++||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            9999986 57899999999975433221 112234678899999965321                      23446799


Q ss_pred             hHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCC------CCCHHHHHHHHHHHHHhccCC
Q 023752          145 YSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGG------QYSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       145 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~d  218 (278)
                      |||||++|+|+++..+++..... ....+.....    +..............      +..........+||.+||+.|
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~-~~~~l~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQ-FNRQLKRNDY----DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHH-HHHHHHhcCC----cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            99999999999876654321100 0001111000    000000111110000      001112335668999999999


Q ss_pred             CCCCCCHHHHHHH
Q 023752          219 PKNRPSMVDVLTS  231 (278)
Q Consensus       219 p~~Rps~~~ll~~  231 (278)
                      |.+|||+.++++|
T Consensus       438 P~kR~ta~e~L~H  450 (566)
T PLN03225        438 GRQRISAKAALAH  450 (566)
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999986

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-27  Score=201.70  Aligned_cols=151  Identities=30%  Similarity=0.426  Sum_probs=134.7

Q ss_pred             HHHHHHhccC---CccccceeeeeecCCccEEEEec-cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            4 TEVIYLGQLR---HENLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         4 ~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      .||+||..++   |+||++++++|++++++|+++|- -+|.+|.+++..+.  .+.+.+...|+.|++.|+++||  +.|
T Consensus       615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh--~~~  690 (772)
T KOG1152|consen  615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLH--DQG  690 (772)
T ss_pred             hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhcccccc--ccC
Confidence            4899999996   99999999999999999999986 44669999998775  7999999999999999999999  999


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC-CccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~  158 (278)
                      |+|||||-+||+++.+|.+||+|||.+....+...    ..++|+..|.|||++.|..|- ..-|||+||+++|.++...
T Consensus       691 ivhrdikdenvivd~~g~~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyke  766 (772)
T KOG1152|consen  691 IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKE  766 (772)
T ss_pred             ceecccccccEEEecCCeEEEeeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEecc
Confidence            99999999999999999999999999876444332    236789999999999998775 6689999999999999988


Q ss_pred             CCCc
Q 023752          159 RALD  162 (278)
Q Consensus       159 ~p~~  162 (278)
                      .||-
T Consensus       767 npyy  770 (772)
T KOG1152|consen  767 NPYY  770 (772)
T ss_pred             CCCc
Confidence            8873

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.9e-25  Score=197.75  Aligned_cols=219  Identities=21%  Similarity=0.242  Sum_probs=148.2

Q ss_pred             HHHHHHhccCCccc-----cceeeeeec--------CCccEEEEeccCCCCHHHHHhhcCC-------------------
Q 023752            4 TEVIYLGQLRHENL-----VKLIGYCSE--------SDNRLLVYEFMPKGSLENHLFRKGV-------------------   51 (278)
Q Consensus         4 ~E~~~l~~l~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~-------------------   51 (278)
                      .|+.++.+++|.++     ++++++|..        .+..++|+||+.+++|.+++.....                   
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            46667777765543     667776643        3467999999999999998864210                   


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCccc
Q 023752           52 ---QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA  128 (278)
Q Consensus        52 ---~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~  128 (278)
                         ..+++..+..++.|++.+|.|||  +.+++|+||||.||+++.++.++|+|||++.......... ......++.|+
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH--~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~  377 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLH--RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYS  377 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHH--HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCccee
Confidence               12355678899999999999999  8999999999999999999999999999986543322111 11123467899


Q ss_pred             CccccccCC--------------------CC--CccchhHHHHHHHHHHhCCC-CCccccCCchhhhHHhhhccccchhH
Q 023752          129 APEYVATGH--------------------LT--PKSDVYSFGVVLLELLSGRR-ALDEDRGGLAEQTLVEWADPFLRDSR  185 (278)
Q Consensus       129 aPE~~~~~~--------------------~~--~~~DiwslG~il~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~  185 (278)
                      |||.+....                    +.  .+.|+||+||++++|++|.. ||.........  +....    ....
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~--~~~~~----~~~~  451 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE--LRQYD----NDLN  451 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH--Hhhcc----chHH
Confidence            999874321                    11  24799999999999999875 66432211110  00000    0000


Q ss_pred             HHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCC---CCCCCHHHHHHH
Q 023752          186 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP---KNRPSMVDVLTS  231 (278)
Q Consensus       186 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~~ll~~  231 (278)
                      ..................+....+|+.+||..+|   .+|+|+.|+++|
T Consensus       452 ~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        452 RWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             HHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            0001111112223345678899999999999876   689999999976

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-25  Score=177.01  Aligned_cols=206  Identities=23%  Similarity=0.347  Sum_probs=147.1

Q ss_pred             hHHHHHHHhcc-CCccccceeee-eecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGY-CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~-~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|...--.| .|.||+..|++ |+..+.+++++||++-|+|.+-+...   ++.+.....++.|+++|+.|+|  +++
T Consensus        67 F~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH--skn  141 (378)
T KOG1345|consen   67 FVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH--SKN  141 (378)
T ss_pred             HHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh--ccc
Confidence            45555544444 58999998875 66667888999999999999888665   4889999999999999999999  999


Q ss_pred             eeecCCCCCceEEcC--CCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-----CCCCCccchhHHHHHHH
Q 023752           80 VIYRDLKASNVLLDS--NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        80 i~H~dl~p~ni~~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----~~~~~~~DiwslG~il~  152 (278)
                      +||||||.+||+|..  ..+|||+|||.....+.     ..........|.+||....     ...++.+|+|.||+++|
T Consensus       142 lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f  216 (378)
T KOG1345|consen  142 LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFF  216 (378)
T ss_pred             hhhcccccceEEEecCCccEEEeeecccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeee
Confidence            999999999999943  34699999999875322     2222334556889987632     24568899999999999


Q ss_pred             HHHhCCCCCccccC-CchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          153 ELLSGRRALDEDRG-GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       153 ~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ++++|..||+...- +........|....           .... +..-..+++.+..+.++-|..++++|--..++.
T Consensus       217 ~cltG~~PWQka~~~d~~Y~~~~~w~~rk-----------~~~~-P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  217 YCLTGKFPWQKASIMDKPYWEWEQWLKRK-----------NPAL-PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             eeecCCCcchhhhccCchHHHHHHHhccc-----------CccC-chhhcccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            99999999973221 11111222221111           1111 111234677888999999999999994444433

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.92  E-value=4.8e-26  Score=198.14  Aligned_cols=208  Identities=25%  Similarity=0.325  Sum_probs=163.7

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      ++|+-+++..+||||+.+++.+.....+|++||||.||+|.+...--+  ++++.++...+...+.+++|||  +.|-+|
T Consensus        60 qqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg--plselqiayvcRetl~gl~ylh--s~gk~h  135 (829)
T KOG0576|consen   60 QQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLH--SQGKIH  135 (829)
T ss_pred             ccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc--cchhHHHHHHHhhhhccchhhh--cCCccc
Confidence            578888999999999999999999999999999999999999775443  7999999999999999999999  899999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccc---ccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~---~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ||||..||++++.|.+|+.|||.+-.+.....  ....+.|+++|+|||+.   ....|...+|+|++|+...++-.-++
T Consensus       136 RdiKGanilltd~gDvklaDfgvsaqitati~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqp  213 (829)
T KOG0576|consen  136 RDIKGANILLTDEGDVKLADFGVSAQITATIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQP  213 (829)
T ss_pred             ccccccceeecccCceeecccCchhhhhhhhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCC
Confidence            99999999999999999999998865433222  23347899999999976   34678899999999999999988887


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |..+.........+.+-.              .+....+-...-++.+.+|++.+|..+|++||+++-+|.
T Consensus       214 plfdlhpmr~l~LmTkS~--------------~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  214 PLFDLHPMRALFLMTKSG--------------FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cccccchHHHHHHhhccC--------------CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            754322211110000000              000001112345678999999999999999999988764

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.91  E-value=8.8e-24  Score=170.13  Aligned_cols=158  Identities=32%  Similarity=0.443  Sum_probs=136.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++.++.++|+|++++++++......++++|++.+++|.+++..... .+++..+..++.+++.++.+||  +.+++
T Consensus        44 ~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh--~~~i~  120 (225)
T smart00221       44 FLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH--SLGIV  120 (225)
T ss_pred             HHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            57899999999999999999999988899999999999999999876542 1789999999999999999999  88999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccc-ccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+|++|.||+++.++.++|+|||.+......... ......+...|++||.. ....++.++|+|+||++++++++|+.|
T Consensus       121 h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~p  199 (225)
T smart00221      121 HRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEP  199 (225)
T ss_pred             cCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999998765443211 11223456779999998 666778899999999999999999999


Q ss_pred             Ccc
Q 023752          161 LDE  163 (278)
Q Consensus       161 ~~~  163 (278)
                      |..
T Consensus       200 f~~  202 (225)
T smart00221      200 FSG  202 (225)
T ss_pred             ccc
Confidence            965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.90  E-value=9.3e-24  Score=175.32  Aligned_cols=223  Identities=23%  Similarity=0.319  Sum_probs=160.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      ..+|+++|..+ .+.||+++.+.+..++..++|+||++.....++..     .++...+..+++.++.||.++|  ..||
T Consensus        81 i~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h--~~GI  153 (418)
T KOG1167|consen   81 ILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH--KNGI  153 (418)
T ss_pred             HHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh--ccCc
Confidence            36899999999 58999999999999999999999999999888885     3667799999999999999999  9999


Q ss_pred             eecCCCCCceEEcC-CCceEEeccccccCCCCCC-------------------------------C-----------Ccc
Q 023752           81 IYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGD-------------------------------N-----------THV  117 (278)
Q Consensus        81 ~H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~-------------------------------~-----------~~~  117 (278)
                      +||||||.|++++. .+.-.|+|||++.......                               .           ...
T Consensus       154 vHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~  233 (418)
T KOG1167|consen  154 VHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSE  233 (418)
T ss_pred             cccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccce
Confidence            99999999999975 4668899999987211100                               0           000


Q ss_pred             ccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCCCccccCCc--hhhhHHhhhccc------------cc
Q 023752          118 STRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL--AEQTLVEWADPF------------LR  182 (278)
Q Consensus       118 ~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~------------~~  182 (278)
                      .....|++.|.|||++.. ...+.+.||||.|+++..++++..||-....+.  ..+...-+....            +.
T Consensus       234 ~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~  313 (418)
T KOG1167|consen  234 RANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLW  313 (418)
T ss_pred             ecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeee
Confidence            112468899999999865 456789999999999999999999995432221  111111110000            00


Q ss_pred             h-------------hHHH-HHHhhh-cc---CCC-CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          183 D-------------SRRV-LRIMDT-RL---GGQ-YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       183 ~-------------~~~~-~~~~~~-~~---~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +             .+.. ...+.+ ..   ..+ .....+..+.+|+++||..||.+|.|++++|+|
T Consensus       314 ~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  314 QKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0             0000 011111 00   011 112345689999999999999999999999975

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=7.9e-25  Score=197.70  Aligned_cols=210  Identities=23%  Similarity=0.292  Sum_probs=166.1

Q ss_pred             HHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecC
Q 023752            5 EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRD   84 (278)
Q Consensus         5 E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~d   84 (278)
                      |+-+-..++|+|++...+.+.+.....-.||||++ +|..++...+  .+....+...+.|++.||.|+|  ..|+.|+|
T Consensus       371 E~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h--~~Giahrd  445 (601)
T KOG0590|consen  371 EFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLH--SMGLAHRD  445 (601)
T ss_pred             heeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHH--hcCceecc
Confidence            44455677999999988888777666556999998 9999998764  5888899999999999999999  99999999


Q ss_pred             CCCCceEEcCCCceEEeccccccCCCCCCCC--ccccccccCCcccCccccccCCCCC-ccchhHHHHHHHHHHhCCCCC
Q 023752           85 LKASNVLLDSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTP-KSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        85 l~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~p~  161 (278)
                      +|++|++++.+|.+||+|||.+..+......  .......|+..|+|||++.+..|++ ..||||.|+++..|.+|+.||
T Consensus       446 lK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~W  525 (601)
T KOG0590|consen  446 LKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPW  525 (601)
T ss_pred             CccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcc
Confidence            9999999999999999999999876666554  4455678899999999999999986 599999999999999999999


Q ss_pred             ccccCCchhh-hHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          162 DEDRGGLAEQ-TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      .......... ........           ........+...++.+.+.+|.+||+.||.+|.|+.+|++
T Consensus       526 k~a~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  526 KVAKKSDNSFKTNNYSDQR-----------NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccccccchhhhcccccc-----------ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            6544332221 00000000           0000112234567788999999999999999999999985

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.88  E-value=6.1e-23  Score=162.09  Aligned_cols=209  Identities=22%  Similarity=0.391  Sum_probs=168.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |+.|.-.|+.+.||||+.+++.+..+.++.+|..|++.|+|..++.+...--....++.+++.+++.|.+|||+...-|.
T Consensus       234 fneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ip  313 (448)
T KOG0195|consen  234 FNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIP  313 (448)
T ss_pred             hhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhh
Confidence            77888999999999999999999999999999999999999999976654345666889999999999999997655666


Q ss_pred             ecCCCCCceEEcCCCceEEe--ccccccCCCCCCCCccccccccCCcccCccccccCCCC---CccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLS--DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~---~~~DiwslG~il~~l~~  156 (278)
                      --.|+...++++++.+.+|.  |--++..         .......+.|++||.++..+-+   .++|+|||++++|++.|
T Consensus       314 r~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~t  384 (448)
T KOG0195|consen  314 RFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNT  384 (448)
T ss_pred             hhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhc
Confidence            66789999999988765553  3222211         1112346789999999776544   57999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      ...||.+...                 .+--.++.....+..+|++.+..+..|+.-|++.||.+||.+..++--|++..
T Consensus       385 revpfadlsp-----------------mecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  385 REVPFADLSP-----------------MECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             cccccccCCc-----------------hhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            9999976543                 12223444456678889999999999999999999999999999998888753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=5.2e-20  Score=156.53  Aligned_cols=221  Identities=23%  Similarity=0.249  Sum_probs=171.4

Q ss_pred             hHHHHHHHhccC----Cccccceeeee-ecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLR----HENLVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +..|..++..+.    .+++..+++.. ..+...|+||+.+ |.+|.++......+.++...+..++.|++.+|.++|  
T Consensus        63 l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH--  139 (322)
T KOG1164|consen   63 LKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH--  139 (322)
T ss_pred             chhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH--
Confidence            567888888886    36999999999 4777889999988 889999887666668999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCC-----CceEEeccccccCCC--CCCCC--c---c-ccccccCCcccCccccccCCCCCccc
Q 023752           77 DANVIYRDLKASNVLLDSN-----FNAKLSDFGLARDGP--TGDNT--H---V-STRIVGTRGYAAPEYVATGHLTPKSD  143 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~-----~~~kl~dfg~~~~~~--~~~~~--~---~-~~~~~~~~~~~aPE~~~~~~~~~~~D  143 (278)
                      +.|++||||||.|++++..     ..+.+.|||++....  .....  .   . .....|+..|.++.+..+...+.+.|
T Consensus       140 ~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DD  219 (322)
T KOG1164|consen  140 SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDD  219 (322)
T ss_pred             hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchh
Confidence            9999999999999999765     358999999998322  22211  1   1 12355899999999999999999999


Q ss_pred             hhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          144 VYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       144 iwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      +||++.++.++..|..||...........+..........              ......+.++..+...+-..+..++|
T Consensus       220 les~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~P  285 (322)
T KOG1164|consen  220 LESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD--------------RFGDLKPEEFAKILEYIDSLDYEDKP  285 (322)
T ss_pred             hhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc--------------cccCCChHHHHHHHHHhhccCCcCCC
Confidence            9999999999999999996554333322222221111111              02233456777777777779999999


Q ss_pred             CHHHHHHHHHhhhcCC
Q 023752          224 SMVDVLTSLEQLHTSK  239 (278)
Q Consensus       224 s~~~ll~~l~~~~~~~  239 (278)
                      ....+...+.++....
T Consensus       286 dy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  286 DYEKLAELLKDVFDSE  301 (322)
T ss_pred             CHHHHHHHHHHHHHhc
Confidence            9999999998888775

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.9e-20  Score=162.61  Aligned_cols=219  Identities=25%  Similarity=0.366  Sum_probs=163.3

Q ss_pred             HhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 023752            9 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS   88 (278)
Q Consensus         9 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~   88 (278)
                      |+++.|.|+.++++.+.++...++|.+||..|+|.|.+.... ..+.......++.+++.|+.|+|++. ..+|+.++..
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-~~~d~~F~~s~~rdi~~Gl~ylh~s~-i~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-IKLDYFFILSFIRDISKGLAYLHNSP-IGYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-cCccHHHHHHHHHHHHHHHHHHhcCc-ceeeeeeccc
Confidence            467899999999999999999999999999999999997744 35888889999999999999999533 2399999999


Q ss_pred             ceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC-------CCCccchhHHHHHHHHHHhCCCCC
Q 023752           89 NVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-------LTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        89 ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-------~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |++++....+|++|||+....................-|.|||.+.+..       .+.+.|+||+|++++++++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            9999999999999999987654311111111122345699999987631       456799999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC--HHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS--KKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ...........+......          .-.....+.++  ....+++..++..||..+|.+||++.++-..++.+....
T Consensus       159 ~~~~~~~~~~eii~~~~~----------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK----------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccCChHHHHHHHHh----------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            764433222111111000          00000111111  134447899999999999999999999999988887753

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=2.1e-19  Score=152.00  Aligned_cols=214  Identities=33%  Similarity=0.510  Sum_probs=165.2

Q ss_pred             hHHHHHHHhccCCc-cccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHE-NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+.++..+.|+ +|+++++.+......+++++++.++++.+++..... ..+.......++.|++.++.++|  ..+
T Consensus        44 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H--~~~  121 (384)
T COG0515          44 FLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH--SKG  121 (384)
T ss_pred             HHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            67899999999888 799999999777778999999999999976655432 25889999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCc----cccccccCCcccCcccccc---CCCCCccchhHHHHHH
Q 023752           80 VIYRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTH----VSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVL  151 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~il  151 (278)
                      ++|+|++|+||+++..+ .++++|||.+..........    ......++..|.+||.+.+   .......|+|++|+++
T Consensus       122 ~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~  201 (384)
T COG0515         122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL  201 (384)
T ss_pred             eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence            99999999999999988 79999999987544433221    2344678899999999987   5788899999999999


Q ss_pred             HHHHhCCCCCccccCC----chhhhHHhhhccccchhHHHHHHhhhccCCCCC----HHHHHHHHHHHHHhccCCCCCCC
Q 023752          152 LELLSGRRALDEDRGG----LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       152 ~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      +++++|..||......    .....+.....+              .......    ......+.+++.+++..+|..|.
T Consensus       202 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~  267 (384)
T COG0515         202 YELLTGLPPFEGEKNSSATSQTLKIILELPTP--------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRL  267 (384)
T ss_pred             HHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--------------ccccccCccccchhhHHHHHHHHHHHhcCchhcC
Confidence            9999999997655431    111111111111              0000111    12246788999999999999999


Q ss_pred             CHHHHHHH
Q 023752          224 SMVDVLTS  231 (278)
Q Consensus       224 s~~~ll~~  231 (278)
                      +..+....
T Consensus       268 ~~~~~~~~  275 (384)
T COG0515         268 SSSSDLSH  275 (384)
T ss_pred             CHHHHhhc
Confidence            98887765

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=7.3e-21  Score=174.24  Aligned_cols=202  Identities=24%  Similarity=0.302  Sum_probs=146.0

Q ss_pred             HhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCC
Q 023752            9 LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKAS   88 (278)
Q Consensus         9 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~   88 (278)
                      ...+++||++.+.-+...+...|+|-+|. ..+|.|++..+.  .+...+.+.++.||+.||..+|  +.||||||||.+
T Consensus        75 ~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH--~~gVcHGDIKsE  149 (1431)
T KOG1240|consen   75 FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCH--KLGVCHGDIKSE  149 (1431)
T ss_pred             HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHH--HcCccccccccc
Confidence            33448999999998888878888998988 459999998776  6888899999999999999999  999999999999


Q ss_pred             ceEEcCCCceEEeccccccCCCCC-CCCcccccc----ccCCcccCcccccc----------CC-CCCccchhHHHHHHH
Q 023752           89 NVLLDSNFNAKLSDFGLARDGPTG-DNTHVSTRI----VGTRGYAAPEYVAT----------GH-LTPKSDVYSFGVVLL  152 (278)
Q Consensus        89 ni~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~----~~~~~~~aPE~~~~----------~~-~~~~~DiwslG~il~  152 (278)
                      ||+++.-+.+.|+||.......-+ ++......+    ..-..|.|||.+-.          .. .+++-||||+||+++
T Consensus       150 NILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCVia  229 (1431)
T KOG1240|consen  150 NILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIA  229 (1431)
T ss_pred             eEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHH
Confidence            999999999999999876432111 111111111    22346999997632          12 467899999999999


Q ss_pred             HHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          153 ELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       153 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||++ |++||.-..       +.........+.+..+..           -.+..++.||..|++.||.+|.++++.|+.
T Consensus       230 ELf~Eg~PlF~LSQ-------L~aYr~~~~~~~e~~Le~-----------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  230 ELFLEGRPLFTLSQ-------LLAYRSGNADDPEQLLEK-----------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHhcCCCcccHHH-------HHhHhccCccCHHHHHHh-----------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            9998 678875321       111111101111111111           123368889999999999999999999976


Q ss_pred             HH
Q 023752          232 LE  233 (278)
Q Consensus       232 l~  233 (278)
                      ..
T Consensus       292 yr  293 (1431)
T KOG1240|consen  292 YR  293 (1431)
T ss_pred             hh
Confidence            33

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=9.4e-20  Score=151.06  Aligned_cols=192  Identities=21%  Similarity=0.291  Sum_probs=139.1

Q ss_pred             CCccccceeeeeec---------------------------CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHH
Q 023752           13 RHENLVKLIGYCSE---------------------------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAID   65 (278)
Q Consensus        13 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~   65 (278)
                      .|||||++.++|.+                           +..+|+||..+ ..+|.+++-.+.   .+.....-++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence            69999999988733                           23468999888 459999997664   667777889999


Q ss_pred             HHHHHHHHhcCCCCeeecCCCCCceEE--cCCC--ceEEeccccccCCCCCCC----CccccccccCCcccCccccccCC
Q 023752           66 VARGLSFLHGLDANVIYRDLKASNVLL--DSNF--NAKLSDFGLARDGPTGDN----THVSTRIVGTRGYAAPEYVATGH  137 (278)
Q Consensus        66 l~~~l~~Lh~~~~~i~H~dl~p~ni~~--~~~~--~~kl~dfg~~~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~  137 (278)
                      +++|+.|||  +.|+.|||+|.+||++  ++++  .+++.|||.+..-....-    .+.....-|....+|||+....+
T Consensus       350 lLEav~hL~--~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLH--KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHH--HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999  9999999999999999  3343  378999998754222111    11122234566789999874321


Q ss_pred             -----C-CCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHH
Q 023752          138 -----L-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVV  211 (278)
Q Consensus       138 -----~-~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  211 (278)
                           . -.++|.|+.|.+.||+++...||-.. +++..+.                +......-+..+..+++.+++++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~r-Gem~L~~----------------r~Yqe~qLPalp~~vpp~~rqlV  490 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKR-GEMLLDT----------------RTYQESQLPALPSRVPPVARQLV  490 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCccccc-chheech----------------hhhhhhhCCCCcccCChHHHHHH
Confidence                 1 24799999999999999999999541 1111111                01112223556778899999999


Q ss_pred             HHhccCCCCCCCCHHH
Q 023752          212 LQCLHMDPKNRPSMVD  227 (278)
Q Consensus       212 ~~~l~~dp~~Rps~~~  227 (278)
                      ..+|+.||.+|++..=
T Consensus       491 ~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNI  506 (598)
T ss_pred             HHHhcCCccccCCccH
Confidence            9999999999987543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.82  E-value=2.2e-18  Score=139.86  Aligned_cols=229  Identities=17%  Similarity=0.223  Sum_probs=181.3

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|++..+.| ..++|..+|-+-.+.-+=.||+|.. |.||+|+..--+ ..|+...+..++.|++.-+.++|  .+.+
T Consensus        70 LrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH--~k~L  145 (449)
T KOG1165|consen   70 LRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVH--EKDL  145 (449)
T ss_pred             HHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHH--hcce
Confidence            56789999988 5789999998887777778999988 889999775444 46999999999999999999999  9999


Q ss_pred             eecCCCCCceEEcCC-----CceEEeccccccCCCCCCCCcc-----ccccccCCcccCccccccCCCCCccchhHHHHH
Q 023752           81 IYRDLKASNVLLDSN-----FNAKLSDFGLARDGPTGDNTHV-----STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~-----~~~kl~dfg~~~~~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i  150 (278)
                      ++|||||+|++|+.-     ..+.++|||++..+..+.....     .....|+.+|++=....|.+-+.+.|+-|||-+
T Consensus       146 IYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHv  225 (449)
T KOG1165|consen  146 IYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHV  225 (449)
T ss_pred             eecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhh
Confidence            999999999999653     3488999999998777654332     234678999999998889999999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      +++++-|..||.+-.....-+.+.+............+           -.+++.++..-+.-.-..+-.+-|+.+.+.+
T Consensus       226 FmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~L-----------c~g~P~efa~Yl~yvR~L~F~E~PDYdylr~  294 (449)
T KOG1165|consen  226 FMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVL-----------CEGFPEEFATYLRYVRRLDFFETPDYDYLRK  294 (449)
T ss_pred             hhhhccCCCccccccCcchHHHHHHhccccccCCHHHH-----------HhcCHHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            99999999999887655444444443332221111111           1357888888888888999999999999999


Q ss_pred             HHHhhhcCCCCCCCC
Q 023752          231 SLEQLHTSKDMPRTP  245 (278)
Q Consensus       231 ~l~~~~~~~~~~~~~  245 (278)
                      .+.++....+.--..
T Consensus       295 Lf~dvldr~g~t~Dg  309 (449)
T KOG1165|consen  295 LFDDVLDRLGETDDG  309 (449)
T ss_pred             HHHHHHHhcCCcccc
Confidence            998888775544433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.78  E-value=3.2e-19  Score=146.04  Aligned_cols=162  Identities=20%  Similarity=0.308  Sum_probs=105.9

Q ss_pred             cEEEEeccCCCCHHHHHh---hcCCC--CCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccc
Q 023752           30 RLLVYEFMPKGSLENHLF---RKGVQ--PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG  104 (278)
Q Consensus        30 ~~lv~e~~~~~~L~~~~~---~~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg  104 (278)
                      .+++++-. .++|.+++.   .....  .+.......+..|++..+++||  ..|++|+||+|+|++++.+|.++|+||+
T Consensus       114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh--~~GlVHgdi~~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH--SYGLVHGDIKPENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--HTTEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred             hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh--hcceEecccceeeEEEcCCCCEEEcChH
Confidence            36777876 568888754   22211  2333344567789999999999  8999999999999999999999999998


Q ss_pred             cccCCCCCCCCccccccccCCcccCcccccc--------CCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhh
Q 023752          105 LARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW  176 (278)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~  176 (278)
                      .....+.....     ...+..|.|||....        -.++.+.|.|+||+++|.++++..||+..........    
T Consensus       191 ~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----  261 (288)
T PF14531_consen  191 SLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW----  261 (288)
T ss_dssp             GEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----
T ss_pred             HHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc----
Confidence            88753332111     223467899997643        2467889999999999999999999975433211110    


Q ss_pred             hccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          177 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                                      .  ..... +.++.++.||..+|+.||.+|
T Consensus       262 ----------------~--f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  262 ----------------D--FSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ----------------G--GTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ----------------c--chhcC-CcCHHHHHHHHHHccCCcccC
Confidence                            0  11223 788999999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=1.2e-18  Score=152.14  Aligned_cols=187  Identities=26%  Similarity=0.355  Sum_probs=155.4

Q ss_pred             HHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            4 TEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         4 ~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .|-.++...+ ||.++++...|+.++..+++.++..|+.|...+....  .+.+.....+...++-++.++|  +.+++|
T Consensus        45 ~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh--~l~iiy  120 (612)
T KOG0603|consen   45 QERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLH--KLGIAY  120 (612)
T ss_pred             cHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcc--hhHHHH
Confidence            4667777776 9999999999999999999999999999988776554  5777788888899999999999  999999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      +|+|++||+++.+|++++.|||+....-.....      .|+..|+|||++.  .-..+.|.||+|+++|++++|..||.
T Consensus       121 rd~k~enilld~~Ghi~~tdfglske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~  192 (612)
T KOG0603|consen  121 RDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG  192 (612)
T ss_pred             hcccccceeecccCccccCCchhhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence            999999999999999999999998753332222      4688899999986  55678999999999999999999996


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      .                     +. ...+ .......|...+..+++++..++..+|.+|.-.
T Consensus       193 ~---------------------~~-~~~I-l~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  193 G---------------------DT-MKRI-LKAELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             h---------------------HH-HHHH-hhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            4                     01 1111 112356788999999999999999999999643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=5.9e-18  Score=144.29  Aligned_cols=119  Identities=21%  Similarity=0.149  Sum_probs=92.8

Q ss_pred             hHHHHHHHhccCCccccc-eeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVK-LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|+++|++++|+||+. +++    .+..|+||||+.|++|.. ..  .   ..   ...++.+++++|.|||  +.|+
T Consensus        68 ~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~-~~--~---~~---~~~~~~~i~~aL~~lH--~~gI  132 (365)
T PRK09188         68 AAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHL-AR--P---HG---DPAWFRSAHRALRDLH--RAGI  132 (365)
T ss_pred             HHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHH-hC--c---cc---hHHHHHHHHHHHHHHH--HCCC
Confidence            689999999999999985 443    246799999999999963 21  1   11   1467889999999999  8999


Q ss_pred             eecCC-CCCceEEcCCCceEEeccccccCCCCCCCCcc------ccccccCCcccCcccccc
Q 023752           81 IYRDL-KASNVLLDSNFNAKLSDFGLARDGPTGDNTHV------STRIVGTRGYAAPEYVAT  135 (278)
Q Consensus        81 ~H~dl-~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~------~~~~~~~~~~~aPE~~~~  135 (278)
                      +|||| ||+||+++.++.++|+|||++...........      .....++..|.+||.+..
T Consensus       133 iHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        133 THNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            99999 99999999899999999999986554432211      123456677899998854

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=1.7e-17  Score=129.28  Aligned_cols=224  Identities=20%  Similarity=0.219  Sum_probs=167.1

Q ss_pred             hHHHHHHHhccCC-ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|..+.+.+++ ..|..+..++.+...-++||+.. |.||.++..-- .+.++...+.-++-|++.-++|+|  .++.
T Consensus        57 L~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH--~r~f  132 (341)
T KOG1163|consen   57 LLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVH--LRNF  132 (341)
T ss_pred             hhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHH--hhcc
Confidence            4578888888864 67777777778888889999988 88998876422 246888999999999999999999  9999


Q ss_pred             eecCCCCCceEEcCC---CceEEeccccccCCCCCCCCc-----cccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           81 IYRDLKASNVLLDSN---FNAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~---~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      +||||||+|++++-+   ..+.++|||++..+.......     ......|+.+|.+-...-+...+.+.|+-|+|.++.
T Consensus       133 iHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLm  212 (341)
T KOG1163|consen  133 IHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLM  212 (341)
T ss_pred             ccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceee
Confidence            999999999999654   458899999998765543322     123367888888877766777788999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ++.-|..||++.......+++...............           =.++|.++.-.+.-|-..--++-|+...+.+.+
T Consensus       213 YfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~L-----------C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  213 YFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVL-----------CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             eeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHH-----------hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            999999999988776666555543332221111111           124566777777777777777778877777766


Q ss_pred             HhhhcCCC
Q 023752          233 EQLHTSKD  240 (278)
Q Consensus       233 ~~~~~~~~  240 (278)
                      .-+....+
T Consensus       282 riLfr~ln  289 (341)
T KOG1163|consen  282 RILFRTLN  289 (341)
T ss_pred             HHHHhhcc
Confidence            66655543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.74  E-value=8.8e-18  Score=131.12  Aligned_cols=148  Identities=19%  Similarity=0.181  Sum_probs=108.5

Q ss_pred             ChHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            1 MWQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         1 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +|++|+++|+++. +++|++++++    +..+++++|+.|.+|.+.....         ...++.|++.+|.++|  ..|
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~~---------~~~~~~qi~~~L~~lH--~~G  111 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPRG---------DLAYFRAARRLLQQLH--RCG  111 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhhh---------hHHHHHHHHHHHHHHH--HCc
Confidence            3689999999995 5889999886    4568999999998886543211         1357789999999999  999


Q ss_pred             eeecCC-CCCceEEcCCCceEEeccccccCCCCCCCC-c--c--------ccccccCCcccCcccccc-CCCC-Cccchh
Q 023752           80 VIYRDL-KASNVLLDSNFNAKLSDFGLARDGPTGDNT-H--V--------STRIVGTRGYAAPEYVAT-GHLT-PKSDVY  145 (278)
Q Consensus        80 i~H~dl-~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~--~--------~~~~~~~~~~~aPE~~~~-~~~~-~~~Diw  145 (278)
                      ++|+|| +|.||+++.++.++|+|||++......... .  .        .......+.++.|+...- ...+ .+.+.+
T Consensus       112 IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~  191 (218)
T PRK12274        112 VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF  191 (218)
T ss_pred             CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence            999999 799999999999999999999854433210 0  0        001123445555553221 1223 567888


Q ss_pred             HHHHHHHHHHhCCCCCcc
Q 023752          146 SFGVVLLELLSGRRALDE  163 (278)
Q Consensus       146 slG~il~~l~~g~~p~~~  163 (278)
                      +.|+.+|.++|+..+.-.
T Consensus       192 ~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        192 ATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HhcchHHHHHhccCCccc
Confidence            999999999999988743

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.73  E-value=2.7e-18  Score=147.08  Aligned_cols=170  Identities=25%  Similarity=0.396  Sum_probs=126.3

Q ss_pred             ccEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEecccccc
Q 023752           29 NRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR  107 (278)
Q Consensus        29 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~  107 (278)
                      .+|+.|++|...+|.+.+.++. ....+......++.|+..++.|     ++.+|+|++|.||++..+..+||+|||+.+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhee
Confidence            4689999999999999996442 2345666788999999999998     689999999999999999999999999998


Q ss_pred             CCCCCCC----CccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC-CCCCccccCCchhhhHHhhhccccc
Q 023752          108 DGPTGDN----THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGGLAEQTLVEWADPFLR  182 (278)
Q Consensus       108 ~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~  182 (278)
                      .......    ...+....++..|++||.+.+..|+.++|||+||+++++++.. ...+..                   
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er-------------------  465 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER-------------------  465 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH-------------------
Confidence            6554441    2234457899999999999999999999999999999999972 121110                   


Q ss_pred             hhHHHHHHhhhccCCCCC---HHHHHHHHHHHHHhccCCCCCCCCHHH
Q 023752          183 DSRRVLRIMDTRLGGQYS---KKEAQAVAAVVLQCLHMDPKNRPSMVD  227 (278)
Q Consensus       183 ~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~  227 (278)
                           ...+.......+|   ...-++-..|+.+|+...|.+||++.+
T Consensus       466 -----~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  466 -----IATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             -----HHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence                 0111111111112   111233457999999999999994443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.72  E-value=6.2e-18  Score=134.57  Aligned_cols=127  Identities=16%  Similarity=0.240  Sum_probs=99.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      |.+|++.+.++.|++|..+.+++...        +..+++|||++|.+|.+..      .+++    ....+++.++..+
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~------~~~~----~~~~~i~~~l~~l  151 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP------EISE----DVKAKIKASIESL  151 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh------hccH----HHHHHHHHHHHHH
Confidence            57899999999999999999986643        3478999999999998863      1333    3456899999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  ..|++|+|++|.||+++++| ++|+|||............              .......++.++|+|+||+.+..
T Consensus       152 H--~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~  214 (232)
T PRK10359        152 H--QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLI  214 (232)
T ss_pred             H--HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehH
Confidence            9  99999999999999999988 9999999886432111110              02233456678999999998776


Q ss_pred             HH
Q 023752          154 LL  155 (278)
Q Consensus       154 l~  155 (278)
                      +.
T Consensus       215 ~~  216 (232)
T PRK10359        215 YK  216 (232)
T ss_pred             HH
Confidence            65

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.65  E-value=6e-16  Score=121.39  Aligned_cols=99  Identities=17%  Similarity=0.216  Sum_probs=79.6

Q ss_pred             HHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCeee
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL-HGLDANVIY   82 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L-h~~~~~i~H   82 (278)
                      +|++++.++.++++........  ...++||||++|+++.....+.  ..++...+..++.|++.+|.++ |  ..|++|
T Consensus        68 ~E~~~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H--~~giiH  141 (190)
T cd05147          68 KEMRNLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQ--DCRLVH  141 (190)
T ss_pred             HHHHHHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHH--hCCccc
Confidence            4999999998877754433322  2238999999887776554333  2688899999999999999999 8  889999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDG  109 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~  109 (278)
                      +||||.||+++ ++.++|+|||++...
T Consensus       142 rDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         142 ADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCCCHHHEEEE-CCcEEEEEccccccC
Confidence            99999999998 478999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10345 hypothetical protein; Provisional

Probab=99.64  E-value=1.3e-15  Score=120.83  Aligned_cols=98  Identities=16%  Similarity=0.192  Sum_probs=78.8

Q ss_pred             hHHHHHHHhcc-----CCccccceeeeeecCC---ccE-EEEec--cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-----RHENLVKLIGYCSESD---NRL-LVYEF--MPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL   70 (278)
Q Consensus         2 ~~~E~~~l~~l-----~h~~i~~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l   70 (278)
                      +.+|+.+++++     .||||++++++++++.   ..+ +|+||  +.+++|.+++.+.   .+++.  ..++.+++.++
T Consensus        43 ~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l  117 (210)
T PRK10345         43 IRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKL  117 (210)
T ss_pred             HHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHH
Confidence            57899999999     5799999999998874   323 78999  4478999999653   35555  35678888777


Q ss_pred             -HHHhcCCCCeeecCCCCCceEEcC----CCceEEeccccc
Q 023752           71 -SFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLA  106 (278)
Q Consensus        71 -~~Lh~~~~~i~H~dl~p~ni~~~~----~~~~kl~dfg~~  106 (278)
                       .|||  +.+|+|+||||+||+++.    ++.++|+|++..
T Consensus       118 ~~yLh--~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        118 KRYLL--DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHH--HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence             9999  999999999999999974    337999995433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=2.1e-15  Score=140.21  Aligned_cols=203  Identities=16%  Similarity=0.140  Sum_probs=149.4

Q ss_pred             HHHhccC---CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            7 IYLGQLR---HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         7 ~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      +++.+|+   -+.|..+...+.-.+..++|++|.+.|+|.++++.  .+.+++..+..++.|++..|..||  ..+|+||
T Consensus       743 q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH--~~~IIHg  818 (974)
T KOG1166|consen  743 QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLH--AMGIIHG  818 (974)
T ss_pred             HHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHH--hcceecc
Confidence            4455555   24566666666777888999999999999999984  458999999999999999999999  9999999


Q ss_pred             CCCCCceEEcC-------CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           84 DLKASNVLLDS-------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        84 dl~p~ni~~~~-------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      ||||+|+++..       ...++|+|||.+.................+-.+-.+|...|..|+...|.|.|+.+++.|+.
T Consensus       819 DiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLF  898 (974)
T KOG1166|consen  819 DIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLF  898 (974)
T ss_pred             cCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHH
Confidence            99999999942       23489999999887655544444445567778899999999999999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHH-HHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKE-AQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |+..= .            +......-.            ..+++-. ......|+..+|+.|-..=|.+.+|...|+.+
T Consensus       899 G~y~q-~------------~~g~~~~~~------------~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~  953 (974)
T KOG1166|consen  899 GKYME-V------------KNGSSWMVK------------TNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV  953 (974)
T ss_pred             HHHHH-h------------cCCcceecc------------ccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence            86421 0            000000000            0011111 23455788999993333338888888888777


Q ss_pred             hcC
Q 023752          236 HTS  238 (278)
Q Consensus       236 ~~~  238 (278)
                      ...
T Consensus       954 ~~~  956 (974)
T KOG1166|consen  954 LAE  956 (974)
T ss_pred             HHH
Confidence            654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.63  E-value=1.7e-15  Score=119.05  Aligned_cols=101  Identities=17%  Similarity=0.152  Sum_probs=81.4

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i~   81 (278)
                      ++|++.+.++.+++|.....+...  ..++||||++|+++........  .++......++.|++.++.++|  . .|++
T Consensus        67 ~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH--~~~giv  140 (190)
T cd05145          67 EKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLY--QEAGLV  140 (190)
T ss_pred             HHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHH--HhCCEe
Confidence            578999999999887554444333  2489999998876544332232  5778889999999999999999  7 9999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGP  110 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~  110 (278)
                      |+||||.||+++ ++.++|+|||++....
T Consensus       141 HrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         141 HGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             cCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            999999999998 7899999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.62  E-value=3.1e-16  Score=143.90  Aligned_cols=139  Identities=24%  Similarity=0.323  Sum_probs=106.4

Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-------------ccccccccCCcccCcccc
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-------------HVSTRIVGTRGYAAPEYV  133 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-------------~~~~~~~~~~~~~aPE~~  133 (278)
                      +.+++|||  +.||+|+|+||+|.+|+.-|++|++|||+..........             .......+++.|.|||++
T Consensus       153 vla~Eylh--~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi  230 (1205)
T KOG0606|consen  153 VLAVEYLH--SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI  230 (1205)
T ss_pred             hHHhHhhc--cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence            78999999  999999999999999999999999999987642221111             112335789999999999


Q ss_pred             ccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHH
Q 023752          134 ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQ  213 (278)
Q Consensus       134 ~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  213 (278)
                      ..+.|....|.|++|+++|+++-|..||.+...+...........                ...+-....+.+++++|.+
T Consensus       231 lrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i----------------~wpE~dea~p~Ea~dli~~  294 (1205)
T KOG0606|consen  231 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI----------------EWPEEDEALPPEAQDLIEQ  294 (1205)
T ss_pred             hhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc----------------cccccCcCCCHHHHHHHHH
Confidence            999999999999999999999999999987644222111111100                0112234467789999999


Q ss_pred             hccCCCCCCC
Q 023752          214 CLHMDPKNRP  223 (278)
Q Consensus       214 ~l~~dp~~Rp  223 (278)
                      +|+.+|..|-
T Consensus       295 LL~qnp~~Rl  304 (1205)
T KOG0606|consen  295 LLRQNPLCRL  304 (1205)
T ss_pred             HHHhChHhhc
Confidence            9999999994

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=1.4e-16  Score=144.40  Aligned_cols=210  Identities=26%  Similarity=0.315  Sum_probs=165.6

Q ss_pred             HHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            5 EVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         5 E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      |..+-+.+. |.|++.+++...+.+..++++++..|+++.+.+........+.......+.|+..++.|+|. ..++.|+
T Consensus        70 e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~-~~~~~h~  148 (601)
T KOG0590|consen   70 ETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP-ENGVTHR  148 (601)
T ss_pred             cccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc-ccccccC
Confidence            455555665 99999999999999999999999999999988844433356777888999999999999996 5799999


Q ss_pred             CCCCCceEEcCCC-ceEEeccccccCCCC-CCCCcccccccc-CCcccCccccccC-CCCCccchhHHHHHHHHHHhCCC
Q 023752           84 DLKASNVLLDSNF-NAKLSDFGLARDGPT-GDNTHVSTRIVG-TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        84 dl~p~ni~~~~~~-~~kl~dfg~~~~~~~-~~~~~~~~~~~~-~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      |++|+|.+++..+ .+++.|||+++.+.. ...........+ ++.|.|||...+. ...+..|+||.|+++..+++|..
T Consensus       149 ~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~  228 (601)
T KOG0590|consen  149 DIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGEL  228 (601)
T ss_pred             CCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCC
Confidence            9999999999999 999999999998777 444444455667 8999999999875 44578999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhh--ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT--RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |++........  ..              .+...  ......+...+....+++.+++..+|..|.+.+++...
T Consensus       229 p~~~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  229 PWDFPSRKDGR--YS--------------SWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             Ccccccccccc--ce--------------eecccccccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence            98754432211  01              11111  11133456677788999999999999999999988743

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.57  E-value=5.2e-15  Score=120.39  Aligned_cols=203  Identities=24%  Similarity=0.329  Sum_probs=140.3

Q ss_pred             HHhccCCccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            8 YLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         8 ~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .|.++.|.||++++.++.+..     ...+++||+..|++.+++++-  ..+.+......+|+-||++||.|||++.--+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi  199 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence            456678999999999886543     468999999999999999653  2346778888999999999999999888899


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCC--ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      +|++++-+.|++..+|-+|++.-.-..........  .......+.++|.+||.-..-+.+.++|||++|+...+|.-+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            99999999999999998888643211111111111  1111234567899999766667778999999999999988775


Q ss_pred             CCCccccC-CchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          159 RALDEDRG-GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       159 ~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .--..... ......+....              ..        .....-+.+|.+|++-.|..||+++.++.|.
T Consensus       280 iq~tnseS~~~~ee~ia~~i--------------~~--------len~lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVI--------------IG--------LENGLQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eccCCCcceeehhhhhhhhe--------------ee--------ccCccccCcCcccccCCCCCCcchhhhhcCc
Confidence            43211111 00101111000              00        0011224578999999999999999998653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.56  E-value=7.1e-14  Score=123.54  Aligned_cols=144  Identities=22%  Similarity=0.288  Sum_probs=113.4

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      ++-++.|+.++||+|+++++.++..+..|+|+|-+  ..|..++.+.+     ...+...++||+.||.+||. +.+++|
T Consensus        57 ~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~Gl~qIl~AL~FL~~-d~~lvH  128 (690)
T KOG1243|consen   57 KRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCLGLFQILAALSFLND-DCNLVH  128 (690)
T ss_pred             HHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHHHHHHHHHHHHHHhc-cCCeee
Confidence            45678899999999999999999999999999987  47777776543     55777788999999999975 789999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      +++.-..|+++..|..||++|.++........  ........-.|..|+.+....  -..|.|.|||++++++.|.
T Consensus       129 gNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  129 GNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             ccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence            99999999999999999999998865333221  111122233466776553333  2479999999999999983

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.51  E-value=1.1e-13  Score=110.53  Aligned_cols=98  Identities=24%  Similarity=0.371  Sum_probs=86.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++..+.|++|.....++.+.+..+++|||++|++|.+.+....     . ....++.+++.+|.++|  ..+++
T Consensus        46 ~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH--~~~i~  117 (211)
T PRK14879         46 TRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH--SAGII  117 (211)
T ss_pred             HHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH--hCCcc
Confidence            4679999999999998887777777788899999999999999886432     1 77889999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      |+|++|.||+++ ++.++++|||.+..
T Consensus       118 H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        118 HGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             cCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999998 78899999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.48  E-value=1.7e-13  Score=108.59  Aligned_cols=95  Identities=23%  Similarity=0.367  Sum_probs=80.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.+.|+++....-++...+..+++|||++|++|.+++....   .      .++.+++.+|.++|  ..|++
T Consensus        44 ~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH--~~gi~  112 (199)
T TIGR03724        44 TRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLH--KAGIV  112 (199)
T ss_pred             HHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHH--HCCee
Confidence            4579999999988876665555566677899999999999999875432   1      78899999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      |+|++|.||+++ ++.++++|||.+..
T Consensus       113 H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724       113 HGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             cCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999999 78999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.48  E-value=1.2e-13  Score=112.04  Aligned_cols=98  Identities=17%  Similarity=0.174  Sum_probs=77.5

Q ss_pred             hHHHHHHHhccCCc--cccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHE--NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+++++++.+.  .+.++++   . +..++||||+.|.+|........  .+....+..++.|++.++.+||  ..|
T Consensus        97 ~~~E~~~L~~L~~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~g  168 (237)
T smart00090       97 AEKEFRNLQRLYEAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLKDV--EPEEEEEFELYDDILEEMRKLY--KEG  168 (237)
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeE---e-cCceEEEEEecCCcccccccccC--CcchHHHHHHHHHHHHHHHHHH--hcC
Confidence            35799999999753  2334443   2 24589999999888876553332  4566677899999999999999  889


Q ss_pred             -eeecCCCCCceEEcCCCceEEeccccccC
Q 023752           80 -VIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        80 -i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                       ++|+||+|.||+++ ++.++|+|||.+..
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~  197 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVE  197 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence             99999999999999 78899999998864

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.47  E-value=2.4e-13  Score=123.30  Aligned_cols=94  Identities=22%  Similarity=0.330  Sum_probs=84.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++|++++....++.+....++||||++|++|.+++.          ....++.+++.+|.+||  +.+++
T Consensus       383 ~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH--~~gii  450 (535)
T PRK09605        383 TRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH--KAGIV  450 (535)
T ss_pred             HHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH--hCCCc
Confidence            5789999999999999988777777777899999999999999874          34678899999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      |+||+|.||++ .++.++|+|||++..
T Consensus       451 HrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        451 HGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             cCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999 677899999999864

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.45  E-value=4.4e-13  Score=108.93  Aligned_cols=98  Identities=26%  Similarity=0.196  Sum_probs=78.8

Q ss_pred             hHHHHHHHhccCCccc--cceeeeeecCCc----cEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQLRHENL--VKLIGYCSESDN----RLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i--~~~~~~~~~~~~----~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      +.+|++++.++.|++|  ++.+++......    .++|+|+++| .+|.+++...   .+++.    .+.+++.+|.+||
T Consensus        87 ~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH  159 (239)
T PRK01723         87 AFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH  159 (239)
T ss_pred             HHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH
Confidence            4679999999988775  667766443322    2599999987 6898887543   34443    3578999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                        ..||+|+||+|.||+++.++.++|+|||.+..
T Consensus       160 --~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        160 --DAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             --HCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence              99999999999999999988999999998875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.34  E-value=3.8e-12  Score=100.77  Aligned_cols=95  Identities=18%  Similarity=0.146  Sum_probs=76.0

Q ss_pred             hHHHHHHHhccCCcc--ccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHEN--LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+.++..+.+++  +.+.++    ....+++|||++|++|.+....        .....++.+++.++.++|  ..|
T Consensus        80 ~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh--~~g  145 (198)
T cd05144          80 AQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY--KHG  145 (198)
T ss_pred             HHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH--HCC
Confidence            357888888887763  444443    2456899999999998765421        245678899999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGP  110 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~  110 (278)
                      ++|+||+|.||+++.++.++|+|||.+....
T Consensus       146 i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         146 IIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.29  E-value=1.4e-11  Score=92.61  Aligned_cols=98  Identities=23%  Similarity=0.231  Sum_probs=82.6

Q ss_pred             hHHHHHHHhccCC--ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-C
Q 023752            2 WQTEVIYLGQLRH--ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-A   78 (278)
Q Consensus         2 ~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~   78 (278)
                      +.+|+.+++.+.+  ..+++++.++...+..++++||+.+..+..+         +......++.+++.++.++|... .
T Consensus        38 ~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~  108 (155)
T cd05120          38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLL  108 (155)
T ss_pred             HHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCce
Confidence            6789999999976  5899999988888889999999988777643         44466778899999999999321 4


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      +++|+|++|.||+++..+.++++||+.+..
T Consensus       109 ~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEecCCCcceEEEECCcEEEEEecccccC
Confidence            799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.27  E-value=5.5e-12  Score=110.43  Aligned_cols=202  Identities=27%  Similarity=0.323  Sum_probs=149.2

Q ss_pred             HHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCC
Q 023752            5 EVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR----GLSFLHGLDAN   79 (278)
Q Consensus         5 E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~----~l~~Lh~~~~~   79 (278)
                      |+...+.+ .|++.++.+..++..+..++-+|.| +.+|.++..... ..+++..++..+.+...    ||.++|  ..+
T Consensus       167 ~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~h--s~~  242 (524)
T KOG0601|consen  167 EFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLH--SNN  242 (524)
T ss_pred             hhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccC--CCc
Confidence            44444445 5889999999999999999999999 578888886654 35888899999999999    999999  999


Q ss_pred             eeecCCCCCceEEcCC-CceEEeccccccCCCCCCCCcc---ccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           80 VIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHV---STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~-~~~kl~dfg~~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                      ++|.|++|.||+...+ ...+++|||+............   .....+...|++||.. +..++...|+|++|.++.+..
T Consensus       243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~  321 (524)
T KOG0601|consen  243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAI  321 (524)
T ss_pred             ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhH
Confidence            9999999999999998 7899999999887655542222   1223577789999976 567788999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ++..+.......       .|  ...++..         ...++-.+-+..+...+..|+..+|-.|+++..+.
T Consensus       322 l~~~~~~~g~~~-------~W--~~~r~~~---------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  322 LGSHLPSVGKNS-------SW--SQLRQGY---------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             hhcccccCCCCC-------Cc--ccccccc---------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            887665432110       00  0000100         01111223344566689999999999999887766

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=1.6e-10  Score=90.28  Aligned_cols=98  Identities=13%  Similarity=0.174  Sum_probs=73.8

Q ss_pred             HHHHHHHhccCC--ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCC
Q 023752            3 QTEVIYLGQLRH--ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL-HGLDAN   79 (278)
Q Consensus         3 ~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L-h~~~~~   79 (278)
                      ++|++.|+++..  -++.+.+++    ..-++||||+.+..+.....+..  .++......+..+++.++..+ |  ..|
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H--~~g  145 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK--ECN  145 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH--hCC
Confidence            389999999943  456667764    45679999997654422221121  345556778889999999998 9  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDG  109 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~  109 (278)
                      ++|+||++.||++. ++.+.|+|||.+...
T Consensus       146 lVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         146 LVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             eecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence            99999999999997 467999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.17  E-value=4.9e-10  Score=94.87  Aligned_cols=200  Identities=15%  Similarity=0.163  Sum_probs=132.1

Q ss_pred             cEEEEeccCCC-CHHHHHh----hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccc
Q 023752           30 RLLVYEFMPKG-SLENHLF----RKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG  104 (278)
Q Consensus        30 ~~lv~e~~~~~-~L~~~~~----~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg  104 (278)
                      ..++|+.+.|. .+..++.    ++......++.+......|+.+.+.||  ..|.+-||+.++|+++++++.|.|.|-+
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH--~~Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH--EHGHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH--hcCCcccccCccceeeecCceEEEEccc
Confidence            45777777654 2333332    223345788899999999999999999  8999999999999999999999999876


Q ss_pred             cccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHhC-CCCCccccCCchh----h-hH
Q 023752          105 LARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLSG-RRALDEDRGGLAE----Q-TL  173 (278)
Q Consensus       105 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g-~~p~~~~~~~~~~----~-~~  173 (278)
                      ......+   .....-.++...|.+||.-.     +..-+...|.|.||+++|+++.| .+||.+.......    + .|
T Consensus       163 sfqi~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I  239 (637)
T COG4248         163 SFQINAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI  239 (637)
T ss_pred             ceeeccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh
Confidence            5544212   22222246788999999753     34566789999999999999886 8999764321111    0 11


Q ss_pred             HhhhccccchhHHHHHHhhhccCCCC-CHHHHHHHHHHHHHhccCC--CCCCCCHHHHHHHHHhhhcC
Q 023752          174 VEWADPFLRDSRRVLRIMDTRLGGQY-SKKEAQAVAAVVLQCLHMD--PKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~d--p~~Rps~~~ll~~l~~~~~~  238 (278)
                      ......+..+    ...-....+... ..-.++.+..|..+|+...  +.-|||++..+..|..+...
T Consensus       240 a~g~f~ya~~----~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         240 AHGRFAYASD----QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             hcceeeechh----ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            1100000000    000000001111 1345778889999999863  56899999999888777654

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.14  E-value=3.5e-10  Score=85.84  Aligned_cols=94  Identities=28%  Similarity=0.373  Sum_probs=76.3

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .+|+.++.+..--.|...+=++.+.....++|||++|..|.+++....         ..++..+-.-+.-||  ..||+|
T Consensus        47 ~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~~---------~~~~r~vG~~vg~lH--~~givH  115 (204)
T COG3642          47 RREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEAR---------PDLLREVGRLVGKLH--KAGIVH  115 (204)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhcc---------hHHHHHHHHHHHHHH--hcCeec
Confidence            578888888865555555545566677789999999999998886551         456777888889999  999999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccC
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      +||+++||++..++ +.++|||+...
T Consensus       116 GDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         116 GDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999997765 89999999864

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=2.3e-11  Score=108.25  Aligned_cols=155  Identities=24%  Similarity=0.357  Sum_probs=109.2

Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccc-------cccccCCcccCccc
Q 023752           60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-------TRIVGTRGYAAPEY  132 (278)
Q Consensus        60 ~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~-------~~~~~~~~~~aPE~  132 (278)
                      ..-+.+++.|+.++|+ +.++||++|.|++|+++.++.+||..|+++............       .-......|.|||+
T Consensus       102 f~nl~~v~dgl~flh~-sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~  180 (700)
T KOG2137|consen  102 FANLGNVADGLAFLHR-SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY  180 (700)
T ss_pred             hhhhhcccchhhhhcc-CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence            3344556789999998 689999999999999999999999999987754442111110       01234567999999


Q ss_pred             cccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHH
Q 023752          133 VATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVL  212 (278)
Q Consensus       133 ~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  212 (278)
                      +.+...+.++|+||||+++|.+..|+.+.....+.........              .........+...++.++++=+.
T Consensus       181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~--------------~~~~~~~~~~s~~~p~el~~~l~  246 (700)
T KOG2137|consen  181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR--------------NLLNAGAFGYSNNLPSELRESLK  246 (700)
T ss_pred             hccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh--------------cccccccccccccCcHHHHHHHH
Confidence            9888888999999999999999965544432222111111111              11111223345678899999999


Q ss_pred             HhccCCCCCCCCHHHHH
Q 023752          213 QCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       213 ~~l~~dp~~Rps~~~ll  229 (278)
                      +++..++.-||++..++
T Consensus       247 k~l~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  247 KLLNGDSAVRPTLDLLL  263 (700)
T ss_pred             HHhcCCcccCcchhhhh
Confidence            99999999999766655

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.08  E-value=4.5e-10  Score=87.91  Aligned_cols=96  Identities=19%  Similarity=0.201  Sum_probs=67.9

Q ss_pred             HHHHHHhccCCcc--ccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q 023752            4 TEVIYLGQLRHEN--LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANV   80 (278)
Q Consensus         4 ~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i   80 (278)
                      .|.+.+.++.+..  +.+.++.    ...++++||+.++.+........  .. ......++.+++.++.++|  . .++
T Consensus        66 ~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~--~~-~~~~~~~~~~~~~~l~~lh--~~~~i  136 (187)
T cd05119          66 KEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV--RL-LEDPEELYDQILELMRKLY--REAGL  136 (187)
T ss_pred             HHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh--hh-cccHHHHHHHHHHHHHHHh--hccCc
Confidence            4555565554332  3444432    24689999998854322111111  01 1567889999999999999  7 999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDG  109 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~  109 (278)
                      +|+||+|+||+++ ++.++++|||.+...
T Consensus       137 vH~Dl~p~Nili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         137 VHGDLSEYNILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             CcCCCChhhEEEE-CCcEEEEECcccccc
Confidence            9999999999999 889999999999653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.00  E-value=1.3e-09  Score=83.84  Aligned_cols=92  Identities=22%  Similarity=0.183  Sum_probs=69.3

Q ss_pred             hHHHHHHHhccCCccc-cceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC-
Q 023752            2 WQTEVIYLGQLRHENL-VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN-   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-   79 (278)
                      +.+|+.+++.+.+.++ .+++....  ...++||||++|.++.+..       .   ....++.+++.+|..||  ..+ 
T Consensus        39 ~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~-------~---~~~~~~~~l~~~l~~LH--~~~~  104 (170)
T cd05151          39 RENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED-------F---SDPENLEKIAKLLKKLH--SSPL  104 (170)
T ss_pred             HHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc-------c---cCHHHHHHHHHHHHHHh--CCCC
Confidence            5789999999865444 44555433  3457999999998876430       1   11345678999999999  666 


Q ss_pred             ----eeecCCCCCceEEcCCCceEEeccccccC
Q 023752           80 ----VIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        80 ----i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                          ++|+|++|.||+++ ++.++++||+.+..
T Consensus       105 ~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151         105 PDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence                49999999999998 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.00  E-value=3.7e-10  Score=104.78  Aligned_cols=192  Identities=21%  Similarity=0.271  Sum_probs=138.5

Q ss_pred             ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcC
Q 023752           15 ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS   94 (278)
Q Consensus        15 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~   94 (278)
                      |-++.....+......+|++++..+++|...+..-+  .............+..++.+||  ...+.|+|++|.|.++..
T Consensus       864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~--s~~r~h~~~~p~~~l~~~  939 (1205)
T KOG0606|consen  864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLH--SSLRKHRDLKPDSLLIAY  939 (1205)
T ss_pred             CceecccCCCCCCCCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccc--cchhhcccccccchhhcc
Confidence            333333333344456789999999999998886655  4555566677778899999999  667899999999999999


Q ss_pred             CCceEEeccccccCCCCC-----------------------------CCCccccccccCCcccCccccccCCCCCccchh
Q 023752           95 NFNAKLSDFGLARDGPTG-----------------------------DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVY  145 (278)
Q Consensus        95 ~~~~kl~dfg~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw  145 (278)
                      +++.++.+|+........                             ..........+++.|.+||...+..-...+|.|
T Consensus       940 ~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~ 1019 (1205)
T KOG0606|consen  940 DGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWW 1019 (1205)
T ss_pred             cCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhh
Confidence            999999999732210000                             000112235678899999999998888899999


Q ss_pred             HHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          146 SFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       146 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ++|+++++.++|..||........-+.+.....++                ...+...+.+.++++...+..+|.+|..+
T Consensus      1020 ~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~----------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1020 SSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPW----------------PEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             hhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCC----------------CCCccccChhhhhhhhhhhccCchhccCc
Confidence            99999999999999997655433322222211111                22345567889999999999999999776


Q ss_pred             H
Q 023752          226 V  226 (278)
Q Consensus       226 ~  226 (278)
                      .
T Consensus      1084 ~ 1084 (1205)
T KOG0606|consen 1084 K 1084 (1205)
T ss_pred             c
Confidence            5

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.00  E-value=3.3e-10  Score=99.44  Aligned_cols=203  Identities=21%  Similarity=0.221  Sum_probs=145.4

Q ss_pred             HHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            5 EVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         5 E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      |+.+...+ .|.+++.++..+...++.|+-.|||+++++.......  ..+.+...+.+..|++.++.++|  +..++|.
T Consensus       315 ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~--s~~~~~~  390 (524)
T KOG0601|consen  315 EVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIH--SKLFVHL  390 (524)
T ss_pred             hhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhcccccc--chhhhcc
Confidence            45555555 5889999999998888888999999999887766333  36888889999999999999999  8999999


Q ss_pred             CCCCCceEEcCC-CceEEeccccccCCCCCCCCccccccccCCcc-cCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           84 DLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY-AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        84 dl~p~ni~~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~-~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |++|.||++..+ +..+++|||..+...........    .+..| .++.+.....+..+.|+++||..+.+.+++...-
T Consensus       391 d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~~----~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls  466 (524)
T KOG0601|consen  391 DVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVFHH----IDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS  466 (524)
T ss_pred             cccccceeeccchhhhhccccccccccceecccccc----cccccccchhhccccccccccccccccccccccccCcccC
Confidence            999999999876 67789999988753222222211    12223 3555555667888999999999999999876432


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      .....   ...+.                   ....+.......++..+.+.++..++..||.+.++..+.+.+..
T Consensus       467 ~~~~~---~~~i~-------------------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  467 ESGVQ---SLTIR-------------------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             ccccc---ceeee-------------------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence            21100   00000                   00122233444788889999999999999999988876655443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.00  E-value=5.8e-09  Score=90.47  Aligned_cols=133  Identities=18%  Similarity=0.283  Sum_probs=103.2

Q ss_pred             HHHHhccCCccccceeeeeec----CCccEEEEeccCC-CCHHHHHhhcC-------------CCCCCHHHHHHHHHHHH
Q 023752            6 VIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPK-GSLENHLFRKG-------------VQPISWPTRVKIAIDVA   67 (278)
Q Consensus         6 ~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~~~~~~-------------~~~~~~~~~~~i~~~l~   67 (278)
                      +++++++.|+|||++.++|..    +.-+++|++|+++ ++|.++.....             ....++..+|.++.||.
T Consensus       324 ve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLt  403 (655)
T KOG3741|consen  324 VEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLT  403 (655)
T ss_pred             HHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHH
Confidence            688999999999999999873    2357899999875 58888664321             12477899999999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHH
Q 023752           68 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF  147 (278)
Q Consensus        68 ~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  147 (278)
                      .||.++|  +.|+.-+-|.+.+|+++.+-+++|...|.........              .+|  +   .-..+-|.=.|
T Consensus       404 aaL~sIH--ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~--------------~~~--l---e~~Qq~D~~~l  462 (655)
T KOG3741|consen  404 AALYSIH--SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP--------------TEP--L---ESQQQNDLRDL  462 (655)
T ss_pred             HHHHHHH--hcCceeecccHhHeEeeCcceEEEecccceeeecCCC--------------Ccc--h---hHHhhhhHHHH
Confidence            9999999  8899999999999999998889988777665432222              011  1   11235788899


Q ss_pred             HHHHHHHHhCCC
Q 023752          148 GVVLLELLSGRR  159 (278)
Q Consensus       148 G~il~~l~~g~~  159 (278)
                      |.+++.|.||..
T Consensus       463 G~ll~aLAt~~~  474 (655)
T KOG3741|consen  463 GLLLLALATGTE  474 (655)
T ss_pred             HHHHHHHhhccc
Confidence            999999999853

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.00  E-value=4.1e-09  Score=79.88  Aligned_cols=104  Identities=22%  Similarity=0.254  Sum_probs=80.6

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      ++|++.|.++.--.|.-..-+|.+...-.++|||++| .++.+++...............++.++-+.+.-||  ..+++
T Consensus        58 ~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH--~ndii  135 (229)
T KOG3087|consen   58 KQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH--DNDII  135 (229)
T ss_pred             HHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh--hCCee
Confidence            5788888888544554444456666667799999976 37888887765444555555889999999999999  99999


Q ss_pred             ecCCCCCceEEcCCCc---eEEeccccccC
Q 023752           82 YRDLKASNVLLDSNFN---AKLSDFGLARD  108 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~---~kl~dfg~~~~  108 (278)
                      ||||+.+||++.+++.   +.++|||+...
T Consensus       136 HGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  136 HGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             cccccccceEEecCCCcCceEEEeecchhc
Confidence            9999999999965543   48999999865

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.99  E-value=3.1e-09  Score=87.52  Aligned_cols=104  Identities=16%  Similarity=0.153  Sum_probs=80.1

Q ss_pred             hHHHHHHHhccCCccc--cceeeeeec-----CCccEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENL--VKLIGYCSE-----SDNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i--~~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|.+.+.++...+|  ++.+++.+.     ....++|+|++++. +|.+++........+......++.+++..+..|
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L  154 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM  154 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            4688888888843333  344555543     22468999999876 899988654333566777889999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcC-------CCceEEecccccc
Q 023752           74 HGLDANVIYRDLKASNVLLDS-------NFNAKLSDFGLAR  107 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~-------~~~~kl~dfg~~~  107 (278)
                      |  ..|++|+|+++.||+++.       +..+.++||+.+.
T Consensus       155 H--~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        155 H--AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             H--HCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9  999999999999999974       4578999999875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.98  E-value=2.1e-09  Score=94.94  Aligned_cols=103  Identities=17%  Similarity=0.184  Sum_probs=72.0

Q ss_pred             hHHHHHHHhccC----Cccccceeeee-ecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH-HHHHHhc
Q 023752            2 WQTEVIYLGQLR----HENLVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR-GLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~----h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~-~l~~Lh~   75 (278)
                      |.+|++.+.++.    +.+-+.+-.++ ...+..+++|||++|++|.++...... ...   ...++..++. .+..+| 
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~-  274 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVL-  274 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHH-
Confidence            567888777772    22222322222 223457899999999999887643211 122   2345555555 467889 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCC
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP  110 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~  110 (278)
                       ..|++|+|++|.||+++.++.++++|||++....
T Consensus       275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence             8999999999999999999999999999987643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=4.8e-09  Score=81.60  Aligned_cols=97  Identities=23%  Similarity=0.278  Sum_probs=65.2

Q ss_pred             hHHHHHHHhccCCc--cccceeeeeecCCccEEEEeccC--CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHH-HhcC
Q 023752            2 WQTEVIYLGQLRHE--NLVKLIGYCSESDNRLLVYEFMP--KGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF-LHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~-Lh~~   76 (278)
                      .++|++.|+++..-  ++.+.+++-    .-++||||++  |..+..+....    ++......++.+++..+.. +|  
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~--  124 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLH--  124 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHH--
Confidence            36899999999655  566776542    3469999998  65555443322    1133556777888885444 68  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDG  109 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~  109 (278)
                      ..|++|||+++.||+++++ .+.++|||.+...
T Consensus       125 ~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  125 KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            8999999999999999887 8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.82  E-value=4.2e-08  Score=78.06  Aligned_cols=102  Identities=25%  Similarity=0.297  Sum_probs=80.0

Q ss_pred             HHHHHHHhccCCc--cccceeeeeecCC----ccEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            3 QTEVIYLGQLRHE--NLVKLIGYCSESD----NRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         3 ~~E~~~l~~l~h~--~i~~~~~~~~~~~----~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      .+|...+.++..-  .+++.+++.+...    ..++|+|++++. +|.+++....  ..+......++.+++..+.-|| 
T Consensus        59 ~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~lH-  135 (206)
T PF06293_consen   59 KREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAKLH-  135 (206)
T ss_pred             HHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHHHH-
Confidence            5677777777432  3455666655432    347999999874 8999887644  2566678899999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCC---ceEEeccccccC
Q 023752           76 LDANVIYRDLKASNVLLDSNF---NAKLSDFGLARD  108 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~---~~kl~dfg~~~~  108 (278)
                       ..|++|+|+++.||++..++   .+.++||+.+..
T Consensus       136 -~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 -DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             -HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence             99999999999999998887   799999988764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.68  E-value=1.3e-07  Score=74.29  Aligned_cols=103  Identities=20%  Similarity=0.209  Sum_probs=80.0

Q ss_pred             hHHHHHHHhccCCcc--ccceeeeeec--CC---ccEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHEN--LVKLIGYCSE--SD---NRLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~--i~~~~~~~~~--~~---~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      |.+|+..|+++..-+  +.+.. ++..  .+   ..+||+|-++| .+|.+.+......+.+......++.+++.++.-|
T Consensus        66 f~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~L  144 (216)
T PRK09902         66 IVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKM  144 (216)
T ss_pred             HHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHH
Confidence            789999999994322  44444 3321  11   35799997754 5898888776555678888899999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCc--eEEecccccc
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFN--AKLSDFGLAR  107 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~--~kl~dfg~~~  107 (278)
                      |  ..|+.|+|+.+.||+++.++.  +.++||.-..
T Consensus       145 H--~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        145 H--SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             H--HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9  999999999999999986666  8999997665

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.66  E-value=1.5e-07  Score=75.46  Aligned_cols=104  Identities=23%  Similarity=0.288  Sum_probs=77.3

Q ss_pred             hHHHHHHHhccCC--ccccceeeeeecCC---ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRH--ENLVKLIGYCSESD---NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h--~~i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+++++.+.+  ..+.+++.+.....   ..++|++|++|.++.+.+..   ..++......++.+++.+|..||+.
T Consensus        42 ~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~  118 (223)
T cd05154          42 VAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSV  118 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCC
Confidence            6789999999965  34577777766542   66899999999887765421   1356666667777777777777731


Q ss_pred             ------------------------------------------------------CCCeeecCCCCCceEEcC--CCceEE
Q 023752           77 ------------------------------------------------------DANVIYRDLKASNVLLDS--NFNAKL  100 (278)
Q Consensus        77 ------------------------------------------------------~~~i~H~dl~p~ni~~~~--~~~~kl  100 (278)
                                                                            ...++|+|+++.||+++.  ++.+.|
T Consensus       119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~i  198 (223)
T cd05154         119 DPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAV  198 (223)
T ss_pred             ChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEE
Confidence                                                                  234699999999999988  566889


Q ss_pred             eccccccC
Q 023752          101 SDFGLARD  108 (278)
Q Consensus       101 ~dfg~~~~  108 (278)
                      +||+.+..
T Consensus       199 ID~e~~~~  206 (223)
T cd05154         199 LDWELATL  206 (223)
T ss_pred             Eecccccc
Confidence            99988864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.66  E-value=6e-08  Score=87.10  Aligned_cols=101  Identities=14%  Similarity=0.117  Sum_probs=65.6

Q ss_pred             hHHHHHHHhccC----Cccccceeeeeec-CCccEEEEeccCCCCHHHHH--hhcCC--CCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLR----HENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHL--FRKGV--QPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~----h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~--~~~~~--~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      |.+|+..+.++.    +...+.+-.++.+ .+..++||||+.|+++.++.  ...+.  +.+.+..+..++.|++     
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-----  277 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-----  277 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-----
Confidence            455666665552    3333443344332 34678999999999998743  22221  1233333444444443     


Q ss_pred             HhcCCCCeeecCCCCCceEEcCCC----ceEEeccccccCCCC
Q 023752           73 LHGLDANVIYRDLKASNVLLDSNF----NAKLSDFGLARDGPT  111 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~~~~~----~~kl~dfg~~~~~~~  111 (278)
                          ..|++|+|++|.||+++.++    +++++|||++.....
T Consensus       278 ----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 ----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                57899999999999999888    999999999876533

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.53  E-value=5.4e-06  Score=64.76  Aligned_cols=101  Identities=27%  Similarity=0.297  Sum_probs=79.2

Q ss_pred             hHHHHHHHhccCC-ccccceeeeeecCCccEEEEeccCCCCHHHH---HhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-C
Q 023752            2 WQTEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENH---LFRKGVQPISWPTRVKIAIDVARGLSFLHG-L   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~-~   76 (278)
                      .++|.-+++.+.+ +++++++|++    +.+++.|+...+++...   +...  -..++..+.+++.++++.+.+|+. .
T Consensus         6 ~~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~   79 (188)
T PF12260_consen    6 QNNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGP   79 (188)
T ss_pred             hccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence            4578889999965 6999999999    33578899876655421   1111  147888999999999999999972 2


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ...+.-.|++++|+-++.++++|++|.+.+..
T Consensus        80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            24588899999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.51  E-value=3.4e-07  Score=73.91  Aligned_cols=93  Identities=17%  Similarity=0.173  Sum_probs=71.2

Q ss_pred             HHHHHHHhccCCc--cccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            3 QTEVIYLGQLRHE--NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         3 ~~E~~~l~~l~h~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      ++|.++|++|...  .|.+.+++    +.-++|||+++|..|...-       +.......++..|+..+..+-  ..|+
T Consensus       157 ~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~--~~Gi  223 (304)
T COG0478         157 EREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY--RRGI  223 (304)
T ss_pred             HHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH--HcCc
Confidence            6899999999654  66666653    4457999999886665433       123345566677777777777  7899


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      +|+|+++-||+++++|.++++||-.+..
T Consensus       224 VHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         224 VHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             cccCCchheEEEecCCCEEEEeCccccc
Confidence            9999999999999999999999977753

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.24  E-value=5.2e-06  Score=78.93  Aligned_cols=195  Identities=21%  Similarity=0.253  Sum_probs=131.2

Q ss_pred             HHHHHHhccCCccccceeeeeecCC----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      -|+..+....|+|+..++.+-.+.-    ...+..++|...++.+.+..-+  ..+......+..++.+|+.++|  ...
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h--~~~  306 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLH--SLS  306 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHH--Hhc
Confidence            4666778889999999988765542    2345668888888888887665  6888899999999999999999  555


Q ss_pred             eeecCCCCC---ceEEcCCCceEEe--ccccccCCCCCCCCccccccccCCcccCccccccCCCCC--ccchhHHHHHHH
Q 023752           80 VIYRDLKAS---NVLLDSNFNAKLS--DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP--KSDVYSFGVVLL  152 (278)
Q Consensus        80 i~H~dl~p~---ni~~~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~--~~DiwslG~il~  152 (278)
                      ..|.-+...   +..++..+.+.++  ||+....+........   ......+.++|.........  ..|+|++|....
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            555544444   3334455556655  8887765544333221   23345577777765555444  479999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .+..|..+-....                    ....++        +.....++.++..+|+..++++|+++.+++.+.
T Consensus       384 ~~~~~~~i~~~~~--------------------~~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  384 QLSQGEDISEKSA--------------------VPVSLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             hhhhcCccccccc--------------------chhhhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            9998765421100                    000000        011111678889999999999999999999764


Q ss_pred             H
Q 023752          233 E  233 (278)
Q Consensus       233 ~  233 (278)
                      -
T Consensus       436 f  436 (1351)
T KOG1035|consen  436 F  436 (1351)
T ss_pred             h
Confidence            3

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.19  E-value=3.3e-06  Score=66.71  Aligned_cols=66  Identities=20%  Similarity=0.217  Sum_probs=51.4

Q ss_pred             ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEecccccc
Q 023752           29 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR  107 (278)
Q Consensus        29 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~  107 (278)
                      ..++++||++|..|.+...      +++    .+...+.+++.-+|  ..|++|||.+|.|++++.++ ++++|++...
T Consensus       117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH--~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH--KHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH--HcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            3468999999988876542      232    24456778899999  99999999999999998654 8999996553

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.03  E-value=6.2e-05  Score=60.73  Aligned_cols=105  Identities=10%  Similarity=0.048  Sum_probs=61.2

Q ss_pred             HHHHHHHhccCCcc--ccceeeeeecCCccEEEEeccCCCC-HHHH--------------Hhh----cCC---CCCCHHH
Q 023752            3 QTEVIYLGQLRHEN--LVKLIGYCSESDNRLLVYEFMPKGS-LENH--------------LFR----KGV---QPISWPT   58 (278)
Q Consensus         3 ~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~-L~~~--------------~~~----~~~---~~~~~~~   58 (278)
                      .+|.++++.+..-.  +.+.+++....+...++|++++|.+ +.+.              +.+    -+.   .......
T Consensus        40 ~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~  119 (226)
T TIGR02172        40 KREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQS  119 (226)
T ss_pred             HHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHH
Confidence            67999998885433  4777888877777889999998863 2111              111    000   0111111


Q ss_pred             HH-HHHHH----------HHHH-HHHH--hcCCCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           59 RV-KIAID----------VARG-LSFL--HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        59 ~~-~i~~~----------l~~~-l~~L--h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      .. .+..+          +... ..+|  +.....++|+|++|.||++++++ +.++||+.+..
T Consensus       120 ~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       120 YKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             HHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            10 01000          0111 1111  11134578999999999999888 99999988753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.01  E-value=3.3e-05  Score=69.29  Aligned_cols=105  Identities=17%  Similarity=0.193  Sum_probs=67.8

Q ss_pred             hHHHHHHHhccC-----CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLR-----HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      |.+|...+.++.     .++|.--.=+++-.+..+++|||++|..+.+...-.. .+.+...+.....+++  +..+=  
T Consensus       208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~--  282 (517)
T COG0661         208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLL--  282 (517)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHH--
Confidence            456777777662     3433222223334466789999999999988753222 2355333332222222  12222  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT  111 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~  111 (278)
                      ..|++|.|.+|.||++..+|++.+.|||.......
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            45899999999999999999999999999876544

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.00  E-value=2.7e-05  Score=62.43  Aligned_cols=99  Identities=20%  Similarity=0.213  Sum_probs=67.2

Q ss_pred             HHHHHHHhccC--CccccceeeeeecCCccEEEEeccCCCCH-HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            3 QTEVIYLGQLR--HENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         3 ~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L-~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.|+..|+++.  +=.+.+-+++..    -.|||||+..... .-.+..-   +++......+..++++.+.-|-. ..+
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~-~a~  187 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK-EAG  187 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH-hcC
Confidence            46777777773  334455555442    2589999854311 1111111   23333677788888888888862 489


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGP  110 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~  110 (278)
                      +||+||+.-||++. ++.+.++||+.+....
T Consensus       188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         188 LVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             cccccchhhheEEE-CCeEEEEECccccccC
Confidence            99999999999998 7889999999987543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.96  E-value=8.1e-05  Score=60.77  Aligned_cols=44  Identities=18%  Similarity=0.166  Sum_probs=33.3

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHH
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENH   45 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   45 (278)
                      +.+|+++++.+. +--+.+++++....+..++|+++++|.++...
T Consensus        38 ~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          38 LEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             hHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            467999988883 34466778877776678999999998777643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.81  E-value=7.5e-06  Score=73.38  Aligned_cols=148  Identities=18%  Similarity=0.175  Sum_probs=106.6

Q ss_pred             HHHHHHHhccCCcc-ccceeeeeecCCccEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            3 QTEVIYLGQLRHEN-LVKLIGYCSESDNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         3 ~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .-++++|.+.+||| .+..++.++.+...++.++++.++ +......... -.+...+...++..-..+++++|  +..-
T Consensus       281 rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se-~~~~~~~~~~~~r~et~~l~~l~--~~~~  357 (829)
T KOG0576|consen  281 RLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSE-IALEQYQFAYPLRKETRPLAELH--SSYK  357 (829)
T ss_pred             HHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhh-Hhhhhhhhhhhhhhhcccccccc--cccc
Confidence            34788999999999 777777777778889999999877 3222221111 12444455667777788899999  5445


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+|    ||+-.. +..+.++|+....+....   ......+++.++|||+.....++...|.|++|.-..++.-|.+|
T Consensus       358 ~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP  429 (829)
T KOG0576|consen  358 VHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP  429 (829)
T ss_pred             cCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence            7777    555543 678899998876654443   12335678899999999999999999999999877777777665


Q ss_pred             C
Q 023752          161 L  161 (278)
Q Consensus       161 ~  161 (278)
                      -
T Consensus       430 r  430 (829)
T KOG0576|consen  430 R  430 (829)
T ss_pred             C
Confidence            4

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.77  E-value=0.00024  Score=55.92  Aligned_cols=92  Identities=22%  Similarity=0.311  Sum_probs=66.5

Q ss_pred             hHHHHHHHhccC------CccccceeeeeecCCccEEEEeccCC------CCHHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLR------HENLVKLIGYCSESDNRLLVYEFMPK------GSLENHLFRKGVQPISWPTRVKIAIDVARG   69 (278)
Q Consensus         2 ~~~E~~~l~~l~------h~~i~~~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~   69 (278)
                      ..+|+....++.      +.+|.+++|+.+.+-+..+|+|.+.+      .+|.+++....   ++. .+...+.++   
T Consensus        58 ~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~~f---  130 (199)
T PF10707_consen   58 NRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALDEF---  130 (199)
T ss_pred             HHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHHHH---
Confidence            356777666665      78999999999999999999987653      37888886553   555 444444444   


Q ss_pred             HHHHhcCCCCeeecCCCCCceEEcCCC----ceEEec
Q 023752           70 LSFLHGLDANVIYRDLKASNVLLDSNF----NAKLSD  102 (278)
Q Consensus        70 l~~Lh~~~~~i~H~dl~p~ni~~~~~~----~~kl~d  102 (278)
                      ..+|-  ..+|+.+|++|+||++...+    .++|+|
T Consensus       131 ~~~l~--~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  131 KRYLL--DHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             HHHHH--HcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence            45555  67799999999999995432    466766

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.59  E-value=0.00038  Score=56.53  Aligned_cols=32  Identities=22%  Similarity=0.221  Sum_probs=26.4

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..+++|+|+++.||+++.++..-|+||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            45589999999999998765567999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.54  E-value=0.00041  Score=62.33  Aligned_cols=99  Identities=17%  Similarity=0.185  Sum_probs=61.9

Q ss_pred             hHHHHHHHhcc----CCcc------ccceeeeeecCCccEEEEeccCCCCHHHH--HhhcCCCCCCHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL----RHEN------LVKLIGYCSESDNRLLVYEFMPKGSLENH--LFRKGVQPISWPTRVKIAIDVARG   69 (278)
Q Consensus         2 ~~~E~~~l~~l----~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~--~~~~~~~~~~~~~~~~i~~~l~~~   69 (278)
                      |.+|++...++    .|-+      |.++|-.+  ....+|+|||++|..+.|+  +.+.+   ++...+..-+.+...-
T Consensus       241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~~  315 (538)
T KOG1235|consen  241 FTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYLE  315 (538)
T ss_pred             hHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHHH
Confidence            55666655544    3444      33333222  2457899999999866653  34443   5544433333332222


Q ss_pred             HHHHhcCCCCeeecCCCCCceEEcC----CCceEEeccccccCC
Q 023752           70 LSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDG  109 (278)
Q Consensus        70 l~~Lh~~~~~i~H~dl~p~ni~~~~----~~~~kl~dfg~~~~~  109 (278)
                      .-+    ..|++|+|=+|.||++..    ++.+.+.|+|+....
T Consensus       316 qIf----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i  355 (538)
T KOG1235|consen  316 QIF----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI  355 (538)
T ss_pred             HHH----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence            222    357999999999999984    567999999998754

>PLN02876 acyl-CoA dehydrogenase

Probab=97.38  E-value=0.0011  Score=63.82  Aligned_cols=40  Identities=18%  Similarity=0.363  Sum_probs=31.1

Q ss_pred             hHHHHHHHhccC-Cccc--cceeeeeecC---CccEEEEeccCCCC
Q 023752            2 WQTEVIYLGQLR-HENL--VKLIGYCSES---DNRLLVYEFMPKGS   41 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~~~   41 (278)
                      +.+|+++|+.+. |.+|  .+++.++.+.   +..|+||||++|..
T Consensus        85 ~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         85 VEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             HHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            578999999995 6655  7777777664   46789999998764

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.08  E-value=0.0013  Score=58.34  Aligned_cols=161  Identities=22%  Similarity=0.324  Sum_probs=89.2

Q ss_pred             HHHHHHhccCCccccceeeeeecC-CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      ...++++.+.|+|...++++-... ....+|+|++ +.||.+.+..+..+..   .   +.         -|    ++.|
T Consensus        31 gr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~---s---~~---------~~----~~~~   90 (725)
T KOG1093|consen   31 GRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDE---S---LL---------AH----GVLH   90 (725)
T ss_pred             hhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchh---h---hc---------cc----ccce
Confidence            456788888999999999987654 3567899998 7799998876641110   0   00         11    1111


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      -     |+       ++.+| .+.+.                   . |     ....+++|||++|.++.++.-|...+.
T Consensus        91 ~-----~~-------~~~td-~~~t~-------------------~-~-----~~~~pKsdVwsl~~i~~el~L~~~l~~  132 (725)
T KOG1093|consen   91 L-----NI-------IYITD-HFLTK-------------------Y-P-----SPIGPKSDVWSLGFIILELYLGISLEA  132 (725)
T ss_pred             e-----hh-------hhccc-ccccc-------------------C-C-----CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence            1     11       12222 11111                   0 0     011149999999999999998866554


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ..........+..........    ......   ..+....+..+.++..+|+-..|..||...++.
T Consensus       133 ~~~~s~~l~~i~k~~~~d~~~----~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  133 ELTESEYLEILLKYYTDDQEL----LSTAME---HLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHHHHHHhccCchhH----HHHHHH---HHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            333322222222211111100    000000   012234567788899999999999888654443

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.97  E-value=0.0037  Score=51.39  Aligned_cols=29  Identities=28%  Similarity=0.324  Sum_probs=25.7

Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      .++|+|+.|.||++++++ +.++||+.+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=96.77  E-value=0.0077  Score=48.32  Aligned_cols=31  Identities=32%  Similarity=0.370  Sum_probs=21.3

Q ss_pred             CCCeeecCCCCCceEEc-CCCceEEecccccc
Q 023752           77 DANVIYRDLKASNVLLD-SNFNAKLSDFGLAR  107 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~-~~~~~kl~dfg~~~  107 (278)
                      ...++|+|++|.||+++ .++.+-|+||+.+.
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccce
Confidence            46799999999999999 55666799997764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.55  E-value=0.00026  Score=69.83  Aligned_cols=156  Identities=13%  Similarity=0.027  Sum_probs=106.8

Q ss_pred             HHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCC--CCCHHHHHHHHHHHHHHHHHHhcC---
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQ--PISWPTRVKIAIDVARGLSFLHGL---   76 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~i~~~l~~~l~~Lh~~---   76 (278)
                      .|...++...|+++...+.-....  ...+..++++.+|.+.+.+.++..+  +.....+.....+.+....-+|+.   
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            344444555788887777655433  3568889999999999998766432  232323333333335555555532   


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      +.-.+|.++++-|.++..+..++++++|+.+....  .....+...+++.|+.|++...-.++.++|+|..|+.+|....
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~ 1435 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSD 1435 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhc
Confidence            22257999999999999999999999999873211  1222334566777888887766678888999999999999988


Q ss_pred             CCCCC
Q 023752          157 GRRAL  161 (278)
Q Consensus       157 g~~p~  161 (278)
                      |-.+|
T Consensus      1436 ~n~~f 1440 (2724)
T KOG1826|consen 1436 GNAYF 1440 (2724)
T ss_pred             ccHHH
Confidence            77665

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.54  E-value=0.0091  Score=47.48  Aligned_cols=85  Identities=13%  Similarity=0.071  Sum_probs=55.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.++++++.+++  .|+++..-  +.-.+.+|.|.|-....           ..    ..++..=+.+|.-+|+...+..
T Consensus       105 y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-----------~~----~N~i~agi~~L~~fH~~~~~~l  165 (308)
T PF07387_consen  105 YFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-----------NF----SNFITAGIKDLMDFHSENQHCL  165 (308)
T ss_pred             hhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-----------ch----hHHHHHhHHHHHHhhccCCCee
Confidence            456666666653  45666521  22245688898843211           11    1222222567778897688999


Q ss_pred             ecCCCCCceEEcCCCceEEecccc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGL  105 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~  105 (278)
                      |||..|+||+.+..|-+||.|=+.
T Consensus       166 HGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  166 HGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             cCCCChhheeecCCCCEEecChhh
Confidence            999999999999999999998543

The function of this family is unknown.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.40  E-value=0.02  Score=48.43  Aligned_cols=34  Identities=21%  Similarity=0.348  Sum_probs=29.3

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccCCCC
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT  111 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~  111 (278)
                      ..++|||+.+.|+++++++-+-++||+.+....+
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence            3479999999999999988888999999986444

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=96.29  E-value=0.076  Score=42.60  Aligned_cols=43  Identities=30%  Similarity=0.476  Sum_probs=33.9

Q ss_pred             ChHHHHHHHhcc---CCccccceeeeeecCCccEEEEeccCCCCHH
Q 023752            1 MWQTEVIYLGQL---RHENLVKLIGYCSESDNRLLVYEFMPKGSLE   43 (278)
Q Consensus         1 ~~~~E~~~l~~l---~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   43 (278)
                      ||.-|+.-|..|   +.-.|.+++.+-.+.++.|+|++|.+-+.+.
T Consensus        54 ~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          54 MFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             HHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            577788877777   3356888899889999999999999875554

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.12  E-value=0.024  Score=48.54  Aligned_cols=29  Identities=21%  Similarity=0.256  Sum_probs=25.4

Q ss_pred             eeecCCCCCceEEcC-CCceEEeccccccC
Q 023752           80 VIYRDLKASNVLLDS-NFNAKLSDFGLARD  108 (278)
Q Consensus        80 i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~  108 (278)
                      .||+|+.+.||++++ ++.++++||.++..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975 46899999998864

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.63  E-value=0.037  Score=47.40  Aligned_cols=71  Identities=20%  Similarity=0.173  Sum_probs=55.3

Q ss_pred             ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           29 NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        29 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..|++|++- |++|.- +     +.-...++..++++.+..+.-+.. +-..-|++++-.||+++ +|.|.|+||.+++.
T Consensus       300 y~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         300 YLYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             EEEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeeec
Confidence            456777764 555542 2     134566888999998888888874 55788999999999999 99999999999874

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=95.45  E-value=0.088  Score=40.46  Aligned_cols=92  Identities=16%  Similarity=0.129  Sum_probs=61.8

Q ss_pred             hHHHHHHHhccCCccccc-eeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVK-LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      ++.|+++|+.+..-++.. +|.+-.+    ++.|||+.|-.|.+.-...     .    .+-+..+++.-.-|.  ..||
T Consensus        62 l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD--~~GI  126 (201)
T COG2112          62 LEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG-----D----RKHLLRVLEKAYKLD--RLGI  126 (201)
T ss_pred             HHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc-----c----HHHHHHHHHHHHHHH--Hhcc
Confidence            578999999987766654 4433322    3459999888887765422     1    222344566656667  7789


Q ss_pred             eecCCC-CCceEEcCCCceEEeccccccC
Q 023752           81 IYRDLK-ASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        81 ~H~dl~-p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      -|+.|+ |...++..++.+.|+||+.++.
T Consensus       127 ~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112         127 EHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhcCCceeEEecCCcEEEEEccchhh
Confidence            999986 4445555555899999998873

>PTZ00384 choline kinase; Provisional

Probab=95.45  E-value=0.077  Score=46.37  Aligned_cols=30  Identities=23%  Similarity=0.090  Sum_probs=24.8

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ...||.|+.+.||+.+. +.+.++||.++..
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            46799999999998754 4699999988863

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.32  E-value=0.043  Score=45.48  Aligned_cols=51  Identities=24%  Similarity=0.111  Sum_probs=38.0

Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           58 TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        58 ~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      .+...+..+-..+.-++.-..-+||+|+.|.|++.++.+.++|+||..+..
T Consensus       133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            344455556666666652013589999999999999999999999998864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.31  E-value=0.032  Score=45.05  Aligned_cols=31  Identities=19%  Similarity=0.260  Sum_probs=27.0

Q ss_pred             CCeeecCCCCCceEEcC-CCceEEeccccccC
Q 023752           78 ANVIYRDLKASNVLLDS-NFNAKLSDFGLARD  108 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~  108 (278)
                      ..++|+|+.+.||++++ ++.+.++||..+..
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            46899999999999998 57899999988753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.04  E-value=0.07  Score=44.96  Aligned_cols=32  Identities=28%  Similarity=0.240  Sum_probs=27.6

Q ss_pred             CCCeeecCCCCCceEEcCC----CceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSN----FNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~----~~~kl~dfg~~~~  108 (278)
                      ...+||+|+.+.||+++.+    +.+.++||.++..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            4568999999999999875    7899999988853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.98  E-value=0.024  Score=47.85  Aligned_cols=92  Identities=15%  Similarity=0.124  Sum_probs=62.4

Q ss_pred             HHHHHHHhccCC--ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            3 QTEVIYLGQLRH--ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         3 ~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .+|+..|+.|..  --|.+.++    .+.-++||+++.|..|.+.-.     -.+.   -.+...+..-+--|.  ..|+
T Consensus       158 ~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~---~~ly~~lm~~Iv~la--~~Gl  223 (465)
T KOG2268|consen  158 TKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDP---PTLYDDLMGLIVRLA--NHGL  223 (465)
T ss_pred             HHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeee-----cCCh---HHHHHHHHHHHHHHH--HcCc
Confidence            457777777632  22333443    344578999998887765432     1222   234444555556666  8899


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      +|+|+.-=||++.+++.++++||-.+..
T Consensus       224 IHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  224 IHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             eecccchheeEEecCCCEEEeechHhhc
Confidence            9999999999999999999999987653

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.94  E-value=0.024  Score=44.04  Aligned_cols=29  Identities=24%  Similarity=0.310  Sum_probs=25.6

Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      -.+|+|+.|.|+++++++ ++++||+++..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            468999999999998877 88999999864

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.75  E-value=0.057  Score=45.69  Aligned_cols=32  Identities=34%  Similarity=0.353  Sum_probs=27.9

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..+++|+|+++.||+++.++.+.++||+.+..
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            47899999999999999887678999988753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=94.75  E-value=0.078  Score=45.05  Aligned_cols=32  Identities=31%  Similarity=0.351  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..++||+|+.|.||+++.+...-++||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45899999999999998665567999998863

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.73  E-value=0.11  Score=44.62  Aligned_cols=99  Identities=17%  Similarity=0.174  Sum_probs=65.5

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHH-HHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN-HLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      ..|++.|++++...|.-..-+...  .-+|||+++....-.. .+..   ..++...+..+-.+++.-+.-|-+ ..++|
T Consensus       214 EKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~-~c~LV  287 (520)
T KOG2270|consen  214 EKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQ-KCRLV  287 (520)
T ss_pred             HHHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHH-Hhcee
Confidence            357888888865554332222222  2358999985322111 1211   246666777777788877777743 78999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      |.||+=-|+++ .+|.+.++|.+.+..
T Consensus       288 HADLSEfN~Ly-hdG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  288 HADLSEFNLLY-HDGKLYIIDVSQSVE  313 (520)
T ss_pred             ccchhhhhheE-ECCEEEEEEcccccc
Confidence            99999999998 556899999988764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.49  E-value=0.095  Score=44.27  Aligned_cols=30  Identities=20%  Similarity=0.224  Sum_probs=25.9

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEecccccc
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR  107 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~  107 (278)
                      ..+++|+|+.+.||+++. +.+.++||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            368999999999999987 678899998764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.39  E-value=0.067  Score=44.90  Aligned_cols=32  Identities=34%  Similarity=0.340  Sum_probs=27.5

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..+++|+|++|.||+++.++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            35799999999999999877778999988753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.98  E-value=0.061  Score=42.76  Aligned_cols=30  Identities=30%  Similarity=0.397  Sum_probs=21.2

Q ss_pred             CCeeecCCCCCceEE-cCCCceEEecccccc
Q 023752           78 ANVIYRDLKASNVLL-DSNFNAKLSDFGLAR  107 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~-~~~~~~kl~dfg~~~  107 (278)
                      .-++|+|+.+.||++ ..++.++++||.++.
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            457899999999999 888999999998875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=93.25  E-value=0.16  Score=43.01  Aligned_cols=32  Identities=19%  Similarity=0.168  Sum_probs=28.6

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..++||+|+.++|+++++++.+.++||+.++.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999998999999988864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=92.54  E-value=0.13  Score=40.44  Aligned_cols=32  Identities=25%  Similarity=0.241  Sum_probs=25.7

Q ss_pred             CCCeeecCCCCCceEEcCCC-----ceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNF-----NAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~-----~~kl~dfg~~~~  108 (278)
                      ...++|||+.+.||++..++     .+.++||..+..
T Consensus       119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             ceEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            34689999999999997543     588999987753

subfamily of choline kinases

>PLN02236 choline kinase

Probab=92.53  E-value=0.24  Score=42.65  Aligned_cols=31  Identities=19%  Similarity=0.305  Sum_probs=26.4

Q ss_pred             CCeeecCCCCCceEEcC-CCceEEeccccccC
Q 023752           78 ANVIYRDLKASNVLLDS-NFNAKLSDFGLARD  108 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~  108 (278)
                      ..++|+|+++.||++++ ++.+.++||.++..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            36899999999999976 46799999988853

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=92.08  E-value=0.31  Score=41.66  Aligned_cols=28  Identities=36%  Similarity=0.525  Sum_probs=25.2

Q ss_pred             eeecCCCCCceEEcCCCc-eEEecccccc
Q 023752           80 VIYRDLKASNVLLDSNFN-AKLSDFGLAR  107 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~-~kl~dfg~~~  107 (278)
                      ++|+|+.|.||+++++.. +.++||+-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999998875 7899998775

>PRK10593 hypothetical protein; Provisional

Probab=91.68  E-value=0.62  Score=39.26  Aligned_cols=67  Identities=18%  Similarity=0.162  Sum_probs=48.2

Q ss_pred             ChHHHHHHHhccCC---ccccceeeeeecC---CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            1 MWQTEVIYLGQLRH---ENLVKLIGYCSES---DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         1 ~~~~E~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      +|..|.+.|+.+..   -.|.++++++...   +..++|||+++|.++.+.       .........+..+++.+|..||
T Consensus        53 ~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-------~~~~~~~~~l~~~l~~~La~LH  125 (297)
T PRK10593         53 VAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-------ARTPERWEQLKDQIVEGLLAWH  125 (297)
T ss_pred             HHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-------CCCHHHHHHHHHHHHHHHHHHh
Confidence            47899999998843   3678888877543   568999999999877651       1233344556677778888888

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=91.54  E-value=0.18  Score=41.94  Aligned_cols=31  Identities=23%  Similarity=0.373  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCceEEcCCCc-eEEeccccccC
Q 023752           78 ANVIYRDLKASNVLLDSNFN-AKLSDFGLARD  108 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~-~kl~dfg~~~~  108 (278)
                      ..++|+|+++.||++++++. .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999987555 45999998865

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG4499 Predicted membrane protein [Function unknown]

Probab=91.31  E-value=1.8  Score=37.10  Aligned_cols=83  Identities=16%  Similarity=0.194  Sum_probs=58.0

Q ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccc
Q 023752           54 ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV  133 (278)
Q Consensus        54 ~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~  133 (278)
                      +.....++++.+.+..|.-+-   ..-.|-=+.|+||+++.++.+.+..+|+-...+              |.=+.||.+
T Consensus        82 ~~k~~Klr~a~~~I~~l~e~~---~tr~~~~laPeNilf~~~l~p~~vH~Glk~~lp--------------Pye~tee~f  144 (434)
T COG4499          82 KEKTRKLRLALQNIATLSELN---NTRYTFFLAPENILFDGGLTPFFVHRGLKNSLP--------------PYEMTEERF  144 (434)
T ss_pred             HHHHHHHHHHHHHHHHHHHhh---ccceeEEecchheEEcCCCceEEEecchhccCC--------------CCCCCHHHH
Confidence            555567787888888887764   345567789999999999999999999874321              122444432


Q ss_pred             ccCCCCCccchhHHHHHHHHHHhCCCCCcc
Q 023752          134 ATGHLTPKSDVYSFGVVLLELLSGRRALDE  163 (278)
Q Consensus       134 ~~~~~~~~~DiwslG~il~~l~~g~~p~~~  163 (278)
                                .-.+-+++..++.|..+|+.
T Consensus       145 ----------~~~ykA~~~~~fn~k~~Fe~  164 (434)
T COG4499         145 ----------LKEYKALAIYAFNGKFSFES  164 (434)
T ss_pred             ----------HHHHHHHHHHHHcCCccHHH
Confidence                      22466777888888888854

>PRK06148 hypothetical protein; Provisional

Probab=90.53  E-value=0.63  Score=46.13  Aligned_cols=32  Identities=38%  Similarity=0.450  Sum_probs=27.0

Q ss_pred             CCCeeecCCCCCceEEcCCC--ceE-EeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNF--NAK-LSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~--~~k-l~dfg~~~~  108 (278)
                      ..+++|+|+++.||+++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            46799999999999998875  555 999998864

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=89.87  E-value=0.9  Score=42.42  Aligned_cols=86  Identities=10%  Similarity=0.028  Sum_probs=66.4

Q ss_pred             CccccceeeeeecCCccEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEE
Q 023752           14 HENLVKLIGYCSESDNRLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL   92 (278)
Q Consensus        14 h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~   92 (278)
                      +.||.++|+++...+.-++++|+... .+|.+.....   ..+..+...|++||+.-=.-|.  ..|++-.=|.++|+.+
T Consensus       179 ~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~---~~~~l~~l~Wl~q~~~LW~~l~--~~~~~~sll~~~nlrv  253 (645)
T PRK14559        179 PTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQ---TLPTLQILYWLNQMTQLWKALE--PWGCCQSLLELENLRV  253 (645)
T ss_pred             cccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhc---CCcHHHHHHHHHHHHHHHHHHH--hcCeehhccchhheee
Confidence            45699999999988888888887632 2444444322   3566788999999999999998  8899999999999999


Q ss_pred             cCCCceEEeccc
Q 023752           93 DSNFNAKLSDFG  104 (278)
Q Consensus        93 ~~~~~~kl~dfg  104 (278)
                      +++..+.|..|-
T Consensus       254 ~~~~~~~l~~l~  265 (645)
T PRK14559        254 DEDQTLGLQQLY  265 (645)
T ss_pred             CCCceehHhhhh
Confidence            877666666553

>PRK11768 serine/threonine protein kinase; Provisional

Probab=89.47  E-value=0.62  Score=39.81  Aligned_cols=30  Identities=20%  Similarity=0.212  Sum_probs=24.8

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..+++|+|+.+.||+++ + .+.++||+-+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            45789999999999995 3 577899987753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=89.42  E-value=0.62  Score=39.06  Aligned_cols=40  Identities=28%  Similarity=0.417  Sum_probs=26.1

Q ss_pred             ChHHHHHHHhccC---CccccceeeeeecCCccEEEEeccCCC
Q 023752            1 MWQTEVIYLGQLR---HENLVKLIGYCSESDNRLLVYEFMPKG   40 (278)
Q Consensus         1 ~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~   40 (278)
                      ||..|.+-|+.|.   .-.+++++.+....+..++++||++.+
T Consensus        55 ~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   55 MFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             HHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             HHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            5788999888883   456778888888777789999998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=87.54  E-value=2.8  Score=35.80  Aligned_cols=94  Identities=18%  Similarity=0.199  Sum_probs=62.9

Q ss_pred             HHHHHHhcc-----CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            4 TEVIYLGQL-----RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         4 ~E~~~l~~l-----~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +|...|.++     .+|.++.+.-       -+|||-|+...-+..--.+.  -.++..+....-.|+..+++-|-. ..
T Consensus       334 kEmhNL~RMq~~GlpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~--v~l~d~E~~~aY~q~~~~M~~lY~-Ec  403 (531)
T KOG2269|consen  334 KEMHNLSRMQKHGLPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKN--VELTDDERRNAYDQVQSIMCRLYK-EC  403 (531)
T ss_pred             HHHHHHHHHHhcCCCCCceeeeec-------ceEEEEeecCCCCCCccccc--cccChHHHHHHHHHHHHHHHHHHH-hh
Confidence            344445544     2455555442       24888888543332211111  248888888888899999888832 77


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      -+||-|++-.|+++..+ .+-++|...+..
T Consensus       404 ~LVHADlSEyN~Lw~~g-Kvw~IDVsQsve  432 (531)
T KOG2269|consen  404 LLVHADLSEYNLLWTPG-KVWVIDVSQSVE  432 (531)
T ss_pred             heeecchhhhhheecCC-ceEEEechhccC
Confidence            89999999999999887 777888766643

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	278
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-40
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		7e-40
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-40
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-39
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-39
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-39
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-36
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-21
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-19
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		6e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-18
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-18
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		8e-18
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-17
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-17
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-17
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-16
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-16
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-16
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-16
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-16
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-16
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-16
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-16
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-16
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-16
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-16
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-16
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-16
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-16
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-16
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		7e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		8e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		8e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		9e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-15
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-15
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-15
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-15
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-15
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-15
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-15
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-15
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-15
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-15
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-15
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-15
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-15
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-15
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-15
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-15
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		6e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-15
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-15
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-15
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-15
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		9e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-15
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-14
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-14
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-14
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		4e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-14
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		8e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-14
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-13
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-13
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-13
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-13
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-13
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-13
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-13
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-13
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-13
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-13
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-13
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-13
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-13
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-13
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-13
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-13
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		5e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		6e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		6e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-13
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		7e-13
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-13
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		8e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		9e-13
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-12
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-12
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-12
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-12
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-12
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-12
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-12
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-12
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-12
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		5e-12
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-12
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		5e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		5e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		5e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-12
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-12
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		6e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-12
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-12
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		8e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		8e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-12
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		9e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		9e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		9e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		9e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		2e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-11
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-11
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		3e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-11
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-11
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		4e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		4e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		6e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		6e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-10
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-10
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-10
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-10
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-10
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-10
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-10
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-10
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-10
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-10
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-10
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-10
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-10
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-10
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-10
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-10
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-10
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-10
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		5e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-10
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		6e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-10
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		7e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-10
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		8e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-09
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-09
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-09
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-09
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-09
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-09
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-09
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-09
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-09
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-09
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-09
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-09
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-09
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		8e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		9e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-08
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-08
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		6e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		9e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-07
3soa_A	444	Full-Length Human Camkii Length = 444		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-07
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-07
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-07
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-07
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		4e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		5e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		5e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		5e-07
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		9e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		9e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-06
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		4e-06
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-06
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		5e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		6e-06
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		7e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-05
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-05
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		5e-05
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-05
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-05
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		6e-05
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-05
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-05
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-05
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		7e-05
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-05
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-05
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  162 bits (411), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 91/236 (38%), Positives = 138/236 (58%), Gaps = 6/236 (2%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTR 59
           +QTEV  +    H NL++L G+C     RLLVY +M  GS+ + L  +     P+ WP R
Sbjct: 82  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 141
Query: 60  VKIAIDVARGLSFLHG-LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            +IA+  ARGL++LH   D  +I+RD+KA+N+LLD  F A + DFGLA+     D  HV 
Sbjct: 142 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVX 200
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDR-GGLAEQTLVEWA 177
             + GT G+ APEY++TG  + K+DV+ +GV+LLEL++G+RA D  R     +  L++W 
Sbjct: 201 XAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 260
Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLE 233
              L++ +++  ++D  L G Y  +E +      L C    P  RP M +V+  LE
Sbjct: 261 KGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  160 bits (405), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 90/229 (39%), Positives = 135/229 (58%), Gaps = 10/229 (4%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKIAIDV 66
           L   RH +LV LIG+C E +  +L+Y++M  G+L+ HL+   +    +SW  R++I I  
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           ARGL +LH     +I+RD+K+ N+LLD NF  K++DFG+++ G   D TH+   + GT G
Sbjct: 149 ARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLG 206
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ--TLVEWADPFLRDS 184
           Y  PEY   G LT KSDVYSFGVVL E+L  R A+ +    L  +   L EWA     ++
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ---SLPREMVNLAEWAVES-HNN 262
Query: 185 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLE 233
            ++ +I+D  L  +   +  +      ++CL +  ++RPSM DVL  LE
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  160 bits (404), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 90/236 (38%), Positives = 137/236 (58%), Gaps = 6/236 (2%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTR 59
           +QTEV  +    H NL++L G+C     RLLVY +M  GS+ + L  +     P+ WP R
Sbjct: 74  FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 60  VKIAIDVARGLSFLHG-LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            +IA+  ARGL++LH   D  +I+RD+KA+N+LLD  F A + DFGLA+     D  HV 
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHVX 192
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDR-GGLAEQTLVEWA 177
             + G  G+ APEY++TG  + K+DV+ +GV+LLEL++G+RA D  R     +  L++W 
Sbjct: 193 XAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLE 233
              L++ +++  ++D  L G Y  +E +      L C    P  RP M +V+  LE
Sbjct: 253 KGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 93/238 (39%), Positives = 139/238 (58%), Gaps = 8/238 (3%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRV 60
           +  E+  + + +HENLV+L+G+ S+ D+  LVY +MP GSL + L    G  P+SW  R 
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KIA   A G++FLH  + + I+RD+K++N+LLD  F AK+SDFGLAR       T + +R
Sbjct: 137 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSR 194
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           IVGT  Y APE +  G +TPKSD+YSFGVVLLE+++G  A+DE R     Q L++  +  
Sbjct: 195 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLLLDIKEEI 250
Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
             + + +   +D ++    S    +       QCLH     RP +  V   L+++  S
Sbjct: 251 EDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  157 bits (398), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 89/229 (38%), Positives = 134/229 (58%), Gaps = 10/229 (4%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKIAIDV 66
           L   RH +LV LIG+C E +  +L+Y++M  G+L+ HL+   +    +SW  R++I I  
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           ARGL +LH     +I+RD+K+ N+LLD NF  K++DFG+++ G     TH+   + GT G
Sbjct: 149 ARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLG 206
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ--TLVEWADPFLRDS 184
           Y  PEY   G LT KSDVYSFGVVL E+L  R A+ +    L  +   L EWA     ++
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ---SLPREMVNLAEWAVES-HNN 262
Query: 185 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLE 233
            ++ +I+D  L  +   +  +      ++CL +  ++RPSM DVL  LE
Sbjct: 263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (396), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 93/238 (39%), Positives = 138/238 (57%), Gaps = 8/238 (3%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRV 60
           +  E+  + + +HENLV+L+G+ S+ D+  LVY +MP GSL + L    G  P+SW  R 
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KIA   A G++FLH  + + I+RD+K++N+LLD  F AK+SDFGLAR       T +  R
Sbjct: 137 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXR 194
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           IVGT  Y APE +  G +TPKSD+YSFGVVLLE+++G  A+DE R     Q L++  +  
Sbjct: 195 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLLLDIKEEI 250
Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
             + + +   +D ++    S    +       QCLH     RP +  V   L+++  S
Sbjct: 251 EDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  155 bits (391), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 92/238 (38%), Positives = 137/238 (57%), Gaps = 8/238 (3%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRV 60
           +  E+  + + +HENLV+L+G+ S+ D+  LVY +MP GSL + L    G  P+SW  R 
Sbjct: 71  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 130
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KIA   A G++FLH  + + I+RD+K++N+LLD  F AK+SDFGLAR         +  R
Sbjct: 131 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXR 188
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           IVGT  Y APE +  G +TPKSD+YSFGVVLLE+++G  A+DE R     Q L++  +  
Sbjct: 189 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLLLDIKEEI 244
Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
             + + +   +D ++    S    +       QCLH     RP +  V   L+++  S
Sbjct: 245 EDEEKTIEDYIDKKMNDADSTS-VEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  148 bits (373), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 92/238 (38%), Positives = 134/238 (56%), Gaps = 8/238 (3%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRV 60
           +  E+    + +HENLV+L+G+ S+ D+  LVY + P GSL + L    G  P+SW  R 
Sbjct: 68  FDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRC 127
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KIA   A G++FLH  + + I+RD+K++N+LLD  F AK+SDFGLAR           +R
Sbjct: 128 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSR 185
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           IVGT  Y APE +  G +TPKSD+YSFGVVLLE+++G  A+DE R     Q L++  +  
Sbjct: 186 IVGTTAYXAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR---EPQLLLDIKEEI 241
Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
             + + +   +D +     S    +       QCLH     RP +  V   L++   S
Sbjct: 242 EDEEKTIEDYIDKKXNDADSTS-VEAXYSVASQCLHEKKNKRPDIKKVQQLLQEXTAS 298

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 122/247 (49%), Gaps = 26/247 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIA 63
           EV  + +LRH N+V  +G  ++  N  +V E++ +GSL   L + G  + +    R+ +A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IV 122
            DVA+G+++LH  +  +++R+LK+ N+L+D  +  K+ DFGL+R      +T +S++   
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTFLSSKSAA 200
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  + APE +       KSDVYSFGV+L EL +    L +  G L    +V  A  F  
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT----LQQPWGNLNPAQVVA-AVGFKC 255
Query: 183 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMP 242
               + R ++ ++                  C   +P  RPS   ++  L  L  S    
Sbjct: 256 KRLEIPRNLNPQVAAIIEG------------CWTNEPWKRPSFATIMDLLRPLIKSA--- 300
Query: 243 RTPPPAK 249
             PPP +
Sbjct: 301 -VPPPNR 306

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 55/151 (36%), Positives = 87/151 (57%), Gaps = 3/151 (1%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIA 63
           EV  + +LRH N+V  +G  ++  N  +V E++ +GSL   L + G  + +    R+ +A
Sbjct: 84  EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
            DVA+G+++LH  +  +++RDLK+ N+L+D  +  K+ DFGL+R          S    G
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAG 201
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
           T  + APE +       KSDVYSFGV+L EL
Sbjct: 202 TPEWMAPEVLRDEPSNEKSDVYSFGVILWEL 232

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
            E   + QLRH NLV+L+G   E    L +V E+M KGSL ++L  +G   +     +K 
Sbjct: 54  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 113
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRI 121
           ++DV   + +L G   N ++RDL A NVL+  +  AK+SDFGL ++   T D   +  + 
Sbjct: 114 SLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK- 170
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
                + APE +     + KSDV+SFG++L E+ S  R
Sbjct: 171 -----WTAPEALREAAFSTKSDVWSFGILLWEIYSFGR 203

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
            E   + QLRH NLV+L+G   E    L +V E+M KGSL ++L  +G   +     +K 
Sbjct: 63  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 122
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRI 121
           ++DV   + +L G   N ++RDL A NVL+  +  AK+SDFGL ++   T D   +  + 
Sbjct: 123 SLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK- 179
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
                + APE +     + KSDV+SFG++L E+ S  R
Sbjct: 180 -----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 212

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
            E   + QLRH NLV+L+G   E    L +V E+M KGSL ++L  +G   +     +K 
Sbjct: 48  AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 107
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRI 121
           ++DV   + +L G   N ++RDL A NVL+  +  AK+SDFGL ++   T D   +  + 
Sbjct: 108 SLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK- 164
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
                + APE +     + KSDV+SFG++L E+ S  R
Sbjct: 165 -----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 91.3 bits (225), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 87/158 (55%), Gaps = 10/158 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
            E   + QLRH NLV+L+G   E    L +V E+M KGSL ++L  +G   +     +K 
Sbjct: 235 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF 294
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRI 121
           ++DV   + +L G   N ++RDL A NVL+  +  AK+SDFGL ++   T D   +  + 
Sbjct: 295 SLDVCEAMEYLEG--NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK- 351
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
                + APE +     + KSDV+SFG++L E+ S  R
Sbjct: 352 -----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 89/169 (52%), Gaps = 15/169 (8%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +Q EV  +  L H N+VKL G         +V EF+P G L + L  K   PI W  +++
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKWSVKLR 126
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-----NFNAKLSDFGLARDGPTGDNTH 116
           + +D+A G+ ++   +  +++RDL++ N+ L S        AK++DFGL++      + H
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVH 181
Query: 117 VSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDE 163
             + ++G   + APE +       T K+D YSF ++L  +L+G    DE
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 122 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GA 175
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 220
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS + 
Sbjct: 221 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE- 277
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 278 PQYQPGENL 286

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 122 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GA 175
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 220
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS + 
Sbjct: 221 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE- 277
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 278 PQYQPGENL 286

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 117/239 (48%), Gaps = 27/239 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 54  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 112
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 113 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GA 166
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 167 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 211
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS +
Sbjct: 212 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 268

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 122 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GA 175
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 220
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS + 
Sbjct: 221 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE- 277
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 278 PQYQPGENL 286

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 154
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGLAR   D P    T      
Sbjct: 155 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYT------ 206
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 260
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 261 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 235 L 235
           L
Sbjct: 307 L 307

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 117/239 (48%), Gaps = 27/239 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 52  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 111 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GA 164
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 165 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 209
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS +
Sbjct: 210 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE 266

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 15/169 (8%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +Q EV  +  L H N+VKL G         +V EF+P G L + L  K   PI W  +++
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKWSVKLR 126
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-----NFNAKLSDFGLARDGPTGDNTH 116
           + +D+A G+ ++   +  +++RDL++ N+ L S        AK++DFG ++      + H
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ-----QSVH 181
Query: 117 VSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDE 163
             + ++G   + APE +       T K+D YSF ++L  +L+G    DE
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + ++RHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 63  EAQVMKKIRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 122 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GA 175
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 220
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS + 
Sbjct: 221 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE- 277
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 278 PQYQPGENL 286

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 10/158 (6%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 56  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 114
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 115 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GA 168
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           +    + APE    G  T KSDV+SFG++L EL +  R
Sbjct: 169 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 88/169 (52%), Gaps = 15/169 (8%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +Q EV  +  L H N+VKL G         +V EF+P G L + L  K   PI W  +++
Sbjct: 70  FQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKWSVKLR 126
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-----NFNAKLSDFGLARDGPTGDNTH 116
           + +D+A G+ ++   +  +++RDL++ N+ L S        AK++DF L++      + H
Sbjct: 127 LMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ-----QSVH 181
Query: 117 VSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDE 163
             + ++G   + APE +       T K+D YSF ++L  +L+G    DE
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 154
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 155 GIASGMKYLS--DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 206
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 260
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 261 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 235 L 235
           L
Sbjct: 307 L 307

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 117/246 (47%), Gaps = 22/246 (8%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     + T         
Sbjct: 122 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPI 179
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 184
           + + APE    G  T KSDV+SFG++L EL +        +G +    +V         +
Sbjct: 180 K-WTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV---------N 221
Query: 185 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 244
           R VL  ++         +  +       QC   DP+ RP+   +   LE   TS + P+ 
Sbjct: 222 REVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE-PQY 280
Query: 245 PPPAKL 250
            P   L
Sbjct: 281 QPGENL 286

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 120/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 122 QIASGMAYVERM--NYVHRDLAAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GA 175
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 220
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS + 
Sbjct: 221 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE- 277
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 278 PQYQPGENL 286

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 288 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GA 341
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 386
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   +P+ RP+   +   LE   TS + 
Sbjct: 387 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE- 443
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 444 PQXQPGENL 452

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 120/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KG L + L  +  + +  P  V +A 
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 122 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GA 175
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 220
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS + 
Sbjct: 221 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE- 277
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 278 PQYQPGENL 286

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 10/158 (6%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 288 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GA 341
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           +    + APE    G  T KSDV+SFG++L EL +  R
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 94  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 152
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 153 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 204
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 205 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 258
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 259 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 304
Query: 235 L 235
           L
Sbjct: 305 L 305

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 154
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 155 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 206
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 260
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 261 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 235 L 235
           L
Sbjct: 307 L 307

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 154
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 155 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 206
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 260
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 261 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 235 L 235
           L
Sbjct: 307 L 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 154
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 155 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 206
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 260
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 261 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 235 L 235
           L
Sbjct: 307 L 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 125
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 126 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 177
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 178 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 231
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 232 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 277
Query: 235 L 235
           L
Sbjct: 278 L 278

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 84  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 142
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 143 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 194
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 195 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 248
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 249 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 294
Query: 235 L 235
           L
Sbjct: 295 L 295

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 154
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 155 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 206
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 260
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 261 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 235 L 235
           L
Sbjct: 307 L 307

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLR 154
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL R   D P    T      
Sbjct: 155 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT------ 206
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 260
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 261 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 235 L 235
           L
Sbjct: 307 L 307

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 120/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KG L + L  +  + +  P  V +A 
Sbjct: 63  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAA 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 122 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GA 175
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 176 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 220
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS + 
Sbjct: 221 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE- 277
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 278 PQYQPGENL 286

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 371 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GA 424
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 469
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   +P+ RP+   +   LE   TS + 
Sbjct: 470 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE- 526
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 527 PQXQPGENL 535

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 121/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 288 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTARQ--GA 341
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 386
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   +P+ RP+   +   LE   TS + 
Sbjct: 387 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE- 443
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 444 PQXQPGENL 452

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 120/249 (48%), Gaps = 28/249 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 230 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAA 288
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGL R     DN + + +  G 
Sbjct: 289 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLGR--LIEDNEYTARQ--GA 342
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           +    + APE    G  T KSDV+SFG++L EL +        +G +    +V       
Sbjct: 343 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT--------KGRVPYPGMV------- 387
Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +       QC   DP+ RP+   +   LE   TS + 
Sbjct: 388 --NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFLEDYFTSTE- 444
Query: 242 PRTPPPAKL 250
           P+  P   L
Sbjct: 445 PQXQPGENL 453

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 116/240 (48%), Gaps = 27/240 (11%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           +GQ  H N+++L G  S+    +++ E+M  G+L+  L  K  +  S    V +   +A 
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAA 158
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRIVGTR 125
           G+ +L  +  N ++RDL A N+L++SN   K+SDFGL+R   D P    T    +I    
Sbjct: 159 GMKYLANM--NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PI 214
Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 184
            + APE ++    T  SDV+SFG+V+ E+++ G R   E    L+   +++     + D 
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----LSNHEVMK----AINDG 266
Query: 185 RRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 244
            R+   MD                   +QC   +   RP   D+++ L++L  + D  +T
Sbjct: 267 FRLPTPMDC----------PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSLKT 316

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 27/231 (11%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +L H  LV+L G C E     LV+EFM  G L ++L R      +  T + + +DV  G+
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGM 116
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           ++L   +A+VI+RDL A N L+  N   K+SDFG+ R     D+ + S+   GT+    +
Sbjct: 117 AYLE--EASVIHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSS--TGTKFPVKW 170
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
           A+PE  +    + KSDV+SFGV++ E+ S  +   E+R               + D    
Sbjct: 171 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------SEVVEDISTG 220
Query: 188 LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
            R+   RL   +  +           C    P++RP+   +L  L  +  S
Sbjct: 221 FRLYKPRLASTHVYQIMN-------HCWKERPEDRPAFSRLLRQLAAIAAS 264

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 27/231 (11%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +L H  LV+L G C E     LV+EFM  G L ++L R      +  T + + +DV  G+
Sbjct: 61  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGM 119
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           ++L   +A VI+RDL A N L+  N   K+SDFG+ R     D+ + S+   GT+    +
Sbjct: 120 AYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSS--TGTKFPVKW 173
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
           A+PE  +    + KSDV+SFGV++ E+ S  +   E+R               + D    
Sbjct: 174 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------SEVVEDISTG 223
Query: 188 LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
            R+   RL   +  +           C    P++RP+   +L  L ++  S
Sbjct: 224 FRLYKPRLASTHVYQIMN-------HCWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 27/231 (11%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +L H  LV+L G C E     LV+EFM  G L ++L R      +  T + + +DV  G+
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGM 114
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           ++L   +A VI+RDL A N L+  N   K+SDFG+ R     D+ + S+   GT+    +
Sbjct: 115 AYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSS--TGTKFPVKW 168
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
           A+PE  +    + KSDV+SFGV++ E+ S  +   E+R               + D    
Sbjct: 169 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------SEVVEDISTG 218
Query: 188 LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
            R+   RL   +  +           C    P++RP+   +L  L ++  S
Sbjct: 219 FRLYKPRLASTHVYQIMN-------HCWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 109/231 (47%), Gaps = 27/231 (11%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +L H  LV+L G C E     LV+EFM  G L ++L R      +  T + + +DV  G+
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGM 116
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           ++L   +A VI+RDL A N L+  N   K+SDFG+ R     D+ + S+   GT+    +
Sbjct: 117 AYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSS--TGTKFPVKW 170
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
           A+PE  +    + KSDV+SFGV++ E+ S  +   E+R               + D    
Sbjct: 171 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------SEVVEDISTG 220
Query: 188 LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
            R+   RL   +  +           C    P++RP+   +L  L ++  S
Sbjct: 221 FRLYKPRLASTHVYQIMN-------HCWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 112/231 (48%), Gaps = 27/231 (11%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +L H  LV+L G C E     LV+EFM  G L ++L R      +  T + + +DV  G+
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGM 136
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           ++L   +A VI+RDL A N L+  N   K+SDFG+ R     D+ + S+   GT+    +
Sbjct: 137 AYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSS--TGTKFPVKW 190
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
           A+PE  +    + KSDV+SFGV++ E+ S  +   E+R   +   +VE       D    
Sbjct: 191 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVE-------DISTG 240
Query: 188 LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
            R+   RL   +  +           C    P++RP+   +L  L ++  S
Sbjct: 241 FRLYKPRLASTHVYQIMN-------HCWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 55/155 (35%), Positives = 87/155 (56%), Gaps = 4/155 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 53  EAQVMKKLRHEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 111
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     + T         
Sbjct: 112 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPI 169
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           + + APE    G  T KSDV+SFG++L EL +  R
Sbjct: 170 K-WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E M  GSL++ L RK     +    V +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGMLR 154
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 155 GIASGMKYLS--DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 206
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 260
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 261 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 235 L 235
           L
Sbjct: 307 L 307

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 91/159 (57%), Gaps = 10/159 (6%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V ++ 
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN + + +  G 
Sbjct: 119 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQ--GA 172
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA 160
           +    + APE    G  T KSDV+SFG++L EL +  R 
Sbjct: 173 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 211

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/167 (35%), Positives = 87/167 (52%), Gaps = 20/167 (11%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E      L+H N++ L G C +  N  LV EF   G L   L  K + P      V  
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPP---DILVNW 110
Query: 63  AIDVARGLSFLHG-LDANVIYRDLKASNVLLD--------SNFNAKLSDFGLARDGPTGD 113
           A+ +ARG+++LH      +I+RDLK+SN+L+         SN   K++DFGLAR+     
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----- 165
Query: 114 NTHVSTRIVGTRGYA--APEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             H +T++     YA  APE +     +  SDV+S+GV+L ELL+G 
Sbjct: 166 -WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E M  GSL++ L RK     +    V +  
Sbjct: 96  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGMLR 154
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 155 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 206
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 207 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 260
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 261 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 306
Query: 235 L 235
           L
Sbjct: 307 L 307

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 114/241 (47%), Gaps = 39/241 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N+++L G  ++S   ++V E M  GSL++ L RK     +    V +  
Sbjct: 67  EASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGMLR 125
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T      
Sbjct: 126 GIASGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYT------ 177
Query: 122 VGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV 174
             TRG      + +PE +A    T  SDV+S+G+VL E++S G R   E    ++ Q ++
Sbjct: 178 --TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE----MSNQDVI 231
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  D    +  R+   MD                   L C   D  NRP    +++ L++
Sbjct: 232 KAVD----EGYRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDK 277
Query: 235 L 235
           L
Sbjct: 278 L 278

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/158 (34%), Positives = 90/158 (56%), Gaps = 10/158 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N++ L G  ++S   +++ EFM  GSL++ L R+     +    V + 
Sbjct: 83  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGML 141
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 121
             +A G+ +L   D N ++RDL A N+L++SN   K+SDFGL+R  +  T D T+ S   
Sbjct: 142 RGIAAGMKYL--ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA-- 197
Query: 122 VGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +G +    + APE +     T  SDV+S+G+V+ E++S
Sbjct: 198 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +L H  LV+L G C E     LV EFM  G L ++L R      +  T + + +DV  G+
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGM 117
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GY 127
           ++L   +A VI+RDL A N L+  N   K+SDFG+ R     D+ + S+   GT+    +
Sbjct: 118 AYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTR--FVLDDQYTSS--TGTKFPVKW 171
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
           A+PE  +    + KSDV+SFGV++ E+ S  +   E+R               + D    
Sbjct: 172 ASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN----------SEVVEDISTG 221
Query: 188 LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
            R+   RL   +  +           C    P++RP+   +L  L ++  S
Sbjct: 222 FRLYKPRLASTHVYQIMN-------HCWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 90/159 (56%), Gaps = 10/159 (6%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V ++ 
Sbjct: 60  EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSA 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++  +  N ++RDL+A+N+L+  N   K++DFGLAR     DN   + +  G 
Sbjct: 119 QIASGMAYVERM--NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEWTARQ--GA 172
Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA 160
           +    + APE    G  T KSDV+SFG++L EL +  R 
Sbjct: 173 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV 211

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 121/257 (47%), Gaps = 45/257 (17%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR---V 60
            E+  L ++ H N+VKL G C   +   LV E+   GSL N L   G +P+ + T    +
Sbjct: 51  VELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAM 106
Query: 61  KIAIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVS 118
              +  ++G+++LH +    +I+RDLK  N+LL +     K+ DFG A D      TH++
Sbjct: 107 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMT 162
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA- 177
               G+  + APE     + + K DV+S+G++L E+++ R+  DE  GG A + +  WA 
Sbjct: 163 NN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI-GGPAFRIM--WAV 218
Query: 178 -----DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSM---VDVL 229
                 P +++  + +  + TR                   C   DP  RPSM   V ++
Sbjct: 219 HNGTRPPLIKNLPKPIESLMTR-------------------CWSKDPSQRPSMEEIVKIM 259
Query: 230 TSLEQLHTSKDMPRTPP 246
           T L +     D P   P
Sbjct: 260 THLMRYFPGADEPLQYP 276

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 121/257 (47%), Gaps = 45/257 (17%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR---V 60
            E+  L ++ H N+VKL G C   +   LV E+   GSL N L   G +P+ + T    +
Sbjct: 50  VELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAM 105
Query: 61  KIAIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVS 118
              +  ++G+++LH +    +I+RDLK  N+LL +     K+ DFG A D      TH++
Sbjct: 106 SWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMT 161
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA- 177
               G+  + APE     + + K DV+S+G++L E+++ R+  DE  GG A + +  WA 
Sbjct: 162 NN-KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI-GGPAFRIM--WAV 217
Query: 178 -----DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSM---VDVL 229
                 P +++  + +  + TR                   C   DP  RPSM   V ++
Sbjct: 218 HNGTRPPLIKNLPKPIESLMTR-------------------CWSKDPSQRPSMEEIVKIM 258
Query: 230 TSLEQLHTSKDMPRTPP 246
           T L +     D P   P
Sbjct: 259 THLMRYFPGADEPLQYP 275

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--------- 52
           +Q E   L  L+H+++V+  G C+E    L+V+E+M  G L   L   G           
Sbjct: 67  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 126
Query: 53  ----PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
               P+     + +A  VA G+ +L GL  + ++RDL   N L+      K+ DFG++RD
Sbjct: 127 VAPGPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRD 184
Query: 109 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + D   V  R +    +  PE +     T +SDV+SFGVVL E+ +
Sbjct: 185 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/159 (36%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           WQ E+  L  L HE++VK  G C +   +   LV E++P GSL ++L R  V        
Sbjct: 57  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCV---GLAQL 113
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A  +  G+++LH    + I+R L A NVLLD++   K+ DFGLA+  P G + +   
Sbjct: 114 LLFAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEG-HEYYRV 170
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R  G     + APE +        SDV+SFGV L ELL+
Sbjct: 171 REDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--------- 52
           +Q E   L  L+H+++V+  G C+E    L+V+E+M  G L   L   G           
Sbjct: 61  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 120
Query: 53  ----PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
               P+     + +A  VA G+ +L GL  + ++RDL   N L+      K+ DFG++RD
Sbjct: 121 VAPGPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRD 178
Query: 109 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + D   V  R +    +  PE +     T +SDV+SFGVVL E+ +
Sbjct: 179 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/159 (36%), Positives = 84/159 (52%), Gaps = 10/159 (6%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           WQ E+  L  L HE++VK  G C +   +   LV E++P GSL ++L R  V        
Sbjct: 58  WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCV---GLAQL 114
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A  +  G+++LH    + I+R L A NVLLD++   K+ DFGLA+  P G + +   
Sbjct: 115 LLFAQQICEGMAYLHA--QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEG-HEYYRV 171
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R  G     + APE +        SDV+SFGV L ELL+
Sbjct: 172 REDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 82/168 (48%), Gaps = 15/168 (8%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--------- 52
           +Q E   L  L+H+++V+  G C+E    L+V+E+M  G L   L   G           
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 53  ----PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
               P+     + +A  VA G+ +L GL  + ++RDL   N L+      K+ DFG++RD
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYLAGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRD 207
Query: 109 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + D   V  R +    +  PE +     T +SDV+SFGVVL E+ +
Sbjct: 208 IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 117 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFP 173
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/236 (30%), Positives = 115/236 (48%), Gaps = 43/236 (18%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAIDVAR 68
           +L H  LVK  G CS+     +V E++  G L N+L    KG++P      +++  DV  
Sbjct: 59  KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEP---SQLLEMCYDVCE 115
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G++FL       I+RDL A N L+D +   K+SDFG+ R     D+ +VS+  VGT+   
Sbjct: 116 GMAFLES--HQFIHRDLAARNCLVDRDLCVKVSDFGMTR--YVLDDQYVSS--VGTKFPV 169
Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 184
            ++APE       + KSDV++FG+++ E+ S G+   D          L   ++  L+ S
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD----------LYTNSEVVLKVS 219
Query: 185 R--RVLR---IMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQL 235
           +  R+ R     DT     YS             C H  P+ RP+   +L+S+E L
Sbjct: 220 QGHRLYRPHLASDTIYQIMYS-------------CWHELPEKRPTFQQLLSSIEPL 262

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------QPISWPTR 59
           +LGQ  HEN+V L+G C+     L++ E+   G L N L RK          +P+     
Sbjct: 97  HLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 154
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  VA+G++FL     N I+RD+ A NVLL +   AK+ DFGLARD     N  V  
Sbjct: 155 LHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 212
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                  + APE +     T +SDV+S+G++L E+ S
Sbjct: 213 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/158 (35%), Positives = 84/158 (53%), Gaps = 8/158 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESD--NRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           W+ E+  L  L HE+++K  G C ++   +  LV E++P GSL ++L R     I     
Sbjct: 80  WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQL 136
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VS 118
           +  A  +  G+++LH    + I+RDL A NVLLD++   K+ DFGLA+  P G   + V 
Sbjct: 137 LLFAQQICEGMAYLHA--QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVR 194
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                   + APE +        SDV+SFGV L ELL+
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 117 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFP 173
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/157 (35%), Positives = 82/157 (52%), Gaps = 12/157 (7%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------QPISWPTR 59
           +LGQ  HEN+V L+G C+     L++ E+   G L N L RK          +P+     
Sbjct: 105 HLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDL 162
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  VA+G++FL     N I+RD+ A NVLL +   AK+ DFGLARD     N  V  
Sbjct: 163 LHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 220
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                  + APE +     T +SDV+S+G++L E+ S
Sbjct: 221 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 83.2 bits (204), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 81/156 (51%), Gaps = 6/156 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 78  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 136
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTR 120
            + VA+G+ FL       ++RDL A N +LD  F  K++DFGLARD      D+ H  T 
Sbjct: 137 GLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 194
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                 + A E + T   T KSDV+SFGV+L EL++
Sbjct: 195 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 81/156 (51%), Gaps = 6/156 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 80  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 138
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTR 120
            + VA+G+ FL       ++RDL A N +LD  F  K++DFGLARD      D+ H  T 
Sbjct: 139 GLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 196
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                 + A E + T   T KSDV+SFGV+L EL++
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 119 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 175
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 81/156 (51%), Gaps = 6/156 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 85  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 143
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTR 120
            + VA+G+ FL       ++RDL A N +LD  F  K++DFGLARD      D+ H  T 
Sbjct: 144 GLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 201
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                 + A E + T   T KSDV+SFGV+L EL++
Sbjct: 202 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 81/156 (51%), Gaps = 6/156 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 80  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 138
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTR 120
            + VA+G+ FL       ++RDL A N +LD  F  K++DFGLARD      D+ H  T 
Sbjct: 139 GLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 196
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                 + A E + T   T KSDV+SFGV+L EL++
Sbjct: 197 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 81/156 (51%), Gaps = 6/156 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 81  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 139
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTR 120
            + VA+G+ FL       ++RDL A N +LD  F  K++DFGLARD      D+ H  T 
Sbjct: 140 GLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTG 197
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                 + A E + T   T KSDV+SFGV+L EL++
Sbjct: 198 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 81/156 (51%), Gaps = 6/156 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 139 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 197
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTR 120
            + VA+G+ FL       ++RDL A N +LD  F  K++DFGLARD      D+ H  T 
Sbjct: 198 GLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                 + A E + T   T KSDV+SFGV+L EL++
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 119 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 175
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 81/156 (51%), Gaps = 6/156 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 81  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 139
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTR 120
            + VA+G+ FL       ++RDL A N +LD  F  K++DFGLARD      D+ H  T 
Sbjct: 140 GLQVAKGMKFL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 197
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                 + A E + T   T KSDV+SFGV+L EL++
Sbjct: 198 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 119 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 175
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 116
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 117 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTFTAHAGAKFP 173
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 174 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 203

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 123
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 124 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 180
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 10/159 (6%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           W+ E+  L  L HE+++K  G C +   +   LV E++P GSL ++L R     I     
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR---HSIGLAQL 119
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A  +  G+++LH    + I+R+L A NVLLD++   K+ DFGLA+  P G + +   
Sbjct: 120 LLFAQQICEGMAYLHA--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEG-HEYYRV 176
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R  G     + APE +        SDV+SFGV L ELL+
Sbjct: 177 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S +    +V ++    SL +HL     +       + 
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLID 124
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   ARG+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA +      +H   ++
Sbjct: 125 IARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 119 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 175
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 87/156 (55%), Gaps = 4/156 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +L+H+ LV+L    SE +   +V E+M KGSL + L     + +  P  V +A 
Sbjct: 54  EAQIMKKLKHDKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAA 112
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            VA G++++  +  N I+RDL+++N+L+ +    K++DFGLAR     + T         
Sbjct: 113 QVAAGMAYIERM--NYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPI 170
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA 160
           + + APE    G  T KSDV+SFG++L EL++  R 
Sbjct: 171 K-WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRV 205

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 112/261 (42%), Gaps = 45/261 (17%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N++K IG   +      + E++  G+L   + +       W  RV  A 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAK 115
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTR- 120
           D+A G+++LH +  N+I+RDL + N L+  N N  ++DFGLAR   D  T      S + 
Sbjct: 116 DIASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 121 --------IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
                   +VG   + APE +       K DV+SFG+VL E++ GR   D D        
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPD-------- 224
Query: 173 LVEWADPFLRDSRRVLRIMDTRLG-----GQYSKKEA-QXXXXXXLQCLHMDPKNRPSMV 226
                         + R MD  L       +Y             ++C  +DP+ RPS V
Sbjct: 225 -------------YLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFV 271
Query: 227 DVLTSLEQL--HTSKDMPRTP 245
            +   LE L  H +  +P  P
Sbjct: 272 KLEHWLETLRMHLAGHLPLGP 292

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 85/159 (53%), Gaps = 10/159 (6%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           W+ E+  L  L HE+++K  G C +   +   LV E++P GSL ++L R     I     
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPR---HSIGLAQL 119
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A  +  G+++LH    + I+R+L A NVLLD++   K+ DFGLA+  P G + +   
Sbjct: 120 LLFAQQICEGMAYLHS--QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEG-HEYYRV 176
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R  G     + APE +        SDV+SFGV L ELL+
Sbjct: 177 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/158 (33%), Positives = 89/158 (56%), Gaps = 10/158 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N++ L G  ++S   +++ EFM  GSL++ L R+     +    V + 
Sbjct: 57  SEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGML 115
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 121
             +A G+ +L   D N ++R L A N+L++SN   K+SDFGL+R  +  T D T+ S   
Sbjct: 116 RGIAAGMKYLA--DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA-- 171
Query: 122 VGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +G +    + APE +     T  SDV+S+G+V+ E++S
Sbjct: 172 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 84/158 (53%), Gaps = 7/158 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV    QL H+N+V +I    E D   LV E++   +L  ++   G  P+S  T + 
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAIN 115
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
               +  G+   H  D  +++RD+K  N+L+DSN   K+ DFG+A+       T  +  +
Sbjct: 116 FTNQILDGIK--HAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHV 172
Query: 122 VGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSGR 158
           +GT  Y +PE  A G  T + +D+YS G+VL E+L G 
Sbjct: 173 LGTVQYFSPEQ-AKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 84/148 (56%), Gaps = 9/148 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L+H+ LV+L    ++ +   ++ EFM KGSL + L       +  P  +  +  +A G++
Sbjct: 64  LQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 123
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYA 128
           ++     N I+RDL+A+NVL+  +   K++DFGLAR     DN + +    G +    + 
Sbjct: 124 YIE--RKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTARE--GAKFPIKWT 177
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
           APE +  G  T KS+V+SFG++L E+++
Sbjct: 178 APEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 83/148 (56%), Gaps = 9/148 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L+H+ LV+L    +  +   ++ E+M KGSL + L       +  P  +  +  +A G++
Sbjct: 65  LQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 124
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR---GYA 128
           ++     N I+RDL+A+NVL+  +   K++DFGLAR     DN + +    G +    + 
Sbjct: 125 YIE--RKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTARE--GAKFPIKWT 178
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
           APE +  G  T KSDV+SFG++L E+++
Sbjct: 179 APEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/181 (35%), Positives = 90/181 (49%), Gaps = 24/181 (13%)
Query: 2   WQTE--VIYLGQLRHENLVKLIGY----CSESDNRLLVYEFMPKGSLENHLFRKGVQPIS 55
           WQ E  V  L  ++HEN+++ IG      S   +  L+  F  KGSL + L       +S
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVS 119
Query: 56  WPTRVKIAIDVARGLSFLH--------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 107
           W     IA  +ARGL++LH        G    + +RD+K+ NVLL +N  A ++DFGLA 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS------DVYSFGVVLLELLSGRRAL 161
               G +   +   VGTR Y APE V  G +  +       D+Y+ G+VL EL S   A 
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 162 D 162
           D
Sbjct: 239 D 239

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 91/161 (56%), Gaps = 14/161 (8%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVK 61
            E   +  L+H+ LVKL    ++ +   ++ EFM KGSL + L       QP+  P  + 
Sbjct: 59  AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLID 115
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            +  +A G++F+     N I+RDL+A+N+L+ ++   K++DFGLAR     DN + +   
Sbjct: 116 FSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTARE- 170
Query: 122 VGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            G +    + APE +  G  T KSDV+SFG++L+E+++  R
Sbjct: 171 -GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 210

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 120 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFP 176
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 86/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 67  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLID 124
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   ARG+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA +      +H   ++
Sbjct: 125 IARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N+++L G  +     ++V E+M  GSL+  L R      +    V + 
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGML 157
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTR 120
             V  G+ +L   D   ++RDL A NVL+DSN   K+SDFGL+R   D P    T    +
Sbjct: 158 RGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGK 215
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           I     + APE +A    +  SDV+SFGVV+ E+L+
Sbjct: 216 I--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 124 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 180
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 124 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFP 180
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 60  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 119
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 120 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFP 176
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 177 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 16/169 (9%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------QP 53
           +Q E   L  L+HE++VK  G C + D  ++V+E+M  G L   L   G         QP
Sbjct: 64  FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 54  ------ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 107
                 +     + IA  +A G+ +L     + ++RDL   N L+ +N   K+ DFG++R
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           D  + D   V    +    +  PE +     T +SDV+SFGV+L E+ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 82/156 (52%), Gaps = 8/156 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N+++L G  +     ++V E+M  GSL+  L R      +    V + 
Sbjct: 99  SEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGML 157
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTR 120
             V  G+ +L   D   ++RDL A NVL+DSN   K+SDFGL+R   D P    T    +
Sbjct: 158 RGVGAGMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGK 215
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           I     + APE +A    +  SDV+SFGVV+ E+L+
Sbjct: 216 I--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 91/161 (56%), Gaps = 14/161 (8%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVK 61
            E   +  L+H+ LVKL    ++ +   ++ EFM KGSL + L       QP+  P  + 
Sbjct: 232 AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLID 288
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            +  +A G++F+     N I+RDL+A+N+L+ ++   K++DFGLAR     DN + +   
Sbjct: 289 FSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTARE- 343
Query: 122 VGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            G +    + APE +  G  T KSDV+SFG++L+E+++  R
Sbjct: 344 -GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 124 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 180
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 121 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFP 177
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 3/152 (1%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 64  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 123
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 124 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 180
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + APE +A    + KSDV++FGV+L E+ +
Sbjct: 181 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 121 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 177
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 81/152 (53%), Gaps = 3/152 (1%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 122
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 123 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 179
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + APE +A    + KSDV++FGV+L E+ +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 81/150 (54%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      +V E+MP G+L ++L     + ++    + +A 
Sbjct: 78  EAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMAT 137
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 138 QISSAMEYLE--KKNFIHRDLAARNCLVGENHVVKVADFGLSRL-MTGDTYTAHAGAKFP 194
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 195 IKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 119 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 175
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 61  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 121 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 177
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 178 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 119 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 175
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 176 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 72  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 131
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R   TGD           
Sbjct: 132 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFP 188
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 189 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 218

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 8/155 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +GQ  H N++ L G  ++S   ++V E+M  GSL+  L +K     +    V +  
Sbjct: 73  EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQFTVIQLVGMLR 131
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTRI 121
            ++ G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T    +I
Sbjct: 132 GISAGMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKI 189
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                + APE +A    T  SDV+S+G+V+ E++S
Sbjct: 190 --PIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 119/242 (49%), Gaps = 35/242 (14%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PISW 56
           E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S 
Sbjct: 63  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D   
Sbjct: 123 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
              + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ     
Sbjct: 181 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ----- 224
Query: 177 ADPFL-RDSRRVLR-IMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL 232
             P+    + +VLR +M+   GG   K +        L   C   +PK RPS +++++S+
Sbjct: 225 --PYQGLSNEQVLRFVME---GGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279
Query: 233 EQ 234
           ++
Sbjct: 280 KE 281

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 119/242 (49%), Gaps = 35/242 (14%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PISW 56
           E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S 
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D   
Sbjct: 132 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
              + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ     
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ----- 233
Query: 177 ADPFL-RDSRRVLR-IMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL 232
             P+    + +VLR +M+   GG   K +        L   C   +PK RPS +++++S+
Sbjct: 234 --PYQGLSNEQVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 288
Query: 233 EQ 234
           ++
Sbjct: 289 KE 290

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 83/161 (51%), Gaps = 16/161 (9%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK----------GVQPISWP 57
           +LGQ  HEN+V L+G C+     L++ E+   G L N L RK           +   +  
Sbjct: 105 HLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLS 162
Query: 58  TR--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
           TR  +  +  VA+G++FL     N I+RD+ A NVLL +   AK+ DFGLARD     N 
Sbjct: 163 TRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            V         + APE +     T +SDV+S+G++L E+ S
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+  L  L HEN+VK  G C+E   +   L+ EF+P GSL+ +L  K    I+   ++
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQL 129
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG-DNTHVST 119
           K A+ + +G+ +L       ++RDL A NVL++S    K+ DFGL +   T  +   V  
Sbjct: 130 KYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 187
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                  + APE +        SDV+SFGV L ELL+
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+  L  L HEN+VK  G C+E   +   L+ EF+P GSL+ +L  K    I+   ++
Sbjct: 59  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQL 117
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG-DNTHVST 119
           K A+ + +G+ +L       ++RDL A NVL++S    K+ DFGL +   T  +   V  
Sbjct: 118 KYAVQICKGMDYLGS--RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 175
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                  + APE +        SDV+SFGV L ELL+
Sbjct: 176 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 85/162 (52%), Gaps = 20/162 (12%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N++ L G  ++    +++ E+M  GSL+  L RK     +    V + 
Sbjct: 79  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGML 137
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTR 120
             +  G+ +L   D + ++RDL A N+L++SN   K+SDFG++R   D P    T     
Sbjct: 138 RGIGSGMKYLS--DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT----- 190
Query: 121 IVGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
              TRG      + APE +A    T  SDV+S+G+V+ E++S
Sbjct: 191 ---TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 88/161 (54%), Gaps = 24/161 (14%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVK 61
            E   +  L+H+ LVKL    ++ +   ++ EFM KGSL + L       QP+  P  + 
Sbjct: 226 AEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLID 282
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            +  +A G++F+     N I+RDL+A+N+L+ ++   K++DFGLAR              
Sbjct: 283 FSAQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLAR-------------- 326
Query: 122 VGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           VG +    + APE +  G  T KSDV+SFG++L+E+++  R
Sbjct: 327 VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 367

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/161 (35%), Positives = 83/161 (51%), Gaps = 16/161 (9%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK----------GVQPISWP 57
           +LGQ  HEN+V L+G C+     L++ E+   G L N L RK           +   +  
Sbjct: 105 HLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 58  TR--VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
           TR  +  +  VA+G++FL     N I+RD+ A NVLL +   AK+ DFGLARD     N 
Sbjct: 163 TRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            V         + APE +     T +SDV+S+G++L E+ S
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 79  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 137
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 138 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNK-T 194
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 195 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+R+L A N L+  N   K++DFGL+R   TGD           
Sbjct: 326 QISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFP 382
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
             + APE +A    + KSDV++FGV+L E+
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 84/159 (52%), Gaps = 7/159 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY ++ DN  +V ++    SL  HL  +  +       + 
Sbjct: 79  FRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETK-FQMFQLID 136
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    N+I+RD+K++N+ L      K+ DFGLA        +    + 
Sbjct: 137 IARQTAQGMDYLHA--KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQP 194
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSG 157
            G+  + APE +      P   +SDVYS+G+VL EL++G
Sbjct: 195 TGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 55  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLID 112
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   ARG+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA        +H   ++
Sbjct: 113 IARQTARGMDYLHA--KSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQL 170
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 171 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 85/162 (52%), Gaps = 20/162 (12%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N++ L G  ++    +++ E+M  GSL+  L RK     +    V + 
Sbjct: 58  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGML 116
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTR 120
             +  G+ +L   D + ++RDL A N+L++SN   K+SDFG++R   D P    T     
Sbjct: 117 RGIGSGMKYLS--DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT----- 169
Query: 121 IVGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
              TRG      + APE +A    T  SDV+S+G+V+ E++S
Sbjct: 170 ---TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 85/162 (52%), Gaps = 20/162 (12%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N++ L G  ++    +++ E+M  GSL+  L RK     +    V + 
Sbjct: 64  SEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGML 122
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTR 120
             +  G+ +L   D + ++RDL A N+L++SN   K+SDFG++R   D P    T     
Sbjct: 123 RGIGSGMKYLS--DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYT----- 175
Query: 121 IVGTRG------YAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
              TRG      + APE +A    T  SDV+S+G+V+ E++S
Sbjct: 176 ---TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/186 (36%), Positives = 95/186 (51%), Gaps = 33/186 (17%)
Query: 2   WQTE--VIYLGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPIS 55
           WQ+E  +     ++HENL++ I       N      L+  F  KGSL ++L  KG   I+
Sbjct: 54  WQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYL--KG-NIIT 110
Query: 56  WPTRVKIAIDVARGLSFLH---------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 106
           W     +A  ++RGLS+LH         G   ++ +RD K+ NVLL S+  A L+DFGLA
Sbjct: 111 WNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170
Query: 107 R----DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS------DVYSFGVVLLELLS 156
                  P GD TH     VGTR Y APE V  G +  +       D+Y+ G+VL EL+S
Sbjct: 171 VRFEPGKPPGD-THGQ---VGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVS 225
Query: 157 GRRALD 162
             +A D
Sbjct: 226 RCKAAD 231

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 84/163 (51%), Gaps = 18/163 (11%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK---GVQPISWPTR----- 59
           +LGQ  HEN+V L+G C+     L++ E+   G L N L RK   G++    P+      
Sbjct: 105 HLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQ 162
Query: 60  ------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
                 +  +  VA+G++FL     N I+RD+ A NVLL +   AK+ DFGLARD     
Sbjct: 163 LSSRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           N  V         + APE +     T +SDV+S+G++L E+ S
Sbjct: 221 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 71  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 128
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA +      +H   ++
Sbjct: 129 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 186
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 187 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/251 (28%), Positives = 113/251 (45%), Gaps = 33/251 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + L  + H  ++++ G   ++    ++ +++  G L + L RK  Q    P     A 
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS-LLRKS-QRFPNPVAKFYAA 113
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           +V   L +LH  D  +IYRDLK  N+LLD N + K++DFG A+  P      V+  + GT
Sbjct: 114 EVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGT 166
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVEW--ADPFL 181
             Y APE V+T       D +SFG+++ E+L+G     D +     E+ L       PF 
Sbjct: 167 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFF 226
Query: 182 RD------SRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQL 235
            +      SR + R +  RLG               LQ    D KN P   +V+   + L
Sbjct: 227 NEDVKDLLSRLITRDLSQRLGN--------------LQNGTEDVKNHPWFKEVVWE-KLL 271
Query: 236 HTSKDMPRTPP 246
             + + P  PP
Sbjct: 272 SRNIETPYEPP 282

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 136
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA +      +H   ++
Sbjct: 137 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 194
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 72  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 130
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 131 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-T 187
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 188 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 81/156 (51%), Gaps = 8/156 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E   +GQ  H N+V L G  +     ++V EFM  G+L+  L RK     +    V + 
Sbjct: 93  CEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL-RKHDGQFTVIQLVGML 151
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVSTR 120
             +A G+ +L   D   ++RDL A N+L++SN   K+SDFGL+R   D P    T    +
Sbjct: 152 RGIAAGMRYL--ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGK 209
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           I     + APE +     T  SDV+S+G+V+ E++S
Sbjct: 210 I--PVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 98  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 156
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 157 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-T 213
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 214 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 51  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 108
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA +      +H   ++
Sbjct: 109 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQL 166
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 80  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 138
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 139 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-T 195
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 79  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 137
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 138 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-T 194
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 195 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 88/154 (57%), Gaps = 10/154 (6%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 68  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 126
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     DN + +    G +   
Sbjct: 127 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTARE--GAKFPI 180
Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            + APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 181 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 77  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 135
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 136 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-T 192
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 193 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 99  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 157
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 158 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-T 214
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 215 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 88/154 (57%), Gaps = 10/154 (6%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 67  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 125
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     DN + +    G +   
Sbjct: 126 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTARE--GAKFPI 179
Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            + APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 180 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 88/154 (57%), Gaps = 10/154 (6%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 72  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 130
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     DN + +    G +   
Sbjct: 131 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTARE--GAKFPI 184
Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            + APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 185 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 75  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 133
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 134 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-T 190
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 191 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 80  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 138
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 139 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-T 195
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 196 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PISW 56
           E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S 
Sbjct: 72  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D   
Sbjct: 132 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 189
Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
              + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ     
Sbjct: 190 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ----- 233
Query: 177 ADPFL-RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSLE 233
             P+    + +VLR +    GG   K +        L   C   +PK RPS +++++S++
Sbjct: 234 --PYQGLSNEQVLRFVME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289
Query: 234 Q 234
           +
Sbjct: 290 E 290

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PISW 56
           E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S 
Sbjct: 69  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D   
Sbjct: 129 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 186
Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
              + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ     
Sbjct: 187 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ----- 230
Query: 177 ADPFL-RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSLE 233
             P+    + +VLR +    GG   K +        L   C   +PK RPS +++++S++
Sbjct: 231 --PYQGLSNEQVLRFVME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 286
Query: 234 Q 234
           +
Sbjct: 287 E 287

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 117/241 (48%), Gaps = 33/241 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PISW 56
           E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D   
Sbjct: 125 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
              + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ     
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ----- 226
Query: 177 ADPFL-RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSLE 233
             P+    + +VLR +    GG   K +        L   C   +PK RPS +++++S++
Sbjct: 227 --PYQGLSNEQVLRFVME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282
Query: 234 Q 234
           +
Sbjct: 283 E 283

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +  
Sbjct: 78  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLIGF 136
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +   V  +  
Sbjct: 137 GLQVAKGMKYL--ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK-T 193
Query: 123 GTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           G +    + A E + T   T KSDV+SFGV+L EL++
Sbjct: 194 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 117/242 (48%), Gaps = 33/242 (13%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PIS 55
            E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S
Sbjct: 70  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
               +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D  
Sbjct: 130 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
               + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ    
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ---- 232
Query: 176 WADPFL-RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL 232
              P+    + +VLR +    GG   K +        L   C   +PK RPS +++++S+
Sbjct: 233 ---PYQGLSNEQVLRFVME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287
Query: 233 EQ 234
           ++
Sbjct: 288 KE 289

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 119/242 (49%), Gaps = 35/242 (14%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PISW 56
           E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S 
Sbjct: 71  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D   
Sbjct: 131 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
              + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ     
Sbjct: 189 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ----- 232
Query: 177 ADPFL-RDSRRVLR-IMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL 232
             P+    + +VLR +M+   GG   K +        L   C   +PK RPS +++++S+
Sbjct: 233 --PYQGLSNEQVLRFVME---GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 287
Query: 233 EQ 234
           ++
Sbjct: 288 KE 289

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 117/242 (48%), Gaps = 33/242 (13%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PIS 55
            E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
               +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D  
Sbjct: 137 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
               + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ    
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ---- 239
Query: 176 WADPFL-RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL 232
              P+    + +VLR +    GG   K +        L   C   +PK RPS +++++S+
Sbjct: 240 ---PYQGLSNEQVLRFVME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
Query: 233 EQ 234
           ++
Sbjct: 295 KE 296

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 88/154 (57%), Gaps = 10/154 (6%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 62  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     DN + +    G +   
Sbjct: 121 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTARE--GAKFPI 174
Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            + APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 175 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 116/241 (48%), Gaps = 33/241 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PISW 56
           E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  +       P S 
Sbjct: 68  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D   
Sbjct: 128 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 185
Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
              + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ     
Sbjct: 186 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ----- 229
Query: 177 ADPFL-RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSLE 233
             P+    + +VLR +    GG   K +        L   C   +PK RPS +++++S++
Sbjct: 230 --PYQGLSNEQVLRFVME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285
Query: 234 Q 234
           +
Sbjct: 286 E 286

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 36/236 (15%)
Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L+V E M  G L+++L           G  P +    +++A ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D      + +    +
Sbjct: 141 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 185
            APE +  G  T  SD++SFGVVL E+ S           LAEQ       P+  L + +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 240
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL-EQLHTS 238
            +  +MD   GG   + +        L   C   +PK RP+ ++++  L + LH S
Sbjct: 241 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 36/236 (15%)
Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L+V E M  G L+++L           G  P +    +++A ++A
Sbjct: 78  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 137
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D      + +    +
Sbjct: 138 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 195
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 185
            APE +  G  T  SD++SFGVVL E+ S           LAEQ       P+  L + +
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 237
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL-EQLHTS 238
            +  +MD   GG   + +        L   C   +PK RP+ ++++  L + LH S
Sbjct: 238 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 290

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 116/242 (47%), Gaps = 33/242 (13%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PIS 55
            E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  +       P S
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
               +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D  
Sbjct: 137 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
               + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ    
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ---- 239
Query: 176 WADPFL-RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL 232
              P+    + +VLR +    GG   K +        L   C   +PK RPS +++++S+
Sbjct: 240 ---PYQGLSNEQVLRFVME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
Query: 233 EQ 234
           ++
Sbjct: 295 KE 296

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 88/154 (57%), Gaps = 10/154 (6%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 57  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 115
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     DN + +    G +   
Sbjct: 116 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTARE--GAKFPI 169
Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            + APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 170 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 85/151 (56%), Gaps = 4/151 (2%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 62  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     + T         + + 
Sbjct: 121 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIK-WT 177
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 13/159 (8%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISW-----PTRV--- 60
           L  L+HE++VK  G C E D  ++V+E+M  G L   L   G   +       PT +   
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 61  ---KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 117
               IA  +A G+ +L     + ++RDL   N L+  N   K+ DFG++RD  + D   V
Sbjct: 129 QMLHIAQQIAAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 186
Query: 118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
               +    +  PE +     T +SDV+S GVVL E+ +
Sbjct: 187 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/242 (26%), Positives = 117/242 (48%), Gaps = 33/242 (13%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PIS 55
            E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S
Sbjct: 99  NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
               +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D  
Sbjct: 159 LSKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
               + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ    
Sbjct: 217 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ---- 261
Query: 176 WADPFL-RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL 232
              P+    + +VLR +    GG   K +        L   C   +PK RPS +++++S+
Sbjct: 262 ---PYQGLSNEQVLRFVME--GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 316
Query: 233 EQ 234
           ++
Sbjct: 317 KE 318

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 81/152 (53%), Gaps = 3/152 (1%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q ++    + +A 
Sbjct: 305 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 364
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+R+L A N L+  N   K++DFGL+R   TGD           
Sbjct: 365 QISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFP 421
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + APE +A    + KSDV++FGV+L E+ +
Sbjct: 422 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 453

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 85/179 (47%), Gaps = 7/179 (3%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q EV    QL+H ++++L  Y  +S+   LV E    G +  +L +  V+P S       
Sbjct: 59  QNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHF 117
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LH     +++RDL  SN+LL  N N K++DFGLA         H +  + 
Sbjct: 118 MHQIITGMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LC 173
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDED--RGGLAEQTLVEWADP 179
           GT  Y +PE         +SDV+S G +   LL GR   D D  +  L +  L ++  P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP 232

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 85/151 (56%), Gaps = 4/151 (2%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 70  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 128
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     + T         + + 
Sbjct: 129 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WT 185
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 186 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 85/151 (56%), Gaps = 4/151 (2%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 68  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 126
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     + T         + + 
Sbjct: 127 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WT 183
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 184 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 85/151 (56%), Gaps = 4/151 (2%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 62  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     + T         + + 
Sbjct: 121 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WT 177
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 90/158 (56%), Gaps = 10/158 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N+++L G  + S   +++ EFM  G+L++ L R      +    V + 
Sbjct: 64  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGML 122
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRI 121
             +A G+ +L   + + ++RDL A N+L++SN   K+SDFGL+R  +  + D T+ S+  
Sbjct: 123 RGIASGMRYLA--EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSS-- 178
Query: 122 VGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +G +    + APE +A    T  SD +S+G+V+ E++S
Sbjct: 179 LGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 85/151 (56%), Gaps = 4/151 (2%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 71  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 129
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     + T         + + 
Sbjct: 130 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WT 186
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 187 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/170 (32%), Positives = 82/170 (48%), Gaps = 25/170 (14%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---------------- 51
           +LGQ  HEN+V L+G C+     L++ E+   G L N L RK                  
Sbjct: 90  HLGQ--HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGL 147
Query: 52  -----QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 106
                +P+     +  +  VA+G++FL     N I+RD+ A NVLL +   AK+ DFGLA
Sbjct: 148 DKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 205
Query: 107 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           RD     N  V         + APE +     T +SDV+S+G++L E+ S
Sbjct: 206 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 85/151 (56%), Gaps = 4/151 (2%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 63  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 121
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     + T         + + 
Sbjct: 122 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WT 178
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 179 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 85/151 (56%), Gaps = 4/151 (2%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 64  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 122
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     + T         + + 
Sbjct: 123 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WT 179
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 180 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 85/151 (56%), Gaps = 4/151 (2%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 62  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     + T         + + 
Sbjct: 121 GMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIK-WT 177
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 86/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S +    +V ++    SL +HL     +       + 
Sbjct: 51  FKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 108
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA        +H   ++
Sbjct: 109 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 85/156 (54%), Gaps = 6/156 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           +E   +GQ  H N+++L G  + S   +++ EFM  G+L++ L R      +    V + 
Sbjct: 66  SEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGML 124
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             +A G+ +L   + + ++RDL A N+L++SN   K+SDFGL+R      +    T  +G
Sbjct: 125 RGIASGMRYLA--EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182
Query: 124 TR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            +    + APE +A    T  SD +S+G+V+ E++S
Sbjct: 183 GKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 116/241 (48%), Gaps = 33/241 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQ------PISW 56
           E   + +    ++V+L+G  S+    L++ E M +G L+++L   R  ++      P S 
Sbjct: 65  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +++A ++A G+++L+      ++RDL A N  +  +F  K+ DFG+ RD    D   
Sbjct: 125 SKMIQMAGEIADGMAYLNA--NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
              + +    + +PE +  G  T  SDV+SFGVVL E+ +           LAEQ     
Sbjct: 183 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT-----------LAEQ----- 226
Query: 177 ADPFL-RDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSLE 233
             P+    + +VLR +    GG   K +        L   C   +PK RPS +++++S++
Sbjct: 227 --PYQGLSNEQVLRFVME--GGLLDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 282
Query: 234 Q 234
           +
Sbjct: 283 E 283

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 86/162 (53%), Gaps = 10/162 (6%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L   RH +++KL    S   +  +V E++  G L +++ + G   +      ++  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQ 123
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +  G+ + H     V++RDLK  NVLLD++ NAK++DFGL+     G+    S    G+
Sbjct: 124 QILSGVDYCHR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GS 178
Query: 125 RGYAAPEYVATGHLT--PKSDVYSFGVVLLELLSGRRALDED 164
             YAAPE V +G L   P+ D++S GV+L  LL G    D+D
Sbjct: 179 PNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD 219

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 78  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 135
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA        +H   ++
Sbjct: 136 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 193
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 194 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 36/236 (15%)
Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L+V E M  G L+++L           G  P +    +++A ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D      + +    +
Sbjct: 141 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 185
            APE +  G  T  SD++SFGVVL E+ S           LAEQ       P+  L + +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 240
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL-EQLHTS 238
            +  +MD   GG   + +        L   C   +PK RP+ ++++  L + LH S
Sbjct: 241 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 79  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 136
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA        +H   ++
Sbjct: 137 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 194
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 195 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 53  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 110
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA        +H   ++
Sbjct: 111 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 168
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 169 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 83/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +      S    +   ++ +  +E  L++    Q +S        
Sbjct: 91  EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFL 150
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+L+++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 151 YQILRGLKYIHS--ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXV 208
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 51  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 108
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA        +H   ++
Sbjct: 109 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 56  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 113
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA        +H   ++
Sbjct: 114 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 85/160 (53%), Gaps = 7/160 (4%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           ++ EV  L + RH N++  +GY S      +V ++    SL +HL     +       + 
Sbjct: 56  FKNEVGVLRKTRHVNILLFMGY-STKPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLID 113
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA        +H   ++
Sbjct: 114 IARQTAQGMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 171
Query: 122 VGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLELLSGR 158
            G+  + APE +      P   +SDVY+FG+VL EL++G+
Sbjct: 172 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 112/236 (47%), Gaps = 36/236 (15%)
Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L+V E M  G L+++L           G  P +    +++A ++A
Sbjct: 80  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 139
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D      + +    +
Sbjct: 140 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 185
            APE +  G  T  SD++SFGVVL E+ S           LAEQ       P+  L + +
Sbjct: 198 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 239
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL-EQLHTS 238
            +  +MD   GG   + +        L   C   +PK RP+ ++++  L + LH S
Sbjct: 240 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 292

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFL 134
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 135 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 79  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 138
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 139 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 196
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 131 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 36/236 (15%)
Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L+V E M  G L+++L           G  P +    +++A ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D      + +    +
Sbjct: 141 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 198
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 185
            APE +  G  T  SD++SFGVVL E+ S           LAEQ       P+  L + +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 240
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL-EQLHTS 238
            +  +MD   GG   + +        L   C   +P  RP+ ++++  L + LH S
Sbjct: 241 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 293

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 88/154 (57%), Gaps = 10/154 (6%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A  +A 
Sbjct: 58  MKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 116
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G++F+   + N I+R+L+A+N+L+    + K++DFGLAR     DN + +    G +   
Sbjct: 117 GMAFIE--ERNYIHRNLRAANILVSDTLSCKIADFGLAR--LIEDNEYTARE--GAKFPI 170
Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            + APE +  G  T KSDV+SFG++L E+++  R
Sbjct: 171 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 136 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 193
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 77  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 136
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 137 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 194
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 68  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 127
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 128 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 185
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 135 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 131 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 131 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 129 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 69  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 128
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 129 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 186
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 131 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 188
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 135 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 135 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 73  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 133 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 135 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYV 192
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 91  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 150
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 151 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 208
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 130
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 131 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYV 188
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 81/157 (51%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L   RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 133 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/153 (34%), Positives = 82/153 (53%), Gaps = 10/153 (6%)
Query: 24  CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 82
           C ++ +RL  V E++  G L  H+  + V     P  V  A +++ GL FLH     +IY
Sbjct: 88  CFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISIGLFFLH--KRGIIY 143
Query: 83  RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTRGYAAPEYVATGHLTPK 141
           RDLK  NV+LDS  + K++DFG+ ++        V+TR   GT  Y APE +A       
Sbjct: 144 RDLKLDNVMLDSEGHIKIADFGMCKEHMM---DGVTTREFCGTPDYIAPEIIAYQPYGKS 200
Query: 142 SDVYSFGVVLLELLSGRRALD-EDRGGLAEQTL 173
            D +++GV+L E+L+G+   D ED   L +  +
Sbjct: 201 VDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM 233

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 79/164 (48%), Gaps = 23/164 (14%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK---------------------GVQ 52
           HEN+V L+G C+ S    L++E+   G L N+L  K                      + 
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 53  PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
            +++   +  A  VA+G+ FL     + ++RDL A NVL+      K+ DFGLARD  + 
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 225
Query: 113 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            N  V         + APE +  G  T KSDV+S+G++L E+ S
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 81/157 (51%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L   RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 73  EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 132
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V
Sbjct: 133 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYV 190
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI----- 62
           YLG   H N+V L+G C+     L++ E+   G L N L RK    I   T   I     
Sbjct: 98  YLGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 155
Query: 63  -----------AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
                      +  VA+G++FL     N I+RDL A N+LL      K+ DFGLARD   
Sbjct: 156 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 213
Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             N  V         + APE +     T +SDV+S+G+ L EL S
Sbjct: 214 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI----- 62
           YLG   H N+V L+G C+     L++ E+   G L N L RK    I   T   I     
Sbjct: 105 YLGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 162
Query: 63  -----------AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
                      +  VA+G++FL     N I+RDL A N+LL      K+ DFGLARD   
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 220
Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             N  V         + APE +     T +SDV+S+G+ L EL S
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI----- 62
           YLG   H N+V L+G C+     L++ E+   G L N L RK    I   T   I     
Sbjct: 100 YLGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 157
Query: 63  -----------AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
                      +  VA+G++FL     N I+RDL A N+LL      K+ DFGLARD   
Sbjct: 158 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 215
Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             N  V         + APE +     T +SDV+S+G+ L EL S
Sbjct: 216 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T      V
Sbjct: 135 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 192
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 5/157 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIA 63
           E+  L + RHEN++ +           +   ++ +  +E  L++    Q +S        
Sbjct: 76  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 135
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIV 122
             + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T      V
Sbjct: 136 YQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXV 193
Query: 123 GTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
            TR Y APE +       KS D++S G +L E+LS R
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 76/165 (46%), Gaps = 20/165 (12%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI----- 62
           YLG   H N+V L+G C+     L++ E+   G L N L RK    I   T   I     
Sbjct: 82  YLGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 63  -----------AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
                      +  VA+G++FL     N I+RDL A N+LL      K+ DFGLARD   
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             N  V         + APE +     T +SDV+S+G+ L EL S
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 111/236 (47%), Gaps = 36/236 (15%)
Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L+V E M  G L+++L           G  P +    +++A ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            G+++L+      ++RDL A N ++  +F  K+ DFG+ RD           + +    +
Sbjct: 141 DGMAYLNA--KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRW 198
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 185
            APE +  G  T  SD++SFGVVL E+ S           LAEQ       P+  L + +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 240
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL-EQLHTS 238
            +  +MD   GG   + +        L   C   +PK RP+ ++++  L + LH S
Sbjct: 241 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 293

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN-HLFRKGVQPISWPTRVKIA 63
           E+  L QLRHENLV L+  C +     LV+EF+    L++  LF  G   + +    K  
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYL 130
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             +  G+ F H    N+I+RD+K  N+L+  +   KL DFG AR         V    V 
Sbjct: 131 FQIINGIGFCHS--HNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVA 186
Query: 124 TRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
           TR Y APE +       K+ DV++ G ++ E+  G 
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/95 (45%), Positives = 59/95 (62%), Gaps = 4/95 (4%)
Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTRIVGT 124
           + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T  V T
Sbjct: 153 ILRGLKYIHS--ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVAT 210
Query: 125 RGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
           R Y APE +       KS D++S G +L E+LS R
Sbjct: 211 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 6/146 (4%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 72
            H  L  +       +N   V E++  G L  H+  +             A ++  GL F
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQF 134
Query: 73  LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           LH     ++YRDLK  N+LLD + + K++DFG+ ++   GD    +    GT  Y APE 
Sbjct: 135 LHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYIAPEI 190
Query: 133 VATGHLTPKSDVYSFGVVLLELLSGR 158
           +         D +SFGV+L E+L G+
Sbjct: 191 LLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-----------FRKGVQP---ISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L           F     P   +S   
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 152 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKT 209
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 36/236 (15%)
Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L+V E M  G L+++L           G  P +    +++A ++A
Sbjct: 81  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 140
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            G+++L+      ++R+L A N ++  +F  K+ DFG+ RD    D      + +    +
Sbjct: 141 DGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 198
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 185
            APE +  G  T  SD++SFGVVL E+ S           LAEQ       P+  L + +
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 240
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL-EQLHTS 238
            +  +MD   GG   + +        L   C   +P  RP+ ++++  L + LH S
Sbjct: 241 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 293

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 111/236 (47%), Gaps = 36/236 (15%)
Query: 16  NLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISWPTRVKIAIDVA 67
           ++V+L+G  S+    L+V E M  G L+++L           G  P +    +++A ++A
Sbjct: 82  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 141
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            G+++L+      ++R+L A N ++  +F  K+ DFG+ RD    D      + +    +
Sbjct: 142 DGMAYLNA--KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF--LRDSR 185
            APE +  G  T  SD++SFGVVL E+ S           LAEQ       P+  L + +
Sbjct: 200 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----------LAEQ-------PYQGLSNEQ 241
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSL-EQLHTS 238
            +  +MD   GG   + +        L   C   +P  RP+ ++++  L + LH S
Sbjct: 242 VLKFVMD---GGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDDLHPS 294

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 7/153 (4%)
Query: 24  CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 82
           C ++ +RL  V E++  G L  H+  + V     P  V  A ++A GL FL      +IY
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIY 144
Query: 83  RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS 142
           RDLK  NV+LDS  + K++DFG+ ++      T  +    GT  Y APE +A        
Sbjct: 145 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSV 202
Query: 143 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
           D ++FGV+L E+L+G+   + +      Q+++E
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 26/178 (14%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK------------ 49
           +Q E   + +  + N+VKL+G C+      L++E+M  G L N   R             
Sbjct: 97  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHS 155
Query: 50  -----------GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA 98
                      G  P+S   ++ IA  VA G+++L   +   ++RDL   N L+  N   
Sbjct: 156 DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVV 213
Query: 99  KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           K++DFGL+R+  + D             +  PE +     T +SDV+++GVVL E+ S
Sbjct: 214 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 6/145 (4%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 73
           H  L  +       +N   V E++  G L  H+  +             A ++  GL FL
Sbjct: 77  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFL 134
Query: 74  HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 133
           H     ++YRDLK  N+LLD + + K++DFG+ ++   GD    +    GT  Y APE +
Sbjct: 135 HS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAPEIL 190
Query: 134 ATGHLTPKSDVYSFGVVLLELLSGR 158
                    D +SFGV+L E+L G+
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 7/153 (4%)
Query: 24  CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY 82
           C ++ +RL  V E++  G L  H+  + V     P  V  A ++A GL FL      +IY
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHI--QQVGRFKEPHAVFYAAEIAIGLFFLQS--KGIIY 465
Query: 83  RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKS 142
           RDLK  NV+LDS  + K++DFG+ ++      T  +    GT  Y APE +A        
Sbjct: 466 RDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSV 523
Query: 143 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
           D ++FGV+L E+L+G+   + +      Q+++E
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK---GVQPISWPTR---------- 59
           +H+N++ L+G C++     ++ E+  KG+L  +L  +   G++    P+           
Sbjct: 77  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 60  -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 137 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 53  KKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 110
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 169 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 159 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 159 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKT 216
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 85/162 (52%), Gaps = 10/162 (6%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L   RH +++KL    S   +  +V E++  G L +++ + G   +      ++  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQ 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     V++RDLK  NVLLD++ NAK++DFGL+     G+    S    G+
Sbjct: 119 QILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GS 173
Query: 125 RGYAAPEYVATGHLT--PKSDVYSFGVVLLELLSGRRALDED 164
             YAAPE V +G L   P+ D++S GV+L  LL G    D++
Sbjct: 174 PNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ EF+P GSL  +L +K  + I     
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKL 119
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 120 LQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 176
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK---GVQPISWPTR---------- 59
           +H+N++ L+G C++     ++ E+  KG+L  +L  +   G++    P+           
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 60  -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 152 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/172 (33%), Positives = 83/172 (48%), Gaps = 8/172 (4%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   R+   +  +  C ++ +RL  V EF+  G L  H+ +K  +      R   
Sbjct: 72  TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARF-Y 129
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           A ++   L FLH  D  +IYRDLK  NVLLD   + KL+DFG+ ++G    N   +    
Sbjct: 130 AAEIISALMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC--NGVTTATFC 185
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD-EDRGGLAEQTL 173
           GT  Y APE +      P  D ++ GV+L E+L G    + E+   L E  L
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 51  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 108
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 109 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 167 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 110
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 169 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 110
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 169 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/178 (31%), Positives = 97/178 (54%), Gaps = 11/178 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 67  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 127 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 179
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR  +    G +A   L+++
Sbjct: 180 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDY 237

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 110
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 169 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 116
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 117 LQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKV 173
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 110
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 169 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 110
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 169 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 205 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 262
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 53  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 110
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 169 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 75
            V  + Y  E+ + L LV   M  G L+ H++  G         V  A ++  GL  LH 
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH- 303
Query: 76  LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 135
               ++YRDLK  N+LLD + + ++SD GLA   P G    +  R VGT GY APE V  
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR-VGTVGYMAPEVVKN 359
Query: 136 GHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
              T   D ++ G +L E+++G+    + +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 75
            V  + Y  E+ + L LV   M  G L+ H++  G         V  A ++  GL  LH 
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH- 303
Query: 76  LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 135
               ++YRDLK  N+LLD + + ++SD GLA   P G    +  R VGT GY APE V  
Sbjct: 304 -RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGR-VGTVGYMAPEVVKN 359
Query: 136 GHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
              T   D ++ G +L E+++G+    + +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 62  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 120
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 121 LQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 177
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 178 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 86  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 146 LVSCTYQLARGMEYLAS--QKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKT 203
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 204 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 57  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 115
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 116 LQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 172
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 173 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 87/156 (55%), Gaps = 14/156 (8%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQP---ISWPTRV 60
           ++ +G L H ++V+L+G C  S  +L V +++P GSL +H+   R  + P   ++W    
Sbjct: 84  MLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNW---- 138
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
              + +A+G+ +L   +  +++R+L A NVLL S    +++DFG+A   P  D   + + 
Sbjct: 139 --GVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 194
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                 + A E +  G  T +SDV+S+GV + EL++
Sbjct: 195 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 56  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 114
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 115 LQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 171
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 172 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------FRKGVQPISWPTR------ 59
           +H+N++ L+G C++     ++ E+  KG+L  +L             P   P        
Sbjct: 81  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 60  -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 141 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 198
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 199 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 91  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 151 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 208
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 209 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------FRKGVQPISWPTR------ 59
           +H+N++ L+G C++     ++ E+  KG+L  +L             P   P        
Sbjct: 85  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 60  -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 145 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 202
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 203 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 65  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 123
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 124 LQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 180
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 181 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 89  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 147
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 148 LQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 204
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 205 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 159 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 83/150 (55%), Gaps = 8/150 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L ++ H  +VKL  Y  +++ +L L+ +F+  G L   L  K V       +  +A ++A
Sbjct: 80  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELA 136
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
             L  LH L   +IYRDLK  N+LLD   + KL+DFGL+++  + D+   +    GT  Y
Sbjct: 137 LALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEY 192
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            APE V     T  +D +SFGV++ E+L+G
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 116
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 117 LQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 173
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 119
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 120 LQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 176
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 116
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 117 LQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 173
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 174 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 64  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 122
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 123 LQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 179
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 180 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------FRKGVQPISWPTR------ 59
           +H+N++ L+G C++     ++ E+  KG+L  +L             P   P        
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 60  -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 152 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------FRKGVQPISWPTR------ 59
           +H+N++ L+G C++     ++ E+  KG+L  +L             P   P        
Sbjct: 92  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 60  -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 152 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 209
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 210 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 134
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 135 LQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 191
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 159 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 88  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 148 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 205
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 206 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 87/156 (55%), Gaps = 14/156 (8%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQP---ISWPTRV 60
           ++ +G L H ++V+L+G C  S  +L V +++P GSL +H+   R  + P   ++W    
Sbjct: 66  MLAIGSLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNW---- 120
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
              + +A+G+ +L   +  +++R+L A NVLL S    +++DFG+A   P  D   + + 
Sbjct: 121 --GVQIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE 176
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                 + A E +  G  T +SDV+S+GV + EL++
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------FRKGVQPISWPTR------ 59
           +H+N++ L+G C++     ++ E+  KG+L  +L             P   P        
Sbjct: 84  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 60  -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 144 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 201
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 202 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 63  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 121
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 122 LQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 178
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 179 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 159 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 7/163 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDE 163
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQ 209

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 9/155 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   L Q  H N+V+LIG C++     +V E +  G     L  +G + +   T +++  
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVG 220
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST---RI 121
           D A G+ +L       I+RDL A N L+      K+SDFG++R+    D  + ++   R 
Sbjct: 221 DAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQ 276
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           V  + + APE +  G  + +SDV+SFG++L E  S
Sbjct: 277 VPVK-WTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 76  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 134
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 135 LQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 191
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 192 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 83/150 (55%), Gaps = 8/150 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L ++ H  +VKL  Y  +++ +L L+ +F+  G L   L  K V       +  +A ++A
Sbjct: 80  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELA 136
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
             L  LH L   +IYRDLK  N+LLD   + KL+DFGL+++  + D+   +    GT  Y
Sbjct: 137 LALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEY 192
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            APE V     T  +D +SFGV++ E+L+G
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 75/165 (45%), Gaps = 20/165 (12%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI----- 62
           YLG   H N+V L+G C+     L++ E+   G L N L RK    I   T   I     
Sbjct: 105 YLGN--HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 162
Query: 63  -----------AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
                      +  VA+G++FL     N I+RDL A N+LL      K+ DFGLAR    
Sbjct: 163 LALDLEDLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKN 220
Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             N  V         + APE +     T +SDV+S+G+ L EL S
Sbjct: 221 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 159 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNT 216
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 83/150 (55%), Gaps = 8/150 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L ++ H  +VKL  Y  +++ +L L+ +F+  G L   L  K V       +  +A ++A
Sbjct: 81  LVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELA 137
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
             L  LH L   +IYRDLK  N+LLD   + KL+DFGL+++  + D+   +    GT  Y
Sbjct: 138 LALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCGTVEY 193
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            APE V     T  +D +SFGV++ E+L+G
Sbjct: 194 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 10/164 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  L   RH +++KL    S   +  +V E++  G L +++ + G   +      ++
Sbjct: 59  KREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRL 116
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +   + + H     V++RDLK  NVLLD++ NAK++DFGL+     G+    S    
Sbjct: 117 FQQILSAVDYCH--RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC--- 171
Query: 123 GTRGYAAPEYVATGHLT--PKSDVYSFGVVLLELLSGRRALDED 164
           G+  YAAPE V +G L   P+ D++S GV+L  LL G    D++
Sbjct: 172 GSPNYAAPE-VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           QTE     Q  +   +  +  C ++++RL  V E++  G L  H+ R+   P        
Sbjct: 68  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 127
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTR 120
             I +A  L++LH  +  +IYRDLK  NVLLDS  + KL+D+G+ ++G   GD T   + 
Sbjct: 128 AEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SX 180
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 162
             GT  Y APE +         D ++ GV++ E+++GR   D
Sbjct: 181 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           QTE     Q  +   +  +  C ++++RL  V E++  G L  H+ R+   P        
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 159
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTR 120
             I +A  L++LH  +  +IYRDLK  NVLLDS  + KL+D+G+ ++G   GD T   + 
Sbjct: 160 AEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---ST 212
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 162
             GT  Y APE +         D ++ GV++ E+++GR   D
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 53  KKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 110
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 111 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 168
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 169 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 82/172 (47%), Gaps = 7/172 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +      P   P   + 
Sbjct: 52  KKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPE--PDAQRF 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 110 FHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX 167
Query: 123 GTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           GT  Y APE +     H  P  DV+S G+VL  +L+G    D+      E +
Sbjct: 168 GTLPYVAPELLKRREFHAEP-VDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 218

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           QTE     Q  +   +  +  C ++++RL  V E++  G L  H+ R+   P        
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 116
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTR 120
             I +A  L++LH  +  +IYRDLK  NVLLDS  + KL+D+G+ ++G   GD T   + 
Sbjct: 117 AEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SX 169
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 162
             GT  Y APE +         D ++ GV++ E+++GR   D
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/164 (32%), Positives = 82/164 (50%), Gaps = 11/164 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+ YL  LRH +++KL    +   + ++V E+   G L +++  K         R   
Sbjct: 57  EREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQ 115
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            I  A      H     +++RDLK  N+LLD N N K++DFGL+     G+    S    
Sbjct: 116 QIICAIEYCHRH----KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC--- 168
Query: 123 GTRGYAAPEYVATGHLT--PKSDVYSFGVVLLELLSGRRALDED 164
           G+  YAAPE V  G L   P+ DV+S G+VL  +L GR   D++
Sbjct: 169 GSPNYAAPE-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------FRKGVQPISWPTR------ 59
           +H+N++ L+G C++     ++ E+  KG+L  +L             P   P        
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 60  -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D    +
Sbjct: 193 LVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV+L E+ +
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 85/190 (44%), Gaps = 15/190 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N+VKL           LV E+   G + ++L   G        R K   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     +++RDLKA N+LLD + N K++DFG + +   G+         G+
Sbjct: 122 QIVSAVQYCH--QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGS 176
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
             YAAPE +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR 
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRG 229
Query: 184 SRRVLRIMDT 193
             R+   M T
Sbjct: 230 KYRIPFYMST 239

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 9/162 (5%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           QTE     Q  +   +  +  C ++++RL  V E++  G L  H+ R+   P        
Sbjct: 53  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS 112
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDG-PTGDNTHVSTR 120
             I +A  L++LH  +  +IYRDLK  NVLLDS  + KL+D+G+ ++G   GD T   + 
Sbjct: 113 AEISLA--LNYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT---SX 165
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 162
             GT  Y APE +         D ++ GV++ E+++GR   D
Sbjct: 166 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 59  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 117
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+R+L   N+L+++    K+ DFGL +  P  D  +   
Sbjct: 118 LQYTSQICKGMEYLG--TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKV 174
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 175 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 77/156 (49%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   L Q  H N+V+LIG C++     +V E +  G     L  +G + +   T +++  
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVG 220
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           D A G+ +L       I+RDL A N L+      K+SDFG++R+   G    V     G 
Sbjct: 221 DAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG----VXAASGGL 274
Query: 125 R----GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R     + APE +  G  + +SDV+SFG++L E  S
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L HE LV+L G C++     ++ E+M  G L N+L R+          +++  DV   + 
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAME 119
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YA 128
           +L       ++RDL A N L++     K+SDFGL+R     D+ + S+R  G++    ++
Sbjct: 120 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSR--GSKFPVRWS 173
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
            PE +     + KSD+++FGV++ E+ S
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 15/190 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N+VKL           LV E+   G + ++L   G        R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     +++RDLKA N+LLD++ N K++DFG + +   G+         G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGS 175
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
             YAAPE +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRG 228
Query: 184 SRRVLRIMDT 193
             R+   M T
Sbjct: 229 KYRIPFYMST 238

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 15/190 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N+VKL           LV E+   G + ++L   G        R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     +++RDLKA N+LLD++ N K++DFG + +   G+         G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGS 175
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
             YAAPE +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRG 228
Query: 184 SRRVLRIMDT 193
             R+   M T
Sbjct: 229 KYRIPFYMST 238

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 52/150 (34%), Positives = 82/150 (54%), Gaps = 8/150 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L  + H  +VKL  Y  +++ +L L+ +F+  G L   L  K V       +  +A ++A
Sbjct: 84  LADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLA-ELA 140
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            GL  LH L   +IYRDLK  N+LLD   + KL+DFGL+++    D+   +    GT  Y
Sbjct: 141 LGLDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVEY 196
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            APE V     +  +D +S+GV++ E+L+G
Sbjct: 197 MAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P+G +   L  + +             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYIT 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 121 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   +++DFGLARD    D    +
Sbjct: 159 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKT 216
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 15/190 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N+VKL           LV E+   G + ++L   G        R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     +++RDLKA N+LLD++ N K++DFG + +   G+         G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGS 175
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
             YAAPE +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRG 228
Query: 184 SRRVLRIMDT 193
             R+   M T
Sbjct: 229 KYRIPFYMST 238

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 15/190 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N+VKL           LV E+   G + ++L   G        R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     +++RDLKA N+LLD++ N K++DFG + +   G+         G+
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGS 175
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
             YAAPE +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRG 228
Query: 184 SRRVLRIMDT 193
             R+   M T
Sbjct: 229 KYRIPFYMST 238

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L HE LV+L G C++     ++ E+M  G L N+L R+          +++  DV   + 
Sbjct: 56  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAME 114
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YA 128
           +L       ++RDL A N L++     K+SDFGL+R     D+ + S+  VG++    ++
Sbjct: 115 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWS 168
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
            PE +     + KSD+++FGV++ E+ S
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 86/190 (45%), Gaps = 15/190 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N+VKL           LV E+   G + ++L   G        R K   
Sbjct: 56  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMK-EKEARAKFR- 113
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     +++RDLKA N+LLD++ N K++DFG + +   G+         G+
Sbjct: 114 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGS 168
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
             YAAPE +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR 
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRG 221
Query: 184 SRRVLRIMDT 193
             R+   M T
Sbjct: 222 KYRIPFYMST 231

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L HE LV+L G C++     ++ E+M  G L N+L R+          +++  DV   + 
Sbjct: 60  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAME 118
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YA 128
           +L       ++RDL A N L++     K+SDFGL+R     D+ + S+  VG++    ++
Sbjct: 119 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWS 172
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
            PE +     + KSD+++FGV++ E+ S
Sbjct: 173 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L     Q +S     + A 
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTAT 116
Query: 65  ---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++A  LS+ H     VI+RD+K  N+LL SN   K++DFG +   P+       T +
Sbjct: 117 YITELANALSYCH--SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTL 170
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            GT  Y  PE +       K D++S GV+  E L G
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 73
           H +++ LI     S    LV++ M KG L ++L  K    +S      I   +   +SFL
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMRSLLEAVSFL 216
Query: 74  HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 133
           H    N+++RDLK  N+LLD N   +LSDFG +     G+       + GT GY APE +
Sbjct: 217 HA--NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEIL 271
Query: 134 ATGH------LTPKSDVYSFGVVLLELLSG 157
                        + D+++ GV+L  LL+G
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L HE LV+L G C++     ++ E+M  G L N+L R+          +++  DV   + 
Sbjct: 61  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAME 119
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YA 128
           +L       ++RDL A N L++     K+SDFGL+R     D+ + S+  VG++    ++
Sbjct: 120 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWS 173
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
            PE +     + KSD+++FGV++ E+ S
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 85/190 (44%), Gaps = 15/190 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N+VKL           LV E+   G + ++L   G        R K   
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFR- 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     +++RDLKA N+LLD++ N K++DFG + +   G+         G 
Sbjct: 121 QIVSAVQYCH--QKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGA 175
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
             YAAPE +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRG 228
Query: 184 SRRVLRIMDT 193
             R+   M T
Sbjct: 229 KYRIPFYMST 238

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L +L H N++KL     +S +  +V E    G L + + ++  +  S     +I  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIK 128
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRI 121
            V  G++++H    N+++RDLK  N+LL+S   + + K+ DFGL+       NT +  RI
Sbjct: 129 QVFSGITYMHK--HNIVHRDLKPENILLESKEKDCDIKIIDFGLS--TCFQQNTKMKDRI 184
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 85/174 (48%), Gaps = 8/174 (4%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V   S       
Sbjct: 200 TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFY 256
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++   L +LH  + NV+YRDLK  N++LD + + K++DFGL ++G   D   + T   
Sbjct: 257 GAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FC 313
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
           GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 314 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 367

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L HE LV+L G C++     ++ E+M  G L N+L R+          +++  DV   + 
Sbjct: 67  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAME 125
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YA 128
           +L       ++RDL A N L++     K+SDFGL+R     D+ + S+  VG++    ++
Sbjct: 126 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWS 179
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
            PE +     + KSD+++FGV++ E+ S
Sbjct: 180 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +   + I     
Sbjct: 61  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QAHAERIDHIKL 119
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P  D      
Sbjct: 120 LQYTSQICKGMEYLGT--KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEXXKV 176
Query: 120 RIVGTR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +  G     + APE +     +  SDV+SFGVVL EL +
Sbjct: 177 KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 109/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +L H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 98  EALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 156
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 157 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 271
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 272 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 311
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 312 ERIEYCTQDPDVINTALPIE 331

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 85/174 (48%), Gaps = 8/174 (4%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V   S       
Sbjct: 197 TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFY 253
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++   L +LH  + NV+YRDLK  N++LD + + K++DFGL ++G   D   + T   
Sbjct: 254 GAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FC 310
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
           GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 311 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L +L H N++KL     +S +  +V E    G L + + ++  +  S     +I  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIK 128
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRI 121
            V  G++++H    N+++RDLK  N+LL+S   + + K+ DFGL+       NT +  RI
Sbjct: 129 QVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS--TCFQQNTKMKDRI 184
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--PISWPTRV 60
           + E+ YL  LRH +++KL       D  ++V E+       N LF   VQ   +S     
Sbjct: 62  EREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEAR 116
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           +    +   + + H     +++RDLK  N+LLD + N K++DFGL+     G+    S  
Sbjct: 117 RFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC- 173
Query: 121 IVGTRGYAAPEYVATGHLT--PKSDVYSFGVVLLELLSGRRALDED 164
             G+  YAAPE V +G L   P+ DV+S GV+L  +L  R   D++
Sbjct: 174 --GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--PISWPTRV 60
           + E+ YL  LRH +++KL       D  ++V E+       N LF   VQ   +S     
Sbjct: 52  EREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEAR 106
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           +    +   + + H     +++RDLK  N+LLD + N K++DFGL+     G+    S  
Sbjct: 107 RFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC- 163
Query: 121 IVGTRGYAAPEYVATGHLT--PKSDVYSFGVVLLELLSGRRALDED 164
             G+  YAAPE V +G L   P+ DV+S GV+L  +L  R   D++
Sbjct: 164 --GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L  K  + I    
Sbjct: 58  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KEAKRIPEEI 115
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
             K++I V RGL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 116 LGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 170
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y APE +   H + +SD++S G+ L+EL  GR
Sbjct: 171 NSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGR 210

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 79/148 (53%), Gaps = 10/148 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L HE LV+L G C++     ++ E+M  G L N+L R+          +++  DV   + 
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAME 134
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YA 128
           +L       ++RDL A N L++     K+SDFGL+R     D+ + S+  VG++    ++
Sbjct: 135 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSS--VGSKFPVRWS 188
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
            PE +     + KSD+++FGV++ E+ S
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 116
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+   T +S    GT
Sbjct: 117 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GT 170
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 83/156 (53%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L +L H N++KL     +S +  +V E    G L + + ++  +  S     +I  
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIK 128
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRI 121
            V  G++++H    N+++RDLK  N+LL+S   + + K+ DFGL+       NT +  RI
Sbjct: 129 QVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS--TCFQQNTKMKDRI 184
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 185 -GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 108/256 (42%), Gaps = 42/256 (16%)
Query: 5   EVIYLGQLRHENLVKLIGYC--SESDNRL----LVYEFMPKGSLENHLF--RKGVQPISW 56
           E   + +  H ++ KL+G    S +  RL    ++  FM  G L   L   R G  P + 
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 57  P--TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
           P  T V+  +D+A G+ +L     N I+RDL A N +L  +    ++DFGL+R   +GD 
Sbjct: 135 PLQTLVRFMVDIACGMEYLSS--RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192
Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
                       + A E +A    T  SDV++FGV + E+++          G      +
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT---------RGQTPYAGI 243
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXX---XLQCLHMDPKNRPSMV----- 226
           E A+           I +  +GG   K+  +          QC   DPK RPS       
Sbjct: 244 ENAE-----------IYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
Query: 227 --DVLTSLEQLHTSKD 240
             ++L  L  L TS+D
Sbjct: 293 LENILGHLSVLSTSQD 308

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/260 (26%), Positives = 109/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +L H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 84  EALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 142
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 143 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 200
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 257
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 297
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 298 ERIEYCTQDPDVINTALPIE 317

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/187 (32%), Positives = 85/187 (45%), Gaps = 24/187 (12%)
Query: 52  QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
           +PI+    +  +  VARG+ FL       I+RDL A N+LL  N   K+ DFGLARD   
Sbjct: 194 EPITMEDLISYSFQVARGMEFLSS--RKCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 112 GDNTHVSTRIVGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 168
             +     R   TR    + APE +     + KSDV+S+GV+L E+ S         GG 
Sbjct: 252 NPDY---VRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS--------LGG- 299
Query: 169 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDV 228
           +    V+  + F    R  +R+       +YS  E        L C H DPK RP   ++
Sbjct: 300 SPYPGVQMDEDFCSRLREGMRMR----APEYSTPEI---YQIMLDCWHRDPKERPRFAEL 352
Query: 229 LTSLEQL 235
           +  L  L
Sbjct: 353 VEKLGDL 359

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--PISWPTRV 60
           + E+ YL  LRH +++KL       D  ++V E+       N LF   VQ   +S     
Sbjct: 61  EREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEAR 115
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           +    +   + + H     +++RDLK  N+LLD + N K++DFGL+     G+    S  
Sbjct: 116 RFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC- 172
Query: 121 IVGTRGYAAPEYVATGHLT--PKSDVYSFGVVLLELLSGRRALDED 164
             G+  YAAPE V +G L   P+ DV+S GV+L  +L  R   D++
Sbjct: 173 --GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 15/166 (9%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--PISWPTRV 60
           + E+ YL  LRH +++KL       D  ++V E+       N LF   VQ   +S     
Sbjct: 56  EREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAG-----NELFDYIVQRDKMSEQEAR 110
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           +    +   + + H     +++RDLK  N+LLD + N K++DFGL+     G+    S  
Sbjct: 111 RFFQQIISAVEYCH--RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC- 167
Query: 121 IVGTRGYAAPEYVATGHLT--PKSDVYSFGVVLLELLSGRRALDED 164
             G+  YAAPE V +G L   P+ DV+S GV+L  +L  R   D++
Sbjct: 168 --GSPNYAAPE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 116 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELCGT 169
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 85/190 (44%), Gaps = 15/190 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N+VKL           L+ E+   G + ++L   G        R K   
Sbjct: 61  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFR- 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     +++RDLKA N+LLD++ N K++DFG + +   G          G+
Sbjct: 119 QIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGS 173
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
             YAAPE +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR 
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRG 226
Query: 184 SRRVLRIMDT 193
             R+   M T
Sbjct: 227 KYRIPFYMST 236

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 11/160 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNR-----LLVYEFMPKGSLENHLF----RKGVQPI 54
           +E   +    H N+++L+G C E  ++     +++  FM  G L  +L       G + I
Sbjct: 85  SEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHI 144
Query: 55  SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
              T +K  +D+A G+ +L   + N ++RDL A N +L  +    ++DFGL++   +GD 
Sbjct: 145 PLQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY 202
Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
                       + A E +A    T KSDV++FGV + E+
Sbjct: 203 YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 51/155 (32%), Positives = 84/155 (54%), Gaps = 9/155 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ-PISWPTRVKIA 63
           E   + QL +  +V+LIG C +++  +LV E    G L   L  K  + P+S     ++ 
Sbjct: 60  EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELL 116
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             V+ G+ +L   + N ++RDL A NVLL +   AK+SDFGL++     D+++ + R  G
Sbjct: 117 HQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAG 173
Query: 124 TR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
                + APE +     + +SDV+S+GV + E LS
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 141
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 142 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 195
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 75  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 132
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 133 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 186
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 187 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 220

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 84/190 (44%), Gaps = 15/190 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N+VKL           L+ E+   G + ++L   G        R K   
Sbjct: 64  EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFR- 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +   + + H     +++RDLKA N+LLD++ N K++DFG + +   G          G 
Sbjct: 122 QIVSAVQYCH--QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGA 176
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
             YAAPE +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR 
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRG 229
Query: 184 SRRVLRIMDT 193
             R+   M T
Sbjct: 230 KYRIPFYMST 239

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++  +  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 159 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 121 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 119 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 172
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E   + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELV 117
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIV 122
             V+ G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T   
Sbjct: 118 HQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGK 175
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
               + APE +     + KSDV+SFGV++ E  S
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 121 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 174
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 116
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+   T     + GT
Sbjct: 117 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGT 170
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L HE LV+L G C++     ++ E+M  G L N+L R+          +++  DV   + 
Sbjct: 76  LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAME 134
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG---YA 128
           +L       ++RDL A N L++     K+SDFGL+R     D+   S+  VG++    ++
Sbjct: 135 YLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEETSS--VGSKFPVRWS 188
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLS 156
            PE +     + KSD+++FGV++ E+ S
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 6/151 (3%)
Query: 7   IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + L  ++H  LV L      +D    V +++  G L  HL R+       P     A ++
Sbjct: 91  VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC--FLEPRARFYAAEI 148
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           A  L +LH L  N++YRDLK  N+LLDS  +  L+DFGL ++    ++T  ++   GT  
Sbjct: 149 ASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPE 204
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y APE +         D +  G VL E+L G
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GLSF H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 111 QLLQGLSFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 166
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+   T     + GT
Sbjct: 116 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGT 169
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 82/149 (55%), Gaps = 6/149 (4%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++   V+ 
Sbjct: 72  MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSM 128
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGY 127
           G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T       +
Sbjct: 129 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            APE +     + KSDV+SFGV++ E  S
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 116 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 169
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+   T     + GT
Sbjct: 121 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGT 174
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V   S       
Sbjct: 59  TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFY 115
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++   L +LH  + NV+YRDLK  N++LD + + K++DFGL ++G     T       
Sbjct: 116 GAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFC 172
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
           GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 173 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 226

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 57  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 114
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 115 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 168
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 169 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 119 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 172
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 116 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLCGT 169
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E   + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++ 
Sbjct: 75  AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELV 131
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIV 122
             V+ G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T   
Sbjct: 132 HQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 189
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
               + APE +     + KSDV+SFGV++ E  S
Sbjct: 190 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 82/149 (55%), Gaps = 6/149 (4%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++   V+ 
Sbjct: 82  MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSM 138
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGY 127
           G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T       +
Sbjct: 139 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            APE +     + KSDV+SFGV++ E  S
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 82/149 (55%), Gaps = 6/149 (4%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++   V+ 
Sbjct: 82  MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSM 138
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGY 127
           G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T       +
Sbjct: 139 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 196
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            APE +     + KSDV+SFGV++ E  S
Sbjct: 197 YAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 119
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 120 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 173
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 174 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E   + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++ 
Sbjct: 61  AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELV 117
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIV 122
             V+ G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T   
Sbjct: 118 HQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 175
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
               + APE +     + KSDV+SFGV++ E  S
Sbjct: 176 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E   + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++ 
Sbjct: 55  AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELV 111
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIV 122
             V+ G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T   
Sbjct: 112 HQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 169
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
               + APE +     + KSDV+SFGV++ E  S
Sbjct: 170 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V   S       
Sbjct: 57  TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFY 113
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++   L +LH  + NV+YRDLK  N++LD + + K++DFGL ++G     T       
Sbjct: 114 GAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFC 170
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
           GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 171 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 224

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+   T     + GT
Sbjct: 116 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD----LCGT 169
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP-SQPSSLAMLD 156
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 157 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 271
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 272 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 311
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 312 ERIEYCTQDPDVINTALPIE 331

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 98  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 156
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 157 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 214
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 215 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 271
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 272 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 311
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 312 ERIEYCTQDPDVINTALPIE 331

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 82/149 (55%), Gaps = 6/149 (4%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++   V+ 
Sbjct: 62  MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSM 118
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGY 127
           G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T       +
Sbjct: 119 GMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            APE +     + KSDV+SFGV++ E  S
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E   + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++ 
Sbjct: 419 AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELV 475
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIV 122
             V+ G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T   
Sbjct: 476 HQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
               + APE +     + KSDV+SFGV++ E  S
Sbjct: 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 55  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 112
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+       T + GT
Sbjct: 113 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGT 166
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 167 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 83/154 (53%), Gaps = 6/154 (3%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E   + QL +  +V++IG C E+++ +LV E    G L  +L +   + +     +++ 
Sbjct: 420 AEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELV 476
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIV 122
             V+ G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T   
Sbjct: 477 HQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 534
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
               + APE +     + KSDV+SFGV++ E  S
Sbjct: 535 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++  +  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D    +
Sbjct: 159 LVSCTYQLARGMEYLAS--QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           T       + APE +     T +SDV+SFGV++ E+ +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 90  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 148
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 149 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 206
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 207 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 263
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 264 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 303
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 304 ERIEYCTQDPDVINTALPIE 323

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/174 (32%), Positives = 83/174 (47%), Gaps = 8/174 (4%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V   S       
Sbjct: 58  TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFY 114
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++   L +LH  + NV+YRDLK  N++LD + + K++DFGL ++G     T       
Sbjct: 115 GAEIVSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFC 171
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
           GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 225

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 141
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 142 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 256
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 257 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 296
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 297 ERIEYCTQDPDVINTALPIE 316

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 100 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 158
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 159 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 216
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 217 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 273
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 274 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 313
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 314 ERIEYCTQDPDVINTALPIE 333

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 75  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 134
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 135 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 187
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 75  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 133
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 134 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 191
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 192 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 248
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 249 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 288
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 289 ERIEYCTQDPDVINTALPIE 308

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRP-SQPSSLAMLD 141
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 142 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 199
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 256
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 257 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 296
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 297 ERIEYCTQDPDVINTALPIE 316

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 110 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 169
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 170 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 222
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 223 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 84  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 142
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 143 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 200
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 257
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 297
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 298 ERIEYCTQDPDVINTALPIE 317

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 110 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 168
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 169 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY 226
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 227 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 283
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 284 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 323
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 324 ERIEYCTQDPDVINTALPIE 343

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 101 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 159
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 160 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 217
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 218 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 274
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 275 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 314
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 315 ERIEYCTQDPDVINTALPIE 334

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 100/227 (44%), Gaps = 25/227 (11%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L Q     + +  G   +S    ++ E++  GS  + L + G  P+       I
Sbjct: 65  QQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPG--PLEETYIATI 121
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++ +GL +LH      I+RD+KA+NVLL    + KL+DFG+A  G   D        V
Sbjct: 122 LREILKGLDYLHS--ERKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNXFV 177
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  + APE +       K+D++S G+  +EL  G    + D   +    L+    P   
Sbjct: 178 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP-NSDLHPMRVLFLIPKNSP--- 233
Query: 183 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
                       L GQ+SK   +        CL+ DP+ RP+  ++L
Sbjct: 234 ----------PTLEGQHSKPFKEFVEA----CLNKDPRFRPTAKELL 266

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 182
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD       
Sbjct: 183 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 297
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 298 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 337
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 338 ERIEYCTQDPDVINTALPIE 357

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 95/194 (48%), Gaps = 22/194 (11%)
Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 75
            +  + Y   + ++L  + + M  G L  HL + GV   S       A ++  GL  +H 
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMH- 309
Query: 76  LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 135
            +  V+YRDLK +N+LLD + + ++SD GLA D  +    H S   VGT GY APE +  
Sbjct: 310 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMAPEVLQK 364
Query: 136 G-HLTPKSDVYSFGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFLRDSRRV 187
           G      +D +S G +L +LL G    R+   +D+  +   TL   VE  D F  + R +
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 188 L-----RIMDTRLG 196
           L     R ++ RLG
Sbjct: 425 LEGLLQRDVNRRLG 438

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 95/194 (48%), Gaps = 22/194 (11%)
Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 75
            +  + Y   + ++L  + + M  G L  HL + GV   S       A ++  GL  +H 
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMH- 309
Query: 76  LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 135
            +  V+YRDLK +N+LLD + + ++SD GLA D  +    H S   VGT GY APE +  
Sbjct: 310 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMAPEVLQK 364
Query: 136 G-HLTPKSDVYSFGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFLRDSRRV 187
           G      +D +S G +L +LL G    R+   +D+  +   TL   VE  D F  + R +
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 188 L-----RIMDTRLG 196
           L     R ++ RLG
Sbjct: 425 LEGLLQRDVNRRLG 438

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 108 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 160
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 105/244 (43%), Gaps = 34/244 (13%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPT------ 58
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + + T      
Sbjct: 85  LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYK 142
Query: 59  -------RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
                   +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD   
Sbjct: 143 DFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIXK 200
Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 171
             +            + APE +     T +SDV+SFGV+L E+ S          G +  
Sbjct: 201 DPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPY 251
Query: 172 TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTS 231
             V+  + F R  +   R+        Y+  E        L C H +P  RP+  +++  
Sbjct: 252 PGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEH 304
Query: 232 LEQL 235
           L  L
Sbjct: 305 LGNL 308

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 51  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 110
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D   ++
Sbjct: 111 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MA 163
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 164 NEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  +S    L+ E+ P G++   L  + +             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 116 ELANALSYCHS--KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGT 169
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P+G +   L  + +             
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYIT 120
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 121 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGT 174
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 175 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L     Q +S     + A 
Sbjct: 62  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTAT 116
Query: 65  ---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++A  LS+ H     VI+RD+K  N+LL SN   K++DFG +   P+         +
Sbjct: 117 YITELANALSYCHS--KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTL 170
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            GT  Y  PE +       K D++S GV+  E L G
Sbjct: 171 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG 206

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 108 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 160
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 165
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 166
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 165
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 114
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 115 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 170
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 117
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 118 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 173
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 174 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 108 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 160
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 166
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 165
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 95/194 (48%), Gaps = 22/194 (11%)
Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 75
            +  + Y   + ++L  + + M  G L  HL + GV   S       A ++  GL  +H 
Sbjct: 253 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMH- 309
Query: 76  LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 135
            +  V+YRDLK +N+LLD + + ++SD GLA D  +    H S   VGT GY APE +  
Sbjct: 310 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMAPEVLQK 364
Query: 136 G-HLTPKSDVYSFGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFLRDSRRV 187
           G      +D +S G +L +LL G    R+   +D+  +   TL   VE  D F  + R +
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 188 L-----RIMDTRLG 196
           L     R ++ RLG
Sbjct: 425 LEGLLQRDVNRRLG 438

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 166
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 28/238 (11%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           + +E + +  L H ++VKLIG   E    +++ E  P G L  H   +    +   T V 
Sbjct: 72  FMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGEL-GHYLERNKNSLKVLTLVL 129
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            ++ + + +++L  +  N ++RD+   N+L+ S    KL DFGL+R     D    S   
Sbjct: 130 YSLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 187
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +  + + +PE +     T  SDV+ F V + E+LS G++                    F
Sbjct: 188 LPIK-WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF------------------F 228
Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSLEQLH 236
             +++ V+ +++   G +  K +        L  +C   DP +RP   +++ SL  ++
Sbjct: 229 WLENKDVIGVLEK--GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 284

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 95/194 (48%), Gaps = 22/194 (11%)
Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG 75
            +  + Y   + ++L  + + M  G L  HL + GV   S       A ++  GL  +H 
Sbjct: 252 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMH- 308
Query: 76  LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT 135
            +  V+YRDLK +N+LLD + + ++SD GLA D  +    H S   VGT GY APE +  
Sbjct: 309 -NRFVVYRDLKPANILLDEHGHVRISDLGLACDF-SKKKPHAS---VGTHGYMAPEVLQK 363
Query: 136 G-HLTPKSDVYSFGVVLLELLSG----RRALDEDRGGLAEQTL---VEWADPFLRDSRRV 187
           G      +D +S G +L +LL G    R+   +D+  +   TL   VE  D F  + R +
Sbjct: 364 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 423
Query: 188 L-----RIMDTRLG 196
           L     R ++ RLG
Sbjct: 424 LEGLLQRDVNRRLG 437

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 68.9 bits (167), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 28/238 (11%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           + +E + +  L H ++VKLIG   E    +++ E  P G L  H   +    +   T V 
Sbjct: 60  FMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGEL-GHYLERNKNSLKVLTLVL 117
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            ++ + + +++L  +  N ++RD+   N+L+ S    KL DFGL+R     D    S   
Sbjct: 118 YSLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 175
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +  + + +PE +     T  SDV+ F V + E+LS G++                    F
Sbjct: 176 LPIK-WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF------------------F 216
Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSLEQLH 236
             +++ V+ +++   G +  K +        L  +C   DP +RP   +++ SL  ++
Sbjct: 217 WLENKDVIGVLEK--GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 111
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 112 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 167
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 108 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 160
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSE--SDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + ++I   Q+ HE N   ++G+     SD  + +  E M  GSL+  L + G  P     
Sbjct: 48  RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG 107
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +V IA  V +GL++L      +++RD+K SN+L++S    KL DFG++  G   D+  ++
Sbjct: 108 KVSIA--VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MA 160
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              VGTR Y +PE +   H + +SD++S G+ L+E+  GR
Sbjct: 161 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 107/238 (44%), Gaps = 28/238 (11%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           + +E + +  L H ++VKLIG   E    +++ E  P G L  H   +    +   T V 
Sbjct: 56  FMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGEL-GHYLERNKNSLKVLTLVL 113
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            ++ + + +++L  +  N ++RD+   N+L+ S    KL DFGL+R     D    S   
Sbjct: 114 YSLQICKAMAYLESI--NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTR 171
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +  + + +PE +     T  SDV+ F V + E+LS G++                    F
Sbjct: 172 LPIK-WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF------------------F 212
Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXL--QCLHMDPKNRPSMVDVLTSLEQLH 236
             +++ V+ +++   G +  K +        L  +C   DP +RP   +++ SL  ++
Sbjct: 213 WLENKDVIGVLEK--GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 268

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 166
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 14/188 (7%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  L +++H N+V L        +  L+ + +  G L + +  KG       +R  +
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--L 121
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVL---LDSNFNAKLSDFGLARDGPTGDNTHVST 119
              V   + +LH  D  +++RDLK  N+L   LD +    +SDFGL++     D   V +
Sbjct: 122 IFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTL---VE 175
              GT GY APE +A    +   D +S GV+   LL G     DE+   L EQ L    E
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 176 WADPFLRD 183
           +  P+  D
Sbjct: 237 FDSPYWDD 244

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R + 
Sbjct: 57  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 112
Query: 63  -AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L +LH  D  V+YRD+K  N++LD + + K++DFGL ++G   D   + T  
Sbjct: 113 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-F 168
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
            GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 169 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 223

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 59  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 117
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 118 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 173
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 174 LWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R + 
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 109
Query: 63  -AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L +LH  D  V+YRD+K  N++LD + + K++DFGL ++G   D   + T  
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-F 165
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
            GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 117
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K+++FG +   P+       T + GT
Sbjct: 118 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGT 171
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 11/175 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R + 
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 109
Query: 63  -AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L +LH  D  V+YRD+K  N++LD + + K++DFGL ++G   D   + T  
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-F 165
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
            GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 90/166 (54%), Gaps = 10/166 (6%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ-PISWPTRVKIA 63
           E   + QL +  +V+LIG C +++  +LV E    G L   L  K  + P+S     ++ 
Sbjct: 386 EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELL 442
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             V+ G+ +L   + N ++R+L A NVLL +   AK+SDFGL++     D+++ + R  G
Sbjct: 443 HQVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAG 499
Query: 124 TR--GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRG 166
                + APE +     + +SDV+S+GV + E LS G++   + +G
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 14/188 (7%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  L +++H N+V L        +  L+ + +  G L + +  KG       +R  +
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--L 121
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVL---LDSNFNAKLSDFGLARDGPTGDNTHVST 119
              V   + +LH  D  +++RDLK  N+L   LD +    +SDFGL++     D   V +
Sbjct: 122 IFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTL---VE 175
              GT GY APE +A    +   D +S GV+   LL G     DE+   L EQ L    E
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 176 WADPFLRD 183
           +  P+  D
Sbjct: 237 FDSPYWDD 244

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 60  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 117
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 118 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 171
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 172 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L H N+VKL           LV E+   G + ++L   G +      R K    +   + 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHG-RXKEKEARAKFR-QIVSAVQ 127
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 131
           + H     +++RDLKA N+LLD++ N K++DFG + +   G+         G   YAAPE
Sbjct: 128 YCH--QKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPE 182
Query: 132 -YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
            +    +  P+ DV+S GV+L  L+SG    D        Q L E  +  LR   R+
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-------GQNLKELRERVLRGKYRI 232

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K+++FG +   P+       T + GT
Sbjct: 119 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGT 172
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 119 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 172
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTR 59
           H N++ L+G C       L  E+ P G+L + L +  V                +S    
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A DVARG+ +L       I+RDL A N+L+  N+ AK++DFGL+R    G   +V  
Sbjct: 145 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 198
Query: 120 RI--VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            +  +  R + A E +     T  SDV+S+GV+L E++S
Sbjct: 199 TMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 14/188 (7%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  L +++H N+V L        +  L+ + +  G L + +  KG       +R  +
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--L 121
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVL---LDSNFNAKLSDFGLARDGPTGDNTHVST 119
              V   + +LH  D  +++RDLK  N+L   LD +    +SDFGL++     D   V +
Sbjct: 122 IFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTL---VE 175
              GT GY APE +A    +   D +S GV+   LL G     DE+   L EQ L    E
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 176 WADPFLRD 183
           +  P+  D
Sbjct: 237 FDSPYWDD 244

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 84/175 (48%), Gaps = 11/175 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R + 
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 109
Query: 63  -AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L +LH  D  V+YRD+K  N++LD + + K++DFGL ++G +   T      
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
            GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 87/188 (46%), Gaps = 14/188 (7%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  L +++H N+V L        +  L+ + +  G L + +  KG       +R  +
Sbjct: 64  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASR--L 121
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVL---LDSNFNAKLSDFGLARDGPTGDNTHVST 119
              V   + +LH  D  +++RDLK  N+L   LD +    +SDFGL++     D   V +
Sbjct: 122 IFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 176
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTL---VE 175
              GT GY APE +A    +   D +S GV+   LL G     DE+   L EQ L    E
Sbjct: 177 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 236
Query: 176 WADPFLRD 183
           +  P+  D
Sbjct: 237 FDSPYWDD 244

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 116 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGT 169
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 84  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 141
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 142 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGT 195
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 196 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 229

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 108/260 (41%), Gaps = 41/260 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L     +P S P+ +    
Sbjct: 84  EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRP-SQPSSLAMLD 142
Query: 62  ---IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+A+D       
Sbjct: 143 LLHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYY 200
Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                 +    +  PE    G  T K+D +SFGV+L E+ S        +   + Q ++E
Sbjct: 201 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 257
Query: 176 WA------DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +       DP       V RIM                     QC    P++RP+   +L
Sbjct: 258 FVTSGGRMDPPKNCPGPVYRIMT--------------------QCWQHQPEDRPNFAIIL 297
Query: 230 TSLEQLHTSKDMPRTPPPAK 249
             +E      D+  T  P +
Sbjct: 298 ERIEYCTQDPDVINTALPIE 317

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E+MP G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     K++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 104/243 (42%), Gaps = 33/243 (13%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 86  LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKD 143
Query: 60  -------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
                  +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD    
Sbjct: 144 FLTLEHLIXYSFQVAKGMEFLAS--RKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 113 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
            +            + APE +     T +SDV+SFGV+L E+ S          G +   
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYP 252
Query: 173 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSL 232
            V+  + F R  +   R+        Y+  E        L C H +P  RP+  +++  L
Sbjct: 253 GVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHL 305
Query: 233 EQL 235
             L
Sbjct: 306 GNL 308

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/144 (33%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E+MP G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     K++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 84/175 (48%), Gaps = 11/175 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R + 
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 109
Query: 63  -AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L +LH  D  V+YRD+K  N++LD + + K++DFGL ++G +   T      
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
            GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 58  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 115
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 116 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLCGT 169
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 170 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 84/175 (48%), Gaps = 11/175 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R + 
Sbjct: 54  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 109
Query: 63  -AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L +LH  D  V+YRD+K  N++LD + + K++DFGL ++G +   T      
Sbjct: 110 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 165
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
            GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 220

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTR 59
           H N++ L+G C       L  E+ P G+L + L +  V                +S    
Sbjct: 75  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A DVARG+ +L       I+RDL A N+L+  N+ AK++DFGL+R    G   +V  
Sbjct: 135 LHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKK 188
Query: 120 RI--VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            +  +  R + A E +     T  SDV+S+GV+L E++S
Sbjct: 189 TMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/175 (32%), Positives = 84/175 (48%), Gaps = 11/175 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           TE   L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R + 
Sbjct: 59  TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFT---EERARF 114
Query: 63  -AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L +LH  D  V+YRD+K  N++LD + + K++DFGL ++G +   T      
Sbjct: 115 YGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXF 170
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVE 175
            GT  Y APE +         D +  GVV+ E++ GR    ++D   L E  L+E
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME 225

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           +V E++   +L + +  +G  P++    +++  D  + L+F H     +I+RD+K +N+L
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIL 148
Query: 92  LDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 150
           + +    K+ DFG+AR    +G++   +  ++GT  Y +PE      +  +SDVYS G V
Sbjct: 149 ISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 151 LLELLSG 157
           L E+L+G
Sbjct: 209 LYEVLTG 215

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 119 ELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALCGT 172
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 116
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 117 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGT 170
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 5   EVIYLGQLRHENLVKLIGY----CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           E+  L   +HEN++ +         E+ N + + + + +  L   +     Q +S     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQ 115
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVS 118
                  R +  LHG  +NVI+RDLK SN+L++SN + K+ DFGLAR  D    DN+  +
Sbjct: 116 YFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 119 ------TRIVGTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
                 T  V TR Y APE + T     ++ DV+S G +L EL   R
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/167 (31%), Positives = 81/167 (48%), Gaps = 18/167 (10%)
Query: 5   EVIYLGQLRHENLVKLIGY----CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           E+  L   +HEN++ +         E+ N + + + + +  L   +     Q +S     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQ 115
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVS 118
                  R +  LHG  +NVI+RDLK SN+L++SN + K+ DFGLAR  D    DN+  +
Sbjct: 116 YFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 119 ------TRIVGTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
                 T  V TR Y APE + T     ++ DV+S G +L EL   R
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 84  LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 60  ---------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
                    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIX 199
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              +            + APE +     T +SDV+SFGV+L E+ S          G + 
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASP 250
Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPS---MVD 227
              V+  + F R  +   R+        Y+  E        L C H +P  RP+   +V+
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVE 303
Query: 228 VLTSLEQLHTSKD 240
            L +L Q +  +D
Sbjct: 304 HLGNLLQANAQQD 316

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 112/259 (43%), Gaps = 43/259 (16%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-KGVQP--------- 53
           +E   L Q+ H +++KL G CS+    LL+ E+   GSL   L   + V P         
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 54  ------------ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 101
                       ++    +  A  +++G+ +L   + ++++RDL A N+L+      K+S
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMSLVHRDLAARNILVAEGRKMKIS 192
Query: 102 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
           DFGL+RD    D+    ++      + A E +     T +SDV+SFGV+L E+++     
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----- 247
Query: 162 DEDRGGLAEQTLVEWADPFLR-DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPK 220
               GG          +P+      R+  ++ T    +     ++      LQC   +P 
Sbjct: 248 ---LGG----------NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPD 294
Query: 221 NRPSMVDVLTSLEQLHTSK 239
            RP   D+   LE++   +
Sbjct: 295 KRPVFADISKDLEKMMVKR 313

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 81/158 (51%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L++ +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 166
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVK 61
            EV+ +   +HEN+V++       D   +V EF+  G+L + +   R   + I+      
Sbjct: 197 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 251
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           + + V + LS LH     VI+RD+K+ ++LL  +   KLSDFG                +
Sbjct: 252 VCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 307
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           VGT  + APE ++     P+ D++S G++++E++ G
Sbjct: 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 104/241 (43%), Gaps = 31/241 (12%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +    K   
Sbjct: 84  LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 62  -------IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
                   +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD     +
Sbjct: 142 TLEHLICYSFQVAKGMEFLAS--RKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 199
Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
                       + APE +     T +SDV+SFGV+L E+ S          G +    V
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGV 250
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  + F R  +   R+        Y+  E        L C H +P  RP+  +++  L  
Sbjct: 251 KIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGN 303
Query: 235 L 235
           L
Sbjct: 304 L 304

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 8/154 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L  + +             
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYIT 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+         + GT
Sbjct: 119 ELANALSYCHS--KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD----LCGT 172
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 173 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 89/189 (47%), Gaps = 16/189 (8%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVK 61
           + E+  L +++HEN+V L       ++  LV + +  G L + +  KG        T ++
Sbjct: 68  ENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIR 127
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVS 118
             +D    + +LH +   +++RDLK  N+L    D      +SDFGL++    GD   V 
Sbjct: 128 QVLD---AVYYLHRM--GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VM 179
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTL---V 174
           +   GT GY APE +A    +   D +S GV+   LL G     DE+   L EQ L    
Sbjct: 180 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEY 239
Query: 175 EWADPFLRD 183
           E+  P+  D
Sbjct: 240 EFDSPYWDD 248

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 75  LIHIGH--HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 60  ---------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
                    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              +            + APE +     T +SDV+SFGV+L E+ S          G + 
Sbjct: 191 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASP 241
Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPS---MVD 227
              V+  + F R  +   R+        Y+  E        L C H +P  RP+   +V+
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVE 294
Query: 228 VLTSLEQLHTSKD 240
            L +L Q +  +D
Sbjct: 295 HLGNLLQANAQQD 307

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 7/156 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L Q     + K  G   +     ++ E++  GS  + L R G  P        +
Sbjct: 69  QQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAG--PFDEFQIATM 125
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++ +GL +LH      I+RD+KA+NVLL    + KL+DFG+A  G   D        V
Sbjct: 126 LKEILKGLDYLHS--EKKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFV 181
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           GT  + APE +       K+D++S G+  +EL  G 
Sbjct: 182 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 217

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 75  LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 60  ---------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
                    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIX 190
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              +            + APE +     T +SDV+SFGV+L E+ S          G + 
Sbjct: 191 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASP 241
Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPS---MVD 227
              V+  + F R  +   R+        Y+  E        L C H +P  RP+   +V+
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVE 294
Query: 228 VLTSLEQLHTSKD 240
            L +L Q +  +D
Sbjct: 295 HLGNLLQANAQQD 307

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+    L++ +    +  I  P       
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLF 113
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 114 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 169
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVK 61
            EV+ +   +HEN+V++       D   +V EF+  G+L + +   R   + I+      
Sbjct: 75  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 129
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           + + V + LS LH     VI+RD+K+ ++LL  +   KLSDFG                +
Sbjct: 130 VCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXL 185
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           VGT  + APE ++     P+ D++S G++++E++ G
Sbjct: 186 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 221

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+    L++ +    +  I  P       
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLF 112
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 113 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 168
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 7/153 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV+ +    H+N+V +       D   +V EF+  G+L + +    +      T   + +
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCL 148
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            V R LS+LH  +  VI+RD+K+ ++LL S+   KLSDFG                +VGT
Sbjct: 149 SVLRALSYLH--NQGVIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKXLVGT 204
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             + APE ++      + D++S G++++E++ G
Sbjct: 205 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 43/259 (16%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-KGVQP--------- 53
           +E   L Q+ H +++KL G CS+    LL+ E+   GSL   L   + V P         
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 54  ------------ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 101
                       ++    +  A  +++G+ +L   +  +++RDL A N+L+      K+S
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKMKIS 192
Query: 102 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
           DFGL+RD    D+    ++      + A E +     T +SDV+SFGV+L E+++     
Sbjct: 193 DFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----- 247
Query: 162 DEDRGGLAEQTLVEWADPFLR-DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPK 220
               GG          +P+      R+  ++ T    +     ++      LQC   +P 
Sbjct: 248 ---LGG----------NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPD 294
Query: 221 NRPSMVDVLTSLEQLHTSK 239
            RP   D+   LE++   +
Sbjct: 295 KRPVFADISKDLEKMMVKR 313

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 166
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 111
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 112 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 167
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 166
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 112
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 113 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 168
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 165
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 109
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 165
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           +V E++   +L + +  +G  P++    +++  D  + L+F H     +I+RD+K +N++
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 148
Query: 92  LDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 150
           + +    K+ DFG+AR    +G++   +  ++GT  Y +PE      +  +SDVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 151 LLELLSG 157
           L E+L+G
Sbjct: 209 LYEVLTG 215

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVK 61
            EV+ +   +HEN+V++       D   +V EF+  G+L + +   R   + I+      
Sbjct: 77  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 131
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           + + V + LS LH     VI+RD+K+ ++LL  +   KLSDFG                +
Sbjct: 132 VCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXL 187
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           VGT  + APE ++     P+ D++S G++++E++ G
Sbjct: 188 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 223

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 166
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           +V E++   +L + +  +G  P++    +++  D  + L+F H     +I+RD+K +N++
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 148
Query: 92  LDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 150
           + +    K+ DFG+AR    +G++   +  ++GT  Y +PE      +  +SDVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 151 LLELLSG 157
           L E+L+G
Sbjct: 209 LYEVLTG 215

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 111 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 166
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 167 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           +V E++   +L + +  +G  P++    +++  D  + L+F H     +I+RD+K +N++
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 148
Query: 92  LDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 150
           + +    K+ DFG+AR    +G++   +  ++GT  Y +PE      +  +SDVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 151 LLELLSG 157
           L E+L+G
Sbjct: 209 LYEVLTG 215

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           +V E++   +L + +  +G  P++    +++  D  + L+F H     +I+RD+K +N++
Sbjct: 93  IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 148
Query: 92  LDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 150
           + +    K+ DFG+AR    +G++   +  ++GT  Y +PE      +  +SDVYS G V
Sbjct: 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 208
Query: 151 LLELLSG 157
           L E+L+G
Sbjct: 209 LYEVLTG 215

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H NL++L G       ++ V E  P GSL + L RK        T  + A+
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAV 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIV 122
            VA G+ +L       I+RDL A N+LL +    K+ DFGL R  P  D+ +V    R V
Sbjct: 119 QVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + APE + T   +  SD + FGV L E+ +  +   E   GL    ++   D   +
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWIGLNGSQILHKID---K 229
Query: 183 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMV 226
           +  R+ R  D            Q      +QC    P++RP+ V
Sbjct: 230 EGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 111
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 112 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 167
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 56  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 114
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 115 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 170
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 112
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 113 QLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 168
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 111
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 112 QLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 167
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 79/155 (50%), Gaps = 11/155 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVKI 62
           EV+ +   +HEN+V++       D   +V EF+  G+L + +   R   + I+      +
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AV 121
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + V + LS LH     VI+RD+K+ ++LL  +   KLSDFG                +V
Sbjct: 122 CLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXLV 177
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           GT  + APE ++     P+ D++S G++++E++ G
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H NL++L G       ++ V E  P GSL + L RK        T  + A+
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAV 128
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIV 122
            VA G+ +L       I+RDL A N+LL +    K+ DFGL R  P  D+ +V    R V
Sbjct: 129 QVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + APE + T   +  SD + FGV L E+ +  +   E   GL    ++   D   +
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWIGLNGSQILHKID---K 239
Query: 183 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMV 226
           +  R+ R  D            Q      +QC    P++RP+ V
Sbjct: 240 EGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFV 273

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 67.0 bits (162), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVK 61
            EV+ +   +HEN+V++       D   +V EF+  G+L + +   R   + I+      
Sbjct: 120 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 174
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           + + V + LS LH     VI+RD+K+ ++LL  +   KLSDFG                +
Sbjct: 175 VCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXL 230
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           VGT  + APE ++     P+ D++S G++++E++ G
Sbjct: 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 113
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 114 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 169
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 113
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 114 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 169
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 54  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 112
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 113 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 168
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 169 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 104/241 (43%), Gaps = 31/241 (12%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTRVK--- 61
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +    K   
Sbjct: 84  LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFL 141
Query: 62  -------IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
                   +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD     +
Sbjct: 142 TLEHLIXYSFQVAKGMEFLAS--RKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPD 199
Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
                       + APE +     T +SDV+SFGV+L E+ S          G +    V
Sbjct: 200 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGV 250
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQ 234
           +  + F R  +   R+        Y+  E        L C H +P  RP+  +++  L  
Sbjct: 251 KIDEEFXRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGN 303
Query: 235 L 235
           L
Sbjct: 304 L 304

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLF 113
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 114 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 169
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 84  LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 60  ---------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
                    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              +            + APE +     T +SDV+SFGV+L E+ S          G + 
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASP 250
Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPS---MVD 227
              V+  + F R  +   R+        Y+  E        L C H +P  RP+   +V+
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVE 303
Query: 228 VLTSLEQLHTSKD 240
            L +L Q +  +D
Sbjct: 304 HLGNLLQANAQQD 316

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H NL++L G       ++ V E  P GSL + L RK        T  + A+
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAV 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIV 122
            VA G+ +L       I+RDL A N+LL +    K+ DFGL R  P  D+ +V    R V
Sbjct: 119 QVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + APE + T   +  SD + FGV L E+ +  +   E   GL    ++   D   +
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWIGLNGSQILHKID---K 229
Query: 183 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMV 226
           +  R+ R  D            Q      +QC    P++RP+ V
Sbjct: 230 EGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRVK 61
            EV+ +   +HEN+V++       D   +V EF+  G+L + +   R   + I+      
Sbjct: 70  NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----A 124
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           + + V + LS LH     VI+RD+K+ ++LL  +   KLSDFG                +
Sbjct: 125 VCLAVLQALSVLHA--QGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKXL 180
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           VGT  + APE ++     P+ D++S G++++E++ G
Sbjct: 181 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/259 (23%), Positives = 111/259 (42%), Gaps = 43/259 (16%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR-KGVQP--------- 53
           +E   L Q+ H +++KL G CS+    LL+ E+   GSL   L   + V P         
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134
Query: 54  ------------ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS 101
                       ++    +  A  +++G+ +L   +  +++RDL A N+L+      K+S
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKMKIS 192
Query: 102 DFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
           DFGL+RD    D+    ++      + A E +     T +SDV+SFGV+L E+++     
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT----- 247
Query: 162 DEDRGGLAEQTLVEWADPFLR-DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPK 220
               GG          +P+      R+  ++ T    +     ++      LQC   +P 
Sbjct: 248 ---LGG----------NPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPD 294
Query: 221 NRPSMVDVLTSLEQLHTSK 239
            RP   D+   LE++   +
Sbjct: 295 KRPVFADISKDLEKMMVKR 313

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/127 (29%), Positives = 72/127 (56%), Gaps = 5/127 (3%)
Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           +V E++   +L + +  +G  P++    +++  D  + L+F H     +I+RD+K +N++
Sbjct: 110 IVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--QNGIIHRDVKPANIM 165
Query: 92  LDSNFNAKLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 150
           + +    K+ DFG+AR    +G++   +  ++GT  Y +PE      +  +SDVYS G V
Sbjct: 166 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCV 225
Query: 151 LLELLSG 157
           L E+L+G
Sbjct: 226 LYEVLTG 232

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H NL++L G       ++ V E  P GSL + L RK        T  + A+
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAV 122
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIV 122
            VA G+ +L       I+RDL A N+LL +    K+ DFGL R  P  D+ +V    R V
Sbjct: 123 QVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + APE + T   +  SD + FGV L E+ +  +   E   GL    ++   D   +
Sbjct: 181 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWIGLNGSQILHKID---K 233
Query: 183 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMV 226
           +  R+ R  D            Q      +QC    P++RP+ V
Sbjct: 234 EGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFV 267

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 99/224 (44%), Gaps = 23/224 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H NL++L G       ++ V E  P GSL + L RK        T  + A+
Sbjct: 65  EVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAV 122
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIV 122
            VA G+ +L       I+RDL A N+LL +    K+ DFGL R  P  D+ +V    R V
Sbjct: 123 QVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 180
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + APE + T   +  SD + FGV L E+ +  +   E   GL    ++   D   +
Sbjct: 181 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWIGLNGSQILHKID---K 233
Query: 183 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMV 226
           +  R+ R  D            Q      +QC    P++RP+ V
Sbjct: 234 EGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFV 267

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+    L+  +    +  I  P       
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLF 113
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 114 QLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 169
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+    L+  +    +  I  P       
Sbjct: 53  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLF 111
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR       T+     V T
Sbjct: 112 QLLQGLAFCHS--HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE--VVT 167
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 168 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 104/245 (42%), Gaps = 39/245 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF----------------- 47
           E +   +L+H N+V L+G  ++     +++ +   G L   L                  
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 138
Query: 48  RKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 107
           +  ++P   P  V +   +A G+ +L     +V+++DL   NVL+    N K+SD GL R
Sbjct: 139 KSALEP---PDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDKLNVKISDLGLFR 193
Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 167
           +    D   +    +    + APE +  G  +  SD++S+GVVL E+ S      +   G
Sbjct: 194 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL---QPYCG 250
Query: 168 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVD 227
            + Q +VE     +  +R+VL   D      Y+           ++C +  P  RP   D
Sbjct: 251 YSNQDVVE-----MIRNRQVLPCPDDCPAWVYA---------LMIECWNEFPSRRPRFKD 296
Query: 228 VLTSL 232
           + + L
Sbjct: 297 IHSRL 301

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 75  LIHIGH--HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 60  ---------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
                    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              +            + APE +     T +SDV+SFGV+L E+ S          G + 
Sbjct: 191 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASP 241
Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPS---MVD 227
              V+  + F R  +   R+        Y+  E        L C H +P  RP+   +V+
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVE 294
Query: 228 VLTSLEQLHTSKD 240
            L +L Q +  +D
Sbjct: 295 HLGNLLQANAQQD 307

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 75  LIHIGH--HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 132
Query: 60  ---------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
                    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD  
Sbjct: 133 KDFLTLEHLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 190
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              +            + APE +     T +SDV+SFGV+L E+ S          G + 
Sbjct: 191 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASP 241
Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPS---MVD 227
              V+  + F R  +   R+        Y+  E        L C H +P  RP+   +V+
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVE 294
Query: 228 VLTSLEQLHTSKD 240
            L +L Q +  +D
Sbjct: 295 HLGNLLQANAQQD 307

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 80/167 (47%), Gaps = 18/167 (10%)
Query: 5   EVIYLGQLRHENLVKLIGY----CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           E+  L   +HEN++ +         E+ N + + + + +  L   +     Q +S     
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI---STQMLSDDHIQ 115
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVS 118
                  R +  LHG  +NVI+RDLK SN+L++SN + K+ DFGLAR  D    DN+  +
Sbjct: 116 YFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 119 ------TRIVGTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
                    V TR Y APE + T     ++ DV+S G +L EL   R
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/156 (33%), Positives = 76/156 (48%), Gaps = 22/156 (14%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR-------VKIAI 64
           L H N++ LIG        +L  E +P   L        +Q I  P R       +   +
Sbjct: 79  LNHPNVLALIGI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD----NTHVSTR 120
            VARG+ +L   +   ++RDL A N +LD +F  K++DFGLARD    +      H   R
Sbjct: 132 QVARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +     + A E + T   T KSDV+SFGV+L ELL+
Sbjct: 190 L--PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 104/245 (42%), Gaps = 39/245 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF----------------- 47
           E +   +L+H N+V L+G  ++     +++ +   G L   L                  
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 48  RKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 107
           +  ++P   P  V +   +A G+ +L     +V+++DL   NVL+    N K+SD GL R
Sbjct: 122 KSALEP---PDFVHLVAQIAAGMEYLSS--HHVVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGG 167
           +    D   +    +    + APE +  G  +  SD++S+GVVL E+ S      +   G
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL---QPYCG 233
Query: 168 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVD 227
            + Q +VE     +  +R+VL   D      Y+           ++C +  P  RP   D
Sbjct: 234 YSNQDVVE-----MIRNRQVLPCPDDCPAWVYA---------LMIECWNEFPSRRPRFKD 279
Query: 228 VLTSL 232
           + + L
Sbjct: 280 IHSRL 284

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 35/245 (14%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 84  LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 60  ---------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
                    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 199
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              +            + APE +     T +SDV+SFGV+L E+ S          G + 
Sbjct: 200 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASP 250
Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLT 230
              V+  + F R  +   R+        Y+  E        L C H +P  RP+  +++ 
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVE 303
Query: 231 SLEQL 235
            L  L
Sbjct: 304 HLGNL 308

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLV-YEFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 121 LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 178
Query: 60  ---------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
                    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD  
Sbjct: 179 KDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 236
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              +            + APE +     T +SDV+SFGV+L E+ S          G + 
Sbjct: 237 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASP 287
Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPS---MVD 227
              V+  + F R  +   R+        Y+  E        L C H +P  RP+   +V+
Sbjct: 288 YPGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVE 340
Query: 228 VLTSLEQLHTSKD 240
            L +L Q +  +D
Sbjct: 341 HLGNLLQANAQQD 353

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 68/151 (45%), Gaps = 13/151 (8%)
Query: 14  HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFR-----KGVQPISWPTRVKIAIDVA 67
           H   +  + Y  E+   L LV   M  G +  H++       G Q    P  +     + 
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAIFYTAQIV 299
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            GL  LH    N+IYRDLK  NVLLD + N ++SD GLA +   G     +    GT G+
Sbjct: 300 SGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGF 355
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
            APE +         D ++ GV L E+++ R
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 68/151 (45%), Gaps = 13/151 (8%)
Query: 14  HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFR-----KGVQPISWPTRVKIAIDVA 67
           H   +  + Y  E+   L LV   M  G +  H++       G Q    P  +     + 
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAIFYTAQIV 299
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            GL  LH    N+IYRDLK  NVLLD + N ++SD GLA +   G     +    GT G+
Sbjct: 300 SGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGF 355
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
            APE +         D ++ GV L E+++ R
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 68/151 (45%), Gaps = 13/151 (8%)
Query: 14  HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFR-----KGVQPISWPTRVKIAIDVA 67
           H   +  + Y  E+   L LV   M  G +  H++       G Q    P  +     + 
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAIFYTAQIV 299
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            GL  LH    N+IYRDLK  NVLLD + N ++SD GLA +   G     +    GT G+
Sbjct: 300 SGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGF 355
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
            APE +         D ++ GV L E+++ R
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 68/151 (45%), Gaps = 13/151 (8%)
Query: 14  HENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFR-----KGVQPISWPTRVKIAIDVA 67
           H   +  + Y  E+   L LV   M  G +  H++       G Q    P  +     + 
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE---PRAIFYTAQIV 299
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
            GL  LH    N+IYRDLK  NVLLD + N ++SD GLA +   G     +    GT G+
Sbjct: 300 SGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGF 355
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
            APE +         D ++ GV L E+++ R
Sbjct: 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 7/156 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L Q     + K  G   +     ++ E++  GS  + L   G  P+       I
Sbjct: 68  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATI 124
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++ +GL +LH      I+RD+KA+NVLL  +   KL+DFG+A  G   D        V
Sbjct: 125 LREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFV 180
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           GT  + APE +       K+D++S G+  +EL  G 
Sbjct: 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     K++DFG A+   G T         + GT  Y APE + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT-------WXLCGTPEYLAPEIIL 211
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 23/159 (14%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTR 59
           H N++ L+G C       L  E+ P G+L + L +  V                +S    
Sbjct: 82  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A DVARG+ +L       I+R+L A N+L+  N+ AK++DFGL+R    G   +V  
Sbjct: 142 LHFAADVARGMDYLS--QKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVKK 195
Query: 120 RI--VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            +  +  R + A E +     T  SDV+S+GV+L E++S
Sbjct: 196 TMGRLPVR-WMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 109/253 (43%), Gaps = 38/253 (15%)
Query: 6   VIYLGQLRHENLVKLIGYCSESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPTR----- 59
           +I++G   H N+V L+G C++    L+V  EF   G+L  +L  K  + + +        
Sbjct: 86  LIHIGH--HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLY 143
Query: 60  ---------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
                    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD  
Sbjct: 144 KDFLTLEHLICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIY 201
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              +            + APE +     T +SDV+SFGV+L E+ S          G + 
Sbjct: 202 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASP 252
Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPS---MVD 227
              V+  + F R  +   R+        Y+  E        L C H +P  RP+   +V+
Sbjct: 253 YPGVKIDEEFCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVE 305
Query: 228 VLTSLEQLHTSKD 240
            L +L Q +  +D
Sbjct: 306 HLGNLLQANAQQD 318

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 133
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 134 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEM--- 186
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 133
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 134 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEM--- 186
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E+ P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     K++DFGLA+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 133
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 134 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEM--- 186
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 7/156 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L Q     + K  G   +     ++ E++  GS  + L   G  P+       I
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATI 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++ +GL +LH      I+RD+KA+NVLL  +   KL+DFG+A  G   D        V
Sbjct: 110 LREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFV 165
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           GT  + APE +       K+D++S G+  +EL  G 
Sbjct: 166 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 7/156 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L Q     + K  G   +     ++ E++  GS  + L   G  P+       I
Sbjct: 53  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATI 109
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++ +GL +LH      I+RD+KA+NVLL  +   KL+DFG+A  G   D        V
Sbjct: 110 LREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFV 165
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           GT  + APE +       K+D++S G+  +EL  G 
Sbjct: 166 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 201

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H NL++L G       ++ V E  P GSL + L RK        T  + A+
Sbjct: 61  EVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAV 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIV 122
            VA G+ +L       I+RDL A N+LL +    K+ DFGL R  P  D+  V    R V
Sbjct: 119 QVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 176
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + APE + T   +  SD + FGV L E+ +  +   E   GL    ++   D   +
Sbjct: 177 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWIGLNGSQILHKID---K 229
Query: 183 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMV 226
           +  R+ R  D            Q      +QC    P++RP+ V
Sbjct: 230 EGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT--GDNTHVSTRIVGTR 125
           RGL ++H   A VI+RDLK SN+L++ N   K+ DFG+AR   T   ++ +  T  V TR
Sbjct: 169 RGLKYMHS--AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 126 GYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRR 159
            Y APE + + H  T   D++S G +  E+L+ R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT--GDNTHVSTRIVGTR 125
           RGL ++H   A VI+RDLK SN+L++ N   K+ DFG+AR   T   ++ +  T  V TR
Sbjct: 170 RGLKYMHS--AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 126 GYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRR 159
            Y APE + + H  T   D++S G +  E+L+ R+
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H NL++L G       ++ V E  P GSL + L RK        T  + A+
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAV 128
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIV 122
            VA G+ +L       I+RDL A N+LL +    K+ DFGL R  P  D+  V    R V
Sbjct: 129 QVAEGMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKV 186
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + APE + T   +  SD + FGV L E+ +  +   E   GL    ++   D   +
Sbjct: 187 -PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPWIGLNGSQILHKID---K 239
Query: 183 DSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMV 226
           +  R+ R  D            Q      +QC    P++RP+ V
Sbjct: 240 EGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFV 273

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 132
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 133 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 185
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 81  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 136
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 137 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 189
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 190 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 132
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 133 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 185
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E+ P G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     K++DFG A+         V  R   + GT  Y APE +
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIKVADFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 132
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 133 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 185
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 131
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 132 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 184
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 70  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 125
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 126 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 178
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 179 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 84/160 (52%), Gaps = 12/160 (7%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +TE   L  +R    +  + Y  +++ +L L+ +++  G L  HL ++          V+
Sbjct: 106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQ 162
Query: 62  IAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           I + ++   L  LH L   +IYRD+K  N+LLDSN +  L+DFGL+++    D T  +  
Sbjct: 163 IYVGEIVLALEHLHKL--GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYD 219
Query: 121 IVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSG 157
             GT  Y AP+ V    +GH     D +S GV++ ELL+G
Sbjct: 220 FCGTIEYMAPDIVRGGDSGH-DKAVDWWSLGVLMYELLTG 258

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 79/158 (50%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+E + +  L+  +    +  I  P       
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLF 109
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G      T  V T
Sbjct: 110 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVT 165
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 128
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 129 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 181
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 128
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 129 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 181
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 128
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 129 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 181
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 137
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 138 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 190
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 191 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 133
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 134 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 186
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 82  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 137
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 138 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM--- 190
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 191 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 131
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 132 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM--- 184
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 131
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 132 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM--- 184
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 149
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 150 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 202
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 203 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 76  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 131
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 132 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 184
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 185 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 146
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 147 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 199
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 200 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 19/160 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGV-----QPISWPT 58
           E+  L QL+H NLV L+          LV+E+     L E   +++GV     + I+W T
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
                    + ++F H    N I+RD+K  N+L+  +   KL DFG AR   TG + +  
Sbjct: 112 --------LQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYD 160
Query: 119 TRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSG 157
              V TR Y +PE  V      P  DV++ G V  ELLSG
Sbjct: 161 DE-VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 146
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 147 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 199
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 200 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 145
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 146 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 198
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 199 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 138
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 139 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 191
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 192 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 138
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 139 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 191
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 192 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 83  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 138
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 139 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 191
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 192 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 90  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 145
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 146 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 198
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 199 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 123
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 124 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 176
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 177 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 7/156 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+  L Q     + K  G   +     ++ E++  GS  + L   G  P+       I
Sbjct: 73  QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPG--PLDETQIATI 129
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++ +GL +LH      I+RD+KA+NVLL  +   KL+DFG+A  G   D        V
Sbjct: 130 LREILKGLDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFV 185
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           GT  + APE +       K+D++S G+  +EL  G 
Sbjct: 186 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 221

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKX--QKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/156 (35%), Positives = 75/156 (48%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L QL H N++KL  +  +  N  LV E    G L + +  +  Q  S      I  
Sbjct: 54  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR--QKFSEVDAAVIMK 111
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVSTRI 121
            V  G ++LH    N+++RDLK  N+LL+S       K+ DFGL+     G    +  R+
Sbjct: 112 QVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGK--MKERL 167
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            GT  Y APE V       K DV+S GV+L  LL G
Sbjct: 168 -GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 122
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 123 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 175
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKX--QKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDXELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 77  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 132
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 133 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEM--- 185
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 69  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 124
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 125 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 177
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 178 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 68  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 123
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 124 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 176
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 177 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 122
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 123 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 175
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 70/141 (49%), Gaps = 9/141 (6%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 146
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 136
           D  +IYRDLK  N+L+D     +++DFG A+       T     + GT  Y APE + + 
Sbjct: 147 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEIILSK 199
Query: 137 HLTPKSDVYSFGVVLLELLSG 157
                 D ++ GV++ E+ +G
Sbjct: 200 GYNKAVDWWALGVLIYEMAAG 220

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 153
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     +++DFG A+   G T         + GT  Y APE + 
Sbjct: 154 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIIL 204
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 181
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 182 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 231
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 70/141 (49%), Gaps = 9/141 (6%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 136
           D  +IYRDLK  N+L+D     +++DFG A+       T     + GT  Y APE + + 
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEIILSK 214
Query: 137 HLTPKSDVYSFGVVLLELLSG 157
                 D ++ GV++ E+ +G
Sbjct: 215 GYNKAVDWWALGVLIYEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E+ P G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     K++DFG A+         V  R   + GT  Y APE +
Sbjct: 162 D--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     +++DFG A+   G T         + GT  Y APE + 
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIIL 212
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/156 (34%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L QL H N++KL  +  +  N  LV E    G L + +  +  Q  S      I  
Sbjct: 71  EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILR--QKFSEVDAAVIMK 128
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVSTRI 121
            V  G ++LH    N+++RDLK  N+LL+S       K+ DFGL+     G         
Sbjct: 129 QVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KER 183
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           +GT  Y APE V       K DV+S GV+L  LL G
Sbjct: 184 LGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     +++DFG A+   G T         + GT  Y APE + 
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIIL 212
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 79/154 (51%), Gaps = 5/154 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  + Q    ++VK  G   ++ +  +V E+   GS+ + + R   + ++      I  
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQ 132
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
              +GL +LH +    I+RD+KA N+LL++  +AKL+DFG+A  G   D       ++GT
Sbjct: 133 STLKGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXMAKRNXVIGT 188
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             + APE +        +D++S G+  +E+  G+
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 83/159 (52%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIG--YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           +Q E+  L  L  + +VK  G  Y     +  LV E++P G L + L R   + +     
Sbjct: 58  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRL 116
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  + +G+ +L       ++RDL A N+L++S  + K++DFGLA+  P   + +V  
Sbjct: 117 LLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV-V 173
Query: 120 RIVGTRG--YAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R  G     + APE ++    + +SDV+SFGVVL EL +
Sbjct: 174 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 17/189 (8%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  L +++HEN+V L      + +  LV + +  G L + +  +GV      T    
Sbjct: 54  ENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVY-----TEKDA 108
Query: 63  AIDVARGLSFLHGLDAN-VIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVS 118
           ++ + + LS +  L  N +++RDLK  N+L    + N    ++DFGL++    G    + 
Sbjct: 109 SLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IM 164
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQT---LV 174
           +   GT GY APE +A    +   D +S GV+   LL G     +E    L E+      
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYY 224
Query: 175 EWADPFLRD 183
           E+  PF  D
Sbjct: 225 EFESPFWDD 233

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 100 ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 155
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 156 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 208
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 209 TGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E+ P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     K++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 73  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 128
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 129 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDSELKILDFGLARH--TDDEM--- 181
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 182 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     +++DFG A+   G T         + GT  Y APE + 
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIIL 212
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 83/159 (52%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIG--YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           +Q E+  L  L  + +VK  G  Y     +  LV E++P G L + L R   + +     
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRL 129
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  + +G+ +L       ++RDL A N+L++S  + K++DFGLA+  P   + +V  
Sbjct: 130 LLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV-V 186
Query: 120 RIVGTRG--YAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R  G     + APE ++    + +SDV+SFGVVL EL +
Sbjct: 187 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     +++DFG A+   G T         + GT  Y APE + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIIL 211
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 82/159 (51%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIG--YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           +Q E+  L  L  + +VK  G  Y     +  LV E++P G L + L R   + +     
Sbjct: 59  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRL 117
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  + +G+ +L       ++RDL A N+L++S  + K++DFGLA+  P  D  +   
Sbjct: 118 LLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVV 174
Query: 120 RIVGTRG--YAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R  G     + APE ++    + +SDV+SFGVVL EL +
Sbjct: 175 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 71/144 (49%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E+ P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     +++DFGLA+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGV-----QPISWPT 58
           EV  L  ++H N+V+      E+ +  +V ++   G L   +  +KGV     Q + W  
Sbjct: 73  EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV 132
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           ++ +A+         H  D  +++RD+K+ N+ L  +   +L DFG+AR         ++
Sbjct: 133 QICLALK--------HVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIAR--VLNSTVELA 182
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 162
              +GT  Y +PE         KSD+++ G VL EL + + A +
Sbjct: 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 73
           H N+++L      +    LV++ M KG L ++L  K    +S     KI   +   +  L
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICAL 127
Query: 74  HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 133
           H L  N+++RDLK  N+LLD + N KL+DFG +     G+       + GT  Y APE +
Sbjct: 128 HKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEII 182
Query: 134 ATGH------LTPKSDVYSFGVVLLELLSG 157
                        + D++S GV++  LL+G
Sbjct: 183 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
              V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
              V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 4/152 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + +  + H +LV+L+G C  S    LV + MP G L  ++       I     +   +
Sbjct: 67  EALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHK-DNIGSQLLLNWCV 124
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A+G+ +L   +  +++RDL A NVL+ S  + K++DFGLAR     +  + +      
Sbjct: 125 QIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 182
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + A E +     T +SDV+S+GV + EL++
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 78/152 (51%), Gaps = 4/152 (2%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + +  + H +LV+L+G C  S    LV + MP G L  ++       I     +   +
Sbjct: 90  EALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHK-DNIGSQLLLNWCV 147
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A+G+ +L   +  +++RDL A NVL+ S  + K++DFGLAR     +  + +      
Sbjct: 148 QIAKGMMYLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 205
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
             + A E +     T +SDV+S+GV + EL++
Sbjct: 206 IKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 79/169 (46%), Gaps = 34/169 (20%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLE--------NHLFRKGVQPISW 56
           E+  L  ++HEN++ L+              F P  SLE         HL    +  I  
Sbjct: 67  ELRLLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVK 114
Query: 57  PTRVK------IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
             ++       +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   
Sbjct: 115 CAKLTDDHVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH-- 170
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T D     T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 171 TDDEM---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 107/251 (42%), Gaps = 35/251 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL------FRKGVQPISWPT 58
           E+     L+H+N+V+ +G  SE+    +  E +P GSL   L       +   Q I + T
Sbjct: 69  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 128
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHV 117
           +      +  GL +LH  D  +++RD+K  NVL+++     K+SDFG ++    G N   
Sbjct: 129 K-----QILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCT 180
Query: 118 STRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
            T   GT  Y APE +  G       +D++S G  ++E+ +G+                E
Sbjct: 181 ET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK------------PPFYE 227
Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQL 235
             +P       + ++   ++  +  +  +       L+C   DP  R    D+L   E L
Sbjct: 228 LGEP----QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD-EFL 282
Query: 236 HTSKDMPRTPP 246
             S    +T P
Sbjct: 283 KVSSKKKKTQP 293

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 84/161 (52%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ D+GLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDYGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 73
           H N+++L      +    LV++ M KG L ++L  K    +S     KI   +   +  L
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICAL 140
Query: 74  HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 133
           H L  N+++RDLK  N+LLD + N KL+DFG +     G+       + GT  Y APE +
Sbjct: 141 HKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---EVCGTPSYLAPEII 195
Query: 134 ATGH------LTPKSDVYSFGVVLLELLSG 157
                        + D++S GV++  LL+G
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 67  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 122
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 123 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 175
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
              V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 176 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  + +L+HEN+V+L       +   LV+EFM    L+ ++  + V   + P  +++ +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVG--NTPRGLELNL 109
Query: 65  ------DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
                  + +GL+F H  +  +++RDLK  N+L++     KL DFGLAR      NT  S
Sbjct: 110 VKYFQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
Query: 119 TRIVGTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGR 158
              V T  Y AP+ +        S D++S G +L E+++G+
Sbjct: 168 E--VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 73
           H N+++L      +    LV++ M KG L ++L  K    +S     KI   +   +  L
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKETRKIMRALLEVICAL 140
Query: 74  HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 133
           H L  N+++RDLK  N+LLD + N KL+DFG +     G+       + GT  Y APE +
Sbjct: 141 HKL--NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR---SVCGTPSYLAPEII 195
Query: 134 ATGH------LTPKSDVYSFGVVLLELLSG 157
                        + D++S GV++  LL+G
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 77/163 (47%), Gaps = 9/163 (5%)
Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFR--KGVQPISW 56
           M  +EV  L +L+H N+V+      +  N  L  V E+   G L + + +  K  Q +  
Sbjct: 51  MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 57  PTRVKIAIDVARGLSFLHGLD---ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
              +++   +   L   H        V++RDLK +NV LD   N KL DFGLAR      
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNH 168
Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +T  +   VGT  Y +PE +       KSD++S G +L EL +
Sbjct: 169 DTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E+ P G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 27/239 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E+  L QL H N++K      E +   +V E    G L   +  F+K  + I   T  K 
Sbjct: 82  EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +   L  +H     V++RD+K +NV + +    KL D GL R       T  +  +V
Sbjct: 142 FVQLCSALEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLV 197
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT-LVEWAD--P 179
           GT  Y +PE +       KSD++S G +L E+ + +     D+  L      +E  D  P
Sbjct: 198 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 257
Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
              D               YS++  Q        C++ DP+ RP +  V    +++H  
Sbjct: 258 LPSD--------------HYSEELRQLVN----MCINPDPEKRPDVTYVYDVAKRMHAC 298

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+E + +  L+  +    +  I  P       
Sbjct: 55  EISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLF 113
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR    G         V T
Sbjct: 114 QLLQGLAFCHS--HRVLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYXHEVVT 169
Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             Y APE  +   + +   D++S G +  E+++ RRAL
Sbjct: 170 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKS--QKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGL R   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDSELKILDFGLCRH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 77/163 (47%), Gaps = 9/163 (5%)
Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFR--KGVQPISW 56
           M  +EV  L +L+H N+V+      +  N  L  V E+   G L + + +  K  Q +  
Sbjct: 51  MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 57  PTRVKIAIDVARGLSFLHGLD---ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
              +++   +   L   H        V++RDLK +NV LD   N KL DFGLAR      
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNH 168
Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +T  +   VGT  Y +PE +       KSD++S G +L EL +
Sbjct: 169 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++ + + ++ N+V  +      D   +V E++  GSL + +    +          +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 123
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           +  + L FLH     VI+RD+K+ N+LL  + + KL+DFG      T + +  ST +VGT
Sbjct: 124 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGT 179
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             + APE V      PK D++S G++ +E++ G 
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 8/159 (5%)
Query: 2   WQTEVIYLGQLRHENLVKLIG--YCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           +Q E+  L  L  + +VK  G  Y        LV E++P G L + L R   + +     
Sbjct: 55  FQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR-LDASRL 113
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  + +G+ +L       ++RDL A N+L++S  + K++DFGLA+  P   +  V  
Sbjct: 114 LLYSSQICKGMEYLGS--RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXV-V 170
Query: 120 RIVGTRG--YAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           R  G     + APE ++    + +SDV+SFGVVL EL +
Sbjct: 171 REPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 91  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 146
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 147 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 199
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
              V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 200 XGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           L KL     ++ N  +V E+ P G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     K++DFG A+         V  R   + GT  Y APE +
Sbjct: 162 D--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 75/157 (47%), Gaps = 13/157 (8%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RKGVQPISWPTRVKIA 63
           EV  L  L H N++KL  +  +  N  LV E    G L + +  R     +     +K  
Sbjct: 86  EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIK-- 143
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVSTR 120
             V  G+++LH    N+++RDLK  N+LL+S       K+ DFGL+      +N      
Sbjct: 144 -QVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKE 197
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            +GT  Y APE V       K DV+S GV+L  LL+G
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G      P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           L KL     ++ N  +V E+ P G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     K++DFG A+         V  R   + GT  Y APE +
Sbjct: 162 D--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G      P     A  +     +LH L
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E+ P G + +HL R G      P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     K++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G      P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++P G + +HL R G      P     A  +     +LH L
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 153
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     +++DFG A+   G T         + GT  Y APE + 
Sbjct: 154 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIIL 204
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAG 227

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 94  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 149
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR   T D     
Sbjct: 150 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM--- 202
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
              V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 203 XGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 8/150 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L +++H  +V LI Y  ++  +L L+ E++  G L   L R+G+      T      +++
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEIS 131
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
             L  LH     +IYRDLK  N++L+   + KL+DFGL ++    D T V+    GT  Y
Sbjct: 132 MALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGT-VTHXFCGTIEY 187
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            APE +         D +S G ++ ++L+G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E+  L +L H N+V LI          LV+EFM K  L+  L   + G+Q     +++KI
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD----SQIKI 123
Query: 63  AI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            +  + RG++  H     +++RDLK  N+L++S+   KL+DFGLAR    G      T  
Sbjct: 124 YLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHE 179
Query: 122 VGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 158
           V T  Y AP+ +  +   +   D++S G +  E+++G+
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 69/141 (48%), Gaps = 9/141 (6%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 181
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG 136
           D  +IYRDLK  N+L+D     +++DFG A+       T     + GT  Y APE + + 
Sbjct: 182 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWT-----LCGTPEYLAPEIILSK 234
Query: 137 HLTPKSDVYSFGVVLLELLSG 157
                 D ++ GV++ E+ +G
Sbjct: 235 GYNKAVDWWALGVLIYEMAAG 255

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 8/150 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L +++H  +V LI Y  ++  +L L+ E++  G L   L R+G+      T      +++
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI--FMEDTACFYLAEIS 131
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
             L  LH     +IYRDLK  N++L+   + KL+DFGL ++    D T V+    GT  Y
Sbjct: 132 MALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGT-VTHTFCGTIEY 187
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            APE +         D +S G ++ ++L+G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 83/158 (52%), Gaps = 13/158 (8%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E+  L +L H N+V LI          LV+EFM K  L+  L   + G+Q     +++KI
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD----SQIKI 123
Query: 63  AI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            +  + RG++  H     +++RDLK  N+L++S+   KL+DFGLAR    G      T  
Sbjct: 124 YLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTHE 179
Query: 122 VGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 158
           V T  Y AP+ +  +   +   D++S G +  E+++G+
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 6/150 (4%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLV-YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           + +L H   VKL  +C + D +L     +   G L  ++ + G    +  TR   A ++ 
Sbjct: 91  MSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EIV 147
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
             L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  Y
Sbjct: 148 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            +PE +        SD+++ G ++ +L++G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L QL H N++KL  +  +     LV E    G L + +  +  +  S     +I  
Sbjct: 76  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIR 133
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRI 121
            V  G++++H     +++RDLK  N+LL+S   + N ++ DFGL+        TH     
Sbjct: 134 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASK 183
Query: 122 -----VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
                +GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 184 KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L QL H N++KL  +  +     LV E    G L + +  +  +  S     +I  
Sbjct: 99  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIR 156
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRI 121
            V  G++++H     +++RDLK  N+LL+S   + N ++ DFGL+        TH     
Sbjct: 157 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASK 206
Query: 122 -----VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
                +GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 207 KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 17/169 (10%)
Query: 2   WQTEVIYLGQLRHENLVKL------IGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQP 53
           W  E+  + +L H N+V        +   + +D  LL  E+   G L  +L  F      
Sbjct: 60  WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 119
Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSDFGLARDGP 110
              P R  ++ D++  L +LH  +  +I+RDLK  N++L         K+ D G A++  
Sbjct: 120 KEGPIRTLLS-DISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 176
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            G+   + T  VGT  Y APE +     T   D +SFG +  E ++G R
Sbjct: 177 QGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 78/161 (48%), Gaps = 21/161 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L QL H N++KL  +  +     LV E    G L + +  +  +  S     +I  
Sbjct: 100 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIR 157
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRI 121
            V  G++++H     +++RDLK  N+LL+S   + N ++ DFGL+        TH     
Sbjct: 158 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASK 207
Query: 122 -----VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
                +GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 208 KMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 17/169 (10%)
Query: 2   WQTEVIYLGQLRHENLVKL------IGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQP 53
           W  E+  + +L H N+V        +   + +D  LL  E+   G L  +L  F      
Sbjct: 59  WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118
Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSDFGLARDGP 110
              P R  ++ D++  L +LH  +  +I+RDLK  N++L         K+ D G A++  
Sbjct: 119 KEGPIRTLLS-DISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
            G+   + T  VGT  Y APE +     T   D +SFG +  E ++G R
Sbjct: 176 QGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 76/156 (48%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L QL H N++KL  +  +     LV E    G L + +  +  +  S     +I  
Sbjct: 82  EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIR 139
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRI 121
            V  G++++H     +++RDLK  N+LL+S   + N ++ DFGL+               
Sbjct: 140 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDK--- 194
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           +GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 195 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+  FGLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILGFGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E+  L    H N+VKL+      +N  ++ EF   G+++  +     +P++      
Sbjct: 81  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQV 139
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR- 120
           +       L++LH  D  +I+RDLKA N+L   + + KL+DFG+     +  NT    R 
Sbjct: 140 VCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRTIQRR 192
Query: 121 --IVGTRGYAAPEYV--ATGHLTP---KSDVYSFGVVLLEL 154
              +GT  + APE V   T    P   K+DV+S G+ L+E+
Sbjct: 193 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 75/138 (54%), Gaps = 4/138 (2%)
Query: 19  KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA 78
           +L+G C  S  +L V + MP G L +H+ R+    +     +   + +A+G+S+L   D 
Sbjct: 83  RLLGICLTSTVQL-VTQLMPYGCLLDHV-RENRGRLGSQDLLNWCMQIAKGMSYLE--DV 138
Query: 79  NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL 138
            +++RDL A NVL+ S  + K++DFGLAR     +  + +        + A E +     
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 139 TPKSDVYSFGVVLLELLS 156
           T +SDV+S+GV + EL++
Sbjct: 199 THQSDVWSYGVTVWELMT 216

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DF LAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFYLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEF---MPKGSLENHLFRKGVQPISWPTRVK 61
           E++ L  ++HEN++ L+   + + +    Y+F   MP   ++  L +      S      
Sbjct: 91  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP--FMQTDLQKIMGMEFSEEKIQY 148
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +   + +GL ++H   A V++RDLK  N+ ++ +   K+ DFGLAR        H    +
Sbjct: 149 LVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEM 198
Query: 122 VG---TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
            G   TR Y APE + +  H     D++S G ++ E+L+G+
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 42/263 (15%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR--------LLVYEFMPKGSLENHLFRKGVQPI 54
           + E+     LRHEN++  I     +DN+         LV ++   GSL ++L R  V   
Sbjct: 51  EAEIYQTVMLRHENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 105
Query: 55  SWPTRVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLA-R 107
                +K+A+  A GL+ LH    G      + +RDLK+ N+L+  N    ++D GLA R
Sbjct: 106 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 163
Query: 108 DGPTGDNTHVS-TRIVGTRGYAAPEY----VATGHLTP--KSDVYSFGVVLLELLSGRRA 160
                D   ++    VGT+ Y APE     +   H     ++D+Y+ G+V  E+   RR 
Sbjct: 164 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRC 221
Query: 161 LDEDRGGLAEQTLVEW-----ADPFLRDSRRVLRIMDTR--LGGQYSKKEAQXXXXXXL- 212
                GG+ E   + +     +DP + + R+V+     R  +  ++   EA       + 
Sbjct: 222 ---SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 278
Query: 213 QCLHMDPKNRPSMVDVLTSLEQL 235
           +C + +   R + + +  +L QL
Sbjct: 279 ECWYANGAARLTALRIKKTLSQL 301

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 9/163 (5%)
Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFR--KGVQPISW 56
           M  +EV  L +L+H N+V+      +  N  L  V E+   G L + + +  K  Q +  
Sbjct: 51  MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 110
Query: 57  PTRVKIAIDVARGLSFLHGLD---ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
              +++   +   L   H        V++RDLK +NV LD   N KL DFGLAR      
Sbjct: 111 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR--ILNH 168
Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
           +   +   VGT  Y +PE +       KSD++S G +L EL +
Sbjct: 169 DEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 162 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 42/263 (15%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR--------LLVYEFMPKGSLENHLFRKGVQPI 54
           + E+     LRHEN++  I     +DN+         LV ++   GSL ++L R  V   
Sbjct: 45  EAEIYQTVMLRHENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 99
Query: 55  SWPTRVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLA-R 107
                +K+A+  A GL+ LH    G      + +RDLK+ N+L+  N    ++D GLA R
Sbjct: 100 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157
Query: 108 DGPTGDNTHVS-TRIVGTRGYAAPEY----VATGHLTP--KSDVYSFGVVLLELLSGRRA 160
                D   ++    VGT+ Y APE     +   H     ++D+Y+ G+V  E+   RR 
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRC 215
Query: 161 LDEDRGGLAEQTLVEW-----ADPFLRDSRRVLRIMDTR--LGGQYSKKEAQXXXXXXL- 212
                GG+ E   + +     +DP + + R+V+     R  +  ++   EA       + 
Sbjct: 216 ---SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
Query: 213 QCLHMDPKNRPSMVDVLTSLEQL 235
           +C + +   R + + +  +L QL
Sbjct: 273 ECWYANGAARLTALRIKKTLSQL 295

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++ + + ++ N+V  +      D   +V E++  GSL + +    +          +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 123
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTHVSTRIVG 123
           +  + L FLH     VI+RD+K+ N+LL  + + KL+DFG  A+  P        + +VG
Sbjct: 124 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSEMVG 178
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           T  + APE V      PK D++S G++ +E++ G 
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 42/263 (15%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR--------LLVYEFMPKGSLENHLFRKGVQPI 54
           + E+     LRHEN++  I     +DN+         LV ++   GSL ++L R  V   
Sbjct: 46  EAEIYQTVMLRHENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 100
Query: 55  SWPTRVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLA-R 107
                +K+A+  A GL+ LH    G      + +RDLK+ N+L+  N    ++D GLA R
Sbjct: 101 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 158
Query: 108 DGPTGDNTHVS-TRIVGTRGYAAPEY----VATGHLTP--KSDVYSFGVVLLELLSGRRA 160
                D   ++    VGT+ Y APE     +   H     ++D+Y+ G+V  E+   RR 
Sbjct: 159 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRC 216
Query: 161 LDEDRGGLAEQTLVEW-----ADPFLRDSRRVLRIMDTR--LGGQYSKKEAQXXXXXXL- 212
                GG+ E   + +     +DP + + R+V+     R  +  ++   EA       + 
Sbjct: 217 ---SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 273
Query: 213 QCLHMDPKNRPSMVDVLTSLEQL 235
           +C + +   R + + +  +L QL
Sbjct: 274 ECWYANGAARLTALRIKKTLSQL 296

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 9/153 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N++ L+       N  LV++FM +  LE  +  K    +  P+ +K  +
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLE--VIIKDNSLVLTPSHIKAYM 118
Query: 65  DVA-RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
            +  +GL +LH     +++RDLK +N+LLD N   KL+DFGLA+    G         V 
Sbjct: 119 LMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYXHQVV 174
Query: 124 TRGYAAPEYVATGHLTPKS-DVYSFGVVLLELL 155
           TR Y APE +    +     D+++ G +L ELL
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E+  L    H N+VKL+      +N  ++ EF   G+++  +     +P++      
Sbjct: 81  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQV 139
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR- 120
           +       L++LH  D  +I+RDLKA N+L   + + KL+DFG+     +  NT    R 
Sbjct: 140 VCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRXIQRR 192
Query: 121 --IVGTRGYAAPEYV--ATGHLTP---KSDVYSFGVVLLEL 154
              +GT  + APE V   T    P   K+DV+S G+ L+E+
Sbjct: 193 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ D GLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDAGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 16/161 (9%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E+  L    H N+VKL+      +N  ++ EF   G+++  +     +P++      
Sbjct: 81  YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQV 139
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR- 120
           +       L++LH  D  +I+RDLKA N+L   + + KL+DFG+     +  NT    R 
Sbjct: 140 VCKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGV-----SAKNTRXIQRR 192
Query: 121 --IVGTRGYAAPEYV--ATGHLTP---KSDVYSFGVVLLEL 154
              +GT  + APE V   T    P   K+DV+S G+ L+E+
Sbjct: 193 DXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 81/163 (49%), Gaps = 18/163 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL------FRKGVQPISWPT 58
           E+     L+H+N+V+ +G  SE+    +  E +P GSL   L       +   Q I + T
Sbjct: 55  EIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT 114
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHV 117
           +      +  GL +LH  D  +++RD+K  NVL+++     K+SDFG ++    G N   
Sbjct: 115 K-----QILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR-LAGINPCT 166
Query: 118 STRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 158
            T   GT  Y APE +  G       +D++S G  ++E+ +G+
Sbjct: 167 ET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 42/263 (15%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR--------LLVYEFMPKGSLENHLFRKGVQPI 54
           + E+     LRHEN++  I     +DN+         LV ++   GSL ++L R  V   
Sbjct: 48  EAEIYQTVMLRHENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 102
Query: 55  SWPTRVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLA-R 107
                +K+A+  A GL+ LH    G      + +RDLK+ N+L+  N    ++D GLA R
Sbjct: 103 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 160
Query: 108 DGPTGDNTHVS-TRIVGTRGYAAPEY----VATGHLTP--KSDVYSFGVVLLELLSGRRA 160
                D   ++    VGT+ Y APE     +   H     ++D+Y+ G+V  E+   RR 
Sbjct: 161 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRC 218
Query: 161 LDEDRGGLAEQTLVEW-----ADPFLRDSRRVLRIMDTR--LGGQYSKKEAQXXXXXXL- 212
                GG+ E   + +     +DP + + R+V+     R  +  ++   EA       + 
Sbjct: 219 ---SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 275
Query: 213 QCLHMDPKNRPSMVDVLTSLEQL 235
           +C + +   R + + +  +L QL
Sbjct: 276 ECWYANGAARLTALRIKKTLSQL 298

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 42/263 (15%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR--------LLVYEFMPKGSLENHLFRKGVQPI 54
           + E+     LRHEN++  I     +DN+         LV ++   GSL ++L R  V   
Sbjct: 71  EAEIYQTVMLRHENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 125
Query: 55  SWPTRVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLA-R 107
                +K+A+  A GL+ LH    G      + +RDLK+ N+L+  N    ++D GLA R
Sbjct: 126 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 183
Query: 108 DGPTGDNTHVS-TRIVGTRGYAAPEY----VATGHLTP--KSDVYSFGVVLLELLSGRRA 160
                D   ++    VGT+ Y APE     +   H     ++D+Y+ G+V  E+   RR 
Sbjct: 184 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRC 241
Query: 161 LDEDRGGLAEQTLVEW-----ADPFLRDSRRVLRIMDTR--LGGQYSKKEAQXXXXXXL- 212
                GG+ E   + +     +DP + + R+V+     R  +  ++   EA       + 
Sbjct: 242 ---SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 298
Query: 213 QCLHMDPKNRPSMVDVLTSLEQL 235
           +C + +   R + + +  +L QL
Sbjct: 299 ECWYANGAARLTALRIKKTLSQL 321

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLAGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 90  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 147
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     +++DFG A+   G T         + GT  Y APE + 
Sbjct: 148 D--LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIIL 198
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAG 221

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     +++DFG A+   G T         + GT  Y APE + 
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-------WXLCGTPEYLAPEIIL 211
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 118/263 (44%), Gaps = 42/263 (15%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR--------LLVYEFMPKGSLENHLFRKGVQPI 54
           + E+     LRHEN++  I     +DN+         LV ++   GSL ++L R  V   
Sbjct: 84  EAEIYQTVMLRHENILGFIA----ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTV- 138
Query: 55  SWPTRVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLA-R 107
                +K+A+  A GL+ LH    G      + +RDLK+ N+L+  N    ++D GLA R
Sbjct: 139 --EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 108 DGPTGDNTHVS-TRIVGTRGYAAPEY----VATGHLTP--KSDVYSFGVVLLELLSGRRA 160
                D   ++    VGT+ Y APE     +   H     ++D+Y+ G+V  E+   RR 
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI--ARRC 254
Query: 161 LDEDRGGLAEQTLVEW-----ADPFLRDSRRVLRIMDTR--LGGQYSKKEAQXXXXXXL- 212
                GG+ E   + +     +DP + + R+V+     R  +  ++   EA       + 
Sbjct: 255 ---SIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 311
Query: 213 QCLHMDPKNRPSMVDVLTSLEQL 235
           +C + +   R + + +  +L QL
Sbjct: 312 ECWYANGAARLTALRIKKTLSQL 334

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++ + + ++ N+V  +      D   +V E++  GSL + +    +          +  
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 124
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTHVSTRIVG 123
           +  + L FLH     VI+RD+K+ N+LL  + + KL+DFG  A+  P        + +VG
Sbjct: 125 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVG 179
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           T  + APE V      PK D++S G++ +E++ G 
Sbjct: 180 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 64/121 (52%), Gaps = 5/121 (4%)
Query: 35  EFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS 94
           EF  KG+LE  + ++  + +     +++   + +G+ ++H     +I+RDLK SN+ L  
Sbjct: 114 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLVD 171
Query: 95  NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL 154
               K+ DFGL     +  N    TR  GT  Y +PE +++     + D+Y+ G++L EL
Sbjct: 172 TKQVKIGDFGLV---TSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 155 L 155
           L
Sbjct: 229 L 229

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ D GLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDRGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 21/235 (8%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRKGVQP---ISWPT 58
           E+  + Q  H N+V         D   LV + +  GS+ +   H+  KG      +   T
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN---T 115
              I  +V  GL +LH      I+RD+KA N+LL  + + +++DFG++    TG +    
Sbjct: 118 IATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 175
Query: 116 HVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
            V    VGT  + APE +        K+D++SFG+  +EL +G     +          +
Sbjct: 176 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 235
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           +   P L        + D  +  +Y K   +        CL  DP+ RP+  ++L
Sbjct: 236 QNDPPSLETG-----VQDKEMLKKYGKSFRKMISL----CLQKDPEKRPTAAELL 281

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 9/155 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++ + + ++ N+V  +      D   +V E++  GSL + +    +          +  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 123
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGDNTHVSTRIVG 123
           +  + L FLH     VI+RD+K+ N+LL  + + KL+DFG  A+  P        + +VG
Sbjct: 124 ECLQALEFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSXMVG 178
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           T  + APE V      PK D++S G++ +E++ G 
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++ + + ++ N+V  +      D   +V E++  GSL + +    +          +  
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE---GQIAAVCR 124
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           +  + L FLH     VI+R++K+ N+LL  + + KL+DFG      T + +  ST +VGT
Sbjct: 125 ECLQALEFLHS--NQVIHRNIKSDNILLGMDGSVKLTDFGFCAQ-ITPEQSKRST-MVGT 180
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             + APE V      PK D++S G++ +E++ G 
Sbjct: 181 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 12/163 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRKGVQP---ISWPT 58
           E+  + Q  H N+V         D   LV + +  GS+ +   H+  KG      +   T
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN---T 115
              I  +V  GL +LH      I+RD+KA N+LL  + + +++DFG++    TG +    
Sbjct: 123 IATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180
Query: 116 HVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSG 157
            V    VGT  + APE +        K+D++SFG+  +EL +G
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLXGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           L KL     ++ N  +V E+ P G + +HL R G      P     A  +     +LH L
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 161
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     K++DFG A+         V  R   + GT  Y APE +
Sbjct: 162 D--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 211
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+   +      E ++  LV   M  G+  N++ +   Q ++   
Sbjct: 71  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDH 126
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ D GLAR   T D     
Sbjct: 127 VQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDGGLARH--TDDEM--- 179
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL+GR
Sbjct: 180 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI--DVARG 69
           L+H ++V+L+   S      +V+EFM    L   + ++      +   V       +   
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 70  LSFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           L + H  D N+I+RD+K  NVLL S  N+   KL DFG+A     G++  V+   VGT  
Sbjct: 143 LRYCH--DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGTPH 198
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           + APE V         DV+  GV+L  LLSG
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+++D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLIIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 ISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEF---MPKGSLENHLFRKGVQPISWPTRVK 61
           E++ L  ++HEN++ L+   + + +    Y+F   MP   ++  L +      S      
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP--FMQTDLQKIMGLKFSEEKIQY 130
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +   + +GL ++H   A V++RDLK  N+ ++ +   K+ DFGLAR        H    +
Sbjct: 131 LVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEM 180
Query: 122 VG---TRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
            G   TR Y APE + +  H     D++S G ++ E+L+G+
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    + P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFAEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 40/268 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGY----CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           +TE+     +RHEN++  I              L+ ++   GSL ++L    +   S   
Sbjct: 79  ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKS--- 135
Query: 59  RVKIAIDVARGLSFLH-------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
            +K+A     GL  LH       G  A + +RDLK+ N+L+  N    ++D GLA     
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLAVKF-I 193
Query: 112 GDNTHV----STRIVGTRGYAAPEYVATG----HLTP--KSDVYSFGVVLLELLSGRRAL 161
            D   V    +TR VGT+ Y  PE +       H      +D+YSFG++L E+   RR +
Sbjct: 194 SDTNEVDIPPNTR-VGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCV 250
Query: 162 DEDRGGLAEQTLVEW-----ADPFLRDSRRVLRIMDTR--LGGQYSKKEAQXXXXXXL-Q 213
               GG+ E+  + +     +DP   D R ++ I   R     ++S  E        + +
Sbjct: 251 S---GGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307
Query: 214 CLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
           C   +P +R + + V  +L ++  S+D+
Sbjct: 308 CWAHNPASRLTALRVKKTLAKMSESQDI 335

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  L+HEN++ L+   + +          LV   M  G+  N++ +   Q +S   
Sbjct: 69  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVK--CQALSDEH 124
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A +I+RDLK SNV ++ +   ++ DFGLAR           
Sbjct: 125 VQFLVYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDCELRILDFGLARQA-----DEEM 177
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL G+
Sbjct: 178 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 89/183 (48%), Gaps = 7/183 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV+ +   +H N+V++       +   ++ EF+  G+L + + +  +      T   +  
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIAT---VCE 148
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            V + L++LH     VI+RD+K+ ++LL  +   KLSDFG         +      +VGT
Sbjct: 149 AVLQALAYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKXLVGT 204
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 184
             + APE ++      + D++S G++++E++ G      D    A + L +   P L++S
Sbjct: 205 PYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNS 264
Query: 185 RRV 187
            +V
Sbjct: 265 HKV 267

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 70/144 (48%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ ++ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 69/141 (48%), Gaps = 12/141 (8%)
Query: 23  YCSESDNRLL--VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV 80
           +C+  D++ L  V E+MP G L N +    V P  W        +V   L  +H +   +
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV-PEKWAKFY--TAEVVLALDAIHSM--GL 195
Query: 81  IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT----G 136
           I+RD+K  N+LLD + + KL+DFG           H  T  VGT  Y +PE + +    G
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-VGTPDYISPEVLKSQGGDG 254
Query: 137 HLTPKSDVYSFGVVLLELLSG 157
           +   + D +S GV L E+L G
Sbjct: 255 YYGRECDWWSVGVFLFEMLVG 275

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 8/158 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+     LRH N++++  Y  +     L+ EF P+G L   L + G              
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFME 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  L + H  +  VI+RD+K  N+L+      K++DFG +   P+         + GT
Sbjct: 122 ELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGT 175
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 162
             Y  PE +       K D++  GV+  E L G    D
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/158 (26%), Positives = 68/158 (43%), Gaps = 8/158 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+     LRH N++++  Y  +     L+ EF P+G L   L + G              
Sbjct: 65  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR--FDEQRSATFME 122
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  L + H  +  VI+RD+K  N+L+      K++DFG +   P+         + GT
Sbjct: 123 ELADALHYCH--ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RXMCGT 176
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD 162
             Y  PE +       K D++  GV+  E L G    D
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  L+HEN++ L+   + +          LV   M  G+  N++ +   Q +S   
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVK--CQALSDEH 132
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A +I+RDLK SNV ++ +   ++ DFGLAR           
Sbjct: 133 VQFLVYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLARQA-----DEEM 185
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL G+
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 69/143 (48%), Gaps = 13/143 (9%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G      P     A  +     +LH L
Sbjct: 98  LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 155
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVA 134
           D  +IYRDLK  N+L+D     +++DFG A+   G T         + GT  Y APE + 
Sbjct: 156 D--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-------XLCGTPEYLAPEIIL 206
Query: 135 TGHLTPKSDVYSFGVVLLELLSG 157
           +       D ++ GV++ E+ +G
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAG 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G      P     A  +     +LH L
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 181
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 182 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 231
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G      P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 18/161 (11%)
Query: 5   EVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  L+HEN++ L+   + +          LV   M  G+  N++ +   Q +S   
Sbjct: 77  ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM--GADLNNIVKS--QALSDEH 132
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A +I+RDLK SNV ++ +   ++ DFGLAR           
Sbjct: 133 VQFLVYQLLRGLKYIHS--AGIIHRDLKPSNVAVNEDSELRILDFGLARQA-----DEEM 185
Query: 119 TRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +    H     D++S G ++ ELL G+
Sbjct: 186 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G      P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  +    +   + +  A 
Sbjct: 61  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAY 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R          ST    +
Sbjct: 119 QLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTXXKAS 170
Query: 125 RG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           +G     + APE +     T  SDV+ FGV + E+L
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L QL H N+ KL  +  +     LV E    G L + +  +  +  S     +I  
Sbjct: 76  EVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIR 133
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRI 121
            V  G+++ H     +++RDLK  N+LL+S   + N ++ DFGL+        TH     
Sbjct: 134 QVLSGITYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS--------THFEASK 183
Query: 122 -----VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
                +GT  Y APE V  G    K DV+S GV+L  LLSG
Sbjct: 184 KXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G      P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 89/215 (41%), Gaps = 17/215 (7%)
Query: 14  HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL 73
           H N+VKL     +  +  LV E +  G L   + +K  +  S      I   +   +S +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHM 122
Query: 74  HGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
           H  D  V++RDLK  N+L    + N   K+ DFG AR  P  DN  + T    T  YAAP
Sbjct: 123 H--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYAAP 178
Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI 190
           E +         D++S GV+L  +LSG+         L   + VE          + ++ 
Sbjct: 179 ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIM--------KKIKK 230
Query: 191 MDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSM 225
            D    G+  K  +Q         L +DP  R  M
Sbjct: 231 GDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKM 265

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 8   YLGQLRHENLVKLIGYCSES----DNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +L    H N+V+L   C+ S    + +L LV+E + +  L  +L +     +   T   +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              + RGL FLH     V++RDLK  N+L+ S+   KL+DFGLAR           T +V
Sbjct: 126 MFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVV 180
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
            T  Y APE +         D++S G +  E+ 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 8   YLGQLRHENLVKLIGYCSES----DNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +L    H N+V+L   C+ S    + +L LV+E + +  L  +L +     +   T   +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              + RGL FLH     V++RDLK  N+L+ S+   KL+DFGLAR           T +V
Sbjct: 126 MFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVV 180
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
            T  Y APE +         D++S G +  E+ 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 110/257 (42%), Gaps = 47/257 (18%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKI 62
           TE+     L + ++V   G+  + D   +V E   + SL E H  RK V   + P     
Sbjct: 75  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAV---TEPEARYF 131
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTHVS 118
                +G+ +LH  +  VI+RDLK  N+ L+ + + K+ DFGLA     DG    +    
Sbjct: 132 MRQTIQGVQYLH--NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD---- 185
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV---- 174
             + GT  Y APE +     + + D++S G +L  LL G+   +       ++T +    
Sbjct: 186 --LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---SCLKETYIRIKK 240
Query: 175 -EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLE 233
            E++ P  R    V   +  R+                   LH DP  RPS+ ++LT  +
Sbjct: 241 NEYSVP--RHINPVASALIRRM-------------------LHADPTLRPSVAELLT--D 277
Query: 234 QLHTSKDMPRTPPPAKL 250
           +  TS   P   P + L
Sbjct: 278 EFFTSGYAPMRLPTSCL 294

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 83/153 (54%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 131
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 132 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 190 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIA 63
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  RK    +   + +  A
Sbjct: 64  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 120
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R          ST    
Sbjct: 121 YQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKA 172
Query: 124 TRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           ++G     + APE +     T  SDV+ FGV + E+L
Sbjct: 173 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 83/153 (54%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 125
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 126 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 184 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 83/153 (54%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 125 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 183 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 83/153 (54%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 127
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 128 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 186 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 86  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETC-TRFYTA-EI 141
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 142 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +     +  SD+++ G ++ +L++G
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 11/153 (7%)
Query: 8   YLGQLRHENLVKLIGYCSES----DNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +L    H N+V+L   C+ S    + +L LV+E + +  L  +L +     +   T   +
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              + RGL FLH     V++RDLK  N+L+ S+   KL+DFGLAR           T +V
Sbjct: 126 MFQLLRGLDFLHS--HRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVV 180
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
            T  Y APE +         D++S G +  E+ 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 110/257 (42%), Gaps = 47/257 (18%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKI 62
           TE+     L + ++V   G+  + D   +V E   + SL E H  RK V   + P     
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAV---TEPEARYF 147
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR----DGPTGDNTHVS 118
                +G+ +LH  +  VI+RDLK  N+ L+ + + K+ DFGLA     DG    +    
Sbjct: 148 MRQTIQGVQYLH--NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKD---- 201
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV---- 174
             + GT  Y APE +     + + D++S G +L  LL G+   +       ++T +    
Sbjct: 202 --LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---SCLKETYIRIKK 256
Query: 175 -EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLE 233
            E++ P  R    V   +  R+                   LH DP  RPS+ ++LT  +
Sbjct: 257 NEYSVP--RHINPVASALIRRM-------------------LHADPTLRPSVAELLT--D 293
Query: 234 QLHTSKDMPRTPPPAKL 250
           +  TS   P   P + L
Sbjct: 294 EFFTSGYAPMRLPTSCL 310

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIA 63
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  RK    +   + +  A
Sbjct: 58  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 114
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R          ST    
Sbjct: 115 YQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKA 166
Query: 124 TRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           ++G     + APE +     T  SDV+ FGV + E+L
Sbjct: 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E+  L    H  +VKL+G         ++ EF P G+++  +     + ++ P    + 
Sbjct: 65  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVC 123
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             +   L+FLH     +I+RDLKA NVL+    + +L+DFG++               +G
Sbjct: 124 RQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIG 179
Query: 124 TRGYAAPEYVATGHL--TP---KSDVYSFGVVLLEL 154
           T  + APE V    +  TP   K+D++S G+ L+E+
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 10/156 (6%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E+  L    H  +VKL+G         ++ EF P G+++  +     + ++ P    + 
Sbjct: 57  VEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVC 115
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             +   L+FLH     +I+RDLKA NVL+    + +L+DFG++               +G
Sbjct: 116 RQMLEALNFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQKRDSFIG 171
Query: 124 TRGYAAPEYVATGHL--TP---KSDVYSFGVVLLEL 154
           T  + APE V    +  TP   K+D++S G+ L+E+
Sbjct: 172 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 83/153 (54%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 126
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 127 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 185 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 39/102 (38%), Positives = 57/102 (55%), Gaps = 8/102 (7%)
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KI +   + L+ L   +  +I+RD+K SN+LLD + N KL DFG++  G   D+    TR
Sbjct: 129 KITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS--GQLVDSI-AKTR 184
Query: 121 IVGTRGYAAPEYV----ATGHLTPKSDVYSFGVVLLELLSGR 158
             G R Y APE +    +      +SDV+S G+ L EL +GR
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 51/89 (57%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S GV++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIA 63
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  RK    +   + +  A
Sbjct: 66  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 122
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R          ST    
Sbjct: 123 YQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKA 174
Query: 124 TRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           ++G     + APE +     T  SDV+ FGV + E+L
Sbjct: 175 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIA 63
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  RK    +   + +  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 117
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R          ST    
Sbjct: 118 YQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKA 169
Query: 124 TRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           ++G     + APE +     T  SDV+ FGV + E+L
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIA 63
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  RK    +   + +  A
Sbjct: 63  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 119
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R          ST    
Sbjct: 120 YQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKA 171
Query: 124 TRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           ++G     + APE +     T  SDV+ FGV + E+L
Sbjct: 172 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIA 63
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  RK    +   + +  A
Sbjct: 61  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 117
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R          ST    
Sbjct: 118 YQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKA 169
Query: 124 TRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           ++G     + APE +     T  SDV+ FGV + E+L
Sbjct: 170 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 63  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 118
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 119 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 177 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 64  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 119
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 120 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 178 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 83/153 (54%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 71  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 128
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 129 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 187 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 77  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 134
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 135 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 192
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 193 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 17/157 (10%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTRVKIA 63
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  RK    +   + +  A
Sbjct: 89  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK--YSLDLASLILYA 145
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R          ST    
Sbjct: 146 YQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKA 197
Query: 124 TRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           ++G     + APE +     T  SDV+ FGV + E+L
Sbjct: 198 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT  Y AP  +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLAPAII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 101 EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 158
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 159 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 216
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 217 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 248

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 61  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 116
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 117 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 175 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 62  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 117
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 118 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 125 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 183 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKI 62
           TE+     L + ++V   G+  + D   +V E   + SL E H  RK V   + P     
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAV---TEPEARYF 147
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
                +G+ +LH  +  VI+RDLK  N+ L+ + + K+ DFGLA       +      + 
Sbjct: 148 MRQTIQGVQYLH--NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATK--IEFDGERKKXLC 203
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV-----EWA 177
           GT  Y APE +     + + D++S G +L  LL G+   +       ++T +     E++
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---SCLKETYIRIKKNEYS 260
Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHT 237
            P  R    V   +  R+                   LH DP  RPS+ ++LT  ++  T
Sbjct: 261 VP--RHINPVASALIRRM-------------------LHADPTLRPSVAELLT--DEFFT 297
Query: 238 SKDMPRTPPPAKL 250
           S   P   P + L
Sbjct: 298 SGYAPMRLPTSCL 310

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 10/149 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGL 70
           L H+++V   G+  ++D   +V E   + SL E H  RK    ++ P        +  G 
Sbjct: 72  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGC 128
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA-RDGPTGDNTHVSTRIVGTRGYAA 129
            +LH     VI+RDLK  N+ L+ +   K+ DFGLA +    G+   V   + GT  Y A
Sbjct: 129 QYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIA 183
Query: 130 PEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           PE ++    + + DV+S G ++  LL G+
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 131
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 132 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 190 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 83/153 (54%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 68  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYV-REHKDNIGSQYLLNWCV 125
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 126 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 184 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 176 -NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/253 (26%), Positives = 108/253 (42%), Gaps = 39/253 (15%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKI 62
           TE+     L + ++V   G+  + D   +V E   + SL E H  RK V   + P     
Sbjct: 91  TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAV---TEPEARYF 147
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
                +G+ +LH  +  VI+RDLK  N+ L+ + + K+ DFGLA       +      + 
Sbjct: 148 MRQTIQGVQYLH--NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATK--IEFDGERKKTLC 203
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV-----EWA 177
           GT  Y APE +     + + D++S G +L  LL G+   +       ++T +     E++
Sbjct: 204 GTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---SCLKETYIRIKKNEYS 260
Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHT 237
            P  R    V   +  R+                   LH DP  RPS+ ++LT  ++  T
Sbjct: 261 VP--RHINPVASALIRRM-------------------LHADPTLRPSVAELLT--DEFFT 297
Query: 238 SKDMPRTPPPAKL 250
           S   P   P + L
Sbjct: 298 SGYAPMRLPTSCL 310

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 125 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 183 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 75/156 (48%), Gaps = 15/156 (9%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  +    +   + +  A 
Sbjct: 441 EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAY 498
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R          ST    +
Sbjct: 499 QLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKAS 550
Query: 125 RG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           +G     + APE +     T  SDV+ FGV + E+L
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 10/149 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGL 70
           L H+++V   G+  ++D   +V E   + SL E H  RK    ++ P        +  G 
Sbjct: 98  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGC 154
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA-RDGPTGDNTHVSTRIVGTRGYAA 129
            +LH     VI+RDLK  N+ L+ +   K+ DFGLA +    G+   V   + GT  Y A
Sbjct: 155 QYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIA 209
Query: 130 PEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           PE ++    + + DV+S G ++  LL G+
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 92  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 149
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 150 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 207
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 208 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 73  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 130
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 131 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 188
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 189 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 80/167 (47%), Gaps = 10/167 (5%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H N++KL           LV E +  G L + +  KG    S       
Sbjct: 96  RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY--SERDAADA 153
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              +   +++LH  +  +++RDLK  N+L  +   +   K++DFGL++     ++  +  
Sbjct: 154 VKQILEAVAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMK 208
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
            + GT GY APE +      P+ D++S G++   LL G     ++RG
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 125 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 183 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 127
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 128 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 186 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 127
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 128 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 186 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 70  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 127
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 128 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 186 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 10/149 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGL 70
           L H+++V   G+  ++D   +V E   + SL E H  RK    ++ P        +  G 
Sbjct: 96  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGC 152
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA-RDGPTGDNTHVSTRIVGTRGYAA 129
            +LH     VI+RDLK  N+ L+ +   K+ DFGLA +    G+   V   + GT  Y A
Sbjct: 153 QYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIA 207
Query: 130 PEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           PE ++    + + DV+S G ++  LL G+
Sbjct: 208 PEVLSKKGHSFEVDVWSIGCIMYTLLVGK 236

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 61  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 119 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 177 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 131
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 132 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 190 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 84  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 139
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 140 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 84  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 139
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 140 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 87  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 142
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 143 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 84  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 139
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 140 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 126
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 127 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 185 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 86  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 141
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 142 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 87  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 142
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 143 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 86  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 141
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 142 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 21/169 (12%)
Query: 3   QTEVIYLGQLRHENLVKLIG------YCSESDNR----------LLVYEFMPKGSLENHL 46
           + EV  L +L H N+V   G      Y  E+ ++           +  EF  KG+LE  +
Sbjct: 52  EREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI 111
Query: 47  FRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 106
            ++  + +     +++   + +G+ ++H     +I RDLK SN+ L      K+ DFGL 
Sbjct: 112 EKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 107 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
               +  N     R  GT  Y +PE +++     + D+Y+ G++L ELL
Sbjct: 170 ---TSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 86  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 141
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 142 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 68  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 123
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 124 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 182 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK-IA 63
           E+  L +L+H+N+V+L           LV+EF  +  L+ +           P  VK   
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFL 107
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             + +GL F H    NV++RDLK  N+L++ N   KL+DFGLAR    G      +  V 
Sbjct: 108 FQLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLADFGLAR--AFGIPVRCYSAEVV 163
Query: 124 TRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGRRAL 161
           T  Y  P+ +    L   S D++S G +  EL +  R L
Sbjct: 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 23/177 (12%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPISWPT 58
           +TE+     LRH+N++  I     S N      L+  +   GSL + L R+ ++P     
Sbjct: 50  ETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HL 106
Query: 59  RVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
            +++A+  A GL+ LH    G      + +RD K+ NVL+ SN    ++D GLA     G
Sbjct: 107 ALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQG 166
Query: 113 -DNTHVSTR-IVGTRGYAAPEYVATGHLT------PKSDVYSFGVVLLELLSGRRAL 161
            D   +     VGT+ Y APE +     T        +D+++FG+VL E+   RR +
Sbjct: 167 SDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTI 221

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 84  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 139
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 140 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ RK        TR   A ++
Sbjct: 83  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EI 138
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 139 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ RK        TR   A ++
Sbjct: 83  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EI 138
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 139 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYV-REHKDNIGSQYLLNWCV 124
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 125 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 183 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T     + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ EL+ G
Sbjct: 193 APEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 174
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 119 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 173
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 214
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 215 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
            E+  L  L H N++KL     +     LV EF   G L   +  +            I 
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIM 152
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSN---FNAKLSDFGLARDGPTGDNTHVSTR 120
             +  G+ +LH    N+++RD+K  N+LL++     N K+ DFGL+       +  +  R
Sbjct: 153 KQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS--SFFSKDYKLRDR 208
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           + GT  Y APE V       K DV+S GV++  LL G
Sbjct: 209 L-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 174
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 174
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 176 -NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 86  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 141
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 142 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 200 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 89  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 144
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 145 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 203 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T     + T  V TR Y 
Sbjct: 136 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TASTNFMMTPYVVTRYYR 190
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ EL+ G
Sbjct: 191 APEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 118
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 119 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 173
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 214
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 215 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 139 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ E++ G
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGL 70
           L H+++V   G+  ++D   +V E   + SL E H  RK    ++ P        +  G 
Sbjct: 74  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGC 130
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
            +LH     VI+RDLK  N+ L+ +   K+ DFGLA       +      + GT  Y AP
Sbjct: 131 QYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKTLCGTPNYIAP 186
Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGR 158
           E ++    + + DV+S G ++  LL G+
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGL 70
           L H+++V   G+  ++D   +V E   + SL E H  RK    ++ P        +  G 
Sbjct: 74  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGC 130
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
            +LH     VI+RDLK  N+ L+ +   K+ DFGLA       +      + GT  Y AP
Sbjct: 131 QYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKTLCGTPNYIAP 186
Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGR 158
           E ++    + + DV+S G ++  LL G+
Sbjct: 187 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 176 -NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 75/151 (49%), Gaps = 8/151 (5%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVY--EFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + +L H   VKL  Y +  D+  L +   +   G L  ++ + G    +  TR   A ++
Sbjct: 86  MSRLDHPFFVKL--YFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETC-TRFYTA-EI 141
Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          +   VGT  
Sbjct: 142 VSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           Y +PE +        SD+++ G ++ +L++G
Sbjct: 200 YVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 26/164 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           E   L    H N++ ++G C    + +  L+  +MP GSL N L       +     VK 
Sbjct: 57  ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS--DFGLARDGPTGDNTHVSTR 120
           A+D+ARG++FLH L+  +    L + +V++D +  A++S  D   +   P          
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP---------- 166
Query: 121 IVGTRGYAAPEYVATGHLTPK--------SDVYSFGVVLLELLS 156
               R Y AP +VA   L  K        +D++SF V+L EL++
Sbjct: 167 ---GRMY-APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 176 -NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 176 -NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 176 -NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGL 70
           L H+++V   G+  ++D   +V E   + SL E H  RK    ++ P        +  G 
Sbjct: 78  LAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGC 134
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
            +LH     VI+RDLK  N+ L+ +   K+ DFGLA       +      + GT  Y AP
Sbjct: 135 QYLH--RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKTLCGTPNYIAP 190
Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGR 158
           E ++    + + DV+S G ++  LL G+
Sbjct: 191 EVLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 176 -NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/144 (30%), Positives = 69/144 (47%), Gaps = 15/144 (10%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL 76
           LVKL     ++ N  +V E++  G + +HL R G    S P     A  +     +LH L
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL 160
Query: 77  DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR---IVGTRGYAAPEYV 133
           D  +IYRDLK  N+L+D     +++DFG A+         V  R   + GT    APE +
Sbjct: 161 D--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEALAPEII 210
Query: 134 ATGHLTPKSDVYSFGVVLLELLSG 157
            +       D ++ GV++ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 64  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 121
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A G+++L   D  +++RDL A NVL+ +  + K++DFGLA+  G      H     V 
Sbjct: 122 QIAEGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 179
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 180 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK-- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 176 -NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 72/164 (43%), Gaps = 22/164 (13%)
Query: 8   YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           Y   L   N VK +    +     +  E+   G+L + +  + +         ++   + 
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQ-QRDEYWRLFRQIL 126
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP---------------TG 112
             LS++H     +I+RDLK  N+ +D + N K+ DFGLA++                 + 
Sbjct: 127 EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 113 DNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELL 155
           DN    T  +GT  Y A E +  TGH   K D+YS G++  E++
Sbjct: 185 DNL---TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 100/235 (42%), Gaps = 34/235 (14%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEK--ESLTEEEATEF 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N+ LLD N      K+ DFGLA     G+     
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 174
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 215
Query: 179 PFLRDSRRV----LRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVL 229
           PFL D+++     +  ++     +Y    +        + L  DPK R ++ D L
Sbjct: 216 PFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDATLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 2   WQ---TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           WQ    EV +L +LRH N ++  G         LV E+   GS  + L     +P+    
Sbjct: 98  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVE 155
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +     +GL++LH    N+I+RD+KA N+LL      KL DFG      +      +
Sbjct: 156 IAAVTHGALQGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFG------SASIMAPA 207
Query: 119 TRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLEL 154
              VGT  + APE +     G    K DV+S G+  +EL
Sbjct: 208 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 50/89 (56%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPEVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ E++ G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 27/185 (14%)
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KIA+ + + L  LH    +VI+RD+K SNVL+++    K+ DFG++  G   D+    T 
Sbjct: 157 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDSV-AKTI 212
Query: 121 IVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
             G + Y APE +       G+ + KSD++S G+ ++EL   R   D             
Sbjct: 213 DAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD------------S 259
Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLT-SLEQ 234
           W  PF    +++ ++++       + K +        QCL  + K RP+  +++      
Sbjct: 260 WGTPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 315
Query: 235 LHTSK 239
           LH SK
Sbjct: 316 LHESK 320

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 21/106 (19%)
Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP--------------- 110
           +   LS++H     +I+RDLK  N+ +D + N K+ DFGLA++                 
Sbjct: 125 ILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 111 TGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELL 155
           + DN    T  +GT  Y A E +  TGH   K D+YS G++  E++
Sbjct: 183 SSDNL---TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 75/162 (46%), Gaps = 22/162 (13%)
Query: 2   WQ---TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS---LENHLFRKGVQPIS 55
           WQ    EV +L +LRH N ++  G         LV E+    +   LE H  +K +Q + 
Sbjct: 59  WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVE 116
Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
                  A+   +GL++LH    N+I+RD+KA N+LL      KL DFG      +    
Sbjct: 117 IAAVTHGAL---QGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFG------SASIM 165
Query: 116 HVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLEL 154
             +   VGT  + APE +     G    K DV+S G+  +EL
Sbjct: 166 APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 49/89 (55%), Gaps = 5/89 (5%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + +    V TR Y 
Sbjct: 140 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMVPFVVTRYYR 194
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G ++ E++ G
Sbjct: 195 APEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 9   LGQLRHENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           L    H N+V+L+  C  S +D  +   LV+E + +  L  +L +     +   T   + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
               RGL FLH     +++RDLK  N+L+ S    KL+DFGLAR           T +V 
Sbjct: 127 RQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALTPVVV 181
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           T  Y APE +         D++S G +  E+ 
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 90/197 (45%), Gaps = 22/197 (11%)
Query: 9   LGQLRHENLVKLIGY---CSESDNRLL----VYEFMPKG--SLENHLFRKGVQPISWPTR 59
           L  L H N+V+L  Y     E D R +    V E++P        + +R+ V P   P  
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP--PIL 130
Query: 60  VKIAI-DVARGLSFLHGLDANVIYRDLKASNVLL-DSNFNAKLSDFGLARD-GPTGDNTH 116
           +K+ +  + R +  LH    NV +RD+K  NVL+ +++   KL DFG A+   P+  N  
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-- 188
Query: 117 VSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
                + +R Y APE +    H T   D++S G +  E++ G       RG  +   L E
Sbjct: 189 --VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF---RGDNSAGQLHE 243
Query: 176 WADPFLRDSRRVLRIMD 192
                   SR VLR ++
Sbjct: 244 IVRVLGCPSREVLRKLN 260

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 126
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFG A+  G      H     V 
Sbjct: 127 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 185 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 87/177 (49%), Gaps = 29/177 (16%)
Query: 5   EVIYLGQLR-HENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           E++ L +L  HEN+V L+      ++R   LV+++M +  L   +    ++P+    +  
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVH---KQY 113
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT---------- 111
           +   + + + +LH     +++RD+K SN+LL++  + K++DFGL+R              
Sbjct: 114 VVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 112 ---------GDNTHVSTRIVGTRGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGR 158
                     D+  + T  V TR Y APE  + +   T   D++S G +L E+L G+
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 71  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 128
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFG A+  G      H     V 
Sbjct: 129 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 187 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 28  DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKA 87
           D   LV EF   GS+ + +       +       I  ++ RGLS LH     VI+RD+K 
Sbjct: 100 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH--QHKVIHRDIKG 157
Query: 88  SNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVSTRIVGTRGYAAPEYVATGH-----LTP 140
            NVLL  N   KL DFG++   D   G         +GT  + APE +A           
Sbjct: 158 QNVLLTENAEVKLVDFGVSAQLDRTVGRR----NTFIGTPYWMAPEVIACDENPDATYDF 213
Query: 141 KSDVYSFGVVLLELLSG 157
           KSD++S G+  +E+  G
Sbjct: 214 KSDLWSLGITAIEMAEG 230

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 82/153 (53%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L++ + MP G L +++ R+    I     +   +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 126
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFG A+  G      H     V 
Sbjct: 127 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 185 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 88/166 (53%), Gaps = 12/166 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           E+  L +L H N+VKL+    +   D+  +V+E + +G +   +    ++P+S       
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARFY 142
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             D+ +G+ +LH     +I+RD+K SN+L+  + + K++DFG++ +    D    +T  V
Sbjct: 143 FQDLIKGIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNT--V 198
Query: 123 GTRGYAAPEYVATGH--LTPKS-DVYSFGVVLLELLSGRRALDEDR 165
           GT  + APE ++      + K+ DV++ GV L   + G+    ++R
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 22/163 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPK--GSLENHLFRKGVQPISW 56
           E+  L  +RHEN++ L+   +  +      +  LV  FM    G L  H  + G   I +
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE-KLGEDRIQF 132
Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
                +   + +GL ++H   A +I+RDLK  N+ ++ +   K+ DFGLAR      ++ 
Sbjct: 133 -----LVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSE 181
Query: 117 VSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGR 158
           +   +V TR Y APE +      T   D++S G ++ E+++G+
Sbjct: 182 MXGXVV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E++ +  + H+N++ L+   +      E  +  LV E M     +        + +S+  
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-- 130
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   +  G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + 
Sbjct: 131 ---LLYQMLXGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           T  V TR Y APE +         D++S G ++ E      L  GR  +D+
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFG A+  G      H     V 
Sbjct: 125 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 182
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 183 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 139 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 84/188 (44%), Gaps = 30/188 (15%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L Q+ H N++ L        + +L+ E +  G L + L +K  + +S       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSF 120
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+++LH     + + DLK  N+ LLD N    + KL DFGLA +   G      
Sbjct: 121 IKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG                   A 
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------------------AS 216
Query: 179 PFLRDSRR 186
           PFL D+++
Sbjct: 217 PFLGDTKQ 224

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 69  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 126
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFG A+  G      H     V 
Sbjct: 127 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 185 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 139 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 193
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 194 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 10/158 (6%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  +  L H  LV L     + ++  +V + +  G L  HL ++ V       ++ I  
Sbjct: 65  ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLFIC- 122
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++   L +L   +  +I+RD+K  N+LLD + +  ++DF +A   P    T ++T + GT
Sbjct: 123 ELVMALDYLQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGT 177
Query: 125 RGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRR 159
           + Y APE  ++      +   D +S GV   ELL GRR
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 132 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 132 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 187 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 227

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 7/158 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L+H+N+V+L           LV+EF  +  L+ + F      +          
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLF 108
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL F H    NV++RDLK  N+L++ N   KL++FGLAR    G      +  V T
Sbjct: 109 QLLKGLGFCHS--RNVLHRDLKPQNLLINRNGELKLANFGLAR--AFGIPVRCYSAEVVT 164
Query: 125 RGYAAPEYVATGHLTPKS-DVYSFGVVLLELLSGRRAL 161
             Y  P+ +    L   S D++S G +  EL +  R L
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 18/176 (10%)
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD     +     
Sbjct: 203 ICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 260
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
                  + APE +     T +SDV+SFGV+L E+ S          G +    V+  + 
Sbjct: 261 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGVKIDEE 311
Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQL 235
           F R  +   R+        Y+  E        L C H +P  RP+  +++  L  L
Sbjct: 312 FCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 137 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 191
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 192 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 232

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGL 70
           L+H N+V+L    SE     LV++ +  G L E+ + R+          ++  ++     
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE----- 114
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
           + LH     V++RDLK  N+LL S       KL+DFGLA +   GD         GT GY
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPGY 172
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
            +PE +         D+++ GV+L  LL G     DED+  L +Q
Sbjct: 173 LSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQ 217

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C  S  +L+  + MP G L +++ R+    I     +   +
Sbjct: 74  EAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYV-REHKDNIGSQYLLNWCV 131
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHVSTRIVG 123
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFG A+  G      H     V 
Sbjct: 132 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 189
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS 156
            + + A E +     T +SDV+S+GV + EL++
Sbjct: 190 IK-WMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 131 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 25/238 (10%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + +L H++LV   G C   D  +LV EF+  GSL+ +L +K    I+   ++++A  +A 
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAA 124
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTR-G 126
            + FL   +  +I+ ++ A N+LL    + K  +    +    G +  V  + I+  R  
Sbjct: 125 AMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 127 YAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 185
           +  PE +    +L   +D +SFG  L E+ SG    D+    L              DS+
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGG---DKPLSAL--------------DSQ 225
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 243
           R L+  + R   Q    +A         C+  +P +RPS   ++  L  L T   +PR
Sbjct: 226 RKLQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 18/176 (10%)
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD     +     
Sbjct: 196 ICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
                  + APE +     T +SDV+SFGV+L E+ S          G +    V+  + 
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGVKIDEE 304
Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQL 235
           F R  +   R+        Y+  E        L C H +P  RP+  +++  L  L
Sbjct: 305 FCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/184 (28%), Positives = 80/184 (43%), Gaps = 21/184 (11%)
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD     +     
Sbjct: 201 ICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 258
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
                  + APE +     T +SDV+SFGV+L E+ S          G +    V+  + 
Sbjct: 259 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGVKIDEE 309
Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPS---MVDVLTSLEQLH 236
           F R  +   R+        Y+  E        L C H +P  RP+   +V+ L +L Q +
Sbjct: 310 FCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 362
Query: 237 TSKD 240
             +D
Sbjct: 363 AQQD 366

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L Q+ H N++ L        + +L+ E +  G L + L +K  + +S       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSF 120
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+++LH     + + DLK  N+ LLD N    + KL DFGLA +   G      
Sbjct: 121 IKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 176 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 230
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 18/176 (10%)
Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD     +     
Sbjct: 194 ICYSFQVAKGMEFLAS--RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 251
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
                  + APE +     T +SDV+SFGV+L E+ S          G +    V+  + 
Sbjct: 252 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS---------LGASPYPGVKIDEE 302
Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQL 235
           F R  +   R+        Y+  E        L C H +P  RP+  +++  L  L
Sbjct: 303 FCRRLKEGTRMR----APDYTTPE---MYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 79/170 (46%), Gaps = 30/170 (17%)
Query: 12  LRHENLVKLI--GYCSESDNR---LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + H+N+ + I       +D R   LLV E+ P GSL  +L    +    W +  ++A  V
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSV 120
Query: 67  ARGLSFLHG-------LDANVIYRDLKASNVLLDSNFNAKLSDFGLA------RDGPTGD 113
            RGL++LH            + +RDL + NVL+ ++    +SDFGL+      R    G+
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLT--------PKSDVYSFGVVLLELL 155
             + +   VGT  Y APE V  G +          + D+Y+ G++  E+ 
Sbjct: 181 EDNAAISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 131 GIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 185
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L Q+ H N++ L        + +L+ E +  G L + L +K  + +S       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSF 120
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+++LH     + + DLK  N+ LLD N    + KL DFGLA +   G      
Sbjct: 121 IKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 25/238 (10%)
Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + +L H++LV   G C   D  +LV EF+  GSL+ +L +K    I+   ++++A  +A 
Sbjct: 66  MSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAW 124
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-IVGTR-G 126
            + FL   +  +I+ ++ A N+LL    + K  +    +    G +  V  + I+  R  
Sbjct: 125 AMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP 182
Query: 127 YAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 185
           +  PE +    +L   +D +SFG  L E+ SG    D+    L              DS+
Sbjct: 183 WVPPECIENPKNLNLATDKWSFGTTLWEICSGG---DKPLSAL--------------DSQ 225
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPR 243
           R L+  + R   Q    +A         C+  +P +RPS   ++  L  L T   +PR
Sbjct: 226 RKLQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPR 281

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  +    +   + +  A 
Sbjct: 61  EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAY 118
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  L++L       ++RD+ A NVL+ +    KL DFGL+R          ST    +
Sbjct: 119 QLSTALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSR------YMEDSTYYKAS 170
Query: 125 RG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           +G     + APE +     T  SDV+ FGV + E+L
Sbjct: 171 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 176 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 230
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 231 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L Q+ H N++ L        + +L+ E +  G L + L +K  + +S       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSF 120
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+++LH     + + DLK  N+ LLD N    + KL DFGLA +   G      
Sbjct: 121 IKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
           E++ +  + H+N++ L+   +      E  +  LV E M     +        + +S+  
Sbjct: 73  ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-- 130
Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   +  G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + 
Sbjct: 131 ---LLYQMLCGIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMM 182
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           T  V TR Y APE +         D++S G ++ E      L  GR  +D+
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L Q+ H N++ L        + +L+ E +  G L + L +K  + +S       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSF 120
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+++LH     + + DLK  N+ LLD N    + KL DFGLA +   G      
Sbjct: 121 IKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 8/155 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  +  LRH  LV L     + +  +++YEFM  G L   +  +  + +S    V+   
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMR 156
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIV 122
            V +GL  +H  + N ++ DLK  N++  +  +   KL DFGL        +  V+T   
Sbjct: 157 QVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 211
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           GT  +AAPE      +   +D++S GV+   LLSG
Sbjct: 212 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDXTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 8/155 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  +  LRH  LV L     + +  +++YEFM  G L   +  +  + +S    V+   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMR 262
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIV 122
            V +GL  +H  + N ++ DLK  N++  +  +   KL DFGL        +  V+T   
Sbjct: 263 QVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 317
Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           GT  +AAPE      +   +D++S GV+   LLSG
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 89/186 (47%), Gaps = 29/186 (15%)
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KIA+ + + L  LH    +VI+RD+K SNVL+++    K+ DFG++  G   D+  V+  
Sbjct: 113 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGIS--GYLVDD--VAKD 167
Query: 121 I-VGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
           I  G + Y APE +       G+ + KSD++S G+ ++EL   R   D            
Sbjct: 168 IDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD------------ 214
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTS-LE 233
            W  PF    +++ ++++       + K +        QCL  + K RP+  +++     
Sbjct: 215 SWGTPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF 270
Query: 234 QLHTSK 239
            LH SK
Sbjct: 271 TLHESK 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L Q+ H N++ L        + +L+ E +  G L + L +K  + +S       
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSF 120
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+++LH     + + DLK  N+ LLD N    + KL DFGLA +   G      
Sbjct: 121 IKQILDGVNYLHT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L ++RH N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 63  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQF 120
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH     + + DLK  N+ LLD N      KL DFG+A     G+     
Sbjct: 121 LKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--- 175
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 78/161 (48%), Gaps = 19/161 (11%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSL---ENHLFRKGVQPISW-P 57
           ++ E+  +  +++E  +   G  +  D   ++YE+M   S+   + + F        + P
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 58  TRVKIAI--DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
            +V   I   V    S++H  + N+ +RD+K SN+L+D N   KLSDFG +         
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESE-------Y 201
Query: 116 HVSTRIVGTRG---YAAPEYVA--TGHLTPKSDVYSFGVVL 151
            V  +I G+RG   +  PE+ +  + +   K D++S G+ L
Sbjct: 202 MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L ++RH N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 56  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQF 113
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH     + + DLK  N+ LLD N      KL DFG+A     G+     
Sbjct: 114 LKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--- 168
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 143 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 197
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 198 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 238

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + T  V TR Y 
Sbjct: 132 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYR 186
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 187 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 227

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 9   LGQLRHENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           L    H N+V+L+  C  S +D  +   LV+E + +  L  +L +     +   T   + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
               RGL FLH     +++RDLK  N+L+ S    KL+DFGLAR             +V 
Sbjct: 119 RQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALAPVVV 173
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           T  Y APE +         D++S G +  E+ 
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 74/156 (47%), Gaps = 15/156 (9%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + + Q  H ++VKLIG  +E +   ++ E    G L + L  +    +   + +  A 
Sbjct: 441 EALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAY 498
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  L++L       ++RD+ A NVL+ +    KL DFGL+R          ST    +
Sbjct: 499 QLSTALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSR------YMEDSTYYKAS 550
Query: 125 RG-----YAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           +G     + APE +     T  SDV+ FGV + E+L
Sbjct: 551 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 11/159 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L ++RH N++ L        + +L+ E +  G L + L  K  + ++     + 
Sbjct: 77  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQF 134
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNV-LLDSNF---NAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH     + + DLK  N+ LLD N      KL DFG+A     G+     
Sbjct: 135 LKQILDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--- 189
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 190 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI--DVARG 69
           L+H ++V+L+   S      +V+EFM    L   + ++      +   V       +   
Sbjct: 85  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 144
Query: 70  LSFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           L + H  D N+I+RD+K   VLL S  N+   KL  FG+A     G++  V+   VGT  
Sbjct: 145 LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPH 200
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           + APE V         DV+  GV+L  LLSG
Sbjct: 201 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 75/152 (49%), Gaps = 21/152 (13%)
Query: 17  LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV--KIAIDVARGLSFL- 73
           +V+  G    + +  +  E M  G+    L ++   PI  P R+  K+ + + + L +L 
Sbjct: 86  IVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPI--PERILGKMTVAIVKALYYLK 141
Query: 74  --HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE 131
             HG    VI+RD+K SN+LLD     KL DFG++  G   D+     R  G   Y APE
Sbjct: 142 EKHG----VIHRDVKPSNILLDERGQIKLCDFGIS--GRLVDD-KAKDRSAGCAAYMAPE 194
Query: 132 YVATGHLTP-----KSDVYSFGVVLLELLSGR 158
            +     T      ++DV+S G+ L+EL +G+
Sbjct: 195 RIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 66/144 (45%), Gaps = 19/144 (13%)
Query: 23  YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWP----TRVKIAIDVARGLSFLHGLD 77
           Y  + D  L +V E+MP G L N +    V P  W       V +A+D    + F+H   
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFIH--- 196
Query: 78  ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-- 135
                RD+K  N+LLD + + KL+DFG              T  VGT  Y +PE + +  
Sbjct: 197 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQG 250
Query: 136 --GHLTPKSDVYSFGVVLLELLSG 157
             G+   + D +S GV L E+L G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 66/144 (45%), Gaps = 19/144 (13%)
Query: 23  YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWP----TRVKIAIDVARGLSFLHGLD 77
           Y  + D  L +V E+MP G L N +    V P  W       V +A+D    + F+H   
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFIH--- 196
Query: 78  ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-- 135
                RD+K  N+LLD + + KL+DFG              T  VGT  Y +PE + +  
Sbjct: 197 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQG 250
Query: 136 --GHLTPKSDVYSFGVVLLELLSG 157
             G+   + D +S GV L E+L G
Sbjct: 251 GDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI--DVARG 69
           L+H ++V+L+   S      +V+EFM    L   + ++      +   V       +   
Sbjct: 83  LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 70  LSFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           L + H  D N+I+RD+K   VLL S  N+   KL  FG+A     G++  V+   VGT  
Sbjct: 143 LRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPH 198
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           + APE V         DV+  GV+L  LLSG
Sbjct: 199 FMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 66/144 (45%), Gaps = 19/144 (13%)
Query: 23  YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWP----TRVKIAIDVARGLSFLHGLD 77
           Y  + D  L +V E+MP G L N +    V P  W       V +A+D    + F+H   
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDV-PEKWARFYTAEVVLALDAIHSMGFIH--- 191
Query: 78  ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-- 135
                RD+K  N+LLD + + KL+DFG              T  VGT  Y +PE + +  
Sbjct: 192 -----RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQG 245
Query: 136 --GHLTPKSDVYSFGVVLLELLSG 157
             G+   + D +S GV L E+L G
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 9   LGQLRHENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           L    H N+V+L+  C  S +D  +   LV+E + +  L  +L +     +   T   + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
               RGL FLH     +++RDLK  N+L+ S    KL+DFGLAR             +V 
Sbjct: 119 RQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALDPVVV 173
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           T  Y APE +         D++S G +  E+ 
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 8/153 (5%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+     L H N+++L  Y  +     L+ E+ P+G L   L +             I  
Sbjct: 73  EIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCT--FDEQRTATIME 130
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  L + HG    VI+RD+K  N+LL      K++DFG +   P+         + GT
Sbjct: 131 ELADALMYCHG--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR----KTMCGT 184
Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             Y  PE +       K D++  GV+  ELL G
Sbjct: 185 LDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGL 70
           L+H N+V+L    SE  +  L+++ +  G L E+ + R+          ++  ++     
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE----- 132
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
           + LH     V++RDLK  N+LL S       KL+DFGLA +              GT GY
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPGY 190
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
            +PE +         D+++ GV+L  LL G     DED+  L +Q
Sbjct: 191 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 235

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL--ARDGPTGDNTHVST 119
           I I +A  + FLH     +++RDLK SN+    +   K+ DFGL  A D    + T ++ 
Sbjct: 169 IFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 120 R--------IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
                     VGT+ Y +PE +   + + K D++S G++L ELL
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 11/152 (7%)
Query: 9   LGQLRHENLVKLIGYC--SESDNRL---LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           L    H N+V+L+  C  S +D  +   LV+E + +  L  +L +     +   T   + 
Sbjct: 60  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 118
Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
               RGL FLH     +++RDLK  N+L+ S    KL+DFGLAR             +V 
Sbjct: 119 RQFLRGLDFLHA--NCIVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMALFPVVV 173
Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
           T  Y APE +         D++S G +  E+ 
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E+  L +L+H N+VKL          +LV+E + +  L+  L     G++ +   T    
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV---TAKSF 105
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +  G+++ H  D  V++RDLK  N+L++     K++DFGLAR    G      T  V
Sbjct: 106 LLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEV 161
Query: 123 GTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSG 157
            T  Y AP+ +  +   +   D++S G +  E+++G
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E+  L +L+H N+VKL          +LV+E + +  L+  L     G++ +   T    
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV---TAKSF 105
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +  G+++ H  D  V++RDLK  N+L++     K++DFGLAR    G      T  V
Sbjct: 106 LLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEV 161
Query: 123 GTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSG 157
            T  Y AP+ +  +   +   D++S G +  E+++G
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  + QL H NL++L       ++ +LV E++  G L + +  +        T +  
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT-ILF 192
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK---LSDFGLARDGPTGDNTHVST 119
              +  G+  +H +   +++ DLK  N+L   N +AK   + DFGLAR     +   V+ 
Sbjct: 193 MKQICEGIRHMHQM--YILHLDLKPENILC-VNRDAKQIKIIDFGLARRYKPREKLKVN- 248
Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
              GT  + APE V    ++  +D++S GV+   LLSG
Sbjct: 249 --FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 12/104 (11%)
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL--ARDGPTGDNTHVS- 118
           I + +A  + FLH     +++RDLK SN+    +   K+ DFGL  A D    + T ++ 
Sbjct: 123 IFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 119 -------TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL 155
                  T  VGT+ Y +PE +     + K D++S G++L ELL
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 11/156 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVKI 62
           E+  L +L+H N+VKL          +LV+E + +  L+  L     G++ +   T    
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESV---TAKSF 105
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +  G+++ H  D  V++RDLK  N+L++     K++DFGLAR    G      T  +
Sbjct: 106 LLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLAR--AFGIPVRKYTHEI 161
Query: 123 GTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSG 157
            T  Y AP+ +  +   +   D++S G +  E+++G
Sbjct: 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 11/160 (6%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRV 60
           + E+  L  L H N++K+     +  N  +V E    G L   +       + +S     
Sbjct: 68  EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLL-DSNFNA--KLSDFGLARDGPTGDNTHV 117
           ++   +   L++ H    +V+++DLK  N+L  D++ ++  K+ DFGLA    + ++   
Sbjct: 128 ELMKQMMNALAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--- 182
Query: 118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           ST   GT  Y APE V    +T K D++S GVV+  LL+G
Sbjct: 183 STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 146
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 147 LYTSKRPNAILKLTDFGFAKETTSHNSL---TEPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 204 GVIMYILLCG 213

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 21/106 (19%)
Query: 66  VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP--------------- 110
           +   LS++H     +I+R+LK  N+ +D + N K+ DFGLA++                 
Sbjct: 125 ILEALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 111 TGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELL 155
           + DN    T  +GT  Y A E +  TGH   K D YS G++  E +
Sbjct: 183 SSDNL---TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 14/169 (8%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H  ++K+  +  ++++  +V E M  G L + +   G + +   T    
Sbjct: 69  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLY 125
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVST 119
              +   + +LH  +  +I+RDLK  NVLL S       K++DFG ++    G+ + + T
Sbjct: 126 FYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 181
Query: 120 RIVGTRGYAAPEY---VATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
            + GT  Y APE    V T       D +S GV+L   LSG     E R
Sbjct: 182 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 229

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 9/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L++ E M  G L + +  +G Q  +     +I  D+   + FLH    N+ +RD+K  N+
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENL 140
Query: 91  LLDSNFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S       KL+DFG A++  T  N   +     T  Y APE +         D++S 
Sbjct: 141 LYTSKEKDAVLKLTDFGFAKE--TTQNALQTP--CYTPYYVAPEVLGPEKYDKSCDMWSL 196
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 197 GVIMYILLCG 206

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 14/169 (8%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H  ++K+  +  ++++  +V E M  G L + +   G + +   T    
Sbjct: 62  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLY 118
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVST 119
              +   + +LH  +  +I+RDLK  NVLL S       K++DFG ++    G+ + + T
Sbjct: 119 FYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 174
Query: 120 RIVGTRGYAAPEY---VATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
            + GT  Y APE    V T       D +S GV+L   LSG     E R
Sbjct: 175 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 222

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/169 (32%), Positives = 82/169 (48%), Gaps = 20/169 (11%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RKGVQPISWPTRVK 61
           + E++Y  Q  H N+++LI +  E D   LV+E M  GS+ +H+  R+    +     V+
Sbjct: 60  EVEMLYQCQ-GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ 118
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARD-GPTGDNTHV 117
              DVA  L FLH  +  + +RDLK  N+L +        K+ DFGL       GD + +
Sbjct: 119 ---DVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPI 173
Query: 118 ST----RIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSG 157
           ST       G+  Y APE V            + D++S GV+L  LLSG
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 14/169 (8%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H  ++K+  +  ++++  +V E M  G L + +   G + +   T    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLY 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVST 119
              +   + +LH  +  +I+RDLK  NVLL S       K++DFG ++    G+ + + T
Sbjct: 120 FYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 175
Query: 120 RIVGTRGYAAPEY---VATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
            + GT  Y APE    V T       D +S GV+L   LSG     E R
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 14/169 (8%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H  ++K+  +  ++++  +V E M  G L + +   G + +   T    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLY 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVST 119
              +   + +LH  +  +I+RDLK  NVLL S       K++DFG ++    G+ + + T
Sbjct: 120 FYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 175
Query: 120 RIVGTRGYAAPEY---VATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
            + GT  Y APE    V T       D +S GV+L   LSG     E R
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 14/169 (8%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H  ++K+  +  ++++  +V E M  G L + +   G + +   T    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLY 119
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVST 119
              +   + +LH  +  +I+RDLK  NVLL S       K++DFG ++    G+ + + T
Sbjct: 120 FYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 175
Query: 120 RIVGTRGYAAPEY---VATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
            + GT  Y APE    V T       D +S GV+L   LSG     E R
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 113/266 (42%), Gaps = 48/266 (18%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRKGVQPISW 56
           +TE+     LRHEN++  I   S+  +R       L+  +   GSL ++L    +  +S 
Sbjct: 50  ETELYNTVMLRHENILGFIA--SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS- 106
Query: 57  PTRVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLA---- 106
              ++I + +A GL+ LH    G      + +RDLK+ N+L+  N    ++D GLA    
Sbjct: 107 --CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 107 ---RDGPTGDNTHVSTRIVGTRGYAAPEY------VATGHLTPKSDVYSFGVVLLELLSG 157
                   G+N       VGT+ Y APE       V       + D+++FG+VL E+   
Sbjct: 165 QSTNQLDVGNNPR-----VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--A 217
Query: 158 RRALDEDRGGLAEQTL-----VEWADPFLRDSRRVLRIMDTR---LGGQYSKKEAQXXXX 209
           RR +     G+ E        V   DP   D R+V+ +   R       +S         
Sbjct: 218 RRMVS---NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK 274
Query: 210 XXLQCLHMDPKNRPSMVDVLTSLEQL 235
              +C + +P  R + + +  +L ++
Sbjct: 275 LMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 61/130 (46%), Gaps = 9/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L++ E M  G L + +  +G Q  +     +I  D+   + FLH    N+ +RD+K  N+
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS--HNIAHRDVKPENL 159
Query: 91  LLDSNFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S       KL+DFG A++  T  N   +     T  Y APE +         D++S 
Sbjct: 160 LYTSKEKDAVLKLTDFGFAKE--TTQNALQTP--CYTPYYVAPEVLGPEKYDKSCDMWSL 215
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 216 GVIMYILLCG 225

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 113/266 (42%), Gaps = 48/266 (18%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRKGVQPISW 56
           +TE+     LRHEN++  I   S+  +R       L+  +   GSL ++L    +  +S 
Sbjct: 50  ETELYNTVMLRHENILGFIA--SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS- 106
Query: 57  PTRVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLA---- 106
              ++I + +A GL+ LH    G      + +RDLK+ N+L+  N    ++D GLA    
Sbjct: 107 --CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 107 ---RDGPTGDNTHVSTRIVGTRGYAAPEY------VATGHLTPKSDVYSFGVVLLELLSG 157
                   G+N       VGT+ Y APE       V       + D+++FG+VL E+   
Sbjct: 165 QSTNQLDVGNNPR-----VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--A 217
Query: 158 RRALDEDRGGLAEQTL-----VEWADPFLRDSRRVLRIMDTR---LGGQYSKKEAQXXXX 209
           RR +     G+ E        V   DP   D R+V+ +   R       +S         
Sbjct: 218 RRMVS---NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK 274
Query: 210 XXLQCLHMDPKNRPSMVDVLTSLEQL 235
              +C + +P  R + + +  +L ++
Sbjct: 275 LMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 192
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 193 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 250 GVIMYILLCG 259

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + +    V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 53.9 bits (128), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 198
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 199 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 255
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 256 GVIMYILLCG 265

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 148
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 149 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 206 GVIMYILLCG 215

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 148
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 149 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 205
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 206 GVIMYILLCG 215

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 146
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 147 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 203
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 204 GVIMYILLCG 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 153
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 154 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 210
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 211 GVIMYILLCG 220

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 152
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 153 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 209
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 210 GVIMYILLCG 219

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 147
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 148 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 204
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 205 GVIMYILLCG 214

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 154
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 155 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 211
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 212 GVIMYILLCG 221

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/240 (25%), Positives = 103/240 (42%), Gaps = 46/240 (19%)
Query: 14  HENLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRKGVQPIS-WPTRVKIAIDVARGLS 71
           H  +++L+ +    +  +LV E  +P   L +++  KG  P+   P+R      VA   +
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVA---A 151
Query: 72  FLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFG---LARDGPTGDNTHVSTRIVGTRGY 127
             H     V++RD+K  N+L+D     AKL DFG   L  D P  D         GTR Y
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-------GTRVY 204
Query: 128 AAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 185
           + PE+++    H  P + V+S G++L +++ G                     PF RD  
Sbjct: 205 SPPEWISRHQYHALPAT-VWSLGILLYDMVCGDI-------------------PFERDQ- 243
Query: 186 RVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTP 245
               I++  L   +    +        +CL   P +RPS+ ++L        ++D+P  P
Sbjct: 244 ---EILEAEL--HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNP 298

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 7/155 (4%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  L  L+H N+V L        +  LV+E++ K  L+ +L   G   I+         
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG-NIINMHNVKLFLF 107
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + RGL++ H     V++RDLK  N+L++     KL+DFGLAR       T+ +   V T
Sbjct: 108 QLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE--VVT 163
Query: 125 RGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  P+  + +   + + D++  G +  E+ +GR
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 24/163 (14%)
Query: 2   WQTEVIYLGQLRHENLVKLIGYCS-ESDNR-----LLVYEFMPKGSLENHLFRKGVQPI- 54
           ++ E   L  L+H N+V+   Y S ES  +     +LV E    G+L+ +L R  V  I 
Sbjct: 72  FKEEAEXLKGLQHPNIVRF--YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIK 129
Query: 55  ---SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGP 110
              SW  ++       +GL FLH     +I+RDLK  N+ +     + K+ D GLA    
Sbjct: 130 VLRSWCRQI------LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---- 179
Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE 153
           T      +  ++GT  + APE     +     DVY+FG   LE
Sbjct: 180 TLKRASFAKAVIGTPEFXAPEXYEEKY-DESVDVYAFGXCXLE 221

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 113/266 (42%), Gaps = 48/266 (18%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRKGVQPISW 56
           +TE+     LRHEN++  I   S+  +R       L+  +   GSL ++L    +  +S 
Sbjct: 79  ETELYNTVMLRHENILGFIA--SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS- 135
Query: 57  PTRVKIAIDVARGLSFLH----GLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLA---- 106
              ++I + +A GL+ LH    G      + +RDLK+ N+L+  N    ++D GLA    
Sbjct: 136 --CLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 193
Query: 107 ---RDGPTGDNTHVSTRIVGTRGYAAPEY------VATGHLTPKSDVYSFGVVLLELLSG 157
                   G+N       VGT+ Y APE       V       + D+++FG+VL E+   
Sbjct: 194 QSTNQLDVGNNPR-----VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--A 246
Query: 158 RRALDEDRGGLAEQTL-----VEWADPFLRDSRRVLRIMDTR---LGGQYSKKEAQXXXX 209
           RR +     G+ E        V   DP   D R+V+ +   R       +S         
Sbjct: 247 RRMVS---NGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAK 303
Query: 210 XXLQCLHMDPKNRPSMVDVLTSLEQL 235
              +C + +P  R + + +  +L ++
Sbjct: 304 LMKECWYQNPSARLTALRIKKTLTKI 329

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 14/169 (8%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H  ++K+  +  ++++  +V E M  G L + +   G + +   T    
Sbjct: 188 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLY 244
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVST 119
              +   + +LH  +  +I+RDLK  NVLL S       K++DFG ++    G+ + + T
Sbjct: 245 FYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 300
Query: 120 RIVGTRGYAAPEY---VATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
            + GT  Y APE    V T       D +S GV+L   LSG     E R
Sbjct: 301 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 75/156 (48%), Gaps = 7/156 (4%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVK 61
           Q E    G+L+  ++V +  +  E D +L V   +  G  L   L R+G  P++ P  V 
Sbjct: 82  QREARTAGRLQEPHVVPIHDF-GEIDGQLYVDXRLINGVDLAAXLRRQG--PLAPPRAVA 138
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           I   +  G +      A   +RD+K  N+L+ ++  A L DFG+A    T +        
Sbjct: 139 IVRQI--GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA-SATTDEKLTQLGNT 195
Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           VGT  Y APE  +  H T ++D+Y+   VL E L+G
Sbjct: 196 VGTLYYXAPERFSESHATYRADIYALTCVLYECLTG 231

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--NIAHRDVKPENL 162
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D++S 
Sbjct: 163 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSL 219
Query: 148 GVVLLELLSG 157
           GV++  LL G
Sbjct: 220 GVIMYILLCG 229

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 12/165 (7%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARGL 70
           L+H N+V+L    SE  +  L+++ +  G L E+ + R+          ++  ++     
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE----- 121
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
           + LH     V++R+LK  N+LL S       KL+DFGLA +              GT GY
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGY 179
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
            +PE +         D+++ GV+L  LL G     DED+  L +Q
Sbjct: 180 LSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ 224

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 14/169 (8%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H  ++K+  +  ++++  +V E M  G L + +   G + +   T    
Sbjct: 202 ETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVV--GNKRLKEATCKLY 258
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVST 119
              +   + +LH  +  +I+RDLK  NVLL S       K++DFG ++    G+ + + T
Sbjct: 259 FYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 314
Query: 120 RIVGTRGYAAPEY---VATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
            + GT  Y APE    V T       D +S GV+L   LSG     E R
Sbjct: 315 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 362

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 52/101 (51%), Gaps = 11/101 (10%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + +    V TR Y 
Sbjct: 138 GIKHLHS--AGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMEPEVVTRYYR 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLE------LLSGRRALDE 163
           APE +         D++S G ++ E      L  GR  +D+
Sbjct: 193 APEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQ 233

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 10/164 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L+H N+V+L    SE     LV++ +  G L   +  +  +  S          +   ++
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCIHQILESVN 144
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
            +H  D  +++RDLK  N+LL S       KL+DFGLA +              GT GY 
Sbjct: 145 HIHQHD--IVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGEQQAWFGFAGTPGYL 200
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
           +PE +         D+++ GV+L  LL G     DED+  L +Q
Sbjct: 201 SPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQ 244

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 23/165 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYC---SESDNRL-----LVYEFMP---KGSLENHLFRKGVQP 53
           E+  L  L+HEN+V LI  C   +   NR      LV++F      G L N L +  +  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
           I      ++   +  GL ++H     +++RD+KA+NVL+  +   KL+DFGLAR      
Sbjct: 126 IK-----RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 114 NTH---VSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLEL 154
           N+       R+V T  Y  PE  +      P  D++  G ++ E+
Sbjct: 179 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 23/167 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYC---SESDNRL-----LVYEFMP---KGSLENHLFRKGVQP 53
           E+  L  L+HEN+V LI  C   +   NR      LV++F      G L N L +  +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
           I      ++   +  GL ++H     +++RD+KA+NVL+  +   KL+DFGLAR      
Sbjct: 127 IK-----RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 114 NTH---VSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLS 156
           N+       R+V T  Y  PE  +      P  D++  G ++ E+ +
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 23/167 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYC---SESDNRL-----LVYEFMP---KGSLENHLFRKGVQP 53
           E+  L  L+HEN+V LI  C   +   NR      LV++F      G L N L +  +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
           I      ++   +  GL ++H     +++RD+KA+NVL+  +   KL+DFGLAR      
Sbjct: 127 IK-----RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 114 NTH---VSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLS 156
           N+       R+V T  Y  PE  +      P  D++  G ++ E+ +
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 89/172 (51%), Gaps = 25/172 (14%)
Query: 5   EVIYLGQLRHENLVKL--------------IGYCSESDNRLLVYEFMPKGSLENHLFRKG 50
           E+  + +L H+N+VK+              +G  +E ++  +V E+M +  L N +  +G
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLAN-VLEQG 115
Query: 51  VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLAR-- 107
             P+           + RGL ++H   ANV++RDLK +N+ +++ +   K+ DFGLAR  
Sbjct: 116 --PLLEEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 158
           D       H+S  +V T+ Y +P  + +  + T   D+++ G +  E+L+G+
Sbjct: 172 DPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 79/167 (47%), Gaps = 23/167 (13%)
Query: 5   EVIYLGQLRHENLVKLIGYC---SESDNRL-----LVYEFMP---KGSLENHLFRKGVQP 53
           E+  L  L+HEN+V LI  C   +   NR      LV++F      G L N L +  +  
Sbjct: 67  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 126
Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
           I      ++   +  GL ++H     +++RD+KA+NVL+  +   KL+DFGLAR      
Sbjct: 127 IK-----RVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 114 NTH---VSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLS 156
           N+       R+V T  Y  PE  +      P  D++  G ++ E+ +
Sbjct: 180 NSQPNRYXNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 52/106 (49%), Gaps = 22/106 (20%)
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG----LARDGPTGDNTHV 117
           IAID    L ++H        RD+K  N+L+D N + +L+DFG    L  DG     T  
Sbjct: 186 IAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLMEDG-----TVQ 232
Query: 118 STRIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSGR 158
           S+  VGT  Y +PE +       G   P+ D +S GV + E+L G 
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/186 (27%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KIA+ + + L  LH    +VI+RD+K SNVL+++    K  DFG++  G   D+  V+  
Sbjct: 140 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKXCDFGIS--GYLVDD--VAKD 194
Query: 121 I-VGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
           I  G + Y APE +       G+ + KSD++S G+  +EL   R   D            
Sbjct: 195 IDAGCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIELAILRFPYD------------ 241
Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQXXXXXXLQCLHMDPKNRPSMVDVLT-SLE 233
            W  PF    +++ ++++       + K +        QCL  + K RP+  ++      
Sbjct: 242 SWGTPF----QQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELXQHPFF 297
Query: 234 QLHTSK 239
            LH SK
Sbjct: 298 TLHESK 303

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 18/168 (10%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E +Y  Q  ++N+++LI +  +     LV+E +  GS+  H+ ++  +  +     ++
Sbjct: 60  EVETLYQCQ-GNKNILELIEFFEDDTRFYLVFEKLQGGSILAHIQKQ--KHFNEREASRV 116
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLA-----RDGPTGDN 114
             DVA  L FLH     + +RDLK  N+L +S       K+ DF L       +  T   
Sbjct: 117 VRDVAAALDFLH--TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPIT 174
Query: 115 THVSTRIVGTRGYAAPEYVA--TGHLT---PKSDVYSFGVVLLELLSG 157
           T   T   G+  Y APE V   T   T    + D++S GVVL  +LSG
Sbjct: 175 TPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 14/102 (13%)
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +AID    L ++H        RD+K  NVLLD N + +L+DFG        D T  S+  
Sbjct: 186 LAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFGSCLK-MNDDGTVQSSVA 236
Query: 122 VGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSGR 158
           VGT  Y +PE +       G   P+ D +S GV + E+L G 
Sbjct: 237 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 13/166 (7%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARG 69
           +L+H N+V+L     E     LV++ +  G L E+ + R+          ++    +   
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILES 116
Query: 70  LSFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           +++ H     +++R+LK  N+LL S       KL+DFGLA +    +  H      GT G
Sbjct: 117 IAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPG 171
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
           Y +PE +     +   D+++ GV+L  LL G     DED+  L  Q
Sbjct: 172 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 217

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 11/165 (6%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +L+H N+V+L     E     LV++ +  G L   +  +  +  S          +   +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESI 118
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
           ++ H     +++R+LK  N+LL S       KL+DFGLA +    +  H      GT GY
Sbjct: 119 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGY 173
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
            +PE +     +   D+++ GV+L  LL G     DED+  L  Q
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 218

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 50/102 (49%), Gaps = 14/102 (13%)
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +AID    L ++H        RD+K  NVLLD N + +L+DFG        D T  S+  
Sbjct: 202 LAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADFGSCLK-MNDDGTVQSSVA 252
Query: 122 VGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSGR 158
           VGT  Y +PE +       G   P+ D +S GV + E+L G 
Sbjct: 253 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 13/166 (7%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSL-ENHLFRKGVQPISWPTRVKIAIDVARG 69
           +L+H N+V+L     E     LV++ +  G L E+ + R+          ++    +   
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---QILES 117
Query: 70  LSFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           +++ H     +++R+LK  N+LL S       KL+DFGLA +    +  H      GT G
Sbjct: 118 IAYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPG 172
Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
           Y +PE +     +   D+++ GV+L  LL G     DED+  L  Q
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 218

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 75/165 (45%), Gaps = 11/165 (6%)
Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           +L+H N+V+L     E     LV++ +  G L   +  +  +  S          +   +
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESI 141
Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
           ++ H     +++R+LK  N+LL S       KL+DFGLA +    +  H      GT GY
Sbjct: 142 AYCHS--NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGY 196
Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
            +PE +     +   D+++ GV+L  LL G     DED+  L  Q
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ 241

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 48/235 (20%)
Query: 14  HENLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRK-----GVQPISWPTRVKIAIDVA 67
           H N+++   +C+E D +       +   +L+ ++ +K     G++PI+      +     
Sbjct: 77  HPNVIRY--FCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT------LLQQTT 128
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLD-----SNFNAKLSDFGLARDGPTGDNTHVSTR-- 120
            GL+ LH L  N+++RDLK  N+L+          A +SDFGL +    G ++  S R  
Sbjct: 129 SGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS-FSRRSG 185
Query: 121 IVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
           + GT G+ APE ++     + T   D++S G V   ++S                  E +
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS------------------EGS 227
Query: 178 DPFLRDSRRVLRIM--DTRLGGQYSKKEAQXXXXXXLQ-CLHMDPKNRPSMVDVL 229
            PF +  +R   I+     L   + +K         ++  + MDP+ RPS   VL
Sbjct: 228 HPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/130 (28%), Positives = 61/130 (46%), Gaps = 8/130 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           L+V E +  G L + +  +G Q  +     +I   +   + +LH +  N+ +RD+K  N+
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSI--NIAHRDVKPENL 192
Query: 91  LLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           L  S   N   KL+DFG A++  + ++    T    T  Y APE +         D +S 
Sbjct: 193 LYTSKRPNAILKLTDFGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDXWSL 249
Query: 148 GVVLLELLSG 157
           GV+   LL G
Sbjct: 250 GVIXYILLCG 259

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 123 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 178 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 123 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 178 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 123 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 178 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 123 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 178 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 91  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 150
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 151 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 206 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 256

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 76  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 135
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 136 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 190
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 191 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 241

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 82  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 141
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 142 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 196
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 197 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 247

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 26/164 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           E   L    H N++ ++G C    + +  L+  + P GSL N L       +     VK 
Sbjct: 57  ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLS--DFGLARDGPTGDNTHVSTR 120
           A+D ARG +FLH L+  +    L + +V +D +  A++S  D   +   P          
Sbjct: 117 ALDXARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSP---------- 166
Query: 121 IVGTRGYAAPEYVATGHLTPK--------SDVYSFGVVLLELLS 156
               R Y AP +VA   L  K        +D +SF V+L EL++
Sbjct: 167 ---GRXY-APAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVT 206

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 64  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 123
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 124 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 178
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 179 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 229

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 68  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 127
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 128 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 182
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 183 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 233

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 71  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 130
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 131 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 185
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 186 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 236

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 135 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 190 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 240

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 99  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 158
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 159 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 214 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 264

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 123 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 178 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 157 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 212 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 262

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 156
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 157 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 212 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 262

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 87/197 (44%), Gaps = 37/197 (18%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           E+  L +L H+++VK++      D    + L V   +     +  LFR  V       + 
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKK-LFRTPVYLTELHIKT 160
Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVS 118
            +  ++  G+ ++H   A +++RDLK +N L++ + + K+ DFGLAR  D P   N+ + 
Sbjct: 161 -LLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 119 -----------------------TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLEL 154
                                  T  V TR Y APE +    + T   DV+S G +  EL
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
Query: 155 LSGRR---ALDEDRGGL 168
           L+  +   A   DRG L
Sbjct: 278 LNMIKENVAYHADRGPL 294

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 122
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 123 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 178 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 75  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 134
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 135 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 189
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 190 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 240

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 142 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 201
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 202 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 257 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 307

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 67  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 126
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 127 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 181
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 182 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 232

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 20/169 (11%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RKGVQPISWPTRVK 61
           + E++Y  Q  H N+++LI +  E D   LV+E M  GS+ +H+  R+    +     V+
Sbjct: 60  EVEMLYQCQ-GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ 118
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGP-TGDNTHV 117
              DVA  L FLH  +  + +RDLK  N+L +        K+ DF L       GD + +
Sbjct: 119 ---DVASALDFLH--NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173
Query: 118 ST----RIVGTRGYAAPEYV-----ATGHLTPKSDVYSFGVVLLELLSG 157
           ST       G+  Y APE V            + D++S GV+L  LLSG
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P+    +  H  R K   P+ 
Sbjct: 101 ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI 160
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 161 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 216 P---NVSYICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 266

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 86/175 (49%), Gaps = 22/175 (12%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKG--SLENHLFR-KGVQPIS 55
           E+  + +L H N+V+L  +   S  +       LV +++P     +  H  R K   P+ 
Sbjct: 63  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVI 122
Query: 56  WPTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGD 113
           +   VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+    G+
Sbjct: 123 Y---VKLYMYQLFRSLAYIHSF--GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
               +   + +R Y APE +  AT + T   DV+S G VL ELL G+     D G
Sbjct: 178 P---NVSXICSRYYRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQPIFPGDSG 228

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 10/164 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L+H N+V+L    SE     LV++ +  G L   +  +     +  +     I  +    
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
            L+G    +++RDLK  N+LL S       KL+DFGLA +   GD         GT GY 
Sbjct: 120 HLNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPGYL 173
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
           +PE +         D+++ GV+L  LL G     DED+  L +Q
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQ 217

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/116 (31%), Positives = 58/116 (50%), Gaps = 23/116 (19%)
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS--- 118
           I  ++  G +F+H  ++ +I+RDLK +N LL+ + + K+ DFGLAR   +  +T++    
Sbjct: 134 ILYNLLLGENFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 119 -----------------TRIVGTRGYAAPEYVATGHLTPKS-DVYSFGVVLLELLS 156
                            T  V TR Y APE +       KS D++S G +  ELL+
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 75/164 (45%), Gaps = 10/164 (6%)
Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
           L+H N+V+L    SE     LV++ +  G L   +  +     +  +     I  +    
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHC 119
Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
            L+G    +++RDLK  N+LL S       KL+DFGLA +   GD         GT GY 
Sbjct: 120 HLNG----IVHRDLKPENLLLASKSKGAAVKLADFGLAIE-VQGDQ-QAWFGFAGTPGYL 173
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQ 171
           +PE +         D+++ GV+L  LL G     DED+  L +Q
Sbjct: 174 SPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQ 217

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/129 (25%), Positives = 67/129 (51%), Gaps = 8/129 (6%)
Query: 31  LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNV 90
           +L+ E+   G + +    +  + +S    +++   +  G+ +LH    N+++ DLK  N+
Sbjct: 105 ILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNIVHLDLKPQNI 162
Query: 91  LLDSNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF 147
           LL S +   + K+ DFG++R    G    +   I+GT  Y APE +    +T  +D+++ 
Sbjct: 163 LLSSIYPLGDIKIVDFGMSR--KIGHACELR-EIMGTPEYLAPEILNYDPITTATDMWNI 219
Query: 148 GVVLLELLS 156
           G++   LL+
Sbjct: 220 GIIAYMLLT 228

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           GL  LH  +A V++RDL   N+LL  N +  + DF LAR+     N    T  V  R Y 
Sbjct: 146 GLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYR 200
Query: 129 APEYVATGH-LTPKSDVYSFGVVLLELLSGRRAL 161
           APE V      T   D++S G V+ E+ + R+AL
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFN-RKAL 233

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           GL  LH  +A V++RDL   N+LL  N +  + DF LAR+     N    T  V  R Y 
Sbjct: 146 GLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYR 200
Query: 129 APEYVATGH-LTPKSDVYSFGVVLLELLSGRRAL 161
           APE V      T   D++S G V+ E+ + R+AL
Sbjct: 201 APELVMQFKGFTKLVDMWSAGCVMAEMFN-RKAL 233

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.1 bits (118), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 58/123 (47%), Gaps = 26/123 (21%)
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS--- 118
           I  ++  G  F+H  ++ +I+RDLK +N LL+ + + K+ DFGLAR   +  + H+    
Sbjct: 136 ILYNLLLGEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193
Query: 119 --------------------TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSG 157
                               T  V TR Y APE +    + T   D++S G +  ELL+ 
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNM 253
Query: 158 RRA 160
            ++
Sbjct: 254 MKS 256

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++    L    +V L G   E     +  E +  GSL   +  +G  P     R    +
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYL 172
Query: 65  DVA-RGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFG----LARDGPTGDNTHVS 118
             A  GL +LH     +++ D+KA NVLL S+  +A L DFG    L  DG  G +    
Sbjct: 173 GQALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGKDLLTG 229
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V       K DV+S   ++L +L+G
Sbjct: 230 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 26/166 (15%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q E+I    LRH N+V+         +  ++ E+   G L   +   G          + 
Sbjct: 64  QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG----------RF 113
Query: 63  AIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGLARDGPTG 112
           + D AR        G+S+ H +   + +RDLK  N LLD +     K+ DFG ++     
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171
Query: 113 DNTHVSTRIVGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSG 157
                +   VGT  Y APE +       K +DV+S GV L  +L G
Sbjct: 172 SQPKST---VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 44/177 (24%)
Query: 14  HENLVKLIGYCSESDNRLLVYEF------------MPKGSLENHLFRKGVQPISWPTRVK 61
           H N+++   YCSE+ +R L                    S EN   +K   PIS      
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------ 119
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------------NFNAKLSDFGLARD 108
           +   +A G++ LH L   +I+RDLK  N+L+ +             N    +SDFGL + 
Sbjct: 120 LLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 109 GPTGDNTHVS--TRIVGTRGYAAPEYVATGH-------LTPKSDVYSFGVVLLELLS 156
             +G ++  +      GT G+ APE +   +       LT   D++S G V   +LS
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++    L    +V L G   E     +  E +  GSL   +  +G  P     R    +
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYL 191
Query: 65  DVA-RGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFG----LARDGPTGDNTHVS 118
             A  GL +LH     +++ D+KA NVLL S+  +A L DFG    L  DG  G +    
Sbjct: 192 GQALEGLEYLH--SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDG-LGKSLLTG 248
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V       K DV+S   ++L +L+G
Sbjct: 249 DYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 75/157 (47%), Gaps = 8/157 (5%)
Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  + QL H  L+ L     +    +L+ EF+  G L + +  +  + +S    +  
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINY 154
Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGLARDGPTGDNTHVSTR 120
                 GL  +H  + ++++ D+K  N++ ++    + K+ DFGLA      +   V+T 
Sbjct: 155 MRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT- 211
Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
              T  +AAPE V    +   +D+++ GV+   LLSG
Sbjct: 212 --ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/121 (33%), Positives = 64/121 (52%), Gaps = 11/121 (9%)
Query: 45  HLFRKGVQPISWPTRVKIAIDVARGL-SFLHGL-DANVIYRDLKASNVLLDSN--FNAKL 100
           H FR   + + +  R K+  ++ R + S LH L +  + +RD+K  N L  +N  F  KL
Sbjct: 155 HGFR---ESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKL 211
Query: 101 SDFGLARDGPTGDN--THVSTRIVGTRGYAAPEYVATGHLT--PKSDVYSFGVVLLELLS 156
            DFGL+++    +N   +  T   GT  + APE + T + +  PK D +S GV+L  LL 
Sbjct: 212 VDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM 271
Query: 157 G 157
           G
Sbjct: 272 G 272

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV+   Q RHEN+V  +G C  S   L +   + KG     + R     +      +IA 
Sbjct: 79  EVMAYRQTRHENVVLFMGACM-SPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQ 137
Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL------ARDGPTGDNTHVS 118
           ++ +G+ +LH     ++++DLK+ NV  D N    ++DFGL       + G   D   + 
Sbjct: 138 EIVKGMGYLHA--KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 119 TRIVGTRGYAAPEYVATGHLTP-----------KSDVYSFGVVLLEL 154
               G   + APE +    L+P            SDV++ G +  EL
Sbjct: 195 N---GWLCHLAPEIIR--QLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 60/145 (41%), Gaps = 27/145 (18%)
Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           + +E + K + E  L     QP   P    +A  +   L FLH  +  + + DLK  N+L
Sbjct: 108 IAFELLGKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENIL 164
Query: 92  L-DSNFNA------------------KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
             +S F                    +++DFG A    T D+ H +T IV TR Y  PE 
Sbjct: 165 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTT-IVATRHYRPPEV 219
Query: 133 VATGHLTPKSDVYSFGVVLLELLSG 157
           +         DV+S G +L E   G
Sbjct: 220 ILELGWAQPCDVWSIGCILFEYYRG 244

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 60/145 (41%), Gaps = 27/145 (18%)
Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           + +E + K + E  L     QP   P    +A  +   L FLH  +  + + DLK  N+L
Sbjct: 99  IAFELLGKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENIL 155
Query: 92  L-DSNFNA------------------KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
             +S F                    +++DFG A    T D+ H +T IV TR Y  PE 
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTT-IVATRHYRPPEV 210
Query: 133 VATGHLTPKSDVYSFGVVLLELLSG 157
           +         DV+S G +L E   G
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRG 235

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 71/173 (41%), Gaps = 40/173 (23%)
Query: 14  HENLVKLIGYCSESDNRLLVYEF------------MPKGSLENHLFRKGVQPISWPTRVK 61
           H N+++   YCSE+ +R L                    S EN   +K   PIS      
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------ 137
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------------NFNAKLSDFGLARD 108
           +   +A G++ LH L   +I+RDLK  N+L+ +             N    +SDFGL + 
Sbjct: 138 LLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 195
Query: 109 GPTGDNTHVS--TRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLS 156
             +G            GT G+ APE +       LT   D++S G V   +LS
Sbjct: 196 LDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++    L    +V L G   E     +  E +  GSL   + + G  P     R    +
Sbjct: 114 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYL 170
Query: 65  DVA-RGLSFLHGLDANVIYRDLKASNVLLDSNFN-AKLSDFG----LARDGPTGDNTHVS 118
             A  GL +LH     +++ D+KA NVLL S+ + A L DFG    L  DG  G +    
Sbjct: 171 GQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG-LGKSLLTG 227
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V       K D++S   ++L +L+G
Sbjct: 228 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 71/173 (41%), Gaps = 40/173 (23%)
Query: 14  HENLVKLIGYCSESDNRLLVYEF------------MPKGSLENHLFRKGVQPISWPTRVK 61
           H N+++   YCSE+ +R L                    S EN   +K   PIS      
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------ 137
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------------NFNAKLSDFGLARD 108
           +   +A G++ LH L   +I+RDLK  N+L+ +             N    +SDFGL + 
Sbjct: 138 LLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 195
Query: 109 GPTGDNTHVS--TRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLS 156
             +G            GT G+ APE +       LT   D++S G V   +LS
Sbjct: 196 LDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++    L    +V L G   E     +  E +  GSL   + + G  P     R    +
Sbjct: 100 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYL 156
Query: 65  DVA-RGLSFLHGLDANVIYRDLKASNVLLDSNFN-AKLSDFG----LARDGPTGDNTHVS 118
             A  GL +LH     +++ D+KA NVLL S+ + A L DFG    L  DG  G +    
Sbjct: 157 GQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG-LGKSLLTG 213
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V       K D++S   ++L +L+G
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E++    L    +V L G   E     +  E +  GSL   + + G  P     R    +
Sbjct: 116 ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYL 172
Query: 65  DVA-RGLSFLHGLDANVIYRDLKASNVLLDSNFN-AKLSDFG----LARDGPTGDNTHVS 118
             A  GL +LH     +++ D+KA NVLL S+ + A L DFG    L  DG  G +    
Sbjct: 173 GQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG-LGKSLLTG 229
Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V       K D++S   ++L +L+G
Sbjct: 230 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 60/145 (41%), Gaps = 27/145 (18%)
Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           + +E + K + E  L     QP   P    +A  +   L FLH  +  + + DLK  N+L
Sbjct: 131 IAFELLGKNTFE-FLKENNFQPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENIL 187
Query: 92  L-DSNFNA------------------KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
             +S F                    +++DFG A    T D+ H +T IV TR Y  PE 
Sbjct: 188 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTT-IVATRHYRPPEV 242
Query: 133 VATGHLTPKSDVYSFGVVLLELLSG 157
           +         DV+S G +L E   G
Sbjct: 243 ILELGWAQPCDVWSIGCILFEYYRG 267

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 26/164 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+I    LRH N+V+         +  +V E+   G L   +   G          + + 
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----------RFSE 114
Query: 65  DVAR--------GLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGLARDGPTGDN 114
           D AR        G+S+ H +   V +RDLK  N LLD +     K+ DFG ++       
Sbjct: 115 DEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 172
Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSG 157
              +   VGT  Y APE +       K +DV+S GV L  +L G
Sbjct: 173 PKST---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 26/164 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+I    LRH N+V+         +  +V E+   G L   +   G          + + 
Sbjct: 64  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----------RFSE 113
Query: 65  DVAR--------GLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGLARDGPTGDN 114
           D AR        G+S+ H +   V +RDLK  N LLD +     K+ DFG ++       
Sbjct: 114 DEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 171
Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSG 157
              +   VGT  Y APE +       K +DV+S GV L  +L G
Sbjct: 172 PKST---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 7/93 (7%)
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           R + F+H L   + +RD+K  N+L++S  N  KL DFG A+     +    S   + +R 
Sbjct: 152 RAVGFIHSL--GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAXICSRF 206
Query: 127 YAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
           Y APE  +     TP  D++S G V  EL+ G+
Sbjct: 207 YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 10/149 (6%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 72
           +H N++ L     +     +V E M  G L + + R+     S      +   + + + +
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF--FSEREASAVLFTITKTVEY 131
Query: 73  LHGLDANVIYRDLKASNVL-LDSNFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           LH     V++RDLK SN+L +D + N    ++ DFG A+     +N  + T    T  + 
Sbjct: 132 LHA--QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAENGLLMTPCY-TANFV 187
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S GV+L  +L+G
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+I    LRH N+V+         +  +V E+   G L   +   G          + + 
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----------RFSE 114
Query: 65  DVAR--------GLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGLARDGPTGDN 114
           D AR        G+S+ H +   V +RDLK  N LLD +     K++DFG ++       
Sbjct: 115 DEARFFFQQLISGVSYAHAM--QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ 172
Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSG 157
              +   VGT  Y APE +       K +DV+S GV L  +L G
Sbjct: 173 PKSA---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 72/177 (40%), Gaps = 44/177 (24%)
Query: 14  HENLVKLIGYCSESDNRLLVYEF------------MPKGSLENHLFRKGVQPISWPTRVK 61
           H N+++   YCSE+ +R L                    S EN   +K   PIS      
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------ 119
Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------------NFNAKLSDFGLARD 108
           +   +A G++ LH L   +I+RDLK  N+L+ +             N    +SDFGL + 
Sbjct: 120 LLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 109 GPTGDNTHVS--TRIVGTRGYAAPEYVATGH-------LTPKSDVYSFGVVLLELLS 156
             +G            GT G+ APE +   +       LT   D++S G V   +LS
Sbjct: 178 LDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 52/268 (19%)
Query: 5   EVIYLGQLR-HENLVKLIGYCS----ESDN---RLLVYEFMPKGSLENHLFR-KGVQPIS 55
           EV ++ +L  H N+V+     S    ESD      L+   + KG L   L + +   P+S
Sbjct: 75  EVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLS 134
Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-------- 107
             T +KI     R +  +H     +I+RDLK  N+LL +    KL DFG A         
Sbjct: 135 CDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDY 194
Query: 108 DGPTGDNTHVSTRIV--GTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALD 162
                    V   I    T  Y  PE +   +   +  K D+++ G +L  LL  R+   
Sbjct: 195 SWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILY-LLCFRQ--- 250
Query: 163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS--KKEAQXXXXXXL--QCLHMD 218
                           PF   ++  LRI++    G+YS    + Q      L    L ++
Sbjct: 251 ---------------HPFEDGAK--LRIVN----GKYSIPPHDTQYTVFHSLIRAMLQVN 289
Query: 219 PKNRPSMVDVLTSLEQLHTSKDM-PRTP 245
           P+ R S+ +V+  L+++  ++++ P++P
Sbjct: 290 PEERLSIAEVVHQLQEIAAARNVNPKSP 317

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 45.8 bits (107), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 54/102 (52%), Gaps = 9/102 (8%)
Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           R L+++H +   + +RD+K  N+LLD      KL DFG A+    G+    +   + +R 
Sbjct: 152 RSLAYIHSI--GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSXICSRY 206
Query: 127 YAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
           Y APE +  AT + T   D++S G V+ EL+ G+     + G
Sbjct: 207 YRAPELIFGATNYTT-NIDIWSTGCVMAELMQGQPLFPGESG 247

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 10/149 (6%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 72
           +H N++ L     +  +  LV E M  G L + + R+     S      +   + + + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEY 136
Query: 73  LHGLDANVIYRDLKASNVL-LDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           LH     V++RDLK SN+L +D + N    ++ DFG A+     +N  + T    T  + 
Sbjct: 137 LH--SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTPCY-TANFV 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G++L  +L+G
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 70/149 (46%), Gaps = 10/149 (6%)
Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSF 72
           +H N++ L     +  +  LV E M  G L + + R+     S      +   + + + +
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF--FSEREASFVLHTIGKTVEY 136
Query: 73  LHGLDANVIYRDLKASNVL-LDSNFNA---KLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           LH     V++RDLK SN+L +D + N    ++ DFG A+     +N  + T    T  + 
Sbjct: 137 LHS--QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQ-LRAENGLLMTPCY-TANFV 192
Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           APE +         D++S G++L  +L+G
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 45.4 bits (106), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 69/161 (42%), Gaps = 31/161 (19%)
Query: 18  VKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHG 75
           V+++ +     +  +V+E +    L  + F K  G  P       K+A  + + ++FLH 
Sbjct: 80  VQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 76  LDANVIYRDLKASNVLLDS-------------------NFNAKLSDFGLARDGPTGDNTH 116
               + + DLK  N+L                      N + K+ DFG A    T D+ H
Sbjct: 137 --NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA----TYDDEH 190
Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
            ST +V TR Y APE +     +   DV+S G +L+E   G
Sbjct: 191 HST-LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 68/164 (41%), Gaps = 26/164 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+I    LRH N+V+         +  +V E+   G L   +   G          + + 
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----------RFSE 114
Query: 65  DVAR--------GLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGLARDGPTGDN 114
           D AR        G+S+ H +   V +RDLK  N LLD +     K+  FG ++       
Sbjct: 115 DEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ 172
Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSG 157
              +   VGT  Y APE +       K +DV+S GV L  +L G
Sbjct: 173 PKST---VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
           +       +S  V+S G++L +++ G    + D   +  Q  
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 255

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
           +       +S  V+S G++L +++ G    + D   +  Q  
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 254

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
           +       +S  V+S G++L +++ G    + D   +  Q  
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 255

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
           +       +S  V+S G++L +++ G    + D   +  Q  
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 255

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.7 bits (104), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
           +       +S  V+S G++L +++ G    + D   +  Q  
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 254

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 180
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
           +       +S  V+S G++L +++ G    + D   +  Q  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 222

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 158 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 213
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
           +       +S  V+S G++L +++ G    + D   +  Q  
Sbjct: 214 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 255

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
           +       +S  V+S G++L +++ G    + D   +  Q  
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVF 254

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 172 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 227
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDED 164
           +       +S  V+S G++L +++ G    + D
Sbjct: 228 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 67/164 (40%), Gaps = 26/164 (15%)
Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+I    LRH N+V+         +  +V E+   G L   +   G          + + 
Sbjct: 65  EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----------RFSE 114
Query: 65  DVAR--------GLSFLHGLDANVIYRDLKASNVLLDSN--FNAKLSDFGLARDGPTGDN 114
           D AR        G+S+ H +   V +RDLK  N LLD +     K+  FG ++       
Sbjct: 115 DEARFFFQQLISGVSYCHAM--QVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQ 172
Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSG 157
                  VGT  Y APE +       K +DV+S GV L  +L G
Sbjct: 173 ---PKDTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 183
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDED 164
           +       +S  V+S G++L +++ G    + D
Sbjct: 184 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 216

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 185
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDED 164
           +       +S  V+S G++L +++ G    + D
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 129 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 184
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDED 164
           +       +S  V+S G++L +++ G    + D
Sbjct: 185 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 217

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 185
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDED 164
           +       +S  V+S G++L +++ G    + D
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 6/93 (6%)
Query: 74  HGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEY 132
           H  +  V++RD+K  N+L+D N    KL DFG    G    +T V T   GTR Y+ PE+
Sbjct: 157 HCHNCGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSPPEW 212
Query: 133 VATGHLTPKS-DVYSFGVVLLELLSGRRALDED 164
           +       +S  V+S G++L +++ G    + D
Sbjct: 213 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	278
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-146
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-130
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-115
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-72
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-63
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-59
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-56
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	7e-54
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-53
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-53
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-52
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-51
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-51
3q4u_A	301	Activin receptor type-1; structural genomics conso	8e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-50
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-42
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-38
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-38
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-38
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-37
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-37
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-37
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-37
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-37
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-36
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-36
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-35
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-35
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-34
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-33
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-33
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-31
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-31
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-30
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-30
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-30
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-30
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-29
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-28
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-27
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-27
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-26
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	9e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-25
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-25
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	5e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-25
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-24
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-24
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-24
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-24
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-23
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-23
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	9e-23
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-22
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-22
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-20
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-20
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-20
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-20
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-20
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	5e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-20
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-20
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	8e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-19
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-19
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-19
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-19
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-19
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	3e-19
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-19
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-19
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-04
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-19
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	7e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-18
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-18
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-18
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-18
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-16
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	4e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-10
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-09
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	8e-07
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  411 bits (1058), Expect = e-146
 Identities = 94/238 (39%), Positives = 143/238 (60%), Gaps = 8/238 (3%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF-RKGVQPISWPTRV 60
           +  E+  + + +HENLV+L+G+ S+ D+  LVY +MP GSL + L    G  P+SW  R 
Sbjct: 77  FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KIA   A G++FLH  + + I+RD+K++N+LLD  F AK+SDFGLAR       T +++R
Sbjct: 137 KIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSR 194

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           IVGT  Y APE +  G +TPKSD+YSFGVVLLE+++G  A+DE R     Q L++  +  
Sbjct: 195 IVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE---PQLLLDIKEEI 250

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
             + + +   +D ++         +A+ +V  QCLH     RP +  V   L+++  S
Sbjct: 251 EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  371 bits (955), Expect = e-130
 Identities = 93/234 (39%), Positives = 138/234 (58%), Gaps = 6/234 (2%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTR 59
           ++TE+  L   RH +LV LIG+C E +  +L+Y++M  G+L+ HL+        +SW  R
Sbjct: 82  FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++I I  ARGL +LH     +I+RD+K+ N+LLD NF  K++DFG+++ G   D TH+ST
Sbjct: 142 LEICIGAARGLHYLH--TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST 199

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
            + GT GY  PEY   G LT KSDVYSFGVVL E+L  R A+ +         L EWA  
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNLAEWAVE 258

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
               + ++ +I+D  L  +   +  +      ++CL +  ++RPSM DVL  LE
Sbjct: 259 SHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  333 bits (856), Expect = e-115
 Identities = 94/235 (40%), Positives = 142/235 (60%), Gaps = 6/235 (2%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF--RKGVQPISWPTRV 60
           QTEV  +    H NL++L G+C     RLLVY +M  GS+ + L    +   P+ WP R 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 61  KIAIDVARGLSFLH-GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +IA+  ARGL++LH   D  +I+RD+KA+N+LLD  F A + DFGLA+     D THV+T
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTT 193

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDR-GGLAEQTLVEWAD 178
            + GT G+ APEY++TG  + K+DV+ +GV+LLEL++G+RA D  R     +  L++W  
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
             L++ +++  ++D  L G Y  +E + +  V L C    P  RP M +V+  LE
Sbjct: 254 GLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  223 bits (571), Expect = 3e-72
 Identities = 72/260 (27%), Positives = 111/260 (42%), Gaps = 26/260 (10%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDN----RLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
            EV  L  ++HEN+++ IG      +      L+  F  KGSL + L       +SW   
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNEL 123

Query: 60  VKIAIDVARGLSFLH--------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
             IA  +ARGL++LH        G    + +RD+K+ NVLL +N  A ++DFGLA     
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183

Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLSGRRALDEDRG 166
           G +   +   VGTR Y APE +            + D+Y+ G+VL EL S   A D    
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243

Query: 167 G--LAEQTLVEWADPFLRDSRR--VLRIMDTRLGGQYSKKEA-QAVAAVVLQCLHMDPKN 221
              L  +  +    P L D +   V +     L   + K      +   + +C   D + 
Sbjct: 244 EYMLPFEEEI-GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 222 RPSMVDVLTSLEQLHTSKDM 241
           R S   V   + Q+    ++
Sbjct: 303 RLSAGCVGERITQMQRLTNI 322

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  201 bits (514), Expect = 1e-63
 Identities = 64/289 (22%), Positives = 111/289 (38%), Gaps = 39/289 (13%)

Query: 2   WQTEV-IY-LGQLRHENLVKLIGYCSE-----SDNRLLVYEFMPKGSLENHLFRKGVQPI 54
           +  E  IY +  + H+N+ + I              LLV E+ P GSL  +L        
Sbjct: 52  FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTS 108

Query: 55  SWPTRVKIAIDVARGLSFLH-------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR 107
            W +  ++A  V RGL++LH            + +RDL + NVL+ ++    +SDFGL+ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

Query: 108 ------DGPTGDNTHVSTRIVGTRGYAAPEY-------VATGHLTPKSDVYSFGVVLLEL 154
                     G+  + +   VGT  Y APE                + D+Y+ G++  E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 155 LSGRRALDEDRGG----LAEQTLVEWADPFLRDSRRVLRIMDTRL----GGQYSKKEAQA 206
                 L          +A QT V    P   D + ++     R       + +    ++
Sbjct: 229 FMRCTDLFPGESVPEYQMAFQTEV-GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287

Query: 207 VAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAKLHHHHH 255
           +   +  C   D + R +       + +L    +  ++  P   HHHHH
Sbjct: 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHHHHH 336

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  189 bits (483), Expect = 3e-59
 Identities = 65/263 (24%), Positives = 102/263 (38%), Gaps = 31/263 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H N++K IG   +      + E++  G+L   +     Q   W  RV  A 
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-YPWSQRVSFAK 115

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR------------DGPTG 112
           D+A G+++LH +  N+I+RDL + N L+  N N  ++DFGLAR                 
Sbjct: 116 DIASGMAYLHSM--NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173

Query: 113 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
            +      +VG   + APE +       K DV+SFG+VL E++    A   D   L    
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA---DPDYLPRTM 230

Query: 173 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
                   +R         +             +   + ++C  +DP+ RPS V +   L
Sbjct: 231 DFGLN---VRGFLDRYCPPNC----------PPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

Query: 233 EQLHTSKDMPRTPPPAKLHHHHH 255
           E L           P        
Sbjct: 278 ETLRMHLAGHLPLGPQLEQLDRG 300

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  182 bits (465), Expect = 2e-56
 Identities = 72/247 (29%), Positives = 118/247 (47%), Gaps = 26/247 (10%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVK 61
             EV  + +LRH N+V  +G  ++  N  +V E++ +GSL   L + G  + +    R+ 
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +A DVA+G+++LH  +  +++R+LK+ N+L+D  +  K+ DFGL+R   +   +  S   
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSA 199

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD-PF 180
            GT  + APE +       KSDVYSFGV+L EL + +                 W +   
Sbjct: 200 AGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ---------------QPWGNLNP 244

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
            +    V      RL  +  +     VAA++  C   +P  RPS   ++  L  L  S  
Sbjct: 245 AQVVAAVGF-KCKRL--EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA- 300

Query: 241 MPRTPPP 247
               PPP
Sbjct: 301 ---VPPP 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  182 bits (464), Expect = 2e-56
 Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 34/263 (12%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP-ISWPTRVK 61
             E+  L ++ H N+VKL G C   +   LV E+   GSL N L      P  +    + 
Sbjct: 49  IVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 62  IAIDVARGLSFLHGLDAN-VIYRDLKASNVLLDSNFN-AKLSDFGLARDGPTGDNTHVST 119
             +  ++G+++LH +    +I+RDLK  N+LL +     K+ DFG A D          T
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMT 161

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
              G+  + APE     + + K DV+S+G++L E+++ R+                   P
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK-------------------P 202

Query: 180 FLRDSRRVLRIMDTRLGGQ---YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
           F        RIM     G      K   + + +++ +C   DP  RPSM +++  +  L 
Sbjct: 203 FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL- 261

Query: 237 TSKDMPRTPPPAKLHHHHHHHNH 259
             +  P    P +    H     
Sbjct: 262 -MRYFPGADEPLQYPCQHSLPPG 283

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  175 bits (447), Expect = 4e-54
 Identities = 62/260 (23%), Positives = 106/260 (40%), Gaps = 70/260 (26%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           Q EV  +  L H N+VKL G         +V EF+P G L + L  K   PI W  ++++
Sbjct: 71  QREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA-HPIKWSVKLRL 127

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS-----NFNAKLSDFGLARDGPTGDNTHV 117
            +D+A G+ ++   +  +++RDL++ N+ L S        AK++DFGL++      + H 
Sbjct: 128 MLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHS 182

Query: 118 STRIVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
            + ++G   + APE +       T K+D YSF ++L  +L+G                  
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG---------------- 226

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVL--------------------QCL 215
              PF                 +YS  + + +  +                       C 
Sbjct: 227 ---PF----------------DEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCW 267

Query: 216 HMDPKNRPSMVDVLTSLEQL 235
             DPK RP    ++  L +L
Sbjct: 268 SGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  174 bits (444), Expect = 1e-53
 Identities = 59/236 (25%), Positives = 107/236 (45%), Gaps = 20/236 (8%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L + RH N++  +GY +      +V ++    SL +HL     +       + I
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDI 125

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           A   ARG+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA +      +H   ++ 
Sbjct: 126 ARQTARGMDYLHAK--SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS 183

Query: 123 GTRGYAAPE---YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
           G+  + APE      +   + +SDVY+FG+VL EL++G+         +  +  +     
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS----NINNRDQIIEM-- 237

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
             R S             +      + +  ++ +CL      RPS   +L  +E+L
Sbjct: 238 VGRGSLSPDLS-------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  174 bits (444), Expect = 5e-53
 Identities = 62/265 (23%), Positives = 110/265 (41%), Gaps = 28/265 (10%)

Query: 1   MWQTEV-IY-LGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPI 54
            W  E  IY    +RHEN++  I    +         L+ ++   GSL ++L       +
Sbjct: 75  SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TL 131

Query: 55  SWPTRVKIAIDVARGLSFLHGLDA------NVIYRDLKASNVLLDSNFNAKLSDFGLAR- 107
              + +K+A     GL  LH           + +RDLK+ N+L+  N    ++D GLA  
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191

Query: 108 -DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP-------KSDVYSFGVVLLELLSGRR 159
               T +        VGT+ Y  PE V    L          +D+YSFG++L E+     
Sbjct: 192 FISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250

Query: 160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR--LGGQYSKKEA-QAVAAVVLQCLH 216
           +             +  +DP   D R ++ I   R     ++S  E  + +  ++ +C  
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310

Query: 217 MDPKNRPSMVDVLTSLEQLHTSKDM 241
            +P +R + + V  +L ++  S+D+
Sbjct: 311 HNPASRLTALRVKKTLAKMSESQDI 335

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  172 bits (438), Expect = 7e-53
 Identities = 53/238 (22%), Positives = 99/238 (41%), Gaps = 29/238 (12%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
             E   L    H N++ ++G C    + +  L+  +MP GSL N L       +     V
Sbjct: 55  NEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAV 114

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           K A+D+ARG++FLH L+  +    L + +V++D +  A++S   +         +  S  
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPG 167

Query: 121 IVGTRGYAAPE---YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
            +    + APE             +D++SF V+L EL++            A+ + +E  
Sbjct: 168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP-------FADLSNMEIG 220

Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
                +  R   I             +  V+ ++  C++ DP  RP    ++  LE++
Sbjct: 221 MKVALEGLR-PTI---------PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  170 bits (432), Expect = 2e-51
 Identities = 47/245 (19%), Positives = 93/245 (37%), Gaps = 33/245 (13%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV+   Q RHEN+V  +G C    +  ++       +L + + R     +      +I
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQI 135

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---DGPTGDNTHVST 119
           A ++ +G+ +LH     ++++DLK+ NV  D N    ++DFGL         G       
Sbjct: 136 AQEIVKGMGYLHAK--GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLR 192

Query: 120 RIVGTRGYAAPE---------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE 170
              G   + APE                +  SDV++ G +  EL +              
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK----TQPA 248

Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 230
           + ++          +  L  +             + ++ ++L C   + + RP+   ++ 
Sbjct: 249 EAIIWQMG---TGMKPNLSQIGM----------GKEISDILLFCWAFEQEERPTFTKLMD 295

Query: 231 SLEQL 235
            LE+L
Sbjct: 296 MLEKL 300

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  167 bits (426), Expect = 4e-51
 Identities = 70/243 (28%), Positives = 106/243 (43%), Gaps = 35/243 (14%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E      L+H N++ L G C +  N  LV EF   G L   L  K    I     V  
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNW 110

Query: 63  AIDVARGLSFLHGLD-ANVIYRDLKASNVLLD--------SNFNAKLSDFGLARDGPTGD 113
           A+ +ARG+++LH      +I+RDLK+SN+L+         SN   K++DFGLAR+     
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE---WH 167

Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
            T   +   G   + APE +     +  SDV+S+GV+L ELL+G                
Sbjct: 168 RTTKMSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE--------------- 211

Query: 174 VEWAD-PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
           V +     L  +  V       L         +  A ++  C + DP +RPS  ++L  L
Sbjct: 212 VPFRGIDGLAVAYGVAM-NKLAL--PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

Query: 233 EQL 235
             +
Sbjct: 269 TTI 271

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  167 bits (426), Expect = 8e-51
 Identities = 61/263 (23%), Positives = 110/263 (41%), Gaps = 36/263 (13%)

Query: 1   MWQTEV-IY-LGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPI 54
            W  E  +Y    LRHEN++  I     S +      L+  +   GSL ++L       +
Sbjct: 46  SWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTL 102

Query: 55  SWPTRVKIAIDVARGLSFLHGLDA------NVIYRDLKASNVLLDSNFNAKLSDFGLAR- 107
              + ++I + +A GL+ LH           + +RDLK+ N+L+  N    ++D GLA  
Sbjct: 103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162

Query: 108 -DGPTGDNTHVSTRIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSGRRA 160
               T      +   VGT+ Y APE       V       + D+++FG+VL E+      
Sbjct: 163 HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR--- 219

Query: 161 LDEDRGGLAEQTLVEWAD-----PFLRDSRRVLRIMDTRL---GGQYSKKEAQAVAAVVL 212
                 G+ E     + D     P   D R+V+ +   R       +S     ++A ++ 
Sbjct: 220 --MVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277

Query: 213 QCLHMDPKNRPSMVDVLTSLEQL 235
           +C + +P  R + + +  +L ++
Sbjct: 278 ECWYQNPSARLTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  168 bits (426), Expect = 2e-50
 Identities = 62/264 (23%), Positives = 112/264 (42%), Gaps = 26/264 (9%)

Query: 1   MWQTEV-IY-LGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPI 54
            W  E  IY    LRHEN++  I   ++ +       LV ++   GSL ++L R     +
Sbjct: 80  SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TV 136

Query: 55  SWPTRVKIAIDVARGLSFLHGLDA------NVIYRDLKASNVLLDSNFNAKLSDFGLAR- 107
           +    +K+A+  A GL+ LH           + +RDLK+ N+L+  N    ++D GLA  
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196

Query: 108 -DGPTGDNTHVSTRIVGTRGYAAPE----YVATGHL--TPKSDVYSFGVVLLELLSGRRA 160
            D  T          VGT+ Y APE     +   H     ++D+Y+ G+V  E+      
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

Query: 161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL---GGQYSKKEAQAVAAVVLQCLHM 217
                        +  +DP + + R+V+     R        S +  + +A ++ +C + 
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316

Query: 218 DPKNRPSMVDVLTSLEQLHTSKDM 241
           +   R + + +  +L QL   + +
Sbjct: 317 NGAARLTALRIKKTLSQLSQQEGI 340

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (375), Expect = 2e-42
 Identities = 64/240 (26%), Positives = 100/240 (41%), Gaps = 36/240 (15%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   L Q  H N+V+LIG C++     +V E +  G     L R     +   T +++  
Sbjct: 162 EARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVG 220

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           D A G+ +L       I+RDL A N L+      K+SDFG++R+   G          G 
Sbjct: 221 DAAAGMEYLE--SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGL 274

Query: 125 RGY----AAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 179
           R       APE +  G  + +SDV+SFG++L E  S G                     P
Sbjct: 275 RQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS-------------------P 315

Query: 180 FLRDS-RRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
           +   S ++    ++   GG+    E    AV  ++ QC   +P  RPS   +   L+ + 
Sbjct: 316 YPNLSNQQTREFVEK--GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  137 bits (348), Expect = 3e-39
 Identities = 66/265 (24%), Positives = 112/265 (42%), Gaps = 58/265 (21%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + +L H++LV   G C   D  +LV EF+  GSL+ +L +K    I+   ++++A  +A 
Sbjct: 66  MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAA 124

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFN--------AKLSDFGLARDGPTGDNTHVSTR 120
            + FL   +  +I+ ++ A N+LL    +         KLSD G++              
Sbjct: 125 AMHFLE--ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------ 170

Query: 121 IVGTRGY------AAPEYVATG-HLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQT 172
           ++             PE +    +L   +D +SFG  L E+ S G +             
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK------------- 217

Query: 173 LVEWADPFL-RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS 231
                 P    DS+R L+  +     Q    +A  +A ++  C+  +P +RPS   ++  
Sbjct: 218 ------PLSALDSQRKLQFYED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269

Query: 232 LEQLHTSKDMPRTPPPAKLHHHHHH 256
           L  L T   +PR       HHHHHH
Sbjct: 270 LNSLFTPDLVPR-----GSHHHHHH 289

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  135 bits (343), Expect = 1e-38
 Identities = 64/260 (24%), Positives = 111/260 (42%), Gaps = 39/260 (15%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + QL +  +V+LIG C   +  +LV E    G L   L     + I      ++  
Sbjct: 60  EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLH 117

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            V+ G+ +L   + N ++RDL A NVLL +   AK+SDFGL++     D+ + +      
Sbjct: 118 QVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAG 173

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + APE +     + +SDV+S+GV + E LS G++                   P+
Sbjct: 174 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-------------------PY 214

Query: 181 LR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
            +     V+  ++   G +          + A++  C     ++RP  + V   +   + 
Sbjct: 215 KKMKGPEVMAFIEQ--GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272

Query: 238 SKDMPRTPPPAKLHHHHHHH 257
           S          + HHHHHHH
Sbjct: 273 S-----LASKVEGHHHHHHH 287

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  135 bits (342), Expect = 1e-38
 Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 35/241 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +L H  LV+L G C E     LV EFM  G L ++L R      +  T + + +
Sbjct: 53  EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCL 111

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           DV  G+++L   +A VI+RDL A N L+  N   K+SDFG+ R     D+ +  T   GT
Sbjct: 112 DVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGT 165

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    +A+PE  +    + KSDV+SFGV++ E+ S G+                    P+
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI-------------------PY 206

Query: 181 LR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
               +  V+  + T  G +  K       V  ++  C    P++RP+   +L  L ++  
Sbjct: 207 ENRSNSEVVEDIST--GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264

Query: 238 S 238
           S
Sbjct: 265 S 265

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  135 bits (342), Expect = 3e-38
 Identities = 65/244 (26%), Positives = 101/244 (41%), Gaps = 23/244 (9%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
            + E+  L  L HEN+VK  G C+E       L+ EF+P GSL+ +L  K    I+   +
Sbjct: 70  LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQ 128

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +K A+ + +G+ +L       ++RDL A NVL++S    K+ DFGL +   T    +   
Sbjct: 129 LKYAVQICKGMDYLG--SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 186

Query: 120 RIVGTR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 175
                     + APE +        SDV+SFGV L ELL+            L       
Sbjct: 187 D--DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244

Query: 176 WADPFLRDSRRVLRIMDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTS 231
                     R++  +    RL             V  ++ +C    P NR S  +++  
Sbjct: 245 GQMT----VTRLVNTLKEGKRL----PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296

Query: 232 LEQL 235
            E L
Sbjct: 297 FEAL 300

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  137 bits (348), Expect = 5e-38
 Identities = 71/246 (28%), Positives = 117/246 (47%), Gaps = 29/246 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++     N ++RDL+A+N+L+  N   K++DFGLAR     + T         
Sbjct: 288 QIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 345

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR- 182
           + + APE    G  T KSDV+SFG++L EL + GR                    P+   
Sbjct: 346 K-WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-------------------PYPGM 385

Query: 183 DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
            +R VL  ++   G +        +++  ++ QC   +P+ RP+   +   LE   TS +
Sbjct: 386 VNREVLDQVER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443

Query: 241 MPRTPP 246
               P 
Sbjct: 444 PQYQPG 449

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  133 bits (337), Expect = 1e-37
 Identities = 58/247 (23%), Positives = 112/247 (45%), Gaps = 22/247 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 116

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P         
Sbjct: 117 LQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVK 174

Query: 120 RIVGTRG---YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
                     + APE +     +  SDV+SFGVVL EL +     ++ +   AE   +  
Sbjct: 175 E--PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIG 229

Query: 177 ADPFLR-DSRRVLRIMDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTS 231
            D   +     ++ ++    RL     + +     +  ++ +C + +   RPS  D+   
Sbjct: 230 NDKQGQMIVFHLIELLKNNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285

Query: 232 LEQLHTS 238
           ++Q+  +
Sbjct: 286 VDQIRDN 292

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  137 bits (347), Expect = 1e-37
 Identities = 60/241 (24%), Positives = 110/241 (45%), Gaps = 28/241 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+R+L A N L+  N   K++DFGL+R   TGD           
Sbjct: 326 QISSAMEYLE--KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFP 382

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR- 182
             + APE +A    + KSDV++FGV+L E+ + G                     P+   
Sbjct: 383 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------------PYPGI 423

Query: 183 DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
           D  +V  +++     +  + E   + V  ++  C   +P +RPS  ++  + E +     
Sbjct: 424 DLSQVYELLEK--DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 481

Query: 241 M 241
           +
Sbjct: 482 I 482

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  136 bits (345), Expect = 1e-37
 Identities = 71/242 (29%), Positives = 114/242 (47%), Gaps = 39/242 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E   + QLRH NLV+L+G   E    L +V E+M KGSL ++L  +G   +     +K +
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
           +DV   + +L     N ++RDL A NVL+  +  AK+SDFGL ++         S+    
Sbjct: 296 LDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDT 345

Query: 124 TR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 179
            +    + APE +     + KSDV+SFG++L E+ S GR                    P
Sbjct: 346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-------------------P 386

Query: 180 FLR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
           + R   + V+  ++   G +    +    AV  V+  C H+D   RP+ + +   LE + 
Sbjct: 387 YPRIPLKDVVPRVEK--GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

Query: 237 TS 238
           T 
Sbjct: 445 TH 446

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  132 bits (335), Expect = 2e-37
 Identities = 72/242 (29%), Positives = 114/242 (47%), Gaps = 39/242 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E   + QLRH NLV+L+G   E    L +V E+M KGSL ++L  +G   +     +K +
Sbjct: 64  EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
           +DV   + +L     N ++RDL A NVL+  +  AK+SDFGL ++         S+    
Sbjct: 124 LDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDT 173

Query: 124 TR---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADP 179
            +    + APE +     + KSDV+SFG++L E+ S GR                    P
Sbjct: 174 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV-------------------P 214

Query: 180 FLR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
           + R   + V+  ++   G +    +    AV  V+  C H+D   RPS + +   LE + 
Sbjct: 215 YPRIPLKDVVPRVEK--GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272

Query: 237 TS 238
           T 
Sbjct: 273 TH 274

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  131 bits (333), Expect = 2e-37
 Identities = 64/239 (26%), Positives = 111/239 (46%), Gaps = 35/239 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +L H  LVK  G CS+     +V E++  G L N+L R   + +     +++  
Sbjct: 53  EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCY 111

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           DV  G++FL       I+RDL A N L+D +   K+SDFG+ R     D+ +VS+   GT
Sbjct: 112 DVCEGMAFLE--SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSV--GT 165

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    ++APE       + KSDV++FG+++ E+ S G+                    P+
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM-------------------PY 206

Query: 181 LRDS-RRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
              +   V+  +    G +  +       +  ++  C H  P+ RP+   +L+S+E L 
Sbjct: 207 DLYTNSEVVLKVSQ--GHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  133 bits (336), Expect = 4e-37
 Identities = 63/264 (23%), Positives = 116/264 (43%), Gaps = 23/264 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           +Q E+  L  L  + +VK  G       +   LV E++P G L + L ++    +     
Sbjct: 71  FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRL 129

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  +  + +G+ +L       ++RDL A N+L++S  + K++DFGLA+  P   + +V  
Sbjct: 130 LLYSSQICKGMEYLG--SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187

Query: 120 RIVGTRG---YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVE 175
                +    + APE ++    + +SDV+SFGVVL EL +   ++        AE   + 
Sbjct: 188 E--PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSAEFLRMM 241

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
             +  +    R+L +++   G +     A    V  ++  C    P++RPS   +   L+
Sbjct: 242 GCERDVPALSRLLELLEE--GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299

Query: 234 QLHTSKDMPRTP----PPAKLHHH 253
            L +      T      P   HH 
Sbjct: 300 MLWSGSRGCETHAFTAHPEGKHHS 323

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (336), Expect = 4e-37
 Identities = 69/247 (27%), Positives = 111/247 (44%), Gaps = 33/247 (13%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           +GQ  H N+++L G  +     ++V E+M  GSL+  L R      +    V +   V  
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGA 162

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G+ +L   D   ++RDL A NVL+DSN   K+SDFGL+R      +   +T   G +   
Sbjct: 163 GMRYLS--DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIPI 218

Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR-D 183
            + APE +A    +  SDV+SFGVV+ E+L+ G R                   P+    
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER-------------------PYWNMT 259

Query: 184 SRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
           +R V+  ++   G +         A+  ++L C H D   RP    +++ L+ L  S + 
Sbjct: 260 NRDVISSVEE--GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317

Query: 242 PRTPPPA 248
            R     
Sbjct: 318 LRATATV 324

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  132 bits (335), Expect = 5e-37
 Identities = 64/246 (26%), Positives = 118/246 (47%), Gaps = 33/246 (13%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           +GQ  H N+++L G  S+    +++ E+M  G+L+  L R+     S    V +   +A 
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAA 158

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G+ +L   + N ++RDL A N+L++SN   K+SDFGL+R     D+   +    G +   
Sbjct: 159 GMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPI 214

Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 184
            + APE ++    T  SDV+SFG+V+ E+++ G R                   P+   S
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-------------------PYWELS 255

Query: 185 -RRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
              V++ ++   G +         A+  +++QC   +   RP   D+++ L++L  + D 
Sbjct: 256 NHEVMKAIND--GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 313

Query: 242 PRTPPP 247
            +T   
Sbjct: 314 LKTLAD 319

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  132 bits (334), Expect = 6e-37
 Identities = 50/243 (20%), Positives = 108/243 (44%), Gaps = 39/243 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C       L+ + MP G L +++ R+    I     +   +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+     +  + +    G 
Sbjct: 125 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---GG 179

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + A E +     T +SDV+S+GV + EL++ G +                   P+
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------------PY 220

Query: 181 L-RDSRRVLRIMDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
               +  +  I++   RL     +       V  ++ +C  +D  +RP   +++    ++
Sbjct: 221 DGIPASEISSILEKGERL----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276

Query: 236 HTS 238
              
Sbjct: 277 ARD 279

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  131 bits (331), Expect = 6e-37
 Identities = 56/238 (23%), Positives = 105/238 (44%), Gaps = 35/238 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  L HE LV+L G C++     ++ E+M  G L N+L R+          +++  
Sbjct: 69  EAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCK 127

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           DV   + +L       ++RDL A N L++     K+SDFGL+R     D+ +  T  VG+
Sbjct: 128 DVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEY--TSSVGS 181

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    ++ PE +     + KSD+++FGV++ E+ S G+                    P+
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM-------------------PY 222

Query: 181 LRDS-RRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
            R +       +    G +  +     + V  ++  C H     RP+   +L+++  +
Sbjct: 223 ERFTNSETAEHIAQ--GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  132 bits (333), Expect = 7e-37
 Identities = 65/246 (26%), Positives = 109/246 (44%), Gaps = 23/246 (9%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           W+ E+  L  L HE+++K  G C ++      LV E++P GSL ++L  +    I     
Sbjct: 80  WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PR--HSIGLAQL 136

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           +  A  +  G+++LH    + I+RDL A NVLLD++   K+ DFGLA+  P G   +   
Sbjct: 137 LLFAQQICEGMAYLHAQ--HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-- 192

Query: 120 RIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
             V   G     + APE +        SDV+SFGV L ELL+   +         E   +
Sbjct: 193 --VREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
                 +     +L       G +  + +     V  ++  C   +   RP+  +++  L
Sbjct: 251 AQGQMTVLRLTELLER-----GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

Query: 233 EQLHTS 238
           + +H  
Sbjct: 306 KTVHEK 311

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  133 bits (336), Expect = 7e-37
 Identities = 67/244 (27%), Positives = 118/244 (48%), Gaps = 27/244 (11%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           +GQ  H N+++L G  ++S   ++V E+M  GSL++ L RK     +    V +   +A 
Sbjct: 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIAS 158

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTR--- 125
           G+ +L   D   ++RDL A N+L++SN   K+SDFGL R     D+   +    G +   
Sbjct: 159 GMKYLS--DMGYVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPI 214

Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDS 184
            + +PE +A    T  SDV+S+G+VL E++S G R        ++ Q +++     + + 
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY----WEMSNQDVIK----AVDEG 266

Query: 185 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRT 244
            R+   MD             A+  ++L C   D  NRP    +++ L++L  +    + 
Sbjct: 267 YRLPPPMDC----------PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKI 316

Query: 245 PPPA 248
              A
Sbjct: 317 ITSA 320

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  131 bits (331), Expect = 8e-37
 Identities = 60/244 (24%), Positives = 113/244 (46%), Gaps = 34/244 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + +A 
Sbjct: 59  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  + +L     N I+RDL A N L+  N   K++DFGL+R      +T+ +    G 
Sbjct: 119 QISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHA--GA 172

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + APE +A    + KSDV++FGV+L E+ + G                     P+
Sbjct: 173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-------------------PY 213

Query: 181 LR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
              D  +V  +++     +  + E   + V  ++  C   +P +RPS  ++  + E +  
Sbjct: 214 PGIDLSQVYELLEK--DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

Query: 238 SKDM 241
              +
Sbjct: 272 ESSI 275

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  136 bits (343), Expect = 8e-37
 Identities = 71/246 (28%), Positives = 117/246 (47%), Gaps = 29/246 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V +A 
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++++     N ++RDL+A+N+L+  N   K++DFGLAR     + T         
Sbjct: 371 QIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 428

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLR- 182
           + + APE    G  T KSDV+SFG++L EL + GR                    P+   
Sbjct: 429 K-WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-------------------PYPGM 468

Query: 183 DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
            +R VL  ++   G +        +++  ++ QC   +P+ RP+   +   LE   TS +
Sbjct: 469 VNREVLDQVER--GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526

Query: 241 MPRTPP 246
               P 
Sbjct: 527 PQYQPG 532

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  131 bits (332), Expect = 1e-36
 Identities = 59/249 (23%), Positives = 113/249 (45%), Gaps = 26/249 (10%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR--LLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           ++ E+  L  L+H+N+VK  G C  +  R   L+ E++P GSL ++L +K  + I     
Sbjct: 89  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKL 147

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           ++    + +G+ +L       I+RDL   N+L+++    K+ DFGL +  P     +   
Sbjct: 148 LQYTSQICKGMEYLG--TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 205

Query: 120 RIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
                 G     + APE +     +  SDV+SFGVVL EL +     ++ +   AE   +
Sbjct: 206 ----EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRM 258

Query: 175 EWADPFLR-DSRRVLRIMDT--RLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVL 229
              D   +     ++ ++    RL     + +     +  ++ +C + +   RPS  D+ 
Sbjct: 259 IGNDKQGQMIVFHLIELLKNNGRL----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLA 314

Query: 230 TSLEQLHTS 238
             ++Q+   
Sbjct: 315 LRVDQIRDQ 323

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  131 bits (331), Expect = 1e-36
 Identities = 64/246 (26%), Positives = 107/246 (43%), Gaps = 41/246 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E I +    H N++ L+G C  S+   L+V  +M  G L N + R      +    +   
Sbjct: 76  EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFG 134

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
           + VA+G+ +L       ++RDL A N +LD  F  K++DFGLARD    +       +  
Sbjct: 135 LQVAKGMKYLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHN 188

Query: 124 TRGYA------APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQT 172
             G        A E + T   T KSDV+SFGV+L EL++        RG      +    
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFD 240

Query: 173 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
           +      +L   RR+L+                 +  V+L+C H   + RPS  ++++ +
Sbjct: 241 ITV----YLLQGRRLLQPEYCP----------DPLYEVMLKCWHPKAEMRPSFSELVSRI 286

Query: 233 EQLHTS 238
             + ++
Sbjct: 287 SAIFST 292

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  130 bits (329), Expect = 2e-36
 Identities = 63/259 (24%), Positives = 114/259 (44%), Gaps = 42/259 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + QL +  +V++IG C   ++ +LV E    G L  +L ++  + +     +++  
Sbjct: 68  EANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYL-QQN-RHVKDKNIIELVH 124

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            V+ G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N + +      
Sbjct: 125 QVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HG 180

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + APE +     + KSDV+SFGV++ E  S G++                   P+
Sbjct: 181 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK-------------------PY 221

Query: 181 LR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
                  V  +++   G +        + +  ++  C   D +NRP    V   L   + 
Sbjct: 222 RGMKGSEVTAMLEK--GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279

Query: 238 SKDMPRTPPPAKLHHHHHH 256
                      + HHHHHH
Sbjct: 280 D-------VVNEGHHHHHH 291

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  129 bits (327), Expect = 3e-36
 Identities = 66/241 (27%), Positives = 107/241 (44%), Gaps = 33/241 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV  +  L H NL++L G         +V E  P GSL + L RK        T  + A+
Sbjct: 71  EVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAV 128

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            VA G+ +L       I+RDL A N+LL +    K+ DFGL R  P  D+ +V       
Sbjct: 129 QVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HR 184

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + APE + T   +  SD + FGV L E+ + G+                    P+
Sbjct: 185 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-------------------PW 225

Query: 181 LR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
           +  +  ++L  +D + G +  + E   Q +  V++QC    P++RP+ V +   L +   
Sbjct: 226 IGLNGSQILHKID-KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

Query: 238 S 238
           +
Sbjct: 285 T 285

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  132 bits (335), Expect = 5e-36
 Identities = 66/250 (26%), Positives = 124/250 (49%), Gaps = 40/250 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  L+H+ LVKL    ++ +   ++ EFM KGSL + L          P  +  + 
Sbjct: 233 EANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++F+     N I+RDL+A+N+L+ ++   K++DFGLAR     DN +  T   G 
Sbjct: 292 QIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGA 345

Query: 125 RG---YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + APE +  G  T KSDV+SFG++L+E+++ GR                    P+
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI-------------------PY 386

Query: 181 LR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
               +  V+R ++   G +  + E   + +  ++++C    P+ RP+   + + L+  +T
Sbjct: 387 PGMSNPEVIRALER--GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444

Query: 238 S-----KDMP 242
           +     +++P
Sbjct: 445 ATESQYEEIP 454

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (324), Expect = 7e-36
 Identities = 64/250 (25%), Positives = 122/250 (48%), Gaps = 35/250 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + +A 
Sbjct: 58  EANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     DN +  T   G 
Sbjct: 117 QIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGA 170

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + APE +  G  T KSDV+SFG++L E+++ GR                    P+
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI-------------------PY 211

Query: 181 LR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
               +  V++ ++   G +  + +   + +  ++  C    P++RP+   + + LE   T
Sbjct: 212 PGMTNPEVIQNLER--GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

Query: 238 SKDMPRTPPP 247
           + +    P P
Sbjct: 270 ATEGQYQPQP 279

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  128 bits (323), Expect = 1e-35
 Identities = 57/241 (23%), Positives = 109/241 (45%), Gaps = 36/241 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + +  L H ++VKLIG   E +   ++ E  P G L ++L  +    +   T V  ++
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSL 120

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + + +++L     N ++RD+   N+L+ S    KL DFGL+R     D  +       T
Sbjct: 121 QICKAMAYLE--SINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS--VT 174

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           R    + +PE +     T  SDV+ F V + E+LS G++                   PF
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ-------------------PF 215

Query: 181 L-RDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
              +++ V+ +++   G +  K +     +  ++ +C   DP +RP   +++ SL  ++ 
Sbjct: 216 FWLENKDVIGVLEK--GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273

Query: 238 S 238
            
Sbjct: 274 M 274

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  127 bits (322), Expect = 3e-35
 Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 55/278 (19%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHL----FRKGVQPI 54
           E   + +  H ++ KL+G    S  +      +++  FM  G L   L      +    +
Sbjct: 75  EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134

Query: 55  SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
              T V+  +D+A G+ +L     N I+RDL A N +L  +    ++DFGL+R   +GD 
Sbjct: 135 PLQTLVRFMVDIACGMEYLS--SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY 192

Query: 115 THVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG--- 166
                   G        + A E +A    T  SDV++FGV + E+++        RG   
Sbjct: 193 YR-----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT--------RGQTP 239

Query: 167 --GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
             G+    +      +L    R+ +  +            + V  ++ QC   DPK RPS
Sbjct: 240 YAGIENAEIYN----YLIGGNRLKQPPECM----------EEVYDLMYQCWSADPKQRPS 285

Query: 225 MVDVLTSLEQLHTSKDMPRTPPPA------KLHHHHHH 256
              +   LE +     +  T          + HHHHHH
Sbjct: 286 FTCLRMELENILGHLSVLSTSQDPLYINIERAHHHHHH 323

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  127 bits (321), Expect = 3e-35
 Identities = 66/261 (25%), Positives = 106/261 (40%), Gaps = 36/261 (13%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRV 60
             E+  L QL H N++K      E +   +V E    G L   +  F+K  + I   T  
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           K  + +   L  +H     V++RD+K +NV + +    KL D GL R       T  +  
Sbjct: 140 KYFVQLCSALEHMH--SRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHS 195

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           +VGT  Y +PE +       KSD++S G +L E+ + +     D+  L            
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----------YS 245

Query: 181 LRDSRRVLRIMDTR----LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
           L       +I            YS    + +  +V  C++ DP+ RP +  V    +++H
Sbjct: 246 L-----CKKIEQCDYPPLPSDHYS----EELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

Query: 237 TSKDMPRTPPPAKLHHHHHHH 257
                      + L HHHHHH
Sbjct: 297 ACTA-------SSLEHHHHHH 310

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  126 bits (320), Expect = 5e-35
 Identities = 66/246 (26%), Positives = 105/246 (42%), Gaps = 41/246 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLL-VYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E + +  L H N++ LIG     +     +  +M  G L   + R   +  +    +   
Sbjct: 72  EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFG 130

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
           + VARG+ +L   +   ++RDL A N +LD +F  K++DFGLARD    +   V      
Sbjct: 131 LQVARGMEYLA--EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 124 ------TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQT 172
                 T    A E + T   T KSDV+SFGV+L ELL+        RG      +    
Sbjct: 189 RLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLT--------RGAPPYRHIDPFD 236

Query: 173 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
           L      FL   RR+ +                ++  V+ QC   DP  RP+   ++  +
Sbjct: 237 LTH----FLAQGRRLPQPEYCP----------DSLYQVMQQCWEADPAVRPTFRVLVGEV 282

Query: 233 EQLHTS 238
           EQ+ ++
Sbjct: 283 EQIVSA 288

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  128 bits (323), Expect = 6e-35
 Identities = 65/246 (26%), Positives = 107/246 (43%), Gaps = 41/246 (16%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E I +    H N++ L+G C  S+   L+V  +M  G L N + R      +    +   
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFG 198

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
           + VA+G+ FL       ++RDL A N +LD  F  K++DFGLARD    +   V  +   
Sbjct: 199 LQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256

Query: 124 ------TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GLAEQT 172
                      A E + T   T KSDV+SFGV+L EL++        RG      +    
Sbjct: 257 KLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGAPPYPDVNTFD 304

Query: 173 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
           +      +L   RR+L+                 +  V+L+C H   + RPS  ++++ +
Sbjct: 305 ITV----YLLQGRRLLQPEYCP----------DPLYEVMLKCWHPKAEMRPSFSELVSRI 350

Query: 233 EQLHTS 238
             + ++
Sbjct: 351 SAIFST 356

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  127 bits (320), Expect = 7e-35
 Identities = 49/243 (20%), Positives = 109/243 (44%), Gaps = 35/243 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   +  + + ++ +L+G C       L+ + MP G L +++ R+    I     +   +
Sbjct: 67  EAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCV 124

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+     +  + +    G 
Sbjct: 125 QIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE---GG 179

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + A E +     T +SDV+S+GV + EL++ G +                   P+
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK-------------------PY 220

Query: 181 L-RDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
               +  +  I++   G +  +       V  ++++C  +D  +RP   +++    ++  
Sbjct: 221 DGIPASEISSILEK--GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278

Query: 238 SKD 240
              
Sbjct: 279 DPQ 281

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  126 bits (319), Expect = 8e-35
 Identities = 56/249 (22%), Positives = 113/249 (45%), Gaps = 47/249 (18%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------FRKGVQPISW 56
           E   + +    ++V+L+G  S+    L++ E M +G L+++L            + P S 
Sbjct: 78  EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137

Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D   
Sbjct: 138 SKMIQMAGEIADGMAYLNAN--KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195

Query: 117 VSTRIVGTRGY-----AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG----- 166
                 G +G       +PE +  G  T  SDV+SFGVVL E+ +               
Sbjct: 196 -----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT--------LAEQPYQ 242

Query: 167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 226
           GL+ + ++     F+ +   + +  +              +  ++  C   +PK RPS +
Sbjct: 243 GLSNEQVLR----FVMEGGLLDKPDNCP----------DMLFELMRMCWQYNPKMRPSFL 288

Query: 227 DVLTSLEQL 235
           ++++S+++ 
Sbjct: 289 EIISSIKEE 297

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  126 bits (319), Expect = 9e-35
 Identities = 63/266 (23%), Positives = 105/266 (39%), Gaps = 47/266 (17%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-----FRKGVQPISWPTR 59
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L            ++    
Sbjct: 83  EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTH 116
           + +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD        
Sbjct: 143 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS--- 197

Query: 117 VSTRIVGTRGY-----AAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG----- 166
                 G           PE    G  T K+D +SFGV+L E+ S         G     
Sbjct: 198 --YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGYMPYP 247

Query: 167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 226
             + Q ++E    F+    R+    +              V  ++ QC    P++RP+  
Sbjct: 248 SKSNQEVLE----FVTSGGRMDPPKNCP----------GPVYRIMTQCWQHQPEDRPNFA 293

Query: 227 DVLTSLEQLHTSKDMPRTPPPAKLHH 252
            +L  +E      D+  T  P +   
Sbjct: 294 IILERIEYCTQDPDVINTALPIEYGP 319

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  126 bits (318), Expect = 1e-34
 Identities = 56/238 (23%), Positives = 110/238 (46%), Gaps = 29/238 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
            ++ +G L H ++V+L+G C  S +  LV +++P GSL +H+ R+    +     +   +
Sbjct: 65  HMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGV 122

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +A+G+ +L   +  +++R+L A NVLL S    +++DFG+A   P  D   + +     
Sbjct: 123 QIAKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS---EA 177

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + A E +  G  T +SDV+S+GV + EL++ G         GL    + +     
Sbjct: 178 KTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA----GLRLAEVPD----L 229

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
           L    R+ +                 V  V+++C  +D   RP+  ++     ++   
Sbjct: 230 LEKGERLAQPQICT----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  125 bits (317), Expect = 2e-34
 Identities = 63/255 (24%), Positives = 105/255 (41%), Gaps = 44/255 (17%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-------------FRKGV 51
           E   L  L+H+++V+  G C+E    L+V+E+M  G L   L                  
Sbjct: 93  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152

Query: 52  QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
            P+     + +A  VA G+ +L     + ++RDL   N L+      K+ DFG++RD  +
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLA--GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210

Query: 112 GDNTHVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDR 165
            D        VG R      +  PE +     T +SDV+SFGVVL E+ + G++      
Sbjct: 211 TDYYR-----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW---- 261

Query: 166 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 225
             L+    ++     +   R + R                 V A++  C   +P+ R S+
Sbjct: 262 YQLSNTEAID----CITQGRELERPRACP----------PEVYAIMRGCWQREPQQRHSI 307

Query: 226 VDVLTSLEQLHTSKD 240
            DV   L+ L  +  
Sbjct: 308 KDVHARLQALAQAPP 322

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  125 bits (317), Expect = 3e-34
 Identities = 53/272 (19%), Positives = 105/272 (38%), Gaps = 23/272 (8%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L  ++H N+V+      E+ +  +V ++   G L   +  +          +  
Sbjct: 71  RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW 130

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +   L  +H  D  +++RD+K+ N+ L  +   +L DFG+AR         ++   +
Sbjct: 131 FVQICLALKHVH--DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACI 186

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  Y +PE         KSD+++ G VL EL + + A +      + + LV        
Sbjct: 187 GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE----AGSMKNLV-------- 234

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS-LEQLHTSKDM 241
              +++      +   YS      + ++V Q    +P++RPS+  +L          K +
Sbjct: 235 --LKIISGSFPPVSLHYS----YDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFL 288

Query: 242 PRTPPPAKLHHHHHHHNHHQGIKHTNPPRKTS 273
                  +           Q I    P    +
Sbjct: 289 SPQLIAEEFCLKTFSKFGSQPIPAKRPASGQN 320

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  124 bits (313), Expect = 3e-34
 Identities = 55/241 (22%), Positives = 97/241 (40%), Gaps = 44/241 (18%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL----------------LVYEFMPKGSLENHLFR 48
           EV  L +L H N+V   G     D                   +  EF  KG+LE  + +
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113

Query: 49  KGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
           +  + +     +++   + +G+ ++H     +I RDLK SN+ L      K+ DFGL   
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT- 170

Query: 109 GPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGL 168
             +  N    TR  GT  Y +PE +++     + D+Y+ G++L ELL             
Sbjct: 171 --SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD--------- 219

Query: 169 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 228
                          S+    + D  +   + KKE      ++ + L   P++RP+  ++
Sbjct: 220 ----------TAFETSKFFTDLRDGIISDIFDKKEKT----LLQKLLSKKPEDRPNTSEI 265

Query: 229 L 229
           L
Sbjct: 266 L 266

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  123 bits (312), Expect = 4e-34
 Identities = 56/241 (23%), Positives = 99/241 (41%), Gaps = 36/241 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E + + Q  H ++VKLIG  +E+    ++ E    G L + L +     +   + +  A 
Sbjct: 66  EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAY 123

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R     D+T+        
Sbjct: 124 QLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS--KG 177

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + APE +     T  SDV+ FGV + E+L  G +                   PF
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-------------------PF 218

Query: 181 LRDS-RRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
                  V+  ++   G +          + +++ +C   DP  RP   ++   L  +  
Sbjct: 219 QGVKNNDVIGRIEN--GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276

Query: 238 S 238
            
Sbjct: 277 E 277

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  124 bits (313), Expect = 5e-34
 Identities = 51/228 (22%), Positives = 81/228 (35%), Gaps = 33/228 (14%)

Query: 5   EVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           EV    ++ +H   V+L     E     L  E     SL+ H    G   +         
Sbjct: 106 EVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYL 163

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
            D    L+ LH     +++ D+K +N+ L      KL DFGL  +  T     V     G
Sbjct: 164 RDTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEG 218

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
              Y APE +   +    +DV+S G+ +LE+                        P   +
Sbjct: 219 DPRYMAPELLQGSY-GTAADVFSLGLTILEVACNMEL------------------PHGGE 259

Query: 184 SRRVLR--IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
             + LR   +        S  E +   +V++  L  DPK R +   +L
Sbjct: 260 GWQQLRQGYLPPEFTAGLS-SELR---SVLVMMLEPDPKLRATAEALL 303

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  123 bits (312), Expect = 8e-34
 Identities = 61/253 (24%), Positives = 108/253 (42%), Gaps = 48/253 (18%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNR-----LLVYEFMPKGSLENHL----FRKGVQPIS 55
           E   +    H N+++L+G C E  ++     +++  FM  G L  +L       G + I 
Sbjct: 86  EAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145

Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
             T +K  +D+A G+ +L   + N ++RDL A N +L  +    ++DFGL++   +GD  
Sbjct: 146 LQTLLKFMVDIALGMEYLS--NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203

Query: 116 HVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG---- 166
                  G        + A E +A    T KSDV++FGV + E+ +        RG    
Sbjct: 204 R-----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--------RGMTPY 250

Query: 167 -GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 225
            G+    + +    +L    R+ +  D              +  ++  C   DP +RP+ 
Sbjct: 251 PGVQNHEMYD----YLLHGHRLKQPEDCL----------DELYEIMYSCWRTDPLDRPTF 296

Query: 226 VDVLTSLEQLHTS 238
             +   LE+L  S
Sbjct: 297 SVLRLQLEKLLES 309

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  124 bits (314), Expect = 1e-33
 Identities = 63/257 (24%), Positives = 104/257 (40%), Gaps = 39/257 (15%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-----QPISWPTR 59
           E + + +  H+N+V+ IG   +S  R ++ E M  G L++ L            ++    
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTH 116
           + +A D+A G  +L   + + I+RD+ A N LL        AK+ DFG+ARD        
Sbjct: 184 LHVARDIACGCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241

Query: 117 VSTRIVGTRGY-----AAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAE 170
                 G           PE    G  T K+D +SFGV+L E+ S G           + 
Sbjct: 242 -----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY----PSKSN 292

Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 230
           Q ++E    F+    R+    +              V  ++ QC    P++RP+   +L 
Sbjct: 293 QEVLE----FVTSGGRMDPPKNCP----------GPVYRIMTQCWQHQPEDRPNFAIILE 338

Query: 231 SLEQLHTSKDMPRTPPP 247
            +E      D+  T  P
Sbjct: 339 RIEYCTQDPDVINTALP 355

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (308), Expect = 2e-33
 Identities = 57/271 (21%), Positives = 97/271 (35%), Gaps = 59/271 (21%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDN---------RLLVY---EFMPKGSLENHL-FRKGV 51
           EV  L +L H  +V+      E +          ++ +Y   +   K +L++ +  R  +
Sbjct: 53  EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112

Query: 52  QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR---- 107
           +       + I + +A  + FLH     +++RDLK SN+    +   K+ DFGL      
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170

Query: 108 ------DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
                            T  VGT+ Y +PE +     + K D++S G++L ELL      
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY----- 225

Query: 162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG------GQYSKKEAQAVAAVVLQCL 215
                            PF     RV  + D R         Q    E      +V   L
Sbjct: 226 -----------------PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYV----MVQDML 264

Query: 216 HMDPKNRPSMVDVLTSLEQLHTSKDMPRTPP 246
              P  RP  ++++ +   +    D P    
Sbjct: 265 SPSPMERPEAINIIEN--AVFEDLDFPGKTV 293

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  121 bits (305), Expect = 6e-33
 Identities = 62/258 (24%), Positives = 107/258 (41%), Gaps = 49/258 (18%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FR 48
           Q E   L  L+HE++VK  G C + D  ++V+E+M  G L   L               R
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 49  KGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
           +    +     + IA  +A G+ +L     + ++RDL   N L+ +N   K+ DFG++RD
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLA--SQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182

Query: 109 GPTGDNTHVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 163
             + D        VG        +  PE +     T +SDV+SFGV+L E+ +       
Sbjct: 183 VYSTDYYR-----VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT------- 230

Query: 164 DRGGLAEQTLVEWADPF-LRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPK 220
                 +Q       P+    +  V+  +    G    +     + V  V+L C   +P+
Sbjct: 231 ----YGKQ-------PWFQLSNTEVIECITQ--GRVLERPRVCPKEVYDVMLGCWQREPQ 277

Query: 221 NRPSMVDVLTSLEQLHTS 238
            R ++ ++   L  L  +
Sbjct: 278 QRLNIKEIYKILHALGKA 295

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  120 bits (303), Expect = 1e-32
 Identities = 48/227 (21%), Positives = 85/227 (37%), Gaps = 28/227 (12%)

Query: 3   QTEVIYLGQLRHENLVKLIGYC---SESDNRLLVY-EFMPKGSLENHLFRKGVQPISWPT 58
           + E   L  L+H N+V+         +    +++  E M  G+L+ +L R     +    
Sbjct: 73  KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKV 130

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHV 117
                  + +GL FLH     +I+RDLK  N+ +     + K+ D GLA    T      
Sbjct: 131 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASF 186

Query: 118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
           +  ++GT  + APE     +     DVY+FG+ +LE+ +      E +            
Sbjct: 187 AKAVIGTPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQ-------- 237

Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
                      R+        + K     V  ++  C+  +   R S
Sbjct: 238 --------IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS 276

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  125 bits (315), Expect = 1e-32
 Identities = 53/233 (22%), Positives = 93/233 (39%), Gaps = 28/233 (12%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           + Q  H ++VKLIG  +E +   ++ E    G L + L +     +   + +  A  ++ 
Sbjct: 445 MRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLST 502

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
            L++L       ++RD+ A NVL+ SN   KL DFGL+R          S   +  +   
Sbjct: 503 ALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM- 559

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRV 187
           APE +     T  SDV+ FGV + E+L               +       PF       V
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEILM-----------HGVK-------PFQGVKNNDV 601

Query: 188 LRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
           +  ++   G +          + +++ +C   DP  RP   ++   L  +   
Sbjct: 602 IGRIEN--GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  120 bits (302), Expect = 2e-32
 Identities = 55/255 (21%), Positives = 97/255 (38%), Gaps = 46/255 (18%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-------------LVYEFMPKGSLENHLFRK 49
            +EV+ L  L H+ +V+      E  N +             +  E+   G+L + +  +
Sbjct: 50  LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE 109

Query: 50  GVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-- 107
            +         ++   +   LS++H     +I+RDLK  N+ +D + N K+ DFGLA+  
Sbjct: 110 NL-NQQRDEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

Query: 108 ----------DGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLS 156
                           ++   T  +GT  Y A E +  TGH   K D+YS G++  E++ 
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

Query: 157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLH 216
                  +R  +            L+  R V             K E +    ++   + 
Sbjct: 227 PFST-GMERVNI------------LKKLRSVSIEFPPDFDDNKMKVEKK----IIRLLID 269

Query: 217 MDPKNRPSMVDVLTS 231
            DP  RP    +L S
Sbjct: 270 HDPNKRPGARTLLNS 284

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  123 bits (311), Expect = 3e-32
 Identities = 57/241 (23%), Positives = 104/241 (43%), Gaps = 34/241 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E   + QL +  +V+LIG C   +  +LV E    G L   L  K  + I      ++  
Sbjct: 386 EAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLH 443

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            V+ G+ +L   + N ++R+L A NVLL +   AK+SDFGL++     D+ + +      
Sbjct: 444 QVSMGMKYLE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR--SAG 499

Query: 125 R---GYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPF 180
           +    + APE +     + +SDV+S+GV + E LS G++                   P+
Sbjct: 500 KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-------------------PY 540

Query: 181 LR-DSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
            +     V+  ++   G +          + A++  C     ++RP  + V   +   + 
Sbjct: 541 KKMKGPEVMAFIEQ--GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598

Query: 238 S 238
           S
Sbjct: 599 S 599

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  118 bits (298), Expect = 5e-32
 Identities = 58/234 (24%), Positives = 102/234 (43%), Gaps = 27/234 (11%)

Query: 3   QTEVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHL--FRKGVQPISWPT 58
            +EV  L +L+H N+V+        ++  L +V E+   G L + +    K  Q +    
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112

Query: 59  RVKIAIDVARGLSFLH---GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
            +++   +   L   H        V++RDLK +NV LD   N KL DFGLAR      +T
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDT 170

Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
             +   VGT  Y +PE +       KSD++S G +L EL +            +++ L  
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT----AFSQKELA- 225

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                     ++      R+  +YS      +  ++ + L++   +RPS+ ++L
Sbjct: 226 ---------GKIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEIL 266

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  117 bits (296), Expect = 1e-31
 Identities = 59/251 (23%), Positives = 103/251 (41%), Gaps = 43/251 (17%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKG 50
           E +   +L+H N+V L+G  ++     +++ +   G L   L               R  
Sbjct: 62  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 51  VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGP 110
              +  P  V +   +A G+ +L     +V+++DL   NVL+    N K+SD GL R+  
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLS--SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179

Query: 111 TGDNTHVSTR----IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDR 165
             D   +       I       APE +  G  +  SD++S+GVVL E+ S G +      
Sbjct: 180 AADYYKLLGNSLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY---- 231

Query: 166 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 225
            G + Q +VE     +R+ + +    D              V A++++C +  P  RP  
Sbjct: 232 CGYSNQDVVE----MIRNRQVLPCPDDCP----------AWVYALMIECWNEFPSRRPRF 277

Query: 226 VDVLTSLEQLH 236
            D+ + L    
Sbjct: 278 KDIHSRLRAWG 288

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (296), Expect = 3e-31
 Identities = 61/260 (23%), Positives = 105/260 (40%), Gaps = 73/260 (28%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D     
Sbjct: 159 LVSCTYQLARGMEYLA--SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY---- 212

Query: 119 TRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GL 168
                T G     + APE +     T +SDV+SFGV++ E+ +         G     G+
Sbjct: 213 -YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGI 263

Query: 169 AEQTLVEWADPFLRDSRR----------VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 218
             + L +     L++  R          +  +M                      C H  
Sbjct: 264 PVEELFK----LLKEGHRMDKPANCTNELYMMM--------------------RDCWHAV 299

Query: 219 PKNRPSMVDVLTSLEQLHTS 238
           P  RP+   ++  L+++ T 
Sbjct: 300 PSQRPTFKQLVEDLDRILTL 319

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  117 bits (294), Expect = 3e-31
 Identities = 51/249 (20%), Positives = 89/249 (35%), Gaps = 34/249 (13%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHL--FRKGVQPISW 56
           Q E        H N+++L+ YC           L+  F  +G+L N +   +     ++ 
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133

Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              + + + + RGL  +H       +RDLK +N+LL       L D G            
Sbjct: 134 DQILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191

Query: 117 VSTRIV-------GTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
                +        T  Y APE  +      +  ++DV+S G VL  ++ G    D    
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251

Query: 167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 226
                 L             V   +      ++S     A+  ++   + +DP  RP + 
Sbjct: 252 KGDSVALA------------VQNQLSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIP 295

Query: 227 DVLTSLEQL 235
            +L+ LE L
Sbjct: 296 LLLSQLEAL 304

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  117 bits (294), Expect = 9e-31
 Identities = 63/252 (25%), Positives = 108/252 (42%), Gaps = 57/252 (22%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L               R   + +++  
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V     +ARG+ +L       I+RDL A NVL+  N   K++DFGLARD    D     
Sbjct: 205 LVSCTYQLARGMEYLASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY---- 258

Query: 119 TRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GL 168
                T G     + APE +     T +SDV+SFGV++ E+ +         G     G+
Sbjct: 259 -YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--------LGGSPYPGI 309

Query: 169 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMV 226
             + L +     L++  R    MD        K       +  ++  C H  P  RP+  
Sbjct: 310 PVEELFK----LLKEGHR----MD--------KPANCTNELYMMMRDCWHAVPSQRPTFK 353

Query: 227 DVLTSLEQLHTS 238
            ++  L+++ T 
Sbjct: 354 QLVEDLDRILTL 365

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  116 bits (292), Expect = 1e-30
 Identities = 62/244 (25%), Positives = 108/244 (44%), Gaps = 48/244 (19%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL------------FRKGVQPISWPTRV 60
           +HEN+V L+G C+     L++ E+   G L N L            F       S    +
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
             +  VA+G++FL     N I+RD+ A NVLL +   AK+ DFGLARD     N      
Sbjct: 168 HFSSQVAQGMAFLA--SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----- 220

Query: 121 IVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
           IV         + APE +     T +SDV+S+G++L E+ S           L       
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS-----------LGLN---- 265

Query: 176 WADPF--LRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDVLTS 231
              P+  +  + +  +++    G Q ++     + + +++  C  ++P +RP+   + + 
Sbjct: 266 ---PYPGILVNSKFYKLVKD--GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320

Query: 232 LEQL 235
           L++ 
Sbjct: 321 LQEQ 324

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  116 bits (291), Expect = 1e-30
 Identities = 52/248 (20%), Positives = 88/248 (35%), Gaps = 45/248 (18%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL-FRKGVQPISWPTR 59
               ++  +     +N V  +   S      +  +   K +L++ +  R  ++       
Sbjct: 107 APSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD----------G 109
           + I I +A  + FLH     +++RDLK SN+    +   K+ DFGL              
Sbjct: 167 LHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224

Query: 110 PTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 169
                    T  VGT+ Y +PE +   + + K D++S G++L ELL              
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY------------- 271

Query: 170 EQTLVEWADPFLRDSRRVLRIMDTRLG------GQYSKKEAQAVAAVVLQCLHMDPKNRP 223
                     F     RV  I D R         Q   +E      +V   L   P  RP
Sbjct: 272 ---------SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHM----MVQDMLSPSPTERP 318

Query: 224 SMVDVLTS 231
              D++ +
Sbjct: 319 EATDIIEN 326

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  116 bits (292), Expect = 1e-30
 Identities = 58/263 (22%), Positives = 103/263 (39%), Gaps = 61/263 (23%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL------------------ 46
           E   + +  + N+VKL+G C+      L++E+M  G L   L                  
Sbjct: 100 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 159

Query: 47  ----FRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 102
                  G  P+S   ++ IA  VA G+++L       ++RDL   N L+  N   K++D
Sbjct: 160 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER--KFVHRDLATRNCLVGENMVVKIAD 217

Query: 103 FGLARDGPTGDNTHVSTRIVGTRGY-----AAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           FGL+R+  + D                     PE +     T +SDV+++GVVL E+ S 
Sbjct: 218 FGLSRNIYSAD-----YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS- 271

Query: 158 RRALDEDRG-----GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVL 212
                   G     G+A + ++     ++RD   +    +              +  ++ 
Sbjct: 272 -------YGLQPYYGMAHEEVIY----YVRDGNILACPENCP----------LELYNLMR 310

Query: 213 QCLHMDPKNRPSMVDVLTSLEQL 235
            C    P +RPS   +   L+++
Sbjct: 311 LCWSKLPADRPSFCSIHRILQRM 333

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  115 bits (290), Expect = 1e-30
 Identities = 65/252 (25%), Positives = 101/252 (40%), Gaps = 56/252 (22%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
            H N++ L+G C       L  E+ P G+L + L                     +S   
Sbjct: 84  HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            +  A DVARG+ +L       I+RDL A N+L+  N+ AK++DFGL+R        +V 
Sbjct: 144 LLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVK 197

Query: 119 TRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GL 168
                T G     + A E +     T  SDV+S+GV+L E++S         G     G+
Sbjct: 198 K----TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS--------LGGTPYCGM 245

Query: 169 AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV 228
               L E     L    R+ + ++              V  ++ QC    P  RPS   +
Sbjct: 246 TCAELYE----KLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSFAQI 291

Query: 229 LTSLEQLHTSKD 240
           L SL ++   + 
Sbjct: 292 LVSLNRMLEERK 303

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  114 bits (288), Expect = 2e-30
 Identities = 58/239 (24%), Positives = 104/239 (43%), Gaps = 23/239 (9%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGL 70
           QL H+N+V +I    E D   LV E++   +L  ++   G  P+S  T +     +  G+
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGI 124

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
              H  D  +++RD+K  N+L+DSN   K+ DFG+A+       T  +  ++GT  Y +P
Sbjct: 125 KHAH--DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSP 181

Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-GLAEQTLVEWADPFLRDSRRVLR 189
           E          +D+YS G+VL E+L G    + +    +A + + +       D R+ + 
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI- 240

Query: 190 IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 248
                          Q+++ V+L+    D  NR   +  +   + L +     R     
Sbjct: 241 --------------PQSLSNVILRATEKDKANRYKTIQEM--KDDLSSVLHENRANEDV 283

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  115 bits (289), Expect = 2e-30
 Identities = 61/267 (22%), Positives = 106/267 (39%), Gaps = 81/267 (30%)

Query: 11  QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL----------------------FR 48
           Q+ H +++KL G CS+    LL+ E+   GSL   L                        
Sbjct: 82  QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141

Query: 49  KGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
              + ++    +  A  +++G+ +L   +  +++RDL A N+L+      K+SDFGL+RD
Sbjct: 142 PDERALTMGDLISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199

Query: 109 GPTGDNTHVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDE 163
               D+      +  ++G     + A E +     T +SDV+SFGV+L E+++       
Sbjct: 200 VYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------- 247

Query: 164 DRG-----GLAEQTLVEWADPFLRDSRR----------VLRIMDTRLGGQYSKKEAQAVA 208
             G     G+  + L       L+   R          + R+M                 
Sbjct: 248 -LGGNPYPGIPPERLFN----LLKTGHRMERPDNCSEEMYRLM----------------- 285

Query: 209 AVVLQCLHMDPKNRPSMVDVLTSLEQL 235
              LQC   +P  RP   D+   LE++
Sbjct: 286 ---LQCWKQEPDKRPVFADISKDLEKM 309

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  115 bits (289), Expect = 2e-30
 Identities = 60/255 (23%), Positives = 92/255 (36%), Gaps = 66/255 (25%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL----------------FRKGVQPISW 56
            H N+V L+G C+     L++ E+   G L N L                       +  
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
              +  +  VA+G++FL     N I+RDL A N+LL      K+ DFGLARD     N  
Sbjct: 145 EDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 117 VSTR----IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
           V       +       APE +     T +SDV+S+G+ L EL S         G      
Sbjct: 203 VKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFS--------LGSSPYPG 250

Query: 173 LVEWAD--PFLRDSRRVLR----------IMDTRLGGQYSKKEAQAVAAVVLQCLHMDPK 220
           +   +     +++  R+L           IM                      C   DP 
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIM--------------------KTCWDADPL 290

Query: 221 NRPSMVDVLTSLEQL 235
            RP+   ++  +E+ 
Sbjct: 291 KRPTFKQIVQLIEKQ 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  114 bits (287), Expect = 4e-30
 Identities = 58/250 (23%), Positives = 99/250 (39%), Gaps = 51/250 (20%)

Query: 13  RHENLVKLIGYCSESDN-RLLVYEFMPKGSLENHL--------------FRKGVQPISWP 57
            H N+V L+G C++     +++ EF   G+L  +L                     ++  
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 58  TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 117
             +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGLARD     +   
Sbjct: 149 HLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--- 203

Query: 118 STRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
              +          + APE +     T +SDV+SFGV+L E+ S           L    
Sbjct: 204 --YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS-----------LGAS- 249

Query: 173 LVEWADPF--LRDSRRVLRIMDTRLGGQYSKKEA--QAVAAVVLQCLHMDPKNRPSMVDV 228
                 P+  ++      R +  + G +    +     +   +L C H +P  RP+  ++
Sbjct: 250 ------PYPGVKIDEEFCRRL--KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 301

Query: 229 LTSLEQLHTS 238
           +  L  L  +
Sbjct: 302 VEHLGNLLQA 311

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  114 bits (287), Expect = 4e-30
 Identities = 57/242 (23%), Positives = 100/242 (41%), Gaps = 24/242 (9%)

Query: 10  GQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           G+L+  ++V +  +  E D +L +    +    L   L R+G  P++ P  V I   +  
Sbjct: 89  GRLQEPHVVPIHDF-GEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGS 145

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
            L   H   A   +RD+K  N+L+ ++  A L DFG+A        T +    VGT  Y 
Sbjct: 146 ALDAAH--AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYM 202

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 188
           APE  +  H T ++D+Y+   VL E L+G      D+  +    + + A P     R  +
Sbjct: 203 APERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQ-AIPRPSTVRPGI 261

Query: 189 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR-PSMVDVLTSLEQLHTSKDMPRTPPP 247
                            A  AV+ + +  +P++R  +  D+  +      + D  R    
Sbjct: 262 ---------------PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDI 306

Query: 248 AK 249
            +
Sbjct: 307 LR 308

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  114 bits (287), Expect = 1e-29
 Identities = 62/262 (23%), Positives = 103/262 (39%), Gaps = 73/262 (27%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--------------FRKGVQPISWPT 58
           +H+N++ L+G C++     ++ E+  KG+L  +L                   + +S   
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
            V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLARD    D     
Sbjct: 193 LVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247

Query: 119 TRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG-----GL 168
                T G     + APE +     T +SDV+SFGV+L E+ +         G     G+
Sbjct: 248 --KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--------LGGSPYPGV 297

Query: 169 AEQTLVEWADPFLRDSRR----------VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 218
             + L +     L++  R          +  +M                      C H  
Sbjct: 298 PVEELFK----LLKEGHRMDKPSNCTNELYMMM--------------------RDCWHAV 333

Query: 219 PKNRPSMVDVLTSLEQLHTSKD 240
           P  RP+   ++  L+++     
Sbjct: 334 PSQRPTFKQLVEDLDRIVALTS 355

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  113 bits (285), Expect = 1e-29
 Identities = 38/164 (23%), Positives = 68/164 (41%), Gaps = 13/164 (7%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV------QPISW 56
           + E+  +  +++E  +   G  +  D   ++YE+M   S+        V        I  
Sbjct: 91  KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150

Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
                I   V    S++H  + N+ +RD+K SN+L+D N   KLSDFG +          
Sbjct: 151 QVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---K 206

Query: 117 VSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGR 158
           +     GT  +  PE+ +    +   K D++S G+ L  +    
Sbjct: 207 IKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  112 bits (283), Expect = 2e-29
 Identities = 60/283 (21%), Positives = 109/283 (38%), Gaps = 51/283 (18%)

Query: 3   QTEVIYLGQLR-HENLVKLIGYCSESDNR-------LLVYEFMPKGSLENHLFRKGVQ-P 53
             EV ++ +L  H N+V+     S             L+   + KG L   L +   + P
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132

Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA---RDGP 110
           +S  T +KI     R +  +H     +I+RDLK  N+LL +    KL DFG A      P
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192

Query: 111 TGDNTHVSTRIV-------GTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRA 160
               +     +V        T  Y  PE +       +  K D+++ G +L  L   +  
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ-- 250

Query: 161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLH 216
                             PF  +    LRI    + G+YS      +     +++   L 
Sbjct: 251 -----------------HPF--EDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQ 287

Query: 217 MDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPAKLHHHHHHHNH 259
           ++P+ R S+ +V+  L+++  ++++    P  +L   +  +  
Sbjct: 288 VNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGS 330

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  116 bits (291), Expect = 2e-29
 Identities = 43/246 (17%), Positives = 82/246 (33%), Gaps = 45/246 (18%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-----LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           L ++ H ++V++  +   +D        +V E++   SL+    +     +     +   
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYL 188

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
           +++   LS+LH     ++Y DLK  N++L      KL D G                + G
Sbjct: 189 LEILPALSYLH--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYG 239

Query: 124 TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRD 183
           T G+ APE +     T  +D+Y+ G  L  L                             
Sbjct: 240 TPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLP-------------------TRNGR 279

Query: 184 SRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTSKDMP 242
               L   D  L          +   ++ + +  DP+ R  +  ++   L  +       
Sbjct: 280 YVDGLPEDDPVLK------TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQ 333

Query: 243 RTPPPA 248
            T  P 
Sbjct: 334 DTGVPR 339

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  110 bits (277), Expect = 1e-28
 Identities = 59/265 (22%), Positives = 105/265 (39%), Gaps = 26/265 (9%)

Query: 11  QLRHENLVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
            L H  +V +               +V E++   +L + +  +G  P++    +++  D 
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADA 125

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST-RIVGTR 125
            + L+F H     +I+RD+K +N+++ +    K+ DFG+AR      N+   T  ++GT 
Sbjct: 126 CQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183

Query: 126 GYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR 185
            Y +PE      +  +SDVYS G VL E+L+G      D       + V  A   +R+  
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVAYQHVREDP 236

Query: 186 RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTP 245
                    L        +  + AVVL+ L  +P+NR      +     L    +     
Sbjct: 237 IPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEM--RADLVRVHNGEPPE 286

Query: 246 PPAKLHHHHHHHNHHQGIKHTNPPR 270
            P  L              + + PR
Sbjct: 287 APKVLTDAERTSLLSSAAGNLSGPR 311

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  110 bits (276), Expect = 3e-28
 Identities = 61/261 (23%), Positives = 102/261 (39%), Gaps = 73/261 (27%)

Query: 13  RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL---------------------FRKGV 51
            HEN+V L+G C+ S    L++E+   G L N+L                       + +
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 52  QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPT 111
             +++   +  A  VA+G+ FL     + ++RDL A NVL+      K+ DFGLARD  +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 112 GDNTHVSTRIVGTRG-----YAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
             N      +V         + APE +  G  T KSDV+S+G++L E+ S         G
Sbjct: 225 DSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS--------LG 271

Query: 167 GLAEQTLVEWAD--PFLRDSRRVLR----------IMDTRLGGQYSKKEAQAVAAVVLQC 214
                 +   A+    +++  ++ +          IM                      C
Sbjct: 272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIM--------------------QSC 311

Query: 215 LHMDPKNRPSMVDVLTSLEQL 235
              D + RPS  ++ + L   
Sbjct: 312 WAFDSRKRPSFPNLTSFLGCQ 332

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  111 bits (279), Expect = 3e-28
 Identities = 52/241 (21%), Positives = 91/241 (37%), Gaps = 41/241 (17%)

Query: 5   EVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           EV  L +   H N+++      +   + +  E     +L+ ++ +K    +       + 
Sbjct: 67  EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPI-TLL 124

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLL-----DSNFNAKLSDFGLAR--DGPTGDNTH 116
                GL+ LH L  N+++RDLK  N+L+          A +SDFGL +         + 
Sbjct: 125 QQTTSGLAHLHSL--NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182

Query: 117 VSTRIVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
            S  + GT G+ APE +      + T   D++S G V   ++S                 
Sbjct: 183 RSG-VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH------------- 228

Query: 174 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAV-----VLQCLHMDPKNRPSMVDV 228
                PF +  +R   I+             +    V     + + + MDP+ RPS   V
Sbjct: 229 -----PFGKSLQRQANIL--LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281

Query: 229 L 229
           L
Sbjct: 282 L 282

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  109 bits (274), Expect = 3e-28
 Identities = 52/240 (21%), Positives = 95/240 (39%), Gaps = 35/240 (14%)

Query: 3   QTEVIYLGQLRH--ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+ YL +L+   + +++L  Y        +V E      L + L +K    I    R 
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERK 111

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
               ++   +  +H     +++ DLK +N L+      KL DFG+A        + V   
Sbjct: 112 SYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 168

Query: 121 IVGTRGYAAPE-----------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 169
            VGT  Y  PE             +   ++PKSDV+S G +L  +  G+    +    ++
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 228

Query: 170 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                           ++  I+D     ++     + +  V+  CL  DPK R S+ ++L
Sbjct: 229 ----------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  108 bits (273), Expect = 3e-28
 Identities = 52/240 (21%), Positives = 94/240 (39%), Gaps = 35/240 (14%)

Query: 3   QTEVIYLGQLRHENL--VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+ YL +L+  +   ++L  Y        +V E      L + L +K    I    R 
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKK--SIDPWERK 130

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
               ++   +  +H     +++ DLK +N L+      KL DFG+A        + V   
Sbjct: 131 SYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 187

Query: 121 IVGTRGYAAPE-----------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 169
            VGT  Y  PE             +   ++PKSDV+S G +L  +  G+    +    ++
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 247

Query: 170 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                           ++  I+D     ++     + +  V+  CL  DPK R S+ ++L
Sbjct: 248 ----------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  109 bits (273), Expect = 1e-27
 Identities = 51/240 (21%), Positives = 93/240 (38%), Gaps = 35/240 (14%)

Query: 3   QTEVIYLGQLRHENL--VKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+ YL +L+  +   ++L  Y        +V E      L + L +K    I    R 
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERK 158

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
               ++   +  +H     +++ DLK +N L+      KL DFG+A        + V   
Sbjct: 159 SYWKNMLEAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS 215

Query: 121 IVGTRGYAAPE-----------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLA 169
            VG   Y  PE             +   ++PKSDV+S G +L  +  G+    +    ++
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS 275

Query: 170 EQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                           ++  I+D     ++     + +  V+  CL  DPK R S+ ++L
Sbjct: 276 ----------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  110 bits (276), Expect = 1e-27
 Identities = 50/239 (20%), Positives = 85/239 (35%), Gaps = 20/239 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLI------GYCSESDNRLLVYEFMPKGSLENHLFRKG-VQPI 54
           W  E+  + +L H N+V            + +D  LL  E+   G L  +L +      +
Sbjct: 59  WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118

Query: 55  SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA---KLSDFGLARDGPT 111
                  +  D++  L +LH  +  +I+RDLK  N++L         K+ D G A++   
Sbjct: 119 KEGPIRTLLSDISSALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE--L 174

Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ 171
                 +   VGT  Y APE +     T   D +SFG +  E ++G R    +   +   
Sbjct: 175 DQGELCTEF-VGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWH 233

Query: 172 TLVEWAD----PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQC-LHMDPKNRPSM 225
             V            D    ++         +            LQC L    + R + 
Sbjct: 234 GKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD 292

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  106 bits (267), Expect = 3e-27
 Identities = 48/254 (18%), Positives = 92/254 (36%), Gaps = 30/254 (11%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGY--CSESDNRLLVYEFMPKGSLENHLFRKG-VQPISWP 57
           +   E   L +L H+N+VKL      + + +++L+ EF P GSL   L        +   
Sbjct: 53  VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112

Query: 58  TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGD 113
             + +  DV  G++ L   +  +++R++K  N++     D     KL+DFG AR+    D
Sbjct: 113 EFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LED 168

Query: 114 NTHVSTRIVGTRGYAAPEYVATGHL--------TPKSDVYSFGVVLLELLSGRRALDEDR 165
           +    + + GT  Y  P+      L            D++S GV      +G        
Sbjct: 169 DEQFVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

Query: 166 GGLAEQTLVE----------WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL 215
           G    + ++            +     ++  +    D  +    S+     +  V+   L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287

Query: 216 HMDPKNRPSMVDVL 229
             D +         
Sbjct: 288 EADQEKCWGFDQFF 301

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  107 bits (269), Expect = 4e-27
 Identities = 50/264 (18%), Positives = 91/264 (34%), Gaps = 30/264 (11%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRL--LVYEFMPKGSLENHLFRKG-VQPISWP 57
           +   E   L +L H+N+VKL     E+  R   L+ EF P GSL   L        +   
Sbjct: 53  VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112

Query: 58  TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGD 113
             + +  DV  G++ L   +  +++R++K  N++     D     KL+DFG AR+    D
Sbjct: 113 EFLIVLRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LED 168

Query: 114 NTHVSTRIVGTRGYAAPEYVATGHL--------TPKSDVYSFGVVLLELLSGRRALDEDR 165
           +    + + GT  Y  P+      L            D++S GV      +G        
Sbjct: 169 DEQFVS-LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227

Query: 166 GGLAEQTLVE----------WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL 215
           G    + ++            +     ++  +    D  +    S+     +  V+   L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287

Query: 216 HMDPKNRPSMVDVLTSLEQLHTSK 239
             D +              +    
Sbjct: 288 EADQEKCWGFDQFFAETSDILHRM 311

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  104 bits (261), Expect = 3e-26
 Identities = 51/232 (21%), Positives = 81/232 (34%), Gaps = 36/232 (15%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E++    L    +V L G   E     +  E +  GSL   + + G   +     +  
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYY 155

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLAR---DGPTGDNTHVS 118
                 GL +LH     +++ D+KA NVLL S+   A L DFG A        G +    
Sbjct: 156 LGQALEGLEYLH--TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213

Query: 119 TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
             I GT  + APE V        K D++S   ++L +L+G                  W 
Sbjct: 214 DYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHP---------------WT 257

Query: 178 DPFLRDSRRVLRIMDTR-----LGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
                     L+I         +    +       A  + + L  +P +R S
Sbjct: 258 Q--YFRGPLCLKIASEPPPIREIPPSCAP----LTAQAIQEGLRKEPVHRAS 303

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  102 bits (257), Expect = 3e-26
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 8/154 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV     LRH N+++L GY  ++    L+ E+ P G++   L +                
Sbjct: 59  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYIT 116

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P   +        GT
Sbjct: 117 ELANALSYCHSK--RVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDL--CGT 170

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++S GV+  E L G+
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  104 bits (261), Expect = 4e-26
 Identities = 28/164 (17%), Positives = 54/164 (32%), Gaps = 16/164 (9%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---QPISWPTRVKIAID 65
           L        +K        +  +LV E    G+L N +        + +     +  A+ 
Sbjct: 121 LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 66  VARGLSFLHGLDANVIYRDLKASNVLL-----------DSNFNAKLSDFGLARDGPTGDN 114
           +   +  +H  D  +I+ D+K  N +L           D +    L D G + D      
Sbjct: 181 MLYMIEQVH--DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             + T    T G+   E ++      + D +     +  +L G 
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  106 bits (265), Expect = 5e-26
 Identities = 52/156 (33%), Positives = 76/156 (48%), Gaps = 7/156 (4%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
            E   L ++    +V L  Y  E+ + L LV   M  G L+ H++  G         V  
Sbjct: 233 NEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           A ++  GL  LH     ++YRDLK  N+LLD + + ++SD GLA   P G       R V
Sbjct: 292 AAEICCGLEDLHRE--RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GR-V 346

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           GT GY APE V     T   D ++ G +L E+++G+
Sbjct: 347 GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  101 bits (255), Expect = 9e-26
 Identities = 41/154 (26%), Positives = 64/154 (41%), Gaps = 8/154 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+     LRH N++++  Y  +     L+ EF P+G L   L + G              
Sbjct: 64  EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFME 121

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  L + H     VI+RD+K  N+L+      K++DFG +   P            GT
Sbjct: 122 ELADALHYCHER--KVIHRDIKPENLLMGYKGELKIADFGWSVHAP-SLRRRTM---CGT 175

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
             Y  PE +       K D++  GV+  E L G 
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  101 bits (255), Expect = 1e-25
 Identities = 52/228 (22%), Positives = 100/228 (43%), Gaps = 28/228 (12%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVK 61
             E+     L+H+N+V+ +G  SE+    +  E +P GSL   L  K G    +  T   
Sbjct: 67  HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTR 120
               +  GL +LH  D  +++RD+K  NVL+++ +   K+SDFG ++          +  
Sbjct: 127 YTKQILEGLKYLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTET 182

Query: 121 IVGTRGYAAPEYV---ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
             GT  Y APE +     G+    +D++S G  ++E+ +G+                 + 
Sbjct: 183 FTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPP---------------FY 226

Query: 178 DPFLRDSRRVL-RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
           +  L + +  + ++   ++  +  +  +    A +L+C   DP  R  
Sbjct: 227 E--LGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC 272

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  103 bits (258), Expect = 2e-25
 Identities = 54/263 (20%), Positives = 96/263 (36%), Gaps = 64/263 (24%)

Query: 5   EVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSL-----ENHLFRKGVQPISWPT 58
           E+  L +   H N+++     +      +  E     +L       ++  + ++      
Sbjct: 58  EIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYN 116

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-------------NFNAKLSDFGL 105
            + +   +A G++ LH L   +I+RDLK  N+L+ +             N    +SDFGL
Sbjct: 117 PISLLRQIASGVAHLHSL--KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174

Query: 106 AR---DGPTGDNTHVSTRIVGTRGYAAPE-------YVATGHLTPKSDVYSFGVVLLELL 155
            +    G +   T+++    GT G+ APE             LT   D++S G V   +L
Sbjct: 175 CKKLDSGQSSFRTNLNN-PSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233

Query: 156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAV----- 210
           S  +                   PF     R   I+     G +S  E + +        
Sbjct: 234 SKGK------------------HPFGDKYSRESNIIR----GIFSLDEMKCLHDRSLIAE 271

Query: 211 ----VLQCLHMDPKNRPSMVDVL 229
               + Q +  DP  RP+ + VL
Sbjct: 272 ATDLISQMIDHDPLKRPTAMKVL 294

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  100 bits (252), Expect = 2e-25
 Identities = 45/252 (17%), Positives = 90/252 (35%), Gaps = 60/252 (23%)

Query: 5   EVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHL--FRKGVQPISWPTRVK 61
           EV     L +H ++V+     +E D+ L+  E+   GSL + +    + +          
Sbjct: 60  EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-------------------FNAKLSD 102
           + + V RGL ++H    ++++ D+K SN+ +                         K+ D
Sbjct: 120 LLLQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 103 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--TGHLTPKSDVYSFGVVLLELLSGRRA 160
            G         +  V     G   + A E +     HL PK+D+++  + ++        
Sbjct: 178 LGHVT---RISSPQV---EEGDSRFLANEVLQENYTHL-PKADIFALALTVVCAAGAE-- 228

Query: 161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT---RLGGQYSKKEAQAVAAVVLQCLHM 217
                             P  R+  +   I      R+    S +E      ++   +H 
Sbjct: 229 ------------------PLPRNGDQWHEIRQGRLPRIPQVLS-QEFT---ELLKVMIHP 266

Query: 218 DPKNRPSMVDVL 229
           DP+ RPS + ++
Sbjct: 267 DPERRPSAMALV 278

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =   99 bits (250), Expect = 5e-25
 Identities = 50/155 (32%), Positives = 76/155 (49%), Gaps = 7/155 (4%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           EV    QL+H ++++L  Y  +S+   LV E    G +  +L  +  +P S         
Sbjct: 61  EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMH 119

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +  G+ +LH     +++RDL  SN+LL  N N K++DFGLA         H  T + GT
Sbjct: 120 QIITGMLYLHSH--GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGT 175

Query: 125 RGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
             Y +PE    + H   +SDV+S G +   LL GR
Sbjct: 176 PNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGR 209

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  101 bits (253), Expect = 8e-25
 Identities = 35/234 (14%), Positives = 70/234 (29%), Gaps = 45/234 (19%)

Query: 29  NRLLVYEFMPK--GSLENHLFRKGVQ--PISWPTRVKIAIDVARGLSFLHGLDANVIYRD 84
           +R  +Y  M     +    L         +    R+++ + V R L+ LH     +++  
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTY 236

Query: 85  LKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---------- 134
           L+  +++LD      L+ F        G +          RG+A PE  A          
Sbjct: 237 LRPVDIVLDQRGGVFLTGFEHLV--RDGASAVSPI----GRGFAPPETTAERMLPFGQHH 290

Query: 135 TGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR 194
              +T   D ++ G+ +  +                        P   D+         R
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADL-------------------PNTDDAALGGSEWIFR 331

Query: 195 LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 248
                     Q V A++   L    ++R   +  + + E      ++    P  
Sbjct: 332 SCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLY 381

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  100 bits (251), Expect = 9e-25
 Identities = 24/208 (11%), Positives = 50/208 (24%), Gaps = 25/208 (12%)

Query: 29  NRLLVYEFMPKGSLEN-----HLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR 83
           N LL+        LE                       +   + R  + L      +++ 
Sbjct: 162 NYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ--SKGLVHG 218

Query: 84  DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL--TPK 141
                N+ +  +    L D        T               YA  E++       T  
Sbjct: 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTRGPA-----SSVPVTYAPREFLNASTATFTHA 273

Query: 142 SDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK 201
            + +  G+ +  +            G+              DS          L      
Sbjct: 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDS----------LAFGSCT 323

Query: 202 KEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                V  ++ + L+ D + R   ++ +
Sbjct: 324 PLPDFVKTLIGRFLNFDRRRRLLPLEAM 351

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  101 bits (254), Expect = 1e-24
 Identities = 64/236 (27%), Positives = 100/236 (42%), Gaps = 38/236 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             EV  L QL H N++KL  +  +     LV E    G L + +  +     S     +I
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARI 131

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              V  G++++H     +++RDLK  N+LL+S   + N ++ DFGL+      + +    
Sbjct: 132 IRQVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMK 186

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             +GT  Y APE V  G    K DV+S GV+L  LLSG                     P
Sbjct: 187 DKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP-------------------P 226

Query: 180 FLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           F   +     I+     G+Y+      KK +++   ++ + L   P  R S  D L
Sbjct: 227 FNGANEY--DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDAL 280

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 99.7 bits (249), Expect = 1e-24
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 8/157 (5%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+     L H+++V   G+  ++D   +V E   + SL     R+    ++ P     
Sbjct: 89  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYY 146

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G  +LH     VI+RDLK  N+ L+ +   K+ DFGLA              + 
Sbjct: 147 LRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-KV-LC 202

Query: 123 GTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           GT  Y APE ++  GH + + DV+S G ++  LL G+
Sbjct: 203 GTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 238

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  101 bits (253), Expect = 1e-24
 Identities = 56/236 (23%), Positives = 88/236 (37%), Gaps = 38/236 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  L  L H N++KL     +     LV EF   G L   +  +            I
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANI 151

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              +  G+ +LH    N+++RD+K  N+LL++     N K+ DFGL+         +   
Sbjct: 152 MKQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYKLR 206

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             +GT  Y APE V       K DV+S GV++  LL G                     P
Sbjct: 207 DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP-------------------P 246

Query: 180 FLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           F   + +   I+     G+Y       K  +     ++   L  D   R +  + L
Sbjct: 247 FGGQNDQ--DIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEAL 300

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  100 bits (249), Expect = 2e-24
 Identities = 33/233 (14%), Positives = 71/233 (30%), Gaps = 48/233 (20%)

Query: 14  HENLVKLIGYCS--ESDNRLLVYEFM--PKGSLENHLFRKGVQ--PISWPTRVKIAIDVA 67
            + ++++          +R  +Y  M     +    L         +    R+++ + V 
Sbjct: 157 KKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 216

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
           R L+ LH     +++  L+  +++LD      L+ F        G           +RG+
Sbjct: 217 RLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGARVVS----SVSRGF 268

Query: 128 AAPEYVAT-----------GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
             PE  A              +T   D ++ G+V+  +                      
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL----------------- 311

Query: 177 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
             P  +D+         R          Q V A++   L    ++R   +  +
Sbjct: 312 --PITKDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAM 358

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (253), Expect = 2e-24
 Identities = 48/159 (30%), Positives = 69/159 (43%), Gaps = 8/159 (5%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWP-TRV 60
             E   L ++    +V L  Y  E+   L LV   M  G +  H++        +   R 
Sbjct: 233 MVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRA 291

Query: 61  KI-AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
                 +  GL  LH    N+IYRDLK  NVLLD + N ++SD GLA +   G       
Sbjct: 292 IFYTAQIVSGLEHLHQR--NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKG 348

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              GT G+ APE +         D ++ GV L E+++ R
Sbjct: 349 Y-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  100 bits (252), Expect = 2e-24
 Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 38/236 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             EV  L  L H N++KL  +  +  N  LV E    G L + +  +     +      I
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVI 141

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              V  G+++LH    N+++RDLK  N+LL+S   +   K+ DFGL+      +N     
Sbjct: 142 IKQVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKKMK 196

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             +GT  Y APE V       K DV+S GV+L  LL+G                     P
Sbjct: 197 ERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP-------------------P 236

Query: 180 FLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           F   + +   I+     G+Y+      K  ++    ++ Q L  D + R S    L
Sbjct: 237 FGGQTDQ--EILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 98.4 bits (246), Expect = 2e-24
 Identities = 44/157 (28%), Positives = 72/157 (45%), Gaps = 8/157 (5%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+     L H+++V   G+  ++D   +V E   + SL     R+    ++ P     
Sbjct: 63  SMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYY 120

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G  +LH     VI+RDLK  N+ L+ +   K+ DFGLA              + 
Sbjct: 121 LRQIVLGCQYLHRN--RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK-KV-LC 176

Query: 123 GTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           GT  Y APE ++  GH + + DV+S G ++  LL G+
Sbjct: 177 GTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGK 212

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  101 bits (252), Expect = 3e-24
 Identities = 48/145 (33%), Positives = 73/145 (50%), Gaps = 13/145 (8%)

Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGLSFLH 74
           +V +  Y   + ++L  + + M  G L  HL + GV   +    ++  A ++  GL  +H
Sbjct: 254 IVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEIILGLEHMH 309

Query: 75  GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 134
                V+YRDLK +N+LLD + + ++SD GLA D       H     VGT GY APE + 
Sbjct: 310 NR--FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--AS-VGTHGYMAPEVLQ 363

Query: 135 TGHLTPKS-DVYSFGVVLLELLSGR 158
            G     S D +S G +L +LL G 
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGH 388

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 98.4 bits (245), Expect = 6e-24
 Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 40/256 (15%)

Query: 3   QTEVIYLGQLRHENLVKLIG-YCSESDNRLLVY---EFMPKGSLENHLFRKGVQPISWPT 58
             E+  L +     +V   G + S+ +    +    E M  GSL+     K    I    
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGE----ISICMEHMDGGSLDQ--VLKKAGRIPEQI 132

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
             K++I V +GL++L      +++RD+K SN+L++S    KL DFG++       ++  +
Sbjct: 133 LGKVSIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ---LIDSMAN 188

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
           +  VGTR Y +PE +   H + +SD++S G+ L+E+  GR  +        E       +
Sbjct: 189 S-FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQ------------------------- 213
               ++    R     L               +L                          
Sbjct: 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 307

Query: 214 CLHMDPKNRPSMVDVL 229
           CL  +P  R  +  ++
Sbjct: 308 CLIKNPAERADLKQLM 323

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 96.2 bits (240), Expect = 2e-23
 Identities = 65/277 (23%), Positives = 106/277 (38%), Gaps = 49/277 (17%)

Query: 7   IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLEN---HLFRKGVQPISWPTRVKIA 63
           + +       +V+  G      +  +  E M   S +    +++      I      KI 
Sbjct: 73  VVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG--DNTHVSTRI 121
           +   + L+ L   +  +I+RD+K SN+LLD + N KL DFG++     G   ++   TR 
Sbjct: 132 LATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-----GQLVDSIAKTRD 185

Query: 122 VGTRGYAAPEYVATGHLTP----KSDVYSFGVVLLELLSGRRALDEDRGGLAEQ--TLVE 175
            G R Y APE +           +SDV+S G+ L EL +GR    +    + +Q   +V+
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW-NSVFDQLTQVVK 244

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS----------- 224
              P L +S             ++S      V      CL  D   RP            
Sbjct: 245 GDPPQLSNSE----------EREFSPSFINFVN----LCLTKDESKRPKYKELLKHPFIL 290

Query: 225 -----MVDVLTSLEQLHTSKDMPRTPPPAKLHHHHHH 256
                 V+V   + ++        + P    HHHHHH
Sbjct: 291 MYEERAVEVACYVCKILDQMPATPSSPMYVDHHHHHH 327

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 95.9 bits (239), Expect = 2e-23
 Identities = 64/243 (26%), Positives = 103/243 (42%), Gaps = 43/243 (17%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCS-ESDNRL-LVYEFMPKGSLEN---HLFRKGVQPISWP 57
             E+  + Q  H N+V    Y S    + L LV + +  GS+ +   H+  KG       
Sbjct: 61  LKEIQAMSQCHHPNIVSY--YTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVL 118

Query: 58  TRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL-ARDGPTGD 113
               IA    +V  GL +LH      I+RD+KA N+LL  + + +++DFG+ A     GD
Sbjct: 119 DESTIATILREVLEGLEYLHKN--GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 114 NTHVSTR--IVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGR---------RAL 161
            T    R   VGT  + APE +        K+D++SFG+  +EL +G          + L
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL 236

Query: 162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN 221
                       ++   P L    +     D  +  +Y K   + ++     CL  DP+ 
Sbjct: 237 ---------MLTLQNDPPSLETGVQ-----DKEMLKKYGKSFRKMIS----LCLQKDPEK 278

Query: 222 RPS 224
           RP+
Sbjct: 279 RPT 281

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 97.4 bits (243), Expect = 3e-23
 Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 38/236 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             EV  L +L H N++KL     +S +  +V E    G L + + ++     S     +I
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARI 126

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              V  G++++H    N+++RDLK  N+LL+S   + + K+ DFGL+             
Sbjct: 127 IKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMK 181

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             +GT  Y APE V  G    K DV+S GV+L  LLSG                     P
Sbjct: 182 DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP-------------------P 221

Query: 180 FLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           F   +     I+     G+Y+      +  +     ++ + L   P  R +    L
Sbjct: 222 FYGKNEY--DILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 95.0 bits (237), Expect = 5e-23
 Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 24/160 (15%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           + +L H   VKL  +  + D +L     +   G L  ++ + G                 
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCT 132

Query: 68  R--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           R         L +LHG    +I+RDLK  N+LL+ + + +++DFG A+          + 
Sbjct: 133 RFYTAEIVSALEYLHGK--GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190

Query: 120 RIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 158
             VGT  Y +PE +         SD+++ G ++ +L++G 
Sbjct: 191 SFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGL 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 94.2 bits (235), Expect = 6e-23
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 21/163 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+     L HEN+VK  G+  E + + L  E+   G L + +               +  
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPE 104

Query: 65  DVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
             A+        G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   
Sbjct: 105 PDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 117 VSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           +  ++ GT  Y APE +          DV+S G+VL  +L+G 
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 94.3 bits (235), Expect = 8e-23
 Identities = 39/169 (23%), Positives = 73/169 (43%), Gaps = 25/169 (14%)

Query: 3   QTEVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+  L +LRH+N+++L+    +E   ++ +V E+   G  E  +     +        
Sbjct: 54  KKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK------- 104

Query: 61  KIAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
           +  +  A         GL +LH     ++++D+K  N+LL +    K+S  G+A      
Sbjct: 105 RFPVCQAHGYFCQLIDGLEYLHSQ--GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162

Query: 113 DNTHVSTRIVGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLSGR 158
                     G+  +  PE +A G  T    K D++S GV L  + +G 
Sbjct: 163 AADDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 95.1 bits (237), Expect = 9e-23
 Identities = 58/241 (24%), Positives = 95/241 (39%), Gaps = 43/241 (17%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV-- 60
           + E      L+H ++V+L+   S      +V+EFM    L   + ++      +   V  
Sbjct: 74  KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHV 117
                +   L + H    N+I+RD+K   VLL S   +   KL  FG+A     G++  V
Sbjct: 134 HYMRQILEALRYCHDN--NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLV 189

Query: 118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
           +   VGT  + APE V         DV+  GV+L  LLSG                    
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL------------------ 231

Query: 178 DPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDV 228
            PF        R+ +  + G+Y           + A+    +V + L +DP  R ++ + 
Sbjct: 232 -PFYGTKE---RLFEGIIKGKYKMNPRQWSHISESAK---DLVRRMLMLDPAERITVYEA 284

Query: 229 L 229
           L
Sbjct: 285 L 285

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 94.4 bits (235), Expect = 1e-22
 Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 32/226 (14%)

Query: 7   IYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV 66
           + L       +V+  G    + +  +  E M   + +  L ++   PI      K+ + +
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAI 133

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG--DNTHVSTRIVGT 124
            + L +L      VI+RD+K SN+LLD     KL DFG++     G   +     R  G 
Sbjct: 134 VKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGIS-----GRLVDDKAKDRSAGC 187

Query: 125 RGYAAPEYVATGHL-----TPKSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVEWAD 178
             Y APE +            ++DV+S G+ L+EL +G+      +        +++   
Sbjct: 188 AAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEP 247

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
           P L                 +S      V      CL  D + RP 
Sbjct: 248 PLLPGHMG------------FSGDFQSFVK----DCLTKDHRKRPK 277

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 93.5 bits (233), Expect = 1e-22
 Identities = 56/229 (24%), Positives = 89/229 (38%), Gaps = 37/229 (16%)

Query: 7   IYLGQLRHENLVKLIG-YCSESDNRLLVY---EFMPKGSLENHL--FRKGVQPISWPTRV 60
           I +  +     V   G    E D    V+   E M   SL+          Q I      
Sbjct: 58  ISMRTVDCPFTVTFYGALFREGD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILG 112

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KIA+ + + L  LH    +VI+RD+K SNVL+++    K+ DFG++       +      
Sbjct: 113 KIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGY---LVDDVAKDI 168

Query: 121 IVGTRGYAAPEYVATGHLTP----KSDVYSFGVVLLELLSGRRALDEDRGGLAE-QTLVE 175
             G + Y APE +           KSD++S G+ ++EL   R   D       + + +VE
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
              P L                ++S +     +    QCL  + K RP+
Sbjct: 229 EPSPQLPA-------------DKFSAEFVDFTS----QCLKKNSKERPT 260

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 95.7 bits (238), Expect = 1e-22
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)

Query: 5   EVIYLGQLRHENLVKLI-----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           E++ +  + H+N++ L+         E    + LV E M     + +L +     +    
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHER 165

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   +  G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + 
Sbjct: 166 MSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 220

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           T  V TR Y APE +         D++S G ++ E++  +
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 93.2 bits (232), Expect = 2e-22
 Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 43/236 (18%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           Q E+  L Q     + K  G     D +L ++ E++  GS    L   G  P+       
Sbjct: 68  QQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSA-LDLLEPG--PLDETQIAT 123

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR- 120
           I  ++ +GL +LH      I+RD+KA+NVLL  +   KL+DFG+A     G  T    + 
Sbjct: 124 ILREILKGLDYLH--SEKKIHRDIKAANVLLSEHGEVKLADFGVA-----GQLTDTQIKR 176

Query: 121 --IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
              VGT  + APE +       K+D++S G+  +EL  G                     
Sbjct: 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE-------------------P 217

Query: 179 PFLR-DSRRVLRIMDT----RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           P       +VL ++       L G YSK   + V      CL+ +P  RP+  ++L
Sbjct: 218 PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE----ACLNKEPSFRPTAKELL 269

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 92.7 bits (231), Expect = 2e-22
 Identities = 45/167 (26%), Positives = 82/167 (49%), Gaps = 28/167 (16%)

Query: 5   EVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           E+  L +L H N+VKL+      +++ L +V+E + +G +              PT   +
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEV-------PTLKPL 134

Query: 63  AIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
           + D AR        G+ +LH     +I+RD+K SN+L+  + + K++DFG++ +   G +
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQ--KIIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSD 191

Query: 115 THVSTRIVGTRGYAAPEYVATGHLT---PKSDVYSFGVVLLELLSGR 158
             +S   VGT  + APE ++           DV++ GV L   + G+
Sbjct: 192 ALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 93.1 bits (232), Expect = 3e-22
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 21/163 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+     L HEN+VK  G+  E + + L  E+   G L + +               +  
Sbjct: 55  EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPE 104

Query: 65  DVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
             A+        G+ +LHG+   + +RD+K  N+LLD   N K+SDFGLA      +   
Sbjct: 105 PDAQRFFHQLMAGVVYLHGI--GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 117 VSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           +  ++ GT  Y APE +          DV+S G+VL  +L+G 
Sbjct: 163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 92.6 bits (231), Expect = 4e-22
 Identities = 64/284 (22%), Positives = 110/284 (38%), Gaps = 51/284 (17%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK 61
           E+  + +L+HEN+V+L       +   LV+EFM    K  +++       + +       
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVST 119
               + +GL+F H  +  +++RDLK  N+L++     KL DFGLAR    P    +    
Sbjct: 113 FQWQLLQGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS--- 167

Query: 120 RIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR----------------RAL 161
            +V T  Y AP+ V  G    +   D++S G +L E+++G+                  +
Sbjct: 168 EVV-TLWYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225

Query: 162 DEDRGGLAEQT------LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL 215
               G   E        L ++     +   R LR     L     +     +   +   L
Sbjct: 226 ----GTPNESLWPSVTKLPKYNPNIQQRPPRDLR---QVLQPHTKEPLDGNLMDFLHGLL 278

Query: 216 HMDPKNRPSMVDVLTSLEQLH---TSKDMPRTPPPAKLHHHHHH 256
            ++P  R S    L      H          +   ++ HHHHHH
Sbjct: 279 QLNPDMRLSAKQALH-----HPWFAEYYHHASMGGSRSHHHHHH 317

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 93.5 bits (233), Expect = 4e-22
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 16/162 (9%)

Query: 4   TEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
            E+  +  L H  LV L  Y  + +  + +V + +  G L  HL +           VK+
Sbjct: 64  KELQIMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVKL 119

Query: 63  -AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L +L      +I+RD+K  N+LLD + +  ++DF +A   P        T +
Sbjct: 120 FICELVMALDYLQNQ--RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTM 174

Query: 122 VGTRGYAAPEYVA----TGHLTPKSDVYSFGVVLLELLSGRR 159
            GT+ Y APE  +     G+ +   D +S GV   ELL GRR
Sbjct: 175 AGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 93.2 bits (232), Expect = 5e-22
 Identities = 54/284 (19%), Positives = 101/284 (35%), Gaps = 53/284 (18%)

Query: 5   EVIYLGQLRHENLVKLIG-YCSESDNRL-----LVYEFMPKGSLENHLFRKGVQPISWPT 58
           E++ +  + H+N++ L+  +  +          +V E M     + +L +     +    
Sbjct: 74  ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHER 128

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   +  G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + + 
Sbjct: 129 MSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 183

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL----------------- 161
           T  V TR Y APE +         D++S G ++ E++     L                 
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFPGTDHIDQWNKVIEQL 242

Query: 162 ----DEDRGGLAEQTLVEWADPFLRDSRRVLRI------MDTRLGGQYSKKEAQAVAAVV 211
                E    L           ++ +  +           D          + +A  A  
Sbjct: 243 GTPCPEFMKKLQPT-----VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297

Query: 212 L--QCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAKLH 251
           L  + L +D   R S+ + L    +   +   +    PP     
Sbjct: 298 LLSKMLVIDASKRISVDEALQHPYINVWYDPSEAEAPPPKIPDK 341

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 93.4 bits (232), Expect = 5e-22
 Identities = 50/261 (19%), Positives = 88/261 (33%), Gaps = 46/261 (17%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCS-ESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           Q E+       H N+V      +  +DN L +V  FM  GS ++ +    +  ++     
Sbjct: 74  QGELHVSKLFNHPNIVPY--RATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-- 129

Query: 61  KIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFG----LARDGPTGD 113
            IA     V + L ++H      ++R +KAS++L+  +    LS       +   G    
Sbjct: 130 -IAYILQGVLKALDYIH--HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186

Query: 114 NTHVSTRI-VGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR---------RAL 161
             H   +  V    + +PE +         KSD+YS G+   EL +G          + L
Sbjct: 187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML 246

Query: 162 ------------------DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKE 203
                              E+      +++          +              Y +  
Sbjct: 247 LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306

Query: 204 AQAVAAVVLQCLHMDPKNRPS 224
           +      V QCL  +P  RPS
Sbjct: 307 SPHFHHFVEQCLQRNPDARPS 327

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 91.1 bits (227), Expect = 8e-22
 Identities = 56/237 (23%), Positives = 90/237 (37%), Gaps = 37/237 (15%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR--V 60
           + E+  L  L H N++K+     +  N  +V E    G L   +     +  +       
Sbjct: 68  EAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA 127

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHV 117
           ++   +   L++ H    +V+++DLK  N+L      +   K+ DFGLA       +   
Sbjct: 128 ELMKQMMNALAYFHSQ--HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEH 182

Query: 118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
           ST   GT  Y APE V    +T K D++S GVV+  LL+G                    
Sbjct: 183 STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCL------------------ 223

Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEA-----QAVAAVVLQCLHMDPKNRPSMVDVL 229
            PF   S     +       + +              ++ Q L  DP+ RPS   VL
Sbjct: 224 -PFTGTSLE--EVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 90.3 bits (225), Expect = 1e-21
 Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 28/167 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+  L   RH +++KL  Y    +     +V E++  G L +++ + G          
Sbjct: 59  KREIQNLKLFRHPHIIKL--YQVISTPTDFFMVMEYVSGGELFDYICKHG---------- 106

Query: 61  KIAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
           ++    AR         + + H     V++RDLK  NVLLD++ NAK++DFGL+     G
Sbjct: 107 RVEEMEARRLFQQILSAVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164

Query: 113 DNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           +    S    G+  YAAPE ++   +  P+ D++S GV+L  LL G 
Sbjct: 165 EFLRTS---CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 91.1 bits (227), Expect = 2e-21
 Identities = 53/153 (34%), Positives = 83/153 (54%), Gaps = 12/153 (7%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDV 66
           L ++ H  +VKL  Y  +++ +L L+ +F+  G L   L ++ +        VK    ++
Sbjct: 80  LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAEL 135

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           A  L  LH L   +IYRDLK  N+LLD   + KL+DFGL+++    +    +    GT  
Sbjct: 136 ALALDHLHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVE 191

Query: 127 YAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           Y APE V   GH T  +D +SFGV++ E+L+G 
Sbjct: 192 YMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 90.0 bits (224), Expect = 2e-21
 Identities = 61/239 (25%), Positives = 98/239 (41%), Gaps = 44/239 (18%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             EV  L +L H N++KL     +S +  +V E    G L + + ++     S     +I
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARI 126

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              V  G++++H    N+++RDLK  N+LL+S   + + K+ DFGL+             
Sbjct: 127 IKQVFSGITYMHKH--NIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMK 181

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             +GT  Y APE V  G    K DV+S GV+L  LLSG                     P
Sbjct: 182 DRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP-------------------P 221

Query: 180 FLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           F   +     I+     G+Y+           +A+    ++ + L   P  R +    L
Sbjct: 222 FYGKNEY--DILKRVETGKYAFDLPQWRTISDDAK---DLIRKMLTFHPSLRITATQCL 275

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 91.2 bits (227), Expect = 2e-21
 Identities = 47/147 (31%), Positives = 75/147 (51%), Gaps = 13/147 (8%)

Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGLSFLH 74
           LV L  Y  +++ +L L+ +++  G L  HL ++          V+I   ++   L  LH
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYVGEIVLALEHLH 176

Query: 75  GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE--- 131
            L   +IYRD+K  N+LLDSN +  L+DFGL+++    +         GT  Y AP+   
Sbjct: 177 KL--GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD-FCGTIEYMAPDIVR 233

Query: 132 YVATGHLTPKSDVYSFGVVLLELLSGR 158
              +GH     D +S GV++ ELL+G 
Sbjct: 234 GGDSGH-DKAVDWWSLGVLMYELLTGA 259

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.9 bits (224), Expect = 3e-21
 Identities = 65/276 (23%), Positives = 104/276 (37%), Gaps = 41/276 (14%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L QL+H NLV L+          LV+E+    ++ + L R   + +       I  
Sbjct: 52  EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ-RGVPEHLVKSITW 109

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVSTRIV 122
              + ++F H    N I+RD+K  N+L+  +   KL DFG AR   GP+          V
Sbjct: 110 QTLQAVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE----V 163

Query: 123 GTRGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGR----------------RALDEDR 165
            TR Y +PE  V      P  DV++ G V  ELLSG                 + L    
Sbjct: 164 ATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL---- 219

Query: 166 GGLAEQTLVEWAD----PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN 221
           G L  +            +    +         L  ++      A+  ++  CLHMDP  
Sbjct: 220 GDLIPRH---QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPAL-GLLKGCLHMDPTE 275

Query: 222 RPSMVDVLTS--LEQLHTSKDMPRTPPPAKLHHHHH 255
           R +   +L     E +   +D+ +       + +  
Sbjct: 276 RLTCEQLLHHPYFENIREIEDLAKEHDKPAENLYFQ 311

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 89.6 bits (223), Expect = 3e-21
 Identities = 56/236 (23%), Positives = 90/236 (38%), Gaps = 38/236 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  +  L H N+++L     ++ +  LV E    G L   +  K           +I
Sbjct: 54  KQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARI 111

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
             DV   +++ H L  NV +RDLK  N L  +   +   KL DFGLA          +  
Sbjct: 112 MKDVLSAVAYCHKL--NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMR 166

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
             VGT  Y +P+ V  G   P+ D +S GV++  LL G                     P
Sbjct: 167 TKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYP-------------------P 206

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEA------QAVAAVVLQCLHMDPKNRPSMVDVL 229
           F   +     +M     G ++  E           +++ + L   PK R + +  L
Sbjct: 207 FSAPTDS--EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQAL 260

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 89.9 bits (224), Expect = 4e-21
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 12/153 (7%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDV 66
           L +++H  +V LI Y  ++  +L L+ E++  G L   L R+G+              ++
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEI 130

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
           +  L  LH     +IYRDLK  N++L+   + KL+DFGL ++         +    GT  
Sbjct: 131 SMALGHLHQK--GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV--THTFCGTIE 186

Query: 127 YAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           Y APE +  +GH     D +S G ++ ++L+G 
Sbjct: 187 YMAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 89.9 bits (223), Expect = 6e-21
 Identities = 53/277 (19%), Positives = 86/277 (31%), Gaps = 73/277 (26%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV-- 60
           +TEV  + +L H N+ +L     +     LV E    G L + L                
Sbjct: 76  KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135

Query: 61  ------------------------------------KIAIDVARGLSFLHGLDANVIYRD 84
                                                I   +   L +LH     + +RD
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ--GICHRD 193

Query: 85  LKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVS--TRIVGTRGYAAPEYVATGHL-- 138
           +K  N L  +N +   KL DFGL+++    +N      T   GT  + APE + T +   
Sbjct: 194 IKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253

Query: 139 TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ 198
            PK D +S GV+L  LL G                     PF   +      +   L  +
Sbjct: 254 GPKCDAWSAGVLLHLLLMGAV-------------------PFPGVNDA--DTISQVLNKK 292

Query: 199 YS--KKEAQAVAA----VVLQCLHMDPKNRPSMVDVL 229
                     ++     ++   L+ +   R   +  L
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRAL 329

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 88.9 bits (221), Expect = 8e-21
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 41/242 (16%)

Query: 1   MWQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
               EV  L ++  H N+++L      +    LV++ M KG L ++L  K    +S    
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKET 126

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
            KI   +   +  LH    N+++RDLK  N+LLD + N KL+DFG +     G+      
Sbjct: 127 RKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL---R 181

Query: 120 RIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
            + GT  Y APE               + D++S GV++  LL+G                
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP-------------- 227

Query: 174 VEWADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVD 227
                PF    +    ++   + G Y          +  V  +V + L + P+ R +  +
Sbjct: 228 -----PFWHRKQM--LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280

Query: 228 VL 229
            L
Sbjct: 281 AL 282

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 12/153 (7%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDV 66
           L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R +    ++
Sbjct: 59  LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEI 114

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LH    +V+YRD+K  N++LD + + K++DFGL ++G +   T + T   GT  
Sbjct: 115 VSALEYLHSR--DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKT-FCGTPE 170

Query: 127 YAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           Y APE +    +     D +  GVV+ E++ GR
Sbjct: 171 YLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGR 202

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 49/167 (29%), Positives = 78/167 (46%), Gaps = 28/167 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV 60
             EV  +  L H N+VKL  +   E++  L L+ E+   G + ++L   G          
Sbjct: 62  FREVRIMKILNHPNIVKL--FEVIETEKTLYLIMEYASGGEVFDYLVAHG---------- 109

Query: 61  KIAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
           ++    AR         + + H     +++RDLKA N+LLD++ N K++DFG + +   G
Sbjct: 110 RMKEKEARSKFRQIVSAVQYCHQK--RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167

Query: 113 DNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
                     G   YAAPE      +  P+ DV+S GV+L  L+SG 
Sbjct: 168 GKLDAF---CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 88.8 bits (221), Expect = 1e-20
 Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 10/148 (6%)

Query: 13  RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGL 70
            H  L  +     ++   L  V E++  G L  H+       +S   R    A ++  GL
Sbjct: 76  EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIILGL 131

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
            FLH     ++YRDLK  N+LLD + + K++DFG+ ++   GD    +T   GT  Y AP
Sbjct: 132 QFLHSK--GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNT-FCGTPDYIAP 187

Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGR 158
           E +         D +SFGV+L E+L G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.9 bits (221), Expect = 1e-20
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 15/161 (9%)

Query: 5   EVIYLGQLRHENLVKL----IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR 59
           E+  L    H N++ L    + +   + ++L LV E M    L   +       IS P  
Sbjct: 79  EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DL-AQVIHDQRIVIS-PQH 135

Query: 60  VK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           ++     +  GL  LH  +A V++RDL   N+LL  N +  + DF LAR           
Sbjct: 136 IQYFMYHILLGLHVLH--EAGVVHRDLHPGNILLADNNDITICDFNLAR---EDTADANK 190

Query: 119 TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 158
           T  V  R Y APE V      T   D++S G V+ E+ + +
Sbjct: 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.5 bits (220), Expect = 1e-20
 Identities = 47/233 (20%), Positives = 87/233 (37%), Gaps = 40/233 (17%)

Query: 12  LRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
               ++V ++       +     L++ E M  G L + +  +G Q  +     +I  D+ 
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138

Query: 68  RGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
             + FLH    N+ +RD+K  N+L    + +   KL+DFG A++        + T    T
Sbjct: 139 TAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQT-PCYT 192

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 184
             Y APE +         D++S GV++  LL G                     PF  ++
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP-------------------PFYSNT 233

Query: 185 RRVL--RIMDTRLGGQYSKKEA------QAVAAVVLQCLHMDPKNRPSMVDVL 229
            + +   +      GQY           +    ++   L  DP  R ++   +
Sbjct: 234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFM 286

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.8 bits (223), Expect = 1e-20
 Identities = 52/164 (31%), Positives = 83/164 (50%), Gaps = 26/164 (15%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L   RH +++KL    S   +  +V E++  G L +++ + G          ++  
Sbjct: 66  EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG----------RLDE 115

Query: 65  DVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
             +R        G+ + H     V++RDLK  NVLLD++ NAK++DFGL+     G+   
Sbjct: 116 KESRRLFQQILSGVDYCHRH--MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 173

Query: 117 VSTRIVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR 158
            S    G+  YAAPE V +G L   P+ D++S GV+L  LL G 
Sbjct: 174 TS---CGSPNYAAPE-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 88.9 bits (221), Expect = 2e-20
 Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 21/164 (12%)

Query: 9   LGQLRHENLVKLI------GYCSESDNRL-LVYEFMPKGSLENHL--FRKGVQPISWPTR 59
           L  L H N+V+L       G     D  L +V E++P  +L      + +       P  
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPP-PIL 130

Query: 60  VKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARD-GPTGDNTH 116
           +K+ +  + R +  LH    NV +RD+K  NVL++ ++   KL DFG A+   P+  N  
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190

Query: 117 VSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 158
                + +R Y APE +     H T   D++S G +  E++ G 
Sbjct: 191 Y----ICSRYYRAPELIFGNQ-HYTTAVDIWSVGCIFAEMMLGE 229

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 87.8 bits (218), Expect = 2e-20
 Identities = 54/247 (21%), Positives = 97/247 (39%), Gaps = 56/247 (22%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  L    H  +VKL+G         ++ EF P G+++  +  +  + +   T  +I
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGL---TEPQI 119

Query: 63  AI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
            +    +   L+FLH     +I+RDLKA NVL+    + +L+DFG++       N     
Sbjct: 120 QVVCRQMLEALNFLHSK--RIIHRDLKAGNVLMTLEGDIRLADFGVS-----AKNLKTLQ 172

Query: 120 R---IVGTRGYAAPEYVATGHLT-----PKSDVYSFGVVLLELLSGR---------RALD 162
           +    +GT  + APE V    +       K+D++S G+ L+E+             R L 
Sbjct: 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL- 231

Query: 163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR 222
                     + +   P L                ++S +    +       L  +P+ R
Sbjct: 232 --------LKIAKSDPPTLLT------------PSKWSVEFRDFLK----IALDKNPETR 267

Query: 223 PSMVDVL 229
           PS   +L
Sbjct: 268 PSAAQLL 274

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 89.0 bits (221), Expect = 2e-20
 Identities = 57/239 (23%), Positives = 103/239 (43%), Gaps = 40/239 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H  ++K+  +  ++++  +V E M  G L + +       +   T    
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLY 244

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              +   + +LH  +  +I+RDLK  NVLL S   +   K++DFG ++    G+ + + T
Sbjct: 245 FYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 300

Query: 120 RIVGTRGYAAPEYVATGHL---TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
            + GT  Y APE + +          D +S GV+L   LSG                   
Sbjct: 301 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY------------------ 341

Query: 177 ADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
             PF     +V  + D    G+Y+       + ++    +V + L +DPK R +  + L
Sbjct: 342 -PPFSEHRTQV-SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 398

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 88.6 bits (220), Expect = 3e-20
 Identities = 50/152 (32%), Positives = 74/152 (48%), Gaps = 9/152 (5%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDV 66
           L   RH  L  L  Y  ++ +RL  V E+   G L  HL R+ V       R +    ++
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEI 257

Query: 67  ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRG 126
              L +LH  + NV+YRDLK  N++LD + + K++DFGL ++G     T       GT  
Sbjct: 258 VSALDYLHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPE 314

Query: 127 YAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
           Y APE +         D +  GVV+ E++ GR
Sbjct: 315 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 87.0 bits (216), Expect = 3e-20
 Identities = 55/237 (23%), Positives = 102/237 (43%), Gaps = 43/237 (18%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E++ + + ++ N+V  +      D   +V E++  GSL + +  +    +       +
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTET--CMDEGQIAAV 121

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR-- 120
             +  + L FLH     VI+RD+K+ N+LL  + + KL+DFG          T   ++  
Sbjct: 122 CRECLQALEFLHSN--QVIHRDIKSDNILLGMDGSVKLTDFGFC-----AQITPEQSKRS 174

Query: 121 -IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
            +VGT  + APE V      PK D++S G++ +E++ G                     P
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE-------------------PP 215

Query: 180 FLRDS-RRVLRIMDT----RLGG--QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           +L ++  R L ++ T     L    + S      +     +CL MD + R S  ++L
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN----RCLEMDVEKRGSAKELL 268

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 87.5 bits (217), Expect = 4e-20
 Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 9/163 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGS-LENHLFRKGVQPISWPTRVKIA 63
           E+  L ++ H N++K++          LV E    G  L   + R     +  P    I 
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIF 136

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVG 123
             +   + +L     ++I+RD+K  N+++  +F  KL DFG A     G   +      G
Sbjct: 137 RQLVSAVGYLRLK--DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF---CG 191

Query: 124 TRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
           T  Y APE +    +  P+ +++S GV L  L+       E  
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE 234

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 87.3 bits (217), Expect = 4e-20
 Identities = 49/155 (31%), Positives = 72/155 (46%), Gaps = 7/155 (4%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L QLRHENLV L+  C +     LV+EF+   ++ + L       + +    K   
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP-NGLDYQVVQKYLF 131

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            +  G+ F H    N+I+RD+K  N+L+  +   KL DFG AR         V    V T
Sbjct: 132 QIINGIGFCH--SHNIIHRDIKPENILVSQSGVVKLCDFGFAR--TLAAPGEVYDDEVAT 187

Query: 125 RGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGR 158
           R Y APE  V         DV++ G ++ E+  G 
Sbjct: 188 RWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 88.2 bits (219), Expect = 4e-20
 Identities = 39/166 (23%), Positives = 64/166 (38%), Gaps = 29/166 (17%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L       + +L  +  + +N L LV E+   G L   L + G          +I  ++A
Sbjct: 115 LVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGE---------RIPAEMA 164

Query: 68  R--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           R         +  +H L    ++RD+K  N+LLD   + +L+DFG               
Sbjct: 165 RFYLAEIVMAIDSVHRL--GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVY-------SFGVVLLELLSGR 158
             VGT  Y +PE +      P +  Y       + GV   E+  G+
Sbjct: 223 -AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 87.0 bits (216), Expect = 5e-20
 Identities = 56/242 (23%), Positives = 100/242 (41%), Gaps = 51/242 (21%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  + Q    ++VK  G   ++ +  +V E+   GS+ + + R   + +   T  +I
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTL---TEDEI 127

Query: 63  AI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           A       +GL +LH +    I+RD+KA N+LL++  +AKL+DFG+A     G  T    
Sbjct: 128 ATILQSTLKGLEYLHFM--RKIHRDIKAGNILLNTEGHAKLADFGVA-----GQLTDTMA 180

Query: 120 R---IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR---------RALDEDRGG 167
           +   ++GT  + APE +        +D++S G+  +E+  G+         RA+      
Sbjct: 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------ 234

Query: 168 LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD 227
                +     P  R                +S      V     QCL   P+ R +   
Sbjct: 235 ---FMIPTNPPPTFRKPEL------------WSDNFTDFVK----QCLVKSPEQRATATQ 275

Query: 228 VL 229
           +L
Sbjct: 276 LL 277

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 87.0 bits (216), Expect = 5e-20
 Identities = 57/239 (23%), Positives = 89/239 (37%), Gaps = 34/239 (14%)

Query: 3   QTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR-- 59
           Q E+  L     H N+VKL     +  +  LV E +  G L   + +K      +     
Sbjct: 53  QKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK----HFSETEA 108

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTH 116
             I   +   +S +H  D  V++RDLK  N+L    + N   K+ DFG AR      +  
Sbjct: 109 SYIMRKLVSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL--KPPDNQ 164

Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
                  T  YAAPE +         D++S GV+L  +LSG+                  
Sbjct: 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF--------------Q 210

Query: 177 ADPFLRDSRRVLRIMDTRLGGQYS--KKEAQAV--AA--VVLQCLHMDPKNRPSMVDVL 229
           +          + IM     G +S   +  + V   A  ++   L +DP  R  M  + 
Sbjct: 211 SHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 86.7 bits (215), Expect = 5e-20
 Identities = 62/254 (24%), Positives = 95/254 (37%), Gaps = 63/254 (24%)

Query: 3   QTEVIYLGQL-RHENLVKLIG-----YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPIS 55
           + E+  L +   H N+    G          D++L LV EF   GS+ + +       + 
Sbjct: 68  KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL- 126

Query: 56  WPTRVKIAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
                 IA    ++ RGLS LH     VI+RD+K  NVLL  N   KL DFG++      
Sbjct: 127 --KEEWIAYICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-----A 177

Query: 113 DNTHVSTR---IVGTRGYAAPEYVATGHLT-----PKSDVYSFGVVLLELLSGR------ 158
                  R    +GT  + APE +A           KSD++S G+  +E+  G       
Sbjct: 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237

Query: 159 ---RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL 215
              RAL           +     P L+               ++SKK    +      CL
Sbjct: 238 HPMRAL---------FLIPRNPAPRLKSK-------------KWSKKFQSFIE----SCL 271

Query: 216 HMDPKNRPSMVDVL 229
             +   RP+   ++
Sbjct: 272 VKNHSQRPATEQLM 285

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 87.8 bits (218), Expect = 5e-20
 Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 22/167 (13%)

Query: 5   EVIYLGQLRHENLVKLIGY-CSESDNRL-----LVYEFMPKGSLENHL--FRKGVQPISW 56
           E+  + +L H N+V+L  +  S  + +      LV +++P+ ++      + +  Q +  
Sbjct: 97  ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP- 154

Query: 57  PTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARD-GPTGD 113
              VK+ +  + R L+++H     + +RD+K  N+LLD +    KL DFG A+       
Sbjct: 155 VIYVKLYMYQLFRSLAYIHS--FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212

Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 158
           N       + +R Y APE +  AT   T   DV+S G VL ELL G+
Sbjct: 213 NVSY----ICSRYYRAPELIFGAT-DYTSSIDVWSAGCVLAELLLGQ 254

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.0 bits (214), Expect = 6e-20
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 21/165 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK 61
           E+  L +L+H+N+V+L           LV+EF     K   ++         +  P  VK
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN-----GDLD-PEIVK 104

Query: 62  -IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVS 118
                + +GL F H    NV++RDLK  N+L++ N   KL++FGLAR    P    +   
Sbjct: 105 SFLFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA-- 160

Query: 119 TRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGRRAL 161
             +V T  Y  P+ V  G    +   D++S G +  EL +  R L
Sbjct: 161 -EVV-TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 87.3 bits (217), Expect = 6e-20
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 12/155 (7%)

Query: 7   IYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AI 64
           + L  ++H  LV L  +  ++ ++L  V +++  G L  HL R+         R +  A 
Sbjct: 91  VLLKNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAA 146

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++A  L +LH L  N++YRDLK  N+LLDS  +  L+DFGL ++    ++T  ++   GT
Sbjct: 147 EIASALGYLHSL--NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGT 202

Query: 125 RGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
             Y APE +    +     D +  G VL E+L G 
Sbjct: 203 PEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGL 236

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 86.6 bits (215), Expect = 6e-20
 Identities = 52/264 (19%), Positives = 96/264 (36%), Gaps = 58/264 (21%)

Query: 5   EVIYLGQLRHE--NLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRKGVQPISWPTRVK 61
           EV+ L ++      +++L+ +    D+ +L+ E   P   L + +  +G   +       
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARS 153

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTR 120
               V   +   H     V++RD+K  N+L+D N    KL DFG                
Sbjct: 154 FFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF-- 208

Query: 121 IVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             GTR Y+ PE++   H      + V+S G++L +++ G                     
Sbjct: 209 -DGTRVYSPPEWIR-YHRYHGRSAAVWSLGILLYDMVCGDI------------------- 247

Query: 179 PFLRDSRRVLRIMDTRLGGQYSK-----KEAQAVAAVVLQCLHMDPKNRPSMVDVLT--- 230
           PF      ++R       GQ         E Q    ++  CL + P +RP+  ++     
Sbjct: 248 PF-EHDEEIIR-------GQVFFRQRVSSECQ---HLIRWCLALRPSDRPTFEEIQNHPW 296

Query: 231 -----SLEQLHTSKDMPRTPPPAK 249
                  ++         +P P+K
Sbjct: 297 MQDVLLPQETAEIHLHSLSPGPSK 320

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 86.5 bits (215), Expect = 6e-20
 Identities = 52/243 (21%), Positives = 94/243 (38%), Gaps = 48/243 (19%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR- 59
             + E+  L +++HEN+V L      + +  LV + +  G L + +  +G     +  + 
Sbjct: 52  SLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG----VYTEKD 107

Query: 60  -VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNT 115
              +   V   + +LH     +++RDLK  N+L  +   N    ++DFGL++    G   
Sbjct: 108 ASLVIQQVLSAVKYLHEN--GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--- 162

Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVE 175
            + +   GT GY APE +A    +   D +S GV+   LL G                  
Sbjct: 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYP---------------- 205

Query: 176 WADPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMV 226
              PF  ++    ++ +    G Y           + A+     +   L  DP  R +  
Sbjct: 206 ---PFYEETES--KLFEKIKEGYYEFESPFWDDISESAK---DFICHLLEKDPNERYTCE 257

Query: 227 DVL 229
             L
Sbjct: 258 KAL 260

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.0 bits (218), Expect = 7e-20
 Identities = 53/239 (22%), Positives = 90/239 (37%), Gaps = 47/239 (19%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  +  LRH  LV L     + +  +++YEFM  G  E  LF K     +  +  +   
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG--E--LFEKVADEHNKMSEDEAVE 259

Query: 65  ---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVST 119
               V +GL  +H    N ++ DLK  N++  +  +   KL DFGL        +  V  
Sbjct: 260 YMRQVCKGLCHMHEN--NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-- 315

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
              GT  +AAPE      +   +D++S GV+   LLSG                     P
Sbjct: 316 -TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS-------------------P 355

Query: 180 FLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           F  ++      +       ++          ++ +     + + L  DP  R ++   L
Sbjct: 356 FGGENDD--ETLRNVKSCDWNMDDSAFSGISEDGK---DFIRKLLLADPNTRMTIHQAL 409

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 87.0 bits (216), Expect = 8e-20
 Identities = 71/268 (26%), Positives = 116/268 (43%), Gaps = 35/268 (13%)

Query: 5   EVIYLGQLRHENLVKLIG----YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR 59
           E+  L + RHEN++ +         E    + +V + M   +    L +   Q +S    
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKT--QHLS-NDH 129

Query: 60  VK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR-DGPTGDNTHV 117
           +      + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T  
Sbjct: 130 ICYFLYQILRGLKYIHS--ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187

Query: 118 STRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDED 164
            T  V TR Y APE +  +   T   D++S G +L E+LS R              +   
Sbjct: 188 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 247

Query: 165 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKK--EAQAVAAVVLQ-CLHMDPKN 221
            G  +++ L    +     +R  L  +  +    +++    A + A  +L   L  +P  
Sbjct: 248 LGSPSQEDLNCIINL---KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 304

Query: 222 RPSMVDVLTS--LEQLHTSKDMPRTPPP 247
           R  +   L    LEQ +   D P    P
Sbjct: 305 RIEVEQALAHPYLEQYYDPSDEPIAEAP 332

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 86.3 bits (214), Expect = 8e-20
 Identities = 51/243 (20%), Positives = 101/243 (41%), Gaps = 55/243 (22%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK- 61
             EV+ +   +H N+V++       +   ++ EF+  G+L +         I    R+  
Sbjct: 90  FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD---------IVSQVRLNE 140

Query: 62  --IAI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
             IA     V + L++LH     VI+RD+K+ ++LL  +   KLSDFG          + 
Sbjct: 141 EQIATVCEAVLQALAYLHAQ--GVIHRDIKSDSILLTLDGRVKLSDFGFC-----AQISK 193

Query: 117 VSTR---IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
              +   +VGT  + APE ++      + D++S G++++E++ G                
Sbjct: 194 DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE--------------- 238

Query: 174 VEWADPFLRDS-RRVLRIMDT----RLGG--QYSKKEAQAVAAVVLQCLHMDPKNRPSMV 226
                P+  DS  + ++ +      +L    + S      +     + L  DP+ R +  
Sbjct: 239 ----PPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLE----RMLVRDPQERATAQ 290

Query: 227 DVL 229
           ++L
Sbjct: 291 ELL 293

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 86.6 bits (215), Expect = 8e-20
 Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 30/169 (17%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           Q E+I    LRH N+V+       +   L ++ E+   G L   +   G          +
Sbjct: 64  QREIINHRSLRHPNIVRFKEVI-LTPTHLAIIMEYASGGELYERICNAG----------R 112

Query: 62  IAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPT 111
            + D AR        G+S+ H +   + +RDLK  N LLD +     K+ DFG ++    
Sbjct: 113 FSEDEARFFFQQLLSGVSYCHSM--QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170

Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHL--TPKSDVYSFGVVLLELLSGR 158
                 +   VGT  Y APE V          +DV+S GV L  +L G 
Sbjct: 171 HSQPKST---VGTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.2 bits (214), Expect = 8e-20
 Identities = 63/249 (25%), Positives = 96/249 (38%), Gaps = 34/249 (13%)

Query: 3   QTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR-- 59
             EV  L Q + H N+++LI +  E D   LV+E M  GS+ +H+ ++      +     
Sbjct: 58  FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR----HFNELEA 113

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLAR-----DGPT 111
             +  DVA  L FLH     + +RDLK  N+L    +     K+ DF L          +
Sbjct: 114 SVVVQDVASALDFLHNK--GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 112 GDNTHVSTRIVGTRGYAAPEYVATGHLTPKS-----DVYSFGVVLLELLSGRRALDEDRG 166
             +T       G+  Y APE V              D++S GV+L  LLSG         
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV---- 227

Query: 167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS--KKEAQAV--AA--VVLQCLHMDPK 220
                      D           + ++   G+Y    K+   +  AA  ++ + L  D K
Sbjct: 228 --GRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK 285

Query: 221 NRPSMVDVL 229
            R S   VL
Sbjct: 286 QRLSAAQVL 294

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 86.2 bits (214), Expect = 1e-19
 Identities = 56/267 (20%), Positives = 106/267 (39%), Gaps = 39/267 (14%)

Query: 5   EVIYLGQLRHENLVKLI-----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           E++ L  ++HEN++ L+          +     LV  FM     +  L +      S   
Sbjct: 73  ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEK 127

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + +GL ++H   A V++RDLK  N+ ++ +   K+ DFGLAR           
Sbjct: 128 IQYLVYQMLKGLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEM 180

Query: 119 TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDR 165
           T  V TR Y APE + +  H     D++S G ++ E+L+G+              + +  
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240

Query: 166 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA-VAAVVL--QCLHMDPKNR 222
           G    + + +  D     ++  ++ +       +++   +A   A  L  + L +D   R
Sbjct: 241 GVPGTEFVQKLNDKA---AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297

Query: 223 PSMVDVLTS--LEQLHTSKDMPRTPPP 247
            +    LT    E     ++      P
Sbjct: 298 LTAAQALTHPFFEPFRDPEEETEAQQP 324

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 52/239 (21%), Positives = 89/239 (37%), Gaps = 42/239 (17%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E      L+H N+V+L    SE  +  L+++ +  G L   +  +     S       
Sbjct: 58  EREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY--YSEADASHC 115

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              +   +   H +   V++R+LK  N+LL S       KL+DFGLA +           
Sbjct: 116 IQQILEAVLHCHQM--GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWF 171

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
              GT GY +PE +         D+++ GV+L  LL G                     P
Sbjct: 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP-------------------P 212

Query: 180 FLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           F  + +   R+      G Y            EA+    ++ + L ++P  R +  + L
Sbjct: 213 FWDEDQH--RLYQQIKAGAYDFPSPEWDTVTPEAK---DLINKMLTINPSKRITAAEAL 266

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 86.3 bits (214), Expect = 1e-19
 Identities = 61/242 (25%), Positives = 98/242 (40%), Gaps = 45/242 (18%)

Query: 3   QTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR-- 59
           + E   L Q+  H +++ LI     S    LV++ M KG L ++L  K     +   +  
Sbjct: 147 RRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV----ALSEKET 202

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
             I   +   +SFLH    N+++RDLK  N+LLD N   +LSDFG +     G+      
Sbjct: 203 RSIMRSLLEAVSFLHAN--NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKL---R 257

Query: 120 RIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
            + GT GY APE               + D+++ GV+L  LL+G                
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP-------------- 303

Query: 174 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEA------QAVAAVVLQCLHMDPKNRPSMVD 227
                PF    +    ++   + GQY             V  ++ + L +DP+ R +   
Sbjct: 304 -----PFWHRRQI--LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356

Query: 228 VL 229
            L
Sbjct: 357 AL 358

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 84.9 bits (211), Expect = 1e-19
 Identities = 52/241 (21%), Positives = 92/241 (38%), Gaps = 43/241 (17%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
             + E     +L+H N+V+L     E     LV++ +  G L   +  +     S     
Sbjct: 51  KLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADAS 108

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHV 117
                +   +++ H     +++R+LK  N+LL S       KL+DFGLA      +++  
Sbjct: 109 HCIQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEA 163

Query: 118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
                GT GY +PE +     +   D+++ GV+L  LL G                    
Sbjct: 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP------------------ 205

Query: 178 DPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDV 228
            PF  + +   R+      G Y            EA+   +++   L ++PK R +    
Sbjct: 206 -PFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAK---SLIDSMLTVNPKKRITADQA 259

Query: 229 L 229
           L
Sbjct: 260 L 260

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 86.2 bits (214), Expect = 1e-19
 Identities = 52/239 (21%), Positives = 92/239 (38%), Gaps = 43/239 (17%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E     +L+H N+V+L     E     LV++ +  G L   +  +     S       
Sbjct: 76  EREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF--YSEADASHC 133

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              +   +++ H     +++R+LK  N+LL S       KL+DFGLA      +++    
Sbjct: 134 IQQILESIAYCHSN--GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWH 188

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
              GT GY +PE +     +   D+++ GV+L  LL G                     P
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP-------------------P 229

Query: 180 FLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           F  + +   R+      G Y            EA+   +++   L ++PK R +    L
Sbjct: 230 FWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAK---SLIDSMLTVNPKKRITADQAL 283

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 11/151 (7%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           L  +    LVKL     ++ N  +V E++  G + +HL R G        R   A  +  
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYAA-QIVL 152

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
              +LH L  ++IYRDLK  N+L+D     +++DFG A+       T     + GT    
Sbjct: 153 TFEYLHSL--DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEAL 205

Query: 129 APEYVAT-GHLTPKSDVYSFGVVLLELLSGR 158
           APE + + G+     D ++ GV++ E+ +G 
Sbjct: 206 APEIILSKGY-NKAVDWWALGVLIYEMAAGY 235

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 12/149 (8%)

Query: 13  RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGL 70
           +   L +L   C ++ +RL  V E++  G L  H+ + G             A ++A GL
Sbjct: 79  KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGL 134

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
            FL      +IYRDLK  NV+LDS  + K++DFG+ ++      T  +    GT  Y AP
Sbjct: 135 FFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAP 190

Query: 131 EYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           E +A   +     D ++FGV+L E+L+G+
Sbjct: 191 EIIAYQPY-GKSVDWWAFGVLLYEMLAGQ 218

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.5 bits (212), Expect = 2e-19
 Identities = 56/241 (23%), Positives = 96/241 (39%), Gaps = 42/241 (17%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + +TE+  L +L H N++KL           LV E +  G L + +  KG    S     
Sbjct: 94  IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY--YSERDAA 151

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHV 117
                +   +++LH     +++RDLK  N+L      +   K++DFGL++     ++  +
Sbjct: 152 DAVKQILEAVAYLHEN--GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVL 206

Query: 118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
              + GT GY APE +      P+ D++S G++   LL G                    
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE------------------ 248

Query: 178 DPFLRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDV 228
            PF  D R    +    L  +Y             A+    +V + + +DPK R +    
Sbjct: 249 -PF-YDERGDQFMFRRILNCEYYFISPWWDEVSLNAK---DLVRKLIVLDPKKRLTTFQA 303

Query: 229 L 229
           L
Sbjct: 304 L 304

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 29/167 (17%)

Query: 3   QTEVIYLGQLRHENLVKLIGY-CSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + E+ YL  LRH +++KL  Y    +   + +V E+   G L +++  K           
Sbjct: 57  EREISYLKLLRHPHIIKL--YDVITTPTDIVMVIEYA-GGELFDYIVEKK---------- 103

Query: 61  KIAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
           ++  D  R         + + H     +++RDLK  N+LLD N N K++DFGL+     G
Sbjct: 104 RMTEDEGRRFFQQIICAIEYCHRH--KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161

Query: 113 DNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGR 158
           +    S    G+  YAAPE +    +  P+ DV+S G+VL  +L GR
Sbjct: 162 NFLKTS---CGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 85.4 bits (212), Expect = 2e-19
 Identities = 49/145 (33%), Positives = 73/145 (50%), Gaps = 12/145 (8%)

Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGLSFLH 74
           L +L   C ++ +RL  V EF+  G L  H+ +      +   R +  A ++   L FLH
Sbjct: 86  LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEIISALMFLH 141

Query: 75  GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 134
                +IYRDLK  NVLLD   + KL+DFG+ ++G     T  +    GT  Y APE + 
Sbjct: 142 DK--GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEILQ 197

Query: 135 -TGHLTPKSDVYSFGVVLLELLSGR 158
              +  P  D ++ GV+L E+L G 
Sbjct: 198 EMLY-GPAVDWWAMGVLLYEMLCGH 221

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 85.0 bits (211), Expect = 3e-19
 Identities = 48/236 (20%), Positives = 96/236 (40%), Gaps = 41/236 (17%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L   RH N++ L       +  ++++EF+    +   +     + ++    V    
Sbjct: 51  EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVH 109

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIV 122
            V   L FLH    N+ + D++  N++  +  ++  K+ +FG AR    GDN  +   + 
Sbjct: 110 QVCEALQFLHSH--NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LF 164

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               Y APE      ++  +D++S G ++  LLSG                     PFL 
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN-------------------PFLA 205

Query: 183 DSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           ++ +  +I++  +  +Y+           EA      V + L  + K+R +  + L
Sbjct: 206 ETNQ--QIIENIMNAEYTFDEEAFKEISIEAM---DFVDRLLVKERKSRMTASEAL 256

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.5 bits (212), Expect = 3e-19
 Identities = 44/167 (26%), Positives = 81/167 (48%), Gaps = 22/167 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL------LVYEFMPKGSLENHL--FRKGVQPISW 56
           E+  +  ++H N+V L  +   + ++       LV E++P+ ++      + K  Q +  
Sbjct: 82  ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP- 139

Query: 57  PTRVKIAI-DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-KLSDFGLARD-GPTGD 113
              +K+ +  + R L+++H     + +RD+K  N+LLD      KL DFG A+       
Sbjct: 140 MLLIKLYMYQLLRSLAYIHS--IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197

Query: 114 NTHVSTRIVGTRGYAAPEYV--ATGHLTPKSDVYSFGVVLLELLSGR 158
           N       + +R Y APE +  AT + T   D++S G V+ EL+ G+
Sbjct: 198 NVSY----ICSRYYRAPELIFGAT-NYTTNIDIWSTGCVMAELMQGQ 239

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 85.0 bits (211), Expect = 3e-19
 Identities = 48/145 (33%), Positives = 80/145 (55%), Gaps = 12/145 (8%)

Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGLSFLH 74
           LV L   C ++++RL  V E++  G L  H+ R+   P       +  + +++  L++LH
Sbjct: 72  LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLALNYLH 127

Query: 75  GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 134
                +IYRDLK  NVLLDS  + KL+D+G+ ++G    +T  ST   GT  Y APE + 
Sbjct: 128 ER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TST-FCGTPNYIAPEILR 183

Query: 135 -TGHLTPKSDVYSFGVVLLELLSGR 158
              +     D ++ GV++ E+++GR
Sbjct: 184 GEDY-GFSVDWWALGVLMFEMMAGR 207

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 86.2 bits (213), Expect = 3e-19
 Identities = 48/148 (32%), Positives = 75/148 (50%), Gaps = 10/148 (6%)

Query: 13  RHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGL 70
           +   L +L   C ++ +RL  V E++  G L  H+ + G             A ++A GL
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIGL 455

Query: 71  SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAP 130
            FL      +IYRDLK  NV+LDS  + K++DFG+ ++      T  +    GT  Y AP
Sbjct: 456 FFLQSK--GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDYIAP 511

Query: 131 EYVATGHLTPKSDVYSFGVVLLELLSGR 158
           E +A        D ++FGV+L E+L+G+
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 84.6 bits (210), Expect = 3e-19
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 11/159 (6%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L Q+ H N++ L        + +L+ E +  G L + L +K    +S       
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGPTGDNTHVS 118
              +  G+++LH     + + DLK  N++L        + KL DFGLA +   G      
Sbjct: 121 IKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN- 177

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 178 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 84.7 bits (210), Expect = 4e-19
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 11/159 (6%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L Q+ H N++ L        + +L+ E +  G L + L +K    +S       
Sbjct: 63  EREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES--LSEEEATSF 120

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGPTGDNTHVS 118
              +  G+++LH     + + DLK  N++L        + KL DFGLA      ++    
Sbjct: 121 IKQILDGVNYLHTK--KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEF 175

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 176 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 85.2 bits (211), Expect = 4e-19
 Identities = 41/170 (24%), Positives = 78/170 (45%), Gaps = 20/170 (11%)

Query: 5   EVIYLGQLRHENLVKLIG-YCSESDNRL-LVYEFMP---KGSLENHLFRKGVQ---PISW 56
           E+  L +L+H N++ L   + S +D ++ L++++        ++ H   K  +    +  
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127

Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA----KLSDFGLAR--DGP 110
                +   +  G+ +LH     V++RDLK +N+L+          K++D G AR  + P
Sbjct: 128 GMVKSLLYQILDGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185

Query: 111 TGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 158
                 +   +V T  Y APE +  G  H T   D+++ G +  ELL+  
Sbjct: 186 LKPLADLDPVVV-TFWYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 83.8 bits (208), Expect = 4e-19
 Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 11/159 (6%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L ++RH N++ L        + +L+ E +  G L + L  K    ++     + 
Sbjct: 56  EREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES--LTEDEATQF 113

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH     + + DLK  N++L      N   KL DFG+A     G+     
Sbjct: 114 LKQILDGVHYLHSK--RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN- 170

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 171 --IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.6 bits (209), Expect = 5e-19
 Identities = 50/200 (25%), Positives = 78/200 (39%), Gaps = 32/200 (16%)

Query: 43  ENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSD 102
           E          ++    +  +  VA+G+ FL       I+RDL A N+LL      K+ D
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICD 236

Query: 103 FGLARDGPTGDNTHVSTRIVGTRGYA-----APEYVATGHLTPKSDVYSFGVVLLELLSG 157
           FGLARD     +      +            APE +     T +SDV+SFGV+L E+ S 
Sbjct: 237 FGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS- 290

Query: 158 RRALDEDRGGLAEQTLVEWAD--PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL 215
                   G      +    +    L++  R    M       Y+  E   +   +L C 
Sbjct: 291 -------LGASPYPGVKIDEEFCRRLKEGTR----MRAP---DYTTPE---MYQTMLDCW 333

Query: 216 HMDPKNRPSMVDVLTSLEQL 235
           H +P  RP+  +++  L  L
Sbjct: 334 HGEPSQRPTFSELVEHLGNL 353

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 41.5 bits (97), Expect = 2e-04
 Identities = 25/98 (25%), Positives = 39/98 (39%), Gaps = 11/98 (11%)

Query: 13  RHENLVKLIGYCSESDNRLLV-YEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
            H N+V L+G C++    L+V  EF   G+L  +L            R +      +G  
Sbjct: 84  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL---------RSKRNEFVPYKTKGAR 134

Query: 72  FLHGLD-ANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
           F  G D    I  DLK     + S+ ++  S F   + 
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 83.8 bits (208), Expect = 5e-19
 Identities = 48/160 (30%), Positives = 78/160 (48%), Gaps = 17/160 (10%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK 61
           E+  L +L H N+V LI          LV+EFM    K  L+ +        +   +++K
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK-----TGLQ-DSQIK 122

Query: 62  -IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
                + RG++  H     +++RDLK  N+L++S+   KL+DFGLAR    G      T 
Sbjct: 123 IYLYQLLRGVAHCH--QHRILHRDLKPQNLLINSDGALKLADFGLAR--AFGIPVRSYTH 178

Query: 121 IVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 158
            V T  Y AP+ V  G    +   D++S G +  E+++G+
Sbjct: 179 EVVTLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 84.1 bits (209), Expect = 5e-19
 Identities = 44/159 (27%), Positives = 77/159 (48%), Gaps = 27/159 (16%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           L  + H  ++++ G   ++    ++ +++  G L + L +            +    VA+
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ----------RFPNPVAK 109

Query: 69  --------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
                    L +LH    ++IYRDLK  N+LLD N + K++DFG A+  P    T     
Sbjct: 110 FYAAEVCLALEYLHSK--DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----- 162

Query: 121 IVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGR 158
           + GT  Y APE V+T  +     D +SFG+++ E+L+G 
Sbjct: 163 LCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGY 200

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 84.8 bits (210), Expect = 6e-19
 Identities = 46/238 (19%), Positives = 90/238 (37%), Gaps = 41/238 (17%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  + QL H  L+ L     +    +L+ EF+  G L + +  +  + +S    +  
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINY 154

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTR 120
                 GL  +H    ++++ D+K  N++ ++   +  K+ DFGLA      +   +   
Sbjct: 155 MRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKV 209

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
              T  +AAPE V    +   +D+++ GV+   LLSG                     PF
Sbjct: 210 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS-------------------PF 250

Query: 181 LRDSRRVLRIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
             +       +       +            EA+     +   L  +P+ R ++ D L
Sbjct: 251 AGEDDL--ETLQNVKRCDWEFDEDAFSSVSPEAK---DFIKNLLQKEPRKRLTVHDAL 303

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 83.9 bits (208), Expect = 7e-19
 Identities = 50/232 (21%), Positives = 87/232 (37%), Gaps = 42/232 (18%)

Query: 12  LRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLS 71
            +H N++ L     +     +V E M  G L + + R+     S      +   + + + 
Sbjct: 73  GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVE 130

Query: 72  FLHGLDANVIYRDLKASNVLLDSNFNA----KLSDFGLARDGPTGDNTHVSTRIVGTRGY 127
           +LH     V++RDLK SN+L           ++ DFG A+     +N  + T    T  +
Sbjct: 131 YLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL-RAENGLLMT-PCYTANF 186

Query: 128 AAPEYVATGHLTPKSDVYSFGVVLLELLSG----RRALDEDRGGLAEQTLVEWADPFLRD 183
            APE +         D++S GV+L  +L+G        D+    +               
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA------------- 233

Query: 184 SRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                RI      G++S         +     +V + LH+DP  R +   VL
Sbjct: 234 -----RIGS----GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.8 bits (208), Expect = 7e-19
 Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 21/162 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK 61
           E+  L +L H N++ L+       N  LV++FM    +  ++++        ++ P+ +K
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN-----SLVLT-PSHIK 115

Query: 62  -IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPTGDNTHVS 118
              +   +GL +LH     +++RDLK +N+LLD N   KL+DFGLA+    P    TH  
Sbjct: 116 AYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH-- 171

Query: 119 TRIVGTRGYAAPE--YVATGHLTPKSDVYSFGVVLLELLSGR 158
            ++V TR Y APE  + A        D+++ G +L ELL   
Sbjct: 172 -QVV-TRWYRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 84.8 bits (210), Expect = 7e-19
 Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 29/165 (17%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L     + +  L  Y  + DN L LV ++   G L   L +            ++  ++A
Sbjct: 128 LVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSK---------FEDRLPEEMA 177

Query: 68  R--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           R         +  +H L  + ++RD+K  N+L+D N + +L+DFG        D T  S+
Sbjct: 178 RFYLAEMVIAIDSVHQL--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSS 234

Query: 120 RIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELLSGR 158
             VGT  Y +PE           +  P+ D +S GV + E+L G 
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGE 278

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 84.3 bits (209), Expect = 7e-19
 Identities = 48/145 (33%), Positives = 80/145 (55%), Gaps = 12/145 (8%)

Query: 17  LVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKI-AIDVARGLSFLH 74
           LV L   C ++++RL  V E++  G L  H+ R+   P       +  + +++  L++LH
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEISLALNYLH 170

Query: 75  GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA 134
                +IYRDLK  NVLLDS  + KL+D+G+ ++G    +T  ST   GT  Y APE + 
Sbjct: 171 ER--GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TST-FCGTPNYIAPEILR 226

Query: 135 -TGHLTPKSDVYSFGVVLLELLSGR 158
              +     D ++ GV++ E+++GR
Sbjct: 227 GEDY-GFSVDWWALGVLMFEMMAGR 250

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.8 bits (208), Expect = 7e-19
 Identities = 46/174 (26%), Positives = 73/174 (41%), Gaps = 33/174 (18%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRL--------LVYEFMP---KGSLENHLFRKGVQP 53
           E+  L  L+HEN+V LI  C    +          LV++F      G L N L       
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL-----VK 120

Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--DGPT 111
            +     ++   +  GL ++H     +++RD+KA+NVL+  +   KL+DFGLAR      
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 112 GDNTHVSTRIVGTRGYAAPE-------YVATGHLTPKSDVYSFGVVLLELLSGR 158
               +  T  V T  Y  PE       Y       P  D++  G ++ E+ +  
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 83.5 bits (207), Expect = 9e-19
 Identities = 59/239 (24%), Positives = 103/239 (43%), Gaps = 40/239 (16%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           +TE+  L +L H  ++K+  +  ++++  +V E M  G L + +       +   T    
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLY 119

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVST 119
              +   + +LH  +  +I+RDLK  NVLL S   +   K++DFG ++    G+ + + T
Sbjct: 120 FYQMLLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 175

Query: 120 RIVGTRGYAAPE---YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
            + GT  Y APE    V T       D +S GV+L   LSG                   
Sbjct: 176 -LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY------------------ 216

Query: 177 ADPFLRDSRRVLRIMDTRLGGQYS------KKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
             PF     +V  + D    G+Y+       + ++    +V + L +DPK R +  + L
Sbjct: 217 -PPFSEHRTQV-SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 82.6 bits (205), Expect = 1e-18
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 21/162 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK 61
           E+  L +L+H N+VKL          +LV+E +    K  L+          +      K
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE-----GGLE-SVTAK 103

Query: 62  -IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVS 118
              + +  G+++ H  D  V++RDLK  N+L++     K++DFGLAR    P    TH  
Sbjct: 104 SFLLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH-- 159

Query: 119 TRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 158
             IV T  Y AP+ V  G    +   D++S G +  E+++G 
Sbjct: 160 -EIV-TLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.0 bits (208), Expect = 1e-18
 Identities = 49/243 (20%), Positives = 95/243 (39%), Gaps = 40/243 (16%)

Query: 3   QTEV-IYLGQLRHENLVKLIGYC----SESDNRLLVYEFMPKGSLENHLFRKGVQPISWP 57
           + EV ++    +  ++V+++       +     L+V E +  G L + +  +G Q  +  
Sbjct: 102 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 161

Query: 58  TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDN 114
              +I   +   + +LH +  N+ +RD+K  N+L  S   N   KL+DFG A++  + + 
Sbjct: 162 EASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN- 218

Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
               T    T  Y APE +         D++S GV++  LL G                 
Sbjct: 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP--------------- 261

Query: 175 EWADPFLRDSRRVL--RIMDTRLGGQYSKKEA------QAVAAVVLQCLHMDPKNRPSMV 226
               PF  +    +   +      GQY           + V  ++   L  +P  R ++ 
Sbjct: 262 ----PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTIT 317

Query: 227 DVL 229
           + +
Sbjct: 318 EFM 320

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 83.1 bits (206), Expect = 1e-18
 Identities = 35/157 (22%), Positives = 73/157 (46%), Gaps = 9/157 (5%)

Query: 5   EVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           E+  L   +    ++ L      +   +L+ E+   G + +    +  + +S    +++ 
Sbjct: 78  EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLI 137

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVSTR 120
             +  G+ +LH    N+++ DLK  N+LL       + K+ DFG++R    G    +   
Sbjct: 138 KQILEGVYYLHQN--NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHACELRE- 192

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           I+GT  Y APE +    +T  +D+++ G++   LL+ 
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 82.7 bits (205), Expect = 1e-18
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 21/162 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK 61
           EV  L  L+H N+V L        +  LV+E++    K  L++         I+    VK
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCG-----NIIN-MHNVK 103

Query: 62  -IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVS 118
                + RGL++ H     V++RDLK  N+L++     KL+DFGLAR    PT    +  
Sbjct: 104 LFLFQLLRGLAYCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN-- 159

Query: 119 TRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 158
             +V T  Y  P+ +  G    + + D++  G +  E+ +GR
Sbjct: 160 -EVV-TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 45/163 (27%), Positives = 67/163 (41%), Gaps = 28/163 (17%)

Query: 9   LGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           +       +V+L  Y  + D  L +V E+MP G L N +               +    A
Sbjct: 123 MAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNY-----------DVPEKWA 170

Query: 68  R--------GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           R         L  +H +    I+RD+K  N+LLD + + KL+DFG              T
Sbjct: 171 RFYTAEVVLALDAIHSM--GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228

Query: 120 RIVGTRGYAAPEYV----ATGHLTPKSDVYSFGVVLLELLSGR 158
             VGT  Y +PE +      G+   + D +S GV L E+L G 
Sbjct: 229 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 82.4 bits (204), Expect = 3e-18
 Identities = 67/267 (25%), Positives = 112/267 (41%), Gaps = 40/267 (14%)

Query: 5   EVIYLGQLRHENLVKLI-----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  ++HEN++ L+         E  N + LV   M    L N++ +   Q ++   
Sbjct: 78  ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DL-NNIVKC--QKLT-DD 132

Query: 59  RVK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV 117
            V+ +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR          
Sbjct: 133 HVQFLIYQILRGLKYIHS--ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTADE 185

Query: 118 STRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDED 164
            T  V TR Y APE +    H     D++S G ++ ELL+GR            + +   
Sbjct: 186 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245

Query: 165 RGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA-VAAVVL--QCLHMDPKN 221
            G    + L + +      +R  ++ +       ++     A   AV L  + L +D   
Sbjct: 246 VGTPGAELLKKISSE---SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302

Query: 222 RPSMVDVLTS--LEQLHTSKDMPRTPP 246
           R +    L      Q H   D P   P
Sbjct: 303 RITAAQALAHAYFAQYHDPDDEPVADP 329

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 81.6 bits (202), Expect = 4e-18
 Identities = 51/248 (20%), Positives = 94/248 (37%), Gaps = 72/248 (29%)

Query: 5   EVIYLGQLR----HENLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRKGVQPISWPTR 59
           EV  L ++     H  +++L+ +    +  +LV E  +P   L +++  KG         
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--------- 134

Query: 60  VKIAIDVAR--------GLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLA---R 107
             +    +R         +   H     V++RD+K  N+L+D     AKL DFG      
Sbjct: 135 -PLGEGPSRCFFGQVVAAIQHCH--SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191

Query: 108 DGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRALDEDRG 166
           D P            GTR Y+ PE+++        + V+S G++L +++ G         
Sbjct: 192 DEPY----TDF---DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI------- 237

Query: 167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK-----KEAQAVAAVVLQCLHMDPKN 221
                       PF    + +L         +         +  A+   + +CL   P +
Sbjct: 238 ------------PF-ERDQEILE-------AELHFPAHVSPDCCAL---IRRCLAPKPSS 274

Query: 222 RPSMVDVL 229
           RPS+ ++L
Sbjct: 275 RPSLEEIL 282

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 81.5 bits (202), Expect = 4e-18
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 11/159 (6%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K    ++     + 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES--LTEEEATEF 119

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDS----NFNAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH L   + + DLK  N++L          K+ DFGLA      D  +  
Sbjct: 120 LKQILNGVYYLHSL--QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEF 174

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
             I GT  + APE V    L  ++D++S GV+   LLSG
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 81.6 bits (202), Expect = 5e-18
 Identities = 60/266 (22%), Positives = 114/266 (42%), Gaps = 38/266 (14%)

Query: 5   EVIYLGQLRHENLVKL--IGYCSESDNRL----LVYEFMPKGSLENHLFRKGVQPISWPT 58
           E+  L  +RHEN++ L  +    E+ +      LV  FM  G+    L +   + +    
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKH--EKLGEDR 129

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + +GL ++H   A +I+RDLK  N+ ++ +   K+ DFGLAR     D+    
Sbjct: 130 IQFLVYQMLKGLRYIHA--AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM-- 182

Query: 119 TRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDR 165
           T  V TR Y APE +      T   D++S G ++ E+++G+            + + +  
Sbjct: 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 242

Query: 166 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQA-VAAVVL--QCLHMDPKNR 222
           G    + +         +++  ++ +       ++     A   AV L  + L +D + R
Sbjct: 243 GTPPAEFVQRLQSD---EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 299

Query: 223 PSMVDVLTS--LEQLHTSKDMPRTPP 246
            +  + L     E LH ++D P+   
Sbjct: 300 VTAGEALAHPYFESLHDTEDEPQVQK 325

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 81.7 bits (202), Expect = 7e-18
 Identities = 63/304 (20%), Positives = 123/304 (40%), Gaps = 63/304 (20%)

Query: 5   EVIYLGQLR-HENLVKLIG-YCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           E++ L +L  HEN+V L+    +++D  + LV+++M   +  + + R     +  P   +
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIRA--NILE-PVHKQ 112

Query: 62  -IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR------------- 107
            +   + + + +LH     +++RD+K SN+LL++  + K++DFGL+R             
Sbjct: 113 YVVYQLIKVIKYLHS--GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170

Query: 108 ------DGPTGDNTHVSTRIVGTRGYAAPEY-VATGHLTPKSDVYSFGVVLLELLSGRRA 160
                      D+  + T  V TR Y APE  + +   T   D++S G +L E+L   + 
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKP 229

Query: 161 L---------------------DEDRGGLAE---QTLVEWADPFLRDSRRVLRIMDTRLG 196
           +                     +ED   +     +T++E     +   +   R + T+  
Sbjct: 230 IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWK 289

Query: 197 GQYSKKEAQAVA---AVVL--QCLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTPPPAK 249
               K   +A     A+ L  + L  +P  R S  D L    +   H   + P       
Sbjct: 290 NLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIIT 349

Query: 250 LHHH 253
           +  +
Sbjct: 350 IPIN 353

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 81.7 bits (202), Expect = 7e-18
 Identities = 41/155 (26%), Positives = 74/155 (47%), Gaps = 8/155 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  + QL H NL++L       ++ +LV E++  G L + +  +    ++    +    
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYN-LTELDTILFMK 194

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTRIV 122
            +  G+  +H +   +++ DLK  N+L  +      K+ DFGLAR     +   V     
Sbjct: 195 QICEGIRHMHQM--YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NF 249

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG 157
           GT  + APE V    ++  +D++S GV+   LLSG
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 81.1 bits (201), Expect = 7e-18
 Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 22/169 (13%)

Query: 5   EVIYLGQLRHENLVKLI----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR 59
           E+  L   +HEN++ +         E+ N + ++ E M   +  + +     Q +S    
Sbjct: 59  EIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIST--QMLS-DDH 113

Query: 60  VK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLAR--------DGP 110
           ++       R +  LHG  +NVI+RDLK SN+L++SN + K+ DFGLAR        +  
Sbjct: 114 IQYFIYQTLRAVKVLHG--SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171

Query: 111 TGDNTHVSTRIVGTRGYAAPEYV-ATGHLTPKSDVYSFGVVLLELLSGR 158
                      V TR Y APE +  +   +   DV+S G +L EL   R
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 80.8 bits (200), Expect = 8e-18
 Identities = 41/172 (23%), Positives = 85/172 (49%), Gaps = 25/172 (14%)

Query: 5   EVIYLGQLRHENLVKLI--------------GYCSESDNRLLVYEFMPKGSLENHLFRKG 50
           E+  + +L H+N+VK+               G  +E ++  +V E+M   +   ++  + 
Sbjct: 58  EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQ- 114

Query: 51  VQPISWPTRVK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLAR- 107
             P+      +     + RGL ++H   ANV++RDLK +N+ +++ +   K+ DFGLAR 
Sbjct: 115 -GPLL-EEHARLFMYQLLRGLKYIHS--ANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170

Query: 108 DGPTGDNTHVSTRIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGR 158
             P   +    +  + T+ Y +P   ++  + T   D+++ G +  E+L+G+
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 80.5 bits (199), Expect = 1e-17
 Identities = 62/242 (25%), Positives = 95/242 (39%), Gaps = 54/242 (22%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             EV +L +LRH N ++  G         LV E+    + +     K   P+     V+I
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PL---QEVEI 156

Query: 63  AI---DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVST 119
           A       +GL++LH    N+I+RD+KA N+LL      KL DFG A        + ++ 
Sbjct: 157 AAVTHGALQGLAYLHSH--NMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAP 206

Query: 120 R--IVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
               VGT  + APE +     G    K DV+S G+  +EL                    
Sbjct: 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER----------------- 249

Query: 175 EWADPFLRD--SRRVLRIMDT----RL-GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD 227
               P L +  +   L  +       L  G +S+     V      CL   P++RP+   
Sbjct: 250 ---KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD----SCLQKIPQDRPTSEV 302

Query: 228 VL 229
           +L
Sbjct: 303 LL 304

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 79.2 bits (196), Expect = 3e-17
 Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 21/164 (12%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMP---KGSLENHLFRKGVQPISWPTRVK 61
           EV  L +L+H N+++L      +    L++E+     K  ++ +        +S      
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN------PDVSMRVIKS 136

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-----KLSDFGLARDGPTGDNTH 116
               +  G++F H      ++RDLK  N+LL  +  +     K+ DFGLAR    G    
Sbjct: 137 FLYQLINGVNFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR--AFGIPIR 192

Query: 117 VSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR 158
             T  + T  Y  PE +  G  H +   D++S   +  E+L   
Sbjct: 193 QFTHEIITLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.0 bits (195), Expect = 7e-17
 Identities = 55/313 (17%), Positives = 105/313 (33%), Gaps = 77/313 (24%)

Query: 5   EVIYLGQLRHENLVKL----IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR 59
           E+  L +L+ + +++L    I       + L +V E     S    LF+     ++    
Sbjct: 75  EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTP-IFLT-EEH 130

Query: 60  VK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +K I  ++  G +F+H   + +I+RDLK +N LL+ + + K+ DFGLAR   +  +T++ 
Sbjct: 131 IKTILYNLLLGENFIHE--SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188

Query: 119 TRIVGTRGYAAP---------EYVAT------------GHLTPKSDVYSFGVVLLELLSG 157
             +                   +V T             + T   D++S G +  ELL+ 
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

Query: 158 RRALDEDRGG----------LAEQTLVEWADPFLRDSRRVL-RIMDTRLG-------GQY 199
            ++   D                           + +R  L  I +  +G          
Sbjct: 249 LQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNI-IGTPTEDDLKNI 307

Query: 200 SKKEAQAV---------------------AAVVL--QCLHMDPKNRPSMVDVLTS--LEQ 234
           +K E                           + L    L  +P  R ++   L    L+ 
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKD 367

Query: 235 LHTSKDMPRTPPP 247
           +   K    +   
Sbjct: 368 VRKKKLENFSTKK 380

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 77.5 bits (191), Expect = 8e-17
 Identities = 34/240 (14%), Positives = 65/240 (27%), Gaps = 48/240 (20%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           L ++    + +++         L+V E++  GSL+  +      P      ++    +A 
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ-EVADTSPSP---VGAIRAMQSLAA 140

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
                H   A V       S V +  + +  L+      D                    
Sbjct: 141 AADAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPATMPDA------------------- 179

Query: 129 APEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL 188
                      P+ D+   G  L  LL  R  L E                   +   + 
Sbjct: 180 ----------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229

Query: 189 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDMPRTPPPA 248
           R +               ++AV  + +  D   R +   +L  ++Q     D      P 
Sbjct: 230 RDI------------PFQISAVAARSVQGDGGIRSAS-TLLNLMQQATAVADRTEVLGPI 276

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 76.9 bits (190), Expect = 2e-16
 Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 21/160 (13%)

Query: 9   LGQLRHENLVKLI----GYCSESDNRL-LVYEFMP---KGSLENHLFRKGVQPISWPTRV 60
           L    H N+V+L        ++ + +L LV+E +       L+        +P      +
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP-----EPGVPTETI 122

Query: 61  K-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVS 118
           K +   + RGL FLH     V++RDLK  N+L+ S+   KL+DFGLAR        T V 
Sbjct: 123 KDMMFQLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV- 179

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
              V T  Y APE +         D++S G +  E+   +
Sbjct: 180 ---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 77.1 bits (190), Expect = 3e-16
 Identities = 39/133 (29%), Positives = 66/133 (49%), Gaps = 14/133 (10%)

Query: 32  LVYEFMPKGSLENHL--FRKGVQPISWPTRVKIAI-DVARGLSFLHGLDANVIYRDLKAS 88
           ++ E++P  +L   L  F +  + I     + I I  + R + F+H     + +RD+K  
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHS--LGICHRDIKPQ 170

Query: 89  NVLLDSNFNA-KLSDFGLARD-GPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVY 145
           N+L++S  N  KL DFG A+   P+  +       + +R Y APE +      TP  D++
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY----ICSRFYRAPELMLGATEYTPSIDLW 226

Query: 146 SFGVVLLELLSGR 158
           S G V  EL+ G+
Sbjct: 227 SIGCVFGELILGK 239

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 76.1 bits (188), Expect = 3e-16
 Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 13/156 (8%)

Query: 9   LGQLRHENLVKLI----GYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRVKIA 63
           L    H N+V+L+       ++ + ++ LV+E + +  L  +L +     +   T   + 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLM 126

Query: 64  IDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTRIV 122
               RGL FLH     +++RDLK  N+L+ S    KL+DFGLAR        T V    V
Sbjct: 127 RQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPV----V 180

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR 158
            T  Y APE +         D++S G +  E+   +
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 74.6 bits (184), Expect = 1e-15
 Identities = 36/163 (22%), Positives = 69/163 (42%), Gaps = 17/163 (10%)

Query: 5   EVIYLGQLR-HENLVKL--IGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           E+  L  LR   N++ L  I     S    LV+E      + N  F++  Q ++    ++
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPALVFEH-----VNNTDFKQLYQTLT-DYDIR 133

Query: 62  IAI-DVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVST 119
             + ++ + L + H     +++RD+K  NV++D  +   +L D+GLA             
Sbjct: 134 FYMYEILKALDYCHS--MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE---FYHPGQEYN 188

Query: 120 RIVGTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRAL 161
             V +R +  PE  V         D++S G +L  ++  +   
Sbjct: 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.5 bits (183), Expect = 2e-15
 Identities = 44/184 (23%), Positives = 77/184 (41%), Gaps = 38/184 (20%)

Query: 5   EVIYLGQLRHENLVKL----IGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTR 59
           E+  L +L H+++VK+    I    E  + L +V E     S    LFR     ++    
Sbjct: 102 EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTP-VYLT-ELH 157

Query: 60  VK-IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
           +K +  ++  G+ ++H   A +++RDLK +N L++ + + K+ DFGLAR     +N +  
Sbjct: 158 IKTLLYNLLVGVKYVH--SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 119 TRIVGTRGYAAP--------------EYVAT------------GHLTPKSDVYSFGVVLL 152
             I                        +V T             + T   DV+S G +  
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275

Query: 153 ELLS 156
           ELL+
Sbjct: 276 ELLN 279

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 63.9 bits (156), Expect = 5e-12
 Identities = 44/246 (17%), Positives = 87/246 (35%), Gaps = 67/246 (27%)

Query: 3   QTEV-IYLGQLRHENLVKLIGYC----SESDNRLLVYEFMPKGSLENHLFRKGVQPISWP 57
           + EV ++    +  ++V+++       +     L+V E +  G L + +  +G Q  +  
Sbjct: 58  RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 117

Query: 58  TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDN 114
              +I   +   + +LH +  N+ +RD+K  N+L  S   N   KL+DFG A        
Sbjct: 118 EASEIMKSIGEAIQYLHSI--NIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------- 167

Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
                +      Y               D++S GV++  LL G                 
Sbjct: 168 -----KETTGEKY-----------DKSCDMWSLGVIMYILLCGYP--------------- 196

Query: 175 EWADPFLRDSRRVL--RIMDTRLGGQYS---------KKEAQAVAAVVLQCLHMDPKNRP 223
               PF  +    +   +      GQY           +E +    ++   L  +P  R 
Sbjct: 197 ----PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK---MLIRNLLKTEPTQRM 249

Query: 224 SMVDVL 229
           ++ + +
Sbjct: 250 TITEFM 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 60.5 bits (147), Expect = 6e-11
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 35/173 (20%)

Query: 11  QLRHENLV-----------KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           QL  E+ +            +    +E D  ++V E +   SLE  LF    +  S  T 
Sbjct: 50  QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP-SLE-DLFNFCSRKFSLKTV 107

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK---LSDFGLA---RDGPTGD 113
           + +A  +   + ++H    N I+RD+K  N L+          + DFGLA   RD  T  
Sbjct: 108 LLLADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH- 164

Query: 114 NTHVSTR----IVGTRGYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 158
             H+  R    + GT  YA+   + T HL    + + D+ S G VL+    G 
Sbjct: 165 -QHIPYRENKNLTGTARYAS---INT-HLGIEQSRRDDLESLGYVLMYFNLGS 212

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 58.6 bits (142), Expect = 4e-10
 Identities = 30/133 (22%), Positives = 61/133 (45%), Gaps = 13/133 (9%)

Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           +V+E +   +L   + +   + I      +I+  +  GL ++H     +I+ D+K  NVL
Sbjct: 107 MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVL 164

Query: 92  LD------SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVY 145
           ++      +    K++D G A       + H +  I  TR Y +PE +        +D++
Sbjct: 165 MEIVDSPENLIQIKIADLGNACW----YDEHYTNSIQ-TREYRSPEVLLGAPWGCGADIW 219

Query: 146 SFGVVLLELLSGR 158
           S   ++ EL++G 
Sbjct: 220 STACLIFELITGD 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 4e-10
 Identities = 29/101 (28%), Positives = 48/101 (47%), Gaps = 9/101 (8%)

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVS 118
           K A  +   L FL   + ++I+ DLK  N+LL +   +  K+ DFG +          + 
Sbjct: 161 KFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIY 216

Query: 119 TRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGR 158
             I  +R Y +PE V  G       D++S G +L+E+ +G 
Sbjct: 217 QYIQ-SRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.4 bits (139), Expect = 7e-10
 Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 37/175 (21%)

Query: 11  QLRHENLV-----------KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           QLR E               +  +  E  + +LV + +   SLE  L     +  S  T 
Sbjct: 51  QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP-SLE-DLLDLCGRKFSVKTV 108

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK-----LSDFGLA---RDGPT 111
              A  +   +  +H  + +++YRD+K  N L+    +       + DFG+    RD  T
Sbjct: 109 AMAAKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 166

Query: 112 GDNTHVSTR----IVGTRGYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 158
               H+  R    + GT  Y +   + T HL    + + D+ + G V +  L G 
Sbjct: 167 K--QHIPYREKKNLSGTARYMS---INT-HLGREQSRRDDLEALGHVFMYFLRGS 215

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 38/128 (29%), Positives = 56/128 (43%), Gaps = 18/128 (14%)

Query: 33  VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 92
           +YE + K            Q  S P   K A  + + L  LH     +I+ DLK  N+LL
Sbjct: 185 LYELIKKNKF---------QGFSLPLVRKFAHSILQCLDALH--KNRIIHCDLKPENILL 233

Query: 93  DSNFNA--KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV 150
                +  K+ DFG +      ++  V T I  +R Y APE +         D++S G +
Sbjct: 234 KQQGRSGIKVIDFGSS----CYEHQRVYTYIQ-SRFYRAPEVILGARYGMPIDMWSLGCI 288

Query: 151 LLELLSGR 158
           L ELL+G 
Sbjct: 289 LAELLTGY 296

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 48/173 (27%), Positives = 76/173 (43%), Gaps = 35/173 (20%)

Query: 11  QLRHENLV-----------KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           QL +E+ +            +  +  E D  +LV + +   SLE  LF    + +S  T 
Sbjct: 48  QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGP-SLE-DLFNFCSRKLSLKTV 105

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK---LSDFGLA---RDGPTGD 113
           + +A  +   + F+H    + ++RD+K  N L+     A    + DFGLA   RD  T  
Sbjct: 106 LMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH- 162

Query: 114 NTHVSTR----IVGTRGYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 158
             H+  R    + GT  YA+   V T HL    + + D+ S G VL+  L G 
Sbjct: 163 -QHIPYRENKNLTGTARYAS---VNT-HLGIEQSRRDDLESLGYVLMYFLRGS 210

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 43/175 (24%), Positives = 68/175 (38%), Gaps = 37/175 (21%)

Query: 11  QLRHENLV-----------KLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTR 59
           QL  E              ++  +        +V E +   SLE  LF    +  S  T 
Sbjct: 50  QLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGP-SLE-DLFDLCDRTFSLKTV 107

Query: 60  VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK-----LSDFGLA---RDGPT 111
           + IAI +   + ++H    N+IYRD+K  N L+    N       + DF LA    D  T
Sbjct: 108 LMIAIQLISRMEYVH--SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET 165

Query: 112 GDNTHVSTR----IVGTRGYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 158
               H+  R    + GT  Y +   + T HL    + + D+ + G + +  L G 
Sbjct: 166 K--KHIPYREHKSLTGTARYMS---INT-HLGKEQSRRDDLEALGHMFMYFLRGS 214

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 4e-09
 Identities = 45/276 (16%), Positives = 83/276 (30%), Gaps = 85/276 (30%)

Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           +V+E +    L   + +   Q +  P   KI   V +GL +LH     +I+ D+K  N+L
Sbjct: 122 MVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENIL 179

Query: 92  L-------------------------------------------------DSNFNAKLSD 102
           L                                                       K++D
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 103 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR--- 159
            G A            T  + TR Y + E +        +D++S   +  EL +G     
Sbjct: 240 LGNACWV---HKHF--TEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFE 294

Query: 160 -----ALDEDRGGLAEQTLV------------EWADPFLRDSRRVLRIMDTRLGG----- 197
                    D   +A    +            +++  F      +  I   +  G     
Sbjct: 295 PHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL 354

Query: 198 ----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
               ++S++EA      +L  L + P+ R +  + L
Sbjct: 355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECL 390

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 49.6 bits (119), Expect = 3e-07
 Identities = 38/145 (26%), Positives = 57/145 (39%), Gaps = 37/145 (25%)

Query: 33  VYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLL 92
            +EF+ + +          QP   P    +A  +   L FLH  +  + + DLK  N+L 
Sbjct: 108 TFEFLKENNF---------QPYPLPHVRHMAYQLCHALRFLH--ENQLTHTDLKPENILF 156

Query: 93  DSNFNA-------------------KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV 133
            ++                      +++DFG A    T D+ H +T IV TR Y  PE V
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTT-IVATRHYRPPE-V 210

Query: 134 ATGHL-TPKSDVYSFGVVLLELLSG 157
                     DV+S G +L E   G
Sbjct: 211 ILELGWAQPCDVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 48.4 bits (116), Expect = 8e-07
 Identities = 34/122 (27%), Positives = 51/122 (41%), Gaps = 38/122 (31%)

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA-------------------KLS 101
           K+A  + + ++FLH     + + DLK  N+L   +                      K+ 
Sbjct: 122 KMAYQICKSVNFLH--SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVV 179

Query: 102 DFGLARDGPTGDNTHVSTRIVGTRGYAAPE------YVATGHLTPKSDVYSFGVVLLELL 155
           DFG A    T D+ H ST +V TR Y APE      +      +   DV+S G +L+E  
Sbjct: 180 DFGSA----TYDDEHHST-LVSTRHYRAPEVILALGW------SQPCDVWSIGCILIEYY 228

Query: 156 SG 157
            G
Sbjct: 229 LG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 35/123 (28%), Positives = 52/123 (42%), Gaps = 34/123 (27%)

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA---------------------- 98
              I++ + L++L     ++ + DLK  N+LLD  +                        
Sbjct: 141 LYCIEILKALNYLR--KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKS 198

Query: 99  ---KLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLEL 154
              KL DFG A    T  + +  + I+ TR Y APE V         SD++SFG VL EL
Sbjct: 199 TGIKLIDFGCA----TFKSDYHGS-IINTRQYRAPE-VILNLGWDVSSDMWSFGCVLAEL 252

Query: 155 LSG 157
            +G
Sbjct: 253 YTG 255

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.8 bits (114), Expect = 1e-06
 Identities = 25/147 (17%), Positives = 61/147 (41%), Gaps = 23/147 (15%)

Query: 25  SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRD 84
           +    R ++ +      L+  ++    +  S  T +++++ +   L ++H  +   ++ D
Sbjct: 122 NGKSYRFMIMDRFGS-DLQ-KIYEANAKRFSRKTVLQLSLRILDILEYIH--EHEYVHGD 177

Query: 85  LKASNVLLDSNFNAK--LSDFGLA---RDGPTGDNTHVSTR----IVGTRGYAAPEYVAT 135
           +KASN+LL+     +  L D+GLA          +   +        GT  + +   +  
Sbjct: 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV--HKAYAADPKRCHDGTIEFTS---IDA 232

Query: 136 GHL----TPKSDVYSFGVVLLELLSGR 158
            H     + + D+   G  +++ L+G 
Sbjct: 233 -HNGVAPSRRGDLEILGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 31/166 (18%), Positives = 65/166 (39%), Gaps = 27/166 (16%)

Query: 9   LGQLRHENLVKLIGY-CSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA 67
           L       +   +G+   +   R LV   + + SL++ L       +S  + +++A  + 
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRLL 169

Query: 68  RGLSFLHGLDANVIYRDLKASNVLLDSNFNAK--LSDFGLA---RDGPTGDNTHVSTR-- 120
             L FLH  +   ++ ++ A N+ +D    ++  L+ +G A            HV+    
Sbjct: 170 DALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP----SGKHVAYVEG 223

Query: 121 ----IVGTRGYAAPEYVATGHL----TPKSDVYSFGVVLLELLSGR 158
                 G   + +   +   H     + +SD+ S G  +L+ L G 
Sbjct: 224 SRSPHEGDLEFIS---MDL-HKGCGPSRRSDLQSLGYCMLKWLYGF 265

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.2 bits (102), Expect = 4e-05
 Identities = 31/145 (21%), Positives = 61/145 (42%), Gaps = 20/145 (13%)

Query: 25  SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRD 84
                R +V E +    L+  +  +        T +++ I +   L ++H  +   ++ D
Sbjct: 122 KGRSYRFMVMERLGI-DLQ-KISGQN-GTFKKSTVLQLGIRMLDVLEYIH--ENEYVHGD 176

Query: 85  LKASNVLLDSNFNAK--LSDFGLA-RDGPTGDNTHVSTR----IVGTRGYAAPEYVATGH 137
           +KA+N+LL      +  L+D+GL+ R  P G++            GT  + +   +   H
Sbjct: 177 IKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTS---LDA-H 232

Query: 138 L----TPKSDVYSFGVVLLELLSGR 158
                + +SDV   G  +L  L G+
Sbjct: 233 KGVALSRRSDVEILGYCMLRWLCGK 257

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 43.3 bits (101), Expect = 4e-05
 Identities = 26/128 (20%), Positives = 36/128 (28%), Gaps = 16/128 (12%)

Query: 32  LVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL 91
           +V EF   G     +  K     S  T   I   +   L+          +RDL   NVL
Sbjct: 139 IVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEAS-LRFEHRDLHWGNVL 194

Query: 92  LDSNFNAKLSDFGLARDG---------PTGDNTHVSTRIVGTRGYA---APEYVATGHLT 139
           L      KL      +              D T       G   +      E + TG   
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254

Query: 140 PKSDVYSF 147
            + D+Y  
Sbjct: 255 YQFDIYRL 262

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	278
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.87
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.7
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.42
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.16
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.98
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.81
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.78
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.64
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.33
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.25
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.08
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.05
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.76
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.67
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.95
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.74
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.71
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.37
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.36
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.17
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.84
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.98
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.5
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	92.45
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.92
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	91.4
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	90.35
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	89.98
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.67
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	89.56
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.2
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.61
3mes_A	424	Choline kinase; malaria, structural genomics, stru	82.99

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.8e-51  Score=345.54  Aligned_cols=208  Identities=23%  Similarity=0.337  Sum_probs=178.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++|||||+++++|++++.+|+|||||+||+|.+++.......+++..+..++.||+.||.|||  +.||+
T Consensus        70 ~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH--~~~Ii  147 (350)
T 4b9d_A           70 SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--DRKIL  147 (350)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--HTTCE
T ss_pred             HHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            6799999999999999999999999999999999999999999998766567899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.+|.+||+|||++......  ........|++.|+|||++.+..|+.++|||||||++|+|++|+.||
T Consensus       148 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF  225 (350)
T 4b9d_A          148 HRDIKSQNIFLTKDGTVQLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAF  225 (350)
T ss_dssp             ETTCCGGGEEECTTCCEEECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred             eccCCHHHEEECCCCCEEEcccccceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999999999764321  11223357999999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+.+.......                 +.. ....+.+..++.++.+||.+||+.||++|||+.|+++|
T Consensus       226 ~~~~~~~~~~~-----------------i~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          226 EAGSMKNLVLK-----------------IIS-GSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             CCSSHHHHHHH-----------------HHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCcCHHHHHHH-----------------HHc-CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            76443211111                 111 12234566788999999999999999999999999975

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.5e-51  Score=340.34  Aligned_cols=206  Identities=20%  Similarity=0.334  Sum_probs=178.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||++++++|++++.+|+|||||.||+|.+++.+.+  .+++..+..++.||+.||.|||  ++||+
T Consensus        79 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~Ii  154 (311)
T 4aw0_A           79 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH--GKGII  154 (311)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCc
Confidence            6789999999999999999999999999999999999999999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       155 HRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF  234 (311)
T 4aw0_A          155 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF  234 (311)
T ss_dssp             CSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999998765444444444567999999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      .+.+.......+                 ...  ...++..+++++.+||.+||+.||.+|||+.|++.
T Consensus       235 ~~~~~~~~~~~i-----------------~~~--~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          235 RAGNEGLIFAKI-----------------IKL--EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             CCSSHHHHHHHH-----------------HHT--CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             CCCCHHHHHHHH-----------------HcC--CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence            764432211111                 111  23456678889999999999999999999998753

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6e-50  Score=338.69  Aligned_cols=217  Identities=28%  Similarity=0.475  Sum_probs=178.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC-------------CCCCCHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-------------VQPISWPTRVKIAIDVAR   68 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~i~~~l~~   68 (278)
                      |.+|+++|++++|||||++++++.+.+..|+|||||++|+|.+++....             ..++++..+..++.|++.
T Consensus        90 f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~  169 (329)
T 4aoj_A           90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA  169 (329)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHH
Confidence            7899999999999999999999999999999999999999999997542             235899999999999999


Q ss_pred             HHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHH
Q 023752           69 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFG  148 (278)
Q Consensus        69 ~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG  148 (278)
                      ||.|||  +.+|+||||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||
T Consensus       170 gl~yLH--~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~G  247 (329)
T 4aoj_A          170 GMVYLA--GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG  247 (329)
T ss_dssp             HHHHHH--HTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHH
T ss_pred             HHHHHh--cCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchH
Confidence            999999  899999999999999999999999999999865443333333445688999999999999999999999999


Q ss_pred             HHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 023752          149 VVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD  227 (278)
Q Consensus       149 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  227 (278)
                      |++|+|+| |+.||.+.+...                  ....+......+.|..+++++.+||.+||+.||++|||+.+
T Consensus       248 vvl~Ellt~G~~Pf~~~~~~~------------------~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~e  309 (329)
T 4aoj_A          248 VVLWEIFTYGKQPWYQLSNTE------------------AIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKD  309 (329)
T ss_dssp             HHHHHHHTTSCCTTCSSCHHH------------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             HHHHHHHcCCCCCCCCCCHHH------------------HHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHH
Confidence            99999999 899997643321                  11222233345667788999999999999999999999999


Q ss_pred             HHHHHHhhhcC
Q 023752          228 VLTSLEQLHTS  238 (278)
Q Consensus       228 ll~~l~~~~~~  238 (278)
                      |+++|+.+...
T Consensus       310 i~~~L~~l~~~  320 (329)
T 4aoj_A          310 VHARLQALAQA  320 (329)
T ss_dssp             HHHHHHHHHHS
T ss_pred             HHHHHHHHhhC
Confidence            99999998765

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.5e-50  Score=339.22  Aligned_cols=217  Identities=23%  Similarity=0.252  Sum_probs=181.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++|||||+++++|.+++.+|+|||||+||+|.+++.+.+  .+++..+..++.|++.||.|||  ++||+
T Consensus        97 ~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH--~~~Ii  172 (336)
T 4g3f_A           97 RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH--TRRIL  172 (336)
T ss_dssp             CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCce
Confidence            3589999999999999999999999999999999999999999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCc---cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTH---VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      ||||||+||+++.+| ++||+|||++..........   ......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       173 HRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG  252 (336)
T 4g3f_A          173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG  252 (336)
T ss_dssp             CSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            999999999999887 69999999998654432211   12235689999999999999999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      ..||.+.+.......+.....+                ....+..+++++.+||.+||+.||.+|||+.|++++|.....
T Consensus       253 ~~Pf~~~~~~~~~~~i~~~~~~----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          253 CHPWTQYFRGPLCLKIASEPPP----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             SCSSTTTCCSCCHHHHHHSCCG----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCCCCHHHHHHHHHcCCCC----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            9999765544333332221110                123456788999999999999999999999999999988776


Q ss_pred             C
Q 023752          238 S  238 (278)
Q Consensus       238 ~  238 (278)
                      .
T Consensus       317 ~  317 (336)
T 4g3f_A          317 E  317 (336)
T ss_dssp             H
T ss_pred             h
Confidence            5

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2e-50  Score=341.71  Aligned_cols=207  Identities=24%  Similarity=0.359  Sum_probs=176.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++|||||+++++|.+++.+|+|||||+||+|.+++.+.   .+++..+..++.||+.||.|||  +.||+
T Consensus       118 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH--~~~Ii  192 (346)
T 4fih_A          118 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH--AQGVI  192 (346)
T ss_dssp             GHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            679999999999999999999999999999999999999999998764   5999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.+|.+||+|||++.......  .......|++.|+|||++.+..|+.++|||||||++|+|++|..||
T Consensus       193 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF  270 (346)
T 4fih_A          193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY  270 (346)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999999999999997654322  2233467999999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+.+.......+....                ....+.+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       271 ~~~~~~~~~~~i~~~~----------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          271 FNEPPLKAMKMIRDNL----------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             TTSCHHHHHHHHHHSS----------------CCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCcCHHHHHHHHHcCC----------------CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            7643322222111110                11223345788999999999999999999999999976

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.6e-50  Score=337.90  Aligned_cols=217  Identities=28%  Similarity=0.469  Sum_probs=184.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC-----------CCCCCHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-----------VQPISWPTRVKIAIDVARGL   70 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~i~~~l~~~l   70 (278)
                      |.+|+++|++++||||+++++++.+++..++|||||++|+|.+++.+.+           ...+++..+..++.|++.||
T Consensus        62 f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl  141 (299)
T 4asz_A           62 FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGM  141 (299)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHH
Confidence            7899999999999999999999999999999999999999999997542           34699999999999999999


Q ss_pred             HHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHH
Q 023752           71 SFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        71 ~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i  150 (278)
                      .|||  +.+|+||||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++|||||||+
T Consensus       142 ~yLH--~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvv  219 (299)
T 4asz_A          142 VYLA--SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVV  219 (299)
T ss_dssp             HHHH--HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred             HHHH--hCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHH
Confidence            9999  89999999999999999999999999999975433222222233457889999999999999999999999999


Q ss_pred             HHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          151 LLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       151 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      +|+|+| |+.||.+.+...                  ....+......+.|..+++++.+||.+||+.||++|||+.+|+
T Consensus       220 l~Ellt~G~~Pf~~~~~~~------------------~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          220 LWEIFTYGKQPWYQLSNNE------------------VIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             HHHHHTTTCCTTTTSCHHH------------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHcCCCCCCCCCCHHH------------------HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            999998 899997644321                  1222223334556778889999999999999999999999999


Q ss_pred             HHHHhhhcC
Q 023752          230 TSLEQLHTS  238 (278)
Q Consensus       230 ~~l~~~~~~  238 (278)
                      +.|+++...
T Consensus       282 ~~L~~~~~~  290 (299)
T 4asz_A          282 TLLQNLAKA  290 (299)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHhc
Confidence            999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-49  Score=332.39  Aligned_cols=220  Identities=28%  Similarity=0.437  Sum_probs=174.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.+ +.+++|||||++|+|.+++.... ..+++..+..++.|++.||.|||  +.+|+
T Consensus        79 f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH--~~~Ii  154 (307)
T 3omv_A           79 FRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH--AKNII  154 (307)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH--HTTCB
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            7899999999999999999998865 57899999999999999997554 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc---CCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ||||||+||+++.++.+||+|||++................|++.|+|||++.+   ..|+.++|||||||++|+|+||+
T Consensus       155 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~  234 (307)
T 3omv_A          155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE  234 (307)
T ss_dssp             CSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             CCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCC
Confidence            999999999999999999999999976544333333344678999999999864   35889999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      .||.+.+............             .........+..++.++.+||.+||+.||++|||+.+|+++|+.+..+
T Consensus       235 ~Pf~~~~~~~~~~~~~~~~-------------~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          235 LPYSHINNRDQIIFMVGRG-------------YASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             CTTTTCCCHHHHHHHHHTT-------------CCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             CCCCCCChHHHHHHHHhcC-------------CCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            9997644321111111000             000011234567889999999999999999999999999999988754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.3e-50  Score=336.04  Aligned_cols=216  Identities=25%  Similarity=0.419  Sum_probs=183.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDVA   67 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l~   67 (278)
                      |.+|+.++++++||||+++++++.+++..++|||||++|+|.+++..+.              ...+++..+..++.|++
T Consensus        76 f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia  155 (308)
T 4gt4_A           76 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIA  155 (308)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHH
Confidence            7899999999999999999999999999999999999999999996532              13589999999999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHH
Q 023752           68 RGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSF  147 (278)
Q Consensus        68 ~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diwsl  147 (278)
                      .||.|||  +.+++||||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++|||||
T Consensus       156 ~gl~yLH--~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSf  233 (308)
T 4gt4_A          156 AGMEYLS--SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSY  233 (308)
T ss_dssp             HHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHH--hCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhH
Confidence            9999999  89999999999999999999999999999875433332223334568899999999999999999999999


Q ss_pred             HHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          148 GVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       148 G~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      ||++|||+| |..||.+.+...                  ....+......+.+..++.++.+|+.+||+.||.+|||+.
T Consensus       234 Gvvl~El~t~g~~Pf~~~~~~~------------------~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~  295 (308)
T 4gt4_A          234 GVVLWEVFSYGLQPYCGYSNQD------------------VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFK  295 (308)
T ss_dssp             HHHHHHHHTTTCCTTTTCCHHH------------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             HHHHHHHHhCCCCCCCCCCHHH------------------HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHH
Confidence            999999998 899997654321                  2222333334556778889999999999999999999999


Q ss_pred             HHHHHHHhhhc
Q 023752          227 DVLTSLEQLHT  237 (278)
Q Consensus       227 ~ll~~l~~~~~  237 (278)
                      +|+++|++..+
T Consensus       296 ei~~~L~a~~n  306 (308)
T 4gt4_A          296 DIHSRLRAWGN  306 (308)
T ss_dssp             HHHHHHHTSCC
T ss_pred             HHHHHHHhccC
Confidence            99999987643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=343.99  Aligned_cols=207  Identities=24%  Similarity=0.359  Sum_probs=176.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+|++++|||||+++++|.+++.+|+|||||+||+|.+++...   .+++..+..++.||+.||.|||  ++||+
T Consensus       195 ~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH--~~~Ii  269 (423)
T 4fie_A          195 LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH--AQGVI  269 (423)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            679999999999999999999999999999999999999999998755   4999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.+|.+||+|||++........  ......|++.|+|||++.+..|+.++|||||||++|+|++|..||
T Consensus       270 HRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF  347 (423)
T 4fie_A          270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY  347 (423)
T ss_dssp             CCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999999999999976543322  223467999999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+.+.......+....                ......+..++.++.+||.+||+.||++|||+.|+++|
T Consensus       348 ~~~~~~~~~~~i~~~~----------------~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          348 FNEPPLKAMKMIRDNL----------------PPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             TTSCHHHHHHHHHHSC----------------CCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCcCHHHHHHHHHcCC----------------CCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            7644322222221111                11223345678899999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.8e-49  Score=326.84  Aligned_cols=204  Identities=25%  Similarity=0.415  Sum_probs=167.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      |.+|+++|++++|||||+++++|.+    ++.+|+|||||+||+|.+++.+.+  .+++..+..++.||+.||.|||  +
T Consensus        72 ~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH--~  147 (290)
T 3fpq_A           72 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH--T  147 (290)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--T
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--H
Confidence            7899999999999999999999875    245799999999999999998765  7999999999999999999999  7


Q ss_pred             CC--eeecCCCCCceEEcC-CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           78 AN--VIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        78 ~~--i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                      ++  |+||||||+||+++. ++.+||+|||++.....    .......||+.|+|||++.+ .++.++|||||||++|+|
T Consensus       148 ~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyel  222 (290)
T 3fpq_A          148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM  222 (290)
T ss_dssp             SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred             CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHH
Confidence            77  999999999999974 78999999999975322    22234579999999999865 699999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhh-hccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD-TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|+.||.+......                 ....+. ...+...+...++++.+||.+||+.||++|||+.++++|
T Consensus       223 ltg~~Pf~~~~~~~~-----------------~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          223 ATSEYPYSECQNAAQ-----------------IYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HHSSCTTTTCSSHHH-----------------HHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHCCCCCCCCCcHHH-----------------HHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            999999965432111                 111111 111122334566789999999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.2e-49  Score=324.55  Aligned_cols=203  Identities=26%  Similarity=0.424  Sum_probs=166.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||++++++|.+++..|+||||+ +|+|.+++.+++  .+++..+..++.||+.||.|||  ++||+
T Consensus        60 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~Ii  134 (275)
T 3hyh_A           60 IEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCH--RHKIV  134 (275)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            679999999999999999999999999999999999 679999998765  7999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p  160 (278)
                      ||||||+||+++.++.+||+|||++.......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.|
T Consensus       135 HRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~P  211 (275)
T 3hyh_A          135 HRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP  211 (275)
T ss_dssp             CCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCC
Confidence            99999999999999999999999997643322   2234579999999999988876 5799999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |.+.+.......+                 ..  .....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       212 F~~~~~~~~~~~i-----------------~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          212 FDDESIPVLFKNI-----------------SN--GVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             SCCSSHHHHHHHH-----------------HH--TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             CCCCCHHHHHHHH-----------------Hc--CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            9754321111111                 11  1234566788999999999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-49  Score=331.13  Aligned_cols=205  Identities=24%  Similarity=0.334  Sum_probs=169.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||++++++|++++.+|+|||||+||+|.+++.+.+  .+++..+..++.||+.||.|||  +.||+
T Consensus        73 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH--~~~Ii  148 (304)
T 3ubd_A           73 TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH--SLGII  148 (304)
T ss_dssp             -----CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCc
Confidence            5789999999999999999999999999999999999999999998775  7999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.+|.+||+|||++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       149 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF  226 (304)
T 3ubd_A          149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF  226 (304)
T ss_dssp             CSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCC
Confidence            99999999999999999999999997543322  1223357899999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  231 (278)
                      .+.+.......+                 ..  .....+..+++++.+||.+||+.||++|||+     +|+++|
T Consensus       227 ~~~~~~~~~~~i-----------------~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          227 QGKDRKETMTMI-----------------LK--AKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             CCSSHHHHHHHH-----------------HH--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             CCcCHHHHHHHH-----------------Hc--CCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            764432211111                 11  1234566788999999999999999999984     677764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=9.4e-48  Score=327.82  Aligned_cols=218  Identities=27%  Similarity=0.393  Sum_probs=183.7

Q ss_pred             hHHHHHHHhccCC-ccccceeeeeecC-CccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRH-ENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAID   65 (278)
Q Consensus         2 ~~~E~~~l~~l~h-~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~   65 (278)
                      |.+|+++|+++.| ||||+++++|.+. +.+++|||||++|+|.+++....              ...+++..+..++.|
T Consensus       114 ~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  193 (353)
T 4ase_A          114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ  193 (353)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHH
Confidence            7889999999965 8999999998765 56899999999999999997532              235889999999999


Q ss_pred             HHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchh
Q 023752           66 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVY  145 (278)
Q Consensus        66 l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw  145 (278)
                      ++.||.|||  +.+|+||||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++|||
T Consensus       194 ia~gl~yLH--~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVw  271 (353)
T 4ase_A          194 VAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW  271 (353)
T ss_dssp             HHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHhHh--hCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEe
Confidence            999999999  899999999999999999999999999999865444333333445678999999999999999999999


Q ss_pred             HHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 023752          146 SFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS  224 (278)
Q Consensus       146 slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  224 (278)
                      ||||++|+|+| |..||.+....                 ......+......+.|..+++++.++|.+||+.||.+|||
T Consensus       272 S~Gv~l~El~t~G~~Pf~~~~~~-----------------~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt  334 (353)
T 4ase_A          272 SFGVLLWEIFSLGASPYPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT  334 (353)
T ss_dssp             HHHHHHHHHTTTSCCSSTTCCCS-----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             ehHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcC
Confidence            99999999998 89999764422                 1222333334445667778899999999999999999999


Q ss_pred             HHHHHHHHHhhhcC
Q 023752          225 MVDVLTSLEQLHTS  238 (278)
Q Consensus       225 ~~~ll~~l~~~~~~  238 (278)
                      +.+|+++|+++...
T Consensus       335 ~~eil~~L~~llq~  348 (353)
T 4ase_A          335 FSELVEHLGNLLQA  348 (353)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHH
Confidence            99999999988643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-45  Score=308.01  Aligned_cols=208  Identities=23%  Similarity=0.350  Sum_probs=156.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc------------cEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN------------RLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVAR   68 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~------------~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~   68 (278)
                      +.+|+++|++++||||++++++|.+.+.            +|+|||||.||+|.+++..+.. ...+...+..++.||++
T Consensus        50 ~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~  129 (299)
T 4g31_A           50 VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE  129 (299)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHH
Confidence            6789999999999999999999976543            6899999999999999976542 23455678899999999


Q ss_pred             HHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc----------cccccccCCcccCccccccCCC
Q 023752           69 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH----------VSTRIVGTRGYAAPEYVATGHL  138 (278)
Q Consensus        69 ~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~~~~~~  138 (278)
                      ||.|||  ++||+||||||+||+++.++.+||+|||++..........          ......||+.|+|||++.+..|
T Consensus       130 al~ylH--~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y  207 (299)
T 4g31_A          130 AVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY  207 (299)
T ss_dssp             HHHHHH--HTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCC
T ss_pred             HHHHHH--HCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC
Confidence            999999  8999999999999999999999999999998654432211          1123569999999999999999


Q ss_pred             CCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCC
Q 023752          139 TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       139 ~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  218 (278)
                      +.++|||||||++|+|++   ||.....  ....+               ..+.....++.....++.+.+||.+||+.|
T Consensus       208 ~~~~DiwSlGvilyell~---Pf~~~~~--~~~~~---------------~~~~~~~~p~~~~~~~~~~~~li~~~L~~d  267 (299)
T 4g31_A          208 SHKVDIFSLGLILFELLY---PFSTQME--RVRTL---------------TDVRNLKFPPLFTQKYPCEYVMVQDMLSPS  267 (299)
T ss_dssp             CTHHHHHHHHHHHHHHHS---CCSSHHH--HHHHH---------------HHHHTTCCCHHHHHHCHHHHHHHHHHTCSS
T ss_pred             CCHHHHHHHHHHHHHHcc---CCCCccH--HHHHH---------------HHHhcCCCCCCCcccCHHHHHHHHHHcCCC
Confidence            999999999999999996   7643211  00000               001111111122345567889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 023752          219 PKNRPSMVDVLTS  231 (278)
Q Consensus       219 p~~Rps~~~ll~~  231 (278)
                      |++|||+.++++|
T Consensus       268 P~~Rps~~eil~h  280 (299)
T 4g31_A          268 PMERPEAINIIEN  280 (299)
T ss_dssp             GGGSCCHHHHHTS
T ss_pred             hhHCcCHHHHhcC
Confidence            9999999999974

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.5e-45  Score=305.85  Aligned_cols=230  Identities=23%  Similarity=0.347  Sum_probs=170.2

Q ss_pred             HHHHHHHhccCCccccceeeeeecCC----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.|+..+.+++||||+++++++.+++    .+|+||||+++|+|.+++.+.   .+++..+..++.|++.||.|||  ..
T Consensus        45 e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH--~~  119 (303)
T 3hmm_A           45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLH--ME  119 (303)
T ss_dssp             HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH--CC
T ss_pred             HHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--Hh
Confidence            45666677889999999999998664    469999999999999999765   4899999999999999999999  55


Q ss_pred             --------CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--cccccccCCcccCccccccC------CCCCcc
Q 023752           79 --------NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATG------HLTPKS  142 (278)
Q Consensus        79 --------~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~  142 (278)
                              +|+||||||+||+++.++.+||+|||++..........  ......|++.|+|||++.+.      .++.++
T Consensus       120 ~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~  199 (303)
T 3hmm_A          120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA  199 (303)
T ss_dssp             BCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHH
T ss_pred             hhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhH
Confidence                    99999999999999999999999999987543332211  12235689999999998654      356789


Q ss_pred             chhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHH-HhhhccCCCCC-----HHHHHHHHHHHHHhcc
Q 023752          143 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR-IMDTRLGGQYS-----KKEAQAVAAVVLQCLH  216 (278)
Q Consensus       143 DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~  216 (278)
                      |||||||++|+|+||..||........-.  .... +.......... ......++..+     ...+..+.+|+.+||+
T Consensus       200 DVwS~Gvvl~El~tg~~~~~~~~~~~~p~--~~~~-~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~  276 (303)
T 3hmm_A          200 DIYAMGLVFWEIARRCSIGGIHEDYQLPY--YDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY  276 (303)
T ss_dssp             HHHHHHHHHHHHHHTBCBTTBCCCCCCTT--TTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCC
T ss_pred             hhhhHHHHHHHHHHCCCCCCccccccccc--hhcc-cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcc
Confidence            99999999999999988875443211100  0000 00001111111 22222333333     2456789999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCC
Q 023752          217 MDPKNRPSMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       217 ~dp~~Rps~~~ll~~l~~~~~~~~  240 (278)
                      .||++|||+.+|++.|+++....+
T Consensus       277 ~dP~~RPt~~ei~~~L~~l~~~~~  300 (303)
T 3hmm_A          277 ANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             cCHhHCcCHHHHHHHHHHHHHHcC
Confidence            999999999999999999876543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=313.34  Aligned_cols=225  Identities=24%  Similarity=0.308  Sum_probs=174.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeec------CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+++|++++||||+++++++..      .+.+|+|||||+ |+|.+++.+++  .+++..+..++.||+.||.||| 
T Consensus       100 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH-  175 (398)
T 4b99_A          100 TLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMH-  175 (398)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH-
Confidence            4689999999999999999998754      357899999995 68999997654  7999999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCC--CccccccccCCcccCccccccC-CCCCccchhHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN--THVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLL  152 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~  152 (278)
                       +.||+||||||+||+++.++.+||+|||++........  ........||+.|+|||++.+. .++.++||||+||++|
T Consensus       176 -~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~  254 (398)
T 4b99_A          176 -SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFG  254 (398)
T ss_dssp             -HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred             -HCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHH
Confidence             89999999999999999999999999999976543221  2223446799999999998775 5689999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhH------HHHHHhhhc-cCCCC-----CHHHHHHHHHHHHHhccCCCC
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR------RVLRIMDTR-LGGQY-----SKKEAQAVAAVVLQCLHMDPK  220 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~~l~~dp~  220 (278)
                      +|++|..||.+.+.......+............      .....+... ...+.     ....+.++.+||.+||+.||.
T Consensus       255 ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~  334 (398)
T 4b99_A          255 EMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS  334 (398)
T ss_dssp             HHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT
T ss_pred             HHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh
Confidence            999999999877665555555443332221110      001111110 00111     124578899999999999999


Q ss_pred             CCCCHHHHHHH
Q 023752          221 NRPSMVDVLTS  231 (278)
Q Consensus       221 ~Rps~~~ll~~  231 (278)
                      +|||+.|+++|
T Consensus       335 ~R~ta~e~L~H  345 (398)
T 4b99_A          335 ARISAAAALRH  345 (398)
T ss_dssp             TSCCHHHHTTS
T ss_pred             HCcCHHHHhcC
Confidence            99999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=8e-44  Score=305.20  Aligned_cols=223  Identities=20%  Similarity=0.289  Sum_probs=167.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++|+.+ +||||++++++|.+++..|+||||++|++|.+++.     .+++..+..++.||+.||.|||  +.||
T Consensus        66 ~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH--~~gI  138 (361)
T 4f9c_A           66 IAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH--QFGI  138 (361)
T ss_dssp             HHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            46899999998 69999999999999999999999999999999883     4899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCC-CceEEeccccccCCCCCCCC--------------------------ccccccccCCcccCcccc
Q 023752           81 IYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNT--------------------------HVSTRIVGTRGYAAPEYV  133 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~-~~~kl~dfg~~~~~~~~~~~--------------------------~~~~~~~~~~~~~aPE~~  133 (278)
                      +||||||+||+++.+ +.+||+|||++.........                          .......||+.|+|||++
T Consensus       139 iHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l  218 (361)
T 4f9c_A          139 VHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL  218 (361)
T ss_dssp             ECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred             EeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence            999999999999876 79999999999754332111                          111234689999999998


Q ss_pred             ccC-CCCCccchhHHHHHHHHHHhCCCCCccccCC-chhhhHHhhhccc--------------------cchhHHHHHHh
Q 023752          134 ATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGG-LAEQTLVEWADPF--------------------LRDSRRVLRIM  191 (278)
Q Consensus       134 ~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~--------------------~~~~~~~~~~~  191 (278)
                      .+. .++.++||||+||++|+|++|+.||...... .....+.......                    ..+.......+
T Consensus       219 ~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  298 (361)
T 4f9c_A          219 TKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERL  298 (361)
T ss_dssp             TTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHH
T ss_pred             cCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhh
Confidence            775 5899999999999999999999999644332 2222222111000                    00000000000


Q ss_pred             ---------------hhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          192 ---------------DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       192 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                                     ......+....+++++.+||.+||+.||.+|||+.|+++|
T Consensus       299 ~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          299 RGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             C----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                           0001112234567889999999999999999999999975

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.2e-43  Score=318.03  Aligned_cols=204  Identities=24%  Similarity=0.319  Sum_probs=171.8

Q ss_pred             HHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      .++.+++.++||||++++++|++.+.+|+|||||.||+|.+++.+.+  .+++..+..++.||+.||.|||  +.||+||
T Consensus       241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH--~~gIiHR  316 (689)
T 3v5w_A          241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH--NRFVVYR  316 (689)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--TTTEECC
T ss_pred             HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcccc
Confidence            34667778899999999999999999999999999999999998775  6999999999999999999999  9999999


Q ss_pred             CCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-cCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           84 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-TGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        84 dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      ||||+||+++.+|++||+|||++........    ....||+.|+|||++. +..|+.++|+|||||++|+|++|..||.
T Consensus       317 DLKPeNILld~~G~vKL~DFGlA~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~  392 (689)
T 3v5w_A          317 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  392 (689)
T ss_dssp             CCSGGGEEECTTSCEEECCCTTCEECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             CCchHHeEEeCCCCEEecccceeeecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999986543322    2357999999999996 4579999999999999999999999997


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      +.+.........              ..  ......++..+++++.+||.+||+.||.+|++     +.+|++|
T Consensus       393 ~~~~~~~~~i~~--------------~i--~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          393 QHKTKDKHEIDR--------------MT--LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             GGGCCCHHHHHH--------------HH--HHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CCChHHHHHHHH--------------hh--cCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            654322211111              11  11234556778999999999999999999998     6888865

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.7e-43  Score=320.14  Aligned_cols=209  Identities=23%  Similarity=0.334  Sum_probs=175.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||++++++|.+++.+|+|||||.||+|.+++.... ..+++..+..++.||+.||.|||  ++||+
T Consensus       201 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH--~~~ii  277 (573)
T 3uto_A          201 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH--ENNYV  277 (573)
T ss_dssp             HHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999986543 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCC--CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLLDSN--FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ||||||+||+++.+  +.+||+|||++.......   ......|++.|+|||++.+..|+.++|||||||++|+|++|..
T Consensus       278 HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~  354 (573)
T 3uto_A          278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS  354 (573)
T ss_dssp             CCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred             eccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            99999999999754  889999999998754332   2234578999999999999999999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||.+.+.......+.....               ......+..++.++.+||.+||+.||.+|||+.|+++|
T Consensus       355 Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          355 PFGGENDDETLRNVKSCDW---------------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             SSCCSSHHHHHHHHHTTCC---------------CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCcCHHHHHHHHHhCCC---------------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            9976543222222221111               11122334678899999999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.8e-41  Score=292.69  Aligned_cols=217  Identities=25%  Similarity=0.417  Sum_probs=182.4

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~~l   66 (278)
                      |.+|+.+++++ +||||+++++++.+.+..|+|+||+.+++|.+++.....              ..+++..+..++.|+
T Consensus       133 ~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  212 (370)
T 2psq_A          133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL  212 (370)
T ss_dssp             HHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHH
Confidence            67899999999 899999999999999999999999999999999976531              347899999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++|+||
T Consensus       213 ~~aL~~LH--~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvws  290 (370)
T 2psq_A          213 ARGMEYLA--SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  290 (370)
T ss_dssp             HHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHH
T ss_pred             HHHHHHHH--hCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHH
Confidence            99999999  8999999999999999999999999999997654433222222344567899999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      |||++|+|++ |..||.+.....                  ....+........+..++.++.++|.+||+.||.+|||+
T Consensus       291 lG~il~ellt~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~  352 (370)
T 2psq_A          291 FGVLMWEIFTLGGSPYPGIPVEE------------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF  352 (370)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCGGG------------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHH------------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            9999999999 999997643321                  112222223344566788899999999999999999999


Q ss_pred             HHHHHHHHhhhcC
Q 023752          226 VDVLTSLEQLHTS  238 (278)
Q Consensus       226 ~~ll~~l~~~~~~  238 (278)
                      .+++++|+++...
T Consensus       353 ~ell~~L~~il~~  365 (370)
T 2psq_A          353 KQLVEDLDRILTL  365 (370)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.5e-41  Score=283.43  Aligned_cols=220  Identities=31%  Similarity=0.482  Sum_probs=173.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCC-
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDAN-   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~-   79 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++..... ..+++..+..++.|++.||.|||  +.| 
T Consensus        81 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~~  158 (309)
T 3p86_A           81 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH--NRNP  158 (309)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH--TSSS
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCC
Confidence            67899999999999999999999999999999999999999999976531 23899999999999999999999  888 


Q ss_pred             -eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 -VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 -i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                       ++|+||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+..++.++||||||+++|+|++|.
T Consensus       159 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  236 (309)
T 3p86_A          159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ  236 (309)
T ss_dssp             CCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCC
T ss_pred             CEECCCCChhhEEEeCCCcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence             9999999999999999999999999987533221  1122346789999999999999999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      .||........                 .............+..++.++.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       237 ~Pf~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          237 QPWGNLNPAQV-----------------VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CTTTTSCHHHH-----------------HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCCCCCCHHHH-----------------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            99975432111                 1111112233455677888999999999999999999999999999999876


Q ss_pred             CCCC
Q 023752          239 KDMP  242 (278)
Q Consensus       239 ~~~~  242 (278)
                      ...|
T Consensus       300 ~~p~  303 (309)
T 3p86_A          300 AVPP  303 (309)
T ss_dssp             ----
T ss_pred             CCCC
Confidence            4433

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.4e-41  Score=283.51  Aligned_cols=207  Identities=24%  Similarity=0.374  Sum_probs=174.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++...+..++||||+.+++|.+++.+.   .+++..+..++.|++.||.|||  +.|++
T Consensus        64 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH--~~~i~  138 (297)
T 3fxz_A           64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVI  138 (297)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--hCCce
Confidence            578999999999999999999999999999999999999999999765   4899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.+||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|+|++|..||
T Consensus       139 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  216 (297)
T 3fxz_A          139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY  216 (297)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876443322  122346889999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...+.......+..                ........+..++..+.+||.+||+.||.+|||+.++++|
T Consensus       217 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          217 LNENPLRALYLIAT----------------NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             TTSCHHHHHHHHHH----------------HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCHHHHHHHHHh----------------CCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            65432211111111                1111233456678899999999999999999999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.6e-41  Score=284.19  Aligned_cols=217  Identities=26%  Similarity=0.411  Sum_probs=182.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC----------------------CCCCHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV----------------------QPISWPTR   59 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~   59 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++.....                      ..+++..+
T Consensus        73 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (314)
T 2ivs_A           73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDL  152 (314)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHH
T ss_pred             HHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHH
Confidence            57899999999999999999999999999999999999999999976542                      24889999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC
Q 023752           60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT  139 (278)
Q Consensus        60 ~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  139 (278)
                      +.++.|++.||.|||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++
T Consensus       153 ~~i~~qi~~~l~~lH--~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  230 (314)
T 2ivs_A          153 ISFAWQISQGMQYLA--EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT  230 (314)
T ss_dssp             HHHHHHHHHHHHHHH--HTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHH--HCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC
Confidence            999999999999999  899999999999999999999999999998765443332222334556789999999888899


Q ss_pred             CccchhHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCC
Q 023752          140 PKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       140 ~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  218 (278)
                      .++|+||||+++|+|++ |..||........                  ...+........+..++..+.++|.+||+.|
T Consensus       231 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  292 (314)
T 2ivs_A          231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERL------------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQE  292 (314)
T ss_dssp             HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH------------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCHHHH------------------HHHhhcCCcCCCCccCCHHHHHHHHHHccCC
Confidence            99999999999999999 9999976443221                  1222222234455678889999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhcC
Q 023752          219 PKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       219 p~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.+|||+.+++++|+++...
T Consensus       293 p~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          293 PDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGGSCCHHHHHHHHHHHHHT
T ss_pred             hhhCcCHHHHHHHHHHHHhh
Confidence            99999999999999998654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=285.42  Aligned_cols=219  Identities=29%  Similarity=0.436  Sum_probs=180.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        97 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH--~~~iv  173 (325)
T 3kul_A           97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS--DLGYV  173 (325)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            6789999999999999999999999999999999999999999996553 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       174 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~  253 (325)
T 3kul_A          174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER  253 (325)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence            99999999999999999999999998654432221 1122344667999999988899999999999999999999 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ||.......                  ....+......+.+..++..+.++|.+||+.||.+|||+.++++.|+.+....
T Consensus       254 p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          254 PYWNMTNRD------------------VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             TTTTSCHHH------------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             CcccCCHHH------------------HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            996543321                  12222223344556678889999999999999999999999999999998764


Q ss_pred             CC
Q 023752          240 DM  241 (278)
Q Consensus       240 ~~  241 (278)
                      ..
T Consensus       316 ~~  317 (325)
T 3kul_A          316 ES  317 (325)
T ss_dssp             C-
T ss_pred             cc
Confidence            43

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=4e-41  Score=285.10  Aligned_cols=234  Identities=39%  Similarity=0.688  Sum_probs=185.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++.....  ..+++..+..++.|++.||.|||  +.|
T Consensus        82 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~  159 (321)
T 2qkw_B           82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRA  159 (321)
T ss_dssp             HHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc--CCC
Confidence            67899999999999999999999999999999999999999998865432  35899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++|+.
T Consensus       160 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~  239 (321)
T 2qkw_B          160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS  239 (321)
T ss_dssp             EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCT
T ss_pred             eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCC
Confidence            99999999999999999999999999876443333222333457889999999988899999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ||............ .+...... .......+........+...+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus       240 p~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          240 AIVQSLPREMVNLA-EWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             TCSCSSSSSCCCHH-HHTHHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             cccccCcHHHHHHH-HHhhhccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            99765443222111 11000000 00000111222234456788999999999999999999999999999999887653

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=288.98  Aligned_cols=222  Identities=26%  Similarity=0.403  Sum_probs=186.4

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~~l   66 (278)
                      +.+|+++++++ +||||+++++++.+.+..++|+||+.+++|.+++.....              ..+++..+..++.|+
T Consensus       121 ~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  200 (382)
T 3tt0_A          121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV  200 (382)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHH
Confidence            57899999999 999999999999999999999999999999999987542              358999999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||
T Consensus       201 ~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Diws  278 (382)
T 3tt0_A          201 ARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS  278 (382)
T ss_dssp             HHHHHHHH--HTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHH
T ss_pred             HHHHHHHH--hCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHH
Confidence            99999999  8999999999999999999999999999998654433322233345667899999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++ |..||......                  .....+........+..++.++.+||.+||+.||++|||+
T Consensus       279 lG~il~ellt~g~~p~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~  340 (382)
T 3tt0_A          279 FGVLLWEIFTLGGSPYPGVPVE------------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF  340 (382)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCHH------------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHhCCCCCCCCCCHH------------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCH
Confidence            9999999999 99999754321                  1222233333344556778899999999999999999999


Q ss_pred             HHHHHHHHhhhcCCCCCC
Q 023752          226 VDVLTSLEQLHTSKDMPR  243 (278)
Q Consensus       226 ~~ll~~l~~~~~~~~~~~  243 (278)
                      .+++++|+++........
T Consensus       341 ~ell~~L~~~~~~~~~~~  358 (382)
T 3tt0_A          341 KQLVEDLDRIVALTSNQE  358 (382)
T ss_dssp             HHHHHHHHHHHHHSCSCC
T ss_pred             HHHHHHHHHHHHHHhcCC
Confidence            999999999987654443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.2e-41  Score=286.48  Aligned_cols=204  Identities=24%  Similarity=0.383  Sum_probs=173.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++...+..|+||||+.+++|.+++...+  .+++..+..++.|++.||.|||  +.|++
T Consensus        61 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH--~~~iv  136 (328)
T 3fe3_A           61 LFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH--QKRIV  136 (328)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            5689999999999999999999999999999999999999999997765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC-CccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~p  160 (278)
                      ||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++ .++|||||||++|+|++|..|
T Consensus       137 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  213 (328)
T 3fe3_A          137 HRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP  213 (328)
T ss_dssp             CSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence            99999999999999999999999987543322   22335688999999999888775 789999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |.+.+.......+.                 .  .....+...+.++.+||.+||+.||.+|||+.++++|
T Consensus       214 f~~~~~~~~~~~i~-----------------~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          214 FDGQNLKELRERVL-----------------R--GKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             SCCSSHHHHHHHHH-----------------H--CCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCCHHHHHHHHH-----------------h--CCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            97654321111111                 1  1233455678899999999999999999999999976

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.3e-41  Score=291.80  Aligned_cols=215  Identities=27%  Similarity=0.415  Sum_probs=178.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++||||+.+++|.+++...+ ..+++..+..++.|++.||.|||  +.|++
T Consensus       159 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~iv  235 (377)
T 3cbl_A          159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE--SKCCI  235 (377)
T ss_dssp             TTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcC
Confidence            6789999999999999999999999999999999999999999997654 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|++++ |..|
T Consensus       236 HrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p  315 (377)
T 3cbl_A          236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP  315 (377)
T ss_dssp             CSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999875332211111111223567999999988889999999999999999998 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      |......                  .....+......+.+..++.++.++|.+||+.||++|||+.++++.|+++..
T Consensus       316 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~  374 (377)
T 3cbl_A          316 YPNLSNQ------------------QTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK  374 (377)
T ss_dssp             STTSCHH------------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHH------------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence            9764321                  1122223333445566778899999999999999999999999999998864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=8.9e-41  Score=287.08  Aligned_cols=208  Identities=25%  Similarity=0.362  Sum_probs=172.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.|++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        62 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~giv  137 (361)
T 2yab_A           62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH--TKKIA  137 (361)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5789999999999999999999999999999999999999999997654  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC----ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNF----NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |+||+|+||+++.++    .+||+|||++........   .....+++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus       138 HrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g  214 (361)
T 2yab_A          138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  214 (361)
T ss_dssp             CCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhC
Confidence            999999999998776    799999999976544221   2234688999999999988999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||.+.+.......+......+               ..+.+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       215 ~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          215 ASPFLGDTKQETLANITAVSYDF---------------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CCSSCCSSHHHHHHHHHTTCCCC---------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCC---------------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            99997644322222221111100               001123467889999999999999999999999964

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=291.99  Aligned_cols=209  Identities=22%  Similarity=0.307  Sum_probs=174.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..|+||||+.|++|.+.+....  .+++..+..++.||+.||.|||  +.|++
T Consensus        57 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH--~~giv  132 (444)
T 3soa_A           57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCH--QMGVV  132 (444)
T ss_dssp             HHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH--HTTCB
T ss_pred             HHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5789999999999999999999999999999999999999999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEc---CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||||+||+++   .++.+||+|||++........  ......+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       133 HrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~  210 (444)
T 3soa_A          133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGY  210 (444)
T ss_dssp             CCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCC
Confidence            999999999998   467899999999976544322  122356899999999999889999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||.+.+.......+.....               ....+....+++++.+||.+||+.||.+|||+.++++|
T Consensus       211 ~Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          211 PPFWDEDQHRLYQQIKAGAY---------------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CSCCCSSHHHHHHHHHHTCC---------------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCccHHHHHHHHHhCCC---------------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            99975443222221111110               11122334678899999999999999999999999975

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-40  Score=279.53  Aligned_cols=219  Identities=28%  Similarity=0.410  Sum_probs=183.7

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCC----------------CCCHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ----------------PISWPTRVKIAI   64 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----------------~~~~~~~~~i~~   64 (278)
                      |.+|+.+++++ +||||+++++++.+.+..++|+||+.+++|.+++......                .+++..+..++.
T Consensus        73 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (313)
T 1t46_A           73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY  152 (313)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHH
T ss_pred             HHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHH
Confidence            67899999999 9999999999999999999999999999999999766422                489999999999


Q ss_pred             HHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccch
Q 023752           65 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDV  144 (278)
Q Consensus        65 ~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  144 (278)
                      |++.||.|||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+
T Consensus       153 qi~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  230 (313)
T 1t46_A          153 QVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV  230 (313)
T ss_dssp             HHHHHHHHHH--HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHH--HCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHH
Confidence            9999999999  89999999999999999999999999999987655443333333456678999999988999999999


Q ss_pred             hHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          145 YSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       145 wslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      ||||+++|+|++ |..||........                 ....+........+..++..+.++|.+||+.||.+||
T Consensus       231 ~slG~il~ellt~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  293 (313)
T 1t46_A          231 WSYGIFLWELFSLGSSPYPGMPVDSK-----------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP  293 (313)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCSSHH-----------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHHHHHHHHHHhCCCCCCCcccchhH-----------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCc
Confidence            999999999998 9999976443211                 1122222223344566788999999999999999999


Q ss_pred             CHHHHHHHHHhhhcCC
Q 023752          224 SMVDVLTSLEQLHTSK  239 (278)
Q Consensus       224 s~~~ll~~l~~~~~~~  239 (278)
                      |+.+++++|+++....
T Consensus       294 s~~ell~~L~~~~~~~  309 (313)
T 1t46_A          294 TFKQIVQLIEKQISES  309 (313)
T ss_dssp             CHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHHHHHh
Confidence            9999999999987653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-40  Score=284.77  Aligned_cols=217  Identities=25%  Similarity=0.404  Sum_probs=178.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC----------------------CCCCCHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------------------VQPISWPTR   59 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~   59 (278)
                      |.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++....                      ...+++..+
T Consensus        97 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  176 (343)
T 1luf_A           97 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ  176 (343)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHH
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHH
Confidence            6789999999999999999999999999999999999999999997642                      146899999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC
Q 023752           60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT  139 (278)
Q Consensus        60 ~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  139 (278)
                      +.++.|++.||.|||  +.|++|+||+|+||+++.++.+||+|||++................++..|+|||.+.+..++
T Consensus       177 ~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  254 (343)
T 1luf_A          177 LCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT  254 (343)
T ss_dssp             HHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHH--hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC
Confidence            999999999999999  899999999999999999999999999998653322221222234567889999999888999


Q ss_pred             CccchhHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCC
Q 023752          140 PKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       140 ~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  218 (278)
                      .++|+||||+++|+|++ |..||.......                  ....+........+..++..+.++|.+||+.|
T Consensus       255 ~~~Di~slG~il~el~t~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~  316 (343)
T 1luf_A          255 TESDVWAYGVVLWEIFSYGLQPYYGMAHEE------------------VIYYVRDGNILACPENCPLELYNLMRLCWSKL  316 (343)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             cccccHHHHHHHHHHHhcCCCcCCCCChHH------------------HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccC
Confidence            99999999999999999 999997543211                  11112222223445677889999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhcC
Q 023752          219 PKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       219 p~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.+|||+.++++.|+++...
T Consensus       317 p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          317 PADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             GGGSCCHHHHHHHHHHTTC-
T ss_pred             cccCCCHHHHHHHHHHHHhh
Confidence            99999999999999998764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-40  Score=282.96  Aligned_cols=233  Identities=40%  Similarity=0.725  Sum_probs=184.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC--CCCCHHHHHHHHHHHHHHHHHHhcCCC-
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--QPISWPTRVKIAIDVARGLSFLHGLDA-   78 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~~l~~~l~~Lh~~~~-   78 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++.....  ..+++..+..++.|++.||.|||  +. 
T Consensus        74 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~  151 (326)
T 3uim_A           74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLH--DHC  151 (326)
T ss_dssp             HHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHH--HSS
T ss_pred             HHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            57899999999999999999999999999999999999999999976532  34899999999999999999999  77 


Q ss_pred             --CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           79 --NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        79 --~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                        |++|+||+|+||+++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       152 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~  230 (326)
T 3uim_A          152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT  230 (326)
T ss_dssp             SSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHh
Confidence              999999999999999999999999999976543322 22233458899999999988889999999999999999999


Q ss_pred             CCCCCccccCC-chhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          157 GRRALDEDRGG-LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       157 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |..||...... ........+....... ...............+...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus       231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          231 GQRAFDLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             CCCSBCHHHHTTTSCSBHHHHHTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             CCCcccccccccccchhHHHHHHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            99999632211 1111111111111111 011112222333456778899999999999999999999999999999975


Q ss_pred             hcC
Q 023752          236 HTS  238 (278)
Q Consensus       236 ~~~  238 (278)
                      ...
T Consensus       310 ~~~  312 (326)
T 3uim_A          310 GLA  312 (326)
T ss_dssp             SCS
T ss_pred             chh
Confidence            444

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.3e-40  Score=274.97  Aligned_cols=215  Identities=29%  Similarity=0.441  Sum_probs=179.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||  +.|++
T Consensus        52 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~  128 (269)
T 4hcu_A           52 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE--EACVI  128 (269)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            6789999999999999999999999999999999999999999996554 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       129 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p  207 (269)
T 4hcu_A          129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP  207 (269)
T ss_dssp             CSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999999875432211 11122345667999999998999999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |........                  ...+........+..++..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus       208 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          208 YENRSNSEV------------------VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             TTTCCHHHH------------------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCHHHH------------------HHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            975433211                  112222223444556788999999999999999999999999999998653

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.4e-39  Score=273.72  Aligned_cols=229  Identities=40%  Similarity=0.652  Sum_probs=183.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++... ....+++..+..++.|++.||.|||  +.|+
T Consensus        77 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i  154 (307)
T 2nru_A           77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHH  154 (307)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh--cCCe
Confidence            678999999999999999999999999999999999999999998643 2346899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+ .++.++|+||||+++|+|++|..|
T Consensus       155 ~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p  233 (307)
T 2nru_A          155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPA  233 (307)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCS
T ss_pred             ecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCC
Confidence            9999999999999999999999999876544333322333567899999998865 478899999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      |...........+.......   .......+.. .....+...+..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          234 VDEHREPQLLLDIKEEIEDE---EKTIEDYIDK-KMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             BCTTBSSSBTTHHHHHHHTT---SCCHHHHSCS-SCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cccCcchHHHHHHHHHhhhh---hhhhhhhccc-cccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            98765443332222211110   0111112221 1234567889999999999999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4e-40  Score=280.57  Aligned_cols=205  Identities=25%  Similarity=0.370  Sum_probs=173.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++++.+.+..|+||||+.|++|.+++.+..  .+++..+..++.||+.||.|||  +.|++
T Consensus        52 ~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~iv  127 (337)
T 1o6l_A           52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH--SRDVV  127 (337)
T ss_dssp             HHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCB
T ss_pred             HHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            4689999999999999999999999999999999999999999997765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++........  ......+++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       128 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  205 (337)
T 1o6l_A          128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCcCCHHHEEECCCCCEEEeeccchhhcccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCC
Confidence            999999999999999999999999875332221  123356889999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...+.......                 ...  ....++..++.++.+||.+||+.||.+||     ++.++++|
T Consensus       206 ~~~~~~~~~~~-----------------i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          206 YNQDHERLFEL-----------------ILM--EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCSSHHHHHHH-----------------HHH--CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCHHHHHHH-----------------HHc--CCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            75432111111                 111  12345567888999999999999999999     89999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-40  Score=286.23  Aligned_cols=218  Identities=27%  Similarity=0.392  Sum_probs=180.8

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCc-cEEEEeccCCCCHHHHHhhcCC----------------------------
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDN-RLLVYEFMPKGSLENHLFRKGV----------------------------   51 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~----------------------------   51 (278)
                      |.+|+++++++ +||||+++++++.+.+. .++|+||+.+++|.+++.....                            
T Consensus        72 ~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  151 (359)
T 3vhe_A           72 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKR  151 (359)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------
T ss_pred             HHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhc
Confidence            67899999999 78999999999987654 8999999999999999976532                            


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCC
Q 023752           52 ------------------------------------QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN   95 (278)
Q Consensus        52 ------------------------------------~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~   95 (278)
                                                          ..+++..+..++.|++.||.|||  +.|++|+||||+||+++.+
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH--~~~ivH~Dikp~NIll~~~  229 (359)
T 3vhe_A          152 RLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEK  229 (359)
T ss_dssp             --------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGG
T ss_pred             cccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH--HCCcccCCCChhhEEEcCC
Confidence                                                12889999999999999999999  8999999999999999999


Q ss_pred             CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCCCccccCCchhhhHH
Q 023752           96 FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLV  174 (278)
Q Consensus        96 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~  174 (278)
                      +.++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.....      
T Consensus       230 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------  303 (359)
T 3vhe_A          230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------  303 (359)
T ss_dssp             GCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------
T ss_pred             CcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------
Confidence            9999999999986544433333344567788999999999999999999999999999998 999997644321      


Q ss_pred             hhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                                 .....+........+..++.++.++|.+||+.||.+|||+.+++++|+++...
T Consensus       304 -----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          304 -----------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             -----------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                       11222222333445666788999999999999999999999999999988753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-40  Score=283.27  Aligned_cols=219  Identities=28%  Similarity=0.403  Sum_probs=181.1

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC---------------------CCCCHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---------------------QPISWPTR   59 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~   59 (278)
                      +.+|+.+++++ +||||+++++++...+..++||||+.+++|.+++.....                     ..+++..+
T Consensus        95 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  174 (344)
T 1rjb_A           95 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL  174 (344)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHH
T ss_pred             HHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHH
Confidence            67899999999 899999999999999999999999999999999976542                     23789999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC
Q 023752           60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT  139 (278)
Q Consensus        60 ~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  139 (278)
                      ..++.|++.||.|||  +.|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++
T Consensus       175 ~~i~~qi~~aL~~LH--~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  252 (344)
T 1rjb_A          175 LCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT  252 (344)
T ss_dssp             HHHHHHHHHHHHHHH--HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHH--hCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC
Confidence            999999999999999  899999999999999999999999999999765443333233334567789999999889999


Q ss_pred             CccchhHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCC
Q 023752          140 PKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       140 ~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  218 (278)
                      .++||||||+++|+|++ |..||........                 ....+........+..++.++.++|.+||+.|
T Consensus       253 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  315 (344)
T 1rjb_A          253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD  315 (344)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             hhHhHHHHHHHHHHHHcCCCCCcccCCcHHH-----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            99999999999999998 9999976543211                 11222222334455667889999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhcCC
Q 023752          219 PKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       219 p~~Rps~~~ll~~l~~~~~~~  239 (278)
                      |.+|||+.+++++|+.+....
T Consensus       316 p~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          316 SRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             GGGSCCHHHHHHHHHHHC---
T ss_pred             chhCcCHHHHHHHHHHHHHHH
Confidence            999999999999999987763

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.2e-40  Score=273.48  Aligned_cols=215  Identities=27%  Similarity=0.415  Sum_probs=178.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+++++|.+++.... ..+++..++.++.|++.||.|||  +.|++
T Consensus        50 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~  126 (268)
T 3sxs_A           50 FFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE--SHQFI  126 (268)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999997654 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       127 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p  205 (268)
T 3sxs_A          127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMP  205 (268)
T ss_dssp             ESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCcCcceEEECCCCCEEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999987644332211 122344567999999988889999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.........                  ..+........+...+..+.++|.+||+.||.+|||+.+++++|+.+...
T Consensus       206 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          206 YDLYTNSEVV------------------LKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             TTTSCHHHHH------------------HHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ccccChHHHH------------------HHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            9654322111                  11122222334555678899999999999999999999999999998654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.1e-40  Score=281.49  Aligned_cols=215  Identities=22%  Similarity=0.357  Sum_probs=178.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+. ..+++++++.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        64 ~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~iv  139 (327)
T 3poz_A           64 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--DRRLV  139 (327)
T ss_dssp             HHHHHHHHHHCCBTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh--hCCee
Confidence            67899999999999999999999875 4789999999999999997754 36999999999999999999999  88999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       140 H~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p  219 (327)
T 3poz_A          140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  219 (327)
T ss_dssp             CSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCC
Confidence            999999999999999999999999876544333333333455778999999999999999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |........                  ...+......+.+..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       220 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          220 YDGIPASEI------------------SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTTCCGGGH------------------HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ccCCCHHHH------------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            976443221                  222223333445666788999999999999999999999999999988654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.7e-40  Score=280.25  Aligned_cols=230  Identities=28%  Similarity=0.382  Sum_probs=176.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc----cEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN----RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      +.+|+.++++++||||+++++++.+...    .++||||+.+++|.+++...   .+++..+..++.|++.||.|||  +
T Consensus        65 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH--~  139 (322)
T 3soc_A           65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH--E  139 (322)
T ss_dssp             HHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT--C
T ss_pred             HHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--h
Confidence            3568888999999999999999987553    69999999999999999765   4899999999999999999999  8


Q ss_pred             C----------CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-----CCCCcc
Q 023752           78 A----------NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-----HLTPKS  142 (278)
Q Consensus        78 ~----------~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----~~~~~~  142 (278)
                      .          |++|+||||+||+++.++.+||+|||++................+++.|+|||++.+.     .++.++
T Consensus       140 ~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  219 (322)
T 3soc_A          140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRI  219 (322)
T ss_dssp             CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHH
T ss_pred             hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccc
Confidence            8          9999999999999999999999999999765443333333335688999999998763     455688


Q ss_pred             chhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHH-hhhccCCCC-----CHHHHHHHHHHHHHhcc
Q 023752          143 DVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI-MDTRLGGQY-----SKKEAQAVAAVVLQCLH  216 (278)
Q Consensus       143 DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~l~~li~~~l~  216 (278)
                      |||||||++|+|++|..||.+.................  ........ .........     ....+.++.+||.+||+
T Consensus       220 DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  297 (322)
T 3soc_A          220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHP--SLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWD  297 (322)
T ss_dssp             HHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSC--CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTC
T ss_pred             hhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCC--chhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHcc
Confidence            99999999999999999997654433222211111110  11111111 111112221     22456789999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcC
Q 023752          217 MDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       217 ~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      .||++|||+.++++.|+++...
T Consensus       298 ~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          298 HDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CChhhCcCHHHHHHHHHHHHHH
Confidence            9999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=280.64  Aligned_cols=218  Identities=28%  Similarity=0.450  Sum_probs=177.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+++..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        54 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~iv  130 (310)
T 3s95_A           54 FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH--SMNII  130 (310)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            6799999999999999999999999999999999999999999998753 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc------------ccccccCCcccCccccccCCCCCccchhHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV------------STRIVGTRGYAAPEYVATGHLTPKSDVYSFGV  149 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~  149 (278)
                      |+||+|+||+++.++.+||+|||++...........            .....+++.|+|||.+.+..++.++||||||+
T Consensus       131 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~  210 (310)
T 3s95_A          131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGI  210 (310)
T ss_dssp             CSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred             CCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHH
Confidence            999999999999999999999999976543322110            11346788999999999999999999999999


Q ss_pred             HHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          150 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       150 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ++|+|++|..||...........         ....   ....    ...+..++..+.++|.+||+.||++|||+.+++
T Consensus       211 ~l~el~~g~~~~~~~~~~~~~~~---------~~~~---~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~  274 (310)
T 3s95_A          211 VLCEIIGRVNADPDYLPRTMDFG---------LNVR---GFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLE  274 (310)
T ss_dssp             HHHHHHHTCCSSTTTSCBCTTSS---------BCHH---HHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HHHHHhcCCCCCcchhhhHHHHh---------hhhh---cccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999865432211100         0000   1111    112345667899999999999999999999999


Q ss_pred             HHHHhhhcC
Q 023752          230 TSLEQLHTS  238 (278)
Q Consensus       230 ~~l~~~~~~  238 (278)
                      +.|+.+...
T Consensus       275 ~~L~~l~~~  283 (310)
T 3s95_A          275 HWLETLRMH  283 (310)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHh
Confidence            999988754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.1e-41  Score=288.00  Aligned_cols=219  Identities=27%  Similarity=0.413  Sum_probs=179.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-----QPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      |.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++.....     ..+++..+..++.|++.||.|||  
T Consensus       121 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--  198 (367)
T 3l9p_A          121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--  198 (367)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH--
Confidence            57899999999999999999999999999999999999999999976532     35899999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCC---ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      +.|++||||||+||+++.++   .+||+|||++................+++.|+|||++.+..++.++|||||||++|+
T Consensus       199 ~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~e  278 (367)
T 3l9p_A          199 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE  278 (367)
T ss_dssp             HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             hCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHH
Confidence            89999999999999998554   599999999864322221222223456788999999999999999999999999999


Q ss_pred             HHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |++ |..||......                  .....+........+..++..+.+||.+||+.||.+|||+.+|+++|
T Consensus       279 llt~g~~pf~~~~~~------------------~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l  340 (367)
T 3l9p_A          279 IFSLGYMPYPSKSNQ------------------EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI  340 (367)
T ss_dssp             HHTTSCCSSTTCCHH------------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhCCCCCCCCCCHH------------------HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            998 99999754322                  12222222223444566788899999999999999999999999999


Q ss_pred             HhhhcCCC
Q 023752          233 EQLHTSKD  240 (278)
Q Consensus       233 ~~~~~~~~  240 (278)
                      +.+....+
T Consensus       341 ~~~~~~~~  348 (367)
T 3l9p_A          341 EYCTQDPD  348 (367)
T ss_dssp             HHHHHCHH
T ss_pred             HHHhhChh
Confidence            99877643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.3e-41  Score=282.92  Aligned_cols=211  Identities=20%  Similarity=0.268  Sum_probs=173.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++++.+.+..++||||+.|++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~giv  124 (321)
T 1tki_A           48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH--SHNIG  124 (321)
T ss_dssp             HHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCCC
Confidence            5789999999999999999999999999999999999999999996543 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcC--CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLLDS--NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      |+||+|+||+++.  ++.+||+|||++.......   ......+++.|+|||++.+..++.++|+||||+++|+|++|..
T Consensus       125 H~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~  201 (321)
T 1tki_A          125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN  201 (321)
T ss_dssp             CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999987  7899999999997654322   2233567899999999988888999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      ||...........+........               ......++.++.+||.+||+.||.+|||+.++++|-.
T Consensus       202 pf~~~~~~~~~~~i~~~~~~~~---------------~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          202 PFLAETNQQIIENIMNAEYTFD---------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             TTCCSSHHHHHHHHHHTCCCCC---------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             CCcCCCHHHHHHHHHcCCCCCC---------------hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            9976543222222221111100               0011246788999999999999999999999998653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.9e-40  Score=279.92  Aligned_cols=219  Identities=25%  Similarity=0.387  Sum_probs=171.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCcc------EEEEeccCCCCHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRKGV----QPISWPTRVKIAIDVARGLS   71 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~l~~~l~   71 (278)
                      |.+|++++++++||||+++++++......      ++|+||+.+++|.+++.....    ..+++..+..++.|++.||.
T Consensus        72 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~  151 (323)
T 3qup_A           72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME  151 (323)
T ss_dssp             HHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHH
Confidence            67899999999999999999999877654      999999999999999865421    25899999999999999999


Q ss_pred             HHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHH
Q 023752           72 FLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        72 ~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il  151 (278)
                      |||  +.|++|+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++|||||||++
T Consensus       152 ~LH--~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il  229 (323)
T 3qup_A          152 YLS--SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM  229 (323)
T ss_dssp             HHH--HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred             HHH--cCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHH
Confidence            999  899999999999999999999999999999765443332222334456789999999999999999999999999


Q ss_pred             HHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          152 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       152 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |+|++ |..||.+........                  .+........+..++.++.++|.+||+.||.+|||+.++++
T Consensus       230 ~ell~~g~~p~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  291 (323)
T 3qup_A          230 WEIMTRGQTPYAGIENAEIYN------------------YLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM  291 (323)
T ss_dssp             HHHHTTSCCTTTTCCGGGHHH------------------HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHhCCCCCccccChHHHHH------------------HHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999 899997654322211                  12222234445667889999999999999999999999999


Q ss_pred             HHHhhhcCCC
Q 023752          231 SLEQLHTSKD  240 (278)
Q Consensus       231 ~l~~~~~~~~  240 (278)
                      .|+++.....
T Consensus       292 ~l~~~l~~~~  301 (323)
T 3qup_A          292 ELENILGHLS  301 (323)
T ss_dssp             HHHHHHHC--
T ss_pred             HHHHHHHHhh
Confidence            9999987643

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1e-40  Score=282.93  Aligned_cols=211  Identities=27%  Similarity=0.360  Sum_probs=173.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        52 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~giv  127 (323)
T 3tki_A           52 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH--GIGIT  127 (323)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6799999999999999999999999999999999999999999986554  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.+||+|||++................+++.|+|||++.+..+ +.++||||||+++|+|++|..|
T Consensus       128 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  207 (323)
T 3tki_A          128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP  207 (323)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999975443332222334568899999999987765 6789999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |...........                ..............++..+.+||.+||+.||.+|||+.+++++-
T Consensus       208 f~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          208 WDQPSDSCQEYS----------------DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             CSSSCTTSHHHH----------------HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             CCCCchHHHHHH----------------HHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence            976543211111                11111111222356778899999999999999999999999763

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.8e-40  Score=279.75  Aligned_cols=208  Identities=25%  Similarity=0.370  Sum_probs=171.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        61 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~iv  136 (326)
T 2y0a_A           61 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH--SLQIA  136 (326)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS--CCBHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC--CcCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            6789999999999999999999999999999999999999999997654  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC----ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNF----NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |+||+|+||+++.++    .+||+|||++........   .....+++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus       137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  213 (326)
T 2y0a_A          137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  213 (326)
T ss_dssp             CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHC
Confidence            999999999998877    799999999976543221   2234688999999999888999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||.+.........+.......               .......++..+.+||.+||+.||.+|||+.++++|
T Consensus       214 ~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          214 ASPFLGDTKQETLANVSAVNYEF---------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CCSSCCSSHHHHHHHHHHTCCCC---------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cCCCCCCCHHHHHHHHHhcCCCc---------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            99997543322211111111000               001113457789999999999999999999999975

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.1e-40  Score=274.23  Aligned_cols=220  Identities=26%  Similarity=0.422  Sum_probs=175.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+.+..++||||+.|++|.+++...+  .+++..+..++.|++.||.|||  +.|++
T Consensus        58 ~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~  133 (294)
T 4eqm_A           58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH--DMRIV  133 (294)
T ss_dssp             HHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999999999999999999999999999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       134 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf  212 (294)
T 4eqm_A          134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF  212 (294)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999999764332211 122345789999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHhhhcCCC
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~~~~~  240 (278)
                      .+...............+   .           .....+..++..+.++|.+||+.||.+|| ++.++.+.|.++.....
T Consensus       213 ~~~~~~~~~~~~~~~~~~---~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          213 NGETAVSIAIKHIQDSVP---N-----------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             CSSCHHHHHHHHHSSCCC---C-----------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             CCCChHHHHHHHhhccCC---C-----------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence            764321111110000000   0           00112345678899999999999999998 89999999998876644

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.5e-40  Score=280.76  Aligned_cols=215  Identities=24%  Similarity=0.420  Sum_probs=177.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++. .+..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        62 ~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~iv  137 (325)
T 3kex_A           62 VTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLE--EHGMV  137 (325)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHH--hCCCC
Confidence            568999999999999999999886 467899999999999999997642 36888899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       138 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p  217 (325)
T 3kex_A          138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP  217 (325)
T ss_dssp             CSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCC
Confidence            999999999999999999999999987655444333344556778999999998999999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.........                  ..+........+..++.++.++|.+||+.||.+|||+.+++++|+++...
T Consensus       218 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          218 YAGLRLAEVP------------------DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             TTTSCTTHHH------------------HHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             ccccCHHHHH------------------HHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            9765432221                  22222223344555677899999999999999999999999999998654

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.5e-40  Score=284.19  Aligned_cols=217  Identities=29%  Similarity=0.445  Sum_probs=170.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        93 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~iv  169 (373)
T 2qol_A           93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLS--DMGYV  169 (373)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            6789999999999999999999999999999999999999999997654 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||||+||+++.++.+||+|||++........... .....++..|+|||.+.+..++.++||||||+++|++++ |..
T Consensus       170 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~  249 (373)
T 2qol_A          170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER  249 (373)
T ss_dssp             CSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-C
T ss_pred             CCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876543322111 111234567999999999999999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ||.......                  ....+......+.+..++..+.++|.+||+.||.+||++.++++.|+++....
T Consensus       250 P~~~~~~~~------------------~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          250 PYWEMSNQD------------------VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             TTTTCCHHH------------------HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             CCCCCCHHH------------------HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            996543211                  11222222233445567889999999999999999999999999999987653

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.6e-40  Score=285.76  Aligned_cols=228  Identities=20%  Similarity=0.243  Sum_probs=171.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++.......+++..+..++.||+.||.|||  +.|++
T Consensus        73 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~iv  150 (389)
T 3gni_B           73 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--HMGYV  150 (389)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999999999999998775567999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC-----CccccccccCCcccCcccccc--CCCCCccchhHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN-----THVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l  154 (278)
                      |+||||+||+++.++.+||+|||.+........     ........++..|+|||++.+  ..++.++|||||||++|+|
T Consensus       151 HrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el  230 (389)
T 3gni_B          151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL  230 (389)
T ss_dssp             CCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHH
Confidence            999999999999999999999998754322111     111122367888999999987  5789999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHH------------------HH---------HHhhhccCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRR------------------VL---------RIMDTRLGGQYSKKEAQAV  207 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~---------~~~~~~~~~~~~~~~~~~l  207 (278)
                      ++|..||.+...............+.......                  ..         .........+.+..++.++
T Consensus       231 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  310 (389)
T 3gni_B          231 ANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF  310 (389)
T ss_dssp             HHSSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHH
T ss_pred             HHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHH
Confidence            99999997655433322221111110000000                  00         0000001122445678899


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 023752          208 AAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       208 ~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+||.+||+.||.+|||+.++++|
T Consensus       311 ~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          311 HHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHHHHhhcCcccCCCHHHHhcC
Confidence            999999999999999999999976

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=8.6e-40  Score=289.08  Aligned_cols=212  Identities=31%  Similarity=0.457  Sum_probs=179.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC-ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD-NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|++++++++||||+++++++.+.. ..++||||+.+++|.+++...+...+++..+..++.|++.||.|||  +.++
T Consensus       233 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~i  310 (450)
T 1k9a_A          233 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNF  310 (450)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            689999999999999999999987665 7899999999999999998876556899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      +|+||+|+||+++.++.+||+|||++.......     ....++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       311 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~  385 (450)
T 1k9a_A          311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV  385 (450)
T ss_dssp             ECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             eCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999987533221     11245678999999999999999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      ||..........                  .+......+.+..++.++.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       386 P~~~~~~~~~~~------------------~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          386 PYPRIPLKDVVP------------------RVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             SSTTSCTTTHHH------------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCHHHHHH------------------HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            997654432221                  1222233455677889999999999999999999999999999998764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.7e-40  Score=283.58  Aligned_cols=208  Identities=22%  Similarity=0.321  Sum_probs=171.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..|+|+||+.|++|.+.+....  .+++..+..++.|++.||.|||  +.|++
T Consensus        75 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~iv  150 (362)
T 2bdw_A           75 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH--SNGIV  150 (362)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHH--HTTCB
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            5789999999999999999999999999999999999999999987654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCC---CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSN---FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||||+||+++.+   +.+||+|||++........   .....+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       151 H~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~  227 (362)
T 2bdw_A          151 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY  227 (362)
T ss_dssp             CCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCC
Confidence            99999999999764   4599999999976543222   22346889999999999889999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||.+.+.......+....               .....+....++.++.+||.+||+.||.+|||+.++++|
T Consensus       228 ~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          228 PPFWDEDQHRLYAQIKAGA---------------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             CSSCCSSHHHHHHHHHHTC---------------CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CCCCCCCHHHHHHHHHhCC---------------CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            9997543221111111110               001122234678899999999999999999999999976

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=5e-40  Score=274.03  Aligned_cols=216  Identities=25%  Similarity=0.403  Sum_probs=183.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus        56 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~i~  133 (288)
T 3kfa_A           56 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFI  133 (288)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH--HHTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999999999999999999999999999998876667999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       134 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p  212 (288)
T 3kfa_A          134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP  212 (288)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999976543322 22222345678999999998999999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |...+....                  ...+........+..++..+.++|.+||+.||.+|||+.++++.|+++...
T Consensus       213 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          213 YPGIDLSQV------------------YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             STTCCGGGH------------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHH------------------HHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            976443222                  122222333445667788999999999999999999999999999987654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.8e-40  Score=278.78  Aligned_cols=215  Identities=22%  Similarity=0.351  Sum_probs=174.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++... ..+++++++.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        64 ~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~iv  139 (327)
T 3lzb_A           64 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--DRRLV  139 (327)
T ss_dssp             HHHHHHHHTTCCBTTBCCCCEEEESS-SEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCeeEEEEEEecC-CceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh--hCCCc
Confidence            67899999999999999999999875 4789999999999999997654 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||||+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       140 H~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p  219 (327)
T 3lzb_A          140 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  219 (327)
T ss_dssp             CSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             CCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999999999999986544433333333455678999999999999999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |........                  ...+......+.+..++.++.++|.+||+.||.+|||+.++++.|+++...
T Consensus       220 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          220 YDGIPASEI------------------SSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTTCCGGGH------------------HHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCCCHHHH------------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            976543222                  222233333455667888999999999999999999999999999998755

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=9.4e-40  Score=276.26  Aligned_cols=202  Identities=25%  Similarity=0.421  Sum_probs=172.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++++.+.+..|+||||+.|++|.+++.+..  .+++..+..++.|++.||.|||  +.|++
T Consensus        53 ~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~iv  128 (318)
T 1fot_A           53 TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH--SKDII  128 (318)
T ss_dssp             HHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH--TTTEE
T ss_pred             HHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            4679999999999999999999999999999999999999999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.+|.+||+|||++......     .....+++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       129 HrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  203 (318)
T 1fot_A          129 YRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF  203 (318)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence            9999999999999999999999999764322     12346889999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...+......                 .....  ...++..++.++.++|.+||+.||.+||     ++.++++|
T Consensus       204 ~~~~~~~~~~-----------------~i~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          204 YDSNTMKTYE-----------------KILNA--ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CCSSHHHHHH-----------------HHHHC--CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCHHHHHH-----------------HHHhC--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            7543211111                 11111  2334566788999999999999999999     89999965

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=7.3e-40  Score=278.90  Aligned_cols=219  Identities=25%  Similarity=0.413  Sum_probs=182.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~~l   66 (278)
                      +.+|+++++++ +||||+++++++.+.+..++|+||+.+++|.+++.....              ..+++..+..++.|+
T Consensus        87 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  166 (334)
T 2pvf_A           87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL  166 (334)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHH
Confidence            57899999999 899999999999999999999999999999999976532              248899999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.+||+|||++................++..|+|||.+.+..++.++||||
T Consensus       167 ~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  244 (334)
T 2pvf_A          167 ARGMEYLA--SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS  244 (334)
T ss_dssp             HHHHHHHH--HTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHH
T ss_pred             HHHHHHHH--hCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHH
Confidence            99999999  8999999999999999999999999999997654433222222334567899999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++ |..||.+.....                  ....+........+..++.++.++|.+||+.||.+|||+
T Consensus       245 lG~il~ellt~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  306 (334)
T 2pvf_A          245 FGVLMWEIFTLGGSPYPGIPVEE------------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF  306 (334)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCHHH------------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHhCCCCCcCcCCHHH------------------HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence            9999999999 999997543211                  112222222344556778899999999999999999999


Q ss_pred             HHHHHHHHhhhcCCC
Q 023752          226 VDVLTSLEQLHTSKD  240 (278)
Q Consensus       226 ~~ll~~l~~~~~~~~  240 (278)
                      .+++++|+++.....
T Consensus       307 ~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          307 KQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHhccc
Confidence            999999999977543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=7.4e-40  Score=292.63  Aligned_cols=216  Identities=25%  Similarity=0.399  Sum_probs=182.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.+.+..++||||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus       263 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~iv  340 (495)
T 1opk_A          263 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFI  340 (495)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            6799999999999999999999999999999999999999999998766567999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       341 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p  419 (495)
T 1opk_A          341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP  419 (495)
T ss_dssp             CSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cCCCChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCC
Confidence            999999999999999999999999976433221 11122334568999999988899999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.+.+....                  ...+......+.+..++..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       420 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          420 YPGIDLSQV------------------YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             STTCCGGGH------------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCCCHHHH------------------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            976543221                  122223334455667889999999999999999999999999999988654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-39  Score=269.20  Aligned_cols=210  Identities=23%  Similarity=0.371  Sum_probs=176.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+.++++++||||+++++++.+.  +..++|+||+.+++|.+++.......+++..+..++.|++.||.|||  +.+
T Consensus        54 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~  131 (271)
T 3kmu_A           54 FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLE  131 (271)
T ss_dssp             HHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT--TSS
T ss_pred             HHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh--cCC
Confidence            67899999999999999999999887  67899999999999999998766556999999999999999999999  788


Q ss_pred             --eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCC---ccchhHHHHHHHHH
Q 023752           80 --VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTP---KSDVYSFGVVLLEL  154 (278)
Q Consensus        80 --i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~---~~DiwslG~il~~l  154 (278)
                        ++|+||+|+||+++.++.+++.|||+......       ....+++.|+|||.+.+..++.   ++||||||+++|+|
T Consensus       132 ~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el  204 (271)
T 3kmu_A          132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWEL  204 (271)
T ss_dssp             SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHH
T ss_pred             CceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHH
Confidence              99999999999999999999999888754222       1235688999999998765554   79999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      ++|..||......                 ...............+..++..+.++|.+||+.||++|||+.++++.|++
T Consensus       205 ~~g~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          205 VTREVPFADLSNM-----------------EIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             HHCSCTTTTSCHH-----------------HHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HhCCCCccccChH-----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            9999999754321                 11122233333455667788999999999999999999999999999998


Q ss_pred             hhc
Q 023752          235 LHT  237 (278)
Q Consensus       235 ~~~  237 (278)
                      +..
T Consensus       268 l~~  270 (271)
T 3kmu_A          268 MQD  270 (271)
T ss_dssp             HCC
T ss_pred             hhc
Confidence            753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8e-40  Score=272.05  Aligned_cols=213  Identities=23%  Similarity=0.370  Sum_probs=167.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++. ++..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        63 ~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~  138 (281)
T 1mp8_A           63 FLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKRFV  138 (281)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            678999999999999999999985 467899999999999999997654 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       139 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p  217 (281)
T 1mp8_A          139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP  217 (281)
T ss_dssp             CSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCC
Confidence            9999999999999999999999998765432211 1122345678999999988899999999999999999996 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      |...........                  +......+.+..++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus       218 f~~~~~~~~~~~------------------i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          218 FQGVKNNDVIGR------------------IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             TTTCCGGGHHHH------------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHH------------------HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            976443222111                  11222334556788899999999999999999999999999998754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.1e-39  Score=276.46  Aligned_cols=208  Identities=23%  Similarity=0.341  Sum_probs=172.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++...+..++||||+.+++|.+++...   .+++..+..++.|++.||.|||  +.|++
T Consensus        89 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH--~~~iv  163 (321)
T 2c30_A           89 LFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLH--AQGVI  163 (321)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            678999999999999999999999999999999999999999988643   5999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.+||+|||++........  ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       164 H~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf  241 (321)
T 2c30_A          164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY  241 (321)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999876443221  122346889999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ...........+.....                ........++..+.++|.+||+.||++|||+.+++++-
T Consensus       242 ~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  296 (321)
T 2c30_A          242 FSDSPVQAMKRLRDSPP----------------PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP  296 (321)
T ss_dssp             TTSCHHHHHHHHHHSSC----------------CCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCCHHHHHHHHhcCCC----------------CCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            75432211111111100                01122345678899999999999999999999999763

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.6e-40  Score=270.59  Aligned_cols=208  Identities=32%  Similarity=0.504  Sum_probs=167.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN--   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~--   79 (278)
                      +.+|+++++.++||||+++++++.+++..++|+||+.+++|.+++...   .+++..+..++.|++.||.|||  +.|  
T Consensus        53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH--~~~~~  127 (271)
T 3dtc_A           53 VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLH--DEAIV  127 (271)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHH--HSSSS
T ss_pred             HHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHH--hCCCC
Confidence            578999999999999999999999999999999999999999988543   6999999999999999999999  777  


Q ss_pred             -eeecCCCCCceEEcC--------CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHH
Q 023752           80 -VIYRDLKASNVLLDS--------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        80 -i~H~dl~p~ni~~~~--------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i  150 (278)
                       ++|+||+|+||+++.        ++.++|+|||++.........    ...+++.|+|||.+.+..++.++|+||||++
T Consensus       128 ~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~  203 (271)
T 3dtc_A          128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM----SAAGAYAWMAPEVIRASMFSKGSDVWSYGVL  203 (271)
T ss_dssp             CCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHH
T ss_pred             ceeecCCchHHEEEecccccccccCcceEEccCCccccccccccc----CCCCccceeCHHHhccCCCCchhhHHHHHHH
Confidence             899999999999986        678999999999754332221    2457889999999998999999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      +|+|++|..||.......                 ............+.+..++..+.++|.+||+.||.+|||+.++++
T Consensus       204 l~~l~~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  266 (271)
T 3dtc_A          204 LWELLTGEVPFRGIDGLA-----------------VAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD  266 (271)
T ss_dssp             HHHHHHCCCTTTTSCHHH-----------------HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhCCCCCCCCCHHH-----------------HHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            999999999997543211                 111122222334456677889999999999999999999999999


Q ss_pred             HHHhh
Q 023752          231 SLEQL  235 (278)
Q Consensus       231 ~l~~~  235 (278)
                      +|+++
T Consensus       267 ~L~~l  271 (271)
T 3dtc_A          267 QLTTI  271 (271)
T ss_dssp             HHHC-
T ss_pred             HHhcC
Confidence            99864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=4.7e-40  Score=273.59  Aligned_cols=215  Identities=23%  Similarity=0.382  Sum_probs=178.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        66 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i~  142 (283)
T 3gen_A           66 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE--SKQFL  142 (283)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999999999999999999999999999997633 35999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       143 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p  221 (283)
T 3gen_A          143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP  221 (283)
T ss_dssp             CSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999875432211 11112334667999999998899999999999999999998 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.........                  ..+........+...+..+.++|.+||+.||.+|||+.+++++|..+...
T Consensus       222 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          222 YERFTNSETA------------------EHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             TTTSCHHHHH------------------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccccChhHHH------------------HHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            9754432111                  12222223344556678899999999999999999999999999988654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-40  Score=272.57  Aligned_cols=222  Identities=25%  Similarity=0.377  Sum_probs=182.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++ +.+..++|+|++.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        57 ~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~  132 (287)
T 1u59_A           57 MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE--EKNFV  132 (287)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            67899999999999999999999 4567899999999999999986543 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus       133 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  212 (287)
T 1u59_A          133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK  212 (287)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999976543322111 122345678999999988889999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ||........                  ...+........+..++.++.++|.+||+.||.+||++.+++++|+++..+.
T Consensus       213 p~~~~~~~~~------------------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  274 (287)
T 1u59_A          213 PYKKMKGPEV------------------MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  274 (287)
T ss_dssp             TTTTCCTHHH------------------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CcccCCHHHH------------------HHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            9975443211                  1222222234556678899999999999999999999999999999998775


Q ss_pred             CCCCCC
Q 023752          240 DMPRTP  245 (278)
Q Consensus       240 ~~~~~~  245 (278)
                      ..+...
T Consensus       275 ~~~~~~  280 (287)
T 1u59_A          275 ASKVEG  280 (287)
T ss_dssp             HTTCSS
T ss_pred             CCcccC
Confidence            554443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=7.4e-40  Score=277.29  Aligned_cols=216  Identities=25%  Similarity=0.420  Sum_probs=177.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------CCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------VQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++....        ...+++..+..++.|++.||.||
T Consensus        75 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  154 (322)
T 1p4o_A           75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL  154 (322)
T ss_dssp             HHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHH
Confidence            5789999999999999999999999999999999999999999986532        13578999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.|++|+||+|+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||||+++|+
T Consensus       155 H--~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  232 (322)
T 1p4o_A          155 N--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE  232 (322)
T ss_dssp             H--HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             H--HCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHH
Confidence            9  89999999999999999999999999999875433222222223345778999999998899999999999999999


Q ss_pred             HHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |++ |..||........                  ...+........+..++..+.++|.+||+.||.+|||+.+++++|
T Consensus       233 l~~~g~~p~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L  294 (322)
T 1p4o_A          233 IATLAEQPYQGLSNEQV------------------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  294 (322)
T ss_dssp             HHHTSCCTTTTSCHHHH------------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhcCCCccccCCHHHH------------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            999 8899865432111                  111112222334566788999999999999999999999999999


Q ss_pred             Hhhhc
Q 023752          233 EQLHT  237 (278)
Q Consensus       233 ~~~~~  237 (278)
                      +++..
T Consensus       295 ~~~~~  299 (322)
T 1p4o_A          295 KEEME  299 (322)
T ss_dssp             GGGSC
T ss_pred             HHhhc
Confidence            98754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-39  Score=279.53  Aligned_cols=202  Identities=23%  Similarity=0.324  Sum_probs=173.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++++.+.+..|+||||+.|++|.+++.+.+  .+++..+..++.|++.||.|||  +.|++
T Consensus        88 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~iv  163 (350)
T 1rdq_E           88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH--SLDLI  163 (350)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            4679999999999999999999999999999999999999999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++.......     ....+++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       164 HrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf  238 (350)
T 1rdq_E          164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cccCccceEEECCCCCEEEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCC
Confidence            99999999999999999999999997643321     2245789999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      ...+.......+                 ...  ....+..++.++.++|.+||+.||.+||+     +.++++|
T Consensus       239 ~~~~~~~~~~~i-----------------~~~--~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          239 FADQPIQIYEKI-----------------VSG--KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CCSSHHHHHHHH-----------------HHC--CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCHHHHHHHH-----------------HcC--CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            754322111111                 111  23445667889999999999999999998     8999865

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=4e-40  Score=280.25  Aligned_cols=218  Identities=28%  Similarity=0.420  Sum_probs=180.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC------------CCCCCHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG------------VQPISWPTRVKIAIDVAR   68 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~i~~~l~~   68 (278)
                      +.+|+.+++++ +||||+++++++.+.+..++|+||+.+++|.+++....            ...+++..+..++.|++.
T Consensus        96 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~  175 (333)
T 2i1m_A           96 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ  175 (333)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHH
Confidence            67899999999 89999999999999999999999999999999986542            235899999999999999


Q ss_pred             HHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHH
Q 023752           69 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFG  148 (278)
Q Consensus        69 ~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG  148 (278)
                      ||.|||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||
T Consensus       176 ~l~~lH--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG  253 (333)
T 2i1m_A          176 GMAFLA--SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG  253 (333)
T ss_dssp             HHHHHH--HTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHH
T ss_pred             HHHHHh--cCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHH
Confidence            999999  899999999999999999999999999999754433322222334456789999999888999999999999


Q ss_pred             HHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH
Q 023752          149 VVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD  227 (278)
Q Consensus       149 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  227 (278)
                      +++|+|++ |..||.+......                 ....+........+...+..+.++|.+||+.||.+|||+.+
T Consensus       254 ~il~el~t~g~~p~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~  316 (333)
T 2i1m_A          254 ILLWEIFSLGLNPYPGILVNSK-----------------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQ  316 (333)
T ss_dssp             HHHHHHTTTSCCSSTTCCSSHH-----------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHcCCCCCCcccchhHH-----------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHH
Confidence            99999998 8899975433211                 11222222333445566789999999999999999999999


Q ss_pred             HHHHHHhhhcC
Q 023752          228 VLTSLEQLHTS  238 (278)
Q Consensus       228 ll~~l~~~~~~  238 (278)
                      +++.|+++...
T Consensus       317 l~~~L~~~~~~  327 (333)
T 2i1m_A          317 ICSFLQEQAQE  327 (333)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHh
Confidence            99999987643

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.3e-39  Score=272.20  Aligned_cols=214  Identities=27%  Similarity=0.403  Sum_probs=177.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++ +.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        65 ~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~~i~  139 (291)
T 1xbb_A           65 LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE--ESNFV  139 (291)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHH--hCCeE
Confidence            67899999999999999999999 5567899999999999999998764  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus       140 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~  219 (291)
T 1xbb_A          140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK  219 (291)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCC
Confidence            999999999999999999999999876544332211 112334577999999988889999999999999999999 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      ||.......                  ....+........+..++..+.++|.+||+.||.+|||+.++++.|+++...
T Consensus       220 p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          220 PYRGMKGSE------------------VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             SSTTCCHHH------------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHH------------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            997543311                  1222222233445667888999999999999999999999999999988654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.3e-40  Score=273.74  Aligned_cols=232  Identities=23%  Similarity=0.365  Sum_probs=178.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|++++++++||||+++++++...  ...++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|
T Consensus        58 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~  134 (295)
T 3ugc_A           58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG--TKR  134 (295)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh--cCC
Confidence            67899999999999999999998653  56899999999999999997654 35899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.+||+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       135 ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  214 (295)
T 3ugc_A          135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI  214 (295)
T ss_dssp             CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcc
Confidence            999999999999999999999999999865433221 1112234566799999999999999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      .||......... ...... ............+......+.+..++.++.++|.+||+.||++|||+.++++.|+++...
T Consensus       215 ~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          215 EKSKSPPAEFMR-MIGNDK-QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             CTTCSHHHHHHH-HHCTTC-CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccCCChHHHHh-hhcCcc-ccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            998653221100 000000 000011122333344445566778889999999999999999999999999999998754

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=5e-39  Score=273.27  Aligned_cols=227  Identities=18%  Similarity=0.223  Sum_probs=182.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++++ +||||+++++++.+.+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||  +.|+
T Consensus        51 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~i  126 (330)
T 2izr_A           51 LHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD-RTFSLKTVLMIAIQLISRMEYVH--SKNL  126 (330)
T ss_dssp             HHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            68999999999 9999999999999999999999999 999999997653 46999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCc-----eEEeccccccCCCCCCCCc-----cccccccCCcccCccccccCCCCCccchhHHHHH
Q 023752           81 IYRDLKASNVLLDSNFN-----AKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~-----~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i  150 (278)
                      +|+||||+||+++.++.     ++|+|||++..........     ......+++.|+|||++.+..++.++|+||||++
T Consensus       127 iHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i  206 (330)
T 2izr_A          127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHM  206 (330)
T ss_dssp             ECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred             eccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHH
Confidence            99999999999998887     9999999997644332211     1234568899999999999999999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      +|+|++|..||.+.........+............           .......+ ++.++|..||+.||.+||++.+|++
T Consensus       207 l~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-----------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          207 FMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI-----------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH-----------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCCCccccccccHHHHHHHHHhhhccCCH-----------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            99999999999876544333322222110000000           00011234 8999999999999999999999999


Q ss_pred             HHHhhhcCCCCCCC
Q 023752          231 SLEQLHTSKDMPRT  244 (278)
Q Consensus       231 ~l~~~~~~~~~~~~  244 (278)
                      .|+++.........
T Consensus       275 ~l~~~~~~~~~~~~  288 (330)
T 2izr_A          275 LFTDLFDRKGYMFD  288 (330)
T ss_dssp             HHHHHHHHTTCCCS
T ss_pred             HHHHHHHHcCCCCC
Confidence            99999877655443

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=282.26  Aligned_cols=205  Identities=26%  Similarity=0.394  Sum_probs=169.8

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|..+++.+ +||||+++++++.+.+..|+||||+.|++|.+++.+..  .+++..+..++.||+.||.|||  +.|+
T Consensus        70 ~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~gi  145 (353)
T 3txo_A           70 TMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLH--DKGI  145 (353)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCC
Confidence            46789999988 79999999999999999999999999999999998765  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus       146 vHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P  223 (353)
T 3txo_A          146 IYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP  223 (353)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCC
Confidence            999999999999999999999999987532221  122335689999999999988999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~  231 (278)
                      |...+.......+.                 .  ....++..++..+.++|.+||+.||.+||++      .++++|
T Consensus       224 f~~~~~~~~~~~i~-----------------~--~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          224 FEAENEDDLFEAIL-----------------N--DEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             SCCSSHHHHHHHHH-----------------H--CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CCCCCHHHHHHHHH-----------------c--CCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            97654322211111                 1  1234456678899999999999999999998      788764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-39  Score=276.07  Aligned_cols=217  Identities=27%  Similarity=0.447  Sum_probs=174.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        93 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~iv  169 (333)
T 1mqb_A           93 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA--NMNYV  169 (333)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            6789999999999999999999999999999999999999999997653 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.+||+|||++........... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus       170 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  249 (333)
T 1mqb_A          170 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER  249 (333)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCC
Confidence            999999999999999999999999876543322111 112334668999999988899999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ||......                  .....+......+.+..++..+.++|.+||+.||.+||++.++++.|+++....
T Consensus       250 pf~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          250 PYWELSNH------------------EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             TTTTCCHH------------------HHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             CcccCCHH------------------HHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            99654321                  111222222234445667889999999999999999999999999999988653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.9e-40  Score=280.45  Aligned_cols=205  Identities=24%  Similarity=0.379  Sum_probs=172.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++++.+.+..++|+||+ +|+|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        56 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~giv  130 (336)
T 3h4j_B           56 VEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH--RHKIV  130 (336)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HHTCC
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            578999999999999999999999999999999999 789999887765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..+ +.++||||||+++|+|++|..|
T Consensus       131 H~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~P  207 (336)
T 3h4j_B          131 HRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP  207 (336)
T ss_dssp             CCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCC
Confidence            99999999999999999999999987643322   2223468899999999988776 6899999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      |.+.........+..                   .....+..++.++.+||.+||+.||.+|||+.+++++-.
T Consensus       208 f~~~~~~~~~~~i~~-------------------~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          208 FDDEFIPNLFKKVNS-------------------CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             SBCSSSTTCBCCCCS-------------------SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             CCCccHHHHHHHHHc-------------------CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence            976433221111110                   112335567888999999999999999999999997643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.8e-39  Score=272.78  Aligned_cols=217  Identities=25%  Similarity=0.411  Sum_probs=170.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhc----CCCCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRK----GVQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      |.+|+.++++++||||+++++++.+.+     ..++|+||+.+++|.+++...    ....+++..++.++.|++.||.|
T Consensus        83 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  162 (313)
T 3brb_A           83 FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEY  162 (313)
T ss_dssp             HHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHH
Confidence            678999999999999999999998765     349999999999999998532    23469999999999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           73 LHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      ||  +.|++|+||+|+||+++.++.++|+|||++................+++.|.|||.+.+..++.++|+||||+++|
T Consensus       163 LH--~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  240 (313)
T 3brb_A          163 LS--NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW  240 (313)
T ss_dssp             HH--TTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHH
T ss_pred             HH--hCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHH
Confidence            99  8999999999999999999999999999987654433222223345677899999999999999999999999999


Q ss_pred             HHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          153 ELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       153 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +|++ |..||..........                  .+........+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       241 el~~~g~~p~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          241 EIATRGMTPYPGVQNHEMYD------------------YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHTTSCCSSTTCCGGGHHH------------------HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCCCCCccCCHHHHHH------------------HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999 889987544322111                  111222334456677899999999999999999999999999


Q ss_pred             HHhhhcC
Q 023752          232 LEQLHTS  238 (278)
Q Consensus       232 l~~~~~~  238 (278)
                      |+++...
T Consensus       303 L~~l~~~  309 (313)
T 3brb_A          303 LEKLLES  309 (313)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9998654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.9e-39  Score=280.39  Aligned_cols=214  Identities=26%  Similarity=0.388  Sum_probs=172.7

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|..+++++ +||||++++++|.+.+..|+||||+.||+|.+++.+..  .+++..+..++.||+.||.|||  +.||
T Consensus        99 ~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~gi  174 (396)
T 4dc2_A           99 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH--ERGI  174 (396)
T ss_dssp             HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCE
Confidence            46889999887 89999999999999999999999999999999998765  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus       175 vHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~P  252 (396)
T 4dc2_A          175 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP  252 (396)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999997532221  122335689999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~  231 (278)
                      |.........         ...........+ ......++..++.++.+||.+||+.||.+||++      .++++|
T Consensus       253 f~~~~~~~~~---------~~~~~~~~~~~i-~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          253 FDIVGSSDNP---------DQNTEDYLFQVI-LEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             STTTTC---------------CCHHHHHHHH-HHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             Cccccccccc---------chhhHHHHHHHH-hccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            9643221100         000001111111 112345667788999999999999999999985      677754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.4e-39  Score=271.70  Aligned_cols=219  Identities=26%  Similarity=0.430  Sum_probs=164.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||++++++. ..+..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        67 ~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH--~~~i~  142 (289)
T 3og7_A           67 FKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH--AKSII  142 (289)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            67899999999999999999965 5567899999999999999986553 46999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.++.++|+|||++................++..|+|||.+.   +..++.++||||||+++|+|++|.
T Consensus       143 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  222 (289)
T 3og7_A          143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ  222 (289)
T ss_dssp             CSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSS
T ss_pred             cccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCC
Confidence            99999999999999999999999987644333333333456789999999986   567888999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      .||...............             .............++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus       223 ~p~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          223 LPYSNINNRDQIIEMVGR-------------GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             CTTSSCCCHHHHHHHHHH-------------TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCccccchHHHHHHHhcc-------------cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            999754332111111000             000001122345678899999999999999999999999999998753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.5e-39  Score=279.82  Aligned_cols=206  Identities=25%  Similarity=0.355  Sum_probs=172.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||++++++|.+.+..|+|+||+.|++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        62 ~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~giv  137 (384)
T 4fr4_A           62 VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQ--NQRII  137 (384)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCce
Confidence            4689999999999999999999999999999999999999999998664  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc---CCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ||||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+   ..++.++|+|||||++|+|++|.
T Consensus       138 HrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~  214 (384)
T 4fr4_A          138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR  214 (384)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             eccCcHHHeEECCCCCEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCC
Confidence            99999999999999999999999997653322   2233568999999999864   46889999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLT  230 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~  230 (278)
                      .||..............               + ......++..++..+.+||.+||+.||.+||+ +.++++
T Consensus       215 ~Pf~~~~~~~~~~~~~~---------------~-~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          215 RPYHIRSSTSSKEIVHT---------------F-ETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CSSCCCTTSCHHHHHHH---------------H-HHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             CCCCCCCCccHHHHHHH---------------H-hhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            99975443222111111               1 11224456678889999999999999999998 777764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.7e-40  Score=280.62  Aligned_cols=208  Identities=26%  Similarity=0.338  Sum_probs=168.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+.++++++||||+++++++.+.+..|+||||+.|++|.+.+...  ....+++..+..++.|++.||.|||  +.|
T Consensus        73 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~~  150 (351)
T 3c0i_A           73 LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH--DNN  150 (351)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            678999999999999999999999999999999999999998877543  2235899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCc---eEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           80 VIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      ++|+||||+||+++.++.   +||+|||++........  ......+++.|+|||++.+..++.++|||||||++|+|++
T Consensus       151 ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~  228 (351)
T 3c0i_A          151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS  228 (351)
T ss_dssp             EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred             ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH
Confidence            999999999999976554   99999999976543221  1223468899999999998899999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccC--CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLG--GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||.+....    ...              ........  ......++.++.+||.+||+.||.+|||+.++++|
T Consensus       229 g~~pf~~~~~~----~~~--------------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          229 GCLPFYGTKER----LFE--------------GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             SSCSSCSSHHH----HHH--------------HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCcHHH----HHH--------------HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            99999753211    000              00110000  00112467889999999999999999999999964

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-39  Score=268.16  Aligned_cols=215  Identities=29%  Similarity=0.430  Sum_probs=178.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        50 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~  126 (267)
T 3t9t_A           50 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE--EACVI  126 (267)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            6789999999999999999999999999999999999999999997653 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........ .......++..|.|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       127 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p  205 (267)
T 3t9t_A          127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP  205 (267)
T ss_dssp             CSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCC
Confidence            999999999999999999999999875432111 11112345667999999988899999999999999999999 8999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |........                  ...+........+..++..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus       206 ~~~~~~~~~------------------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          206 YENRSNSEV------------------VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             TTTCCHHHH------------------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCHHHH------------------HHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            975432111                  111122222334556788999999999999999999999999999998653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.4e-39  Score=273.07  Aligned_cols=224  Identities=23%  Similarity=0.266  Sum_probs=173.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        66 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH--~~~iv  141 (311)
T 3niz_A           66 AIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH--QHRIL  141 (311)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5689999999999999999999999999999999996 58888887654 35999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||||+||+++.++.+||+|||++........  ......+++.|+|||++.+ ..++.++|+|||||++|+|++|..|
T Consensus       142 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  219 (311)
T 3niz_A          142 HRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL  219 (311)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999976433222  1223457889999999876 5689999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccch----hHHHHHHhhhccC-------CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRD----SRRVLRIMDTRLG-------GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |.+.........+..........    .............       ......++.++.+||.+||+.||.+|||+.+++
T Consensus       220 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  299 (311)
T 3niz_A          220 FPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM  299 (311)
T ss_dssp             CCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred             CCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence            98776655554444322211110    0000000000000       001234567899999999999999999999999


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      +|
T Consensus       300 ~h  301 (311)
T 3niz_A          300 NH  301 (311)
T ss_dssp             TS
T ss_pred             cC
Confidence            75

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-39  Score=276.05  Aligned_cols=205  Identities=23%  Similarity=0.348  Sum_probs=167.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..|+||||+.+++|.+++...+  .+++..+..++.|++.||.|||  +.|++
T Consensus        68 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~iv  143 (327)
T 3a62_A           68 TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLH--QKGII  143 (327)
T ss_dssp             ---HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH--hCCEE
Confidence            5689999999999999999999999999999999999999999998765  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.+||+|||++........  ......+++.|+|||++.+..++.++|+||||+++|+|++|..||
T Consensus       144 H~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf  221 (327)
T 3a62_A          144 YRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF  221 (327)
T ss_dssp             CCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             cccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCC
Confidence            999999999999999999999999865322211  122346789999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...+.......+                 ..  .....+..++.++.++|.+||+.||.+||     ++.++++|
T Consensus       222 ~~~~~~~~~~~i-----------------~~--~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          222 TGENRKKTIDKI-----------------LK--CKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             CCSSHHHHHHHH-----------------HH--TCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CCCCHHHHHHHH-----------------Hh--CCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            754332111111                 11  12334556788999999999999999999     78899875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-39  Score=275.73  Aligned_cols=216  Identities=28%  Similarity=0.421  Sum_probs=179.1

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l   66 (278)
                      |.+|+++++++ +||||+++++++.+.+..++||||+.+++|.+++....              ...+++..++.++.|+
T Consensus        72 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  151 (327)
T 1fvr_A           72 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV  151 (327)
T ss_dssp             HHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHH
Confidence            67899999999 89999999999999999999999999999999997543              2468999999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.|++|+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+..++.++|+||
T Consensus       152 ~~aL~~LH--~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~s  226 (327)
T 1fvr_A          152 ARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWS  226 (327)
T ss_dssp             HHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHH
T ss_pred             HHHHHHHH--hCCccCCCCccceEEEcCCCeEEEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchH
Confidence            99999999  89999999999999999999999999999864322111   12234567899999998888999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++ |..||.......                  ....+........+..++..+.++|.+||+.||.+|||+
T Consensus       227 lG~il~ellt~g~~pf~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  288 (327)
T 1fvr_A          227 YGVLLWEIVSLGGTPYCGMTCAE------------------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF  288 (327)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCHHH------------------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHcCCCCCCCCCcHHH------------------HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            9999999998 999997543211                  111122222334456678899999999999999999999


Q ss_pred             HHHHHHHHhhhcCCC
Q 023752          226 VDVLTSLEQLHTSKD  240 (278)
Q Consensus       226 ~~ll~~l~~~~~~~~  240 (278)
                      .+++++|.++.....
T Consensus       289 ~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          289 AQILVSLNRMLEERK  303 (327)
T ss_dssp             HHHHHHHHHHHHSSS
T ss_pred             HHHHHHHHHHHHhhc
Confidence            999999999988744

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-39  Score=288.71  Aligned_cols=217  Identities=31%  Similarity=0.453  Sum_probs=176.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+ +..++||||+.+++|.+++.......+++..+..++.|++.||.|||  +.+++
T Consensus       226 ~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~iv  302 (452)
T 1fmk_A          226 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYV  302 (452)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            6899999999999999999999876 67899999999999999997543346899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       303 HrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P  381 (452)
T 1fmk_A          303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP  381 (452)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             CCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCC
Confidence            9999999999999999999999999764332111 1112335678999999988899999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCCC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  240 (278)
                      |.+.....                  ....+......+.+..++..+.++|.+||+.||++|||+.+|++.|+.+.....
T Consensus       382 ~~~~~~~~------------------~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          382 YPGMVNRE------------------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             STTCCHHH------------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCCCCHHH------------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            97543211                  112222233345566788899999999999999999999999999999987643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-39  Score=279.07  Aligned_cols=212  Identities=24%  Similarity=0.341  Sum_probs=163.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++++.+.+..++|+||+.+++|.+++...+  .+++..+..++.|++.||.|||  +.|++
T Consensus        63 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH--~~~iv  138 (361)
T 3uc3_A           63 VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCH--SMQIC  138 (361)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5789999999999999999999999999999999999999999997765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCc--eEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCc-cchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFN--AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK-SDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~  158 (278)
                      |+||||+||+++.++.  +||+|||++.......   ......+++.|+|||++.+..++.+ +|||||||++|+|++|.
T Consensus       139 H~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  215 (361)
T 3uc3_A          139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA  215 (361)
T ss_dssp             SCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCC
Confidence            9999999999987665  9999999986422221   1223468899999999988877655 89999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      .||.............             ..........+....++.++.+||.+||+.||.+|||+.++++|--
T Consensus       216 ~Pf~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          216 YPFEDPEEPRDYRKTI-------------QRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             CSCC----CCCHHHHH-------------HHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             CCCCCCccHHHHHHHH-------------HHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            9997654322211111             1111122222223356788999999999999999999999998743

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.9e-40  Score=273.71  Aligned_cols=216  Identities=26%  Similarity=0.399  Sum_probs=170.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        59 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH--~~~iv  135 (289)
T 4fvq_A           59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE--ENTLI  135 (289)
T ss_dssp             HHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh--hCCeE
Confidence            6789999999999999999999999999999999999999999997664 24899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCc--------eEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFN--------AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~--------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~  152 (278)
                      |+||||+||+++.++.        ++|+|||++.....      .....++..|+|||.+.+ ..++.++||||||+++|
T Consensus       136 H~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  209 (289)
T 4fvq_A          136 HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLW  209 (289)
T ss_dssp             CCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHH
T ss_pred             CCCcCcceEEEecCCcccccccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHH
Confidence            9999999999988877        99999999864322      122346788999999987 67899999999999999


Q ss_pred             HHHhCCCC-CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          153 ELLSGRRA-LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       153 ~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +|++|..| |........                  .....  .....+...+.++.++|.+||+.||.+|||+.+++++
T Consensus       210 el~~g~~~~~~~~~~~~~------------------~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          210 EICSGGDKPLSALDSQRK------------------LQFYE--DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHTTTCCTTTTSCHHHH------------------HHHHH--TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCccccchHHH------------------HHHhh--ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99996544 433221110                  01111  1123334456789999999999999999999999999


Q ss_pred             HHhhhcCCCCCCCCC
Q 023752          232 LEQLHTSKDMPRTPP  246 (278)
Q Consensus       232 l~~~~~~~~~~~~~~  246 (278)
                      |+++.++...+....
T Consensus       270 l~~l~~p~~~~~~~~  284 (289)
T 4fvq_A          270 LNSLFTPDLVPRGSH  284 (289)
T ss_dssp             HHTCC----------
T ss_pred             HHHhcCCCCCCCCcc
Confidence            999999876665543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.4e-39  Score=268.86  Aligned_cols=205  Identities=26%  Similarity=0.438  Sum_probs=171.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        56 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH--~~~i~  131 (279)
T 3fdn_A           56 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH--SKRVI  131 (279)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTCE
T ss_pred             HHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            5789999999999999999999999999999999999999999997764  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.......    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       132 H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  207 (279)
T 3fdn_A          132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF  207 (279)
T ss_dssp             ECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             cccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence            99999999999999999999999886533322    22346788999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      ...........+.                   ......+..++..+.+||.+||+.||.+|||+.++++|--
T Consensus       208 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          208 EANTYQETYKRIS-------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             CCSSHHHHHHHHH-------------------HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             CCCcHHHHHHHHH-------------------hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            7543221111111                   1123445567888999999999999999999999998744

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-39  Score=274.83  Aligned_cols=218  Identities=27%  Similarity=0.390  Sum_probs=180.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCC-ccEEEEeccCCCCHHHHHhhcCC--------------CCCCHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESD-NRLLVYEFMPKGSLENHLFRKGV--------------QPISWPTRVKIAID   65 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~~   65 (278)
                      +.+|+.+++++ +||||+++++++...+ ..++|+||+.+++|.+++.....              ..+++..+..++.|
T Consensus        77 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  156 (316)
T 2xir_A           77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ  156 (316)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHH
T ss_pred             HHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHH
Confidence            57899999999 7999999999987765 58999999999999999976542              12789999999999


Q ss_pred             HHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchh
Q 023752           66 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVY  145 (278)
Q Consensus        66 l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw  145 (278)
                      ++.||.|||  +.|++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|
T Consensus       157 i~~al~~lH--~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~  234 (316)
T 2xir_A          157 VAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW  234 (316)
T ss_dssp             HHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHHH--hCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHH
Confidence            999999999  899999999999999999999999999999865444333333345567889999999999999999999


Q ss_pred             HHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 023752          146 SFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS  224 (278)
Q Consensus       146 slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  224 (278)
                      |||+++|+|++ |..||.......                 .....+........+..++..+.++|.+||+.||.+|||
T Consensus       235 slG~il~~l~t~g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  297 (316)
T 2xir_A          235 SFGVLLWEIFSLGASPYPGVKIDE-----------------EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT  297 (316)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCCSH-----------------HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HHHHHHHHHHhCCCCCCcccchhH-----------------HHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence            99999999998 999997543221                 111222222233445567889999999999999999999


Q ss_pred             HHHHHHHHHhhhcC
Q 023752          225 MVDVLTSLEQLHTS  238 (278)
Q Consensus       225 ~~~ll~~l~~~~~~  238 (278)
                      +.+++++|+.+...
T Consensus       298 ~~ell~~L~~~~~~  311 (316)
T 2xir_A          298 FSELVEHLGNLLQA  311 (316)
T ss_dssp             HHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhh
Confidence            99999999988754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.6e-39  Score=270.19  Aligned_cols=217  Identities=27%  Similarity=0.414  Sum_probs=175.3

Q ss_pred             hHHHHHHHhccCCccccceeeee-ecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|+.++++++||||+++++++ ..++..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|+
T Consensus        73 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH--~~~i  149 (298)
T 3f66_A           73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLA--SKKF  149 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCCc
Confidence            67899999999999999999985 45568899999999999999997543 46899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-C
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-G  157 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g  157 (278)
                      +|+||+|+||+++.++.++|+|||++..........  ......+++.|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus       150 ~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~  229 (298)
T 3f66_A          150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG  229 (298)
T ss_dssp             CCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             cCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence            999999999999999999999999997654332111  1122445678999999999999999999999999999999 5


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      .+||...........+                  ........+..++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus       230 ~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  291 (298)
T 3f66_A          230 APPYPDVNTFDITVYL------------------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  291 (298)
T ss_dssp             CCSSTTSCTTTHHHHH------------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCccCCHHHHHHHH------------------hcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            5666544332221111                  1112233345567889999999999999999999999999999887


Q ss_pred             CC
Q 023752          238 SK  239 (278)
Q Consensus       238 ~~  239 (278)
                      ..
T Consensus       292 ~~  293 (298)
T 3f66_A          292 TF  293 (298)
T ss_dssp             TS
T ss_pred             hh
Confidence            53

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=8.3e-39  Score=266.59  Aligned_cols=209  Identities=31%  Similarity=0.576  Sum_probs=171.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC--
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN--   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~--   79 (278)
                      |.+|++++++++||||+++++++.+..  ++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|  
T Consensus        70 ~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH--~~~~~  144 (287)
T 4f0f_A           70 FQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ--NQNPP  144 (287)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH--TSSSC
T ss_pred             HHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH--hCCCC
Confidence            578999999999999999999997654  79999999999999886554 36999999999999999999999  888  


Q ss_pred             eeecCCCCCceEEcCCCc-----eEEeccccccCCCCCCCCccccccccCCcccCccccc--cCCCCCccchhHHHHHHH
Q 023752           80 VIYRDLKASNVLLDSNFN-----AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--TGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~-----~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--~~~~~~~~DiwslG~il~  152 (278)
                      ++|+||+|+||+++.++.     ++|+|||++.....     ......+++.|+|||.+.  +..++.++|+||||+++|
T Consensus       145 ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~  219 (287)
T 4f0f_A          145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILY  219 (287)
T ss_dssp             CBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHH
T ss_pred             eecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHH
Confidence            999999999999988776     99999999874322     122346789999999983  456788999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +|++|..||........               ...............+..++.++.++|.+||+.||.+|||+.++++.|
T Consensus       220 ~l~~g~~pf~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  284 (287)
T 4f0f_A          220 TILTGEGPFDEYSYGKI---------------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL  284 (287)
T ss_dssp             HHHHSSCTTTTCCCCHH---------------HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHcCCCCCccccccHH---------------HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            99999999975433211               111112223334455677889999999999999999999999999999


Q ss_pred             Hhh
Q 023752          233 EQL  235 (278)
Q Consensus       233 ~~~  235 (278)
                      +++
T Consensus       285 ~~l  287 (287)
T 4f0f_A          285 SEL  287 (287)
T ss_dssp             HTC
T ss_pred             HhC
Confidence            864

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.3e-39  Score=270.80  Aligned_cols=227  Identities=28%  Similarity=0.436  Sum_probs=182.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|++++++++||||+++++++.+.  +..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|
T Consensus        70 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~  146 (302)
T 4e5w_A           70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG--SRQ  146 (302)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh--cCC
Confidence            57899999999999999999999877  56899999999999999996554 35999999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       147 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  226 (302)
T 4e5w_A          147 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYC  226 (302)
T ss_dssp             EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred             cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHcc
Confidence            999999999999999999999999999765544322 1222345677799999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhcccc--chhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          159 RALDEDRGGLAEQTLVEWADPFL--RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      .|+.....     .......+..  .........+......+.+..++..+.++|.+||+.||.+|||+.++++.|+++.
T Consensus       227 ~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          227 DSDSSPMA-----LFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CGGGSHHH-----HHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCcchhh-----HHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            98643211     1111111111  1222333444444556667788999999999999999999999999999999874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=268.85  Aligned_cols=235  Identities=20%  Similarity=0.286  Sum_probs=177.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC--ccEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD--NRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|++++++++||||+++++++...+  ..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||  +.
T Consensus        54 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~  131 (319)
T 4euu_A           54 QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--EN  131 (319)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             HHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH--HC
Confidence            568999999999999999999998765  67999999999999999976532 23999999999999999999999  89


Q ss_pred             CeeecCCCCCceEE----cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc--------cCCCCCccchhH
Q 023752           79 NVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA--------TGHLTPKSDVYS  146 (278)
Q Consensus        79 ~i~H~dl~p~ni~~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~--------~~~~~~~~Diws  146 (278)
                      |++|+||||+||++    +.++.+||+|||++.........   ....++..|+|||++.        +..++.++||||
T Consensus       132 ~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diws  208 (319)
T 4euu_A          132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS  208 (319)
T ss_dssp             TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHH
T ss_pred             CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHH
Confidence            99999999999998    77778999999999765443221   2245788999999885        467889999999


Q ss_pred             HHHHHHHHHhCCCCCccccCCchhh-hHHhhhccccch----hHH----HHHHh-hhccCCCCCHHHHHHHHHHHHHhcc
Q 023752          147 FGVVLLELLSGRRALDEDRGGLAEQ-TLVEWADPFLRD----SRR----VLRIM-DTRLGGQYSKKEAQAVAAVVLQCLH  216 (278)
Q Consensus       147 lG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~----~~~----~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~  216 (278)
                      |||++|+|++|..||.......... .+..........    ...    ...+. ........+..++..+.++|.+||+
T Consensus       209 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~  288 (319)
T 4euu_A          209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE  288 (319)
T ss_dssp             HHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhcc
Confidence            9999999999999997543322111 111111100000    000    00000 0011234567899999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCC
Q 023752          217 MDPKNRPSMVDVLTSLEQLHTSKDM  241 (278)
Q Consensus       217 ~dp~~Rps~~~ll~~l~~~~~~~~~  241 (278)
                      .||++|||+.|++++.....-..+.
T Consensus       289 ~dP~~R~s~~ell~h~~d~~~~~~~  313 (319)
T 4euu_A          289 ADQEKCWGFDQFFAETSDILHRGNS  313 (319)
T ss_dssp             CCTTTSCCHHHHHHHHHHHTC----
T ss_pred             CChhhhccHHHhhhccHHHhhcCCc
Confidence            9999999999999999876544333

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.4e-40  Score=289.20  Aligned_cols=216  Identities=26%  Similarity=0.453  Sum_probs=178.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++. .+..++||||+.+|+|.+++.......++...+..++.|++.||.|||  +.+++
T Consensus       230 ~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~iv  306 (454)
T 1qcf_A          230 FLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE--QRNYI  306 (454)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            689999999999999999999986 567899999999999999997553335889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      ||||+|+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus       307 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P  385 (454)
T 1qcf_A          307 HRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP  385 (454)
T ss_dssp             CSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             CCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCC
Confidence            999999999999999999999999975432110 11111234567999999988899999999999999999999 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      |.+......                  ...+......+.+..++.++.++|.+||+.||++|||+.+|++.|+.+....
T Consensus       386 ~~~~~~~~~------------------~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          386 YPGMSNPEV------------------IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             STTCCHHHH------------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCCCHHHH------------------HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            975432211                  1222222334456678889999999999999999999999999999987764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.7e-39  Score=267.95  Aligned_cols=213  Identities=24%  Similarity=0.385  Sum_probs=173.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+ +..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        60 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~  135 (281)
T 3cc6_A           60 FMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE--SINCV  135 (281)
T ss_dssp             HHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999999875 46789999999999999997654 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++.......... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       136 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p  214 (281)
T 3cc6_A          136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP  214 (281)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCccceEEECCCCcEEeCccCCCcccccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999987654332111 122345678999999988899999999999999999998 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      |..........                  .+......+.+..+++.+.++|.+||+.||.+|||+.+++++|+++..
T Consensus       215 ~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~  273 (281)
T 3cc6_A          215 FFWLENKDVIG------------------VLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ  273 (281)
T ss_dssp             TTTSCGGGHHH------------------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccCChHHHHH------------------HHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence            96543322211                  112222334455678889999999999999999999999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6e-39  Score=268.68  Aligned_cols=217  Identities=26%  Similarity=0.369  Sum_probs=176.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCcc-EEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|+.++++++||||+++++++.+.+.. +++++|+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|+
T Consensus        69 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~i  145 (298)
T 3pls_A           69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLA--EQKF  145 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHH--hCCc
Confidence            57899999999999999999999877655 99999999999999997643 46899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCC--CccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN--THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      +|+||+|+||+++.++.++|+|||++........  ........++..|.|||.+.+..++.++|+||||+++|+|++|.
T Consensus       146 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  225 (298)
T 3pls_A          146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRG  225 (298)
T ss_dssp             CCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred             ccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCC
Confidence            9999999999999999999999999975433221  11112245677899999999989999999999999999999965


Q ss_pred             CCC-ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          159 RAL-DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       159 ~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      .|+ ...+..                  .....+........+..++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus       226 ~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  287 (298)
T 3pls_A          226 APPYRHIDPF------------------DLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS  287 (298)
T ss_dssp             CCTTTTSCGG------------------GHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCccCCHH------------------HHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            554 332221                  1112222222344456678899999999999999999999999999999877


Q ss_pred             CC
Q 023752          238 SK  239 (278)
Q Consensus       238 ~~  239 (278)
                      ..
T Consensus       288 ~l  289 (298)
T 3pls_A          288 AL  289 (298)
T ss_dssp             HC
T ss_pred             HH
Confidence            64

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1e-38  Score=267.32  Aligned_cols=224  Identities=15%  Similarity=0.159  Sum_probs=180.7

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.+++++ +|+|++++++++.+....++|+||+ +++|.+++.... ..+++..+..++.|++.||.|||  +.|+
T Consensus        52 ~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i  127 (298)
T 1csn_A           52 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH--EKSL  127 (298)
T ss_dssp             HHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--TTTE
T ss_pred             HHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCE
Confidence            67899999999 7999999999999999999999999 999999997654 35999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCc-----eEEeccccccCCCCCCCCc-----cccccccCCcccCccccccCCCCCccchhHHHHH
Q 023752           81 IYRDLKASNVLLDSNFN-----AKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~-----~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i  150 (278)
                      +|+||+|+||+++.++.     ++|+|||++..........     ......+++.|+|||.+.+..++.++||||||++
T Consensus       128 vH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i  207 (298)
T 1csn_A          128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV  207 (298)
T ss_dssp             ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHH
Confidence            99999999999987765     9999999997654432211     1233568899999999999899999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      +|+|++|..||...........+.......           ...........++.++.++|.+||+.||++|||+.+|++
T Consensus       208 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          208 FMYFLRGSLPWQGLKAATNKQKYERIGEKK-----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHHSSCTTSSCCSCCHHHHHHHHHHHH-----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHcCCCCcchhhccccHHHHHHHHhhc-----------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            999999999998755433322222211100           000000112346788999999999999999999999999


Q ss_pred             HHHhhhcCCC
Q 023752          231 SLEQLHTSKD  240 (278)
Q Consensus       231 ~l~~~~~~~~  240 (278)
                      .|+++....+
T Consensus       277 ~l~~~~~~~~  286 (298)
T 1csn_A          277 LFSKVLERLN  286 (298)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHhcC
Confidence            9999987644

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-39  Score=276.85  Aligned_cols=232  Identities=24%  Similarity=0.348  Sum_probs=183.0

Q ss_pred             hHHHHHHHhccCCccccceeeeee--cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCS--ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|++++++++||||+++++++.  +.+..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|
T Consensus        71 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~  147 (327)
T 3lxl_A           71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG--SRR  147 (327)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            679999999999999999999886  4456899999999999999997643 25899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       148 ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~  227 (327)
T 3lxl_A          148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC  227 (327)
T ss_dssp             EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred             ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999998654433221 122245677799999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      .||.............   .............+......+.+..++..+.++|.+||+.||.+|||+.+++++|+.+...
T Consensus       228 ~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          228 DKSCSPSAEFLRMMGC---ERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             CGGGSHHHHHHHHCC-------CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             CCCccccchhhhhccc---ccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            9986543211111000   0111122333444445555666778899999999999999999999999999999998765


Q ss_pred             C
Q 023752          239 K  239 (278)
Q Consensus       239 ~  239 (278)
                      .
T Consensus       305 ~  305 (327)
T 3lxl_A          305 S  305 (327)
T ss_dssp             -
T ss_pred             h
Confidence            3

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-39  Score=278.54  Aligned_cols=218  Identities=28%  Similarity=0.406  Sum_probs=169.8

Q ss_pred             hHHHHHHHhccCCccccceeeeee-cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCS-ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|+.++++++||||+++++++. .++..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|+
T Consensus       137 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~i  213 (373)
T 3c1x_A          137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA--SKKF  213 (373)
T ss_dssp             HHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCE
Confidence            678999999999999999999865 4567899999999999999997543 35889999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-C
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-G  157 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g  157 (278)
                      +|+||+|+||+++.++.+||+|||++..........  ......++..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus       214 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~  293 (373)
T 3c1x_A          214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG  293 (373)
T ss_dssp             CCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             ecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCc
Confidence            999999999999999999999999997543322111  1122345678999999999999999999999999999999 6


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      ..||...........+                  ........+..++..+.++|.+||+.||++|||+.++++.|+++..
T Consensus       294 ~~p~~~~~~~~~~~~~------------------~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~  355 (373)
T 3c1x_A          294 APPYPDVNTFDITVYL------------------LQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS  355 (373)
T ss_dssp             CCSCTTSCSSCHHHHH------------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHH------------------HcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            7777654432222111                  1112233355677889999999999999999999999999999987


Q ss_pred             CCC
Q 023752          238 SKD  240 (278)
Q Consensus       238 ~~~  240 (278)
                      ...
T Consensus       356 ~~~  358 (373)
T 3c1x_A          356 TFI  358 (373)
T ss_dssp             TCC
T ss_pred             hcc
Confidence            754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-39  Score=281.56  Aligned_cols=209  Identities=21%  Similarity=0.312  Sum_probs=172.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        95 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~giv  171 (387)
T 1kob_A           95 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH--EHSIV  171 (387)
T ss_dssp             HHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999999999999987543 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcC--CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLLDS--NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      |+||||+||+++.  ++.+||+|||++........   .....+++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       172 HrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~  248 (387)
T 1kob_A          172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS  248 (387)
T ss_dssp             CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred             ecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCC
Confidence            9999999999974  46799999999986543221   223468899999999998899999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||.+.+.......+....               ..........++.++.+||.+||+.||.+|||+.+++++
T Consensus       249 Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          249 PFAGEDDLETLQNVKRCD---------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             SSCCSSHHHHHHHHHHCC---------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCHHHHHHHHHhCC---------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            997643322111111110               011222345678899999999999999999999999976

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-39  Score=275.42  Aligned_cols=219  Identities=27%  Similarity=0.414  Sum_probs=178.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-----QPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      |.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++.....     ..+++..++.++.|++.||.|||  
T Consensus        80 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH--  157 (327)
T 2yfx_A           80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE--  157 (327)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh--
Confidence            57899999999999999999999999999999999999999999987642     34889999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcC---CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      +.|++|+||+|+||+++.   +..++|+|||++................++..|+|||.+.+..++.++|+||||+++|+
T Consensus       158 ~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e  237 (327)
T 2yfx_A          158 ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWE  237 (327)
T ss_dssp             HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             hCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHH
Confidence            899999999999999984   44699999999864322222222223456788999999988899999999999999999


Q ss_pred             HHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |++ |..||.......                  ....+........+..++..+.++|.+||+.||.+||++.+++++|
T Consensus       238 llt~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  299 (327)
T 2yfx_A          238 IFSLGYMPYPSKSNQE------------------VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI  299 (327)
T ss_dssp             HHTTSCCSSTTCCHHH------------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHcCCCCCCCCcCHHH------------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            998 899997543211                  1122222223344566788999999999999999999999999999


Q ss_pred             HhhhcCCC
Q 023752          233 EQLHTSKD  240 (278)
Q Consensus       233 ~~~~~~~~  240 (278)
                      +.+....+
T Consensus       300 ~~~~~~~~  307 (327)
T 2yfx_A          300 EYCTQDPD  307 (327)
T ss_dssp             HHHHHCHH
T ss_pred             HHHhcCHH
Confidence            99877644

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.4e-39  Score=274.13  Aligned_cols=214  Identities=26%  Similarity=0.383  Sum_probs=172.2

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.+++++ +||||+++++++.+.+..|+||||+.|++|.+++.+..  .+++..+..++.|++.||.|||  +.|+
T Consensus        56 ~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH--~~~i  131 (345)
T 3a8x_A           56 VQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLH--ERGI  131 (345)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCc
Confidence            46799999888 89999999999999999999999999999999998764  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus       132 vHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  209 (345)
T 3a8x_A          132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP  209 (345)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             eecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999987532221  122335688999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH------HHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM------VDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~  231 (278)
                      |.........         ...........+. .....++..++.++.++|.+||+.||.+||++      .++++|
T Consensus       210 f~~~~~~~~~---------~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          210 FDIVGSSDNP---------DQNTEDYLFQVIL-EKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             TTTTTC----------------CHHHHHHHHH-HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             cCCccccccc---------ccccHHHHHHHHH-cCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            9643211000         0000111111111 12344566788999999999999999999985      677765

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-39  Score=278.33  Aligned_cols=205  Identities=24%  Similarity=0.391  Sum_probs=171.4

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|..+++.+ +||||+++++++.+.+..|+||||+.||+|.+++.+.+  .+++..+..++.|++.||.|||  +.|+
T Consensus        64 ~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~i  139 (345)
T 1xjd_A           64 TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH--SKGI  139 (345)
T ss_dssp             HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            45788888877 89999999999999999999999999999999998764  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++.++.+||+|||++........  ......+++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus       140 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  217 (345)
T 1xjd_A          140 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP  217 (345)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EeCCCChhhEEECCCCCEEEeEChhhhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCC
Confidence            9999999999999999999999999875332211  12335688999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~~  231 (278)
                      |.+.+.......+.                 .  ....++..++.++.+||.+||+.||.+||++. ++++|
T Consensus       218 f~~~~~~~~~~~i~-----------------~--~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          218 FHGQDEEELFHSIR-----------------M--DNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             SCCSSHHHHHHHHH-----------------H--CCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             CCCCCHHHHHHHHH-----------------h--CCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            97543321111111                 1  12334566788999999999999999999997 77643

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=280.45  Aligned_cols=209  Identities=22%  Similarity=0.314  Sum_probs=171.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus       133 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~iv  209 (373)
T 2x4f_A          133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMH--QMYIL  209 (373)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6799999999999999999999999999999999999999999886543 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEE--cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLL--DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      |+||||+||++  +.++.+||+|||++........   .....+++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       210 H~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~  286 (373)
T 2x4f_A          210 HLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS  286 (373)
T ss_dssp             CCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence            99999999999  5677899999999986543322   222458899999999988889999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||.+.+.......+......               ........++.++.+||.+||+.||.+|||+.++++|
T Consensus       287 pf~~~~~~~~~~~i~~~~~~---------------~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          287 PFLGDNDAETLNNILACRWD---------------LEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             TTCCSSHHHHHHHHHHTCCC---------------SCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCHHHHHHHHHhccCC---------------CChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            99765432222222111100               0111224567899999999999999999999999974

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.8e-39  Score=271.63  Aligned_cols=224  Identities=25%  Similarity=0.296  Sum_probs=170.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        49 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH--~~~iv  124 (311)
T 4agu_A           49 ALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCH--KHNCI  124 (311)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHH--HCCCc
Confidence            5689999999999999999999999999999999999999988876554  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..|
T Consensus       125 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  202 (311)
T 4agu_A          125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPL  202 (311)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999976443221  1223457888999999876 5789999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhh--ccCCCC----------CHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT--RLGGQY----------SKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      |.+.........+....................  ....+.          ...++..+.+||.+||+.||.+|||+.++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  282 (311)
T 4agu_A          203 WPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL  282 (311)
T ss_dssp             CCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHH
Confidence            977655444333333222221111111110000  000000          13467789999999999999999999999


Q ss_pred             HHH
Q 023752          229 LTS  231 (278)
Q Consensus       229 l~~  231 (278)
                      ++|
T Consensus       283 l~h  285 (311)
T 4agu_A          283 LHH  285 (311)
T ss_dssp             HTS
T ss_pred             hcC
Confidence            975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.4e-39  Score=270.18  Aligned_cols=212  Identities=31%  Similarity=0.453  Sum_probs=171.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC-CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|++++++++||||+++++++.+. +..++|+||+.+++|.+++.......+++..+..++.|++.||.|||  +.|+
T Consensus        61 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH--~~~i  138 (278)
T 1byg_A           61 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNF  138 (278)
T ss_dssp             HHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH--hCCc
Confidence            67899999999999999999987554 57899999999999999997664334889999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      +|+||+|+||+++.++.++|+|||++.......     ....++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus       139 ~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~  213 (278)
T 1byg_A          139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV  213 (278)
T ss_dssp             CCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999987543321     12245778999999988899999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      ||.........                  ..+........+..++..+.++|.+||+.||.+|||+.++++.|+++...
T Consensus       214 p~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          214 PYPRIPLKDVV------------------PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             SCTTSCGGGHH------------------HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHH------------------HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            99754332111                  11222223445567788999999999999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.9e-39  Score=285.68  Aligned_cols=204  Identities=27%  Similarity=0.443  Sum_probs=172.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++++.++||||+++++++.+.+..++|+||+.|++|.+++.+++  .+++..+..++.|++.||.|||  +.|++
T Consensus        63 ~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~giv  138 (476)
T 2y94_A           63 IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCH--RHMVV  138 (476)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHH--TTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCCC
Confidence            5789999999999999999999999999999999999999999997654  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..+ +.++|+|||||++|+|++|..|
T Consensus       139 HrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P  215 (476)
T 2y94_A          139 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP  215 (476)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence            99999999999999999999999997654322   1223468899999999988765 6799999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |.+.........+..                 .  ....+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       216 f~~~~~~~~~~~i~~-----------------~--~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          216 FDDDHVPTLFKKICD-----------------G--IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             SCCSSSHHHHHHHHT-----------------T--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCCCCHHHHHHHHhc-----------------C--CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            976443221111111                 1  123345577889999999999999999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.2e-39  Score=275.29  Aligned_cols=205  Identities=28%  Similarity=0.410  Sum_probs=172.2

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|..++..+ +||+|+++++++.+.+..|+||||+.||+|.+++.+.+  .+++..+..++.|++.||.|||  +.|+
T Consensus        67 ~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~gi  142 (353)
T 2i0e_A           67 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ--SKGI  142 (353)
T ss_dssp             HHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCE
Confidence            46789999988 89999999999999999999999999999999998765  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus       143 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~P  220 (353)
T 2i0e_A          143 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP  220 (353)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCC
Confidence            999999999999999999999999987532221  112335689999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      |...+.......                 +..  ....++..++.++.+||.+||+.||.+||+     +.++++|
T Consensus       221 f~~~~~~~~~~~-----------------i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          221 FEGEDEDELFQS-----------------IME--HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             SCCSSHHHHHHH-----------------HHH--CCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CCCCCHHHHHHH-----------------HHh--CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            975432211111                 111  123455678889999999999999999995     6888865

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-39  Score=274.42  Aligned_cols=229  Identities=29%  Similarity=0.436  Sum_probs=182.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|++++++++||||+++++++.+.  ...++|+||+.+++|.+++.+..   +++..++.++.|++.||.|||  +.|
T Consensus        80 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH--~~~  154 (318)
T 3lxp_A           80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH--AQH  154 (318)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            67899999999999999999999875  46799999999999999997653   899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       155 ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~  234 (318)
T 3lxp_A          155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHC  234 (318)
T ss_dssp             EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred             ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999999998755433221 122345677799999999888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      .||.........  ..... ............+......+.+..++.++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       235 ~p~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          235 DSSQSPPTKFLE--LIGIA-QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             CGGGSHHHHHHH--HHCSC-CHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Ccccccchhhhh--hhccc-ccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            998643221000  00000 000111223334444455666778899999999999999999999999999999988654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.4e-39  Score=266.39  Aligned_cols=203  Identities=25%  Similarity=0.356  Sum_probs=169.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH--~~~i~  128 (277)
T 3f3z_A           53 FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCH--KLNVA  128 (277)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999999999999999999999999999987765  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEE---cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||++   +.++.++|+|||++........   .....+++.|+|||.+.+. ++.++|+||||+++|+|++|.
T Consensus       129 H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~  204 (277)
T 3f3z_A          129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGY  204 (277)
T ss_dssp             CCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSS
T ss_pred             CCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCC
Confidence            99999999999   7788999999999876543322   2234578899999988654 899999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCH----HHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSK----KEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||...........+....                   ...+.    .++..+.++|.+||+.||.+|||+.++++|
T Consensus       205 ~p~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          205 PPFSAPTDSEVMLKIREGT-------------------FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             CSSCCSSHHHHHHHHHHCC-------------------CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCCCCCCHHHHHHHHHhCC-------------------CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9997644322222221111                   11121    467889999999999999999999999965

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-39  Score=270.43  Aligned_cols=206  Identities=24%  Similarity=0.370  Sum_probs=166.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeec--CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|++++++++||||+++++++.+  .+..++||||+.+++|.+++..   ..+++..+..++.|++.||.|||  +.|
T Consensus        83 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH--~~~  157 (298)
T 2zv2_A           83 VYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLH--YQK  157 (298)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            5789999999999999999999987  4578999999999999886533   36999999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC---CCCccchhHHHHHHHHHHh
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH---LTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~DiwslG~il~~l~~  156 (278)
                      ++|+||+|+||+++.++.+||+|||++........  ......+++.|+|||.+.+..   ++.++|+||||+++|+|++
T Consensus       158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            99999999999999999999999999876443221  122346889999999987654   3678999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||..........                 .........+....++..+.++|.+||+.||++|||+.++++|
T Consensus       236 g~~pf~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          236 GQCPFMDERIMCLHS-----------------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSCSSCCSSHHHHHH-----------------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCCCCCccHHHHHH-----------------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            999997543211111                 1111111222234577889999999999999999999999865

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=267.01  Aligned_cols=214  Identities=29%  Similarity=0.449  Sum_probs=170.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLD---   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~---   77 (278)
                      |.+|++++++++||||+++++++.+  ..++|+||+.+++|.+++..... ..++...+..++.|++.||.|||  +   
T Consensus        48 ~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH--~~~~  123 (307)
T 2eva_A           48 FIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH--SMQP  123 (307)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH--TCSS
T ss_pred             HHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH--hCCC
Confidence            6789999999999999999998874  48999999999999999976542 24788899999999999999999  6   


Q ss_pred             CCeeecCCCCCceEEcCCCc-eEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           78 ANVIYRDLKASNVLLDSNFN-AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~-~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      .|++|+||+|+||+++.++. +||+|||++.......     ....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus       124 ~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~  198 (307)
T 2eva_A          124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT  198 (307)
T ss_dssp             SCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHH
Confidence            79999999999999988886 7999999987543221     22357889999999998899999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      |..||........                ............+.+..++..+.++|.+||+.||.+|||+.++++.|+.+.
T Consensus       199 g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          199 RRKPFDEIGGPAF----------------RIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             TCCTTTTTCSSHH----------------HHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             CCCCchhhCccHH----------------HHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            9999975432111                011111222233445567889999999999999999999999999999987


Q ss_pred             cCCC
Q 023752          237 TSKD  240 (278)
Q Consensus       237 ~~~~  240 (278)
                      ....
T Consensus       263 ~~~~  266 (307)
T 2eva_A          263 RYFP  266 (307)
T ss_dssp             GGCC
T ss_pred             Hhcc
Confidence            6543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.4e-39  Score=272.60  Aligned_cols=208  Identities=25%  Similarity=0.361  Sum_probs=171.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        62 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH--~~~iv  137 (321)
T 2a2a_A           62 IEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLH--TKKIA  137 (321)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            6789999999999999999999999999999999999999999997654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC----ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNF----NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |+||+|+||+++.++    .++|+|||++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       138 H~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  214 (321)
T 2a2a_A          138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  214 (321)
T ss_dssp             CCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             cCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHC
Confidence            999999999999887    799999999876543322   1234578899999999888999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||...........+.......               ....+..++..+.+||.+||+.||.+|||+.++++|
T Consensus       215 ~~pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          215 ASPFLGDTKQETLANITSVSYDF---------------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CCSSCCSSHHHHHHHHHTTCCCC---------------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             CCCCCCCCHHHHHHHHHhccccc---------------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            99997543322211111111000               000113456789999999999999999999999974

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6e-39  Score=267.10  Aligned_cols=203  Identities=23%  Similarity=0.413  Sum_probs=172.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        61 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~  136 (284)
T 2vgo_A           61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH--ERKVI  136 (284)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--TTTEE
T ss_pred             HHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCce
Confidence            5789999999999999999999999999999999999999999998765  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.......    .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       137 H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  212 (284)
T 2vgo_A          137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF  212 (284)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCC
Confidence            99999999999999999999999986543322    12245788999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...........+                 ..  .....+..++..+.++|.+||+.||.+|||+.++++|
T Consensus       213 ~~~~~~~~~~~~-----------------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          213 DSPSHTETHRRI-----------------VN--VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CCSSHHHHHHHH-----------------HT--TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             CCCCHhHHHHHH-----------------hc--cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            754321111111                 11  1233456678899999999999999999999999975

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.5e-39  Score=273.76  Aligned_cols=221  Identities=22%  Similarity=0.316  Sum_probs=171.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC----CCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----VQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      +.+|++++++++||||+++++++.+++..++|+||+. ++|.+++....    ...+++..+..++.|++.||.|||  +
T Consensus        50 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH--~  126 (317)
T 2pmi_A           50 AIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH--E  126 (317)
T ss_dssp             HHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred             HHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH--H
Confidence            5689999999999999999999999999999999997 59999886542    235899999999999999999999  8


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHh
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~  156 (278)
                      .|++|+||||+||+++.++.+||+|||++........  ......+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus       127 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  204 (317)
T 2pmi_A          127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT  204 (317)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999876533221  1223457889999999876 468999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchh----H---------------HHHHHhhhccCCCCCHHHHHHHHHHHHHhccC
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDS----R---------------RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHM  217 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  217 (278)
                      |..||.+.+.......+...........    .               .....+.    ......++.++.+||.+||+.
T Consensus       205 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~L~~  280 (317)
T 2pmi_A          205 GKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQ----PHTKEPLDGNLMDFLHGLLQL  280 (317)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHG----GGCSSCCCHHHHHHHHHHSCS
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhc----ccccccCCHHHHHHHHHHCCC
Confidence            9999987654433333332211110000    0               0000000    011224567899999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 023752          218 DPKNRPSMVDVLTS  231 (278)
Q Consensus       218 dp~~Rps~~~ll~~  231 (278)
                      ||++|||+.++++|
T Consensus       281 dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          281 NPDMRLSAKQALHH  294 (317)
T ss_dssp             SGGGSCCHHHHTTS
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.4e-39  Score=267.28  Aligned_cols=210  Identities=27%  Similarity=0.369  Sum_probs=171.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~  127 (276)
T 2yex_A           52 IKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH--GIGIT  127 (276)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999999999999886543  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||.+................++..|.|||.+.+..+ +.++|+||||+++|+|++|..|
T Consensus       128 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  207 (276)
T 2yex_A          128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP  207 (276)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred             ccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999875433222222233467889999999987665 6789999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |.........  +..              .............++..+.++|.+||+.||.+|||+.+++++
T Consensus       208 ~~~~~~~~~~--~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          208 WDQPSDSCQE--YSD--------------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             CSCSCTTSHH--HHH--------------HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCchHHHH--HHH--------------hhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence            9764432111  111              111111112234577889999999999999999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.1e-39  Score=266.16  Aligned_cols=208  Identities=22%  Similarity=0.322  Sum_probs=171.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+.+....  .+++..+..++.|++.||.|||  +.|++
T Consensus        52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~  127 (284)
T 3kk8_A           52 LEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCH--SNGIV  127 (284)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcC
Confidence            5689999999999999999999999999999999999999999887765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCc---eEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.++.   ++|+|||.+........   .....+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       128 H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~  204 (284)
T 3kk8_A          128 HRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY  204 (284)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             cCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC
Confidence            9999999999976655   99999999976443322   12345788999999999999999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||...........+....               .....+....++.++.++|.+||+.||++|||+.+++++
T Consensus       205 ~pf~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          205 PPFWDEDQHRLYAQIKAGA---------------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CSSCCSSHHHHHHHHHHTC---------------CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCCCCCchhHHHHHHHhcc---------------ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            9996543322211111111               011122234677889999999999999999999999975

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.5e-39  Score=275.01  Aligned_cols=210  Identities=25%  Similarity=0.398  Sum_probs=166.9

Q ss_pred             hHHHHHHHhccCC--ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRH--ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+.+++++.|  +||+++++++.+.+..++|||+ .+++|.+++....  .+++..+..++.|++.||.|||  +.|
T Consensus        54 ~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~  128 (343)
T 3dbq_A           54 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHG  128 (343)
T ss_dssp             HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            6789999999976  9999999999999999999995 5889999998765  6999999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-----------CCCCCccchhHHH
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFG  148 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG  148 (278)
                      ++|+||||+||+++ ++.+||+|||++................+++.|+|||++.+           ..++.++||||||
T Consensus       129 iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG  207 (343)
T 3dbq_A          129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG  207 (343)
T ss_dssp             CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHH
T ss_pred             eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHH
Confidence            99999999999996 67899999999986554433333334568999999999865           6788899999999


Q ss_pred             HHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          149 VVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       149 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      |++|+|++|..||.....                ........+........+...+..+.+||.+||+.||.+|||+.++
T Consensus       208 ~il~ell~g~~pf~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~  271 (343)
T 3dbq_A          208 CILYYMTYGKTPFQQIIN----------------QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  271 (343)
T ss_dssp             HHHHHHHHSSCTTTTCCS----------------HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHhCCCcchhhhh----------------HHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            999999999999964322                1112222233333444555667789999999999999999999999


Q ss_pred             HHHHH
Q 023752          229 LTSLE  233 (278)
Q Consensus       229 l~~l~  233 (278)
                      ++|-.
T Consensus       272 l~hp~  276 (343)
T 3dbq_A          272 LAHPY  276 (343)
T ss_dssp             HTSHH
T ss_pred             HhCcc
Confidence            98754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4e-39  Score=267.40  Aligned_cols=216  Identities=26%  Similarity=0.428  Sum_probs=177.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+ +..++|+||+.+++|.+++.......+++..+..++.|++.||.|||  +.|++
T Consensus        55 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~i~  131 (279)
T 1qpc_A           55 FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYI  131 (279)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            6789999999999999999999864 56899999999999999996543235899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++......... ......++..|.|||.+.+..++.++|+||||+++++|++ |..|
T Consensus       132 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p  210 (279)
T 1qpc_A          132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP  210 (279)
T ss_dssp             CSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             ccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998765432211 1122345678999999988889999999999999999999 8999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      |........                  ...+........+..++.++.++|.+||+.||.+|||+.++++.|+.+....
T Consensus       211 ~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          211 YPGMTNPEV------------------IQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             STTCCHHHH------------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CcccCHHHH------------------HHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            975432111                  1112222233445667889999999999999999999999999999987663

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.7e-39  Score=269.50  Aligned_cols=224  Identities=23%  Similarity=0.264  Sum_probs=168.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+++..++||||+.+ ++.+.+.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        48 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH--~~~iv  123 (292)
T 3o0g_A           48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCH--SRNVL  123 (292)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            56899999999999999999999999999999999965 6666665533 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC-CCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||||+||+++.++.+||+|||++........  ......++..|+|||++.+.. ++.++||||||+++|+|++|..|
T Consensus       124 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p  201 (292)
T 3o0g_A          124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred             cCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCC
Confidence            999999999999999999999999976433221  222345788999999987765 79999999999999999998887


Q ss_pred             Cc-cccCCchhhhHHhhhccccch-hHHHHHHhh---------hccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LD-EDRGGLAEQTLVEWADPFLRD-SRRVLRIMD---------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |. ..+.......+.......... .........         ..........++.++.+||.+||+.||++|||+.+++
T Consensus       202 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  281 (292)
T 3o0g_A          202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL  281 (292)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence            53 332222222222211111100 000000000         0001112345778999999999999999999999999


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      +|
T Consensus       282 ~h  283 (292)
T 3o0g_A          282 QH  283 (292)
T ss_dssp             TS
T ss_pred             cC
Confidence            75

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.2e-39  Score=285.24  Aligned_cols=205  Identities=26%  Similarity=0.366  Sum_probs=167.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i   80 (278)
                      +.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+++.+..  .+++..+..++.|++.||.|||  + .|+
T Consensus       195 ~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~gi  270 (446)
T 4ejn_A          195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLH--SEKNV  270 (446)
T ss_dssp             ------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HHTCC
T ss_pred             HHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHh--hcCCE
Confidence            4678999999999999999999999999999999999999999997765  6999999999999999999999  7 899


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus       271 iHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P  348 (446)
T 4ejn_A          271 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP  348 (446)
T ss_dssp             CCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCC
Confidence            999999999999999999999999987532221  122335689999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      |...+.......+                 ..  ....++..++.++.+||.+||+.||.+||     ++.++++|
T Consensus       349 f~~~~~~~~~~~i-----------------~~--~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          349 FYNQDHEKLFELI-----------------LM--EEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             SCCSSHHHHHHHH-----------------HH--CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCCCCHHHHHHHH-----------------Hh--CCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            9754332111111                 11  12344566788999999999999999999     99999964

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.1e-38  Score=265.19  Aligned_cols=209  Identities=25%  Similarity=0.399  Sum_probs=173.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeec----------------CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE----------------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAID   65 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~   65 (278)
                      +.+|++++++++||||+++++++..                ....++|+||+.+++|.+++.......+++..+..++.|
T Consensus        51 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~q  130 (284)
T 2a19_B           51 AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ  130 (284)
T ss_dssp             GHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHH
Confidence            6789999999999999999998854                345799999999999999997664457999999999999


Q ss_pred             HHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchh
Q 023752           66 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVY  145 (278)
Q Consensus        66 l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw  145 (278)
                      ++.||.|||  +.|++|+||+|+||+++.++.++|+|||++........   .....+++.|+|||.+.+..++.++|+|
T Consensus       131 i~~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~  205 (284)
T 2a19_B          131 ITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLY  205 (284)
T ss_dssp             HHHHHHHHH--HTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHH
T ss_pred             HHHHHHHHH--hCCeeeccCCHHHEEEcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhH
Confidence            999999999  89999999999999999999999999999876543322   1224578899999999988999999999


Q ss_pred             HHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          146 SFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       146 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      |||+++|+|++|..|+.....                    ....+   .....+..++..+.++|.+||+.||.+|||+
T Consensus       206 slG~il~~l~~~~~~~~~~~~--------------------~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~  262 (284)
T 2a19_B          206 ALGLILAELLHVCDTAFETSK--------------------FFTDL---RDGIISDIFDKKEKTLLQKLLSKKPEDRPNT  262 (284)
T ss_dssp             HHHHHHHHHHSCCSSHHHHHH--------------------HHHHH---HTTCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHhcCCcchhHHH--------------------HHHHh---hcccccccCCHHHHHHHHHHccCChhhCcCH
Confidence            999999999999988742110                    00001   1122344567789999999999999999999


Q ss_pred             HHHHHHHHhhhcC
Q 023752          226 VDVLTSLEQLHTS  238 (278)
Q Consensus       226 ~~ll~~l~~~~~~  238 (278)
                      .+++++|..+...
T Consensus       263 ~e~l~~l~~~~~~  275 (284)
T 2a19_B          263 SEILRTLTVWKKS  275 (284)
T ss_dssp             HHHHHHHHHHTC-
T ss_pred             HHHHHHHHHHhhC
Confidence            9999999998766

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.2e-39  Score=269.40  Aligned_cols=224  Identities=22%  Similarity=0.292  Sum_probs=167.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+|++.+ +|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~  122 (288)
T 1ob3_A           47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH--DRRVL  122 (288)
T ss_dssp             HHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            56899999999999999999999999999999999965 9999887543 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||||+||+++.++.+||+|||++........  ......+++.|+|||++.+. .++.++|+|||||++|+|++|..|
T Consensus       123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  200 (288)
T 1ob3_A          123 HRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL  200 (288)
T ss_dssp             CSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999875432211  11224578899999998764 589999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhcccc-chhHHHHH--Hhhhcc-------CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFL-RDSRRVLR--IMDTRL-------GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |...........+........ ........  ......       .......++.++.+||.+||+.||++|||+.++++
T Consensus       201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            976544333222222111100 00000000  000000       00112346788999999999999999999999997


Q ss_pred             H
Q 023752          231 S  231 (278)
Q Consensus       231 ~  231 (278)
                      |
T Consensus       281 h  281 (288)
T 1ob3_A          281 H  281 (288)
T ss_dssp             S
T ss_pred             C
Confidence            5

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.5e-39  Score=275.40  Aligned_cols=214  Identities=23%  Similarity=0.361  Sum_probs=171.4

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|++++.++ +||||+++++++.+.+..|+||||+.|++|.+++.+..  .+++..+..++.|++.||.|||  +.|+
T Consensus        62 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH--~~gi  137 (342)
T 2qr7_A           62 PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLH--AQGV  137 (342)
T ss_dssp             CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCc
Confidence            46899999988 79999999999999999999999999999999997664  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCC----CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           81 IYRDLKASNVLLDSN----FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~----~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      +|+||||+||++...    +.+||+|||++........  ......+++.|+|||++.+..++.++|+|||||++|+|++
T Consensus       138 vHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  215 (342)
T 2qr7_A          138 VHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLT  215 (342)
T ss_dssp             ECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhc
Confidence            999999999998543    3599999999876433221  1223457899999999988888999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      |..||...........+......            ........+..++.++.+||.+||+.||++|||+.++++|--
T Consensus       216 g~~Pf~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          216 GYTPFANGPDDTPEEILARIGSG------------KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             SSCSSCSSTTSCHHHHHHHHHHC------------CCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             CCCCCCCCCcCCHHHHHHHHccC------------CcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence            99999754332221111111100            001112234567889999999999999999999999997644

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=290.54  Aligned_cols=216  Identities=25%  Similarity=0.389  Sum_probs=177.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.. +..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus       383 ~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH--~~~ii  458 (613)
T 2ozo_A          383 MMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE--EKNFV  458 (613)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence            6799999999999999999999976 56899999999999999996543 46999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       459 HrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~  538 (613)
T 2ozo_A          459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK  538 (613)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999999999999999997654332211 1112234578999999998999999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      ||........                  ...+......+.+..++.++.++|.+||+.||++||++.+|++.|+.+....
T Consensus       539 Pf~~~~~~~~------------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          539 PYKKMKGPEV------------------MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             TTTTCCSHHH------------------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHH------------------HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            9976543221                  2222233344556778899999999999999999999999999999886553

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.6e-39  Score=269.46  Aligned_cols=221  Identities=24%  Similarity=0.307  Sum_probs=168.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+++..++++||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        81 ~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~i~  156 (309)
T 2h34_A           81 MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAH--AAGAT  156 (309)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCcCC
Confidence            5789999999999999999999999999999999999999999998764  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       157 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  235 (309)
T 2h34_A          157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPY  235 (309)
T ss_dssp             CSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999999998764332211 122345788999999998889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHhhhcCCC
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~~~~~~~~  240 (278)
                      ...........+...                .......+..++.++.++|.+||+.||++|| ++.++++.|+++....+
T Consensus       236 ~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          236 QGDQLSVMGAHINQA----------------IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CSCHHHHHHHHHHSC----------------CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CCchHHHHHHHhccC----------------CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            754321111111000                0001123456778899999999999999999 99999999999877755


Q ss_pred             CCC
Q 023752          241 MPR  243 (278)
Q Consensus       241 ~~~  243 (278)
                      ..+
T Consensus       300 ~~~  302 (309)
T 2h34_A          300 QDR  302 (309)
T ss_dssp             ---
T ss_pred             ccc
Confidence            443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.6e-38  Score=267.78  Aligned_cols=222  Identities=24%  Similarity=0.338  Sum_probs=170.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++...  ....+++..++.++.|++.||.|||  +.|
T Consensus        79 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~  156 (310)
T 2wqm_A           79 CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH--SRR  156 (310)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh--hCC
Confidence            578999999999999999999999999999999999999999988642  2346899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus       157 i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~  234 (310)
T 2wqm_A          157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS  234 (310)
T ss_dssp             CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999875433221  1122457889999999988899999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhh-hccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD-TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      ||.+......                .....+. ..........++.++.++|.+||+.||.+|||+.++++.|+++.+.
T Consensus       235 p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          235 PFYGDKMNLY----------------SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             TTC---CCHH----------------HHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCcccchhHH----------------HHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            9965432110                0111111 1111122345788999999999999999999999999999999877


Q ss_pred             CCCCC
Q 023752          239 KDMPR  243 (278)
Q Consensus       239 ~~~~~  243 (278)
                      ...|-
T Consensus       299 ~~~~~  303 (310)
T 2wqm_A          299 TASSL  303 (310)
T ss_dssp             HC---
T ss_pred             hhhhh
Confidence            55543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.5e-39  Score=278.59  Aligned_cols=216  Identities=21%  Similarity=0.324  Sum_probs=165.3

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|++++.++ +||||++++++|..    .+..|+||||+.||+|.+++.......+++..+..++.|++.||.|||  
T Consensus       101 ~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH--  178 (400)
T 1nxk_A          101 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--  178 (400)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            46788887544 89999999999875    557899999999999999998765557999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcC---CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      +.|++|+||||+||+++.   ++.+||+|||++........   .....+++.|+|||++.+..++.++|||||||++|+
T Consensus       179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  255 (400)
T 1nxk_A          179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI  255 (400)
T ss_dssp             HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHH
T ss_pred             HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHH
Confidence            899999999999999987   78899999999975433221   223457889999999998999999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      |++|..||...........+..           ...........+....++.++.+||.+||+.||.+|||+.++++|-.
T Consensus       256 ll~g~~pf~~~~~~~~~~~~~~-----------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          256 LLCGYPPFYSNHGLAISPGMKT-----------RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             HHHSSCSCCCCTTCSSCCSHHH-----------HHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             HHhCCCCCCCCccccccHHHHH-----------HHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            9999999976543221110000           00000011112223467889999999999999999999999998754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=275.71  Aligned_cols=207  Identities=26%  Similarity=0.406  Sum_probs=161.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        95 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH--~~~iv  170 (349)
T 2w4o_A           95 VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLH--ENGIV  170 (349)
T ss_dssp             ----CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            5789999999999999999999999999999999999999999997654  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcC---CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.   ++.+||+|||++.......   ......+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  247 (349)
T 2w4o_A          171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGF  247 (349)
T ss_dssp             CCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence            9999999999975   8899999999987543321   122345788999999999889999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhc--cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR--LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||.........                ........  ...+....++.++.+||.+||+.||++|||+.+++++
T Consensus       248 ~pf~~~~~~~~~----------------~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          248 EPFYDERGDQFM----------------FRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CTTCCTTCHHHH----------------HHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCcccHHH----------------HHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            999654332100                00111111  1122335678899999999999999999999999975

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.4e-39  Score=276.16  Aligned_cols=213  Identities=26%  Similarity=0.373  Sum_probs=152.8

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.+++.+. ||||+++++++.+.+..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|+
T Consensus        52 ~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~~i  127 (325)
T 3kn6_A           52 TQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMH--DVGV  127 (325)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCC
Confidence            468999999996 9999999999999999999999999999999998764  7999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCC---ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           81 IYRDLKASNVLLDSNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      +|+||+|+||+++.++   .++|+|||++........  ......+++.|+|||++.+..++.++||||||+++|+|++|
T Consensus       128 vH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  205 (325)
T 3kn6_A          128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG  205 (325)
T ss_dssp             ECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHS
T ss_pred             eecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence            9999999999997765   799999999975433221  12234568899999999999999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhh-cc--CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT-RL--GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||............           ......+.. ..  ..+.+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       206 ~~pf~~~~~~~~~~~~-----------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          206 QVPFQSHDRSLTCTSA-----------VEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             SCTTC-------CCCH-----------HHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             CCCCCCCccccccccH-----------HHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            9999765432111000           011111111 11  111123568899999999999999999999999865

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.9e-39  Score=273.68  Aligned_cols=219  Identities=24%  Similarity=0.401  Sum_probs=165.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCcc----EEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNR----LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~----~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      |.+|++++++++||||+++++++......    |+||||+++++|.+++...+  .+++..+..++.|++.||.|||  +
T Consensus        59 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~  134 (311)
T 3ork_A           59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--Q  134 (311)
T ss_dssp             HHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred             HHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--H
Confidence            57899999999999999999999776544    99999999999999998765  6999999999999999999999  8


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      .|++|+||+|+||+++.++.+||+|||++......... .......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus       135 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~  214 (311)
T 3ork_A          135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT  214 (311)
T ss_dssp             TTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHh
Confidence            99999999999999999999999999999765443222 11223457899999999999999999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHH-HHHHHHhh
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVD-VLTSLEQL  235 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~-ll~~l~~~  235 (278)
                      |..||..................   .            .......++.++.++|.+||+.||.+||++.+ +...+.++
T Consensus       215 g~~pf~~~~~~~~~~~~~~~~~~---~------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          215 GEPPFTGDSPVSVAYQHVREDPI---P------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             SSCSCCCSSHHHHHHHHHHCCCC---C------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCCCCCCChHHHHHHHhcCCCC---C------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            99999754332111111100000   0            00012346788999999999999999996555 55666666


Q ss_pred             hcCC
Q 023752          236 HTSK  239 (278)
Q Consensus       236 ~~~~  239 (278)
                      ....
T Consensus       280 ~~~~  283 (311)
T 3ork_A          280 HNGE  283 (311)
T ss_dssp             HTTC
T ss_pred             hcCC
Confidence            5543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-38  Score=276.69  Aligned_cols=209  Identities=24%  Similarity=0.395  Sum_probs=166.1

Q ss_pred             hHHHHHHHhccC--CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLR--HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+.+++++.  ||||+++++++...+..|+||| +.+++|.+++....  .+++..+..++.||+.||.|||  +.|
T Consensus       101 ~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH--~~~  175 (390)
T 2zmd_A          101 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHG  175 (390)
T ss_dssp             HHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH--TTT
T ss_pred             HHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            678999999996  5999999999999999999999 55889999998765  6899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-----------CCCCCccchhHHH
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFG  148 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG  148 (278)
                      |+||||||+||+++ ++.+||+|||++................+++.|+|||++.+           ..++.++||||||
T Consensus       176 ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlG  254 (390)
T 2zmd_A          176 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG  254 (390)
T ss_dssp             CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHH
T ss_pred             eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHH
Confidence            99999999999995 57899999999986544333222334568999999999865           3688899999999


Q ss_pred             HHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          149 VVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       149 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      |++|+|++|..||......                .......+........+...+.++.+||.+||+.||.+|||+.++
T Consensus       255 vil~ell~G~~Pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~el  318 (390)
T 2zmd_A          255 CILYYMTYGKTPFQQIINQ----------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  318 (390)
T ss_dssp             HHHHHHHHSSCTTTTCCCH----------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHHCCCcchhhhHH----------------HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHH
Confidence            9999999999999643211                111122222233334445557789999999999999999999999


Q ss_pred             HHHH
Q 023752          229 LTSL  232 (278)
Q Consensus       229 l~~l  232 (278)
                      +++-
T Consensus       319 l~hp  322 (390)
T 2zmd_A          319 LAHP  322 (390)
T ss_dssp             HTSH
T ss_pred             hhCc
Confidence            9764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=7e-39  Score=265.83  Aligned_cols=206  Identities=28%  Similarity=0.405  Sum_probs=152.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        58 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i~  134 (278)
T 3cok_A           58 VQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLH--SHGIL  134 (278)
T ss_dssp             HHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999987653 46899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       135 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  212 (278)
T 3cok_A          135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF  212 (278)
T ss_dssp             CSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSS
T ss_pred             cCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998764432221  12245788999999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...........+.                   ......+..++.++.++|.+||+.||++|||+.+++++
T Consensus       213 ~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          213 DTDTVKNTLNKVV-------------------LADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             CCCSCC-----CC-------------------SSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             CChhHHHHHHHHh-------------------hcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            7644321111100                   01123345677889999999999999999999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.1e-39  Score=287.89  Aligned_cols=210  Identities=28%  Similarity=0.420  Sum_probs=177.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||+++++++.+.+..|+||||+.||+|.+++...+...+++..+..++.||+.||.|||  +.||+
T Consensus       231 ~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH--~~gIv  308 (576)
T 2acx_A          231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH--RERIV  308 (576)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            5789999999999999999999999999999999999999999998766556999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++........   .....+++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       309 HrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF  385 (576)
T 2acx_A          309 YRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF  385 (576)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999976543221   22346899999999999888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      ...........+..              .+. .....++..++.++.+||.+||+.||.+||     ++.++++|
T Consensus       386 ~~~~~~~~~~~i~~--------------~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          386 QQRKKKIKREEVER--------------LVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             SCSSSCCCHHHHHH--------------HHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             cccccchhHHHHHH--------------Hhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            76543222111111              111 123445667889999999999999999999     78999865

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.4e-39  Score=272.50  Aligned_cols=222  Identities=27%  Similarity=0.326  Sum_probs=165.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++++ +||||+++++++.+.+..++||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|+
T Consensus        57 ~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~i  132 (316)
T 2ac3_A           57 VFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLH--NKGI  132 (316)
T ss_dssp             HHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--hCCc
Confidence            57899999885 79999999999999999999999999999999998764  6999999999999999999999  8899


Q ss_pred             eecCCCCCceEEcCCCc---eEEeccccccCCCCCCCC-----ccccccccCCcccCcccccc-----CCCCCccchhHH
Q 023752           81 IYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVAT-----GHLTPKSDVYSF  147 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~---~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~-----~~~~~~~Diwsl  147 (278)
                      +|+||+|+||+++.++.   +||+|||++.........     .......++..|+|||++.+     ..++.++|||||
T Consensus       133 vH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl  212 (316)
T 2ac3_A          133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSL  212 (316)
T ss_dssp             CCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHH
T ss_pred             eeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhH
Confidence            99999999999988765   999999998754322111     11122457889999999865     468899999999


Q ss_pred             HHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC----HHHHHHHHHHHHHhccCCCCCCC
Q 023752          148 GVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       148 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      ||++|+|++|..||...............   ...........+... ....+    ..++.++.+||.+||+.||.+||
T Consensus       213 G~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  288 (316)
T 2ac3_A          213 GVILYILLSGYPPFVGRCGSDCGWDRGEA---CPACQNMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRL  288 (316)
T ss_dssp             HHHHHHHHHSSCSCCCCCCSCSCC----C---CHHHHHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             HHHHHHHHHCCCCCccccccccccccccc---chhHHHHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCC
Confidence            99999999999999765432211000000   000000111111111 11222    23678899999999999999999


Q ss_pred             CHHHHHHH
Q 023752          224 SMVDVLTS  231 (278)
Q Consensus       224 s~~~ll~~  231 (278)
                      |+.++++|
T Consensus       289 s~~e~l~h  296 (316)
T 2ac3_A          289 SAAQVLQH  296 (316)
T ss_dssp             CHHHHHHS
T ss_pred             CHHHHhcC
Confidence            99999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.8e-39  Score=280.35  Aligned_cols=209  Identities=21%  Similarity=0.234  Sum_probs=172.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+++.++||||++++++|.+.+..|+||||+.||+|.+++...   .+++..+..++.|++.||.|||  +.|++
T Consensus       116 ~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH--~~giv  190 (410)
T 3v8s_A          116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH--SMGFI  190 (410)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            678999999999999999999999999999999999999999998765   4899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC----CCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH----LTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~----~~~~~DiwslG~il~~l~~g  157 (278)
                      ||||||+||+++.++.+||+|||++........ .......+++.|+|||++.+..    ++.++|+|||||++|+|++|
T Consensus       191 HrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G  269 (410)
T 3v8s_A          191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG  269 (410)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHS
T ss_pred             eccCCHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhC
Confidence            999999999999999999999999976443221 1122356899999999997665    78899999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~  231 (278)
                      ..||...+.......+....               .....+....++.++.+||.+||+.+|.+  ||++.+|++|
T Consensus       270 ~~Pf~~~~~~~~~~~i~~~~---------------~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          270 DTPFYADSLVGTYSKIMNHK---------------NSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             SCTTCCSSHHHHHHHHHTHH---------------HHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             CCCCCCCChhhHHHHHHhcc---------------ccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            99997644322222221110               01112223457889999999999999988  9999999976

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3.4e-39  Score=290.80  Aligned_cols=217  Identities=30%  Similarity=0.448  Sum_probs=179.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.+ +..++||||+.+++|.+++.......+++..+..++.||+.||.|||  +.+++
T Consensus       309 ~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~iv  385 (535)
T 2h8h_A          309 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYV  385 (535)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            6899999999999999999999876 67899999999999999997543346899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      |+||+|+||+++.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       386 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P  464 (535)
T 2h8h_A          386 HRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP  464 (535)
T ss_dssp             CSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCS
T ss_pred             CCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999976432110 11112234567999999988899999999999999999999 8999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCCC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  240 (278)
                      |.+.....                  ....+......+.+..++..+.+||.+||+.||++|||+.+|++.|+.+.....
T Consensus       465 ~~~~~~~~------------------~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          465 YPGMVNRE------------------VLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             STTCCHHH------------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CCCCCHHH------------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            97543211                  112222233344566788899999999999999999999999999999887643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-38  Score=292.35  Aligned_cols=213  Identities=27%  Similarity=0.409  Sum_probs=176.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.. +..++||||+.+++|.+++....  .+++..+..++.||+.||.|||  +.||+
T Consensus       417 ~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH--~~~ii  491 (635)
T 4fl3_A          417 LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE--ESNFV  491 (635)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHH--HCCEe
Confidence            6789999999999999999999965 56889999999999999997664  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       492 HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~  571 (635)
T 4fl3_A          492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK  571 (635)
T ss_dssp             CSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999998765433221 11222345678999999999999999999999999999998 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      ||.+....                  .....+........+..++.++.+||.+||+.||++||++.+|++.|+.+..
T Consensus       572 Pf~~~~~~------------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          572 PYRGMKGS------------------EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             SSTTCCHH------------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHH------------------HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            99764432                  1222333333455567788999999999999999999999999999998764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=3.5e-38  Score=263.25  Aligned_cols=205  Identities=25%  Similarity=0.396  Sum_probs=165.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      |.+|+.++++++||||+++++++..    ....++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +
T Consensus        72 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~  147 (290)
T 1t4h_A           72 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH--T  147 (290)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--T
T ss_pred             HHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH--c
Confidence            6789999999999999999999865    345799999999999999998764  6899999999999999999999  7


Q ss_pred             CC--eeecCCCCCceEEc-CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           78 AN--VIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        78 ~~--i~H~dl~p~ni~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                      .+  ++|+||+|+||+++ .++.++|+|||++.......    .....+++.|+|||.+. ..++.++|+||||+++|+|
T Consensus       148 ~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l  222 (290)
T 1t4h_A          148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEM  222 (290)
T ss_dssp             SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHH
T ss_pred             CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHH
Confidence            77  99999999999997 78899999999987533322    22345789999999886 4589999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|..||..........                ............+...+.++.++|.+||+.||.+|||+.++++|
T Consensus       223 ~~g~~pf~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          223 ATSEYPYSECQNAAQIY----------------RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HHSSCTTTTCSSHHHHH----------------HHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HhCCCCCCCcCcHHHHH----------------HHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            99999996533211110                01111111122233455789999999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2e-38  Score=282.99  Aligned_cols=208  Identities=25%  Similarity=0.331  Sum_probs=170.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+.+....  .+++..+..++.|++.||.|||  +.|++
T Consensus        68 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH--~~~iv  143 (486)
T 3mwu_A           68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH--KHNIV  143 (486)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            5789999999999999999999999999999999999999999887765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEc---CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||||+||+++   .++.+||+|||++.......   ......+++.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus       144 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~  219 (486)
T 3mwu_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT  219 (486)
T ss_dssp             CSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSS
T ss_pred             eccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCC
Confidence            999999999995   45679999999987543322   1223468899999999875 5899999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .||.+.........+.....               ....+.+..++.++.+||.+||+.||.+|||+.++++|-
T Consensus       220 ~pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp  278 (486)
T 3mwu_A          220 PPFYGKNEYDILKRVETGKY---------------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP  278 (486)
T ss_dssp             CSSCCSSHHHHHHHHHHTCC---------------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred             CCCCCCCHHHHHHHHHhCCC---------------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence            99976443222222111110               111222356788999999999999999999999999873

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.3e-38  Score=273.73  Aligned_cols=222  Identities=24%  Similarity=0.308  Sum_probs=173.2

Q ss_pred             hHHHHHHHhccC-----CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLR-----HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +..|+.+++.+.     ||||+++++++...+..++|||++ +++|.+++.......+++..+..++.||+.||.|||  
T Consensus        78 ~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--  154 (360)
T 3llt_A           78 AKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR--  154 (360)
T ss_dssp             HHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             hHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            467899999986     999999999999999999999999 899999998877667999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcC-------------------------CCceEEeccccccCCCCCCCCccccccccCCcccCcc
Q 023752           77 DANVIYRDLKASNVLLDS-------------------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE  131 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~-------------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE  131 (278)
                      +.|++|+||||+||+++.                         ++.+||+|||++.......     ....+++.|+|||
T Consensus       155 ~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE  229 (360)
T 3llt_A          155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPE  229 (360)
T ss_dssp             HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHH
T ss_pred             HCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcH
Confidence            899999999999999975                         7889999999997533322     2345788999999


Q ss_pred             ccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhh-------------------
Q 023752          132 YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD-------------------  192 (278)
Q Consensus       132 ~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  192 (278)
                      ++.+..++.++|||||||++|+|++|..||...+.......+.....+.............                   
T Consensus       230 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  309 (360)
T 3llt_A          230 VILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENAS  309 (360)
T ss_dssp             HHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCS
T ss_pred             HHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCccccc
Confidence            9999999999999999999999999999998765444444333333222211100000000                   


Q ss_pred             --------hccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          193 --------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       193 --------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                              ...........+..+.+||.+||+.||.+|||+.++++|
T Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          310 SINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             chhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                    000000011123678899999999999999999999864

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.8e-38  Score=266.76  Aligned_cols=208  Identities=24%  Similarity=0.402  Sum_probs=172.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++...+  .+++..+..++.|++.||.|||  +.|++
T Consensus        53 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~  128 (304)
T 2jam_A           53 LENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH--ENGIV  128 (304)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5789999999999999999999999999999999999999999987665  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEE---cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||++   +.++.++|+|||++......    ......+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~  204 (304)
T 2jam_A          129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGY  204 (304)
T ss_dssp             CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCC
Confidence            99999999999   67889999999998653322    122345788999999999889999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .||...........+....               .....+.+..++..+.++|.+||+.||.+|||+.+++++-
T Consensus       205 ~pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          205 PPFYEETESKLFEKIKEGY---------------YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             CTTTTSCHHHHHHHHHHCC---------------CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             CCCCCCCHHHHHHHHHcCC---------------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence            9997543221111111110               0112233456788999999999999999999999999753

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.6e-39  Score=273.95  Aligned_cols=213  Identities=23%  Similarity=0.240  Sum_probs=165.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC-------------------------------
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-------------------------------   50 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------------------------------   50 (278)
                      +.+|++++++++||||+++++++.+.+..++||||+.+++|.+++....                               
T Consensus        75 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (345)
T 3hko_A           75 IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI  154 (345)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC
T ss_pred             HHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccc
Confidence            5789999999999999999999999999999999999999999885210                               


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCC--ceEEeccccccCCCCCCCC--cccc
Q 023752           51 -------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPTGDNT--HVST  119 (278)
Q Consensus        51 -------~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~--~~kl~dfg~~~~~~~~~~~--~~~~  119 (278)
                             ...+++..++.++.|++.||.|||  +.|++|+||+|+||+++.++  .+||+|||++.........  ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  232 (345)
T 3hko_A          155 HGFRESLDFVQREKLISNIMRQIFSALHYLH--NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT  232 (345)
T ss_dssp             --CEEECCHHHHHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC------
T ss_pred             ccccccccccccHHHHHHHHHHHHHHHHHHH--HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcccccccc
Confidence                   112356788899999999999999  88999999999999998766  8999999998754322111  1123


Q ss_pred             ccccCCcccCcccccc--CCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCC
Q 023752          120 RIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGG  197 (278)
Q Consensus       120 ~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (278)
                      ...+++.|+|||.+.+  ..++.++||||||+++|+|++|..||...........+......               ...
T Consensus       233 ~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~  297 (345)
T 3hko_A          233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC---------------FEN  297 (345)
T ss_dssp             --CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC---------------TTS
T ss_pred             ccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc---------------cCC
Confidence            3567889999999865  67889999999999999999999999765432222111111100               011


Q ss_pred             CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          198 QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       198 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +....++..+.+||.+||+.||.+|||+.+++++
T Consensus       298 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          298 PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            1223467899999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-38  Score=265.56  Aligned_cols=216  Identities=28%  Similarity=0.394  Sum_probs=174.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.++. .++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        68 ~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~  143 (291)
T 1u46_A           68 FIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE--SKRFI  143 (291)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            578999999999999999999998754 889999999999999997653 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      |+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..
T Consensus       144 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~  223 (291)
T 1u46_A          144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE  223 (291)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876544332211 122345667999999988889999999999999999999 999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      ||...+.....                 ..........+.+..++..+.++|.+||+.||.+|||+.++++.|.++...
T Consensus       224 p~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          224 PWIGLNGSQIL-----------------HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             TTTTCCHHHHH-----------------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CcccCCHHHHH-----------------HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            99754321111                 111122223344566788999999999999999999999999999998765

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.3e-38  Score=271.31  Aligned_cols=205  Identities=25%  Similarity=0.396  Sum_probs=173.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        88 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH--~~~iv  163 (335)
T 2owb_A           88 MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH--RNRVI  163 (335)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCCE
Confidence            5789999999999999999999999999999999999999999987764  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       164 H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf  241 (335)
T 2owb_A          164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF  241 (335)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecCCCchhEEEcCCCCEEEeeccCceecccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCC
Confidence            9999999999999999999999998764332211  22345788999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..........                 ....  .....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~-----------------~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          242 ETSCLKETYL-----------------RIKK--NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CCSSHHHHHH-----------------HHHH--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CCCCHHHHHH-----------------HHhc--CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            7543211111                 1111  1223455677889999999999999999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-38  Score=265.80  Aligned_cols=206  Identities=25%  Similarity=0.390  Sum_probs=173.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        62 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~i~  137 (294)
T 2rku_A           62 MSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLH--RNRVI  137 (294)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            5789999999999999999999999999999999999999999987764  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++.........  .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       138 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  215 (294)
T 2rku_A          138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF  215 (294)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCChHhEEEcCCCCEEEEeccCceecccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999998764432221  22345788999999998888999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      ..........                 ....  .....+..++..+.++|.+||+.||++|||+.+++++-
T Consensus       216 ~~~~~~~~~~-----------------~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          216 ETSCLKETYL-----------------RIKK--NEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             CCSSHHHHHH-----------------HHHT--TCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             CCCCHHHHHH-----------------HHhh--ccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            7543211111                 1111  12334556778899999999999999999999999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-37  Score=263.78  Aligned_cols=220  Identities=23%  Similarity=0.347  Sum_probs=168.7

Q ss_pred             HHHHHHHhcc--CCccccceeeeeecC----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            3 QTEVIYLGQL--RHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         3 ~~E~~~l~~l--~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      ..|.+++...  +||||+++++++.+.    ...++||||+.+++|.+++...   .+++..+..++.|++.||.|||  
T Consensus        77 ~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH--  151 (337)
T 3mdy_A           77 FRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH--  151 (337)
T ss_dssp             HHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH--
T ss_pred             hhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH--
Confidence            4555666555  899999999999877    6789999999999999999765   4899999999999999999999  


Q ss_pred             CC--------CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc--ccccccCCcccCccccccCCCCCc-----
Q 023752           77 DA--------NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV--STRIVGTRGYAAPEYVATGHLTPK-----  141 (278)
Q Consensus        77 ~~--------~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~-----  141 (278)
                      ..        |++|+||||+||+++.++.+||+|||++...........  .....+++.|+|||.+.+...+..     
T Consensus       152 ~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  231 (337)
T 3mdy_A          152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYI  231 (337)
T ss_dssp             SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHH
T ss_pred             HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCcc
Confidence            77        999999999999999999999999999875443322211  123468899999999987766655     


Q ss_pred             -cchhHHHHHHHHHHhC----------CCCCccccCCchhhhHHhhhccccchhHHHHHH-hhhccCCCCC-----HHHH
Q 023752          142 -SDVYSFGVVLLELLSG----------RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRI-MDTRLGGQYS-----KKEA  204 (278)
Q Consensus       142 -~DiwslG~il~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~  204 (278)
                       +|||||||++|+|++|          ..||.........             ....... .........+     ..++
T Consensus       232 ~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (337)
T 3mdy_A          232 MADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS-------------YEDMREIVCIKKLRPSFPNRWSSDECL  298 (337)
T ss_dssp             HHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-------------HHHHHHHHTTSCCCCCCCGGGGGSHHH
T ss_pred             ccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCc-------------hhhhHHHHhhhccCccccccchhhHHH
Confidence             9999999999999999          5555432211110             0011111 1111122222     3678


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCCC
Q 023752          205 QAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       205 ~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  240 (278)
                      .++.++|.+||+.||.+|||+.+++++|+++....+
T Consensus       299 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  334 (337)
T 3mdy_A          299 RQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD  334 (337)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence            899999999999999999999999999999988754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.1e-38  Score=271.97  Aligned_cols=230  Identities=15%  Similarity=0.163  Sum_probs=176.5

Q ss_pred             HHHHHHHhccCCccccceeeeeecC----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      ..|+..++.++||||+++++++...    ...++||||+ |++|.+++.... ..+++..+..++.|++.||.|||  +.
T Consensus        96 ~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH--~~  171 (364)
T 3op5_A           96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIH--EH  171 (364)
T ss_dssp             HHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             HHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--HC
Confidence            3466677788899999999998765    3479999999 999999997753 46999999999999999999999  88


Q ss_pred             CeeecCCCCCceEEc--CCCceEEeccccccCCCCCCCCc-----cccccccCCcccCccccccCCCCCccchhHHHHHH
Q 023752           79 NVIYRDLKASNVLLD--SNFNAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~--~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il  151 (278)
                      |++|+||||+||+++  .++.+||+|||++..........     ......+++.|+|||.+.+..++.++|||||||++
T Consensus       172 ~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l  251 (364)
T 3op5_A          172 EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCM  251 (364)
T ss_dssp             TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHH
Confidence            999999999999998  88999999999997543322111     11224588999999999998999999999999999


Q ss_pred             HHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          152 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       152 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |+|++|..||.+...............     .......+....   ....++.++.+++..||+.||.+||++.+|++.
T Consensus       252 ~el~~g~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~  323 (364)
T 3op5_A          252 IQWLTGHLPWEDNLKDPKYVRDSKIRY-----RENIASLMDKCF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDI  323 (364)
T ss_dssp             HHHHHSCCTTGGGTTCHHHHHHHHHHH-----HHCHHHHHHHHS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHhCCCCccccccCHHHHHHHHHHh-----hhhHHHHHHHhc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHH
Confidence            999999999986433222111111000     001111111111   013457789999999999999999999999999


Q ss_pred             HHhhhcCCCCCCC
Q 023752          232 LEQLHTSKDMPRT  244 (278)
Q Consensus       232 l~~~~~~~~~~~~  244 (278)
                      |+++....+....
T Consensus       324 l~~~~~~~~~~~~  336 (364)
T 3op5_A          324 LLQGLKAIGSKDD  336 (364)
T ss_dssp             HHHHHHHTTCCCC
T ss_pred             HHHHHHHcCCCcC
Confidence            9999887655433

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.8e-38  Score=270.43  Aligned_cols=198  Identities=23%  Similarity=0.315  Sum_probs=168.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+|++.++ +|.+++....  .+++..+..++.|++.||.|||  +.|+
T Consensus        76 ~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH--~~~i  151 (335)
T 3dls_A           76 VTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLR--LKDI  151 (335)
T ss_dssp             EEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            457999999999999999999999999999999998666 9999997664  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~  159 (278)
                      +|+||||+||+++.++.+||+|||++........   .....+++.|+|||++.+..+ +.++||||||+++|+|++|..
T Consensus       152 vH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  228 (335)
T 3dls_A          152 IHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN  228 (335)
T ss_dssp             ECSCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred             EEeccCHHHEEEcCCCcEEEeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence            9999999999999999999999999976543322   223467899999999988776 788999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||.......                       .  .....+..++.++.+||.+||+.||++|||+.+++++
T Consensus       229 pf~~~~~~~-----------------------~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          229 PFCELEETV-----------------------E--AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             SCSSGGGGT-----------------------T--TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             chhhHHHHH-----------------------h--hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            996422100                       0  0112233467889999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=272.81  Aligned_cols=223  Identities=17%  Similarity=0.167  Sum_probs=173.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      +.+|+.+++.++||||+++++++..    ....++||||+ +++|.+++....  .+++..+..++.|++.||.|||  +
T Consensus        95 ~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~  169 (345)
T 2v62_A           95 CIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH--E  169 (345)
T ss_dssp             HHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred             HHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--h
Confidence            4578888999999999999999987    66889999999 999999997665  6999999999999999999999  8


Q ss_pred             CCeeecCCCCCceEEcCCC--ceEEeccccccCCCCCCC-----CccccccccCCcccCccccccCCCCCccchhHHHHH
Q 023752           78 ANVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPTGDN-----THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~--~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i  150 (278)
                      .|++|+||+|+||+++.++  .+||+|||++........     ........++..|+|||.+.+..++.++||||||++
T Consensus       170 ~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i  249 (345)
T 2v62_A          170 NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYC  249 (345)
T ss_dssp             TTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHH
T ss_pred             CCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHH
Confidence            8999999999999998877  999999999975432211     111133568899999999999899999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhh-hHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          151 LLELLSGRRALDEDRGGLAEQ-TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      +|+|++|..||.......... ........   ...   .....   ......++.++.++|.+||+.||++|||+.+|+
T Consensus       250 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~---~~~---~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~  320 (345)
T 2v62_A          250 MLRWLCGKLPWEQNLKDPVAVQTAKTNLLD---ELP---QSVLK---WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALK  320 (345)
T ss_dssp             HHHHHHSSCTTGGGTTCHHHHHHHHHHHHH---TTT---HHHHH---HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             HHHHHhCCCCccccccccHHHHHHHHhhcc---ccc---HHHHh---hccccccHHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            999999999996532211111 10000000   000   00000   000125677899999999999999999999999


Q ss_pred             HHHHhhhcC
Q 023752          230 TSLEQLHTS  238 (278)
Q Consensus       230 ~~l~~~~~~  238 (278)
                      +.|+++...
T Consensus       321 ~~L~~~~~~  329 (345)
T 2v62_A          321 KILNPHGIP  329 (345)
T ss_dssp             HHHCTTCCC
T ss_pred             HHHhccCCc
Confidence            999987653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=267.73  Aligned_cols=224  Identities=25%  Similarity=0.324  Sum_probs=171.5

Q ss_pred             hHHHHHHHhccC---CccccceeeeeecCC-----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLR---HENLVKLIGYCSESD-----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~---h~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+.+++++.   ||||+++++++....     ..++++|++. ++|.+++.......+++..+..++.|++.||.||
T Consensus        58 ~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~l  136 (308)
T 3g33_A           58 TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFL  136 (308)
T ss_dssp             HHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            457888877774   999999999998765     4789999996 6999999877655699999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.|++|+||||+||+++.++.+||+|||++........   .....+++.|+|||.+.+..++.++|||||||++|+
T Consensus       137 H--~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~  211 (308)
T 3g33_A          137 H--ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE  211 (308)
T ss_dssp             H--HTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHH
T ss_pred             H--HCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cCCccccccccCchHHcCCCCCchHHHHHHHHHHHH
Confidence            9  89999999999999999999999999999976433222   233567899999999999999999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchhH-HHHHHhhhccC-------CCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDSR-RVLRIMDTRLG-------GQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      |++|..||...........+............ ...........       ......++..+.+||.+||+.||++|||+
T Consensus       212 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~  291 (308)
T 3g33_A          212 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISA  291 (308)
T ss_dssp             TTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCH
Confidence            99999999776544443333332211110000 00000000000       00113467889999999999999999999


Q ss_pred             HHHHHH
Q 023752          226 VDVLTS  231 (278)
Q Consensus       226 ~~ll~~  231 (278)
                      .++++|
T Consensus       292 ~e~l~h  297 (308)
T 3g33_A          292 FRALQH  297 (308)
T ss_dssp             HHHHTS
T ss_pred             HHHhcC
Confidence            999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.7e-39  Score=275.61  Aligned_cols=222  Identities=25%  Similarity=0.344  Sum_probs=172.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-Ce
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA-NV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~i   80 (278)
                      +.+|+.++++++||||+++++++.+++..++||||+.+++|.+++....  .+++..+..++.|++.||.|||  +. |+
T Consensus        78 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh--~~~~i  153 (360)
T 3eqc_A           78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR--EKHKI  153 (360)
T ss_dssp             HHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HHHCC
T ss_pred             HHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HhCCE
Confidence            5789999999999999999999999999999999999999999998765  6899999999999999999999  75 99


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +|+||+|+||+++.++.++|+|||++......    ......+++.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus       154 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  229 (360)
T 3eqc_A          154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP  229 (360)
T ss_dssp             CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCC
T ss_pred             EcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999988542111    11224678899999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhh-------------------------ccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhc
Q 023752          161 LDEDRGGLAEQTLVEWA-------------------------DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL  215 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  215 (278)
                      |...........+....                         .+.......................++.++.+||.+||
T Consensus       230 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  309 (360)
T 3eqc_A          230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL  309 (360)
T ss_dssp             SSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHh
Confidence            97654322211111000                         00000011111112222222223456889999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 023752          216 HMDPKNRPSMVDVLTS  231 (278)
Q Consensus       216 ~~dp~~Rps~~~ll~~  231 (278)
                      +.||.+|||+.++++|
T Consensus       310 ~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          310 IKNPAERADLKQLMVH  325 (360)
T ss_dssp             CSSTTTSCCHHHHHTS
T ss_pred             hcChhhCCCHHHHhhC
Confidence            9999999999999965

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.1e-38  Score=271.27  Aligned_cols=224  Identities=26%  Similarity=0.420  Sum_probs=169.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.++.....  .+++..+..++.|++.||.|||  +.|++
T Consensus        71 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH--~~~iv  146 (331)
T 4aaa_A           71 AMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCH--SHNII  146 (331)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence            5689999999999999999999999999999999999888888765444  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+. .++.++||||||+++|+|++|..|
T Consensus       147 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p  224 (331)
T 4aaa_A          147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL  224 (331)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999875433221  12234578899999998775 788999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhh--hccC-----CC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMD--TRLG-----GQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-----~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      |...........+...................  ....     ..     ....++..+.+||.+||+.||.+|||+.++
T Consensus       225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~el  304 (331)
T 4aaa_A          225 FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL  304 (331)
T ss_dssp             CCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGG
T ss_pred             CCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHH
Confidence            97765443333333222222111111100000  0000     00     012467889999999999999999999999


Q ss_pred             HHH
Q 023752          229 LTS  231 (278)
Q Consensus       229 l~~  231 (278)
                      ++|
T Consensus       305 l~h  307 (331)
T 4aaa_A          305 LHH  307 (331)
T ss_dssp             GGS
T ss_pred             hcC
Confidence            965

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.4e-38  Score=283.08  Aligned_cols=207  Identities=27%  Similarity=0.361  Sum_probs=170.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..|+|+||+.+++|.+.+....  .+++..+..++.|++.||.|||  +.|++
T Consensus        83 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~iv  158 (494)
T 3lij_A           83 LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLH--KHNIV  158 (494)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCce
Confidence            5789999999999999999999999999999999999999999887765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCC---CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSN---FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||||+||+++..   +.+||+|||++.......   ......+++.|+|||++. ..++.++|||||||++|+|++|.
T Consensus       159 H~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~  234 (494)
T 3lij_A          159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY  234 (494)
T ss_dssp             CSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             eccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCC
Confidence            99999999999764   459999999987654322   123346899999999885 56899999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||.+.........+......               ...+.+..++..+.+||.+||+.||.+|||+.++++|
T Consensus       235 ~pf~~~~~~~~~~~i~~~~~~---------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          235 PPFGGQTDQEILRKVEKGKYT---------------FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             CSSCCSSHHHHHHHHHHTCCC---------------CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCCCCCCHHHHHHHHHhCCCC---------------CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            999765432222222211110               1112234577899999999999999999999999965

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.6e-38  Score=268.48  Aligned_cols=208  Identities=24%  Similarity=0.351  Sum_probs=163.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC-----------------------------------------------------
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD-----------------------------------------------------   28 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-----------------------------------------------------   28 (278)
                      +.+|++++++++||||+++++++.+..                                                     
T Consensus        51 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  130 (332)
T 3qd2_B           51 VMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS  130 (332)
T ss_dssp             HHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------------
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCC
Confidence            678999999999999999999986543                                                     


Q ss_pred             ----ccEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEecc
Q 023752           29 ----NRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF  103 (278)
Q Consensus        29 ----~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~df  103 (278)
                          ..++||||+.+++|.+++.+... ...++..+..++.|++.||.|||  +.|++|+||||+||+++.++.+||+||
T Consensus       131 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~~ivH~Dlkp~NIll~~~~~~kL~Df  208 (332)
T 3qd2_B          131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDF  208 (332)
T ss_dssp             -CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH--HTTEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHH--hCCeeecCCCcccEEEeCCCCEEEeec
Confidence                27999999999999999986542 23556678999999999999999  899999999999999999999999999


Q ss_pred             ccccCCCCCCCC----------ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhH
Q 023752          104 GLARDGPTGDNT----------HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL  173 (278)
Q Consensus       104 g~~~~~~~~~~~----------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~  173 (278)
                      |++.........          .......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+....        
T Consensus       209 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------  280 (332)
T 3qd2_B          209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------  280 (332)
T ss_dssp             TTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------
T ss_pred             CcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------
Confidence            998865443211          11223468899999999999999999999999999999999877643210        


Q ss_pred             HhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          174 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                                  ..................++.+.++|.+||+.||.+|||+.+++++
T Consensus       281 ------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          281 ------------RIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             ------------HHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ------------HHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence                        0011111111111224556788999999999999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.9e-38  Score=263.83  Aligned_cols=213  Identities=24%  Similarity=0.383  Sum_probs=170.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        55 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH--~~~i~  130 (283)
T 3bhy_A           55 IEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLH--SKRIA  130 (283)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            6789999999999999999999999999999999999999999997654  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC----ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNF----NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      |+||+|+||+++.++    .++|+|||++........   .....+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus       131 H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g  207 (283)
T 3bhy_A          131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  207 (283)
T ss_dssp             CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             CCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHC
Confidence            999999999998876    799999999876433221   1224578899999999888999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHhh
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQL  235 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~  235 (278)
                      ..||...........+.......               .......++..+.++|.+||+.||.+|||+.+++++  +..+
T Consensus       208 ~~p~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          208 ASPFLGETKQETLTNISAVNYDF---------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             SCTTCCSSHHHHHHHHHTTCCCC---------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             CCCCCCcchHHHHHHhHhcccCC---------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            99997643322111111110000               001112456789999999999999999999999974  4444


Q ss_pred             h
Q 023752          236 H  236 (278)
Q Consensus       236 ~  236 (278)
                      .
T Consensus       273 ~  273 (283)
T 3bhy_A          273 R  273 (283)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4e-38  Score=264.56  Aligned_cols=208  Identities=19%  Similarity=0.259  Sum_probs=168.2

Q ss_pred             hHHHHHHHhccCCccccceeeeee--cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCS--ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|++++++++||||+++++++.  +.+..++|+||+.++ |.+++.......+++..+..++.|++.||.|||  +.|
T Consensus        53 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH--~~~  129 (305)
T 2wtk_C           53 VKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH--SQG  129 (305)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            678999999999999999999984  445789999999765 888887765567999999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC--CCCccchhHHHHHHHHHHhC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~--~~~~~DiwslG~il~~l~~g  157 (278)
                      ++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..  ++.++|+||||+++|+|++|
T Consensus       130 i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  209 (305)
T 2wtk_C          130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTG  209 (305)
T ss_dssp             EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHS
T ss_pred             eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhC
Confidence            9999999999999999999999999997654433333333456788999999987643  36789999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||...........+                  .. .....+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       210 ~~p~~~~~~~~~~~~i------------------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          210 LYPFEGDNIYKLFENI------------------GK-GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             SCSCCCSSHHHHHHHH------------------HH-CCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CCCCCCchHHHHHHHH------------------hc-CCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            9999754321111111                  11 1223455677889999999999999999999999976

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-38  Score=264.91  Aligned_cols=208  Identities=26%  Similarity=0.333  Sum_probs=163.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++...  ....+++..+..++.|++.||.|||  +.|
T Consensus        67 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~  144 (285)
T 3is5_A           67 IEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--SQH  144 (285)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            578999999999999999999999999999999999999999988543  2246999999999999999999999  899


Q ss_pred             eeecCCCCCceEE---cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           80 VIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        80 i~H~dl~p~ni~~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      ++|+||+|+||++   +.++.++|+|||++........   .....+++.|+|||.+. ..++.++|+||||+++|+|++
T Consensus       145 ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~  220 (285)
T 3is5_A          145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLT  220 (285)
T ss_dssp             CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHh
Confidence            9999999999999   4567899999999976433221   22345788999999875 568899999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||.+.............                ..........+++++.+||.+||+.||.+|||+.+++++
T Consensus       221 g~~pf~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          221 GCLPFTGTSLEEVQQKATYK----------------EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             SSCSSCCSSHHHHHHHHHHC----------------CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCHHHHHhhhccC----------------CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            99999764322111111110                000011112356789999999999999999999999964

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.4e-39  Score=285.05  Aligned_cols=208  Identities=27%  Similarity=0.344  Sum_probs=172.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        73 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~iv  148 (484)
T 3nyv_A           73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMH--KNKIV  148 (484)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999997664  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEE---cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||||+||++   +.++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus       149 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~  224 (484)
T 3nyv_A          149 HRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC  224 (484)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCC
Confidence            99999999999   5678899999999876443322   233468899999999866 6899999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .||.+.+.......+.....               ....+.+..++.++.+||.+||+.||.+|||+.++++|-
T Consensus       225 ~pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          225 PPFNGANEYDILKKVEKGKY---------------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             CSSCCSSHHHHHHHHHHCCC---------------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             CCCCCCCHHHHHHHHHcCCC---------------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence            99976543222222111110               011222356788999999999999999999999999764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3e-38  Score=283.03  Aligned_cols=208  Identities=25%  Similarity=0.329  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.||+.||.|||  +.|++
T Consensus        93 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH--~~~iv  168 (504)
T 3q5i_A           93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLH--KHNIV  168 (504)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCeE
Confidence            5689999999999999999999999999999999999999999987765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC---ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.++   .+||+|||++........   .....+++.|+|||++. ..++.++|||||||++|+|++|.
T Consensus       169 H~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~  244 (504)
T 3q5i_A          169 HRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGY  244 (504)
T ss_dssp             CSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             eCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCC
Confidence            999999999998776   699999999976543322   22346889999999986 46899999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      .||.+.+.......+.......               ..+.+..++.++.+||.+||+.||.+|||+.++++|-
T Consensus       245 ~pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          245 PPFGGQNDQDIIKKVEKGKYYF---------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             CSSCCSSHHHHHHHHHHCCCCC---------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCC---------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence            9997654332222222211100               0001134678899999999999999999999999763

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3e-38  Score=265.28  Aligned_cols=210  Identities=26%  Similarity=0.370  Sum_probs=175.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++...   .+++..+..++.|++.||.|||  +.|++
T Consensus        67 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH--~~~i~  141 (303)
T 3a7i_A           67 IQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG---PLDETQIATILREILKGLDYLH--SEKKI  141 (303)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH--HCCCc
Confidence            678999999999999999999999999999999999999999998653   5899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       142 H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  219 (303)
T 3a7i_A          142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH  219 (303)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCC
Confidence            999999999999999999999999876433221  122345788899999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      .......                  ....+........+..++..+.++|.+||+.||.+|||+.+++++.--..
T Consensus       220 ~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  276 (303)
T 3a7i_A          220 SELHPMK------------------VLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR  276 (303)
T ss_dssp             TTSCHHH------------------HHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred             CCcCHHH------------------HHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence            6543211                  11111222233445567888999999999999999999999998754433

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-39  Score=272.33  Aligned_cols=224  Identities=22%  Similarity=0.297  Sum_probs=168.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH--~~~iv  122 (324)
T 3mtl_A           47 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH--RQKVL  122 (324)
T ss_dssp             CCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            3469999999999999999999999999999999996 59999887654 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.+||+|||++........  ......++..|+|||++.+ ..++.++||||||+++|+|++|..|
T Consensus       123 H~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  200 (324)
T 3mtl_A          123 HRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL  200 (324)
T ss_dssp             ESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999875432221  1223456889999999876 5689999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccch-------hHHHHHHhhhccCC----CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRD-------SRRVLRIMDTRLGG----QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |.+.+.......+..........       ..............    .....++.++.+||.+||+.||.+|||+.+++
T Consensus       201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  280 (324)
T 3mtl_A          201 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM  280 (324)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             CCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence            98765544444333322211110       00000000000000    01234577899999999999999999999999


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      +|
T Consensus       281 ~h  282 (324)
T 3mtl_A          281 KH  282 (324)
T ss_dssp             TS
T ss_pred             cC
Confidence            75

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=269.10  Aligned_cols=231  Identities=23%  Similarity=0.357  Sum_probs=179.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC--ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD--NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|++++++++||||+++++++...+  ..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|
T Consensus        89 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH--~~~  165 (326)
T 2w1i_A           89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG--TKR  165 (326)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--hCC
Confidence            678999999999999999999987654  7899999999999999997764 35899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-ccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus       166 ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~  245 (326)
T 2w1i_A          166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI  245 (326)
T ss_dssp             EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTT
T ss_pred             EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcC
Confidence            99999999999999999999999999986544332111 12234566799999998888999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      .||........ ..+.... ............+......+.+..++.++.++|.+||+.||.+|||+.++++.|+++..
T Consensus       246 ~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          246 EKSKSPPAEFM-RMIGNDK-QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             CGGGSHHHHHH-HHHCTTC-CTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHH-Hhhcccc-chhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            98864321100 0000000 00000112223333333445567788999999999999999999999999999998864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=267.43  Aligned_cols=220  Identities=24%  Similarity=0.330  Sum_probs=173.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|++++++++||||+++++++..    ....++|+||+.+++|.+++...  ....+++..++.++.|++.||.||| 
T Consensus        73 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-  151 (317)
T 2buj_A           73 AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-  151 (317)
T ss_dssp             HHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            6789999999999999999999863    34679999999999999988753  2346999999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCcc-------ccccccCCcccCccccccCC---CCCccchh
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-------STRIVGTRGYAAPEYVATGH---LTPKSDVY  145 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~-------~~~~~~~~~~~aPE~~~~~~---~~~~~Diw  145 (278)
                       +.|++|+||+|+||+++.++.++|+|||++...........       .....+++.|+|||.+.+..   ++.++|||
T Consensus       152 -~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~  230 (317)
T 2buj_A          152 -AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVW  230 (317)
T ss_dssp             -HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHH
T ss_pred             -hCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHH
Confidence             88999999999999999999999999998765322111110       01234588899999986543   68899999


Q ss_pred             HHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          146 SFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       146 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      |||+++|+|++|..||........                ............+.+..++..+.++|.+||+.||.+|||+
T Consensus       231 slG~il~el~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  294 (317)
T 2buj_A          231 SLGCVLYAMMFGEGPYDMVFQKGD----------------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHI  294 (317)
T ss_dssp             HHHHHHHHHHHSSCTTHHHHHTTS----------------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             HHHHHHHHHHhCCCChhhhhcccc----------------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCH
Confidence            999999999999999964211100                0001111112233345677899999999999999999999


Q ss_pred             HHHHHHHHhhhcCC
Q 023752          226 VDVLTSLEQLHTSK  239 (278)
Q Consensus       226 ~~ll~~l~~~~~~~  239 (278)
                      .+++++|+.+....
T Consensus       295 ~~ll~~L~~~~~~~  308 (317)
T 2buj_A          295 PLLLSQLEALQPPA  308 (317)
T ss_dssp             HHHHHHHHHTCCCC
T ss_pred             HHHHHHhhhcCCCC
Confidence            99999999987653

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-38  Score=276.92  Aligned_cols=233  Identities=22%  Similarity=0.356  Sum_probs=172.9

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCC--ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESD--NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|+.+++++. ||||+++++++...+  ..|+||||+. ++|.+++..+   .+++..+..++.|++.||.|||  +.
T Consensus        55 ~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH--~~  128 (388)
T 3oz6_A           55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLH--SG  128 (388)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             HHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH--hC
Confidence            458999999997 999999999997554  6899999996 6899988764   5899999999999999999999  89


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCCC-------------------CCccccccccCCcccCcccccc-CCC
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD-------------------NTHVSTRIVGTRGYAAPEYVAT-GHL  138 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~-------------------~~~~~~~~~~~~~~~aPE~~~~-~~~  138 (278)
                      |++||||||+||+++.++.+||+|||++.......                   .........+++.|+|||++.+ ..+
T Consensus       129 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  208 (388)
T 3oz6_A          129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY  208 (388)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCC
T ss_pred             CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCC
Confidence            99999999999999999999999999987543211                   0111233568899999999876 678


Q ss_pred             CCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchh---------HHHHHHhhhcc--------------
Q 023752          139 TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS---------RRVLRIMDTRL--------------  195 (278)
Q Consensus       139 ~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~--------------  195 (278)
                      +.++|||||||++|+|++|..||.+.+.......+...........         ......+....              
T Consensus       209 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (388)
T 3oz6_A          209 TKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKW  288 (388)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHH
T ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcch
Confidence            9999999999999999999999987665444444332221111000         00000000000              


Q ss_pred             -----CCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHhhhcCCC
Q 023752          196 -----GGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTSKD  240 (278)
Q Consensus       196 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~~~~  240 (278)
                           ....+..++.++.+||.+||+.||.+|||+.++++|  +..+....+
T Consensus       289 ~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~  340 (388)
T 3oz6_A          289 KNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNE  340 (388)
T ss_dssp             HHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGG
T ss_pred             hhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCcc
Confidence                 000112456789999999999999999999999987  555544433

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.6e-38  Score=269.84  Aligned_cols=206  Identities=29%  Similarity=0.356  Sum_probs=169.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+++..++|+||+. |+|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus       101 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~iv  176 (348)
T 1u5q_A          101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH--SHNMI  176 (348)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH--HTTCB
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            5789999999999999999999999999999999996 68888876443 36999999999999999999999  88999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.++.+||+|||++......      ....+++.|+|||++.   +..++.++||||||+++|+|++|.
T Consensus       177 H~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~  250 (348)
T 1u5q_A          177 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  250 (348)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             eCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            9999999999999999999999998764322      2245789999999984   467899999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHh
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ  234 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  234 (278)
                      .||...+......                 ...........+..++..+.+||.+||+.||++|||+.+++++.--
T Consensus       251 ~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~  309 (348)
T 1u5q_A          251 PPLFNMNAMSALY-----------------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  309 (348)
T ss_dssp             CTTTTSCHHHHHH-----------------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             CCCCCCChHHHHH-----------------HHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence            9996543211111                 1111111222344567889999999999999999999999976543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.5e-38  Score=265.42  Aligned_cols=209  Identities=22%  Similarity=0.311  Sum_probs=171.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+.+..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        71 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH--~~~i~  147 (314)
T 3com_A           71 IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLH--FMRKI  147 (314)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCCc
Confidence            5789999999999999999999999999999999999999999986443 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||+|+||+++.++.++|+|||++........  ......++..|.|||.+.+..++.++|+||||+++|+|++|..||
T Consensus       148 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~  225 (314)
T 3com_A          148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY  225 (314)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             CCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999875433211  122345788999999999889999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...........+..                ........+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       226 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          226 ADIHPMRAIFMIPT----------------NPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             TTSCHHHHHHHHHH----------------SCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCCChHHHHHHHhc----------------CCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            75432111110000                0111122345567899999999999999999999999974

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.6e-38  Score=274.03  Aligned_cols=204  Identities=26%  Similarity=0.364  Sum_probs=164.5

Q ss_pred             HHHHHH-HhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            3 QTEVIY-LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         3 ~~E~~~-l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      .+|..+ ++.++||||++++++|.+.+..|+||||+.|++|.+++.+..  .+++..+..++.||+.||.|||  +.|++
T Consensus        86 ~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~giv  161 (373)
T 2r5t_A           86 MSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLH--SLNIV  161 (373)
T ss_dssp             -----CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCce
Confidence            345555 567899999999999999999999999999999999998765  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.+|++||+|||++.......  .......+++.|+|||++.+..++.++|+|||||++|+|++|..||
T Consensus       162 HrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf  239 (373)
T 2r5t_A          162 YRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF  239 (373)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999987522211  1122356899999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH----HHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV----DVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~----~ll~~  231 (278)
                      ...+.......                 ++..  ...++..++.++.+||.+||+.||.+||++.    ++++|
T Consensus       240 ~~~~~~~~~~~-----------------i~~~--~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          240 YSRNTAEMYDN-----------------ILNK--PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             CCSBHHHHHHH-----------------HHHS--CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             CCCCHHHHHHH-----------------HHhc--ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence            75433211111                 1111  2334556788999999999999999999874    55543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=7.1e-39  Score=265.86  Aligned_cols=213  Identities=24%  Similarity=0.317  Sum_probs=171.2

Q ss_pred             hHHHHHHHhccCCccccceeeeee--cCCccEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCS--ESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      |.+|++++++++||||+++++++.  ..+..++|+||+.+++|.+++....  ...+++..++.++.|++.||.|||  +
T Consensus        52 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~  129 (279)
T 2w5a_A           52 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--R  129 (279)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred             HHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh--c
Confidence            678999999999999999999874  3567899999999999999987542  235999999999999999999999  7


Q ss_pred             CC-----eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           78 AN-----VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        78 ~~-----i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      .+     ++|+||+|+||+++.++.++|+|||++.......  .......++..|+|||.+.+..++.++|+||||+++|
T Consensus       130 ~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~  207 (279)
T 2w5a_A          130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY  207 (279)
T ss_dssp             HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred             ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHH
Confidence            77     9999999999999999999999999987643321  1122345788999999998888999999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +|++|..||.........                  ..+........+..++.++.++|.+||+.||.+|||+.++++++
T Consensus       208 ~l~~g~~p~~~~~~~~~~------------------~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          208 ELCALMPPFTAFSQKELA------------------GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHSSCSSCCSSHHHHH------------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHCCCCCcccCHHHHH------------------HHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            999999999754321111                  11112222344566788999999999999999999999999876


Q ss_pred             Hhhh
Q 023752          233 EQLH  236 (278)
Q Consensus       233 ~~~~  236 (278)
                      ..-.
T Consensus       270 ~~~~  273 (279)
T 2w5a_A          270 LILE  273 (279)
T ss_dssp             TCCG
T ss_pred             hhhh
Confidence            5443

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.4e-38  Score=261.07  Aligned_cols=226  Identities=19%  Similarity=0.239  Sum_probs=177.8

Q ss_pred             hHHHHHHHhccCCccccceeeee-ecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++.++|++++..+..+ .+.+..++++|++ +++|.+++.... ..+++..+..++.|++.||.|||  +.|+
T Consensus        51 ~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~i  126 (296)
T 4hgt_A           51 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH--SKNF  126 (296)
T ss_dssp             HHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            67899999999988877766655 5666789999999 899999987543 35999999999999999999999  8999


Q ss_pred             eecCCCCCceEE---cCCCceEEeccccccCCCCCCCCc-----cccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           81 IYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        81 ~H~dl~p~ni~~---~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      +|+||+|+||++   +.++.+||+|||++..........     ......++..|+|||.+.+..++.++||||||+++|
T Consensus       127 vH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  206 (296)
T 4hgt_A          127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM  206 (296)
T ss_dssp             ECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHH
Confidence            999999999999   788999999999997654432211     122356788999999999989999999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +|++|..||...........+...........           .......++.++.++|.+||+.||++|||+.++++.|
T Consensus       207 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l  275 (296)
T 4hgt_A          207 YFNLGSLPWQGLKAATKRQKYERISEKKMSTP-----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF  275 (296)
T ss_dssp             HHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred             HHhcCCCCCcccchhhhhhhhhhhhcccccch-----------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHH
Confidence            99999999987554333222222111000000           0001134577899999999999999999999999999


Q ss_pred             HhhhcCCCCC
Q 023752          233 EQLHTSKDMP  242 (278)
Q Consensus       233 ~~~~~~~~~~  242 (278)
                      +++....+..
T Consensus       276 ~~~~~~~~~~  285 (296)
T 4hgt_A          276 RNLFHRQGFS  285 (296)
T ss_dssp             HHHHHHHTCC
T ss_pred             HHHHHHhCCC
Confidence            9998875543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-38  Score=271.10  Aligned_cols=226  Identities=23%  Similarity=0.335  Sum_probs=174.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|++++++++||||+++++++...+      ..|+|+||+ +++|.+++...   .+++..+..++.|++.||.||| 
T Consensus        71 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH-  145 (367)
T 1cm8_A           71 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH-  145 (367)
T ss_dssp             HHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-
Confidence            568999999999999999999997763      459999999 88999998764   5899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.|++|+||||+||+++.++.+||+|||++......     .....+++.|+|||++.+ ..++.++|+|||||++++|
T Consensus       146 -~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  219 (367)
T 1cm8_A          146 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM  219 (367)
T ss_dssp             -HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHH
T ss_pred             -HCCccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHH
Confidence             899999999999999999999999999999764332     223467889999999877 6799999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchh------HHHHHHhhh---cc---CCCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDS------RRVLRIMDT---RL---GGQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~---~~---~~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|+.||.+.+.......+...........      ......+..   ..   ........+..+.+||.+||+.||.+|
T Consensus       220 l~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R  299 (367)
T 1cm8_A          220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR  299 (367)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred             HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHC
Confidence            999999987655444443333222111110      000111110   00   011234567899999999999999999


Q ss_pred             CCHHHHHHH--HHhhhcC
Q 023752          223 PSMVDVLTS--LEQLHTS  238 (278)
Q Consensus       223 ps~~~ll~~--l~~~~~~  238 (278)
                      ||+.++++|  +..+...
T Consensus       300 ~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          300 VTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             CCHHHHHHSGGGTTTC--
T ss_pred             CCHHHHhcChHHHhhcCC
Confidence            999999985  4444443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.5e-38  Score=260.63  Aligned_cols=204  Identities=26%  Similarity=0.427  Sum_probs=164.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        58 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i~  133 (276)
T 2h6d_A           58 IKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH--RHMVV  133 (276)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HHCSS
T ss_pred             HHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCCc
Confidence            5789999999999999999999999999999999999999999997765  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.++|+|||++........   .....+++.|+|||.+.+..+ +.++|+||||+++++|++|..|
T Consensus       134 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  210 (276)
T 2h6d_A          134 HRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP  210 (276)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCC
Confidence            999999999999999999999999876543221   122457888999999987765 5899999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |...........+                  .. .....+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       211 ~~~~~~~~~~~~~------------------~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          211 FDDEHVPTLFKKI------------------RG-GVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             SCCSSHHHHHHHH------------------HH-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCCCcHHHHHHHh------------------hc-CcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            9754321111111                  11 1123345567889999999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.3e-38  Score=281.19  Aligned_cols=211  Identities=26%  Similarity=0.405  Sum_probs=174.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      +.+|++++++++||||++++++|.+.+..|+||||+.|++|.+++....  ...+++..+..++.||+.||.|||  +.|
T Consensus       232 ~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH--~~g  309 (543)
T 3c4z_A          232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH--QRN  309 (543)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH--HcC
Confidence            5689999999999999999999999999999999999999999987643  346999999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ++||||||+||+++.+|.+||+|||++.........  .....+++.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus       310 IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~  387 (543)
T 3c4z_A          310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARG  387 (543)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCC
Confidence            999999999999999999999999999765433221  122468999999999999999999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  231 (278)
                      ||...........+..             ....  ....++..++..+.+||.+||+.||.+||++     .++++|
T Consensus       388 PF~~~~~~~~~~~~~~-------------~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          388 PFRARGEKVENKELKQ-------------RVLE--QAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             SSCCTTCCCCHHHHHH-------------HHHH--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             CCCCCccchhHHHHHH-------------HHhh--cccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            9976543211111111             1111  1234566788999999999999999999964     777753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.6e-38  Score=270.39  Aligned_cols=208  Identities=29%  Similarity=0.439  Sum_probs=168.8

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.+++++ +||||+++++++...+..++||||+.|++|.+++....  .+++..+..++.|++.||.|||  +.|+
T Consensus       146 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH--~~gi  221 (365)
T 2y7j_A          146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLH--ANNI  221 (365)
T ss_dssp             HHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            57899999999 79999999999999999999999999999999997664  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc------CCCCCccchhHHHHHHHHH
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~il~~l  154 (278)
                      +|+||+|+||+++.++.++|+|||++........   .....+++.|+|||++.+      ..++.++||||||+++|+|
T Consensus       222 ~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el  298 (365)
T 2y7j_A          222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL  298 (365)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHH
Confidence            9999999999999999999999999876543322   223467899999999863      3588899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|..||...........+.......               ..+.+..++..+.++|.+||+.||.+|||+.++++|
T Consensus       299 l~g~~pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          299 LAGSPPFWHRRQILMLRMIMEGQYQF---------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTCCCC---------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHCCCCCCCCCHHHHHHHHHhCCCCC---------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            99999997543221111111110000               000012356789999999999999999999999975

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.1e-39  Score=274.47  Aligned_cols=224  Identities=20%  Similarity=0.253  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHH------HhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENH------LFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      |.+|++++++++||||+++++++.+.+..++||||+.+++|.++      +.......+++..+..++.|++.||.||| 
T Consensus        90 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH-  168 (348)
T 2pml_X           90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH-  168 (348)
T ss_dssp             HHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh-
Confidence            67899999999999999999999999999999999999999998      65543467999999999999999999999 


Q ss_pred             CC-CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCC-ccchhHHHHHHH
Q 023752           76 LD-ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTP-KSDVYSFGVVLL  152 (278)
Q Consensus        76 ~~-~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~-~~DiwslG~il~  152 (278)
                       + .|++|+||+|+||+++.++.++|+|||.+......    ......++..|+|||.+.+. .++. ++|+||||+++|
T Consensus       169 -~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~  243 (348)
T 2pml_X          169 -NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY  243 (348)
T ss_dssp             -HTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred             -ccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence             7 99999999999999999999999999998764332    22334678899999999876 6665 999999999999


Q ss_pred             HHHhCCCCCccccCC-chhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          153 ELLSGRRALDEDRGG-LAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +|++|..||...... .....+.............................++.++.+||.+||+.||.+|||+.++++|
T Consensus       244 ~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          244 VMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999999999765441 1111111111110000000000000000001124577899999999999999999999999974

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2e-38  Score=269.23  Aligned_cols=210  Identities=20%  Similarity=0.306  Sum_probs=170.7

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.+++++ +||||+++++++.+.+..++|+||+.+++|.+++.......+++..+..++.|++.||.|||  +.|+
T Consensus        75 ~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH--~~gi  152 (327)
T 3lm5_A           75 ILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH--QNNI  152 (327)
T ss_dssp             HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            56899999999 56999999999999999999999999999999987665567999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcC---CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           81 IYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        81 ~H~dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      +|+||+|+||+++.   ++.++|+|||++........   .....+++.|+|||++.+..++.++|+||||+++|+|++|
T Consensus       153 vH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g  229 (327)
T 3lm5_A          153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH  229 (327)
T ss_dssp             ECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred             ecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence            99999999999987   78999999999976543222   1234678999999999989999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||...........+...               ......+....++..+.++|.+||+.||.+|||+.+++++
T Consensus       230 ~~pf~~~~~~~~~~~i~~~---------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          230 TSPFVGEDNQETYLNISQV---------------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             SCSSCCSSHHHHHHHHHHT---------------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCCCchHHHHHHHhc---------------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            9999764432221111111               1112223345678889999999999999999999999975

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-38  Score=280.08  Aligned_cols=225  Identities=22%  Similarity=0.307  Sum_probs=161.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC-----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+++|+.++||||+++++++...     ...|+|+|++ +++|.+++....  .+++..+..++.||+.||.|||  
T Consensus        99 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH--  173 (458)
T 3rp9_A           99 ILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPV--YLTELHIKTLLYNLLVGVKYVH--  173 (458)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCC--CCCHHHHHHHHHHHHHHHHHHH--
Confidence            56899999999999999999999433     5689999998 679999887654  6999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-------------------------ccccccccCCcccCcc
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-------------------------HVSTRIVGTRGYAAPE  131 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-------------------------~~~~~~~~~~~~~aPE  131 (278)
                      +.||+||||||+||+++.++.+||+|||++.........                         .......+++.|+|||
T Consensus       174 ~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE  253 (458)
T 3rp9_A          174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE  253 (458)
T ss_dssp             HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred             hCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence            899999999999999999999999999999865432211                         1123356789999999


Q ss_pred             cc-ccCCCCCccchhHHHHHHHHHHh-----------CCCCCccccCC--------------------chhhhHHhhhcc
Q 023752          132 YV-ATGHLTPKSDVYSFGVVLLELLS-----------GRRALDEDRGG--------------------LAEQTLVEWADP  179 (278)
Q Consensus       132 ~~-~~~~~~~~~DiwslG~il~~l~~-----------g~~p~~~~~~~--------------------~~~~~~~~~~~~  179 (278)
                      ++ .+..++.++|||||||++|+|++           |..+|.+....                    .....+......
T Consensus       254 ~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~  333 (458)
T 3rp9_A          254 LILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT  333 (458)
T ss_dssp             HHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCC
T ss_pred             HhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCC
Confidence            76 56679999999999999999998           56666543311                    000111111100


Q ss_pred             ccch------hHHHHHHhhh---ccC---CCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          180 FLRD------SRRVLRIMDT---RLG---GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       180 ~~~~------~~~~~~~~~~---~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ....      ..........   ...   .......+.++.+||.+||+.||.+|||+.++++|
T Consensus       334 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          334 PSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             CCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0000      0000000000   000   01123457889999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.1e-38  Score=279.87  Aligned_cols=220  Identities=24%  Similarity=0.302  Sum_probs=164.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++.++||||+++++++...+      ..|+||||+.+ +|.+.+..    .+++..+..++.|++.||.||| 
T Consensus       108 ~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH-  181 (464)
T 3ttj_A          108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLH-  181 (464)
T ss_dssp             HHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH-
Confidence            568999999999999999999997654      46999999965 57666632    4899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                       +.||+||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++|||||||++|+|+
T Consensus       182 -~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell  257 (464)
T 3ttj_A          182 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV  257 (464)
T ss_dssp             -HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             -HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHH
Confidence             8899999999999999999999999999997643321   223356899999999999999999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchh-----HHHHHHhhhcc---------------C---CCCCHHHHHHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDS-----RRVLRIMDTRL---------------G---GQYSKKEAQAVAAVVL  212 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~---------------~---~~~~~~~~~~l~~li~  212 (278)
                      +|+.||.+.+.......+...........     ......+....               .   .......+.++.+||.
T Consensus       258 ~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~  337 (464)
T 3ttj_A          258 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS  337 (464)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHH
Confidence            99999987665444444433222111100     00011111000               0   0011223788999999


Q ss_pred             HhccCCCCCCCCHHHHHHH
Q 023752          213 QCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       213 ~~l~~dp~~Rps~~~ll~~  231 (278)
                      +||+.||++|||+.|+++|
T Consensus       338 ~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          338 KMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHSCSSTTTSCCHHHHHTS
T ss_pred             HHcCCChhhCCCHHHHhcC
Confidence            9999999999999999976

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.7e-38  Score=276.70  Aligned_cols=212  Identities=18%  Similarity=0.222  Sum_probs=173.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++..++||||++++++|.+.+..|+||||+.||+|.+++.+.. ..+++..+..++.|++.||.|||  +.|++
T Consensus       121 ~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH--~~gii  197 (437)
T 4aw2_A          121 FREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVH--QLHYV  197 (437)
T ss_dssp             HHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCeE
Confidence            6789999999999999999999999999999999999999999997643 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~  156 (278)
                      ||||||+||+++.++.+||+|||++........ .......+++.|+|||++.     ...++.++|+|||||++|+|++
T Consensus       198 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt  276 (437)
T 4aw2_A          198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY  276 (437)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH
T ss_pred             ecccCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh
Confidence            999999999999999999999999875433222 1122356899999999986     4568999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKN--RPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~  231 (278)
                      |..||.+.+.......+....              .....+.....++.++.+||.+||+.+|++  ||++.++++|
T Consensus       277 G~~Pf~~~~~~~~~~~i~~~~--------------~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          277 GETPFYAESLVETYGKIMNHK--------------ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             SSCTTCCSSHHHHHHHHHTHH--------------HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             CCCCCCCCChhHHHHhhhhcc--------------ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            999997654322222222110              000111222447889999999999998888  9999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.7e-37  Score=259.65  Aligned_cols=227  Identities=19%  Similarity=0.230  Sum_probs=177.4

Q ss_pred             hHHHHHHHhccCCccccceeeee-ecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.+++.++|++++..+..+ .+.+..++|+||+ +++|.+++.... ..+++..+..++.|++.||.|||  +.|+
T Consensus        51 ~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH--~~~i  126 (296)
T 3uzp_A           51 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH--SKNF  126 (296)
T ss_dssp             HHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            57899999999988877766655 5556779999999 899999997543 36999999999999999999999  8999


Q ss_pred             eecCCCCCceEEc---CCCceEEeccccccCCCCCCCCc-----cccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           81 IYRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        81 ~H~dl~p~ni~~~---~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      +|+||+|+||+++   .++.+||+|||++..........     ......++..|+|||.+.+..++.++||||||+++|
T Consensus       127 vH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~  206 (296)
T 3uzp_A          127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM  206 (296)
T ss_dssp             ECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             eeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHH
Confidence            9999999999994   78899999999987654433211     123356888999999999989999999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +|++|..||...........+..........           ........++.++.++|.+||+.||.+|||+.++++.|
T Consensus       207 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  275 (296)
T 3uzp_A          207 YFNLGSLPWQGLKAATKRQKYERISEKKMST-----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF  275 (296)
T ss_dssp             HHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS-----------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHH
T ss_pred             HHHhCCCCCCCcCchhhhhhhhhhcccccCC-----------chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHH
Confidence            9999999998654332222221111100000           00011234678899999999999999999999999999


Q ss_pred             HhhhcCCCCCC
Q 023752          233 EQLHTSKDMPR  243 (278)
Q Consensus       233 ~~~~~~~~~~~  243 (278)
                      +++....+.+.
T Consensus       276 ~~~~~~~~~~~  286 (296)
T 3uzp_A          276 RNLFHRQGFSY  286 (296)
T ss_dssp             HHHHHHTTCCS
T ss_pred             HHHHHhcCCcc
Confidence            99988766543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.1e-38  Score=261.13  Aligned_cols=210  Identities=26%  Similarity=0.398  Sum_probs=170.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.+++.++||||+++++++.+.+..++|+|++.+++|.+++.... ...+++..+..++.|++.||.|||  +.|+
T Consensus        66 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH--~~~i  143 (295)
T 2clq_A           66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH--DNQI  143 (295)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH--hCCE
Confidence            6789999999999999999999999999999999999999999997653 235678899999999999999999  8999


Q ss_pred             eecCCCCCceEEcC-CCceEEeccccccCCCCCCCCccccccccCCcccCccccccC--CCCCccchhHHHHHHHHHHhC
Q 023752           81 IYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        81 ~H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~il~~l~~g  157 (278)
                      +|+||+|+||+++. ++.++|+|||++........  ......++..|+|||.+.+.  .++.++|+||||+++|+|++|
T Consensus       144 ~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  221 (295)
T 2clq_A          144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG  221 (295)
T ss_dssp             ECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT
T ss_pred             EccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            99999999999987 88999999999876433211  12234578899999998764  378899999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||........                ..............+..++.++.++|.+||+.||++||++.+++++
T Consensus       222 ~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          222 KPPFYELGEPQA----------------AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             SCTTGGGSSHHH----------------HHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             CCCccCCCchhH----------------HHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999964322110                0011111122344566788899999999999999999999999964

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.6e-38  Score=269.69  Aligned_cols=226  Identities=15%  Similarity=0.185  Sum_probs=177.2

Q ss_pred             hHHHHHHHhccCCccccc---------------eeeeeec-CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVK---------------LIGYCSE-SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAID   65 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~   65 (278)
                      +.+|++++++++||||++               +++++.. .+..++||||+ +++|.+++.......+++..+..++.|
T Consensus        89 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~q  167 (352)
T 2jii_A           89 LFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACR  167 (352)
T ss_dssp             HHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHH
Confidence            679999999999999998               5666655 56789999999 999999998763347999999999999


Q ss_pred             HHHHHHHHhcCCCCeeecCCCCCceEEcCCC--ceEEeccccccCCCCCCCC-----ccccccccCCcccCccccccCCC
Q 023752           66 VARGLSFLHGLDANVIYRDLKASNVLLDSNF--NAKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHL  138 (278)
Q Consensus        66 l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~--~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~  138 (278)
                      ++.||.|||  +.|++|+||+|+||+++.++  .++|+|||++.........     .......+++.|+|||.+.+..+
T Consensus       168 i~~~L~~LH--~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  245 (352)
T 2jii_A          168 LLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP  245 (352)
T ss_dssp             HHHHHHHHH--HTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC
T ss_pred             HHHHHHHHH--hCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC
Confidence            999999999  88999999999999999988  8999999999764432211     11122467889999999998899


Q ss_pred             CCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhcc----CCCCCHHHHHHHHHHHHHh
Q 023752          139 TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL----GGQYSKKEAQAVAAVVLQC  214 (278)
Q Consensus       139 ~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~~  214 (278)
                      +.++||||||+++|+|++|..||........  .+....          ........    .......++.++.++|.+|
T Consensus       246 ~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  313 (352)
T 2jii_A          246 SRRSDLQSLGYCMLKWLYGFLPWTNCLPNTE--DIMKQK----------QKFVDKPGPFVGPCGHWIRPSETLQKYLKVV  313 (352)
T ss_dssp             CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--HHHHHH----------HHHHHSCCCEECTTSCEECCCHHHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcccCCcCHH--HHHHHH----------HhccCChhhhhhhccccCCCcHHHHHHHHHH
Confidence            9999999999999999999999976532111  010000          00000000    0111124578999999999


Q ss_pred             ccCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 023752          215 LHMDPKNRPSMVDVLTSLEQLHTSKDMP  242 (278)
Q Consensus       215 l~~dp~~Rps~~~ll~~l~~~~~~~~~~  242 (278)
                      |+.||.+|||+.++++.|+++.......
T Consensus       314 l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          314 MALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             HTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence            9999999999999999999998775543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.4e-38  Score=269.01  Aligned_cols=223  Identities=22%  Similarity=0.229  Sum_probs=164.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+++..++||||+. ++|.+++....  .+++..+..++.||+.||.|||  +.|++
T Consensus        80 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH--~~~iv  154 (329)
T 3gbz_A           80 AIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH--SRRCL  154 (329)
T ss_dssp             CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEE
Confidence            5789999999999999999999999999999999996 59999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEc-----CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHH
Q 023752           82 YRDLKASNVLLD-----SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        82 H~dl~p~ni~~~-----~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~  155 (278)
                      |+||||+||+++     ..+.+||+|||++........  ......++..|+|||++.+. .++.++|||||||++|+|+
T Consensus       155 H~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  232 (329)
T 3gbz_A          155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML  232 (329)
T ss_dssp             CSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            999999999994     445699999999875432211  12224568899999998774 5899999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccc-hhHHHH---HHhhhc-------cCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLR-DSRRVL---RIMDTR-------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPS  224 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  224 (278)
                      +|..||...........+......... ......   .+....       .....+..++.++.+||.+||+.||.+|||
T Consensus       233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  312 (329)
T 3gbz_A          233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS  312 (329)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred             HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence            999999765543333332221111000 000000   000000       000011225678999999999999999999


Q ss_pred             HHHHHHH
Q 023752          225 MVDVLTS  231 (278)
Q Consensus       225 ~~~ll~~  231 (278)
                      +.++++|
T Consensus       313 ~~e~l~h  319 (329)
T 3gbz_A          313 AKNALEH  319 (329)
T ss_dssp             HHHHHTS
T ss_pred             HHHHhCC
Confidence            9999974

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=273.48  Aligned_cols=211  Identities=21%  Similarity=0.262  Sum_probs=170.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|..++..++||||++++++|.+.+..|+||||+.||+|.+++.+.+ ..+++..+..++.|++.||.|||  +.|++
T Consensus       108 ~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH--~~gii  184 (412)
T 2vd5_A          108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH--RLGYV  184 (412)
T ss_dssp             HHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            6789999999999999999999999999999999999999999997653 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-------cCCCCCccchhHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-------TGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-------~~~~~~~~DiwslG~il~~l  154 (278)
                      ||||||+||+++.++++||+|||++......... ......+++.|+|||++.       +..++.++|+|||||++|+|
T Consensus       185 HrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyel  263 (412)
T 2vd5_A          185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM  263 (412)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHH
T ss_pred             ecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHH
Confidence            9999999999999999999999999765433221 122346899999999986       35689999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCC---CCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR---PSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~  231 (278)
                      ++|..||...+.......+.....              .......+..++.++.+||.+||+ +|.+|   |++.++++|
T Consensus       264 ltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          264 FYGQTPFYADSTAETYGKIVHYKE--------------HLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             HHSSCTTCCSSHHHHHHHHHTHHH--------------HCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             HhCCCCCCCCCHHHHHHHHHhccc--------------CcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            999999976543222222221100              000111234678899999999999 99998   599999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.7e-38  Score=265.24  Aligned_cols=219  Identities=26%  Similarity=0.369  Sum_probs=162.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc------CCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK------GVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|++++++++||||+++++++...+..++|+||+.+++|.+++...      ....+++..+..++.|++.||.||| 
T Consensus        60 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH-  138 (303)
T 2vwi_A           60 LLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH-  138 (303)
T ss_dssp             ------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            568999999999999999999999999999999999999999988641      2235899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCC---CccccccccCCcccCcccccc-CCCCCccchhHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN---THVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVL  151 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il  151 (278)
                       +.|++|+||+|+||+++.++.++|+|||++........   ........+++.|+|||.+.+ ..++.++|+||||+++
T Consensus       139 -~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il  217 (303)
T 2vwi_A          139 -KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA  217 (303)
T ss_dssp             -HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHH
T ss_pred             -hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHH
Confidence             89999999999999999999999999999865433221   111223467889999999865 5789999999999999


Q ss_pred             HHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          152 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       152 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |+|++|..||.................+....         ..........++.++.++|.+||+.||.+|||+.+++++
T Consensus       218 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          218 IELATGAAPYHKYPPMKVLMLTLQNDPPSLET---------GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             HHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHhCCCCCccCchhhHHHHHhccCCCcccc---------ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            99999999997654322211111110000000         000112234567789999999999999999999999974

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.2e-37  Score=261.13  Aligned_cols=217  Identities=23%  Similarity=0.328  Sum_probs=164.7

Q ss_pred             HHHHHHHhc--cCCccccceeeeeecC----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            3 QTEVIYLGQ--LRHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         3 ~~E~~~l~~--l~h~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      ..|.+++..  ++||||+++++++...    ...++|+||+.+++|.+++...   .+++..+..++.|++.||.|||+.
T Consensus        48 ~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~  124 (301)
T 3q4u_A           48 FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIE  124 (301)
T ss_dssp             HHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHh
Confidence            456666666  7999999999986543    4579999999999999999544   599999999999999999999932


Q ss_pred             ------CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--cccccccCCcccCccccccC------CCCCcc
Q 023752           77 ------DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATG------HLTPKS  142 (278)
Q Consensus        77 ------~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~------~~~~~~  142 (278)
                            +.+++|+||||+||+++.++.+||+|||++..........  ......+++.|+|||.+.+.      .++.++
T Consensus       125 ~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~  204 (301)
T 3q4u_A          125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRV  204 (301)
T ss_dssp             BCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHH
T ss_pred             hhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchh
Confidence                  4689999999999999999999999999986533322211  11224688999999998766      344689


Q ss_pred             chhHHHHHHHHHHhC----------CCCCccccCCch-hhhHHhhhccccchhHHHHHHhhhccCCCC-----CHHHHHH
Q 023752          143 DVYSFGVVLLELLSG----------RRALDEDRGGLA-EQTLVEWADPFLRDSRRVLRIMDTRLGGQY-----SKKEAQA  206 (278)
Q Consensus       143 DiwslG~il~~l~~g----------~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~  206 (278)
                      ||||||+++|+|++|          ..||........ ...+...             ..........     +...+..
T Consensus       205 DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~  271 (301)
T 3q4u_A          205 DIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV-------------VCVDQQRPNIPNRWFSDPTLTS  271 (301)
T ss_dssp             HHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH-------------HTTSCCCCCCCGGGGGSHHHHH
T ss_pred             hHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHH-------------HhccCCCCCCChhhccCccHHH
Confidence            999999999999999          777754322111 1111110             0011111122     2357889


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          207 VAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       207 l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      +.++|.+||+.||.+|||+.++++.|+++
T Consensus       272 l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          272 LAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            99999999999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=8e-38  Score=266.28  Aligned_cols=230  Identities=21%  Similarity=0.320  Sum_probs=165.9

Q ss_pred             HHHHHhccCCccccceeeeeec-----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-
Q 023752            5 EVIYLGQLRHENLVKLIGYCSE-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA-   78 (278)
Q Consensus         5 E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-   78 (278)
                      |+..+..++||||+++++.+..     ....++||||+++++|.+++....   .++..+..++.|++.||.|||  +. 
T Consensus        57 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH--~~~  131 (336)
T 3g2f_A           57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLH--TEL  131 (336)
T ss_dssp             HHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHH--CCB
T ss_pred             HHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHH--hhh
Confidence            3334455899999999985532     235689999999999999997664   588899999999999999999  78 


Q ss_pred             --------CeeecCCCCCceEEcCCCceEEeccccccCCCCCCC------CccccccccCCcccCcccccc-------CC
Q 023752           79 --------NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN------THVSTRIVGTRGYAAPEYVAT-------GH  137 (278)
Q Consensus        79 --------~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~------~~~~~~~~~~~~~~aPE~~~~-------~~  137 (278)
                              |++|+||||+||+++.++.+||+|||++........      ........++..|+|||++.+       ..
T Consensus       132 ~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  211 (336)
T 3g2f_A          132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES  211 (336)
T ss_dssp             CCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHH
T ss_pred             ccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccc
Confidence                    999999999999999999999999999976543221      111223468899999999876       35


Q ss_pred             CCCccchhHHHHHHHHHHhCCCCCccccCCchhh-hHHhhhccccchhHHHHHHh-hhccCCCC------CHHHHHHHHH
Q 023752          138 LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQ-TLVEWADPFLRDSRRVLRIM-DTRLGGQY------SKKEAQAVAA  209 (278)
Q Consensus       138 ~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~l~~  209 (278)
                      ++.++|||||||++|+|++|..||.......... .+...... ..........+ ........      ...++..+.+
T Consensus       212 ~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  290 (336)
T 3g2f_A          212 ALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN-HPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKE  290 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCS-SCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHH
T ss_pred             cccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCC-CchHHHHHhhhcccccCCCCCcccccccchHHHHHH
Confidence            5678999999999999999977764433221111 11110000 00111111111 11111222      2357889999


Q ss_pred             HHHHhccCCCCCCCCHHHHHHHHHhhhcCCC
Q 023752          210 VVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       210 li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  240 (278)
                      ||.+||+.||++|||+.++++.|+++...-.
T Consensus       291 li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          291 TIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             HHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999987643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-38  Score=268.89  Aligned_cols=225  Identities=24%  Similarity=0.252  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+||+.+ +|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        59 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~iv  134 (346)
T 1ua2_A           59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLH--QHWIL  134 (346)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence            46899999999999999999999999999999999965 8888886553 35888899999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      |+||+|+||+++.++.+||+|||++........  ......+++.|+|||.+.+. .++.++|||||||++|+|++|..|
T Consensus       135 H~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~  212 (346)
T 1ua2_A          135 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF  212 (346)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            999999999999999999999999976543221  12234578899999998654 588999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccc-cchhHHH---HHHhhhccCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPF-LRDSRRV---LRIMDTRLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |.+.........+....... .......   ...........     ....++.++.+||.+||+.||.+|||+.++++|
T Consensus       213 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          213 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            97655433333222211110 0000000   00000000000     113456889999999999999999999999986


Q ss_pred             H
Q 023752          232 L  232 (278)
Q Consensus       232 l  232 (278)
                      -
T Consensus       293 ~  293 (346)
T 1ua2_A          293 K  293 (346)
T ss_dssp             G
T ss_pred             h
Confidence            4

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-37  Score=267.00  Aligned_cols=226  Identities=22%  Similarity=0.306  Sum_probs=169.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|++++++++||||+++++++...        +..++|+||+.+ +|.+.+.... ..+++..+..++.|++.||.||
T Consensus        63 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~L  140 (351)
T 3mi9_A           63 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYI  140 (351)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            56899999999999999999999773        467999999964 7877776543 3599999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC--ccccccccCCcccCcccccc-CCCCCccchhHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVV  150 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~i  150 (278)
                      |  +.|++|+||||+||+++.++.+||+|||++.........  .......+++.|+|||++.+ ..++.++|||||||+
T Consensus       141 H--~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  218 (351)
T 3mi9_A          141 H--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI  218 (351)
T ss_dssp             H--HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred             H--HCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHH
Confidence            9  899999999999999999999999999998765432221  12233467889999998876 457999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHH---HHhhhc-----cCCCCC-----HHHHHHHHHHHHHhccC
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVL---RIMDTR-----LGGQYS-----KKEAQAVAAVVLQCLHM  217 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-----~~~~~~-----~~~~~~l~~li~~~l~~  217 (278)
                      +|+|++|..||.+.........+...............   ......     ......     ...++.+.+||.+||+.
T Consensus       219 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  298 (351)
T 3mi9_A          219 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL  298 (351)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence            99999999999876554444333332221111100000   000000     000000     01256789999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 023752          218 DPKNRPSMVDVLTS  231 (278)
Q Consensus       218 dp~~Rps~~~ll~~  231 (278)
                      ||.+|||+.++++|
T Consensus       299 dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          299 DPAQRIDSDDALNH  312 (351)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhhCCCHHHHhCC
Confidence            99999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.8e-38  Score=277.20  Aligned_cols=232  Identities=22%  Similarity=0.286  Sum_probs=166.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC-----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+++|++++||||+++++++...     +..|+|+|++. ++|.+++....  .+++..+..++.||+.||.|||  
T Consensus        72 ~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qil~aL~~LH--  146 (432)
T 3n9x_A           72 ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPI--FLTEEHIKTILYNLLLGENFIH--  146 (432)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSC--CCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--
Confidence            56899999999999999999999776     56899999985 69999997654  6999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC--------------------ccccccccCCcccCcccc-cc
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT--------------------HVSTRIVGTRGYAAPEYV-AT  135 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~--------------------~~~~~~~~~~~~~aPE~~-~~  135 (278)
                      +.|++||||||+||+++.++.+||+|||++.........                    .......+++.|+|||++ .+
T Consensus       147 ~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~  226 (432)
T 3n9x_A          147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ  226 (432)
T ss_dssp             HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTC
T ss_pred             HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC
Confidence            899999999999999999999999999999865443221                    112345789999999986 56


Q ss_pred             CCCCCccchhHHHHHHHHHHhCCCCCc-----------cccCC-----------------chhhhHHhhhc-cccc----
Q 023752          136 GHLTPKSDVYSFGVVLLELLSGRRALD-----------EDRGG-----------------LAEQTLVEWAD-PFLR----  182 (278)
Q Consensus       136 ~~~~~~~DiwslG~il~~l~~g~~p~~-----------~~~~~-----------------~~~~~~~~~~~-~~~~----  182 (278)
                      ..++.++|||||||++|+|++|..||.           +.+..                 .....+.+... +...    
T Consensus       227 ~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~  306 (432)
T 3n9x_A          227 ENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKN  306 (432)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHh
Confidence            679999999999999999998655543           22110                 00111111111 1000    


Q ss_pred             -hhHHHHHHhhhc-cCCCC-----CHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHhhhcC
Q 023752          183 -DSRRVLRIMDTR-LGGQY-----SKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS  238 (278)
Q Consensus       183 -~~~~~~~~~~~~-~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--l~~~~~~  238 (278)
                       ........+... ...+.     ...++.++.+||.+||+.||.+|||+.++++|  +..+...
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          307 INKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             ccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence             001111111110 01111     13467899999999999999999999999976  4444433

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-37  Score=273.08  Aligned_cols=222  Identities=22%  Similarity=0.274  Sum_probs=171.9

Q ss_pred             hHHHHHHHhcc------CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQL------RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l------~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+++++.+      +|+||+++++.+...+..++|+|++. ++|.+++.......+++..+..++.||+.||.||| 
T Consensus       140 ~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH-  217 (429)
T 3kvw_A          140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH-  217 (429)
T ss_dssp             HHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            45788888887      57799999999999999999999995 69999998877667999999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCc--eEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFN--AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                       +.|++|+||||+||+++.++.  +||+|||++.......     ....+++.|+|||++.+..++.++|||||||++|+
T Consensus       218 -~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e  291 (429)
T 3kvw_A          218 -KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAE  291 (429)
T ss_dssp             -HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHH
T ss_pred             -HCCeecCCCCHHHeEEccCCCcceEEeecccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHH
Confidence             889999999999999999887  9999999987543222     22457889999999999999999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchh----HHHHHHhhhccC----------------------------CC---
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDS----RRVLRIMDTRLG----------------------------GQ---  198 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~----------------------------~~---  198 (278)
                      |++|..||.+.+.......+...........    .....++.....                            .+   
T Consensus       292 lltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  371 (429)
T 3kvw_A          292 LLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESR  371 (429)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCS
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccch
Confidence            9999999987655444333333222111110    000001000000                            00   


Q ss_pred             -----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          199 -----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       199 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                           .+...++.+.+||.+||+.||.+|||+.|+++|
T Consensus       372 ~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H  409 (429)
T 3kvw_A          372 EWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH  409 (429)
T ss_dssp             CHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence                 011236789999999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-37  Score=263.86  Aligned_cols=209  Identities=27%  Similarity=0.351  Sum_probs=163.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeec------CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSE------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      +.+|+.+++++ +||||+++++++..      .+..++|+||+.+++|.+++.......+++..+..++.|++.||.|||
T Consensus        67 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH  146 (326)
T 2x7f_A           67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH  146 (326)
T ss_dssp             HHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            57899999999 79999999999976      457899999999999999998764457999999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGV  149 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~  149 (278)
                        +.|++|+||+|+||+++.++.++|+|||++........  ......++..|+|||.+.     +..++.++|+||||+
T Consensus       147 --~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~  222 (326)
T 2x7f_A          147 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI  222 (326)
T ss_dssp             --HTTCCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHH
T ss_pred             --HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHH
Confidence              89999999999999999999999999999876433211  112245788999999986     457889999999999


Q ss_pred             HHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          150 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       150 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ++|+|++|..||..........                 ...........+..++..+.++|.+||..||.+||++.+++
T Consensus       223 il~~l~~g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  285 (326)
T 2x7f_A          223 TAIEMAEGAPPLCDMHPMRALF-----------------LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM  285 (326)
T ss_dssp             HHHHHHHSSCTTTTSCHHHHHH-----------------HHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             HHHHHHhCCCCCCCCcHHHHHH-----------------HhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHh
Confidence            9999999999996543211111                 11111111222345678899999999999999999999999


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      ++
T Consensus       286 ~h  287 (326)
T 2x7f_A          286 KH  287 (326)
T ss_dssp             TS
T ss_pred             hC
Confidence            75

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-37  Score=259.75  Aligned_cols=208  Identities=27%  Similarity=0.389  Sum_probs=169.8

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++++. ||||+++++++.+.+..++|+||+.+++|.+++..+.  .+++..+..++.|++.||.|||  +.|+
T Consensus        70 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~i  145 (298)
T 1phk_A           70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH--KLNI  145 (298)
T ss_dssp             HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCc
Confidence            568999999995 9999999999999999999999999999999998764  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc------cCCCCCccchhHHHHHHHHH
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA------TGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~------~~~~~~~~DiwslG~il~~l  154 (278)
                      +|+||+|+||+++.++.++|+|||++........   .....++..|.|||.+.      ...++.++|+||||+++|+|
T Consensus       146 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l  222 (298)
T 1phk_A          146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL  222 (298)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             ccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHH
Confidence            9999999999999999999999999876443221   22245788999999885      35678899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|..||...........+....               .....+....++..+.++|.+||+.||.+|||+.+++++
T Consensus       223 ~~g~~p~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          223 LAGSPPFWHRKQMLMLRMIMSGN---------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTC---------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHCCCCCcCccHHHHHHHHhcCC---------------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            99999996543221111111100               001112234678899999999999999999999999864

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.1e-38  Score=259.92  Aligned_cols=201  Identities=18%  Similarity=0.289  Sum_probs=164.4

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--VQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|+.++.++ +||||+++++++.+.+..++|+||+++++|.+++....  ...+++..+..++.|++.||.|||  +.
T Consensus        57 ~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH--~~  134 (289)
T 1x8b_A           57 ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH--SM  134 (289)
T ss_dssp             HHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             HHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH--hC
Confidence            46788889988 99999999999999999999999999999999997642  136899999999999999999999  89


Q ss_pred             CeeecCCCCCceEEcCC-------------------CceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CC
Q 023752           79 NVIYRDLKASNVLLDSN-------------------FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HL  138 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~-------------------~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~  138 (278)
                      |++|+||+|+||+++.+                   ..++|+|||.+........      ..++..|+|||.+.+. .+
T Consensus       135 ~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~------~~gt~~y~aPE~~~~~~~~  208 (289)
T 1x8b_A          135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV------EEGDSRFLANEVLQENYTH  208 (289)
T ss_dssp             TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSCC------CCCCGGGCCHHHHTTCCTT
T ss_pred             CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCccc------cCCCccccChhHhcCCCCC
Confidence            99999999999999844                   4799999999876543221      2478899999998765 56


Q ss_pred             CCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCC
Q 023752          139 TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       139 ~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  218 (278)
                      +.++||||||+++|+|++|..++.....                     ...+........+..++..+.++|.+||+.|
T Consensus       209 ~~~~Di~slG~il~~l~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  267 (289)
T 1x8b_A          209 LPKADIFALALTVVCAAGAEPLPRNGDQ---------------------WHEIRQGRLPRIPQVLSQEFTELLKVMIHPD  267 (289)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCSSSHH---------------------HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSS
T ss_pred             CchhhHHHHHHHHHHHhcCCCCCcchhH---------------------HHHHHcCCCCCCCcccCHHHHHHHHHHhCCC
Confidence            6799999999999999999877643210                     0111112223445667889999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 023752          219 PKNRPSMVDVLTS  231 (278)
Q Consensus       219 p~~Rps~~~ll~~  231 (278)
                      |.+|||+.++++|
T Consensus       268 p~~Rps~~~ll~h  280 (289)
T 1x8b_A          268 PERRPSAMALVKH  280 (289)
T ss_dssp             GGGSCCHHHHHTC
T ss_pred             cccCCCHHHHhhC
Confidence            9999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-38  Score=268.56  Aligned_cols=211  Identities=26%  Similarity=0.370  Sum_probs=171.5

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++++ +||||+++++++...+..++||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|+
T Consensus       105 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~~i  180 (355)
T 1vzo_A          105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH--KLGI  180 (355)
T ss_dssp             CCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH--HCCc
Confidence            45799999999 79999999999999999999999999999999998765  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc--CCCCCccchhHHHHHHHHHHhCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      +|+||||+||+++.++.+||+|||++........ .......+++.|+|||++.+  ..++.++|||||||++|+|++|.
T Consensus       181 vH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~  259 (355)
T 1vzo_A          181 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  259 (355)
T ss_dssp             CCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC
Confidence            9999999999999999999999999875432221 11223468999999999875  35788999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTSL  232 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~l  232 (278)
                      .||...........+..             ...  ....+.+..++..+.+||.+||+.||.+||     ++.+++++.
T Consensus       260 ~pf~~~~~~~~~~~~~~-------------~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          260 SPFTVDGEKNSQAEISR-------------RIL--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             CTTSCTTSCCCHHHHHH-------------HHH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             CCCccCCccchHHHHHH-------------HHh--ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            99975443222111111             111  112445667788999999999999999999     999999764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-37  Score=272.19  Aligned_cols=207  Identities=25%  Similarity=0.368  Sum_probs=160.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||+++++++.. +..++||||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus       187 ~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~~iv  261 (419)
T 3i6u_A          187 VETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH--ENGII  261 (419)
T ss_dssp             HHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6789999999999999999999865 45799999999999999887654  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC---ceEEeccccccCCCCCCCCccccccccCCcccCcccccc---CCCCCccchhHHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNF---NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        82 H~dl~p~ni~~~~~~---~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~il~~l~  155 (278)
                      |+||||+||+++.++   .+||+|||++.......   ......+++.|+|||++.+   ..++.++|+||||+++|+|+
T Consensus       262 HrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~ll  338 (419)
T 3i6u_A          262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL  338 (419)
T ss_dssp             CSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHH
T ss_pred             ccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHH
Confidence            999999999997544   59999999998654322   2233567899999999853   56788999999999999999


Q ss_pred             hCCCCCccccCCchhh-hHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQ-TLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +|..||.......... .+........               .+.+..++..+.+||.+||+.||.+|||+.++++|
T Consensus       339 tg~~pf~~~~~~~~~~~~i~~~~~~~~---------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          339 SGYPPFSEHRTQVSLKDQITSGKYNFI---------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HSSCSSCCCSSSCCHHHHHHTTCCCCC---------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HCCCCCCCCcchHHHHHHHhcCCCCCC---------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            9999997644322211 1111110000               00112457789999999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-37  Score=285.67  Aligned_cols=205  Identities=28%  Similarity=0.410  Sum_probs=173.6

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|..++..+ +||+|++++++|.+.+.+|+||||+.|++|.+++...+  .+++..+..++.||+.||.|||  +.||
T Consensus       388 ~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH--~~gI  463 (674)
T 3pfq_A          388 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ--SKGI  463 (674)
T ss_dssp             HHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTSE
T ss_pred             HHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            46788899988 79999999999999999999999999999999998765  6999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++.++.+||+|||++........  ......+++.|+|||++.+..++.++|+||||+++|+|++|..|
T Consensus       464 iHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~P  541 (674)
T 3pfq_A          464 IYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP  541 (674)
T ss_dssp             ECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCC
Confidence            9999999999999999999999999875322221  22345689999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH-----HHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM-----VDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  231 (278)
                      |.+.+.......+                 +.  ....++..++.++.+||.+||+.||.+||++     .+|++|
T Consensus       542 f~~~~~~~~~~~i-----------------~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          542 FEGEDEDELFQSI-----------------ME--HNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             SCCSSHHHHHHHH-----------------HS--SCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             CCCCCHHHHHHHH-----------------Hh--CCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            9764432221111                 11  1234566788999999999999999999997     788754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.7e-37  Score=261.38  Aligned_cols=222  Identities=21%  Similarity=0.320  Sum_probs=173.7

Q ss_pred             hHHHHHHHhccCCcc------ccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHEN------LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+++++.++|++      |+++++++.+.+..++|+||+ +++|.+++.......+++..+..++.|++.||.||| 
T Consensus        58 ~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH-  135 (339)
T 1z57_A           58 ARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH-  135 (339)
T ss_dssp             HHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH-
Confidence            568999999997664      999999999999999999999 889999998876667999999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcC-------------------CCceEEeccccccCCCCCCCCccccccccCCcccCccccccC
Q 023752           76 LDANVIYRDLKASNVLLDS-------------------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG  136 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~-------------------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  136 (278)
                       +.|++|+||+|+||+++.                   ++.++|+|||++.......     ....+++.|+|||++.+.
T Consensus       136 -~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~  209 (339)
T 1z57_A          136 -SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILAL  209 (339)
T ss_dssp             -HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTS
T ss_pred             -HCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCC
Confidence             899999999999999987                   6679999999987633321     224578899999999998


Q ss_pred             CCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchh--------------------HHHHHHhhh---
Q 023752          137 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS--------------------RRVLRIMDT---  193 (278)
Q Consensus       137 ~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~---  193 (278)
                      .++.++|+||||+++|+|++|..||...+.......+.....+.....                    .........   
T Consensus       210 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (339)
T 1z57_A          210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK  289 (339)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc
Confidence            999999999999999999999999986554433333322222111100                    000000000   


Q ss_pred             --ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          194 --RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       194 --~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                        ..........+.++.+||.+||+.||.+|||+.++++|
T Consensus       290 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             chhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence              00112345678899999999999999999999999975

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-37  Score=261.25  Aligned_cols=200  Identities=25%  Similarity=0.285  Sum_probs=158.3

Q ss_pred             HHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            4 TEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         4 ~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      .|+..+.++ +||||+++++++.+.+..++|+|++ +++|.+++.... ..+++..+..++.|++.||.|||  +.+++|
T Consensus       105 ~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~~ivH  180 (311)
T 3p1a_A          105 AEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH--SQGLVH  180 (311)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH--HTTEEC
T ss_pred             HHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEec
Confidence            455555444 8999999999999999999999999 679999887664 36999999999999999999999  889999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      +||||+||+++.++.+||+|||++........   .....+++.|+|||++.+ .++.++||||||+++|+|++|..|+.
T Consensus       181 ~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~  256 (311)
T 3p1a_A          181 LDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPH  256 (311)
T ss_dssp             CCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred             CCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999876433222   222457889999999876 78999999999999999999976664


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ....   ...+                 .........+..++.++.++|.+||+.||++|||+.+++++
T Consensus       257 ~~~~---~~~~-----------------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          257 GGEG---WQQL-----------------RQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             SHHH---HHHH-----------------TTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CccH---HHHH-----------------hccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            3211   0000                 00111111223467889999999999999999999999974

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.4e-37  Score=283.40  Aligned_cols=213  Identities=23%  Similarity=0.379  Sum_probs=174.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+ +..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus       438 ~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH--~~giv  513 (656)
T 2j0j_A          438 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE--SKRFV  513 (656)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            6789999999999999999999854 67899999999999999997654 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      ||||||+||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..|
T Consensus       514 HrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~P  592 (656)
T 2j0j_A          514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP  592 (656)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCC
Confidence            9999999999999999999999999765433211 1122345678999999988899999999999999999997 9999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      |.+......                  ...+......+.+..++..+.++|.+||+.||.+|||+.++++.|+++..
T Consensus       593 f~~~~~~~~------------------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          593 FQGVKNNDV------------------IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             TTTCCHHHH------------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHH------------------HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            975432211                  11122223344566788899999999999999999999999999998754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.8e-37  Score=261.09  Aligned_cols=222  Identities=24%  Similarity=0.372  Sum_probs=171.9

Q ss_pred             hHHHHHHHhc--cCCccccceeeeeecCC----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQ--LRHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~--l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+++++.  ++||||+++++++....    ..++|+||+.+++|.+++.+.   .+++..++.++.|++.||.|||+
T Consensus        81 ~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~  157 (342)
T 1b6c_B           81 WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHM  157 (342)
T ss_dssp             HHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHH
Confidence            4678888887  78999999999998876    789999999999999999765   48999999999999999999993


Q ss_pred             C------CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--cccccccCCcccCccccccCC------CCCc
Q 023752           76 L------DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGH------LTPK  141 (278)
Q Consensus        76 ~------~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~------~~~~  141 (278)
                      .      +.+++|+||+|+||+++.++.+||+|||++..........  ......++..|+|||.+.+..      ++.+
T Consensus       158 ~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~  237 (342)
T 1b6c_B          158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR  237 (342)
T ss_dssp             CBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHH
T ss_pred             HHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCc
Confidence            2      3689999999999999999999999999987543332211  122346788999999987652      3368


Q ss_pred             cchhHHHHHHHHHHhC----------CCCCccccCCc-hhhhHHhhhccccchhHHHHHHhhhccCCCCC-----HHHHH
Q 023752          142 SDVYSFGVVLLELLSG----------RRALDEDRGGL-AEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS-----KKEAQ  205 (278)
Q Consensus       142 ~DiwslG~il~~l~~g----------~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~  205 (278)
                      +||||||+++|+|++|          ..||....... ....+..             ...........+     ..++.
T Consensus       238 ~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~  304 (342)
T 1b6c_B          238 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK-------------VVCEQKLRPNIPNRWQSCEALR  304 (342)
T ss_dssp             HHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH-------------HHTTSCCCCCCCGGGGTSHHHH
T ss_pred             ccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHH-------------HHHHHHhCCCCcccccchhHHH
Confidence            9999999999999999          66775432211 1111111             111111122222     35778


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          206 AVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       206 ~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      .+.++|.+||+.||.+|||+.+++++|+++....
T Consensus       305 ~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          305 VMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998763

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-37  Score=268.61  Aligned_cols=232  Identities=20%  Similarity=0.280  Sum_probs=177.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC--ccEEEEeccCCCCHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD--NRLLVYEFMPKGSLENHLFRKGV-QPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|++++++++||||+++++++.+.+  ..++||||+.+++|.+++..... ..+++..+..++.|++.||.|||  +.
T Consensus        54 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~  131 (396)
T 4eut_A           54 QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR--EN  131 (396)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             HHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH--HC
Confidence            568999999999999999999998765  67999999999999999976432 23999999999999999999999  89


Q ss_pred             CeeecCCCCCceEE----cCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc--------CCCCCccchhH
Q 023752           79 NVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT--------GHLTPKSDVYS  146 (278)
Q Consensus        79 ~i~H~dl~p~ni~~----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Diws  146 (278)
                      |++|+||||+||++    +.++.+||+|||++........   .....++..|+|||++.+        ..++.++||||
T Consensus       132 ~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwS  208 (396)
T 4eut_A          132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWS  208 (396)
T ss_dssp             TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHH
T ss_pred             CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHH
Confidence            99999999999999    6777899999999976433221   223457899999999865        46778999999


Q ss_pred             HHHHHHHHHhCCCCCccccCCc-hhhhHHhhhccccch----h----HHHHHH-hhhccCCCCCHHHHHHHHHHHHHhcc
Q 023752          147 FGVVLLELLSGRRALDEDRGGL-AEQTLVEWADPFLRD----S----RRVLRI-MDTRLGGQYSKKEAQAVAAVVLQCLH  216 (278)
Q Consensus       147 lG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~----~----~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~  216 (278)
                      |||++|+|++|..||....... ....+..........    .    .....+ -........+..++..+.++|.+||+
T Consensus       209 lG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~  288 (396)
T 4eut_A          209 IGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILE  288 (396)
T ss_dssp             HHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhc
Confidence            9999999999999997543321 111111111100000    0    000000 00011234557889999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcC
Q 023752          217 MDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       217 ~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      .||++||++.++++.+..+...
T Consensus       289 ~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          289 ADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cChhhhccHHHHHHHHHHHhhc
Confidence            9999999999999999998765

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.7e-38  Score=263.79  Aligned_cols=208  Identities=24%  Similarity=0.355  Sum_probs=165.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++++.++||||+++++++.+.+..++|+||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        63 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~i~  139 (302)
T 2j7t_A           63 YIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH--SKRII  139 (302)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh--cCCcc
Confidence            5789999999999999999999999999999999999999999887643 35999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~  156 (278)
                      |+||+|+||+++.++.++|+|||++......  ........++..|+|||.+.     +..++.++|+||||+++|+|++
T Consensus       140 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~  217 (302)
T 2j7t_A          140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ  217 (302)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc
Confidence            9999999999999999999999986421100  00112235788899999883     5678899999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhc-cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR-LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||...+......                 ...... .....+..++..+.++|.+||+.||.+|||+.++++|
T Consensus       218 g~~p~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          218 IEPPHHELNPMRVLL-----------------KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             SSCTTTTSCHHHHHH-----------------HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             CCCCCccCCHHHHHH-----------------HHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            999997543211111                 111111 1122345678899999999999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.7e-37  Score=264.06  Aligned_cols=217  Identities=23%  Similarity=0.349  Sum_probs=156.5

Q ss_pred             hHHHHHHHhccC-Cccccceeeeee--------cCCccEEEEeccCCCCHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCS--------ESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRVKIAIDVARGLS   71 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~l~~~l~   71 (278)
                      +.+|+.+++++. ||||+++++++.        .....++++||+. |+|.+++... ....+++..++.++.|++.||.
T Consensus        72 ~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~  150 (337)
T 3ll6_A           72 IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQ  150 (337)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            578999999996 999999999984        3335789999995 7999988652 2346999999999999999999


Q ss_pred             HHhcCCCC--eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc----------cccccccCCcccCcccc---ccC
Q 023752           72 FLHGLDAN--VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH----------VSTRIVGTRGYAAPEYV---ATG  136 (278)
Q Consensus        72 ~Lh~~~~~--i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~----------~~~~~~~~~~~~aPE~~---~~~  136 (278)
                      |||  +.|  ++|+||+|+||+++.++.+||+|||++..........          ......+++.|+|||++   .+.
T Consensus       151 ~LH--~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (337)
T 3ll6_A          151 HMH--RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF  228 (337)
T ss_dssp             HHH--TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTS
T ss_pred             HHH--hCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccC
Confidence            999  788  9999999999999999999999999998654432211          01123578889999998   566


Q ss_pred             CCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhcc
Q 023752          137 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLH  216 (278)
Q Consensus       137 ~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  216 (278)
                      .++.++||||||+++|+|++|..||.......                     ........+.....+..+.+||.+||+
T Consensus       229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~li~~~l~  287 (337)
T 3ll6_A          229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQ  287 (337)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHSSCCC---------------------------------CCCCTTCCSSGGGHHHHHHHSC
T ss_pred             CCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---------------------hhcCcccCCcccccchHHHHHHHHHcc
Confidence            78899999999999999999999996533211                     111111122233445668899999999


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCCCCC
Q 023752          217 MDPKNRPSMVDVLTSLEQLHTSKDMP  242 (278)
Q Consensus       217 ~dp~~Rps~~~ll~~l~~~~~~~~~~  242 (278)
                      .||.+|||+.+++++|+.+.......
T Consensus       288 ~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          288 VNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             SSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             CChhhCcCHHHHHHHHHHHHhccCCC
Confidence            99999999999999999998765443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-37  Score=267.00  Aligned_cols=222  Identities=21%  Similarity=0.322  Sum_probs=167.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC--------------------------------------CccEEEEeccCCCCHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES--------------------------------------DNRLLVYEFMPKGSLE   43 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~--------------------------------------~~~~lv~e~~~~~~L~   43 (278)
                      ..+|+++++.++||||++++++|...                                      ...++||||+. ++|.
T Consensus        47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~  125 (383)
T 3eb0_A           47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH  125 (383)
T ss_dssp             CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHH
T ss_pred             HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHH
Confidence            35799999999999999999998443                                      34789999996 5877


Q ss_pred             HHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEc-CCCceEEeccccccCCCCCCCCccccc
Q 023752           44 NHLFR--KGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTR  120 (278)
Q Consensus        44 ~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~  120 (278)
                      +.+..  .....+++..+..++.|++.||.|||  +.|++|+||||+||+++ .++.+||+|||++........   ...
T Consensus       126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~  200 (383)
T 3eb0_A          126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH--SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVA  200 (383)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCC
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcC
Confidence            77653  22347999999999999999999999  89999999999999997 688999999999976433322   223


Q ss_pred             cccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhh------
Q 023752          121 IVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT------  193 (278)
Q Consensus       121 ~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  193 (278)
                      ..++..|+|||.+.+. .++.++|||||||++|+|++|..||.+.........+.........+.  .......      
T Consensus       201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~--~~~~~~~~~~~~~  278 (383)
T 3eb0_A          201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQ--MIRMNPHYTEVRF  278 (383)
T ss_dssp             CCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH--HHHHCTTC--CCC
T ss_pred             cccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH--HHHhCcccccccC
Confidence            4578889999998765 589999999999999999999999987655444333333222111110  0000000      


Q ss_pred             ------ccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          194 ------RLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       194 ------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                            ......+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          279 PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                  00001234567889999999999999999999999954

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.2e-38  Score=264.64  Aligned_cols=217  Identities=20%  Similarity=0.312  Sum_probs=167.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+.+..++++||+.+++|.+++.... ..+++..+..++.|++.||.|||  +.|++
T Consensus        76 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH--~~~i~  152 (319)
T 2y4i_B           76 FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH--AKGIL  152 (319)
T ss_dssp             CCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            5689999999999999999999999999999999999999999997653 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCC---CccccccccCCcccCcccccc---------CCCCCccchhHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN---THVSTRIVGTRGYAAPEYVAT---------GHLTPKSDVYSFGV  149 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~~~~aPE~~~~---------~~~~~~~DiwslG~  149 (278)
                      |+||+|+||+++ ++.++|+|||++........   ........++..|+|||++.+         ..++.++||||||+
T Consensus       153 H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~  231 (319)
T 2y4i_B          153 HKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT  231 (319)
T ss_dssp             CCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHH
T ss_pred             ccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHH
Confidence            999999999998 67999999999765332111   111222457788999999864         35788999999999


Q ss_pred             HHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          150 VLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       150 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      ++|+|++|..||...........+.                 ...........++.++.++|.+||..||.+|||+.+++
T Consensus       232 il~el~~g~~p~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~  294 (319)
T 2y4i_B          232 IWYELHAREWPFKTQPAEAIIWQMG-----------------TGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLM  294 (319)
T ss_dssp             HHHHHHHSSCSSSSCCHHHHHHHHH-----------------TTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHhc-----------------cCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence            9999999999997543221111111                 11111112234677899999999999999999999999


Q ss_pred             HHHHhhhcCC
Q 023752          230 TSLEQLHTSK  239 (278)
Q Consensus       230 ~~l~~~~~~~  239 (278)
                      +.|+++....
T Consensus       295 ~~l~~l~~~~  304 (319)
T 2y4i_B          295 DMLEKLPKRN  304 (319)
T ss_dssp             HHHTTC----
T ss_pred             HHHHHHHHhh
Confidence            9999988764

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=2.2e-37  Score=267.23  Aligned_cols=221  Identities=24%  Similarity=0.313  Sum_probs=160.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++.++||||+++++++...+      ..++||||+. ++|.+.+..    .+++..+..++.|++.||.||| 
T Consensus        71 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH-  144 (371)
T 2xrw_A           71 AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLH-  144 (371)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHH-
Confidence            568999999999999999999997665      6799999996 578888752    4889999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                       +.|++|+||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+..++.++|||||||++|+|+
T Consensus       145 -~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~  220 (371)
T 2xrw_A          145 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI  220 (371)
T ss_dssp             -HTTCCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             -HCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHH
Confidence             8999999999999999999999999999997543321   122346788999999999989999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccch----h-HHHHHHhhhc---------------c---CCCCCHHHHHHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRD----S-RRVLRIMDTR---------------L---GGQYSKKEAQAVAAVVL  212 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~-~~~~~~~~~~---------------~---~~~~~~~~~~~l~~li~  212 (278)
                      +|..||.+.+.......+..........    . ..........               .   ....+...+.++.+||.
T Consensus       221 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  300 (371)
T 2xrw_A          221 KGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLS  300 (371)
T ss_dssp             HSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHH
Confidence            9999998755433332222211110000    0 0000000000               0   00111335789999999


Q ss_pred             HhccCCCCCCCCHHHHHHHH
Q 023752          213 QCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       213 ~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +||+.||.+|||+.++++|-
T Consensus       301 ~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          301 KMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHSCSSGGGSCCHHHHHHSH
T ss_pred             HHCcCChhhCCCHHHHhCCc
Confidence            99999999999999999764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.3e-37  Score=262.72  Aligned_cols=224  Identities=24%  Similarity=0.326  Sum_probs=171.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC-----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|++++++++||||+++++++...     ...++|+|++. ++|.+++...   .+++..+..++.|++.||.|||  
T Consensus        72 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH--  145 (364)
T 3qyz_A           72 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH--  145 (364)
T ss_dssp             HHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH--
Confidence            56899999999999999999999655     36799999996 5999988765   4999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                      +.|++|+||+|+||+++.++.++|+|||++.......... ......+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus       146 ~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el  225 (364)
T 3qyz_A          146 SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM  225 (364)
T ss_dssp             HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHH
T ss_pred             HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHH
Confidence            8999999999999999999999999999997644322211 1233468899999998654 4589999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhH------HHHHHhhh-ccCCC-----CCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSR------RVLRIMDT-RLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||.+.........+............      ........ .....     ....++.++.+||.+||+.||.+|
T Consensus       226 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  305 (364)
T 3qyz_A          226 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR  305 (364)
T ss_dssp             HHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred             HHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence            9999999877655555444433222111100      00000000 00011     113457789999999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      ||+.++++|
T Consensus       306 ~t~~e~l~h  314 (364)
T 3qyz_A          306 IEVEQALAH  314 (364)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHhcC
Confidence            999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.3e-37  Score=261.15  Aligned_cols=206  Identities=26%  Similarity=0.376  Sum_probs=164.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++..++ .++|+||+.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        62 ~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH--~~~iv  136 (322)
T 2ycf_A           62 VETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLH--ENGII  136 (322)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            678999999999999999999997654 899999999999999887554  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCc---eEEeccccccCCCCCCCCccccccccCCcccCccccc---cCCCCCccchhHHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il~~l~  155 (278)
                      |+||+|+||+++.++.   +||+|||++......   .......++..|+|||++.   +..++.++|+||||+++|+|+
T Consensus       137 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~  213 (322)
T 2ycf_A          137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL  213 (322)
T ss_dssp             CCCCSGGGEEESSSSSSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHH
T ss_pred             ccCCCHHHEEEecCCCCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence            9999999999987654   999999998764322   1122345788999999874   467889999999999999999


Q ss_pred             hCCCCCccccCCchh-hhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          156 SGRRALDEDRGGLAE-QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      +|..||......... ..+........               ...+..++..+.+||.+||+.||.+|||+.++++
T Consensus       214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          214 SGYPPFSEHRTQVSLKDQITSGKYNFI---------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HSSCSSCSTTCSSCHHHHHHHTCCCCC---------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hCCCCCcccchHHHHHHHHHhCccccC---------------chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            999999765432211 11111110000               0011245778999999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.7e-37  Score=267.85  Aligned_cols=229  Identities=21%  Similarity=0.333  Sum_probs=168.6

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCc------cEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDN------RLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      .+|+++++.++||||++++++|...+.      .++|+||+.+ ++.+.+..  .....+++..+..++.|++.||.|||
T Consensus        80 ~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH  158 (394)
T 4e7w_A           80 NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH  158 (394)
T ss_dssp             CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            479999999999999999999965443      7899999976 44443321  22347999999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEc-CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHH
Q 023752           75 GLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLL  152 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~  152 (278)
                        +.|++||||||+||+++ .++.+||+|||++........   .....+++.|+|||++.+. .++.++|||||||++|
T Consensus       159 --~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~  233 (394)
T 4e7w_A          159 --SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA  233 (394)
T ss_dssp             --HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             --HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHH
Confidence              89999999999999998 789999999999976433222   1234578899999998664 5899999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccch-hHHHHHHh-hhccC--------CCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRD-SRRVLRIM-DTRLG--------GQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      +|++|+.||.+.+.......+.......... ........ .....        ..++...+.++.+||.+||+.||.+|
T Consensus       234 ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (394)
T 4e7w_A          234 ELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR  313 (394)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhC
Confidence            9999999998765544433333322211111 00000000 00000        01123467899999999999999999


Q ss_pred             CCHHHHHHH--HHhhhc
Q 023752          223 PSMVDVLTS--LEQLHT  237 (278)
Q Consensus       223 ps~~~ll~~--l~~~~~  237 (278)
                      ||+.++++|  +..+..
T Consensus       314 ~t~~e~l~hp~f~~~~~  330 (394)
T 4e7w_A          314 LTAIEALCHPFFDELRT  330 (394)
T ss_dssp             CCHHHHHTSGGGSTTTS
T ss_pred             CCHHHHhcChhhhhhcc
Confidence            999999986  544444

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=4.1e-37  Score=259.52  Aligned_cols=209  Identities=25%  Similarity=0.396  Sum_probs=164.0

Q ss_pred             hHHHHHHHhccC--CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 023752            2 WQTEVIYLGQLR--HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDAN   79 (278)
Q Consensus         2 ~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~   79 (278)
                      |.+|+++++++.  |+||+++++++.+.+..++++| +.+++|.+++....  .+++..+..++.|++.||.|||  +.|
T Consensus        73 ~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH--~~~  147 (313)
T 3cek_A           73 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH--QHG  147 (313)
T ss_dssp             HHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH--HTT
T ss_pred             HHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCC
Confidence            678999999996  5999999999999999999999 55889999998764  6899999999999999999999  899


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-----------CCCCCccchhHHH
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-----------GHLTPKSDVYSFG  148 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-----------~~~~~~~DiwslG  148 (278)
                      ++|+||+|+||+++. +.+||+|||++................+++.|+|||.+.+           ..++.++||||||
T Consensus       148 ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG  226 (313)
T 3cek_A          148 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG  226 (313)
T ss_dssp             CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHH
T ss_pred             ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHH
Confidence            999999999999964 8999999999986544333222233467899999999865           4678899999999


Q ss_pred             HHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          149 VVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       149 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      +++|+|++|..||......                ................+...+.++.++|.+||+.||.+|||+.++
T Consensus       227 ~il~el~~g~~pf~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el  290 (313)
T 3cek_A          227 CILYYMTYGKTPFQQIINQ----------------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL  290 (313)
T ss_dssp             HHHHHHHHSSCTTTTCCSH----------------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHHHHHhCCCchhhHHHH----------------HHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHH
Confidence            9999999999999643221                111122222223334455567889999999999999999999999


Q ss_pred             HHHH
Q 023752          229 LTSL  232 (278)
Q Consensus       229 l~~l  232 (278)
                      +++-
T Consensus       291 l~h~  294 (313)
T 3cek_A          291 LAHP  294 (313)
T ss_dssp             HTSH
T ss_pred             hcCc
Confidence            9764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.2e-37  Score=268.08  Aligned_cols=220  Identities=23%  Similarity=0.329  Sum_probs=170.0

Q ss_pred             hHHHHHHHhccC--------Cccccceeeeee----cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLR--------HENLVKLIGYCS----ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARG   69 (278)
Q Consensus         2 ~~~E~~~l~~l~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~   69 (278)
                      +.+|+++++++.        |+||+++++++.    +....++|||++ +++|.+.+.......+++..+..++.||+.|
T Consensus        80 ~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~a  158 (397)
T 1wak_A           80 ALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQG  158 (397)
T ss_dssp             HHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence            568999999995        788999999997    556789999999 6778777776655579999999999999999


Q ss_pred             HHHHhcCCC-CeeecCCCCCceEEcCCC-------------------------------------------------ceE
Q 023752           70 LSFLHGLDA-NVIYRDLKASNVLLDSNF-------------------------------------------------NAK   99 (278)
Q Consensus        70 l~~Lh~~~~-~i~H~dl~p~ni~~~~~~-------------------------------------------------~~k   99 (278)
                      |.|||  +. |++|+||||+||+++.++                                                 .++
T Consensus       159 L~~lH--~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k  236 (397)
T 1wak_A          159 LDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK  236 (397)
T ss_dssp             HHHHH--HTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEE
T ss_pred             HHHHH--HhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceE
Confidence            99999  77 999999999999998775                                                 799


Q ss_pred             EeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchh------hhH
Q 023752          100 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAE------QTL  173 (278)
Q Consensus       100 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~------~~~  173 (278)
                      |+|||++......     .....++..|+|||++.+..++.++|||||||++|+|++|..||...+.....      ..+
T Consensus       237 l~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~  311 (397)
T 1wak_A          237 IADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALI  311 (397)
T ss_dssp             ECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHH
T ss_pred             ecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHH
Confidence            9999999764332     12245789999999999999999999999999999999999999765443211      111


Q ss_pred             Hhhhccccchh-------------------------HHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHH
Q 023752          174 VEWADPFLRDS-------------------------RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDV  228 (278)
Q Consensus       174 ~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  228 (278)
                      ...........                         ......+.  .....+...+..+.+||.+||+.||.+|||+.++
T Consensus       312 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~  389 (397)
T 1wak_A          312 IELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV--EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC  389 (397)
T ss_dssp             HHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHH--HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHH
T ss_pred             HHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhh--hhcccchhhHHHHHHHHHHHhccChhhcCCHHHH
Confidence            11111100000                         00000000  1123467888999999999999999999999999


Q ss_pred             HHH
Q 023752          229 LTS  231 (278)
Q Consensus       229 l~~  231 (278)
                      ++|
T Consensus       390 l~h  392 (397)
T 1wak_A          390 LRH  392 (397)
T ss_dssp             HTS
T ss_pred             hhC
Confidence            975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.5e-37  Score=269.38  Aligned_cols=221  Identities=24%  Similarity=0.326  Sum_probs=164.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC------CccEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+++|++++||||++++++|...      ..+++|+||+.+ +|.+.+..  .....+++..+..++.||+.||.||
T Consensus        94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L  172 (420)
T 1j1b_A           94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI  172 (420)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            35799999999999999999998542      136799999965 67666543  2234799999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCC-CceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVL  151 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il  151 (278)
                      |  +.||+||||||+||+++.+ +.+||+|||++........   .....+++.|+|||++.+. .++.++|||||||++
T Consensus       173 H--~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il  247 (420)
T 1j1b_A          173 H--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL  247 (420)
T ss_dssp             H--TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             H--HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHH
Confidence            9  8999999999999999965 5689999999976433221   1234678999999998764 789999999999999


Q ss_pred             HHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhc-cCCC------------CCHHHHHHHHHHHHHhccCC
Q 023752          152 LELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR-LGGQ------------YSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       152 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~------------~~~~~~~~l~~li~~~l~~d  218 (278)
                      |+|++|+.||.+.+.......+.........+  .+.. .... ....            ++...+.++.+||.+||+.|
T Consensus       248 ~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~--~~~~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~d  324 (420)
T 1j1b_A          248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE--QIRE-MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT  324 (420)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH--HHHH-HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSS
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH--HHHh-hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCC
Confidence            99999999998765433333332221111110  0000 0100 0000            12345789999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 023752          219 PKNRPSMVDVLTS  231 (278)
Q Consensus       219 p~~Rps~~~ll~~  231 (278)
                      |.+|||+.++++|
T Consensus       325 P~~R~t~~e~l~h  337 (420)
T 1j1b_A          325 PTARLTPLEACAH  337 (420)
T ss_dssp             GGGSCCHHHHHTS
T ss_pred             hhHCCCHHHHhCC
Confidence            9999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.6e-38  Score=273.66  Aligned_cols=198  Identities=18%  Similarity=0.255  Sum_probs=154.0

Q ss_pred             hHHHH---HHHhccCCcccccee-------eeeecCC-----------------ccEEEEeccCCCCHHHHHhhcCC---
Q 023752            2 WQTEV---IYLGQLRHENLVKLI-------GYCSESD-----------------NRLLVYEFMPKGSLENHLFRKGV---   51 (278)
Q Consensus         2 ~~~E~---~~l~~l~h~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~---   51 (278)
                      |.+|+   +++++++||||++++       +++.+.+                 ..|++|||+ +|+|.+++.....   
T Consensus       120 ~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~  198 (377)
T 3byv_A          120 MKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS  198 (377)
T ss_dssp             HHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc
Confidence            57899   455555899999998       6666553                 278999999 6799999976531   


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccC
Q 023752           52 --QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA  129 (278)
Q Consensus        52 --~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~a  129 (278)
                        ..+++..+..++.|++.||.|||  +.|++|+||||+||+++.++.+||+|||++.....     ......+ +.|+|
T Consensus       199 ~~~~l~~~~~~~i~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~a  270 (377)
T 3byv_A          199 THKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEP  270 (377)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCC
T ss_pred             ccccccHHHHHHHHHHHHHHHHHHH--hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccC
Confidence              11224788899999999999999  89999999999999999999999999999975222     2223456 89999


Q ss_pred             ccccccC-----------CCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCC
Q 023752          130 PEYVATG-----------HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQ  198 (278)
Q Consensus       130 PE~~~~~-----------~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (278)
                      ||++.+.           .++.++|||||||++|+|++|..||...........+.                       .
T Consensus       271 PE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~-----------------------~  327 (377)
T 3byv_A          271 PELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF-----------------------R  327 (377)
T ss_dssp             HHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG-----------------------S
T ss_pred             hhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh-----------------------h
Confidence            9999877           89999999999999999999999997544322111111                       0


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          199 YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       199 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ....++.++.+||.+||+.||.+|||+.+++++
T Consensus       328 ~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          328 SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            123456789999999999999999999999963

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=260.83  Aligned_cols=212  Identities=16%  Similarity=0.170  Sum_probs=173.2

Q ss_pred             hHHHHHHHhccC---CccccceeeeeecCCccEEEEeccCCCCHHHHHhhc---CCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLR---HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK---GVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +..|++++++++   |+||+++++++...+..++||||+.+|+|.+++...   ....+++..+..++.|++.||.||| 
T Consensus       111 ~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH-  189 (365)
T 3e7e_A          111 FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH-  189 (365)
T ss_dssp             HHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh-
Confidence            567888888886   899999999999999999999999999999999752   2346999999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcC-----------CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccch
Q 023752           76 LDANVIYRDLKASNVLLDS-----------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDV  144 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~-----------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  144 (278)
                       +.||+||||||+||+++.           ++.+||+|||++................++..|+|||++.+..++.++||
T Consensus       190 -~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  268 (365)
T 3e7e_A          190 -DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDY  268 (365)
T ss_dssp             -TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHH
T ss_pred             -hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccH
Confidence             899999999999999988           89999999999965433333333344578999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCC-C
Q 023752          145 YSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNR-P  223 (278)
Q Consensus       145 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-p  223 (278)
                      |||||++|+|++|+.||.........  +.    ..               ...  ...++.+.+++..||+.+|.+| |
T Consensus       269 wslG~il~elltg~~pf~~~~~~~~~--~~----~~---------------~~~--~~~~~~~~~~~~~~l~~~p~~r~~  325 (365)
T 3e7e_A          269 FGVAATVYCMLFGTYMKVKNEGGECK--PE----GL---------------FRR--LPHLDMWNEFFHVMLNIPDCHHLP  325 (365)
T ss_dssp             HHHHHHHHHHHHSSCCCEEEETTEEE--EC----SC---------------CTT--CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred             HHHHHHHHHHHhCCCccccCCCCcee--ec----hh---------------ccc--cCcHHHHHHHHHHHcCCCCCCcch
Confidence            99999999999999999654331110  00    00               000  1236678899999999999999 5


Q ss_pred             CHHHHHHHHHhhhcC
Q 023752          224 SMVDVLTSLEQLHTS  238 (278)
Q Consensus       224 s~~~ll~~l~~~~~~  238 (278)
                      ++.++.+.|+.+...
T Consensus       326 ~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          326 SLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             CHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHH
Confidence            788888888887654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.8e-37  Score=259.87  Aligned_cols=224  Identities=25%  Similarity=0.336  Sum_probs=171.5

Q ss_pred             hHHHHHHHhcc---CCccccceeeeee-----cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL---RHENLVKLIGYCS-----ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+.+++.+   .||||+++++++.     .....++|+||+. ++|.+++.......+++..+..++.|++.||.||
T Consensus        58 ~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l  136 (326)
T 1blx_A           58 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL  136 (326)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence            46788888877   8999999999987     4567899999996 6999999877656699999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.|++|+||+|+||+++.++.++|+|||++......   .......++..|+|||.+.+..++.++|+||||+++|+
T Consensus       137 H--~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~  211 (326)
T 1blx_A          137 H--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE  211 (326)
T ss_dssp             H--HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred             H--HCCceeccCCHHHeEEcCCCCEEEecCcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHH
Confidence            9  899999999999999999999999999998754322   12223467889999999988899999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccc-cchhHHH---H-HHhh---hccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPF-LRDSRRV---L-RIMD---TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~-~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      |++|..||...........+....... .......   . ....   ..........++..+.+||.+||+.||.+|||+
T Consensus       212 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  291 (326)
T 1blx_A          212 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  291 (326)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCH
Confidence            999999998655433333332211100 0000000   0 0000   000011234567889999999999999999999


Q ss_pred             HHHHHH
Q 023752          226 VDVLTS  231 (278)
Q Consensus       226 ~~ll~~  231 (278)
                      .++++|
T Consensus       292 ~e~l~h  297 (326)
T 1blx_A          292 YSALSH  297 (326)
T ss_dssp             HHHHTS
T ss_pred             HHHhcC
Confidence            999964

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.5e-36  Score=257.88  Aligned_cols=220  Identities=18%  Similarity=0.256  Sum_probs=166.2

Q ss_pred             hHHHHHHHhccC-Cccccceeeeeec--CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|+++++++. ||||+++++++.+  ....++|+||+.+++|.+++.     .+++..+..++.|++.||.|||  +.
T Consensus        77 ~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH--~~  149 (330)
T 3nsz_A           77 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH--SM  149 (330)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             HHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH--hC
Confidence            578999999997 9999999999987  567899999999999999884     3888999999999999999999  89


Q ss_pred             CeeecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHh
Q 023752           79 NVIYRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~  156 (278)
                      |++|+||||+||+++.++ .++|+|||++........   .....++..|+|||.+.+ ..++.++|||||||++|+|++
T Consensus       150 ~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  226 (330)
T 3nsz_A          150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF  226 (330)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHh
Confidence            999999999999999776 899999999976443322   222457888999999877 678999999999999999999


Q ss_pred             CCCCCccccCC-chhhhHHhhhcc-ccch---------hHHHHHHhhh--------ccCCCCCHHHHHHHHHHHHHhccC
Q 023752          157 GRRALDEDRGG-LAEQTLVEWADP-FLRD---------SRRVLRIMDT--------RLGGQYSKKEAQAVAAVVLQCLHM  217 (278)
Q Consensus       157 g~~p~~~~~~~-~~~~~~~~~~~~-~~~~---------~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~  217 (278)
                      |..||...... .....+...... ...+         ..........        ......+..++.++.+||.+||+.
T Consensus       227 g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  306 (330)
T 3nsz_A          227 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY  306 (330)
T ss_dssp             TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCS
T ss_pred             CCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcC
Confidence            99999543321 111111111100 0000         0000000000        011122334688999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 023752          218 DPKNRPSMVDVLTS  231 (278)
Q Consensus       218 dp~~Rps~~~ll~~  231 (278)
                      ||.+|||+.++++|
T Consensus       307 dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          307 DHQSRLTAREAMEH  320 (330)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             CcccCCCHHHHhcC
Confidence            99999999999975

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.4e-36  Score=268.27  Aligned_cols=226  Identities=19%  Similarity=0.246  Sum_probs=178.4

Q ss_pred             hHHHHHHHhccCC-ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++.+.| ++|..+..++.+.+..++||||+ +++|.+++.... ..+++..+..++.||+.||.|||  +.||
T Consensus        49 ~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH--~~gI  124 (483)
T 3sv0_A           49 LLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH--SKSF  124 (483)
T ss_dssp             HHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--HCCE
Confidence            6789999999977 55555666667777889999999 899999997543 36999999999999999999999  8999


Q ss_pred             eecCCCCCceEE---cCCCceEEeccccccCCCCCCCCc-----cccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           81 IYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        81 ~H~dl~p~ni~~---~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      +|+||||+||++   +.++.+||+|||++..........     ......++..|+|||.+.+..++.++|||||||++|
T Consensus       125 vHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~  204 (483)
T 3sv0_A          125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM  204 (483)
T ss_dssp             ECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             eecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHH
Confidence            999999999999   578899999999997654433211     112456889999999999999999999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +|++|..||.+.......+.+.............           .....++.++.+||.+||+.||++||++.+|++.|
T Consensus       205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~-----------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L  273 (483)
T 3sv0_A          205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE-----------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLF  273 (483)
T ss_dssp             HHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH-----------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHH
T ss_pred             HHHhCCCCCccccchhHHHHHHHHhhccccccHH-----------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence            9999999998766544444333322211111000           01124567899999999999999999999999999


Q ss_pred             HhhhcCCCCC
Q 023752          233 EQLHTSKDMP  242 (278)
Q Consensus       233 ~~~~~~~~~~  242 (278)
                      +.+......+
T Consensus       274 ~~l~~~~~~~  283 (483)
T 3sv0_A          274 RDLFIREGFQ  283 (483)
T ss_dssp             HHHHHHTTCC
T ss_pred             HHHHHHcCCC
Confidence            9997765443

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.9e-37  Score=255.50  Aligned_cols=207  Identities=26%  Similarity=0.342  Sum_probs=167.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+.+..++|+|++.+++|.+++....  .+++..+..++.|++.||.|||  +.|++
T Consensus        68 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH--~~~i~  143 (287)
T 2wei_A           68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH--KHNIV  143 (287)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999887664  6899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCC---CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSN---FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~---~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      |+||+|+||+++.+   +.++|+|||++.........   ....++..|+|||.+.+ .++.++|+||||+++|+|++|.
T Consensus       144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~  219 (287)
T 2wei_A          144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGT  219 (287)
T ss_dssp             CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSC---SCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCChhhEEEecCCCcccEEEeccCcceeecCCCcc---ccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCC
Confidence            99999999999654   46999999998754332211   22346788999998865 4889999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||...........+.....               ....+....++.++.++|.+||+.||.+|||+.+++++
T Consensus       220 ~p~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          220 PPFYGKNEYDILKRVETGKY---------------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             CSSCCSSHHHHHHHHHHCCC---------------CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCCHHHHHHHHHcCCC---------------CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            99976433211111111100               00111124567889999999999999999999999975

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=4.9e-37  Score=264.57  Aligned_cols=219  Identities=24%  Similarity=0.339  Sum_probs=157.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+++++.++||||+++++++...      ...|++++++ +++|.+++...   .+++..+..++.||+.||.||| 
T Consensus        75 ~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH-  149 (367)
T 2fst_X           75 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH-  149 (367)
T ss_dssp             HHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH-
Confidence            46899999999999999999998654      5679999998 78999988653   5999999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.|++|+||||+||+++.++.+||+|||++......     .....++..|+|||++.+ ..++.++|||||||++|+|
T Consensus       150 -~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  223 (367)
T 2fst_X          150 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL  223 (367)
T ss_dssp             -HTTCCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHH
T ss_pred             -HCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHH
Confidence             899999999999999999999999999999754322     223467899999999876 6789999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccch------hHHHHHHhhhccC-CC-----CCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRD------SRRVLRIMDTRLG-GQ-----YSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|+.||.+.+.......+..........      .......+..... ..     .....+..+.+||.+||+.||.+|
T Consensus       224 l~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R  303 (367)
T 2fst_X          224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR  303 (367)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGS
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccC
Confidence            99999998766544444433322211110      0011111111000 00     012346789999999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      ||+.++++|
T Consensus       304 ~t~~e~L~h  312 (367)
T 2fst_X          304 ITAAQALAH  312 (367)
T ss_dssp             CCHHHHHTS
T ss_pred             cCHHHHhcC
Confidence            999999976

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=5.6e-37  Score=255.70  Aligned_cols=207  Identities=24%  Similarity=0.298  Sum_probs=155.9

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCC-C
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLDA-N   79 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~   79 (278)
                      .++...++.++||||+++++++.+.+..++|+||++ ++|.+++...  ....+++..+..++.|++.||.|||  +. |
T Consensus        54 ~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH--~~~~  130 (290)
T 3fme_A           54 MDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH--SKLS  130 (290)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH--HHSC
T ss_pred             HHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh--hcCC
Confidence            345556888899999999999999999999999996 5888877542  2347999999999999999999999  77 9


Q ss_pred             eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccc----ccCCCCCccchhHHHHHHHHHH
Q 023752           80 VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV----ATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        80 i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~il~~l~  155 (278)
                      ++|+||+|+||+++.++.++|+|||++........   .....+++.|+|||.+    .+..++.++|+||||+++|+|+
T Consensus       131 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~  207 (290)
T 3fme_A          131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELA  207 (290)
T ss_dssp             CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999876433222   1223578899999996    4567888999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +|..||......                ...................++.++.++|.+||+.||++|||+.++++|
T Consensus       208 ~g~~p~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          208 ILRFPYDSWGTP----------------FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             HTSCSSCCCSCH----------------HHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HCCCCccccCch----------------HHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            999999743221                111111222222222234578899999999999999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.9e-37  Score=267.57  Aligned_cols=229  Identities=19%  Similarity=0.246  Sum_probs=158.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeec--CCccEEEEeccCCCCHHHHHhhc-------CCCCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRK-------GVQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      +.+|+.+|++++||||+++++++..  ....++|+||+. ++|.+++...       ....+++..+..++.||+.||.|
T Consensus        65 ~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~  143 (405)
T 3rgf_A           65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY  143 (405)
T ss_dssp             HHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            5689999999999999999999954  567899999995 5888877532       11248999999999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEE----cCCCceEEeccccccCCCCCCCC-ccccccccCCcccCccccccC-CCCCccchhH
Q 023752           73 LHGLDANVIYRDLKASNVLL----DSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYS  146 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~----~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~-~~~~~~Diws  146 (278)
                      ||  +.||+|+||||+||++    +.++.+||+|||++......... .......+++.|+|||++.+. .++.++||||
T Consensus       144 LH--~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  221 (405)
T 3rgf_A          144 LH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA  221 (405)
T ss_dssp             HH--HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHH
T ss_pred             HH--hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHH
Confidence            99  8999999999999999    67789999999999865433221 122335678999999998774 5899999999


Q ss_pred             HHHHHHHHHhCCCCCccccCCc---------hhhhHHhhh-ccccch---------hHHHHHHhhhccCCC---------
Q 023752          147 FGVVLLELLSGRRALDEDRGGL---------AEQTLVEWA-DPFLRD---------SRRVLRIMDTRLGGQ---------  198 (278)
Q Consensus       147 lG~il~~l~~g~~p~~~~~~~~---------~~~~~~~~~-~~~~~~---------~~~~~~~~~~~~~~~---------  198 (278)
                      |||++|+|++|..||.......         ....+.... .+....         ...............         
T Consensus       222 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (405)
T 3rgf_A          222 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK  301 (405)
T ss_dssp             HHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhh
Confidence            9999999999999997554321         111111110 010000         000000000000000         


Q ss_pred             CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 023752          199 YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE  233 (278)
Q Consensus       199 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~  233 (278)
                      .....+..+.+||.+||+.||.+|||+.++++|--
T Consensus       302 ~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~  336 (405)
T 3rgf_A          302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  336 (405)
T ss_dssp             TTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             cCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence            00112567899999999999999999999998643

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.1e-36  Score=259.08  Aligned_cols=222  Identities=21%  Similarity=0.290  Sum_probs=172.0

Q ss_pred             hHHHHHHHhccCCcc------ccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHEN------LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++++.|++      ++.+++++...+..++|||++ +++|.+++.......+++..+..++.||+.||.||| 
T Consensus        63 ~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH-  140 (355)
T 2eu9_A           63 ARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH-  140 (355)
T ss_dssp             HHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-
Confidence            568999999997766      899999999999999999999 678888887766567999999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEE-------------------cCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC
Q 023752           76 LDANVIYRDLKASNVLL-------------------DSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG  136 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~-------------------~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  136 (278)
                       +.|++|+||||+||++                   +.++.+||+|||++.......     ....+++.|+|||++.+.
T Consensus       141 -~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~  214 (355)
T 2eu9_A          141 -ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILEL  214 (355)
T ss_dssp             -TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTC
T ss_pred             -HCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecC
Confidence             8999999999999999                   567889999999987533222     224578899999999999


Q ss_pred             CCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchh--------------------HHHHHHhhhc--
Q 023752          137 HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS--------------------RRVLRIMDTR--  194 (278)
Q Consensus       137 ~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~--  194 (278)
                      .++.++|+||||+++|+|++|..||...........+.....+.....                    ..........  
T Consensus       215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (355)
T 2eu9_A          215 GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK  294 (355)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred             CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC
Confidence            999999999999999999999999986554433333332221111100                    0000000000  


Q ss_pred             ---cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          195 ---LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       195 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                         .........+.++.+||.+||+.||.+|||+.++++|
T Consensus       295 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence               0112234567899999999999999999999999964

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.9e-37  Score=266.67  Aligned_cols=223  Identities=24%  Similarity=0.298  Sum_probs=163.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeec-----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|++++++++||||+++++++..     ....++|+||+. ++|.+.+.... ..+++..+..++.|++.||.|||  
T Consensus        76 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--  151 (362)
T 3pg1_A           76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLH--  151 (362)
T ss_dssp             HHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH--
Confidence            5789999999999999999999843     235799999996 68888887543 46999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~  155 (278)
                      +.|++|+||+|+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+|||||++|+|+
T Consensus       152 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~  228 (362)
T 3pg1_A          152 EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF  228 (362)
T ss_dssp             HTTCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHH
T ss_pred             HCcCEecCCChHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHH
Confidence            89999999999999999999999999999974332221   223457888999999876 67899999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchh------HHHHHHhhhccCC-------CCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDS------RRVLRIMDTRLGG-------QYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      +|..||.+.........+...........      .............       ......+..+.+||.+||+.||.+|
T Consensus       229 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  308 (362)
T 3pg1_A          229 NRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRR  308 (362)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGS
T ss_pred             hCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhC
Confidence            99999987654444443333222211110      0001111110000       0123456789999999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      ||+.++++|
T Consensus       309 pt~~ell~h  317 (362)
T 3pg1_A          309 ISTEQALRH  317 (362)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHHcC
Confidence            999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-36  Score=253.28  Aligned_cols=210  Identities=23%  Similarity=0.407  Sum_probs=159.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeec-------------CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE-------------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR   68 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~   68 (278)
                      +.+|+.++++++||||+++++++.+             .+..++|+||+.+++|.+++.... ..+++..++.++.|++.
T Consensus        49 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~  127 (303)
T 1zy4_A           49 ILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILE  127 (303)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHH
Confidence            5789999999999999999998865             346789999999999999997654 35788899999999999


Q ss_pred             HHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCC------------CccccccccCCcccCccccccC
Q 023752           69 GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN------------THVSTRIVGTRGYAAPEYVATG  136 (278)
Q Consensus        69 ~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~aPE~~~~~  136 (278)
                      ||.|||  +.|++|+||+|+||+++.++.++|+|||++........            ........++..|+|||.+.+.
T Consensus       128 ~l~~LH--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  205 (303)
T 1zy4_A          128 ALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT  205 (303)
T ss_dssp             HHHHHH--HTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred             HHHHHH--hCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence            999999  89999999999999999999999999999876543211            1112234578899999998764


Q ss_pred             -CCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhc
Q 023752          137 -HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCL  215 (278)
Q Consensus       137 -~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  215 (278)
                       .++.++|+||||+++|+|++   ||......  ......            ........+...+...+..+.++|.+||
T Consensus       206 ~~~~~~~Di~slG~il~~l~~---p~~~~~~~--~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~li~~~l  268 (303)
T 1zy4_A          206 GHYNEKIDMYSLGIIFFEMIY---PFSTGMER--VNILKK------------LRSVSIEFPPDFDDNKMKVEKKIIRLLI  268 (303)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHHHHH------------HHSTTCCCCTTCCTTTSHHHHHHHHHHT
T ss_pred             CCCcchhhHHHHHHHHHHHHh---ccCCchhH--HHHHHh------------ccccccccCccccccchHHHHHHHHHHH
Confidence             68999999999999999998   44321100  000000            0001111223345667788999999999


Q ss_pred             cCCCCCCCCHHHHHHH
Q 023752          216 HMDPKNRPSMVDVLTS  231 (278)
Q Consensus       216 ~~dp~~Rps~~~ll~~  231 (278)
                      +.||.+|||+.+++++
T Consensus       269 ~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          269 DHDPNKRPGARTLLNS  284 (303)
T ss_dssp             CSSGGGSCCHHHHHHS
T ss_pred             hcCcccCcCHHHHhCC
Confidence            9999999999999974

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=257.01  Aligned_cols=224  Identities=23%  Similarity=0.340  Sum_probs=164.8

Q ss_pred             hHHHHHHHhccCCccccceeeeee--------------cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCS--------------ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVA   67 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~   67 (278)
                      +.+|++++++++||||+++++++.              +.+..++|+||+. ++|.+++...   .+++..+..++.|++
T Consensus        55 ~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~  130 (320)
T 2i6l_A           55 ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLL  130 (320)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHH
Confidence            578999999999999999999874              3356799999996 6999988643   589999999999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCceEEc-CCCceEEeccccccCCCCCCCC-ccccccccCCcccCcccccc-CCCCCccch
Q 023752           68 RGLSFLHGLDANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT-GHLTPKSDV  144 (278)
Q Consensus        68 ~~l~~Lh~~~~~i~H~dl~p~ni~~~-~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di  144 (278)
                      .||.|||  +.|++|+||+|+||+++ .++.+||+|||++......... .......++..|+|||.+.+ ..++.++|+
T Consensus       131 ~~l~~lH--~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  208 (320)
T 2i6l_A          131 RGLKYIH--SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM  208 (320)
T ss_dssp             HHHHHHH--HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHH
T ss_pred             HHHHHHH--hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhh
Confidence            9999999  89999999999999997 5678999999999865432111 11122456788999998865 678899999


Q ss_pred             hHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchh-HHHHH----HhhhccC-C-----CCCHHHHHHHHHHHHH
Q 023752          145 YSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS-RRVLR----IMDTRLG-G-----QYSKKEAQAVAAVVLQ  213 (278)
Q Consensus       145 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~-~-----~~~~~~~~~l~~li~~  213 (278)
                      ||||+++|+|++|..||...........+........... .....    ....... .     .....++.++.+||.+
T Consensus       209 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  288 (320)
T 2i6l_A          209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ  288 (320)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHT
T ss_pred             HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHH
Confidence            9999999999999999986554333332222111111000 00000    0000000 0     0123467899999999


Q ss_pred             hccCCCCCCCCHHHHHHH
Q 023752          214 CLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       214 ~l~~dp~~Rps~~~ll~~  231 (278)
                      ||+.||.+|||+.++++|
T Consensus       289 ~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          289 ILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             TSCSSGGGSCCHHHHHTS
T ss_pred             HcCCCccccCCHHHHhCC
Confidence            999999999999999975

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.6e-36  Score=258.47  Aligned_cols=218  Identities=23%  Similarity=0.342  Sum_probs=165.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCcc------EEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++.++||||+++++++...+..      ++|+||+. ++|.+++.    ..+++..+..++.|++.||.||| 
T Consensus        88 ~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH-  161 (371)
T 4exu_A           88 AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH-  161 (371)
T ss_dssp             HHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH-
Confidence            56899999999999999999999877654      99999996 68887773    24899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.|++|+||+|+||+++.++.++|+|||++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|
T Consensus       162 -~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (371)
T 4exu_A          162 -SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM  235 (371)
T ss_dssp             -HTTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHH
T ss_pred             -HCCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHH
Confidence             899999999999999999999999999999754332     222457889999999877 6889999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccch------hHHHHHHhhhccCCC------CCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRD------SRRVLRIMDTRLGGQ------YSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||.+.+.......+..........      ...............      ....++..+.+||.+||+.||++|
T Consensus       236 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  315 (371)
T 4exu_A          236 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR  315 (371)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTS
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhc
Confidence            99999998765433333333222111100      000001111100000      123457899999999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      ||+.++++|
T Consensus       316 pt~~ell~h  324 (371)
T 4exu_A          316 LTAAQALTH  324 (371)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHhcC
Confidence            999999976

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.7e-36  Score=259.42  Aligned_cols=224  Identities=21%  Similarity=0.227  Sum_probs=169.7

Q ss_pred             hHHHHHHHhccC-Cc-----cccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLR-HE-----NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+++.+. |+     +|+++++++...+..++|||++. ++|.+++.......+++..+..++.|++.||.|||+
T Consensus        97 ~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~  175 (382)
T 2vx3_A           97 AQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT  175 (382)
T ss_dssp             HHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc
Confidence            456888888884 44     49999999999999999999995 599999987765679999999999999999999995


Q ss_pred             CCCCeeecCCCCCceEEc--CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLD--SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      ...||+|+||||+||+++  .++.+||+|||++.......     ....+++.|+|||++.+..++.++|||||||++|+
T Consensus       176 ~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~e  250 (382)
T 2vx3_A          176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE  250 (382)
T ss_dssp             TTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred             CCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHH
Confidence            457999999999999995  46789999999997653322     23457889999999999999999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchh----HHHHHHhhhc-----------------------------------
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDS----RRVLRIMDTR-----------------------------------  194 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-----------------------------------  194 (278)
                      |++|..||.+.+.......+...........    ......+...                                   
T Consensus       251 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  330 (382)
T 2vx3_A          251 MHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGG  330 (382)
T ss_dssp             HHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTS
T ss_pred             HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccC
Confidence            9999999987654433333332211111000    0000000000                                   


Q ss_pred             ------cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          195 ------LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       195 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                            ...........++.+||.+||+.||.+|||+.++++|
T Consensus       331 ~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~h  373 (382)
T 2vx3_A          331 PGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQH  373 (382)
T ss_dssp             GGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcC
Confidence                  0001122345689999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.5e-36  Score=257.80  Aligned_cols=224  Identities=24%  Similarity=0.286  Sum_probs=167.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC-----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|++++++++||||+++++++...     ...++++|++. ++|.+++...   .+++..+..++.|++.||.|||  
T Consensus        56 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH--  129 (353)
T 2b9h_A           56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLH--  129 (353)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH--
Confidence            56899999999999999999987654     57899999996 6999988764   5999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--------cccccccCCcccCcccccc-CCCCCccchhHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--------VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSF  147 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--------~~~~~~~~~~~~aPE~~~~-~~~~~~~Diwsl  147 (278)
                      +.|++|+||+|+||+++.++.++|+|||++..........        ......++..|+|||++.+ ..++.++|+|||
T Consensus       130 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl  209 (353)
T 2b9h_A          130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSC  209 (353)
T ss_dssp             HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHH
T ss_pred             HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHH
Confidence            8999999999999999999999999999987654322111        1122457889999998754 678899999999


Q ss_pred             HHHHHHHHhCCCCCccccCCchhhhHHhhhccccc-------hhHHHHHHhhhccCC------CCCHHHHHHHHHHHHHh
Q 023752          148 GVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR-------DSRRVLRIMDTRLGG------QYSKKEAQAVAAVVLQC  214 (278)
Q Consensus       148 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~~  214 (278)
                      ||++|+|++|..||.+.+.......+.........       ...............      .....++.++.+||.+|
T Consensus       210 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  289 (353)
T 2b9h_A          210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRM  289 (353)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHh
Confidence            99999999999999876543332222221111100       000011111110000      01235678899999999


Q ss_pred             ccCCCCCCCCHHHHHHH
Q 023752          215 LHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       215 l~~dp~~Rps~~~ll~~  231 (278)
                      |+.||.+|||+.++++|
T Consensus       290 L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          290 LVFDPAKRITAKEALEH  306 (353)
T ss_dssp             SCSSGGGSCCHHHHHTS
T ss_pred             cCcCcccCCCHHHHhcC
Confidence            99999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-36  Score=261.23  Aligned_cols=220  Identities=20%  Similarity=0.320  Sum_probs=166.8

Q ss_pred             hHHHHHHHhccC-----------CccccceeeeeecCC----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLR-----------HENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l   66 (278)
                      +.+|+.+++++.           |+||+++++++...+    ..++++|++ +++|.+++.......+++..+..++.||
T Consensus        62 ~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi  140 (373)
T 1q8y_A           62 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL  140 (373)
T ss_dssp             HHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHH
T ss_pred             hhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHH
Confidence            568999999886           889999999997654    689999999 8899999987665679999999999999


Q ss_pred             HHHHHHHhcCCC-CeeecCCCCCceEEcC------CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC
Q 023752           67 ARGLSFLHGLDA-NVIYRDLKASNVLLDS------NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT  139 (278)
Q Consensus        67 ~~~l~~Lh~~~~-~i~H~dl~p~ni~~~~------~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  139 (278)
                      +.||.|||  +. |++|+||||+||+++.      .+.+||+|||++.......     ....+++.|+|||++.+..++
T Consensus       141 ~~aL~~lH--~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~  213 (373)
T 1q8y_A          141 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWG  213 (373)
T ss_dssp             HHHHHHHH--HTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCC
T ss_pred             HHHHHHHH--hcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCC
Confidence            99999999  87 9999999999999943      3479999999987643321     223578899999999999999


Q ss_pred             CccchhHHHHHHHHHHhCCCCCccccCCch------hhhHHhhhccccch----hH---------------------HHH
Q 023752          140 PKSDVYSFGVVLLELLSGRRALDEDRGGLA------EQTLVEWADPFLRD----SR---------------------RVL  188 (278)
Q Consensus       140 ~~~DiwslG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~----~~---------------------~~~  188 (278)
                      .++||||||+++|+|++|..||........      ...+..........    ..                     ...
T Consensus       214 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (373)
T 1q8y_A          214 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE  293 (373)
T ss_dssp             THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred             chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchh
Confidence            999999999999999999999976543211      11111111100000    00                     000


Q ss_pred             HHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          189 RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ...  ......+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       294 ~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          294 DVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HHH--HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             hhh--hhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence            001  11234567889999999999999999999999999975

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.8e-36  Score=258.65  Aligned_cols=218  Identities=24%  Similarity=0.346  Sum_probs=165.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc------cEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN------RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.++++++||||+++++++...+.      .++++||+. ++|.+++.    ..+++..+..++.|++.||.||| 
T Consensus        70 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH-  143 (353)
T 3coi_A           70 AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIH-  143 (353)
T ss_dssp             HHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH-
Confidence            5689999999999999999999987654      499999996 58887763    24899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.|++|+||+|+||+++.++.++|+|||++......     .....+++.|+|||.+.+ ..++.++|+||||+++|+|
T Consensus       144 -~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el  217 (353)
T 3coi_A          144 -SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM  217 (353)
T ss_dssp             -HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHH
T ss_pred             -HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHH
Confidence             899999999999999999999999999998754322     122457889999999876 6789999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccc-------hh--HHHHHHhhhcc---CCCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLR-------DS--RRVLRIMDTRL---GGQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||.+.+.......+.........       ..  ......+....   .......++.++.+||.+||+.||.+|
T Consensus       218 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  297 (353)
T 3coi_A          218 LTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR  297 (353)
T ss_dssp             HHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTS
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccC
Confidence            9999999875543333322221111100       00  00001000000   112234678899999999999999999


Q ss_pred             CCHHHHHHH
Q 023752          223 PSMVDVLTS  231 (278)
Q Consensus       223 ps~~~ll~~  231 (278)
                      ||+.++++|
T Consensus       298 pt~~e~l~h  306 (353)
T 3coi_A          298 LTAAQALTH  306 (353)
T ss_dssp             CCHHHHHTS
T ss_pred             CCHHHHhcC
Confidence            999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=8.7e-36  Score=256.04  Aligned_cols=229  Identities=24%  Similarity=0.305  Sum_probs=168.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc-------cEEEEeccCCCCHHHHHhh--cCCCCCCHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN-------RLLVYEFMPKGSLENHLFR--KGVQPISWPTRVKIAIDVARGLSF   72 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~~l~~~l~~   72 (278)
                      +.+|++.++.++||||+++++++...+.       .++||||+.+ +|.+.+..  .....+++..+..++.|++.||.|
T Consensus        66 ~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  144 (360)
T 3e3p_A           66 ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC  144 (360)
T ss_dssp             HHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            3567777888899999999999965443       7899999965 55554432  223468999999999999999999


Q ss_pred             HhcCCCCeeecCCCCCceEEcC-CCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHH
Q 023752           73 LHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVV  150 (278)
Q Consensus        73 Lh~~~~~i~H~dl~p~ni~~~~-~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~i  150 (278)
                      ||..+.|++|+||||+||+++. ++.+||+|||++.........   ....++..|+|||++.+. .++.++|||||||+
T Consensus       145 lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i  221 (360)
T 3e3p_A          145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCI  221 (360)
T ss_dssp             HTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHH
Confidence            9965679999999999999997 899999999999865433221   224578899999998654 48999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhh----------------ccCCCCCHHHHHHHHHHHHHh
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDT----------------RLGGQYSKKEAQAVAAVVLQC  214 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~l~~li~~~  214 (278)
                      +|+|++|..||...+.......+...........   ......                .........++.++.+||.+|
T Consensus       222 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  298 (360)
T 3e3p_A          222 FAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV---LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL  298 (360)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH---HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred             HHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH---HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHH
Confidence            9999999999987655444433333222111110   000000                000112233678999999999


Q ss_pred             ccCCCCCCCCHHHHHHH--HHhhhc
Q 023752          215 LHMDPKNRPSMVDVLTS--LEQLHT  237 (278)
Q Consensus       215 l~~dp~~Rps~~~ll~~--l~~~~~  237 (278)
                      |+.||.+|||+.++++|  +.++..
T Consensus       299 L~~dP~~Rpt~~e~l~hp~f~~~~~  323 (360)
T 3e3p_A          299 LQYLPEERMKPYEALCHPYFDELHD  323 (360)
T ss_dssp             TCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred             hccCccccCCHHHHhcCccccccCC
Confidence            99999999999999976  444443

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.3e-36  Score=264.54  Aligned_cols=210  Identities=24%  Similarity=0.360  Sum_probs=157.2

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++|+++ +||||+++++++.+.+..|+|+|++. ++|.+++..... ...+..+..++.|++.||.|||  +.|+
T Consensus        64 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH--~~~i  139 (432)
T 3p23_A           64 ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLH--SLNI  139 (432)
T ss_dssp             CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHH--HCcC
Confidence            46899999999 79999999999999999999999995 699999976643 3445567899999999999999  8999


Q ss_pred             eecCCCCCceEEcC---C--CceEEeccccccCCCCCCCC-ccccccccCCcccCccccc---cCCCCCccchhHHHHHH
Q 023752           81 IYRDLKASNVLLDS---N--FNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVA---TGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        81 ~H~dl~p~ni~~~~---~--~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~---~~~~~~~~DiwslG~il  151 (278)
                      +||||||+||+++.   +  ..++|+|||++......... .......+++.|+|||++.   ...++.++|||||||++
T Consensus       140 vHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il  219 (432)
T 3p23_A          140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF  219 (432)
T ss_dssp             CCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHH
T ss_pred             EeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHH
Confidence            99999999999953   2  35789999999765433221 1223356899999999987   35677899999999999


Q ss_pred             HHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          152 LELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       152 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |+|++ |..||...............                ...........+..+.+||.+||+.||.+|||+.++++
T Consensus       220 ~ellt~g~~pf~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          220 YYVISEGSHPFGKSLQRQANILLGAC----------------SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHTTSCBTTBSTTTHHHHHHTTCC----------------CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHcCCCCCcchhhHHHHHHHhccC----------------CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            99999 89998543221110000000                00011123456778999999999999999999999995


Q ss_pred             H
Q 023752          231 S  231 (278)
Q Consensus       231 ~  231 (278)
                      |
T Consensus       284 h  284 (432)
T 3p23_A          284 H  284 (432)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.4e-36  Score=258.86  Aligned_cols=208  Identities=21%  Similarity=0.321  Sum_probs=144.3

Q ss_pred             HHhccCCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            8 YLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         8 ~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      .++.+.||||+++++++..    ....++||||+.+++|.+++.+.....+++..++.++.|++.||.|||  +.|++|+
T Consensus        75 ~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~ivH~  152 (336)
T 3fhr_A           75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--SHNIAHR  152 (336)
T ss_dssp             HHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH--HTTEECS
T ss_pred             HHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCeecC
Confidence            4566699999999999976    345899999999999999998776567999999999999999999999  8999999


Q ss_pred             CCCCCceEEcC---CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           84 DLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        84 dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      ||+|+||+++.   ++.++|+|||++.......    .....+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus       153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  228 (336)
T 3fhr_A          153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP  228 (336)
T ss_dssp             CCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCC
T ss_pred             CCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence            99999999976   4559999999987543322    1224568899999999888889999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |..............           ...........+....++.++.+||.+||+.||.+|||+.+++++-
T Consensus       229 f~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          229 FYSNTGQAISPGMKR-----------RIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             C--------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             CCCccchhhhhhHHH-----------hhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            975543221111100           0000011112223356788999999999999999999999999854

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5e-36  Score=252.73  Aligned_cols=197  Identities=25%  Similarity=0.436  Sum_probs=162.5

Q ss_pred             hHHHHHHHhcc----CCccccceeeeeecCCccEEEEec-cCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQL----RHENLVKLIGYCSESDNRLLVYEF-MPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l----~h~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.+++++    +||||+++++++.+.+..++|+|+ +.+++|.+++..+.  .+++..+..++.|++.||.|||  
T Consensus        81 ~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH--  156 (312)
T 2iwi_A           81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH--  156 (312)
T ss_dssp             CCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--
Confidence            45799999999    899999999999999999999999 78899999998765  6999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEc-CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC-CccchhHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT-PKSDVYSFGVVLLEL  154 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~il~~l  154 (278)
                      +.|++|+||+|+||+++ .++.++|+|||++.......    .....++..|+|||.+.+..+. .++|+||||+++|+|
T Consensus       157 ~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  232 (312)
T 2iwi_A          157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDM  232 (312)
T ss_dssp             HHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred             HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHH
Confidence            88999999999999998 78999999999987654322    1234578899999998777664 589999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|..||.....                       ...  .....+..++..+.++|.+||+.||++|||+.+++++
T Consensus       233 ~~g~~pf~~~~~-----------------------~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          233 VCGDIPFERDQE-----------------------ILE--AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHSSCSCCSHHH-----------------------HHH--TCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHCCCCCCChHH-----------------------Hhh--hccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            999999964211                       000  1123455678889999999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.5e-36  Score=254.72  Aligned_cols=197  Identities=21%  Similarity=0.383  Sum_probs=165.4

Q ss_pred             hHHHHHHHhccC--CccccceeeeeecCCccEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLR--HENLVKLIGYCSESDNRLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|+.+++++.  |+||+++++++.+.+..++|+|++.+ ++|.+++....  .+++..+..++.|++.||.|||  +.
T Consensus        93 ~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH--~~  168 (320)
T 3a99_A           93 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH--NC  168 (320)
T ss_dssp             EEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             HHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HC
Confidence            457999999996  59999999999999999999999976 89999998765  6899999999999999999999  89


Q ss_pred             CeeecCCCCCceEEc-CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHh
Q 023752           79 NVIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~  156 (278)
                      |++|+||+|+||+++ .++.+||+|||++.......    .....++..|+|||.+.+..+ +.++|+||||+++|+|++
T Consensus       169 ~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~  244 (320)
T 3a99_A          169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC  244 (320)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH
Confidence            999999999999998 77899999999987654322    122457889999999877766 678999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||.....      +                 ..  .....+..++.++.++|.+||+.||.+|||+.+++++
T Consensus       245 g~~pf~~~~~------~-----------------~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          245 GDIPFEHDEE------I-----------------IR--GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             SSCSCCSHHH------H-----------------HH--CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCChhh------h-----------------hc--ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            9999964311      0                 00  0122334567889999999999999999999999874

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.3e-36  Score=264.21  Aligned_cols=213  Identities=22%  Similarity=0.353  Sum_probs=157.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCC-----CCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQP-----ISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+++++++ +||||+++++++.+.+..++|+|++. ++|.+++.......     ..+..++.++.|++.||.||| 
T Consensus        55 ~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-  132 (434)
T 2rio_A           55 ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-  132 (434)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH-
Confidence            46899999887 89999999999999999999999995 69999997654211     123345789999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCC-------------CceEEeccccccCCCCCCCCc--cccccccCCcccCcccccc-----
Q 023752           76 LDANVIYRDLKASNVLLDSN-------------FNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVAT-----  135 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~-------------~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~-----  135 (278)
                       +.|++|+||||+||+++.+             +.+||+|||++..........  ......+++.|+|||++.+     
T Consensus       133 -~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  211 (434)
T 2rio_A          133 -SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ  211 (434)
T ss_dssp             -HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTS
T ss_pred             -HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccc
Confidence             8999999999999999754             479999999998654432211  1223468899999999865     


Q ss_pred             --CCCCCccchhHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHH
Q 023752          136 --GHLTPKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVL  212 (278)
Q Consensus       136 --~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  212 (278)
                        ..++.++|||||||++|+|++ |..||.......  ..+.......            .......+..++.++.++|.
T Consensus       212 ~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~------------~~~~~~~~~~~~~~~~~li~  277 (434)
T 2rio_A          212 TKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSL------------DEMKCLHDRSLIAEATDLIS  277 (434)
T ss_dssp             CCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCC------------CCCTTCCCHHHHHHHHHHHH
T ss_pred             cccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCc------------ccccccccccchHHHHHHHH
Confidence              568899999999999999999 999996532211  1111100000            00111224578899999999


Q ss_pred             HhccCCCCCCCCHHHHHHH
Q 023752          213 QCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       213 ~~l~~dp~~Rps~~~ll~~  231 (278)
                      +||+.||.+|||+.++++|
T Consensus       278 ~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          278 QMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HHTCSSGGGSCCHHHHHTS
T ss_pred             HHhhCChhhCCCHHHHHhC
Confidence            9999999999999999863

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-36  Score=263.00  Aligned_cols=211  Identities=12%  Similarity=0.085  Sum_probs=146.7

Q ss_pred             hHHHHHHHhcc--CCcccccee-------eeeecCC-----------------ccEEEEeccCCCCHHHHHhhcCCCCCC
Q 023752            2 WQTEVIYLGQL--RHENLVKLI-------GYCSESD-----------------NRLLVYEFMPKGSLENHLFRKGVQPIS   55 (278)
Q Consensus         2 ~~~E~~~l~~l--~h~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~~~~~~~~~~~   55 (278)
                      +++|+.+++.+  +||||++++       +++...+                 ..|+||||+. ++|.+++...+. .++
T Consensus       109 ~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~  186 (371)
T 3q60_A          109 LHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYV  186 (371)
T ss_dssp             HHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCC
T ss_pred             HHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccc
Confidence            45775444444  699988855       4443332                 3799999997 899999976532 244


Q ss_pred             HHHH------HHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccC
Q 023752           56 WPTR------VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAA  129 (278)
Q Consensus        56 ~~~~------~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~a  129 (278)
                      ...+      ..++.||+.||.|||  +.|++||||||+||+++.++.+||+|||++......     .....+++.|+|
T Consensus       187 ~~~~~~~~vk~~i~~qi~~aL~~LH--~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~a  259 (371)
T 3q60_A          187 FRGDEGILALHILTAQLIRLAANLQ--SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAP  259 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHH--HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCC
T ss_pred             hhhhhhhhhHHHHHHHHHHHHHHHH--HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcC
Confidence            4455      677799999999999  899999999999999999999999999999764321     112345689999


Q ss_pred             cccccc--CCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHH
Q 023752          130 PEYVAT--GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAV  207 (278)
Q Consensus       130 PE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  207 (278)
                      ||++.+  ..++.++|||||||++|+|++|..||.......... ...   ...      ..........+....++..+
T Consensus       260 PE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~-~~~---~~~------~~~~~~~~~~~~~~~~~~~~  329 (371)
T 3q60_A          260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS-WKR---PSL------RVPGTDSLAFGSCTPLPDFV  329 (371)
T ss_dssp             HHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC-CCB---CCT------TSCCCCSCCCTTSSCCCHHH
T ss_pred             hhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc-hhh---hhh------hhccccccchhhccCCCHHH
Confidence            999977  678999999999999999999999997654321110 000   000      00000011122234678899


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 023752          208 AAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       208 ~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+||.+||+.||++|||+.++++|
T Consensus       330 ~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          330 KTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcC
Confidence            999999999999999999999853

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.1e-35  Score=252.17  Aligned_cols=209  Identities=25%  Similarity=0.335  Sum_probs=144.9

Q ss_pred             HHHH-HHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhh---cCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-
Q 023752            4 TEVI-YLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFR---KGVQPISWPTRVKIAIDVARGLSFLHGLDA-   78 (278)
Q Consensus         4 ~E~~-~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-   78 (278)
                      .|+. +++.++||||+++++++.+.+..++|+||+.+ +|.+++..   .....+++..+..++.|++.||.|||  +. 
T Consensus        69 ~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH--~~~  145 (327)
T 3aln_A           69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENL  145 (327)
T ss_dssp             HHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH--HHH
T ss_pred             HHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh--ccC
Confidence            4454 77778999999999999999999999999965 88877753   22347999999999999999999999  77 


Q ss_pred             CeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccc----ccCCCCCccchhHHHHHHHHH
Q 023752           79 NVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYV----ATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----~~~~~~~~~DiwslG~il~~l  154 (278)
                      |++|+||+|+||+++.++.+||+|||++........   .....++..|+|||.+    .+..++.++|+||||+++|+|
T Consensus       146 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l  222 (327)
T 3aln_A          146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL  222 (327)
T ss_dssp             SCCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHH
T ss_pred             CEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999999999876433221   1223578899999998    456789999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|..||........  .+.....    .       ............++..+.+||.+||+.||.+|||+.+++++
T Consensus       223 ~~g~~pf~~~~~~~~--~~~~~~~----~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          223 ATGRFPYPKWNSVFD--QLTQVVK----G-------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             HHSCCCSSCC---------CCCCC----S-------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHCCCCCCCcchHHH--HHHHHhc----C-------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence            999999975432100  0000000    0       00001111223567889999999999999999999999864

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.5e-35  Score=246.74  Aligned_cols=206  Identities=23%  Similarity=0.336  Sum_probs=153.5

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-Cee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA-NVI   81 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~-~i~   81 (278)
                      .++..+++.++||||+++++++.+++..++|+||+ ++.+..+..... ..+++..+..++.|++.||.|||  +. |++
T Consensus        72 ~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH--~~~~i~  147 (318)
T 2dyl_A           72 MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ-GPIPERILGKMTVAIVKALYYLK--EKHGVI  147 (318)
T ss_dssp             HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH--HHHCCC
T ss_pred             HHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH--hhCCEE
Confidence            34555788889999999999999999999999999 556666555432 46999999999999999999999  75 999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~  156 (278)
                      |+||+|+||+++.++.++|+|||++........   .....+++.|+|||.+.     +..++.++||||||+++|+|++
T Consensus       148 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~  224 (318)
T 2dyl_A          148 HRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT  224 (318)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH
T ss_pred             eCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh
Confidence            999999999999999999999999865433221   22345788999999984     4568889999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhc-cCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTR-LGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||.......                .......... ...+....++.++.++|.+||+.||.+||++.+++++
T Consensus       225 g~~pf~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          225 GQFPYKNCKTDF----------------EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             SSCTTTTCCSHH----------------HHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCCCCCCCCccH----------------HHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            999997532210                0111111111 1111223467889999999999999999999999964

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.9e-34  Score=261.09  Aligned_cols=233  Identities=23%  Similarity=0.304  Sum_probs=171.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeec------CCccEEEEeccCCCCHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE------SDNRLLVYEFMPKGSLENHLFRKG-VQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      |.+|++++++++||||+++++++..      .+..++|+||+.|++|.+++.... ...+++..+..++.|++.||.|||
T Consensus        59 ~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH  138 (676)
T 3qa8_A           59 WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH  138 (676)
T ss_dssp             HHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            6789999999999999999998765      667899999999999999997643 235888899999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCc---eEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVL  151 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~---~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il  151 (278)
                        +.|++|+||+|+||+++.++.   ++|+|||++........   .....++..|+|||.+.+..++.++|+||||+++
T Consensus       139 --s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviL  213 (676)
T 3qa8_A          139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA  213 (676)
T ss_dssp             --HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHH
T ss_pred             --HCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHH
Confidence              899999999999999987665   89999999986543322   2234678999999999999999999999999999


Q ss_pred             HHHHhCCCCCccccCCchh-hhHHhhhcc---ccchhHHHHHH-hhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH
Q 023752          152 LELLSGRRALDEDRGGLAE-QTLVEWADP---FLRDSRRVLRI-MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV  226 (278)
Q Consensus       152 ~~l~~g~~p~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  226 (278)
                      |+|++|..||......... ..+......   ..........+ ............++..+.++|.+||..||.+|||+.
T Consensus       214 yeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~  293 (676)
T 3qa8_A          214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDP  293 (676)
T ss_dssp             HHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCT
T ss_pred             HHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHH
Confidence            9999999999653211000 000000000   00000000000 000112234567899999999999999999999998


Q ss_pred             H-----HHHHHHhhhcCC
Q 023752          227 D-----VLTSLEQLHTSK  239 (278)
Q Consensus       227 ~-----ll~~l~~~~~~~  239 (278)
                      +     ..+.+..+...+
T Consensus       294 elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          294 QNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             TCCCCTTHHHHHHHHCCC
T ss_pred             HHhcCHHHHHHHHHHhcc
Confidence            8     456666666654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.6e-34  Score=242.19  Aligned_cols=190  Identities=21%  Similarity=0.335  Sum_probs=150.3

Q ss_pred             hHHHHHHH-hccCCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYL-GQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l-~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.++ +..+||||+++++++..    .+..++|+||+.+++|.+++.......+++..+..++.|++.||.|||  
T Consensus        57 ~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH--  134 (299)
T 3m2w_A           57 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--  134 (299)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence            46788888 55589999999999876    567899999999999999998876567999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcC---CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      +.|++|+||+|+||+++.   ++.++|+|||++....                        +..++.++|+|||||++|+
T Consensus       135 ~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~e  190 (299)
T 3m2w_A          135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYI  190 (299)
T ss_dssp             HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHH
T ss_pred             hCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHH
Confidence            899999999999999988   7889999999885321                        2346778999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC----HHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS----KKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |++|..||...........+.....               ......+    ..++.++.++|.+||+.||.+|||+.+++
T Consensus       191 l~tg~~pf~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l  255 (299)
T 3m2w_A          191 LLCGYPPFYSNHGLAISPGMKTRIR---------------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM  255 (299)
T ss_dssp             HHHSSCSCCC-------CCSCCSSC---------------TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             HHHCCCCCCCCcchhhhHHHHHHHh---------------hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHh
Confidence            9999999975443211111000000               0001111    34678899999999999999999999999


Q ss_pred             HHH
Q 023752          230 TSL  232 (278)
Q Consensus       230 ~~l  232 (278)
                      +|-
T Consensus       256 ~hp  258 (299)
T 3m2w_A          256 NHP  258 (299)
T ss_dssp             TSH
T ss_pred             cCh
Confidence            753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.8e-34  Score=239.27  Aligned_cols=191  Identities=17%  Similarity=0.143  Sum_probs=151.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+++..|+||||+.|++|.+++.++    .....+..++.|++.||.|||  +.|++
T Consensus        78 ~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH--~~giv  151 (286)
T 3uqc_A           78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH--RAGVA  151 (286)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH--HCCCc
Confidence            678999999999999999999999999999999999999999998532    355678889999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      |+||||+||+++.++.++|++++..                      +       .++.++|||||||++|+|++|..||
T Consensus       152 H~Dikp~NIll~~~g~~kl~~~~~~----------------------~-------~~~~~~Di~slG~il~elltg~~Pf  202 (286)
T 3uqc_A          152 LSIDHPSRVRVSIDGDVVLAYPATM----------------------P-------DANPQDDIRGIGASLYALLVNRWPL  202 (286)
T ss_dssp             CCCCSGGGEEEETTSCEEECSCCCC----------------------T-------TCCHHHHHHHHHHHHHHHHHSEECS
T ss_pred             cCCCCcccEEEcCCCCEEEEecccc----------------------C-------CCCchhHHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999854322                      2       2678999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCCC
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  240 (278)
                      .+.+...................            ......++.++.++|.+||+.||++| |+.++++.|+++.....
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          203 PEAGVRSGLAPAERDTAGQPIEP------------ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             CCCSBCCCSEECCBCTTSCBCCH------------HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             CcCCcchhhHHHHHHhccCCCCh------------hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            86554321110000000000000            01123567789999999999999999 99999999999987643

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-33  Score=260.26  Aligned_cols=195  Identities=23%  Similarity=0.369  Sum_probs=156.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc-----cEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN-----RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      |.+|++++++++||||+++++++.+.+.     .|+||||+.|++|.+++..    .+++..+..++.||+.||.|||  
T Consensus       126 ~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH--  199 (681)
T 2pzi_A          126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH--  199 (681)
T ss_dssp             HHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH--
Confidence            5789999999999999999999987765     6999999999999887643    5899999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      +.||+|+||||+||+++.+ .+||+|||++......      ....+++.|+|||++.+. ++.++||||||+++|+|++
T Consensus       200 ~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~  271 (681)
T 2pzi_A          200 SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTL  271 (681)
T ss_dssp             HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHS
T ss_pred             HCCCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHh
Confidence            8999999999999999875 8999999998764332      234588999999998665 4889999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-HHHHHHHHHhh
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-MVDVLTSLEQL  235 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~l~~~  235 (278)
                      |..||.+......         +   .             .......+..+.++|.+||+.||.+||+ ++++...|..+
T Consensus       272 g~~~~~~~~~~~~---------~---~-------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          272 DLPTRNGRYVDGL---------P---E-------------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             CCCEETTEECSSC---------C---T-------------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCCCcccccccc---------c---c-------------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence            9988864321100         0   0             0001234567899999999999999995 55566655544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.97  E-value=5.8e-33  Score=242.79  Aligned_cols=171  Identities=18%  Similarity=0.268  Sum_probs=132.7

Q ss_pred             ccEEEEeccCCCCHHHHHh-----hcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEecc
Q 023752           29 NRLLVYEFMPKGSLENHLF-----RKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDF  103 (278)
Q Consensus        29 ~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~df  103 (278)
                      ..+++++.+ +++|.+++.     ......+++..+..++.|++.||.|||  +.||+||||||+||+++.++.+||+||
T Consensus       179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH--~~~iiHrDiKp~NILl~~~~~~kL~DF  255 (413)
T 3dzo_A          179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRGGVFLTGF  255 (413)
T ss_dssp             SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH--HTTEECSCCCGGGEEECTTCCEEECCG
T ss_pred             ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCcccceEEEecCCeEEEEec
Confidence            356777765 689999884     222235778889999999999999999  899999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCCcccCcccc----------ccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhH
Q 023752          104 GLARDGPTGDNTHVSTRIVGTRGYAAPEYV----------ATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL  173 (278)
Q Consensus       104 g~~~~~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~  173 (278)
                      |++......     .....+ +.|+|||++          .+..++.++|||||||++|+|++|+.||...........+
T Consensus       256 G~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~  329 (413)
T 3dzo_A          256 EHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI  329 (413)
T ss_dssp             GGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG
T ss_pred             cceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH
Confidence            998753322     223456 899999998          4556788999999999999999999999764432111111


Q ss_pred             HhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          174 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .                       .....++..+.+||.+||+.||++||++.+++++
T Consensus       330 ~-----------------------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          330 F-----------------------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             G-----------------------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             H-----------------------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0                       0012356789999999999999999998777643

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=2.7e-32  Score=232.33  Aligned_cols=200  Identities=18%  Similarity=0.131  Sum_probs=149.5

Q ss_pred             hHHHHHHHhccC--------------------------Cccccceeeeeec-------------CCccEEEEeccCCCCH
Q 023752            2 WQTEVIYLGQLR--------------------------HENLVKLIGYCSE-------------SDNRLLVYEFMPKGSL   42 (278)
Q Consensus         2 ~~~E~~~l~~l~--------------------------h~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L   42 (278)
                      +.+|+.+++.++                          ||||++++++|.+             .+..|+||||+.+|++
T Consensus        70 ~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~l  149 (336)
T 2vuw_A           70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID  149 (336)
T ss_dssp             HHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEE
T ss_pred             HHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCcc
Confidence            578999998886                          6666666666664             6789999999999977


Q ss_pred             HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCC--------------------ceEEec
Q 023752           43 ENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNF--------------------NAKLSD  102 (278)
Q Consensus        43 ~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~--------------------~~kl~d  102 (278)
                      .+.+.+   +.+++..+..++.||+.||.|||+ +.||+||||||+||+++.++                    .+||+|
T Consensus       150 l~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D  225 (336)
T 2vuw_A          150 LEQMRT---KLSSLATAKSILHQLTASLAVAEA-SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID  225 (336)
T ss_dssp             TGGGTT---TCCCHHHHHHHHHHHHHHHHHHHH-HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred             HHHHHh---cCCCHHHHHHHHHHHHHHHHHHHH-hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence            766644   358999999999999999999993 36899999999999999887                    899999


Q ss_pred             cccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHH-HHHHHhCCCCCccccCCchhhhHHhhhcccc
Q 023752          103 FGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV-LLELLSGRRALDEDRGGLAEQTLVEWADPFL  181 (278)
Q Consensus       103 fg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i-l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  181 (278)
                      ||++.....       ....+++.|+|||++.+.. +.++||||||++ .+++++|..||......   ....       
T Consensus       226 FG~a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~---~~~~-------  287 (336)
T 2vuw_A          226 YTLSRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL---HYLT-------  287 (336)
T ss_dssp             CTTCBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH---HHHH-------
T ss_pred             ccccEecCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh---hHHH-------
Confidence            999975432       1236889999999998766 889999998777 77788899988531100   0000       


Q ss_pred             chhHHHHHHhh--hccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH-HH
Q 023752          182 RDSRRVLRIMD--TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL-TS  231 (278)
Q Consensus       182 ~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll-~~  231 (278)
                         ........  .......+..+++++.+||.+||+.|     |+.+++ +|
T Consensus       288 ---~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          288 ---DKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             ---HHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             ---HhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence               00000000  00111123568999999999999977     999998 64

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=1.7e-30  Score=235.04  Aligned_cols=148  Identities=22%  Similarity=0.170  Sum_probs=112.7

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|+++|+++ .|+||+++++++++++..||||||++|++|.+++.+++  ++++.   .++.||+.||.|+|  ++||
T Consensus       288 ~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH--~~GI  360 (569)
T 4azs_A          288 LHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALE--KQGF  360 (569)
T ss_dssp             HHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHH--HCCc
Confidence            78999999999 79999999999999999999999999999999998765  56654   47899999999999  9999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      +||||||+||+++.+|.+||+|||++.......  .......|++.|+|||++.+. +..++|+|++|++++.+.++..
T Consensus       361 IHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          361 WHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             EESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             eeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence            999999999999999999999999987644332  223345789999999998754 5678999999999887766543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.87  E-value=1.5e-23  Score=188.71  Aligned_cols=146  Identities=17%  Similarity=0.231  Sum_probs=121.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++..++...+..|+||||+++++|.+++..          +..++.|++.+|.|||  +.|++
T Consensus       386 ~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH--~~gIi  453 (540)
T 3en9_A          386 TAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH--KNDVI  453 (540)
T ss_dssp             HHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH--HCcCc
Confidence            68999999999999999665555567788999999999999999864          4589999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-----cccccccCCcccCcccccc--CCCCCccchhHHHHHHHHH
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVAT--GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~--~~~~~~~DiwslG~il~~l  154 (278)
                      |+||||+||+++.  .+||+|||++..........     ......+++.|+|||++.+  ..|+..+|+|+..+-..+-
T Consensus       454 HrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~  531 (540)
T 3en9_A          454 HNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKD  531 (540)
T ss_dssp             CTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHH
T ss_pred             cCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHH
Confidence            9999999999998  99999999998754422111     1123568899999999977  5678889999998888888


Q ss_pred             HhCCCCC
Q 023752          155 LSGRRAL  161 (278)
Q Consensus       155 ~~g~~p~  161 (278)
                      +.++.+|
T Consensus       532 v~~r~rY  538 (540)
T 3en9_A          532 VERRARY  538 (540)
T ss_dssp             HHTCSCC
T ss_pred             HHhcccc
Confidence            7777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.70  E-value=9.2e-18  Score=139.00  Aligned_cols=102  Identities=13%  Similarity=0.117  Sum_probs=84.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++  | +++.+++.. +..|+||||++|++|.+ +.      .  .....++.|++.||.|||  +.|++
T Consensus       151 ~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH--~~gii  215 (282)
T 1zar_A          151 ARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFY--HRGIV  215 (282)
T ss_dssp             HHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHH--HCCCE
Confidence            579999999998  5 677776544 56799999999999988 42      1  134579999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA  134 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  134 (278)
                      |+||||+||+++ ++.++|+|||++..               ...+.|||.+.
T Consensus       216 HrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          216 HGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             CSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             eCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            999999999999 99999999999863               23457888763

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.42  E-value=1.5e-13  Score=112.15  Aligned_cols=95  Identities=19%  Similarity=0.191  Sum_probs=74.4

Q ss_pred             hHHHHHHHhccCCccc--cceeeeeecCCccEEEEeccCC-C----CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQLRHENL--VKLIGYCSESDNRLLVYEFMPK-G----SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      +.+|+.+|+++.|++|  +.+++.    +..++||||+.+ |    +|.+....     .++..+..++.|++.+|.|||
T Consensus       117 ~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH  187 (258)
T 1zth_A          117 TEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLY  187 (258)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHH
Confidence            4689999999988754  344432    367899999942 3    67766532     223467889999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           75 GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      . ..|++|+||||.||+++.  .++|+|||++..
T Consensus       188 ~-~~givHrDlkp~NILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          188 Q-EAELVHADLSEYNIMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             H-TSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred             H-HCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence            4 369999999999999988  899999999964

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.16  E-value=6.5e-12  Score=107.31  Aligned_cols=93  Identities=12%  Similarity=0.144  Sum_probs=65.9

Q ss_pred             HHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      .|...|.++.+.++. ....+.. ...++||||++|++|.++..      .+  ....++.|++.+|.+||  ..|++||
T Consensus       162 kE~~nL~rL~~~gv~-vp~p~~~-~~~~LVME~i~G~~L~~l~~------~~--~~~~l~~qll~~l~~lH--~~gIVHr  229 (397)
T 4gyi_A          162 KEFAFMKALYEEGFP-VPEPIAQ-SRHTIVMSLVDALPMRQVSS------VP--DPASLYADLIALILRLA--KHGLIHG  229 (397)
T ss_dssp             HHHHHHHHHHHTTCS-CCCEEEE-ETTEEEEECCSCEEGGGCCC------CS--CHHHHHHHHHHHHHHHH--HTTEECS
T ss_pred             HHHHHHHHHHhcCCC-CCeeeec-cCceEEEEecCCccHhhhcc------cH--HHHHHHHHHHHHHHHHH--HCCCcCC
Confidence            455566666433322 1111211 23479999999888765431      11  34578899999999999  8999999


Q ss_pred             CCCCCceEEcCCC----------ceEEeccccccC
Q 023752           84 DLKASNVLLDSNF----------NAKLSDFGLARD  108 (278)
Q Consensus        84 dl~p~ni~~~~~~----------~~kl~dfg~~~~  108 (278)
                      ||||.||++++++          .+.|+||+.+..
T Consensus       230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999998776          388999998864

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.98  E-value=7.2e-10  Score=90.32  Aligned_cols=99  Identities=15%  Similarity=0.070  Sum_probs=78.7

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD---   77 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~---   77 (278)
                      +.+|+.+++.+. +..+.++++++.+.+..|+|||+++|.+|.+...       +......++.++..++..||+..   
T Consensus        56 ~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~  128 (263)
T 3tm0_A           56 VEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISD  128 (263)
T ss_dssp             HHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             HHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCccc
Confidence            678999999994 6778899999988888999999999999887631       11123467888999999999410   


Q ss_pred             ------------------------------------------------------CCeeecCCCCCceEEcCCCceEEecc
Q 023752           78 ------------------------------------------------------ANVIYRDLKASNVLLDSNFNAKLSDF  103 (278)
Q Consensus        78 ------------------------------------------------------~~i~H~dl~p~ni~~~~~~~~kl~df  103 (278)
                                                                            ..++|+|++|.||++++++.+.|+||
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDw  208 (263)
T 3tm0_A          129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL  208 (263)
T ss_dssp             CSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCC
T ss_pred             CCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEc
Confidence                                                                  44899999999999987655679999


Q ss_pred             cccc
Q 023752          104 GLAR  107 (278)
Q Consensus       104 g~~~  107 (278)
                      +.+.
T Consensus       209 e~a~  212 (263)
T 3tm0_A          209 GRSG  212 (263)
T ss_dssp             TTCE
T ss_pred             hhcc
Confidence            8764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.81  E-value=9.3e-09  Score=83.33  Aligned_cols=96  Identities=19%  Similarity=0.172  Sum_probs=72.2

Q ss_pred             hHHHHHHHhccCCcc--ccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--
Q 023752            2 WQTEVIYLGQLRHEN--LVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD--   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~--   77 (278)
                      +.+|+.+++.+.+.+  +.+++++....+..++||||++|.+|.  ..     ...   ...++.+++..+..||+..  
T Consensus        60 ~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~  129 (264)
T 1nd4_A           60 LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPA  129 (264)
T ss_dssp             HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGG
T ss_pred             hhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCC
Confidence            578999999985434  566888888888899999999998874  21     111   2356677778888888321  


Q ss_pred             ------------------------------------------------------CCeeecCCCCCceEEcCCCceEEecc
Q 023752           78 ------------------------------------------------------ANVIYRDLKASNVLLDSNFNAKLSDF  103 (278)
Q Consensus        78 ------------------------------------------------------~~i~H~dl~p~ni~~~~~~~~kl~df  103 (278)
                                                                            ..++|+|++|.||++++++.+.|+||
T Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~  209 (264)
T 1nd4_A          130 TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDC  209 (264)
T ss_dssp             GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCC
T ss_pred             CCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcc
Confidence                                                                  12999999999999987766679999


Q ss_pred             cccc
Q 023752          104 GLAR  107 (278)
Q Consensus       104 g~~~  107 (278)
                      +.+.
T Consensus       210 ~~a~  213 (264)
T 1nd4_A          210 GRLG  213 (264)
T ss_dssp             TTCE
T ss_pred             hhcc
Confidence            8874

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.78  E-value=2.1e-08  Score=85.53  Aligned_cols=103  Identities=16%  Similarity=0.258  Sum_probs=81.6

Q ss_pred             hHHHHHHHhccC--CccccceeeeeecC---CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLR--HENLVKLIGYCSES---DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~--h~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.+++.+.  +..+++++.++.+.   +..|+|||+++|..+.+..    ...++......++.+++..|..||+.
T Consensus        83 ~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~  158 (359)
T 3dxp_A           83 IEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTV  158 (359)
T ss_dssp             HHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCC
Confidence            578999999996  45578888888776   4579999999988775421    12467778888999999999999942


Q ss_pred             --------------------------------------------------------CCCeeecCCCCCceEEcCCCc--e
Q 023752           77 --------------------------------------------------------DANVIYRDLKASNVLLDSNFN--A   98 (278)
Q Consensus        77 --------------------------------------------------------~~~i~H~dl~p~ni~~~~~~~--~   98 (278)
                                                                              ...++|+|+++.||+++.++.  +
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~  238 (359)
T 3dxp_A          159 DYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVL  238 (359)
T ss_dssp             CTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEE
T ss_pred             CchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEE
Confidence                                                                    146899999999999987653  6


Q ss_pred             EEeccccccC
Q 023752           99 KLSDFGLARD  108 (278)
Q Consensus        99 kl~dfg~~~~  108 (278)
                      .|+||+.+..
T Consensus       239 ~viDwe~a~~  248 (359)
T 3dxp_A          239 AVLDWELSTL  248 (359)
T ss_dssp             EECCCTTCEE
T ss_pred             EEECcccccc
Confidence            8999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.64  E-value=3.4e-08  Score=82.20  Aligned_cols=150  Identities=20%  Similarity=0.202  Sum_probs=94.8

Q ss_pred             hHHHHHHHhccC-Ccc--ccceeeeeecCC---ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLR-HEN--LVKLIGYCSESD---NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+|+.+. +..  +.+++......+   ..|+||++++|.+|.+....    .++..+...++.+++..+..||+
T Consensus        57 ~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~  132 (304)
T 3sg8_A           57 LFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHS  132 (304)
T ss_dssp             HHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHc
Confidence            578999998883 322  345555443333   34899999999888754321    35666677777777777777773


Q ss_pred             C--------------------------------------------------------CCCeeecCCCCCceEEcC--CCc
Q 023752           76 L--------------------------------------------------------DANVIYRDLKASNVLLDS--NFN   97 (278)
Q Consensus        76 ~--------------------------------------------------------~~~i~H~dl~p~ni~~~~--~~~   97 (278)
                      .                                                        ...++|+|++|.||++++  .+.
T Consensus       133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~  212 (304)
T 3sg8_A          133 INISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTI  212 (304)
T ss_dssp             SCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEE
T ss_pred             CCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCE
Confidence            1                                                        124799999999999988  455


Q ss_pred             eEEeccccccCCCCCCCCccccccccCCcc---cCccccc----cC-C---------CCCccchhHHHHHHHHHHhCCCC
Q 023752           98 AKLSDFGLARDGPTGDNTHVSTRIVGTRGY---AAPEYVA----TG-H---------LTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        98 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~---~aPE~~~----~~-~---------~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +.++||+.+.........      ......   ..|+...    .. .         .....+.|++|.+++.+.+|..+
T Consensus       213 ~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          213 CGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             EEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHH
T ss_pred             EEEEeCCCCccCChHHHH------HHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHH
Confidence            789999987653221100      000001   1222111    00 0         01125889999999999999876


Q ss_pred             C
Q 023752          161 L  161 (278)
Q Consensus       161 ~  161 (278)
                      |
T Consensus       287 ~  287 (304)
T 3sg8_A          287 W  287 (304)
T ss_dssp             H
T ss_pred             H
Confidence            5

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.33  E-value=5e-06  Score=64.63  Aligned_cols=138  Identities=14%  Similarity=0.040  Sum_probs=93.2

Q ss_pred             CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccc
Q 023752           41 SLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR  120 (278)
Q Consensus        41 ~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  120 (278)
                      +|.+.+...+ +++++.++|.++.|.+.+|.-+-. .+.-...-+.|..|++..+|.|-+.+- ...             
T Consensus        34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~-~~~~~~~i~~~~~i~l~~dG~V~f~~~-~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAAR-RRQPRHRVRSAAQIRVWRDGAVTLAPA-ADD-------------   97 (229)
T ss_dssp             EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSGGGEEEETTSCEEECCC-----------------
T ss_pred             cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhh-cccCCceecCCcceEEecCCceecccc-ccc-------------
Confidence            7999988776 589999999999999999888721 122224455678999999998887641 110             


Q ss_pred             cccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCC
Q 023752          121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYS  200 (278)
Q Consensus       121 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (278)
                       .....+.|||... ...+.+.=|||||+++|..+-...|=                                    ..+
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e------------------------------------~eE  139 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE------------------------------------NEE  139 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT------------------------------------TEE
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc------------------------------------ccc
Confidence             0123467887652 34456778999999999999655442                                    224


Q ss_pred             HHHHHHHHHHHHHhccCC-------------------------CCCCCCHHHHHHHH
Q 023752          201 KKEAQAVAAVVLQCLHMD-------------------------PKNRPSMVDVLTSL  232 (278)
Q Consensus       201 ~~~~~~l~~li~~~l~~d-------------------------p~~Rps~~~ll~~l  232 (278)
                      ..+++.|.+||..|....                         +..|+++++|++.=
T Consensus       140 ~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C  196 (229)
T 2yle_A          140 RELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLC  196 (229)
T ss_dssp             ECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHH
T ss_pred             hhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHH
Confidence            557788999999998662                         45788999988643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.08  E-value=1.1e-05  Score=65.51  Aligned_cols=100  Identities=20%  Similarity=0.170  Sum_probs=72.6

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL----   76 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~----   76 (278)
                      +.+|..+|+.+. +--|.+++.++.+.+..++||++++|.++.+......      .....+..++...|..||+.    
T Consensus        66 ~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~  139 (272)
T 4gkh_A           66 VTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCN  139 (272)
T ss_dssp             HHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGG
T ss_pred             HHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCccc
Confidence            568999998884 3236788888888889999999999988877654321      12334555666666666621    


Q ss_pred             ----------------------------------------------------CCCeeecCCCCCceEEcCCCceEEeccc
Q 023752           77 ----------------------------------------------------DANVIYRDLKASNVLLDSNFNAKLSDFG  104 (278)
Q Consensus        77 ----------------------------------------------------~~~i~H~dl~p~ni~~~~~~~~kl~dfg  104 (278)
                                                                          ...++|+|+.+.||++++++.+-|+||+
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe  219 (272)
T 4gkh_A          140 CPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVG  219 (272)
T ss_dssp             CCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCT
T ss_pred             CCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECc
Confidence                                                                0126899999999999887767799998


Q ss_pred             ccc
Q 023752          105 LAR  107 (278)
Q Consensus       105 ~~~  107 (278)
                      .+.
T Consensus       220 ~a~  222 (272)
T 4gkh_A          220 RVG  222 (272)
T ss_dssp             TCE
T ss_pred             ccc
Confidence            775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.05  E-value=1.9e-05  Score=65.62  Aligned_cols=103  Identities=17%  Similarity=0.171  Sum_probs=67.7

Q ss_pred             hHHHHHHHhccCCc---cccceeeeee-cCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc--
Q 023752            2 WQTEVIYLGQLRHE---NLVKLIGYCS-ESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG--   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~--   75 (278)
                      +.+|+++|+.+.+.   .|.+++.+.. ..+..+++|++++|.++.+....    .++......++.++...|..||+  
T Consensus        56 ~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~  131 (306)
T 3tdw_A           56 LNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFP  131 (306)
T ss_dssp             HHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            57899999999642   3566666664 44567899999999887653211    12333333444444444444442  


Q ss_pred             --------------------------------------------------------CCCCeeecCCCCCceEEcC---CC
Q 023752           76 --------------------------------------------------------LDANVIYRDLKASNVLLDS---NF   96 (278)
Q Consensus        76 --------------------------------------------------------~~~~i~H~dl~p~ni~~~~---~~   96 (278)
                                                                              ....++|+|+++.||+++.   ++
T Consensus       132 ~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~  211 (306)
T 3tdw_A          132 VETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQT  211 (306)
T ss_dssp             HHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSC
T ss_pred             cccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCC
Confidence                                                                    1335799999999999987   45


Q ss_pred             c-eEEeccccccC
Q 023752           97 N-AKLSDFGLARD  108 (278)
Q Consensus        97 ~-~kl~dfg~~~~  108 (278)
                      . +.|+||+.+..
T Consensus       212 ~~~~~iD~~~a~~  224 (306)
T 3tdw_A          212 PLTGIIDFGDAAI  224 (306)
T ss_dssp             CEEEECCCTTCEE
T ss_pred             ceEEEEehhhcCC
Confidence            5 47999987754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.76  E-value=5.5e-05  Score=64.06  Aligned_cols=42  Identities=0%  Similarity=-0.008  Sum_probs=31.0

Q ss_pred             hHHHHHHHhccCC---ccccceeeeeecC---CccEEEEeccCCCCHH
Q 023752            2 WQTEVIYLGQLRH---ENLVKLIGYCSES---DNRLLVYEFMPKGSLE   43 (278)
Q Consensus         2 ~~~E~~~l~~l~h---~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~   43 (278)
                      +.+|+.+++.+..   -.+.+++.+..+.   +..++|||+++|..+.
T Consensus        74 ~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           74 LDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             HHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             HHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            5789999998842   3567788877665   3568999999886653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.74  E-value=0.007  Score=50.45  Aligned_cols=32  Identities=28%  Similarity=0.297  Sum_probs=27.5

Q ss_pred             CCCeeecCCCCCceEEcCC----CceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSN----FNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~----~~~kl~dfg~~~~  108 (278)
                      ...++|+|+++.||+++.+    +.+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4579999999999999874    6789999988764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.71  E-value=0.0026  Score=52.38  Aligned_cols=30  Identities=17%  Similarity=0.082  Sum_probs=25.2

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..++|+|+.+.||+ ..++.+.++||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            45899999999999 5666789999988764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.37  E-value=0.0075  Score=50.01  Aligned_cols=42  Identities=21%  Similarity=0.259  Sum_probs=33.9

Q ss_pred             ChHHHHHHHhccC---CccccceeeeeecCCccEEEEeccCCCCH
Q 023752            1 MWQTEVIYLGQLR---HENLVKLIGYCSESDNRLLVYEFMPKGSL   42 (278)
Q Consensus         1 ~~~~E~~~l~~l~---h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   42 (278)
                      +|..|+..|+.+.   ...+++++.+....+..++||||++|..+
T Consensus        74 ~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           74 MFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             HHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             HHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            3678999998883   35688888888877889999999998754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.36  E-value=0.0041  Score=53.05  Aligned_cols=102  Identities=17%  Similarity=0.176  Sum_probs=61.5

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHH--------------HHhhcC------CCCCC--HHH
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLEN--------------HLFRKG------VQPIS--WPT   58 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~--------------~~~~~~------~~~~~--~~~   58 (278)
                      +.+|.++++.+. +.-..++++.+.+    .+|++|++|..|..              .+.+-+      .+...  ..+
T Consensus       100 ~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~  175 (379)
T 3feg_A          100 LVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGT  175 (379)
T ss_dssp             HHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHH
Confidence            357899988884 3334667776654    28999998754421              111100      11122  345


Q ss_pred             HHHHHHHHHH-------------------HHHHH----hc--CCCCeeecCCCCCceEEcCC----CceEEecccccc
Q 023752           59 RVKIAIDVAR-------------------GLSFL----HG--LDANVIYRDLKASNVLLDSN----FNAKLSDFGLAR  107 (278)
Q Consensus        59 ~~~i~~~l~~-------------------~l~~L----h~--~~~~i~H~dl~p~ni~~~~~----~~~kl~dfg~~~  107 (278)
                      +..+..++-.                   .+..|    ..  ....++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       176 i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          176 MERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            5555544322                   12222    21  13468999999999999876    689999998875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.17  E-value=0.018  Score=49.16  Aligned_cols=31  Identities=19%  Similarity=0.249  Sum_probs=26.1

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ...++|||+.+.||+++.+ .+.++||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            5679999999999999876 488999977754

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.84  E-value=0.01  Score=49.46  Aligned_cols=31  Identities=23%  Similarity=0.249  Sum_probs=27.8

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEecccccc
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR  107 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~  107 (278)
                      ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            5789999999999999878889999998774

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.98  E-value=0.029  Score=48.44  Aligned_cols=31  Identities=16%  Similarity=0.216  Sum_probs=27.8

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ...++|+|+++.||+++.++ +.++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            67899999999999998876 99999988865

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.50  E-value=0.044  Score=45.22  Aligned_cols=30  Identities=37%  Similarity=0.314  Sum_probs=25.5

Q ss_pred             CCeeecCCCCCceEEcCCCceEEecccccc
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLAR  107 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~  107 (278)
                      .+++|+|+++.||++++++.+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            478999999999999877556799998764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=92.45  E-value=0.16  Score=41.91  Aligned_cols=30  Identities=23%  Similarity=0.288  Sum_probs=25.4

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ...++|+|+++.||+++ + .+.++||+.+..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            45689999999999998 4 789999987753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.92  E-value=0.4  Score=37.07  Aligned_cols=115  Identities=7%  Similarity=0.124  Sum_probs=74.9

Q ss_pred             CCccccceeeeeecCCccEEEEeccC-CCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeecCCCCCceE
Q 023752           13 RHENLVKLIGYCSESDNRLLVYEFMP-KGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVL   91 (278)
Q Consensus        13 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~   91 (278)
                      .||+.+.. .+-.+.+.+.+.++.-. +.++.. +     +.++....+.++.+|+....+++    .-+|--++|+|++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-----k~~~~~eKlr~l~ni~~l~~~~~----~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-----KSFTKNEKLRYLLNIKNLEEVNR----TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-----GGSCHHHHHHHHHHGGGGGGGGG----SSEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-----HhcCHHHHHHHHHHHHHHHHHhc----CceEEEEecceEE
Confidence            57777766 34455555444444322 123333 2     14778889999999998885555    3578899999999


Q ss_pred             EcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           92 LDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        92 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      ++.++.+++.-.|+-..                   ++|.     .++...-.-.+=|++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999988776532                   2221     12222234456778888998888875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=91.40  E-value=0.2  Score=43.69  Aligned_cols=35  Identities=20%  Similarity=0.174  Sum_probs=24.7

Q ss_pred             HHHHHHHhccCCccc-cceeeeeecCCccEEEEeccCCCC
Q 023752            3 QTEVIYLGQLRHENL-VKLIGYCSESDNRLLVYEFMPKGS   41 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~e~~~~~~   41 (278)
                      .+|..+++.+...++ .++++.+.  +  .+|++|++|.+
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            589999999965444 56777763  2  25999998743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=90.35  E-value=0.14  Score=43.22  Aligned_cols=29  Identities=21%  Similarity=0.317  Sum_probs=24.3

Q ss_pred             CCeeecCCCCCceEEcCCCceEEecccccc
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLAR  107 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~  107 (278)
                      ..++|+|+.+.||++++++ +.++||+.+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            4689999999999997654 8999998775

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=89.98  E-value=0.12  Score=43.05  Aligned_cols=31  Identities=19%  Similarity=0.163  Sum_probs=27.1

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..++|+|+.+.||+++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4689999999999999888899999987653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=89.56  E-value=0.15  Score=44.21  Aligned_cols=31  Identities=29%  Similarity=0.307  Sum_probs=24.5

Q ss_pred             CCeeecCCCCCceEEcCC----------------------------CceEEeccccccC
Q 023752           78 ANVIYRDLKASNVLLDSN----------------------------FNAKLSDFGLARD  108 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~----------------------------~~~kl~dfg~~~~  108 (278)
                      ..++|+|+.+.||+++.+                            +.+.|+||+++..
T Consensus       249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            358999999999999875                            6788999987753

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.20  E-value=1.6  Score=33.88  Aligned_cols=114  Identities=11%  Similarity=0.118  Sum_probs=73.0

Q ss_pred             CCccccceeeeeecCCccEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCeeecCCCCCce
Q 023752           13 RHENLVKLIGYCSESDNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVARGLS-FLHGLDANVIYRDLKASNV   90 (278)
Q Consensus        13 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~-~Lh~~~~~i~H~dl~p~ni   90 (278)
                      .||++  -..+-.+++.+.+.++.-.++ +.....      .++....+.++.+|+.... +++    .-+|--++|+|+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~----~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSA----RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCS----SSEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhh----CceeEEEeCceE
Confidence            56777  333335555655555543232 444332      4778888999998887766 444    457889999999


Q ss_pred             EEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           91 LLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        91 ~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      +++.++.+++.-.|+-..                   ++|.-     .+..--.-.+=|++..++.++..|+
T Consensus       116 ~f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999988776532                   23321     1211223456677788888777664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=86.61  E-value=0.35  Score=41.33  Aligned_cols=30  Identities=23%  Similarity=0.210  Sum_probs=24.8

Q ss_pred             CeeecCCCCCceEEc------CCCceEEeccccccC
Q 023752           79 NVIYRDLKASNVLLD------SNFNAKLSDFGLARD  108 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~------~~~~~kl~dfg~~~~  108 (278)
                      .+||+|+.+.||++.      .++.+.++||.++..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            367999999999993      456799999998863

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=82.99  E-value=0.56  Score=40.45  Aligned_cols=30  Identities=20%  Similarity=0.303  Sum_probs=26.0

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..++|+|+.+.||+ +.++.+.++||.++..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            35899999999999 7788899999988763

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	278
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-66
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-56
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	3e-55
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-54
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-52
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-52
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	6e-52
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-51
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-51
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-50
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-50
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-47
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-46
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-45
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-44
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-40
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-39
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-37
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-37
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-36
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-35
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	5e-34
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-33
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-33
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	6e-33
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-32
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-30
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	7e-29
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-26
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-24
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-23
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-09

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (522), Expect = 6e-66
 Identities = 60/246 (24%), Positives = 111/246 (45%), Gaps = 22/246 (8%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
            ++ EV  L + RH N++  +GY +      +V ++    SL +HL             +
Sbjct: 50  AFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLI 107

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
            IA   A+G+ +LH    ++I+RDLK++N+ L  +   K+ DFGLA        +H   +
Sbjct: 108 DIARQTAQGMDYLH--AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQ 165

Query: 121 IVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
           + G+  + APE +        + +SDVY+FG+VL EL++G+           +Q +    
Sbjct: 166 LSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVG 223

Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT 237
             +L                +      +A+  ++ +CL      RP    +L S+E L  
Sbjct: 224 RGYLSPDLS-----------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL-- 270

Query: 238 SKDMPR 243
           ++ +P+
Sbjct: 271 ARSLPK 276

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 4e-57
 Identities = 57/260 (21%), Positives = 115/260 (44%), Gaps = 24/260 (9%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + E+     LRHEN++  I   ++ +       LV ++   GSL ++L R     ++   
Sbjct: 45  EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEG 101

Query: 59  RVKIAIDVARGLSFLH------GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTG 112
            +K+A+  A GL+ LH           + +RDLK+ N+L+  N    ++D GLA    + 
Sbjct: 102 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 161

Query: 113 DNT--HVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLELLSGRRALDED 164
            +T        VGT+ Y APE +             ++D+Y+ G+V  E+          
Sbjct: 162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 221

Query: 165 RGGLAEQTLVEWADPFLRDSRRVL--RIMDTRLGGQYSKKEA-QAVAAVVLQCLHMDPKN 221
                    +  +DP + + R+V+  + +   +  ++   EA + +A ++ +C + +   
Sbjct: 222 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 281

Query: 222 RPSMVDVLTSLEQLHTSKDM 241
           R + + +  +L QL   + +
Sbjct: 282 RLTALRIKKTLSQLSQQEGI 301

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 5e-56
 Identities = 68/239 (28%), Positives = 109/239 (45%), Gaps = 25/239 (10%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           +  E   + QLRH NLV+L+G   E    L +V E+M KGSL ++L  +G   +     +
Sbjct: 47  FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 106

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           K ++DV   + +L     N ++RDL A NVL+  +  AK+SDFGL ++  +  +T     
Sbjct: 107 KFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG---- 160

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
                 + APE +     + KSDV+SFG++L E+ S  R                     
Sbjct: 161 -KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR---------------- 203

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
               + V+  ++             AV  V+  C H+D   RPS + +   LE + T +
Sbjct: 204 -IPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 8e-56
 Identities = 56/237 (23%), Positives = 106/237 (44%), Gaps = 21/237 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E   + QL+H+ LV+L    ++ +   ++ E+M  GSL + L       ++    + 
Sbjct: 55  FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 113

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +A  +A G++F+   + N I+RDL+A+N+L+    + K++DFGLAR     +        
Sbjct: 114 MAAQIAEGMAFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGA 170

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
                + APE +  G  T KSDV+SFG++L E+++  R              +E     +
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
           R                      + +  ++  C    P++RP+   + + LE   T+
Sbjct: 231 RPD-----------------NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  177 bits (450), Expect = 3e-55
 Identities = 57/241 (23%), Positives = 107/241 (44%), Gaps = 20/241 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E   + +++H NLV+L+G C+      ++ EFM  G+L ++L     Q +S    + 
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY 119

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +A  ++  + +L     N I+RDL A N L+  N   K++DFGL+R    GD        
Sbjct: 120 MATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGA 176

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
                + APE +A    + KSDV++FGV+L E+ +   +                     
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------- 219

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
            D  +V  +++     +  +   + V  ++  C   +P +RPS  ++  + E +     +
Sbjct: 220 IDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 279

Query: 242 P 242
            
Sbjct: 280 S 280

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 5e-55
 Identities = 51/234 (21%), Positives = 94/234 (40%), Gaps = 21/234 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E   +  L HE LV+L G C++     ++ E+M  G L N+L             ++
Sbjct: 46  FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLE 104

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +  DV   + +L       ++RDL A N L++     K+SDFGL+R     D    S   
Sbjct: 105 MCKDVCEAMEYLE--SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGS 161

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
                ++ PE +     + KSD+++FGV++ E+ S  +   E                  
Sbjct: 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER----------------- 204

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
             +      +   L        ++ V  ++  C H     RP+   +L+++  +
Sbjct: 205 FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-55
 Identities = 67/244 (27%), Positives = 112/244 (45%), Gaps = 21/244 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E   + +LRHE LV+L    SE +   +V E+M KGSL + L  +  + +  P  V 
Sbjct: 59  FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 117

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +A  +A G++++     N ++RDL+A+N+L+  N   K++DFGLAR     +        
Sbjct: 118 MAAQIASGMAYVE--RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGA 174

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
                + APE    G  T KSDV+SFG++L EL +  R                      
Sbjct: 175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG----------------- 217

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKDM 241
             +R VL  ++         +  +++  ++ QC   +P+ RP+   +   LE   TS + 
Sbjct: 218 MVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277

Query: 242 PRTP 245
              P
Sbjct: 278 QYQP 281

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 2e-54
 Identities = 55/252 (21%), Positives = 99/252 (39%), Gaps = 32/252 (12%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  L +     +V   G         +  E M  GSL+  L + G   I      K+
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKV 109

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           +I V +GL++L      +++RD+K SN+L++S    KL DFG++          ++   V
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFV 164

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL--------- 173
           GTR Y +PE +   H + +SD++S G+ L+E+  GR  +        E            
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224

Query: 174 ------------VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA----VVLQCLHM 217
                       +       R    +  ++D  +     K  +   +      V +CL  
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284

Query: 218 DPKNRPSMVDVL 229
           +P  R  +  ++
Sbjct: 285 NPAERADLKQLM 296

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 1e-53
 Identities = 67/234 (28%), Positives = 107/234 (45%), Gaps = 21/234 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E   + +L H  LV+L G C E     LV+EFM  G L ++  R      +  T + 
Sbjct: 47  FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLG 105

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           + +DV  G+++L   +A VI+RDL A N L+  N   K+SDFG+ R     D    ST  
Sbjct: 106 MCLDVCEGMAYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGT 162

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
                +A+PE  +    + KSDV+SFGV++ E+ S  +   E+R               +
Sbjct: 163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR----------SNSEVV 212

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
            D     R+   RL        +  V  ++  C    P++RP+   +L  L ++
Sbjct: 213 EDISTGFRLYKPRL-------ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 4e-53
 Identities = 61/257 (23%), Positives = 106/257 (41%), Gaps = 29/257 (11%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
              E   + QL +  +V+LIG C +++  +LV E    G L   L  K  + I      +
Sbjct: 56  MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAE 113

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTR 120
           +   V+ G+ +L   + N ++RDL A NVLL +   AK+SDFGL++  G         + 
Sbjct: 114 LLHQVSMGMKYLE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 171

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
                 + APE +     + +SDV+S+GV + E LS  +                   P+
Sbjct: 172 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK------------------PY 213

Query: 181 LRDS-RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK 239
            +     V+  ++     +   +    + A++  C     ++RP  + V   +       
Sbjct: 214 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR--ACYY 271

Query: 240 DMPRTPPPAKLHHHHHH 256
            +         HHHHHH
Sbjct: 272 SLASKVEG---HHHHHH 285

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  172 bits (437), Expect = 5e-53
 Identities = 59/237 (24%), Positives = 108/237 (45%), Gaps = 23/237 (9%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           + +E   +GQ  H N++ L G  ++S   +++ EFM  GSL+    R+     +    V 
Sbjct: 74  FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SFLRQNDGQFTVIQLVG 132

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
           +   +A G+ +L   D N ++RDL A N+L++SN   K+SDFGL+R      +    T  
Sbjct: 133 MLRGIAAGMKYLA--DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSA 190

Query: 122 VG---TRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
           +G      + APE +     T  SDV+S+G+V+ E++S       D              
Sbjct: 191 LGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD-------------- 236

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
                ++ V+  ++             A+  ++L C   D  +RP    ++ +L+++
Sbjct: 237 ---MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 7e-53
 Identities = 62/255 (24%), Positives = 104/255 (40%), Gaps = 44/255 (17%)

Query: 3   QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------- 50
            +E+  + QL  HEN+V L+G C+ S    L++E+   G L N+L  K            
Sbjct: 88  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147

Query: 51  ----------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKL 100
                     +  +++   +  A  VA+G+ FL     + ++RDL A NVL+      K+
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKI 205

Query: 101 SDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA 160
            DFGLARD  +  N  V         + APE +  G  T KSDV+S+G++L E+ S    
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265

Query: 161 LDEDRGGLAEQTLVEWADPFLRDSRR--VLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD 218
                             P+          +++             + +  ++  C   D
Sbjct: 266 ------------------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD 307

Query: 219 PKNRPSMVDVLTSLE 233
            + RPS  ++ + L 
Sbjct: 308 SRKRPSFPNLTSFLG 322

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (435), Expect = 9e-53
 Identities = 57/256 (22%), Positives = 105/256 (41%), Gaps = 41/256 (16%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------- 50
           +Q E   + +  + N+VKL+G C+      L++E+M  G L   L               
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 51  -----------VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAK 99
                        P+S   ++ IA  VA G+++L   +   ++RDL   N L+  N   K
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVK 180

Query: 100 LSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR 159
           ++DFGL+R+  + D             +  PE +     T +SDV+++GVVL E+ S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDP 219
                  G+A + ++ +    +RD   +             +     +  ++  C    P
Sbjct: 241 QPYY---GMAHEEVIYY----VRDGNIL----------ACPENCPLELYNLMRLCWSKLP 283

Query: 220 KNRPSMVDVLTSLEQL 235
            +RPS   +   L+++
Sbjct: 284 ADRPSFCSIHRILQRM 299

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 2e-52
 Identities = 55/228 (24%), Positives = 97/228 (42%), Gaps = 21/228 (9%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+     L HEN+VK  G+  E + + L  E+   G L + +       +  P   + 
Sbjct: 51  KKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRF 108

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              +  G+ +LH     + +RD+K  N+LLD   N K+SDFGLA      +   +  ++ 
Sbjct: 109 FHQLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 166

Query: 123 GTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
           GT  Y APE +          DV+S G+VL  +L+G    D+      E +  +    +L
Sbjct: 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 226

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
              +++                  A  A++ + L  +P  R ++ D+ 
Sbjct: 227 NPWKKI----------------DSAPLALLHKILVENPSARITIPDIK 258

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (428), Expect = 4e-52
 Identities = 55/229 (24%), Positives = 95/229 (41%), Gaps = 27/229 (11%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
             + EV     LRH N+++L GY  ++    L+ E+ P G++   L +            
Sbjct: 52  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTA 109

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
               ++A  LS+ H     VI+RD+K  N+LL S    K++DFG +   P+   T +   
Sbjct: 110 TYITELANALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL--- 164

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
             GT  Y  PE +       K D++S GV+  E L G+                    PF
Sbjct: 165 -CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-------------------PF 204

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
             ++ +      +R+   +     +    ++ + L  +P  RP + +VL
Sbjct: 205 EANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVL 253

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 6e-52
 Identities = 60/250 (24%), Positives = 97/250 (38%), Gaps = 35/250 (14%)

Query: 3   QTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQ--------- 52
            +E+  L  L  H N+V L+G C+     L++ E+   G L N L RK            
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 53  -------PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 105
                   +     +  +  VA+G++FL     N I+RDL A N+LL      K+ DFGL
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGL 191

Query: 106 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
           ARD     N  V         + APE +     T +SDV+S+G+ L EL S   +     
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 166 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 225
                               +  +++         +     +  ++  C   DP  RP+ 
Sbjct: 252 ----------------PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTF 295

Query: 226 VDVLTSLEQL 235
             ++  +E+ 
Sbjct: 296 KQIVQLIEKQ 305

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-51
 Identities = 65/240 (27%), Positives = 108/240 (45%), Gaps = 23/240 (9%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR-LLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
           + TE I +    H N++ L+G C  S+   L+V  +M  G L N +  +   P +    +
Sbjct: 75  FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP-TVKDLI 133

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD--GPTGDNTHVS 118
              + VA+G+ FL       ++RDL A N +LD  F  K++DFGLARD      D+ H  
Sbjct: 134 GFGLQVAKGMKFLA--SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
           T       + A E + T   T KSDV+SFGV+L EL++       D          +   
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD------VNTFDITV 245

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS 238
             L+  R +             +     +  V+L+C H   + RPS  ++++ +  + ++
Sbjct: 246 YLLQGRRLLQ-----------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-51
 Identities = 57/244 (23%), Positives = 113/244 (46%), Gaps = 21/244 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E   +GQ  H N+++L G  S+    +++ E+M  G+  +   R+     S    V 
Sbjct: 56  FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVG 114

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVSTR 120
           +   +A G+ +L   + N ++RDL A N+L++SN   K+SDFGL+R      + T+ ++ 
Sbjct: 115 MLRGIAAGMKYLA--NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
                 + APE ++    T  SDV+SFG+V+ E+++       +                
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE---------------- 216

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD 240
              +  V++ ++             A+  +++QC   +   RP   D+++ L++L  + D
Sbjct: 217 -LSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

Query: 241 MPRT 244
             +T
Sbjct: 276 SLKT 279

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 5e-51
 Identities = 51/233 (21%), Positives = 89/233 (38%), Gaps = 28/233 (12%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWP 57
           ++ E   L  L+H N+V+       +       +LV E M  G+L+ +L R     +   
Sbjct: 55  FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIK 112

Query: 58  TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTH 116
                   + +GL FLH     +I+RDLK  N+ +     + K+ D GLA          
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRAS 168

Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
            +  ++GT  + APE           DVY+FG+ +LE+ +      E +       +   
Sbjct: 169 FAKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYSECQN---AAQIYR- 223

Query: 177 ADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                       R+        + K     V  ++  C+  +   R S+ D+L
Sbjct: 224 ------------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (424), Expect = 7e-51
 Identities = 58/230 (25%), Positives = 90/230 (39%), Gaps = 30/230 (13%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             EV +L +LRH N ++  G         LV E+    + +     K   P+       +
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAV 120

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
                +GL++LH    N+I+RD+KA N+LL      KL DFG A           +   V
Sbjct: 121 THGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFV 172

Query: 123 GTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
           GT  + APE +     G    K DV+S G+  +EL   +  L       A   + +   P
Sbjct: 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP 232

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
            L+                 S   ++     V  CL   P++RP+   +L
Sbjct: 233 ALQ-----------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 1e-50
 Identities = 50/232 (21%), Positives = 89/232 (38%), Gaps = 26/232 (11%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  L    H N+VKL+      +N  ++ EF   G+++  +     +P++      +
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVV 115

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
                  L++LH  D  +I+RDLKA N+L   + + KL+DFG++               +
Sbjct: 116 CKQTLDALNYLH--DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFI 171

Query: 123 GTRGYAAPEYVAT-----GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
           GT  + APE V            K+DV+S G+ L+E+        E         + +  
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 231

Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
            P L    R                 +      + +CL  +   R +   +L
Sbjct: 232 PPTLAQPSRW----------------SSNFKDFLKKCLEKNVDARWTTSQLL 267

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 2e-50
 Identities = 44/233 (18%), Positives = 99/233 (42%), Gaps = 21/233 (9%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E   +  + + ++ +L+G C       L+ + MP G L +++       I     +  
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNW 116

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +A+G+++L   D  +++RDL A NVL+ +  + K++DFGLA+     +  + +    
Sbjct: 117 CVQIAKGMNYLE--DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
               + A E +     T +SDV+S+GV + EL++      +                   
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-----------------I 217

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
            +  +  I++              V  ++++C  +D  +RP   +++    ++
Sbjct: 218 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 3e-50
 Identities = 57/235 (24%), Positives = 101/235 (42%), Gaps = 25/235 (10%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
              E   + QL +  +V++IG C E+++ +LV E    G L  +L +     +     ++
Sbjct: 55  LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIE 111

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTR 120
           +   V+ G+ +L   ++N ++RDL A NVLL +   AK+SDFGL++     +N +   T 
Sbjct: 112 LVHQVSMGMKYLE--ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
                 + APE +     + KSDV+SFGV++ E  S  +                   P+
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK------------------PY 211

Query: 181 LRDS-RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQ 234
                  V  +++            + +  ++  C   D +NRP    V   L  
Sbjct: 212 RGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (413), Expect = 9e-50
 Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 27/236 (11%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLL--VYEFMPKGSLENHLFR--KGVQPISW 56
           M  +EV  L +L+H N+V+      +  N  L  V E+   G L + + +  K  Q +  
Sbjct: 49  MLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE 108

Query: 57  PTRVKIAIDVARGLSFLH---GLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
              +++   +   L   H        V++RDLK +NV LD   N KL DFGLAR      
Sbjct: 109 EFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNH 166

Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
           +T  +   VGT  Y +PE +       KSD++S G +L EL +               + 
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-------SQ 219

Query: 174 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
            E A        ++      R+  +YS      +  ++ + L++   +RPS+ ++L
Sbjct: 220 KELA-------GKIREGKFRRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 2e-48
 Identities = 64/249 (25%), Positives = 100/249 (40%), Gaps = 37/249 (14%)

Query: 2   WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV--------- 51
           +  E+  L +L  H N++ L+G C       L  E+ P G+L + L +  V         
Sbjct: 57  FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116

Query: 52  -----QPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 106
                  +S    +  A DVARG+ +L       I+RDL A N+L+  N+ AK++DFGL+
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLS 174

Query: 107 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
           R           T       + A E +     T  SDV+S+GV+L E++S          
Sbjct: 175 RGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-- 229

Query: 167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 226
                T  E  +   +  R            +        V  ++ QC    P  RPS  
Sbjct: 230 ----MTCAELYEKLPQGYRL-----------EKPLNCDDEVYDLMRQCWREKPYERPSFA 274

Query: 227 DVLTSLEQL 235
            +L SL ++
Sbjct: 275 QILVSLNRM 283

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 4e-48
 Identities = 61/235 (25%), Positives = 97/235 (41%), Gaps = 21/235 (8%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  EV  +  L H NL++L G         +V E  P GSL + L +         T  +
Sbjct: 58  FIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSR 115

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHV-STR 120
            A+ VA G+ +L       I+RDL A N+LL +    K+ DFGL R  P  D+ +V    
Sbjct: 116 YAVQVAEGMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
                 + APE + T   +  SD + FGV L E+ +  +               +     
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL------NGSQILHKI 227

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
            ++  R+ R  D            Q +  V++QC    P++RP+ V +   L + 
Sbjct: 228 DKEGERLPRPEDC----------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 3e-47
 Identities = 50/227 (22%), Positives = 96/227 (42%), Gaps = 23/227 (10%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E++ + + ++ N+V  +      D   +V E++  GSL + +       +       +
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAV 121

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             +  + L FLH     VI+RD+K+ N+LL  + + KL+DFG              + +V
Sbjct: 122 CRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMV 177

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  + APE V      PK D++S G++ +E++ G      +    A   +     P L+
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           +  ++                +      + +CL MD + R S  ++L
Sbjct: 238 NPEKL----------------SAIFRDFLNRCLDMDVEKRGSAKELL 268

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 2e-46
 Identities = 56/242 (23%), Positives = 109/242 (45%), Gaps = 27/242 (11%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------VQP 53
           +  E   + +    ++V+L+G  S+    L++ E M +G L+++L            + P
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 54  ISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGD 113
            S    +++A ++A G+++L+      ++RDL A N ++  +F  K+ DFG+ RD    D
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 187

Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
                 + +    + +PE +  G  T  SDV+SFGVVL E+ +      +      EQ L
Sbjct: 188 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVL 245

Query: 174 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
               +  L D                       +  ++  C   +PK RPS +++++S++
Sbjct: 246 RFVMEGGLLD---------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

Query: 234 QL 235
           + 
Sbjct: 291 EE 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-45
 Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 22/234 (9%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +  E + + Q  H ++VKLIG  +E +   ++ E    G L + L  +    +   + + 
Sbjct: 55  FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVR-KYSLDLASLIL 112

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
            A  ++  L++L       ++RD+ A NVL+ SN   KL DFGL+R        + +++ 
Sbjct: 113 YAYQLSTALAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKG 169

Query: 122 VGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFL 181
                + APE +     T  SDV+ FGV + E+L       +          +E  +   
Sbjct: 170 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL- 228

Query: 182 RDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL 235
                                    + +++ +C   DP  RP   ++   L  +
Sbjct: 229 ----------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (381), Expect = 9e-45
 Identities = 43/236 (18%), Positives = 86/236 (36%), Gaps = 23/236 (9%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
               E   + +L H   VKL     + +       +   G L  ++ + G          
Sbjct: 54  YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTR 111

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
               ++   L +LH     +I+RDLK  N+LL+ + + +++DFG A+          +  
Sbjct: 112 FYTAEIVSALEYLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 169

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
            VGT  Y +PE +        SD+++ G ++ +L++G                     PF
Sbjct: 170 FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP-------------------PF 210

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH 236
              +  ++     +L   + +K       +V + L +D   R    ++        
Sbjct: 211 RAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 2e-44
 Identities = 60/250 (24%), Positives = 100/250 (40%), Gaps = 33/250 (13%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRL-LVYEFMPKGSLENHLFRKGVQ------- 52
           +     I +    H N+V L+G C++    L ++ EF   G+L  +L  K  +       
Sbjct: 63  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122

Query: 53  -------PISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGL 105
                   ++    +  +  VA+G+ FL       I+RDL A N+LL      K+ DFGL
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGL 180

Query: 106 ARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDR 165
           ARD     +            + APE +     T +SDV+SFGV+L E+ S   +     
Sbjct: 181 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG- 239

Query: 166 GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 225
                  + E     L++  R+          +        +   +L C H +P  RP+ 
Sbjct: 240 -----VKIDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTF 284

Query: 226 VDVLTSLEQL 235
            +++  L  L
Sbjct: 285 SELVEHLGNL 294

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  150 bits (381), Expect = 4e-44
 Identities = 62/280 (22%), Positives = 102/280 (36%), Gaps = 25/280 (8%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  +  LRH  LV L     + +  +++YEFM  G L   +  +    +S    V+ 
Sbjct: 71  RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEY 129

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN--AKLSDFGLARDGPTGDNTHVSTR 120
              V +GL  +H  + N ++ DLK  N++  +  +   KL DFGL        +  V+T 
Sbjct: 130 MRQVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT- 186

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
             GT  +AAPE      +   +D++S GV+   LLSG      +             D  
Sbjct: 187 --GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----------DDET 233

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 238
           LR+ +     MD       S    +     + + L  DP  R ++   L    L   +  
Sbjct: 234 LRNVKSCDWNMDDSAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289

Query: 239 KDMPRTPPPAKLHHHHHHHNHHQGIKHTNPPRKTSITNSK 278
               + P              +       PP       S 
Sbjct: 290 GRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSS 329

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 5e-44
 Identities = 56/249 (22%), Positives = 104/249 (41%), Gaps = 34/249 (13%)

Query: 2   WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG---------- 50
             +E+  +  + +H+N++ L+G C++     ++ E+  KG+L  +L  +           
Sbjct: 65  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124

Query: 51  ----VQPISWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLA 106
                + +S    V  A  VARG+ +L       I+RDL A NVL+  +   K++DFGLA
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLA 182

Query: 107 RDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG 166
           RD    D    +T       + APE +     T +SDV+SFGV+L E+ +   +      
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-- 240

Query: 167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 226
                               + +++               +  ++  C H  P  RP+  
Sbjct: 241 ---------------VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 285

Query: 227 DVLTSLEQL 235
            ++  L+++
Sbjct: 286 QLVEDLDRI 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  144 bits (364), Expect = 2e-42
 Identities = 56/240 (23%), Positives = 107/240 (44%), Gaps = 25/240 (10%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRL----LVYEFMPKGSLENHLFRKGVQPISWPT 58
           + E      L H  +V +               +V E++   +L + +  +G  P++   
Sbjct: 55  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKR 112

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHV 117
            +++  D  + L+F H     +I+RD+K +N+++ +    K+ DFG+AR    +G++   
Sbjct: 113 AIEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 170

Query: 118 STRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWA 177
           +  ++GT  Y +PE      +  +SDVYS G VL E+L+G      D       + V  A
Sbjct: 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-------SPVSVA 223

Query: 178 DPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLEQLH 236
              +R+           L        +  + AVVL+ L  +P+NR  +  ++   L ++H
Sbjct: 224 YQHVREDPIPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  144 bits (364), Expect = 1e-41
 Identities = 53/279 (18%), Positives = 102/279 (36%), Gaps = 27/279 (9%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  + QL H  L+ L     +    +L+ EF+  G L + +  +    +S    +  
Sbjct: 74  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINY 132

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTR 120
                 GL  +H  + ++++ D+K  N++ ++   +  K+ DFGLA      +       
Sbjct: 133 MRQACEGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---V 187

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
              T  +AAPE V    +   +D+++ GV+   LLSG                    +  
Sbjct: 188 TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF--------------AGEDD 233

Query: 181 LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLHTS 238
           L   + V R         +S    +A    +   L  +P+ R ++ D L    L+  H  
Sbjct: 234 LETLQNVKRCDWEFDEDAFSSVSPEAK-DFIKNLLQKEPRKRLTVHDALEHPWLKGDH-- 290

Query: 239 KDMPRTPPPAKLHHHHHHHNHHQGIKHTNPPRKTSITNS 277
            ++    P ++ +                 P    I N 
Sbjct: 291 SNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANF 329

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-40
 Identities = 50/225 (22%), Positives = 84/225 (37%), Gaps = 25/225 (11%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           + +      H  L  +       +N   V E++  G L  H+                A 
Sbjct: 53  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAA 110

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
           ++  GL FLH     ++YRDLK  N+LLD + + K++DFG+ ++   GD         GT
Sbjct: 111 EIILGLQFLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGT 166

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS 184
             Y APE +         D +SFGV+L E+L G+                    PF    
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS-------------------PFHGQD 207

Query: 185 RRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
              L          Y +   +    ++++    +P+ R  +   +
Sbjct: 208 EEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 2e-40
 Identities = 52/287 (18%), Positives = 108/287 (37%), Gaps = 43/287 (14%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  L   RH N++ L       +  ++++EF+    +   +       ++    V  
Sbjct: 49  KKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSY 107

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNA--KLSDFGLARDGPTGDNTHVSTR 120
              V   L FLH    N+ + D++  N++  +  ++  K+ +FG AR    GDN  +   
Sbjct: 108 VHQVCEALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--- 162

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPF 180
           +     Y APE      ++  +D++S G ++  LLSG                     PF
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN-------------------PF 203

Query: 181 LRDSRRVL--RIMDTRLG--GQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT------ 230
           L ++ + +   IM+       +  K+ +      V + L  + K+R +  + L       
Sbjct: 204 LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263

Query: 231 SLEQLHTSKDMPRTPPPAKLHHHHHHHNHHQGIKHTNPPRKTSITNS 277
            +E++ T             H  ++H    + +       + S   +
Sbjct: 264 KIERVSTK------VIRTLKHRRYYHTLIKKDLNMVVSAARISCGGA 304

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  138 bits (348), Expect = 6e-40
 Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 37/239 (15%)

Query: 2   WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
              EV  L ++  H N+++L      +    LV++ M KG L ++L  K    +S     
Sbjct: 56  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETR 113

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
           KI   +   +  LH    N+++RDLK  N+LLD + N KL+DFG +      D       
Sbjct: 114 KIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLRE 168

Query: 121 IVGTRGYAAPEYVATGHL------TPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
           + GT  Y APE +             + D++S GV++  LL+G                 
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP--------------- 213

Query: 175 EWADPFLRDSRRVL--RIM--DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
               PF    + ++   IM  + + G       +  V  +V + L + P+ R +  + L
Sbjct: 214 ----PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  136 bits (344), Expect = 4e-39
 Identities = 53/234 (22%), Positives = 94/234 (40%), Gaps = 33/234 (14%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E+  L +++H N+V L        +  L+ + +  G L + +  KG    +     ++
Sbjct: 55  ENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 112

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLL---DSNFNAKLSDFGLARDGPTGDNTHVST 119
              V   + +LH  D  +++RDLK  N+L    D +    +SDFGL++     D   V +
Sbjct: 113 IFQVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLS 167

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
              GT GY APE +A    +   D +S GV+   LL G                     P
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP-------------------P 208

Query: 180 FLRDSRRVL--RIM--DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           F  ++   L  +I+  +      Y    + +    +   +  DP+ R +    L
Sbjct: 209 FYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (339), Expect = 2e-38
 Identities = 57/259 (22%), Positives = 90/259 (34%), Gaps = 18/259 (6%)

Query: 1   MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
               E+  L +L H N++ L+       N  LV++FM                ++     
Sbjct: 46  TALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL--VLTPSHIK 103

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTR 120
              +   +GL +LH     +++RDLK +N+LLD N   KL+DFGLA+    G      T 
Sbjct: 104 AYMLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTH 159

Query: 121 IVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDED---------RGGLAE 170
            V TR Y APE +    +     D+++ G +L ELL     L  D            L  
Sbjct: 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 219

Query: 171 QTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT 230
            T  +W D          +                 +  ++      +P  R +    L 
Sbjct: 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

Query: 231 S--LEQLHTSKDMPRTPPP 247
                         + P P
Sbjct: 280 MKYFSNRPGPTPGCQLPRP 298

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-37
 Identities = 42/230 (18%), Positives = 91/230 (39%), Gaps = 23/230 (10%)

Query: 7   IYLGQLRHENLVKLIGYC----SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           ++    +  ++V+++       +     L+V E +  G L + +  +G Q  +     +I
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN---AKLSDFGLARDGPTGDNTHVST 119
              +   + +LH    N+ +RD+K  N+L  S       KL+DFG A++  + ++     
Sbjct: 117 MKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--- 171

Query: 120 RIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
               T  Y APE +         D++S GV++  LL G      + G      +      
Sbjct: 172 TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------ 225

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                +  +R+           + ++ V  ++   L  +P  R ++ + +
Sbjct: 226 -----KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (334), Expect = 3e-37
 Identities = 48/218 (22%), Positives = 79/218 (36%), Gaps = 25/218 (11%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVAR 68
           +       +V +       D    + + M  G L  HL + G    S       A ++  
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIIL 118

Query: 69  GLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYA 128
           GL  +H  +  V+YRDLK +N+LLD + + ++SD GLA D             VGT GY 
Sbjct: 119 GLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYM 172

Query: 129 APEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRV 187
           APE +  G      +D +S G +L +LL G     + +     +         +      
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232

Query: 188 LRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 225
                           +  + +++   L  D   R   
Sbjct: 233 ----------------SPELRSLLEGLLQRDVNRRLGC 254

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-37
 Identities = 66/269 (24%), Positives = 108/269 (40%), Gaps = 19/269 (7%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK-GVQPISWPTRV 60
              E+  L + RHEN++ +           +   ++    +   L++    Q +S     
Sbjct: 53  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC 112

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD-GPTGDNTHVST 119
                + RGL ++H   ANV++RDLK SN+LL++  + K+ DFGLAR   P  D+T   T
Sbjct: 113 YFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170

Query: 120 RIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGR------------RALDEDRG 166
             V TR Y APE +      T   D++S G +L E+LS R              +    G
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230

Query: 167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 226
             +++ L    +   R+    L   +     +           ++ + L  +P  R  + 
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

Query: 227 DVLTS--LEQLHTSKDMPRTPPPAKLHHH 253
             L    LEQ +   D P    P K    
Sbjct: 291 QALAHPYLEQYYDPSDEPIAEAPFKFDME 319

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 2e-36
 Identities = 54/255 (21%), Positives = 101/255 (39%), Gaps = 30/255 (11%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + EV  L +++H N++ L        + +L+ E +  G L + L  K    ++     + 
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEF 118

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSN----FNAKLSDFGLARDGPTGDNTHVS 118
              +  G+ +LH     + + DLK  N++L          K+ DFGLA     G+     
Sbjct: 119 LKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--- 173

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
             I GT  + APE V    L  ++D++S GV+   LLSG      D              
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT------------- 220

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS--LEQLH 236
              +++   +  ++     +Y    +      + + L  DPK R ++ D L    ++   
Sbjct: 221 --KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278

Query: 237 TSKDMPR--TPPPAK 249
           T + +    + P  +
Sbjct: 279 TQQALSSAWSHPQFE 293

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 4e-36
 Identities = 55/233 (23%), Positives = 88/233 (37%), Gaps = 17/233 (7%)

Query: 9   LGQLRHENLVKLIGYCSESDNRLLVYEFMP----KGSLENHLFRKGVQPISWPTRVKIAI 64
           L    H N+V+L   C+ S         +        L  +L +     +   T   +  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + RGL FLH     V++RDLK  N+L+ S+   KL+DFGLAR           T +V T
Sbjct: 124 QLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVT 178

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL-DEDRGGLAEQTLVEWADPFLRD 183
             Y APE +         D++S G +  E+   +             + L     P   D
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 184 SRRVLRIMDTRLGGQYSKKEAQAVAAV-------VLQCLHMDPKNRPSMVDVL 229
             R + +       + ++   + V  +       +L+CL  +P  R S    L
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (321), Expect = 1e-35
 Identities = 54/224 (24%), Positives = 97/224 (43%), Gaps = 32/224 (14%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E + L  + H  ++++ G   ++    ++ +++  G L + L +   Q    P     
Sbjct: 52  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFY 109

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           A +V   L +LH    ++IYRDLK  N+LLD N + K++DFG A+  P    T     + 
Sbjct: 110 AAEVCLALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LC 162

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  Y APE V+T       D +SFG+++ E+L+G                     PF  
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT-------------------PFYD 203

Query: 183 DSRRVL--RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
            +      +I++  L  ++     + V  ++ + +  D   R  
Sbjct: 204 SNTMKTYEKILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLG 245

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  126 bits (316), Expect = 3e-35
 Identities = 42/242 (17%), Positives = 77/242 (31%), Gaps = 24/242 (9%)

Query: 3   QTEVIYLGQLRHENLVKLIGYC-SESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
             E      ++    +  I +C +E D  ++V E +     +   F       S  T + 
Sbjct: 50  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLL 107

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVL---LDSNFNAKLSDFGLAR-----DGPTGD 113
           +A  +   + ++H    N I+RD+K  N L           + DFGLA+           
Sbjct: 108 LADQMISRIEYIH--SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 165

Query: 114 NTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTL 173
               +  + GT  YA+         + + D+ S G VL+    G       +     Q  
Sbjct: 166 PYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225

Query: 174 VEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLE 233
              ++  +     VL            K      A  +  C  +   ++P    +     
Sbjct: 226 ERISEKKMSTPIEVLC-----------KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

Query: 234 QL 235
            L
Sbjct: 275 NL 276

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 5e-34
 Identities = 49/256 (19%), Positives = 98/256 (38%), Gaps = 42/256 (16%)

Query: 3   QTEVIYLGQLR--HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRV 60
             EV+ L ++      +++L+ +    D+ +L+ E             +    +      
Sbjct: 55  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELAR 113

Query: 61  KIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVST 119
                V   +   H  +  V++RD+K  N+L+D N    KL DFG            V T
Sbjct: 114 SFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYT 167

Query: 120 RIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWAD 178
              GTR Y+ PE++    +    + V+S G++L +++ G                     
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------------------- 208

Query: 179 PFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT- 237
           PF  D      I+  ++   + ++ +     ++  CL + P +RP+  ++       H  
Sbjct: 209 PFEHDE----EIIRGQV--FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN-----HPW 257

Query: 238 SKDMPRTPPPAKLHHH 253
            +D+      A++H H
Sbjct: 258 MQDVLLPQETAEIHLH 273

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  120 bits (302), Expect = 3e-33
 Identities = 47/237 (19%), Positives = 91/237 (38%), Gaps = 15/237 (6%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  L +L+H N+VKL          +LV+E + +   +     +G   +   T    
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSF 105

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
            + +  G+++ H  D  V++RDLK  N+L++     K++DFGLAR        +    IV
Sbjct: 106 LLQLLNGIAYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIV 162

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG---------GLAEQTL 173
                A    + +   +   D++S G +  E+++G                   L     
Sbjct: 163 TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222

Query: 174 VEWADPF-LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
             W +   L        + +      + K   ++   ++ + L +DP  R +    L
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 3e-33
 Identities = 51/251 (20%), Positives = 96/251 (38%), Gaps = 28/251 (11%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR--------LLVYEFMPKGSLENHLFRKGVQPI 54
             E+  L  L+HEN+V LI  C    +          LV++F                  
Sbjct: 57  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KF 114

Query: 55  SWPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDN 114
           +     ++   +  GL ++H     +++RD+KA+NVL+  +   KL+DFGLAR      N
Sbjct: 115 TLSEIKRVMQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 172

Query: 115 THVS--TRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRRALDEDR------ 165
           +  +  T  V T  Y  PE +       P  D++  G ++ E+ +    +  +       
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232

Query: 166 ------GGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA-VVLQCLHMD 218
                 G +  +      +  L +   +++    ++  +         A  ++ + L +D
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292

Query: 219 PKNRPSMVDVL 229
           P  R    D L
Sbjct: 293 PAQRIDSDDAL 303

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 5e-33
 Identities = 53/235 (22%), Positives = 94/235 (40%), Gaps = 14/235 (5%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAI 64
           E+  L +L H N+VKL+      +   LV+EF+ +  L+  +    +  I  P       
Sbjct: 51  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLF 109

Query: 65  DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGT 124
            + +GL+F H     V++RDLK  N+L+++    KL+DFGLAR          +  +V  
Sbjct: 110 QLLQGLAFCH--SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTL 166

Query: 125 RGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDED----------RGGLAEQTLV 174
              A    +   + +   D++S G +  E+++ R     D          R       +V
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226

Query: 175 EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
                 + D +        +   +      +   +++ Q LH DP  R S    L
Sbjct: 227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  120 bits (301), Expect = 6e-33
 Identities = 33/243 (13%), Positives = 72/243 (29%), Gaps = 24/243 (9%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
           + E      L     +  + Y  +     ++   +   SLE+ L   G +  S  T    
Sbjct: 48  RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG-RKFSVKTVAMA 106

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFN-----AKLSDFGLAR-----DGPTG 112
           A  +   +  +H  + +++YRD+K  N L+    +       + DFG+ +          
Sbjct: 107 AKQMLARVQSIH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQH 164

Query: 113 DNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQT 172
                   + GT  Y +         + + D+ + G V +  L G       +    +Q 
Sbjct: 165 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 173 LVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL 232
                +       R L                +     +    ++     P    +    
Sbjct: 225 YERIGEKKQSTPLRELC-----------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

Query: 233 EQL 235
            ++
Sbjct: 274 SKV 276

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 2e-32
 Identities = 54/223 (24%), Positives = 86/223 (38%), Gaps = 25/223 (11%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
            TE   L   RH  L  L       D    V E+   G L  HL R+  +  +       
Sbjct: 53  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFY 110

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
             ++   L +LH    +V+YRD+K  N++LD + + K++DFGL ++G +   T       
Sbjct: 111 GAEIVSALEYLH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFC 166

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT  Y APE +         D +  GVV+ E++ GR                    PF  
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL-------------------PFYN 207

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 225
                L  +      ++ +  +    +++   L  DPK R   
Sbjct: 208 QDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGG 250

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 7e-32
 Identities = 52/269 (19%), Positives = 96/269 (35%), Gaps = 25/269 (9%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHL-FRKGVQPIS 55
             E+  + +L H N+V+L  +   S  +       LV +++P+        + +  Q + 
Sbjct: 61  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 120

Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDN 114
                     + R L+++H     + +RD+K  N+LLD +    KL DFG A+       
Sbjct: 121 VIYVKLYMYQLFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRG 176

Query: 115 THVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV 174
               + I      A          T   DV+S G VL ELL G+     D G      ++
Sbjct: 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEII 236

Query: 175 EWADPFLRDSRRVL----------RIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS 224
           +      R+  R +          +I        +  +      A+  + L   P  R +
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 296

Query: 225 MVDVLTS--LEQLHT-SKDMPRTPPPAKL 250
            ++       ++L   +  +P       L
Sbjct: 297 PLEACAHSFFDELRDPNVKLPNGRDTPAL 325

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-30
 Identities = 55/239 (23%), Positives = 87/239 (36%), Gaps = 18/239 (7%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E+  L +L+H+N+V+L           LV+EF  +   +      G            
Sbjct: 49  LREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSF 106

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
              + +GL F H    NV++RDLK  N+L++ N   KL++FGLAR        +  +  V
Sbjct: 107 LFQLLKGLGFCH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEV 162

Query: 123 GTRGYAAPE-YVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRG----------GLAEQ 171
            T  Y  P+        +   D++S G +  EL +  R L                L   
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222

Query: 172 TLVEWADPF-LRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL 229
           T  +W     L D +       T        K       ++   L  +P  R S  + L
Sbjct: 223 TEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 2e-30
 Identities = 49/266 (18%), Positives = 107/266 (40%), Gaps = 30/266 (11%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNR------LLVYEFMPKGSLENHLFRKGVQPIS 55
              E+  L  +RHEN++ L+   +  +         LV  FM  G+    L +     + 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLG 119

Query: 56  WPTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT 115
                 +   + +GL ++H   A +I+RDLK  N+ ++ +   K+ DFGLAR      ++
Sbjct: 120 EDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DS 173

Query: 116 HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR------------RALDE 163
            ++  +V     A    +     T   D++S G ++ E+++G+            + + +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233

Query: 164 DRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 223
             G    + +        ++  + L  ++ +         +     ++ + L +D + R 
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293

Query: 224 SMVDVLTS--LEQLHTSKDMPRTPPP 247
           +  + L     E LH ++D P+    
Sbjct: 294 TAGEALAHPYFESLHDTEDEPQVQKY 319

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (276), Expect = 7e-29
 Identities = 49/221 (22%), Positives = 84/221 (38%), Gaps = 28/221 (12%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKI 62
             E   L  +    LVKL     ++ N  +V E++  G + +HL R G    S P     
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFY 146

Query: 63  AIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIV 122
           A  +     +LH    ++IYRDLK  N+L+D     +++DFG A+       T     + 
Sbjct: 147 AAQIVLTFEYLH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LC 199

Query: 123 GTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLR 182
           GT    APE + +       D ++ GV++ E+ +G                     PF  
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP-------------------PFFA 240

Query: 183 DSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP 223
           D    +         ++    +  +  ++   L +D   R 
Sbjct: 241 DQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRF 281

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  102 bits (256), Expect = 3e-26
 Identities = 41/253 (16%), Positives = 90/253 (35%), Gaps = 34/253 (13%)

Query: 1   MWQTEVIYLGQLR-HENLVKLIGYCSESDNRL--LVYEFMPKGSLENHLFRKGVQPISWP 57
             + E+  L  LR   N++ L     +  +R   LV+E +     +        Q ++  
Sbjct: 75  KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDY 129

Query: 58  TRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDS-NFNAKLSDFGLARDGPTGDNTH 116
                  ++ + L + H     +++RD+K  NV++D  +   +L D+GLA     G    
Sbjct: 130 DIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186

Query: 117 VSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLV- 174
                V +R +  PE +          D++S G +L  ++  +           +   + 
Sbjct: 187 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 175 -----EWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAA-------------VVLQCLH 216
                E    ++      L      + G++S+K  +                  + + L 
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304

Query: 217 MDPKNRPSMVDVL 229
            D ++R +  + +
Sbjct: 305 YDHQSRLTAREAM 317

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.2 bits (246), Expect = 1e-24
 Identities = 54/262 (20%), Positives = 102/262 (38%), Gaps = 26/262 (9%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCSES----DNRLLVYEFMPKGSLENHLFRKGVQPISWPT 58
             E+  L  ++HEN++ L+   + +    +   +       G+  N++ +     ++   
Sbjct: 65  YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDH 122

Query: 59  RVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS 118
              +   + RGL ++H   A++I+RDLK SN+ ++ +   K+ DFGLAR        +V+
Sbjct: 123 VQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA 180

Query: 119 TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR------------RALDEDRG 166
           TR       A    +   H     D++S G ++ ELL+GR            + +    G
Sbjct: 181 TRW----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236

Query: 167 GLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV 226
               + L + +    R+  + L  M                  ++ + L +D   R +  
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296

Query: 227 DVLTS--LEQLHTSKDMPRTPP 246
             L      Q H   D P   P
Sbjct: 297 QALAHAYFAQYHDPDDEPVADP 318

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.4 bits (239), Expect = 7e-24
 Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 23/226 (10%)

Query: 3   QTEVIYLGQLRHE-NLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +TE   L  +R    LV L           L+ +++  G L  HL ++  +  +      
Sbjct: 76  RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQI 133

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRI 121
              ++   L  LH     +IYRD+K  N+LLDSN +  L+DFGL+++    +    +   
Sbjct: 134 YVGEIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDF 190

Query: 122 VGTRGYAAPEYVATGH--LTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADP 179
            GT  Y AP+ V  G        D +S GV++ ELL+G                  +   
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---------------FTVD 235

Query: 180 FLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM 225
             ++S+  +     +    Y ++ +     ++ + L  DPK R   
Sbjct: 236 GEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGC 281

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.8 bits (237), Expect = 2e-23
 Identities = 53/276 (19%), Positives = 103/276 (37%), Gaps = 41/276 (14%)

Query: 3   QTEVIYLGQLRHENLVKLIGYCS------ESDNRLLVYEFMPKGSLENHLFRKGVQPISW 56
             E++ +  + H+N++ L+   +      E  +  LV E M     +          +  
Sbjct: 64  YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDH 118

Query: 57  PTRVKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH 116
                +   +  G+  LH   A +I+RDLK SN+++ S+   K+ DFGLAR   T   + 
Sbjct: 119 ERMSYLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSF 173

Query: 117 VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRALDEDRGGLAEQTLVEW 176
           + T  V TR Y APE +         D++S G ++ E++  +              ++E 
Sbjct: 174 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Query: 177 ADPFLRDS-----------------------RRVLRIMDTRLGGQYSKKEAQAVAAVVLQ 213
                 +                         ++          +++K +A     ++ +
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSK 293

Query: 214 CLHMDPKNRPSMVDVLTS--LEQLHTSKDMPRTPPP 247
            L +DP  R S+ D L    +   +   ++   PP 
Sbjct: 294 MLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQ 329

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 88.2 bits (217), Expect = 1e-20
 Identities = 45/258 (17%), Positives = 95/258 (36%), Gaps = 34/258 (13%)

Query: 5   EVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLF---RKGVQPISWPTRVK 61
           +      +   +++KL+ + +      +    + +   EN L    +   + I      +
Sbjct: 70  DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 129

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTR 120
           I+  +  GL ++H     +I+ D+K  NVL++       L    +A  G         T 
Sbjct: 130 ISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 121 IVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR----------ALDEDRGGLAE 170
            + TR Y +PE +        +D++S   ++ EL++G              D+D      
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

Query: 171 QTLVEWADPFLRDSRRVLRIMDTR-------------------LGGQYSKKEAQAVAAVV 211
           + L E     LR+ +      ++R                      ++SK EA+ ++  +
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308

Query: 212 LQCLHMDPKNRPSMVDVL 229
              L +DP+ R     ++
Sbjct: 309 SPMLQLDPRKRADAGGLV 326

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 53.6 bits (128), Expect = 2e-09
 Identities = 15/107 (14%), Positives = 34/107 (31%), Gaps = 8/107 (7%)

Query: 2   WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVK 61
           +    I   +     L KL G           Y +     L   +  K +  +      +
Sbjct: 53  FSVLAIRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE 107

Query: 62  IAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARD 108
           +   +   ++  +     +++ DL   NVL+       + DF  + +
Sbjct: 108 VLDMILEEVAKFY--HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE 151

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	278
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.62
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.86
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.39
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.57
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.96
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.23
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	90.72

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-49  Score=321.55  Aligned_cols=203  Identities=26%  Similarity=0.453  Sum_probs=175.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||+++++++.+++..|+|||||.+|+|.+++.+..  .+++..+..++.||+.||.|||  +.|++
T Consensus        53 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH--~~~iv  128 (263)
T d2j4za1          53 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH--SKRVI  128 (263)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++.......    .....|++.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       129 HrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf  204 (263)
T d2j4za1         129 HRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF  204 (263)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             eeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCC
Confidence            99999999999999999999999997654332    22356899999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+.+.......+.                   ......+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       205 ~~~~~~~~~~~i~-------------------~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         205 EANTYQETYKRIS-------------------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             CCSSHHHHHHHHH-------------------TTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             CCCCHHHHHHHHH-------------------cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            7643221111111                   11234556788999999999999999999999999975

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-49  Score=325.02  Aligned_cols=211  Identities=27%  Similarity=0.354  Sum_probs=175.7

Q ss_pred             ChHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            1 MWQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         1 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      .+.+|+++|++++||||+++++++.+++..|+|||||.+|+|.+++.++.  .+++..+..++.|+++||.|||  +.||
T Consensus        49 ~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH--~~~I  124 (271)
T d1nvra_          49 NIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLH--GIGI  124 (271)
T ss_dssp             CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHH--HcCC
Confidence            36899999999999999999999999999999999999999999986554  7999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHhCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~  159 (278)
                      +||||||+||+++.++.+||+|||++................||+.|+|||++.+..+ +.++|||||||++|+|++|+.
T Consensus       125 iHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~  204 (271)
T d1nvra_         125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL  204 (271)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCC
Confidence            9999999999999999999999999986544333333344678999999999988776 578999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||............                ..........+..++.++.+||.+||+.||++|||+.|+++|
T Consensus       205 pf~~~~~~~~~~~~----------------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         205 PWDQPSDSCQEYSD----------------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             SCSSSSTTSHHHHH----------------HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCCCCChHHHHHHH----------------HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            99765432211111                111111122235678899999999999999999999999864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=322.33  Aligned_cols=207  Identities=24%  Similarity=0.374  Sum_probs=175.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||++++++|.+++..|+|||||.||+|.+++.++   .+++..+..++.||+.||.|||  +.||+
T Consensus        64 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH--~~~ii  138 (293)
T d1yhwa1          64 IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH--SNQVI  138 (293)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH--HCCCc
Confidence            679999999999999999999999999999999999999999988765   5999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++........  ......|++.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       139 HrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf  216 (293)
T d1yhwa1         139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY  216 (293)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCC
Confidence            999999999999999999999999986543322  223356899999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+.+.......+..                ......+.+..++.++.+||.+||+.||.+|||+.|+++|
T Consensus       217 ~~~~~~~~~~~~~~----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         217 LNENPLRALYLIAT----------------NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             TTSCHHHHHHHHHH----------------HCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCHHHHHHHHHh----------------CCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            75432111111111                1112234456788999999999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=317.30  Aligned_cols=219  Identities=26%  Similarity=0.414  Sum_probs=172.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |++|+++|++++||||+++++++.+ +..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||  +.+|+
T Consensus        51 ~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH--~~~iv  126 (276)
T d1uwha_          51 FKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH--AKSII  126 (276)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHh--cCCEe
Confidence            7899999999999999999998754 57899999999999999997654 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC---CCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG---HLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ||||||+||+++.++.+||+|||++................+++.|+|||++.+.   .++.++|||||||++|+|+||+
T Consensus       127 HrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~  206 (276)
T d1uwha_         127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ  206 (276)
T ss_dssp             CSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC
Confidence            9999999999999999999999999765443333333445789999999998643   5788999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      .||.+.+............             .........+..+++++.+||.+||+.||++|||+.+|+++|+.+..
T Consensus       207 ~Pf~~~~~~~~~~~~~~~~-------------~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         207 LPYSNINNRDQIIFMVGRG-------------YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CTTTTCCCHHHHHHHHHHT-------------SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCChHHHHHHHHhcC-------------CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9997644322111111100             00001123455678899999999999999999999999999998874

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-47  Score=319.42  Aligned_cols=216  Identities=27%  Similarity=0.436  Sum_probs=173.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.+++..++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        74 ~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH--~~~ii  150 (299)
T d1jpaa_          74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLA--DMNYV  150 (299)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHh--hCCCc
Confidence            7899999999999999999999999999999999999999999887653 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccc---cccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-C
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS---TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-G  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g  157 (278)
                      ||||||+||+++.++.+||+|||++............   ....+++.|+|||.+.+..++.++|||||||++|+|+| |
T Consensus       151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g  230 (299)
T d1jpaa_         151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG  230 (299)
T ss_dssp             CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCC
Confidence            9999999999999999999999999765443222111   12346788999999999999999999999999999998 8


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      ..||.+....                  .....+......+.+..++.++.+||.+||+.||++|||+.+|++.|+++..
T Consensus       231 ~~Pf~~~~~~------------------~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         231 ERPYWDMTNQ------------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCTTTTCCHH------------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHH------------------HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            9999764332                  1222223333455567788999999999999999999999999999998764


Q ss_pred             C
Q 023752          238 S  238 (278)
Q Consensus       238 ~  238 (278)
                      .
T Consensus       293 ~  293 (299)
T d1jpaa_         293 N  293 (299)
T ss_dssp             S
T ss_pred             C
Confidence            3

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=322.23  Aligned_cols=207  Identities=21%  Similarity=0.326  Sum_probs=173.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|++++++++||||++++++|.+++..|+||||+.||+|.+++...+  .+++..+..++.|++.||.|||  +.||+
T Consensus        55 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~ii  130 (288)
T d1uu3a_          55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH--GKGII  130 (288)
T ss_dssp             HHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhc--cccEE
Confidence            6789999999999999999999999999999999999999999988775  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++................|++.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       131 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf  210 (288)
T d1uu3a_         131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF  210 (288)
T ss_dssp             CSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCC
Confidence            99999999999999999999999998765444333344457899999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .+.+.......+                 ..  ....++..+++++.+||.+||+.||.+|||++|++.+
T Consensus       211 ~~~~~~~~~~~i-----------------~~--~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         211 RAGNEYLIFQKI-----------------IK--LEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CCSSHHHHHHHH-----------------HT--TCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CCcCHHHHHHHH-----------------Hc--CCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            764322111111                 11  1234556788899999999999999999999998654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-47  Score=315.61  Aligned_cols=218  Identities=25%  Similarity=0.392  Sum_probs=185.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.+++..++||||+.+|+|.+++.+.....+++..+..++.|++.||.|||  +.||+
T Consensus        60 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH--~~~ii  137 (287)
T d1opja_          60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFI  137 (287)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH--HCCcc
Confidence            6899999999999999999999999999999999999999999998776678999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus       138 HrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~  216 (287)
T d1opja_         138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP  216 (287)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             cCccccCeEEECCCCcEEEccccceeecCCCCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence            999999999999999999999999986543322 2222345678899999999999999999999999999999977766


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCC
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSK  239 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  239 (278)
                      .....                 .......+......+.+..+++++.+||.+||+.||++|||+.+|++.|+.+....
T Consensus       217 ~~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         217 YPGID-----------------LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             STTCC-----------------HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             CCcch-----------------HHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            43221                 11222333344455667788999999999999999999999999999999886553

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=312.30  Aligned_cols=205  Identities=25%  Similarity=0.410  Sum_probs=166.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      |.+|+++|++++||||+++++++.+    ++.+|+||||+++|+|.+++.+..  .+++..+..++.||+.||.|||  +
T Consensus        55 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH--~  130 (270)
T d1t4ha_          55 FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLH--T  130 (270)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--T
T ss_pred             HHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHH--H
Confidence            6799999999999999999999865    345799999999999999998765  6999999999999999999999  7


Q ss_pred             CC--eeecCCCCCceEEc-CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHH
Q 023752           78 AN--VIYRDLKASNVLLD-SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        78 ~~--i~H~dl~p~ni~~~-~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l  154 (278)
                      .+  |+||||||+||+++ .++.+||+|||++......    ......|++.|+|||++.+ .++.++|||||||++|+|
T Consensus       131 ~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel  205 (270)
T d1t4ha_         131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM  205 (270)
T ss_dssp             SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred             CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHH
Confidence            77  99999999999996 5789999999999753222    2234578999999999865 599999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|+.||.+.......   ..             .......+...+...++++.+||.+||+.||++|||+.|+++|
T Consensus       206 ~~g~~Pf~~~~~~~~~---~~-------------~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         206 ATSEYPYSECQNAAQI---YR-------------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             HHSSCTTTTCSSHHHH---HH-------------HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHCCCCCCCcccHHHH---HH-------------HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence            9999999654321111   00             1111111122344567789999999999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-48  Score=318.88  Aligned_cols=209  Identities=22%  Similarity=0.326  Sum_probs=173.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.+++..++|||||.+|+|.+++.+.. +.+++..+..++.||+.||.|||  +.||+
T Consensus        56 ~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH--~~~iv  132 (288)
T d2jfla1          56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH--DNKII  132 (288)
T ss_dssp             THHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCEE
Confidence            6799999999999999999999999999999999999999999886653 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccc-----cCCCCCccchhHHHHHHHHHHh
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVA-----TGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~-----~~~~~~~~DiwslG~il~~l~~  156 (278)
                      ||||||+||+++.++.+||+|||++......  ........|++.|+|||++.     +..++.++|||||||++|+|++
T Consensus       133 HrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt  210 (288)
T d2jfla1         133 HRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE  210 (288)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH
T ss_pred             EeecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh
Confidence            9999999999999999999999998643221  11122356899999999984     4568899999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||.+.+.......+...                .......+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       211 g~~Pf~~~~~~~~~~~i~~~----------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         211 IEPPHHELNPMRVLLKIAKS----------------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             SSCTTTTSCGGGHHHHHHHS----------------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCCCCCCCCHHHHHHHHHcC----------------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            99999765432222221111                111233456788999999999999999999999999875

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=320.96  Aligned_cols=213  Identities=29%  Similarity=0.423  Sum_probs=181.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCC---------------------CCCCHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGV---------------------QPISWPTR   59 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~   59 (278)
                      |.+|+.+|.++ +||||+++++++.+.+..++|||||++|+|.+++..+..                     ..+++..+
T Consensus        87 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  166 (325)
T d1rjba_          87 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL  166 (325)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHH
T ss_pred             HHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHH
Confidence            67899999998 899999999999999999999999999999999975431                     24889999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC
Q 023752           60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT  139 (278)
Q Consensus        60 ~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  139 (278)
                      ..++.|++.||.|||  +.+|+||||||+||+++.++.+||+|||++................+++.|+|||++.+..++
T Consensus       167 ~~i~~qi~~gl~yLH--~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~  244 (325)
T d1rjba_         167 LCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT  244 (325)
T ss_dssp             HHHHHHHHHHHHHHH--HTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHH--hCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence            999999999999999  899999999999999999999999999999765444443333445678999999999999999


Q ss_pred             CccchhHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCC
Q 023752          140 PKSDVYSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       140 ~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  218 (278)
                      .++|||||||++|+|++ |..||.+.+....                 ....+......+.+..+++++.+||.+||+.|
T Consensus       245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~-----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~d  307 (325)
T d1rjba_         245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDAN-----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFD  307 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             cceeccchhHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCC
Confidence            99999999999999997 8999976443221                 22223333445567778899999999999999


Q ss_pred             CCCCCCHHHHHHHHH
Q 023752          219 PKNRPSMVDVLTSLE  233 (278)
Q Consensus       219 p~~Rps~~~ll~~l~  233 (278)
                      |++|||+.+|+++|.
T Consensus       308 P~~RPt~~ei~~~L~  322 (325)
T d1rjba_         308 SRKRPSFPNLTSFLG  322 (325)
T ss_dssp             GGGSCCHHHHHHHHH
T ss_pred             hhHCcCHHHHHHHHh
Confidence            999999999999985

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=310.54  Aligned_cols=214  Identities=29%  Similarity=0.444  Sum_probs=170.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+++..++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        47 ~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH--~~~ii  123 (263)
T d1sm2a_          47 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE--EACVI  123 (263)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhh--cccee
Confidence            6899999999999999999999999999999999999999999887554 46889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG-RRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~p  160 (278)
                      ||||||+||+++.++.+||+|||++.......... .....++..|+|||++.+..++.++||||||+++|+|+|+ .+|
T Consensus       124 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~  202 (263)
T d1sm2a_         124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP  202 (263)
T ss_dssp             CTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ecccchhheeecCCCCeEecccchheeccCCCcee-ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCC
Confidence            99999999999999999999999997654332221 2234578899999999999999999999999999999995 555


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      |...+..                  .....+........+..+++++.+||.+||+.||++|||+++|+++|+++..
T Consensus       203 ~~~~~~~------------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         203 YENRSNS------------------EVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             TCSCCHH------------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHH------------------HHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            5432221                  1122222333445566778899999999999999999999999999998853

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-48  Score=316.18  Aligned_cols=208  Identities=25%  Similarity=0.333  Sum_probs=163.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeec--CCccEEEEeccCCCCHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE--SDNRLLVYEFMPKGSLENHLFRK--GVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      |.+|++++++++||||+++++++.+  ++.+|+|||||++|+|.+++.+.  ....+++..++.++.|++.||.|||  +
T Consensus        50 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH--~  127 (269)
T d2java1          50 LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH--R  127 (269)
T ss_dssp             HHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred             HHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH--H
Confidence            6789999999999999999999865  45689999999999999998643  2347999999999999999999999  5


Q ss_pred             CC-----eeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           78 AN-----VIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        78 ~~-----i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      .+     |+||||||+||+++.++.+||+|||++.......  .......+++.|+|||++.+..++.++|||||||++|
T Consensus       128 ~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvily  205 (269)
T d2java1         128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY  205 (269)
T ss_dssp             HCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             hcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHH
Confidence            44     9999999999999999999999999997654322  1223356899999999999999999999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      +|++|+.||.+.+.....                  ..+........+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       206 el~tg~~Pf~~~~~~~~~------------------~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         206 ELCALMPPFTAFSQKELA------------------GKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             HHHHSSCSCCCSSHHHHH------------------HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhhCCCCCCCCCHHHHH------------------HHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            999999999754332111                  1111222234566788999999999999999999999999874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=312.73  Aligned_cols=212  Identities=27%  Similarity=0.410  Sum_probs=178.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++.+..  .+++..+..++.||+.||.|||  +.+++
T Consensus        55 ~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH--~~~ii  129 (277)
T d1xbba_          55 LLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE--ESNFV  129 (277)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHH--hCCcc
Confidence            7899999999999999999999965 46789999999999999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      ||||||+||+++.++.+||+|||++.......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       130 HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~  209 (277)
T d1xbba_         130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK  209 (277)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred             cCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCC
Confidence            99999999999999999999999997654433322 2223567889999999999999999999999999999998 899


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  236 (278)
                      ||.+.+..                  .....+......+.+..++.++.+||.+||+.||++|||+.+|++.|+...
T Consensus       210 Pf~~~~~~------------------~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         210 PYRGMKGS------------------EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             SSTTCCHH------------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHH------------------HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            99764321                  122223333445667788899999999999999999999999998887754

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-47  Score=313.51  Aligned_cols=214  Identities=26%  Similarity=0.401  Sum_probs=180.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.+ +..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        56 ~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH--~~~ii  131 (285)
T d1u59a_          56 MMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE--EKNFV  131 (285)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHH--hCCee
Confidence            7899999999999999999999875 46899999999999999875443 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      ||||||+||+++.++.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|+| |..
T Consensus       132 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~  211 (285)
T d1u59a_         132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK  211 (285)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCC
Confidence            99999999999999999999999998655433221 1223457889999999998999999999999999999998 899


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      ||.+.....                  ....+......+.+..++.++.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       212 Pf~~~~~~~------------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         212 PYKKMKGPE------------------VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             TTTTCCTHH------------------HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHH------------------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            997654321                  122223333456677888999999999999999999999999999987664

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=322.20  Aligned_cols=227  Identities=23%  Similarity=0.338  Sum_probs=175.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC-CCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD-ANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~-~~i   80 (278)
                      +.+|+.+|++++||||++++++|.+++..|+||||+.||+|.+++.+.+  .+++..+..++.|++.||.|||  + .||
T Consensus        51 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH--~~~~I  126 (322)
T d1s9ja_          51 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR--EKHKI  126 (322)
T ss_dssp             HHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HHHCC
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH--HhCCE
Confidence            5789999999999999999999999999999999999999999998765  6999999999999999999999  6 489


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++.++.+||+|||++......    ......|++.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus       127 iHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~P  202 (322)
T d1s9ja_         127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP  202 (322)
T ss_dssp             CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCC
T ss_pred             EccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            99999999999999999999999998753221    12335789999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhcc------------------------ccchhHHHHHHhhhccCCCCC-HHHHHHHHHHHHHhc
Q 023752          161 LDEDRGGLAEQTLVEWADP------------------------FLRDSRRVLRIMDTRLGGQYS-KKEAQAVAAVVLQCL  215 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l  215 (278)
                      |.+.+..............                        ....................+ ...+.++.+||.+||
T Consensus       203 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  282 (322)
T d1s9ja_         203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL  282 (322)
T ss_dssp             SSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHc
Confidence            9765433221111000000                        000001111111111112222 345789999999999


Q ss_pred             cCCCCCCCCHHHHHHH--HHhhh
Q 023752          216 HMDPKNRPSMVDVLTS--LEQLH  236 (278)
Q Consensus       216 ~~dp~~Rps~~~ll~~--l~~~~  236 (278)
                      +.||.+|||+.|+++|  +.+..
T Consensus       283 ~~dP~~R~ta~e~L~Hpf~~~~~  305 (322)
T d1s9ja_         283 IKNPAERADLKQLMVHAFIKRSD  305 (322)
T ss_dssp             CSSTTTSCCHHHHHTSHHHHHHH
T ss_pred             CCChhHCcCHHHHhhCHhhCcCC
Confidence            9999999999999985  55443

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-47  Score=317.75  Aligned_cols=208  Identities=23%  Similarity=0.395  Sum_probs=164.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+|++++||||+++++++.+++..|+|||||+||+|.+++.+.+  .+++..+..++.||+.||.|||  +.|++
T Consensus        54 ~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH--~~~ii  129 (307)
T d1a06a_          54 MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLH--DLGIV  129 (307)
T ss_dssp             -CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhh--hceee
Confidence            5689999999999999999999999999999999999999999997664  7999999999999999999999  89999


Q ss_pred             ecCCCCCceEEc---CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLD---SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~---~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ||||||+||++.   .++.+||+|||++.......   ......|++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus       130 HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~  206 (307)
T d1a06a_         130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY  206 (307)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             eEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCC
Confidence            999999999994   47889999999997543322   223356899999999999999999999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||.+.........+....               .....+.+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       207 ~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         207 PPFYDENDAKLFEQILKAE---------------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CSCCCSSHHHHHHHHHTTC---------------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCCHHHHHHHHhccC---------------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            9997543322111111110               111223445788899999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=304.55  Aligned_cols=212  Identities=24%  Similarity=0.391  Sum_probs=179.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+++.+++||||+.+|+|.+++.... ..+++..+..++.|+++||.|||  +.|++
T Consensus        46 ~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH--~~~ii  122 (258)
T d1k2pa_          46 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE--SKQFL  122 (258)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH--HTTBC
T ss_pred             HHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh--hcCcc
Confidence            7899999999999999999999999999999999999999999876553 35889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      ||||+|+||+++.++.+||+|||++......... ......++..|+|||++.+..++.++||||||+++|+|+| |+.|
T Consensus       123 H~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~P  201 (258)
T d1k2pa_         123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP  201 (258)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cccccceeEEEcCCCcEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCC
Confidence            9999999999999999999999999764433222 2223457889999999999999999999999999999998 8999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      |........                  ...+........+...++++.+||.+||+.||++|||+.+++++|..+
T Consensus       202 f~~~~~~~~------------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         202 YERFTNSET------------------AEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             TTTSCHHHH------------------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCCCHHHH------------------HHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            976543221                  122223334555677888999999999999999999999999998653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-46  Score=313.14  Aligned_cols=203  Identities=28%  Similarity=0.367  Sum_probs=170.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||+++++++.+++..|+|||||.+|+|..++..+.  .+++..+..++.||+.||.|||  +.||+
T Consensus        62 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH--~~~ii  137 (309)
T d1u5ra_          62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLH--SHNMI  137 (309)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHH--HTTCB
T ss_pred             HHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            6789999999999999999999999999999999999998877666554  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc---CCCCCccchhHHHHHHHHHHhCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT---GHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      ||||||+||+++.++.+||+|||++......      ....|++.|+|||++.+   ..++.++|||||||++|+|++|.
T Consensus       138 HrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~  211 (309)
T d1u5ra_         138 HRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  211 (309)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred             ccCCCcceEEECCCCCEEEeecccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCC
Confidence            9999999999999999999999999764322      23468999999999864   45889999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .||.+......                 .............+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       212 ~Pf~~~~~~~~-----------------~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         212 PPLFNMNAMSA-----------------LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             CTTTTSCHHHH-----------------HHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCCCCHHHH-----------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            99975432111                 111222222233345678899999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-46  Score=308.44  Aligned_cols=215  Identities=26%  Similarity=0.421  Sum_probs=178.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+ +..++||||+.+|+|.+++.......+++..+..++.|++.||.|||  +.+++
T Consensus        55 ~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH--~~~iv  131 (272)
T d1qpca_          55 FLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERNYI  131 (272)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcc
Confidence            7899999999999999999998755 56799999999999999876554446899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|+||+.|+
T Consensus       132 HrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~  210 (272)
T d1qpca_         132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP  210 (272)
T ss_dssp             CSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cCccchhheeeecccceeeccccceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCC
Confidence            999999999999999999999999986543221 1222345788999999999889999999999999999999966554


Q ss_pred             -ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          162 -DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       162 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                       .....                  ......+........+..+++++.+||.+||+.||++|||+.+|++.|+.+.++
T Consensus       211 ~~~~~~------------------~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         211 YPGMTN------------------PEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             STTCCH------------------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCH------------------HHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence             33221                  112222333344556677889999999999999999999999999999988765

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=311.67  Aligned_cols=205  Identities=25%  Similarity=0.372  Sum_probs=176.7

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+|++++||||++++++|.+++.+|+||||+.||+|.+++.+..  .+++..+..++.|++.||.|||  +.|++
T Consensus        52 ~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH--~~~ii  127 (337)
T d1o6la_          52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH--SRDVV  127 (337)
T ss_dssp             HHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTCB
T ss_pred             HHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh--hcCcc
Confidence            5689999999999999999999999999999999999999999998776  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.+|.+||+|||++........  ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||
T Consensus       128 HRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf  205 (337)
T d1o6la_         128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF  205 (337)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCC
Confidence            999999999999999999999999986433222  223456899999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      .+.+.......                 ..  .....+|..+++++.+||.+||+.||.+|++     +.++++|
T Consensus       206 ~~~~~~~~~~~-----------------i~--~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         206 YNQDHERLFEL-----------------IL--MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             CCSSHHHHHHH-----------------HH--HCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCcCHHHHHHH-----------------Hh--cCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            76543211111                 11  1234556778899999999999999999994     8899875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=305.44  Aligned_cols=217  Identities=26%  Similarity=0.423  Sum_probs=175.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+.+..++|+||+.++++.+++.... ..+++..+..++.|++.||.|||  +.+|+
T Consensus        56 ~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH--~~~ii  132 (283)
T d1mqba_          56 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA--NMNYV  132 (283)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc--ccccc
Confidence            6799999999999999999999999999999999999999999876654 46999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCc-cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH-VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      ||||||+||+++.++.+||+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus       133 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~  212 (283)
T d1mqba_         133 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER  212 (283)
T ss_dssp             CSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCC
Confidence            99999999999999999999999997654432221 12234578899999999999999999999999999999997666


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      +.....                 .......+......+.+..++.++.+||.+||+.||++|||+.+|++.|+++...
T Consensus       213 ~~~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         213 PYWELS-----------------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             TTTTCC-----------------HHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ccccCC-----------------HHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            533211                 1122233344445666777889999999999999999999999999999988765

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-46  Score=309.52  Aligned_cols=208  Identities=25%  Similarity=0.370  Sum_probs=173.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+++|++++||||++++++|.+++..|+|||||+||+|.+++.+++  .+++..+..++.|++.||.|||  +.+++
T Consensus        60 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH--~~~iv  135 (293)
T d1jksa_          60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH--SLQIA  135 (293)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh--hccee
Confidence            6799999999999999999999999999999999999999999998765  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCC----ceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhC
Q 023752           82 YRDLKASNVLLDSNF----NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSG  157 (278)
Q Consensus        82 H~dl~p~ni~~~~~~----~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g  157 (278)
                      ||||||+||+++.++    .+|++|||++........   .....+++.|+|||++.+..++.++|||||||++|+|++|
T Consensus       136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g  212 (293)
T d1jksa_         136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG  212 (293)
T ss_dssp             CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred             ecccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcC
Confidence            999999999998766    499999999876543322   2234678899999999999999999999999999999999


Q ss_pred             CCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          158 RRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       158 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ..||.+.+.......+.......               ....+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       213 ~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         213 ASPFLGDTKQETLANVSAVNYEF---------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             SCSSCCSSHHHHHHHHHTTCCCC---------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCC---------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            99997654322222222111100               011123467889999999999999999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.5e-46  Score=315.86  Aligned_cols=209  Identities=23%  Similarity=0.338  Sum_probs=174.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||++++++|.+++..|+|||||.||+|.+++.+.. ..+++..+..++.||+.||.|||  +.|++
T Consensus        70 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH--~~~ii  146 (350)
T d1koaa2          70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH--ENNYV  146 (350)
T ss_dssp             HHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH--hcCCe
Confidence            6789999999999999999999999999999999999999999986443 36999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcC--CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLLDS--NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~--~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ||||||+||+++.  ++.+||+|||++........   .....+++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       147 HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~  223 (350)
T d1koaa2         147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS  223 (350)
T ss_dssp             CCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSC
T ss_pred             eeeechhHeeeccCCCCeEEEeecchheecccccc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCC
Confidence            9999999999954  57899999999976543322   233568999999999999999999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||.+.+.......+.....               .........+++++.+||.+||+.||.+|||+.|+++|
T Consensus       224 Pf~~~~~~~~~~~i~~~~~---------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         224 PFGGENDDETLRNVKSCDW---------------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             SSCCSSHHHHHHHHHHTCC---------------CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCHHHHHHHHHhCCC---------------CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            9976543222222211110               11122335678899999999999999999999999986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.9e-46  Score=316.47  Aligned_cols=209  Identities=21%  Similarity=0.319  Sum_probs=175.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||++++++|.+++..|+|||||+||+|.+++...+ ..+++..+..++.||+.||.|||  +.||+
T Consensus        73 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH--~~~ii  149 (352)
T d1koba_          73 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMH--EHSIV  149 (352)
T ss_dssp             HHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCee
Confidence            5789999999999999999999999999999999999999999876553 35999999999999999999999  89999


Q ss_pred             ecCCCCCceEEc--CCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLLD--SNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ||||||+||+++  .++.+||+|||++.......   ......+++.|+|||++.+..++.++|||||||++|+|++|..
T Consensus       150 HRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~  226 (352)
T d1koba_         150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS  226 (352)
T ss_dssp             CCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred             ecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCC
Confidence            999999999997  57899999999998754432   2233568899999999999999999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||.+.+.......+....               ...+...+..++.++.+||.+||+.||.+|||+.|+++|
T Consensus       227 Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         227 PFAGEDDLETLQNVKRCD---------------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             SSCCSSHHHHHHHHHHCC---------------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCHHHHHHHHHhCC---------------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            997644322211111110               111233445788999999999999999999999999975

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=302.88  Aligned_cols=213  Identities=23%  Similarity=0.374  Sum_probs=169.9

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.+ +..++||||+.+|+|.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        55 ~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH--~~~ii  130 (273)
T d1mp8a_          55 FLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLE--SKRFV  130 (273)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhc--ccCee
Confidence            6899999999999999999999964 67899999999999999876554 36899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..|
T Consensus       131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P  209 (273)
T d1mp8a_         131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP  209 (273)
T ss_dssp             CSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             ccccchhheeecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCC
Confidence            999999999999999999999999976443222 12223457889999999999999999999999999999998 8899


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhc
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHT  237 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  237 (278)
                      |...+.......                  +......+.+..+++++.+||.+||+.||++|||+.+|+++|+++..
T Consensus       210 ~~~~~~~~~~~~------------------i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         210 FQGVKNNDVIGR------------------IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             TTTCCGGGHHHH------------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHH------------------HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            876544322211                  22223345677788999999999999999999999999999998753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-46  Score=302.53  Aligned_cols=212  Identities=31%  Similarity=0.458  Sum_probs=173.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeec-CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|++++++++||||+++++++.+ ++.+++||||+.+|+|.+++..+....+++..+..++.||+.||.|||  +.++
T Consensus        47 ~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH--~~~i  124 (262)
T d1byga_          47 FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--GNNF  124 (262)
T ss_dssp             HHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc--cCce
Confidence            6899999999999999999998854 467899999999999999997654446899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      +||||+|+||+++.++.+|++|||++.......     ....++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       125 vH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~  199 (262)
T d1byga_         125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV  199 (262)
T ss_dssp             CCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCC
Confidence            999999999999999999999999987543322     22346788999999999999999999999999999998 677


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      ||........                  ...+......+.+...++++.+||.+||+.||.+|||+.+++++|+++.+.
T Consensus       200 p~~~~~~~~~------------------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         200 PYPRIPLKDV------------------VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             SCTTSCGGGH------------------HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHH------------------HHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            7765433222                  222223344566777889999999999999999999999999999998753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5e-45  Score=305.58  Aligned_cols=202  Identities=25%  Similarity=0.416  Sum_probs=174.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.++++++||||+++++++.+++..|+||||+.||+|..++....  .+++..+..++.||+.||.|||  ++||+
T Consensus        51 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH--~~~ii  126 (316)
T d1fota_          51 TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH--SKDII  126 (316)
T ss_dssp             HHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH--TTTEE
T ss_pred             HHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhc--cCcEE
Confidence            5789999999999999999999999999999999999999999988776  6889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.+|.+||+|||++.......     ....|++.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       127 HrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf  201 (316)
T d1fota_         127 YRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF  201 (316)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred             ccccCchheeEcCCCCEEEecCccceEecccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCC
Confidence            99999999999999999999999998654322     2356899999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      .+.+......                 ....  .....+..+++++.++|.+||+.||.+|+     |++++++|
T Consensus       202 ~~~~~~~~~~-----------------~i~~--~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         202 YDSNTMKTYE-----------------KILN--AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CCSSHHHHHH-----------------HHHH--CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCcCHHHHHH-----------------HHHc--CCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            7643221111                 1111  12345667888999999999999999996     89999976

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-45  Score=306.55  Aligned_cols=215  Identities=22%  Similarity=0.357  Sum_probs=178.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|++++++++||||+++++++.++ ..+++++++.+++|.+.+.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        58 ~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH--~~~ii  133 (317)
T d1xkka_          58 ILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE--DRRLV  133 (317)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHH--HcCcc
Confidence            68999999999999999999999875 5678889999999999887654 46999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p  160 (278)
                      ||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|+| |..|
T Consensus       134 HrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p  213 (317)
T d1xkka_         134 HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP  213 (317)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCC
Confidence            999999999999999999999999987554443333334567899999999999999999999999999999998 7888


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.+......                  ...+......+.+..++.++.+||.+||+.||.+|||+.+|+++|.++...
T Consensus       214 ~~~~~~~~~------------------~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         214 YDGIPASEI------------------SSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             TTTSCGGGH------------------HHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCHHHH------------------HHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            876543222                  222333344556677889999999999999999999999999999987643

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-45  Score=300.87  Aligned_cols=218  Identities=30%  Similarity=0.444  Sum_probs=176.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.++++++||||+++++++.+ +..++||||+.+|+|..++.....+.+++..+..++.||+.||.|||  +.|++
T Consensus        59 ~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH--~~~iv  135 (285)
T d1fmka3          59 FLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE--RMNYV  135 (285)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh--hhhee
Confidence            7899999999999999999999865 56899999999999999887654456999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||
T Consensus       136 H~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~  214 (285)
T d1fmka3         136 HRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP  214 (285)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             cccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence            999999999999999999999999975433221 2223346788999999999999999999999999999999976665


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcCCC
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTSKD  240 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  240 (278)
                      .....                 .......+......+.+..+++++.+||.+||+.||++|||+.+|++.|+...+...
T Consensus       215 ~~~~~-----------------~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         215 YPGMV-----------------NREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             STTCC-----------------HHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CCCCC-----------------HHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            43221                 112222233334456677888999999999999999999999999999999887644

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.5e-45  Score=298.44  Aligned_cols=208  Identities=27%  Similarity=0.389  Sum_probs=173.6

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.++++++ ||||+++++++.+++..|+||||+++|+|.+++..++  .+++..+..++.||+.||.|||  ..|+
T Consensus        56 ~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH--~~~i  131 (277)
T d1phka_          56 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH--KLNI  131 (277)
T ss_dssp             HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH--HcCC
Confidence            578999999997 9999999999999999999999999999999998765  7999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc------CCCCCccchhHHHHHHHHH
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT------GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~DiwslG~il~~l  154 (278)
                      +||||||+||+++.++.+||+|||++........   .....+++.|.|||.+.+      ..++.++||||+||++|+|
T Consensus       132 vHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyem  208 (277)
T d1phka_         132 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL  208 (277)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHH
T ss_pred             cccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhh
Confidence            9999999999999999999999999987544322   233568899999999853      3467899999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ++|+.||.+.+.......+....               .....+...++++++.+||.+||+.||.+|||+.++++|
T Consensus       209 l~g~~Pf~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         209 LAGSPPFWHRKQMLMLRMIMSGN---------------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTC---------------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccCCCCCCCCCHHHHHHHHHhCC---------------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            99999997654322211111110               011222345788999999999999999999999999875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-44  Score=307.05  Aligned_cols=202  Identities=23%  Similarity=0.318  Sum_probs=174.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||+++++++.+.+..++|+||+.+|+|.+++.+.+  .+++..+..++.||+.||.|||  +.||+
T Consensus        88 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH--~~~ii  163 (350)
T d1rdqe_          88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH--SLDLI  163 (350)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH--hCCEe
Confidence            5789999999999999999999999999999999999999999998775  6999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRAL  161 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~  161 (278)
                      ||||||+||+++.+|.+||+|||++.......     ....|++.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       164 HRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf  238 (350)
T d1rdqe_         164 YRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF  238 (350)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             cCcCCHHHcccCCCCCEEeeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCC
Confidence            99999999999999999999999998654322     2346899999999999999999999999999999999999999


Q ss_pred             ccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          162 DEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      .+.+.......+                 ..  .....+..+++++.+||.+||+.||.+|+     |+.++++|
T Consensus       239 ~~~~~~~~~~~i-----------------~~--~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         239 FADQPIQIYEKI-----------------VS--GKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             CCSSHHHHHHHH-----------------HH--CCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCcCHHHHHHHH-----------------hc--CCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            754322111111                 11  12344567888999999999999999994     89999974

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.6e-45  Score=299.48  Aligned_cols=215  Identities=24%  Similarity=0.420  Sum_probs=170.6

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCc----cEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDN----RLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      |.+|++++++++||||+++++++...+.    .|+||||++|++|.+++...+  .+++..+..++.||+.||.|||  +
T Consensus        54 ~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH--~  129 (277)
T d1o6ya_          54 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH--Q  129 (277)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred             HHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH--h
Confidence            6799999999999999999999976543    789999999999999987775  6999999999999999999999  8


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHh
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~  156 (278)
                      .|++||||||+||+++.++.++++|||.+......... .......|++.|+|||++.+..++.++|||||||++|+|++
T Consensus       130 ~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyellt  209 (277)
T d1o6ya_         130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT  209 (277)
T ss_dssp             TTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHh
Confidence            99999999999999999999999999988654333222 22234578999999999999999999999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhcc--CCCCCHHHHHHHHHHHHHhccCCCCCCC-CHHHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRL--GGQYSKKEAQAVAAVVLQCLHMDPKNRP-SMVDVLTSLE  233 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rp-s~~~ll~~l~  233 (278)
                      |..||.+.+......                 ..+....  .......+++++.++|.+||+.||.+|| |+++++..|.
T Consensus       210 G~~Pf~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         210 GEPPFTGDSPVSVAY-----------------QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             SSCSCCCSSHHHHHH-----------------HHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCCCCCcCHHHHHH-----------------HHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            999997543211111                 1111111  1122345788999999999999999999 8999999999


Q ss_pred             hhhc
Q 023752          234 QLHT  237 (278)
Q Consensus       234 ~~~~  237 (278)
                      ++.+
T Consensus       273 r~~n  276 (277)
T d1o6ya_         273 RVHN  276 (277)
T ss_dssp             HHHC
T ss_pred             HHhC
Confidence            8864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-44  Score=299.71  Aligned_cols=216  Identities=26%  Similarity=0.419  Sum_probs=183.8

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~l   66 (278)
                      +.+|...+.++ +||||+++++++.+++..++||||+.+|+|.+++....              .+.+++..+..++.|+
T Consensus        65 ~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  144 (299)
T d1fgka_          65 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV  144 (299)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHH
Confidence            56788888888 79999999999999999999999999999999996553              2358999999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.+++||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++.++||||
T Consensus       145 ~~al~ylH--~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS  222 (299)
T d1fgka_         145 ARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS  222 (299)
T ss_dssp             HHHHHHHH--HTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHH
T ss_pred             HHHHHHhh--hCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHH
Confidence            99999999  8999999999999999999999999999998655544443344456788999999999999999999999


Q ss_pred             HHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++ |..||.+....                  .....+......+.+..+++++.+||.+||+.||.+|||+
T Consensus       223 ~Gvvl~ell~~g~~p~~~~~~~------------------~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~  284 (299)
T d1fgka_         223 FGVLLWEIFTLGGSPYPGVPVE------------------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF  284 (299)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCHH------------------HHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hHHHHHHhccCCCCCCCCCCHH------------------HHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCH
Confidence            9999999998 68888654321                  1222333344556677788999999999999999999999


Q ss_pred             HHHHHHHHhhhc
Q 023752          226 VDVLTSLEQLHT  237 (278)
Q Consensus       226 ~~ll~~l~~~~~  237 (278)
                      .+|++.|+++.+
T Consensus       285 ~eil~~L~~i~a  296 (299)
T d1fgka_         285 KQLVEDLDRIVA  296 (299)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhh
Confidence            999999998854

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-45  Score=306.60  Aligned_cols=214  Identities=21%  Similarity=0.310  Sum_probs=170.4

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeec----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSE----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+.++.++ +||||++++++|++    +..+|+|||||+||+|.+++.+++...+++..+..++.||+.||.|||  
T Consensus        51 ~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH--  128 (335)
T d2ozaa1          51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--  128 (335)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH--
Confidence            56899987655 89999999999875    356899999999999999998766567999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcC---CCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      +.|++||||||+||+++.   .+.+||+|||++........   .....|++.|+|||++.+..++.++|||||||++|+
T Consensus       129 ~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~  205 (335)
T d2ozaa1         129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYI  205 (335)
T ss_dssp             HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHH
T ss_pred             HcCCccccccccccccccccccccccccccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHH
Confidence            899999999999999975   56799999999976544322   233568999999999999999999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |++|+.||.+.+.......+........           ...+.+....+++++.+||.+||+.||++|||+.|+++|
T Consensus       206 lltg~~Pf~~~~~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         206 LLCGYPPFYSNHGLAISPGMKTRIRMGQ-----------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             HTTSSCSCEETTCC--------CCCSCS-----------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhhCCCCCCCCCHHHHHHHHHHHHhcCC-----------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            9999999976554333222211110000           000111224578899999999999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.8e-44  Score=305.70  Aligned_cols=204  Identities=24%  Similarity=0.322  Sum_probs=171.0

Q ss_pred             HHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 023752            4 TEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIYR   83 (278)
Q Consensus         4 ~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H~   83 (278)
                      +|+++++.++||||++++++|.+++..|+||||+.||+|.+++.++.  .+++..+..++.||+.||.|||  +.|++||
T Consensus        56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH--~~~iiHr  131 (364)
T d1omwa3          56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH--NRFVVYR  131 (364)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HTTEECC
T ss_pred             HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHH--HCCccce
Confidence            34677788899999999999999999999999999999999998775  6899999999999999999999  8999999


Q ss_pred             CCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCCCc
Q 023752           84 DLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRALD  162 (278)
Q Consensus        84 dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p~~  162 (278)
                      ||||+||+++.+|.+||+|||++........    ....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus       132 DlKP~NILl~~~g~iKl~DFGla~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~  207 (364)
T d1omwa3         132 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR  207 (364)
T ss_dssp             CCSGGGEEECSSSCEEECCCTTCEECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             eeccceeEEcCCCcEEEeeeceeeecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999986543322    23468999999999864 578999999999999999999999997


Q ss_pred             cccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 023752          163 EDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS-----MVDVLTS  231 (278)
Q Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  231 (278)
                      .............                ........+..+++++.+||.+||+.||.+|||     ++++++|
T Consensus       208 ~~~~~~~~~~~~~----------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         208 QHKTKDKHEIDRM----------------TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             SSCSSCHHHHHHH----------------SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCCHHHHHHHHHh----------------cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            6544322111111                111223455678899999999999999999999     7999875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-45  Score=305.13  Aligned_cols=209  Identities=20%  Similarity=0.287  Sum_probs=172.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||++++++|++++.+|+|||||.|++|.+++.+.+ ..+++..+..++.||+.||.|||  +.||+
T Consensus        48 ~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH--~~~ii  124 (321)
T d1tkia_          48 VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH--SHNIG  124 (321)
T ss_dssp             HHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--HcCCC
Confidence            5799999999999999999999999999999999999999999997654 35899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCC--CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCC
Q 023752           82 YRDLKASNVLLDSN--FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~  159 (278)
                      ||||||+||+++.+  ..++|+|||++.......   ......+++.|+|||...+..++.++|||||||++|+|++|..
T Consensus       125 HrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~  201 (321)
T d1tkia_         125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN  201 (321)
T ss_dssp             CCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred             cccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCC
Confidence            99999999999754  479999999987643322   2233567889999999999999999999999999999999999


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      ||...+.......+......+               ....+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       202 Pf~~~~~~~~~~~i~~~~~~~---------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         202 PFLAETNQQIIENIMNAEYTF---------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             TTCCSSHHHHHHHHHHTCCCC---------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCHHHHHHHHHhCCCCC---------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            997654332222222211110               001112467889999999999999999999999985

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=296.62  Aligned_cols=213  Identities=29%  Similarity=0.391  Sum_probs=176.5

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      |.+|+.+|++++||||+++++++.+ +..++|+||+.++++.+++.... ..+++..+..++.|++.||.|||  +.+++
T Consensus        58 ~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH--~~~ii  133 (273)
T d1u46a_          58 FIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE--SKRFI  133 (273)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhh--hCCEe
Confidence            6899999999999999999999976 46789999999999999887654 35999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccc-cccccCCcccCccccccCCCCCccchhHHHHHHHHHHh-CCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVS-TRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLS-GRR  159 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~  159 (278)
                      ||||||+||+++.++.+||+|||++............ ....++..|+|||.+.+..++.++||||||+++|+|++ |..
T Consensus       134 HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~  213 (273)
T d1u46a_         134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE  213 (273)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCC
Confidence            9999999999999999999999999875444333222 23456778999999999999999999999999999998 899


Q ss_pred             CCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhh
Q 023752          160 ALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQL  235 (278)
Q Consensus       160 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  235 (278)
                      ||.+.+.....                 ..........+.+..++.++.+||.+||+.||++|||+.+|++.|.+.
T Consensus       214 Pf~~~~~~~~~-----------------~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         214 PWIGLNGSQIL-----------------HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TTTTCCHHHHH-----------------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcCHHHHH-----------------HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            99754332211                 122223334455677888999999999999999999999999998875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-44  Score=299.33  Aligned_cols=215  Identities=25%  Similarity=0.393  Sum_probs=178.4

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC----------------------CCCCCHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------------------VQPISWPTR   59 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~   59 (278)
                      |.+|+++|++++||||+++++++.+.+..++++|++.+|+|.+++....                      ...+++..+
T Consensus        63 ~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  142 (301)
T d1lufa_          63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQ  142 (301)
T ss_dssp             HHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHH
T ss_pred             HHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHH
Confidence            7899999999999999999999999999999999999999999986432                      234888999


Q ss_pred             HHHHHHHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCC
Q 023752           60 VKIAIDVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLT  139 (278)
Q Consensus        60 ~~i~~~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  139 (278)
                      ..++.|++.||.|||  +.+++||||||+||+++.++.+||+|||++................+++.|+|||.+.+..++
T Consensus       143 ~~i~~qi~~gl~ylH--~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t  220 (301)
T d1lufa_         143 LCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT  220 (301)
T ss_dssp             HHHHHHHHHHHHHHH--HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHhhhcc--cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC
Confidence            999999999999999  899999999999999999999999999998654333222223334577889999999999999


Q ss_pred             CccchhHHHHHHHHHHhCC-CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCC
Q 023752          140 PKSDVYSFGVVLLELLSGR-RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       140 ~~~DiwslG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  218 (278)
                      .++|||||||++|+|++|. .||.+.+...                  ....+......+.+..+++++.+||.+||+.|
T Consensus       221 ~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e------------------~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~  282 (301)
T d1lufa_         221 TESDVWAYGVVLWEIFSYGLQPYYGMAHEE------------------VIYYVRDGNILACPENCPLELYNLMRLCWSKL  282 (301)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCTTTTSCHHH------------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             hhhhhccchhhHHHHHccCCCCCCCCCHHH------------------HHHHHHcCCCCCCCccchHHHHHHHHHHcCCC
Confidence            9999999999999999986 5676543221                  12222333345566778889999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhh
Q 023752          219 PKNRPSMVDVLTSLEQLH  236 (278)
Q Consensus       219 p~~Rps~~~ll~~l~~~~  236 (278)
                      |++|||+.+|++.|+++.
T Consensus       283 P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         283 PADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             GGGSCCHHHHHHHHHHTT
T ss_pred             hhHCcCHHHHHHHHHHhc
Confidence            999999999999999874

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-44  Score=297.86  Aligned_cols=216  Identities=27%  Similarity=0.380  Sum_probs=172.1

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecC-CccEEEEeccCCCCHHHHHhhcC--------------CCCCCHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSES-DNRLLVYEFMPKGSLENHLFRKG--------------VQPISWPTRVKIAID   65 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~~   65 (278)
                      |.+|..++.++ +|+||+.+++++.+. +..++|||||++|+|.+++....              ...+++..+..++.|
T Consensus        63 ~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  142 (299)
T d1ywna1          63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ  142 (299)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHH
T ss_pred             HHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHH
Confidence            56777777777 689999999987665 46899999999999999996542              235889999999999


Q ss_pred             HHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchh
Q 023752           66 VARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVY  145 (278)
Q Consensus        66 l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diw  145 (278)
                      ++.||.|||  +.+|+||||||+||+++.++.+||+|||++................+++.|+|||++.+..++.++|||
T Consensus       143 i~~gl~ylH--~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw  220 (299)
T d1ywna1         143 VAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW  220 (299)
T ss_dssp             HHHHHHHHH--HTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHHH--hCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCccccee
Confidence            999999999  899999999999999999999999999999765544444334446788999999999999999999999


Q ss_pred             HHHHHHHHHHhCC-CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCC
Q 023752          146 SFGVVLLELLSGR-RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPS  224 (278)
Q Consensus       146 slG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  224 (278)
                      ||||++|+|++|. .||......                 ......+......+.+..+++++.++|.+||+.||++|||
T Consensus       221 S~Gvil~ellt~~~~p~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt  283 (299)
T d1ywna1         221 SFGVLLWEIFSLGASPYPGVKID-----------------EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT  283 (299)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCCS-----------------HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             ehHHHHHHHHhCCCCCCCCCCHH-----------------HHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcC
Confidence            9999999999864 577654322                 1122233333445566778889999999999999999999


Q ss_pred             HHHHHHHHHhhh
Q 023752          225 MVDVLTSLEQLH  236 (278)
Q Consensus       225 ~~~ll~~l~~~~  236 (278)
                      +.+++++|+++.
T Consensus       284 ~~eil~~L~~il  295 (299)
T d1ywna1         284 FSELVEHLGNLL  295 (299)
T ss_dssp             HHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHH
Confidence            999999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=301.83  Aligned_cols=224  Identities=23%  Similarity=0.231  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||+++++++.+++..|+||||+.++++..+...+  ..+++..+..++.||+.||.|||  +.|++
T Consensus        47 ~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH--~~~ii  122 (299)
T d1ua2a_          47 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLH--QHWIL  122 (299)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhh--cccee
Confidence            568999999999999999999999999999999999887666555433  36889999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      ||||||+||+++.++.+||+|||++.........  .....+++.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus       123 HrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p  200 (299)
T d1ua2a_         123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF  200 (299)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence            9999999999999999999999999764443222  223468899999998864 4679999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchh----HHHHHHhhhccCCC-----CCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDS----RRVLRIMDTRLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |.+.........+...........    ..............     .....++++.+||.+||+.||++|||+.|+++|
T Consensus       201 f~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         201 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            976654443333333221111000    00000000000000     112457789999999999999999999999975

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-44  Score=297.75  Aligned_cols=214  Identities=28%  Similarity=0.403  Sum_probs=179.0

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--------------CCCCCCHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--------------GVQPISWPTRVKIAIDV   66 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~i~~~l   66 (278)
                      |.+|+++|+++ +||||+++++++.+++..++||||+++|+|.+++.++              ....+++..+..++.|+
T Consensus        57 ~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  136 (309)
T d1fvra_          57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV  136 (309)
T ss_dssp             HHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHH
Confidence            68999999999 7999999999999999999999999999999998654              12469999999999999


Q ss_pred             HHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhH
Q 023752           67 ARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYS  146 (278)
Q Consensus        67 ~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Diws  146 (278)
                      +.||.|||  +.+++||||||+||+++.++.+||+|||++.........   ....++..|+|||.+.+..++.++||||
T Consensus       137 a~gl~~lH--~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwS  211 (309)
T d1fvra_         137 ARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWS  211 (309)
T ss_dssp             HHHHHHHH--HTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHH
T ss_pred             HHHHHhhh--cCCccccccccceEEEcCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeeh
Confidence            99999999  899999999999999999999999999998753322221   2245788999999999999999999999


Q ss_pred             HHHHHHHHHhCC-CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          147 FGVVLLELLSGR-RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       147 lG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      ||+++|+|++|. .||.+.+...                  ....+......+.+..+++++.+||.+||+.||++|||+
T Consensus       212 fGvil~ell~~~~~p~~~~~~~~------------------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  273 (309)
T d1fvra_         212 YGVLLWEIVSLGGTPYCGMTCAE------------------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSF  273 (309)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCHHH------------------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             hHHHHHHHHhcCCCCCCCCCHHH------------------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence            999999999976 4665433211                  122222333455667788999999999999999999999


Q ss_pred             HHHHHHHHhhhcC
Q 023752          226 VDVLTSLEQLHTS  238 (278)
Q Consensus       226 ~~ll~~l~~~~~~  238 (278)
                      .+|+++|+++...
T Consensus       274 ~eil~~L~~i~~~  286 (309)
T d1fvra_         274 AQILVSLNRMLEE  286 (309)
T ss_dssp             HHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHHhc
Confidence            9999999998764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=296.58  Aligned_cols=219  Identities=28%  Similarity=0.413  Sum_probs=184.2

Q ss_pred             hHHHHHHHhcc-CCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcC----------------CCCCCHHHHHHHHH
Q 023752            2 WQTEVIYLGQL-RHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKG----------------VQPISWPTRVKIAI   64 (278)
Q Consensus         2 ~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~i~~   64 (278)
                      |.+|+.+++.+ +||||+++++++.+.+..++|||||++|+|.+++.+..                ...+++..+..++.
T Consensus        73 ~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  152 (311)
T d1t46a_          73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY  152 (311)
T ss_dssp             HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHH
T ss_pred             HHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHH
Confidence            67899999999 69999999999999999999999999999999987543                22588999999999


Q ss_pred             HHHHHHHHHhcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccch
Q 023752           65 DVARGLSFLHGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDV  144 (278)
Q Consensus        65 ~l~~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  144 (278)
                      |++.||.|||  +.+++||||||+||+++.++.++++|||.+................+++.|+|||.+.+..++.++||
T Consensus       153 qi~~gl~~LH--~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI  230 (311)
T d1t46a_         153 QVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV  230 (311)
T ss_dssp             HHHHHHHHHH--HTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHH--hCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccc
Confidence            9999999999  89999999999999999999999999999987655444444444677899999999999999999999


Q ss_pred             hHHHHHHHHHHh-CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          145 YSFGVVLLELLS-GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       145 wslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      ||||+++|+|++ |.+||.......                 .+...+........+...+..+.+||.+||+.||.+||
T Consensus       231 wS~G~~l~ellt~g~p~~~~~~~~~-----------------~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP  293 (311)
T d1t46a_         231 WSYGIFLWELFSLGSSPYPGMPVDS-----------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP  293 (311)
T ss_dssp             HHHHHHHHHHHTTTCCSSTTCCSSH-----------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred             cchHHHHHHHHhCCCCCCCCCCHHH-----------------HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCc
Confidence            999999999999 455554433221                 22233334445556677889999999999999999999


Q ss_pred             CHHHHHHHHHhhhcCC
Q 023752          224 SMVDVLTSLEQLHTSK  239 (278)
Q Consensus       224 s~~~ll~~l~~~~~~~  239 (278)
                      |+.+|++.|+++....
T Consensus       294 s~~~il~~L~~~i~~~  309 (311)
T d1t46a_         294 TFKQIVQLIEKQISES  309 (311)
T ss_dssp             CHHHHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHhhccC
Confidence            9999999999876553

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-44  Score=300.63  Aligned_cols=204  Identities=25%  Similarity=0.397  Sum_probs=171.7

Q ss_pred             hHHHHHHHh-ccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLG-QLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+.++. .++||||+++++++.+++..|+||||+++|+|.+++....  .+++..+..++.||+.||.|||  ++|+
T Consensus        49 ~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH--~~~i  124 (320)
T d1xjda_          49 TMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH--SKGI  124 (320)
T ss_dssp             HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH--hCCe
Confidence            345666654 6899999999999999999999999999999999998765  6899999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCCCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      +||||||+||+++.++.+||+|||++.......  .......|++.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus       125 iHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~P  202 (320)
T d1xjda_         125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP  202 (320)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eeccCcccceeecCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCC
Confidence            999999999999999999999999997644332  222335689999999999999999999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHH-HHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMV-DVLT  230 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~-~ll~  230 (278)
                      |.+.+.......+.                   .....++..+++++.+||.+||+.||.+||++. ++++
T Consensus       203 F~~~~~~~~~~~i~-------------------~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         203 FHGQDEEELFHSIR-------------------MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             SCCSSHHHHHHHHH-------------------HCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCCCCHHHHHHHHH-------------------cCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            97644322111111                   123455667889999999999999999999995 7765

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-43  Score=293.79  Aligned_cols=219  Identities=27%  Similarity=0.410  Sum_probs=178.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeec-CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE-SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      |.+|+++|++++||||+++++++.+ ++..++|||||.+++|.+++.... ...++..+..++.|++.||.|||  +.++
T Consensus        75 ~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH--~~~i  151 (311)
T d1r0pa_          75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLA--SKKF  151 (311)
T ss_dssp             HHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhc--ccCc
Confidence            7899999999999999999999765 467899999999999999887554 35778889999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--cccccccCCcccCccccccCCCCCccchhHHHHHHHHHHhCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~~g~  158 (278)
                      +||||||+||+++.++.+||+|||++..........  ......++..|+|||.+.+..++.++||||||+++|+|++|+
T Consensus       152 iHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~  231 (311)
T d1r0pa_         152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG  231 (311)
T ss_dssp             CCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred             ccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCC
Confidence            999999999999999999999999998654432222  222346788999999999999999999999999999999988


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHHHhhhcC
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  238 (278)
                      .||........                 ....+........+..+++++.+||.+||+.||++|||+.||+++|+++...
T Consensus       232 ~p~~~~~~~~~-----------------~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         232 APPYPDVNTFD-----------------ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCSCC-----------------------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCHHH-----------------HHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            88754322111                 1111122223445567788999999999999999999999999999999876


Q ss_pred             CC
Q 023752          239 KD  240 (278)
Q Consensus       239 ~~  240 (278)
                      ..
T Consensus       295 ~~  296 (311)
T d1r0pa_         295 FI  296 (311)
T ss_dssp             CC
T ss_pred             hh
Confidence            33

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-43  Score=293.37  Aligned_cols=225  Identities=25%  Similarity=0.312  Sum_probs=171.0

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+++|++++||||++++++|.+++..|+||||+. +++.+++.....+.+++..+..++.|++.||.|||  +.||+
T Consensus        48 ~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH--~~~Ii  124 (298)
T d1gz8a_          48 AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--SHRVL  124 (298)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCcEEEeccccccccceeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh--cCCEE
Confidence            5789999999999999999999999999999999995 46666665555567999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCC-CCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGH-LTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      ||||||+||+++.++.+||+|||.+.......  .......+++.|+|||.+.... ++.++|+|||||++|+|++|+.|
T Consensus       125 HrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~P  202 (298)
T d1gz8a_         125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRAL  202 (298)
T ss_dssp             CSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccCchheeecccCcceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCC
Confidence            99999999999999999999999987543322  2233356889999999876655 57899999999999999999999


Q ss_pred             CccccCCchhhhHHhhhccccch-hHHHHHHhhhc--c-C---C---CCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWADPFLRD-SRRVLRIMDTR--L-G---G---QYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~-~---~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |.+.+.......+.......... ...........  . .   .   .....++.++.+||.+||+.||++|||+.|+++
T Consensus       203 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         203 FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            97655433322222211111100 00000000000  0 0   0   001245678999999999999999999999998


Q ss_pred             H
Q 023752          231 S  231 (278)
Q Consensus       231 ~  231 (278)
                      |
T Consensus       283 H  283 (298)
T d1gz8a_         283 H  283 (298)
T ss_dssp             S
T ss_pred             C
Confidence            7

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=290.06  Aligned_cols=216  Identities=25%  Similarity=0.413  Sum_probs=180.8

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhc--------CCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRK--------GVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--------~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      |.+|++++++++||||+++++++..++..++|+||+.+|+|.+++...        ....+++..+..++.|++.||.||
T Consensus        70 ~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L  149 (308)
T d1p4oa_          70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL  149 (308)
T ss_dssp             HHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence            689999999999999999999999999999999999999999988543        223578889999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.+++||||||+||+++.++++||+|||++................+++.|+|||.+.+..++.++|+||||+++|+
T Consensus       150 H--~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~E  227 (308)
T d1p4oa_         150 N--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE  227 (308)
T ss_dssp             H--HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred             h--hCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHH
Confidence            9  89999999999999999999999999999976444333333344567899999999999999999999999999999


Q ss_pred             HHhCC-CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          154 LLSGR-RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       154 l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      |++|. .||.+.+...                  ....+......+.+..++..+.++|.+||+.||++|||+.+|+++|
T Consensus       228 l~t~~~~p~~~~~~~~------------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L  289 (308)
T d1p4oa_         228 IATLAEQPYQGLSNEQ------------------VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI  289 (308)
T ss_dssp             HHHTSCCTTTTSCHHH------------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHhCCCCCCCCCCHHH------------------HHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence            99985 6775443221                  1222223334555677889999999999999999999999999999


Q ss_pred             Hhhhc
Q 023752          233 EQLHT  237 (278)
Q Consensus       233 ~~~~~  237 (278)
                      ++...
T Consensus       290 ~~~~~  294 (308)
T d1p4oa_         290 KEEME  294 (308)
T ss_dssp             GGGSC
T ss_pred             HHhcC
Confidence            87643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-43  Score=288.42  Aligned_cols=197  Identities=21%  Similarity=0.384  Sum_probs=165.8

Q ss_pred             hHHHHHHHhccC--CccccceeeeeecCCccEEEEeccCC-CCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLR--HENLVKLIGYCSESDNRLLVYEFMPK-GSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~--h~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|+.+|++++  ||||+++++++.+++..++|+|++.+ +++.+++.++.  .+++..+..++.||+.||.|||  +.
T Consensus        54 ~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH--~~  129 (273)
T d1xwsa_          54 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCH--NC  129 (273)
T ss_dssp             EEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             HHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH--HC
Confidence            468999999996  89999999999999999999999976 57888887665  6999999999999999999999  89


Q ss_pred             CeeecCCCCCceEEcCC-CceEEeccccccCCCCCCCCccccccccCCcccCccccccCCC-CCccchhHHHHHHHHHHh
Q 023752           79 NVIYRDLKASNVLLDSN-FNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHL-TPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~il~~l~~  156 (278)
                      |++||||||+||+++.+ +.+||+|||++.......    .....|++.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       130 ~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~  205 (273)
T d1xwsa_         130 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC  205 (273)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh
Confidence            99999999999999854 789999999997643322    233568999999999987765 567999999999999999


Q ss_pred             CCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          157 GRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       157 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      |..||...+.      +.                 .  .....+..++.++.+||.+||+.||.+|||+.|+++|
T Consensus       206 g~~Pf~~~~~------i~-----------------~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         206 GDIPFEHDEE------II-----------------R--GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             SSCSCCSHHH------HH-----------------H--CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCCCCCchH------Hh-----------------h--cccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            9999965321      00                 0  1123345678899999999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-42  Score=288.21  Aligned_cols=224  Identities=24%  Similarity=0.325  Sum_probs=169.1

Q ss_pred             hHHHHHHHhcc---CCccccceeeeeec-----CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQL---RHENLVKLIGYCSE-----SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+.+|+.+   +||||++++++|..     ....++++|++.++++.. ........+++..+..++.|++.||.||
T Consensus        54 ~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~-~~~~~~~~~~~~~~~~~~~qi~~aL~yL  132 (305)
T d1blxa_          54 TIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY-LDKVPEPGVPTETIKDMMFQLLRGLDFL  132 (305)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHH-HHHSCTTCSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhh-hhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            46788888777   79999999999853     346799999997765543 4344445799999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLE  153 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~  153 (278)
                      |  +.+|+||||||+||+++.++.+||+|||++.....   ........||+.|+|||++.+..++.++|||||||++|+
T Consensus       133 H--~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~e  207 (305)
T d1blxa_         133 H--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE  207 (305)
T ss_dssp             H--HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred             H--hCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHH
Confidence            9  89999999999999999999999999999875322   222344678999999999999999999999999999999


Q ss_pred             HHhCCCCCccccCCchhhhHHhhhccccchhH--------HHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCH
Q 023752          154 LLSGRRALDEDRGGLAEQTLVEWADPFLRDSR--------RVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSM  225 (278)
Q Consensus       154 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  225 (278)
                      |++|+.||.+.+.......+............        ..................++.+.+||.+||+.||++|||+
T Consensus       208 ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa  287 (305)
T d1blxa_         208 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA  287 (305)
T ss_dssp             HHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred             HHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCH
Confidence            99999999876544333333322111110000        0000000000112234567889999999999999999999


Q ss_pred             HHHHHH
Q 023752          226 VDVLTS  231 (278)
Q Consensus       226 ~~ll~~  231 (278)
                      .|+++|
T Consensus       288 ~e~L~H  293 (305)
T d1blxa_         288 YSALSH  293 (305)
T ss_dssp             HHHHTS
T ss_pred             HHHhcC
Confidence            999976

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.3e-42  Score=285.30  Aligned_cols=224  Identities=21%  Similarity=0.270  Sum_probs=167.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +.+|+.+|++++||||++++++|.+++..+++++++.++.+..+...+  +.+++..+..++.||+.||.|||  +.+|+
T Consensus        47 ~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH--~~~Iv  122 (286)
T d1ob3a_          47 TIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCH--DRRVL  122 (286)
T ss_dssp             HHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHH--HTTCC
T ss_pred             HHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhc--cCcEE
Confidence            578999999999999999999999999999999999776666555444  37999999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      ||||||+||+++.++.+|++|||.+........  ......+++.|.|||.+.+. .++.++|+|||||++|+|++|+.|
T Consensus       123 HrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~p  200 (286)
T d1ob3a_         123 HRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL  200 (286)
T ss_dssp             CSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCC
Confidence            999999999999999999999999876433222  12234578899999998764 568999999999999999999999


Q ss_pred             CccccCCchhhhHHhhhc-cccchh---HHHHHHhh------hccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          161 LDEDRGGLAEQTLVEWAD-PFLRDS---RRVLRIMD------TRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      |.+.+.......+..... +.....   ........      ...........++.+.+||.+||+.||++|||+.|+++
T Consensus       201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            976543332222221111 100000   00000000      00001123456789999999999999999999999986


Q ss_pred             H
Q 023752          231 S  231 (278)
Q Consensus       231 ~  231 (278)
                      |
T Consensus       281 H  281 (286)
T d1ob3a_         281 H  281 (286)
T ss_dssp             S
T ss_pred             C
Confidence            5

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=284.03  Aligned_cols=230  Identities=23%  Similarity=0.315  Sum_probs=169.7

Q ss_pred             HHHHHHHhccCCccccceeeeeecCC----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC--
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL--   76 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~--   76 (278)
                      +.|+..+.+++||||+++++++.+.+    .+|+||||+.+|+|.+++.+.   .+++..+..++.+++.||.|+|+.  
T Consensus        45 e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~  121 (303)
T d1vjya_          45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIV  121 (303)
T ss_dssp             HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred             HHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhh
Confidence            34555667789999999999997654    478999999999999999875   489999999999999999999942  


Q ss_pred             ----CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCc--cccccccCCcccCccccccCC------CCCccch
Q 023752           77 ----DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTH--VSTRIVGTRGYAAPEYVATGH------LTPKSDV  144 (278)
Q Consensus        77 ----~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~------~~~~~Di  144 (278)
                          +.||+||||||+||+++.++.+||+|||++..........  ......+++.|+|||.+.+..      ++.++||
T Consensus       122 ~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di  201 (303)
T d1vjya_         122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI  201 (303)
T ss_dssp             STTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred             hhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhh
Confidence                2599999999999999999999999999987654432211  223356899999999987643      5668999


Q ss_pred             hHHHHHHHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHH-HhhhccCCCCC-----HHHHHHHHHHHHHhccCC
Q 023752          145 YSFGVVLLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLR-IMDTRLGGQYS-----KKEAQAVAAVVLQCLHMD  218 (278)
Q Consensus       145 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~l~~li~~~l~~d  218 (278)
                      |||||++|+|+||..||................   ......... ......++..+     ......+.+|+.+||+.|
T Consensus       202 ~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~d  278 (303)
T d1vjya_         202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS---DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN  278 (303)
T ss_dssp             HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS---SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSS
T ss_pred             hhhHHHHHHHhhCCCCCCcccccccchhhcccc---cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccC
Confidence            999999999999998885433321111100000   001111111 12222222222     235567999999999999


Q ss_pred             CCCCCCHHHHHHHHHhhhcC
Q 023752          219 PKNRPSMVDVLTSLEQLHTS  238 (278)
Q Consensus       219 p~~Rps~~~ll~~l~~~~~~  238 (278)
                      |.+|||+.||++.|+++...
T Consensus       279 p~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         279 GAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             GGGSCCHHHHHHHHHHHHHH
T ss_pred             HhHCcCHHHHHHHHHHHHHh
Confidence            99999999999999998754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-41  Score=284.85  Aligned_cols=230  Identities=23%  Similarity=0.361  Sum_probs=173.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC------ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD------NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+++|++++||||++++++|...+      .+|+||||+ +.+|..+....   .+++..+..++.||+.||.||| 
T Consensus        64 ~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH-  138 (346)
T d1cm8a_          64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIH-  138 (346)
T ss_dssp             HHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHH-
Confidence            468999999999999999999997654      469999999 67888877554   5999999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLEL  154 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l  154 (278)
                       +.||+||||||+||+++.++.+|++|||++.......     ....+++.|+|||++.+ ..++.++|||||||++|+|
T Consensus       139 -~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el  212 (346)
T d1cm8a_         139 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM  212 (346)
T ss_dssp             -HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHH
T ss_pred             -hCCCcccccCcchhhcccccccccccccceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHH
Confidence             8999999999999999999999999999998654332     23468899999999876 4578999999999999999


Q ss_pred             HhCCCCCccccCCchhhhHHhhhccccch---------hHHHHHHhhhccC---CCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          155 LSGRRALDEDRGGLAEQTLVEWADPFLRD---------SRRVLRIMDTRLG---GQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       155 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      ++|..||.+.+.......+..........         .............   .......++++.+||.+||+.||.+|
T Consensus       213 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R  292 (346)
T d1cm8a_         213 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR  292 (346)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTS
T ss_pred             HHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHC
Confidence            99999998765443333333222211110         0000111101000   11234567889999999999999999


Q ss_pred             CCHHHHHHH--HHhhhcCCCCC
Q 023752          223 PSMVDVLTS--LEQLHTSKDMP  242 (278)
Q Consensus       223 ps~~~ll~~--l~~~~~~~~~~  242 (278)
                      ||+.|+++|  ++.+....+.|
T Consensus       293 ~ta~eiL~Hp~f~~~~~~~~~~  314 (346)
T d1cm8a_         293 VTAGEALAHPYFESLHDTEDEP  314 (346)
T ss_dssp             CCHHHHHHSGGGTTTC------
T ss_pred             cCHHHHhcChhhCcCCCccccc
Confidence            999999987  66665444444

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=282.38  Aligned_cols=231  Identities=23%  Similarity=0.306  Sum_probs=168.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC------CccEEEEeccCCCCHHHHHh-hcCCCCCCHHHHHHHHHHHHHHHHHHh
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLF-RKGVQPISWPTRVKIAIDVARGLSFLH   74 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~i~~~l~~~l~~Lh   74 (278)
                      +.+|+++|++++||||++++++|...      .++++||||++++.+..+.. ......+++..+..++.||+.||.|||
T Consensus        60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH  139 (350)
T d1q5ka_          60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH  139 (350)
T ss_dssp             CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45899999999999999999998543      24689999997653333322 123347999999999999999999999


Q ss_pred             cCCCCeeecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCccccccccCCcccCcccccc-CCCCCccchhHHHHHHH
Q 023752           75 GLDANVIYRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        75 ~~~~~i~H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~  152 (278)
                        +.||+||||||+||+++.++ .+||+|||++.......   ......++..|+|||.+.+ ..++.++|||||||++|
T Consensus       140 --~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~  214 (350)
T d1q5ka_         140 --SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA  214 (350)
T ss_dssp             --TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             --hcCCcccCCCcceEEEecCCCceeEecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEE
Confidence              89999999999999998775 89999999987643322   2223568899999998765 57899999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhH-HHHHH-hhhccC--------CCCCHHHHHHHHHHHHHhccCCCCCC
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSR-RVLRI-MDTRLG--------GQYSKKEAQAVAAVVLQCLHMDPKNR  222 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R  222 (278)
                      +|++|..||...+.......+.........+.. ..... ......        .......++++.+||.+||+.||++|
T Consensus       215 el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R  294 (350)
T d1q5ka_         215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR  294 (350)
T ss_dssp             HHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred             ehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHC
Confidence            999999999766544333333322211111100 00000 000000        01123467889999999999999999


Q ss_pred             CCHHHHHHH--HHhhhc
Q 023752          223 PSMVDVLTS--LEQLHT  237 (278)
Q Consensus       223 ps~~~ll~~--l~~~~~  237 (278)
                      ||+.|+++|  ++++..
T Consensus       295 ~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         295 LTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CCHHHHHTSGGGGGGGC
T ss_pred             cCHHHHhcCHhhccccC
Confidence            999999976  555543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-41  Score=280.87  Aligned_cols=210  Identities=25%  Similarity=0.358  Sum_probs=173.3

Q ss_pred             hHHHHHHHhccCC-ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|++++++++| |||+++++++.+....++++||+.+++|.+++....  .+++..+..++.||+.||.|+|  +.++
T Consensus        75 ~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH--~~~i  150 (322)
T d1vzoa_          75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH--KLGI  150 (322)
T ss_dssp             CCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH--HTTC
T ss_pred             HHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh--cCCE
Confidence            5689999999966 899999999999999999999999999999998776  6789999999999999999999  8999


Q ss_pred             eecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC--CCCCccchhHHHHHHHHHHhCC
Q 023752           81 IYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG--HLTPKSDVYSFGVVLLELLSGR  158 (278)
Q Consensus        81 ~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~  158 (278)
                      +||||||+||+++.++.++|+|||++......... ......+++.|++||.+.+.  .++.++|||||||++|+|++|.
T Consensus       151 vHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~  229 (322)
T d1vzoa_         151 IYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA  229 (322)
T ss_dssp             CCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS
T ss_pred             EeccCCccceeecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCC
Confidence            99999999999999999999999998764433222 22335688899999998654  4678999999999999999999


Q ss_pred             CCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 023752          159 RALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRP-----SMVDVLTS  231 (278)
Q Consensus       159 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  231 (278)
                      .||...........+....               .....+++..++.++.+||.+||+.||++||     |++|+++|
T Consensus       230 ~PF~~~~~~~~~~~i~~~~---------------~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         230 SPFTVDGEKNSQAEISRRI---------------LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             CTTSCTTSCCCHHHHHHHH---------------HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHhc---------------ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            9997765443332222211               1123455677899999999999999999999     48999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-40  Score=278.76  Aligned_cols=232  Identities=24%  Similarity=0.314  Sum_probs=170.3

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCC----ccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESD----NRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLD   77 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~   77 (278)
                      +.+|+++|++++||||+++++++....    ..+++++++.+++|.+++..+   .+++..+..++.|++.||.|||  +
T Consensus        53 ~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH--~  127 (345)
T d1pmea_          53 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH--S  127 (345)
T ss_dssp             HHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH--H
T ss_pred             HHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH--H
Confidence            578999999999999999999997653    234444556689999999765   5999999999999999999999  8


Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC-ccccccccCCcccCcccccc-CCCCCccchhHHHHHHHHHH
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT-HVSTRIVGTRGYAAPEYVAT-GHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~il~~l~  155 (278)
                      .||+||||||+||+++.++.+||+|||++......... .......+++.|+|||++.. ..++.++||||+||++|+|+
T Consensus       128 ~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml  207 (345)
T d1pmea_         128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML  207 (345)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHH
T ss_pred             CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHh
Confidence            99999999999999999999999999998764333221 12234568899999999854 56788999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccchh-------HHHHHHhhhccCCC-----CCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRDS-------RRVLRIMDTRLGGQ-----YSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      +|..||...+...................       ..............     .....+.++.+||.+||+.||.+||
T Consensus       208 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  287 (345)
T d1pmea_         208 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI  287 (345)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred             hCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc
Confidence            99999976554332222222111111000       00000000000011     1234567899999999999999999


Q ss_pred             CHHHHHHH--HHhhhcC
Q 023752          224 SMVDVLTS--LEQLHTS  238 (278)
Q Consensus       224 s~~~ll~~--l~~~~~~  238 (278)
                      |+.++++|  +++....
T Consensus       288 ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         288 EVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             CHHHHHTSGGGTTTCCG
T ss_pred             CHHHHhcCHhhccCCCC
Confidence            99999987  5544443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-40  Score=278.25  Aligned_cols=226  Identities=22%  Similarity=0.297  Sum_probs=165.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeec--------CCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSE--------SDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFL   73 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~L   73 (278)
                      +.+|+++|++++||||+++++++..        ++..|++||++.++.+......  ...+++..++.++.|+++||.||
T Consensus        56 ~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~l  133 (318)
T d3blha1          56 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYI  133 (318)
T ss_dssp             HHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHh
Confidence            5689999999999999999999855        3467999999976655544332  24799999999999999999999


Q ss_pred             hcCCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCC--ccccccccCCcccCccccccC-CCCCccchhHHHHH
Q 023752           74 HGLDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNT--HVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVV  150 (278)
Q Consensus        74 h~~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~i  150 (278)
                      |  +.||+||||||+||+++.++.+|++|||++.........  .......+++.|+|||++.+. .++.++|||||||+
T Consensus       134 H--~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvi  211 (318)
T d3blha1         134 H--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI  211 (318)
T ss_dssp             H--HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             c--cCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCce
Confidence            9  899999999999999999999999999999765433221  122234689999999998765 68899999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchh------HHHHHHhhhccCCCCC-------HHHHHHHHHHHHHhccC
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDS------RRVLRIMDTRLGGQYS-------KKEAQAVAAVVLQCLHM  217 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~-------~~~~~~l~~li~~~l~~  217 (278)
                      +|+|++|+.||.+.........+...........      ................       ...++++.+||.+||+.
T Consensus       212 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~  291 (318)
T d3blha1         212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL  291 (318)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred             eeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcC
Confidence            9999999999986554444443333322211110      0000000000000000       12356788999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 023752          218 DPKNRPSMVDVLTS  231 (278)
Q Consensus       218 dp~~Rps~~~ll~~  231 (278)
                      ||++|||+.|+++|
T Consensus       292 dP~~R~sa~elL~H  305 (318)
T d3blha1         292 DPAQRIDSDDALNH  305 (318)
T ss_dssp             STTTSCCHHHHHHS
T ss_pred             ChhHCcCHHHHHcC
Confidence            99999999999976

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-39  Score=270.32  Aligned_cols=224  Identities=22%  Similarity=0.250  Sum_probs=171.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCee
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVI   81 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~   81 (278)
                      +++|+.+|+.++||||+++++++.+....+++++++.+++|..++...+  .+++..+..++.|++.||+|||  +.||+
T Consensus        48 ~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH--~~~Iv  123 (292)
T d1unla_          48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCH--SRNVL  123 (292)
T ss_dssp             HHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHH--HTTEE
T ss_pred             HHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhh--cCCEe
Confidence            5799999999999999999999999999999999998888888776554  7899999999999999999999  89999


Q ss_pred             ecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHhCCCC
Q 023752           82 YRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLSGRRA  160 (278)
Q Consensus        82 H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p  160 (278)
                      ||||||+||+++.++.+||+|||.+.........  .....++..|.|||.+.+. .++.++|||||||++|+|++|+.|
T Consensus       124 HrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p  201 (292)
T d1unla_         124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_dssp             CCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCC
T ss_pred             eecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCC
Confidence            9999999999999999999999999865443322  2223567789999988765 468999999999999999999998


Q ss_pred             CccccC-CchhhhHHhhhccccch-hHHHHHHh---------hhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHH
Q 023752          161 LDEDRG-GLAEQTLVEWADPFLRD-SRRVLRIM---------DTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVL  229 (278)
Q Consensus       161 ~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  229 (278)
                      |..... ......+.....+.... ........         ............++.+.+||.+||+.||.+|||++|++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L  281 (292)
T d1unla_         202 LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL  281 (292)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             CCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            754332 22222222211111110 00000000         00011223345678899999999999999999999999


Q ss_pred             HH
Q 023752          230 TS  231 (278)
Q Consensus       230 ~~  231 (278)
                      +|
T Consensus       282 ~H  283 (292)
T d1unla_         282 QH  283 (292)
T ss_dssp             TS
T ss_pred             cC
Confidence            75

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5e-39  Score=271.04  Aligned_cols=220  Identities=17%  Similarity=0.249  Sum_probs=164.4

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecC--CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSES--DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDA   78 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~   78 (278)
                      +.+|+++|++++ ||||++++++|...  ...++||||+.+++|..+.     +.+++..+..++.||+.||.|||  +.
T Consensus        76 ~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH--~~  148 (328)
T d3bqca1          76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH--SM  148 (328)
T ss_dssp             HHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH--HT
T ss_pred             HHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh--hc
Confidence            578999999995 99999999999744  5689999999999987653     36999999999999999999999  89


Q ss_pred             CeeecCCCCCceEEcCCC-ceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHHh
Q 023752           79 NVIYRDLKASNVLLDSNF-NAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELLS  156 (278)
Q Consensus        79 ~i~H~dl~p~ni~~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~~  156 (278)
                      ||+||||||+||+++.++ .++|+|||++........   .....+++.|+|||.+.+. .++.++|+||+||++|++++
T Consensus       149 gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~  225 (328)
T d3bqca1         149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF  225 (328)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhcc
Confidence            999999999999998655 699999999976544322   2234678899999998765 57999999999999999999


Q ss_pred             CCCCCccccCCch-hhhHHhhhcccc-chhH---------HHHHHh--------hhccCCCCCHHHHHHHHHHHHHhccC
Q 023752          157 GRRALDEDRGGLA-EQTLVEWADPFL-RDSR---------RVLRIM--------DTRLGGQYSKKEAQAVAAVVLQCLHM  217 (278)
Q Consensus       157 g~~p~~~~~~~~~-~~~~~~~~~~~~-~~~~---------~~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~  217 (278)
                      |+.||........ ...+........ ....         ......        ...........+++++.+||.+||+.
T Consensus       226 g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~  305 (328)
T d3bqca1         226 RKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY  305 (328)
T ss_dssp             TCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCS
T ss_pred             CCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccC
Confidence            9999975543211 111111111000 0000         000000        00011122345678999999999999


Q ss_pred             CCCCCCCHHHHHHH
Q 023752          218 DPKNRPSMVDVLTS  231 (278)
Q Consensus       218 dp~~Rps~~~ll~~  231 (278)
                      ||.+|||++|+++|
T Consensus       306 dP~~R~ta~e~L~H  319 (328)
T d3bqca1         306 DHQSRLTAREAMEH  319 (328)
T ss_dssp             SGGGSCCHHHHHTS
T ss_pred             ChhHCcCHHHHhcC
Confidence            99999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-38  Score=265.61  Aligned_cols=222  Identities=18%  Similarity=0.195  Sum_probs=168.3

Q ss_pred             hHHHHHHHhccCCccccc-eeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRHENLVK-LIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +..|++++++++|++++. +.+++.+.+..++|||++ ++++.+.+.... +.+++..+..++.|++.||.|||  +.||
T Consensus        49 ~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH--~~~i  124 (299)
T d1ckia_          49 LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH--SKNF  124 (299)
T ss_dssp             HHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--HTTE
T ss_pred             HHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHH--HCCe
Confidence            678999999998776555 555667777889999999 667777665543 46999999999999999999999  8999


Q ss_pred             eecCCCCCceEEcC---CCceEEeccccccCCCCCCCCc-----cccccccCCcccCccccccCCCCCccchhHHHHHHH
Q 023752           81 IYRDLKASNVLLDS---NFNAKLSDFGLARDGPTGDNTH-----VSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLL  152 (278)
Q Consensus        81 ~H~dl~p~ni~~~~---~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~  152 (278)
                      +||||||+||+++.   +..++|+|||++..........     ......|++.|+|||.+.+..++.++|||||||++|
T Consensus       125 iHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~  204 (299)
T d1ckia_         125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLM  204 (299)
T ss_dssp             ECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHH
T ss_pred             eeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHH
Confidence            99999999999853   4569999999998755433221     123357899999999999999999999999999999


Q ss_pred             HHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 023752          153 ELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTSL  232 (278)
Q Consensus       153 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l  232 (278)
                      +|++|..||...........+..........           ........+++++.++|.+||+.||++||++.++.+.|
T Consensus       205 el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l  273 (299)
T d1ckia_         205 YFNLGSLPWQGLKAATKRQKYERISEKKMST-----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF  273 (299)
T ss_dssp             HHHHSSCTTCCCC-------HHHHHHHHHHS-----------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHH
T ss_pred             HHHhCCCcccccchHHHHHHHHHhhcccCCC-----------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence            9999999997655433333222211110000           00111235678899999999999999999999998888


Q ss_pred             HhhhcC
Q 023752          233 EQLHTS  238 (278)
Q Consensus       233 ~~~~~~  238 (278)
                      +++...
T Consensus       274 ~~~~~~  279 (299)
T d1ckia_         274 RNLFHR  279 (299)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            877543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-39  Score=273.98  Aligned_cols=220  Identities=24%  Similarity=0.318  Sum_probs=161.1

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC------CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES------DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHG   75 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~   75 (278)
                      +.+|+.+|++++||||++++++|...      ..+|+||||+.+ ++.+.+.    ..+++..+..++.||+.||.||| 
T Consensus        63 ~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH-  136 (355)
T d2b1pa1          63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH-  136 (355)
T ss_dssp             HHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH-
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhh-
Confidence            46899999999999999999999643      578999999965 4555442    25899999999999999999999 


Q ss_pred             CCCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCccchhHHHHHHHHHH
Q 023752           76 LDANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        76 ~~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~il~~l~  155 (278)
                       +.||+||||||+||+++.++.++++|||+........   ......+++.|+|||++.+..++.++||||+||++++|+
T Consensus       137 -~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell  212 (355)
T d2b1pa1         137 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV  212 (355)
T ss_dssp             -HTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             -hcccccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHh
Confidence             8999999999999999999999999999887543322   223346789999999999999999999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccch-----hHHHHHHhhhc------------------cCCCCCHHHHHHHHHHHH
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRD-----SRRVLRIMDTR------------------LGGQYSKKEAQAVAAVVL  212 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~------------------~~~~~~~~~~~~l~~li~  212 (278)
                      +|+.||.+.+.......+.........+     ...........                  .........+.++.+||.
T Consensus       213 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~  292 (355)
T d2b1pa1         213 RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS  292 (355)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHH
Confidence            9999997665443333332221111000     00000001100                  001112456889999999


Q ss_pred             HhccCCCCCCCCHHHHHHH
Q 023752          213 QCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       213 ~~l~~dp~~Rps~~~ll~~  231 (278)
                      +||..||++|||++|+++|
T Consensus       293 ~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         293 KMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHSCSSTTTSCCHHHHHTS
T ss_pred             HHCcCChhHCcCHHHHhcC
Confidence            9999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.1e-38  Score=260.56  Aligned_cols=222  Identities=15%  Similarity=0.153  Sum_probs=176.9

Q ss_pred             hHHHHHHHhccCC-ccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCe
Q 023752            2 WQTEVIYLGQLRH-ENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANV   80 (278)
Q Consensus         2 ~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i   80 (278)
                      +.+|+++++.+.| +||+.+++++.+....++|||++ +++|.+++...+ ..++...+..++.|++.||.|||  +.|+
T Consensus        47 ~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH--~~gi  122 (293)
T d1csna_          47 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH--EKSL  122 (293)
T ss_dssp             HHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH--TTTE
T ss_pred             HHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH--HCCc
Confidence            5789999999965 89999999999999999999999 789999887654 36999999999999999999999  9999


Q ss_pred             eecCCCCCceEEcC-----CCceEEeccccccCCCCCCCC-----ccccccccCCcccCccccccCCCCCccchhHHHHH
Q 023752           81 IYRDLKASNVLLDS-----NFNAKLSDFGLARDGPTGDNT-----HVSTRIVGTRGYAAPEYVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        81 ~H~dl~p~ni~~~~-----~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~i  150 (278)
                      +||||||+||+++.     ++.++|+|||++.........     .......||+.|+|||++.+..++.++||||||++
T Consensus       123 iHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~  202 (293)
T d1csna_         123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHV  202 (293)
T ss_dssp             ECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred             eeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHH
Confidence            99999999999964     578999999999865433221     11233578999999999999999999999999999


Q ss_pred             HHHHHhCCCCCccccCCchhhhHHhhhccccchhHHHHHHhhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 023752          151 LLELLSGRRALDEDRGGLAEQTLVEWADPFLRDSRRVLRIMDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLT  230 (278)
Q Consensus       151 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  230 (278)
                      +|+|++|..||.+..................           ..........+++++.+++..|+..+|++||++..+.+
T Consensus       203 l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-----------~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         203 FMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-----------STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-----------HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHhCCCcCCCccchhHHHHHHHHHhccC-----------CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            9999999999986655433332222111000           00000112345678999999999999999999999998


Q ss_pred             HHHhhhcC
Q 023752          231 SLEQLHTS  238 (278)
Q Consensus       231 ~l~~~~~~  238 (278)
                      .|+++...
T Consensus       272 ~l~~~~~~  279 (293)
T d1csna_         272 LFSKVLER  279 (293)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            88887654

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-39  Score=273.34  Aligned_cols=226  Identities=23%  Similarity=0.323  Sum_probs=166.2

Q ss_pred             hHHHHHHHhccCCccccceeeeeecC-----CccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 023752            2 WQTEVIYLGQLRHENLVKLIGYCSES-----DNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL   76 (278)
Q Consensus         2 ~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~   76 (278)
                      +.+|+++|++++||||+++++++...     ...+++++++.|++|.+++..+   .+++..+..++.||+.||.|||  
T Consensus        64 ~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH--  138 (348)
T d2gfsa1          64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIH--  138 (348)
T ss_dssp             HHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHH--
Confidence            46899999999999999999998643     3346666777899999998544   5999999999999999999999  


Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCccccccC-CCCCccchhHHHHHHHHHH
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATG-HLTPKSDVYSFGVVLLELL  155 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~il~~l~  155 (278)
                      +.||+||||||+||+++.++.++++|||.+......     .....++..|+|||...+. .++.++|||||||++|+|+
T Consensus       139 ~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll  213 (348)
T d2gfsa1         139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL  213 (348)
T ss_dssp             HTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHH
T ss_pred             hCCCcccccCCccccccccccccccccchhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHH
Confidence            899999999999999999999999999998753322     2234577889999987665 5688999999999999999


Q ss_pred             hCCCCCccccCCchhhhHHhhhccccch------hHHHHHHhhhccC-CC-----CCHHHHHHHHHHHHHhccCCCCCCC
Q 023752          156 SGRRALDEDRGGLAEQTLVEWADPFLRD------SRRVLRIMDTRLG-GQ-----YSKKEAQAVAAVVLQCLHMDPKNRP  223 (278)
Q Consensus       156 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~-~~-----~~~~~~~~l~~li~~~l~~dp~~Rp  223 (278)
                      +|..||.+.+.......+..........      ............. ..     .....++++.+||.+||+.||.+||
T Consensus       214 ~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~  293 (348)
T d2gfsa1         214 TGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI  293 (348)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc
Confidence            9999998765544444333322211110      0001111110000 00     0124578899999999999999999


Q ss_pred             CHHHHHHH--HHhhhc
Q 023752          224 SMVDVLTS--LEQLHT  237 (278)
Q Consensus       224 s~~~ll~~--l~~~~~  237 (278)
                      |+.|+++|  +.++..
T Consensus       294 ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         294 TAAQALAHAYFAQYHD  309 (348)
T ss_dssp             CHHHHHTSGGGTTTCC
T ss_pred             CHHHHhcCHhhCCCCC
Confidence            99999985  444433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.4e-33  Score=238.22  Aligned_cols=222  Identities=20%  Similarity=0.298  Sum_probs=156.8

Q ss_pred             hHHHHHHHhccC-----------CccccceeeeeecC--CccEEEEeccCCC-CHHHHHhhcCCCCCCHHHHHHHHHHHH
Q 023752            2 WQTEVIYLGQLR-----------HENLVKLIGYCSES--DNRLLVYEFMPKG-SLENHLFRKGVQPISWPTRVKIAIDVA   67 (278)
Q Consensus         2 ~~~E~~~l~~l~-----------h~~i~~~~~~~~~~--~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~~l~   67 (278)
                      +.+|+++++.++           |+||+++++++...  ...++++.++..+ .............+++..+..++.|++
T Consensus        56 ~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil  135 (362)
T d1q8ya_          56 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL  135 (362)
T ss_dssp             HHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHH
Confidence            467899888875           57899999988654  3455555554433 444445555556799999999999999


Q ss_pred             HHHHHHhcCCCCeeecCCCCCceEEcCCCc------eEEeccccccCCCCCCCCccccccccCCcccCccccccCCCCCc
Q 023752           68 RGLSFLHGLDANVIYRDLKASNVLLDSNFN------AKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPEYVATGHLTPK  141 (278)
Q Consensus        68 ~~l~~Lh~~~~~i~H~dl~p~ni~~~~~~~------~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  141 (278)
                      .||.|||+ ..||+||||||+||+++.++.      ++++|||.+.......     ....+++.|+|||.+.+..++.+
T Consensus       136 ~al~~lh~-~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~  209 (362)
T d1q8ya_         136 LGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCG  209 (362)
T ss_dssp             HHHHHHHH-TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTH
T ss_pred             HHHHHHhh-hcCcccccCChhHeeeeccCcccccceeeEeeccccccccccc-----ccccccccccChhhccccCCCcc
Confidence            99999993 389999999999999976543      8999999987543322     23468889999999999999999


Q ss_pred             cchhHHHHHHHHHHhCCCCCccccCCchhh---hHHh---hhccccch----hH---------------------HHHHH
Q 023752          142 SDVYSFGVVLLELLSGRRALDEDRGGLAEQ---TLVE---WADPFLRD----SR---------------------RVLRI  190 (278)
Q Consensus       142 ~DiwslG~il~~l~~g~~p~~~~~~~~~~~---~~~~---~~~~~~~~----~~---------------------~~~~~  190 (278)
                      +|+||+||++++|++|+.||..........   .+..   ........    ..                     .....
T Consensus       210 ~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (362)
T d1q8ya_         210 ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV  289 (362)
T ss_dssp             HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHH
T ss_pred             ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhh
Confidence            999999999999999999997544321111   1110   00000000    00                     00000


Q ss_pred             hhhccCCCCCHHHHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 023752          191 MDTRLGGQYSKKEAQAVAAVVLQCLHMDPKNRPSMVDVLTS  231 (278)
Q Consensus       191 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  231 (278)
                      .  ......+...++++.+||.+||..||.+|||+.|+|+|
T Consensus       290 ~--~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         290 L--TEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             H--HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             c--ccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0  01234467789999999999999999999999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.62  E-value=5.3e-17  Score=124.84  Aligned_cols=122  Identities=12%  Similarity=0.091  Sum_probs=88.9

Q ss_pred             HHHHHHHhccCCccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 023752            3 QTEVIYLGQLRHENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGLDANVIY   82 (278)
Q Consensus         3 ~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~~~~i~H   82 (278)
                      ..|...+.++.|.+++..+++.    ..+++||++.+..+.+         ++......++.|++.++.|||  ..|++|
T Consensus        62 ~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH--~~giiH  126 (191)
T d1zara2          62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFY--HRGIVH  126 (191)
T ss_dssp             HHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHH--HTTEEC
T ss_pred             HHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHh--hCCEEE
Confidence            4688899999999999888653    2479999998765432         334456788999999999999  899999


Q ss_pred             cCCCCCceEEcCCCceEEeccccccCCCCCCCCccccccccCCcccCcc-----ccccCCCCCccchhHHHHH
Q 023752           83 RDLKASNVLLDSNFNAKLSDFGLARDGPTGDNTHVSTRIVGTRGYAAPE-----YVATGHLTPKSDVYSFGVV  150 (278)
Q Consensus        83 ~dl~p~ni~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~aPE-----~~~~~~~~~~~DiwslG~i  150 (278)
                      +||||+||+++++ .++|+|||++..........          |....     ......|+.++|+||+.--
T Consensus       127 rDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~----------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         127 GDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWRE----------ILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             SCCSTTSEEEETT-EEEECCCTTCEETTSTTHHH----------HHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             ccCChhheeeeCC-CEEEEECCCcccCCCCCcHH----------HHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            9999999999865 48899999987543221111          11110     0113567888999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.86  E-value=3.2e-05  Score=60.52  Aligned_cols=99  Identities=14%  Similarity=0.077  Sum_probs=66.9

Q ss_pred             hHHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC----
Q 023752            2 WQTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSLENHLFRKGVQPISWPTRVKIAIDVARGLSFLHGL----   76 (278)
Q Consensus         2 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~l~~~l~~Lh~~----   76 (278)
                      +.+|...++.+. +--+.+++.+..+++..++|+++++|.++.+......       ....++.++...+..||+.    
T Consensus        56 ~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~-------~~~~~~~~l~~~l~~lH~~~~~~  128 (263)
T d1j7la_          56 VEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ-------SPEKIIELYAECIRLFHSIDISD  128 (263)
T ss_dssp             HHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS-------CHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             HHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc-------cHHHHHHHHHHHHHHHhccCccc
Confidence            467888888774 3336778888888888999999999887765442111       1222334444444444410    


Q ss_pred             -----------------------------------------------------CCCeeecCCCCCceEEcCCCceEEecc
Q 023752           77 -----------------------------------------------------DANVIYRDLKASNVLLDSNFNAKLSDF  103 (278)
Q Consensus        77 -----------------------------------------------------~~~i~H~dl~p~ni~~~~~~~~kl~df  103 (278)
                                                                           ...++|+|+.|.||++++++.+-|+||
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDw  208 (263)
T d1j7la_         129 CPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDL  208 (263)
T ss_dssp             CSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCC
T ss_pred             cccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeec
Confidence                                                                 112689999999999987766679999


Q ss_pred             cccc
Q 023752          104 GLAR  107 (278)
Q Consensus       104 g~~~  107 (278)
                      +.+.
T Consensus       209 e~a~  212 (263)
T d1j7la_         209 GRSG  212 (263)
T ss_dssp             TTCE
T ss_pred             hhcc
Confidence            8774

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.39  E-value=0.00015  Score=56.16  Aligned_cols=41  Identities=20%  Similarity=0.207  Sum_probs=31.5

Q ss_pred             hHHHHHHHhccCC--ccccceeeeeecCCccEEEEeccCCCCH
Q 023752            2 WQTEVIYLGQLRH--ENLVKLIGYCSESDNRLLVYEFMPKGSL   42 (278)
Q Consensus         2 ~~~E~~~l~~l~h--~~i~~~~~~~~~~~~~~lv~e~~~~~~L   42 (278)
                      +..|...++.+..  -.+.+++.+..+++..++|+++++|.++
T Consensus        51 l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          51 LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             HHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            5678888887732  2356788888888889999999987654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.57  E-value=0.0045  Score=51.02  Aligned_cols=30  Identities=20%  Similarity=0.207  Sum_probs=25.6

Q ss_pred             CCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           78 ANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        78 ~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..++|||+++.||++++++ ++|+||..+..
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            4689999999999998764 89999987754

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.96  E-value=0.0033  Score=51.89  Aligned_cols=36  Identities=25%  Similarity=0.250  Sum_probs=25.0

Q ss_pred             HHHHHHHhccC-CccccceeeeeecCCccEEEEeccCCCCH
Q 023752            3 QTEVIYLGQLR-HENLVKLIGYCSESDNRLLVYEFMPKGSL   42 (278)
Q Consensus         3 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   42 (278)
                      .+|..+++.+. +.-..++++++.+    ++|++|++|..+
T Consensus        92 ~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          92 VAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             HHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             HHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            57888888884 4334578877753    578999987533

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.23  E-value=0.007  Score=48.04  Aligned_cols=31  Identities=35%  Similarity=0.296  Sum_probs=27.2

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEecccccc
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLAR  107 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~  107 (278)
                      ..|++|+|+.++||+++.+...-++||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            5679999999999999988767899998775

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=90.72  E-value=0.17  Score=39.84  Aligned_cols=30  Identities=23%  Similarity=0.269  Sum_probs=23.9

Q ss_pred             CCCeeecCCCCCceEEcCCCceEEeccccccC
Q 023752           77 DANVIYRDLKASNVLLDSNFNAKLSDFGLARD  108 (278)
Q Consensus        77 ~~~i~H~dl~p~ni~~~~~~~~kl~dfg~~~~  108 (278)
                      ..+++|+|+.+.||+++++  ..++||+-+..
T Consensus       191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            4578999999999999743  45789987764